PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Alis, CM; Lim, MT				Alis, Christian M.; Lim, May T.			Spatio-Temporal Variation of Conversational Utterances on Twitter	PLOS ONE			English	Article							SENTENCE LENGTH; FREQUENT	Conversations reflect the existing norms of a language. Previously, we found that utterance lengths in English fictional conversations in books and movies have shortened over a period of 200 years. In this work, we show that this shortening occurs even for a brief period of 3 years (September 2009-December 2012) using 229 million utterances from Twitter. Furthermore, the subset of geographically-tagged tweets from the United States show an inverse proportion between utterance lengths and the state-level percentage of the Black population. We argue that shortening of utterances can be explained by the increasing usage of jargon including coined words.	[Alis, Christian M.; Lim, May T.] Univ Philippines, Natl Inst Phys, Quezon City 1101, Philippines	University of the Philippines System; University of the Philippines Diliman	Lim, MT (corresponding author), Univ Philippines, Natl Inst Phys, Quezon City 1101, Philippines.	mlim@nip.upd.edu.ph	Alis, Christian/GRJ-3506-2022	Alis, Christian/0000-0001-7397-6803	Amazon AWS for Education; Office of the Vice Chancellor for Research and Development-University of the Philippines Diliman	Amazon AWS for Education; Office of the Vice Chancellor for Research and Development-University of the Philippines Diliman	This work was partially supported by grants from Amazon AWS for Education (http://aws.amazon.com) and the Office of the Vice Chancellor for Research and Development-University of the Philippines Diliman (http://ovcrd.upd.edu.ph). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alis CM, 2012, EUROPEAN PHYS J B, V85, P1; [Anonymous], 2011, SCIENCE, DOI [DOI 10.21055/0370-1069-2020-1-51-60, DOI 10.1016/j.jocs.2010.12.007]; Cafaro M, 2011, CONCURR COMP-PRACT E, V23, P1774, DOI 10.1002/cpe.1761; Cancho RFI, 2003, P NATL ACAD SCI USA, V100, P788, DOI 10.1073/pnas.0335980100; Collins J, 1999, EBONICS CONTROVERSY; Dollaghan CA, 1999, J SPEECH LANG HEAR R, V42, P1432, DOI 10.1044/jslhr.4206.1432; Eisenstein J, 2012, P SOC NETW SOC MED A; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Goncalves B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022656; Huberman B, 2008, SOCIAL NETWORK MATTE; Kalucki J., 2010, STREAMING API DOCUME; KLEE T, 1985, J CHILD LANG, V12, P251, DOI 10.1017/S0305000900006437; Kloumann IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029484; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Kumar R., 2010, P 16 ACM SIGKDD INT, P553, DOI DOI 10.1145/1835804.1835875; Kwak H., 2010, PROC 19 INT C WORLD, P591, DOI 10.1145/1772690.1772751; Lui Marco, 2012, P ACL 2012 SYST DEM; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Metwally A, 2005, LECT NOTES COMPUT SC, V3363, P398, DOI 10.1007/978-3-540-30570-5_27; Mocanu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061981; Nakatani S., 2012, SHORT TEXT LANGUAGE; Noah A.Smith, 2010, EMNLP; O'Donovan J, 2012, PROCEEDINGS OF 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON PRIVACY, SECURITY, RISK AND TRUST AND 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM/PASSAT 2012), P293, DOI 10.1109/SocialCom-PASSAT.2012.128; Ritter A., 2010, HUMAN LANGUAGE TECHN, P172; Semiocast, 2012, TWITTER REACHES HALF; Sigurd B, 2004, STUD LINGUISTICA, V58, P37, DOI 10.1111/j.0039-3193.2004.00109.x; Smith A, 2012, TWITTER USE; Strauss U., 2007, CONTRIBUTIONS SCI TE, V31, P277, DOI DOI 10.1007/978-1-4020-4068-9_13; Twitter, 2012, T CO URL WRAPP; Twitter, 2013, FAQS TWEET LOC; Twitter, 2012, WHAT AR REPL MENT; United States Census Bureau, 2013, STAT CONT QUICKFACTS; USBEA, 2012, 2012 INP OUTP ACC DA; Williams E, 2008, REPLIES WORK TWITTER; Wooffitt R., 2005, CONVERSATION ANAL DI; Yule GU, 1939, BIOMETRIKA, V30, P363, DOI 10.1093/biomet/30.3-4.363	36	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e77793	10.1371/journal.pone.0077793	http://dx.doi.org/10.1371/journal.pone.0077793			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24204968	Green Published, Green Submitted, gold			2022-12-27	WOS:000326373800008
J	Berner, AZ; Fuentes, S; Dostal, A; Payne, AN; Gutierrez, PV; Chassard, C; Grattepanche, F; de Vos, WM; Lacroix, C				Berner, Annina Zihler; Fuentes, Susana; Dostal, Alexandra; Payne, Amanda N.; Gutierrez, Pamela Vazquez; Chassard, Christophe; Grattepanche, Franck; de Vos, Willem M.; Lacroix, Christophe			Novel Polyfermentor Intestinal Model (PolyFermS) for Controlled Ecological Studies: Validation and Effect of pH	PLOS ONE			English	Article							IN-VITRO MODEL; BUTYRATE-PRODUCING BACTERIA; COLONIC FERMENTATION MODEL; HUMAN GUT; CHILD GUT; PHYLOGENETIC MICROARRAY; MICROBIAL COMMUNITIES; SPECIES COMPOSITION; FECAL MICROBIOTA; HUMAN FECES	In vitro gut fermentation modeling offers a useful platform for ecological studies of the intestinal microbiota. In this study we describe a novel Polyfermentor Intestinal Model (PolyFermS) designed to compare the effects of different treatments on the same complex gut microbiota. The model operated in conditions of the proximal colon is composed of a first reactor containing fecal microbiota immobilized in gel beads, and used to continuously inoculate a set of parallel second-stage reactors. The PolyFermS model was validated with three independent intestinal fermentations conducted for 38 days with immobilized human fecal microbiota obtained from three child donors. The microbial diversity of reactor effluents was compared to donor feces using the HITChip, a high-density phylogenetic microarray targeting small subunit rRNA sequences of over 1100 phylotypes of the human gastrointestinal tract. Furthermore, the metabolic response to a decrease of pH from 5.7 to 5.5, applied to balance the high fermentative activity in inoculum reactors, was studied. We observed a reproducible development of stable intestinal communities representing major taxonomic bacterial groups at ratios similar to these in feces of healthy donors, a high similarity of microbiota composition produced in second-stage reactors within a model, and a high time stability of microbiota composition and metabolic activity over 38 day culture. For all tested models, the pH-drop of 0.2 units in inoculum reactors enhanced butyrate production at the expense of acetate, but was accompanied by a donor-specific reorganization of the reactor community, suggesting a concerted metabolic adaptation and trigger of community-specific lactate or acetate cross-feeding pathways in response to varying pH. Our data showed that the PolyFermS model allows the stable cultivation of complex intestinal microbiota akin to the fecal donor and can be developed for the direct comparison of different experimental conditions in parallel reactors continuously inoculated with the exact same microbiota.	[Berner, Annina Zihler; Dostal, Alexandra; Payne, Amanda N.; Gutierrez, Pamela Vazquez; Chassard, Christophe; Grattepanche, Franck; Lacroix, Christophe] Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Zurich, Switzerland; [Fuentes, Susana; de Vos, Willem M.] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [de Vos, Willem M.] Univ Helsinki, Dept Basic Vet Med, FIN-00014 Helsinki, Finland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Wageningen University & Research; University of Helsinki	Lacroix, C (corresponding author), Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Zurich, Switzerland.	christophe.lacroix@hest.ethz.ch	Lacroix, Christophe/B-5139-2016	Lacroix, Christophe/0000-0003-4360-2020				Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000; Belenguer A, 2007, APPL ENVIRON MICROB, V73, P6526, DOI 10.1128/AEM.00508-07; Belenguer A, 2006, APPL ENVIRON MICROB, V72, P3593, DOI 10.1128/AEM.72.5.3593-3599.2006; Cinquin C, 2004, MICROB ECOL, V48, P128, DOI 10.1007/s00248-003-2022-7; Cinquin C, 2006, FEMS MICROBIOL ECOL, V57, P226, DOI 10.1111/j.1574-6941.2006.00118.x; Cinquin C, 2006, FEMS MICROBIOL ECOL, V57, P324, DOI 10.1111/j.1574-6941.2006.00117.x; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Cleusix V, 2008, FEMS MICROBIOL ECOL, V63, P56, DOI 10.1111/j.1574-6941.2007.00412.x; CUMMINGS JH, 1991, J APPL BACTERIOL, V70, P443, DOI 10.1111/j.1365-2672.1991.tb02739.x; Cummings JH, 1997, NUTRITION, V13, P476, DOI 10.1016/S0899-9007(97)00114-7; CUMMINGS JH, 1995, HUMAN COLONIC BACTER, P101; Dostal A, 2013, FEMS MICROBIOL ECOL, V83, P161, DOI 10.1111/j.1574-6941.2012.01461.x; Duncan SH, 2004, APPL ENVIRON MICROB, V70, P5810, DOI 10.1128/AEM.70.10.5810-5817.2004; Duncan SH, 2009, ENVIRON MICROBIOL, V11, P2112, DOI 10.1111/j.1462-2920.2009.01931.x; Falony G, 2006, APPL ENVIRON MICROB, V72, P7835, DOI 10.1128/AEM.01296-06; Flint Harry J., 2007, P101; Frank DN, 2008, CURR OPIN GASTROEN, V24, P4, DOI 10.1097/MOG.0b013e3282f2b0e8; Gumienna M, 2011, INT J FOOD SCI NUTR, V62, P226, DOI 10.3109/09637486.2010.532115; Jalanka-Tuovinen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023035; Kovatcheva-Datchary Petia, 2009, Therap Adv Gastroenterol, V2, P9, DOI 10.1177/1756283X09337646; Kovatcheva-Datchary P, 2009, ENVIRON MICROBIOL, V11, P914, DOI 10.1111/j.1462-2920.2008.01815.x; Le Blay G, 2009, FEMS MICROBIOL ECOL, V67, P198, DOI 10.1111/j.1574-6941.2008.00625.x; Le Blay G, 2010, BRIT J NUTR, V103, P403, DOI 10.1017/S0007114509991796; Louis P, 2004, J BACTERIOL, V186, P2099, DOI 10.1128/JB.186.7.2099-2106.2004; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Maccaferri S, 2010, J ANTIMICROB CHEMOTH, V65, P2556, DOI 10.1093/jac/dkq345; Macfarlane GT, 2007, CURR OPIN BIOTECH, V18, P156, DOI 10.1016/j.copbio.2007.01.011; Macfarlane GT, 1998, MICROB ECOL, V35, P180, DOI 10.1007/s002489900072; Macfarlane S, 2007, J APPL MICROBIOL, V102, P1187, DOI 10.1111/j.1365-2672.2007.03287.x; Matsumoto M, 2002, CURR MICROBIOL, V44, P212, DOI 10.1007/s00284-001-0087-4; Michel C, 1998, ANAEROBE, V4, P257, DOI 10.1006/anae.1998.0178; Payne AN, 2012, FEMS MICROBIOL ECOL, V80, P608, DOI 10.1111/j.1574-6941.2012.01330.x; Payne AN, 2012, TRENDS BIOTECHNOL, V30, P17, DOI 10.1016/j.tibtech.2011.06.011; Pompei A, 2008, ANAEROBE, V14, P280, DOI 10.1016/j.anaerobe.2008.07.002; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rajilic-Stojanovic M., 2012, ENV MICROBIOL; Rajilic-Stojanovic M, 2010, MICROBIOL-SGM, V156, P3270, DOI 10.1099/mic.0.042044-0; RAJILICSTOJANOV.M, 2009, ENV MICROBIOL; Roy Claude C, 2006, Nutr Clin Pract, V21, P351, DOI 10.1177/0115426506021004351; Russell JB, 1998, ADV MICROB PHYSIOL, V39, P205; Salminen S, 1998, BRIT J NUTR, V80, pS147, DOI 10.1079/BJN19980108; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Scott KP, 2012, PHARM RES; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Van den Abbeele P, 2010, APPL ENVIRON MICROB, V76, P5237, DOI 10.1128/AEM.00759-10; Walker AW, 2008, ENVIRON MICROBIOL, V10, P3275, DOI 10.1111/j.1462-2920.2008.01717.x; Walker AW, 2005, APPL ENVIRON MICROB, V71, P3692, DOI 10.1128/AEM.71.7.3692-3700.2005; Wang QJ, 2012, CAN J MICROBIOL, V58, P93, DOI 10.1139/W11-108; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Zihler A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-264; Zihler A, 2010, MICROBIOL-SGM, V156, P3342, DOI 10.1099/mic.0.042036-0; Zoetendal EG, 2006, MOL MICROBIOL, V59, P1639, DOI 10.1111/j.1365-2958.2006.05056.x	54	53	57	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77772	10.1371/journal.pone.0077772	http://dx.doi.org/10.1371/journal.pone.0077772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204958	Green Published, gold, Green Submitted			2022-12-27	WOS:000326334500056
J	Wu, SC; Yang, JCS; Rau, CS; Chen, YC; Lu, TH; Lin, MW; Tzeng, SL; Wu, YC; Wu, CJ; Hsieh, CH				Wu, Shao-Chun; Yang, Johnson Chia-Shen; Rau, Cheng-Shyuan; Chen, Yi-Chun; Lu, Tsu-Hsiang; Lin, Ming-Wei; Tzeng, Siou-Ling; Wu, Yi-Chan; Wu, Chia-Jung; Hsieh, Ching-Hua			Profiling Circulating MicroRNA Expression in Experimental Sepsis Using Cecal Ligation and Puncture	PLOS ONE			English	Article							INFLAMMATORY RESPONSE; ANIMAL DEVELOPMENT; HOST GENES; BIOMARKERS; CELLS; SERUM; DISEASES; PROTEIN; MODELS; CANCER	The levels of circulating microRNAs (miRNAs) in mice with experimental sepsis induced by cecal ligation and puncture (CLP) were determined using whole blood samples obtained from C57BL/6 mice at 4, 8, and 24 h after CLP; miRNA expression analysis was performed in these samples using an miRNA array. Microarray analysis revealed upregulation of 10 miRNA targets (miR-16, miR-17, miR-20a, miR-20b, miR-26a, miR-26b, miR-106a, miR-106b, miR-195, and miR-451). The expression of these miRNA targets in the whole blood, serum, and white blood cells (WBCs) of CLP mice was quantified using quantitative real-time PCR; these values were compared to those in sham-operated C57BL/6 mice, and the results indicated that these miRNA targets were significantly up-regulated in the whole blood and serum but not in the WBCs. In addition, the levels of these 10 miRNA targets in the serum of Tlr2-/-, Tlr4-/-, and NF-kappa B-/- mice at 8 h after CLP did not decrease significantly., which indicated that the transcription of these miRNAs was not directly mediated by the TLR2/NF-kappa B or TLR4/NF-kappa B pathway, and pathways induced by exposure to the gram-positive or gram-negative bacteria. Immunoprecipitation with the Argonaute 2 ribonucleoprotein complex revealed significantly increased expression of the 10 miRNA targets in the serum of mice after CLP, and the levels of 6 (miR-16, miR-17, miR-20a, miR-20b, miR-26a, and miR-26b) of these 10 miRNA targets increased significantly in exosomes isolated using ExoQuick precipitation solution. In this study, we identified circulating miRNAs that were up-regulated after CLP and determined the increase in the levels of these miRNAs, and our results suggest that circulating Ago2 complexes and exosomes may be responsible for the stability of miRNAs in the serum.	[Wu, Shao-Chun] Kaohsiung Chang Gung Mem Hosp, Dept Anesthesiol, Kaohsiung, Taiwan; [Yang, Johnson Chia-Shen; Chen, Yi-Chun; Lu, Tsu-Hsiang; Lin, Ming-Wei; Tzeng, Siou-Ling; Wu, Yi-Chan; Wu, Chia-Jung; Hsieh, Ching-Hua] Kaohsiung Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Kaohsiung, Taiwan; [Wu, Shao-Chun; Yang, Johnson Chia-Shen; Rau, Cheng-Shyuan; Chen, Yi-Chun; Lu, Tsu-Hsiang; Lin, Ming-Wei; Tzeng, Siou-Ling; Wu, Yi-Chan; Wu, Chia-Jung; Hsieh, Ching-Hua] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Rau, Cheng-Shyuan] Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Hsieh, CH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Kaohsiung, Taiwan.	m93chinghua@gmail.com	Yang, Johnson Chia-Shen/AAT-6599-2020	WU, Shaochun/0000-0002-0984-6921	Taiwan National Science Council [NMRPG8A6082]; Chang Gung Memorial Hospital [CMRPG8A1051, CMRPG8B1131]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	The work was supported by Taiwan National Science Council (NMRPG8A6082) and Chang Gung Memorial Hospital (CMRPG8A1051 & CMRPG8B1131) to Ching-Hua Hsieh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bakre A, 2012, J GEN VIROL, V93, P2346, DOI 10.1099/vir.0.044255-0; Bonauer A, 2009, CELL CYCLE, V8, P3866, DOI 10.4161/cc.8.23.9994; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889, 10.1517/14712590902932889 ]; Cuenca AG, 2010, CURR PROTOC IMMUNOL, V19, P13; Ding J, 2013, HEPATOLOGY, V11, P26378; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Engel C, 2007, INTENS CARE MED, V33, P606, DOI 10.1007/s00134-006-0517-7; Hsieh CH, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-2; Hsieh CH, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-69; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lima WF, 2009, J BIOL CHEM, V284, P26017, DOI 10.1074/jbc.M109.010835; Min M, 2013, CHINESE MED J-PEKING, V126, P1532, DOI 10.3760/cma.j.issn.0366-6999.20122989; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Philippe L, 2012, ANN RHEUM DIS, V27, P27; Philippe L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00070; Pickering MT, 2009, ONCOGENE, V28, P140, DOI 10.1038/onc.2008.372; Podolska A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-459; Precone V, 2013, LIVER INT, V16, P12169; Remick DG, 2000, SHOCK, V13, P110, DOI 10.1097/00024382-200013020-00004; Resnick KE, 2009, GYNECOL ONCOL, V112, P55, DOI 10.1016/j.ygyno.2008.08.036; Rittirsch D, 2007, J LEUKOCYTE BIOL, V81, P137, DOI 10.1189/jlb.0806542; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Roderburg C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054612; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Swarup V, 2007, FEBS LETT, V581, P795, DOI 10.1016/j.febslet.2007.01.051; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tan GS, 2009, NUCLEIC ACIDS RES, V37, P7533, DOI 10.1093/nar/gkp812; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vasilescu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007405; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Wang HJ, 2012, CLIN CHEM LAB MED, V50, P1423, DOI 10.1515/cclm-2011-0826; Wang JF, 2010, BIOCHEM BIOPH RES CO, V394, P184, DOI 10.1016/j.bbrc.2010.02.145; Wang JP, 2007, CHINESE MED J-PEKING, V120, P313, DOI 10.1097/00029330-200702020-00011; Wang K, 2010, NUCLEIC ACIDS RES, V38, P7248, DOI 10.1093/nar/gkq601; Warren HS, 1997, NEW ENGL J MED, V336, P952, DOI 10.1056/NEJM199703273361311; Witwer KW, 2010, J IMMUNOL, V184, P2369, DOI 10.4049/jimmunol.0902712; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735; Zhu D, 2013, J ALLERGY CLIN IMMUN, V4; Zhu Y, 2012, NUCLEIC ACIDS RES, V40, P4615, DOI 10.1093/nar/gkr1278	48	42	45	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77936	10.1371/journal.pone.0077936	http://dx.doi.org/10.1371/journal.pone.0077936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205035	Green Published, Green Submitted, gold			2022-12-27	WOS:000326334500079
J	Xu, XX; An, L; Mi, XC; Zhang, T				Xu, Xiaxia; An, Lei; Mi, Xichao; Zhang, Tao			Impairment of Cognitive Function and Synaptic Plasticity Associated with Alteration of Information Flow in Theta and Gamma Oscillations in Melamine-Treated Rats	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PHASE SYNCHRONIZATION; WATER-MAZE; FREQUENCY; MODEL; LTP; REDUCTION; CHANNELS; RHYTHMS; MEMORY	Changes of neural oscillations at a variety of physiological rhythms are effectively associated with cognitive performance. The present study investigated whether the directional indices of neural information flow (NIF) could be used to symbolize the synaptic plasticity impairment in hippocampal CA3-CA1 network in a rat model of melamine. Male Wistar rats were employed while melamine was administered at a dose of 300 mg/kg/day for 4 weeks. Behavior was measured by the Morris water maze(MWM)test. Local field potentials (LFPs) were recorded before long-term potentiation (LTP) induction. Generalized partial directed coherence (gPDC) and phase-amplitude coupling conditional mutual information (PAC_CMI) were used to measure the unidirectional indices in both theta and low gamma oscillations (LG, similar to 30-50 Hz). Our results showed that melamine induced the cognition deficits consistent with the reduced LTP in CA1 area. Phase locking values (PLVs) showed that the synchronization between CA3 and CA1 in both theta and LG rhythms was reduced by melamine. In both theta and LG rhythms, unidirectional indices were significantly decreased in melamine treated rats while a similar variation trend was observed in LTP reduction, implying that the effects of melamine on cognitive impairment were possibly mediated via profound alterations of NIF on CA3-CA1 pathway in hippocampus. The results suggested that LFPs activities at these rhythms were most likely involved in determining the alterations of information flow in the hippocampal CA3-CA1 network, which might be associated with the alteration of synaptic transmission to some extent.	[Zhang, Tao] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; Nankai Univ, Minist Educ, Key Lab Bioact Mat, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Zhang, T (corresponding author), Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China.	zhangtao@nankai.edu.cn	An, Lei/GQB-0039-2022		National Natural Science Foundation of China [31171053, 11232005]; Tianjin research program of application foundation and advanced technology [12JCZDJC22300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin research program of application foundation and advanced technology	This work was supported by grants from the National Natural Science Foundation of China (31171053, 11232005) and Tianjin research program of application foundation and advanced technology (12JCZDJC22300). The founder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An L, 2011, TOXICOL LETT, V206, P276, DOI 10.1016/j.toxlet.2011.08.009; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Baccala LA, 2007, PROCEEDINGS OF THE 2007 15TH INTERNATIONAL CONFERENCE ON DIGITAL SIGNAL PROCESSING, P163, DOI 10.1109/ICDSP.2007.4288544; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; BASAREROGLU C, 1992, INT J PSYCHOPHYSIOL, V13, P161, DOI 10.1016/0167-8760(92)90055-G; BAUER LO, 1993, J STUD ALCOHOL, V54, P577, DOI 10.15288/jsa.1993.54.577; Behrendt RP, 2010, NEUROSCI BIOBEHAV R, V34, P1121, DOI 10.1016/j.neubiorev.2009.12.009; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Chavez M, 2003, IEEE T BIO-MED ENG, V50, P571, DOI 10.1109/TBME.2003.810696; Colgin LL, 2012, NEURON, V75, P549, DOI 10.1016/j.neuron.2012.08.006; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Colon-Ramos DA, 2009, CURR TOP DEV BIOL, V87, P53, DOI 10.1016/S0070-2153(09)01202-2; DeShazer DJ, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.044101; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Gallinat J, 2006, PSYCHOPHARMACOLOGY, V187, P103, DOI 10.1007/s00213-006-0397-0; Guan N, 2009, NEW ENGL J MED, V360, P1067, DOI 10.1056/NEJMoa0809550; Kahana MJ, 2001, CURR OPIN NEUROBIOL, V11, P739, DOI 10.1016/S0959-4388(01)00278-1; Kirk IJ, 2003, CORTEX, V39, P993, DOI 10.1016/S0010-9452(08)70874-8; Lante F, 2006, HIPPOCAMPUS, V16, P345, DOI 10.1002/hipo.20146; Li ZY, 2011, NEUROCHEM RES, V36, P1840, DOI 10.1007/s11064-011-0502-6; Liang H, 2000, MED BIOL ENG COMPUT, V38, P35, DOI 10.1007/BF02344686; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MAREN S, 1994, BEHAV NEUROSCI, V108, P44, DOI 10.1037/0735-7044.108.1.44; Miyamoto E, 2006, J PHARMACOL SCI, V100, P433, DOI 10.1254/jphs.CPJ06007X; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Munk MHJ, 1996, SCIENCE, V272, P271, DOI 10.1126/science.272.5259.271; Ozerdem A, 2008, BRAIN RES, V1235, P98, DOI 10.1016/j.brainres.2008.06.101; Palus M, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.055201; Palus M, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.046211; Scoville WB, 2000, J NEUROPSYCH CLIN N, V12, P103; Skarsfeldt T, 1996, PSYCHOPHARMACOLOGY, V124, P126, DOI 10.1007/BF02245612; Sun N, 2009, CHINESE MED J-PEKING, V122, P245, DOI 10.3760/cma.j.issn.0366-6999.2009.03.002; Taylor GW, 1995, J NEUROSCI, V15, P8039; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Xu X, 2012, NEUROSCIENCE, V206, P136, DOI 10.1016/j.neuroscience.2011.12.050; Xu XX, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00027; Yang JJ, 2010, TOXICOL LETT, V198, P171, DOI 10.1016/j.toxlet.2010.06.013; Yang JJ, 2010, TOXICOL IN VITRO, V24, P397, DOI 10.1016/j.tiv.2009.10.019; Yang JJ, 2011, TOXICOLOGY, V289, P167, DOI 10.1016/j.tox.2011.08.011; Zhang M, 2011, NEUROSIGNALS, V19, P189, DOI 10.1159/000329302; Zheng CG, 2013, COGN NEURODYNAMICS, V7, P167, DOI 10.1007/s11571-012-9225-x; Zheng CG, 2011, NEUROSCI LETT, V490, P52, DOI 10.1016/j.neulet.2010.12.024	45	32	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77796	10.1371/journal.pone.0077796	http://dx.doi.org/10.1371/journal.pone.0077796			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204970	gold, Green Published			2022-12-27	WOS:000326334500061
J	Mortensen, LJ; Levy, O; Phillips, JP; Stratton, T; Triana, B; Ruiz, JP; Gu, FQ; Karp, JM; Lin, CP				Mortensen, Luke J.; Levy, Oren; Phillips, Joseph P.; Stratton, Tara; Triana, Brian; Ruiz, Juan P.; Gu, Fangqi; Karp, Jeffrey M.; Lin, Charles P.			Quantification of Mesenchymal Stem Cell (MSC) Delivery to a Target Site Using In Vivo Confocal Microscopy	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW; STROMAL CELLS; IFN-GAMMA; ATTENUATE; TRAFFICKING; ENGRAFTMENT; EXPRESSION; CXCR4; MICE	The ability to deliver cells to appropriate target tissues is a prerequisite for successful cell-based therapy. To optimize cell therapy it is therefore necessary to develop a robust method of in vivo cell delivery quantification. Here we examine Mesenchymal Stem Cells (MSCs) labeled with a series of 4 membrane dyes from which we select the optimal dye combination for pair-wise comparisons of delivery to inflamed tissue in the mouse ear using confocal fluorescence imaging. The use of an optimized dye pair for simultaneous tracking of two cell populations in the same animal enables quantification of a test population that is referenced to an internal control population, thereby eliminating intra-subject variations and variations in injected cell numbers. Consistent results were obtained even when the administered cell number varied by more than an order of magnitude, demonstrating an ability to neutralize one of the largest sources of in vivo experimental error and to greatly reduce the number of cells required to evaluate cell delivery. With this method, we are able to show a small but significant increase in the delivery of cytokine pre-treated MSCs (TNF-alpha & IFN-gamma) compared to control MSCs. Our results suggest future directions for screening cell strategies using our in vivo cell delivery assay, which may be useful to develop methods to maximize cell therapeutic potential.	[Mortensen, Luke J.; Stratton, Tara; Triana, Brian; Lin, Charles P.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA 02114 USA; [Mortensen, Luke J.; Stratton, Tara; Triana, Brian; Lin, Charles P.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA USA; [Levy, Oren; Phillips, Joseph P.; Ruiz, Juan P.; Gu, Fangqi; Karp, Jeffrey M.] Harvard Univ, Sch Med, Harvard Stem Cell Inst,Harvard MIT Div Hlth Sci &, Ctr Regenerat Therapeut,Brigham & Womens Hosp, Cambridge, MA 02138 USA; [Levy, Oren; Phillips, Joseph P.; Ruiz, Juan P.; Gu, Fangqi; Karp, Jeffrey M.] Harvard Univ, Sch Med, Harvard Stem Cell Inst,Harvard MIT Div Hlth Sci &, Dept Med,Brigham & Womens Hosp, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Lin, CP (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA 02114 USA.	charles_lin@hms.harvard.edu	Mortensen, Luke/N-2640-2018; Levey, Allan/F-2104-2011	Mortensen, Luke/0000-0002-4331-4099; Levey, Allan/0000-0002-3153-502X; Sancheznieto, Fatima/0000-0002-1335-8840	Sanofi; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095722] Funding Source: NIH RePORTER	Sanofi; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors would like to acknowledge Sanofi for funding to support this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancin H, 1996, CYTOMETRY, V25, P221; Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Bartosh TJ, 2010, P NATL ACAD SCI USA, V107, P13724, DOI 10.1073/pnas.1008117107; Chapel A, 2003, J GENE MED, V5, P1028, DOI 10.1002/jgm.452; Choi JJ, 2008, CLIN EXP IMMUNOL, V153, P269, DOI 10.1111/j.1365-2249.2008.03683.x; Crisostomo PR, 2008, AM J PHYSIOL-CELL PH, V294, pC675, DOI 10.1152/ajpcell.00437.2007; Degano IR, 2008, BIOMATERIALS, V29, P427, DOI 10.1016/j.biomaterials.2007.10.006; Deuse T, 2009, CIRCULATION, V120, pS247, DOI 10.1161/CIRCULATIONAHA.108.843680; Forero MG, 2011, IMAGE PROCESSING MET; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Halter M, 2007, CYTOM PART A, V71A, P827, DOI 10.1002/cyto.a.20461; Han JY, 2007, J KOREAN MED SCI, V22, P242, DOI 10.3346/jkms.2007.22.2.242; Hung SC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000416; Joo SY, 2011, CELL BIOL INT, V35, P417, DOI 10.1042/CBI20100563; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kidd S, 2009, STEM CELLS, V27, P2614, DOI 10.1002/stem.187; Ko IK, 2010, MOL THER, V18, P1365, DOI 10.1038/mt.2010.54; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Lin G, 2003, CYTOM PART A, V56A, P23, DOI 10.1002/cyto.a.10079; Lin YC, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-88; Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Min CK, 2007, BONE MARROW TRANSPL, V39, P637, DOI 10.1038/sj.bmt.1705644; Mortensen LJ, 2011, BIOMED OPT EXPRESS, V2, P1610, DOI 10.1364/BOE.2.001610; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Polchert D, 2008, EUR J IMMUNOL, V38, P1745, DOI 10.1002/eji.200738129; Prasad VK, 2011, BIOL BLOOD MARROW TR, V17, P534, DOI 10.1016/j.bbmt.2010.04.014; Prockop DJ, 2012, MOL THER, V20, P14, DOI 10.1038/mt.2011.211; Rombouts WJC, 2003, LEUKEMIA, V17, P160, DOI 10.1038/sj.leu.2402763; Sackstein R, 2008, NAT MED, V14, P181, DOI 10.1038/nm1703; Salomatina E, 2008, PHYS MED BIOL, V53, P2797, DOI 10.1088/0031-9155/53/11/003; Sarkar D, 2011, BLOOD, V118, pE184, DOI 10.1182/blood-2010-10-311464; Sarkar D, 2011, BIOMATERIALS, V32, P3053, DOI 10.1016/j.biomaterials.2010.12.036; Sarkar D, 2010, BIOMATERIALS, V31, P5266, DOI 10.1016/j.biomaterials.2010.03.006; Segers VFM, 2006, AM J PHYSIOL-HEART C, V290, pH1370, DOI 10.1152/ajpheart.00523.2005; Shi MX, 2007, HAEMATOLOGICA, V92, P897, DOI 10.3324/haematol.10669; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Veilleux I, 2008, IEEE J SEL TOP QUANT, V14, P10, DOI 10.1109/JSTQE.2007.912751; von Bahr L, 2011, BIOL BLOOD MARROW TR; Wang H, 2009, STEM CELLS, V27, P1548, DOI 10.1002/stem.81; Zhao WA, 2011, NAT NANOTECHNOL, V6, P524, DOI [10.1038/NNANO.2011.101, 10.1038/nnano.2011.101]	45	14	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78145	10.1371/journal.pone.0078145	http://dx.doi.org/10.1371/journal.pone.0078145			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205131	Green Submitted, Green Published, gold			2022-12-27	WOS:000326270700079
J	Schmid-Bindert, G; Wang, YS; Jiang, HB; Sun, H; Henzler, T; Wang, H; Pilz, LR; Ren, SX; Zhou, CC				Schmid-Bindert, Gerald; Wang, Yongsheng; Jiang, Hongbin; Sun, Hui; Henzler, Thomas; Wang, Hao; Pilz, Lothar R.; Ren, Shengxiang; Zhou, Caicun			EBUS-TBNA Provides Highest RNA Yield for Multiple Biomarker Testing from Routinely Obtained Small Biopsies in Non-Small Cell Lung Cancer Patients - A Comparative Study of Three Different Minimal Invasive Sampling Methods	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; ENDOBRONCHIAL ULTRASOUND; NEEDLE-ASPIRATION; MUTATION ANALYSIS; GENE-EXPRESSION; ADVANCED NSCLC; MESSENGER-RNA; EGFR MUTATION; CHEMOTHERAPY; ASSOCIATION	Background: Multiple biomarker testing is necessary to facilitate individualized treatment of lung cancer patients. More than 80% of lung cancers are diagnosed based on very small tumor samples. Often there is not enough tissue for molecular analysis. We compared three minimal invasive sampling methods with respect to RNA quantity for molecular testing. Methods: 106 small biopsies were prospectively collected by three different methods forceps biopsy, endobronchial ultrasound (EBUS) guided transbronchial needle aspiration (TBNA), and CT-guided core biopsy. Samples were split into two halves. One part was formalin fixed and paraffin embedded for standard pathological evaluation. The other part was put in RNAlater for immediate RNA/DNA extraction. If the pathologist confirmed the diagnosis of non-small cell lung cancer(NSCLC), the following molecular markers were tested: EGFR mutation, ERCC1, RRM1 and BRCA1. Results: Overall, RNA-extraction was possible in 101 out of 106 patients (95.3%). We found 49% adenocarcinomas, 38% squamouscarcinomas, and 14% non-otherwise-specified(NOS). The highest RNA yield came from endobronchial ultrasound guided needle aspiration, which was significantly higher than bronchoscopy (37.74+/-41.09 vs. 13.74+/-15.53 ng respectively, P = 0.005) and numerically higher than CT-core biopsy (37.74+/-41.09 vs. 28.72+/-44.27 ng respectively, P = 0.244). EGFR mutation testing was feasible in 100% of evaluable patients and its incidence was 40.8%, 7.9% and 14.3% in adenocarcinomas, squamouscarcinomas and NSCLC NOS subgroup respectively. There was no difference in the feasibility of molecular testing between the three sampling methods with feasibility rates for ERCC1, RRM1 and BRCA1 of 91%, 87% and 81% respectively. Conclusion: All three methods can provide sufficient tumor material for multiple biomarkers testing from routinely obtained small biopsies in lung cancer patients. In our study EBUS guided needle aspiration provided the highest amount of tumor RNA compared to bronchoscopy or CT guided core biopsy. Thus EBUS should be considered as an acceptable option for tissue acquisition for molecular testing.	[Schmid-Bindert, Gerald] Heidelberg Univ, Dept Surg, Univ Med Ctr Mannheim, Med Fac Mannheim, Mannheim, Germany; [Wang, Yongsheng; Sun, Hui; Ren, Shengxiang; Zhou, Caicun] Tongji Univ, Sch Med, Inst Canc, Dept Med Oncol,Shanghai Pulm Hosp, Shanghai 200092, Peoples R China; [Wang, Yongsheng] Nanjing Univ, Nanjing Drum Tower Hosp, Dept Resp Med, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [Jiang, Hongbin] Tongji Univ, Emergency Dept, Shanghai Pulm Hosp, Sch Med, Shanghai 200092, Peoples R China; [Henzler, Thomas] Heidelberg Univ, Inst Clin Radiol & Nucl Med, Univ Med Ctr Mannheim, Med Fac Mannheim, Mannheim, Germany; [Wang, Hao] Tongji Univ, Sch Med, Dept Surg, Shanghai Pulm Hosp, Shanghai 200092, Peoples R China; [Pilz, Lothar R.] Mannheim Heidelberg Univ, Fac Med, Mannheim, Germany	Ruprecht Karls University Heidelberg; Tongji University; Nanjing University; Tongji University; Ruprecht Karls University Heidelberg; Tongji University; Ruprecht Karls University Heidelberg	Ren, SX (corresponding author), Tongji Univ, Sch Med, Inst Canc, Dept Med Oncol,Shanghai Pulm Hosp, Shanghai 200092, Peoples R China.	harry_ren@126.com			China-German cooperation project; National Science Foundation of China [81172108, 81201707]; Science and Technology Commission of Shanghai Municipality [06DZ19502, 12ZR1426000]	China-German cooperation project; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was supported in part by a China-German cooperation project and grants from the National Science Foundation of China (No.81172108 and No.81201707) and projects of the Science and Technology Commission of Shanghai Municipality (No.06DZ19502 and No.12ZR1426000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040109; Billah S, 2011, CANCER CYTOPATHOL, V119, P111, DOI 10.1002/cncy.20151; Bozzetti C, 2013, DIAGN CYTOPATHOL, V41, P595, DOI 10.1002/dc.22905; Bozzetti C, 2013, LUNG CANCER, V80, P35, DOI 10.1016/j.lungcan.2013.01.007; Brambilla E, 2001, EUR RESPIR J, V18, P1059, DOI 10.1183/09031936.01.00275301; Gandara DR, 2010, J THORAC ONCOL, V5, P1933, DOI 10.1097/JTO.0b013e3181fd418d; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kerr KM, 2012, HISTOPATHOLOGY, V60, P531, DOI 10.1111/j.1365-2559.2011.03854.x; Lawson MH, 2010, J THORAC ONCOL, V5, P956, DOI 10.1097/JTO.0b013e3181ddbbe9; Lee YJ, 2010, J CANCER RES CLIN, V136, P1937, DOI 10.1007/s00432-010-0853-4; Masago K, 2008, INT J CLIN ONCOL, V13, P442, DOI 10.1007/s10147-008-0772-4; Ren SX, 2012, CHINESE J CANCER RES, V24, P226, DOI 10.1007/s11670-012-0226-4; Ren SX, 2012, CANCER-AM CANCER SOC, V118, P5588, DOI 10.1002/cncr.27603; Ren SX, 2010, CANCER INVEST, V28, P1078, DOI 10.3109/07357901003735659; Schmid-Bindert G, 2012, RESPIROLOGY, V17, P1190, DOI 10.1111/j.1440-1843.2012.02223.x; Smouse JH, 2009, CANCER CYTOPATHOL, V117, P67, DOI 10.1002/cncy.20011; Su CX, 2011, MED ONCOL, V28, P1411, DOI 10.1007/s12032-010-9553-9; Treat J, 2012, LUNG CANCER, V76, P222, DOI 10.1016/j.lungcan.2011.10.021; Varela-Lema L, 2009, EUR RESPIR J, V33, P1156, DOI 10.1183/09031936.00097908; Wakelee HA, 2012, LUNG CANCER, V76, P410, DOI 10.1016/j.lungcan.2011.12.006; Wu YL, 2007, J THORAC ONCOL, V2, P430, DOI 10.1097/01.JTO.0000268677.87496.4c; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Zhou CC, 2006, CANCER J, V12, P33, DOI 10.1097/00130404-200601000-00007	23	37	39	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77948	10.1371/journal.pone.0077948	http://dx.doi.org/10.1371/journal.pone.0077948			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205040	Green Published, gold, Green Submitted			2022-12-27	WOS:000326270700063
J	Hua, KF; Yang, SM; Kao, TY; Chang, JM; Chen, HL; Tsai, YJ; Chen, A; Yang, SS; Chao, LK; Ka, SM				Hua, Kuo-Feng; Yang, Shun-Min; Kao, Tzu-Yang; Chang, Jia-Ming; Chen, Hui-Ling; Tsai, Yung-Jen; Chen, Ann; Yang, Sung-Sen; Chao, Louis Kuoping; Ka, Shuk-Man			Osthole Mitigates Progressive IgA Nephropathy by Inhibiting Reactive Oxygen Species Generation and NF-kappa B/NLRP3 Pathway	PLOS ONE			English	Article							NF-KAPPA-B; NLRP3 INFLAMMASOME ACTIVATION; HUMAN MESANGIAL CELLS; PROTEIN-KINASE-C; OXIDATIVE STRESS; CRESCENTIC GLOMERULONEPHRITIS; PROINFLAMMATORY CYTOKINES; DIABETIC-NEPHROPATHY; SIGNALING PATHWAYS; RENAL PROGNOSIS	Renal reactive oxygen species (ROS) and mononuclear leukocyte infiltration are involved in the progressive stage (exacerbation) of IgA nephropathy (IgAN), which is characterized by glomerular proliferation and renal inflammation. The identification of the mechanism responsible for this critical stage of IgAN and the development of a therapeutic strategy remain a challenge. Osthole is a pure compound isolated from Cnidiummonnieri (L.) Cusson seeds, which are used as a traditional Chinese medicine, and is anti-inflammatory, anti-apoptotic, and anti-fibrotic both in vitro and in vivo. Recently, we showed that osthole acts as an anti-inflammatory agent by reducing nuclear factor-kappa B (NF-kappa B) activation in and ROS release by activated macrophages. In this study, we examined whether osthole could prevent the progression of IgAN using a progressive IgAN (Prg-IgAN) model in mice. Our results showed that osthole administration resulted in prevention of albuminuria, improved renal function, and blocking of renal progressive lesions, including glomerular proliferation, glomerular sclerosis, and periglomerular mononuclear leukocyte infiltration. These findings were associated with (1) reduced renal superoxide anion levels and increased Nrf2 nuclear translocation, (2) inhibited renal activation of NF-kappa B and the NLRP3 inflammasome, (3) decreased renal MCP-1 expression and mononuclear leukocyte infiltration, (4) inhibited ROS production and NLRP3 inflammasome activation in cultured, activated macrophages, and (5) inhibited ROS production and MCP-1 protein levels in cultured, activated mesangial cells. The results suggest that osthole exerts its reno-protective effects on the progression of IgAN by inhibiting ROS production and activation of NF-kappa B and the NLRP3 inflammasome in the kidney. Our data also confirm that ROS generation and activation of NF-kappa B and the NLRP3 inflammasome are crucial mechanistic events involved in the progression of the renal disorder.	[Hua, Kuo-Feng; Kao, Tzu-Yang] Natl Ilan Univ, Dept Biotechnol & Anim Sci, Ilan, Taiwan; [Yang, Shun-Min; Chen, Ann] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan; [Chang, Jia-Ming; Tsai, Yung-Jen] Dev Ctr Biotechnol, Inst Drug Evaluat Platform, Dept Pharmacol, Taipei, Taiwan; [Chen, Hui-Ling] Dev Ctr Biotechnol, Inst Drug Evaluat Platform, IND Core Team, Taipei, Taiwan; [Yang, Sung-Sen] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Nephrol, Taipei, Taiwan; [Chao, Louis Kuoping] China Med Univ, Dept Cosmeceut, Taichung, Taiwan; [Ka, Shuk-Man] Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Taipei, Taiwan	National Ilan University; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; China Medical University Taiwan; National Defense Medical Center	Ka, SM (corresponding author), Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Taipei, Taiwan.	shukmanka@gmail.com	chen, hui/HDO-2955-2022		Ministry of Economic Affairs [101-EC-17-A-19-S1-161]; National Science Council, Taiwan, ROC [NSC 99-2320-B-016-006-MY3, NSC 102-2321-B-016-002, NSC 102-2628-B-197-001-MY3]	Ministry of Economic Affairs; National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the Ministry of Economic Affairs (101-EC-17-A-19-S1-161) and National Science Council (NSC 99-2320-B-016-006-MY3; NSC 102-2321-B-016-002; NSC 102-2628-B-197-001-MY3), Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIMA S, 1991, KIDNEY INT, V39, P684, DOI 10.1038/ki.1991.82; Ashizawa M, 2003, AM J KIDNEY DIS, V42, P76, DOI 10.1016/S0272-6386(03)00411-6; Silva GEB, 2012, CLINICS, V67, P697, DOI 10.6061/clinics/2012(07)01; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bertelli R, 2010, CLIN EXP IMMUNOL, V161, P151, DOI 10.1111/j.1365-2249.2010.04160.x; Camilla R, 2011, CLIN J AM SOC NEPHRO, V6, P1903, DOI 10.2215/CJN.11571210; Chan Loretta Y Y, 2004, Clin Exp Nephrol, V8, P297; Chao TK, 2006, KIDNEY INT, V70, P283, DOI 10.1038/sj.ki.5001533; Chao XD, 2010, BRAIN RES, V1363, P206, DOI 10.1016/j.brainres.2010.09.052; Chen A, 1997, AM J KIDNEY DIS, V30, P693, DOI 10.1016/S0272-6386(97)90495-9; CHEN A, 1994, J PATHOL, V173, P119, DOI 10.1002/path.1711730208; Chen MK, 2011, INT IMMUNOPHARMACOL, V11, P549, DOI 10.1016/j.intimp.2010.11.025; Chen R, 2011, TOXICOL APPL PHARM, V256, P168, DOI 10.1016/j.taap.2011.08.005; Chen XH, 2010, EUR J PHARMACOL, V629, P40, DOI 10.1016/j.ejphar.2009.12.008; Chihara Y, 2006, CLIN NEPHROL, V65, P385; Coppo R, 2010, NEPHRON CLIN PRACT, V116, pC196, DOI 10.1159/000317199; Coppo R, 2010, J NEPHROL, V23, P626; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Danilewicz M, 1998, J NEPHROL, V11, P255; de Haan JB, 2011, DIABETES, V60, P2683, DOI 10.2337/db11-1072; Duffield JS, 2005, AM J PATHOL, V167, P1207, DOI 10.1016/S0002-9440(10)61209-6; Hahn WH, 2009, PEDIATR NEPHROL, V24, P1329, DOI 10.1007/s00467-009-1146-5; He YL, 2012, BRAIN RES, V1433, P127, DOI 10.1016/j.brainres.2011.11.027; Hou XH, 2009, J ASIAN NAT PROD RES, V11, P663, DOI 10.1080/10286020902975772; Hua KF, 2012, INFLAMM RES, V61, P1107, DOI 10.1007/s00011-012-0503-1; Ka SM, 2012, DIABETOLOGIA, V55, P509, DOI 10.1007/s00125-011-2364-5; Ka SM, 2007, J AM SOC NEPHROL, V18, P2473, DOI 10.1681/ASN.2006111242; Ka SM, 2011, AM J PHYSIOL-RENAL, V301, pF1218, DOI 10.1152/ajprenal.00050.2011; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kim MJ, 2012, J IMMUNOL, V189, P3751, DOI 10.4049/jimmunol.1102603; Kobori H, 2007, BIOCHEM BIOPH RES CO, V358, P156, DOI 10.1016/j.bbrc.2007.04.105; Lai KN, 2011, PEDIATR NEPHROL, V26, P257, DOI 10.1007/s00467-010-1703-y; Leung JCK, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-169; Liao PC, 2013, INFLAMM RES, V62, P89, DOI 10.1007/s00011-012-0555-2; Liao PC, 2010, J AGR FOOD CHEM, V58, P10445, DOI 10.1021/jf102812t; Lichtnekert J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026778; Maljaars PWJ, 2011, BRIT J NUTR, V106, P1609, DOI 10.1017/S0007114511002054; Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168; Matsumoto K, 2001, NEPHRON, V88, P334, DOI 10.1159/000046017; Minhas U, 2011, DRUG DISCOV THER, V5, P195, DOI 10.5582/ddt.2011.v5.4.195; MONTINARO V, 1992, KIDNEY INT, V42, P341, DOI 10.1038/ki.1992.295; Mori Honami, 2005, Clin Exp Nephrol, V9, P297, DOI 10.1007/s10157-005-0375-6; Myllymaki JM, 2007, KIDNEY INT, V71, P343, DOI 10.1038/sj.ki.5002046; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Ohashi N, 2009, CLIN EXP PHARMACOL P, V36, P509, DOI 10.1111/j.1440-1681.2008.05107.x; Okamoto T, 2003, BIOCHEM PHARMACOL, V65, P677, DOI 10.1016/S0006-2952(02)01606-4; Ootaka T, 1997, AM J KIDNEY DIS, V29, P843, DOI 10.1016/S0272-6386(97)90457-1; Qiu LQ, 2004, J AM SOC NEPHROL, V15, P79, DOI 10.1097/01.ASN.0000104573.54132.2E; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shi BL, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/728417; Shi Y, 2013, EUR J PHARM SCI, V48, P819, DOI 10.1016/j.ejps.2012.12.031; Silva GEB, 2011, DIS MARKERS, V31, P9, DOI [10.1155/2011/940827, 10.3233/DMA-2011-0795]; Tam KY, 2009, KIDNEY INT, V75, P1330, DOI 10.1038/ki.2009.71; Torres DD, 2008, KIDNEY INT, V73, P327, DOI 10.1038/sj.ki.5002621; Tsai PY, 2012, ARTHRITIS RHEUM-US, V64, P232, DOI 10.1002/art.33328; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Urushihara M, 2010, AM J PHYSIOL-RENAL, V298, pF167, DOI 10.1152/ajprenal.00124.2009; Vilaysane A, 2010, J AM SOC NEPHROL, V21, P1732, DOI 10.1681/ASN.2010020143; Wagrowska-Danilewicz Malgorzata, 2005, Polish Journal of Pathology, V56, P121; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Yang SM, 2013, FREE RADICAL BIO MED, V61, P285, DOI 10.1016/j.freeradbiomed.2013.03.024; Yano N, 1997, J CLIN IMMUNOL, V17, P396, DOI 10.1023/A:1027368308453; Zhang JJ, 2011, PHYTOTHER RES, V25, P638, DOI 10.1002/ptr.3315; Zheng Y, 2013, UROL INT	65	60	68	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77794	10.1371/journal.pone.0077794	http://dx.doi.org/10.1371/journal.pone.0077794			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204969	Green Published, gold, Green Submitted			2022-12-27	WOS:000326241200041
J	Taskinen, B; Zmurko, J; Ojanen, M; Kukkurainen, S; Parthiban, M; Maatta, JAE; Leppiniemi, J; Janis, J; Parikka, M; Turpeinen, H; Ramet, M; Pesu, M; Johnson, MS; Kulomaa, MS; Airenne, TT; Hytonen, VP				Taskinen, Barbara; Zmurko, Joanna; Ojanen, Markus; Kukkurainen, Sampo; Parthiban, Marimuthu; Maatta, Juha A. E.; Leppiniemi, Jenni; Janis, Janne; Parikka, Mataleena; Turpeinen, Hannu; Ramet, Mika; Pesu, Marko; Johnson, Mark S.; Kulomaa, Markku S.; Airenne, Tomi T.; Hytonen, Vesa P.			Zebavidin - An Avidin-Like Protein from Zebrafish	PLOS ONE			English	Article							BIOTIN-BINDING PROTEINS; THERMAL-STABILITY; SIGNAL PEPTIDES; LIGAND-BINDING; BRADAVIDIN-II; DANIO-RERIO; STREPTAVIDIN; MODEL; GENES; PREDICTION	The avidin protein family members are well known for their high affinity towards D-biotin and high structural stability. These properties make avidins valuable tools for a wide range of biotechnology applications. We have identified a new member of the avidin family in the zebrafish (Danio rerio) genome, hereafter called zebavidin. The protein is highly expressed in the gonads of both male and female zebrafish and in the gills of male fish, but our data suggest that zebavidin is not crucial for the developing embryo. Biophysical and structural characterisation of zebavidin revealed distinct properties not found in any previously characterised avidins. Gel filtration chromatography and native mass spectrometry suggest that the protein forms dimers in the absence of biotin at low ionic strength, but assembles into tetramers upon binding biotin. Ligand binding was analysed using radioactive and fluorescently labelled biotin and isothermal titration calorimetry. Moreover, the crystal structure of zebavidin in complex with biotin was solved at 2.4 angstrom resolution and unveiled unique ligand binding and subunit interface architectures; the atomic-level details support our physicochemical observations.	[Taskinen, Barbara; Zmurko, Joanna; Ojanen, Markus; Kukkurainen, Sampo; Maatta, Juha A. E.; Leppiniemi, Jenni; Parikka, Mataleena; Turpeinen, Hannu; Ramet, Mika; Pesu, Marko; Kulomaa, Markku S.; Hytonen, Vesa P.] Univ Tampere, Inst Biomed Technol, BioMediTech, FIN-33101 Tampere, Finland; [Taskinen, Barbara; Kukkurainen, Sampo; Maatta, Juha A. E.; Pesu, Marko; Hytonen, Vesa P.] Pirkanmaa Hosp Dist, Fimlab Labs, Tampere, Finland; [Zmurko, Joanna] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland; [Parthiban, Marimuthu; Johnson, Mark S.; Airenne, Tomi T.] Abo Akad Univ, Dept Biosci, Turku, Finland; [Leppiniemi, Jenni; Ramet, Mika; Kulomaa, Markku S.] Tampere Univ Hosp, Tampere, Finland; [Janis, Janne] Univ Eastern Finland, Dept Chem, Joensuu, Finland; Tampere Univ Hosp, Dept Paediat, Tampere, Finland	Tampere University; Pirkanmaa Hospital District; University of Glasgow; Abo Akademi University; Tampere University; Tampere University Hospital; University of Eastern Finland; Tampere University; Tampere University Hospital	Hytonen, VP (corresponding author), Univ Tampere, Inst Biomed Technol, BioMediTech, FIN-33101 Tampere, Finland.	vesa.hytonen@uta.fi	Leppiniemi, Jenni/S-6262-2019; Jänis, Janne/B-7326-2014; Ojanen, Markus/AAI-8316-2021; Määttä, Juha/A-6629-2016; Pesu, Marko/L-6344-2013; Marimuthu, Parthiban/AAU-6138-2021; Leppiniemi, Jenni/A-6641-2016; Kulomaa, Markku S/C-9063-2014; Hytonen, Vesa P./E-8855-2013; Parikka, Mataleena/D-4364-2014	Leppiniemi, Jenni/0000-0002-7225-1648; Ojanen, Markus/0000-0001-6623-844X; Määttä, Juha/0000-0003-3885-6149; Pesu, Marko/0000-0002-7541-3921; Marimuthu, Parthiban/0000-0003-4960-2160; Leppiniemi, Jenni/0000-0002-7225-1648; Hytonen, Vesa P./0000-0002-9357-1480; Parikka, Mataleena/0000-0001-5555-3815; Taskinen, Barbara/0000-0003-2989-7563; Kukkurainen, Sampo/0000-0002-0635-784X	Academy of Finland [115976, 121236, 136288, 140978, 257814, 261285]; National Doctoral Programme in Informational and Structural Biology (ISB); Tampere Graduate Program in Biomedicine and Biotechnology (TGPBB); Foundation of Angstrombo Akademi (Centre of Excellence in Cell Stress and Aging); Sigrid Juselius Foundation; e, Pentti and Tor Borg Memorial Fund; European Community; Emil Aaltonen Foundation; Tampere Tuberculosis Foundation; Tampere University Hospital [9M019, 9M042, 9M080, 9N056]	Academy of Finland(Academy of Finland); National Doctoral Programme in Informational and Structural Biology (ISB); Tampere Graduate Program in Biomedicine and Biotechnology (TGPBB); Foundation of Angstrombo Akademi (Centre of Excellence in Cell Stress and Aging); Sigrid Juselius Foundation(Sigrid Juselius Foundation); e, Pentti and Tor Borg Memorial Fund; European Community(European Commission); Emil Aaltonen Foundation; Tampere Tuberculosis Foundation; Tampere University Hospital	This work was funded by the Academy of Finland [projects 115976, 121236, 136288, 140978, 257814 and 261285], the National Doctoral Programme in Informational and Structural Biology (ISB), the Tampere Graduate Program in Biomedicine and Biotechnology (TGPBB), the Foundation of angstrom bo Akademi (Centre of Excellence in Cell Stress and Aging), the Sigrid Juselius Foundation, the Joe, Pentti and Tor Borg Memorial Fund, a Marie Curie International Reintegration Grant within the 7th European Community Framework Programme, Emil Aaltonen Foundation, and Tampere Tuberculosis Foundation. This study was financially supported by the Competitive Research Funding of the Tampere University Hospital [Grants 9M019, 9M042, 9M080 and 9N056]. The authors acknowledge the FIRI infrastructure support for structural biology from the Academy of Finland. Biocenter Finland is acknowledged for the infrastructure support and for the analysis of the zebavidin isolated from fish eggs. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Airenne KJ, 1997, PROTEIN EXPRES PURIF, V9, P100, DOI 10.1006/prep.1996.0660; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bayer EA, 1996, ELECTROPHORESIS, V17, P1319, DOI 10.1002/elps.1150170808; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; CHAIET L, 1964, ARCH BIOCHEM BIOPHYS, V106, P1, DOI 10.1016/0003-9861(64)90150-X; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DIAMANDIS EP, 1991, CLIN CHEM, V37, P625; ELO HA, 1980, EXPERIENTIA, V36, P312, DOI 10.1007/BF01952296; ELO HA, 1980, J STEROID BIOCHEM, V12, P279, DOI 10.1016/0022-4731(80)90279-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GENTRYWEEKS CR, 1992, J BACTERIOL, V174, P7729, DOI 10.1128/JB.174.23.7729-7742.1992; Gonzalez M, 1999, BIOMOL ENG, V16, P67, DOI 10.1016/S1050-3862(99)00041-8; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; Hayouka R, 2008, ACTA CRYSTALLOGR D, V64, P302, DOI 10.1107/S0907444907067844; Helppolainen SH, 2008, BBA-PROTEINS PROTEOM, V1784, P1002, DOI 10.1016/j.bbapap.2008.04.010; Helppolainen SH, 2007, BIOCHEM J, V405, P397, DOI 10.1042/BJ20070076; Hytonen VP, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-8; Hytonen VP, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-28; Hytonen VP, 2005, J BIOL CHEM, V280, P10228, DOI 10.1074/jbc.M414196200; Hytonen VR, 2004, BIOCHEM J, V384, P385, DOI 10.1042/BJ20041114; JOHNSON MS, 1993, J MOL BIOL, V233, P716, DOI 10.1006/jmbi.1993.1548; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KEINANEN RA, 1994, EUR J BIOCHEM, V220, P615, DOI 10.1111/j.1432-1033.1994.tb18663.x; Klumb LA, 1998, BIOCHEMISTRY-US, V37, P7657, DOI 10.1021/bi9803123; KORPELA JK, 1981, EXPERIENTIA, V37, P1065, DOI 10.1007/BF02085010; Laitinen OH, 1999, FEBS LETT, V461, P52, DOI 10.1016/S0014-5793(99)01423-4; Laitinen OH, 2001, J BIOL CHEM, V276, P8219, DOI 10.1074/jbc.M007930200; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Leppiniemi J, 2013, PROTEIN SCI, V22, P980, DOI 10.1002/pro.2281; LIVNAH O, 1993, P NATL ACAD SCI USA, V90, P5076, DOI 10.1073/pnas.90.11.5076; Lohi O, 2013, ACTA PAEDIATR, V102, P104, DOI 10.1111/j.1651-2227.2012.02835.x; Lubzens E, 2010, GEN COMP ENDOCR, V165, P367, DOI 10.1016/j.ygcen.2009.05.022; Maatta JAE, 2008, CHEMBIOCHEM, V9, P1124, DOI 10.1002/cbic.200700671; Maatta JAE, 2011, BIOTECHNOL BIOENG, V108, P481, DOI 10.1002/bit.22962; Maatta JAE, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-63; MAJUMDER K, 1992, GENE, V110, P89, DOI 10.1016/0378-1119(92)90448-X; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nielsen H, 1997, Int J Neural Syst, V8, P581, DOI 10.1142/S0129065797000537; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Niskanen EA, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-41; NORDBACK I, 1982, COMP BIOCHEM PHYS A, V71, P389, DOI 10.1016/0300-9629(82)90423-6; Nordlund HR, 2005, J BIOL CHEM, V280, P13250, DOI 10.1074/jbc.M414336200; Nordlund HR, 2003, FEBS LETT, V555, P449, DOI 10.1016/S0014-5793(03)01302-4; Nordlund HR, 2003, J BIOL CHEM, V278, P2479, DOI 10.1074/jbc.M210721200; OMALLEY BW, 1967, BIOCHEMISTRY-US, V6, P2546, DOI 10.1021/bi00860a036; Parikka M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002944; Pazy Y, 2003, J BIOL CHEM, V278, P7131, DOI 10.1074/jbc.M209983200; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; PUGLIESE L, 1993, J MOL BIOL, V231, P698, DOI 10.1006/jmbi.1993.1321; Qureshi MH, 2001, J BIOL CHEM, V276, P46422, DOI 10.1074/jbc.M107398200; Rounioja S, 2012, DEV COMP IMMUNOL, V36, P342, DOI 10.1016/j.dci.2011.05.008; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sano T, 1997, P NATL ACAD SCI USA, V94, P6153, DOI 10.1073/pnas.94.12.6153; Sigurskjold BW, 2000, ANAL BIOCHEM, V277, P260, DOI 10.1006/abio.1999.4402; Sreenivasan R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001791; Takakura Y, 2009, FEBS J, V276, P1383, DOI 10.1111/j.1742-4658.2009.06879.x; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; TUOHIMAA P, 1989, International Journal of Developmental Biology, V33, P125; WHITE HB, 1987, BIOCHEM J, V241, P677, DOI 10.1042/bj2410677; WHITE HB, 1976, BIOCHEM J, V157, P395, DOI 10.1042/bj1570395; WHITE HB, 1985, ANN NY ACAD SCI, V447, P202, DOI 10.1111/j.1749-6632.1985.tb18438.x; Wixon J, 2000, YEAST, V17, P225, DOI 10.1002/1097-0061(20000930)17:3&lt;225::AID-YEA34&gt;3.0.CO;2-5	72	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77207	10.1371/journal.pone.0077207	http://dx.doi.org/10.1371/journal.pone.0077207			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204770	Green Published, gold, Green Submitted			2022-12-27	WOS:000326152300017
J	Akers, JC; Ramakrishnan, V; Kim, R; Skog, J; Nakano, I; Pingle, S; Kalinina, J; Hua, W; Kesari, S; Mao, Y; Breakefield, XO; Hochberg, FH; Van Meir, EG; Carter, BS; Chen, CC				Akers, Johnny C.; Ramakrishnan, Valya; Kim, Ryan; Skog, Johan; Nakano, Ichiro; Pingle, Sandeep; Kalinina, Juliya; Hua, Wei; Kesari, Santosh; Mao, Ying; Breakefield, Xandra O.; Hochberg, Fred H.; Van Meir, Erwin G.; Carter, Bob S.; Chen, Clark C.			miR-21 in the Extracellular Vesicles (EVs) of Cerebrospinal Fluid (CSF): A Platform for Glioblastoma Biomarker Development	PLOS ONE			English	Article							QUANTITATIVE PCR; RNA EXPRESSION; CELL-LINES; MICROVESICLES; EXOSOMES; MICRORNA; GLIOMA; MULTIFORME; TUMORS; GENES	Glioblastoma cells secrete extra-cellular vesicles (EVs) containing microRNAs (miRNAs). Analysis of these EV miRNAs in the bio-fluids of afflicted patients represents a potential platform for biomarker development. However, the analytic algorithm for quantitative assessment of EV miRNA remains under-developed. Here, we demonstrate that the reference transcripts commonly used for quantitative PCR (including GAPDH, 18S rRNA, and hsa-miR-103) were unreliable for assessing EV miRNA. In this context, we quantitated EV miRNA in absolute terms and normalized this value to the input EV number. Using this method, we examined the abundance of miR-21, a highly over-expressed miRNA in glioblastomas, in EVs. In a panel of glioblastoma cell lines, the cellular levels of miR-21 correlated with EV miR-21 levels (p<0.05), suggesting that glioblastoma cells actively secrete EVs containing miR-21. Consistent with this hypothesis, the CSF EV miR-21 levels of glioblastoma patients (n=13) were, on average, ten-fold higher than levels in EVs isolated from the CSF of non-oncologic patients (n=13, p<0.001). Notably, none of the glioblastoma CSF harbored EV miR-21 level below 0.25 copies per EV in this cohort. Using this cut-off value, we were able to prospectively distinguish CSF derived from glioblastoma and non-oncologic patients in an independent cohort of twenty-nine patients (Sensitivity=87%; Specificity=93%; AUC=0.91, p<0.01). Our results suggest that CSF EV miRNA analysis of miR-21 may serve as a platform for glioblastoma biomarker development.	[Akers, Johnny C.; Ramakrishnan, Valya; Kim, Ryan; Carter, Bob S.; Chen, Clark C.] Univ Calif San Diego, Ctr Theoret & Appl Neurooncol, San Diego, CA 92103 USA; [Skog, Johan] Exosome Diagnost, New York, NY USA; [Nakano, Ichiro] Ohio State Univ, Dept Neurosurg, Dardinger Lab Neurosci, Columbus, OH 43210 USA; [Pingle, Sandeep; Kesari, Santosh] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Breakefield, Xandra O.; Hochberg, Fred H.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Neurol Serv, Boston, MA USA; [Breakefield, Xandra O.; Hochberg, Fred H.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Kalinina, Juliya; Van Meir, Erwin G.] Emory Univ, Sch Med, Dept Neurosurg & Hematol & Med Oncol, Atlanta, GA USA; [Kalinina, Juliya; Van Meir, Erwin G.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Hua, Wei; Mao, Ying] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China	University of California System; University of California San Diego; University System of Ohio; Ohio State University; University of California System; University of California San Diego; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Emory University; Emory University; Fudan University	Chen, CC (corresponding author), Univ Calif San Diego, Ctr Theoret & Appl Neurooncol, San Diego, CA 92103 USA.	clarkchen@ucsd.edu	Nakano, Ichiro/AAR-9562-2020; Chen, Clark C/C-8714-2013; Nakano, Ichiro/F-2076-2014; RAMAKRISHNAN, VALYA/L-6415-2016; Kesari, Santosh/E-8461-2013; Carter, Bob/AAB-4868-2021	Nakano, Ichiro/0000-0002-0916-3207; Chen, Clark C/0000-0001-6258-9277; Nakano, Ichiro/0000-0002-6734-3468; Carter, Bob/0000-0002-3586-1324; Mao, Ying/0000-0001-8055-115X; Skog, Johan/0000-0002-0926-1691; Van Meir, Erwin G./0000-0003-2444-7707	Doris Duke Charitable Foundation; Sontag Foundation; Burroughs Wellcome Fund; Forbeck Foundation; Kimmel Foundation; NATIONAL CANCER INSTITUTE [R01CA163722, P01CA069246] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000931, UH3TR000931] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Sontag Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Forbeck Foundation; Kimmel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	CCC is supported by the Doris Duke Charitable Foundation http://www.ddcf.org/, Sontag Foundation http://www.sontagfoundation.com/display.aspx?page=home, Burroughs Wellcome Fund http://www.bwfund.org/, Forbeck Foundation http://wgfrf.org/, and Kimmel Foundation http://www.kimmelfoundation.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Air EL, 2009, J NEUROSURG, V111, P820, DOI 10.3171/2009.3.JNS081695; Akers JC, 2013, J NEURO-ONCOL, V113, P1, DOI 10.1007/s11060-013-1084-8; [Anonymous], 1908, BIOMETRIKA, V6, P1; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Bangert A, 2012, ONCOGENE, V31, P4677, DOI 10.1038/onc.2011.614; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Bhagat TD, 2013, BLOOD, V121, P2875, DOI 10.1182/blood-2011-12-397067; Blanchard N, 2002, J IMMUNOL, V168, P3235, DOI 10.4049/jimmunol.168.7.3235; Boon RA, 2013, ARTERIOSCL THROM VAS, V33, P186, DOI 10.1161/ATVBAHA.112.300139; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Camussi G, 2011, AM J CANCER RES, V1, P98; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen CC, 2009, CLIN NEUROL NEUROSUR, V111, P835, DOI 10.1016/j.clineuro.2009.08.013; Clark MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000832; D'Souza-Schorey C, 2012, GENE DEV, V26, P1287, DOI 10.1101/gad.192351.112; de Biase D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035596; Deftereos G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028423; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Ehtesham M, 2006, ONCOGENE, V25, P2801, DOI 10.1038/sj.onc.1209302; Filipe V, 2010, PHARM RES-DORDR, V27, P796, DOI 10.1007/s11095-010-0073-2; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gercel-Taylor C, 2012, ANAL BIOCHEM, V428, P44, DOI 10.1016/j.ab.2012.06.004; Ghosh A, 2010, IMMUNOL LETT, V131, P3, DOI 10.1016/j.imlet.2010.03.003; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Gonda DD, 2013, NEUROSURGERY, V72, P501, DOI 10.1227/NEU.0b013e3182846e63; Grossman SA, 2004, SEMIN ONCOL, V31, P635, DOI 10.1053/j.seminoncol.2004.07.005; Gu C, 2013, STEM CELLS; Guduric-Fuchs J, 2012, J CELL BIOCHEM, V113, P2098, DOI 10.1002/jcb.24084; Hong BS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-556; Huan J, 2013, CANCER RES, V73, P918, DOI 10.1158/0008-5472.CAN-12-2184; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; Jarboe JS, 2007, CANCER RES, V67, P7983, DOI 10.1158/0008-5472.CAN-07-1493; Joshi K, 2013, STEM CELLS, V31, P1051, DOI 10.1002/stem.1358; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Li LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046957; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Moller HG, 2013, MOL NEUROBIOL, V47, P131, DOI 10.1007/s12035-012-8349-7; Ng Kimberly, 2009, Clin Neurosurg, V56, P107; Noerholm M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-22; PONTEN J, 1967, INT J CANCER, V2, P434, DOI 10.1002/ijc.2910020505; Qi LQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-163; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Rana S, 2013, NEOPLASIA, V15, P281, DOI 10.1593/neo.122010; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Santangelo PJ, 2012, METHOD ENZYMOL, V505, P383, DOI 10.1016/B978-0-12-388448-0.00028-0; Shao HL, 2012, NAT MED, V18, P1835, DOI 10.1038/nm.2994; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Sorensen AG, 2008, NAT CLIN PRACT ONCOL, V5, P634, DOI 10.1038/ncponc1204; Stigler S, 1989, STAT SCI, V4, P7; Street JM, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-5; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Taylor DD, 2006, J IMMUNOL, V176, P1534, DOI 10.4049/jimmunol.176.3.1534; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Teodori L, 2006, CYTOM PART A, V69A, P75, DOI 10.1002/cyto.a.20208; Teplyuk NM, 2012, NEURO-ONCOLOGY, V14, P689, DOI 10.1093/neuonc/nos074; Thang NNT, 2010, CANCER RES, V70, P4829, DOI 10.1158/0008-5472.CAN-09-3074; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trang P, 2011, MOL THER, V19, P1116, DOI 10.1038/mt.2011.48; Vallhov H, 2011, J IMMUNOL, V186, P73, DOI 10.4049/jimmunol.1001145; Van Meir EG, 2012, CA-CANCER J CLIN, V60, P166; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Visani M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055314; Wada Y, 2011, CYTOTECHNOLOGY, V63, P25, DOI 10.1007/s10616-010-9315-8; Wang H, 2003, CANCER RES, V63, P4315; Wang Q, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-97; Witwer KW, 2012, J EXTRACELL IN PRESS; Wotschofsky Z, 2011, ANAL BIOCHEM, V417, P233, DOI 10.1016/j.ab.2011.06.009; Wright Matthew, 2012, Methods Mol Biol, V906, P511, DOI 10.1007/978-1-61779-953-2_41; Xiao DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046874; ZWEIG MH, 1993, CLIN CHEM, V39, P561	79	207	215	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78115	10.1371/journal.pone.0078115	http://dx.doi.org/10.1371/journal.pone.0078115			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205116	gold, Green Published, Green Submitted			2022-12-27	WOS:000326032600072
J	Daly, R; Froneman, PW; Smale, MJ				Daly, Ryan; Froneman, Pierre W.; Smale, Malcolm J.			Comparative Feeding Ecology of Bull Sharks (Carcharhinus leucas) in the Coastal Waters of the Southwest Indian Ocean Inferred from Stable Isotope Analysis	PLOS ONE			English	Article							APEX PREDATORY SHARKS; TROPHIC POSITION; MOVEMENT PATTERNS; SOUTHERN AFRICA; FLORIDA ESTUARY; HABITAT USE; FOOD-WEB; DIET; FISHES; CONSERVATION	As apex predators, sharks play an important role shaping their respective marine communities through predation and associated risk effects. Understanding the predatory dynamics of sharks within communities is, therefore, necessary to establish effective ecologically based conservation strategies. We employed non-lethal sampling methods to investigate the feeding ecology of bull sharks (Carcharhinus leucas) using stable isotope analysis within a subtropical marine community in the southwest Indian Ocean. The main objectives of this study were to investigate and compare the predatory role that sub-adult and adult bull sharks play within a top predatory teleost fish community. Bull sharks had significantly broader niche widths compared to top predatory teleost assemblages with a wide and relatively enriched range of delta C-13 values relative to the local marine community. This suggests that bull sharks forage from a more diverse range of delta C-13 sources over a wider geographical range than the predatory teleost community. Adult bull sharks appeared to exhibit a shift towards consistently higher trophic level prey from an expanded foraging range compared to sub-adults, possibly due to increased mobility linked with size. Although predatory teleost fish are also capable of substantial migrations, bull sharks may have the ability to exploit a more diverse range of habitats and appeared to prey on a wider diversity of larger prey. This suggests that bull sharks play an important predatory role within their respective marine communities and adult sharks in particular may shape and link ecological processes of a variety of marine communities over a broad range.	[Daly, Ryan; Froneman, Pierre W.] Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, Eastern Cape, South Africa; [Smale, Malcolm J.] Port Elizabeth Museum Bayworld, Port Elizabeth, Eastern Cape, South Africa; [Smale, Malcolm J.] Nelson Mandela Metropolitan Univ, Dept Zool, Port Elizabeth, Eastern Cape, South Africa	Rhodes University; Nelson Mandela University	Daly, R (corresponding author), Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, Eastern Cape, South Africa.	ryandaly.mail@gmail.com	Froneman, William/C-9085-2012; Froneman, William/GLS-0460-2022	Froneman, William/0000-0003-0615-1355; Smale, Malcolm/0000-0002-1135-8687	Professional Development Programme of the South African National Research Foundation (NRF); Rhodes University; Port Elizabeth Museum at Bayworld; Fathoms Research; Bayworld Center for Research and Education	Professional Development Programme of the South African National Research Foundation (NRF); Rhodes University; Port Elizabeth Museum at Bayworld; Fathoms Research; Bayworld Center for Research and Education	This study would not have been possible without funding and support from the Professional Development Programme of the South African National Research Foundation (NRF), Rhodes University, Port Elizabeth Museum at Bayworld and Bayworld Center for Research and Education who administered the grant, as well as Fathoms Research who contributed to the research funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes KG, 2011, MAR ECOL PROG SER, V442, P133, DOI 10.3354/meps09395; Bachok Z, 2004, DIET COMPOSITION FOO, V27, P41; Bass A.J., 1973, SHARKS E COAST SO AF, P33; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Borrell A, 2011, ENVIRON BIOL FISH, V92, P559, DOI 10.1007/s10641-011-9879-y; Boyle MD, 2012, J FISH BIOL, V80, P1485, DOI 10.1111/j.1095-8649.2012.03243.x; BRANSTETTER S, 1987, ENVIRON BIOL FISH, V20, P169, DOI 10.1007/BF00004952; Brunnschweiler JM, 2010, J FISH BIOL, V77, P1343, DOI 10.1111/j.1095-8649.2010.02757.x; Brunnschweiler JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058522; Carlisle AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030492; Carlson JK, 2010, J FISH BIOL, V77, P661, DOI 10.1111/j.1095-8649.2010.02707.x; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Celliers L, 2008, BIODIVERS CONSERV, V17, P3097, DOI 10.1007/s10531-007-9271-6; Cheung WWL, 2005, BIOL CONSERV, V124, P97, DOI 10.1016/j.biocon.2005.01.017; CLIFF G, 1991, S AFR J MARINE SCI, V10, P253; Compagno LJV, 1984, FAO FISHERIES SYNO 2, V4; Cortes E, 1999, ICES J MAR SCI, V56, P707, DOI 10.1006/jmsc.1999.0489; Cruz-Martinez A., 2005, Journal of Northwest Atlantic Fishery Science, V35, P367; Curtis TH, 2011, T AM FISH SOC, V140, P1213, DOI 10.1080/00028487.2011.618352; Daly R, 2013, AFR J MAR SCI, V35, P129, DOI 10.2989/1814232X.2013.769910; Drymon JM, 2012, ENVIRON BIOL FISH, V95, P21, DOI 10.1007/s10641-011-9922-z; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Estrada JA, 2006, ECOLOGY, V87, P829, DOI 10.1890/0012-9658(2006)87[829:UOIAOV]2.0.CO;2; Estrada JA, 2003, J MAR BIOL ASSOC UK, V83, P1347, DOI 10.1017/S0025315403008798; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Floros C, 2012, AFR J MAR SCI, V34, P55, DOI 10.2989/1814232X.2012.673284; Froese F., 2009, FISHBASE; Gaines SD, 2007, OCEANOGRAPHY, V20, P90, DOI 10.5670/oceanog.2007.32; Hammerschlag N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045958; Hammerschlag Neil, 2011, Endangered Species Research, V14, P135, DOI 10.3354/esr00354; Hammerschlag-Peyer CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027104; HARMELINVIVIEN ML, 1981, OCEANOL ACTA, V4, P365; Heemstra P.C., 2004, COASTAL FISHES SO AF; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Heithaus MR, 2009, J ANIM ECOL, V78, P556, DOI 10.1111/j.1365-2656.2008.01512.x; Heupel MR, 2011, MAR ECOL PROG SER, V433, P237, DOI 10.3354/meps09191; Hill JM, 2006, MAR ECOL PROG SER, V318, P63, DOI 10.3354/meps318063; HOBSON ES, 1974, FISH B-NOAA, V72, P915; Hussey NE, 2012, J FISH BIOL, V80, P1449, DOI 10.1111/j.1095-8649.2012.03251.x; Hussey NE, 2011, CAN J FISH AQUAT SCI, V68, P2029, DOI 10.1139/F2011-115; Hussey NE, 2010, COMP BIOCHEM PHYS A, V155, P445, DOI 10.1016/j.cbpa.2009.09.023; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; KIM SL, 2011, ENVIRON BIOL FISH, V95, P37, DOI DOI 10.1007/S10641-011-9919-7; Kim SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045068; Kim SL, 2012, ENVIRON BIOL FISH, V95, P53, DOI 10.1007/s10641-011-9860-9; Lee SY, 2006, AUSTRAL ECOL, V31, P149, DOI 10.1111/j.1442-9993.2006.01581.x; Logan JM, 2010, HYDROBIOLOGIA, V644, P231, DOI 10.1007/s10750-010-0120-3; Lowe CG, 1996, ENVIRON BIOL FISH, V47, P203, DOI 10.1007/BF00005044; MacNeil MA, 2006, CAN J FISH AQUAT SCI, V63, P345, DOI 10.1139/F05-219; MacNeill MA, 2005, MAR ECOL PROG SER, V302, P199, DOI 10.3354/meps302199; Mann BQ, 2000, OCEANOGRAPHIC RES I, V7; Matich P, 2014, J ANIM ECOL, V83, P199, DOI 10.1111/1365-2656.12106; Matich P, 2011, J ANIM ECOL, V80, P294, DOI 10.1111/j.1365-2656.2010.01753.x; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Ortega LA, 2009, ENVIRON BIOL FISH, V84, P361, DOI 10.1007/s10641-009-9442-2; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Phillips DL, 2002, OECOLOGIA, V130, P114, DOI 10.1007/s004420100786; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Quevedo M, 2009, ECOLOGY, V90, P2263, DOI 10.1890/07-1580.1; RANDALL JOHN E., 1967, STUD TROP OCEANOGR INST MAR SCI UNIV MIAMI, V5, P665; Simpfendorfer CA, 2011, MAR FRESHWATER RES, V62, P518, DOI 10.1071/MF11086; Simpfendorfer CA, 2005, ESTUARIES, V28, P78, DOI 10.1007/BF02732755; Smale MJ., 1986, S AFRICAN J MARINE S, V4, P11, DOI [10.2989/025776186784461873, DOI 10.2989/025776186784461873]; Smith SE, 1998, MAR FRESHWATER RES, V49, P663, DOI 10.1071/MF97135; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Speed CW, 2012, CORAL REEFS, V31, P357, DOI 10.1007/s00338-011-0850-3; Sudekum AE, 1991, FISH B-NOAA, V89, P413; Vaudo JJ, 2011, MAR ECOL PROG SER, V425, P247, DOI 10.3354/meps08988; Vorwerk PD, 2009, AFR J AQUAT SCI, V34, P137, DOI 10.2989/AJAS.2009.34.2.4.891; Werry JM, 2011, MAR FRESHWATER RES, V62, P1421, DOI 10.1071/MF11136; Werry JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049796; Wintner SP, 2002, MAR FRESHWATER RES, V53, P557, DOI 10.1071/MF01062; Worm B, 2013, MAR POLICY, V40, P194, DOI 10.1016/j.marpol.2012.12.034	75	26	26	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78229	10.1371/journal.pone.0078229	http://dx.doi.org/10.1371/journal.pone.0078229			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205168	Green Published, gold, Green Submitted			2022-12-27	WOS:000326032600085
J	Mejdoubi, J; van den Heijkant, SCCM; van Leerdam, FJM; Heymans, MW; Hirasing, RA; Crijnen, AAM				Mejdoubi, Jamila; van den Heijkant, Silvia C. C. M.; van Leerdam, Frank J. M.; Heymans, Martijn W.; Hirasing, Remy A.; Crijnen, Alfons A. M.			Effect of Nurse Home Visits vs. Usual Care on Reducing Intimate Partner Violence in Young High-Risk Pregnant Women: A Randomized Controlled Trial	PLOS ONE			English	Article							MATERNAL LIFE-COURSE; CONFLICT-TACTICS-SCALES; PREVENTING CHILD-ABUSE; DOMESTIC VIOLENCE; FOLLOW-UP; DATING VIOLENCE; PRENATAL-CARE; SUBSTANCE USE; HEALTH; VISITATION	Background: Expectant mothers and mothers of young children are especially vulnerable to intimate partner violence (IPV). The nurse-family partnership (NFP) is a home visitation program in the United States effective for the prevention of adverse child health outcomes. Evidence regarding the effect of nurse home visiting on IPV is inconsistent. This study aims to study the effect of VoorZorg, the Dutch NFP, on IPV. Methods: A random sample of 460 eligible disadvantaged women <26 years, with no previous live births, was randomized. Women in the control group (C; n=223) received usual care; women in the intervention group (I; n=237) received usual care plus nurse home visits periodically during pregnancy and until the child's second birthday. Results: At 32 weeks of pregnancy, women in the intervention group self-reported significantly less IPV victimization than women in the control group in: level 2 psychological aggression (C: 56% vs. I: 39%), physical assault level 1 (C: 58% vs. I: 40%) and level 2 (C: 31% vs. I: 20%), and level 1 sexual coercion (C: 16% vs. I: 8%). Furthermore, women in the intervention group reported significantly less IPV perpetration in: level 2 psychological aggression (C: 60% vs. I: 46%), level 1 physical assault (C: 65% vs. I: 52%), and level 1 injury (C: 27% vs. I: 17%). At 24 months after birth, IPV victimization was significantly lower in the intervention group for level 1 physical assault (C: 44% vs. I: 26%), and IPV perpetration was significantly lower for level 1 sexual assault (C: 18% vs. I: 3%). Multilevel analyses showed a significant improvement in IPV victimization and perpetration among women in the intervention group at 24 months after birth. Conclusion: VoorZorg, compared with the usual care, is effective in reducing IPV during pregnancy and in the two years after birth among young high-risk women.	[Mejdoubi, Jamila; van den Heijkant, Silvia C. C. M.; van Leerdam, Frank J. M.; Hirasing, Remy A.] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Heymans, Martijn W.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Crijnen, Alfons A. M.] Waag, Ctr Forens Serv, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Crijnen, AAM (corresponding author), Waag, Ctr Forens Serv, Amsterdam, Netherlands.	crijnen@xs4all.nl		Heymans, Martijn/0000-0002-3889-0921	Netherlands Organization for Health Research and Development (ZonMw); Dutch government	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Dutch government	The conduct of the RCT was funded by the Netherlands Organization for Health Research and Development (ZonMw), which is the funding organization from the Dutch government (http://www.zonmw.nl/nl/). Participating Youth Health Care organizations and participating city councils provided funding for the implementation of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach TM, 2001, J CONSULT CLIN PSYCH, V69, P699, DOI 10.1037/0022-006X.69.4.699; Archer J, 2000, PSYCHOL BULL, V126, P651, DOI [10.1037/0033-2909.126.5.651, 10.1037//0033-2909.126.5.651]; Bender R, 2002, J CLIN EPIDEMIOL, V55, P525, DOI 10.1016/S0895-4356(01)00510-8; Bewley S, 1997, BRIT J OBSTET GYNAEC, V104, P528, DOI 10.1111/j.1471-0528.1997.tb11526.x; BOHN DK, 1990, J NURSE-MIDWIFERY, V35, P86, DOI 10.1016/0091-2182(90)90064-C; BRADLEY RH, 1979, AM J MENT DEF, V84, P235; Coker AL, 2006, AM J PREV MED, V30, P528, DOI 10.1016/j.amepre.2006.03.002; Coker AL, 2003, PREV MED, V37, P259, DOI 10.1016/S0091-7435(03)00122-1; DeKeseredy W.S., 1998, MEASURING EXTENT WOM; Dutton DG, 1997, J INTERPERS VIOLENCE, V12, P70, DOI 10.1177/088626097012001005; Dutton DG, 2012, PREV SCI, V13, P395, DOI 10.1007/s11121-012-0306-1; Eckenrode J, 2000, JAMA-J AM MED ASSOC, V284, P1385, DOI 10.1001/jama.284.11.1385; Evanson TA, 2006, J COMMUN HEALTH NURS, V23, P95, DOI 10.1207/s15327655jchn2302_3; Huizink AC, 2003, J CHILD PSYCHOL PSYC, V44, P810, DOI 10.1111/1469-7610.00166; Johnson MP, 2006, VIOLENCE AGAINST WOM, V12, P1003, DOI 10.1177/1077801206293328; Johnson MP, 2005, J FAM ISSUES, V26, P322, DOI 10.1177/0192513X04270345; Kitzmann KM, 2003, J CONSULT CLIN PSYCH, V71, P339, DOI 10.1037/0022-006X.71.2.339; Kooiman K, 2006, ADJUSTMENTS DUTCH VE; Kooiman K, 2004, ADJUSTMENTS DUTCH VE; Langhinrichsen-Rohling J, 2012, PREV SCI, V13, P384, DOI 10.1007/s11121-011-0240-7; MAKEPEACE JM, 1986, FAM RELAT, V35, P383, DOI 10.2307/584365; MCFARLANE J, 1992, JAMA-J AM MED ASSOC, V267, P3176, DOI 10.1001/jama.267.23.3176; Mejdoubi J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-823; Mezey GC, 1997, BRIT MED J, V314, P1295, DOI 10.1136/bmj.314.7090.1295; Nicolaidis C, 2008, J GEN INTERN MED, V23, P1157, DOI 10.1007/s11606-008-0606-0; Olds David L, 2002, Prev Sci, V3, P153, DOI 10.1023/A:1019990432161; Olds DL, 2010, ARCH PEDIAT ADOL MED, V164, P419, DOI 10.1001/archpediatrics.2010.49; Olds DL, 2004, PEDIATRICS, V114, P1550, DOI 10.1542/peds.2004-0962; OLDS DL, 1986, PEDIATRICS, V77, P16; OLDS DL, 1986, PEDIATRICS, V78, P65; Olds DL, 1997, JAMA-J AM MED ASSOC, V278, P637, DOI 10.1001/jama.278.8.637; Olds DL, 2004, PEDIATRICS, V114, P1560, DOI 10.1542/peds.2004-0961; PARKER B, 1994, OBSTET GYNECOL, V84, P323; Renner LM, 2006, CHILD ABUSE NEGLECT, V30, P599, DOI 10.1016/j.chiabu.2005.12.005; Schore AN, 2001, INFANT MENT HEALTH J, V22, P201, DOI 10.1002/1097-0355(200101/04)22:1<201::AID-IMHJ8>3.0.CO;2-9; Senn TE, 2010, J NATL MED ASSOC, V102, P614, DOI 10.1016/S0027-9684(15)30639-8; Sharps PW, 2007, TRAUMA VIOLENCE ABUS, V8, P105, DOI 10.1177/1524838007302594; Silverman JG, 2006, AM J OBSTET GYNECOL, V195, P140, DOI 10.1016/j.ajog.2005.12.052; Silverman JG, 2001, JAMA-J AM MED ASSOC, V286, P572, DOI 10.1001/jama.286.5.572; Stirling J, 2009, PEDIATRICS, V123, P197, DOI 10.1542/peds.2008-3077; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Straus MA, 2012, BEHAV SCI LAW, V30, P538, DOI 10.1002/bsl.2023; Stuart GL, 2013, ADDICTION; Taft AJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-178; Wathen CN, 2003, JAMA-J AM MED ASSOC, V289, P589, DOI 10.1001/jama.289.5.589; Wekerle C, 1999, CLIN PSYCHOL REV, V19, P435, DOI 10.1016/S0272-7358(98)00091-9; Widmer ED, 1998, J SEX RES, V35, P349, DOI 10.1080/00224499809551953; Wiemann C M, 2000, Matern Child Health J, V4, P93, DOI 10.1023/A:1009518220331; Wood SL, 2011, J CHILD ADOL PS NURS, V24, P223, DOI 10.1111/j.1744-6171.2011.00302.x	49	53	55	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78185	10.1371/journal.pone.0078185	http://dx.doi.org/10.1371/journal.pone.0078185			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239NN	24205150	Green Published, gold, Green Submitted			2022-12-27	WOS:000326032600080
J	Seung, E; Dudek, TE; Allen, TM; Freeman, GJ; Luster, AD; Tager, AM				Seung, Edward; Dudek, Timothy E.; Allen, Todd M.; Freeman, Gordon J.; Luster, Andrew D.; Tager, Andrew M.			PD-1 Blockade in Chronically HIV-1-Infected Humanized Mice Suppresses Viral Loads	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; B-LYMPHOCYTE DYSFUNCTION; HUMAN IMMUNE-SYSTEM; T-CELL EXHAUSTION; SCID-HU MOUSE; HIV-1 INFECTION; NEW-GENERATION; BLT MICE; IN-VIVO; RESPONSES	An estimated 34 million people are living with HIV worldwide (UNAIDS, 2012), with the number of infected persons rising every year. Increases in HIV prevalence have resulted not only from new infections, but also from increases in the survival of HIV-infected persons produced by effective anti-retroviral therapies. Augmentation of anti-viral immune responses may be able to further increase the survival of HIV-infected persons. One strategy to augment these responses is to reinvigorate exhausted anti-HIV immune cells present in chronically infected persons. The PD-1-PD-L1 pathway has been implicated in the exhaustion of virus-specific T cells during chronic HIV infection. Inhibition of PD-1 signaling using blocking anti-PD-1 antibodies has been shown to reduce simian immunodeficiency virus (SIV) loads in monkeys. We now show that PD-1 blockade can improve control of HIV replication in vivo in an animal model. BLT (Bone marrow-Liver-Thymus) humanized mice chronically infected with HIV-1 were treated with an anti-PD-1 antibody over a 10-day period. The PD-1 blockade resulted in a very significant 45-fold reduction in HIV viral loads in humanized mice with high CD8(+) T cell expression of PD-1, compared to controls at 4 weeks post-treatment. The anti-PD-1 antibody treatment also resulted in a significant increase in CD8(+) T cells. PD-1 blockade did not affect T cell expression of other inhibitory receptors co-expressed with PD-1, including CD244, CD160 and LAG-3, and did not appear to affect virus-specific humoral immune responses. These data demonstrate that inhibiting PD-1 signaling can reduce HIV viral loads in vivo in the humanized BLT mouse model, suggesting that blockade of the PD-1-PD-L1 pathway may have therapeutic potential in the treatment of patients already infected with the AIDS virus.	[Seung, Edward; Luster, Andrew D.; Tager, Andrew M.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA USA; [Seung, Edward; Luster, Andrew D.; Tager, Andrew M.] Harvard Univ, Sch Med, Charlestown, MA USA; [Seung, Edward; Luster, Andrew D.; Tager, Andrew M.] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Charlestown, MA USA; [Tager, Andrew M.] Massachusetts Gen Hosp, Pulm & Crit Care Unit, Charlestown, MA USA; [Dudek, Timothy E.; Allen, Todd M.] MIT, Ragon Inst MGH, Cambridge, MA 02139 USA; [Dudek, Timothy E.; Allen, Todd M.] Harvard, Cambridge, MA USA; [Freeman, Gordon J.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol,Dept Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Seung, E (corresponding author), Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA USA.	seung.edward@mgh.harvard.edu; amtager@partners.org	Allen, Todd/F-5473-2011; Luster, Andrew/ABE-6504-2020; Freeman, Gordon/AAC-5380-2019	Allen, Todd/0000-0002-6609-1318; Luster, Andrew/0000-0001-9679-7912; Freeman, Gordon/0000-0002-7210-5616	Harvard University; Ragon Institute of MGH, Massachusetts Institute of Technology; Harvard Platform Award; National Institutes of Health [P30AI060354, P01AI078897, U19-AI082630, R01-AI090698, HIVRAD P01-AI104715, 5T32-AI07387-22, P01AI080192]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, P01AI080192, P01AI078897, U19AI082630, P01AI104715, R01AI090698, T32AI007387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	Harvard University; Ragon Institute of MGH, Massachusetts Institute of Technology; Harvard Platform Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Harvard University CFAR Scholar Award (ES) and Subcontract (AMT), a Ragon Institute of MGH, Massachusetts Institute of Technology and Harvard Platform Award (AMT), and National Institutes of Health grants P30AI060354, P01AI078897, U19-AI082630 (TMA), R01-AI090698 (TMA), HIVRAD P01-AI104715 (TMA) and training grant 5T32-AI07387-22 (TED) and P01AI080192 (GJF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkina R, 2013, VIROLOGY, V435, P14, DOI 10.1016/j.virol.2012.10.007; Baenziger S, 2006, P NATL ACAD SCI USA, V103, P15951, DOI 10.1073/pnas.0604493103; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Berges BK, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-76; Berges BK, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-65; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Boliar S, 2012, J VIROL, V86, P8031, DOI 10.1128/JVI.00771-12; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Boutwell CL, 2009, J VIROL, V83, P2460, DOI 10.1128/JVI.01970-08; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brainard DM, 2009, J VIROL, V83, P7305, DOI 10.1128/JVI.02207-08; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Denton PW, 2008, PLOS MED, V5, P79, DOI 10.1371/journal.pmed.0050016; Dorfman DM, 2006, AM J SURG PATHOL, V30, P802, DOI 10.1097/01.pas.0000209855.28282.ce; Gorantla S, 2007, J VIROL, V81, P2700, DOI 10.1128/JVI.02010-06; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Moir S, 2008, J ALLERGY CLIN IMMUN, V122, P12, DOI 10.1016/j.jaci.2008.04.034; Moir S, 2013, IMMUNOL REV, V254, P207, DOI 10.1111/imr.12067; MOSIER DE, 1988, NATURE, V335, P256, DOI 10.1038/335256a0; MOSIER DE, 1991, SCIENCE, V251, P791, DOI 10.1126/science.1990441; NAMIKAWA R, 1988, SCIENCE, V242, P1684, DOI 10.1126/science.3201256; Palmer BE, 2013, J IMMUNOL, V190, P211, DOI 10.4049/jimmunol.1201108; PANTALEO G, 1994, NATURE, V370, P463, DOI 10.1038/370463a0; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Porichis F, 2011, BLOOD, V118, P965, DOI 10.1182/blood-2010-12-328070; Power K.A., 2012, SCI TRANSL MED, V4; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Tonomura N, 2008, BLOOD, V111, P4293, DOI 10.1182/blood-2007-11-121319; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Wagner L, 1998, NATURE, V391, P908, DOI 10.1038/36129; WALKER CM, 1986, SCIENCE, V234, P1563, DOI 10.1126/science.2431484; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Yang OO, 1999, J VIROL, V73, P4582, DOI 10.1128/JVI.73.6.4582-4589.1999; Yang OO, 1996, J VIROL, V70, P5799, DOI 10.1128/JVI.70.9.5799-5806.1996; Yang OO, 1997, J VIROL, V71, P3120, DOI 10.1128/JVI.71.4.3120-3128.1997; Yang OO, 2002, J INFECT DIS, V185, P1174, DOI 10.1086/339678; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	47	69	79	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77780	10.1371/journal.pone.0077780	http://dx.doi.org/10.1371/journal.pone.0077780			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204962	Green Published, gold, Green Submitted			2022-12-27	WOS:000326032600047
J	Subramaniam, S; Preeyanon, L; Cheng, HH				Subramaniam, Sugalesini; Preeyanon, Likit; Cheng, Hans H.			Transcriptional Profiling of MEq-Dependent Genes in Marek's Disease Resistant and Susceptible Inbred Chicken Lines	PLOS ONE			English	Article							VIRUS-INFECTION; EXPRESSION; PATHWAYS; ONCOPROTEIN; RESPONSES; COMPLEX; PROTEIN	Marek's disease (MD) is an economically significant disease in chickens caused by the highly oncogenic Marek's disease virus (MDV). Understanding the genes and biological pathways that confer MD genetic resistance should lead towards the development of more disease resistant commercial poultry flocks or improved MD vaccines. MDV mEq, a bZIP transcription factor, is largely attributed to viral oncogenicity though only a few host target genes have been described, which has impeded our understanding of MDV-induced tumorigenesis. Given the importance of mEq in MDV-induced pathogenesis, we explored the role of mEq in genetic resistance to MDV. Using global transcriptome analysis and cells from MD resistant or susceptible birds, we compared the response to infection with either wild type MDV or a nononcogenic recombinant lacking mEq. As a result, we identified a number of specific genes and pathways associated with either MD resistance or susceptibility. Additionally, integrating prior information from ChIP-seq, microarray analysis, and SNPs exhibiting allele-specific expression (ASE) in response to MDV infection, we were able to provide evidence for 24 genes that are polymorphic within mEq binding sites are likely to account for gene expression in an allele-specific manner and potentially for the underlying genetic differences in MD incidence.	[Subramaniam, Sugalesini] Michigan State Univ, Coll Vet Med, Comparat Med & Integrat Biol Program, E Lansing, MI 48824 USA; [Subramaniam, Sugalesini; Cheng, Hans H.] ARS, USDA, Avian Dis & Oncol Lab, E Lansing, MI USA; [Preeyanon, Likit] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Michigan State University; United States Department of Agriculture (USDA); Michigan State University	Cheng, HH (corresponding author), ARS, USDA, Avian Dis & Oncol Lab, E Lansing, MI USA.	hans.cheng@ars.usda.gov		Preeyanon, Likit/0000-0002-2728-7625; Cheng, Hans/0000-0003-2071-4644	National Research Initiative Competitive Grant USDA National Institute of Food and Agriculture [2007-04201]; ARS [ARS-0423660] Funding Source: Federal RePORTER	National Research Initiative Competitive Grant USDA National Institute of Food and Agriculture; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This project was supported by National Research Initiative Competitive Grant no. 2007-04201 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon LD, 2001, CURR TOP MICROBIOL, V255, P121; Bacon LD, 2000, POULTRY SCI, V79, P1082, DOI 10.1093/ps/79.8.1082; Boudny V, 2002, NEOPLASMA, V49, P349; BRILES WE, 1977, SCIENCE, V195, P193, DOI 10.1126/science.831269; Bumstead N., 2004, MAREKS DIS EVOLVING, P112; Burgess SC, 2001, VET PATHOL, V38, P129, DOI 10.1354/vp.38-2-129; Cheng H, 2008, DEV BIOLOGICALS, V132, P365, DOI 10.1159/000317187; Cheng HH, 2013, ANNU REV ANIM BIOSCI, V1, P239, DOI 10.1146/annurev-animal-031412-103701; COLE RK, 1968, AVIAN DIS, V12, P9, DOI 10.2307/1588081; Estaquier J, 2012, ADV EXP MED BIOL, V942, P157, DOI 10.1007/978-94-007-2869-1_7; Gimeno IM, 2008, VACCINE, V26, pC31, DOI 10.1016/j.vaccine.2008.04.009; JONES D, 1992, P NATL ACAD SCI USA, V89, P4042, DOI 10.1073/pnas.89.9.4042; Liu HC, 2003, CYTOGENET GENOME RES, V102, P304, DOI 10.1159/000075767; Liu HC, 2001, P NATL ACAD SCI USA, V98, P9203, DOI 10.1073/pnas.161466898; Liu JL, 1997, J VIROL, V71, P3188, DOI 10.1128/JVI.71.4.3188-3196.1997; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longenecker B M, 1977, Adv Exp Med Biol, V88, P287; Maceachern S., 2011, FRONT GENET, V2, P113, DOI [10.3389/fgene.2011.00113, DOI 10.3389/fgene.2011.00113]; McElroy JP, 2005, POULTRY SCI, V84, P1678, DOI 10.1093/ps/84.11.1678; Niikura M, 2007, VIROLOGY, V359, P212, DOI 10.1016/j.virol.2006.09.010; Niikura M, 2011, J GEN VIROL, V92, P598, DOI 10.1099/vir.0.026864-0; Perumbakkam S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-64; Sarson AJ, 2008, ANIM GENET, V39, P232, DOI 10.1111/j.1365-2052.2008.01710.x; Silva RF, 2010, AVIAN DIS, V54, P862, DOI 10.1637/9048-090409-Reg.1; Smith J, 2011, J VIROL, V85, P11146, DOI 10.1128/JVI.05499-11; STONE HA, 1975, TECHNICAL B, V1514; Subramaniam S, 2013, J VIROL, V87, P9016, DOI 10.1128/JVI.01163-13; Vallejo RL, 1998, GENETICS, V148, P349; Wettenhall JM, 2006, BIOINFORMATICS, V22, P897, DOI 10.1093/bioinformatics/btl025; Witter RL, 1997, AVIAN DIS, V41, P149, DOI 10.2307/1592455; Yu Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-501	31	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78171	10.1371/journal.pone.0078171	http://dx.doi.org/10.1371/journal.pone.0078171			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205146	gold, Green Published, Green Submitted			2022-12-27	WOS:000326032600078
J	Lu, MC; Yin, WY; Tsai, TY; Koo, M; Lai, NS				Lu, Ming-Chi; Yin, Wen-Yao; Tsai, Tzung-Yi; Koo, Malcolm; Lai, Ning-Sheng			Increased Risk of Primary Sjogren's Syndrome in Female Patients with Thyroid Disorders: A Longitudinal Population-Based Study in Taiwan	PLOS ONE			English	Article							DISEASE; PREVALENCE; GLAND; ASSOCIATION; ANTIBODIES; FEATURES	Background: A number of reports have indicated an association between thyroid diseases and primary Sjogren's syndrome (pSS). However, fewer studies have investigated whether the presence of thyroid diseases is associated with increased risk of developing pSS. Thus, the aim of our study was to use a nationwide health claims database to explore the prevalence and risk of pSS in female patients with thyroid diseases. Methods: From the Registry of Catastrophic Illness database in the National Health Insurance Research Database in Taiwan, we identified 389 female patients with a diagnosis of pSS from 2005 to 2010. We also obtained 1945 control subjects frequency-matched on sex, 10-year age interval, and year of index date from the Longitudinal Health Insurance Database (LHID2000). Both groups were retrospectively traced back to a period of eight years to obtain diagnosis of thyroid diseases prior to index date. Results: A significantly higher risk of pSS was associated with the presence of thyroid diseases (adjusted odds ratio (AOR) = 2.1, 95% confidence interval (CI) = 1.6-2.9). Among the sub-categories of thyroid diseases, patients with thyroiditis (AOR = 3.6, 95% CI = 1.7-7.5), thyrotoxicosis (AOR = 2.5, 95% CI = 1.6-3.8), and unspecified hypothyroidism (AOR = 2.4, 95% CI = 1.2-4.6), and simple and unspecified goiter (AOR = 2.0, 95% CI = 1.3-3.3) were significantly associated with increased risk of pSS. The associations were generally stronger in the mid-forties to mid-sixties age group, except in patients with unspecified hypothyroidism. Conclusions: The risk of pSS was significantly increased in female patients with thyroid diseases, particularly those in their mid-forties to mid-sixties. An increased awareness of the possibility of pSS in perimenopausal females with thyroid diseases is important to preserve their quality of life and to avoid comorbidity.	[Lu, Ming-Chi; Lai, Ning-Sheng] Buddhist Dalin Tzu Chi Hosp, Div Allergy Immunol & Rheumatol, Chiayi, Taiwan; [Lu, Ming-Chi; Yin, Wen-Yao; Lai, Ning-Sheng] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Yin, Wen-Yao] Buddhist Dalin Tzu Chi Hosp, Div Gen Surg, Chiayi, Taiwan; [Tsai, Tzung-Yi; Koo, Malcolm] Buddhist Dalin Tzu Chi Hosp, Dept Med Res, Chiayi, Taiwan; [Tsai, Tzung-Yi] Tzu Chi Coll Technol, Dept Nursing, Hualien, Taiwan; [Tsai, Tzung-Yi] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Koo, Malcolm] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1A1, Canada	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University of Science & Technology; National Cheng Kung University; University of Toronto	Koo, M (corresponding author), Buddhist Dalin Tzu Chi Hosp, Dept Med Res, Chiayi, Taiwan.	m.koo@utoronto.ca; tzuchilai@gmail.com	Koo, Malcolm/AAE-5822-2020	Koo, Malcolm/0000-0002-9242-9167				ADAMSON TC, 1983, J IMMUNOL, V130, P203; Asmussen KH, 2001, RHEUMATOLOGY, V40, P1085, DOI 10.1093/rheumatology/40.10.1085; Biro E, 2006, CLIN RHEUMATOL, V25, P240, DOI 10.1007/s10067-005-1165-y; Bjoro T, 2000, EUR J ENDOCRINOL, V143, P639, DOI 10.1530/eje.0.1430639; Bureau of National Health Insurance, 2013, REG GOV EX NAT HLTH; Chen WS, 2007, FORMOSAN J RHEUMATOL, V21, P20; Coll J, 1997, J RHEUMATOL, V24, P1719; Franklyn JA, 2012, LANCET, V379, P1155, DOI 10.1016/S0140-6736(11)60782-4; GUDBJORNSSON B, 1994, J RHEUMATOL, V21, P215; Helmick CG, 2008, ARTHRITIS RHEUM-US, V58, P15, DOI 10.1002/art.23177; Jara LJ, 2007, CLIN RHEUMATOL, V26, P1601, DOI 10.1007/s10067-007-0638-6; Kang JH, 2010, J RHEUMATOL, V37, P1188, DOI 10.3899/jrheum.090942; KROMER G, 1985, J IMMUNOL, V135, P2452; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Manji N, 2006, J CLIN ENDOCR METAB, V91, P4873, DOI 10.1210/jc.2006-1402; Robazzi TCMV, 2012, REV BRAS REUMATOL, V52, P417; Mavragani CP, 2012, J AUTOIMMUN, V39, P354, DOI 10.1016/j.jaut.2012.05.011; Peri Y, 2012, BEST PRACT RES CL RH, V26, P105, DOI 10.1016/j.berh.2012.01.012; Punzi L, 1996, REV RHUM, V63, P809; Tektonidou MG, 2004, ANN RHEUM DIS, V63, P1159, DOI 10.1136/ard.2004.022624; Vanderpump MPJ, 2011, BRIT MED BULL, V99, P39, DOI 10.1093/bmb/ldr030; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; WARFVINGE G, 1992, ORAL SURG ORAL MED O, V74, P288, DOI 10.1016/0030-4220(92)90061-T; Weng MY, 2011, J RHEUMATOL, V38, P706, DOI 10.3899/jrheum.100883	24	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77210	10.1371/journal.pone.0077210	http://dx.doi.org/10.1371/journal.pone.0077210			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204772	gold, Green Published, Green Submitted			2022-12-27	WOS:000326029300089
J	Spence, S; Delve, J; Stamp, E; Matthews, JNS; White, M; Adamson, AJ				Spence, Suzanne; Delve, Jennifer; Stamp, Elaine; Matthews, John N. S.; White, Martin; Adamson, Ashley J.			The Impact of Food and Nutrient-Based Standards on Primary School Children's Lunch and Total Dietary Intake: A Natural Experimental Evaluation of Government Policy in England	PLOS ONE			English	Article							NUTRITIONAL INTAKE; PACKED LUNCHES; OBESITY	In 2005, the nutritional content of children's school lunches in England was widely criticised, leading to a major policy change in 2006. Food and nutrient-based standards were reintroduced requiring primary schools to comply by September 2008. We aimed to determine the effect of the policy on the nutritional content at lunchtime and in children's total diet. We undertook a natural experimental evaluation, analysing data from cross-sectional surveys in 12 primary schools in North East England, pre and post policy. Dietary data were collected on four consecutive days from children aged 4-7 years (n = 385 in 2003-4; n = 632 in 2008-9). We used linear mixed effect models to analyse the effects of gender, year, and lunch type on children's mean total daily intake. Both pre- and post-implementation, children who ate a school lunch consumed less sodium (mean change -128 mg, 95% CI: -183 to -73 mg) in their total diet than children eating home-packed lunches. Post-implementation, children eating school lunches consumed a lower % energy from fat (-1.8%, -2.8 to -0.9) and saturated fat (-1.0%; -1.6 to -0.5) than children eating packed lunches. Children eating school lunches post implementation consumed significantly more carbohydrate (16.4 g, 5.3 to 27.6), protein (3.6 g, 1.1 to 6.0), non-starch polysaccharides (1.5 g, 0.5 to 1.9), vitamin C (0.7 mg, 0.6 to 0.8), and folate (12.3 mu g, 9.7 to 20.4) in their total diet than children eating packed lunches. Implementation of school food policy standards was associated with significant improvements in the nutritional content of school lunches; this was reflected in children's total diet. School food-and nutrient-based standards can play an important role in promoting dietary health and may contribute to tackling childhood obesity. Similar policy measures should be considered for other environments influencing children's diet.	[Spence, Suzanne; Delve, Jennifer; Stamp, Elaine; Adamson, Ashley J.] Newcastle Univ, Human Nutr Res Ctr, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Matthews, John N. S.] Newcastle Univ, Sch Math & Stat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [White, Martin] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [White, Martin; Adamson, Ashley J.] UKCRC Ctr Translat Res Publ Hlth, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Adamson, AJ (corresponding author), Newcastle Univ, Human Nutr Res Ctr, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	ashley.adamson@ncl.ac.uk	Matthews, John N S/H-7502-2013	Matthews, John N S/0000-0003-2559-037X; Spence, Suzanne/0000-0002-7089-7197; Adamson, Ashley/0000-0003-3735-2846; White, Martin/0000-0002-1861-6757	Department of Health (DH) Policy Research Programme; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research, under the auspices of the UKCRC; Economic and Social Research Council [ES/G007470/1] Funding Source: researchfish; Medical Research Council [MR/K02325X/1] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-02-12-001, PHCS/C4/4/008] Funding Source: researchfish; ESRC [ES/G007470/1] Funding Source: UKRI	Department of Health (DH) Policy Research Programme; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research, under the auspices of the UKCRC; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was undertaken as part of the research programme of the Public Health Research Consortium. The Public Health Research Consortium is funded by the Department of Health (DH) Policy Research Programme. The views expressed in this publication are those of the authors and not necessarily those of DH. Information about the wider programme of the PHRC is available from http://phrc.lshtm.ac.uk/. The funders had no role in the study design, data collection or analysis, interpretation of findings, writing of, or the decision to submit for publication. All authors had access to data, and take responsibility for the integrity of the data and the accuracy of the data analysis. MW and AJA are partly funded as members of Fuse, the Centre for Translational Research in Public Health, a UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence. Funding for Fuse from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, and the National Institute for Health Research, under the auspices of the UKCRC, is gratefully acknowledged. AJA is funded by the National Institute of Health Research. Opinions expressed are not necessarily those of the funders.	ADAMSON A, 1992, BRIT J NUTR, V68, P543, DOI 10.1079/BJN19920114; Adamson A, 2011, PROCESS IMPACT CHANG; Adamson A. J., 2003, Proceedings of the Nutrition Society, V62, p84A; [Anonymous], 2003, DIET NUTR PREV CHRON; Bates B, 2011, NATL DIET NUTR SURVE; Bates B, 2010, NATL DIET NUTR SURV; Bates CJ, 2000, NATL DIET NUTR SURVE; Craig P, 2012, J EPIDEMIOL COMMUN H, V66, P1182, DOI 10.1136/jech-2011-200375; Department for Education and Skills, 2006, NUTR STAND SCH LUNCH; Department of Health, 1991, DIET REF VAL FOOD EN; Department of Health, 2011, NAT CHILD MEAS PROGR; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Evans CEL, 2010, J EPIDEMIOL COMMUN H, V64, DOI 10.1136/jech.2008.085977; Evans CEL, 2010, J EPIDEMIOL COMMUN H, V64, DOI 10.1136/jech.2008.085837; Fletcher ES, 2004, BRIT J NUTR, V92, P321, DOI 10.1079/BJN20041199; Foresight, 2007, TACKL OB FUT CHOIC P; Gatenby LA, 2011, NUTR BULL, V36, P87, DOI 10.1111/j.1467-3010.2010.01872.x; Golley R, 2011, PUBLIC HEALTH NUTR, V14, P271, DOI 10.1017/S1368980010002120; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7; Haroun D, 2011, PUBLIC HEALTH NUTR, V14, P209, DOI 10.1017/S1368980010002132; HM Government, 2010, HLTH LIV HLTH PEOPL; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Marmot Review, 2010, FAIR SOC HLTH LIV; Nelson M., 2006, SCH MEALS PRIMARY SC; Nelson M, 2004, SCH MEALS SECONDARY; Pearce J, 2011, PUBLIC HEALTH NUTR, V14, P1507, DOI 10.1017/S1368980010003605; Public Health England, 2021, MCCANCE WIDDOWSONS C; Rees GA, 2008, J HUM NUTR DIET, V21, P420, DOI 10.1111/j.1365-277X.2008.00885.x; Rogers IS, 2007, EUR J CLIN NUTR, V61, P856, DOI 10.1038/sj.ejcn.1602592; Ruag-Gunn AJ, 2007, PUBLIC HEALTH NUTR, V10, P354, DOI 10.1017/S1368980007249729; School Meals Review Panel, 2005, TURN TABL TRANSF SCH; Spence D, 2005, BRIT MED J, P330, DOI DOI 10.1136/BMJ.330.7492.678; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Taber DR, 2013, JAMA PEDIATR, V167, P513, DOI 10.1001/jamapediatrics.2013.399	35	34	34	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78298	10.1371/journal.pone.0078298	http://dx.doi.org/10.1371/journal.pone.0078298			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205190	Green Published, gold, Green Submitted			2022-12-27	WOS:000326334500112
J	Barrett, BT; Panesar, GK; Scally, AJ; Pacey, IE				Barrett, Brendan T.; Panesar, Gurvinder K.; Scally, Andrew J.; Pacey, Ian E.			Binocular Summation and Other Forms of Non-Dominant Eye Contribution in Individuals with Strabismic Amblyopia during Habitual Viewing	PLOS ONE			English	Article							VISUAL-FIELD DEFECTS; INTEROCULAR SUPPRESSION; CONTRAST SUMMATION; DEPTH-PERCEPTION; COMMON FORMS; VISION; STEREOPSIS; DEFICITS; MICROSTRABISMUS; DISCRIMINATION	Background: Adults with amblyopia ('lazy eye'), long-standing strabismus (ocular misalignment) or both typically do not experience visual symptoms because the signal from weaker eye is given less weight than the signal from its fellow. Here we examine the contribution of the weaker eye of individuals with strabismus and amblyopia with both eyes open and with the deviating eye in its anomalous motor position. Methodology/Results: The task consisted of a blue-on-yellow detection task along a horizontal line across the central 50 degrees of the visual field. We compare the results obtained in ten individuals with strabismic amblyopia with ten visual normals. At each field location in each participant, we examined how the sensitivity exhibited under binocular conditions compared with sensitivity from four predictions, (i) a model of binocular summation, (ii) the average of the monocular sensitivities, (iii) dominant-eye sensitivity or (iv) non-dominant-eye sensitivity. The proportion of field locations for which the binocular summation model provided the best description of binocular sensitivity was similar in normals (50.6%) and amblyopes (48.2%). Average monocular sensitivity matched binocular sensitivity in 14.1% of amblyopes' field locations compared to 8.8% of normals'. Dominant-eye sensitivity explained sensitivity at 27.1% of field locations in amblyopes but 21.2% in normals. Non-dominant-eye sensitivity explained sensitivity at 10.6% of field locations in amblyopes but 19.4% in normals. Binocular summation provided the best description of the sensitivity profile in 6/10 amblyopes compared to 7/10 of normals. In three amblyopes, dominant-eye sensitivity most closely reflected binocular sensitivity (compared to two normals) and in the remaining amblyope, binocular sensitivity approximated to an average of the monocular sensitivities. Conclusions: Our results suggest a strong positive contribution in habitual viewing from the non-dominant eye in strabismic amblyopes. This is consistent with evidence from other sources that binocular mechanisms are frequently intact in strabismic and amblyopic individuals.	[Barrett, Brendan T.; Panesar, Gurvinder K.; Pacey, Ian E.] Univ Bradford, Bradford Sch Optometry & Vis Sci, Bradford BD7 1DP, W Yorkshire, England; [Scally, Andrew J.] Univ Bradford, Sch Hlth Studies, Bradford BD7 1DP, W Yorkshire, England	University of Bradford; University of Bradford	Barrett, BT (corresponding author), Univ Bradford, Bradford Sch Optometry & Vis Sci, Bradford BD7 1DP, W Yorkshire, England.	b.t.barrett@bradford.ac.uk		Barrett, Brendan/0000-0003-4159-4223				Agrawal R, 2006, ARCH OPHTHALMOL-CHIC, V124, P844, DOI 10.1001/archopht.124.6.844; Baker DH, 2008, VISION RES, V48, P1625, DOI 10.1016/j.visres.2008.04.017; Baker DH, 2007, INVEST OPHTH VIS SCI, V48, P5332, DOI 10.1167/iovs.07-0194; Barrett BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036611; BIRCH EE, 1985, INVEST OPHTH VIS SCI, V26, P1624; Birch EE, 2013, PROG RETIN EYE RES, V33, P67, DOI 10.1016/j.preteyeres.2012.11.001; Black JM, 2012, JOVE-J VIS EXP, DOI 10.3791/3927; BRADLEY A, 1986, INVEST OPHTH VIS SCI, V27, P1404; Bron AJ, 2000, OPHTHALMOLOGICA, V214, P86, DOI 10.1159/000027475; Buckley JG, 2010, INVEST OPHTH VIS SCI, V51, P2487, DOI 10.1167/iovs.09-3858; CAMPOS EC, 1982, DOC OPHTHALMOL, V53, P249, DOI 10.1007/BF00140423; Ciuffreda KJ, 1990, AMBLYOPIA BASIC CLIN; Daw NW, 1998, ARCH OPHTHALMOL-CHIC, V116, P502, DOI 10.1001/archopht.116.4.502; DEBELSUNCE S, 1991, INVEST OPHTH VIS SCI, V32, P2645; DENGLER B, 1993, GRAEF ARCH CLIN EXP, V231, P199, DOI 10.1007/BF00918841; Donahue SP, 1999, AM J OPHTHALMOL, V127, P312, DOI 10.1016/S0002-9394(98)90327-0; Durnian JM, 2011, BRIT J OPHTHALMOL, V95, P450, DOI 10.1136/bjo.2010.188425; Engle EC, 2007, ARCH OPHTHALMOL-CHIC, V125, P189, DOI 10.1001/archopht.125.2.189; Frandsen AD, 1960, ACTA OPHTHALMOL S, V62; Freeman AW, 1996, VISION RES, V36, P765, DOI 10.1016/0042-6989(95)00171-9; Grant S, 2007, INVEST OPHTH VIS SCI, V48, P1139, DOI 10.1167/iovs.06-0976; Harrad R, 1996, BRIT J OPHTHALMOL, V80, P373, DOI 10.1136/bjo.80.4.373; Herbison N, 2013, EYE, V27, P1077, DOI 10.1038/eye.2013.113; Hess RF, 2012, OPTOMETRY, V83, P87; Hess RF, 2011, STRABISMUS, V19, P110, DOI 10.3109/09273972.2011.600418; Hess RF, 2013, J AAPOS, V17, P89, DOI 10.1016/j.jaapos.2012.10.018; Hess RF, 2010, J NEUROPHYSIOL, V104, P475, DOI 10.1152/jn.01060.2009; HOLOPIGIAN K, 1988, INVEST OPHTH VIS SCI, V29, P444; Huang CB, 2011, J VISION, V11, DOI 10.1167/11.6.4; Huang PC, 2012, J VISION, V12, DOI 10.1167/12.11.29; JAMPOLSKY A, 1955, ARCH OPHTHALMOL-CHIC, V54, P683; Joose M V, 2000, Strabismus, V8, P135, DOI 10.1076/0927-3972(200006)8:2;1-2;FT135; Joosse M V, 2000, Strabismus, V8, P233, DOI 10.1076/stra.8.4.233.686; Joosse MV, 1999, GRAEF ARCH CLIN EXP, V237, P535, DOI 10.1007/s004170050276; Joosse MV, 1997, VISION RES, V37, P2801, DOI 10.1016/S0042-6989(97)00067-9; KITAOJI H, 1987, INVEST OPHTH VIS SCI, V28, P1260; LEGGE GE, 1984, VISION RES, V24, P385, DOI 10.1016/0042-6989(84)90064-6; LEGGE GE, 1984, VISION RES, V24, P373, DOI 10.1016/0042-6989(84)90063-4; LEGGE GE, 1981, PERCEPT PSYCHOPHYS, V30, P49, DOI 10.3758/BF03206136; Li JR, 2011, INVEST OPHTH VIS SCI, V52, P4169, DOI 10.1167/iovs.11-7233; Maeda M, 1999, INVEST OPHTH VIS SCI, V28, P1260; McKee SP, 2003, J VISION, V3, P380, DOI 10.1167/3.5.5; MEHDORN E, 1989, DOC OPHTHALMOL, V71, P1, DOI 10.1007/BF00155128; Mohney BG, 2001, OPHTHALMOLOGY, V108, P805, DOI 10.1016/S0161-6420(00)00639-4; Mohney BG, 2003, OPHTHALMOLOGY, V110, P2093, DOI 10.1016/j.ophtha.2003.04.001; Mullen KT, 1996, VISION RES, V36, P645, DOI 10.1016/0042-6989(95)00159-X; Nelson-Quigg JM, 2000, INVEST OPHTH VIS SCI, V41, P2212; O'Connor AR, 2010, INVEST OPHTH VIS SCI, V51, P2019, DOI 10.1167/iovs.09-4434; PHILIPP W, 1989, GRAEF ARCH CLIN EXP, V227, P448, DOI 10.1007/BF02172897; Poinoosawmy D, 1998, OPHTHALMOLOGY, V105, P988, DOI 10.1016/S0161-6420(98)96049-3; PRATTJOHNSON JA, 1984, BRIT J OPHTHALMOL, V68, P174, DOI 10.1136/bjo.68.3.174; PRATTJOHNSON JA, 1983, ARCH OPHTHALMOL-CHIC, V101, P218; ROUSE MW, 1989, OPTOMETRY VISION SCI, V66, P355, DOI 10.1097/00006324-198906000-00004; Sireteanu R, 1982, Hum Neurobiol, V1, P31; SIRETEANU R, 1981, VISION RES, V21, P1055, DOI 10.1016/0042-6989(81)90010-9; Von Noorden G. K., 2002, BINOCULAR VISION OCU, V6th; VONNOORDEN GK, 1985, INVEST OPHTH VIS SCI, V26, P1704; Watanabe Y, 2008, BRIT J OPHTHALMOL, V92, P47, DOI 10.1136/bjo.2007.117507; WOOD JM, 1992, OPHTHAL PHYSL OPT, V12, P46, DOI 10.1111/j.1475-1313.1992.tb00253.x	59	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77871	10.1371/journal.pone.0077871	http://dx.doi.org/10.1371/journal.pone.0077871			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205005	Green Submitted, Green Published, gold			2022-12-27	WOS:000326270700057
J	Diamantopoulos, AP; Hoff, M; Hochberg, M; Haugeberg, G				Diamantopoulos, Andreas P.; Hoff, Mari; Hochberg, Marc; Haugeberg, Glenn			Predictors of Short- and Long-Term Mortality in Males and Females with Hip Fracture - A Prospective Observational Cohort Study	PLOS ONE			English	Article							EXCESS MORTALITY; OLDER WOMEN; INSTITUTIONALIZATION; COMPLICATIONS; OSTEOPOROSIS; METAANALYSIS; RISK; MEN	Background: Hip fracture is associated with increased mortality. Our aim was to study potential risk factors, including osteoporosis, associated with short-and long-term mortality in a prospectively recruited cohort of fragility hip fracture patients. Methodology/Principal Findings: Fragility hip fracture patients aged >50 years admitted to a county hospital in Southern Norway in 2004 and 2005 were consecutively identified and invited for assessment. Patients with high energy or pathological fractures, patients with confusion, serious infections or who were non-residents in the catchment area were excluded. As part of a clinical routine, data were collected using questionnaires. Standardized bone density measurements of lumbar spine and hip were performed. Potential predictors of hip fracture mortality were tested using univariate and multivariate logistic regression analysis. A total of 432 hip fracture patients (129 males and 303 females) were prospectively identified. Among them 296 (85 males and 211 females) patients [mean age 80.7 (SD 9.1)] were assessed at the Osteoporosis center. Variables independently associated with short-term mortality (after 1 year) were in females older age [Odds Ratio (OR) 6.95] and in males older age (OR 5.74) and pulmonary disease (OR 3.20), whereas no associations were observed with mortality for 3 months after the fragility hip fracture. Variables independently associated with 5 years mortality in males was osteoporosis (OR 3.91) and older age (OR 6.95), and in females was dementia (OR 4.16) and older age (OR 2.80). Conclusion: Apart from known predictors as age and comorbidity osteoporosis in our study was identified as a potential independent predictor of long-term hip fracture mortality in males. This is of particular importance as treatment with bisphosphonates after hip fracture has been shown to reduce hip fracture mortality and may be a clinical target to reduce the burden of the disease. Further studies however are needed to confirm the validity of this finding.	[Diamantopoulos, Andreas P.; Haugeberg, Glenn] Hosp Southern Norway Trust, Dept Rheumatol, Kristiansand, Norway; [Diamantopoulos, Andreas P.] Norwegian Univ Sci & Technol, Fac Med, Dept Neurosci, N-7034 Trondheim, Norway; [Hoff, Mari] Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [Hochberg, Marc] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Hochberg, Marc] Univ Maryland, Sch Med, Dept Epidemiol, Baltimore, MD 21201 USA; [Hochberg, Marc] Univ Maryland, Sch Med, Dept Prevent Med, Baltimore, MD 21201 USA; [Haugeberg, Glenn] Univ Agder, Fac Hlth & Sport Sci, Kristiansand, Norway; [Hoff, Mari] St Olavs Hosp, Dept Rheumatol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Agder; Norwegian University of Science & Technology (NTNU)	Diamantopoulos, AP (corresponding author), Hosp Southern Norway Trust, Dept Rheumatol, Kristiansand, Norway.	andreas.diamantopoulos@sshf.no	Hoff, Mari/AAZ-7302-2021	Hoff, Mari/0000-0002-9992-8663	Competence Development Fund of Southern Norway; Hospital of Southern Norway Trust	Competence Development Fund of Southern Norway; Hospital of Southern Norway Trust	This work has been supported and funded by the Competence Development Fund of Southern Norway and the Hospital of Southern Norway Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen B, 2009, OSTEOPOROSIS INT, V20, P1633, DOI 10.1007/s00198-009-0920-3; Alegre-Lopez J, 2005, OSTEOPOROSIS INT, V16, P729, DOI 10.1007/s00198-004-1740-0; Beaupre LA, 2011, OSTEOPOROSIS INT, V22, P983, DOI 10.1007/s00198-010-1411-2; Browner WS, 1996, ARCH INTERN MED, V156, P1521, DOI 10.1001/archinte.156.14.1521; Consensus Development Conference, 1993, AM J MED, V94, P646; Cree MW, 2003, OSTEOPOROSIS INT, V14, P722, DOI 10.1007/s00198-003-1430-3; Diamantopoulos AP, 2013, CLIN INTERV AGING, V8, P817, DOI 10.2147/CIA.S45468; Fransen M, 2002, J AM GERIATR SOC, V50, P685, DOI 10.1046/j.1532-5415.2002.50163.x; Giversen IM, 2007, OSTEOPOROSIS INT, V18, P721, DOI 10.1007/s00198-006-0300-1; Haentjens P, 2010, ANN INTERN MED, V152, P380, DOI 10.7326/0003-4819-152-6-201003160-00008; Hu FK, 2012, INJURY, V43, P676, DOI 10.1016/j.injury.2011.05.017; Jiang HX, 2005, J BONE MINER RES, V20, P494, DOI 10.1359/JBMR.041133; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; Lyles KW, 2007, N ENGL J MED, V357; MAGAZINER J, 1989, AM J PUBLIC HEALTH, V79, P274, DOI 10.2105/AJPH.79.3.274; MAROTTOLI RA, 1994, AM J PUBLIC HEALTH, V84, P1807, DOI 10.2105/AJPH.84.11.1807; Mathew RO, 2013, AM J PHYS MED REHABI; McLellan AR, 2003, OSTEOPOROSIS INT, V14, P1028, DOI 10.1007/s00198-003-1507-z; Meyer HE, 2000, OSTEOPOROSIS INT, V11, P228, DOI 10.1007/s001980050285; Panula J, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-105; Pioli G, 2006, AGING CLIN EXP RES, V18, P381; Roche JJW, 2005, BMJ-BRIT MED J, V331, P1374, DOI 10.1136/bmj.38643.663843.55; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P1583, DOI 10.1007/s00198-007-0403-3	23	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78169	10.1371/journal.pone.0078169	http://dx.doi.org/10.1371/journal.pone.0078169			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205145	Green Published, Green Submitted, gold			2022-12-27	WOS:000326270700081
J	Zhang, JM; Fu, LY; Shi, JP; Chen, X; Li, YZ; Ma, B; Zhang, Y				Zhang, Jianming; Fu, Lingyu; Shi, Jingpu; Chen, Xin; Li, Yongze; Ma, Bing; Zhang, Yao			The Risk of Metabolic Syndrome in Patients with Rheumatoid Arthritis: A Meta-Analysis of Observational Studies	PLOS ONE			English	Article							ACUTE-PHASE RESPONSE; INSULIN-RESISTANCE; CARDIOVASCULAR RISK; INCREASED FREQUENCY; PROVISIONAL REPORT; DISEASE-ACTIVITY; PREVALENCE; INFLAMMATION; WOMEN; ATHEROSCLEROSIS	Background: Observational studies suggest an association between the incidence of rheumatoid arthritis (RA) and the prevalence of metabolic syndrome (MetS). However, the relationship between RA and MetS is controversial and research in this area is currently lacking. Objective: The aim of this study was to assess whether the prevalence of MetS was higher in a group of RA patients compared to subjects without RA. Design: A PubMed database search was conducted during April 2013 to identify observational studies of RA and risk of MetS. Reference lists of retrieved articles were also reviewed. Two authors independently extracted information on the study design, the characteristics of the study participants, exposure and outcome assessments, and the method used to control for potential confounding factors. A random-effects model was used for the risk estimates. Results: Our meta-analysis of four cross-sectional controlled studies plus eight case-control studies involving a total of 2283 cases and 4403 controls identified a significant association between RA and risk of MetS, with an overall OR of 1.24 (95% CI, 1.03-1.50). Conclusion: This meta-analysis provides further evidence supporting patients with RA have a higher prevalence of MetS than subjects without RA. In addition, the geographic region of the population and the criteria used for MetS diagnosis could influence the association. However, these observations would need to be evaluated using prospective, randomized studies.	[Zhang, Jianming; Fu, Lingyu; Shi, Jingpu; Chen, Xin; Ma, Bing; Zhang, Yao] China Med Univ, Dept Clin Epidemiol & Evidence Based Med, Affiliated Hosp 1, Shenyang, Peoples R China; [Li, Yongze] China Med Univ, No Hosp, Dept Lab Med, Key Lab AIDS Immunol,Minist Hlth, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University	Fu, LY (corresponding author), China Med Univ, Dept Clin Epidemiol & Evidence Based Med, Affiliated Hosp 1, Shenyang, Peoples R China.	fulingyucmu@sina.com		LI, YONGZE/0000-0001-8782-3314	National Natural Science Foundation of China [30800944, 30671796]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (30800944 and 30671796). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Altman DG, 2001, BMJ-BRIT MED J, V323, P224, DOI 10.1136/bmj.323.7306.224; Baker JF, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2012.01.025; Balkau B, 1999, DIABETIC MED, V16, P442; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BOCHAROV AV, 1995, METABOLISM, V44, P730, DOI 10.1016/0026-0495(95)90185-X; Channual J, 2009, DERMATOL THER, V22, P61, DOI 10.1111/j.1529-8019.2008.01217.x; Choi HK, 2005, J RHEUMATOL, V32, P2311; Chung CP, 2008, ATHEROSCLEROSIS, V196, P756, DOI 10.1016/j.atherosclerosis.2007.01.004; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Crowson CS, 2011, J RHEUMATOL, V38, P29, DOI 10.3899/jrheum.100346; da Cunha VR, 2012, SCAND J RHEUMATOL, V41, P186, DOI 10.3109/03009742.2011.626443; Dao HH, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3203; del Rincon I, 2001, ARTHRITIS RHEUM-US, V44, P2737, DOI 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dessein PH, 2007, J RHEUMATOL, V34, P681; Dessein PH, 2006, J RHEUMATOL, V33, P2425; Dessein PH, 2002, ARTHRITIS RES, V4, DOI 10.1186/ar428; Dessein PH, 2002, J RHEUMATOL, V29, P462; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferraccioli G, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13211; Ford ES, 2005, DIABETES CARE, V28, P1769, DOI 10.2337/diacare.28.7.1769; Gabriel SE, 2001, RHEUM DIS CLIN N AM, V27, P269, DOI 10.1016/S0889-857X(05)70201-5; Gonzalez-Gay MA, 2010, CLIN EXP RHEUMATOL, V28, P56; Goshayeshi L, 2012, CLIN RHEUMATOL, V31, P1197, DOI 10.1007/s10067-012-1995-3; Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001; Gualillo O, 2007, TRENDS CARDIOVAS MED, V17, P275, DOI 10.1016/j.tcm.2007.09.005; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Karakoc Mehmet, 2012, J Clin Med Res, V4, P279, DOI 10.4021/jocmr1001w; Karimi M, 2011, INT J RHEUM DIS, V14, P248, DOI 10.1111/j.1756-185X.2011.01595.x; Karvounaris SA, 2007, ANN RHEUM DIS, V66, P28, DOI 10.1136/ard.2006.053488; La Montagna Giovanni, 2007, Diab Vasc Dis Res, V4, P130; Lee SG, 2013, KOREAN J INTERN MED, V28, P206, DOI 10.3904/kjim.2013.28.2.206; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P722, DOI 10.1002/art.20878; Meigs JB, 2004, DIABETES CARE, V27, P2761, DOI 10.2337/diacare.27.11.2761; Mok CC, 2011, ARTHRIT CARE RES, V63, P195, DOI 10.1002/acr.20363; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Ormseth MJ, 2013, ARTHRITIS CARE RES; Pamuk ON, 2006, J RHEUMATOL, V33, P2447; Park YB, 2002, AM J MED, V113, P188, DOI 10.1016/S0002-9343(02)01186-5; Raterman HG, 2010, ANN RHEUM DIS, V69, P39, DOI 10.1136/ard.2008.100776; Raterman HG, 2009, ARTHRITIS RES THER, V11, pR110, DOI [10.1186/ar2653, DOI 10.1186/AR2653.PUBMED:19607680]; Reaven G M, 1997, Nutrition, V13, P66; Reilly MP, 2003, CIRCULATION, V108, P1546, DOI 10.1161/01.CIR.0000088846.10655.E0; Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869; Sahebari M, 2011, THESCIENTIFICWORLDJO, V11, P1195, DOI 10.1100/tsw.2011.111; Santos MJ, 2010, CARDIOVASCULAR RISK; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; SVENSON KLG, 1987, METABOLISM, V36, P944, DOI 10.1016/0026-0495(87)90129-6; Terrin N, 2003, STAT MED, V22, P2113, DOI 10.1002/sim.1461; Toms TE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2765; Toms TE, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2578; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Wulan SN, 2010, MATURITAS, V65, P315, DOI 10.1016/j.maturitas.2009.12.012; Zonana-Nacach A, 2008, JCR-J CLIN RHEUMATOL, V14, P74, DOI 10.1097/RHU.0b013e31816b2faa	58	55	56	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78151	10.1371/journal.pone.0078151	http://dx.doi.org/10.1371/journal.pone.0078151			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205134	Green Submitted, Green Published, gold			2022-12-27	WOS:000326155400073
J	Adhikari, BM; Quinn, KM; Dhamala, M				Adhikari, Bhim M.; Quinn, Kristen M.; Dhamala, Mukesh			Is the Brain's Inertia for Motor Movements Different for Acceleration and Deceleration?	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; FREQUENCY-DEPENDENT CHANGES; FINGER MOVEMENTS; PARAHIPPOCAMPAL CORTEX; BASAL GANGLIA; SENSORIMOTOR SYNCHRONIZATION; CONTEXTUAL ASSOCIATIONS; SENSORY STIMULATION; TEMPORAL CONTROL; TIME PERCEPTION	The brain's ability to synchronize movements with external cues is used daily, yet neuroscience is far from a full understanding of the brain mechanisms that facilitate and set behavioral limits on these sequential performances. This functional magnetic resonance imaging (fMRI) study was designed to help understand the neural basis of behavioral performance differences on a synchronizing movement task during increasing (acceleration) and decreasing (deceleration) metronome rates. In the MRI scanner, subjects were instructed to tap their right index finger on a response box in synchrony to visual cues presented on a display screen. The tapping rate varied either continuously or in discrete steps ranging from 0.5 Hz to 3 Hz. Subjects were able to synchronize better during continuously accelerating rhythms than in continuously or discretely decelerating rhythms. The fMRI data revealed that the precuneus was activated more during continuous deceleration than during acceleration with the hysteresis effect significant at rhythm rates above 1 Hz. From the behavioral data, two performance measures, tapping rate and synchrony index, were derived to further analyze the relative brain activity during acceleration and deceleration of rhythms. Tapping rate was associated with a greater brain activity during deceleration in the cerebellum, superior temporal gyrus and parahippocampal gyrus. Synchrony index was associated with a greater activity during the continuous acceleration phase than during the continuous deceleration or discrete acceleration phases in a distributed network of regions including the prefrontal cortex and precuneus. These results indicate that the brain's inertia for movement is different for acceleration and deceleration, which may have implications in understanding the origin of our perceptual and behavioral limits.	[Adhikari, Bhim M.; Quinn, Kristen M.; Dhamala, Mukesh] Georgia State Univ, Dept Phys & Astron, Ctr Behav Neurosci, Inst Neurosci, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Adhikari, BM (corresponding author), Georgia State Univ, Dept Phys & Astron, Ctr Behav Neurosci, Inst Neurosci, Atlanta, GA 30303 USA.	badhikari1@student.gsu.edu	Dhamala, Mukesh/AAX-3207-2021; Adhikari, Bhim/K-7390-2019		Georgia State University faculty Brains and Behavior seed grant; National Science Foundation CAREER award [BCS 0955037]; Center for Behavioral Neuroscience, Georgia State University; Direct For Social, Behav & Economic Scie [0955037] Funding Source: National Science Foundation	Georgia State University faculty Brains and Behavior seed grant; National Science Foundation CAREER award(National Science Foundation (NSF)); Center for Behavioral Neuroscience, Georgia State University; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This research was supported by Georgia State University faculty Brains and Behavior seed grant and the National Science Foundation CAREER award (BCS 0955037) to the author MD. The Institute on Neuroscience (ION) program directed by Dr. Kyle Franz at the Center for Behavioral Neuroscience, Georgia State University provided a summer fellowship to the author KQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman MJ, 2012, BRAIN, V135, P656, DOI 10.1093/brain/awr210; Aminoff E, 2007, CEREB CORTEX, V17, P1493, DOI 10.1093/cercor/bhl078; ARTIEDA J, 1992, BRAIN, V115, P199, DOI 10.1093/brain/115.1.199; Aschersleben G, 2002, BRAIN COGNITION, V48, P66, DOI 10.1006/brcg.2001.1304; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Bar M, 2008, J NEUROSCI, V28, P8539, DOI 10.1523/JNEUROSCI.0987-08.2008; Bar M, 2008, CEREB CORTEX, V18, P1233, DOI 10.1093/cercor/bhm170; BERNS GS, 1999, J NEUROSCI, V19, P1; Boecker H, 2008, NEUROIMAGE, V39, P1356, DOI 10.1016/j.neuroimage.2007.09.069; BOECKER H, 1994, BRAIN, V117, P1231, DOI 10.1093/brain/117.6.1231; Brett M., 2002, INT C FUNCT MAPP HUM, V16, DOI 10.1016/S1053-8119(02)90013-3; Brown S, 2006, CEREB CORTEX, V16, P1157, DOI 10.1093/cercor/bhj057; Carver FW, 2002, CLIN NEUROPHYSIOL, V113, P1921, DOI 10.1016/S1388-2457(02)00299-7; Catalan MJ, 1998, BRAIN, V121, P253, DOI 10.1093/brain/121.2.253; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Clements-Stephens AM, 2009, NEUROSCI LETT, V449, P155, DOI 10.1016/j.neulet.2008.10.094; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dhamala M, 2003, NEUROIMAGE, V20, P918, DOI 10.1016/S1053-8119(03)00304-5; Dhamala M, 2007, NEUROIMAGE, V34, P764, DOI 10.1016/j.neuroimage.2006.07.044; Fraisse P., 2009, PSYCHOMUSICOLOGY MUS, V20, P170; Fraisse P, 1982, RHYTHM TEMPO; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gardini S, 2011, BEHAV NEUROL, V24, P123, DOI [10.3233/BEN-2011-0279, 10.1155/2011/547451]; Gilboa G, 2005, J NEUROSCI, V25, P6479, DOI 10.1523/JNEUROSCI.0763-05.2005; Habas C, 2004, NEUROREPORT, V15, P1571, DOI 10.1097/01.wnr.0000133970.53139.e3; HALSBAND U, 1993, BRAIN, V116, P243, DOI 10.1093/brain/116.1.243; Hanakawa T, 2008, CEREB CORTEX, V18, P2775, DOI 10.1093/cercor/bhn036; Hardy MW, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00019; Harrington DL, 1998, NEUROPSYCHOLOGY, V12, P3, DOI 10.1037/0894-4105.12.1.3; Heekeren HR, 2008, NAT REV NEUROSCI, V9, P467, DOI 10.1038/nrn2374; Horenstein C, 2009, HUM BRAIN MAPP, V30, P1397, DOI 10.1002/hbm.20610; Huys R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000061; Ivry RB, 1996, CURR OPIN NEUROBIOL, V6, P851, DOI 10.1016/S0959-4388(96)80037-7; Jancke L, 1998, NEUROSCI LETT, V252, P37, DOI 10.1016/S0304-3940(98)00540-0; Jantzen KJ, 2004, P NATL ACAD SCI USA, V101, P6815, DOI 10.1073/pnas.0401300101; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Jueptner M, 1998, BRAIN, V121, P1437, DOI 10.1093/brain/121.8.1437; Kelso S., 1995, DYNAMIC PATTERNS SEL; Kleinschmidt A, 2002, NEURON, V34, P659, DOI 10.1016/S0896-6273(02)00694-3; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lewis PA, 2004, NEUROPSYCHOLOGIA, V42, P1301, DOI 10.1016/j.neuropsychologia.2004.03.001; Lutz K, 2000, NEUROREPORT, V11, P1301, DOI 10.1097/00001756-200004270-00031; Mangels JA, 1998, COGNITIVE BRAIN RES, V7, P15, DOI 10.1016/S0926-6410(98)00005-6; Mayville JM, 2002, HUM BRAIN MAPP, V17, P214, DOI 10.1002/hbm.10065; Molinari M, 2003, ANN NY ACAD SCI, V999, P313, DOI 10.1196/annals.1284.042; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Olmo MFD, 2007, J NEUROPHYSIOL, V98, P145; Ramnani N, 2001, J COGNITIVE NEUROSCI, V13, P952, DOI 10.1162/089892901753165863; RAO SM, 1993, NEUROLOGY, V43, P2311, DOI 10.1212/WNL.43.11.2311; Rao SM, 1997, J NEUROSCI, V17, P5528; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Rivkin MJ, 2003, PEDIATR NEUROL, V28, P89, DOI 10.1016/S0887-8994(02)00492-7; ROLAND PE, 1985, HUM NEUROBIOL, V4, P155; Sadato N, 1997, J CEREBR BLOOD F MET, V17, P670; Sadato N, 1996, J CEREBR BLOOD F MET, V16, P23, DOI 10.1097/00004647-199601000-00003; Sakai K, 1999, J NEUROSCI, V19, P10074; Salman MS, 2002, J CHILD NEUROL, V17, P1, DOI 10.1177/088307380201700101; Schaal S, 2004, NAT NEUROSCI, V7, P1137, DOI 10.1038/nn1322; Schwiedrzik CM, 2014, CEREB CORTEX, V24, P1152, DOI 10.1093/cercor/bhs396; SHIBASAKI H, 1993, BRAIN, V116, P1387, DOI 10.1093/brain/116.6.1387; Spencer RMC, 2007, NEUROIMAGE, V36, P378, DOI 10.1016/j.neuroimage.2007.03.009; Tal D, 2001, NEUROSCI LETT, V300, P21, DOI 10.1016/S0304-3940(01)01534-8; Talairach J, 1988, CO PLANAR STEREOTAXI; Thaut MH, 2006, ANN NY ACAD SCI, V999, P364; Thaut MH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002312; Toib A, 1998, J NEUROSCI, V18, P1893; Turgeon M, 2012, PSYCHIAT RES, V197, P13, DOI 10.1016/j.psychres.2012.03.003; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; Wendelken C, 2011, DEV COGN NEUROS-NETH, V1, P175, DOI 10.1016/j.dcn.2010.11.001; Wenderoth N, 2005, EUR J NEUROSCI, V22, P235, DOI 10.1111/j.1460-9568.2005.04176.x; WESSEL K, 1995, BRAIN, V118, P379, DOI 10.1093/brain/118.2.379; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Witt ST, 2008, NEUROIMAGE, V42, P343, DOI 10.1016/j.neuroimage.2008.04.025; Wu T, 2010, BRAIN, V133, P2394, DOI 10.1093/brain/awq151	75	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78055	10.1371/journal.pone.0078055	http://dx.doi.org/10.1371/journal.pone.0078055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205088	gold, Green Published			2022-12-27	WOS:000326032600065
J	Low, C; Yau, YH; Pardon, E; Jegerschold, C; Wahlin, L; Quistgaard, EM; Moberg, P; Geifman-Shochat, S; Steyaert, J; Nordlund, P				Low, Christian; Yau, Yin Hoe; Pardon, Els; Jegerschold, Caroline; Wahlin, Lisa; Quistgaard, Esben M.; Moberg, Per; Geifman-Shochat, Susana; Steyaert, Jan; Nordlund, Par			Nanobody Mediated Crystallization of an Archeal Mechanosensitive Channel	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; SIZE-EXCLUSION CHROMATOGRAPHY; CRYSTAL-STRUCTURE; MEMBRANE-PROTEINS; BINDING-PROTEINS; MOLECULAR-BASIS; DOMAIN; OVEREXPRESSION; IDENTIFICATION; OPTIMIZATION	Mechanosensitive channels (MS) are integral membrane proteins and allow bacteria to survive sudden changes in external osmolarity due to transient opening of their pores. The efflux of cytoplasmic osmolytes reduces the membrane tension and prevents membrane rupture. Therefore these channels serve as emergency valves when experiencing significant environmental stress. The preparation of high quality crystals of integral membrane proteins is a major bottleneck for structure determination by X-ray crystallography. Crystallization chaperones based on various protein scaffolds have emerged as promising tool to increase the crystallization probability of a selected target protein. So far archeal mechanosensitive channels of small conductance have resisted crystallization in our hands. To structurally analyse these channels, we selected nanobodies against an archeal MS channel after immunization of a llama with recombinant expressed, detergent solubilized and purified protein. Here we present the characterization of 23 different binders regarding their interaction with the channel protein using analytical gel filtration, western blotting and surface plasmon resonance. Selected nanobodies bound the target with affinities in the pico- to nanomolar range and some binders had a profound effect on the crystallization of the MS channel. Together with previous data we show that nanobodies are a versatile and valuable tool in structural biology by widening the crystallization space for highly challenging proteins, protein complexes and integral membrane proteins.	[Low, Christian; Quistgaard, Esben M.; Moberg, Per; Nordlund, Par] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Yau, Yin Hoe; Wahlin, Lisa; Geifman-Shochat, Susana] Nanyang Technol Univ, Div Chem Biol & Biotechnol, Singapore 639798, Singapore; [Pardon, Els; Steyaert, Jan] Vrije Univ Brussel VIB, Struct Biol Res Ctr, B-1050 Brussels, Belgium; [Pardon, Els; Steyaert, Jan] Vrije Univ Brussel, Brussels, Belgium; [Jegerschold, Caroline] Royal Inst Technol, Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Jegerschold, Caroline] Royal Inst Technol, Sch Technol & Hlth, Huddinge, Sweden; [Nordlund, Par] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	Karolinska Institutet; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Vrije Universiteit Brussel; Karolinska Institutet; Royal Institute of Technology; Royal Institute of Technology; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Low, C (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	christian.low@ki.se; par.nordlund@ki.se	Steyaert, Jan/H-4662-2011; Hoe, YAU Yin/A-2817-2011; steyaert, jan/GQP-7811-2022	Steyaert, Jan/0000-0002-3825-874X; Hoe, YAU Yin/0000-0001-8136-2393; Jegerschold, Caroline/0000-0003-2419-6354; Quistgaard, Esben/0000-0002-1381-3364; Pardon, Els/0000-0002-2466-0172; Loew, Christian/0000-0003-0764-7483	Danish Council for Independent Research (Medical Sciences) [271-09-0187]; European Molecular Biology Organization (EMBO) postdoctoral fellowship; Fonds Wetenschappelijk Onderzoek-Vlaanderen [G011110N, G049512N]; Innoviris Brussels through Impulse Life Science program [BRGEOZ132]; Belgian Federal Science Policy Office [IAP7-40]; SBO program from the Flemish Agency for Innovation by Science and Technology [IWT120026]; Swedish Research Council; Swedish Cancer Society; integrated EU project EDICT (European drug initiative on channels and transporters); Singapore NRF-CRP (National Research Foundation - Competitive Research Programme) grant	Danish Council for Independent Research (Medical Sciences)(Det Frie Forskningsrad (DFF)); European Molecular Biology Organization (EMBO) postdoctoral fellowship; Fonds Wetenschappelijk Onderzoek-Vlaanderen(FWO); Innoviris Brussels through Impulse Life Science program(Innoviris); Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); SBO program from the Flemish Agency for Innovation by Science and Technology; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); integrated EU project EDICT (European drug initiative on channels and transporters); Singapore NRF-CRP (National Research Foundation - Competitive Research Programme) grant(National Research Foundation, Singapore)	E.M.Q. was supported by The Danish Council for Independent Research (Medical Sciences; grant 271-09-0187). C. L. was supported by a European Molecular Biology Organization (EMBO) postdoctoral fellowship. E. P. and J.S. were supported by the Fonds Wetenschappelijk Onderzoek-Vlaanderen through research grants G011110N and G049512N, Innoviris Brussels through Impulse Life Science program BRGEOZ132, the Belgian Federal Science Policy Office through IAP7-40 and by SBO program IWT120026 from the Flemish Agency for Innovation by Science and Technology. This research was further supported by grants from the Swedish Research Council, Swedish Cancer Society and the integrated EU project EDICT (European drug initiative on channels and transporters), as well as a Singapore NRF-CRP (National Research Foundation - Competitive Research Programme) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadvand D, 2008, HYBRIDOMA, V27, P353, DOI 10.1089/hyb.2008.0014; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Balleza D, 2009, EUR BIOPHYS J BIOPHY, V38, P1013, DOI 10.1007/s00249-009-0460-y; Baranova E, 2012, NATURE, V487, P119, DOI 10.1038/nature11155; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Bill RM, 2011, NAT BIOTECHNOL, V29, P335, DOI 10.1038/nbt.1833; Boersma YL, 2011, CURR OPIN BIOTECH, V22, P849, DOI 10.1016/j.copbio.2011.06.004; Booth IR, 1999, CURR OPIN MICROBIOL, V2, P166, DOI 10.1016/S1369-5274(99)80029-0; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Conrath K, 2009, PROTEIN SCI, V18, P619, DOI 10.1002/pro.69; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; De Genst EJ, 2010, J MOL BIOL, V402, P326, DOI 10.1016/j.jmb.2010.07.001; Domanska K, 2011, P NATL ACAD SCI USA, V108, P1314, DOI 10.1073/pnas.1008560108; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Drew DE, 2001, FEBS LETT, V507, P220, DOI 10.1016/S0014-5793(01)02980-5; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Feilmeier BJ, 2000, J BACTERIOL, V182, P4068, DOI 10.1128/JB.182.14.4068-4076.2000; Granier S, 2012, NAT CHEM BIOL, V8, P670, DOI 10.1038/nchembio.1025; Guettou F, 2013, EMBO REP, V14, P804, DOI 10.1038/embor.2013.107; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hammon J, 2009, PROTEIN SCI, V18, P121, DOI 10.1002/pro.18; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Hilf RJC, 2009, CURR OPIN STRUC BIOL, V19, P418, DOI 10.1016/j.sbi.2009.07.006; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kiefer H, 2003, BBA-BIOMEMBRANES, V1610, P57, DOI 10.1016/S0005-2736(02)00717-4; Koide A, 2007, P NATL ACAD SCI USA, V104, P6632, DOI 10.1073/pnas.0700149104; Koide S, 2009, CURR OPIN STRUC BIOL, V19, P449, DOI 10.1016/j.sbi.2009.04.008; Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Kung C, 2010, ANNU REV MICROBIOL, V64, P313, DOI 10.1146/annurev.micro.112408.134106; LAI JY, 2013, PROTEIN SCI; Lange C, 2002, P NATL ACAD SCI USA, V99, P2800, DOI 10.1073/pnas.052704699; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Lieberman RL, 2011, METHODS, V55, P293, DOI 10.1016/j.ymeth.2011.08.004; Lipovsek D, 2007, J MOL BIOL, V368, P1024, DOI 10.1016/j.jmb.2007.02.029; Lofblom J, 2010, FEBS LETT, V584, P2670, DOI 10.1016/j.febslet.2010.04.014; Lofblom J, 2011, CURR OPIN BIOTECH, V22, P843, DOI 10.1016/j.copbio.2011.06.002; Low C, 2013, BBA-GEN SUBJECTS, V1830, P3497, DOI 10.1016/j.bbagen.2013.02.001; Low C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038244; Lu M, 2013, P NATL ACAD SCI USA, V110, P2099, DOI 10.1073/pnas.1219901110; Martinac B, 2008, PHYSIOL REV, V88, P1449, DOI 10.1152/physrev.00005.2008; Monroe N, 2011, J STRUCT BIOL, V174, P269, DOI 10.1016/j.jsb.2011.01.014; Ostermeier C, 1997, P NATL ACAD SCI USA, V94, P10547, DOI 10.1073/pnas.94.20.10547; PARK YJ, 2012, NATURE, V487, P119; Park YJ, 2012, NUCLEIC ACIDS RES, V40, P1828, DOI 10.1093/nar/gkr867; Perozo E, 2003, CURR OPIN STRUC BIOL, V13, P432, DOI 10.1016/S0959-440X(03)00106-4; Pivetti CD, 2003, MICROBIOL MOL BIOL R, V67, P66, DOI 10.1128/MMBR.67.1.66-85.2003; Quistgaard EM, 2013, NAT STRUCT MOL BIOL, V20, P766, DOI 10.1038/nsmb.2569; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Skerra A, 2008, FEBS J, V275, P2677, DOI 10.1111/j.1742-4658.2008.06439.x; STERN J, 1992, BIOCHIM BIOPHYS ACTA, V1128, P227, DOI 10.1016/0005-2760(92)90312-J; Steyaert J, 2011, CURR OPIN STRUC BIOL, V21, P567, DOI 10.1016/j.sbi.2011.06.011; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; Wang WJ, 2008, SCIENCE, V321, P1179, DOI 10.1126/science.1159262; Woestenenk Esmeralda A., 2004, Journal of Structural and Functional Genomics, V5, P217, DOI 10.1023/B:jsfg.0000031965.37625.0e; Xu LH, 2002, CHEM BIOL, V9, P933, DOI 10.1016/S1074-5521(02)00187-4; Yan N, 2013, TRENDS BIOCHEM SCI, V38, P151, DOI 10.1016/j.tibs.2013.01.003; Zhang XZ, 2012, P NATL ACAD SCI USA, V109, P18180, DOI 10.1073/pnas.1207977109	66	18	18	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77984	10.1371/journal.pone.0077984	http://dx.doi.org/10.1371/journal.pone.0077984			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205053	Green Submitted, Green Published, gold			2022-12-27	WOS:000326032600057
J	Yi, GH; Brendel, VP; Shu, C; Li, PW; Palanathan, S; Kao, CC				Yi, Guanghui; Brendel, Volker P.; Shu, Chang; Li, Pingwei; Palanathan, Satheesh; Kao, C. Cheng			Single Nucleotide Polymorphisms of Human STING Can Affect Innate Immune Response to Cyclic Dinucleotides	PLOS ONE			English	Article							CYTOSOLIC DNA SENSOR; DI-GMP; AMP; ADAPTER; 2ND-MESSENGER; RECOGNITION; RECEPTORS; IDENTIFICATION; STIMULATOR; REVEALS	The STING (stimulator of interferon genes) protein can bind cyclic dinucleotides to activate the production of type I interferons and inflammatory cytokines. The cyclic dinucleotides can be bacterial second messengers c-di-GMP and c-di-AMP, 3'5'-3'5' cyclic GMP-AMP (3'3' cGAMP) produced by Vibrio cholerae and metazoan second messenger 2'5'-3'5' Cyclic GMP-AMP (2'3' cGAMP). Analysis of single nucleotide polymorphism (SNP) data from the 1000 Genome Project revealed that R71H-G230A-R293Q (HAQ) occurs in 20.4%, R232H in 13.7%, G230A-R293Q (AQ) in 5.2%, and R293Q in 1.5% of human population. In the absence of exogenous ligands, the R232H, R293Q and AQ SNPs had only modest effect on the stimulation of IFN-beta and NF-kappa B promoter activities in HEK293T cells, while HAQ had significantly lower intrinsic activity. The decrease was primarily due to the R71H substitution. The SNPs also affected the response to the cyclic dinucleotides. In the presence of c-di-GMP, the R232H variant partially decreased the ability to activate IFN-beta signaling, while it was defective for the response to c-di-AMP and 3'3' cGAMP. The R293Q dramatically decreased the stimulatory response to all bacterial ligands. Surprisingly, the AQ and HAQ variants maintained partial abilities to activate the IFN-beta signaling in the presence of ligands due primarily to the G230A substitution. Biochemical analysis revealed that the recombinant G230A protein could affect the conformation of the C-terminal domain of STING and the binding to c-di-GMP. Comparison of G230A structure with that of WT revealed that the conformation of the lid region that clamps onto the c-di-GMP was significantly altered. These results suggest that hSTING variation can affect innate immune signaling and that the common HAQ haplotype expresses a STING protein with reduced intrinsic signaling activity but retained the ability to response to bacterial cyclic dinucleotides.	[Yi, Guanghui; Palanathan, Satheesh; Kao, C. Cheng] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA; [Brendel, Volker P.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Brendel, Volker P.] Indiana Univ, Sch Informat & Comp, Bloomington, IN USA; [Shu, Chang; Li, Pingwei] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Texas A&M University System; Texas A&M University College Station	Kao, CC (corresponding author), Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA.	ckao@indiana.edu	shu, chang/H-4452-2015	shu, chang/0000-0002-6738-8973				Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Burdette Dara L, 2013, Nat Immunol, V14, P19, DOI 10.1038/ni.2491; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cavlar T, 2013, EMBO J, V32, P1440, DOI 10.1038/emboj.2013.86; Conlon J, 2013, J IMMUNOL, V190, P5216, DOI 10.4049/jimmunol.1300097; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Huang YH, 2012, NAT STRUCT MOL BIOL, V19, P728, DOI 10.1038/nsmb.2333; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jin L, 2011, GENES IMMUN, V12, P263, DOI 10.1038/gene.2010.75; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Kim S, 2013, ACS CHEM BIOL; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Netea MG, 2012, NAT IMMUNOL, V13, P535, DOI 10.1038/ni.2284; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Pothlichet J, 2013, INT REV IMMUNOL, V32, P157, DOI 10.3109/08830185.2013.777064; Prantner D, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.382986; Ranjith-Kumar CT, 2007, J BIOL CHEM, V282, P17696, DOI 10.1074/jbc.M700209200; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Shang GJ, 2012, NAT STRUCT MOL BIOL, V19, P725, DOI 10.1038/nsmb.2332; Shigemoto T, 2009, J BIOL CHEM, V284, P13348, DOI 10.1074/jbc.M809449200; Shu C, 2012, NAT STRUCT MOL BIOL, V19, P722, DOI 10.1038/nsmb.2331; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yin Q, 2012, MOL CELL, V46, P735, DOI 10.1016/j.molcel.2012.05.029; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	45	143	172	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77846	10.1371/journal.pone.0077846	http://dx.doi.org/10.1371/journal.pone.0077846			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204993	Green Submitted, gold, Green Published			2022-12-27	WOS:000326032600050
J	Abrams, EW; Cheng, YL; Andrew, DJ				Abrams, Elliott W.; Cheng, Yim Ling; Andrew, Deborah J.			Drosophila KDEL Receptor Function in the Embryonic Salivary Gland and Epidermis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM RETENTION; PROTEIN DISULFIDE-ISOMERASE; LUMINAL ER PROTEINS; TRANSMEMBRANE PROTEINS; PROLYL 4-HYDROXYLASE; SECRETORY PATHWAY; FAMILY-MEMBERS; GOLGI; YEAST; IDENTIFICATION	Core components of the secretory pathway have largely been identified and studied in single cell systems such as the budding yeast S. cerevisiae or in mammalian tissue culture. These studies provide details on the molecular functions of the secretory machinery; they fail, however, to provide insight into the role of these proteins in the context of specialized organs of higher eukaryotes. Here, we identify and characterize the first loss-of-function mutations in a KDEL receptor gene from higher eukaryotes. Transcripts from the Drosophila KDEL receptor gene KdelR - formerly known as dmErd2 - are provided maternally and, at later stages, are at elevated levels in several embryonic cell types, including the salivary gland secretory cells, the fat body and the epidermis. We show that, unlike Saccharomyces cerevisiae Erd2 mutants, which are viable, KdelR mutations are early larval lethal, with homozygous mutant animals dying as first instar larvae. KdelR mutants have larval cuticle defects similar to those observed with loss-of-function mutations in other core secretory pathway genes and with mutations in CrebA, which encodes a bZip transcription factor that coordinately upregulates secretory pathway component genes in specialized secretory cell types. Using the salivary gland, we demonstrate a requirement for KdelR in maintaining the ER pool of a subset of soluble resident ER proteins. These studies underscore the utility of the Drosophila salivary gland as a unique system for studying the molecular machinery of the secretory pathway in vivo in a complex eukaryote.	[Abrams, Elliott W.; Cheng, Yim Ling; Andrew, Deborah J.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21218 USA	Johns Hopkins University	Andrew, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21218 USA.	dandrew@jhmi.edu			NIH [RO1 DE013899]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F31DE021285, R01DE013899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by NIH RO1 DE013899 to D.J.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams EW, 2006, DEVELOPMENT, V133, P3517, DOI 10.1242/dev.02525; Abrams EW, 2002, MECH DEVELOP, V112, P165, DOI 10.1016/S0925-4773(01)00636-0; Abrams EW, 2005, DEVELOPMENT, V132, P2743, DOI 10.1242/dev.01863; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; BEH CT, 1995, P NATL ACAD SCI USA, V92, P9820, DOI 10.1073/pnas.92.21.9820; Cabrera M, 2003, MOL BIOL CELL, V14, P4114, DOI 10.1091/mbc.E03-04-0194; CLEGG NJ, 1993, GENETICS, V134, P221; COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252; Culi J, 2004, EMBO J, V23, P1372, DOI 10.1038/sj.emboj.7600132; Culi J, 2003, CELL, V112, P343, DOI 10.1016/S0092-8674(02)01279-5; DENECKE J, 1992, EMBO J, V11, P2345, DOI 10.1002/j.1460-2075.1992.tb05294.x; Dominguez M, 1998, J CELL BIOL, V140, P751, DOI 10.1083/jcb.140.4.751; Fox RM, 2010, J CELL BIOL, V191, P479, DOI 10.1083/jcb.201004062; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Giannotta M, 2012, EMBO J, V31, P2869, DOI 10.1038/emboj.2012.134; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; Konsolaki M, 1998, GENE DEV, V12, P120, DOI 10.1101/gad.12.1.120; Kopczynski CC, 1998, P NATL ACAD SCI USA, V95, P9973, DOI 10.1073/pnas.95.17.9973; LEHMANN R, 1994, METHOD CELL BIOL, V44, P575, DOI 10.1016/S0091-679X(08)60933-4; LEWIS MJ, 1990, NATURE, V348, P162, DOI 10.1038/348162a0; LEWIS MJ, 1990, CELL, V61, P1359, DOI 10.1016/0092-8674(90)90699-F; LEWIS MJ, 1992, CELL, V68, P353, DOI 10.1016/0092-8674(92)90476-S; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; NAPIER RM, 1992, J CELL SCI, V102, P261; NISHIKAWA S, 1993, P NATL ACAD SCI USA, V90, P8179, DOI 10.1073/pnas.90.17.8179; PELHAM HRB, 1988, EMBO J, V7, P1757, DOI 10.1002/j.1460-2075.1988.tb03005.x; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; REUTER R, 1990, DEVELOPMENT, V110, P1031; Scheel AA, 1998, J BIOL CHEM, V273, P2467, DOI 10.1074/jbc.273.4.2467; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; Sen J, 2000, DEVELOPMENT, V127, P5541; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; SONNICHSEN B, 1994, J CELL SCI, V107, P2705; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TOWNSLEY FM, 1993, EMBO J, V12, P2821, DOI 10.1002/j.1460-2075.1993.tb05943.x; Valcarcel R, 1999, J CELL SCI, V112, P4389; VUORI K, 1992, EMBO J, V11, P4213, DOI 10.1002/j.1460-2075.1992.tb05515.x; Wang P, 2011, NEUROSCIENCE, V190, P43, DOI 10.1016/j.neuroscience.2011.06.008; WILSON DW, 1993, J BIOL CHEM, V268, P7465	42	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77618	10.1371/journal.pone.0077618	http://dx.doi.org/10.1371/journal.pone.0077618			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204897	gold, Green Published, Green Submitted			2022-12-27	WOS:000326029300107
J	Sy, BT; Ratsch, BA; Toan, NL; Song, LH; Wollboldt, C; Bryniok, A; Nguyen, HM; Luong, HV; Velavan, TP; Wedemeyer, H; Kremsner, PG; Bock, CT				Bui Tien Sy; Ratsch, Boris A.; Nguyen Linh Toan; Le Huu Song; Wollboldt, Christian; Bryniok, Agnes; Hung Minh Nguyen; Hoang Van Luong; Velavan, Thirumalaisamy P.; Wedemeyer, Heiner; Kremsner, Peter G.; Bock, C-Thomas			High Prevalence and Significance of Hepatitis D Virus Infection among Treatment-Naive HBsAg-Positive Patients in Northern Vietnam	PLOS ONE			English	Article							B-VIRUS; LIVER-DISEASE; CLINICAL-SIGNIFICANCE; FULMINANT-HEPATITIS; VANISHING DISEASE; ENDEMIC AREA; GENOTYPE-I; DELTA; HDV; MANAGEMENT	Background: Hepatitis D virus (HDV) infection is considered to cause more severe hepatitis than hepatitis B virus (HBV) monoinfection. With more than 9.5 million HBV-infected people, Vietnam will face an enormous health burden. The prevalence of HDV in Vietnamese HBsAg-positive patients is speculative. Therefore, we assessed the prevalence of HDV in Vietnamese patients, determined the HDV-genotype distribution and compared the findings with the clinical outcome. Methods: 266 sera of well-characterized HBsAg-positive patients in Northern Vietnam were analysed for the presence of HDV using newly developed HDV-specific RT-PCRs. Sequencing and phylogenetic analysis were performed for HDV-genotyping. Results: The HDV-genome prevalence observed in the Vietnamese HBsAg-positive patients was high with 15.4% while patients with acute hepatitis showed 43.3%. Phylogenetic analysis demonstrated a predominance of HDV-genotype 1 clustering in an Asian clade while HDV-genotype 2 could be also detected. The serum aminotransferase levels (AST, ALT) as well as total and direct bilirubin were significantly elevated in HDV-positive individuals (p<0.05). HDV loads were mainly low (<300 to 4.108 HDV-copies/ml). Of note, higher HDV loads were mainly found in HBV-genotype mix samples in contrast to single HBV-infections. In HBV/HDV-coinfections, HBV loads were significantly higher in HBV-genotype C in comparison to HBV-genotype A samples (p<0.05). Conclusion: HDV prevalence is high in Vietnamese individuals, especially in patients with acute hepatitis B. HDV replication activity showed a HBV-genotype dependency and could be associated with elevated liver parameters. Besides serological assays molecular tests are recommended for diagnosis of HDV. Finally, the high prevalence of HBV and HDV prompts the urgent need for HBV-vaccination coverage.	[Bui Tien Sy; Ratsch, Boris A.; Wollboldt, Christian; Bryniok, Agnes; Bock, C-Thomas] Robert Koch Inst, Dept Infect Dis, Berlin, Germany; [Bui Tien Sy; Nguyen Linh Toan; Hoang Van Luong] Vietnam Mil Med Univ, Dept Pathophysiol, Hanoi, Ha Dong, Vietnam; [Le Huu Song] Tran Hung Dao Hosp, Inst Clin Med & Pharmaceut Sci 108, Hanoi, Vietnam; [Hung Minh Nguyen] Duy Tan Univ, Ctr Res & Dev, Da Nang, Vietnam; [Velavan, Thirumalaisamy P.; Kremsner, Peter G.] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Wedemeyer, Heiner] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Bock, C-Thomas] Univ Tubingen, Dept Mol Pathol, Tubingen, Germany	Robert Koch Institute; Duy Tan University; Eberhard Karls University of Tubingen; Hannover Medical School; Eberhard Karls University of Tubingen	Bock, CT (corresponding author), Robert Koch Inst, Dept Infect Dis, Berlin, Germany.	bockc@rki.de	Velavan, Thirumalaisamy P/C-1223-2010; Bock, C.-Thomas/A-3518-2012	Velavan, Thirumalaisamy P/0000-0002-9809-9883; Ratsch, Boris/0000-0003-0478-1652; Bock, C.-Thomas/0000-0002-2773-486X	project 322 of Vietnam Ministry of Education and Training, Vietnam; Deutsche Forschungsgemeinschaft (DFG); Open Access Publishing Fund of Tuebingen University	project 322 of Vietnam Ministry of Education and Training, Vietnam; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Open Access Publishing Fund of Tuebingen University	B.T. Sy was supported by a scholarship from project 322 of Vietnam Ministry of Education and Training, Vietnam. The authors acknowledge the support by the Deutsche Forschungsgemeinschaft (DFG) and Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado-Mora MV, 2011, INFECT GENET EVOL, V11, P1462, DOI 10.1016/j.meegid.2011.05.020; Babiker ZOE, 2012, J MED MICROBIOL, V61, P1780, DOI 10.1099/jmm.0.046649-0; Barros LMF, 2011, VIRUS RES, V160, P333, DOI 10.1016/j.virusres.2011.07.006; Brichler S, 2013, CLIN GASTROENTEROL H, V11, P734, DOI 10.1016/j.cgh.2013.01.025; Casey JL, 1996, J INFECT DIS, V174, P920, DOI 10.1093/infdis/174.5.920; CIANCIO A, 2002, P 10 INT S VIR HEP L, P271; Cross TJS, 2008, J MED VIROL, V80, P277, DOI 10.1002/jmv.21078; Davaalkham D, 2006, AM J TROP MED HYG, V75, P365, DOI 10.4269/ajtmh.2006.75.365; Dunford L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039027; Duraisamy G, 1994, Med J Malaysia, V49, P212; Flodgren E, 2000, J CLIN MICROBIOL, V38, P3311, DOI 10.1128/JCM.38.9.3311-3316.2000; Gaeta GB, 2000, HEPATOLOGY, V32, P824, DOI 10.1053/jhep.2000.17711; Gish RG, 2012, J GASTROEN HEPATOL, V27, P238, DOI 10.1111/j.1440-1746.2011.06974.x; Gomes-Gouvea MS, 2009, J GEN VIROL, V90, P2638, DOI 10.1099/vir.0.013615-0; Hsu SC, 2002, HEPATOLOGY, V35, P665, DOI 10.1053/jhep.2002.31777; Hughes SA, 2011, LANCET, V378, P73, DOI 10.1016/S0140-6736(10)61931-9; Huo TI, 1997, J GASTROEN HEPATOL, V12, P747, DOI 10.1111/j.1440-1746.1997.tb00364.x; IMAZEKI F, 1990, J VIROL, V64, P5594, DOI 10.1128/JVI.64.11.5594-5599.1990; Ivaniushina V, 2001, J GEN VIROL, V82, P2709, DOI 10.1099/0022-1317-82-11-2709; Kabacam G, 2012, CLIN INFECT DIS, V55, P645, DOI 10.1093/cid/cis459; Kim HS, 2011, J MED VIROL, V83, P1172, DOI 10.1002/jmv.22095; Le Gal F, 2006, EMERG INFECT DIS, V12, P1447, DOI 10.3201/eid1209.060112; Lu SN, 2003, J MED VIROL, V70, P74, DOI 10.1002/jmv.10361; Lusida MI, 2003, MICROBIOL IMMUNOL, V47, P969, DOI 10.1111/j.1348-0421.2003.tb03457.x; Mederacke I, 2010, J CLIN MICROBIOL, V48, P2022, DOI 10.1128/JCM.00084-10; Mumtaz K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-312; NAVASCUES CA, 1995, AM J GASTROENTEROL, V90, P1981; Nguyen VTT, 2008, LIVER INT, V28, P525, DOI 10.1111/j.1478-3231.2007.01646.x; Nguyen VTT, 2007, J GASTROEN HEPATOL, V22, P2093, DOI 10.1111/j.1440-1746.2007.05010.x; Niro GA, 2010, J HEPATOL, V53, P834, DOI 10.1016/j.jhep.2010.06.008; Pascarella S, 2011, LIVER INT, V31, P7, DOI 10.1111/j.1478-3231.2010.02320.x; Pollicino T, 2011, J VIROL, V85, P432, DOI 10.1128/JVI.01609-10; Popescu GA, 2013, J MED VIROL, V85, P769, DOI 10.1002/jmv.23524; Rizzetto M, 2013, LIVER INT, V33, P195, DOI 10.1111/liv.12058; Rizzetto M, 2009, J HEPATOL, V50, P1043, DOI 10.1016/j.jhep.2009.01.004; Romeo R, 2009, GASTROENTEROLOGY, V136, P1629, DOI 10.1053/j.gastro.2009.01.052; Sakugawa H, 1999, J MED VIROL, V58, P366, DOI 10.1002/(SICI)1096-9071(199908)58:4&lt;366::AID-JMV8&gt;3.0.CO;2-X; Song LH, 2004, J MED VIROL, V73, P244, DOI 10.1002/jmv.20082; Song LH, 2003, J CLIN VIROL, V28, P93, DOI 10.1016/S1386-6532(02)00271-8; Stroffolini T, 2009, J MED VIROL, V81, P1999, DOI 10.1002/jmv.21643; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TAN D S K, 1989, SMJ Singapore Medical Journal, V30, P34; Taylor JM, 2006, VIROLOGY, V344, P71, DOI 10.1016/j.virol.2005.09.033; Taylor JM, 2012, SEMIN LIVER DIS, V32, P195, DOI 10.1055/s-0032-1323623; Taylor JM, 2009, ADV VIRUS RES, V74, P103, DOI 10.1016/S0065-3527(09)74003-5; Theamboonlers A, 2002, INFECTION, V30, P140, DOI 10.1007/s15010-002-2061-x; Toan NL, 2006, HEPATOLOGY, V43, P1375, DOI 10.1002/hep.21188; Tran HTT, 2003, HEPATOL RES, V26, P275, DOI 10.1016/S1386-6346(03)00166-9; Watanabe H, 2003, J GEN VIROL, V84, P3275, DOI 10.1099/vir.0.19499-0; Wedemeyer H, 2007, HEPATOLOGY, V45, P1331, DOI 10.1002/hep.21590; Wedemeyer H, 2011, NEW ENGL J MED, V364, P322, DOI 10.1056/NEJMoa0912696; Wedemeyer H, 2011, LIVER INT, V31, P140, DOI 10.1111/j.1478-3231.2010.02408.x; Wedemeyer H, 2010, NAT REV GASTRO HEPAT, V7, P31, DOI 10.1038/nrgastro.2009.205; Wu JC, 2006, CURR TOP MICROBIOL, V307, P173; Wu JC, 1995, HEPATOLOGY, V22, P1656, DOI 10.1016/0270-9139(95)90187-6	55	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78094	10.1371/journal.pone.0078094	http://dx.doi.org/10.1371/journal.pone.0078094			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205106	Green Submitted, Green Published, gold			2022-12-27	WOS:000326029300138
J	Haileselassie, Y; Johansson, MA; Zimmer, CL; Bjorkander, S; Petursdottir, DH; Dicksved, J; Petersson, M; Persson, JO; Fernandez, C; Roos, S; Holmlund, U; Sverremark-Ekstrom, E				Haileselassie, Yeneneh; Johansson, Maria A.; Zimmer, Christine L.; Bjorkander, Sophia; Petursdottir, Dagbjort H.; Dicksved, Johan; Petersson, Mikael; Persson, Jan-Olov; Fernandez, Carmen; Roos, Stefan; Holmlund, Ulrika; Sverremark-Ekstrom, Eva			Lactobacilli Regulate Staphylococcus aureus 161:2-Induced Pro-Inflammatory T-Cell Responses In Vitro	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; INTESTINAL MICROFLORA; DENDRITIC CELLS; IMMUNE-RESPONSES; GUT MICROBIOTA; BACTERIA; HEALTHY; BIFIDOBACTERIUM; ALLERGY; GENE	There seems to be a correlation between early gut microbiota composition and postnatal immune development. Alteration in the microbial composition early in life has been associated with immune mediated diseases, such as autoimmunity and allergy. We have previously observed associations between the presence of lactobacilli and Staphylococcus (S.) aureus in the early-life gut microbiota, cytokine responses and allergy development in children. Consistent with the objective to understand how bacteria modulate the cytokine response of intestinal epithelial cell (IEC) lines and immune cells, we exposed IEC lines (HT29, SW480) to UV-killed bacteria and/or culture supernatants (-sn) from seven Lactobacillus strains and three S. aureus strains, while peripheral blood mononuclear cells (PBMC) and cord blood mononuclear cells (CBMC) from healthy donors were stimulated by bacteria-sn or with bacteria conditioned IEC-sn. Although the overall IEC response to bacterial exposure was characterized by limited sets of cytokine and chemokine production, S. aureus 161: 2-sn induced an inflammatory response in the IEC, characterized by CXCL1/GROa and CXCL8/IL-8 production, partly in a MyD88-dependent manner. UV-killed bacteria did not induce a response in the IEC line, and a combination of both UV-killed bacteria and the bacteria-sn had no additive effect to that of the supernatant alone. In PBMC, most of the Lactobacillus-sn and S. aureus-sn strains were able to induce a wide array of cytokines, but only S. aureus-sn induced the T-cell associated cytokines IL-2, IL-17 and IFN-gamma, independently of IEC-produced factors, and induced up regulation of CTLA-4 expression and IL-10 production by T-regulatory cells. Notably, S. aureus-sn-induced T-cell production of IFN-gamma and IL-17 was down regulated by the simultaneous presence of any of the different Lactobacillus strains, while the IEC CXCL8/IL-8 response was unaltered. Thus these studies present a possible role for lactobacilli in induction of immune cell regulation, although the mechanisms need to be further elucidated.	[Haileselassie, Yeneneh; Johansson, Maria A.; Zimmer, Christine L.; Bjorkander, Sophia; Petursdottir, Dagbjort H.; Fernandez, Carmen; Holmlund, Ulrika; Sverremark-Ekstrom, Eva] Stockholm Univ, Dept Mol Biosci, Wenner Gren Inst, S-10691 Stockholm, Sweden; [Dicksved, Johan] Swedish Univ Agr Sci, Dept Anim Nutr & Management, Uppsala, Sweden; [Petersson, Mikael; Persson, Jan-Olov] Stockholm Univ, Dept Math, Div Math Stat, S-10691 Stockholm, Sweden; [Roos, Stefan] Swedish Univ Agr Sci, Dept Microbiol, Uppsala, Sweden	Stockholm University; Swedish University of Agricultural Sciences; Stockholm University; Swedish University of Agricultural Sciences	Haileselassie, Y (corresponding author), Stockholm Univ, Dept Mol Biosci, Wenner Gren Inst, S-10691 Stockholm, Sweden.	yeneneh.haileselassie@su.se; eva.sverremark@su.se	Sverremark-Ekström, Eva/A-2305-2016	Sverremark-Ekström, Eva/0000-0001-6271-8681; Roos, Stefan/0000-0002-1606-1794; Dicksved, Johan/0000-0002-7515-4480; Haileselassie, Yeneneh/0000-0003-3726-7393	Swedish Research Council [57X-15160-07-03, 57X-15160-10-4]; Ragnar Soderberg Foundation; Cancer and Allergy Foundation; Swedish Asthma and Allergy Association's Research Foundation; Mjolkdroppen Foundation; Konsul Th C Bergh Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Ragnar Soderberg Foundation; Cancer and Allergy Foundation; Swedish Asthma and Allergy Association's Research Foundation; Mjolkdroppen Foundation; Konsul Th C Bergh Foundation	The Swedish Research Council (grants 57X-15160-07-03, 57X-15160-10-4), The Ragnar Soderberg Foundation (http://www.ragnarsoderbergsstiftelse.se/), The Cancer and Allergy Foundation (http://www.cancerochallergifonden.se/), The Swedish Asthma and Allergy Association's Research Foundation (http://www.astmaoallergiforbundet.se/), The Mjolkdroppen Foundation (http://www.mjolkdroppen.se) and The Konsul Th C Bergh Foundation (www.konsulbergh.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoudruz P, 2005, J ALLERGY CLIN IMMUN, V115, P1304, DOI 10.1016/j.jaci.2005.02.036; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Biazik JM, 2010, WORLD J GASTROENTERO, V16, P2743, DOI 10.3748/wjg.v16.i22.2743; Bjorksten B, 2001, J ALLERGY CLIN IMMUN, V108, P516, DOI 10.1067/mai.2001.118130; Bjorksten B, 1999, CLIN EXP ALLERGY, V29, P342, DOI 10.1046/j.1365-2222.1999.00560.x; BJORNEHOLM S, 2011, MICROB ECOL HLTH DIS, V14, P57564; Edwards LA, 2012, INFLAMM BOWEL DIS, V18, P624, DOI 10.1002/ibd.21852; Fournier B, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2012.00167; Ghadimi D, 2008, IMMUNOBIOLOGY, V213, P677, DOI 10.1016/j.imbio.2008.02.001; Holmlund U, 2010, CLIN EXP IMMUNOL, V162, P500, DOI 10.1111/j.1365-2249.2010.04275.x; Imaoka A, 2008, WORLD J GASTROENTERO, V14, P2511, DOI 10.3748/wjg.14.2511; Islander U, 2010, INFECT IMMUN, V78, P381, DOI 10.1128/IAI.00724-09; Isolauri E, 2004, BEST PRACT RES CL GA, V18, P299, DOI 10.1016/j.bpg.2003.10.006; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Johansson MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049315; Johansson MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023031; Konieczna P, 2012, GUT, V61, P354, DOI 10.1136/gutjnl-2011-300936; Lelouard H, 2012, GASTROENTEROLOGY, V142, P592, DOI 10.1053/j.gastro.2011.11.039; Lindberg E, 2000, PEDIATR RES, V48, P741, DOI 10.1203/00006450-200012000-00007; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; MAUDSDOTTER L, 2011, ANTIMICROB AGENTS CH, P45448; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Niebuhr M, 2011, INFECT IMMUN, V79, P1615, DOI 10.1128/IAI.00958-10; Nowrouzian FL, 2011, J INFECT DIS, V204, P714, DOI 10.1093/infdis/jir388; Ostman S, 2006, EUR J IMMUNOL, V36, P2336, DOI 10.1002/eji.200535244; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rosander A, 2008, APPL ENVIRON MICROB, V74, P6032, DOI 10.1128/AEM.00991-08; Rosengren A, 2010, INT J FOOD MICROBIOL, V144, P263, DOI 10.1016/j.ijfoodmicro.2010.10.004; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Schmaler M, 2011, J IMMUNOL, V186, P443, DOI 10.4049/jimmunol.1001407; Sjogren YM, 2009, CLIN EXP ALLERGY, V39, P518, DOI 10.1111/j.1365-2222.2008.03156.x; Smith AW, 2011, J NEUROIMMUNOL, V232, P179, DOI 10.1016/j.jneuroim.2010.09.030; Spinler JK, 2008, ANAEROBE, V14, P166, DOI 10.1016/j.anaerobe.2008.02.001; Strauch UG, 2005, GUT, V54, P1546, DOI 10.1136/gut.2004.059451; Sun KY, 2013, J BIOMED RES, V27, P116, DOI 10.7555/JBR.27.20120074; Swamy M, 2010, NAT IMMUNOL, V11, P656, DOI 10.1038/ni.1905; Takahashi K, 2011, J BIOL CHEM, V286, P35755, DOI 10.1074/jbc.M111.271007; Thomas CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031951; van Baarlen P, 2013, TRENDS IMMUNOL, V34, P208, DOI 10.1016/j.it.2013.01.005; Verdier J, 2012, INFLAMM BOWEL DIS, V18, P1260, DOI 10.1002/ibd.21905; Vesterlund S, 2006, MICROBIOL-SGM, V152, P1819, DOI 10.1099/mic.0.28522-0; Wells JM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S17; Wesch D, 2011, CELL MOL LIFE SCI, V68, P2357, DOI 10.1007/s00018-011-0699-1; Zeuthen LH, 2006, CLIN VACCINE IMMUNOL, V13, P365, DOI 10.1128/CVI.13.3.365-375.2006; Zeuthen LH, 2008, IMMUNOLOGY, V123, P197, DOI 10.1111/j.1365-2567.2007.02687.x	45	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77893	10.1371/journal.pone.0077893	http://dx.doi.org/10.1371/journal.pone.0077893			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205015	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300123
J	Zhao, X; Zhai, SY; An, MS; Wang, YH; Yang, YF; Ge, HQ; Liu, JH; Pu, XP				Zhao, Xin; Zhai, Shenyu; An, Ming-Sheng; Wang, Yue-Hua; Yang, Ying-Fan; Ge, Hui-Qi; Liu, Jin-Hao; Pu, Xiao-Ping			Neuroprotective Effects of Protocatechuic Aldehyde against Neurotoxin-Induced Cellular and Animal Models of Parkinson's Disease	PLOS ONE			English	Article							MEDIUM SPINY NEURONS; ALPHA-SYNUCLEIN; SUBSTANTIA-NIGRA; IN-VITRO; DOPAMINERGIC-NEURONS; COGNITIVE DECLINE; UP-REGULATION; PC12 CELLS; DJ-1; HIPPOCAMPAL	Protocatechuic aldehyde (PAL) has been reported to bind to DJ-1, a key protein involved in Parkinson's disease (PD), and exerts potential neuroprotective effects via DJ-1 in SH-SY5Y cells. In this study, we investigated the neuroprotective pharmacological effects of PAL against neurotoxin-induced cell and animal models of PD. In cellular models of PD, PAL markedly increased cell viability rates, mitochondrial oxidation-reduction activity and mitochondrial membrane potential, and reduced intracellular ROS levels to prevent neurotoxicity in PC12 cells. In animal models of PD, PAL reduced the apomorphine injection, caused turning in 6-OHDA treated rats, and increased the motor coordination and stride decreases in MPTP treated mice. Meanwhile, in an MPTP mouse model, PAL prevented a decrease of the contents of dopamine (DA) and its metabolites in the striatum and TH-positive dopaminergic neuron loss in the substantia nigra (SN). In addition, PAL increased the protein expression of DJ-1 and reduced the level of a-synuclein in the SN of MPTP lesioned mice. PAL also increased the spine density in hippocampal CA1 neurons. The current study demonstrates that PAL can efficiently protect dopaminergic neurons against neurotoxin injury in vitro and in vivo, and that the potential mechanisms may be related to its effects in increasing DJ-1, decreasing a-synuclein and its growth-promoting effect on spine density.	[Zhao, Xin; An, Ming-Sheng; Yang, Ying-Fan; Ge, Hui-Qi; Liu, Jin-Hao; Pu, Xiao-Ping] Peking Univ, Natl Key Res Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China; [Zhao, Xin; An, Ming-Sheng; Wang, Yue-Hua; Yang, Ying-Fan; Ge, Hui-Qi; Liu, Jin-Hao; Pu, Xiao-Ping] Peking Univ, Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Beijing 100871, Peoples R China; [Zhai, Shenyu] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Wang, Yue-Hua] Chinese Acad Med Sci, Inst Mat Med, Beijing Key Lab Drug Target Identificat & Drug Sc, Beijing 100050, Peoples R China; [Wang, Yue-Hua] Peking Union Med Coll, Beijing 100021, Peoples R China	Peking University; Peking University; Duke University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Pu, XP (corresponding author), Peking Univ, Natl Key Res Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China.	pxp123@bjmu.edu.cn		Zhai, Shenyu/0000-0002-7097-9387	National Natural Science Funds of China [81202937, 30973889]; Significant new drugs creation Five-Year plan special science and Technology Major [2012ZX09103201-042]	National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); Significant new drugs creation Five-Year plan special science and Technology Major	This work was supported by National Natural Science Funds of China (Grant No. 81202937, No. 30973889) and a Grant from Significant new drugs creation Five-Year plan special science and Technology Major (No. 2012ZX09103201-042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batelli S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001884; Beyer MK, 2013, J NEUROL NEUROSUR PS, V84, P23, DOI 10.1136/jnnp-2012-303054; Blesa J, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/845618; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bruck A, 2004, J NEUROL NEUROSUR PS, V75, P1467, DOI 10.1136/jnnp.2003.031237; Camicioli R, 2003, MOVEMENT DISORD, V18, P784, DOI 10.1002/mds.10444; Carlesimo GA, 2012, NEUROLOGY, V78, P1939, DOI 10.1212/WNL.0b013e318259e1c5; Chang ZQ, 2011, J NUTR SCI VITAMINOL, V57, P118, DOI 10.3177/jnsv.57.118; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; DICKSON DW, 1995, NEUROBIOL AGING, V16, P285, DOI 10.1016/0197-4580(95)00013-5; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Du F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004593; Galvin JE, 1999, P NATL ACAD SCI USA, V96, P13450, DOI 10.1073/pnas.96.23.13450; Gao JW, 2011, J PHARMACOL SCI, V115, P36, DOI 10.1254/jphs.10271FP; INGHAM CA, 1989, BRAIN RES, V503, P334, DOI 10.1016/0006-8993(89)91686-7; Khan W, 2012, CNS NEUROL DISORD-DR, V11, P456, DOI 10.2174/187152712800792929; Kim ST, 2010, BRAIN RES, V1306, P176, DOI 10.1016/j.brainres.2009.09.103; Lev N, 2009, J NEURAL TRANSM, V116, P151, DOI 10.1007/s00702-008-0134-4; Li CM, 2012, PHARM BIOL, V50, P413, DOI 10.3109/13880209.2011.608193; Li S, 2011, BIOL PHARM BULL, V34, P1291, DOI 10.1248/bpb.34.1291; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lin E, 2008, J NEUROSCI RES, V86, P108, DOI 10.1002/jnr.21478; Liu F, 2008, J NEUROCHEM, V105, P2435, DOI 10.1111/j.1471-4159.2008.05333.x; Moon CY, 2012, BIOCHEM BIOPH RES CO, V423, P116, DOI 10.1016/j.bbrc.2012.05.092; O'Brien JA, 2006, NAT PROTOC, V1, P977, DOI 10.1038/nprot.2006.145; Ottolini D, 2013, HUM MOL GENET; Paterna JC, 2007, MOL THER, V15, P698, DOI 10.1038/sj.mt.6300067; Perez-Cruz C, 2011, J NEUROSCI, V31, P3926, DOI 10.1523/JNEUROSCI.6142-10.2011; Poewe W, 2009, NEUROLOGY, V72, pS65, DOI 10.1212/WNL.0b013e31819908ce; Purisai MG, 2005, NEUROBIOL DIS, V20, P898, DOI 10.1016/j.nbd.2005.05.028; REBOIS RV, 1980, BIOCHEMISTRY-US, V19, P1240, DOI 10.1021/bi00547a031; Satoh T, 1996, J BIOCHEM-TOKYO, V120, P540; Schnabel J, 2010, NATURE, V466, pS2, DOI 10.1038/466S2b; Shiozaki S, 1999, PSYCHOPHARMACOLOGY, V147, P90, DOI 10.1007/s002130051146; Smith DL, 2009, P NATL ACAD SCI USA, V106, P16877, DOI 10.1073/pnas.0908706106; Soderstrom KE, 2010, EUR J NEUROSCI, V31, P478, DOI 10.1111/j.1460-9568.2010.07077.x; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stephens B, 2005, NEUROSCIENCE, V132, P741, DOI 10.1016/j.neuroscience.2005.01.007; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Sun SY, 2012, BRAIN RES BULL, V88, P609, DOI 10.1016/j.brainresbull.2012.05.013; Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Takahashi-Niki K, 2004, BIOCHEM BIOPH RES CO, V320, P389, DOI 10.1016/j.bbrc.2004.05.187; Tang BS, 2006, HUM MOL GENET, V15, P1816, DOI 10.1093/hmg/ddl104; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Tyler WJ, 2003, J PHYSIOL-LONDON, V553, P497, DOI 10.1113/jphysiol.2003.052639; Vila M, 2000, J NEUROCHEM, V74, P721, DOI 10.1046/j.1471-4159.2000.740721.x; Wang YH, 2013, J FUNCT FOODS, V5, P337, DOI 10.1016/j.jff.2012.11.004; Weintraub D, 2011, ARCH NEUROL-CHICAGO, V68, P1562, DOI 10.1001/archneurol.2011.725; Xing YL, 2012, PHYTOTHER RES, V26, P1334, DOI 10.1002/ptr.3720; Xu Y, 2012, BASIC CLIN PHARMACOL, V110, P384, DOI 10.1111/j.1742-7843.2011.00827.x; Zaja-Milatovic S, 2005, NEUROLOGY, V64, P545, DOI 10.1212/01.WNL.0000150591.33787.A4; Zhang SP, 2010, BIOL PHARM BULL, V33, P1529, DOI 10.1248/bpb.33.1529; Zhao X, 2007, PROTEOM CLIN APPL, V1, P1559, DOI 10.1002/prca.200700077; Zhou WB, 2011, J BIOL CHEM, V286, P14941, DOI 10.1074/jbc.M110.211029; Zhou Z, 2007, ANTIVIR RES, V74, P59, DOI 10.1016/j.antiviral.2006.12.005	58	22	23	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78220	10.1371/journal.pone.0078220	http://dx.doi.org/10.1371/journal.pone.0078220			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205164	Green Submitted, gold, Green Published			2022-12-27	WOS:000326029300149
J	Krstic, D; Boll, W; Noll, M				Krstic, Dimitrije; Boll, Werner; Noll, Markus			Influence of the White Locus on the Courtship Behavior of Drosophila Males	PLOS ONE			English	Article							GENETIC DISSECTION; MELANOGASTER; SEROTONIN; AROUSAL; MEMORY; BIOSYNTHESIS; EXPRESSION; TRYPTOPHAN; DOPAMINE; MUTANTS	Since its discovery by Morgan, the Drosophila white gene has become one of the most intensely studied genes and has been widely used as a genetic marker. Earlier reports that over- and misexpression of White protein in Drosophila males leads to male-male courtship implicated white in courtship control. While previous studies suggested that it is the mislocalization of White protein within cells that causes the courtship phenotype, we demonstrate here that also the lack of extra-retinal White can cause very similar behavioral changes. Moreover, we provide evidence that the lack of White function increases the sexual arousal of males in general, of which the enhanced male-male courtship might be an indirect effect. We further show that white mutant flies are not only optomotor blind but also dazzled by the over-flow of light in daylight. Implications of these findings for the proper interpretation of behavioral studies with white mutant flies are discussed.	[Krstic, Dimitrije; Boll, Werner; Noll, Markus] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland	University of Zurich	Noll, M (corresponding author), Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.	markus.noll@imls.uzh.ch			Swiss National Science Foundation [3100A0-105823]; Kanton Zurich, Switzerland	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Kanton Zurich, Switzerland	This work has been supported by the Swiss National Science Foundation grant 3100A0-105823 (to M.N.) and by the Kanton Zurich, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaka M, 2008, J NEUROGENET, V22, P243, DOI 10.1080/01677060802309629; Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Boll W, 2002, DEVELOPMENT, V129, P5667, DOI 10.1242/dev.00157; Borycz J, 2008, J EXP BIOL, V211, P3454, DOI 10.1242/jeb.021162; BRAND AH, 1993, DEVELOPMENT, V118, P401; Campbell JL, 2001, J NEUROBIOL, V49, P339, DOI 10.1002/neu.10009; Cheng YZ, 2008, GENETICS, V178, P2413, DOI 10.1534/genetics.107.085324; Diegelmann S, 2006, LEARN MEMORY, V13, P72, DOI 10.1101/lm.45506; Ewart GD, 1998, METHOD ENZYMOL, V292, P213; FERGUSON J, 1970, SCIENCE, V168, P499, DOI 10.1126/science.168.3930.499; FRATTA W, 1977, LIFE SCI, V21, P379, DOI 10.1016/0024-3205(77)90518-5; Green MM, 1996, GENETICS, V142, P329; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Hall JC, 2002, J NEUROGENET, V16, P135, DOI 10.1080/01677060215307; HENGSTEN, 1967, KYBERNETIK, V3, P276; Hing ALY, 1996, J NEUROBIOL, V30, P454; Hoyer SC, 2008, CURR BIOL, V18, P159, DOI 10.1016/j.cub.2007.12.052; Jiao RJ, 2001, DEVELOPMENT, V128, P3307; Kain JS, 2012, P NATL ACAD SCI USA, V109, P19834, DOI 10.1073/pnas.1211988109; Kalmus H, 1943, J GENET, V42, P206, DOI 10.1007/BF02982936; KLEMENZ R, 1987, NUCLEIC ACIDS RES, V15, P3947, DOI 10.1093/nar/15.10.3947; Krstic D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004457; Liu T, 2008, J NEUROSCI, V28, P5539, DOI 10.1523/JNEUROSCI.5290-07.2008; Murch SJ, 2000, PLANT CELL REP, V19, P698, DOI 10.1007/s002990000206; Sitaraman D, 2008, P NATL ACAD SCI USA, V105, P5579, DOI 10.1073/pnas.0710168105; Sitaraman D, 2007, J COMP PHYSIOL A, V193, P903, DOI 10.1007/s00359-007-0243-9; STEPHENSON RS, 1983, SYM SOC EXP BIOL, P477; Streiner DL, 1996, CAN J PSYCHIAT, V41, P498, DOI 10.1177/070674379604100805; SULLIVAN DT, 1974, J EXP ZOOL, V188, P225, DOI 10.1002/jez.1401880210; SUMMERS KM, 1982, ADV INSECT PHYSIOL, V16, P119, DOI 10.1016/S0065-2806(08)60153-8; TAGLIAMONTE A, 1969, SCIENCE, V166, P1433, DOI 10.1126/science.166.3911.1433; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; Van Swinderen B, 2011, P ROY SOC B-BIOL SCI, V278, P906, DOI 10.1098/rspb.2010.2564; Villella A, 1997, GENETICS, V147, P1107; Visser JE, 2000, BRAIN RES REV, V32, P449, DOI 10.1016/S0165-0173(99)00094-6; von Lintig J, 2001, P NATL ACAD SCI USA, V98, P1130, DOI 10.1073/pnas.031576398; WU CF, 1977, J GEN PHYSIOL, V69, P705, DOI 10.1085/jgp.69.6.705; Yamamoto D, 1997, ANNU REV ENTOMOL, V42, P551, DOI 10.1146/annurev.ento.42.1.551; ZHANG SD, 1995, P NATL ACAD SCI USA, V92, P5525, DOI 10.1073/pnas.92.12.5525	39	46	47	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77904	10.1371/journal.pone.0077904	http://dx.doi.org/10.1371/journal.pone.0077904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205022	gold, Green Submitted, Green Published			2022-12-27	WOS:000326334500074
J	Peng, Y; Xie, ZX; Liu, JB; Pang, YS; Deng, XW; Xie, ZQ; Xie, LJ; Fan, Q; Luo, SS				Peng, Yi; Xie, Zhi-xun; Liu, Jia-bo; Pang, Yao-shan; Deng, Xian-wen; Xie, Zhi-qin; Xie, Li-ji; Fan, Qing; Luo, Si-si			Epidemiological Surveillance of Low Pathogenic Avian Influenza Virus (LPAIV) from Poultry in Guangxi Province, Southern China	PLOS ONE			English	Article							A VIRUSES; HUMAN INFECTION; HONG-KONG; ORIGIN; TRANSMISSION; EVOLUTION; CELLS; GENE	Low pathogenic avian influenza virus (LPAIV) usually causes mild disease or asymptomatic infection in poultry. However, some LPAIV strains can be transmitted to humans and cause severe infection. Genetic rearrangement and recombination of even low pathogenic influenza may generate a novel virus with increased virulence, posing a substantial risk to public health. Southern China is regarded as the world "influenza epicenter'', due to a rash of outbreaks of influenza in recent years. In this study, we conducted an epidemiological survey of LPAIV at different live bird markets (LBMs) in Guangxi province, Southern China. From January 2009 to December 2011, we collected 3,121 cotton swab samples of larynx, trachea and cloaca from the poultry at LBMs in Guangxi. Virus isolation, hemagglutination inhibition (HI) assay, and RT-PCR were used to detect and subtype LPAIV in the collected samples. Of the 3,121 samples, 336 samples (10.8%) were LPAIV positive, including 54 (1.7%) in chicken and 282 (9.1%) in duck. The identified LPAIV were H3N1, H3N2, H6N1, H6N2, H6N5, H6N6, H6N8, and H9N2, which are combinations of seven HA subtypes (H1, H3, H4, H6, H9, H10 and H11) and five NA subtypes (N1, N2, N5, N6 and N8). The H3 and H9 subtypes are predominant in the identified LPAIVs. Among the 336 cases, 29 types of mixed infection of different HA subtypes were identified in 87 of the cases (25.9%). The mixed infections may provide opportunities for genetic recombination. Our results suggest that the LPAIV epidemiology in poultry in the Guangxi province in southern China is complicated and highlights the need for further epidemiological and genetic studies of LPAIV in this area.	[Peng, Yi; Xie, Zhi-xun; Liu, Jia-bo; Pang, Yao-shan; Deng, Xian-wen; Xie, Zhi-qin; Xie, Li-ji; Fan, Qing; Luo, Si-si] Guangxi Vet Res Inst, Guangxi Key Lab Anim Vaccines & Diagnost, Nanning, Guangxi Provinc, Peoples R China	Guangxi Veterinary Research Institute	Xie, ZX (corresponding author), Guangxi Vet Res Inst, Guangxi Key Lab Anim Vaccines & Diagnost, Nanning, Guangxi Provinc, Peoples R China.	xiezhixun@126.com			Guangxi Science and Technology Bureau [1222003-2 4]; Guangxi Government Senior Scientist Foundation [2011B020]; Guangxi Natural Science Foundation [2011GXNSFA018088, 2013GXNSFDA09015]	Guangxi Science and Technology Bureau; Guangxi Government Senior Scientist Foundation; Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province)	This study was supported by the Guangxi Science and Technology Bureau (1222003-2 4), Guangxi Government Senior Scientist Foundation (2011B020), Guangxi Natural Science Foundation (2011GXNSFA018088), and Guangxi Natural Science Foundation (2013GXNSFDA09015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Bateman AC, 2010, J BIOL CHEM, V285, P34016, DOI 10.1074/jbc.M110.115998; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Chen LM, 2012, VIROLOGY, V422, P105, DOI 10.1016/j.virol.2011.10.006; Claas ECJ, 1998, VACCINE, V16, P977, DOI 10.1016/S0264-410X(98)00005-X; COCKBURN WC, 1969, B WORLD HEALTH ORGAN, V41, P345; Desnos-Ollivier M, 2010, MBIO, V1, DOI 10.1128/mBio.00091-10; Edwards S, 2006, DEV BIOLOGICALS, V124, P159; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Furuse Y, 2010, J CLIN MICROBIOL, V48, P369, DOI 10.1128/JCM.01795-09; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Guo CT, 2007, GLYCOBIOLOGY, V17, P713, DOI 10.1093/glycob/cwm038; Hanashima S, 2007, CHEM-ASIAN J, V2, P1447, DOI 10.1002/asia.200600424; He CQ, 2009, MOL BIOL EVOL, V26, P177, DOI 10.1093/molbev/msn238; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Khiabanian H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007366; Kim JK, 2009, INFLUENZA OTHER RESP, V3, P121, DOI 10.1111/j.1750-2659.2009.00084.x; Kirkeby S, 2009, VIRUS RES, V144, P225, DOI 10.1016/j.virusres.2009.05.004; Ma Wenjun, 2008, J Mol Genet Med, V3, P158; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Reid AH, 2003, J GEN VIROL, V84, P2285, DOI 10.1099/vir.0.19302-0; Shortridge KF, 1998, VIROLOGY, V252, P331, DOI 10.1006/viro.1998.9488; Shortridge KF, 1997, CHINESE MED J-PEKING, V110, P637; SHORTRIDGE KF, 1982, LANCET, V2, P812; Suarez DL, 1998, J VIROL, V72, P6678, DOI 10.1128/JVI.72.8.6678-6688.1998; Walther T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003223; WEBSTER RG, 1987, J VIROL, V61, P2910, DOI 10.1128/JVI.61.9.2910-2916.1987; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Xu C, 2013, EMERG INFECT DIS, V19; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Zhang QY, 2013, SCIENCE, V341, P410, DOI 10.1126/science.1240532; Zhao Chang-an, 2004, Zhonghua Er Ke Za Zhi, V42, P310	33	45	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77132	10.1371/journal.pone.0077132	http://dx.doi.org/10.1371/journal.pone.0077132			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204754	gold, Green Submitted, Green Published			2022-12-27	WOS:000326334500018
J	Gao, ZR; Liu, CL; Zhang, YZ; Li, Y; Yi, KK; Zhao, XH; Cui, ML				Gao, Zhenrui; Liu, Chuanliang; Zhang, Yanzhao; Li, Ying; Yi, Keke; Zhao, Xinhua; Cui, Min-Long			The Promoter Structure Differentiation of a MYB Transcription Factor RLC1 Causes Red Leaf Coloration in Empire Red Leaf Cotton under Light	PLOS ONE			English	Article							ANTHOCYANIN BIOSYNTHETIC-PATHWAY; REGULATORY GENE; DNA-BINDING; ARABIDOPSIS; PROTEIN; PIGMENTATION; EXPRESSION; FAMILY; DOMAIN; FRUIT	The red leaf coloration of Empire Red Leaf Cotton (ERLC) (Gossypium hirsutum L.), resulted from anthocyanin accumulation in light, is a well known dominant agricultural trait. However, the underpin molecular mechanism remains elusive. To explore this, we compared the molecular biological basis of anthocyanin accumulation in both ERLC and the green leaf cotton variety CCRI 24 (Gossypium hirsutum L.). Introduction of R2R3-MYB transcription factor Rosea1, the master regulator anthocyanin biosynthesis in Antirrhinum majus, into CCRI 24 induced anthocyanin accumulation, indicating structural genes for anthocyanin biosynthesis are not defected and the leaf coloration might be caused by variation of regulatory genes expression. Expression analysis found that a transcription factor RLC1 (Red Leaf Cotton 1) which encodes the ortholog of PAP1/Rosea1 was highly expressed in leaves of ERLC but barely expressed in CCRI 24 in light. Ectopic expression of RLC1 from ERLC and CCRI 24 in hairy roots of Antirrhinum majus and CCRI 24 significantly enhanced anthocyanin accumulation. Comparison of RLC1 promoter sequences between ERLC and CCRI 24 revealed two 228-bp tandem repeats presented in ERLC with only one repeat in CCRI 24. Transient assays in cotton leave tissue evidenced that the tandem repeats in ERLC is responsible for light-induced RLC1 expression and therefore anthocyanin accumulation. Taken together, our results in this article strongly support an important step toward understanding the role of R2R3-MYB transcription factors in the regulatory menchanisms of anthocyanin accumulation in red leaf cotton under light.	[Gao, Zhenrui; Zhang, Yanzhao; Li, Ying; Cui, Min-Long] Chinese Acad Sci, Inst Appl Ecol, Key Lab Pollut Ecol & Environm Engn, Shenyang 110016, Peoples R China; [Liu, Chuanliang; Zhao, Xinhua; Cui, Min-Long] State Key Lab Cotton Biol, Anyang, Peoples R China; [Liu, Chuanliang; Zhao, Xinhua] Chinese Acad Agr Sci, Inst Cotton Res, Anyang, Peoples R China; [Yi, Keke] Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Inst Virol & Biotechnol, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Zhejiang Academy of Agricultural Sciences	Cui, ML (corresponding author), Chinese Acad Sci, Inst Appl Ecol, Key Lab Pollut Ecol & Environm Engn, Shenyang 110016, Peoples R China.	min-long.cui@iae.ac.cn	Yi, Keke/P-3964-2017; cui, min/HGD-8340-2022; Yi, Keke/N-8482-2019	Yi, Keke/0000-0002-3916-477X; Yi, Keke/0000-0002-3916-477X	Chinese Academy of Sciences [KSCX3-EW-N-03]; Yunnan Provincial Science and Technology Department [2012IB011]	Chinese Academy of Sciences(Chinese Academy of Sciences); Yunnan Provincial Science and Technology Department	This work was supported by the Chinese Academy of Sciences (grant no. KSCX3-EW-N-03), and the Yunnan Provincial Science and Technology Department (grant no. 2012IB011) to M. L. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius F, 2005, J EXP BOT, V56, P37, DOI 10.1093/jxb/eri004; Aharoni A, 2001, PLANT J, V28, P319, DOI 10.1046/j.1365-313X.2001.01154.x; Albert NW, 2011, PLANT J, V65, P771, DOI 10.1111/j.1365-313X.2010.04465.x; Ali I, 2009, PAK J BOT, V41, P1127; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Butelli E, 2012, PLANT CELL, V24, P1242, DOI 10.1105/tpc.111.095232; Chagne D, 2013, PLANT PHYSIOL, V161, P225, DOI 10.1104/pp.112.206771; Cominelli E, 2008, J PLANT PHYSIOL, V165, P886, DOI 10.1016/j.jplph.2007.06.010; CONE KC, 1993, PLANT CELL, V5, P1795, DOI 10.1105/tpc.5.12.1795; Cui M, 2001, PLANT CELL REP, V20, P55, DOI 10.1007/s002990000277; Debeaujon I, 2003, PLANT CELL, V15, P2514, DOI 10.1105/tpc.014043; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Espley RV, 2009, PLANT CELL, V21, P168, DOI 10.1105/tpc.108.059329; FITT GP, 1994, ANNU REV ENTOMOL, V39, P543, DOI 10.1146/annurev.en.39.010194.002551; GIULIANO G, 1988, P NATL ACAD SCI USA, V85, P7089, DOI 10.1073/pnas.85.19.7089; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; GOODRICH J, 1992, CELL, V68, P955, DOI 10.1016/0092-8674(92)90038-E; GROTEWOLD E, 1991, P NATL ACAD SCI USA, V88, P4587, DOI 10.1073/pnas.88.11.4587; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Jefferson R A, 1987, EMBO J, V6, P3901; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Killough DT, 1933, GENETICS, V18, P0329; Kobayashi S, 2002, PLANTA, V215, P924, DOI 10.1007/s00425-002-0830-5; Kobayashi S, 2004, SCIENCE, V304, P982, DOI 10.1126/science.1095011; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li YJ, 2013, J PROTEOMICS, V78, P374, DOI 10.1016/j.jprot.2012.10.005; Li YY, 2012, PLANT PHYSIOL, V160, P1011, DOI 10.1104/pp.112.199703; Lin-Wang Kui, 2010, BMC Plant Biol, V10, P50, DOI 10.1186/1471-2229-10-50; MARTIN C, 1991, PLANT J, V1, P37, DOI 10.1111/j.1365-313X.1991.00037.x; Matsui K, 2008, PLANT J, V55, P954, DOI 10.1111/j.1365-313X.2008.03565.x; Nesi N, 2000, PLANT CELL, V12, P1863, DOI 10.1105/tpc.12.10.1863; Page M, 2012, PLANT CELL ENVIRON, V35, P388, DOI 10.1111/j.1365-3040.2011.02369.x; Park KI, 2007, PLANT J, V49, P641, DOI 10.1111/j.1365-313X.2006.02988.x; Pattanaik S, 2010, PLANTA, V231, P1061, DOI 10.1007/s00425-010-1108-y; Payne CT, 2000, GENETICS, V156, P1349; Pelletier MK, 1996, PLANT PHYSIOL, V111, P339, DOI 10.1104/pp.111.1.339; Pelletier MK, 1997, PLANT PHYSIOL, V113, P1437, DOI 10.1104/pp.113.4.1437; Piazza P, 2002, PLANT PHYSIOL, V128, P1077, DOI 10.1104/pp.010799; Quattrocchio F, 1999, PLANT CELL, V11, P1433, DOI 10.1105/tpc.11.8.1433; RABINO I, 1986, PLANT PHYSIOL, V81, P922, DOI 10.1104/pp.81.3.922; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; Rose A, 1999, PLANT J, V20, P641, DOI 10.1046/j.1365-313X.1999.00638.x; Rosinski JA, 1998, J MOL EVOL, V46, P74, DOI 10.1007/PL00006285; Routaboul JM, 2006, PLANTA, V224, P96, DOI 10.1007/s00425-005-0197-5; Sainz MB, 1997, PLANT CELL, V9, P611, DOI 10.1105/tpc.9.4.611; Schwinn K, 2006, PLANT CELL, V18, P831, DOI 10.1105/tpc.105.039255; SHEN WJ, 1989, NUCLEIC ACIDS RES, V17, P8385, DOI 10.1093/nar/17.20.8385; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Spelt C, 2002, PLANT CELL, V14, P2121, DOI 10.1105/tpc.003772; STEPHENS SG, 1974, J GENET, V61, P128, DOI 10.1007/BF02984077; Takos AM, 2006, PLANT PHYSIOL, V142, P1216, DOI 10.1104/pp.106.088104; Tamagnone L, 1998, PLANT CELL, V10, P135, DOI 10.1105/tpc.10.2.135; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Matus JT, 2009, J EXP BOT, V60, P853, DOI 10.1093/jxb/ern336; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Walker AR, 2007, PLANT J, V49, P772, DOI 10.1111/j.1365-313X.2006.02997.x; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Xiao YH, 2007, BIOCHEM BIOPH RES CO, V358, P73, DOI 10.1016/j.bbrc.2007.04.084; Zhang F, 2003, DEVELOPMENT, V130, P4859, DOI 10.1242/dev.00681; Zimmermann IM, 2004, PLANT J, V40, P22, DOI 10.1111/j.1365-313X.2004.02183.x	65	25	26	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77891	10.1371/journal.pone.0077891	http://dx.doi.org/10.1371/journal.pone.0077891			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205014	gold, Green Submitted, Green Published			2022-12-27	WOS:000326270700058
J	Southan, C; Varkonyi, P; Boppana, K; Jagarlapudi, SARP; Muresan, S				Southan, Christopher; Varkonyi, Peter; Boppana, Kiran; Jagarlapudi, Sarma A. R. P.; Muresan, Sorel			Tracking 20 Years of Compound-to-Target Output from Literature and Patents	PLOS ONE			English	Article							DIPEPTIDYL PEPTIDASE-IV; IN-VITRO; DISCOVERY; BETA; PRODUCTIVITY; INHIBITION; QUALITY; BACE2	The statistics of drug development output and declining yield of approved medicines has been the subject of many recent reviews. However, assessing research productivity that feeds development is more difficult. Here we utilise an extensive database of structure-activity relationships extracted from papers and patents. We have used this database to analyse published compounds cumulatively linked to nearly 4000 protein target identifiers from multiple species over the last 20 years. The compound output increases up to 2005 followed by a decline that parallels a fall in pharmaceutical patenting. Counts of protein targets have plateaued but not fallen. We extended these results by exploring compounds and targets for one large pharmaceutical company. In addition, we examined collective time course data for six individual protease targets, including average molecular weight of the compounds. We also tracked the PubMed profile of these targets to detect signals related to changes in compound output. Our results show that research compound output had decreased 35% by 2012. The major causative factor is likely to be a contraction in the global research base due to mergers and acquisitions across the pharmaceutical industry. However, this does not rule out an increasing stringency of compound quality filtration and/or patenting cost control. The number of proteins mapped to compounds on a yearly basis shows less decline, indicating the cumulative published target capacity of global research is being sustained in the region of 300 proteins for large companies. The tracking of six individual targets shows uniquely detailed patterns not discernible from cumulative snapshots. These are interpretable in terms of events related to validation and de-risking of targets that produce detectable follow-on surges in patenting. Further analysis of the type we present here can provide unique insights into the process of drug discovery based on the data it actually generates.	[Southan, Christopher] TW2Informatics, Gothenburg, Sweden; [Varkonyi, Peter; Muresan, Sorel] AstraZeneca R&D, Chem Innovat Ctr, Discovery Sci, Molndal, Sweden; [Boppana, Kiran; Jagarlapudi, Sarma A. R. P.] GVK Biosci Pvt Ltd, Hyderabad, Andhra Pradesh, India; [Muresan, Sorel] Banats Univ Agr Sci & Vet Med, Food Control Dept, Timisoara, Romania	AstraZeneca; GVK Biosciences Private Limited; Banat University of Agricultural Sciences & Veterinary Medicine	Muresan, S (corresponding author), AstraZeneca R&D, Chem Innovat Ctr, Discovery Sci, Molndal, Sweden.	sorel.muresan@gmail.com	Southan, Christopher/B-1550-2010; Muresan, Sorel/C-1961-2009	Southan, Christopher/0000-0001-9580-0446; Muresan, Sorel/0000-0003-2386-0436				Agarwal P, 2009, NAT REV DRUG DISCOV, V8, P865, DOI 10.1038/nrd2973; Ahmed Shameer, 2012, Cardiovascular & Hematological Agents in Medicinal Chemistry, V10, P116; Ahren B, 2002, DIABETES CARE, V25, P869, DOI 10.2337/diacare.25.5.869; Barnes MR, 2009, NAT REV DRUG DISCOV, V8, P701, DOI 10.1038/nrd2944; BODUSZEK B, 1994, J MED CHEM, V37, P3969, DOI 10.1021/jm00049a016; Bunnage ME, 2011, NAT CHEM BIOL, V7, P335, DOI 10.1038/nchembio.581; Clark RL, 2010, DRUG DISCOV TODAY, V15, P679, DOI 10.1016/j.drudis.2010.06.003; Esterhazy D, 2011, CELL METAB, V14, P365, DOI 10.1016/j.cmet.2011.06.018; Fisher NDL, 2001, EXPERT OPIN INV DRUG, V10, P417, DOI 10.1517/13543784.10.3.417; Frye S, 2011, NAT REV DRUG DISCOV, V10, P409, DOI 10.1038/nrd3462; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Gustafsson D, 2004, NAT REV DRUG DISCOV, V3, P649, DOI 10.1038/nrd1466; Heifets A, 2012, NUCLEIC ACIDS RES, V40, pD428, DOI 10.1093/nar/gkr919; Holst JJ, 1998, DIABETES, V47, P1663, DOI 10.2337/diabetes.47.11.1663; Jeppsson F, 2012, J BIOL CHEM; Leeson PD, 2011, NAT REV DRUG DISCOV, V10, P749, DOI 10.1038/nrd3552; Macarron R, 2011, NAT REV DRUG DISCOV, V10, P188, DOI 10.1038/nrd3368; Matthews S, 2012, NAT MED, V18, P1445, DOI 10.1038/nm1012-1445; May PC, 2011, J NEUROSCI, V31, P16507, DOI 10.1523/JNEUROSCI.3647-11.2011; Mullard A, 2012, NAT REV DRUG DISCOV, V11, P91, DOI 10.1038/nrd3657; Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961; Muresan S, 2011, DRUG DISCOV TODAY, V16, P1019, DOI 10.1016/j.drudis.2011.10.005; Pammolli F, 2011, NAT REV DRUG DISCOV, V10, P428, DOI 10.1038/nrd3405; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Perzborn E, 2011, NAT REV DRUG DISCOV, V10, P61, DOI 10.1038/nrd3185; Phimister B, 2000, NAT BIOTECHNOL, V18, P16, DOI 10.1038/71846; Sanseau P, 2009, DRUG DISCOV TODAY, V14, P334, DOI 10.1016/j.drudis.2008.12.001; Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681; Southan C, 2012, DRUG DISCOVERY TODAY; Southan C, 2013, EXPERT OPIN THER PAT, V23, P649, DOI 10.1517/13543776.2013.780032; Southan C, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-14; Southan C, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-10; van de Waterbeemd H, 2009, CHEM BIODIVERS, V6, P1760, DOI 10.1002/cbdv.200900056; Walters WP, 2011, J MED CHEM, V54, P6405, DOI 10.1021/jm200504p; Webber PM, 2003, NAT REV DRUG DISCOV, V2, P823, DOI 10.1038/nrd1200	35	15	15	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77142	10.1371/journal.pone.0077142	http://dx.doi.org/10.1371/journal.pone.0077142			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204758	Green Submitted, Green Published, gold			2022-12-27	WOS:000326270700019
J	Hu, ZG; Shen, WJ; Cortez, Y; Tang, XD; Liu, LF; Kraemer, FB; Azhar, S				Hu, Zhigang; Shen, Wen-Jun; Cortez, Yuan; Tang, Xudong; Liu, Li-Fen; Kraemer, Fredric B.; Azhar, Salman			Hormonal Regulation of MicroRNA Expression in Steroid Producing Cells of the Ovary, Testis and Adrenal Gland	PLOS ONE			English	Article							LOW-DENSITY LIPOPROTEIN; RECEPTOR CLASS-B; GENE-EXPRESSION; POSTTRANSCRIPTIONAL REGULATION; STEROIDOGENESIS; IDENTIFICATION; CHOLESTEROL; PROTEIN; MIRNAS; BIOSYNTHESIS	Background: Given the emerging roles of miRNAs as potential posttranscriptional/posttranslational regulators of the steroidogenic process in adrenocortical and gonadal cells, we sought to determine miRNA profiles in rat adrenals from animals treated with vehicle, ACTH, 17 alpha-E2 or dexamethasone. Key observations were also confirmed using hormone (Bt(2)cAMP)-treated mouse Leydig tumor cells, MLTC-1, and primary rat ovarian granulosa cells. Methodology: RNA was extracted from rat adrenal glands and miRNA profiles were established using microarray and confirmed with qRT-PCR. The expression of some of the hormone-sensitive miRNAs was quantified in MLTC-1 and granulosa cells after stimulation with Bt(2)cAMP. Targets of hormonally altered miRNAs were explored by qRT-PCR and Western blotting in adrenals and granulosa cells. Results: Adrenals from ACTH, 17 alpha-E2 and dexamethasone treated rats exhibited miRNA profiles distinct from control animals. ACTH up-regulated the expression of miRNA-212, miRNA-182, miRNA-183, miRNA-132, and miRNA-96 and down-regulated the levels of miRNA-466b, miRNA-214, miRNA-503, and miRNA-27a. The levels of miR-212, miRNA-183, miRNA-182, miRNA-132, miRNA-370, miRNA-377, and miRNA-96 were up-regulated, whereas miR-125b, miRNA-200b, miR-122, miRNA-466b, miR-138, miRNA-214, miRNA-503 and miRNA27a were down-regulated in response to 17 alpha-E2 treatment. Dexamethasone treatment decreased miRNA-200b, miR-122, miR-19a, miRNA-466b and miRNA27a levels, but increased miRNA-183 levels. Several adrenal miRNAs are subject to regulation by more than one hormone. Significant cAMP-induced changes in certain miRNAs were also noted in MLTC-1 and granulosa cells. Some of the hormone-induced miRNAs in steroidogenic cells were predicted to target proteins involved in lipid metabolism/steroidogenesis. We also obtained evidence that miR-132 and miRNA-214 inhibit the expression of SREBP-1c and LDLR, respectively. Conclusion: Our results demonstrate that expression of a number of miRNAs in steroidogenic cells of the testis, ovary and adrenal glands is subject to hormonal regulation and that miRNAs and their regulation by specific hormones are likely to play a key role in posttranscriptional/posttranslational regulation of steroidogenesis.	[Hu, Zhigang; Shen, Wen-Jun; Cortez, Yuan; Tang, Xudong; Liu, Li-Fen; Kraemer, Fredric B.; Azhar, Salman] VA Palo Alto Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Palo Alto, CA USA; [Hu, Zhigang; Shen, Wen-Jun; Tang, Xudong; Liu, Li-Fen; Kraemer, Fredric B.] Stanford Univ, Div Endocrinol, Stanford, CA 94305 USA; [Azhar, Salman] Stanford Univ, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University	Azhar, S (corresponding author), VA Palo Alto Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Palo Alto, CA USA.	salman.azhar@va.gov	Kraemer, Fredric/AAC-3633-2019	Kraemer, Fredric/0000-0003-2468-7807; Shen, Wen-Jun/0000-0001-5150-1698	Office of Research and Development, Medical Service, Department of Veterans Affairs and Public Health Services [R01HL33881]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033881] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001923, I01BX000398] Funding Source: NIH RePORTER	Office of Research and Development, Medical Service, Department of Veterans Affairs and Public Health Services; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Office of Research and Development, Medical Service, Department of Veterans Affairs and Public Health Services Grant R01HL33881. The fund sponsors had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ahn HW, 2010, MOL HUM REPROD, V16, P463, DOI 10.1093/molehr/gaq017; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Azhar S, 2002, J LIPID RES, V43, P861; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Carletti MZ, 2010, BIOL REPROD, V83, P286, DOI 10.1095/biolreprod.109.081448; Christenson L. K., 2010, Animal Reproduction, V7, P129; da Silveira Juliano C, 2012, Biol Reprod, V86, P71, DOI 10.1095/biolreprod.111.093252; Donadeu FX, 2012, J ENDOCRINOL, V215, P323, DOI 10.1530/JOE-12-0252; EPSTEIN LF, 1991, MOL CELL ENDOCRINOL, V81, P113, DOI 10.1016/0303-7207(91)90210-J; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fiedler SD, 2008, BIOL REPROD, V79, P1030, DOI 10.1095/biolreprod.108.069690; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Finnegan EF, 2013, CRIT REV BIOCHEM MOL, V48, P51, DOI 10.3109/10409238.2012.738643; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gillen AE, 2011, BIOCHEM J, V438, P25, DOI 10.1042/BJ20110672; Hossain MM, 2012, CELL TISSUE RES, V349, P679, DOI 10.1007/s00441-012-1469-6; Hossain MM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-443; Hu J, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-47; Hu ZG, 2013, J BIOL CHEM, V288, P11416, DOI 10.1074/jbc.M112.437368; Hu ZG, 2012, MOL CELL BIOL, V32, P5035, DOI 10.1128/MCB.01002-12; Huang JM, 2011, INT J BIOL SCI, V7, P1016, DOI 10.7150/ijbs.7.1016; KELLERWOOD ME, 1984, ENDOCR REV, V5, P1, DOI 10.1210/edrv-5-1-1; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; KOVANEN PT, 1980, J BIOL CHEM, V255, P5591; KOVANEN PT, 1979, J BIOL CHEM, V254, P1367; Kraemer FB, 2002, J LIPID RES, V43, P1585, DOI 10.1194/jlr.R200009-JLR200; Krishnan K, 2013, RNA, V19, P230, DOI 10.1261/rna.034926.112; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; LaVoie HA, 2009, EXP BIOL MED, V234, P880, DOI 10.3181/0903-MR-97; LeHoux JG, 1998, ENDOCRINOLOGY, V139, P3913, DOI 10.1210/en.139.9.3913; Lei L, 2010, MOL CELL ENDOCRINOL, V315, P63, DOI 10.1016/j.mce.2009.09.021; Li MT, 2011, INT J INNOV COMPUT I, V7, P1055; Lin F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038640; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma TH, 2011, J APPL GENET, V52, P481, DOI 10.1007/s13353-011-0055-z; Manna P. R., 2011, J SIGNAL TRANSDUCT, V2011, DOI [10.1155/2011/821615, DOI 10.1155/2011/821615]; Manna PR, 2009, MOL HUM REPROD, V15, P321, DOI 10.1093/molehr/gap025; McBride D, 2012, REPRODUCTION, V144, P221, DOI 10.1530/REP-12-0025; Miles JR, 2012, ANIM REPROD SCI, V130, P16, DOI 10.1016/j.anireprosci.2011.12.021; Miller WL, 2011, J LIPID RES, V52, P2111, DOI 10.1194/jlr.R016675; Miller Walter L., 2008, V13, P1, DOI 10.1159/000134751; MILLER WL, 1988, ENDOCR REV, V9, P295, DOI 10.1210/edrv-9-3-295; Mishima T, 2008, REPRODUCTION, V136, P811, DOI 10.1530/REP-08-0349; Pan Q, 2008, J CELL MOL MED, V12, P227, DOI 10.1111/j.1582-4934.2007.00207.x; PAYNE AH, 1992, J STEROID BIOCHEM, V43, P895, DOI 10.1016/0960-0760(92)90317-C; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; PON LA, 1988, ENDOCRINOLOGY, V123, P1942, DOI 10.1210/endo-123-4-1942; PON LA, 1986, J BIOL CHEM, V261, P3309; Reaven E, 1996, J BIOL CHEM, V271, P16208, DOI 10.1074/jbc.271.27.16208; Riester A, 2012, ENDOCRINOLOGY, V153, P212, DOI 10.1210/en.2011-1285; Ro S, 2007, RNA, V13, P2366, DOI 10.1261/rna.754207; Rone MB, 2009, BBA-MOL CELL BIOL L, V1791, P646, DOI 10.1016/j.bbalip.2009.03.001; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; SIMPSON E, 1992, J STEROID BIOCHEM, V41, P409, DOI 10.1016/0960-0760(92)90366-Q; SIMPSON ER, 1988, ANNU REV PHYSIOL, V50, P427, DOI 10.1146/annurev.ph.50.030188.002235; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Sirotkin AV, 2009, J CELL PHYSIOL, V219, P415, DOI 10.1002/jcp.21689; Stocco DM, 1996, ENDOCR REV, V17, P221, DOI 10.1210/er.17.3.221; Stocco DM, 2001, ANNU REV PHYSIOL, V63, P193, DOI 10.1146/annurev.physiol.63.1.193; Tesfaye D, 2009, MOL REPROD DEV, V76, P665, DOI 10.1002/mrd.21005; Tripurani SK, 2010, ANIM REPROD SCI, V120, P16, DOI 10.1016/j.anireprosci.2010.03.001; Venkataraman S, 2013, J BIOL CHEM, V288, P1918, DOI 10.1074/jbc.M112.396762; VERSCHOORKLOOTWYK AH, 1982, J BIOL CHEM, V257, P7666; Yao GD, 2010, MOL ENDOCRINOL, V24, P540, DOI 10.1210/me.2009-0432; Yao N, 2010, ENDOCRINE, V38, P158, DOI 10.1007/s12020-010-9345-1; Zhang Q, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054250, 10.1371/journal.pone.0059667]	72	56	62	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e78040	10.1371/journal.pone.0078040	http://dx.doi.org/10.1371/journal.pone.0078040			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24205079	Green Published, gold, Green Submitted			2022-12-27	WOS:000326241200050
J	Kong, XY; Zhang, YQ; Liu, CF; Guo, W; Li, XB; Su, XH; Wan, HY; Sun, YQ; Lin, N				Kong, Xiangying; Zhang, Yanqiong; Liu, Chunfang; Guo, Wei; Li, Xiangbin; Su, Xiaohui; Wan, Hongye; Sun, Yanqun; Lin, Na			Anti-Angiogenic Effect of Triptolide in Rheumatoid Arthritis by Targeting Angiogenic Cascade	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; ENDOTHELIAL GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; WILFORDII HOOK-F; TNF-ALPHA; DITERPENOID TRIEPOXIDE; SYNOVIAL FIBROBLASTS; CHRONIC INFLAMMATION; CELL PROLIFERATION; SUPPRESSES	Rheumatoid arthritis (RA) is characterized by a pre-vascular seriously inflammatory phase, followed by a vascular phase with high increase in vessel growth. Since angiogenesis has been considered as an essential event in perpetuating inflammatory and immune responses, as well as supporting pannus growth and development of RA, inhibition of angiogenesis has been proposed as a novel therapeutic strategy for RA. Triptolide, a diterpenoid triepoxide from Tripterygium wilfordii Hook F, has been extensively used in treatment of RA patients. It also acts as a small molecule inhibitor of tumor angiogenesis in several cancer types. However, it is unclear whether triptolide possesses an anti-angiogenic effect in RA. To address this problem, we constructed collagen-induced arthritis (CIA) model using DA rats by the injection of bovine type II collagen. Then, CIA rats were treated with triptolide (11-45 mu g/kg/day) starting on the day 1 after first immunization. The arthritis scores (P<0.05) and the arthritis incidence (P<0.05) of inflamed joints were both significantly decreased in triptolide-treated CIA rats compared to vehicle CIA rats. More interestingly, doses of 11 similar to 45 mu g/kg triptolide could markedly reduce the capillaries, small, medium and large vessel density in synovial membrane tissues of inflamed joints (all P<0.05). Moreover, triptolide inhibited matrigel-induced cell adhesion of HFLS-RA and HUVEC. It also disrupted tube formation of HUVEC on matrigel and suppressed the VEGF-induced chemotactic migration of HFLS-RA and HUVEC, respectively. Furthermore, triptolide significantly reduced the expression of angiogenic activators including TNF-alpha, IL-17, VEGF, VEGFR, Ang-1, Ang-2 and Tie2, as well as suppressed the IL1-beta-induced phosphorylated of ERK, p38 and JNK at protein levels. In conclusion, our data suggest for the first time that triptolide may possess anti-angiogenic effect in RA both in vivo and in vitro assay systems by downregulating the angiogenic activators and inhibiting the activation of mitogen-activated protein kinase downstream signal pathway.	[Kong, Xiangying; Zhang, Yanqiong; Liu, Chunfang; Guo, Wei; Li, Xiangbin; Su, Xiaohui; Wan, Hongye; Sun, Yanqun; Lin, Na] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China	China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS	Lin, N (corresponding author), China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China.	linna888@163.com			national drug research and development projects [2009ZX09502-019, 2009ZX09301-005-007]; China Academy of Chinese Medical Sciences [ZZ20090105]; Beijing Natural Science Foundation [7062051]; National Natural Science Foundation of China [81274167, 30672647]	national drug research and development projects; China Academy of Chinese Medical Sciences(Chinese Academy of Sciences); Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the national drug research and development projects (2009ZX09502-019, 2009ZX09301-005-007), the project of China Academy of Chinese Medical Sciences (ZZ20090105), the Beijing Natural Science Foundation (7062051), and the National Natural Science Foundation of China (81274167, 30672647). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottomley MJ, 1999, CLIN EXP IMMUNOL, V117, P171; Brenner M, 2005, ARTHRITIS RHEUM-US, V52, P322, DOI 10.1002/art.20782; Chen YJ, 2009, LIFE SCI, V85, P642, DOI 10.1016/j.lfs.2009.09.003; Chen Zhan Kun, 2008, Beijing Da Xue Xue Bao Yi Xue Ban, V40, P567; Ding Yi, 2005, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V22, P778; Ding Yi, 2005, Sichuan Da Xue Xue Bao Yi Xue Ban, V36, P347; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fuchs Ota, 2010, Curr Mol Pharmacol, V3, P98; Goldbach-Mansky R, 2009, ANN INTERN MED, V151, P229, DOI 10.7326/0003-4819-151-4-200908180-00005; Gu WZ, 1998, INT J IMMUNOPHARMACO, V20, P389, DOI 10.1016/S0192-0561(98)00035-6; Guadagni F, 2007, IN VIVO, V21, P147; Hangai M, 2006, J NEUROIMMUNOL, V171, P45, DOI 10.1016/j.jneuroim.2005.09.018; He MF, 2010, INT J CANCER, V126, P266, DOI 10.1002/ijc.24694; HIRATA S, 1989, ARTHRITIS RHEUM, V32, P1065, DOI 10.1002/anr.1780320903; Karamysheva AF, 2008, BIOCHEMISTRY-MOSCOW+, V73, P751, DOI 10.1134/S0006297908070031; Kok T. W., 2005, Angiogenesis, V8, P3, DOI 10.1007/s10456-005-2892-z; Konisti S, 2012, NAT REV RHEUMATOL, V8, P153, DOI 10.1038/nrrheum.2011.205; Li H, 2010, CANCER GENE THER, V17, P700, DOI 10.1038/cgt.2010.26; Lin N, 2001, ARTHRITIS RHEUM-US, V44, P2193, DOI 10.1002/1529-0131(200109)44:9&lt;2193::AID-ART373&gt;3.0.CO;2-5; Lin N, 2007, BIOCHEM PHARMACOL, V73, P136, DOI 10.1016/j.bcp.2006.08.027; Liu CF, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/626038; Lu Y, 2008, INFLAMM RES, V57, P260, DOI 10.1007/s00011-007-7128-9; Mantovani A, 2009, NATURE, V457, P36, DOI 10.1038/457036b; Marrelli A, 2011, AUTOIMMUN REV, V10, P595, DOI 10.1016/j.autrev.2011.04.020; Maruotti N, 2006, HISTOL HISTOPATHOL, V21, P557, DOI 10.14670/HH-21.557; Matta R, 2009, AM J TRANSL RES, V1, P267; Mould AW, 2003, ARTHRITIS RHEUM-US, V48, P2660, DOI 10.1002/art.11232; Nagashima M, 2000, RHEUMATOLOGY, V39, P1255, DOI 10.1093/rheumatology/39.11.1255; Paleolog EM, 1998, ARTHRITIS RHEUM, V41, P1258, DOI 10.1002/1529-0131(199807)41:7<1258::AID-ART17>3.0.CO;2-1; Pan Xiao-dong, 2008, Yaoxue Xuebao, V43, P1179; Pickens SR, 2010, J IMMUNOL, V184, P3233, DOI 10.4049/jimmunol.0903271; Remmers EF, 2002, ARTHRITIS RHEUM, V46, P2225, DOI 10.1002/art.10439; ROTHSCHILD BM, 1982, ARTHRITIS RHEUM, V25, P588, DOI 10.1002/art.1780250516; Saeki Y, 2012, EXPERT REV CLIN IMMU, V8, P455, DOI [10.1586/eci.12.35, 10.1586/ECI.12.35]; Sun LX, 2011, BIOCHEM BIOPH RES CO, V416, P99, DOI 10.1016/j.bbrc.2011.11.004; Thairu N, 2011, ANGIOGENESIS, V14, P223, DOI 10.1007/s10456-011-9208-2; Wang JX, 2012, ANAT REC, V295, P922, DOI 10.1002/ar.22479; Wang Y, 2008, SCAND J IMMUNOL, V68, P383, DOI 10.1111/j.1365-3083.2008.02147.x; Wang YF, 2007, PHARMACOL REP, V59, P795; Xiao Cheng, 2009, Chin Med, V4, P13, DOI 10.1186/1749-8546-4-13; Xiao C, 2009, NAT PROD RES, V23, P1699, DOI 10.1080/14786410802187783; Xue M, 2010, FITOTERAPIA, V81, P1109, DOI 10.1016/j.fitote.2010.07.007; Yang YL, 1998, IMMUNOPHARMACOLOGY, V40, P139, DOI 10.1016/S0162-3109(98)00036-8; Zhang Wan-Dong, 2007, Zhongguo Zhong Yao Za Zhi, V32, P414; Zhang WD, 2007, PLANTA MED, V73, P336, DOI 10.1055/s-2007-967136; Zhu WB, 2010, VASC PHARMACOL, V52, P46, DOI 10.1016/j.vph.2009.10.006; Zhu WB, 2009, MOL PHARMACOL, V75, P812, DOI 10.1124/mol.108.052605	47	55	65	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77513	10.1371/journal.pone.0077513	http://dx.doi.org/10.1371/journal.pone.0077513			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204851	Green Submitted, Green Published, gold			2022-12-27	WOS:000326241200030
J	Plaza-Diaz, J; Gomez-Llorente, C; Campana-Martin, L; Matencio, E; Ortuno, I; Martinez-Silla, R; Gomez-Gallego, C; Periago, MJ; Ros, G; Chenoll, E; Genoves, S; Casinos, B; Silva, A; Corella, D; Portoles, O; Romero, F; Ramon, D; de la Cruz, AP; Gil, A; Fontana, L				Plaza-Diaz, Julio; Gomez-Llorente, Carolina; Campana-Martin, Laura; Matencio, Esther; Ortuno, Inmaculada; Martinez-Silla, Rosario; Gomez-Gallego, Carlos; Jesus Periago, Maria; Ros, Gaspar; Chenoll, Empar; Genoves, Salvador; Casinos, Beatriz; Silva, Angela; Corella, Dolores; Portoles, Olga; Romero, Fernando; Ramon, Daniel; Perez de la Cruz, Antonio; Gil, Angel; Fontana, Luis			Safety and Immunomodulatory Effects of Three Probiotic Strains Isolated from the Feces of Breast-Fed Infants in Healthy Adults: SETOPROB Study	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; CLOSTRIDIUM-DIFFICILE; BIFIDOBACTERIUM; PROBES; IDENTIFICATION; VALIDATION; MICROBIOTA; BACTERIA; FLORA	We previously described the isolation and characterization of three probiotic strains from the feces of exclusively breast-fed newborn infants: Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036. These strains were shown to adhere to intestinal mucus in vitro, to be sensitive to antibiotics and to resist biliary salts and low pH. In the present study, a multicenter, randomized, double-blind, placebo-controlled trial with 100 healthy volunteers in three Spanish cities was carried out to evaluate the tolerance, safety, gut colonization and immunomodulatory effects of these three probiotics. Volunteers underwent a 15-day washout period, after which they were randomly divided into 5 groups that received daily a placebo, a capsule containing one of the 3 strains or a capsule containing a mixture of two strains for 30 days. The intervention was followed by another 15-day washout period. Patients did not consume fermented milk for the entire duration of the study. Gastrointestinal symptoms, defecation frequency and stool consistency were not altered by probiotic intake. No relevant changes in blood and serum, as well as no adverse events occurred during or after treatment. Probiotic administration slightly modified bacterial populations in the volunteers' feces. Intestinal persistence occurred in volunteers who received L. rhamnosus CNCM I-4036. Administration of B. breve CNCM I-4035 resulted in a significant increase in fecal secretory IgA content. IL-4 and IL-10 increased, whereas IL-12 decreased in the serum of volunteers treated with any of the three strains. These results demonstrate that the consumption of these three bacterial strains was safe and exerted varying degrees of immunomodulatory effects.	[Plaza-Diaz, Julio; Gomez-Llorente, Carolina; Gil, Angel; Fontana, Luis] Univ Granada, Sch Pharm, Dept Biochem & Mol Biol 2, Granada, Spain; [Plaza-Diaz, Julio; Gomez-Llorente, Carolina; Campana-Martin, Laura; Gil, Angel; Fontana, Luis] Univ Granada, Inst Nutr & Food Technol Jose Mataix, Biomed Res Ctr, Granada, Spain; [Matencio, Esther; Ortuno, Inmaculada; Martinez-Silla, Rosario; Romero, Fernando] Hero Spain SA, Hero Global Technol Ctr, Murcia, Spain; [Gomez-Gallego, Carlos; Jesus Periago, Maria; Ros, Gaspar] Univ Murcia, Dept Human Nutr & Food Sci, Fac Vet Sci, Murcia, Spain; [Chenoll, Empar; Genoves, Salvador; Casinos, Beatriz; Silva, Angela; Ramon, Daniel] Parc Cient Univ Valencia, Biopolis Sl, Dept Food Biotechnol, Valencia, Spain; [Corella, Dolores] Univ Valencia, Dept Prevent Med & Publ Hlth, Valencia, Spain; [Corella, Dolores; Portoles, Olga] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr, Madrid, Spain; [Perez de la Cruz, Antonio] Virgen de las Nieves Hosp, Unit Nutr & Dietet, Granada, Spain	University of Granada; University of Granada; University of Murcia; University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Hospital Universitario Virgen de las Nieves	Fontana, L (corresponding author), Univ Granada, Sch Pharm, Dept Biochem & Mol Biol 2, Granada, Spain.	fontana@ugr.es	Gomez-Gallego, Carlos/M-2523-2014; Plaza-Diaz, Julio/C-8094-2016; Llorente, Carolina Gomez/K-7484-2015; Berruezo, Gaspar Ros/ABE-8913-2020; Gómez-Gallego, Carlos/ABH-9091-2020; Fontana, Luis/K-5528-2015; Periago, María Jesús/K-5251-2017; Gómez-Gallego, Carlos/GGG-6822-2022; Chenoll, Empar/S-1446-2019; Gil, Angel/ABA-7621-2020; Gil, Angel/L-2275-2014; Chenoll, Empar/I-3174-2017	Gomez-Gallego, Carlos/0000-0003-0219-1827; Plaza-Diaz, Julio/0000-0002-5171-9408; Llorente, Carolina Gomez/0000-0003-3948-1473; Berruezo, Gaspar Ros/0000-0002-8894-4481; Fontana, Luis/0000-0001-8395-8393; Gómez-Gallego, Carlos/0000-0003-0219-1827; Gil, Angel/0000-0001-7663-0939; Gil, Angel/0000-0001-7663-0939; Chenoll, Empar/0000-0002-6891-3573	company Hero Spain, S. A. [3582]	company Hero Spain, S. A.	Part of the research currently in progress in the authors' laboratory is funded by the company Hero Spain, S. A. through the grant #3582 managed by the Fundacion General Empresa-Universidad de Granada. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bermudez-Brito M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059370; Bermudez-Brito M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043197; Collins JK, 1998, INT DAIRY J, V8, P487, DOI 10.1016/S0958-6946(98)00073-9; Fallani M, 2006, J MICROBIOL METH, V67, P150, DOI 10.1016/j.mimet.2006.03.010; Fallani M, 2010, J PEDIATR GASTR NUTR, V51, P77, DOI 10.1097/MPG.0b013e3181d1b11e; FAO/WHO, 2002, GUIDELINES EVALUATIO; Fontana L, 2013, BRIT J NUTR, V109, pS35, DOI 10.1017/S0007114512004011; Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336; Frick JS, 2007, INFLAMM BOWEL DIS, V13, P83, DOI 10.1002/ibd.20009; Gomez-Llorente C, 2013, J PEDIAT GA IN PRESS; GORBACH SL, 1987, LANCET, V2, P1519; Gourbeyre P, 2011, J LEUKOCYTE BIOL, V89, P685, DOI 10.1189/jlb.1109753; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Harmsen Hermie J.M., 1999, Microbial Ecology in Health and Disease, V11, P3, DOI 10.1080/089106099435862; Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019; LANGENDIJK PS, 1995, APPL ENVIRON MICROB, V61, P3069, DOI 10.1128/AEM.61.8.3069-3075.1995; Lawrence SJ, 2005, J MED MICROBIOL, V54, P905, DOI 10.1099/jmm.0.46096-0; Lay C, 2005, ENVIRON MICROBIOL, V7, P933, DOI 10.1111/j.1462-2920.2005.00763.x; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Makelainen H, 2003, MICROBIOL IMMUNOL, V47, P911, DOI 10.1111/j.1348-0421.2003.tb03464.x; Mantis NJ, 2011, MUCOSAL IMMUNOL, V4, P603, DOI 10.1038/mi.2011.41; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Munoz-Quezada S, 2013, BRIT J NUTR, V109, pS51, DOI 10.1017/S0007114512005211; Na X, 2011, J CLIN GASTROENTEROL, V45, pS154, DOI 10.1097/MCG.0b013e31822ec787; Ouwehand AC, 2002, ANTON LEEUW INT J G, V82, P279, DOI 10.1023/A:1020620607611; Rios S., 1967, METODOS ESTADISTICOS; SCARDOVI V, 1986, BERGEYS MANUAL SYSTE, V2, P1418; Sghir A, 2000, APPL ENVIRON MICROB, V66, P2263, DOI 10.1128/AEM.66.5.2263-2266.2000; SVEDLUND J, 1988, DIGEST DIS SCI, V33, P129, DOI 10.1007/BF01535722; Van Aerde J, 2003, INT PEDIAT, V18, P95; Vankerckhoven V, 2008, TRENDS FOOD SCI TECH, V19, P102, DOI 10.1016/j.tifs.2007.07.013; Whelan K, 2004, EUR J CLIN NUTR, V58, P1030, DOI 10.1038/sj.ejcn.1601927; Wind RD, 2010, BRIT J NUTR, V104, P1806, DOI 10.1017/S0007114510002746	33	30	32	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e78111	10.1371/journal.pone.0078111	http://dx.doi.org/10.1371/journal.pone.0078111			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24205115	Green Published, Green Submitted, gold			2022-12-27	WOS:000326241200053
J	Acencio, ML; Bovolenta, LA; Camilo, E; Lemke, N				Acencio, Marcio Luis; Bovolenta, Luiz Augusto; Camilo, Esther; Lemke, Ney			Prediction of Oncogenic Interactions and Cancer-Related Signaling Networks Based on Network Topology	PLOS ONE			English	Article							BETA-CATENIN; CYCLIN D1; GENES; INTEGRATION; KEGG	Cancer has been increasingly recognized as a systems biology disease since many investigators have demonstrated that this malignant phenotype emerges from abnormal protein-protein, regulatory and metabolic interactions induced by simultaneous structural and regulatory changes in multiple genes and pathways. Therefore, the identification of oncogenic interactions and cancer-related signaling networks is crucial for better understanding cancer. As experimental techniques for determining such interactions and signaling networks are labor-intensive and time-consuming, the development of a computational approach capable to accomplish this task would be of great value. For this purpose, we present here a novel computational approach based on network topology and machine learning capable to predict oncogenic interactions and extract relevant cancer-related signaling subnetworks from an integrated network of human genes interactions (INHGI). This approach, called graph2sig, is twofold: first, it assigns oncogenic scores to all interactions in the INHGI and then these oncogenic scores are used as edge weights to extract oncogenic signaling subnetworks from INHGI. Regarding the prediction of oncogenic interactions, we showed that graph2sig is able to recover 89% of known oncogenic interactions with a precision of 77%. Moreover, the interactions that received high oncogenic scores are enriched in genes for which mutations have been causally implicated in cancer. We also demonstrated that graph2sig is potentially useful in extracting oncogenic signaling subnetworks: more than 80% of constructed subnetworks contain more than 50% of original interactions in their corresponding oncogenic linear pathways present in the KEGG PATHWAY database. In addition, the potential oncogenic signaling subnetworks discovered by graph2sig are supported by experimental evidence. Taken together, these results suggest that graph2sig can be a useful tool for investigators involved in cancer research interested in detecting signaling networks most prone to contribute with the emergence of malignant phenotype.	[Acencio, Marcio Luis; Bovolenta, Luiz Augusto; Camilo, Esther; Lemke, Ney] Univ Estadual Paulista, Dept Phys & Biophys, Botucatu Biosci Inst, Sao Paulo, Brazil	Universidade Estadual Paulista	Acencio, ML (corresponding author), Univ Estadual Paulista, Dept Phys & Biophys, Botucatu Biosci Inst, Sao Paulo, Brazil.	mlacencio@ibb.unesp.br	Lemke, Ney/L-6761-2019; Acencio, Marcio L/D-9264-2012; Lemke, Ney/A-8213-2008; Bovolenta, Luiz Augusto/AAQ-6356-2021; Acencio, Marcio Luis/ABH-1930-2020	Lemke, Ney/0000-0001-7463-4303; Acencio, Marcio L/0000-0002-8278-240X; Lemke, Ney/0000-0001-7463-4303; Bovolenta, Luiz Augusto/0000-0002-8116-8280; Acencio, Marcio Luis/0000-0002-8278-240X	Sao Paulo Research Foundation [2010/20684-3, 2012/13450-1, 2012/00741-8, 2013/02018-4]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work has been supported by grants #2010/20684-3, #2012/13450-1, #2012/00741-8 and #2013/02018-4 from the Sao Paulo Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acencio ML, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-290; Bovolenta LA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-405; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Coluccia AML, 2007, EMBO J, V26, P1456, DOI 10.1038/sj.emboj.7601485; Costa PR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S5-S9; Cui QH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100200; Demsar J, 2006, J MACH LEARN RES, V7, P1; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; FILMUS J, 1994, ONCOGENE, V9, P3627; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hand DJ, 2001, MACH LEARN, V45, P171, DOI 10.1023/A:1010920819831; Huang J, 2005, IEEE T KNOWL DATA EN, V17, P299, DOI 10.1109/TKDE.2005.50; Huss M, 2007, IET SYST BIOL, V1, P280, DOI 10.1049/iet-syb:20060077; Ivanov VN, 2001, MOL CELL, V7, P517, DOI 10.1016/S1097-2765(01)00199-X; Jaganathan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019605; Jimenez VM, 1999, LECT NOTES COMPUT SC, V1668, P15; Kandasamy K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r3; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kim JK, 2009, J CELL PHYSIOL, V220, P292, DOI 10.1002/jcp.21791; Kittler J, 1998, IEEE T PATTERN ANAL, V20, P226, DOI 10.1109/34.667881; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Malempati S, 2006, LEUKEMIA, V20, P1572, DOI 10.1038/sj.leu.2404317; da Silva JPM, 2008, PHYSICA A, V387, P1049, DOI 10.1016/j.physa.2007.10.044; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Schaefer MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031826; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; Syed ZA, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-180; Wang E, 2007, CELL MOL LIFE SCI, V64, P1752, DOI 10.1007/s00018-007-7054-6; Wang E, 2010, CH CRC MATH COMP BIO, P1, DOI 10.1201/9781439811863-f; Wang E, 2012, CANC LETT; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; WILCOXON F, 1947, BIOMETRICS, V3, P119, DOI 10.2307/3001946; Witten I.H., 2000, DATA MINING PRACTICA	37	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77521	10.1371/journal.pone.0077521	http://dx.doi.org/10.1371/journal.pone.0077521			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204854	Green Submitted, Green Published, gold			2022-12-27	WOS:000326155400041
J	Yuan, C; Sun, YN				Yuan, Cheng; Sun, Yanni			RNA-CODE: A Noncoding RNA Classification Tool for Short Reads in NGS Data Lacking Reference Genomes	PLOS ONE			English	Article							GENES; EXPRESSION; MICRORNAS; ALIGNMENT	The number of transcriptomic sequencing projects of various non-model organisms is still accumulating rapidly. As non-coding RNAs (ncRNAs) are highly abundant in living organism and play important roles in many biological processes, identifying fragmentary members of ncRNAs in small RNA-seq data is an important step in post-NGS analysis. However, the state-of-the-art ncRNA search tools are not optimized for next-generation sequencing (NGS) data, especially for very short reads. In this work, we propose and implement a comprehensive ncRNA classification tool (RNA-CODE) for very short reads. RNA-CODE is specifically designed for ncRNA identification in NGS data that lack quality reference genomes. Given a set of short reads, our tool classifies the reads into different types of ncRNA families. The classification results can be used to quantify the expression levels of different types of ncRNAs in RNA-seq data and ncRNA composition profiles in metagenomic data, respectively. The experimental results of applying RNA-CODE to RNA-seq of Arabidopsis and a metagenomic data set sampled from human guts demonstrate that RNA-CODE competes favorably in both sensitivity and specificity with other tools. The source codes of RNA-CODE can be downloaded at http://www.cse.msu.edu/similar to chengy/RNA_CODE.	[Yuan, Cheng; Sun, Yanni] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA	Michigan State University	Sun, YN (corresponding author), Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA.	yannisun@cse.msu.edu	Sun, Yanni/AAZ-7373-2021; SUN, Yanni/AHC-4163-2022	SUN, Yanni/0000-0003-1373-8023	NSF [DBI-0953738]	NSF(National Science Foundation (NSF))	NSF DBI-0953738 (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bengtsson J, 2011, ANTON LEEUW INT J G, V100, P471, DOI 10.1007/s10482-011-9598-6; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Fan L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039948; Ge X, 2013, INT J BIOL SCI, V9, P1, DOI 10.7150/ijbs.5249; Gruber AR, 2007, NUCLEIC ACIDS RES, V35, pW335, DOI 10.1093/nar/gkm222; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kolbe DL, 2009, BIOINFORMATICS, V25, P1236, DOI 10.1093/bioinformatics/btp154; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lowe TM, 1999, SCIENCE, V283, P1168, DOI 10.1126/science.283.5405.1168; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu SF, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh170; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Miller CS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r44; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Peng X, 2011, MBIO, V2; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Sea Stricklin, 2005, C ELEGANS NONCODING; Shah N, 2011, BIOCOMPUT-PAC SYM, P165; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Vilo C., 2012, METAGENOMICS, V1, P1, DOI DOI 10.4303/MG/235551; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029860; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	26	6	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77596	10.1371/journal.pone.0077596	http://dx.doi.org/10.1371/journal.pone.0077596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204885	Green Submitted, gold, Green Published			2022-12-27	WOS:000326155400047
J	Lopez-Madrigal, S; Balmand, S; Latorre, A; Heddi, A; Moya, A; Gil, R				Lopez-Madrigal, Sergio; Balmand, Severine; Latorre, Amparo; Heddi, Abdelaziz; Moya, Andres; Gil, Rosario			How Does Tremblaya princeps Get Essential Proteins from Its Nested Partner Moranella endobia in the Mealybug Planoccocus citri?	PLOS ONE			English	Article							MECHANOSENSITIVE CHANNEL MSCL; ELONGATION-FACTOR TU; ESCHERICHIA-COLI; OSMOTIC-SHOCK; BETA-PROTEOBACTERIA; SIGNAL PEPTIDES; SECA ALLELES; ENDOSYMBIONTS; SYMBIONTS; EVOLUTION	Many insects maintain intracellular mutualistic symbiosis with a wide range of bacteria which are considered essential for their survival (primary or P-endosymbiont) and typically suffer drastic genome degradation. Progressive loss of P-endosymbiont metabolic capabilities could lead to the recruitment of co-existent facultative endosymbiont (secondary or S-endosymbiont), thus adding more complexity to the symbiotic system. Planococcus citri, among other mealybug species, harbors an unconventional nested endosymbiotic system where every Tremblaya princeps cell (beta-proteobacterium) harbors many Moranella endobia cells (gamma-proteobacterium). In this system, T. princeps possess one of the smallest prokaryote genome known so far. This extreme genome reduction suggests the supply of many metabolites and essential gene products by M. endobia. Although sporadic cell lysis is plausible, the bacterial participation on the regulation of the predicted molecular exchange (at least to some extent) cannot be excluded. Although the comprehensive analysis of the protein translocation ability of M. endobia PCVAL rules out the existence of specific mechanisms for the exportation of proteins from M. endobia to T. princeps, immunolocation of two M. endobia proteins points towards a non-massive but controlled protein provision. We propose a sporadic pattern for the predicted protein exportation events, which could be putatively controlled by the host and/or mediated by local osmotic stress.	[Lopez-Madrigal, Sergio; Latorre, Amparo; Moya, Andres; Gil, Rosario] Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Paterna, Valencia, Spain; [Balmand, Severine; Heddi, Abdelaziz] INRA, INSA Lyon, UMR203 BF2I, Villeurbanne, France; [Latorre, Amparo; Moya, Andres] Fdn El Fomento Invest Sanitaria & Biomed Comunita, Area Genom & Salud, Valencia, Spain	University of Valencia; INRAE; Institut National des Sciences Appliquees de Lyon - INSA Lyon	Gil, R (corresponding author), Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Paterna, Valencia, Spain.	rosario.gil@uv.es	Gil, Rosario/R-6932-2018; Latorre, Amparo/E-4997-2015; Moya, Andrés/A-8190-2008	Gil, Rosario/0000-0002-9397-1003; Latorre, Amparo/0000-0002-9146-7284; Moya, Andrés/0000-0002-2867-1119	Ministerio de Economia y Competitividad, Spain [BFU2012-39816-C02-01]; Conselleria d'Educacio, Generalitat Valenciana, Spain [Prometeo/2009/092]; ImmunSymbArt [ANR-2010-BLAN-170101]; Ministerio de Educacion (Spain)	Ministerio de Economia y Competitividad, Spain; Conselleria d'Educacio, Generalitat Valenciana, Spain(Center for Forestry Research & Experimentation (CIEF)); ImmunSymbArt; Ministerio de Educacion (Spain)	Financial support was provided by grants BFU2012-39816-C02-01 (Ministerio de Economia y Competitividad, Spain; http://www.mineco.gob.es/) to A. Latorre, Prometeo/2009/092 (Conselleria d'Educacio, Generalitat Valenciana, Spain; http://www.cece.gva.es/es/) to A. Moya, and ANR-2010-BLAN-170101 (ImmunSymbArt; http://www.agence-nationale-recherche.fr/en/) to A. Heddi. S. Lopez-Madrigal is a recipient of a fellowship from the Ministerio de Educacion (Spain; http://www.mecd.gob.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajouz B, 1998, J BIOL CHEM, V273, P26670, DOI 10.1074/jbc.273.41.26670; Bagos PG, 2010, BIOINFORMATICS, V26, P2811, DOI 10.1093/bioinformatics/btq530; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Berrier C, 2000, J BACTERIOL, V182, P248, DOI 10.1128/JB.182.1.248-251.2000; BERRIER C, 1992, EUR J BIOCHEM, V206, P559, DOI 10.1111/j.1432-1033.1992.tb16960.x; BOST S, 1995, EMBO J, V14, P4412, DOI 10.1002/j.1460-2075.1995.tb00120.x; ELYAAGOUBI A, 1994, J BACTERIOL, V176, P7074, DOI 10.1128/JB.176.22.7074-7078.1994; Fares MA, 2002, NATURE, V417, P398, DOI 10.1038/417398a; FIKES JD, 1989, J BACTERIOL, V171, P402, DOI 10.1128/jb.171.1.402-409.1989; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gatehouse LN, 2012, APPL ENVIRON MICROB, V78, P1187, DOI 10.1128/AEM.06340-11; Gil R, 2010, MICROBIOL MONOGR, V19, P207, DOI 10.1007/978-3-642-13615-3_11; Hantash FM, 1997, MICROBIOL-UK, V143, P147, DOI 10.1099/00221287-143-1-147; HARA E, 1990, INSECT BIOCHEM, V20, P429, DOI 10.1016/0020-1790(90)90064-2; HUIE JL, 1995, J BACTERIOL, V177, P3518, DOI 10.1128/jb.177.12.3518-3526.1995; Husnik F, 2013, CELL, V153, P1567, DOI 10.1016/j.cell.2013.05.040; JACOBSON GR, 1976, NATURE, V261, P23, DOI 10.1038/261023a0; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143; Khatib K, 2002, GENETICS, V162, P1031; Kono M, 2008, APPL ENVIRON MICROB, V74, P4175, DOI 10.1128/AEM.00250-08; Lamelas A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002357; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lopez-Madrigal S, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-74; Lopez-Madrigal S, 2011, J BACTERIOL, V193, P5587, DOI 10.1128/JB.05749-11; McCutcheon JP, 2012, NAT REV MICROBIOL, V10, P13, DOI 10.1038/nrmicro2670; McCutcheon JP, 2011, CURR BIOL, V21, P1366, DOI 10.1016/j.cub.2011.06.051; McCutcheon JP, 2010, GENOME BIOL EVOL, V2, P708, DOI 10.1093/gbe/evq055; McCutcheon JP, 2009, P NATL ACAD SCI USA, V106, P15394, DOI 10.1073/pnas.0906424106; Meredith TC, 2006, ACS CHEM BIOL, V1, P33, DOI 10.1021/cb0500015; Moe PC, 1998, MOL MICROBIOL, V28, P583, DOI 10.1046/j.1365-2958.1998.00821.x; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; Oakley AJ, 1999, PROTEIN SCI, V8, P1915, DOI 10.1110/ps.8.10.1915; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pop OI, 2009, FEBS J, V276, P4891, DOI 10.1111/j.1742-4658.2009.07188.x; Russell JA, 2003, MOL ECOL, V12, P1061, DOI 10.1046/j.1365-294X.2003.01780.x; Smith MA, 2005, J BACTERIOL, V187, P6454, DOI 10.1128/JB.187.18.6454-6465.2005; Sukharev S, 1999, FASEB J, V13, pS55; Thao ML, 2002, APPL ENVIRON MICROB, V68, P3190, DOI 10.1128/AEM.68.7.3190-3197.2002; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; van den Bogaart G, 2007, BIOPHYS J, V92, P1233, DOI 10.1529/biophysj.106.088708; Vasquez-Laslop N, 2001, J BACTERIOL, V183, P2399, DOI 10.1128/JB.183.8.2399-2404.2001; von Dohlen CD, 2001, NATURE, V412, P433, DOI 10.1038/35086563; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188	44	16	16	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77307	10.1371/journal.pone.0077307	http://dx.doi.org/10.1371/journal.pone.0077307			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204799	Green Published, gold, Green Submitted			2022-12-27	WOS:000326032600030
J	Szalay, KZ; Csermely, P				Szalay, Kristof Z.; Csermely, Peter			Perturbation Centrality and Turbine: A Novel Centrality Measure Obtained Using a Versatile Network Dynamics Tool	PLOS ONE			English	Article							MAMMALIAN CYTOCHROME P4502B4; CELLULAR NETWORKS; PROTEINS; DATABASE; SYSTEMS; SIMULATIONS; INFORMATION; PROPAGATION; PARADIGM; RESIDUES	Analysis of network dynamics became a focal point to understand and predict changes of complex systems. Here we introduce Turbine, a generic framework enabling fast simulation of any algorithmically definable dynamics on very large networks. Using a perturbation transmission model inspired by communicating vessels, we define a novel centrality measure: perturbation centrality. Hubs and inter-modular nodes proved to be highly efficient in perturbation propagation. High perturbation centrality nodes of the Met-tRNA synthetase protein structure network were identified as amino acids involved in intra-protein communication by earlier studies. Changes in perturbation centralities of yeast interactome nodes upon various stresses well recapitulated the functional changes of stressed yeast cells. The novelty and usefulness of perturbation centrality was validated in several other model, biological and social networks. The Turbine software and the perturbation centrality measure may provide a large variety of novel options to assess signaling, drug action, environmental and social interventions.	[Szalay, Kristof Z.; Csermely, Peter] Semmelweis Univ, Dept Med Chem, H-1085 Budapest, Hungary	Semmelweis University	Csermely, P (corresponding author), Semmelweis Univ, Dept Med Chem, H-1085 Budapest, Hungary.	csermely.peter@med.semmelweis-univ.hu	Csermely, Peter/J-2067-2017	Csermely, Peter/0000-0001-9234-0659; Szalay, Kristof/0000-0001-7876-3516	Hungarian National Science Foundation [OTKA-K83314]; EU [TAMOP-4.2.2/B-10/1-2010-0013]	Hungarian National Science Foundation; EU(European Commission)	Funding has been provided by research grants from the Hungarian National Science Foundation (OTKA-K83314) and from the EU (TAMOP-4.2.2/B-10/1-2010-0013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-16; [Anonymous], 2010, PYMOL MOL GRAPHICS S; Antal MA, 2009, CURR PROTEIN PEPT SC, V10, P161, DOI 10.2174/138920309787847617; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Behar M, 2007, P NATL ACAD SCI USA, V104, P16146, DOI 10.1073/pnas.0703894104; Bode C, 2007, FEBS LETT, V581, P2776, DOI 10.1016/j.febslet.2007.05.021; Calzone L, 2006, BIOINFORMATICS, V22, P1805, DOI 10.1093/bioinformatics/btl172; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chen C.-T., 1998, LINEAR SYSTEM THEORY; Csardi ~ G, 2006, INTERJ COMP SYST, V1695; Csermely P, 2005, TRENDS PHARMACOL SCI, V26, P178, DOI 10.1016/j.tips.2005.02.007; Csermely P., 2006, WEAK LINKS UNIVERSAL; Csermely P, 2013, PHARMACOL THERAPEUT, V138, P333, DOI 10.1016/j.pharmthera.2013.01.016; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Danon L, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036103; de Almeida RMC, 2001, J NON-CRYST SOLIDS, V287, P201, DOI 10.1016/S0022-3093(01)00628-7; Di Paola L, 2013, CHEM REV, V113, P1598, DOI 10.1021/cr3002356; Doncheva NT, 2011, TRENDS BIOCHEM SCI, V36, P179, DOI 10.1016/j.tibs.2011.01.002; Farkas IJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001950; Franks DW, 2008, ADAPT BEHAV, V16, P264, DOI 10.1177/1059712308090536; Garg A, 2012, METHODS MOL BIOL, V786, P397, DOI 10.1007/978-1-61779-292-2_22; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P15711, DOI 10.1073/pnas.0704459104; Gong YC, 2007, ANN NY ACAD SCI, V1115, P267, DOI 10.1196/annals.1407.011; Gong YC, 2007, ANN NY ACAD SCI, V1115, P249, DOI 10.1196/annals.1407.010; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Kitano H, 2007, NAT REV DRUG DISCOV, V6, P202, DOI 10.1038/nrd2195; Kovacs IA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012528; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016118; Li F, 2010, BIOINFORMATICS, V26, P275, DOI 10.1093/bioinformatics/btp634; LINDQUIST S, 1981, NATURE, V293, P311, DOI 10.1038/293311a0; Liu T, 2007, P NATL ACAD SCI USA, V104, P4347, DOI 10.1073/pnas.0607132104; Martin AJM, 2011, BIOINFORMATICS, V27, P2003, DOI 10.1093/bioinformatics/btr191; Maslov S, 2007, P NATL ACAD SCI USA, V104, P13655, DOI 10.1073/pnas.0702905104; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; Mihalik A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002187; Miller JC, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.020901; MIZOCK BA, 1995, AM J MED, V98, P75, DOI 10.1016/S0002-9343(99)80083-7; Nussinov R, 2011, TRENDS PHARMACOL SCI, V32, P686, DOI 10.1016/j.tips.2011.08.004; Page L., 1998, PAGERANK CITATION RA, DOI [10.1007/978-3-319-08789-4_10, DOI 10.1007/978-3-319-08789-4_10]; Palotai R, 2008, IUBMB LIFE, V60, P10, DOI 10.1002/iub.8; Piazza F, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026001; R Core Team, 2012, R LANG ENV STAT COMP; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Rothkegel A, 2012, CHAOS, V22, DOI 10.1063/1.3685527; Saadatpour A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002267; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Scott EE, 2004, J BIOL CHEM, V279, P27294, DOI 10.1074/jbc.M403349200; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Shmulevich I, 2002, BIOINFORMATICS, V18, P1319, DOI 10.1093/bioinformatics/18.10.1319; Stojmirovic A, 2009, BIOINFORMATICS, V25, P2447, DOI 10.1093/bioinformatics/btp398; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Trpevski D, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.056102; Vishveshwara S, 2009, CURR PROTEIN PEPT SC, V10, P146, DOI 10.2174/138920309787847590; Wang RS, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-44; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80	59	17	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78059	10.1371/journal.pone.0078059	http://dx.doi.org/10.1371/journal.pone.0078059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205090	Green Published, gold, Green Submitted			2022-12-27	WOS:000326032600066
J	Yang, ZY; Sun, YF; Xue, J; Yao, ZF; Xu, JY; Cheng, JY; Shi, W; Zhu, BL; Zhang, YP; Zhang, YJ				Yang, Zhongyi; Sun, Yifei; Xue, Jing; Yao, Zhifeng; Xu, Junyan; Cheng, Jingyi; Shi, Wei; Zhu, Beiling; Zhang, Yongping; Zhang, Yingjian			Can Positron Emission Tomography/Computed Tomography with the Dual Tracers Fluorine-18 Fluoroestradiol and Fluorodeoxyglucose Predict Neoadjuvant Chemotherapy Response of Breast Cancer?-A Pilot Study	PLOS ONE			English	Article							SURGICAL ADJUVANT BREAST; PATHOLOGICAL RESPONSE; PREOPERATIVE CHEMOTHERAPY; PET; ESTROGEN; THERAPY; F-18-FLUOROESTRADIOL; WOMEN; ER	Objective: To assess the clinical value of dual tracers Positron emission tomography/computed tomography (PET/CT) F-18-fluoroestradiol (F-18-FES) and F-18-fluorodeoxyglucose (F-18-FDG) in predicting neoadjuvant chemotherapy response (NAC) of breast cancer. Methods: Eighteen consecutive patients with newly diagnosed, non-inflammatory, stage II and III breast cancer undergoing NAC were included. Before chemotherapy, they underwent both F-18-FES and F-18-FDG PET/CT scans. Surgery was performed after three to six cycles of chemotherapy. Tumor response was graded and divided into two groups: the responders and non-responders. We used the maximum standardized uptake value (SUVmax) to qualify each primary lesion. Results: Pathologic analysis revealed 10 patients were responders while the other 8 patients were non-responders. There was no statistical difference of SUVmax-FDG and tumor size between these two groups (P>0.05). On the contrary, SUVmax-FES was lower in responders (1.75+/-0.66 versus 4.42+/-1.14; U=5, P=0.002); and SUVmax-FES/FDG also showed great value in predicting outcome (0.16+/-0.06 versus 0.54+/-0.22; U=5, P=0.002). Conclusions: Our study showed F-18-FES PET/CT might be feasible to predict response of NAC. However, whether the use of dual tracers F-18-FES and F-18-FDG has complementary value should be further studied.	[Yang, Zhongyi; Sun, Yifei; Xue, Jing; Yao, Zhifeng; Xu, Junyan; Cheng, Jingyi; Shi, Wei; Zhu, Beiling; Zhang, Yongping; Zhang, Yingjian] Fudan Univ, Dept Nucl Med, Shanghai Canc Ctr, Dept Oncol,Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University	Zhang, YJ (corresponding author), Fudan Univ, Dept Nucl Med, Shanghai Canc Ctr, Dept Oncol,Shanghai Med Coll, Shanghai 200433, Peoples R China.	profzhangyj@163.com						Ah-See MLW, 2008, CLIN CANCER RES, V14, P6580, DOI 10.1158/1078-0432.CCR-07-4310; Aitken SJ, 2010, ANN ONCOL, V21, P1254, DOI 10.1093/annonc/mdp427; Bassa P, 1996, J NUCL MED, V37, P931; Bear HD, 2006, J CLIN ONCOL, V24, P2019, DOI 10.1200/JCO.2005.04.1665; Burcombe RJ, 2002, EUR J CANCER, V38, P375, DOI 10.1016/S0959-8049(01)00379-3; Cochet Alexandre, 2011, Journal of the National Cancer Institute Monographs, P111, DOI 10.1093/jncimonographs/lgr035; Colleoni M, 2012, ANN ONCOL, V23, P243, DOI 10.1093/annonc/mds305; Croshaw R, 2011, ANN SURG ONCOL, V18, P3160, DOI 10.1245/s10434-011-1919-5; Danishad KKA, 2010, NMR BIOMED, V23, P233, DOI 10.1002/nbm.1436; Dehdashti F, 2009, BREAST CANCER RES TR, V113, P509, DOI 10.1007/s10549-008-9953-0; Dieci MV, 2013, ANN ONCOL, V24, P101, DOI 10.1093/annonc/mds248; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Emmering J, 2008, ANN ONCOL, V19, P1573, DOI 10.1093/annonc/mdn185; Fisher B, 1997, J CLIN ONCOL, V15, P2483, DOI 10.1200/JCO.1997.15.7.2483; Fisher B, 1998, J CLIN ONCOL, V16, P2672, DOI 10.1200/JCO.1998.16.8.2672; Goldhirsch A, 2001, J CLIN ONCOL, V19, P3817, DOI 10.1200/JCO.2001.19.18.3817; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Houssami N, 2012, EUR J CANCER, V48, P3342, DOI 10.1016/j.ejca.2012.05.023; Kim SJ, 2004, ANN ONCOL, V15, P1352, DOI 10.1093/annonc/mdh345; Kurland BF, 2011, J NUCL MED, V52, P1541, DOI 10.2967/jnumed.111.091439; Linden HM, 2006, J CLIN ONCOL, V24, P2793, DOI 10.1200/JCO.2005.04.3810; Mori T, 2006, NUCL MED BIOL, V33, P281, DOI 10.1016/j.nucmedbio.2005.11.002; Pickles MD, 2006, MAGN RESON IMAGING, V24, P843, DOI 10.1016/j.mri.2005.11.005; Precht LM, 2010, BREAST J, V16, P362, DOI 10.1111/j.1524-4741.2010.00935.x; Pusztai L, 2006, ONCOLOGIST, V11, P868, DOI 10.1634/theoncologist.11-8-868; Rousseau C, 2006, J CLIN ONCOL, V24, P5366, DOI 10.1200/JCO.2006.05.7406; SATALOFF DM, 1995, J AM COLL SURGEONS, V180, P297; Sharangpani GM, 2007, J MICROSC-OXFORD, V226, P244, DOI 10.1111/j.1365-2818.2007.01772.x; Smith IC, 2000, J CLIN ONCOL, V18, P1676, DOI 10.1200/JCO.2000.18.8.1676; Sundararajan L, 2007, SEMIN NUCL MED, V37, P470, DOI 10.1053/j.semnuclmed.2007.08.003; Tan MC, 2009, AM J SURG, V198, P520, DOI 10.1016/j.amjsurg.2009.06.004; van Kruchten M, 2012, J NUCL MED, V53, P182, DOI 10.2967/jnumed.111.092734; Wolmark N, 2001, J Natl Cancer Inst Monogr, P96; Zhang Yu, 2011, Chinese Journal of Applied and Environmental Biology, V17, P196, DOI 10.3724/SP.J.1145.2011.00196	34	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78192	10.1371/journal.pone.0078192	http://dx.doi.org/10.1371/journal.pone.0078192			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205151	Green Published, Green Submitted, gold			2022-12-27	WOS:000326032600081
J	Sagar, N; Pandey, AK; Gurbani, D; Khan, K; Singh, D; Chaudhari, BP; Soni, VP; Chattopadhyay, N; Dhawan, A; Bellare, JR				Sagar, Nitin; Pandey, Alok K.; Gurbani, Deepak; Khan, Kainat; Singh, Dhirendra; Chaudhari, Bhushan P.; Soni, Vivek P.; Chattopadhyay, Naibedya; Dhawan, Alok; Bellare, Jayesh R.			In-Vivo Efficacy of Compliant 3D Nano-Composite in Critical-Size Bone Defect Repair: a Six Month Preclinical Study in Rabbit	PLOS ONE			English	Article							CARBOXYMETHYL-CHITIN; INJECTABLE MATERIAL; FRACTURE HEMATOMA; TISSUE; SCAFFOLDS; CALCIFICATION; RECEPTOR; SURFACE	Bone defects above critical size do not heal completely by itself and thus represent major clinical challenge to reconstructive surgery. Numerous bone substitutes have already been used to promote bone regeneration, however their use, particularly for critical-sized bone defects along with their long term in vivo safety and efficacy remains a concern. The present study was designed to obtain a complete healing of critical-size defect made in the proximal tibia of New Zealand White rabbit, using nano-hydroxyapatite/gelatin and chemically carboxymethylated chitin (n-HA/gel/CMC) scaffold construct. The bone-implant interfaces and defect site healing was evaluated for a period up to 25 weeks using radiography, micro-computed tomography, fluorescence labeling, and histology and compared with respective SHAM (empty contra lateral control). The viscoelastic porous scaffold construct allows easy surgical insertion and post-operatively facilitate oxygenation and angiogenesis. Radiography of defect treated with scaffold construct suggested expedited healing at defect edges and within the defect site, unlike confined healing at edges of the SHAM sites. The architecture indices analyzed by micro-computed tomography showed a significant increase in percentage of bone volume fraction, resulted in reconciled cortico-trabecular bone formation at n-HA/gel/CMC constructs treated site (15.2% to 52.7%) when compared with respective SHAM (10.2% to 31.8%). Histological examination and fluorescence labeling revealed that the uniformly interconnected porous surface of scaffold construct enhanced osteoblasts' activity and mineralization. These preclinical data suggest that, n-HA/gel/CMC construct exhibit stimulation of bone's innate regenerative capacity, thus underscoring their use in guided bone regeneration.	[Sagar, Nitin; Soni, Vivek P.; Bellare, Jayesh R.] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India; [Pandey, Alok K.; Gurbani, Deepak; Dhawan, Alok] Indian Inst Toxicol Res, Council Sci & Ind Res, Nanomat Toxicol Grp, Lucknow, Uttar Pradesh, India; [Singh, Dhirendra; Chaudhari, Bhushan P.] Indian Inst Toxicol Res, Regulatory Toxicol Grp, Council Sci & Ind Res, Lucknow, Uttar Pradesh, India; [Khan, Kainat; Chattopadhyay, Naibedya] Cent Drug Res Inst, Div Endocrinol, Council Sci & Ind Res 12, Lucknow, Uttar Pradesh, India; [Dhawan, Alok] Ahmedabad Univ, Inst Life Sci, Ahmadabad, Gujarat, India; [Bellare, Jayesh R.] Indian Inst Technol, Dept Chem Engn, Bombay, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Ahmedabad University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Bellare, JR (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.	jb@iitb.ac.in	PANDEY, ALOK KUMAR/AAZ-7403-2021; Chattopadhyay, Naibedya/AAQ-3213-2021; Bellare, Jayesh/AAO-8713-2020; Dhawan, Alok/AAF-7376-2019; Chattopadhyay, Naibedya/AAF-2058-2019; Dhawan, Alok/A-6588-2010	PANDEY, ALOK KUMAR/0000-0001-9005-2477; Chattopadhyay, Naibedya/0000-0003-2473-0246; Bellare, Jayesh/0000-0002-6792-8327; Dhawan, Alok/0000-0002-4405-9608; GURBANI, DEEPAK/0000-0002-0982-7173	Council of Scientific and Industrial Research (CSIR); Department of Science and Technology (DST); Department of Biotechnology (DBT), Government of India	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (DST)(Department of Science & Technology (India)); Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	This study was supported by the Council of Scientific and Industrial Research (CSIR), Department of Science and Technology (DST) and Department of Biotechnology (DBT), Government of India, for providing fellowship and equipment support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A; Aviv-Gavriel M, 2013, LANGMUIR, V29, P683, DOI 10.1021/la303693d; Betre H, 2002, BIOMACROMOLECULES, V3, P910, DOI 10.1021/bm0255037; BLEEK K, ACTA BIOMATERIALIA; BOLANDER ME, 1994, BONE FORMATION REPAI, P117; Brooks AE, 2008, BIOMACROMOLECULES, V9, P1506, DOI 10.1021/bm701124p; Cancedda R, 2007, BIOMATERIALS, V28, P2505, DOI 10.1016/j.biomaterials.2007.01.022; Chirila TV, 2007, ACTA BIOMATER, V3, P95, DOI 10.1016/j.actbio.2006.07.011; Correia C, 2012, ACTA BIOMATER, V8, P2483, DOI 10.1016/j.actbio.2012.03.019; Da H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054838; Dahe GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025236; Davies JE, 2007, BIOMATERIALS, V28, P5058, DOI 10.1016/j.biomaterials.2007.07.049; Deng M, 2011, ADV FUNCT MATER, V21, P2641, DOI 10.1002/adfm.201100275; Gerentes P, 2002, BIOMATERIALS, V23, P1295, DOI 10.1016/S0142-9612(01)00247-2; He Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042525; Jayakumar R, 2011, INT J MOL SCI, V12, P1876, DOI 10.3390/ijms12031876; Kang TY, 2013, ACTA BIOMATER, V9, P4716, DOI 10.1016/j.actbio.2012.08.042; Kim TG, 2012, ADV FUNCT MATER, V22, P2446, DOI 10.1002/adfm.201103083; Lalwani G, 2013, BIOMACROMOLECULES, V14, P900, DOI 10.1021/bm301995s; Langstaff S, 2001, BIOMATERIALS, V22, P135, DOI 10.1016/S0142-9612(00)00139-3; Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19; Li M, 2003, J BONE MINER RES, V18, P2033, DOI 10.1359/jbmr.2003.18.11.2033; Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022; Lim DW, 2008, BIOMACROMOLECULES, V9, P222, DOI 10.1021/bm7007982; Liu X, 2009, BIOMATERIALS, V30, P2252, DOI 10.1016/j.biomaterials.2008.12.068; Lu Chuanyong, 2006, Iowa Orthop J, V26, P17; Mahony O, 2010, ADV FUNCT MATER, V20, P3835, DOI 10.1002/adfm.201000838; Mandal BB, 2009, ACTA BIOMATER, V5, P2579, DOI 10.1016/j.actbio.2009.02.033; Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006; MAROTTI G, 1993, CALCIFIED TISSUE INT, V53, pS47, DOI 10.1007/BF01673402; Matsumura G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035760; MIZUNO K, 1990, J BONE JOINT SURG BR, V72, P822, DOI 10.1302/0301-620X.72B5.2211764; MUNTING E, 1993, J MATER SCI-MATER M, V4, P337, DOI 10.1007/BF00122290; Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063; Perren S. M., 1980, CURRENT CONCEPTS INT, P63; Phipps MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016813; Poon YF, 2007, ADV FUNCT MATER, V17, P2139, DOI 10.1002/adfm.200600420; Rahn BA, 2002, BONE CLIN ORTHOPEDIC, P287; Sagar N, 2012, J BIOMED MATER RES B, V100B, P624, DOI 10.1002/jbm.b.31983; SCHILLER AL, 1988, PATHOLOGY, P1304; Serrano MC, 2010, ADV FUNCT MATER, V20, P192, DOI 10.1002/adfm.200901040; Sharan K, 2011, J BONE MINER RES, V26, P2096, DOI 10.1002/jbmr.434; Sharma S, 2009, J TISSUE ENG REGEN M, V3, P501, DOI 10.1002/term.186; Street J, 2000, CLIN ORTHOP RELAT R, P224, DOI 10.1097/00003086-200009000-00033; Tanase CE, 2012, J BIOMED MATER RES B, V100B, P700, DOI 10.1002/jbm.b.32502; Tokura S, 2001, BIOMACROMOLECULES, V2, P417, DOI 10.1021/bm0001345; Uda H, 2006, J PLAST RECONSTR AES, V59, P188, DOI 10.1016/j.bjps.2004.11.022; Lluch AV, 2009, COLLOID SURFACE B, V70, P218, DOI 10.1016/j.colsurfb.2008.12.027; Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n; Wan ACA, 1998, J BIOMED MATER RES, V41, P541, DOI 10.1002/(SICI)1097-4636(19980915)41:4<541::AID-JBM5>3.0.CO;2-C; Wan ACA, 1998, BIOMATERIALS, V19, P1309; Wan ACA, 1996, BIOMATERIALS, V17, P1529, DOI 10.1016/0142-9612(96)89778-X; Wang GC, 2011, ACS APPL MATER INTER, V3, P1692, DOI 10.1021/am2002185; Wang XH, 2002, BIOMATERIALS, V23, P4167, DOI 10.1016/S0142-9612(02)00153-9; WEINER S, 1992, FASEB J, V6, P879, DOI 10.1096/fasebj.6.3.1740237; Yu JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057564	56	11	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77578	10.1371/journal.pone.0077578	http://dx.doi.org/10.1371/journal.pone.0077578			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204879	Green Published, Green Submitted, gold			2022-12-27	WOS:000326029300104
J	Beperet, I; Barrera, G; Simon, O; Williams, T; Lopez-Ferber, M; Gasmi, L; Herrero, S; Caballero, P				Beperet, Ines; Barrera, Gloria; Simon, Oihane; Williams, Trevor; Lopez-Ferber, Miguel; Gasmi, Laila; Herrero, Salvador; Caballero, Primitivo			The sf32 Unique Gene of Spodoptera frugiperda Multiple Nucleopolyhedrovirus (SfMNPV) Is a Non-Essential Gene That Could Be Involved in Nucleocapsid Organization in Occlusion-Derived Virions	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; GENOME SEQUENCE; DELETION MUTANT; BACULOVIRUS; PROTEIN; PREDICTION; INSECT; MYRISTOYLATION; IDENTIFICATION; HETEROGENEITY	A recombinant virus lacking the sf32 gene (Sf32null), unique to the Spodoptera frugiperda multiple nucleopolyhedrovirus (SfMNPV), was generated by homologous recombination from a bacmid comprising the complete viral genome (Sfbac). Transcriptional analysis revealed that sf32 is an early gene. Occlusion bodies (OBs) of Sf32null contained 62% more genomic DNA than viruses containing the sf32 gene, Sfbac and Sf32null-repair, although Sf32null DNA was three-fold less infective when injected in vivo. Sf32null OBs were 18% larger in diameter and contained 17% more nucleocapsids within ODVs than those of Sfbac. No significant differences were detected in OB pathogenicity (50% lethal concentration), speed-of-kill or budded virus production in vivo. In contrast, the production of OBs/larva was reduced by 39% in insects infected by Sf32null compared to those infected by Sfbac. The SF32 predicted protein sequence showed homology (25% identity, 44% similarity) to two adhesion proteins from Streptococcus pyogenes and a single N-mirystoylation site was predicted. We conclude that SF32 is a non-essential protein that could be involved in nucleocapsid organization during ODV assembly and occlusion, resulting in increased numbers of nucleocapsids within ODVs.	[Beperet, Ines; Barrera, Gloria; Simon, Oihane; Caballero, Primitivo] CSIC UPNA Gobierno Navarra, Inst Agrobiotecnol, Navarra, Spain; [Barrera, Gloria] Corp Colombiana Invest Agr CORPOICA, Bogota, Colombia; [Williams, Trevor] Inst Ecol AC, Xalapa, Veracruz, Mexico; [Lopez-Ferber, Miguel] Ecole Mines Ales, Ales, France; [Gasmi, Laila; Herrero, Salvador] Univ Valencia, Dept Genet, Valencia, Spain; [Caballero, Primitivo] Univ Publ Navarra, Dept Prod Agr, Navarra, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Universidad Publica de Navarra; Corporacion Colombiana de Investigacion Agropecuaria, AGROSAVIA; Instituto de Ecologia - Mexico; IMT - Institut Mines-Telecom; IMT Mines Ales; University of Valencia; Universidad Publica de Navarra	Caballero, P (corresponding author), CSIC UPNA Gobierno Navarra, Inst Agrobiotecnol, Navarra, Spain.	pcm92@unavarra.es	Williams, Trevor/J-4239-2013; Williams, Trevor/F-1447-2011; Caballero, Primitivo/D-5063-2009; Williams, Trevor/ABG-3961-2020; Herrero, Salva/ABE-5123-2020; Lopez-Ferber, Miguel/F-5465-2012; Herrero, Salvador/J-5767-2013; Simon, Oihane/G-5703-2014; gasmi, laila/AAT-6469-2021	Williams, Trevor/0000-0003-3414-3440; Williams, Trevor/0000-0003-3414-3440; Caballero, Primitivo/0000-0003-0065-9625; Herrero, Salva/0000-0001-5690-2108; Lopez-Ferber, Miguel/0000-0002-3850-1703; Herrero, Salvador/0000-0001-5690-2108; Simon, Oihane/0000-0003-1239-1486; gasmi, laila/0000-0003-1553-8252	Spanish Ministry for Science and Technology [AGL2008-05456-C03-01, AGL2011-30352-C02-01]; CSIC	Spanish Ministry for Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CSIC	This study received financial support from the Spanish Ministry for Science and Technology (AGL2008-05456-C03-01, AGL2011-30352-C02-01). I. B. received a CSIC studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; An SH, 2006, VIRUS GENES, V32, P21, DOI 10.1007/s11262-005-5841-4; Black B.C., 1997, BACULOVIRUSES, DOI [10.1007/978-1-4899-1834-5_13, DOI 10.1007/978-1-4899-1834-5_13]; Boucias D.G., 1998, PRINCIPLES INSECT PA, P177; Wolff JL, 2008, J GEN VIROL, V89, P1202, DOI 10.1099/vir.0.83581-0; Castillejos V, 2002, BIOL CONTROL, V24, P300, DOI 10.1016/S1049-9644(02)00030-0; Cory JS, 2004, FUNCT ECOL, V18, P443, DOI 10.1111/j.0269-8463.2004.00853.x; Crawley M.J., 1993, GLIM ECOLOGISTS; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Escribano A, 1999, J ECON ENTOMOL, V92, P1079, DOI 10.1093/jee/92.5.1079; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Fuxa JR, 2004, AGR ECOSYST ENVIRON, V103, P27, DOI 10.1016/j.agee.2003.10.013; GREENE GL, 1976, J ECON ENTOMOL, V69, P487, DOI 10.1093/jee/69.4.487; Groner A., 1986, BIOL BACULOVIRUSES, V1, P177; Harrison RL, 2003, J GEN VIROL, V84, P1827, DOI 10.1099/vir.0.19146-0; Harrison RL, 2008, J GEN VIROL, V89, P775, DOI 10.1099/vir.0.83566-0; HAWTIN RE, 1995, VIROLOGY, V212, P673, DOI 10.1006/viro.1995.1525; Hernandez-Crespo P, 2001, APPL ENVIRON MICROB, V67, P1140, DOI 10.1128/AEM.67.3.1140-1146.2001; Herniou EA, 2003, ANNU REV ENTOMOL, V48, P211, DOI 10.1146/annurev.ento.48.091801.112756; Herniou EA, 2001, J VIROL, V75, P8117, DOI 10.1128/JVI.75.17.8117-8126.2001; Hodgson DJ, 2001, EVOL ECOL RES, V3, P687; Hong Jiang, 2008, Acta Entomologica Sinica, V51, P322; Hughes AL, 2003, MOL BIOL EVOL, V20, P979, DOI 10.1093/molbev/msg107; Hughes PR, 1987, BIOL BACULOVIRUSES, P1; Hulo N, 2008, NUCLEIC ACIDS RES, V36, pD245, DOI 10.1093/nar/gkm977; Jehle JA, 2006, ARCH VIROL, V151, P1257, DOI 10.1007/s00705-006-0763-6; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Katsuma S, 1999, J GEN VIROL, V80, P783, DOI 10.1099/0022-1317-80-3-783; KNELL JD, 1981, VIROLOGY, V112, P190, DOI 10.1016/0042-6822(81)90624-3; LeOra Software, 1987, POLO PC US GUID PROB; Lung OY, 2003, J VIROL, V77, P328, DOI 10.1128/JVI.77.1.328-339.2003; LYNN DE, 1992, BIOTECHNIQUES, V13, P282; Maurer-Stroh S, 2004, TRENDS MICROBIOL, V12, P178, DOI 10.1016/j.tim.2004.02.006; Maurer-Stroh S, 2002, J MOL BIOL, V317, P541, DOI 10.1006/jmbi.2002.5426; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Moscardi F, 1999, ANNU REV ENTOMOL, V44, P257, DOI 10.1146/annurev.ento.44.1.257; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Possee RD., 1992, BACULOVIRUS EXPRESSI; Robertson J. L., 1992, PESTICIDE BIOASSAYS; Rohrmann GF, 2008, BACULOVIRUS MOL BIOL; SCHNEEWIND O, 1990, J BACTERIOL, V172, P3310, DOI 10.1128/jb.172.6.3310-3317.1990; SHAPIRO DI, 1991, J INVERTEBR PATHOL, V58, P96, DOI 10.1016/0022-2011(91)90167-O; Simon O, 2005, APPL ENVIRON MICROB, V71, P4254, DOI 10.1128/AEM.71.8.4254-4262.2005; Simon O, 2004, APPL ENVIRON MICROB, V70, P5579, DOI 10.1128/AEM.70.9.5579-5588.2004; Simon O, 2008, J VIROL, V82, P7897, DOI 10.1128/JVI.00099-08; Simon O, 2012, J INVERTEBR PATHOL, V109, P117, DOI 10.1016/j.jip.2011.10.010; Simon O, 2011, J INVERTEBR PATHOL, V107, P33, DOI 10.1016/j.jip.2011.01.002; Thiem SM, 2009, IN VITRO CELL DEV-AN, V45, P111, DOI 10.1007/s11626-008-9170-5; Todd JW, 1996, J VIROL, V70, P2307, DOI 10.1128/JVI.70.4.2307-2317.1996; Valicente F. H., 2008, Revista Brasileira de Milho e Sorgo, V7, P77; van Oers MM, 2005, J GEN VIROL, V86, P2069, DOI 10.1099/vir.0.80964-0; Vega FE, 2012, INSECT PATHOLOGY, 2ND EDITION, P1	52	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77683	10.1371/journal.pone.0077683	http://dx.doi.org/10.1371/journal.pone.0077683			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204916	Green Published, Green Submitted, gold			2022-12-27	WOS:000326334500043
J	Boboc, IA; Dinica, MC				Boboc, Ioana-Andreea; Dinica, Mihai-Cristian			An Algorithm for Testing the Efficient Market Hypothesis	PLOS ONE			English	Article							FOREIGN-EXCHANGE MARKET; TECHNICAL TRADING RULES; US STOCK-MARKET; REALITY CHECK; RETURN PREDICTABILITY; PROFITS; TIME	The objective of this research is to examine the efficiency of EUR/USD market through the application of a trading system. The system uses a genetic algorithm based on technical analysis indicators such as Exponential Moving Average (EMA), Moving Average Convergence Divergence (MACD), Relative Strength Index (RSI) and Filter that gives buying and selling recommendations to investors. The algorithm optimizes the strategies by dynamically searching for parameters that improve profitability in the training period. The best sets of rules are then applied on the testing period. The results show inconsistency in finding a set of trading rules that performs well in both periods. Strategies that achieve very good returns in the training period show difficulty in returning positive results in the testing period, this being consistent with the efficient market hypothesis (EMH).	[Boboc, Ioana-Andreea] Ecole Polytech Fed Lausanne, Swiss Finance Inst, Financial Engn Sect, Lausanne, Switzerland; [Dinica, Mihai-Cristian] Bucharest Univ Econ Studies, Dept Finance, Bucharest, Romania	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Finance Institute (SFI); Bucharest University of Economic Studies	Dinica, MC (corresponding author), Bucharest Univ Econ Studies, Dept Finance, Bucharest, Romania.	mihai.dinica@gmail.com	Dinica, Mihai Cristian/D-9261-2014; Chanelian, Serena/ABE-4873-2021	Dinica, Mihai Cristian/0000-0002-2197-1389; Chanelian, Serena/0000-0001-5727-6137	European Social Fund through Sectorial Operational Programme Human Resources Development [POSDRU/107/1.5/S/77213]	European Social Fund through Sectorial Operational Programme Human Resources Development	This work was co-financed from the European Social Fund through Sectorial Operational Programme Human Resources Development 2007-2013, project number POSDRU/107/1.5/S/77213, Ph.D. for a career in interdisciplinary economic research at the European standards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abounooria E, 2012, PHYSICA A, V391, P3170, DOI 10.1016/j.physa.2011.12.045; Allen F, 1999, J FINANC ECON, V51, P245, DOI 10.1016/S0304-405X(98)00052-X; Alvarez-Ramirez J, 2012, PHYSICA A, V391, P5643, DOI 10.1016/j.physa.2012.06.051; Armeanu D, 2008, ECON COMPUT ECON CYB, V42, P201; Charles A, 2012, J INT MONEY FINANC, V31, P1607, DOI 10.1016/j.jimonfin.2012.03.003; Charles Amelie, 2009, ECON SYST, V33, P117; Cheung YW, 2001, J INT MONEY FINANC, V20, P439, DOI 10.1016/S0261-5606(01)00002-X; De Grauwe P, 1992, J INT COMP EC, V1, P87; Dempster M. A. H., 2001, Quantitative Finance, V1, P397, DOI 10.1088/1469-7688/1/4/301; Deng SK, 2012, PROCEDIA COMPUT SCI, V13, P86, DOI 10.1016/j.procs.2012.09.117; Dragota V, 2009, ROM J ECON FORECAST, V10, P147; FAMA EF, 1970, J FINANC, V25, P383, DOI 10.2307/2325486; Grolund A, 2012, PLOS ONE, V7; Harris L, 2013, FINANC ANAL J, V69, P6; Hasan MZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037047; Holland J., 1962, J ACM, V3, P297; Hsu P.H., 2005, J FINANCIAL ECONOMET, V3, P606, DOI [10.1093/jjfinec/nbi026, DOI 10.1093/JJFINEC/NBI026]; Hsu PH, 2010, J EMPIR FINANC, V17, P471, DOI 10.1016/j.jempfin.2010.01.001; Kim JH, 2008, J EMPIR FINANC, V15, P518, DOI 10.1016/j.jempfin.2007.07.001; Kim JH, 2011, J EMPIR FINANC, V18, P868, DOI 10.1016/j.jempfin.2011.08.002; Kwon K.-Y., 2002, Q REV EC FINANCE, V42, P611, DOI DOI 10.1016/51062-9769(01)00089-8; Mendes L, 2012, J HEURISTICS, V18, P627, DOI 10.1007/s10732-012-9201-y; Metghalchi M, 2012, APPL ECON, V44, P1539, DOI 10.1080/00036846.2010.543084; Neely C, 1997, J FINANC QUANT ANAL, V32, P405, DOI 10.2307/2331231; Olson D, 2004, J BANK FINANC, V28, P85, DOI 10.1016/S0378-4266(02)00399-0; Osler CL, 2000, FEDERAL RESERVE BANK, V6, P53; Park CH, 2010, J FUTURES MARKETS, V30, P633, DOI 10.1002/fut.20435; Qi M, 2006, J MONEY CREDIT BANK, V38, P2135, DOI 10.1353/mcb.2007.0006; Ready MJ, 2002, FINANC MANAGE, V31, P43, DOI 10.2307/3666314; Roberts MC, 2005, J FUTURES MARKETS, V25, P643, DOI 10.1002/fut.20161; Rosillo R, 2013, APPL ECON, V45, P1541, DOI 10.1080/00036846.2011.631894; Savin G, 2007, J FINANC ECONOMET, V5, P243, DOI 10.1093/jjfinec/nb1012; Shynkevich A, 2012, J BANK FINANC, V36, P193, DOI 10.1016/j.jbankfin.2011.07.001; Sullivan R, 1999, J FINANC, V54, P1647, DOI 10.1111/0022-1082.00163; Szakmary AC, 2010, J BANK FINANC, V34, P409, DOI 10.1016/j.jbankfin.2009.08.004; TAYLOR MP, 1992, J INT MONEY FINANC, V11, P304, DOI 10.1016/0261-5606(92)90048-3; Trolle AB, 2010, J DERIV, V17, P15, DOI 10.3905/jod.2010.17.3.015; White H, 2000, ECONOMETRICA, V68, P1097, DOI 10.1111/1468-0262.00152	38	8	8	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78177	10.1371/journal.pone.0078177	http://dx.doi.org/10.1371/journal.pone.0078177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	242VF	24205148	Green Published, Green Submitted, gold			2022-12-27	WOS:000326270700082
J	Zook, JD; Molugu, TR; Jacobsen, NE; Lin, GX; Soll, J; Cherry, BR; Brown, MF; Fromme, P				Zook, James D.; Molugu, Trivikram R.; Jacobsen, Neil E.; Lin, Guangxin; Soll, Juergen; Cherry, Brian R.; Brown, Michael F.; Fromme, Petra			High-Resolution NMR Reveals Secondary Structure and Folding of Amino Acid Transporter from Outer Chloroplast Membrane	PLOS ONE			English	Article							TRIPLE-RESONANCE NMR; CHEMICAL-SHIFTS; HETERONUCLEAR NMR; BACKBONE DYNAMICS; LARGER PROTEINS; LIPID-BILAYERS; SPIN-LATTICE; RELAXATION; OEP16; N-15	Solving high-resolution structures for membrane proteins continues to be a daunting challenge in the structural biology community. In this study we report our high-resolution NMR results for a transmembrane protein, outer envelope protein of molar mass 16 kDa (OEP16), an amino acid transporter from the outer membrane of chloroplasts. Three-dimensional, high-resolution NMR experiments on the C-13, N-15, H-2-triply-labeled protein were used to assign protein backbone resonances and to obtain secondary structure information. The results yield over 95% assignment of N, H-N, CO, C-alpha, and C-beta chemical shifts, which is essential for obtaining a high resolution structure from NMR data. Chemical shift analysis from the assignment data reveals experimental evidence for the first time on the location of the secondary structure elements on a per residue basis. In addition T-1Z and T-2 relaxation experiments were performed in order to better understand the protein dynamics. Arginine titration experiments yield an insight into the amino acid residues responsible for protein transporter function. The results provide the necessary basis for high-resolution structural determination of this important plant membrane protein.	[Zook, James D.; Cherry, Brian R.; Fromme, Petra] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85069 USA; [Molugu, Trivikram R.; Jacobsen, Neil E.; Lin, Guangxin; Brown, Michael F.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ USA; [Lin, Guangxin] Saudi Basic Ind Corp, Mt Vernon, IA USA; [Soll, Juergen] Univ Munich, Dept Biol, Munich, Germany; [Brown, Michael F.] Univ Arizona, Dept Phys, Tucson, AZ 85721 USA	Arizona State University; Arizona State University-Tempe; University of Arizona; Saudi Basic Industries Corporation (SABIC); University of Munich; University of Arizona	Fromme, P (corresponding author), Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85069 USA.	pfromme@asu.edu	Molugu, Trivikram Rao/I-6637-2019	Molugu, Trivikram Rao/0000-0002-3254-0445	U.S. National Institutes of Health [GM095583, EY012049, EY018891]; NATIONAL EYE INSTITUTE [R01EY012049, R01EY018891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095583] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the U.S. National Institutes of Health (GM095583 to P. F. and EY012049 and EY018891 to M. F. B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abragam A., 1961, PRINCIPLES NUCL MAGN; BAX A, 1990, J MAGN RESON, V86, P304, DOI 10.1016/0022-2364(90)90262-8; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BROWN MF, 1982, J CHEM PHYS, V77, P1576, DOI 10.1063/1.443940; Brown MF., 1996, ENCY NUCL MAGNETIC R; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Cheng NS, 2008, IND ENG CHEM RES, V47, P3285, DOI 10.1021/ie071349z; CLUBB RT, 1992, J MAGN RESON, V97, P213, DOI 10.1016/0022-2364(92)90252-3; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; CUATRECASAS P, 1974, ANNU REV BIOCHEM, V43, P169, DOI 10.1146/annurev.bi.43.070174.001125; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fromme P, 2011, CURR OPIN STRUC BIOL, V21, P509, DOI 10.1016/j.sbi.2011.06.001; Goddard D., 2008, SPARKY 3; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kobilka B, 2008, TRENDS PHARMACOL SCI, V29, P79, DOI 10.1016/j.tips.2007.11.009; Lee LK, 1997, J BIOMOL NMR, V9, P287, DOI 10.1023/A:1018631009583; Linke D, 2004, BIOPHYS J, V86, P1479, DOI 10.1016/S0006-3495(04)74216-2; Linke D, 2000, BIOCHEMISTRY-US, V39, P11050, DOI 10.1021/bi001034m; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; MARION D, 1989, J AM CHEM SOC, V111, P1515, DOI 10.1021/ja00186a066; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Meirovitch E, 2010, PROG NUCL MAG RES SP, V56, P360, DOI 10.1016/j.pnmrs.2010.03.002; Nevzorov AA, 1998, PHYS REV E, V58, P2259, DOI 10.1103/PhysRevE.58.2259; Nevzorov AA, 1997, J CHEM PHYS, V107, P10288, DOI 10.1063/1.474169; Ni D, 2011, PROTEIN EXPRES PURIF, V80, P157, DOI 10.1016/j.pep.2011.08.004; Pohlmeyer K, 1997, P NATL ACAD SCI USA, V94, P9504, DOI 10.1073/pnas.94.17.9504; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Steinkamp T, 2000, J BIOL CHEM, V275, P11758, DOI 10.1074/jbc.275.16.11758; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033	36	2	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78116	10.1371/journal.pone.0078116	http://dx.doi.org/10.1371/journal.pone.0078116			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205117	Green Submitted, gold, Green Published			2022-12-27	WOS:000326270700077
J	Wei, ZH; Xu, ZX; Li, B; Xu, FQ				Wei, Zehong; Xu, Zhixiang; Li, Bo; Xu, Fuqiang			Numerical Simulation of Airway Dimension Effects on Airflow Patterns and Odorant Deposition Patterns in the Rat Nasal Cavity	PLOS ONE			English	Article							COMPUTATIONAL FLUID-DYNAMICS; COMPUTER-SIMULATION; INHALED FORMALDEHYDE; ACOUSTIC RHINOMETRY; F344 RAT; TRANSPORT; DOSIMETRY; FIXATION; MODEL; PREDICTIONS	The sense of smell is largely dependent on the airflow and odorant transport in the nasal cavity, which in turn depends on the anatomical structure of the nose. In order to evaluate the effect of airway dimension on rat nasal airflow patterns and odorant deposition patterns, we constructed two 3-dimensional, anatomically accurate models of the left nasal cavity of a Sprague-Dawley rat: one was based on high-resolution MRI images with relatively narrow airways and the other was based on artificially-widening airways of the MRI images by referencing the section images with relatively wide airways. Airflow and odorant transport, in the two models, were determined using the method of computational fluid dynamics with finite volume method. The results demonstrated that an increase of 34 mm in nasal airway dimension significantly decreased the average velocity in the whole nasal cavity by about 10% and in the olfactory region by about 12% and increased the volumetric flow into the olfactory region by about 3%. Odorant deposition was affected to a larger extent, especially in the olfactory region, where the maximum odorant deposition difference reached one order of magnitude. The results suggest that a more accurate nasal cavity model is necessary in order to more precisely study the olfactory function of the nose when using the rat.	[Wei, Zehong; Xu, Fuqiang] Wuhan Natl Lab Optoelect, Div Biomed Photon, Wuhan, Peoples R China; [Wei, Zehong; Xu, Zhixiang; Li, Bo; Xu, Fuqiang] Chinese Acad Sci, Wuhan Inst Phys & Math, State Key Lab Magnet Resonance Atom & Mol Phys, Wuhan, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS	Xu, FQ (corresponding author), Wuhan Natl Lab Optoelect, Div Biomed Photon, Wuhan, Peoples R China.	fuqiang.xu@wipm.ac.cn	xu, fuqiang/AAI-1571-2019	Xu, Zhixiang/0000-0002-0962-7702; xu, fu qiang/0000-0002-4382-9797	National Natural Science Foundation of China [91132307/H09, 31171061/C090208]; Chinese Academy of Sciences [XDB02050500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from the National Natural Science Foundation of China (91132307/H09 and 31171061/C090208) and the Chinese Academy of Sciences (XDB02050500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOONSTRA H, 1983, VIRCHOWS ARCH A, V402, P195, DOI 10.1007/BF00695061; Botsis T, 2004, CIN-COMPUT INFORM NU, V22, P162, DOI 10.1097/00024665-200405000-00011; Chen XB, 2011, AM J RHINOL ALLERGY, V25, pE39, DOI 10.2500/ajra.2011.25.3565; Chen XB, 2010, RHINOLOGY, V48, P163, DOI 10.4193/Rhin09.093; Churchill SE, 2004, AM J HUM BIOL, V16, P625, DOI 10.1002/ajhb.20074; Clement PAR, 2005, RHINOLOGY, V43, P169; Corley RA, 2009, INHAL TOXICOL, V21, P512, DOI 10.1080/08958370802598005; Craven BA, 2010, J R SOC INTERFACE, V7, P933, DOI 10.1098/rsif.2009.0490; GETCHELL TV, 1984, PROG NEUROBIOL, V23, P317, DOI 10.1016/0301-0082(84)90008-X; GROTBERG JB, 1990, J BIOMECH ENG-T ASME, V112, P168, DOI 10.1115/1.2891168; HAHN I, 1994, J THEOR BIOL, V167, P115, DOI 10.1006/jtbi.1994.1057; HAHN I, 1993, J APPL PHYSIOL, V75, P2273, DOI 10.1152/jappl.1993.75.5.2273; HORNUNG DE, 1987, ARCH OTOLARYNGOL, V113, P169; HORNUNG DE, 1987, BRAIN RES, V413, P147, DOI 10.1016/0006-8993(87)90163-6; Hornung DE, 1980, OLFACTION TASTE, P167; Kepler GM, 1998, TOXICOL APPL PHARM, V150, P1, DOI 10.1006/taap.1997.8350; Keyhani K, 1995, J BIOMECH ENG-T ASME, V117, P429, DOI 10.1115/1.2794204; Keyhani K, 1997, J THEOR BIOL, V186, P279, DOI 10.1006/jtbi.1996.0347; KIMBELL JS, 1993, TOXICOL APPL PHARM, V121, P253, DOI 10.1006/taap.1993.1152; Kimbell JS, 1997, TOXICOL APPL PHARM, V145, P388, DOI 10.1006/taap.1997.8206; Kimbell JS, 2001, TOXICOL SCI, V64, P100, DOI 10.1093/toxsci/64.1.100; Kimbell JS, 2001, TOXICOL SCI, V64, P111, DOI 10.1093/toxsci/64.1.111; Kimbell JS, 1990, TOXICOLOGIST, V10, P259; Kurtz DB, 2004, CHEM SENSES, V29, P763, DOI 10.1093/chemse/bjh079; Lee CF, 2012, BIOMED ENG-APP BAS C, V24, P327, DOI 10.4015/S1016237212500251; Lee JH, 2010, RESP PHYSIOL NEUROBI, V172, P136, DOI 10.1016/j.resp.2010.05.010; Lindemann J, 2005, AM J OTOLARYNG, V26, P175, DOI 10.1016/j.amjoto.2005.02.010; Liu B, 2011, CHINESE PHYS B, V20, DOI 10.1088/1674-1056/20/12/128702; Liu B, 2011, COMMUN THEOR PHYS, V56, P913, DOI 10.1088/0253-6102/56/5/19; Liu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022487; Liu B, 2011, J THEOR BIOL, V269, P104, DOI 10.1016/j.jtbi.2010.10.009; Liu B, 2011, MOL BIOSYST, V7, P457, DOI 10.1039/c0mb00133c; Mosges R, 2010, B-ENT, V6, P161; MORGAN KT, 1991, TOXICOL APPL PHARM, V110, P223, DOI 10.1016/S0041-008X(05)80005-5; Nebot A, 2003, SIMUL-T SOC MOD SIM, V79, P648, DOI 10.1177/0037549703038883; PATRA AL, 1986, J APPL PHYSIOL, V61, P1959, DOI 10.1152/jappl.1986.61.5.1959; Pedley TJ, 1977, LUNG BIOL HLTH DISEA, P163; Quester R, 1997, J NEUROSCI METH, V75, P81, DOI 10.1016/S0165-0270(97)00050-2; Reber M., 1998, Rhinology (Utrecht), V36, P184; Riazuddin VN, 2011, J MED BIOL ENG, V31, P201, DOI 10.5405/jmbe.781; ROITHMANN R, 1994, J OTOLARYNGOL, V23, P454; Segal RA, 2008, ANN BIOMED ENG, V36, P1870, DOI 10.1007/s10439-008-9556-2; STROTMANN J, 1994, CELL TISSUE RES, V278, P11, DOI 10.1007/s004410050189; Subramaniam RP, 1998, INHAL TOXICOL, V10, P91, DOI 10.1080/089583798197772; Tan J, 2012, EUR ARCH OTO-RHINO-L, V269, P881, DOI 10.1007/s00405-011-1771-z; Wang DY, 2012, CLIN EXP OTORHINOLAR, V5, P181, DOI 10.3342/ceo.2012.5.4.181; Wen J, 2008, RESP PHYSIOL NEUROBI, V161, P125, DOI 10.1016/j.resp.2008.01.012; Werner M, 2000, AM J SURG PATHOL, V24, P1016, DOI 10.1097/00000478-200007000-00014; Wexler D, 2005, ARCH OTOLARYNGOL, V131, P1102, DOI 10.1001/archotol.131.12.1102; Whitaker S, 1992, INTRO FLUID MECH, P474; Xiong GX, 2008, MED BIOL ENG COMPUT, V46, P1161, DOI 10.1007/s11517-008-0384-1; Xu FQ, 2000, P NATL ACAD SCI USA, V97, P10601, DOI 10.1073/pnas.180321397; Xu FQ, 2003, P NATL ACAD SCI USA, V100, P11029, DOI 10.1073/pnas.1832864100; Yang GC, 2007, CHEM SENSES, V32, P273, DOI 10.1093/chemse/bjl056; Yang GC, 2007, CHEM SENSES, V32, P215, DOI 10.1093/chemse/bjl047; YOUNGENTOB SL, 1987, PHYSIOL BEHAV, V41, P59, DOI 10.1016/0031-9384(87)90131-4; Zannoli R, 2009, PHYS MEDICA, V25, P94, DOI 10.1016/j.ejmp.2008.02.007; Zhao K, 2006, CHEM SENSES, V31, P107, DOI 10.1093/chemse/bjj008; Zhao K, 2004, CHEM SENSES, V29, P365, DOI 10.1093/chemse/bjh033; Zhu JH, 2011, RESP PHYSIOL NEUROBI, V175, P62, DOI 10.1016/j.resp.2010.09.008; Zubair M, 2010, ASIAN BIOMED, V4, P657, DOI 10.2478/abm-2010-0085	62	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77570	10.1371/journal.pone.0077570	http://dx.doi.org/10.1371/journal.pone.0077570			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204875	Green Published, gold, Green Submitted			2022-12-27	WOS:000326241200033
J	Bos, MEH; Taverne, FJ; van Geijlswijk, IM; Mouton, JW; Mevius, DJ; Heederik, DJJ				Bos, Marian E. H.; Taverne, Femke J.; van Geijlswijk, Ingeborg M.; Mouton, Johan W.; Mevius, Dik J.; Heederik, Dick J. J.		Netherlands Vet Med Authority SDa	Consumption of Antimicrobials in Pigs, Veal Calves, and Broilers in The Netherlands: Quantitative Results of Nationwide Collection of Data in 2011	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; ANIMALS; FARMERS; HEALTH; COSTS; HERDS; USAGE; MEAT; FOOD	In 2011, Dutch animal production sectors started recording veterinary antimicrobial consumption. These data are used by the Netherlands Veterinary Medicines Authority to create transparency in and define benchmark indicators for veterinary consumption of antimicrobials. This paper presents the results of sector wide consumption of antimicrobials, in the form of prescriptions or deliveries, for all pig, veal calf, and broiler farms. Data were used to calculate animal defined daily dosages per year (ADDD/Y) per pig or veal calf farm. For broiler farms, number of animal treatment days per year was calculated. Furthermore, data were used to calculate the consumption of specific antimicrobial classes per administration route per pig or veal calf farm. The distribution of antimicrobial consumption per farm varied greatly within and between farm categories. All categories, except for rose starter farms, showed a highly right skewed distribution with a long tail. Median ADDD/Y values varied from 1.2 ADDD/Y for rose finisher farms to 83.2 ADDD/Y for rose starter farms, with 28.6 ADDD/Y for white veal calf farms. Median consumption in pig farms was 9.3 ADDD/Y for production pig farms and 3.0 ADDD/Y for slaughter pig farms. Median consumption in broiler farms was 20.9 ATD/Y. Regarding specific antimicrobial classes, fluoroquinolones were mainly used on veal calf farms, but in low quantities: P75 range was 0 - 0.99 ADDD/Y, and 0 - 0.04 ADDD/Y in pig farms. The P75 range for 3rd/4th - generation cephalosporins was 0 - 0.07 ADDD/Y for veal calf farms, and 0 - 0.1 ADDD/Y for pig farms. The insights obtained from these results, and the full transparency obtained by monitoring antimicrobial consumption per farm, will help reduce antimicrobial consumption and endorse antimicrobial stewardship. The wide and skewed distribution in consumption has important practical and methodological implications for benchmarking, surveillance and future analysis of trends.	[Bos, Marian E. H.; Heederik, Dick J. J.] Univ Utrecht, Div Environm Epidemiol, Inst Risk Assessment Sci, Utrecht, Netherlands; [Taverne, Femke J.; van Geijlswijk, Ingeborg M.] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands; [Mouton, Johan W.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Mevius, Dik J.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Mevius, Dik J.] Wageningen UR, Cent Vet Inst, Lelystad, Netherlands	Utrecht University; Utrecht University; Radboud University Nijmegen; Utrecht University; Wageningen University & Research	Bos, MEH (corresponding author), Univ Utrecht, Div Environm Epidemiol, Inst Risk Assessment Sci, Utrecht, Netherlands.	m.e.h.bos@uu.nl	mouton, johan w/C-5915-2014; van Geijlswijk, Ingeborg M./A-5022-2015	mouton, johan w/0000-0001-6736-4149; van Geijlswijk, Ingeborg M./0000-0003-1306-8605; Heederik, Dick/0000-0002-4550-1437				Alban L, 2013, PREV VET MED, V108, P334, DOI 10.1016/j.prevetmed.2012.11.010; Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Bondt N., 2012, TRENDS VET ANTIBIOTI; Bondt N, 2013, PREV VET MED, V108, P10, DOI 10.1016/j.prevetmed.2012.07.009; Bos MEH, 2012, PREV VET MED, V105, P155, DOI 10.1016/j.prevetmed.2012.01.002; Callens B, 2012, PREV VET MED, V106, P53, DOI 10.1016/j.prevetmed.2012.03.001; Dierikx C, 2013, J ANTIMICROB CHEMOTH, V68, P60, DOI 10.1093/jac/dks349; European Center for disease prevention and control, 2012, ANN REP EUR ANT RES; European Centre for Disease Prevention and Control, 2012, SUMM LAT DAT ANT CON; European Medicines Agency, 2012, EMA887282012; European Surveillance of Veterinary Antimicrobial Consumption, 2012, EMA2864162012CONSULT; Graveland H, 2012, PREV VET MED, V107, P180, DOI 10.1016/j.prevetmed.2012.06.006; Health Council of the Netherlands, 2011, ANT FOOD AN PROD RES; Jensen VF, 2004, PREV VET MED, V64, P201, DOI 10.1016/j.prevetmed.2004.04.001; Jensen VF, 2006, J ANTIMICROB CHEMOTH, V58, P101, DOI 10.1093/jac/dkl201; Jensen VF, 2010, PREV VET MED, V95, P239, DOI 10.1016/j.prevetmed.2010.04.001; Kluytmans JAJW, 2013, CLIN INFECT DIS, V56, P478, DOI 10.1093/cid/cis929; Liebana E, 2013, CLIN INFECT DIS, V56, P1030, DOI 10.1093/cid/cis1043; Mevius D, 2012, MONITORING ANTIMICRO; Mevius D.J.K., 2009, MONITORING ANTIMICRO; Moulin G, 2008, J ANTIMICROB CHEMOTH, V62, P617, DOI 10.1093/jac/dkn213; Pardon B, 2012, J ANTIMICROB CHEMOTH, V67, P1027, DOI 10.1093/jac/dkr570; Sapkota AR, 2007, ENVIRON HEALTH PERSP, V115, P663, DOI 10.1289/ehp.9760; SCHOP WA, 2012, INFECTIEZIEKTEN B, V23, P77; The Danish Integrated Antimicrobial Resistance Monitoring and Research Programme, 2012, DANMAP 2011 US ANT A; Timmerman T, 2006, PREV VET MED, V74, P251, DOI 10.1016/j.prevetmed.2005.10.003; van der Fels-Klerx HJ, 2011, J ANIM SCI, V89, P1922, DOI 10.2527/jas.2010-3046; van der Zee A, 2013, AM J INFECT CONTROL, V41, P204, DOI 10.1016/j.ajic.2012.02.033; van Rijen MML, 2009, EUR J CLIN MICROBIOL, V28, P1245, DOI 10.1007/s10096-009-0775-8; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; World Health Organisation, 2012, WHO FACT SHEET ANT R	31	75	74	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77525	10.1371/journal.pone.0077525	http://dx.doi.org/10.1371/journal.pone.0077525			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204857	Green Published, gold, Green Submitted			2022-12-27	WOS:000326032600035
J	Salemme, M; Sica, M; Iazzetti, G; Gaudio, L; Aceto, S				Salemme, Marinella; Sica, Maria; Iazzetti, Giovanni; Gaudio, Luciano; Aceto, Serena			The AP2-Like Gene OitaAP2 Is Alternatively Spliced and Differentially Expressed in Inflorescence and Vegetative Tissues of the Orchid Orchis italica	PLOS ONE			English	Article							FLORAL ORGAN IDENTITY; MERISTEM CELL FATE; MADS-BOX GENES; TRANSCRIPTION FACTOR; APETALA2-LIKE GENES; ARABIDOPSIS FLOWER; PICEA-ABIES; SEED MASS; DOMAIN; MICRORNA	The AP2/ERF proteins are plant-specific transcription factors involved in multiple regulatory pathways, from plant organ development to response to various environmental stresses. One of the mechanisms that regulates the AP2-like genes involves the microRNA miR172, which controls their activity at the post-transcriptional level. Extensive studies on AP2-like genes are available in many different species; however, in orchids, one of the largest plant families, studies are restricted to a few species, all belonging to the Epidendroideae subfamily. In the present study, we report the isolation of an AP2-like gene in the Mediterranean orchid Orchis italica (Orchidoideae). The OitaAP2 locus includes 10 exons and 9 introns, and its transcript is alternatively spliced, resulting in the long OitaAP2 and the short OitaAP2_ISO isoforms, with the latter skipping exon 9. Both isoforms contain the conserved target site for miR172, whose action is demonstrated by the presence of cleaved OitaAP2 mRNA. The OitaAP2 and OitaAP2_ISO mRNAs are present in the tepals and lip before and after anthesis at different expression levels. In addition, the OitaAP2_ISO isoform is expressed in the ovary before pollination and in the root and stem. The isoform-specific expression pattern suggests a functional differentiation of the OitaAP2 alternatively spliced transcripts. The expression profile of miR172 is complementary to that of the OitaAP2 isoforms in inflorescence tissues before anthesis, whereas after anthesis and in ovary tissue before and after pollination, this relationship disappears, suggesting the existence of OitaAP2 inhibitory mechanisms in these tissues that differ from that involving miR172.	[Salemme, Marinella; Sica, Maria; Iazzetti, Giovanni; Gaudio, Luciano; Aceto, Serena] Univ Naples Federico II, Dept Biol, Naples, Italy	University of Naples Federico II	Aceto, S (corresponding author), Univ Naples Federico II, Dept Biol, Naples, Italy.	serena.aceto@unina.it	Gaudio, Luciano/AAF-4322-2020; Aceto, Serena/E-5350-2010	Gaudio, Luciano/0000-0002-0172-2190; Aceto, Serena/0000-0003-3906-4872	Regione Campania [L.R. N5/2002]	Regione Campania(Regione Campania)	This work was supported by the 2009 Regione Campania Grant L.R. N5/2002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018937; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Boutilier K, 2002, PLANT CELL, V14, P1737, DOI 10.1105/tpc.001941; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chuck G, 2008, DEVELOPMENT, V135, P3013, DOI 10.1242/dev.024273; Chuck G, 2007, NAT GENET, V39, P1517, DOI 10.1038/ng.2007.20; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Dinh TT, 2012, DEVELOPMENT, V139, P1978, DOI 10.1242/dev.077073; Doyle J. J., 1987, PHYTOCHEM B, P11; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Gil-Humanes J, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-66; Guillaumot D, 2008, J PLANT PHYSIOL, V165, P1003, DOI 10.1016/j.jplph.2007.08.009; Gutterson N, 2004, CURR OPIN PLANT BIOL, V7, P465, DOI 10.1016/j.pbi.2004.04.007; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Javelle M, 2011, JOVE-J VIS EXP, DOI 10.3791/3328; Jofuku KD, 2005, P NATL ACAD SCI USA, V102, P3117, DOI 10.1073/pnas.0409893102; JOFUKU KD, 1994, PLANT CELL, V6, P1211, DOI 10.1105/tpc.6.9.1211; Kagaya Y, 1999, NUCLEIC ACIDS RES, V27, P470, DOI 10.1093/nar/27.2.470; Kim S, 2006, MOL BIOL EVOL, V23, P107, DOI 10.1093/molbev/msj014; Klucher KM, 1996, PLANT CELL, V8, P137, DOI 10.1105/tpc.8.2.137; KUNST L, 1989, PLANT CELL, V1, P1195, DOI 10.1105/tpc.1.12.1195; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; Licausi F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-719; Lin CS, 2013, PLANT MOL BIOL, V82, P193, DOI 10.1007/s11103-013-0055-y; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Mondragon-Palomino M, 2011, PLANT J, V66, P1008, DOI 10.1111/j.1365-313X.2011.04560.x; Nilsson L, 2007, PLANTA, V225, P589, DOI 10.1007/s00425-006-0374-1; Ohto M, 2005, P NATL ACAD SCI USA, V102, P3123, DOI 10.1073/pnas.0409858102; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; Pinyopich A, 2003, NATURE, V424, P85, DOI 10.1038/nature01741; Rashid M, 2012, EVOL BIOINFORM, V8, P321, DOI 10.4137/EBO.S9369; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Riechmann JL, 1998, BIOL CHEM, V379, P633; Salemme M, 2013, MOL BIOL REP, V40, P3523, DOI 10.1007/s11033-012-2426-x; Salemme M, 2011, DEV GENES EVOL, V221, P241, DOI 10.1007/s00427-011-0372-6; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sharoni AM, 2011, PLANT CELL PHYSIOL, V52, P344, DOI 10.1093/pcp/pcq196; Shi Rui, 2012, Methods Mol Biol, V822, P53, DOI 10.1007/978-1-61779-427-8_4; Shigyo M, 2004, DEV GENES EVOL, V214, P105, DOI 10.1007/s00427-004-0385-5; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vahala T, 2001, J EXP BOT, V52, P1111, DOI 10.1093/jexbot/52.358.1111; Varkonyi-Gasic E, 2012, PLANT MOL BIOL, V78, P417, DOI 10.1007/s11103-012-9877-2; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; WEIGEL D, 1995, PLANT CELL, V7, P388, DOI 10.1105/tpc.7.4.388; Wollmann H, 2010, DEVELOPMENT, V137, P3633, DOI 10.1242/dev.036673; Wurschum T, 2006, PLANT CELL, V18, P295, DOI 10.1105/tpc.105.038398; Xu YF, 2006, PLANT J, V46, P54, DOI 10.1111/j.1365-313X.2006.02669.x; Yant L, 2010, PLANT CELL, V22, P2156, DOI 10.1105/tpc.110.075606; Zahn LM, 2005, J HERED, V96, P225, DOI 10.1093/jhered/esi033; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	56	9	11	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77454	10.1371/journal.pone.0077454	http://dx.doi.org/10.1371/journal.pone.0077454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204832	Green Published, Green Submitted, gold			2022-12-27	WOS:000326032600033
J	Liu, JP; Zhao, JY; Ma, LW; Liu, GC; Wu, D; Zhang, JS				Liu, Jianping; Zhao, Jiangyue; Ma, Liwei; Liu, Guangcong; Wu, Di; Zhang, Jinsong			Contrast Sensitivity and Spherical Aberration in Eyes Implanted with AcrySof IQ and AcrySof Natural Intraocular Lens: the Results of a Meta-Analysis	PLOS ONE			English	Article							HIGHER-ORDER ABERRATIONS; WAVE-FRONT ANALYSIS; CATARACT-SURGERY; CORNEAL ABERRATIONS; OCULAR ABERRATIONS; VISUAL IMPAIRMENT; PERFORMANCE; DISABILITY; SURFACE; DESIGN	Background: To systematically evaluate the visual performance of aspheric AcrySof IQ and spherical AcrySof Natural intraocular lens (IOL) after cataract surgery. Methodology/Principal Findings: Potential randomized controlled trials (RCTs) that involved implanting AcrySof IQ and AcrySof Natural were searched from PubMed, Web of science, EMBASE, Chinese Science and Technology Periodicals Databases and Cochrane Central Register of Controlled Trials. The methodological quality of the studies was assessed by the Jadad method. Standardized mean differences (SMDs) with 95% confidence intervals (CIs) of best-corrected visual acuity (BCVA), contrast sensitivity and spherical aberration were pooled using a random-effects model. Seven studies were identified and analyzed to compare AcrySof IQ (236 eyes) with AcrySof Natural (232 eyes) after phacoemulsification. There was no significant difference in postoperative BCVA between AcrySof IQ and AcrySof Natural (p =0.137) after a follow up of 3 months. For contrast sensitivity, these differences reached statistical significance under photopic conditions at two spatial frequencies (3 cycles per degree (cpd), 6 cpd, 12 cpd, and 18 cpd; p =0.022, p =0.017, p = 0.065, and p=0.191, respectively) and under mesopic conditions at three spatial frequencies (3 cpd, 6 cpd, 12 cpd, and 18 cpd; p =0.007, p =0.033, p =0.030, and p =0.080, respectively). Eyes with AcrySof IQ also had statistically significant less spherical aberration than eyes with AcrySof Natural (p<0.001). Sensitivity analysis showed that the results were relatively stable and reliable. Conclusions/Significance: The overall findings indicate that AcrySof IQ with a modified aspheric surface induced significantly less spherical aberration than AcrySof Natural. Contrast sensitivity in eyes with AcrySof IQ is better than that in eyes with AcrySof Natural, especially under mesopic conditions.	[Liu, Jianping; Zhao, Jiangyue; Ma, Liwei; Zhang, Jinsong] China Med Univ, Affiliated Hosp 4, Dept Ophthalmol, Shenyang, Peoples R China; [Liu, Jianping; Zhao, Jiangyue; Ma, Liwei; Wu, Di; Zhang, Jinsong] China Med Univ, Hosp Eye, Shenyang, Peoples R China; [Liu, Jianping; Zhao, Jiangyue; Wu, Di; Zhang, Jinsong] Key Lens Res Lab Liaoning Prov, Shenyang, Peoples R China; [Liu, Guangcong] China Med Univ, Sch Publ Hlth, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Zhang, JS (corresponding author), China Med Univ, Affiliated Hosp 4, Dept Ophthalmol, Shenyang, Peoples R China.	ZhangJS_CMU@163.com	zhao, zhaojiangyue/GQQ-2821-2022		China Natural Science Project [81270988]	China Natural Science Project	Funding came from the China Natural Science Project to JSZ(81270988). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARDEN GB, 1978, BRIT J OPHTHALMOL, V62, P198, DOI 10.1136/bjo.62.4.198; Artal P, 2002, J OPT SOC AM A, V19, P137, DOI 10.1364/JOSAA.19.000137; Artal P, 2001, J VISION, V1, DOI 10.1167/1.1.1; Awwad ST, 2008, J REFRACT SURG, V24, P619, DOI 10.3928/1081597X-20080601-12; CHEN YY, 2012, GUANGXI YI KE XUE XU, V34, P284; DerSimonian R, 1996, STAT MED, V15, P1237, DOI 10.1002/(SICI)1097-0258(19960630)15:12<1237::AID-SIM301>3.0.CO;2-N; Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533; ELLIOTT DB, 1993, OPTOMETRY VISION SCI, V70, P896, DOI 10.1097/00006324-199311000-00006; Erie JC, 2001, J CATARACT REFR SURG, V27, P614, DOI 10.1016/S0886-3350(00)00781-1; GINSBURG AP, 1982, AM J OPTOM PHYS OPT, V59, P105; Glasser A, 1998, VISION RES, V38, P209, DOI 10.1016/S0042-6989(97)00102-8; Guirao A, 2000, J OPT SOC AM A, V17, P1697, DOI 10.1364/JOSAA.17.001697; Guirao A, 1999, INVEST OPHTH VIS SCI, V40, P203; Guirao A, 2004, INVEST OPHTH VIS SCI, V45, P4312, DOI 10.1167/iovs.04-0693; Holladay JT, 2002, J REFRACT SURG, V18, P683; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kennis H, 2004, Bull Soc Belge Ophtalmol, P49; LI HW, 2009, INT J OPHTHALMOL SEN, P2092; Munoz G, 2006, J CATARACT REFR SURG, V32, P1320, DOI 10.1016/j.jcrs.2006.02.055; Nakagawa T, 2009, INVEST OPHTH VIS SCI, V50, P2660, DOI 10.1167/iovs.08-2754; Nanavaty MA, 2009, J CATARACT REFR SURG, V35, P663, DOI 10.1016/j.jcrs.2008.12.011; Nochez Y, 2010, BRIT J OPHTHALMOL, V94, P440, DOI 10.1136/bjo.2009.167775; Oen F. T. S., 1994, Annals Academy of Medicine Singapore, V23, P322; Olawoye O, 2012, West Afr J Med, V31, P114; Packer M, 2004, J CATARACT REFR SURG, V30, P986, DOI 10.1016/j.jcrs.2003.10.022; Packer M, 2002, J REFRACT SURG, V18, P692; Pandita D, 2007, J CATARACT REFR SURG, V33, P603, DOI 10.1016/j.jcrs.2007.01.009; Pesudovs K, 2005, J CATARACT REFR SURG, V31, P725, DOI 10.1016/j.jcrs.2004.09.028; Portney V, 2012, OPTOMETRY VISION SCI, V89, P80, DOI 10.1097/OPX.0b013e3182376ba8; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Rocha KM, 2006, AM J OPHTHALMOL, V142, P750, DOI 10.1016/j.ajo.2006.06.031; Rubin GS, 2001, INVEST OPHTH VIS SCI, V42, P64; Santhiago MR, 2010, AM J OPHTHALMOL, V149, P383, DOI 10.1016/j.ajo.2009.09.019; SEKULER R, 1986, OPHTHAL PHYSL OPT, V6, P229, DOI 10.1111/j.1475-1313.1986.tb01147.x; Thomas James, 2012, BMC Res Notes, V5, P571, DOI 10.1186/1756-0500-5-571; Tzelikis PF, 2007, J CATARACT REFR SURG, V33, P1918, DOI 10.1016/j.jcrs.2007.06.053; Wang JM, 2012, INT J OPHTHALMOL-CHI, V5, P620, DOI 10.3980/j.issn.2222-3959.2012.05.15; Wang Lu, 2010, Zhonghua Yan Ke Za Zhi, V46, P254	38	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77860	10.1371/journal.pone.0077860	http://dx.doi.org/10.1371/journal.pone.0077860			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205001	Green Published, Green Submitted, gold			2022-12-27	WOS:000326029300120
J	Saha, P; Chowdhury, AR; Dutta, S; Chatterjee, S; Ghosh, I; Datta, K				Saha, Paramita; Chowdhury, Anindya Roy; Dutta, Shubhra; Chatterjee, Soumya; Ghosh, Ilora; Datta, Kasturi			Autophagic Vacuolation Induced by Excess ROS Generation in HABP1/p32/gC1qR Overexpressing Fibroblasts and Its Reversal by Polymeric Hyaluronan	PLOS ONE			English	Article							BINDING PROTEIN-1 HABP1/P32/GC1QR; SPLICING FACTOR SF2; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNALING PATHWAYS; OXIDATIVE STRESS; SYNOVIAL-FLUID; FREE-RADICALS; CELL-DEATH; ACID; APOPTOSIS	The ubiquitous hyaladherin, hyaluronan-binding protein 1 (HABP1/p32/gC1qR) upon stable overexpression in normal fibroblasts (F-HABP07) has been reported to induce mitochondrial dysfunction, growth retardation and apoptosis after 72 h of growth. HABP1 has been observed to accumulate in the mitochondria resulting in generation of excess Reactive Oxygen Species (ROS), mitochondrial Ca++ efflux and drop in mitochondrial membrane potential. In the present study, autophagic vacuolation was detected with monodansylcadaverin (MDC) staining from 36 h to 60 h of culture period along with elevated level of ROS in F-HABP07 cells. Increased expression of autophagic markers like MAP-LC3-II, Beclin 1 and autophagic modulator, DRAM confirmed the occurrence of the phenomenon. Reduced vacuole formation was observed upon treatment with 3-MA, a known PI3 kinase inhibitor, only at 32 h and was ineffective if treated later, as high ROS level was already attained. Treatment of F111 and F-HABP07 cells with bafilomycin A1 further indicated an increase in autophagosome formation along with autophagic degradation in HABP1 overexpressed fibroblasts. Comparison between normal fibroblast (F111) and F-HABP07 cells indicate reduced level of polymeric HA, its depolymerization and perturbed HA-HABP1 interaction in F-HABP07. Interestingly, supplementation of polymeric HA, an endogenous ROS scavenger, in the culture medium prompted reduction in number of vacuoles in F-HABP07 along with drop in ROS level, implying that excess ROS generation triggers initiation of autophagic vacuole formation prior to apoptosis due to overexpression of HABP1. Thus, the phenomenon of autophagy takes place prior to apoptosis induction in the HABP1 overexpressing cell line, F-HABP07.	[Saha, Paramita; Chowdhury, Anindya Roy; Dutta, Shubhra; Chatterjee, Soumya; Ghosh, Ilora; Datta, Kasturi] Jawaharlal Nehru Univ, Sch Environm Sci, Toxicol & Biochem Lab, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Ghosh, I (corresponding author), Jawaharlal Nehru Univ, Sch Environm Sci, Toxicol & Biochem Lab, New Delhi 110067, India.	ighosh@mail.jnu.ac.in; kdatta@mail.jnu.ac.in		Dutta, Shubhra/0000-0003-0024-9618; Chatterjee, Soumya/0000-0002-7889-8389; Ghosh, Ilora/0000-0003-3957-8152	Department of Biotechnology (DBT), Government of India, New Delhi; Department of Science and Technology (DST), Government of India, New Delhi; Council of Scientific and Industrial Research (CSIR), New Delhi, India	Department of Biotechnology (DBT), Government of India, New Delhi(Department of Biotechnology (DBT) India); Department of Science and Technology (DST), Government of India, New Delhi(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	KD received financial support from Department of Biotechnology (DBT), Government of India, New Delhi. IG is financially supported by Department of Science and Technology (DST), Government of India, New Delhi. PS obtained individual fellowship for her doctoral work from Council of Scientific and Industrial Research (CSIR), New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; ARTOLA A, 1993, OPHTHALMIC RES, V25, P172, DOI 10.1159/000267286; Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Balogh GT, 2003, ARCH BIOCHEM BIOPHYS, V410, P76, DOI 10.1016/S0003-9861(02)00661-6; Bhilocha S, 2011, ANAL BIOCHEM, V417, P41, DOI 10.1016/j.ab.2011.05.026; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Campo GM, 2008, J APPL TOXICOL, V28, P509, DOI 10.1002/jat.1302; Cardaci S, 2012, J CELL SCI, V125, P2115, DOI 10.1242/jcs.095216; Chen YQ, 2007, J CELL SCI, V120, P4155, DOI 10.1242/jcs.011163; Chowdhury AR, 2008, EXP CELL RES, V314, P651, DOI 10.1016/j.yexcr.2007.10.033; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Deb TB, 1996, J BIOL CHEM, V271, P2206, DOI 10.1074/jbc.271.4.2206; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; Desaint S, 2004, J BIOL CHEM, V279, P31157, DOI 10.1074/jbc.M401888200; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Dutta S, 2011, FREE RADICAL RES, V45, P1279, DOI 10.3109/10715762.2011.610794; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; GHEBREHIWET B, 1994, J EXP MED, V179, P1809, DOI 10.1084/jem.179.6.1809; Gorski SM, 2003, CURR BIOL, V13, P358, DOI 10.1016/S0960-9822(03)00082-4; GREENWALD RA, 1980, ARTHRITIS RHEUM-US, V23, P455, DOI 10.1002/art.1780230408; Grishko V, 2009, J BIOL CHEM, V284, P9132, DOI 10.1074/jbc.M804178200; HAAS AL, 1982, J BIOL CHEM, V257, P329; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; Hawkins CL, 1998, FREE RADICAL BIO MED, V24, P1396, DOI 10.1016/S0891-5849(98)00009-4; Jiang JZ, 1999, P NATL ACAD SCI USA, V96, P3572, DOI 10.1073/pnas.96.7.3572; Kaul R, 2012, J BIOL CHEM, V287, P19750, DOI 10.1074/jbc.M111.266270; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; KRAINER AR, 1991, CELL, V66, P383, DOI 10.1016/0092-8674(91)90627-B; Lee CY, 2003, CURR BIOL, V13, P350, DOI 10.1016/S0960-9822(03)00085-X; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Li Y, 2011, NEUROSCIENCE, V199, P346, DOI 10.1016/j.neuroscience.2011.10.003; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Lorin S, 2010, AUTOPHAGY, V6, P153, DOI 10.4161/auto.6.1.10537; Lorin S, 2009, CANCER RES, V69, P6924, DOI 10.1158/0008-5472.CAN-09-1270; Lu YL, 1999, ONCOGENE, V18, P7034, DOI 10.1038/sj.onc.1203183; Majumdar M, 2002, BIOCHEM BIOPH RES CO, V291, P829, DOI 10.1006/bbrc.2002.6491; Majumdar M, 1998, GENOMICS, V51, P476, DOI 10.1006/geno.1998.5364; MCCORD JM, 1974, SCIENCE, V185, P529, DOI 10.1126/science.185.4150.529; MCNEIL JD, 1985, ANN RHEUM DIS, V44, P780, DOI 10.1136/ard.44.11.780; Meenakshi J, 2003, BIOCHEM BIOPH RES CO, V300, P686, DOI 10.1016/S0006-291X(02)02788-2; Mungai PT, 2011, MOL CELL BIOL, V31, P3531, DOI 10.1128/MCB.05124-11; Nguyen KT, 2002, J BIOL CHEM, V277, P11107, DOI 10.1074/jbc.M108166200; Nho RS, 2006, J BIOL CHEM, V281, P33291, DOI 10.1074/jbc.M606450200; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Prakash M, 2011, CELL SIGNAL, V23, P1563, DOI 10.1016/j.cellsig.2011.04.009; Reef S, 2007, ONCOGENE, V26, P6677, DOI 10.1038/sj.onc.1210485; Reef S, 2006, MOL CELL, V22, P463, DOI 10.1016/j.molcel.2006.04.014; Rees MD, 2003, J AM CHEM SOC, V125, P13719, DOI 10.1021/ja0370591; Rubinsztein DC, 2007, NEURON, V54, P854, DOI 10.1016/j.neuron.2007.06.005; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; SATO H, 1988, ARTHRITIS RHEUM, V31, P63, DOI 10.1002/art.1780310110; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Soltes L, 2006, BIOMACROMOLECULES, V7, P659, DOI 10.1021/bm050867v; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Tolkacheva T, 2000, ONCOGENE, V19, P680, DOI 10.1038/sj.onc.1203331; Toole BP, 1990, CURR OPIN CELL BIOL, V2, P839, DOI 10.1016/0955-0674(90)90081-O; Weng LP, 2001, HUM MOL GENET, V10, P237, DOI 10.1093/hmg/10.3.237; Xu Z, 2002, CELL GROWTH DIFFER, V13, P285; Yagi M, 2012, NUCLEIC ACIDS RES, V40, P9717, DOI 10.1093/nar/gks774; Yamazaki Kenji, 2003, Pathophysiology, V9, P215, DOI 10.1016/S0928-4680(03)00024-5; Zhang HY, 2009, TOXICOL SCI, V110, P376, DOI 10.1093/toxsci/kfp101; Zhu Y, 2007, NEUROCHEM INT, V50, P507, DOI 10.1016/j.neuint.2006.10.010	70	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78131	10.1371/journal.pone.0078131	http://dx.doi.org/10.1371/journal.pone.0078131			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205125	Green Published, Green Submitted, gold			2022-12-27	WOS:000326029300143
J	Currie, S; Hoggard, N; Clark, MJR; Sanders, DS; Wilkinson, ID; Griffiths, PD; Hadjivassiliou, M				Currie, Stuart; Hoggard, Nigel; Clark, Matthew J. R.; Sanders, David S.; Wilkinson, Iain D.; Griffiths, Paul D.; Hadjivassiliou, Marios			Alcohol Induces Sensitization to Gluten in Genetically Susceptible Individuals: A Case Control Study	PLOS ONE			English	Article							CELIAC-DISEASE; CEREBELLAR DEGENERATION; TISSUE TRANSGLUTAMINASE; LIVER-DISEASE; BRAIN IMAGES; MR-IMAGES; ATAXIA; ROBUST; REGISTRATION; SPECTROSCOPY	Background: The mechanisms of cerebellar degeneration attributed to prolonged and excessive alcohol intake remain unclear. Additional or even alternative causes of cerebellar degeneration are often overlooked in suspected cases of alcohol-related ataxia. The objectives of this study were two fold: (1) to investigate the prevalence of gluten-related serological markers in patients with alcohol-related ataxia and; (2) to compare the pattern of brain involvement on magnetic resonance imaging between patients with alcohol and gluten ataxias. Materials & Methods: Patients diagnosed with alcohol and gluten ataxias were identified from a retrospective review of patients attending a tertiary clinic. HLA genotype and serological markers of gluten-related disorders were recorded. Cerebellar volumetry, MR spectroscopy and voxel-based morphometric analyses were performed on patients and compared with matched control data. Results: Of 904 registered patients, 104 had alcohol ataxia and 159 had gluten ataxia. 61% of the alcohol ataxia group and 70% of the gluten ataxia group had HLA DQ2/DQ8 genotype compared to 30% in healthy local blood donors. 44% of patients with alcohol ataxia had antigliadin antibodies compared to 12% in the healthy local population and 10% in patients with genetically confirmed ataxias. None of the patients with alcohol ataxia and antigliadin antibodies had celiac disease compared to 40% in patients with gluten ataxia. The pattern of structural brain abnormality in patients with alcohol ataxia who had antigliadin antibodies differed from gluten ataxia and was identical to that of alcohol ataxia. Conclusions: Alcohol related cerebellar degeneration may, in genetically susceptible individuals, induce sensitization to gluten. Such sensitization may result from a primary cerebellar insult, but a more systemic effect is also possible. The duration and amount of exposure to alcohol may not be the only factors responsible for the cerebellar insult.	[Currie, Stuart; Hoggard, Nigel; Clark, Matthew J. R.; Wilkinson, Iain D.; Griffiths, Paul D.] Univ Sheffield, Acad Unit Radiol, Sheffield, S Yorkshire, England; [Sanders, David S.] Sheffield Teaching Hosp NHS Fdn Trust, Dept Gastroenterol, Sheffield, S Yorkshire, England; [Hadjivassiliou, Marios] Sheffield Teaching Hosp NHS Fdn Trust, Dept Neurol, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield	Currie, S (corresponding author), Univ Sheffield, Acad Unit Radiol, Sheffield, S Yorkshire, England.	s.currie@sheffield.ac.uk		Clark, Matthew/0000-0003-2152-2257; Wilkinson, Iain/0000-0003-2703-6890				Alikunju S, 2011, BRAIN BEHAV IMMUN, V25, pS129, DOI 10.1016/j.bbi.2011.01.007; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bartsch AJ, 2007, BRAIN, V130, P36, DOI 10.1093/brain/awl303; Bradunaite R, 2002, ACTA MED LITUANICA, V9, P245; Cavanagh JB, 1997, NEUROPATH APPL NEURO, V23, P355; Currie S, 2013, CEREBELLUM, V12, P205, DOI 10.1007/s12311-012-0415-1; Currie S, 2013, CEREBELLUM, V12, P245, DOI 10.1007/s12311-012-0405-3; Currie S, 2012, J NEUROL NEUROSUR PS, V83, P1216, DOI 10.1136/jnnp-2012-303281; Dewar D, 2004, INT J BIOCHEM CELL B, V36, P17, DOI 10.1016/S1357-2725(03)00239-5; Durazzo TC, 2011, ALCOHOL CLIN EXP RES, V35, P1187, DOI 10.1111/j.1530-0277.2011.01452.x; FLOREANI A, 1992, ITAL J GASTROENTEROL, V24, P457; Germenis AE, 2005, CLIN DIAGN LAB IMMUN, V12, P941, DOI 10.1128/CDLI.12.8.941-948.2005; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; GREENLEE JE, 1995, ACTA NEUROPATHOL, V89, P341; Hadjivassiliou M, 2003, BRAIN, V126, P685, DOI 10.1093/brain/awg050; Hadjivassiliou M, 2006, NEUROLOGY, V66, P373, DOI 10.1212/01.wnl.0000196480.55601.3a; Hadjivassiliou M, 1998, LANCET, V352, P1582, DOI 10.1016/S0140-6736(98)05342-2; Hadjivassiliou M, 1996, LANCET, V347, P369, DOI 10.1016/S0140-6736(96)90540-1; Hadjivassiliou M, 2008, ANN NEUROL, V64, P332, DOI 10.1002/ana.21450; Hadjivassiliou Marios, 2012, Handb Clin Neurol, V103, P189, DOI 10.1016/B978-0-444-51892-7.00011-5; Hadjivassiliou M, 2010, LANCET NEUROL, V9, P318, DOI 10.1016/S1474-4422(09)70290-X; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Koivisto H, 2008, DIGEST DIS SCI, V53, P500, DOI 10.1007/s10620-007-9874-5; Kril JJ, 1997, HEPATOLOGY, V26, P837, DOI 10.1053/jhep.1997.v26.pm0009328301; Lindfors K, 2010, AUTOIMMUN REV, V9, P744, DOI 10.1016/j.autrev.2010.06.003; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Mascalchi M, 2002, J MAGN RESON IMAGING, V16, P532, DOI 10.1002/jmri.10189; Meyerhoff DJ, 2004, ALCOHOL CLIN EXP RES, V28, P650, DOI 10.1097/01.ALC.0000121805.12350.CA; Michalak S, 2010, FOLIA NEUROPATHOL, V48, P93; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nissenkorn A, 2011, J PEDIATR-US, V159, P466, DOI 10.1016/j.jpeds.2011.02.005; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Shams'ili S, 2003, BRAIN, V126, P1409, DOI 10.1093/brain/awg133; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2001, J COMPUT ASSIST TOMO, V25, P466, DOI 10.1097/00004728-200105000-00022; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stamnaes J, 2010, AMINO ACIDS, V39, P1183, DOI 10.1007/s00726-010-0554-y; Waszkiewicz Napoleon, 2010, Pol Merkur Lekarski, V29, P269; Wilkinson ID, 2005, J NEUROL NEUROSUR PS, V76, P1011, DOI 10.1136/jnnp.2004.049809; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	44	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77638	10.1371/journal.pone.0077638	http://dx.doi.org/10.1371/journal.pone.0077638			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24204900	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000325894100088
J	Pescador, N; Perez-Barba, M; Ibarra, JM; Corbaton, A; Martinez-Larrad, MT; Serrano-Rios, M				Pescador, Nuria; Perez-Barba, Milagros; Maria Ibarra, Jose; Corbaton, Arturo; Teresa Martinez-Larrad, Maria; Serrano-Rios, Manuel			Serum Circulating microRNA Profiling for Identification of Potential Type 2 Diabetes and Obesity Biomarkers	PLOS ONE			English	Article							DIFFERENTIATION; EXPRESSION; CELLS; CANCER	Background and Aim: MicroRNAs are small non-coding RNAs that play important regulatory roles in a variety of biological processes, including complex metabolic processes, such as energy and lipid metabolism, which have been studied in the context of diabetes and obesity. Some particular microRNAs have recently been demonstrated to abundantly and stably exist in serum and to be potentially disease-specific. The aim of this profiling study was to characterize the expression of miRNA in serum samples of obese, nonobese diabetic and obese diabetic individuals to determine whether miRNA expression was deregulated in these serum samples and to identify whether any observed deregulation was specific to either obesity or diabetes or obesity with diabetes. Patients and Methods: Thirteen patients with type 2 diabetes, 20 obese patients, 16 obese patients with type 2 diabetes and 20 healthy controls were selected for this study. MiRNA PCR panels were employed to screen serum levels of 739 miRNAs in pooled samples from these four groups. We compared the levels of circulating miRNAs between serum pools of each group. Individual validation of the twelve microRNAs selected as promising biomarkers was carried out using RT-qPCR. Results: Three serum microRNAs, miR-138, miR-15b and miR-376a, were found to have potential as predictive biomarkers in obesity. Use of miR-138 or miR-376a provides a powerful predictive tool for distinguishing obese patients from normal healthy controls, diabetic patients, and obese diabetic patients. In addition, the combination of miR-503 and miR-138 can distinguish diabetic from obese diabetic patients. Conclusion: This study is the first to show a panel of serum miRNAs for obesity, and compare them with miRNAs identified in serum for diabetes and obesity with diabetes. Our results support the use of some miRNAs extracted from serum samples as potential predictive tools for obesity and type 2 diabetes.	[Pescador, Nuria; Maria Ibarra, Jose; Corbaton, Arturo; Teresa Martinez-Larrad, Maria; Serrano-Rios, Manuel] Spanish Biomed Res Ctr Diabet & Associated Metab, Madrid, Spain; [Pescador, Nuria; Perez-Barba, Milagros; Maria Ibarra, Jose; Corbaton, Arturo; Teresa Martinez-Larrad, Maria; Serrano-Rios, Manuel] Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, Madrid, Spain		Serrano-Rios, M (corresponding author), Spanish Biomed Res Ctr Diabet & Associated Metab, Madrid, Spain.	mserrano.hcsc@salud.madrid.org	Corbatón-Anchuelo, Arturo/I-4390-2013; Serrano Ríos, Manuel/E-4625-2019; Pescador, Nuria/ABG-8337-2020	Corbatón-Anchuelo, Arturo/0000-0002-8775-4766; Serrano Ríos, Manuel/0000-0002-3214-1444; 	CIBER in Diabetes and Associated Metabolic Disorders (ISCIII, Ministerio de Ciencia e Innovacion); Madrid Autonomous Community [MOIR S2010/BMD-2423]; Eli Lilly Lab, Spain	CIBER in Diabetes and Associated Metabolic Disorders (ISCIII, Ministerio de Ciencia e Innovacion); Madrid Autonomous Community; Eli Lilly Lab, Spain(Eli Lilly)	This work was funded by CIBER in Diabetes and Associated Metabolic Disorders (ISCIII, Ministerio de Ciencia e Innovacion) and Madrid Autonomous Community (MOIR S2010/BMD-2423). Partial support also came from Educational Grants from Eli Lilly Lab, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki N, 2007, ENDOCRINOLOGY, V148, P3850, DOI 10.1210/en.2006-1479; Aranceta Bartrina J, 2002, Nutr Hosp, V17 Suppl 1, P34; Baeyens L, 2006, CELL DEATH DIFFER, V13, P1892, DOI 10.1038/sj.cdd.4401883; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Fayyad-Kazan H, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-31; Gholam PM, 2007, AM J GASTROENTEROL, V102, P399, DOI 10.1111/j.1572-0241.2006.01041.x; Gong H, 2013, CLIN CANCER RES, V19, P1083, DOI 10.1158/1078-0432.CCR-12-3169; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Heneghan HM, 2011, J CLIN ENDOCR METAB, V96, pE846, DOI 10.1210/jc.2010-2701; Heremans Y, 2002, J CELL BIOL, V159, P303, DOI 10.1083/jcb.200203074; Joglekar MV, 2007, TRENDS ENDOCRIN MET, V18, P393, DOI 10.1016/j.tem.2007.10.001; Ortega FJ, 2013, CLIN CHEM, V59, P781, DOI 10.1373/clinchem.2012.195776; Kaduthanam S, 2013, LUNG CANCER, V80, P223, DOI 10.1016/j.lungcan.2013.01.013; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kong L, 2011, ACTA DIABETOL, V48, P61, DOI 10.1007/s00592-010-0226-0; Kussmann M, 2006, J BIOTECHNOL, V124, P758, DOI 10.1016/j.jbiotec.2006.02.014; Liu JJ, 2013, CHINESE J CANCER RES, V25, P46, DOI 10.3978/j.issn.1000-9604.2012.11.04; Macias-Gonzalez M, 2009, EUR J CLIN INVEST, V39, P972, DOI 10.1111/j.1365-2362.2009.02198.x; Mellitzer G, 2004, MOL ENDOCRINOL, V18, P2765, DOI 10.1210/me.2004-0243; Mueller Guenter, 2010, Archives of Physiology and Biochemistry, V116, P28, DOI 10.3109/13813450903508812; Pandey AK, 2009, CELL PHYSIOL BIOCHEM, V23, P221, DOI 10.1159/000218169; Permana PA, 2004, NUTRITION, V20, P134, DOI 10.1016/j.nut.2003.09.023; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Rocha PM, 2008, METABOLISM, V57, P1315, DOI 10.1016/j.metabol.2008.01.003; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Schmid C, 2006, SWISS MED WKLY, V136, P254; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yang Z, 2011, STEM CELLS DEV, V20, P259, DOI 10.1089/scd.2010.0072; Youssef WI, 2002, BEST PRACT RES CL GA, V16, P733, DOI 10.1053/bega.2002.0334; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zhang YH, 2013, DIABETES RES CLIN PR, V99, P327, DOI 10.1016/j.diabres.2012.11.025; Zheng YX, 2012, FEBS LETT, V586, P2396, DOI 10.1016/j.febslet.2012.05.054	34	180	188	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77251	10.1371/journal.pone.0077251	http://dx.doi.org/10.1371/journal.pone.0077251			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24204780	gold, Green Published, Green Submitted			2022-12-27	WOS:000325894100052
J	Li, N; Liu, EQ; Guo, J; Pan, L; Li, BJ; Wang, P; Liu, J; Wang, Y; Liu, GS; Hu, G				Li, Nan; Liu, Enqing; Guo, Jia; Pan, Lei; Li, Baojuan; Wang, Ping; Liu, Jin; Wang, Yue; Liu, Gongshu; Hu, Gang			Maternal Prepregnancy Body Mass Index and Gestational Weight Gain on Offspring Overweight in Early Infancy	PLOS ONE			English	Article							HIGH BIRTH-WEIGHT; CHILDHOOD OVERWEIGHT; OBESITY; PREGNANCY; ASSOCIATIONS; DISEASE; GROWTH; TRENDS; RISK; AGE	Objective: The aim of the present study was to evaluate the association of maternal prepregnancy body mass index (BMI) and gestational weight gain (GWG) with anthropometry in the offspring from birth to 12 months old in Tianjin, China. Methods: Between 2009 and 2011, health care records of 38,539 pregnant women had been collected, and their children had been measured body weight and length at birth, 3, 6, 9 and 12 months of age. The independent and joint associations of pre-pregnancy BMI and GWG based on the Institute of Medicine (IOM) guidelines with anthropometry in the offspring were examined using General Linear Model and Logistic Regression. Results: Prepregnancy BMI and maternal GWG were positively associated with Z-scores for birth weight-for-gestational age, birth length-for-gestational age, and birth weight-for-length. Infants born to mothers with excessive GWG had the greatest changes in Z-scores for weight-for-age from birth to Month 3, and from Month 6 to Month 12, and the greatest changes in Z-scores for length-for-age from birth to months 3 and 12 compared with infants born to mothers with adequate GWG. Excessive GWG was associated with an increased risk of offspring overweight or obesity at 12 months old in all BMI categories except underweight. Conclusions: Maternal prepregnancy overweight/obesity and excessive GWG were associated with greater weight gain and length gain of offspring in early infancy. Excessive GWG was associated with increased infancy overweight and obesity risk.	[Li, Nan; Liu, Enqing; Guo, Jia; Pan, Lei; Li, Baojuan; Wang, Ping; Liu, Jin; Wang, Yue; Liu, Gongshu] Tianjin Womens & Childrens Hlth Ctr, Tianjin, Peoples R China; [Li, Nan; Hu, Gang] Pennington Biomed Res Ctr, Chron Dis Epidemiol Lab, Baton Rouge, LA USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Hu, G (corresponding author), Pennington Biomed Res Ctr, Chron Dis Epidemiol Lab, Baton Rouge, LA USA.	gang.hu@pbrc.edu	Hu, Gang/N-1971-2017; Hu, Gang/V-7947-2019	Hu, Gang/0000-0002-6172-8017; Hu, Gang/0000-0002-6172-8017	Tianjin Women's and Children's Health Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER	Tianjin Women's and Children's Health Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	All phases of this study were supported by Tianjin Women's and Children's Health Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Chen CM, 2008, OBES REV, V9, P14, DOI 10.1111/j.1467-789X.2007.00433.x; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; Deierlein AL, 2012, PEDIATR OBES, V7, P134, DOI 10.1111/j.2047-6310.2011.00025.x; Deierlein AL, 2011, J PEDIATR-US, V158, P221, DOI 10.1016/j.jpeds.2010.08.008; Drake AJ, 2010, REPRODUCTION, V140, P387, DOI 10.1530/REP-10-0077; Frederick IO, 2008, MATERN CHILD HLTH J, V12, P557, DOI 10.1007/s10995-007-0276-2; Guelinckx I, 2008, OBES REV, V9, P140, DOI 10.1111/j.1467-789X.2007.00464.x; Haidar Yarah M, 2011, Clin Colon Rectal Surg, V24, P205, DOI 10.1055/s-0031-1295684; Institute of Medicine, 2009, WEIGHT GAIN PREGN RE; Johannsson E, 2006, INT J OBESITY, V30, P1265, DOI 10.1038/sj.ijo.0803253; Kim SY, 2007, OBESITY, V15, P986, DOI 10.1038/oby.2007.621; Li CY, 2007, OBESITY, V15, P760, DOI 10.1038/oby.2007.585; Liu YY, 2012, ARCH GYNECOL OBSTET, V286, P905, DOI 10.1007/s00404-012-2403-6; Mamun AA, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-62; Min J, 2012, PEDIATR OBES, V7, P365, DOI [10.1111/j.2047-6310.2012.00074, 10.1111/j.2047-6310.2012.00074.x]; Nohr EA, 2008, AM J CLIN NUTR, V87, P1750, DOI 10.1093/ajcn/87.6.1750; Olson Christine M, 2010, Child Obes, V6, P201, DOI 10.1089/chi.2010.0419; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Rugholm S, 2005, OBES RES, V13, P2187, DOI 10.1038/oby.2005.271; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Stotland NE, 2006, OBSTET GYNECOL, V108, P635, DOI 10.1097/01.AOG.0000228960.16678.bd; Stuebe AM, 2009, INT J OBESITY, V33, P743, DOI 10.1038/ijo.2009.101; SUITOR CW, 1991, J AM DIET ASSOC, V91, P96; Tianjin Women's and Children's Health Center, 2010, TIANJ WOM CHILDR HLT; von Kries R, 2011, INT J PEDIATR OBES, V6, P45, DOI 10.3109/17477161003792564; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; WHO, 2006, WHO CHILD GROWTH STA; WHO / IDF, 2006, DEF DIAGN DIAB MELL; Wrotniak BH, 2008, AM J CLIN NUTR, V87, P1818, DOI 10.1093/ajcn/87.6.1818; Yang Yan-dong, 2012, Zhonghua Fu Chan Ke Za Zhi, V47, P646; Young TK, 2002, AM J OBSTET GYNECOL, V187, P312, DOI 10.1067/mob.2002.126200; Zhang X, 2009, PREV MED, V49, P172, DOI 10.1016/j.ypmed.2009.07.013; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	35	79	84	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77809	10.1371/journal.pone.0077809	http://dx.doi.org/10.1371/journal.pone.0077809			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24204979	Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400139
J	Acloque, H; Bonnet-Garnier, A; Mompart, F; Pinton, A; Yerle-Bouissou, M				Acloque, Herve; Bonnet-Garnier, Amelie; Mompart, Florence; Pinton, Alain; Yerle-Bouissou, Martine			Sperm Nuclear Architecture Is Locally Modified in Presence of a Robertsonian Translocation t(13;17)	PLOS ONE			English	Article							DEFINED GENOME ARCHITECTURE; IN-SITU HYBRIDIZATION; PERICENTRIC HETEROCHROMATIN; CHROMOSOME TERRITORIES; CHROMATIN ORGANIZATION; MEIOTIC SEGREGATION; SEX-CHROMOSOMES; CELLS; SPERMATOZOA; FISH	In mammals, the non-random organization of the sperm nucleus supports an early function during embryonic development. Altering this organization may interfere with the zygote development and reduce fertility or prolificity. Thus, rare studies on sperm cells from infertile patients described an altered nuclear organization that may be a cause or a consequence of their respective pathologies. Thereby, chromosomal rearrangements and aneuploidy can be studied not only for their adverse effects on production of normal/balanced gametes at meiosis but also for their possible impact on sperm nuclear architecture and the epigenetic consequences of altered chromosome positioning. We decided to compare the global architecture of sperm nuclei from boars, either with a normal chromosome composition or with a Robertsonian translocation involving chromosomes 13 and 17. We hypothesized that the fusion between these chromosomes may change their spatial organization and we examined to what extend it could also modify the global sperm nuclear architecture. Analysis of telomeres, centromeres and gonosomes repartition does not support a global nuclear disorganization. But specific analysis of chromosomes 13 and 17 territories highlights an influence of chromosome 17 for the positioning of the fused chromosomes within the nucleus. We also observed a specific clustering of centromeres depending of the chromosome subtypes. Altogether our results showed that chromosome fusion does not significantly alter sperm nucleus architecture but suggest that centromere remodelling after chromosome fusion locally impacts chromosome positioning.	[Acloque, Herve; Bonnet-Garnier, Amelie; Mompart, Florence; Pinton, Alain; Yerle-Bouissou, Martine] INRA, Genet Cellulaire UMR444, F-31326 Castanet Tolosan, France; [Acloque, Herve; Bonnet-Garnier, Amelie; Mompart, Florence; Pinton, Alain; Yerle-Bouissou, Martine] Univ Toulouse, INP, ENVT, Genet Cellulaire UMR444, Toulouse, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse	Acloque, H (corresponding author), INRA, Genet Cellulaire UMR444, F-31326 Castanet Tolosan, France.	herve.acloque@toulouse.inra.fr	Pinton, Alain/AAQ-1648-2020; Bonnet-Garnier, Amelie/AAF-6841-2020	Pinton, Alain/0000-0002-0809-7180; Bonnet-Garnier, Amelie/0000-0002-2095-3365; Acloque, Herve/0000-0003-4761-1055	INRA	INRA	This work was funded by INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; Baumann C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-29; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Cremer T, 2006, CURR OPIN CELL BIOL, V18, P307, DOI 10.1016/j.ceb.2006.04.007; de Vries M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031485; Ducos A, 2008, CYTOGENET GENOME RES, V120, P26, DOI 10.1159/000118738; Foster HA, 2005, J CELL SCI, V118, P1811, DOI 10.1242/jcs.02301; Foster HA, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-30; Garagna S, 2001, J CELL SCI, V114, P4429; Geyer PK, 2011, CURR OPIN CELL BIOL, V23, P354, DOI 10.1016/j.ceb.2011.03.002; Govin J, 2007, J CELL BIOL, V176, P283, DOI 10.1083/jcb.200604141; Greaves IK, 2003, CHROMOSOME RES, V11, P503, DOI 10.1023/A:1024982929452; Gue M, 2005, CYTOM PART A, V67A, P18, DOI 10.1002/cyto.a.20170; Gurevitch M, 2001, MOL REPROD DEV, V60, P507, DOI 10.1002/mrd.1116; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Hassanane M, 1999, MOL REPROD DEV, V53, P407, DOI 10.1002/(SICI)1098-2795(199908)53:4&lt;407::AID-MRD6&gt;3.0.CO;2-O; Hazzouri M, 2000, MOL REPROD DEV, V55, P307, DOI 10.1002/(SICI)1098-2795(200003)55:3<307::AID-MRD9>3.0.CO;2-P; Hubner MR, 2013, CURR OPIN GENET DEV, V23, P89, DOI 10.1016/j.gde.2012.11.006; Iannuccelli E, 2010, BIOINFORMATICS, V26, P696, DOI 10.1093/bioinformatics/btq013; Ioannou D, 2011, CYTOGENET GENOME RES, V133, P269, DOI 10.1159/000322060; Itoh Yuichiro, 2007, Journal of Biology, V6, pUnpaginated, DOI 10.1186/jbiol53; Jiang L, 2013, CELL, V153, P773, DOI 10.1016/j.cell.2013.04.041; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Manvelyan M, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-25; Meyer-Ficca M, 1998, J CELL SCI, V111, P1363; Midro AT, 2006, AM J MED GENET A, V140A, P245, DOI 10.1002/ajmg.a.31083; Milan D, 1996, MAMM GENOME, V7, P194, DOI 10.1007/s003359900053; MILLER JR, 1993, CYTOGENET CELL GENET, V62, P37, DOI 10.1159/000133441; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Mompart F, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-30; Mudrak OS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052944; OLIVA R, 1991, PROG NUCLEIC ACID RE, V40, P25; Olszewska M, 2008, CHROMOSOME RES, V16, P875, DOI 10.1007/s10577-008-1246-2; Pinton A, 2009, HUM REPROD, V24, P2034, DOI 10.1093/humrep/dep118; Posfai E, 2012, GENE DEV, V26, P920, DOI 10.1101/gad.188094.112; Potok ME, 2013, CELL, V153, P759, DOI 10.1016/j.cell.2013.04.030; Rogel-Gaillard C, 1997, CYTOGENET CELL GENET, V79, P79, DOI 10.1159/000134687; Scascitelli M, 2003, CYTOGENET GENOME RES, V101, P136, DOI 10.1159/000074169; SCHMID M, 1979, CHROMOSOMA, V75, P215, DOI 10.1007/BF00292209; Schroeder-Reiter E, 2009, CYTOGENET GENOME RES, V124, P239, DOI 10.1159/000218129; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Solinhac R, 2011, CHROMOSOMA, V120, P501, DOI 10.1007/s00412-011-0328-7; Solov'eva L, 2004, CHROMOSOME RES, V12, P817, DOI 10.1007/s10577-005-5513-1; Solovei IV, 1998, CHROMOSOMA, V107, P184, DOI 10.1007/s004120050295; Stimpson KM, 2010, CURR OPIN CELL BIOL, V22, P772, DOI 10.1016/j.ceb.2010.07.002; TELENIUS H, 1992, GENE CHROMOSOME CANC, V4, P257, DOI 10.1002/gcc.2870040311; Tsend-Ayush E, 2009, CHROMOSOMA, V118, P53, DOI 10.1007/s00412-008-0177-1; Volpi EV, 2000, J CELL SCI, V113, P1565; Wiland E, 2008, PRENATAL DIAG, V28, P36, DOI 10.1002/pd.1899; Wiland E, 2008, CHROMOSOME RES, V16, P291, DOI 10.1007/s10577-007-1194-2; YERLE M, 1993, GENOMICS, V16, P97, DOI 10.1006/geno.1993.1146; Yerle-Bouissou M, 2009, CHROMOSOME RES, V17, P847, DOI 10.1007/s10577-009-9074-6; Zalenskaya IA, 2004, CHROMOSOME RES, V12, P163, DOI 10.1023/B:CHRO.0000013166.04629.97; Zalensky AO, 1997, EXP CELL RES, V232, P29, DOI 10.1006/excr.1997.3482; ZALENSKY AO, 1995, CHROMOSOMA, V103, P577	55	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e78005	10.1371/journal.pone.0078005	http://dx.doi.org/10.1371/journal.pone.0078005			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24205066	gold, Green Published, Green Submitted			2022-12-27	WOS:000326373800012
J	AlFadhli, S; Al-Jafer, H; Hadi, M; Al-Mutairi, M; Nizam, R				AlFadhli, Suad; Al-Jafer, Hassan; Hadi, Mays; Al-Mutairi, Mashael; Nizam, Rasheeba			The Effect of UGT1A1 Promoter Polymorphism in the Development of Hyperbilirubinemia and Cholelithiasis in Hemoglobinopathy Patients	PLOS ONE			English	Article							SICKLE-CELL-DISEASE; DIPHOSPHO-GLUCURONOSYLTRANSFERASE 1A1; GILBERTS-SYNDROME; GENETIC POLYMORPHISMS; BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE-1; BREAST-CANCER; TATA-BOX; ASSOCIATION; POPULATION; ANEMIA	Present study was aimed to explore the effect of (TA)(n) UGT1A1 gene promoter polymorphism on bilirubin metabolism, bilirubinaemia, predisposition to cholelithiasis and subsequent cholecystectomy, in Sickle-Cell Anemia (SCA) and beta-Thalasemia major (bTH) in Kuwaiti subjects compared to other population. This polymorphism was analyzed and correlated to total bilirubin and cholelithiasis in 270 age, gender, ethnically matched subjects (92 bTH, 116 SCA and 62 Controls) using PCR, dHPLC, fragment analysis and direct sequencing. Four genotypes of UGT1A1 were detected in this study (TA6/6, TA6/7, TA6/8 and TA7/7). (TA)6/8 was found only in four individuals; hence it was not included in the analysis. There was a statistically significant association of genotypes with serum total bilirubin levels in both bTH and SCA groups (p<0.001). Subjects with (TA)7/7 had the highest total serum bilirubin level (178.7 +/- 3.5 mu mole/l). A significant association was observed between allele (TA) 7 and cholelithiasis development (p = 0.0001). The 40%, 67.5% and 100% of SCA with (TA)6/6, (TA)6/7 and (TA) 7/7 respectively developed cholelithiasis and were subsequently cholecystectomized. Our results confirm UGT1A1 (TA) 7 allele as one of the factors accounting for the hyperbilirubinemia and cholelithiasis observed in SCA and bTH.	[AlFadhli, Suad; Hadi, Mays; Al-Mutairi, Mashael; Nizam, Rasheeba] Kuwait Univ, Dept Med Lab Sci, Jabriya, Kuwait; [Al-Jafer, Hassan] Minist Hlth, Al Amiri Hosp Med Lab, Kuwait, Kuwait	Kuwait University	AlFadhli, S (corresponding author), Kuwait Univ, Dept Med Lab Sci, Jabriya, Kuwait.	s.alfadhli@hsc.edu.kw			Kuwait University research administration grant [NM 01/07]	Kuwait University research administration grant	This work was supported by Kuwait University research administration grant NM 01/07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal SK, 2009, PEDIATR RES, V65, P675, DOI 10.1203/PDR.0b013e31819ed5de; Arambula E, 2002, BLOOD CELL MOL DIS, V28, P86, DOI 10.1006/bcmd.2001.0481; Babaoglu MO, 2006, BASIC CLIN PHARMACOL, V98, P377, DOI 10.1111/j.1742-7843.2006.pto_341.x; Beutler E, 1998, P NATL ACAD SCI USA, V95, P8170, DOI 10.1073/pnas.95.14.8170; Biondi ML, 1999, CLIN CHEM, V45, P897; Borlak J, 2000, HEPATOLOGY, V32, P792, DOI 10.1053/jhep.2000.18193; Bosma PJ, 2003, J HEPATOL, V38, P107, DOI 10.1016/S0168-8278(02)00359-8; BOSMA PJ, 1994, J BIOL CHEM, V269, P17960; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Clarke DJ, 1997, CLIN CHIM ACTA, V266, P63, DOI 10.1016/S0009-8981(97)00167-8; Deming SL, 2008, CANCER EPIDEM BIOMAR, V17, P563, DOI 10.1158/1055-9965.EPI-07-0752; Farheen S, 2006, WORLD J GASTROENTERO, V12, P2269, DOI 10.3748/wjg.v12.i14.2269; Fertrin KY, 2002, AM J MED GENET, V108, P117, DOI 10.1002/ajmg.10209; Grant DJ, 2004, MUTAT RES-GEN TOX EN, V560, P1, DOI 10.1016/j.mrgentox.2004.01.010; Guillemette C, 2000, CANCER RES, V60, P950; Guillemette C, 2001, CANCER EPIDEM BIOMAR, V10, P711; Haberkern CM, 1997, BLOOD, V89, P1533; Hall D, 1999, PHARMACOGENETICS, V9, P591, DOI 10.1097/01213011-199910000-00006; Heeney MM, 2003, J LAB CLIN MED, V141, P279, DOI 10.1067/mlc.2003.28; Huo DZ, 2008, BREAST CANCER RES TR, V110, P367, DOI 10.1007/s10549-007-9720-7; Kalotychou V, 2003, BLOOD CELL MOL DIS, V31, P38, DOI 10.1016/S1079-9796(03)00118-9; Ki CS, 2003, CLIN CHEM, V49, P2078, DOI 10.1373/clinchem.2003.024174; Kohle C, 2003, BIOCHEM PHARMACOL, V65, P1521, DOI 10.1016/S0006-2952(03)00074-1; MCCALL IW, 1977, AM J HEMATOL, V3, P15, DOI 10.1002/ajh.2830030102; Monaghan G, 1996, LANCET, V347, P578, DOI 10.1016/S0140-6736(96)91273-8; Nikolac N, 2008, CLIN CHEM LAB MED, V46, P174, DOI 10.1515/CCLM.2008.035; Ostanek B, 2007, BLOOD CELL MOL DIS, V38, P78, DOI 10.1016/j.bcmd.2006.10.160; Premawardhena A, 2003, BLOOD CELL MOL DIS, V31, P98, DOI 10.1016/S1079-9796(03)00071-8; Raijmakers MTM, 2000, J HEPATOL, V33, P348, DOI 10.1016/S0168-8278(00)80268-8; Rantner B, 2008, CLIN CHEM, V54, P851, DOI 10.1373/clinchem.2007.102046; Samilchuk E, 2003, BLOOD CELL MOL DIS, V31, P201, DOI 10.1016/S1079-9796(03)00125-6; Sampietro M, 1999, HAEMATOLOGICA, V84, P150; SARNAIK S, 1980, J PEDIATR-US, V96, P1005, DOI 10.1016/S0022-3476(80)80626-3; SCHUBERT TT, 1986, GASTROENTEROLOGY, V90, P2013, DOI 10.1016/0016-5085(86)90276-3; SERJEANT GR, 1993, BLOOD REV, V7, P137, DOI 10.1016/0268-960X(93)90001-K; Sugatani J, 2008, N-S ARCH PHARMACOL, V377, P597, DOI 10.1007/s00210-007-0226-y; te Morsche RHM, 2001, HEPATOLOGY, V33, P765, DOI 10.1053/jhep.2001.0103303le03; Tsezou A, 2009, GENET TEST MOL BIOMA, V13, P143, DOI 10.1089/gtmb.2008.0095; Vasavda N, 2007, BRIT J HAEMATOL, V138, P263, DOI 10.1111/j.1365-2141.2007.06643.x; WEBB DKH, 1989, ARCH DIS CHILD, V64, P693, DOI 10.1136/adc.64.5.693	40	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77681	10.1371/journal.pone.0077681	http://dx.doi.org/10.1371/journal.pone.0077681			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204915	gold, Green Published, Green Submitted			2022-12-27	WOS:000326334500042
J	Kurtenbach, S; Wewering, S; Hatt, H; Neuhaus, EM; Lubbert, H				Kurtenbach, Stefan; Wewering, Sonja; Hatt, Hanns; Neuhaus, Eva M.; Luebbert, Hermann			Olfaction in Three Genetic and Two MPTP-Induced Parkinson's Disease Mouse Models	PLOS ONE			English	Article							NEURONAL CHLORIDE ACCUMULATION; ALPHA-SYNUCLEIN; EXPRESSION PATTERN; MICE LACKING; SENSITIVITY; PATHOLOGY; AGE; DYSFUNCTION; IMPAIRMENT; EPITHELIUM	Various genetic or toxin-induced mouse models are frequently used for investigation of early PD pathology. Although olfactory impairment is known to precede motor symptoms by years, it is not known whether it is caused by impairments in the brain, the olfactory epithelium, or both. In this study, we investigated the olfactory function in three genetic Parkinson's disease (PD) mouse models and mice treated with MPTP intraperitoneally and intranasally. To investigate olfactory function, we performed electro-olfactogram recordings (EOGs) and an olfactory behavior test (cookie-finding test). We show that neither a parkin knockout mouse strain, nor intraperitoneal MPTP treated animals display any olfactory impairment in EOG recordings and the applied behavior test. We also found no difference in the responses of the olfactory epithelium to odorants in a mouse strain over-expressing doubly mutated alpha-synuclein, while this mouse strain was not suitable to test olfaction in a cookie-finding test as it displays a mobility impairment. A transgenic mouse expressing mutated alpha-synuclein in dopaminergic neurons performed equal to control animals in the cookie-finding test. Further we show that intranasal MPTP application can cause functional damage of the olfactory epithelium.	[Kurtenbach, Stefan; Hatt, Hanns] Ruhr Univ Bochum, Dept Cell Physiol, Bochum, Germany; [Wewering, Sonja; Luebbert, Hermann] Ruhr Univ Bochum, Dept Anim Physiol, Bochum, Germany; [Neuhaus, Eva M.] Charite, Neurosci Res Ctr, D-13353 Berlin, Germany; [Neuhaus, Eva M.] Charite, Cluster Excellence NeuroCure, D-13353 Berlin, Germany	Ruhr University Bochum; Ruhr University Bochum; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kurtenbach, S (corresponding author), Ruhr Univ Bochum, Dept Cell Physiol, Univ Str 150, Bochum, Germany.	stefan.kurtenbach@rub.de	Kurtenbach, Stefan/H-3786-2019; Neuhaus, Eva M./L-1428-2015	Kurtenbach, Stefan/0000-0002-7445-596X; Neuhaus, Eva M./0000-0003-3363-1231; Luebbert, Herrmann/0000-0003-3429-5233	German National Academic Foundation; Research School of the Ruhr University Bochum; Deutsche Forschungsgemeinschaft [Exc257 NeuroCure, SFB642]; International Max Planck Research School (IMPRS)	German National Academic Foundation; Research School of the Ruhr University Bochum; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Max Planck Research School (IMPRS)	This work was supported by The German National Academic Foundation (SM), the Research School of the Ruhr University Bochum, the Deutsche Forschungsgemeinschaft (Exc257 NeuroCure and the SFB642) and the International Max Planck Research School (IMPRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSARI KA, 1975, J CHRON DIS, V28, P493, DOI 10.1016/0021-9681(75)90058-2; Biskup S, 2008, J NEUROL, V255, P8, DOI 10.1007/s00415-008-5005-2; Braak H, 2004, NEUROBIOL AGING, V25, P19, DOI 10.1016/j.neurobiolaging.2003.04.001; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; DOTY RL, 1992, ANN NEUROL, V32, P97, DOI 10.1002/ana.410320116; Filipov NM, 2009, NEUROREPORT, V20, P713, DOI 10.1097/WNR.0b013e32832aa95b; Flagella M, 1999, J BIOL CHEM, V274, P26946, DOI 10.1074/jbc.274.38.26946; Fleming SM, 2008, EUR J NEUROSCI, V28, P247, DOI 10.1111/j.1460-9568.2008.06346.x; FULLER RW, 1990, TOXICOL LETT, V54, P253, DOI 10.1016/0378-4274(90)90192-O; Getchell TV, 2003, AGEING RES REV, V2, P211, DOI 10.1016/S1568-1637(02)00066-1; Haehner A, 2007, MOVEMENT DISORD, V22, P839, DOI 10.1002/mds.21413; Hawkes CH, 1997, J NEUROL NEUROSUR PS, V62, P436, DOI 10.1136/jnnp.62.5.436; Hawkes CH, 1999, QJM-MON J ASSOC PHYS, V92, P473, DOI 10.1093/qjmed/92.8.473; Kim YH, 2011, NEUROSCIENCE, V172, P379, DOI 10.1016/j.neuroscience.2010.10.072; Kuhn K, 2003, EUR J NEUROSCI, V17, P1, DOI 10.1046/j.1460-9568.2003.02408.x; Martins LM, 2004, MOL CELL BIOL, V24, P9848, DOI 10.1128/MCB.24.22.9848-9862.2004; Maskri L, 2004, NEURODEGENER DIS, V1, P255, DOI 10.1159/000085064; Mendritzki S, 2010, PARKINSONS DIS-US, V2010, DOI 10.4061/2010/375462; Mesholam RI, 1998, ARCH NEUROL-CHICAGO, V55, P84, DOI 10.1001/archneur.55.1.84; Muller A, 2002, J NEURAL TRANSM, V109, P805, DOI 10.1007/s007020200067; Nickell WT, 2007, J PHYSIOL-LONDON, V583, P1005, DOI 10.1113/jphysiol.2007.129601; Nickell WT, 2006, J NEUROPHYSIOL, V95, P2003, DOI 10.1152/jn.00962.2005; Nijjar RK, 2002, NEUROBIOL AGING, V23, P65, DOI 10.1016/S0197-4580(01)00263-9; Nordin S, 1995, J Int Neuropsychol Soc, V1, P281; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; Orimo S, 2011, NEUROPATH APPL NEURO, V37, P791, DOI 10.1111/j.1365-2990.2011.01194.x; Pan-Montojo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008762; Periquet M, 2005, J NEUROCHEM, V95, P1259, DOI 10.1111/j.1471-4159.2005.03442.x; Ponsen MM, 2004, ANN NEUROL, V56, P173, DOI 10.1002/ana.20160; Prediger RDS, 2006, EXP NEUROL, V202, P391, DOI 10.1016/j.expneurol.2006.07.001; Prediger RDS, 2010, NEUROTOX RES, V17, P114, DOI 10.1007/s12640-009-9087-0; Przedborski S, 2004, J BIOENERG BIOMEMBR, V36, P375, DOI 10.1023/B:JOBB.0000041771.66775.d5; Razani J, 1996, PHYSIOL BEHAV, V59, P877, DOI 10.1016/0031-9384(95)02163-9; Rojo AI, 2006, EUR J NEUROSCI, V24, P1874, DOI 10.1111/j.1460-9568.2006.05060.x; Ross CA, 2007, PARKINSONISM RELAT D, V13, pS309, DOI 10.1016/S1353-8020(08)70022-1; Schapira AHV, 2006, NEUROLOGY, V66, pS10, DOI 10.1212/WNL.66.10_suppl_4.S10; Schiesling C, 2008, NEUROPATH APPL NEURO, V34, P255, DOI 10.1111/j.1365-2990.2008.00952.x; Schmidt N, 2001, J NEURAL TRANSM, V108, P1263, DOI 10.1007/s007020100004; Schmidt S, 2011, HUM MOL GENET, V20, P1197, DOI 10.1093/hmg/ddq564; SONSALLA PK, 1986, EUR J PHARMACOL, V129, P339, DOI 10.1016/0014-2999(86)90444-9; STICHEL CC, 1990, EXP BRAIN RES, V82, P575; Stichel CC, 2007, HUM MOL GENET, V16, P2377, DOI 10.1093/hmg/ddm083; Taylor TN, 2009, J NEUROSCI, V29, P8103, DOI 10.1523/JNEUROSCI.1495-09.2009; Turetsky BI, 2009, SCHIZOPHRENIA BULL, V35, P1117, DOI 10.1093/schbul/sbp111; Ubeda-Banon I, 2012, BRAIN STRUCT FUNCT, V217, P447, DOI 10.1007/s00429-011-0347-4; Vitalis T, 2003, J COMP NEUROL, V464, P392, DOI 10.1002/cne.10804; WARD CD, 1983, NEUROLOGY, V33, P943, DOI 10.1212/WNL.33.7.943; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999	49	25	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77509	10.1371/journal.pone.0077509	http://dx.doi.org/10.1371/journal.pone.0077509			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204848	Green Submitted, Green Published, gold			2022-12-27	WOS:000326334500031
J	Priebe, S; Menzel, U; Zarse, K; Groth, M; Platzer, M; Ristow, M; Guthke, R				Priebe, Steffen; Menzel, Uwe; Zarse, Kim; Groth, Marco; Platzer, Matthias; Ristow, Michael; Guthke, Reinhard			Extension of Life Span by Impaired Glucose Metabolism in Caenorhabditis elegans Is Accompanied by Structural Rearrangements of the Transcriptomic Network	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; GENE-EXPRESSION; DIETARY RESTRICTION; C. ELEGANS; RECONSTRUCTION; COEXPRESSION; BIOLOGY; MODEL; TOR	Glucose restriction mimicked by feeding the roundworm Caenorhabditis elegans with 2-deoxy-D-glucose (DOG) - a glucose molecule that lacks the ability to undergo glycolysis - has been found to increase the life span of the nematodes considerably. To facilitate understanding of the molecular mechanisms behind this life extension, we analyzed transcriptomes of DOG-treated and untreated roundworms obtained by RNA-seq at different ages. We found that, depending on age, DOG changes the magnitude of the expression values of about 2 to 24 percent of the genes significantly, although our results reveal that the gross changes introduced by DOG are small compared to the age-induced changes. We found that 27 genes are constantly either up-or down-regulated by DOG over the whole life span, among them several members of the cytochrome P450 family. The monotonic change with age of the temporal expression patterns of the genes was investigated, leading to the result that 21 genes reverse their monotonic behaviour under impaired glycolysis. Put simply, the DOG-treatment reduces the gross transcriptional activity but increases the interconnectedness of gene expression. However, a detailed analysis of network parameters discloses that the introduced changes differ remarkably between individual signalling pathways. We found a reorganization of the hubs of the mTOR pathway when standard diet is replaced by DOG feeding. By constructing correlation based difference networks, we identified those signalling pathways that are most vigorously changed by impaired glycolysis. Taken together, we have found a number of genes and pathways that are potentially involved in the DOG-driven extension of life span of C. elegans. Furthermore, our results demonstrate how the network structure of ageing-relevant signalling pathways is reorganised under impaired glycolysis.	[Priebe, Steffen; Menzel, Uwe; Guthke, Reinhard] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Syst Biol & Bioinformat Grp, Jena, Germany; [Zarse, Kim; Ristow, Michael] Univ Jena, Inst Nutr, Dept Human Nutr, Jena, Germany; [Groth, Marco; Platzer, Matthias] Fritz Lipmann Inst, Leibniz Inst Age Res, Genome Anal Grp, Jena, Germany	Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Priebe, S (corresponding author), Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Syst Biol & Bioinformat Grp, Jena, Germany.	steffen.priebe@hki-jena.de	Ristow, Michael/O-9858-2014; Zarse, Kim/D-2133-2016	Ristow, Michael/0000-0003-2109-2453; Zarse, Kim/0000-0003-2542-6123; Groth, Marco/0000-0002-9199-8990	German Ministry for Education and Research (Bundesministerium fur Bildung und Forschung - BMBF) [BMBF 0315581]	German Ministry for Education and Research (Bundesministerium fur Bildung und Forschung - BMBF)(Federal Ministry of Education & Research (BMBF))	This work is part of the research program of the Jena Centre for Systems Biology of Ageing funded by the German Ministry for Education and Research (Bundesministerium fur Bildung und Forschung - BMBF; support code BMBF 0315581). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Antebi A, 2007, PLOS GENET, V3, P1565, DOI 10.1371/journal.pgen.0030129; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Birnby DA, 2000, GENETICS, V155, P85; Brink TC, 2009, BIOGERONTOLOGY, V10, P549, DOI 10.1007/s10522-008-9197-8; Cornu M, 2013, CURR OPIN GENET DEV, V23, P53, DOI 10.1016/j.gde.2012.12.005; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Gems D, 2009, CELL CYCLE, V8, P1681, DOI 10.4161/cc.8.11.8595; Guo YF, 2008, ACTA BIOCH BIOPH SIN, V40, P426, DOI 10.1111/j.1745-7270.2008.00418.x; Guthke R, 2005, BIOINFORMATICS, V21, P1626, DOI 10.1093/bioinformatics/bti226; Ha MK, 2006, PROTEOMICS, V6, P3339, DOI 10.1002/pmic.200500395; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Heilbronn LK, 2003, AM J CLIN NUTR, V78, P361, DOI 10.1093/ajcn/78.3.361; Jenkins NL, 2004, P ROY SOC B-BIOL SCI, V271, P2523, DOI 10.1098/rspb.2004.2897; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; McCormick MA, 2011, PHILOS T R SOC B, V366, P17, DOI 10.1098/rstb.2010.0198; Menzel R, 2005, ARCH BIOCHEM BIOPHYS, V438, P93, DOI 10.1016/j.abb.2005.03.020; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; R Development Core Team, 2012, R LANG ENV STAT COMP; Rea S, 2003, DEV CELL, V5, P197, DOI 10.1016/S1534-5807(03)00242-9; Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Schmeisser S, 2013, MOL METAB, V2, P92, DOI 10.1016/j.molmet.2013.02.002; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Song L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-328; Southworth LK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000776; Syntichaki P, 2007, NATURE, V445, P922, DOI 10.1038/nature05603; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Waveren C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-18; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Walker G, 2005, MECH AGEING DEV, V126, P929, DOI 10.1016/j.mad.2005.03.014; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115; Zahn JM, 2007, CURR OPIN BIOTECH, V18, P355, DOI 10.1016/j.copbio.2007.07.004; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013	47	16	16	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77776	10.1371/journal.pone.0077776	http://dx.doi.org/10.1371/journal.pone.0077776			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204961	gold, Green Submitted, Green Published			2022-12-27	WOS:000326334500059
J	Salek, M; McGowan, S; Trudgian, DC; Dushek, O; de Wet, B; Efstathiou, G; Acuto, O				Salek, Mogjiborahman; McGowan, Simon; Trudgian, David C.; Dushek, Omer; de Wet, Ben; Efstathiou, Georgios; Acuto, Oreste			Quantitative Phosphoproteome Analysis Unveils LAT as a Modulator of CD3 zeta and ZAP-70 Tyrosine Phosphorylation	PLOS ONE			English	Article							SCALE-FREE NETWORKS; SIGNALING NETWORKS; MASS-SPECTROMETRY; PROTEOMICS; PROTEIN; ACTIVATION; MUTATION; SITE	Signaling through the T cell receptor (TCR) initiates adaptive immunity and its perturbation may results in autoimmunity. The plasma membrane scaffolding protein LAT acts as a central organizer of the TCR signaling machinery to activate many functional pathways. LAT-deficient mice develop an autoimmune syndrome but the mechanism of this pathology is unknown. In this work we have compared global dynamics of TCR signaling by MS-based quantitative phosphoproteomics in LAT-sufficient and LAT-defective Jurkat T cells. Surprisingly, we found that many TCR-induced phosphorylation events persist in the absence of LAT, despite ERK and PLC gamma 1 phosphorylation being repressed. Most importantly, the absence of LAT resulted in augmented and persistent tyrosine phosphorylation of CD3 zeta and ZAP70. This indicates that LAT signaling hub is also implicated in negative feedback signals to modulate upstream phosphorylation events. Phosphorylation kinetics data resulting from this investigation is documented in a database (phosphoTCR) accessible online. The MS data have been deposited to the ProteomeXchange with identifier PXD000341.	[Salek, Mogjiborahman; de Wet, Ben; Efstathiou, Georgios; Acuto, Oreste] Univ Oxford, Sir William Dunn Sch Pathol, T Cell Signaling Lab, Oxford OX1 3RE, England; [Trudgian, David C.; de Wet, Ben] Univ Oxford, Sir William Dunn Sch Pathol, Cent Prote Facil, Oxford OX1 3RE, England; [Dushek, Omer] Univ Oxford, Sir William Dunn Sch Pathol, Mol Immunol Grp, Oxford OX1 3RE, England; [McGowan, Simon] Univ Oxford, Nuffield Dept Med, Computat Biol Res Grp, Oxford, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford	Salek, M (corresponding author), Prote Consulting, Toulouse, France.	mogjibs@gmail.com; oreste.acuto@path.ox.ac.uk	Efstathiou, Georgios/E-2848-2013	McGowan, Simon/0000-0001-9720-1914; Salek, Mogjiborahman/0000-0002-6664-4752; Efstathiou, Georgios/0000-0002-8245-9549	Wellcome Trust [GR076558MA, WT094296MA, 098363]; EU-FP7 "Sybilla" Grant [201106]; Sir Henry Dale Fellowship; Royal Society [098363]	Wellcome Trust(Wellcome Trust); EU-FP7 "Sybilla" Grant; Sir Henry Dale Fellowship; Royal Society(Royal Society of London)	This work was supported by Wellcome Trust Grants GR076558MA, WT094296MA, and EU-FP7 "Sybilla" Grant 201106 to O.A. O.D. is supported by the Sir Henry Dale Fellowship, which is jointly funded by the Wellcome Trust and the Royal Society (098363). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2011, ANNU REV IMMUNOL, V29, P493, DOI 10.1146/annurev-immunol-040210-092915; Acuto O, 2008, NAT REV IMMUNOL, V8, P699, DOI 10.1038/nri2397; Aguado E, 2002, SCIENCE, V296, P2036, DOI 10.1126/science.1069057; Barabasi AL, 2003, SCI AM, V288, P60, DOI 10.1038/scientificamerican0503-60; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Brockmeyer C, 2011, J BIOL CHEM, V286, P7535, DOI 10.1074/jbc.M110.201236; Carpino N, 2004, IMMUNITY, V20, P37, DOI 10.1016/S1074-7613(03)00351-0; Choudhary C, 2010, NAT REV MOL CELL BIO, V11, P427, DOI 10.1038/nrm2900; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Feshchenko EA, 2004, ONCOGENE, V23, P4690, DOI 10.1038/sj.onc.1207627; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Mingueneau M, 2009, IMMUNITY, V31, P197, DOI 10.1016/j.immuni.2009.05.013; Nika K, 2006, MOL CELL BIOL, V26, P1806, DOI 10.1128/MCB.26.5.1806-1816.2006; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Phee H, 2005, NAT IMMUNOL, V6, P608, DOI 10.1038/ni1199; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sommers CL, 2005, J EXP MED, V201, P1125, DOI 10.1084/jem.20041869; Trudgian DC, 2010, BIOINFORMATICS, V26, P1131, DOI 10.1093/bioinformatics/btq081; Turner CE, 2001, CURR OPIN CELL BIOL, V13, P593, DOI 10.1016/S0955-0674(00)00256-8; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhang WG, 1999, INT IMMUNOL, V11, P943, DOI 10.1093/intimm/11.6.943	26	25	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77423	10.1371/journal.pone.0077423	http://dx.doi.org/10.1371/journal.pone.0077423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204825	Green Submitted, Green Published, gold			2022-12-27	WOS:000326334500027
J	Wedel, MJ; Taylor, MP				Wedel, Mathew J.; Taylor, Michael P.			Caudal Pneumaticity and Pneumatic Hiatuses in the Sauropod Dinosaurs Giraffatitan and Apatosaurus	PLOS ONE			English	Article							SP-NOV SAUROPODA; POSTCRANIAL PNEUMATICITY; VERTEBRAL PNEUMATICITY; THEROPOD DINOSAURS; AIR SACS; EVOLUTION; SKELETON; RECONSTRUCTION; DIPLODOCOIDEA; REDESCRIPTION	Skeletal pneumaticity is found in the presacral vertebrae of most sauropod dinosaurs, but pneumaticity is much less common in the vertebrae of the tail. We describe previously unrecognized pneumatic fossae in the mid-caudal vertebrae of specimens of Giraffatitan and Apatosaurus. In both taxa, the most distal pneumatic vertebrae are separated from other pneumatic vertebrae by sequences of three to seven apneumatic vertebrae. Caudal pneumaticity is not prominent in most individuals of either of these taxa, and its unpredictable development means that it may be more widespread than previously recognised within Sauropoda and elsewhere in Saurischia. The erratic patterns of caudal pneumatization in Giraffatitan and Apatosaurus, including the pneumatic hiatuses, show that pneumatic diverticula were more broadly distributed in the bodies of the living animals than are their traces in the skeleton. Together with recently published evidence of cryptic diverticula-those that leave few or no skeletal traces-in basal sauropodomorphs and in pterosaurs, this is further evidence that pneumatic diverticula were widespread in ornithodirans, both across phylogeny and throughout anatomy.	[Wedel, Mathew J.] Western Univ Hlth Sci, Coll Osteopath Med Pacific, Pomona, CA USA; [Wedel, Mathew J.] Western Univ Hlth Sci, Coll Podiatr Med, Pomona, CA USA; [Taylor, Michael P.] Univ Bristol, Dept Earth Sci, Bristol BS8 1TH, Avon, England	Western University of Health Sciences; Western University of Health Sciences; University of Bristol	Wedel, MJ (corresponding author), Western Univ Hlth Sci, Coll Osteopath Med Pacific, Pomona, CA USA.	mathew.wedel@gmail.com; dino@miketaylor.org.uk		Taylor, Mike/0000-0002-1003-5675	DFG Research Unit 533: Biology of the Sauropod Dinosaurs; Jurassic Foundation	DFG Research Unit 533: Biology of the Sauropod Dinosaurs; Jurassic Foundation	Research for this study was conducted on a field trip sponsored by DFG Research Unit 533: Biology of the Sauropod Dinosaurs; DFG 533 also supported our travel to Germany. The authors thank Martin Sander (University of Bonn) and the organisers and participants of the field trip. The Field Museum of Natural History supported our travel to Chicago. Research at the Carnegie Museum was supported by a grant from the Jurassic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, PNEUMATIC POSTCRANIA; Benson RBJ, 2012, BIOL REV, V87, P168, DOI 10.1111/j.1469-185X.2011.00190.x; Bonde Niels, 2003, Geological Society Special Publication, V217, P217, DOI 10.1144/GSL.SP.2003.217.01.13; Borsuk-Biatynicka M., 1977, Palaeontologia Polonica, V37, P5; Britt B., 1997, ENCY DINOSAURS, P590; Butler RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034094; Calvo JO, 2007, AN ACAD BRAS CIENC, V79, P529, DOI 10.1590/S0001-37652007000300013; Campos D.D.A., 2005, ARQ MUS NAC, V63, P565; Carvalho ID, 2003, CRETACEOUS RES, V24, P697, DOI 10.1016/j.cretres.2003.07.005; Casal Gabriel, 2007, Revista Brasileira de Paleontologia, V10, P53; Cerda IA, 2012, PALAEONTOL Z, V86, P441, DOI 10.1007/s12542-012-0140-6; Claessens LPAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004497; COVER MS, 1953, AM J VET RES, V14, P239; Cranford TW, 1996, J MORPHOL, V228, P223; Duncker H.-R., 1971, ADV ANAT EMBRYOL CEL, V45, P1; Fanti F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3080; Fronimos J, 2011, J VERTEBR PALEONTOL, V31, P112; Gilmore C. W., 1936, Memoirs of the Carnegie Museum, V11, P175; GILMORE CHARLES W., 1932, PROC U S NATION MUS, V81, P1; Gower DJ, 2001, NATURWISSENSCHAFTEN, V88, P119, DOI 10.1007/s001140100206; Harris JD, 2006, J SYST PALAEONTOL, V4, P185, DOI 10.1017/S1477201906001805; Hatcher JB., 1903, MEM CARNEGIE MUS, V2, P1; Hatcher JB., 1901, MEM CARNEGIE MUS, V1, P1, DOI [10.5962/p.234818, DOI 10.5962/P.234818]; HOGG DA, 1984, J ANAT, V139, P105; Janensch W., 1950, Paleontographica Stuttgart Suppl 7 1 3, V2, P27; Janensch W., 1950, Paleontographica Stuttgart Suppl 7 1 3, V2, P95; Janensch W., 1929, PALAEONTOGRAPHICA S7, V2, P35; Janensch W., 1947, PALAEONTOGRAPHICA S, V7, P1; Kellner Alexander W.A., 1999, National Science Museum Monographs, V15, P111; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; KING A. S., 1957, ACTA ANAT, V31, P220; Lovelace David M., 2007, Arquivos do Museu Nacional (Rio de Janeiro), V65, P527; Lu Junchang, 2009, [Journal of the paleontological Society of Korea, 고생물학회지], V25, P43; Lull R. S., 1919, MEMOIRS CONNECTICUT, V6, P1; Mannion PD, 2011, J SYSTEMATIC PALAEON, V10, P521; Mannion PD, 2013, CRETACEOUS RES, V45, P49, DOI 10.1016/j.cretres.2013.07.007; Mannion PD, 2013, ZOOL J LINN SOC-LOND, V168, P98, DOI 10.1111/zoj.12029; Mannion PD, 2011, CRETACEOUS RES, V32, P774, DOI 10.1016/j.cretres.2011.05.005; Mannion PD, 2010, PALAEONTOLOGY, V53, P277, DOI 10.1111/j.1475-4983.2009.00919.x; Marsh O. C, 1896, 16 US GEOL SURV, P133; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Martinelli Agustin G., 2004, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V6, P257; Matthew W. D., 1905, American Museum Journal, V5; MAZZETTA G. V., 2004, HIST BIOL, V16, P1; McIntosh JS, 2005, LIFE O PAST, P38; Migeod FWH, 1931, NATURAL HIST MAGAZIN, V3, P87; O'Connor PM, 2006, J MORPHOL, V267, P1199, DOI 10.1002/jmor.10470; O'Connor PM, 2009, J EXP ZOOL PART A, V311A, P629, DOI 10.1002/jez.548; O'Connor PM, 2004, J MORPHOL, V261, P141, DOI 10.1002/jmor.10190; O'Connor PM, 2005, NATURE, V436, P253, DOI 10.1038/nature03716; Osborn H. F., 1921, Memoirs from the American Museum of Natural History New York NS, V3, P247; Osborn H. F., 1899, tt cc, P191; Osborn H. F., 1898, Bulletin of the American Museum of Natural History, Vx, P219; Ostrom J. A., 1966, MARSHS DINOSAURS COL; Otero A, 2010, ACTA PALAEONTOL POL, V55, P399, DOI 10.4202/app.2009.0099; OWEN R, 1859, MONOGRAPHS PALAEONTO, P1; Powell JE., 2003, RECORDS QUEEN VICTOR, V111, P1; Remes K, 2006, J VERTEBR PALEONTOL, V26, P651, DOI 10.1671/0272-4634(2006)26[651:ROTTSD]2.0.CO;2; Riggs ES., 1904, FIELD COLUMBIAN MUSE, V2, P229; RIGGS ES, 1903, FIELD COLUMBIAN MUSE, V2, P165; Ruben JA, 1997, SCIENCE, V278, P1267, DOI 10.1126/science.278.5341.1267; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2082, DOI 10.1139/e93-180; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Schwarz D, 2007, ACTA PALAEONTOL POL, V52, P167; Schwarz D, 2006, ECLOGAE GEOL HELV, V99, P65, DOI 10.1007/s00015-006-1177-x; Schwarz-Wings D, 2008, PALAEONTOL ELECTRON, V11; Sereno PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003303; Smith ND, 2012, EVOLUTION, V66, P1059, DOI 10.1111/j.1558-5646.2011.01494.x; Taylor MP, 2007, PALAEONTOLOGY, V50, P1547, DOI 10.1111/j.1475-4983.2007.00728.x; Taylor MP, 2013, PEERJ, V1, DOI 10.7717/peerj.36; Taylor MP, 2009, J VERTEBR PALEONTOL, V29, P787, DOI 10.1671/039.029.0309; Taylor MP, 2005, 53 S VERT PAL COMP A, P25; Tidwell Virginia, 1999, Oryctos, V2, P21; Tidwell Virginia, 2001, P139; Fernandez-Baldor FT, 2011, ACTA PALAEONTOL POL, V56, P535, DOI 10.4202/app.2010.0003; Upchurch P, 1998, ZOOL J LINN SOC-LOND, V124, P43, DOI 10.1111/j.1096-3642.1998.tb00569.x; Upchurch P., 2004, NATL SCI MUS MONOGR, V26, P1; Upchurch P, 2009, PALAEONTOLOGY, V52, P1195, DOI 10.1111/j.1475-4983.2009.00909.x; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Wedel M, 2007, SPEC PAP PALAEONTOL, P207; Wedel MJ, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P201; Wedel MJ, 2009, J EXP ZOOL PART A, V311A, P611, DOI 10.1002/jez.513; Wedel MJ, 2003, J VERTEBR PALEONTOL, V23, P344, DOI 10.1671/0272-4634(2003)023[0344:TEOVPI]2.0.CO;2; Wedel MJ, 2003, PALEOBIOLOGY, V29, P243, DOI 10.1666/0094-8373(2003)029<0243:VPASAT>2.0.CO;2; Weiglein A.H., 1999, PARANASAL SINUSES HI, P35; Whitlock JA, 2011, ZOOL J LINN SOC-LOND, V161, P872, DOI 10.1111/j.1096-3642.2010.00665.x; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P591, DOI 10.1080/02724634.1999.10011168; Wilson JA, 2006, J VERTEBR PALEONTOL, V26, P471, DOI 10.1671/0272-4634(2006)26[471:ATDSAF]2.0.CO;2; Wilson JA, 2009, J SYST PALAEONTOL, V7, P199, DOI 10.1017/S1477201908002691; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027; Yates Adam M., 2003, Journal of Systematic Palaeontology, V1, P1, DOI 10.1017/S1477201903001007; Yates AM, 2012, ACTA PALAEONTOL POL, V57, P85, DOI 10.4202/app.2010.0075	95	28	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78213	10.1371/journal.pone.0078213	http://dx.doi.org/10.1371/journal.pone.0078213			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205162	Green Published, gold, Green Submitted			2022-12-27	WOS:000326334500104
J	Liu, Y; Gu, DD; Wu, W; Wen, XX; Liao, YC				Liu, Yang; Gu, Dandan; Wu, Wei; Wen, Xiaoxia; Liao, Yuncheng			The Relationship between Polyamines and Hormones in the Regulation of Wheat Grain Filling	PLOS ONE			English	Article							ABSCISIC-ACID; POSTANTHESIS DEVELOPMENT; ENDOGENOUS HORMONES; SUPERIOR SPIKELETS; CYTOKININ CONTENT; MAIZE KERNELS; RICE; PLANT; GROWTH; ETHYLENE	The grain weight of wheat is strongly influenced by filling. Polyamines (PA) are involved in regulating plant growth. However, the effects of PA on wheat grain filling and its mechanism of action are unclear. The objective of the present study was to investigate the relationship between PAs and hormones in the regulation of wheat grain filling. Three PAs, spermidine (Spd), spermine (Spm), and putrescine (Put), were exogenously applied, and the grain filling characteristics and changes in endogenous PA and hormones, i.e., indole-3-acetic acid (IAA), zeatin (Z) + zeatin riboside (ZR), abscisic acid (ABA), ethylene (ETH) and gibberellin 1+4 (GAs), were quantified during wheat grain filling. Exogenous applications of Spd and Spm significantly increased the grain filling rate and weight, but exogenous Put had no significant effects on these measures. Exogenous Spd and Spm significantly increased the endogenous Spd, Spm, Z+ZR, ABA, and IAA contents and significantly decreased ETH evolution in grains. The endogenous Spd, Spm and Z+ZR contents were positively and significantly correlated with the grain filling rate and weight of wheat, and the endogenous ETH evolution was negatively and significantly correlated with the wheat grain filling rate and weight. Based upon these results, we concluded that PAs were involved in the balance of hormones that regulated the grain filling of wheat.	[Liu, Yang; Wu, Wei; Wen, Xiaoxia; Liao, Yuncheng] Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China; [Gu, Dandan] Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Liao, YC (corresponding author), Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China.	yunchengliao@126.com	Wu, Wei/AAG-3230-2020	Wu, Wei/0000-0003-1867-1446	National Natural Science Foundation of China [31070375, 31171506]; Program of Introducing Talents of Discipline to Universities [B12007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project)	This work was supported by the National Natural Science Foundation of China (Project No. 31070375, 31171506) and the Program of Introducing Talents of Discipline to Universities (B12007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar R, 2006, BIOTECHNOL LETT, V28, P1867, DOI 10.1007/s10529-006-9179-3; BUENO M, 1992, PHYSIOL PLANTARUM, V85, P531, DOI 10.1111/j.1399-3054.1992.tb05822.x; Davies P. J., 1987, Plant hormones and their role in plant growth and development., P1; DIETRICH JT, 1995, PLANT PHYSIOL BIOCH, V33, P327; FUHRER J, 1982, PLANT PHYSIOL, V70, P1597, DOI 10.1104/pp.70.6.1597; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; KUROGOCHI S, 1979, PLANTA, V146, P185, DOI 10.1007/BF00388230; Kusano T, 2007, J PLANT RES, V120, P345, DOI 10.1007/s10265-007-0074-3; Liang YL, 2002, CROP SCI, V42, P1217, DOI 10.2135/cropsci2002.1217; Liu J, 2005, J INTEGR PLANT BIOL, V47, P1326, DOI 10.1111/j.1744-7909.2005.00183.x; Liu J., 2002, TEC MET, V38, P596; Liu Y, 2011, PLANT GROWTH REGUL, V65, P247, DOI 10.1007/s10725-011-9594-x; MICHAEL G, 1972, CROP SCI, V12, P162, DOI 10.2135/cropsci1972.0011183X001200020002x; MORRIS RO, 1993, AUST J PLANT PHYSIOL, V20, P621, DOI 10.1071/PP9930621; Paschalidis KA, 2005, PLANT PHYSIOL, V138, P2174, DOI 10.1104/pp.105.063941; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; SAHA S, 1986, Canadian Journal of Botany, V64, P2068, DOI 10.1139/b86-271; Saini HS, 2000, ADV AGRON, V68, P59; SETH AK, 1967, J EXP BOT, V18, P65, DOI 10.1093/jxb/18.1.65; SINGH G, 1982, Plant Physiology and Biochemistry, V9, P22; SMITH MA, 1985, PLANT PHYSIOL, V78, P92, DOI 10.1104/pp.78.1.92; Steiner N, 2007, PLANT CELL TISS ORG, V89, P55, DOI 10.1007/s11240-007-9216-5; SUZUKI Y, 1981, PLANT CELL PHYSIOL, V22, P1085; Tan GuiLu, 2009, Acta Agronomica Sinica, V35, P2225, DOI 10.3724/SP.J.1006.2009.02225; Tomosugi M, 2006, PLANTA, V223, P349, DOI 10.1007/s00425-005-0083-1; Walden R, 1997, PLANT PHYSIOL, V113, P1009, DOI 10.1104/pp.113.4.1009; Xu GW, 2007, FIELD CROP RES, V101, P53, DOI 10.1016/j.fcr.2006.09.008; Yang JC, 2006, NEW PHYTOL, V169, P223, DOI 10.1111/j.1469-8137.2005.01597.x; Yang JC, 2000, PLANT GROWTH REGUL, V30, P261, DOI 10.1023/A:1006356125418; Yang JC, 2002, ANN BOT-LONDON, V90, P369, DOI 10.1093/aob/mcf198; Yang JC, 2001, PLANT PHYSIOL, V127, P315, DOI 10.1104/pp.127.1.315; Yang JC, 2008, PLANTA, V228, P137, DOI 10.1007/s00425-008-0725-1; Yang JC, 2006, NEW PHYTOL, V171, P293, DOI 10.1111/j.1469-8137.2006.01753.x; Zahedi M, 2003, J AGR SCI-CAMBRIDGE, V141, P203, DOI 10.1017/S0021859603003411; Zhang H, 2009, PLANT PHYSIOL BIOCH, V47, P195, DOI 10.1016/j.plaphy.2008.11.012; Zhang ZC, 2009, J AGR SCI-CAMBRIDGE, V147, P423, DOI 10.1017/S0021859609008557	36	36	38	3	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78196	10.1371/journal.pone.0078196	http://dx.doi.org/10.1371/journal.pone.0078196			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205154	Green Published, gold, Green Submitted			2022-12-27	WOS:000326270700083
J	Bucci, MP; Bui-Quoc, E; Gerard, CL				Bucci, Maria Pia; Bui-Quoc, Emmanuel; Gerard, Christophe-Loic			The Effect of a Stroop-like Task on Postural Control in Dyslexic Children	PLOS ONE			English	Article							IMPOSED OPTIC FLOW; DEVELOPMENTAL DYSLEXIA; DUAL-TASK; BALANCE; INFORMATION; PARAMETERS; RESPONSES; ADULTS; SWAY; GAIT	The influence of a secondary task on concurrent postural control was explored in twenty-one dyslexic children (mean age: 10.4 +/- 0.3 years). Data were compared with twenty age-matched non-dyslexic children. As a secondary task, a modified Stroop test was used, in which words were replaced with pictures of fruits. The postural control of children was recorded in standard Romberg condition as the children were asked to name the colour of fruits appearing consecutively on a computer screen. Two conditions were tested: a congruent condition, in which the fruit was drawn in its natural ripe colour, and a non-congruent colour condition (NC), in which the fruit was drawn in three abnormal colours. A fixating condition was used as baseline. We analyzed the surface, length and mean speed of the center of pressure and measured the number of correct responses in the Stroop-like tasks. Dyslexic children were seen to be significantly more unstable than non-dyslexic ones. For both groups of children, the secondary task significantly increased postural instability in comparison with the fixating condition. The number of correct responses in the modified Stroop task was significantly higher in the non-dyslexic than in the dyslexic group. The postural instability observed in dyslexic children is in line with the cerebellar hypothesis and supports the idea of a deficit in automatic performance in such children. Furthermore, in accordance with cross domain competition model, our findings show that attentional resources are used to a greater extent by the secondary task than in controlling body stability.	[Bucci, Maria Pia] Hop Robert Debre, UMR 676, F-75019 Paris, France; [Bui-Quoc, Emmanuel] Hop Robert Debre, Serv Ophtalmol, F-75019 Paris, France; [Gerard, Christophe-Loic] Hop Robert Debre, Serv Psychopathol Enfant & Adolescent, F-75019 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Bucci, MP (corresponding author), Hop Robert Debre, UMR 676, F-75019 Paris, France.	mariapia.bucci@gmail.com						American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Barela AMF, 2009, MOTOR CONTROL, V13, P119, DOI 10.1123/mcj.13.2.119; Barela JA, 2003, EXP BRAIN RES, V150, P434, DOI 10.1007/s00221-003-1441-5; Barela JA, 2011, RES DEV DISABIL, V32, P1814, DOI 10.1016/j.ridd.2011.03.011; Blanchard Yvette, 2005, Pediatr Phys Ther, V17, P189, DOI 10.1097/01.PEP.0000176578.57147.5d; BOUISSET S, 1994, NEUROREPORT, V5, P957, DOI 10.1097/00001756-199404000-00026; Brandt T., 2003, VERTIGO ITS MULTISEN; Brookes RL, 2010, DYSLEXIA, V16, P358, DOI 10.1002/dys.420; Bucci M. P., 2012, DYSLEXIA COMPREHENSI; Bucci MP, 2012, PLOSONES; Chevrie-Muller C, 1997, BATTERIE LANGAGE ORA; Chiari L, 2002, CLIN BIOMECH, V17, P666, DOI 10.1016/S0268-0033(02)00107-9; DuPaul GJ, 1998, J PSYCHOPATHOL BEHAV, V20, P83, DOI 10.1023/A:1023087410712; Eckert MA, 2003, BRAIN, V126, P482, DOI 10.1093/brain/awg026; Faccioli C, 2008, CHILD NEUROPSYCHOL, V14, P277, DOI 10.1080/09297040701290040; FRANK J, 1973, J AM ACAD CHILD PSY, V12, P690, DOI 10.1016/S0002-7138(09)61276-0; Gagey P.M., 1999, POSTUROLOGIE REGULAT; GEURTS ACH, 1993, ARCH PHYS MED REHAB, V74, P1144; Hatzitaki V, 2002, J MOTOR BEHAV, V34, P161, DOI 10.1080/00222890209601938; KERR B, 1985, J EXP PSYCHOL HUMAN, V11, P617, DOI 10.1037/0096-1523.11.5.617; Konczak J, 2005, BRAIN, V128, P1428, DOI 10.1093/brain/awh385; Lacour M, 2008, NEUROPHYSIOL CLIN, V38, P411, DOI 10.1016/j.neucli.2008.09.005; Legrand A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035301; MAKI BE, 1990, J AM GERIATR SOC, V38, P1, DOI 10.1111/j.1532-5415.1990.tb01588.x; Minshew NJ, 1999, NEUROLOGY, V52, P917, DOI 10.1212/WNL.52.5.917; Moe-Nilssen R, 2003, EXP BRAIN RES, V150, P237, DOI 10.1007/s00221-003-1450-4; Nicolson R. I., 1999, DYSLEXIA INT J RES P, V5, P155, DOI [DOI 10.1002/(SICI)1099-0909(199909)5:3<155::AID-DYS143>3.0.CO;2-4, 10.1002/(SICI)1099-0909(199909)5:3&LT;155::AID-DYS143&GT;3.0.CO;2-4]; Olivier I, 2007, NEUROREPORT, V18, P817, DOI 10.1097/WNR.0b013e3280e129e1; Olivier I, 2010, GAIT POSTURE, V32, P494, DOI 10.1016/j.gaitpost.2010.07.008; Quercia P, 2011, EXP BRAIN RES, V209, P599, DOI 10.1007/s00221-011-2593-3; Rae C, 1998, LANCET, V351, P1849, DOI 10.1016/S0140-6736(97)99001-2; RIDDELL PM, 1990, PERCEPT MOTOR SKILL, V70, P707, DOI 10.2466/PMS.70.3.707-718; Ruffino M, 2010, NEUROPSYCHOLOGIA, V48, P3793, DOI 10.1016/j.neuropsychologia.2010.09.002; Schmid M, 2007, EXP BRAIN RES, V179, P375, DOI 10.1007/s00221-006-0795-x; STEIN JF, 1987, EYE, V1, P433, DOI 10.1038/eye.1987.66; Stoet G, 2007, COGN AFFECT BEHAV NE, V7, P192, DOI 10.3758/CABN.7.3.192; Stoffregen TA, 2006, MOTOR CONTROL, V10, P24, DOI 10.1123/mcj.10.1.24; Stoodley CJ, 2005, EXP BRAIN RES, V167, P370, DOI 10.1007/s00221-005-0042-x; Thach WT, 2004, PROG BRAIN RES, V143, P353, DOI 10.1016/S0079-6123(03)43034-3; Vieira S, 2009, NEUROSCI LETT, V462, P125, DOI 10.1016/j.neulet.2009.06.093	40	16	16	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77920	10.1371/journal.pone.0077920	http://dx.doi.org/10.1371/journal.pone.0077920			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	242KW	24205028	Green Published, gold			2022-12-27	WOS:000326241200049
J	Mittermeyer, G; Malinowsky, K; Beese, C; Hofler, H; Schmalfeldt, B; Becker, KF; Avril, S				Mittermeyer, Gabriele; Malinowsky, Katharina; Beese, Christian; Hoefler, Heinz; Schmalfeldt, Barbara; Becker, Karl-Friedrich; Avril, Stefanie			Variation in Cell Signaling Protein Expression May Introduce Sampling Bias in Primary Epithelial Ovarian Cancer	PLOS ONE			English	Article							PARAFFIN-EMBEDDED TISSUES; CISPLATIN RESISTANCE; INTRATUMORAL HETEROGENEITY; BREAST-CANCER; PHASE-II; MICROARRAYS; PATHWAY; ACTIVATION; INHIBITOR; CARCINOMA	Although the expression of cell signaling proteins is used as prognostic and predictive biomarker, variability of protein levels within tumors is not well studied. We assessed intratumoral heterogeneity of protein expression within primary ovarian cancer. Full-length proteins were extracted from 88 formalin-fixed and paraffin-embedded tissue samples of 13 primary high-grade serous ovarian carcinomas with 5-9 samples each. In addition, 14 samples of normal fallopian tube epithelium served as reference. Quantitative reverse phase protein arrays were used to analyze the expression of 36 cell signaling proteins including HER2, EGFR, PI3K/Akt, and angiogenic pathways as well as 15 activated (phosphorylated) proteins. We found considerable intratumoral heterogeneity in the expression of proteins with a mean coefficient of variation of 25% (range 17-53%). The extent of intratumoral heterogeneity differed between proteins (p<0.005). Interestingly, there were no significant differences in the extent of heterogeneity between phosphorylated and non-phosphorylated proteins. In comparison, we assessed the variation of protein levels amongst tumors from different patients, which revealed a similar mean coefficient of variation of 21% (range 12-48%). Based on hierarchical clustering, samples from the same patient clustered more closely together compared to samples from different patients. However, a clear separation of tumor versus normal tissue by clustering was only achieved when mean expression values of all individual samples per tumor were analyzed. While differential expression of some proteins was detected independently of the sampling method used, the majority of proteins only demonstrated differential expression when mean expression values of multiple samples per tumor were analyzed. Our data indicate that assessment of established and novel cell signaling proteins as diagnostic or prognostic markers may require sampling of serous ovarian cancers at several distinct locations to avoid sampling bias.	[Mittermeyer, Gabriele; Malinowsky, Katharina; Beese, Christian; Hoefler, Heinz; Becker, Karl-Friedrich; Avril, Stefanie] Tech Univ Munich, Dept Pathol, D-80290 Munich, Germany; [Schmalfeldt, Barbara] Helmholtz Zentrum Munchen, Inst Pathol, Neuherberg, Germany; [Hoefler, Heinz] Tech Univ Munich, Dept Obstet & Gynecol, D-80290 Munich, Germany	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Becker, KF (corresponding author), Tech Univ Munich, Dept Pathol, D-80290 Munich, Germany.	kf.becker@lrz.tum.de; stefanie.avril@lrz.tum.de	Avril, Stefanie/J-6668-2016; Becker, Karl-Friedrich/D-3636-2015	Avril, Stefanie/0000-0002-3394-8733; Becker, Karl-Friedrich/0000-0002-6801-4498	Department of Pathology; Department of Obstetrics and Gynecology	Department of Pathology; Department of Obstetrics and Gynecology	This study was funded by internal grants from the Department of Pathology and the Department of Obstetrics and Gynecology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson S, 2012, STEM CELLS, V30, P415, DOI 10.1002/stem.1029; Alaiya AA, 1999, ELECTROPHORESIS, V20, P1039, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<1039::AID-ELPS1039>3.0.CO;2-4; Berg D, 2011, METHODS MOL BIOL, V785, P109, DOI 10.1007/978-1-61779-286-1_8; Burger RA, 2007, J CLIN ONCOL, V25, P5165, DOI 10.1200/JCO.2007.11.5345; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Cannistra SA, 2007, J CLIN ONCOL, V25, P5180, DOI 10.1200/JCO.2007.12.0782; Crum CP, 2009, MOL ONCOL, V3, P165, DOI 10.1016/j.molonc.2009.01.004; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Espina V, 2003, PROTEOMICS, V3, P2091, DOI 10.1002/pmic.200300592; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; GLUER CC, 1995, OSTEOPOROSIS INT, V5, P262, DOI 10.1007/BF01774016; Gross AL, 2010, J ONCOL, V2010, P126; Grubb RL, 2003, PROTEOMICS, V3, P2142, DOI 10.1002/pmic.200300598; Guo HF, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-56; Hall M, 2013, BRIT J CANCER, V108, P250, DOI 10.1038/bjc.2012.541; Heintz APM, 2006, INT J GYNECOL OBSTET, V95, pS161, DOI 10.1016/S0020-7292(06)60033-7; Kobel M, 2011, INT J GYNECOL PATHOL, V30, P366, DOI 10.1097/PGP.0b013e31820d20ba; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Lee S, 2005, GYNECOL ONCOL, V97, P26, DOI 10.1016/j.ygyno.2004.11.051; Liotta LA, 2003, CANCER CELL, V3, P317, DOI 10.1016/S1535-6108(03)00086-2; Machida S, 2005, INT J CANCER, V114, P224, DOI 10.1002/ijc.20751; Malinowsky K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040285; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; Peng DJ, 2010, BIOCHEM BIOPH RES CO, V394, P600, DOI 10.1016/j.bbrc.2010.03.029; RUBIN SC, 1991, AM J OBSTET GYNECOL, V164, P558, DOI 10.1016/S0002-9378(11)80020-7; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Wolff C, 2011, METHODS MOL BIOL, V785, P123, DOI 10.1007/978-1-61779-286-1_9; Wolff C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016353; Wolff C, 2011, J PATHOL, V223, P54, DOI 10.1002/path.2791; Wulfkuhle JD, 2006, NAT CLIN PRACT ONCOL, V3, P256, DOI 10.1038/ncponc0485; Wulfkuhle JD, 2012, CLIN CANCER RES, V18, P6426, DOI 10.1158/1078-0432.CCR-12-0452; Xu L, 2000, INT J ONCOL, V16, P445; Yang XK, 2006, CANCER RES, V66, P3126, DOI 10.1158/0008-5472.CAN-05-0425; Zborovskaya I, 1999, INT J CANCER, V82, P822, DOI 10.1002/(SICI)1097-0215(19990909)82:6<822::AID-IJC9>3.3.CO;2-9	34	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77825	10.1371/journal.pone.0077825	http://dx.doi.org/10.1371/journal.pone.0077825			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204986	Green Published, Green Submitted, gold			2022-12-27	WOS:000326241200045
J	Walker, M; Fureix, C; Palme, R; Mason, G				Walker, Michael; Fureix, Carole; Palme, Rupert; Mason, Georgia			Co-Housing Rodents with Different Coat Colours as a Simple, Non-Invasive Means of Individual Identification: Validating Mixed-Strain Housing for C57BL/6 and DBA/2 Mice	PLOS ONE			English	Article							BACTERIAL COMPOSITION; STRESS; BEHAVIOR; ANXIETY; RATS; CORTICOSTERONE; WELFARE; TUMORS; SEX; CONSEQUENCES	Standard practice typically requires the marking of laboratory mice so that they can be individually identified. However, many of the common methods compromise the welfare of the individuals being marked (as well as requiring time, effort, and/or resources on the part of researchers and technicians). Mixing strains of different colour within a cage would allow them to be readily visually identifiable, negating the need for more invasive marking techniques. Here we assess the impact that mixed strain housing has on the phenotypes of female C57BL/6 (black) and DBA/2 (brown) mice, and on the variability in the data obtained from them. Mice were housed in either mixed strain or single strain pairs for 19 weeks, and their phenotypes then assessed using 23 different behavioural, morphological, haematological and physiological measures widely used in research and/or important for assessing mouse welfare. No negative effects of mixed strain housing could be found on the phenotypes of either strain, including variables relevant to welfare. Differences and similarities between the two strains were almost all as expected from previously published studies, and none were affected by whether mice were housed in mixed-or single-strain pairs. Only one significant main effect of housing type was detected: mixed strain pairs had smaller red blood cell distribution widths, a measure suggesting better health (findings that now need replicating in case they were Type 1 errors resulting from our multiplicity of tests). Furthermore, mixed strain housing did not increase the variation in data obtained from the mice: the standard errors for all variables were essentially identical between the two housing conditions. Mixed strain housing also made animals very easy to distinguish while in the home cage. Female DBA/2 and C57BL/6 mice can thus be housed in mixed strain pairs for identification purposes, with no apparent negative effects on their welfare or the data they generate. This suggests that there is much value in exploring other combinations of strains.	[Walker, Michael; Fureix, Carole; Mason, Georgia] Univ Guelph, Guelph, ON N1G 2W1, Canada; [Palme, Rupert] Univ Vet Med, Dept Biomed, Vienna, Austria	University of Guelph; University of Veterinary Medicine Vienna	Mason, G (corresponding author), Univ Guelph, Guelph, ON N1G 2W1, Canada.	gmason@uoguelph.ca	Palme, Rupert/A-3499-2008	Palme, Rupert/0000-0001-9466-3662	NSERC [145607319, PGSD3-426294-2012]; Fyssen Foundation	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fyssen Foundation	NSERC Discovery Grant - Reference number: 145607319 (http://www.nserc-crsng.gc.ca/index_eng.asp). NSERC Postgraduate Scholarship - Reference number PGSD3-426294-2012 (http://www.nserc-crsng.gc.ca/index_eng.asp). Fyssen Foundation Grant (http://www.fondation-fyssen.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamec R, 2006, PHYSIOL BEHAV, V88, P12, DOI 10.1016/j.physbeh.2006.03.005; Berglund ED, 2008, DIABETES, V57, P1790, DOI 10.2337/db07-1615; BRAND KG, 1976, CRC CR REV TOXICOL, V4, P353, DOI 10.1080/10408447609164018; Brennan K, 2001, PSYCHOPHARMACOLOGY, V157, P269, DOI 10.1007/s002130100805; Burn CC, 2008, DEV PSYCHOBIOL, V50, P266, DOI 10.1002/dev.20279; Cabib S, 1997, PHYSIOL BEHAV, V61, P499, DOI 10.1016/S0031-9384(96)00463-5; Cannon CZ, 2011, LAB ANIMAL, V40, P85, DOI 10.1038/laban0311-85; Castelhano-Carlos MJ, 2010, LAB ANIM-UK, V44, P88, DOI 10.1258/la.2009.009044; Choleris E, 2011, NEUROPSYCHOPHARMACOL, V36, P1689, DOI 10.1038/npp.2011.50; Cinelli P, 2007, LAB ANIM-UK, V41, P174, DOI 10.1258/002367707780378113; Curley JP, 2010, BEHAV GENET, V40, P220, DOI 10.1007/s10519-010-9334-4; Dahlborn K, 2013, LAB ANIM-UK, V47, P2, DOI 10.1177/002367712473290; Deacon RMJ, 2006, NAT PROTOC, V1, P936, DOI 10.1038/nprot.2006.120; Dellu F, 1996, PSYCHONEUROENDOCRINO, V21, P441, DOI 10.1016/0306-4530(96)00017-0; Elcock LE, 2001, EXP TOXICOL PATHOL, V52, P483, DOI 10.1016/S0940-2993(01)80002-6; Ennaceur A, 2005, BEHAV BRAIN RES, V159, P247, DOI 10.1016/j.bbr.2004.11.006; Garner JP, 2004, APPL ANIM BEHAV SCI, V89, P263, DOI 10.1016/j.applanim.2004.07.004; Goes TC, 2009, NEUROSCI LETT, V450, P266, DOI 10.1016/j.neulet.2008.11.037; Gonder JC, 2007, ILAR J, V48, P29, DOI 10.1093/ilar.48.1.29; Grafen A, 2002, MODERN STAT LIFE SCI, Vi-xv, P1; GRIEBEL G, 1993, BEHAV PHARMACOL, V4, P637; GUILLOT PV, 1994, BRAIN RES, V660, P167, DOI 10.1016/0006-8993(94)90852-4; Han JS, 2005, J NEUROSCI METH, V141, P261, DOI 10.1016/j.jneumeth.2004.07.005; Harizi H, 2007, J NEUROIMMUNOL, V189, P59, DOI 10.1016/j.jneuroim.2007.06.019; Howerton CL, 2012, J NEUROSCI METH, V209, P74, DOI 10.1016/j.jneumeth.2012.06.001; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Hurst JL, 2010, NAT METHODS, V7, P825, DOI [10.1038/nmeth.1500, 10.1038/NMETH.1500]; IWAKI S, 1989, LAB ANIM, V23, P361, DOI 10.1258/002367789780746024; Jones BC, 1998, PSYCHONEUROENDOCRINO, V23, P505; Kasanen IHE, 2011, LAB ANIM-UK, V45, P154, DOI 10.1258/la.2011.010113; Kelley SP, 1996, PHARMACOL BIOCHEM BE, V53, P141, DOI 10.1016/0091-3057(95)02006-3; Lazic SE, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-5; Le Calvez S, 2006, EXP TOXICOL PATHOL, V57, P255, DOI 10.1016/j.etp.2005.10.007; Martin P, 1994, MEASURING BEHAV INTR, Vi-xvi, P1; Mason GJ, 2004, ANIM WELFARE, V13, pS57; Meijer MK, 2006, LAB ANIM-UK, V40, P382, DOI 10.1258/002367706778476370; Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030; Nevison CM, 1999, ANIM WELFARE, V8, P361; Nevison CM, 2000, P ROY SOC B-BIOL SCI, V267, P687, DOI 10.1098/rspb.2000.1057; Newman JA, 1997, ECOLOGY, V78, P1312; Olsson IAS, 2007, APPL ANIM BEHAV SCI, V103, P229, DOI 10.1016/j.applanim.2006.05.022; Orwoll ES, 2001, J BONE MINER RES, V16, P1962, DOI 10.1359/jbmr.2001.16.11.1962; Palme R, 2012, ANIM WELFARE, V21, P331, DOI 10.7120/09627286.21.3.331; Perlstein TS, 2009, ARCH INTERN MED, V169, P588, DOI 10.1001/archinternmed.2009.55; Podhorna J, 2002, GENES BRAIN BEHAV, V1, P96, DOI 10.1034/j.1601-183X.2002.10205.x; Pothion S, 2004, BEHAV BRAIN RES, V155, P135, DOI 10.1016/j.bbr.2004.04.008; Priebe K, 2005, DEV PSYCHOBIOL, V47, P398, DOI 10.1002/dev.20098; Richter SH, 2009, NAT METHODS, V6, P257, DOI [10.1038/NMETH.1312, 10.1038/nmeth.1312]; Roitt I., 1998, IMMUNOLOGY; Russell WMS., 1959, MED J AUSTRALIA; Sanger GJ, 2000, BRIT J PHARMACOL, V130, P706, DOI 10.1038/sj.bjp.0703367; Santoso A, 2006, J NEUROSCI METH, V153, P208, DOI 10.1016/j.jneumeth.2005.10.025; Schaefer DC, 2010, LAB ANIM-UK, V44, P7, DOI 10.1258/la.2009.009020; Sherrington C.S., 1906, INTEGRATIVE ACTION N, Vfirst, DOI 10.1037/13798-000; Sheward WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009783; SILVERS WK (ED), 1979, COAT COLORS MICE MOD; Singer P, 2009, PSYCHOPHARMACOLOGY, V206, P677, DOI 10.1007/s00213-009-1568-6; Sorensen DB, 2007, LAB ANIM-UK, V41, P19, DOI 10.1258/002367707779399383; The_Jackson_Laboratory, 2007, HEM SURV 11 INBR STR; Tillmann T, 1997, EXP TOXICOL PATHOL, V49, P197, DOI 10.1016/S0940-2993(97)80007-3; Tilly SLC, 2010, ANIM BEHAV, V80, P363, DOI 10.1016/j.anbehav.2010.06.008; Toivanen P, 2001, INFECT IMMUN, V69, P2372, DOI 10.1128/IAI.69.4.2372-2377.2001; Touma C, 2004, HORM BEHAV, V45, P10, DOI 10.1016/j.yhbeh.2003.07.002; Touma C, 2003, GEN COMP ENDOCR, V130, P267, DOI 10.1016/S0016-6480(02)00620-2; TRULLAS R, 1993, PSYCHOPHARMACOLOGY, V111, P323, DOI 10.1007/BF02244948; Urban R, 2011, PAIN, V152, P990, DOI 10.1016/j.pain.2010.12.003; Vaahtovuo J, 2003, FEMS MICROBIOL ECOL, V44, P131, DOI 10.1016/S0168-6496(02)00460-9; Walker MD, 2011, BEHAV BRAIN RES, V224, P207, DOI 10.1016/j.bbr.2011.06.003; Williams WO, 2008, J AM ASSOC LAB ANIM, V47, P8; WILLNER P, 1992, NEUROSCI BIOBEHAV R, V16, P525, DOI 10.1016/S0149-7634(05)80194-0; Winter Y, 2011, J NEUROSCI METH, V196, P276, DOI 10.1016/j.jneumeth.2011.01.017	71	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77541	10.1371/journal.pone.0077541	http://dx.doi.org/10.1371/journal.pone.0077541			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204864	Green Submitted, Green Published, gold			2022-12-27	WOS:000326241200031
J	Barth, JMI; Matschiner, M; Robertson, BC				Barth, Julia M. I.; Matschiner, Michael; Robertson, Bruce C.			Phylogenetic Position and Subspecies Divergence of the Endangered New Zealand Dotterel (Charadrius obscurus)	PLOS ONE			English	Article							MTDNA CONTROL REGION; SUBSTITUTION MODELS; MITOCHONDRIAL-DNA; BIRDS; EVOLUTION; SEQUENCES; AVES; CHARADRIIFORMES; SYSTEMATICS; SHOREBIRDS	The New Zealand Dotterel (Charadrius obscurus), an endangered shorebird of the family Charadriidae, is endemic to New Zealand where two subspecies are recognized. These subspecies are not only separated geographically, with C. o. aquilonius being distributed in the New Zealand North Island and C. o. obscurus mostly restricted to Stewart Island, but also differ substantially in morphology and behavior. Despite these divergent traits, previous work has failed to detect genetic differentiation between the subspecies, and the question of when and where the two populations separated is still open. Here, we use mitochondrial and nuclear markers to address molecular divergence between the subspecies, and apply maximum likelihood and Bayesian methods to place C. obscurus within the non-monophyletic genus Charadrius. Despite very little overall differentiation, distinct haplotypes for the subspecies were detected, thus supporting molecular separation of the northern and southern populations. Phylogenetic analysis recovers a monophyletic clade combining the New Zealand Dotterel with two other New Zealand endemic shorebirds, the Wrybill and the Double-Banded Plover, thus suggesting a single dispersal event as the origin of this group. Divergence dates within Charadriidae were estimated with BEAST 2, and our results indicate a Middle Miocene origin of New Zealand endemic Charadriidae, a Late Miocene emergence of the lineage leading to the New Zealand Dotterel, and a Middle to Late Pleistocene divergence of the two New Zealand Dotterel subspecies.	[Barth, Julia M. I.; Robertson, Bruce C.] Univ Otago, Dept Zool, Dunedin, New Zealand; [Matschiner, Michael] Univ Canterbury, Dept Math & Stat, Allan Wilson Ctr Mol Ecol & Evolut, Christchurch 1, New Zealand	University of Otago; University of Canterbury	Barth, JMI (corresponding author), Univ Otago, Dept Zool, POB 56, Dunedin, New Zealand.	jmi.barth@gmail.com		Barth, Julia/0000-0001-5125-819X; Matschiner, Michael/0000-0003-4741-3884	New Zealand Department of Conservation's Conservation Management Units Fund; Swiss National Science Foundation [PBBSP3-138680]; University of Otago	New Zealand Department of Conservation's Conservation Management Units Fund; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Otago	This work was supported by the New Zealand Department of Conservation's Conservation Management Units Fund (JB and BR), the Swiss National Science Foundation (PBBSP3-138680) (MM), and the University of Otago (BR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker AJ, 2007, BIOL LETTERS, V3, P205, DOI 10.1098/rsbl.2006.0606; Baker AJ, 2012, MOL PHYLOGENET EVOL, V65, P631, DOI 10.1016/j.ympev.2012.07.018; Baker Allan J., 1997, P51, DOI 10.1016/B978-012498315-1/50005-4; Banks JC, 2007, NEW ZEAL J ZOOL, V34, P141, DOI 10.1080/03014220709510072; Barlow Maida, 1993, Notornis, V40, P15; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bock WJ, 1958, B MUS COMP ZOOL HARV, V118, P25; Buller WL., 1888, HIST BIRDS NZ, V2; BURTON P J K, 1972, Notornis, V19, P26; Chapple DG, 2009, MOL PHYLOGENET EVOL, V52, P470, DOI 10.1016/j.ympev.2009.03.021; CHRISTIAN PD, 1992, AUST J ZOOL, V40, P225, DOI 10.1071/ZO9920225; Crochet PA, 2000, MOL ECOL, V9, P1463, DOI 10.1046/j.1365-294x.2000.01026.x; Crochet PA, 2000, MOL BIOL EVOL, V17, P1797, DOI 10.1093/oxfordjournals.molbev.a026280; Crocker T, 2010, NOTORNIS, V57, P27; DOWDING J E, 1991, Notornis, V38, P89; Dowding J.E., 2007, NZ DOTTEREL CHARADRI; Dowding JE, 1997, PRED WORKSH; Dowding JE, 1993, NZ DOTTEREL RECOVERY; Dowding JE, 2006, HABITAT NETWORKS IND; Dowding John E., 1999, Notornis, V46, P167; Dowding John E., 1993, Notornis, V40, P1; Dowding John E., 1994, Notornis, V41, P221; Drummond A.J., 2007, TRACER VERSION 15; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dyke GJ, 2004, ZOOL J LINN SOC-LOND, V141, P153, DOI 10.1111/j.1096-3642.2004.00118.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Field BD., 2002, REV MEXICANA CIENCIA, V19, P242; Gernhard T, 2008, J MATH BIOL, V57, P713, DOI 10.1007/s00285-008-0186-y; Gray GR, 1862, IBIS, V4, P214; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; Herbert JM, 1993, CONSERVATION ADVISOR, V41; Holdaway RN, 2001, NEW ZEAL J ZOOL, V28, P119, DOI 10.1080/03014223.2001.9518262; Holloway J., 1977, LEPIDOPTERA NORFOLK; Hou LH, 2002, CONDOR, V104, P896, DOI 10.1650/0010-5422(2002)104[0896:AMESFC]2.0.CO;2; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IUCN, 2012, IUCN RED LIST THREAT; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Joseph L, 1999, J BIOGEOGR, V26, P329, DOI 10.1046/j.1365-2699.1999.00269.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kuro-O M, 2010, CONSERV GENET, V11, P127, DOI 10.1007/s10592-009-0011-1; Lee DE, 2001, AUST J BOT, V49, P341, DOI 10.1071/BT00031; Leigh JW, 2008, SYST BIOL, V57, P104, DOI 10.1080/10635150801910436; Lemmon AR, 2009, SYST BIOL, V58, P130, DOI 10.1093/sysbio/syp017; Livezey BC, 2010, ZOOL J LINN SOC-LOND, V160, P567, DOI 10.1111/j.1096-3642.2010.00635.x; MACLEAN GL, 1977, EMU, V77, P199, DOI 10.1071/MU9770199; Maddison WP, 2009, MESQUITE MODULAR SYS; Mayr G., 2009, PALEOGENE FOSSIL BIR, DOI DOI 10.1007/978-3-540-89628-9; Mayr G, 2011, B GEOL SOC DENMARK, V59, P23; MCDOUGALL I, 1981, J GEOL SOC AUST, V28, P155, DOI 10.1080/00167618108729154; Miller M.A., 2010, P GAT COMP ENV WORKS; Miskelly Colin M., 2008, Notornis, V55, P117; Nabholz B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-54; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; OSNZ Checklist Committee, 2022, ORNITHOLOGICAL SOC N, V1, P208; Pang JF, 2003, CONSERV GENET, V4, P109, DOI 10.1023/A:1021817925740; Parham JF, 2012, SYST BIOL, V61, P346, DOI 10.1093/sysbio/syr107; Paton TA, 2003, MOL PHYLOGENET EVOL, V29, P268, DOI 10.1016/S1055-7903(03)00098-8; Paton TA, 2006, MOL PHYLOGENET EVOL, V39, P657, DOI 10.1016/j.ympev.2006.01.011; PHILLIPS RE, 1980, EMU, V80, P177, DOI 10.1080/01584197.1980.11799274; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Prychitko TM, 1997, MOL PHYLOGENET EVOL, V8, P193, DOI 10.1006/mpev.1997.0420; Prychitko TM, 2003, MOL BIOL EVOL, V20, P762, DOI 10.1093/molbev/msg080; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Robertson BC, 2011, MOL PHYLOGENET EVOL, V61, P949, DOI 10.1016/j.ympev.2011.08.001; Ruokonen M, 2002, MOL PHYLOGENET EVOL, V23, P422, DOI 10.1016/S1055-7903(02)00021-0; Seebohm H., 1888, GEOGRAPHICAL DISTRIB; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Sorenson MD, 1999, MOL PHYLOGENET EVOL, V12, P105, DOI 10.1006/mpev.1998.0602; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Thomas GH, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-28; Thomas GH, 2004, MOL PHYLOGENET EVOL, V30, P516, DOI 10.1016/S1055-7903(03)00222-7; Trewick SA, 2001, EVOLUTION, V55, P2170; Wallis GP, 2009, MOL ECOL, V18, P3548, DOI 10.1111/j.1365-294X.2009.04294.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wiens JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042925; Wiens JJ, 2011, SYST BIOL, V60, P719, DOI 10.1093/sysbio/syr025; Worthy TH, 2007, J SYST PALAEONTOL, V5, P1, DOI 10.1017/S1477201906001957; Wu CH, 2013, MOL BIOL EVOL, V30, P669, DOI 10.1093/molbev/mss258; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x; Zwickl DJ., 2006, THESIS	84	15	15	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78068	10.1371/journal.pone.0078068	http://dx.doi.org/10.1371/journal.pone.0078068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205094	Green Submitted, Green Published, gold			2022-12-27	WOS:000326155400069
J	Greve, C; Zijlstra, W; Hortobagyi, T; Bongers, RM				Greve, Christian; Zijlstra, Wiebren; Hortobagyi, Tibor; Bongers, Raoul M.			Not All Is Lost: Old Adults Retain Flexibility in Motor Behaviour during Sit-to-Stand	PLOS ONE			English	Article							AGE-RELATED-CHANGES; MUSCLE STRENGTH; JOINT COORDINATION; CHAIR; TASK; VARIABILITY; MOVEMENT; SYNERGIES; CONSTRAINTS; FREQUENCY	Sit-to-stand is a fundamental activity of daily living, which becomes increasingly difficult with advancing age. Due to severe loss of leg strength old adults are required to change the way they rise from a chair and maintain stability. Here we examine whether old compared to young adults differently prioritize task-important performance variables and whether there are age-related differences in the use of available motor flexibility. We applied the uncontrolled manifold analysis to decompose trial-to-trial variability in joint kinematics into variability that stabilizes and destabilizes task-important performance variables. Comparing the amount of variability stabilizing and destabilizing task-important variables enabled us to identify the variable of primary importance for the task. We measured maximal isometric voluntary force of three muscle groups in the right leg. Independent of age and muscle strength, old and young adults similarly prioritized stability of the ground reaction force vector during sit-to-stand. Old compared to young adults employed greater motor flexibility, stabilizing ground reaction forces during sit-to-sand. We concluded that freeing those degrees of freedom that stabilize task-important variables is a strategy used by the aging neuromuscular system to compensate for strength deficits.	[Greve, Christian; Hortobagyi, Tibor; Bongers, Raoul M.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [Zijlstra, Wiebren] German Sport Univ Cologne, Inst Movement & Sports Gerontol, Cologne, Germany	University of Groningen; German Sport University Cologne	Bongers, RM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	R.M.Bongers@umcg.nl	Bongers, Raoul/C-1094-2012	Bongers, Raoul/0000-0002-3518-7464				Alexander NB, 2001, J GERONTOL A-BIOL, V56, pM538, DOI 10.1093/gerona/56.9.M538; Alexander NB, 1997, MUSCLE NERVE, pS56; Arnold CM, 2010, J STRENGTH COND RES, V24, P815, DOI 10.1519/JSC.0b013e3181aa36b8; Bohannon RW, 1996, J ORTHOP SPORT PHYS, V24, P86, DOI 10.2519/jospt.1996.24.2.86; Dall PM, 2010, APPL ERGON, V41, P58, DOI 10.1016/j.apergo.2009.04.005; Danneskiold-Samsoe B, 2009, ACTA PHYSIOL, V197, P1, DOI 10.1111/j.1748-1716.2009.02022.x; Enoka R.M., 2008, NEUROMECHANICS HUMAN; Freitas SMSF, 2010, J NEUROSCI METH, V188, P89, DOI 10.1016/j.jneumeth.2010.01.023; Gelfand I M, 1998, Motor Control, V2, P306; Gera G, 2010, MOTOR CONTROL, V14, P83, DOI 10.1123/mcj.14.1.83; Gorniak S, 2009, EXP BRAIN RES, V194, P1, DOI 10.1007/s00221-008-1663-7; Grant PM, 2011, AGING CLIN EXP RES, V23, P437, DOI 10.1007/BF03325239; Gross MM, 1998, GAIT POSTURE, V8, P175, DOI 10.1016/S0966-6362(98)00033-2; HORTOBAGYI T, 1995, J GERONTOL A-BIOL, V50, pB399, DOI 10.1093/gerona/50A.6.B399; Hortobagyi T, 2003, J GERONTOL A-BIOL, V58, P453; Hsu WL, 2013, AGE, V35, P1299, DOI 10.1007/s11357-012-9422-x; Hsu WL, 2012, HUM MOVEMENT SCI, V31, P844, DOI 10.1016/j.humov.2011.07.017; HUGHES MA, 1994, CLIN BIOMECH, V9, P187, DOI 10.1016/0268-0033(94)90020-5; Hughes MA, 1996, J BIOMECH, V29, P1509, DOI 10.1016/0021-9290(96)00083-8; Kapur S, 2010, J APPL PHYSIOL, V109, P1827, DOI 10.1152/japplphysiol.00430.2010; Klous M, 2010, EXP BRAIN RES, V202, P457, DOI 10.1007/s00221-009-2153-2; Latash ML, 2007, MOTOR CONTROL, V11, P276, DOI 10.1123/mcj.11.3.276; Lindemann U, 2007, J GERONTOL A-BIOL, V62, P636, DOI 10.1093/gerona/62.6.636; MEHR DR, 1993, J AM GERIATR SOC, V41, P1095, DOI 10.1111/j.1532-5415.1993.tb06458.x; Muller H, 2003, BIOL CYBERN, V89, P22, DOI 10.1007/s00422-003-0399-5; Olafsdottir H, 2007, J APPL PHYSIOL, V102, P1490, DOI 10.1152/japplphysiol.00966.2006; Park J, 2011, EXP BRAIN RES, V212, P1, DOI 10.1007/s00221-011-2692-1; Ranganathan R, 2010, J MOTOR BEHAV, V42, P307, DOI 10.1080/00222895.2010.510542; Reisman DS, 2002, J ELECTROMYOGR KINES, V12, P493, DOI 10.1016/S1050-6411(02)00029-9; Reisman DS, 2002, GAIT POSTURE, V15, P45, DOI 10.1016/S0966-6362(01)00158-8; RILEY PO, 1991, J BIOMECH, V24, P77, DOI 10.1016/0021-9290(91)90328-K; Robert T, 2008, EXP BRAIN RES, V187, P237, DOI 10.1007/s00221-008-1299-7; de Freitas SMSF, 2010, J BIOMECH, V43, P775, DOI 10.1016/j.jbiomech.2009.10.033; Schollhorn W.I., 2000, ACTA ACAD OLYMP EST, V8, P25; Schollhorn WI, 2006, INT J SPORT PSYCHOL, V2, P34; Scholz JP, 2007, EXP BRAIN RES, V180, P163, DOI 10.1007/s00221-006-0848-1; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Scholz JP, 2001, EXP BRAIN RES, V141, P485, DOI 10.1007/s002210100878; Singh T, 2010, NEUROSCI LETT, V485, P204, DOI 10.1016/j.neulet.2010.09.012; Singh T, 2010, J NEUROPHYSIOL, V103, P2990, DOI 10.1152/jn.00077.2010; Spirduso W, 2005, PHYS DIMENSIONS AGIN, V2; van der Steen MC, 2011, EXP BRAIN RES, V208, P411, DOI 10.1007/s00221-010-2493-y; van Rossum JHA, 1990, HUM MOVEMENT SCI, V9, P187; Verrel J, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.07.006; WINTER DA, 1990, MED PROG TECHNOL, V16, P31; Wulf G, 1997, J EXP PSYCHOL LEARN, V23, P987, DOI 10.1037/0278-7393.23.4.987; Yamada T, 2010, ARCH GERONTOL GERIAT, V50, pE46, DOI 10.1016/j.archger.2009.05.009; Yamada T, 2009, ARCH GERONTOL GERIAT, V48, P73, DOI 10.1016/j.archger.2007.10.006; Zhang W, 2008, J NEUROPHYSIOL, V99, P500, DOI 10.1152/jn.01029.2007; Zijlstra A, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-75	50	21	21	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77760	10.1371/journal.pone.0077760	http://dx.doi.org/10.1371/journal.pone.0077760			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	241GW	24204952	Green Submitted, Green Published, gold			2022-12-27	WOS:000326155400056
J	Kevorkova, O; Martineau, C; Martin-Falstrault, L; Sanchez-Dardon, J; Brissette, L; Moreau, R				Kevorkova, Olha; Martineau, Corine; Martin-Falstrault, Louise; Sanchez-Dardon, Jaime; Brissette, Louise; Moreau, Robert			Low-Bone- Mass Phenotype of Deficient Mice for the Cluster of Differentiation 36 (CD36)	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; SCAVENGER RECEPTOR; DOWN-REGULATION; OSTEOPOROSIS; METABOLISM; LIPOPROTEIN; NEOVASCULARIZATION; THROMBOSPONDIN-1; CALCIFICATION; ANGIOGENESIS	Bone tissue is continuously remodeled by bone cells and maintenance of its mass relies on the balance between the processes of resorption and formation. We have reported the expression of numerous scavenger receptors, namely scavenger receptor (SR) class B type I and II (SR-BI and SR-BII), and CD36, in bone-forming osteoblasts but their physiological roles in bone metabolism are still unknown. To unravel the role of CD36 in bone metabolism, we determined the bone phenotype of CD36 knockout (CD36KO) mice and characterized the cell functions of osteoblasts lacking CD36. Weights of CD36KO mice were significantly lower than corresponding wild-type (WT) mice, yet no significant difference was found in femoral nor tibial length between CD36KO and WT mice. Analysis of bone architecture by micro-computed tomography revealed a low bone mass phenotype in CD36KO mice of both genders. Femoral trabecular bone from 1 to 6 month-old CD36KO mice showed lower bone volume, higher trabecular separation and reduced trabeculae number compared to WT mice; similar alterations were noticed for lumbar vertebrae. Plasma levels of osteocalcin (OCN) and N-terminal propeptide of type I procollagen (PINP), two known markers of bone formation, were significantly lower in CD36KO mice than in WT mice, whereas plasma levels of bone resorption markers were similar. Accordingly, histology highlighted lower osteoblast perimeter and reduced bone formation rate. In vitro functional characterization of bone marrow stromal cells and osteoblasts isolated from CD36KO mice showed reduced cell culture expansion and survival, lower gene expression of osteoblastic Runt-related transcription factor 2 (Runx2) and osterix (Osx), as well as bone sialoprotein (BSP) and osteocalcin (OCN). Our results indicate that CD36 is mandatory for adequate bone metabolism, playing a role in osteoblast functions ensuring adequate bone formation.	[Kevorkova, Olha; Martineau, Corine; Sanchez-Dardon, Jaime; Moreau, Robert] Univ Quebec, Dept Sci Biol, Ctr BioMed, Lab Metab Osseux, Montreal, PQ H3C 3P8, Canada; [Martin-Falstrault, Louise; Brissette, Louise] Univ Quebec, Dept Sci Biol, Ctr BioMed, Lab Metab Lipoprot, Montreal, PQ H3C 3P8, Canada	University of Quebec; University of Quebec Montreal; University of Quebec; University of Quebec Montreal	Moreau, R (corresponding author), Univ Quebec, Dept Sci Biol, Ctr BioMed, Lab Metab Osseux, CP 8888, Montreal, PQ H3C 3P8, Canada.	moreau.robert@uqam.ca		Martineau, Corine/0000-0002-1550-2420	Canadian Institute of Health Research (CIHR); Le Fond de la Recherche en Sante du Quebec (FRSQ); Natural Sciences and Engineering Research Council (NSERC) of Canada	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Le Fond de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from the Canadian Institute of Health Research (CIHR). OK and CM are recipients of scholarships from Le Fond de la Recherche en Sante du Quebec (FRSQ) and Natural Sciences and Engineering Research Council (NSERC) of Canada, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; BANKS LM, 1994, EUR J CLIN INVEST, V24, P813, DOI 10.1111/j.1365-2362.1994.tb02024.x; Bao Y, 2012, J CEREBR BLOOD F MET, V32, P1567, DOI 10.1038/jcbfm.2012.52; Baranova IN, 2008, J IMMUNOL, V181, P7147, DOI 10.4049/jimmunol.181.10.7147; Brodeur MR, 2008, J BONE MINER RES, V23, P326, DOI 10.1359/JBMR.071022; Brundert M, 2011, J LIPID RES, V52, P745, DOI 10.1194/jlr.M011981; Carron JA, 2000, BIOCHEM BIOPH RES CO, V270, P1124, DOI 10.1006/bbrc.2000.2574; Chen K, 2008, CIRC RES, V102, P1512, DOI 10.1161/CIRCRESAHA.108.172064; Christiaens V, 2012, BBA-GEN SUBJECTS, V1820, P949, DOI 10.1016/j.bbagen.2012.04.001; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Erben RG, 1997, J HISTOCHEM CYTOCHEM, V45, P307, DOI 10.1177/002215549704500215; Eriksen EF, 2010, REV ENDOCR METAB DIS, V11, P219, DOI 10.1007/s11154-010-9153-1; Faje A, 2012, CURR OSTEOPOROS REP, V10, P208, DOI 10.1007/s11914-012-0106-3; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Frost HM, 2001, AM J HUM BIOL, V13, P235, DOI 10.1002/1520-6300(200102/03)13:2<235::AID-AJHB1034>3.3.CO;2-D; Ghosh A, 2008, J CLIN INVEST, V118, P1934, DOI 10.1172/JCI34904; Goudriaan JR, 2005, J LIPID RES, V46, P2175, DOI 10.1194/jlr.M500112-JLR200; Goudriaan JR, 2003, J LIPID RES, V44, P2270, DOI 10.1194/jlr.M300143-JLR200; Hajri T, 2007, DIABETES, V56, P1872, DOI 10.2337/db06-1699; Haque WA, 2002, J CLIN ENDOCR METAB, V87, P2395, DOI 10.1210/jc.87.5.2395; Helming L, 2009, J CELL SCI, V122, P453, DOI 10.1242/jcs.037200; Hjortnaes J, 2010, EUR HEART J, V31, P1975, DOI 10.1093/eurheartj/ehq237; Houssier M, 2008, PLOS MED, V5, P323, DOI 10.1371/journal.pmed.0050039; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; Lane NE, 2006, AM J OBSTET GYNECOL, V194, pS3, DOI 10.1016/j.ajog.2005.08.047; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Luangrath V, 2008, ARTERIOSCL THROM VAS, V28, P1290, DOI 10.1161/ATVBAHA.107.161653; McGilvray ID, 2000, BLOOD, V96, P3231, DOI 10.1182/blood.V96.9.3231; Moreau R, 1997, J BONE MINER RES, V12, P1984, DOI 10.1359/jbmr.1997.12.12.1984; Mwaikambo BR, 2008, CORNEA, V27, P1037, DOI 10.1097/ICO.0b013e31817780b6; PARFITT AM, 1984, CALCIFIED TISSUE INT, V36, pS123, DOI 10.1007/BF02406145; Podrez EA, 2007, NAT MED, V13, P1086, DOI 10.1038/nm1626; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Ruiz-Gaspa S, 2010, CALCIFIED TISSUE INT, V86, P220, DOI 10.1007/s00223-010-9336-5; Shen CL, 2009, NUTR RES, V29, P437, DOI 10.1016/j.nutres.2009.06.008; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Turner RT, 2013, J BONE MINER RES, V28, P22, DOI 10.1002/jbmr.1734; Valverde-Franco G, 2004, HUM MOL GENET, V13, P271, DOI 10.1093/hmg/ddh034; Yamazaki H, 2004, ONCOL REP, V11, P371	42	29	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77701	10.1371/journal.pone.0077701	http://dx.doi.org/10.1371/journal.pone.0077701			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204923	gold, Green Published, Green Submitted			2022-12-27	WOS:000326155400051
J	Nitta, CF; Orlando, RA				Nitta, Carolina Franco; Orlando, Robert A.			Crosstalk between Immune Cells and Adipocytes Requires Both Paracrine Factors and Cell Contact to Modify Cytokine Secretion	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; HUMAN ADIPOSE-TISSUE; MONOCYTE CHEMOATTRACTANT PROTEIN-1; FACTOR-KAPPA-B; INDUCED INFLAMMATORY CHANGES; LONG PENTRAXIN PTX3; FREE FATTY-ACIDS; KILLER T-CELLS; INSULIN-RESISTANCE; TNF-ALPHA	Increased adiposity results in a heightened infiltration of immune cells into fat depots, which in turn generates a pro-inflammatory phenotype in obese individuals. To better understand the causal factors that establish this pro-inflammatory profile, we examined events leading to crosstalk between adipocytes and immune cells. Using isolated spleen-derived immune cells, stimulated with LPS, together with cultured adipocytes, we differentiated the effects of paracrine factors and cell-cell contact on TNF alpha, IL-6 and MCP-1 secretion levels and secretion profiles. When splenocytes and adipocytes were co-cultured without direct contact, permitting only paracrine communication, secretion of IL-6 and MCP-1 were increased by 3- and 2.5-fold, respectively, over what was secreted by individual cultures, whereas TNF alpha secretion was reduced by 55%. When cells were co-cultured with direct cell-cell contact, IL-6 and MCP-1 secretion were increased by an additional 36% and 38%, respectively, over that measured from just paracrine stimulation alone, indicating that cell contact provides a synergistic signal that amplifies elevated cytokine secretion stimulated by paracrine signals. Using splenocytes from TNF alpha(-/-) mice showed that the absence of TNF alpha has little effect on paracrine stimulation of cytokine secretion, but attenuates cell contact-mediated enhancement of IL-6 and MCP-1 secretion. Furthermore, TNF alpha supports cell contact-mediated signaling in part, but not exclusively, through Nuclear Factor-kappa B activation. These findings indicate that engagement of cell contact between immune cells and adipocytes, in conjunction with locally secreted paracrine factors, activates a unique signaling pathway that mediates crosstalk between these cell types leading to marked effects on cytokine secretion and profile.	[Nitta, Carolina Franco; Orlando, Robert A.] Univ New Mexico, Sch Med, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA	University of New Mexico	Orlando, RA (corresponding author), Univ New Mexico, Sch Med, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA.	rorlando@salud.unm.edu			University of New Mexico, School of Medicine, Office of Research; New Mexico IDeA Networks of Biomedical Research Excellence (NM-INBRE)	University of New Mexico, School of Medicine, Office of Research; New Mexico IDeA Networks of Biomedical Research Excellence (NM-INBRE)	This work was support by a generous gift of Gap Funding to RAO from the University of New Mexico, School of Medicine, Office of Research. CFN was sponsored by a pre-doctoral scholarship from the New Mexico IDeA Networks of Biomedical Research Excellence (NM-INBRE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderrahim-Ferkoune A, 2003, J LIPID RES, V44, P994, DOI 10.1194/jlr.M200382-JLR200; Alberti L, 2009, ATHEROSCLEROSIS, V202, P455, DOI 10.1016/j.atherosclerosis.2008.05.015; Alexopoulou L, 1997, EUR J IMMUNOL, V27, P2588, DOI 10.1002/eji.1830271018; Avitsur R, 2002, J NEUROIMMUNOL, V132, P66, DOI 10.1016/S0165-5728(02)00310-7; Bays H, 2004, J CLIN ENDOCR METAB, V89, P463, DOI 10.1210/jc.2003-030723; Bruun JM, 2005, J CLIN ENDOCR METAB, V90, P2282, DOI 10.1210/jc.2004-1696; Christiansen T, 2005, INT J OBESITY, V29, P146, DOI 10.1038/sj.ijo.0802839; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; De Taeye BM, 2007, AM J PHYSIOL-ENDOC M, V293, pE713, DOI 10.1152/ajpendo.00194.2007; Duffaut C, 2009, BIOCHEM BIOPH RES CO, V384, P482, DOI 10.1016/j.bbrc.2009.05.002; Esposito K, 2003, J CLIN ENDOCR METAB, V88, P1055, DOI 10.1210/jc.2002-021437; Fain JN, 2004, INT J OBESITY, V28, P616, DOI 10.1038/sj.ijo.0802594; Fain JN, 2003, BIOCHEM BIOPH RES CO, V300, P674, DOI 10.1016/S0006-291X(02)02864-4; Fain JN, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/513948; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Garrow J. S., 1988, OBESITY RELATED DIS; Georgopoulos S, 1996, J INFLAMM, V46, P86; Gonzales AM, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-17; Gotoh K, 2012, DIABETES, V61, P1994, DOI 10.2337/db11-1688; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Horiuchi T, 2010, RHEUMATOLOGY, V49, P1215, DOI 10.1093/rheumatology/keq031; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Idriss HT, 2000, MICROSC RES TECHNIQ, V50, P184, DOI 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H; Jensen MD, 2006, OBESITY, V14, p20S, DOI 10.1038/oby.2006.278; Ji YW, 2012, J BIOL CHEM, V287, P13561, DOI 10.1074/jbc.M112.350066; Juge-Aubry CE, 2005, CYTOKINE, V29, P270, DOI 10.1016/j.cyto.2004.10.017; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kruisbeek Ada M, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0314s24; Lappas M, 2005, ENDOCRINOLOGY, V146, P1491, DOI 10.1210/en.2004-0809; Liu ZG, 2005, CELL RES, V15, P24, DOI 10.1038/sj.cr.7290259; Livak K, 1997, USER B BIOSYSTEMS PA, V2; McDonnell ME, 2012, OBESITY, V20, P1372, DOI 10.1038/oby.2012.54; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; PEREZ C, 1990, CELL, V63, P251, DOI 10.1016/0092-8674(90)90158-B; Permana PA, 2006, BIOCHEM BIOPH RES CO, V341, P507, DOI 10.1016/j.bbrc.2006.01.012; Permana PA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1076, DOI 10.1152/ajpendo.91013.2008; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Ruan H, 2003, J BIOL CHEM, V278, P47585, DOI 10.1074/jbc.M305257200; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; Samuvel DJ, 2010, J BIOL CHEM, V285, P3916, DOI 10.1074/jbc.M109.033951; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Sun SY, 2012, ANNU REV NUTR, V32, P261, DOI 10.1146/annurev-nutr-071811-150623; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tornatore L, 2012, TRENDS CELL BIOL, V22, P557, DOI 10.1016/j.tcb.2012.08.001; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Wu L, 2012, P NATL ACAD SCI USA, V109, pE1143, DOI 10.1073/pnas.1200498109; Xie LL, 2010, CLIN VACCINE IMMUNOL, V17, P651, DOI 10.1128/CVI.00494-09; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamashita A, 2007, OBESITY, V15, P2549, DOI 10.1038/oby.2007.305; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007	67	24	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77306	10.1371/journal.pone.0077306	http://dx.doi.org/10.1371/journal.pone.0077306			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204798	Green Submitted, Green Published, gold			2022-12-27	WOS:000326032600029
J	Panzhinskiy, E; Ren, J; Nair, S				Panzhinskiy, Evgeniy; Ren, Jun; Nair, Sreejayan			Protein Tyrosine Phosphatase 1B and Insulin Resistance: Role of Endoplasmic Reticulum Stress/Reactive Oxygen Species/Nuclear Factor Kappa B Axis	PLOS ONE			English	Article							STRESS-INDUCED ACTIVATION; LIVER-SPECIFIC DELETION; SKELETAL-MUSCLE; PTP1B EXPRESSION; FATTY-ACIDS; INFLAMMATION; OBESITY; SENSITIVITY; HOMEOSTASIS; INHIBITION	Obesity-induced endoplasmic reticulum (ER) stress has been proposed as an important pathway in the development of insulin resistance. Protein-tyrosine phosphatase 1B (PTP1B) is a negative regulator of insulin signaling and is tethered to the ER-membrane. The aim of the study was to determine the mechanisms involved in the crosstalk between ER-stress and PTP1B. PTP1B whole body knockout and C57BL/6J mice were subjected to a high-fat or normal chow-diet for 20 weeks. High-fat diet feeding induced body weight gain, increased adiposity, systemic glucose intolerance, and hepatic steatosis were attenuated by PTP1B deletion. High-fat diet-fed PTP1B knockout mice also exhibited improved glucose uptake measured using [H-3]-2-deoxy-glucose incorporation assay and Akt phosphorylation in the skeletal muscle tissue, compared to their wild-type control mice which received similar diet. High-fat diet-induced upregulation of glucose-regulated protein-78, phosphorylation of eukaryotic initiation factor 2 alpha and c-Jun NH2-terminal kinase-2 were significantly attenuated in the PTP1B knockout mice. Mice lacking PTP1B showed decreased expression of the autophagy related protein p62 and the unfolded protein response adaptor protein NCK1 (non-catalytic region of tyrosine kinase). Treatment of C2C12 myotubes with the ER-stressor tunicamycin resulted in the accumulation of reactive oxygen species (ROS), leading to the activation of protein expression of PTP1B. Furthermore, tunicamycin-induced ROS production activated nuclear translocation of NFkB p65 and was required for ER stress-mediated expression of PTP1B. Our data suggest that PTP1B is induced by ER stress via the activation of the ROS-NF kappa B axis which is causes unfolded protein response and mediates insulin resistance in the skeletal muscle under obese condition.	[Nair, Sreejayan] Univ Wyoming, Coll Hlth Sci, Sch Pharm, Laramie, WY 82071 USA; Univ Wyoming, Coll Hlth Sci, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA	University of Wyoming; University of Wyoming	Nair, S (corresponding author), Univ Wyoming, Coll Hlth Sci, Sch Pharm, Laramie, WY 82071 USA.	sreejay@uwyo.edu	Ren, Jun/ACG-5366-2022	Ren, Jun/0000-0002-0275-0783	NIH [P20RR016474]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016474] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by grants from NIH P20RR016474 (SN, JR). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agouni A, 2011, BIOCHEM J, V438, P369, DOI 10.1042/BJ20110373; Ahima RS, 2011, J CLIN INVEST, V121, P2076, DOI 10.1172/JCI58719; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Novelli ELB, 2009, PHARMACOL RES, V59, P74, DOI 10.1016/j.phrs.2008.10.004; Battiprolu PK, 2012, J CLIN INVEST, V122, P1109, DOI 10.1172/JCI60329; Brasier AR, 2006, CARDIOVASC TOXICOL, V6, P111, DOI 10.1385/CT:6:2:111; Ceylan-Isik AF, 2011, J MOL CELL CARDIOL, V50, P107, DOI 10.1016/j.yjmcc.2010.10.023; Chiarugi P, 2003, TRENDS BIOCHEM SCI, V28, P509, DOI 10.1016/S0968-0004(03)00174-9; Clark J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012333; Deldicque L, 2011, EUR J APPL PHYSIOL, V111, P1553, DOI 10.1007/s00421-010-1783-1; Deldicque L, 2010, AM J PHYSIOL-ENDOC M, V299, pE695, DOI 10.1152/ajpendo.00038.2010; Delibegovic M, 2007, MOL CELL BIOL, V27, P7727, DOI 10.1128/MCB.00959-07; Delibegovic M, 2009, DIABETES, V58, P590, DOI 10.2337/db08-0913; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Fu SN, 2012, CELL METAB, V15, P623, DOI 10.1016/j.cmet.2012.03.007; Fukada T, 2003, EMBO J, V22, P479, DOI 10.1093/emboj/cdg067; Garcia-San Frutos M, 2012, MECH AGEING DEV, V133, P489, DOI 10.1016/j.mad.2012.06.001; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Gonzalez-Rodriguez A, 2012, AGING CELL, V11, P284, DOI 10.1111/j.1474-9726.2011.00786.x; Gonzalez-Rodriguez A, 2010, DIABETES, V59, P588, DOI 10.2337/db09-0796; Gregersen N, 2010, METHODS MOL BIOL, V648, P3, DOI 10.1007/978-1-60761-756-3_1; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Gu F, 2004, J BIOL CHEM, V279, P49689, DOI 10.1074/jbc.C400261200; Guo R, 2013, BIOCH BIOPH IN PRESS; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2005, DIABETES, V54, pS73, DOI 10.2337/diabetes.54.suppl_2.S73; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Kandadi MR, 2010, BIOCHEM PHARMACOL, V79, P623, DOI 10.1016/j.bcp.2009.09.018; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Latreille M, 2006, J BIOL CHEM, V281, P26633, DOI 10.1074/jbc.M513556200; Latreille M, 2011, AM J PHYSIOL-ENDOC M, V300, pE423, DOI 10.1152/ajpendo.00088.2010; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; MohammadTaghvaei N, 2012, CELL SIGNAL, V24, P1964, DOI 10.1016/j.cellsig.2012.04.019; Nedachi T, 2006, AM J PHYSIOL-ENDOC M, V291, pE817, DOI 10.1152/ajpendo.00194.2006; Nieto-Vazquez I, 2007, DIABETES, V56, P404, DOI 10.2337/db06-0989; Orgel E, 2012, CURRENT DIABETES REP, P1; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pagliassotti MJ, 2012, ANNU REV NUTR, V32, P17, DOI 10.1146/annurev-nutr-071811-150644; Panzhinskiy E, 2013, CURR MED CHEM, V20, P2609, DOI 10.2174/0929867311320210001; Panzhinskiy E, 2013, DIABETOLOGIA, V56, P598, DOI 10.1007/s00125-012-2782-z; Pauli JR, 2010, MECH AGEING DEV, V131, P323, DOI 10.1016/j.mad.2010.03.004; Peter A, 2009, DIABETES, V58, P1757, DOI 10.2337/db09-0188; Popov D, 2012, BIOCHEM BIOPH RES CO, V422, P535, DOI 10.1016/j.bbrc.2012.05.048; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Shimizu S, 2003, J BIOL CHEM, V278, P43095, DOI 10.1074/jbc.M306880200; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Silveira LR, 2008, J CELL PHYSIOL, V217, P1, DOI 10.1002/jcp.21514; Tsou PS, 2012, ARTHRITIS RHEUM-US, V64, P1978, DOI 10.1002/art.34336; Turpin SM, 2009, J PHYSIOL-LONDON, V587, P1593, DOI 10.1113/jphysiol.2008.166033; Wang N, 2009, MOL CELL ENDOCRINOL, V307, P89, DOI 10.1016/j.mce.2009.03.001; Wang XL, 2006, DIABETES, V55, P2301, DOI 10.2337/db05-1574; Yip SC, 2010, TRENDS BIOCHEM SCI, V35, P442, DOI 10.1016/j.tibs.2010.03.004; Zabolotny JM, 2008, J BIOL CHEM, V283, P14230, DOI 10.1074/jbc.M800061200; Zabolotny JM, 2004, J BIOL CHEM, V279, P24844, DOI 10.1074/jbc.M310688200; Zhao M, 2012, MOLECULES, V17, P7083, DOI 10.3390/molecules17067083	55	73	78	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77228	10.1371/journal.pone.0077228	http://dx.doi.org/10.1371/journal.pone.0077228			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204775	gold, Green Published, Green Submitted			2022-12-27	WOS:000326029300090
J	Sivova, N; Launay, D; Wemeau-Stervinou, L; De Groote, P; Remy-Jardin, M; Denis, G; Lambert, M; Lamblin, N; Morell-Dubois, S; Fertin, M; Lefevre, G; Sobanski, V; Le Rouzic, O; Hatron, PY; Wallaert, B; Hachulla, E; Perez, T				Sivova, Nadia; Launay, David; Wemeau-Stervinou, Lidwine; De Groote, Pascal; Remy-Jardin, Martine; Denis, Guillaume; Lambert, Marc; Lamblin, Nicolas; Morell-Dubois, Sandrine; Fertin, Marie; Lefevre, Guillaume; Sobanski, Vincent; Le Rouzic, Olivier; Hatron, Pierre-Yves; Wallaert, Benoit; Hachulla, Eric; Perez, Thierry			Relevance of Partitioning DLCO to Detect Pulmonary Hypertension in Systemic Sclerosis	PLOS ONE			English	Article							INTERSTITIAL LUNG-DISEASE; CAPILLARY BLOOD-VOLUME; MEMBRANE DIFFUSING-CAPACITY; ARTERIAL-HYPERTENSION; FIBROSING ALVEOLITIS; STANDARDIZATION; PNEUMONIA; EXCHANGE; NO; CO	We investigated whether partitioning DLCO into membrane conductance for CO (DmCO) and pulmonary capillary blood volume (Vcap) was helpful in suspecting precapillary pulmonary (arterial) hypertension (P(A) H) in systemic sclerosis (SSc) patients with or without interstitial lung disease (ILD). We included 63 SSc patients with isolated PAH (n=6), isolated ILD (n=19), association of both (n=12) or without PAH and ILD (n=26). Partitioning of DLCO was performed by the combined DLNO/DLCO method. DLCO, DmCO and Vcap were equally reduced in patients with isolated PAH and patients with isolated ILD but Vcap/alveolar volume (VA) ratio was significantly lower in the isolated PAH group. In patients without ILD, DLCO, DmCO, Vcap and Vcap/VA ratio were reduced in patients with isolated PAH when compared to patients without PAH and both Vcap/VA and DLCO had the highest AUC to detect PAH. In patients with ILD, Vcap had the highest AUC and performed better than DLCO to detect PH in this subgroup. In conclusion, Vcap/VA was lower in PAH than in ILD in SSC whereas DLCO was not different. Vcap/VA ratio and DLCO had similar high performance to detect PAH in patients without ILD. Vcap had better AUC than DLCO, DmCO and FVC/DLCO ratio to detect PH in SSC patients with ILD. These results suggest that partitioning of DLCO might be of interest to detect P(A) H in SSC patients with or without ILD.	[Sivova, Nadia; Launay, David; Denis, Guillaume; Lambert, Marc; Morell-Dubois, Sandrine; Lefevre, Guillaume; Sobanski, Vincent; Hatron, Pierre-Yves; Hachulla, Eric] Univ Lille Nord France, CHRU Lille, Hop Claude Huriez,Ctr Competence Hypertens Arteri, Serv Med Interne,Ctr Reference Malad Autoimmunes, Lille, France; [Launay, David; Lefevre, Guillaume; Sobanski, Vincent] Univ Lille Nord France, Fac Med, Lab Immunol EA2686, Lille, France; [Wemeau-Stervinou, Lidwine; Le Rouzic, Olivier; Wallaert, Benoit; Perez, Thierry] Univ Lille Nord France, CHRU Lille, Hop Calmette,Ctr Competence Malad Pulm Rares, Clin Malad Resp,Ctr Competence Hypertens Arteriel, Lille, France; [De Groote, Pascal; Lamblin, Nicolas; Fertin, Marie] Univ Lille Nord France, CHRU Lille, Hop Cardiol,Serv Cardiol, Ctr Competence Hypertens Arterielle Pulm Severe, Lille, France; [Remy-Jardin, Martine] Univ Lille Nord France, CHRU Lille, Hop Calmette, Serv Radiol Thorac, Lille, France; [Perez, Thierry] Univ Lille Nord France, CHRU Lille, Hop Calmette, Serv Explorat Fonct Resp, Lille, France	Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille	Perez, T (corresponding author), Univ Lille Nord France, CHRU Lille, Hop Calmette,Ctr Competence Malad Pulm Rares, Clin Malad Resp,Ctr Competence Hypertens Arteriel, Lille, France.	thierry.perez@chru-lille.fr	lambert, marc/V-7380-2017; Thierry, PEREZ/AAB-4853-2020; Launay, David/H-1674-2016; Sobanski, Vincent/Q-6411-2016; Launay, David/A-5270-2018; HACHULLA, ERIC/R-8488-2018; Sobanski, Vincent/U-5676-2019; LEFEVRE, Guillaume/I-7168-2018	lambert, marc/0000-0002-3485-8238; Launay, David/0000-0003-1840-1817; Sobanski, Vincent/0000-0003-3083-2441; Launay, David/0000-0003-1840-1817; HACHULLA, ERIC/0000-0001-7432-847X; LAMBLIN, NICOLAS/0000-0003-3754-1241; de Groote, Pascal/0000-0002-6211-0147; LEFEVRE, Guillaume/0000-0002-9427-7267; Le Rouzic, Olivier/0000-0003-4439-2950				Aguilaniu B, 2008, EUR RESPIR J, V31, P1091, DOI 10.1183/09031936.00063207; AGUSTI AGN, 1991, AM REV RESPIR DIS, V143, P219, DOI 10.1164/ajrccm/143.2.219; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Chang B, 2003, J RHEUMATOL, V30, P2398; Condliffe R, 2009, AM J RESP CRIT CARE, V179, P151, DOI 10.1164/rccm.200806-953OC; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Degano B, 2009, J APPL PHYSIOL, V107, P139, DOI 10.1152/japplphysiol.91621.2008; Desai SR, 2004, RADIOLOGY, V232, P560, DOI 10.1148/radiol.2322031223; Galie N, 2009, EUR RESPIR J, V34, P1219, DOI 10.1183/09031936.00139009; Goh NSL, 2008, AM J RESP CRIT CARE, V177, P1248, DOI 10.1164/rccm.200706-877OC; GUENARD H, 1987, RESP PHYSIOL, V70, P113, DOI 10.1016/S0034-5687(87)80036-1; Hachulla E, 2005, ARTHRITIS RHEUM-US, V52, P3792, DOI 10.1002/art.21433; Hachulla E, 2011, CLIN REV ALLERG IMMU, V40, P78, DOI 10.1007/s12016-010-8198-y; Launay D, 2012, ANN RHEUM D IN PRESS; Launay D, 2007, J RHEUMATOL, V34, P1005; Launay D, 2006, J RHEUMATOL, V33, P1789; Le Pavec J, 2011, CLIN REV ALLERG IMMU, V40, P104, DOI 10.1007/s12016-009-8194-2; Lefevre G, 2013, ARTHRITIS R IN PRESS; LeRoy EC, 2001, J RHEUMATOL, V28, P1573; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Mathai SC, 2009, ARTHRITIS RHEUM-US, V60, P569, DOI 10.1002/art.24267; Overbeek MJ, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-68; PANDE JN, 1975, RESPIRATION, V32, P317, DOI 10.1159/000193670; Pernot J, 2012, RESPIRATION, V84, P461, DOI 10.1159/000335473; Plummer AL, 2008, CHEST, V134, P663, DOI 10.1378/chest.07-1771; Renzoni EA, 2003, AM J RESP CRIT CARE, V167, P438, DOI 10.1164/rccm.200202-135OC; ROUGHTON FJW, 1957, J APPL PHYSIOL, V11, P290, DOI 10.1152/jappl.1957.11.2.290; Steen V, 2003, ARTHRITIS RHEUM, V48, P516, DOI 10.1002/art.10775; Sun CG, 2003, J AM COLL CARDIOL, V41, P1028, DOI 10.1016/S0735-1097(02)02964-9; Trad S, 2006, ARTHRITIS RHEUM-US, V54, P184, DOI 10.1002/art.21538; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Wemeau-Stervinou L, 2012, RESP MED, V106, P564, DOI 10.1016/j.rmed.2011.12.011	32	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78001	10.1371/journal.pone.0078001	http://dx.doi.org/10.1371/journal.pone.0078001			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205063	gold, Green Published, Green Submitted			2022-12-27	WOS:000326029300131
J	Zhang, DT; Liu, WT; Yang, P; Zhang, Y; Li, XY; Germ, KE; Tang, S; Sun, WJ; Wang, QY				Zhang, Daitao; Liu, Wenting; Yang, Peng; Zhang, Yi; Li, Xinyu; Germ, Kaylyn E.; Tang, Song; Sun, Wenjie; Wang, Quanyi			Factors Associated with Household Transmission of Pandemic (H1N1) 2009 among Self-Quarantined Patients in Beijing, China	PLOS ONE			English	Article							INFLUENZA-A H1N1; SECONDARY ATTACK RATES; APRIL-MAY 2009; UNITED-STATES; VIRUS; INTERVENTIONS; INFECTION; STUDENTS; CONTACTS; ILLNESS	As the pandemic (H1N1) 2009 progressed, the Ministry of Health of China advised cases with mild symptoms to remain home for isolation and observation, which may have increased the risk for infection among other household members. Describing the transmission characteristics of this novel virus is indispensable to effectively controlling the spread of disease; thus, the aim of this study was to assess risk factors associated with household transmission of pandemic H1N1 from self-quarantined patients in Beijing, the capital city of China. A 1: 2 case-control study with 54 case households and 108 control households was conducted between August 1 and September 30, 2009 in Beijing. Cases were households with a self-quarantined index patient and a secondary case, while controls were households with a self-quarantined index patient and a close contact. Controls were also matched to cases for sex and age of index case-patient. A structured interview guide was used to collect the data. Conditional logistical models were employed to estimate Odds Ratios (OR) with 95% confidence intervals (95% CI). Results indicated that higher education level (OR 0.42; 95% CI 0.22-0.83), sharing room with an index case-patient (OR 3.29; 95% CI 1.23-8.78), daily room ventilation (OR 0.28; 95% CI 0.08-0.93), and hand washing >= 3/d (OR 0.71; 95% CI 0.48-0.94) were related to the household transmission of pandemic H1N1 from self-quarantined patients. These results highlight that health education, as well as the quarantine of the index case-patient immediately after infection, frequent hand hygiene, and ventilation are critical to mitigating household spread of pandemic H1N1 virus and minimizing its impact. Household contacts should be educated to promote these in-home practices to contain transmission, particularly when household members are quarantined at home.	[Zhang, Daitao; Liu, Wenting; Yang, Peng; Zhang, Yi; Li, Xinyu; Wang, Quanyi] Beijing Ctr Dis Prevent & Control, Beijing, Peoples R China; [Germ, Kaylyn E.; Tang, Song] Texas Tech Univ, Inst Environm & Human Hlth, Lubbock, TX 79409 USA; [Sun, Wenjie] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Environm Hlth Sci, New Orleans, LA USA	Texas Tech University System; Texas Tech University; Tulane University	Wang, QY (corresponding author), Beijing Ctr Dis Prevent & Control, Beijing, Peoples R China.	bjcdcxm@126.com	sun, wenjie/J-8928-2013; Tang, Song/E-9843-2013; Sun, Wenjie/I-7692-2013	Tang, Song/0000-0003-3219-1422	National High Technology Research and Development Program of China (863 Program) [2008AA02Z416]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This study was supported by grant from the National High Technology Research and Development Program of China (http://www.863.gov.cn/) (863 Program; 2008AA02Z416). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carcione D, 2011, EUROSURVEILLANCE, V16, P1; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; France AM, 2010, J INFECT DIS, V201, P984, DOI 10.1086/651145; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Guh A, 2011, CLIN INFECT DIS, V52, pS131, DOI 10.1093/cid/ciq029; Hirotsu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031519; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3675; Kim CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038166; Lau LLH, 2012, EPIDEMIOLOGY, V23, P531, DOI 10.1097/EDE.0b013e31825588b8; Looker C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013702; Loustalot F, 2011, CLIN INFECT DIS, V52, pS146, DOI 10.1093/cid/ciq057; Luby SP, 2005, LANCET, V366, P225, DOI 10.1016/S0140-6736(05)66912-7; Morrison LG, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-258; Pang XH, 2011, EMERG INFECT DIS, V17, P1824, DOI 10.3201/eid1710.101344; Papenburg J, 2010, CLIN INFECT DIS, V51, P1033, DOI 10.1086/656582; Ryan MAK, 2001, AM J PREV MED, V21, P79, DOI 10.1016/S0749-3797(01)00323-3; Savage R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-234; Sikora C, 2010, J CLIN VIROL, V49, P90, DOI 10.1016/j.jcv.2010.06.015; Simmerman JM, 2010, CLIN INFECT DIS, V51, P1053, DOI 10.1086/656581; Suess T, 2010, AM J EPIDEMIOL, V171, P1157, DOI 10.1093/aje/kwq071; van Boven M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011442; van Gemert C, 2011, EMERG INFECT DIS, V17, P1599, DOI 10.3201/eid1709.101948; White C, 2003, AM J INFECT CONTROL, V31, P364, DOI 10.1016/S0196-6553(03)00041-5; World Health Organization, 2009, WHO GUID HAND HYG HL; Zhang Y, 2013, INFLUENZA OTHER RESP, V7, P466, DOI 10.1111/irv.12025	26	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77873	10.1371/journal.pone.0077873	http://dx.doi.org/10.1371/journal.pone.0077873			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205006	Green Submitted, Green Published, gold			2022-12-27	WOS:000326029300121
J	Magera, AM; Flemming, JEM; Kaschner, K; Christensen, LB; Lotze, HK				Magera, Anna M.; Flemming, Joanna E. Mills; Kaschner, Kristin; Christensen, Line B.; Lotze, Heike K.			Recovery Trends in Marine Mammal Populations	PLOS ONE			English	Article							EXTINCTION RISK; HARBOR SEALS; ABUNDANCE; CONSERVATION; WHALES; IMPACTS; SIZE; DEPLETION; DOLPHINS; FISHERY	Marine mammals have greatly benefitted from a shift from resource exploitation towards conservation. Often lauded as symbols of conservation success, some marine mammal populations have shown remarkable recoveries after severe depletions. Others have remained at low abundance levels, continued to decline, or become extinct or extirpated. Here we provide a quantitative assessment of (1) publicly available population-level abundance data for marine mammals worldwide, (2) abundance trends and recovery status, and (3) historic population decline and recent recovery. We compiled 182 population abundance time series for 47 species and identified major data gaps. In order to compare across the largest possible set of time series with varying data quality, quantity and frequency, we considered an increase in population abundance as evidence of recovery. Using robust log-linear regression over three generations, we were able to classify abundance trends for 92 spatially non-overlapping populations as Significantly Increasing (42%), Significantly Decreasing (10%), Non-Significant Change (28%) and Unknown (20%). Our results were comparable to IUCN classifications for equivalent species. Among different groupings, pinnipeds and other marine mammals (sirenians, polar bears and otters) showed the highest proportion of recovering populations, likely benefiting from relatively fast life histories and nearshore habitats that provided visibility and protective management measures. Recovery was less frequent among cetaceans, but more common in coastal than offshore populations. For marine mammals with available historical abundance estimates (n = 47), larger historical population declines were associated with low or variable recent recoveries so far. Overall, our results show that many formerly depleted marine mammal populations are recovering. However, data-deficient populations and those with decreasing and non-significant trends require attention. In particular, increased study of populations with major data gaps, including offshore small cetaceans, cryptic species, and marine mammals in low latitudes and developing nations, is needed to better understand the status of marine mammal populations worldwide.	[Magera, Anna M.; Lotze, Heike K.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Flemming, Joanna E. Mills] Dalhousie Univ, Dept Math & Stat, Halifax, NS, Canada; [Kaschner, Kristin] Univ Freiburg, Dept Biometry & Environm Syst Anal, D-79106 Freiburg, Germany; [Kaschner, Kristin] Domaine Petit Arbois, CESAB Ctr Synth & Anal Biodivers, Aix En Provence, France; [Christensen, Line B.] Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada	Dalhousie University; Dalhousie University; University of Freiburg; University of British Columbia	Magera, AM (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	ammagera@gmail.com	Kaschner, Kristin/GQQ-6475-2022	Lotze, Heike/0000-0001-6258-1304; Mills Flemming, Joanna/0000-0002-3517-3089; Kaschner, Kristin/0000-0002-4061-626X	Census of Marine Life's Future of Marine Animal Populations (FMAP) program; Natural Sciences and Engineering Research Council (NSERC); Dalhousie University; Pew Charitable Trusts	Census of Marine Life's Future of Marine Animal Populations (FMAP) program; Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Dalhousie University; Pew Charitable Trusts	Financial support was provided by the Census of Marine Life's Future of Marine Animal Populations (FMAP) program (www.fmap.ca) with a grant to HKL, the Natural Sciences and Engineering Research Council (NSERC, http://www.nserc-crsng.gc.ca) with grants to HKL and JMF, and Dalhousie University (www.dal.ca). Financial support for data collection was provided by Pew Charitable Trusts (www.pewtrusts.org) through the Sea Around Us Project (www.seaaroundus.org) for populating the abundance databases provided by KK and LBC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams W.M., 2004, EXTINCTION STORY CON, DOI 10.4324/9781849770415; Alter SE, 2007, P NATL ACAD SCI USA, V104, P15162, DOI 10.1073/pnas.0706056104; Angliss RP, 2009, ALASKA MARINE MAMMAL; [Anonymous], 2010, OXFORD DICT; ARON W, 1988, COAST MANAGE, V16, P99, DOI 10.1080/08920758809362051; Baker CS, 2004, TRENDS ECOL EVOL, V19, P365, DOI 10.1016/j.tree.2004.05.005; BEST PB, 1993, ICES J MAR SCI, V50, P169, DOI 10.1006/jmsc.1993.1018; Bhargava M, 2005, ECOL LAW QUART, V32, P939; BIGG MA, 1988, CAN FIELD NAT, V102, P315; Boyd IL, 2002, ENCY MARINE MAMMALS; Brown RE, 2005, MAR MAMMAL SCI, V21, P657, DOI 10.1111/j.1748-7692.2005.tb01258.x; Christensen LB, 2006, MARINE MAMMAL POPULA; Clapham PJ, 1999, MAMMAL REV, V29, P35; Colten RH, 2002, INT J OSTEOARCHAEOL, V12, P12, DOI 10.1002/oa.609; COSEWIC, 2008, COSEWIC ASS UPD STAT; COSEWIC, 2005, COSEWIC ASS UPD STAT; COSEWIC (Committee on the Status of Endangered Wildlife in Canada), 2015, COSEWIC ASS STAT REP; COSEWIC (Committee on the Status of Endangered Wildlife in Canada), 2013, COSEWIC ASS STAT REP; Dale A, 2011, MAR POLICY, V35, P440, DOI 10.1016/j.marpol.2010.10.019; David J, 2008, S AFR J SCI, V104, P107; Davidson AD, 2012, P NATL ACAD SCI USA, V109, P3395, DOI 10.1073/pnas.1121469109; Fisheries and Oceans Canada, 2011, 2011 2015 INT FISH M; Forcada J, 2012, BIOL CONSERV, V149, P40, DOI 10.1016/j.biocon.2012.02.002; Forney KA, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P145; Freeman Milton M. R., 2008, Endangered Species Research, V6, P173, DOI 10.3354/esr00102; Garner GW, 1999, MARINE MAMMALS SURVE, pXI; Gerber Leah, 1998, Integrative Biology, V1, P90, DOI 10.1002/(SICI)1520-6602(1998)1:3<90::AID-INBI3>3.3.CO;2-H; Gerber LR, 2000, AM SCI, V88, P316, DOI 10.1511/2000.29.773; Gerber LR, 2001, MAMMAL REV, V31, P131, DOI 10.1046/j.1365-2907.2001.00081.x; GERRODETTE T, 1990, MAR MAMMAL SCI, V6, P1, DOI 10.1111/j.1748-7692.1990.tb00221.x; Gerrodette T, 2008, ESTIMATES 2006 DOLPH; Gotelli N.J., 1995, PRIMER ECOLOGY; Hoezel AR, 2002, MARINE MAMMAL BIOL E; Hutchings JA, 2004, BIOSCIENCE, V54, P297, DOI 10.1641/0006-3568(2004)054[0297:MFPCCF]2.0.CO;2; Hutchings JA, 2001, J FISH BIOL, V59, P306, DOI 10.1006/jfbi.2001.1756; Hutchings JA, 2000, NATURE, V406, P882, DOI 10.1038/35022565; Hutchings JA, 2012, TRENDS ECOL EVOL, V27, P542, DOI 10.1016/j.tree.2012.06.005; Hutchings JA, 2010, CAN J FISH AQUAT SCI, V67, P1205, DOI 10.1139/F10-081; IUCN, 2012, IUCN RED LIST CATEGO, V2nd ed., P32; IUCN Standards and Petitions Subcommittee, 2010, GUID US IUCN RED LIS; Jefferson T.A., 2015, COMPREHENSIVE GUIDE; Jeffries S, 2003, J WILDLIFE MANAGE, V67, P207, DOI 10.2307/3803076; Jepson PD, 2003, NATURE, V425, P575, DOI 10.1038/425575a; Jewell R, 2012, MAR ECOL PROG SER, V453, P227, DOI 10.3354/meps09636; Kappel CV, 2005, FRONT ECOL ENVIRON, V3, P275, DOI 10.2307/3868490; Kaschner K, 2006, MAR ECOL PROG SER, V316, P285, DOI 10.3354/meps316285; Kaschner K, 2004, MODELLING MAPPING RE; Kaschner K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044075; Kasuya T, 2007, ENVIRON SCI POLLUT R, V14, P39, DOI 10.1065/espr2006.09.346; Kirkman SP, 2010, S AFR J SCI, V106, P1, DOI 10.4102/sajs.v106i3/4.166; Kovacs KM, 2006, POPULATION STRUCTURE, P416; Lake S, 2008, MAR ECOL PROG SER, V366, P259, DOI 10.3354/meps07502; Lavigne David M., 1999, P10; Lotze HK, 2007, FISH RES, V87, P208, DOI 10.1016/j.fishres.2006.12.009; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lotze HK, 2011, TRENDS ECOL EVOL, V26, P595, DOI 10.1016/j.tree.2011.07.008; Lotze HK, 2009, TRENDS ECOL EVOL, V24, P254, DOI 10.1016/j.tree.2008.12.004; Lotze HK, 2004, ECOL APPL, V14, P1428, DOI 10.1890/03-5027; Marsh H, 2002, DUGONG STATUS REPORT; Neiman S., 2009, MORAL CLARITY GUIDE; Nichol LM, 2005, ASSESSMENT ABUNDANCE; NMFS, 2005, REC PLAN N ATL RIGHT; Pauly D, 2005, PHILOS T R SOC B, V360, P5, DOI 10.1098/rstb.2004.1574; Perry S.L., 1999, MAR FISH REV, V61, P1; Pyenson ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021295; Read AJ, 2008, J MAMMAL, V89, P541, DOI 10.1644/07-MAMM-S-315R1.1; Reeves R.R., 2003, DOLPHINS WHALES PORP, DOI 10.2305/IUCN.CH.2003.SSC-AP.2.en; Reeves RR, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P82; Reeves RR, 2002, MAMMAL REV, V32, P71, DOI 10.1046/j.1365-2907.2002.00100.x; Reeves RR, 1996, INTERCIENCIA, V21, P246; REIJNDERS PJH, 1994, HYDROBIOLOGIA, V283, P557; REIJNDERS PJH, 1993, SEALS FUR SEALS SEA; Reynolds JD, 2005, P ROY SOC B-BIOL SCI, V272, P2337, DOI 10.1098/rspb.2005.3281; Roman J, 2003, SCIENCE, V301, P508, DOI 10.1126/science.1084524; Sanderson EW, 2006, BIOSCIENCE, V56, P911, DOI 10.1641/0006-3568(2006)56[911:HMADWW]2.0.CO;2; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Sea Otter Recovery Team, 2007, REC STRAT SEA OTT EN, pvii; Sethi SA, 2010, P NATL ACAD SCI USA, V107, P12163, DOI 10.1073/pnas.1003236107; Silva MA, 2001, MAR MAMMAL SCI, V17, P418, DOI 10.1111/j.1748-7692.2001.tb01285.x; Smith I, 2005, EXPLOITATION AND CULTURAL IMPORTANCE OF SEA MAMMALS, P6; Southwell C, 2008, J APPL ECOL, V45, P622, DOI 10.1111/j.1365-2664.2007.01399.x; Swartz SL, 2006, MAMMAL REV, V36, P66, DOI 10.1111/j.1365-2907.2006.00082.x; Taylor BL, 2007, MAR MAMMAL SCI, V23, P157, DOI 10.1111/j.1748-7692.2006.00092.x; Thomas L, 2008, ESTIMATING SIZE UK G; Thomas L, 2007, FISHERIES OCEANS CAN; Valade JA, 2009, MAN POP EC MAN WORKS; Wade PR, 2007, MAR ECOL PROG SER, V343, P1, DOI 10.3354/meps07069; Wade PR, SOCIAL BEHAV F UNPUB; Ward EJ, 2009, J APPL ECOL, V46, P632, DOI 10.1111/j.1365-2664.2009.01647.x; Whitehead H, 2004, BIOL CONSERV, V120, P427, DOI 10.1016/j.biocon.2004.03.017; Whitehead H, 2002, MAR ECOL PROG SER, V242, P295, DOI 10.3354/meps242295; Whitehead H, 2000, CETACEAN SOCIETIES, P219; Whitehead H, 2012, ENDANGER SPECIES RES, V19, P47, DOI 10.3354/esr00458; Wilkinson L, 1999, AM PSYCHOL, V54, P594, DOI 10.1037/0003-066X.54.8.594; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Zamar R, 2009, PACKAGE ROBUST	96	113	113	2	148	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77908	10.1371/journal.pone.0077908	http://dx.doi.org/10.1371/journal.pone.0077908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205025	Green Submitted, Green Published, gold			2022-12-27	WOS:000326334500077
J	Meng, L; Wan, YJ; Sun, YY; Zhang, YL; Wang, ZY; Song, Y; Wang, F				Meng, Li; Wan, Yongjie; Sun, Yanyan; Zhang, Yanli; Wang, Ziyu; Song, Yang; Wang, Feng			Generation of Five Human Lactoferrin Transgenic Cloned Goats Using Fibroblast Cells and Their Methylation Status of Putative Differential Methylation Regions of IGF2R and H19 Imprinted Genes	PLOS ONE			English	Article							NUCLEAR TRANSFER EMBRYOS; LARGE-SCALE PRODUCTION; SOMATIC-CELLS; ADULT; PIGS; EXPRESSION; FETAL; CLONING; SHEEP; MILK	Background: Somatic cell nuclear transfer (SCNT) is a promising technique to produce transgenic cloned mammalian, including transgenic goats which may produce Human Lactoferrin (hLF). However, success percentage of SCNT is low, because of gestational and neonatal failure of transgenic embryos. According to the studies on cattle and mice, DNA methylation of some imprinted genes, which plays a vital role in the reprogramming of embryo in NT maybe an underlying mechanism. Methodology/Principal Findings: Fibroblast cells were derived from the ear of a two-month-old goat. The vector expressing hLF was constructed and transfected into fibroblasts. G418 selection, EGFP expression, PCR, and cell cycle distribution were applied sequentially to select transgenic cells clones. After NT and embryo transfer, five transgenic cloned goats were obtained from 240 cloned transgenic embryos. These transgenic goats were identified by 8 microsatellites genotyping and southern blot. Of the five transgenic goats, 3 were lived after birth, while 2 were dead during gestation. We compared differential methylation regions (DMR) pattern of two paternally imprinted genes (H19 and IGF2R) of the ear tissues from the lived transgenic goats, dead transgenic goats, and control goats from natural reproduction. Hyper-methylation pattern appeared in cloned aborted goats, while methylation status was relatively normal in cloned lived goats compared with normal goats. Conclusions/Significance: In this study, we generated five hLF transgenic cloned goats by SCNT. This is the first time the DNA methylation of lived and dead transgenic cloned goats was compared. The results demonstrated that the methylation status of DMRs of H19 and IGF2R were different in lived and dead transgenic goats and therefore this may be potentially used to assess the reprogramming status of transgenic cloned goats. Understanding the pattern of gene imprinting may be useful to improve cloning techniques in future.	[Meng, Li; Wan, Yongjie; Zhang, Yanli; Wang, Ziyu; Song, Yang; Wang, Feng] Nanjing Agr Univ, Jiangsu Livestock Embryo Engn Lab, Nanjing, Jiangsu, Peoples R China; [Meng, Li] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [Sun, Yanyan] Wageningen Univ, Anim Breeding & Genom Ctr, NL-6700 AP Wageningen, Netherlands	Nanjing Agricultural University; Wageningen University & Research; Wageningen University & Research	Wang, F (corresponding author), Nanjing Agr Univ, Jiangsu Livestock Embryo Engn Lab, Nanjing, Jiangsu, Peoples R China.	caeet@njau.edu.cn	Song, Yang/HGU-4953-2022	sun, yanyan/0000-0001-6425-7786; Wan, Yongjie/0000-0001-6846-3755	National Major Special Projects on New Cultivation for Transgenic Organisms [2013ZX08008-004]; National Natural Science Foundation of China [31272443]; Fundamental Research Funds for the Central Universities [KYZ201211]	National Major Special Projects on New Cultivation for Transgenic Organisms; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was financially supported by the National Major Special Projects on New Cultivation for Transgenic Organisms (number 2013ZX08008-004), National Natural Science Foundation of China (31272443) and Fundamental Research Funds for the Central Universities (number KYZ201211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040469; Arat S, 2002, BIOL REPROD, V66, P1768, DOI 10.1095/biolreprod66.6.1768; Betthauser J, 2000, NAT BIOTECHNOL, V18, P1055, DOI 10.1038/80242; Bhure S, 2007, DNA SEQUENCE, V18, P39, DOI 10.1080/10425170601017145; Bondioli K, 2001, MOL REPROD DEV, V60, P189, DOI 10.1002/mrd.1076; Cedar H, 2012, ANNU REV BIOCHEM, V81, P97, DOI 10.1146/annurev-biochem-052610-091920; Charalambous Marika, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P3, DOI 10.1097/MED.0b013e328013daa2; Chen SH, 2002, BIOL REPROD, V67, P1488, DOI 10.1095/biolreprod.102.006981; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; DOPPLER W, 1989, P NATL ACAD SCI USA, V86, P104, DOI 10.1073/pnas.86.1.104; Ezashi T, 2012, REPROD DOMEST ANIM, V47, P92, DOI 10.1111/j.1439-0531.2012.02061.x; Flisikowska T, 2012, GASTROENTEROLOGY, V143, P1173, DOI 10.1053/j.gastro.2012.07.110; Galli C, 2012, REPROD DOMEST ANIM, V47, P2, DOI 10.1111/j.1439-0531.2012.02045.x; Gong GC, 2004, MOL REPROD DEV, V69, P278, DOI 10.1002/mrd.20130; Han DW, 2008, MOL REPROD DEV, V75, P777, DOI 10.1002/mrd.20802; Hill JR, 2000, BIOL REPROD, V62, P1135, DOI 10.1095/biolreprod62.5.1135; Iacobuzio-Donahue CA, 2009, ANNU REV PATHOL-MECH, V4, P229, DOI 10.1146/annurev.pathol.3.121806.151442; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; Keefer CL, 2002, BIOL REPROD, V66, P199, DOI 10.1095/biolreprod66.1.199; Kubota C, 2000, P NATL ACAD SCI USA, V97, P990, DOI 10.1073/pnas.97.3.990; Kurome M, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-43; Le F, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106070; Leuchs S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043323; Liu JH, 2008, MOL REPROD DEV, V75, P598, DOI 10.1002/mrd.20803; Ogawa H, 2003, REPRODUCTION, V126, P549, DOI 10.1530/rep.0.1260549; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Pollock DP, 1999, J IMMUNOL METHODS, V231, P147, DOI 10.1016/S0022-1759(99)00151-9; Reinius B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056611; Renner S, 2010, DIABETES, V59, P1228, DOI 10.2337/db09-0519; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Robl JM, 2007, THERIOGENOLOGY, V67, P127, DOI 10.1016/j.theriogenology.2006.09.034; Rosen JM, 1999, ANNU REV NUTR, V19, P407, DOI 10.1146/annurev.nutr.19.1.407; Salmon V, 1997, PROTEIN EXPRES PURIF, V9, P203, DOI 10.1006/prep.1996.0687; Shen CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032812; Shen W, 2007, MOL REPROD DEV, V74, P428, DOI 10.1002/mrd.20595; Su JM, 2011, THERIOGENOLOGY, V75, P1346, DOI 10.1016/j.theriogenology.2010.11.045; van Berkel PHC, 2002, NAT BIOTECHNOL, V20, P484, DOI 10.1038/nbt0502-484; van der Does AM, 2012, J IMMUNOL, V188, P5012, DOI 10.4049/jimmunol.1102777; Verma OP, 2012, IN VITRO CELL DEV-AN, V48, P349, DOI 10.1007/s11626-012-9515-y; Wakayama T, 2007, J REPROD DEVELOP, V53, P13, DOI 10.1262/jrd.18120; Wan YJ, 2012, THERIOGENOLOGY, V78, P583, DOI 10.1016/j.theriogenology.2012.03.004; WARD PP, 1995, BIO-TECHNOL, V13, P498, DOI 10.1038/nbt0595-498; Wells DN, 1999, BIOL REPROD, V60, P996, DOI 10.1095/biolreprod60.4.996; Wilkins JF, 2003, NAT REV GENET, V4, P359, DOI 10.1038/nrg1062; Wilmut I, 2007, CLONING STEM CELLS, V9, P3, DOI 10.1089/clo.2006.0002; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yang PH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003453; Young LE, 2003, MECH DEVELOP, V120, P1433, DOI 10.1016/j.mod.2003.09.006; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769; Yu HQ, 2012, J BIOTECHNOL, V161, P198, DOI 10.1016/j.jbiotec.2012.06.035; Zhang L, 2009, ANIM REPROD SCI, V112, P182, DOI 10.1016/j.anireprosci.2008.04.017; Zhang YL, 2010, THERIOGENOLOGY, V73, P681, DOI 10.1016/j.theriogenology.2009.11.008; Zhao LX, 2012, REPROD DOMEST ANIM, V47, P504, DOI 10.1111/j.1439-0531.2011.01911.x	53	16	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77798	10.1371/journal.pone.0077798	http://dx.doi.org/10.1371/journal.pone.0077798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204972	Green Published, gold			2022-12-27	WOS:000326334500062
J	Melvin, AT; Woss, GS; Park, JH; Dumberger, LD; Waters, ML; Allbritton, NL				Melvin, Adam T.; Woss, Gregery S.; Park, Jessica H.; Dumberger, Lukas D.; Waters, Marcey L.; Allbritton, Nancy L.			A Comparative Analysis of the Ubiquitination Kinetics of Multiple Degrons to Identify an Ideal Targeting Sequence for a Proteasome Reporter	PLOS ONE			English	Article							SINGLE CELLS; CAPILLARY-ELECTROPHORESIS; DEGRADATION; PROTEIN; PEPTIDE; SUBSTRATE; INHIBITOR; LIGASE; PHOSPHORYLATION; QUANTIFICATION	The ubiquitin proteasome system (UPS) is the primary pathway responsible for the recognition and degradation of misfolded, damaged, or tightly regulated proteins. The conjugation of a polyubiquitin chain, or polyubiquitination, to a target protein requires an increasingly diverse cascade of enzymes culminating with the E3 ubiquitin ligases. Protein recognition by an E3 ligase occurs through a specific sequence of amino acids, termed a degradation sequence or degron. Recently, degrons have been incorporated into novel reporters to monitor proteasome activity; however only a limited few degrons have successfully been incorporated into such reporters. The goal of this work was to evaluate the ubiquitination kinetics of a small library of portable degrons that could eventually be incorporated into novel single cell reporters to assess proteasome activity. After an intensive literary search, eight degrons were identified from proteins recognized by a variety of E3 ubiquitin ligases and incorporated into a four component degron-based substrate to comparatively calculate ubiquitination kinetics. The mechanism of placement of multiple ubiquitins on the different degron-based substrates was assessed by comparing the data to computational models incorporating first order reaction kinetics using either multi-monoubiquitination or polyubiquitination of the degron-based substrates. A subset of three degrons was further characterized to determine the importance of the location and proximity of the ubiquitination site lysine with respect to the degron. Ultimately, this work identified three candidate portable degrons that exhibit a higher rate of ubiquitination compared to peptidase-dependent degradation, a desired trait for a proteasomal targeting motif.	[Melvin, Adam T.; Woss, Gregery S.; Park, Jessica H.; Dumberger, Lukas D.; Waters, Marcey L.; Allbritton, Nancy L.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Allbritton, Nancy L.] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC USA; [Allbritton, Nancy L.] N Carolina State Univ, Raleigh, NC 27695 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University	Allbritton, NL (corresponding author), Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA.	nlallbri@unc.edu			National Institutes of Biomedical Imaging and Bioengineering [R01EB011763]; National Cancer Institute [F32CA162574]; NATIONAL CANCER INSTITUTE [F32CA162574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011763] Funding Source: NIH RePORTER	National Institutes of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by grants from the National Institutes of Biomedical Imaging and Bioengineering, R01EB011763 (NLA), and the National Cancer Institute, F32CA162574 (ATM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrends C, 2011, NAT STRUCT MOL BIOL, V18, P520, DOI 10.1038/nsmb.2066; Bonger KM, 2011, NAT CHEM BIOL, V7, P531, DOI [10.1038/NCHEMBIO.598, 10.1038/nchembio.598]; Brazhnik P, 2007, MATH BIOSCI, V210, P60, DOI 10.1016/j.mbs.2007.05.005; CARLSON N, 1987, J CELL BIOL, V104, P537, DOI 10.1083/jcb.104.3.537; Chen SJ, 2001, ANAL CHEM, V73, P111, DOI 10.1021/ac0009088; Cheng ZH, 2007, CHEMBIOCHEM, V8, P880, DOI 10.1002/cbic.200600565; Chou TF, 2011, J BIOL CHEM, V286, P16546, DOI 10.1074/jbc.M110.215319; Cirit M, 2010, J BIOL CHEM, V285, P36736, DOI 10.1074/jbc.M110.148759; Cline LL, 2009, BIOPOLYMERS, V92, P502, DOI 10.1002/bip.21266; David Y, 2011, J BIOL CHEM, V286, P44104, DOI 10.1074/jbc.M111.234559; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Geiger M, 2012, ANAL CHEM, V84, P577, DOI 10.1021/ac203205a; Gonzalez-Vera JA, 2012, CHEM SOC REV, V41, P1652, DOI 10.1039/c1cs15198c; Grabbe C, 2011, NAT REV MOL CELL BIO, V12, P295, DOI 10.1038/nrm3099; Gu JJ, 2000, MOL CELL BIOL, V20, P1243, DOI 10.1128/MCB.20.4.1243-1253.2000; Henderson A, 2011, J BIOL CHEM, V286, P17495, DOI 10.1074/jbc.M110.212027; HERSHKO A, 1979, P NATL ACAD SCI USA, V76, P3107, DOI 10.1073/pnas.76.7.3107; Hjerpe R, 2009, EMBO REP, V10, P1250, DOI 10.1038/embor.2009.192; Inobe T, 2011, NAT CHEM BIOL, V7, P161, DOI 10.1038/NCHEMBIO.521; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Jiang DC, 2010, ELECTROPHORESIS, V31, P2558, DOI 10.1002/elps.201000054; Kaiser SE, 2011, NAT METHODS, V8, P691, DOI [10.1038/NMETH.1649, 10.1038/nmeth.1649]; Keren-Kaplan T, 2012, EMBO J, V31, P378, DOI 10.1038/emboj.2011.397; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kovarik ML, 2011, TRENDS BIOTECHNOL, V29, P222, DOI 10.1016/j.tibtech.2011.01.003; Kraut DA, 2011, ACS CHEM BIOL, V6, P1087, DOI 10.1021/cb2002285; Kuang ZH, 2010, J CELL BIOL, V190, P129, DOI 10.1083/jcb.200912087; Kuhn DJ, 2007, BLOOD, V110, P3281, DOI 10.1182/blood-2007-01-065888; Kumar KGS, 2004, J BIOL CHEM, V279, P46614, DOI 10.1074/jbc.M407082200; Lee KA, 2011, J BIOL CHEM, V286, P41530, DOI 10.1074/jbc.M111.248856; Lee K, 2010, BIOCHEM PHARMACOL, V80, P982, DOI 10.1016/j.bcp.2010.06.018; Li CK, 2008, LINEAR MULTILINEAR A, V56, P1, DOI 10.1080/03081080701538074; Li J, 2011, J BIOMOL SCREEN, V16, P450, DOI 10.1177/1087057111399191; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Matsoukas J, 2005, J MED CHEM, V48, P1470, DOI 10.1021/jm040849g; Maupin-Furlow J, 2012, NAT REV MICROBIOL, V10, P100, DOI 10.1038/nrmicro2696; Melvin A, 2013, CELL BIOCH BIOPHYSIC; Neklesa TK, 2011, NAT CHEM BIOL, V7, P538, DOI [10.1038/NCHEMBIO.597, 10.1038/nchembio.597]; Nelson AR, 2007, BIOCHEMISTRY-US, V46, P14771, DOI 10.1021/bi701295k; Nonaka T, 2009, BIOCHEMISTRY-US, V48, P8014, DOI 10.1021/bi900619j; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Proctor A, 2012, ANAL CHEM, V84, P7195, DOI 10.1021/ac301489d; Proctor A, 2012, ANALYST, V137, P3028, DOI 10.1039/c2an16162a; Purbeck C, 2010, BIOCHEMISTRY-US, V49, P1361, DOI 10.1021/bi9014693; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Sonyang Z, 1995, NATURE, V373, P536; Sriram SM, 2011, NAT REV MOL CELL BIO, V12, P735, DOI 10.1038/nrm3217; Thiele A, 2011, MOL BIOTECHNOL, V49, P283, DOI 10.1007/s12033-011-9402-x; Tobinai K, 2007, INT J CLIN ONCOL, V12, P318, DOI 10.1007/s10147-007-0695-5; Urru SAM, 2010, J MED CHEM, V53, P7452, DOI 10.1021/jm100362x; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Zhu H, 2010, MOL CELL BIOL, V30, P4379, DOI 10.1128/MCB.01193-09	55	6	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78082	10.1371/journal.pone.0078082	http://dx.doi.org/10.1371/journal.pone.0078082			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205101	Green Published, gold, Green Submitted			2022-12-27	WOS:000326270700072
J	Reithmeier, L; Kernaghan, G				Reithmeier, Laura; Kernaghan, Gavin			Availability of Ectomycorrhizal Fungi to Black Spruce above the Present Treeline in Eastern Labrador	PLOS ONE			English	Article							DOUGLAS-FIR FOREST; MYCORRHIZAL FUNGI; GLACIER FOREFRONT; SPORE DISPERSAL; PINUS-CONTORTA; SUB-ALPINE; DIVERSITY; SEEDLINGS; COLONIZATION; INOCULUM	Ectomycorrhizal fungi (ECMF) are an important biotic factor in the survival of conifer seedlings under stressful conditions and therefore have the potential to facilitate conifer establishment into alpine and tundra habitats. In order to assess patterns of ectomycorrhizal availability and community structure above treeline, we conducted soil bioassays in which Picea mariana (black spruce) seedlings were grown in field-collected soils under controlled conditions. Soils were collected from distinct alpine habitats, each dominated by a different ectomycorrhizal host shrub: Betula glandulosa, Arctostaphylos alpina or Salix herbacaea. Within each habitat, half of the soils collected contained roots of ectomycorrhizal shrubs (host(+)) and the other half were free of host plants (host(-)). Forest and glacial moraine soils were also included for comparison. Fungi forming ectomycorrhizae during the bioassays were identified by DNA sequencing. Our results indicate that ECMF capable of colonizing black spruce are widespread above the current tree line in Eastern Labrador and that the level of available inoculum has a significant influence on the growth of seedlings under controlled conditions. Many of the host(-) soils possessed appreciable levels of ectomycorrhizal inoculum, likely in the form of spore banks. Inoculum levels in these soils may be influenced by spore production from neighboring soils where ectomycorrhizal shrubs are present. Under predicted temperature increases, ectomycorrhizal inoculum in soils with host shrubs as well as in nearby soils without host shrubs have the potential to facilitate conifer establishment above the present tree line.	[Reithmeier, Laura] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Kernaghan, Gavin] Mt St Vincent Univ, Dept Biol, Halifax, NS B3M 2J6, Canada	Dalhousie University; Mount Saint Vincent University	Kernaghan, G (corresponding author), Mt St Vincent Univ, Dept Biol, Halifax, NS B3M 2J6, Canada.	gavin.kernaghan@msvu.ca			Government of Canada Program for International Polar Year [2006-SR1-CC-027]	Government of Canada Program for International Polar Year	This research was supported by the Government of Canada Program for International Polar Year (http://www.api-ipy.gc.ca) grant number 2006-SR1-CC-027. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Agerer R., 2004, DEEMY INFORM SYSTEM; Agerer R, 1998, COLOUR ATLAS ECTOMYC; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Ashkannejhad S, 2006, NEW PHYTOL, V169, P345, DOI 10.1111/j.1469-8137.2005.01593.x; BA AM, 1991, CAN J BOT, V69, P2442, DOI 10.1139/b91-303; Baar J, 1999, NEW PHYTOL, V143, P409, DOI 10.1046/j.1469-8137.1999.00452.x; Baxter JW, 2001, NEW PHYTOL, V152, P139, DOI 10.1046/j.0028-646x.2001.00245.x; Bruns TD, 2009, NEW PHYTOL, V181, P463, DOI 10.1111/j.1469-8137.2008.02652.x; CAZARES E, 1994, MYCOLOGIA, V86, P507, DOI 10.2307/3760743; Colpaert JV, 1999, NEW PHYTOL, V143, P589, DOI 10.1046/j.1469-8137.1999.00471.x; Correa A, 2012, OIKOS, V121, P449, DOI 10.1111/j.1600-0706.2011.19406.x; Courty PE, 2005, NEW PHYTOL, V167, P309, DOI 10.1111/j.1469-8137.2005.01401.x; Cripps CL, 2005, ARCT ANTARCT ALP RES, V37, P177, DOI 10.1657/1523-0430(2005)037[0177:DOMTAA]2.0.CO;2; Danby RK, 2007, J ECOL, V95, P352, DOI 10.1111/j.1365-2745.2006.01200.x; DANIELSON RM, 1984, CAN J FOREST RES, V14, P33, DOI 10.1139/x84-007; Deslippe JR, 2011, GLOBAL CHANGE BIOL, V17, P1625, DOI 10.1111/j.1365-2486.2010.02318.x; Dickie IA, 2005, J ECOL, V93, P244, DOI 10.1111/j.1365-2745.2005.00977.x; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egger KN., 1996, MANUAL CONCISE DESCR, DOI [DOI 10.1007/S005720050212, 10.1007/s005720050212]; Ferrier R. C., 1985, Ecological interactions in soil: plants, microbes and animals, P175; FINLAY RD, 1992, NEW PHYTOL, V120, P105, DOI 10.1111/j.1469-8137.1992.tb01063.x; FRIES N, 1980, EXPERIENTIA, V36, P1056, DOI 10.1007/BF01965965; Galante TE, 2011, MYCOLOGIA, V103, P1175, DOI 10.3852/10-388; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gardes M, 1996, NEW PHYTOL, V133, P147, DOI 10.1111/j.1469-8137.1996.tb04350.x; Germino MJ, 2002, PLANT ECOL, V162, P157, DOI 10.1023/A:1020385320738; Hagerman SM, 2004, CAN J BOT, V82, P742, DOI [10.1139/b04-047, 10.1139/B04-047]; Hagerman SM, 1999, CAN J FOREST RES, V29, P124, DOI 10.1139/cjfr-29-1-124; Hagerman SM, 2001, CAN J FOREST RES, V31, P711, DOI 10.1139/cjfr-31-4-711; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harsch MA, 2009, ECOL LETT, V12, P1040, DOI 10.1111/j.1461-0248.2009.01355.x; Hasselquist N, 2005, NEW PHYTOL, V165, P867, DOI 10.1111/j.1469-8137.2005.01275.x; Hogberg P, 1999, P NATL ACAD SCI USA, V96, P8534, DOI 10.1073/pnas.96.15.8534; Ingleby K, 1990, IDENTIFICATON ECTOMY; Ishida TA, 2008, NEW PHYTOL, V180, P491, DOI 10.1111/j.1469-8137.2008.02572.x; Jacobs JD, 2007, LABRADOR HIGHLANDS R; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Jonsson L, 1999, NEW PHYTOL, V142, P151, DOI 10.1046/j.1469-8137.1999.00383.x; Jonsson LM, 2001, OIKOS, V93, P353, DOI 10.1034/j.1600-0706.2001.930301.x; Jumpponen A, 2003, NEW PHYTOL, V158, P569, DOI 10.1046/j.1469-8137.2003.00767.x; Jumpponen A, 2002, MYCORRHIZA, V12, P43, DOI 10.1007/s00572-001-0152-7; Kernaghan G, 2001, ECOGRAPHY, V24, P181, DOI 10.1034/j.1600-0587.2001.240208.x; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; Korner C, 1999, ALPINE PLANT LIFE FU; Krpata D, 2007, FOREST ECOL MANAG, V250, P167, DOI 10.1016/j.foreco.2007.05.012; Kupfer JA, 1996, PROG PHYS GEOG, V20, P253, DOI 10.1177/030913339602000301; Lilleskov EA, 2005, MYCOLOGIA, V97, P762, DOI 10.3852/mycologia.97.4.762; Maher EL, 2005, CAN J FOREST RES, V35, P567, DOI 10.1139/X04-201; Martin KJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-28; MASON PA, 1983, PLANT SOIL, V71, P247, DOI 10.1007/BF02182659; Muhlmann O, 2008, MYCORRHIZA, V18, P171, DOI 10.1007/s00572-008-0169-2; Muhsin TM, 2002, NEW PHYTOL, V153, P153, DOI 10.1046/j.0028-646X.2001.00297.x; Munier A, 2010, PLANT ECOL, V210, P19, DOI 10.1007/s11258-010-9724-y; Myers-Smith IH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045509; Nagy L, 2009, BIOL ALPINE HABITATS; Nara K, 2004, ECOLOGY, V85, P1700, DOI 10.1890/03-0373; Nara K, 2006, NEW PHYTOL, V171, P187, DOI 10.1111/j.1469-8137.2006.01744.x; NEWTON AC, 1991, NEW PHYTOL, V117, P53, DOI 10.1111/j.1469-8137.1991.tb00944.x; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Onguene NA, 2002, MYCORRHIZA, V12, P13, DOI 10.1007/s00572-001-0140-y; Peay KG, 2012, MOL ECOL, V21, P4122, DOI 10.1111/j.1365-294X.2012.05666.x; Perez-Moreno J, 2000, NEW PHYTOL, V145, P301, DOI 10.1046/j.1469-8137.2000.00569.x; Persson J, 2003, OECOLOGIA, V137, P252, DOI 10.1007/s00442-003-1334-0; Ryberg M, 2009, ARCT ANTARCT ALP RES, V41, P506, DOI 10.1657/1938-4246-41.4.506; Simard SW, 2004, CAN J BOT, V82, P1140, DOI [10.1139/b04-116, 10.1139/B04-116]; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; STRIBLEY DP, 1980, NEW PHYTOL, V86, P261, DOI 10.1111/j.1469-8137.1980.tb00786.x; Teste FP, 2009, FUNGAL ECOL, V2, P21, DOI 10.1016/j.funeco.2008.11.003; THEODOROU C, 1987, NEW PHYTOL, V106, P217, DOI 10.1111/j.1469-8137.1987.tb00137.x; Thiet RK, 2007, MYCORRHIZA, V17, P507, DOI 10.1007/s00572-007-0123-8; THOMSON BD, 1994, NEW PHYTOL, V126, P517, DOI 10.1111/j.1469-8137.1994.tb04250.x; Tibbett M, 2002, ANN BOT-LONDON, V89, P783, DOI 10.1093/aob/mcf129; Tranquillini W., 1979, PHYSL ECOLOGY ALPINE; VISSER S, 1995, NEW PHYTOL, V129, P389, DOI 10.1111/j.1469-8137.1995.tb04309.x; Wheeler JA, 2011, OIKOS, V120, P1263, DOI 10.1111/j.1600-0706.2010.18966.x	79	16	16	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77527	10.1371/journal.pone.0077527	http://dx.doi.org/10.1371/journal.pone.0077527			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204858	gold, Green Published, Green Submitted			2022-12-27	WOS:000326270700034
J	Chen, KM; Shi, WM; Xin, ZH; Wang, HF; Zhu, XL; Wu, XP; Li, Z; Li, H; Liu, Y				Chen, Kangmei; Shi, Weimei; Xin, Zhenhui; Wang, Huifen; Zhu, Xilin; Wu, Xiaopan; Li, Zhuo; Li, Hui; Liu, Ying			Replication of Genome Wide Association Studies on Hepatocellular Carcinoma Susceptibility Loci in a Chinese Population	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; RISK-FACTORS; C VIRUS; HCV; POLYMORPHISMS; INFECTIONS; GENE; HBV	Background: Genome-wide association studies (GWAS) have identified three loci (rs17401966 in KIF1B, rs7574865 in STAT4, rs9275319 in HLA-DQ) as being associated with hepatitis B virus-related hepatocellular carcinoma (HBV-related HCC) in a Chinese population, two loci (rs2596542 in MICA, rs9275572 located between HLA-DQA and HLA-DQB) with hepatitis C virus-related HCC (HCV-related HCC) in a Japanese population. In the present study, we sought to determine whether these SNPs are predictive for HBV-related HCC development in other Chinese population as well. Method and Findings: We genotyped 4 SNPs, rs2596542, rs9275572, rs17401966, rs7574865, in 506 HBV-related HCC patients and 772 chronic hepatitis B (CHB) patients in Han Chinese by TaqMan methods. Odds ratio(OR) and 95% confidence interval (CI) were calculated by logistic regression. In our case-control study, significant association between rs9275572 and HCC were observed (P = 0.02, OR = 0.73, 95% CI = 0.56-0.95). In the further haplotype analysis between rs2596542 at 6p21.33 and rs9275572 at 6p21.3, G-A showed a protective effect on HBV-related HCC occurrence (P<0.001, OR = 0.66, 95% CI = 0.52-0.84). Conclusion: These findings provided convincing evidence that rs9275572 significantly associated with HBV-related HCC.	[Chen, Kangmei; Shi, Weimei; Xin, Zhenhui; Zhu, Xilin; Wu, Xiaopan; Liu, Ying] Chinese Acad Med Sci, Natl Lab Med Mol Biol, Inst Basic Med Sci, Sch Basic Med,Peking Union Med Coll, Beijing 100730, Peoples R China; [Wang, Huifen] Peoples Liberat Army, Hosp 302, Liver Failure Treatment & Res Ctr, Beijing, Peoples R China; [Li, Zhuo] Capital Univ Med Sci, Affiliated Youan Hosp, Dept Infect Dis, Beijing, Peoples R China; [Li, Hui] Chinese Acad Med Sci, Dept Epidemiol, Inst Basic Med Sci, Sch Basic Med,Peking Union Med Coll, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Fifth Medical Center of Chinese PLA General Hospital; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Li, H (corresponding author), Chinese Acad Med Sci, Dept Epidemiol, Inst Basic Med Sci, Sch Basic Med,Peking Union Med Coll, Beijing 100730, Peoples R China.	lihui99360@sohu.com; liuyingpumc@163.com			National Basic Research Program of China (973 Program) [2012CB519005]; Natural Sciences Foundation of China (NSFC) [81101543]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Sciences Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Basic Research Program of China (973 Program) (No. 2012CB519005) and the Natural Sciences Foundation of China (NSFC, Grant No. 81101543). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Clark A, 2013, INFECT GENET EVOL, V18, P257, DOI 10.1016/j.meegid.2013.05.025; Clifford RJ, 2010, HEPATOLOGY, V52, P2034, DOI 10.1002/hep.23943; Deng GH, 2008, GASTROENTEROLOGY, V134, P716, DOI 10.1053/j.gastro.2007.12.044; Gourraud PA, 2011, GENET EPIDEMIOL, V35, P568, DOI 10.1002/gepi.20592; Gurtsevitch VE, 2008, BIOCHEMISTRY-MOSCOW+, V73, P504, DOI 10.1134/S0006297908050039; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang DK, 2013, NAT GENET, V45, P72, DOI 10.1038/ng.2483; Kong SY, 2007, HEPATOLOGY, V46, P446, DOI 10.1002/hep.21720; Kumar V, 2011, NAT GENET, V43, P455, DOI 10.1038/ng.809; Lange CM, 2013, J HEPATOL; LIAW YF, 1995, HEPATOLOGY, V22, P1101, DOI 10.1016/0270-9139(95)90615-0; Long XD, 2010, HEPATOLOGY, V52, P1301, DOI 10.1002/hep.23807; Maluccio M, 2012, CA-CANCER J CLIN, V62, P394, DOI 10.3322/caac.21161; Michalak TI, 2007, FUTURE VIROL, V2, P451, DOI 10.2217/17460794.2.5.451; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Noble WS, 2009, NAT BIOTECHNOL, V27, P1135, DOI 10.1038/nbt1209-1135; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Sarma Manash Pratim, 2012, Cancer Biology Medicine, V9, P172, DOI 10.7497/j.issn.2095-3941.2012.03.004; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Singh R, 2007, WORLD J GASTROENTERO, V13, P1770, DOI 10.3748/wjg.v13.i12.1770; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Wang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056459; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638	24	34	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77315	10.1371/journal.pone.0077315	http://dx.doi.org/10.1371/journal.pone.0077315			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204805	Green Published, gold, Green Submitted			2022-12-27	WOS:000326241200022
J	Cosentino, S; Larsen, MV; Aarestrup, FM; Lund, O				Cosentino, Salvatore; Larsen, Mette Voldby; Aarestrup, Frank Moller; Lund, Ole			PathogenFinder - Distinguishing Friend from Foe Using Bacterial Whole Genome Sequence Data	PLOS ONE			English	Article							BORRELIA-BURGDORFERI; GENETIC ELEMENTS; VIRULENCE; PROTEIN; EVOLUTION; TOXIN; PATHOGENESIS; INSIGHTS; BIOINFORMATICS; ADAPTATION	Although the majority of bacteria are harmless or even beneficial to their host, others are highly virulent and can cause serious diseases, and even death. Due to the constantly decreasing cost of high-throughput sequencing there are now many completely sequenced genomes available from both human pathogenic and innocuous strains. The data can be used to identify gene families that correlate with pathogenicity and to develop tools to predict the pathogenicity of newly sequenced strains, investigations that previously were mainly done by means of more expensive and time consuming experimental approaches. We describe PathogenFinder (http://cge.cbs.dtu.dk/services/PathogenFinder/), a web-server for the prediction of bacterial pathogenicity by analysing the input proteome, genome, or raw reads provided by the user. The method relies on groups of proteins, created without regard to their annotated function or known involvement in pathogenicity. The method has been built to work with all taxonomic groups of bacteria and using the entire training-set, achieved an accuracy of 88.6% on an independent test-set, by correctly classifying 398 out of 449 completely sequenced bacteria. The approach here proposed is not biased on sets of genes known to be associated with pathogenicity, thus the approach could aid the discovery of novel pathogenicity factors. Furthermore the pathogenicity prediction web-server could be used to isolate the potential pathogenic features of both known and unknown strains.	[Cosentino, Salvatore; Larsen, Mette Voldby; Lund, Ole] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Aarestrup, Frank Moller] Tech Univ Denmark, Natl Food Inst, DK-2800 Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark	Cosentino, S (corresponding author), Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark.	salvocos@cbs.dtu.dk	Lund, Ole/F-4437-2014; Cosentino, Salvatore/V-9201-2019	Lund, Ole/0000-0003-1108-0491; Cosentino, Salvatore/0000-0002-1066-8659; Aarestrup, Frank/0000-0002-7116-2723	Center for Genomic Epidemiology at the Technical University of Denmark; Danish Council for Strategic Research [09-067103/DSF]	Center for Genomic Epidemiology at the Technical University of Denmark; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This work was supported by the Center for Genomic Epidemiology (http://www.genomicepidemiology.org) at the Technical University of Denmark and was funded by grant 09-067103/DSF from the Danish Council for Strategic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup Frank M, 2012, Emerg Infect Dis, V18, pe1, DOI 10.3201/eid/1811.120453; Abramovitch RB, 2006, NAT REV MOL CELL BIO, V7, P601, DOI 10.1038/nrm1984; ALOUF JE, 1980, PHARMACOL THERAPEUT, V11, P661, DOI 10.1016/0163-7258(80)90045-5; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amagai M, 2000, NAT MED, V6, P1275, DOI 10.1038/81385; Andreatta M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013680; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Brogden KA, 2005, LANCET, V365, P253, DOI 10.1016/S0140-6736(05)70155-0; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Day WA, 2001, INFECT IMMUN, V69, P7471, DOI 10.1128/IAI.69.12.7471-7480.2001; den Heijer CDJ, 2013, LANCET INFECT DIS, V13, P409, DOI 10.1016/S1473-3099(13)70036-7; Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226; DuPont AW, 2011, NAT REV GASTRO HEPAT, V8, P523, DOI 10.1038/nrgastro.2011.133; Falkow S, 1997, ASM NEWS, V63, P359; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Garg A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-62; Gillespie JJ, 2011, INFECT IMMUN, V79, P4286, DOI 10.1128/IAI.00207-11; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Grimm D, 2004, INFECT IMMUN, V72, P5938, DOI 10.1128/IAI.72.10.5938-5946.2004; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Iraola G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042144; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KROGFELT KA, 1991, REV INFECT DIS, V13, P721; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lina G, 1997, CLIN INFECT DIS, V25, P1369, DOI 10.1086/516129; Ma S, 1992, MOLEKULIARNAIA BIOL, V27, P1218; Manning SD, 2008, P NATL ACAD SCI USA, V105, P4868, DOI 10.1073/pnas.0710834105; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Maurelli AT, 2007, FEMS MICROBIOL LETT, V267, P1, DOI 10.1111/j.1574-6968.2006.00526.x; METZGER M, 1994, J BACTERIOL, V176, P450, DOI 10.1128/JB.176.2.450-459.1994; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; MOURA I, 1994, METHOD ENZYMOL, V243, P216; Nanni L, 2012, IEEE ACM T COMPUT BI, V9, P467, DOI 10.1109/TCBB.2011.117; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Paine K, 2002, J MOL MICROB BIOTECH, V4, P357; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Smits THM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-2; Spalding MD, 2010, MICROBIOL MOL BIOL R, V74, P200, DOI 10.1128/MMBR.00008-10; Stewart PE, 2005, PLASMID, V53, P1, DOI 10.1016/j.plasmid.2004.10.006; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Sui SJH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008094; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Turner SM, 2005, BIOCHEM J, V388, P545, DOI 10.1042/BJ20041766; WALKER KE, 1994, INFECT IMMUN, V62, P3817, DOI 10.1128/IAI.62.9.3817-3828.1994; Wassenaar TM, 2001, FEMS MICROBIOL LETT, V201, P1; YOUNG RA, 1985, NATURE, V316, P450, DOI 10.1038/316450a0; Zhang XH, 2005, J APPL MICROBIOL, V98, P1011, DOI 10.1111/j.1365-2672.2005.02583.x	60	241	247	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77302	10.1371/journal.pone.0077302	http://dx.doi.org/10.1371/journal.pone.0077302			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204795	Green Published, gold, Green Submitted			2022-12-27	WOS:000326241200021
J	Schwartz, LM; Persson, EC; Weinstein, SJ; Graubard, BI; Freedman, ND; Mannisto, S; Albanes, D; McGlynn, KA				Schwartz, Lauren M.; Persson, E. Christina; Weinstein, Stephanie J.; Graubard, Barry I.; Freedman, Neal D.; Mannisto, Satu; Albanes, Demetrius; McGlynn, Katherine A.			Alcohol Consumption, One-Carbon Metabolites, Liver Cancer and Liver Disease Mortality	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; CIGARETTE-SMOKING; UNITED-STATES; FOLATE INTAKE; COHORT; RISK; CARCINOGENESIS; BURDEN; REPRODUCIBILITY; VITAMIN-B-12	Background: Excess alcohol consumption adversely affects one-carbon metabolism and increases the risk of liver disease and liver cancer. Conversely, higher folate levels have been inversely associated with liver damage. The current study investigated the effects of alcohol and one-carbon metabolite intake on liver cancer incidence and liver disease mortality within the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study. Methods: Cox proportional hazards modeling was used to calculate hazard ratios and 95% confidence intervals (CIs) in a population of 27,086 Finnish males with 194 incident liver cancers and 213 liver disease deaths. In a nested case-control subset (95 liver cancers, 103 controls), logistic regression was used to calculate odds ratios and 95% CIs for serum one-carbon metabolites in relation to liver cancer risk. Results: Daily alcohol consumption of more than 20.44 g was associated with an increased risk of both liver cancer incidence (Hazard Ratio (HR) 1.52, 95% CI 1.06-2.18) and liver disease mortality (HR 6.68, 95% CI 4.16-10.71). These risks were unaffected by one-carbon metabolite intake. Similarly, in the case-control study, none of the serum one-carbon metabolites were associated with liver cancer. Conclusions: The current study provided no convincing evidence for a protective association of one-carbon metabolite intake or serum level on the risk of liver cancer or liver disease mortality.	[Schwartz, Lauren M.; Persson, E. Christina; Weinstein, Stephanie J.; Graubard, Barry I.; Freedman, Neal D.; Albanes, Demetrius; McGlynn, Katherine A.] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA; [Persson, E. Christina] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Mannisto, Satu] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Statens Serum Institut; Finland National Institute for Health & Welfare	McGlynn, KA (corresponding author), NCI, Div Canc Epidemiol & Genet, Rockville, MD USA.	mcglynnk@mail.nih.gov	Albanes, Demetrius/B-9749-2015; Freedman, Neal David/B-9741-2015; Weinstein, Stephanie J/P-1627-2017	Freedman, Neal David/0000-0003-0074-1098; Weinstein, Stephanie J/0000-0002-3834-1535; Schwartz, Lauren/0000-0002-2264-3029; Mannisto, Satu/0000-0002-8668-3046	National Cancer Institute, NIH; NATIONAL CANCER INSTITUTE [ZIACP010158] Funding Source: NIH RePORTER	National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was financially supported by the Intramural Research Program of the National Cancer Institute, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; [Anonymous], 1994, Ann Epidemiol, V4, P1, DOI 10.1016/1047-2797(94)90036-1; ARAKI A, 1987, J CHROMATOGR-BIOMED, V422, P43, DOI 10.1016/0378-4347(87)80438-3; Boffetta P, 2006, INT J CANCER, V119, P884, DOI 10.1002/ijc.21903; Choi SW, 2000, J NUTR, V130, P129, DOI 10.1093/jn/130.2.129; Choumenkovitch SF, 2002, J NUTR, V132, P2792, DOI 10.1093/jn/132.9.2792; Dong CH, 2011, J STUD ALCOHOL DRUGS, V72, P892, DOI 10.15288/jsad.2011.72.892; Fears TR, 2002, CANCER EPIDEM BIOMAR, V11, P785; Friso S, 2005, CURR DRUG METAB, V6, P37, DOI 10.2174/1389200052997339; Gabriel HE, 2006, AM J CLIN NUTR, V83, P835, DOI 10.1093/ajcn/83.4.835; Halsted CH, 2002, J NUTR, V132, p2367S, DOI 10.1093/jn/132.8.2367S; Heinen MM, 2009, AM J EPIDEMIOL, V169, P1233, DOI 10.1093/aje/kwp028; Ibiebele TI, 2011, J NUTR, V141, P274, DOI 10.3945/jn.110.131235; Kim YI, 1999, J NUTR BIOCHEM, V10, P66, DOI 10.1016/S0955-2863(98)00074-6; Mannino DM, 2003, NICOTINE TOB RES, V5, P357, DOI 10.1080/1462220031000094330; Persson EC, 2013, CANCER EPIDEM BIOMAR, V22, P415, DOI 10.1158/1055-9965.EPI-12-1169; PIETINEN P, 1988, AM J EPIDEMIOL, V128, P655, DOI 10.1093/oxfordjournals.aje.a115013; PIYATHILAKE CJ, 1994, AM J CLIN NUTR, V60, P559, DOI 10.1093/ajcn/60.4.559; Schutze M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1584; Seitz HK, 2007, NAT REV CANCER, V7, P599, DOI 10.1038/nrc2191; Shimazu T, 2012, INT J CANCER, V130, P2645, DOI 10.1002/ijc.26255; SHINBUEHRING YS, 1981, CLIN CHIM ACTA, V112, P257, DOI 10.1016/0009-8981(81)90448-4; Stolzenberg-Solomon RZ, 2006, AM J CLIN NUTR, V83, P895, DOI 10.1093/ajcn/83.4.895; Stover PJ, 2004, NUTR REV, V62, pS3, DOI 10.1111/j.1753-4887.2004.tb00070.x; Trichopoulos D, 2011, JNCI-J NATL CANCER I, V103, P1686, DOI 10.1093/jnci/djr395; Welzel TM, 2007, CANCER EPIDEM BIOMAR, V16, P1279, DOI 10.1158/1055-9965.EPI-06-0853; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; ZEMPLENI J, 1992, INT J VITAM NUTR RES, V62, P165	28	13	13	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e78156	10.1371/journal.pone.0078156	http://dx.doi.org/10.1371/journal.pone.0078156			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24205137	gold, Green Submitted, Green Published			2022-12-27	WOS:000326241200054
J	Witham, KL; Butcher, NJ; Sugamori, KS; Brenneman, D; Grant, DM; Minchin, RF				Witham, Katey L.; Butcher, Neville J.; Sugamori, Kim S.; Brenneman, Debbie; Grant, Denis M.; Minchin, Rodney F.			5-Methyl-Tetrahydrofolate and the S-Adenosylmethionine Cycle in C57BL/6J Mouse Tissues: Gender Differences and Effects of Arylamine N-Acetyltransferase-1 Deletion	PLOS ONE			English	Article							GLYCINE N-METHYLTRANSFERASE; FOLATE INTAKE; FOLIC-ACID; METABOLISM; MICE; ACETYLTRANSFERASE; DISEASE; CANCER; GENE; DEFECTS	Folate catabolism involves cleavage of the C-9-N-10 bond to form p-aminobenzoylgluamate (PABG) and pterin. PABG is then acetylated by human arylamine N-acetyltransferase 1 (NAT1) before excretion in the urine. Mice null for the murine NAT1 homolog (Nat2) show several phenotypes consistent with altered folate homeostasis. However, the exact role of Nat2 in the folate pathway in vivo has not been reported. Here, we examined the effects of Nat2 deletion in male and female mice on the tissue levels of 5-methyl-tetrahydrofolate and the methionine-S-adenosylmethionine cycle. We found significant gender differences in hepatic and renal homocysteine, S-adenosylmethionine and methionine levels consistent with a more active methionine-S-adenosylmethionine cycle in female tissues. In addition, methionine levels were significantly higher in female liver and kidney. PABG was higher in female liver tissue but lower in kidney compared to male tissues. In addition, qPCR of mRNA extracted from liver tissue suggested a significantly lower level of Nat2 expression in female animals. Deletion of Nat2 affected liver 5- methyl-tetrahydrofolate in female mice but had little effect on other components of the methionine-S-adenosylmethionine cycle. No N-acetyl-PABG was observed in any tissues in Nat2 null mice, consistent with the role of Nat2 in PABG acetylation. Surprisingly, tissue PABG levels were similar between wild type and Nat2 null mice. These results show that Nat2 is not required to maintain tissue PABG homeostasis in vivo under normal conditions.	[Witham, Katey L.; Butcher, Neville J.; Minchin, Rodney F.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Sugamori, Kim S.; Brenneman, Debbie; Grant, Denis M.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada	University of Queensland; University of Toronto	Minchin, RF (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.	r.minchin@uq.edu.au		Minchin, Rodney/0000-0002-3178-4835; Butcher, Neville/0000-0002-0709-5589	Australian National Health and Medical Research Council; Canadian Institutes of Health Research	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Australian National Health and Medical Research Council, and by the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butcher NJ, 2012, PHARMACOL REV, V64, P147, DOI 10.1124/pr.110.004275; Chang HB, 2011, J NUTR BIOCHEM, V22, P1172, DOI 10.1016/j.jnutbio.2010.10.003; Chew TW, 2011, J NUTR, V141, P1475, DOI 10.3945/jn.111.138859; Christensen KE, 2010, J NUTR, V140, P1736, DOI 10.3945/jn.110.124917; Crider KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028144; Ernest S, 2005, PHYSIOL GENOMICS, V21, P404, DOI 10.1152/physiolgenomics.00199.2004; Estrada-Rodgers L, 1998, DRUG METAB DISPOS, V26, P502; Jensen LE, 2005, BIRTH DEFECTS RES A, V73, P512, DOI 10.1002/bdra.20143; Kawamura A, 2008, BIOCHEM PHARMACOL, V75, P1550, DOI 10.1016/j.bcp.2007.12.012; Kwok JBJ, 2010, EPIGENOMICS-UK, V2, P671, DOI 10.2217/EPI.10.43; Lammer EJ, 2004, BIRTH DEFECTS RES A, V70, P846, DOI 10.1002/bdra.20081; Liao YJ, 2009, INT J CANCER, V124, P816, DOI 10.1002/ijc.23979; Mato JM, 2008, ANNU REV NUTR, V28, P273, DOI 10.1146/annurev.nutr.28.061807.155438; McMullen MH, 2002, ARCH BIOCHEM BIOPHYS, V401, P73, DOI 10.1016/S0003-9861(02)00030-9; MINCHIN RF, 1995, BIOCHEM J, V307, P1; Monch S, 2010, ANAL BIOCHEM, V398, P150, DOI 10.1016/j.ab.2009.11.007; Pitkin RM, 2007, AM J CLIN NUTR, V85, p285S, DOI 10.1093/ajcn/85.1.285S; Ponziani FR, 2012, EUR REV MED PHARMACO, V16, P376; SCHMITZ JC, 1994, BIOCHEM PHARMACOL, V48, P319, DOI 10.1016/0006-2952(94)90103-1; Solimando R, 2011, BEST PRACT RES CL GA, V25, P555, DOI 10.1016/j.bpg.2011.09.004; Wakefield L, 2007, BIOCHEM BIOPH RES CO, V364, P556, DOI 10.1016/j.bbrc.2007.10.026; Wakefield L, 2007, MAMM GENOME, V18, P270, DOI 10.1007/s00335-007-9010-z; Wang ZM, 2011, FOLATE RISK CORONARY; Wilcox AJ, 2007, BMJ-BRIT MED J, V334, P464, DOI 10.1136/bmj.39079.618287.0B; Zhao RB, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000969	25	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77923	10.1371/journal.pone.0077923	http://dx.doi.org/10.1371/journal.pone.0077923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205029	Green Published, Green Submitted, gold			2022-12-27	WOS:000326155400060
J	Calvo, J; Sanchez-Cid, L; Munoz, M; Lozano, JJ; Thomson, TM; Fernandez, PL				Calvo, Julia; Sanchez-Cid, Lourdes; Munoz, Montserrat; Jose Lozano, Juan; Thomson, Timothy M.; Fernandez, Pedro L.			Infrequent Loss of Luminal Differentiation in Ductal Breast Cancer Metastasis	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURE; ESTROGEN-RECEPTOR; CARBONIC-ANHYDRASES; ALPHA EXPRESSION; GATA3 EXPRESSION; ER-ALPHA; SURVIVAL; GROWTH; FOXA1; CLASSIFICATION	Lymph node involvement is a major prognostic variable in breast cancer. Whether the molecular mechanisms that drive breast cancer cells to colonize lymph nodes are shared with their capacity to form distant metastases is yet to be established. In a transcriptomic survey aimed at identifying molecular factors associated with lymph node involvement of ductal breast cancer, we found that luminal differentiation, assessed by the expression of estrogen receptor (ER) and/or progesterone receptor (PR) and GATA3, was only infrequently lost in node-positive primary tumors and in matched lymph node metastases. The transcription factor GATA3 critically determines luminal lineage specification of mammary epithelium and is widely considered a tumor and metastasis suppressor in breast cancer. Strong expression of GATA3 and ER in a majority of primary node-positive ductal breast cancer was corroborated by quantitative RT-PCR and immunohistochemistry in the initial sample set, and by immunohistochemistry in an additional set from 167 patients diagnosed of node-negative and -positive primary infiltrating ductal breast cancer, including 102 samples from loco-regional lymph node metastases matched to their primary tumors, as well as 37 distant metastases. These observations suggest that loss of luminal differentiation is not a major factor driving the ability of breast cancer cells to colonize regional lymph nodes.	[Calvo, Julia; Sanchez-Cid, Lourdes; Fernandez, Pedro L.] Hosp Clin Barcelona, Dept Pathol, Barcelona, Spain; [Sanchez-Cid, Lourdes; Thomson, Timothy M.] Natl Res Council CSIC, Mol Biol Inst Barcelona IBMB, Dept Cell Biol, Barcelona, Spain; [Munoz, Montserrat] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain; [Munoz, Montserrat; Fernandez, Pedro L.] Univ Barcelona, Dept Anat Patol Farmacol & Microbiol, Barcelona, Spain; [Jose Lozano, Juan] Hosp Clin Barcelona, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Jose Lozano, Juan] CEK, Ctr Invest Esther Koplowitz, Barcelona, Spain; [Thomson, Timothy M.] Ctr Invest Biomed Red Bioingn Biomat & Nanomed CI, Barcelona, Spain; [Sanchez-Cid, Lourdes; Fernandez, Pedro L.] Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Thomson, TM (corresponding author), Natl Res Council CSIC, Mol Biol Inst Barcelona IBMB, Dept Cell Biol, Barcelona, Spain.	titbmc@ibmb.csic.es; plfernan@clinic.ub.es	Fernandez, Pedro L/H-2594-2017; Muñoz, Montserrat/AAO-9617-2020; Thomson, Timothy/Z-6271-2019	Muñoz, Montserrat/0000-0001-7772-1437; Thomson, Timothy/0000-0002-4670-9440; Lozano, Juan Jose/0000-0001-7613-3908	Institut d'Investigacions Biomediques August Pi y Sunyer; Xarxa de Bancs de Tumours de Catalunya-Pla Director d'Oncologia; Fondo Europeo de Desarrollo Regional, Union Europea "Una manera de hacer Europa"; Red de Biobancos RETIC [RD06/0020]; Red Tematica de Investigacion Cooperativa del Cancer from The National Institute of Health Carlos III [RD06/0020/0039, RD12/0036/0023]; Ministry of Economy and Competitivity [SAF2012-40017-C02-02, SAF2012-40017-C02-01]; Ministry of Science and Innovation [FIS-PI080274, SAF2008-04136-C02-01, SAF2011-24686]; AECC of Barcelona; Agencia de Gestio d'Ajuts Universitaris i de Recerca de la Generalitat de Catalunya [2009SGR1482]	Institut d'Investigacions Biomediques August Pi y Sunyer; Xarxa de Bancs de Tumours de Catalunya-Pla Director d'Oncologia; Fondo Europeo de Desarrollo Regional, Union Europea "Una manera de hacer Europa"; Red de Biobancos RETIC; Red Tematica de Investigacion Cooperativa del Cancer from The National Institute of Health Carlos III; Ministry of Economy and Competitivity; Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); AECC of Barcelona; Agencia de Gestio d'Ajuts Universitaris i de Recerca de la Generalitat de Catalunya(Generalitat de Catalunya)	JC and LS were supported by grants from the Institut d'Investigacions Biomediques August Pi y Sunyer. This study was supported by grants from the Xarxa de Bancs de Tumours de Catalunya-Pla Director d'Oncologia and Fondo Europeo de Desarrollo Regional, Union Europea "Una manera de hacer Europa", Red de Biobancos RETIC RD06/0020 and Red Tematica de Investigacion Cooperativa del Cancer (RD06/0020/0039, RD12/0036/0023) from The National Institute of Health Carlos III, grant SAF2012-40017-C02-02 (Ministry of Economy and Competitivity) and grant FIS-PI080274 (Ministry of Science and Innovation) to PLF; and grants SAF2008-04136-C02-01 and SAF2011-24686 (Ministry of Science and Innovation), SAF2012-40017-C02-01 (Ministry of Economy and Competitivity), AECC of Barcelona and 2009SGR1482 (Agencia de Gestio d'Ajuts Universitaris i de Recerca de la Generalitat de Catalunya) to TMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achen MG, 2008, ANN NY ACAD SCI, V1131, P225, DOI 10.1196/annals.1413.020; Albergaria A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2327; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Arnold A, 2005, J CLIN ONCOL, V23, P4215, DOI 10.1200/JCO.2005.05.064; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Asselin-Labat ML, 2011, MOL CELL BIOL, V31, P4609, DOI 10.1128/MCB.05766-11; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bernardo GM, 2010, DEVELOPMENT, V137, P2045, DOI 10.1242/dev.043299; Beug H, 2009, CELL, V138, P623, DOI 10.1016/j.cell.2009.08.007; Campos B, 2010, CLIN CANCER RES, V16, P2715, DOI 10.1158/1078-0432.CCR-09-1800; Chu IM, 2012, ONCOGENE, V31, P2017, DOI 10.1038/onc.2011.382; CIMINOMATHEWS A, 2013, HUM PATHOL; Ciocca V, 2009, HUM PATHOL, V40, P489, DOI 10.1016/j.humpath.2008.09.010; Cuzick J, 2011, J CLIN ONCOL, V29, P4273, DOI 10.1200/JCO.2010.31.2835; de The H, 2010, NAT REV CANCER, V10, P775, DOI 10.1038/nrc2943; Dunkler D, 2007, EUR J CANCER, V43, P745, DOI 10.1016/j.ejca.2006.11.018; Dydensborg AB, 2009, ONCOGENE, V28, P2634, DOI 10.1038/onc.2009.126; Eeckhoute J, 2007, CANCER RES, V67, P6477, DOI 10.1158/0008-5472.CAN-07-0746; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018; Foulkes WD, 2010, NAT REV CLIN ONCOL, V7, P348, DOI 10.1038/nrclinonc.2010.39; Gulbinas A, 2006, J HISTOCHEM CYTOCHEM, V54, P161, DOI 10.1369/jhc.5A6626.2005; Halsted WS, 1907, ANN SURG, V46, P1, DOI 10.1097/00000658-190707000-00001; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoch RV, 1999, INT J CANCER, V84, P122; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ivanov S, 2001, AM J PATHOL, V158, P905, DOI 10.1016/S0002-9440(10)64038-2; Jiang Shoulei, 2010, Hormones & Cancer, V1, P11, DOI 10.1007/s12672-010-0006-x; Kawada K, 2011, CANCER RES, V71, P1214, DOI 10.1158/0008-5472.CAN-10-3277; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Kong SL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.59; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Lacroix M, 2004, MOL CELL ENDOCRINOL, V219, P1, DOI 10.1016/j.mce.2004.02.021; Lakhani SR, 2012, WHO CLASSIFICATION T; Mehra R, 2005, CANCER RES, V65, P11259, DOI 10.1158/0008-5472.CAN-05-2495; Molenaar JJ, 2010, ONCOGENE, V29, P2739, DOI 10.1038/onc.2010.21; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pastorekova S, 2008, CURR PHARM DESIGN, V14, P685, DOI 10.2174/138161208783877893; Pei XH, 2009, CANCER CELL, V15, P389, DOI 10.1016/j.ccr.2009.03.004; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Punglia RS, 2007, NEW ENGL J MED, V356, P2399, DOI 10.1056/NEJMra065241; Rakha EA, 2011, ADV ANAT PATHOL, V18, P255, DOI 10.1097/PAP.0b013e318220f5d1; Rakha EA, 2009, PATHOLOGY, V41, P40, DOI 10.1080/00313020802563510; Singletary SE, 2002, J CLIN ONCOL, V20, P3628, DOI 10.1200/JCO.2002.02.026; Sneath P.H.A., 1973, NUMERICAL TAXONOMY; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van Hamburg JP, 2008, MOL IMMUNOL, V45, P3085, DOI 10.1016/j.molimm.2008.03.018; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Weigelt B, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2734; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Xing P, 2011, J INVEST MED, V59, P803, DOI 10.2310/JIM.0b013e31821451a1; Yan W, 2010, J BIOL CHEM, V285, P14042, DOI 10.1074/jbc.M110.105262; Yoon NK, 2010, HUM PATHOL, V41, P1794, DOI 10.1016/j.humpath.2010.06.010	60	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78097	10.1371/journal.pone.0078097	http://dx.doi.org/10.1371/journal.pone.0078097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205108	Green Published, gold, Green Submitted			2022-12-27	WOS:000326032600071
J	Hsu, J; Weiss, EL				Hsu, Jonathan; Weiss, Eric L.			Cell Cycle Regulated Interaction of a Yeast Hippo Kinase and Its Activator MO25/Hym1	PLOS ONE			English	Article							NDR-PROTEIN-KINASE; MITOTIC EXIT; SACCHAROMYCES-CEREVISIAE; SIGNALING NETWORK; PATHWAY; DROSOPHILA; PHOSPHORYLATION; PROMOTES; PROLIFERATION; SALVADOR	Hippo pathways are ancient signaling systems that contribute to cell growth and proliferation in a wide diversity of eukaryotes, and have emerged as a conserved regulator of organ size control in metazoans. In budding yeast, a Hippo signaling pathway called the Regulation of Ace2 and Morphogenesis (RAM) network promotes polarized cell growth and the final event in the separation of mother and daughter cells. A crucial regulatory input for RAM network control of cell separation is phosphorylation of a conserved hydrophobic motif (HM) site on the NDR/LATS family kinase Cbk1. Here we provide the first direct evidence that the Hippo-like kinase Kic1 in fact phosphorylates the HM site of Cbk1, and show that Kic1 is allosterically activated by Hym1, a highly conserved protein related to mammalian MO25. Using the structure of mammalian MO25 in complex with the Kic1-related pseudokinase STRAD, we identified conserved residues on Kic1 that are required for interaction with Hym1. We find that Kic1 and Hym1 protein levels remain constant throughout the cell cycle but the proteins' association is regulated, with maximal interaction coinciding with peak Cbk1 HM site phosphorylation. We show that this association is necessary but not sufficient for this phosphorylation, suggesting another level of regulation is required to promote the complex to act upon its substrates. This work presents a previously undiscovered cell cycle regulated interaction between a Hippo kinase and a broadly conserved allosteric activator. Because of the conserved nature of this pathway in higher eukaryotes, this work may also provide insight into the modularity of Hippo signaling pathways.	[Hsu, Jonathan; Weiss, Eric L.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA	Northwestern University	Weiss, EL (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	elweiss@northwestern.edu			National Institutes of Health - NIGMS [R01 GM084223]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084223] Funding Source: NIH RePORTER	National Institutes of Health - NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health - NIGMS. The relevant grant number is R01 GM084223. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Archambault V, 2004, MOL CELL, V14, P699, DOI 10.1016/j.molcel.2004.05.025; Bidlingmaier S, 2001, MOL CELL BIOL, V21, P2449, DOI 10.1128/MCB.21.7.2449-2462.2001; Bogomolnaya LM, 2006, CURR GENET, V49, P384, DOI 10.1007/s00294-006-0069-y; Boudeau J, 2004, J CELL SCI, V117, P6365, DOI 10.1242/jcs.01571; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Brace J, 2011, MOL CELL BIOL, V31, P721, DOI 10.1128/MCB.00403-10; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Cong JL, 2001, DEVELOPMENT, V128, P2793; Dettmann A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002950; Du LL, 2002, MOL BIOL CELL, V13, P503, DOI 10.1091/mbc.01-07-0365; Emoto K, 2004, CELL, V119, P245, DOI 10.1016/j.cell.2004.09.036; Fang XL, 2010, DEV BIOL, V341, P360, DOI 10.1016/j.ydbio.2010.02.029; Filippi BM, 2011, EMBO J, V30, P1730, DOI 10.1038/emboj.2011.78; Goshima T, 2010, J BIOL CHEM, V285, P35196, DOI 10.1074/jbc.M110.176867; Gupta S, 2013, CURR BIOL, V23, P333, DOI 10.1016/j.cub.2013.01.014; Gupta S, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-19; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Hergovich A, 2009, BIOFACTORS, V35, P338, DOI 10.1002/biof.47; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Jansen G, 2005, GENE, V344, P43, DOI 10.1016/j.gene.2004.10.016; Jansen JM, 2006, J CELL BIOL, V175, P755, DOI 10.1083/jcb.200604107; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kanai M, 2005, EMBO J, V24, P3012, DOI 10.1038/sj.emboj.7600782; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mah AS, 2001, P NATL ACAD SCI USA, V98, P7325, DOI 10.1073/pnas.141098998; Mayhew MB, 2011, BIOINFORMATICS, V27, pI295, DOI 10.1093/bioinformatics/btr244; Mehellou Y, 2013, BIOCHEM BIOPH RES CO, V431, P604, DOI 10.1016/j.bbrc.2012.12.113; Milburn CC, 2004, NAT STRUCT MOL BIOL, V11, P193, DOI 10.1038/nsmb716; Millward TA, 1999, J BIOL CHEM, V274, P33847, DOI 10.1074/jbc.274.48.33847; Nelson B, 2003, MOL BIOL CELL, V14, P3782, DOI 10.1091/mbc.E03-01-0018; Orlando DA, 2007, CELL CYCLE, V6, P478, DOI 10.4161/cc.6.4.3859; Orlando DA, 2009, ANN APPL STAT, V3, P1521, DOI 10.1214/09-AOAS264; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Panozzo C, 2010, MOL GENET GENOMICS, V283, P111, DOI 10.1007/s00438-009-0501-3; Rajakulendran T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3111pe8; Rock JM, 2013, SCIENCE, V340, P871, DOI 10.1126/science.1235822; Stegert MR, 2005, MOL CELL BIOL, V25, P11019, DOI 10.1128/MCB.25.24.11019-11029.2005; Sudol M, 2010, TRENDS BIOCHEM SCI, V35, P627, DOI 10.1016/j.tibs.2010.05.010; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Tamaskovic R, 2003, J BIOL CHEM, V278, P6710, DOI 10.1074/jbc.M210590200; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Visintin R, 2001, MOL BIOL CELL, V12, P2961, DOI 10.1091/mbc.12.10.2961; Weiss EL, 2002, J CELL BIOL, V158, P885, DOI 10.1083/jcb.200203094; Weiss EL, 2012, GENETICS, V192, P1165, DOI 10.1534/genetics.112.145516; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377; Zeqiraj E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000126	54	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78334	10.1371/journal.pone.0078334	http://dx.doi.org/10.1371/journal.pone.0078334			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205201	gold, Green Submitted, Green Published			2022-12-27	WOS:000326032600097
J	Krieger, N; Waterman, PD; Kosheleva, A; Chen, JT; Smith, KW; Carney, DR; Bennett, GG; Williams, DR; Thornhill, G; Freeman, ER				Krieger, Nancy; Waterman, Pamela D.; Kosheleva, Anna; Chen, Jarvis T.; Smith, Kevin W.; Carney, Dana R.; Bennett, Gary G.; Williams, David R.; Thornhill, Gisele; Freeman, Elmer R.			Racial Discrimination & Cardiovascular Disease Risk: My Body My Story Study of 1005 US-Born Black and White Community Health Center Participants (US)	PLOS ONE			English	Article							AFRICAN-AMERICANS; IMPLICIT MEASURES; BLOOD-PRESSURE; PERCEIVED DISCRIMINATION; DISPARITIES; HYPERTENSION; EPIDEMIOLOGY	Objectives: To date, limited and inconsistent evidence exists regarding racial discrimination and risk of cardiovascular disease (CVD). Methods: Cross-sectional observational study of 1005 US-born non-Hispanic black (n = 504) and white (n = 501) participants age 35-64 randomly selected from community health centers in Boston, MA (2008-2010; 82.4% response rate), using 3 racial discrimination measures: explicit self-report; implicit association test (IAT, a time reaction test for self and group as target vs. perpetrator of discrimination); and structural (Jim Crow status of state of birth, i.e. legal racial discrimination prior 1964). Results: Black and white participants both had adverse cardiovascular and socioeconomic profiles, with black participants most highly exposed to racial discrimination. Positive crude associations among black participants occurred for Jim Crow birthplace and hypertension (odds ratio (OR) 1.92, 95% confidence interval (CI) 1.28, 2.89) and for explicit self-report and the Framingham 10 year CVD risk score (beta = 0.04; 95% CI 0.01, 0.07); among white participants, only negative crude associations existed (for IAT for self, for lower systolic blood pressure (SBP; beta = -4.86; 95% CI -9.08, -0.64) and lower Framingham CVD score (beta = -0.36, 95% CI -0.63, -0.08)). All of these associations were attenuated and all but the white IAT-Framingham risk score association were rendered null in analyses that controlled for lifetime socioeconomic position and additional covariates. Controlling for racial discrimination, socioeconomic position, and other covariates did not attenuate the crude black excess risk for SBP and hypertension and left unaffected the null excess risk for the Framingham CVD score. Conclusion: Despite worse exposures among the black participants, racial discrimination and socioeconomic position were not associated, in multivariable analyses, with risk of CVD. We interpret results in relation to constrained variability of exposures and outcomes and discuss implications for valid research on social determinants of health.	[Krieger, Nancy; Waterman, Pamela D.; Kosheleva, Anna; Chen, Jarvis T.; Williams, David R.] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Smith, Kevin W.] RTI Int, Waltham, MA USA; [Carney, Dana R.] Univ Calif Berkeley, Haas Sch Business, Berkeley, CA 94720 USA; [Bennett, Gary G.] Duke Univ, Durham, NC USA; [Bennett, Gary G.] Duke Univ, Duke Global Hlth Initiat, Durham, NC USA; [Williams, David R.] Harvard Univ, Dept Sociol, Cambridge, MA 02138 USA; [Thornhill, Gisele; Freeman, Elmer R.] Ctr Community Hlth Educ Res & Serv, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Research Triangle Institute; University of California System; University of California Berkeley; Duke University; Duke University; Harvard University	Krieger, N (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, 665 Huntington Ave, Boston, MA 02115 USA.	nkrieger@hsph.harvard.edu			National Institutes of Health/National Institute on Aging [1 R01 AG027122-01, R01AG27122-3S1]; NATIONAL INSTITUTE ON AGING [R01AG027122] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was funded by the National Institutes of Health/National Institute on Aging (1 R01 AG027122-01 and R01AG27122-3S1); the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAPOR, 2016, STAND DEF FIN DISP C; Almond D, 2008, WORKING PAPER; Almond DV, 2006, 0704 MIT; American Diabetes Association, 2013, STAND MED CAR DIAB 2; [Anonymous], 2013, CHOLESTECH LDX SYSTE; Banaji MR., 2013, BLIND SPOT HIDDEN BI; Bastos JL, 2010, SOC SCI MED, V70, P1091, DOI 10.1016/j.socscimed.2009.12.020; Batsis JA, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-29; Berry JD, 2012, NEW ENGL J MED, V366, P321, DOI 10.1056/NEJMoa1012848; Borrell LN, 2007, AM J EPIDEMIOL, V166, P1068, DOI 10.1093/aje/kwm180; Borrell LN, 2006, SOC SCI MED, V63, P1415, DOI 10.1016/j.socscimed.2006.04.008; Boston Public Health Commission, 2013, HLTH BOST; Brondolo E, 2003, ANN BEHAV MED, V25, P55, DOI 10.1207/S15324796ABM2501_08; Brondolo E, 2011, AM J HYPERTENS, V24, P518, DOI 10.1038/ajh.2011.9; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Carney DR, 2010, SELF IDENTITY, V9, P162, DOI 10.1080/13594320902847927; Chay KY, 2000, AM ECON REV, V90, P326, DOI 10.1257/aer.90.2.326; Couto PF, 2012, ARQ BRAS CARDIOL, V99, P956, DOI 10.1590/S0066-782X2012005000090; Cuffee YL, 2012, ETHNIC DIS, V22, P422; D'Anna LH, 2010, ETHNIC HEALTH, V15, P121, DOI 10.1080/13557850903490298; Fazio RH, 2003, ANNU REV PSYCHOL, V54, P297, DOI 10.1146/annurev.psych.54.101601.145225; Gee GC, 2012, AM J PUBLIC HEALTH, V102, P967, DOI 10.2105/AJPH.2012.300666; Gidron Y, 2001, J BEHAV MED, V24, P1, DOI 10.1023/A:1005631819744; Harper S, 2011, ANNU REV PUBL HEALTH, V32, P39, DOI 10.1146/annurev-publhealth-031210-101234; HAYS RD, 1989, EDUC PSYCHOL MEAS, V49, P629, DOI 10.1177/001316448904900315; Heerwig JA, 2009, SOCIOL SCI Q, V90, P675; Hernan MA, 2009, AM J EPIDEMIOL, V170, P959, DOI 10.1093/aje/kwp293; Kaplan G, 2008, MAKING AM HLTH SOCIA, P145; Karlamangla AS, 2010, ANN EPIDEMIOL, V20, P617, DOI 10.1016/j.annepidem.2010.05.003; King G, 2001, AM POLIT SCI REV, V95, P49, DOI 10.1017/S0003055401000235; KRIEGER N, 1990, SOC SCI MED, V30, P1273, DOI 10.1016/0277-9536(90)90307-E; Krieger N, 2005, SOC SCI MED, V61, P1576, DOI 10.1016/j.socscimed.2005.03.006; Krieger N, 2005, AM J PUBLIC HEALTH, V95, P312, DOI 10.2105/AJPH.2003.032482; KRIEGER N, 1994, SOC SCI MED, V39, P887, DOI 10.1016/0277-9536(94)90202-X; Krieger N, 1999, INT J HEALTH SERV, V29, P295, DOI 10.2190/M11W-VWXE-KQM9-G97Q; Krieger N, 2001, INT J EPIDEMIOL, V30, P668, DOI 10.1093/ije/30.4.668; Krieger N, AM J PUBLIC HLTH; Krieger N, SOCIAL EPID IN PRESS; Krieger N., 2011, EPIDEMIOLOGY PEOPLES, DOI [DOI 10.1093/ACPROF:OSO/9780195383874.001.0001, DOI 10.1007/s10803-010-0982-2]; Krieger N, 2007, EPIDEMIOLOGY, V18, P658, DOI 10.1097/EDE.0b013e318156bfcd; Krieger N, 2012, AM J PUBLIC HEALTH, V102, P936, DOI 10.2105/AJPH.2011.300544; Krieger N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027636; Krieger N, 2010, AM J PUBLIC HEALTH, V100, P1485, DOI 10.2105/AJPH.2009.159517; Krieger N, 2008, SOC SCI MED, V67, P1970, DOI 10.1016/j.socscimed.2008.09.039; LIEBERSON S, 1992, AM SOCIOL REV, V57, P1, DOI 10.2307/2096141; Link CL, 2009, ETHNIC DIS, V19, P288; Longino H. E., 2013, STUDYING HUMAN BEHAV; Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04; Murray Pauli., 1950, STATES LAWS RACE COL; *NAT CTR HLTH STAT, 2000, 2000 NAT HLTH INT SU; National Association of Community Health Centers, 2011, AM HLTH CTR FACT SHE; National Center for Health Statistics, 2009, NAT HLTH NUTR EX SUR; National Center for Health Statistics, 2012, NAT HLTH NUTR EX SUR; National Center for Health Statistics. Centers for Disease Control and Prevention, 2008, NAT HLTH NUTR EX SUR; National Center forHealth Statistics, 2011, HLTH US 2010 SPEC FE; National Health Lung and Blood Institute National Institutes of Health, 2003, 7 JOINT NAT COMM PRE; Nelson AR, 2002, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Nosek B.A., 2007, AUTOMATIC PROCESSES, P265, DOI DOI 10.1037/0022-3514.89.3.277; Office of Applied Studies Substance Abuse and Mental Health Services Administration, 2001, DEV COMP ASS INT PRO; Ostchega Y, 2012, NATL HLTH STAT REPOR; Pascoe EA, 2009, PSYCHOL BULL, V135, P531, DOI 10.1037/a0016059; Pigeot I, 2007, HDB EPIDEMIOLOGY; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; SAS Institute, 2002, SAS 9 1 3 LANG REF D; Seedat S, 2009, SAMJ S AFR MED J, V99, P375; Sellers R M, 1998, Pers Soc Psychol Rev, V2, P18, DOI 10.1207/s15327957pspr0201_2; Shariff-Marco S, 2011, DU BOIS REV, V8, P159, DOI 10.1017/S1742058X11000129; Sims M, 2012, AM J PUBLIC HEALTH, V102, pS258, DOI 10.2105/AJPH.2011.300523; Sternthal MJ, 2011, DU BOIS REV, V8, P95, DOI 10.1017/S1742058X11000087; The Framingham Heart Study, 2013, RISK SCOR PROF; U.S. Census Bureau, 2013, AM COMM SURV; Walters KL, 2011, DU BOIS REV, V8, P179, DOI 10.1017/S1742058X1100018X; Weiss N, 2012, EXERCISES EPIDEMIOLO; Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0; WILLIAMS DR, 1997, J HLTH PSYCHOL, V0002	75	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77174	10.1371/journal.pone.0077174	http://dx.doi.org/10.1371/journal.pone.0077174			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239MM	24204765	Green Published, Green Submitted, gold			2022-12-27	WOS:000326029300087
J	Dicken, J; Mildner, A; Leshkowitz, D; Touw, IP; Hantisteanu, S; Jung, S; Groner, Y				Dicken, Joseph; Mildner, Alexander; Leshkowitz, Dena; Touw, Ivo P.; Hantisteanu, Shay; Jung, Steffen; Groner, Yoram			Transcriptional Reprogramming of CD11b(+)Esam(hi) Dendritic Cell Identity and Function by Loss of Runx3	PLOS ONE			English	Article							IN-VIVO; SIGNALING CONTROLS; HUMAN GENOME; FACTOR ZDC; EXPRESSION; HOMEOSTASIS; DIFFERENTIATION; MACROPHAGES; PROGENITORS; REGULATOR	Classical dendritic cells (cDC) are specialized antigen-presenting cells mediating immunity and tolerance. cDC cell-lineage decisions are largely controlled by transcriptional factor regulatory cascades. Using an in vivo cell-specific targeting of Runx3 at various stages of DC lineage development we show that Runx3 is required for cell-identity, homeostasis and function of splenic Esam(hi) DC. Ablation of Runx3 in DC progenitors led to a substantial decrease in splenic CD4(+)/CD11b(+) DC. Combined chromatin immunoprecipitation sequencing and gene expression analysis of purified DC-subsets revealed that Runx3 is a key gene expression regulator that facilitates specification and homeostasis of CD11b(+)Esam(hi) DC. Mechanistically, loss of Runx3 alters Esam(hi) DC gene expression to a signature characteristic of WT Esam(low) DC. This transcriptional reprogramming caused a cellular change that diminished phagocytosis and hampered Runx3(-/-) Esam(hi) DC capacity to prime CD4(+) T cells, attesting to the significant role of Runx3 in specifying Esam(hi) DC identity and function.	[Dicken, Joseph; Hantisteanu, Shay; Groner, Yoram] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Mildner, Alexander; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Leshkowitz, Dena] Weizmann Inst Sci, Bioinformat Unit, Israel Natl Ctr Personalized Med, IL-76100 Rehovot, Israel; [Touw, Ivo P.] Erasmus MC, Dept Hematol, Rotterdam, Netherlands	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Erasmus University Rotterdam; Erasmus MC	Groner, Y (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	yoram.groner@weizmann.ac.il	Mildner, Alexander/ABG-6122-2020; mildner, alexander/AFK-2161-2022; Jung, Steffen/K-1409-2012; mildner, alexander/AAF-9451-2022; mildner, alexander/GQA-3761-2022	mildner, alexander/0000-0002-2019-8427; Jung, Steffen/0000-0003-4290-5716; mildner, alexander/0000-0002-2019-8427; mildner, alexander/0000-0002-2019-8427	Israel Science Foundation	Israel Science Foundation(Israel Science Foundation)	This study was supported by grants from Israel Science Foundation individual grants to YG. URL: http://isf.org.il. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bar-On L, 2010, IMMUNOL REV, V234, P76, DOI 10.1111/j.0105-2896.2009.00875.x; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cervantes-Barragan L, 2012, P NATL ACAD SCI USA, V109, P3012, DOI 10.1073/pnas.1117359109; Chen YW, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r11; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Fainaru O, 2004, EMBO J, V23, P969, DOI 10.1038/sj.emboj.7600085; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Fu YX, 2011, J BIOL CHEM, V286, P11803, DOI 10.1074/jbc.M111.222331; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ghosh HS, 2010, IMMUNITY, V33, P905, DOI 10.1016/j.immuni.2010.11.023; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Levanon D, 2011, EMBO MOL MED, V3, P593, DOI 10.1002/emmm.201100168; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Meredith MM, 2012, J EXP MED, V209, P1583, DOI 10.1084/jem.20121003; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Mildner A, 2013, BLOOD, V121, P1016, DOI 10.1182/blood-2012-07-445999; Pencovich N, 2011, BLOOD, V117, pE1, DOI 10.1182/blood-2010-07-295113; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sandve GK, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r121; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Strobl H, 1996, J IMMUNOL, V157, P1499; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Tailor P, 2008, BLOOD, V111, P1942, DOI 10.1182/blood-2007-07-100750; Ulitsky I, 2010, NAT PROTOC, V5, P303, DOI 10.1038/nprot.2009.230; Wolfler A, 2010, BLOOD, V116, P4116, DOI 10.1182/blood-2010-03-275404; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	41	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77490	10.1371/journal.pone.0077490	http://dx.doi.org/10.1371/journal.pone.0077490			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24204843	gold, Green Published, Green Submitted			2022-12-27	WOS:000325894100075
J	Nilsson, SRO; Somerville, EM; Clifton, PG				Nilsson, Simon R. O.; Somerville, Elizabeth M.; Clifton, Peter G.			Dissociable Effects of 5-HT2C Receptor Antagonism and Genetic Inactivation on Perseverance and Learned Non-Reward in an Egocentric Spatial Reversal Task	PLOS ONE			English	Article							SEROTONIN (5-HT)(2C) RECEPTORS; LONG-TERM POTENTIATION; CAUDATE-NUCLEUS; PREFRONTAL CORTEX; DENTATE GYRUS; SCHIZOPHRENIC-PATIENTS; PARKINSONS-DISEASE; LATENT INHIBITION; FRONTAL-CORTEX; IN-VIVO	Cognitive flexibility can be assessed in reversal learning tests, which are sensitive to modulation of 5-HT2C receptor (5-HT2CR) function. Successful performance in these tests depends on at least two dissociable cognitive mechanisms which may separately dissipate associations of previous positive and negative valence. The first is opposed by perseverance and the second by learned non-reward. The current experiments explored the effect of reducing function of the 5-HT2CR on the cognitive mechanisms underlying egocentric reversal learning in the mouse. Experiment 1 used the 5-HT2CR antagonist SB242084 (0.5 mg/kg) in a between-groups serial design and Experiment 2 used 5-HT2CR KO mice in a repeated measures design. Animals initially learned to discriminate between two egocentric turning directions, only one of which was food rewarded (denoted CS+, CS-), in a T- or Y-maze configuration. This was followed by three conditions; (1) Full reversal, where contingencies reversed; (2) Perseverance, where the previous CS+ became CS- and the previous CS- was replaced by a novel CS+; (3) Learned non-reward, where the previous CS- became CS+ and the previous CS+ was replaced by a novel CS-. SB242084 reduced perseverance, observed as a decrease in trials and incorrect responses to criterion, but increased learned non-reward, observed as an increase in trials to criterion. In contrast, 5-HT2CR KO mice showed increased perseverance. 5-HT2CR KO mice also showed retarded egocentric discrimination learning. Neither manipulation of 5-HT2CR function affected performance in the full reversal test. These results are unlikely to be accounted for by increased novelty attraction, as SB242084 failed to affect performance in an unrewarded novelty task. In conclusion, acute 5-HT2CR antagonism and constitutive loss of the 5-HT2CR have opposing effects on perseverance in egocentric reversal learning in mice. It is likely that this difference reflects the broader impact of 5HT(2C)R loss on the development and maintenance of cognitive function.	[Nilsson, Simon R. O.; Clifton, Peter G.] Univ Sussex, Sch Psychol, Brighton, E Sussex, England; [Somerville, Elizabeth M.] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	University of Sussex; University of Sussex	Nilsson, SRO (corresponding author), Univ Sussex, Sch Psychol, Brighton, E Sussex, England.	sn440@cam.ac.uk		Clifton, Pete/0000-0003-1230-133X; Nilsson, Simon/0000-0001-9591-614X	BBSRC; Eli Lilly through CASE studentship [BB/F529054/1]	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Eli Lilly through CASE studentship(Eli Lilly)	Supported by BBSRC and Eli Lilly through CASE studentship (BB/F529054/1). The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Abdallah L, 2009, J NEUROSCI, V29, P8156, DOI 10.1523/JNEUROSCI.3905-08.2009; ARORA RC, 1991, J NEURAL TRANSM-GEN, V85, P19, DOI 10.1007/BF01244654; Baker PM, 2011, BEHAV BRAIN RES, V219, P123, DOI 10.1016/j.bbr.2010.12.031; Barch DM, 2005, ANNU REV CLIN PSYCHO, V1, P321, DOI 10.1146/annurev.clinpsy.1.102803.143959; Bari A, 2010, NEUROPSYCHOPHARMACOL, V35, P1290, DOI 10.1038/npp.2009.233; BLISS TVP, 1983, J PHYSIOL-LONDON, V334, P475, DOI 10.1113/jphysiol.1983.sp014507; Boulougouris V, 2008, NEUROPSYCHOPHARMACOL, V33, P2007, DOI 10.1038/sj.npp.1301584; Boulougouris V, 2010, J NEUROSCI, V30, P930, DOI 10.1523/JNEUROSCI.4312-09.2010; BUTTER CM, 1969, PHYSIOL BEHAV, V4, P163, DOI 10.1016/0031-9384(69)90075-4; Cassaday HJ, 1993, J PSYCHOPHARMACOL, P63, DOI DOI 10.1177/026988119300700110; Castensson A, 2005, AM J MED GENET B, V134B, P84, DOI 10.1002/ajmg.b.30151; Clarke HF, 2007, CEREB CORTEX, V17, P18, DOI 10.1093/cercor/bhj120; Clarke HF, 2011, J NEUROSCI, V31, P4290, DOI 10.1523/JNEUROSCI.5066-10.2011; Clatworthy PL, 2009, J NEUROSCI, V29, P4690, DOI 10.1523/JNEUROSCI.3266-08.2009; Clifton PG, 2003, EUR J NEUROSCI, V17, P185, DOI 10.1046/j.1460-9568.2003.02437.x; COOK D, 1988, BEHAV NEURAL BIOL, V49, P332, DOI 10.1016/S0163-1047(88)90338-X; DAVIS S, 1992, J NEUROSCI, V12, P21; Di Giovanni G, 2000, SYNAPSE, V35, P53, DOI 10.1002/(SICI)1098-2396(200001)35:1<53::AID-SYN7>3.0.CO;2-2; Di Matteo V, 1999, NEUROPHARMACOLOGY, V38, P1195, DOI 10.1016/S0028-3908(99)00047-7; Di Matteo V, 2001, TRENDS PHARMACOL SCI, V22, P503, DOI 10.1016/S0165-6147(00)01812-5; Elliott R, 1998, COGNITIVE NEUROPSYCH, V3, P45, DOI DOI 10.1080/135468098396242; Floresco SB, 2006, NEUROPSYCHOPHARMACOL, V31, P297, DOI 10.1038/sj.npp.1300825; Floresco SB, 2006, J NEUROSCI, V26, P2449, DOI 10.1523/JNEUROSCI.4431-05.2006; Gobert A, 2000, SYNAPSE, V36, P205, DOI 10.1002/(SICI)1098-2396(20000601)36:3<205::AID-SYN5>3.0.CO;2-D; Harvey PD, 1998, AM J PSYCHIAT, V155, P1080, DOI 10.1176/ajp.155.8.1080; JEFFERY KJ, 1993, HIPPOCAMPUS, V3, P133, DOI 10.1002/hipo.450030205; JONES B, 1972, EXP NEUROL, V36, P362, DOI 10.1016/0014-4886(72)90030-1; Kennett GA, 1997, NEUROPHARMACOLOGY, V36, P609, DOI 10.1016/S0028-3908(97)00038-5; Lapiz-Bluhm MDS, 2009, PSYCHOPHARMACOLOGY, V202, P329, DOI 10.1007/s00213-008-1224-6; Leeson VC, 2009, BIOL PSYCHIAT, V66, P586, DOI 10.1016/j.biopsych.2009.05.016; LUBOW RE, 1995, PSYCHOL BULL, V117, P87, DOI 10.1037/0033-2909.117.1.87; Masaki D, 2006, PSYCHOPHARMACOLOGY, V189, P249, DOI 10.1007/s00213-006-0559-0; Millan MJ, 1998, NEUROPHARMACOLOGY, V37, P953, DOI 10.1016/S0028-3908(98)00078-1; MITCHELL JA, 1988, Q J EXP PSYCHOL-B, V40, P243; Ni YG, 1997, P NATL ACAD SCI USA, V94, P2036, DOI 10.1073/pnas.94.5.2036; Nilsson SRO, 2012, PSYCHOPHARMACOLOGY, V224, P241, DOI 10.1007/s00213-012-2746-5; PACKARD MG, 1989, J NEUROSCI, V9, P1465; Packard MG, 1996, NEUROBIOL LEARN MEM, V65, P65, DOI 10.1006/nlme.1996.0007; Palvimaki EP, 1996, PSYCHOPHARMACOLOGY, V126, P234, DOI 10.1007/BF02246453; PARK SB, 1994, NEUROPHARMACOLOGY, V33, P575, DOI 10.1016/0028-3908(94)90089-2; Pennanen L, 2013, NEUROPSYCHOPHARMACOL, V38, P957, DOI 10.1038/npp.2012.258; POTEGAL M, 1969, J COMP PHYSIOL PSYCH, V69, P756, DOI 10.1037/h0028168; Powchik P, 1998, SCHIZOPHRENIA BULL, V24, P325, DOI 10.1093/oxfordjournals.schbul.a033330; Ragozzino ME, 2002, BRAIN RES, V953, P205, DOI 10.1016/S0006-8993(02)03287-0; Roberts AC, 2011, BIOL PSYCHIAT, V69, P1185, DOI 10.1016/j.biopsych.2010.12.037; SANDSON J, 1984, NEUROPSYCHOLOGIA, V22, P715, DOI 10.1016/0028-3932(84)90098-8; Shadach E, 2000, NEUROPSYCHOPHARMACOL, V23, P151, DOI 10.1016/S0893-133X(00)00096-8; Sharp T, 2007, TRENDS PHARMACOL SCI, V28, P629, DOI 10.1016/j.tips.2007.10.009; Slabosz A, 2006, NEUROPSYCHOLOGY, V20, P578, DOI 10.1037/0894-4105.20.5.578; Sodhi MS, 2001, MOL PSYCHIATR, V6, P373, DOI 10.1038/sj.mp.4000920; Swainson R, 2000, NEUROPSYCHOLOGIA, V38, P596, DOI 10.1016/S0028-3932(99)00103-7; Tait DS, 2007, ANN NY ACAD SCI, V1121, P407, DOI 10.1196/annals.1401.010; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Tecott LH, 1998, P NATL ACAD SCI USA, V95, P15026, DOI 10.1073/pnas.95.25.15026; WEINBERGER DR, 1988, ARCH GEN PSYCHIAT, V45, P609; Wieselgren IM, 1998, PSYCHIAT RES, V81, P101, DOI 10.1016/S0165-1781(98)00090-0; Young AMJ, 2005, BEHAV BRAIN RES, V156, P277, DOI 10.1016/j.bbr.2004.05.034	57	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77762	10.1371/journal.pone.0077762	http://dx.doi.org/10.1371/journal.pone.0077762			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204954	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000326334500055
J	Takizawa, N; Fujiwara, T; Yamasaki, M; Saito, A; Fukao, A; Nomoto, A; Mizumoto, K				Takizawa, Naoki; Fujiwara, Toshinobu; Yamasaki, Manabu; Saito, Ayako; Fukao, Akira; Nomoto, Akio; Mizumoto, Kiyohisa			The Essential Role for the RNA Triphosphatase Cet1p in Nuclear Import of the mRNA Capping Enzyme Cet1p-Ceg1p Complex of Saccharomyces cerevisiae	PLOS ONE			English	Article							CARBOXY-TERMINAL DOMAIN; POLYMERASE-II; CAP METHYLTRANSFERASE; FAMILY-MEMBERS; IN-VIVO; YEAST; GUANYLYLTRANSFERASE; METHYLATION; APPARATUS; SUBUNIT	mRNA capping is the first cotranscriptional modification of mRNA in the nucleus. In Saccharomyces cerevisiae, the first two steps of mRNA capping are catalyzed by the RNA triphosphatase Cet1p and the RNA guanylyltransferase Ceg1p. Cet1p and Ceg1p interact to form a mRNA capping enzyme complex and the guanylyltransferase activity of Ceg1p is stimulated by binding with Cet1p. The Cet1p-Ceg1p complex needs to be transported into the nucleus, where mRNA capping occurs. However, the molecular mechanism of nuclear transport of the Cet1p-Ceg1p complex is not known. Here, we show that Cet1p is responsible and that the Cet1p-Ceg1p interaction is essential for the nuclear localization of the Cet1p-Ceg1p complex. The results indicate that the Cet1p-Ceg1p interaction is important not only for the activation of Ceg1p, but also for nuclear import of the complex.	[Takizawa, Naoki; Fujiwara, Toshinobu; Yamasaki, Manabu; Fukao, Akira; Nomoto, Akio] Inst Microbial Chem, Lab Basic Biol, Tokyo 141, Japan; [Saito, Ayako] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol Hlth Sci, Nagoya, Aichi, Japan; [Mizumoto, Kiyohisa] Kitasato Univ, Sch Pharmaceut Sci, Dept Biochem, Tokyo 108, Japan	Nagoya City University; Kitasato University	Takizawa, N (corresponding author), Inst Microbial Chem, Lab Basic Biol, Tokyo 141, Japan.	takizawan@bikaken.or.jp		Takizawa, Naoki/0000-0002-3714-2219	Ministry of Education, Culture, Sports, Science and Technology Japan [23390113]; Grants-in-Aid for Scientific Research [24659139] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research to A.N. (No. 23390113) from the Ministry of Education, Culture, Sports, Science and Technology Japan. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison JD, 1996, SCIENCE, V274, P624, DOI 10.1126/science.274.5287.624; Cho EJ, 1998, GENE DEV, V12, P3482, DOI 10.1101/gad.12.22.3482; Cole MD, 2009, ONCOGENE, V28, P1169, DOI 10.1038/onc.2008.463; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Furuichi Y, 2000, ADV VIRUS RES, V55, P135, DOI 10.1016/S0065-3527(00)55003-9; Ghosh A, 2010, WIRES RNA, V1, P152, DOI 10.1002/wrna.19; Gonatopoulos-Pournatzis T, 2011, MOL CELL, V44, P585, DOI 10.1016/j.molcel.2011.08.041; Gu MG, 2010, STRUCTURE, V18, P216, DOI 10.1016/j.str.2009.12.009; Hausmann S, 2001, J BIOL CHEM, V276, P36116, DOI 10.1074/jbc.M105856200; Ho CK, 1998, J BIOL CHEM, V273, P34151, DOI 10.1074/jbc.273.51.34151; Ho CK, 1999, NUCLEIC ACIDS RES, V27, P4671, DOI 10.1093/nar/27.24.4671; Ho CK, 1998, MOL CELL BIOL, V18, P5189, DOI 10.1128/MCB.18.9.5189; ITOH N, 1987, J BIOL CHEM, V262, P1989; ITOH N, 1984, J BIOL CHEM, V259, P3923; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Lehman K, 2001, J BIOL CHEM, V276, P14996, DOI 10.1074/jbc.M100588200; Lehman K, 1999, J BIOL CHEM, V274, P22668, DOI 10.1074/jbc.274.32.22668; Lima CD, 1999, CELL, V99, P533, DOI 10.1016/S0092-8674(00)81541-X; MAO XD, 1995, MOL CELL BIOL, V15, P4167; McCracken S, 1997, GENE DEV, V11, P3306, DOI 10.1101/gad.11.24.3306; MIZUMOTO K, 1987, PROG NUCLEIC ACID RE, V34, P1, DOI 10.1016/S0079-6603(08)60491-2; Moteki S, 2002, MOL CELL, V10, P599, DOI 10.1016/S1097-2765(02)00660-3; Radomski N, 2002, BBA-MOL CELL RES, V1590, P93, DOI 10.1016/S0167-4889(02)00205-7; Schwer B, 2000, GENETICS, V155, P1561; Seedorf M, 1997, P NATL ACAD SCI USA, V94, P8590, DOI 10.1073/pnas.94.16.8590; Senger B, 1998, EMBO J, V17, P2196, DOI 10.1093/emboj/17.8.2196; SHIBAGAKI Y, 1992, J BIOL CHEM, V267, P9521; Shuman S, 1997, P NATL ACAD SCI USA, V94, P12758, DOI 10.1073/pnas.94.24.12758; SHUMAN S, 1995, PROG NUCLEIC ACID RE, V50, P101, DOI 10.1016/S0079-6603(08)60812-0; Takase Y, 2000, MOL CELL BIOL, V20, P9307, DOI 10.1128/MCB.20.24.9307-9316.2000; Topisirovic I, 2012, WILEY INTERDISCIP RE, V2, P277; Toyn JH, 2000, YEAST, V16, P553, DOI 10.1002/(SICI)1097-0061(200004)16:6<553::AID-YEA554>3.0.CO;2-7; Tsukamoto T, 1998, BIOCHEM BIOPH RES CO, V251, P27, DOI 10.1006/bbrc.1998.9402; Tsukamoto T, 1997, BIOCHEM BIOPH RES CO, V239, P116, DOI 10.1006/bbrc.1997.7439; Varani G, 1997, STRUCTURE, V5, P855, DOI 10.1016/S0969-2126(97)00239-6; Wen YX, 2000, GENE DEV, V14, P2944, DOI 10.1101/gad.848200; Yamada-Okabe T, 1998, NUCLEIC ACIDS RES, V26, P1700, DOI 10.1093/nar/26.7.1700; Yue ZY, 1997, P NATL ACAD SCI USA, V94, P12898, DOI 10.1073/pnas.94.24.12898; Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979	40	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78000	10.1371/journal.pone.0078000	http://dx.doi.org/10.1371/journal.pone.0078000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205062	Green Published, Green Submitted, gold			2022-12-27	WOS:000326334500088
J	Salonen, J; Ronnholm, G; Kalkkinen, N; Vihinen, M				Salonen, Johanna; Ronnholm, Gunilla; Kalkkinen, Nisse; Vihinen, Mauno			Proteomic Changes during B Cell Maturation: 2D-DIGE Approach	PLOS ONE			English	Article							FUNCTIONALLY RELATED PROTEINS; X-LINKED AGAMMAGLOBULINEMIA; ANTIGEN RECEPTOR; PLASMA-CELL; TYROSINE KINASE; GENE-EXPRESSION; MESSENGER-RNA; BURKITT-LYMPHOMA; CROSS-LINKING; LINE	B cells play a pivotal role in adaptive immune system, since they maintain a delicate balance between recognition and clearance of foreign pathogens and tolerance to self. During maturation, B cells progress through a series of developmental stages defined by specific phenotypic surface markers and the rearrangement and expression of immunoglobulin (Ig) genes. To get insight into B cell proteome during the maturation pathway, we studied differential protein expression in eight human cell lines, which cover four distinctive developmental stages; early pre-B, pre-B, plasma cell and immature B cell upon anti-IgM stimulation. Our two-dimensional differential gel electrophoresis (2D-DIGE) and mass spectrometry based proteomic study indicates the involvement of large number of proteins with various functions. Notably, proteins related to cytoskeleton were relatively highly expressed in early pre-B and pre-B cells, whereas plasma cell proteome contained endoplasmic reticulum and Golgi system proteins. Our long time series analysis in anti-IgM stimulated Ramos B cells revealed the dynamic regulation of cytoskeleton organization, gene expression and metabolic pathways, among others. The findings are related to cellular processes in B cells and are discussed in relation to experimental information for the proteins and pathways they are involved in. Representative 2D-DIGE maps of different B cell maturation stages are available online at http://structure.bmc.lu.se/BcellProteome/.	[Salonen, Johanna; Vihinen, Mauno] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland; [Salonen, Johanna; Vihinen, Mauno] BioMediTech, Tampere, Finland; [Salonen, Johanna; Vihinen, Mauno] Tampere Univ Hosp, Res Unit, Tampere, Finland; [Ronnholm, Gunilla; Kalkkinen, Nisse] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Vihinen, Mauno] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Tampere University; Tampere University; Tampere University Hospital; University of Helsinki; Lund University	Vihinen, M (corresponding author), Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland.	mauno.vihinen@med.lu.se	Vihinen, Mauno/A-8452-2012	Vihinen, Mauno/0000-0002-9614-7976; Salonen, Johanna/0000-0002-1039-3392	Medical Research Fund of Tampere University Hospital; Magnus Ehrnrooth foundation; Orion-Farmos research foundation; Finnish Cultural Fund; Sigrid Juselius foundation; University of Tampere; BioMediTech Finland	Medical Research Fund of Tampere University Hospital; Magnus Ehrnrooth foundation; Orion-Farmos research foundation; Finnish Cultural Fund(Finnish Cultural Foundation); Sigrid Juselius foundation(Sigrid Juselius Foundation); University of Tampere; BioMediTech Finland	Funding provided by Medical Research Fund of Tampere University Hospital, Magnus Ehrnrooth foundation, Orion-Farmos research foundation, Finnish Cultural Fund, Sigrid Juselius foundation, University of Tampere and BioMediTech Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ballow M, 2002, J ALLERGY CLIN IMMUN, V109, P581, DOI 10.1067/mai.2002.122466; BENJAMIN D, 1982, J IMMUNOL, V129, P1336; Bertolotti M, 2010, ANTIOXID REDOX SIGN, V13, P1133, DOI 10.1089/ars.2009.3079; Besnault L, 2001, J IMMUNOL, V167, P733, DOI 10.4049/jimmunol.167.2.733; Blom B, 2012, BONE MARROW LYMPHOID, P1; Bohnenberger H, 2011, EUR J IMMUNOL, V41, P1550, DOI 10.1002/eji.201041326; CAMBIER JC, 1984, J IMMUNOL, V133, P576; Cernuda-Morollon E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012393; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Conley ME, 2009, ANNU REV IMMUNOL, V27, P199, DOI 10.1146/annurev.immunol.021908.132649; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; Daniel PT, 1997, EUR J IMMUNOL, V27, P1029, DOI 10.1002/eji.1830270433; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FINDLEY HW, 1982, BLOOD, V60, P1305; Fischer A, 2004, NAT IMMUNOL, V5, P23, DOI 10.1038/ni1023; Fukata Y, 1999, BIOPHYS CHEM, V82, P139, DOI 10.1016/S0301-4622(99)00113-1; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Guo X, 2011, P NATL ACAD SCI USA, V108, P18649, DOI 10.1073/pnas.1113170108; Gupta N, 2006, NAT IMMUNOL, V7, P625, DOI 10.1038/ni1337; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hardy RR, 2007, IMMUNITY, V26, P703, DOI 10.1016/j.immuni.2007.05.013; Harwood NE, 2010, COLD SPRING HARB PER, V3; Hoffmann R, 2003, CURR OPIN IMMUNOL, V15, P239, DOI 10.1016/S0952-7915(03)00047-5; HURWITZ R, 1979, INT J CANCER, V23, P174, DOI 10.1002/ijc.2910230206; Iritani BM, 1997, EMBO J, V16, P7019, DOI 10.1093/emboj/16.23.7019; Jeon HK, 2005, IMMUNOL LETT, V98, P303, DOI 10.1016/j.imlet.2004.12.005; Jin SH, 2003, PROTEOMICS, V3, P2428, DOI 10.1002/pmic.200300576; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Karp NA, 2005, PROTEOMICS, V5, P81, DOI 10.1002/pmic.200400881; KLEIN G, 1975, INTERVIROLOGY, V5, P319, DOI 10.1159/000149930; Korte J, 2013, PROTEOMICS, V13, P119, DOI 10.1002/pmic.201200177; Laurent J, 2006, FREE RADICAL BIO MED, V40, P1971, DOI 10.1016/j.freeradbiomed.2006.01.029; Lee KH, 2000, EUR J IMMUNOL, V30, P892, DOI 10.1002/1521-4141(200003)30:3<892::AID-IMMU892>3.0.CO;2-U; LILIENBAUM A, 1986, EMBO J, V5, P2809, DOI 10.1002/j.1460-2075.1986.tb04572.x; MADSEN PS, 1995, BLOOD, V85, P510; Marmorstein R, 2001, CURR OPIN GENET DEV, V11, P155, DOI 10.1016/S0959-437X(00)00173-8; Martin A, 2003, J EXP MED, V198, P1171, DOI 10.1084/jem.20030880; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; MINOWADA J, 1979, LEUKEMIA RES, V3, P261, DOI 10.1016/0145-2126(79)90050-X; Mongini PKA, 1998, BLOOD, V92, P3756, DOI 10.1182/blood.V92.10.3756.422k42_3756_3771; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; Nilsson J, 2004, IMMUNOL LETT, V94, P83, DOI 10.1016/j.imlet.2004.04.004; NILSSON K, 1970, CLIN EXP IMMUNOL, V7, P477; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; Notarangelo Luigi D, 2003, Rev Clin Exp Hematol, V7, P84; Ogata H., 1999, NUCLEIC ACIDS RES, V27, P29, DOI DOI 10.1093/nar/27.1.29; Ollila J, 2003, GENES IMMUN, V4, P343, DOI 10.1038/sj.gene.6363974; Ollila J, 2002, VITAM HORM, V64, P77, DOI 10.1016/S0083-6729(02)64003-8; Ollila J, 1998, BIOCHEM BIOPH RES CO, V249, P475, DOI 10.1006/bbrc.1998.9176; Ollila J, 2007, MOL IMMUNOL, V44, P3537, DOI 10.1016/j.molimm.2007.03.009; Paris LL, 2010, J BIOL CHEM, V285, P39844, DOI 10.1074/jbc.M110.164509; PEGORARO L, 1984, P NATL ACAD SCI-BIOL, V81, P7166, DOI 10.1073/pnas.81.22.7166; Perrot A, 2011, BLOOD, V118, pE1, DOI 10.1182/blood-2011-02-335125; Piirila H, 2006, HUM MUTAT, V27, P1200, DOI 10.1002/humu.20405; Raaphorst FM, 2001, TRENDS IMMUNOL, V22, P682, DOI 10.1016/S1471-4906(01)02082-8; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Radaev S, 2010, STRUCTURE, V18, P934, DOI 10.1016/j.str.2010.04.019; RAMBOTTI MG, 1993, CELL MOL BIOL RES, V39, P579; Romijn EP, 2005, MOL CELL PROTEOMICS, V4, P1297, DOI 10.1074/mcp.M500123-MCP200; ROSENFELD C, 1977, NATURE, V267, P841, DOI 10.1038/267841a0; RUSH JS, 1991, ARCH BIOCHEM BIOPHYS, V284, P63, DOI 10.1016/0003-9861(91)90264-J; Salonen JM, 2006, PROTEOMICS, V6, P5152, DOI 10.1002/pmic.200600156; SAMSTAG Y, 1994, P NATL ACAD SCI USA, V91, P4494, DOI 10.1073/pnas.91.10.4494; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Shaw AC, 1999, P NATL ACAD SCI USA, V96, P2239, DOI 10.1073/pnas.96.5.2239; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SIECKMANN DG, 1980, IMMUNOL REV, V52, P181, DOI 10.1111/j.1600-065X.1980.tb00335.x; Speck O, 2003, NATURE, V421, P83, DOI 10.1038/nature01295; STONG RC, 1985, BLOOD, V65, P21, DOI 10.1182/blood.V65.1.21.21; TERASHIMA M, 1994, EMBO J, V13, P3782, DOI 10.1002/j.1460-2075.1994.tb06689.x; Toledano BJ, 1997, J IMMUNOL, V158, P3705; Tsai CM, 2008, J IMMUNOL, V181, P4570, DOI 10.4049/jimmunol.181.7.4570; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; Vettermann C, 2011, PROTEOMICS, V11, P1228, DOI 10.1002/pmic.201000491; Wabnitz GH, 2007, EUR J IMMUNOL, V37, P649, DOI 10.1002/eji.200636320; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wang JS, 2006, CELL MOL IMMUNOL, V3, P255; Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6; Yoshida T, 2000, INT IMMUNOL, V12, P517, DOI 10.1093/intimm/12.4.517; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang DH, 2007, INT J ONCOL, V31, P577	89	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77894	10.1371/journal.pone.0077894	http://dx.doi.org/10.1371/journal.pone.0077894			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205016	Green Published, gold, Green Submitted			2022-12-27	WOS:000326270700059
J	Zaza, G; Granata, S; Masola, V; Rugiu, C; Fantin, F; Gesualdo, L; Schena, FP; Lupo, A				Zaza, Gianluigi; Granata, Simona; Masola, Valentina; Rugiu, Carlo; Fantin, Francesco; Gesualdo, Loreto; Schena, Francesco Paolo; Lupo, Antonio			Downregulation of Nuclear-Encoded Genes of Oxidative Metabolism in Dialyzed Chronic Kidney Disease Patients	PLOS ONE			English	Article							PERITONEAL-DIALYSIS FLUIDS; MITOCHONDRIA; STRESS; DYSREGULATION; BIOSYNTHESIS; COACTIVATORS; ACTIVATION; MECHANISMS; HEALTH	Background: Mitochondria, essential eukaryotic cells organelles defined as the "powerhouse of the cell" because of their ability to produce the vast majority of energy necessary for cellular metabolism, may have a primary role in the oxidative stress-related intracellular machinery associated to chronic kidney disease (CKD). Methods: To better assess this research assumption, we decided to study the key factors regulating mitochondrial oxidative metabolism in CKD patients in peritoneal dialysis (PD, n = 15) using several bio-molecular methodologies. Results: RT-PCR experiments demonstrate that the expression level of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) and nuclear respiratory factor-1 (NRF-1), two genes primarily involved in mitochondrial biogenesis and functions, were significantly hypo-expressed in peripheral blood mononuclear cells of PD patients compared to healthy subjects (HS, n = 15). Additionally, mRNA levels of several PGC1-alpha downstream target genes (TFAM, COX6C, COX7C, UQCRH and MCAD) were profoundly down-regulated in PD cells. TFAM protein analysis confirmed gene-expression results. High plasmatic concentration of Malondialdehyde found in PD patients, confirmed the contribution of the oxidative stress to these biological effects. Finally, Nuclear factor erythroid-derived 2-like 2 (NRF2 or NFE2L2), a transcription factor for numerous antioxidant/detoxifying enzymes and one of its target genes, superoxide dismutase-2 mitochondrial (SOD2) were up-regulated in PD compared to HS. Conclusions: Our results revealed, for the first time, that CKD-PD patients' PBMC, through a complex intracellular biochemical machinery, are able to modulate their mitochondrial functions probably in the attempt to reduce oxidative metabolic damage and to turn on a valuable defense cellular strategy against oxidative stress.	[Zaza, Gianluigi; Granata, Simona; Masola, Valentina; Rugiu, Carlo; Lupo, Antonio] Univ Hosp Verona, Dept Med, Renal Unit, Verona, Italy; [Fantin, Francesco] Univ Hosp Verona, Sect Geriatr, Dept Med, Verona, Italy; [Gesualdo, Loreto; Schena, Francesco Paolo] Univ Bari, Dept Emergency & Transplantat, Renal Dialysis & Transplant Unit, Bari, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; Universita degli Studi di Bari Aldo Moro	Zaza, G (corresponding author), Univ Hosp Verona, Dept Med, Renal Unit, Verona, Italy.	gianluigi.zaza@univr.it	Schena, Francesco P/K-6982-2016; Zaza, Gianluigi/K-3827-2018; Gesualdo, Loreto/K-7751-2016; granata, simona/K-4148-2016	Schena, Francesco P/0000-0001-7927-5207; Gesualdo, Loreto/0000-0002-4861-0911; /0000-0003-1763-6024; granata, simona/0000-0002-3740-7598; Masola, Valentina/0000-0003-2341-2481; Zaza, Gianluigi/0000-0002-6004-6196	Ministero dell' Universita e della Ricerca Scientifica (PRIN)	Ministero dell' Universita e della Ricerca Scientifica (PRIN)(Ministry of Education, Universities and Research (MIUR))	This study was supported by Ministero dell' Universita e della Ricerca Scientifica (PRIN 2003 granted to G. Pertosa, L. Gesualdo and G. Grandaliano and PRIN 2005 granted to G. Pertosa and L. Gesualdo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005; Almeida S, 2010, NEUROTOX RES, V17, P399, DOI 10.1007/s12640-009-9116-z; Arnoult D, 2011, EMBO REP, V12, P901, DOI 10.1038/embor.2011.157; Bazanelli AP, 2006, PERITON DIALYSIS INT, V26, P697; Beinert H., 1963, ENZYMES, P447; Blake PG, 2001, NEPHROL DIAL TRANSPL, V16, P61, DOI 10.1093/ndt/16.suppl_5.61; BREBOROWICZ A, 1992, PERITON DIALYSIS INT, V12, P194; Catalan MPE, 2005, KIDNEY INT, V68, P1303; Chatterjee A, 2011, CANCER PREV RES, V4, P638, DOI 10.1158/1940-6207.CAPR-10-0326; Davies SJ, 2001, PERITON DIALYSIS INT, V21, pS269; Dou L, 2007, J THROMB HAEMOST, V5, P1302, DOI 10.1111/j.1538-7836.2007.02540.x; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Granata S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-388; Green DR, 1998, CELL, V94, P695, DOI 10.1016/S0092-8674(00)81728-6; Gyorgy H, 2006, CELL CALCIUM, V40, P553, DOI 10.1016/j.ceca.2006.08.016; Hall AM, 2007, NEPHRON PHYSIOL, V105, P1, DOI 10.1159/000096860; Kalantar-Zadeh K, 2001, AM J KIDNEY DIS, V38, P1343, DOI 10.1053/ajkd.2001.29250; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kim KW, 2012, ENVIRON GEOCHEM HLTH, V34, P1, DOI 10.1007/s10653-011-9402-6; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; McDonald SP, 2009, J AM SOC NEPHROL, V20, P155, DOI 10.1681/ASN.2007111188; Meyer TW, 2007, NEW ENGL J MED, V357, P1316, DOI 10.1056/NEJMra071313; Michel H, 1999, BIOCHEMISTRY-US, V38, P15129, DOI 10.1021/bi9910934; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; Mortier S, 2003, J AM SOC NEPHROL, V14, P1296, DOI 10.1097/01.ASN.0000060681.91079.30; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Noh H, 2006, KIDNEY INT, V69, P2022, DOI 10.1038/sj.ki.5001506; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; Robinson BH, 1998, J INHERIT METAB DIS, V21, P598, DOI 10.1023/A:1005427323835; Rossier MF, 2006, CELL CALCIUM, V40, P155, DOI 10.1016/j.ceca.2006.04.020; Scarpulla RC, 2002, GENE, V286, P81, DOI 10.1016/S0378-1119(01)00809-5; Schepers E, 2007, NEPHROL DIAL TRANSPL, V22, P592, DOI 10.1093/ndt/gfl584; Serviddio G, 2011, CURR PHARM DESIGN, V17, P2036, DOI 10.2174/138161211796904740; Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015; Tam P, 2009, PERITON DIALYSIS INT, V29, pS108; Tarng DC, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000013301.11876.7E; Theofilou Paraskevi, 2011, J Clin Med Res, V3, P132, DOI 10.4021/jocmr552w; TOPLEY N, 1991, NEPHROL DIAL TRANSPL, V6, P574, DOI 10.1093/ndt/6.8.574; Van Biesen W, 2007, NEPHROL DIAL TRANSPL, V22, P53, DOI 10.1093/ndt/gfl601; Widlansky ME, 2011, ANTIOXID REDOX SIGN, V15, P1517, DOI 10.1089/ars.2010.3642; WITOWSKI J, 1995, KIDNEY INT, V47, P282, DOI 10.1038/ki.1995.36; Yagi K, 1998, Methods Mol Biol, V108, P101; Zaza G, 2008, NEPHROL DIAL TRANSPL, V23, P1673, DOI 10.1093/ndt/gfm804	46	50	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77847	10.1371/journal.pone.0077847	http://dx.doi.org/10.1371/journal.pone.0077847			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204994	Green Submitted, gold, Green Published			2022-12-27	WOS:000326241200046
J	Nakanishi, W; Yamaguchi, S; Matsuda, A; Suzukawa, M; Shibui, A; Nambu, A; Kondo, K; Suto, H; Saito, H; Matsumoto, K; Yamasoba, T; Nakae, S				Nakanishi, Wakako; Yamaguchi, Sachiko; Matsuda, Akira; Suzukawa, Maho; Shibui, Akiko; Nambu, Aya; Kondo, Kenji; Suto, Hajime; Saito, Hirohisa; Matsumoto, Kenji; Yamasoba, Tatuya; Nakae, Susumu			IL-33, but Not IL-25, Is Crucial for the Development of House Dust Mite Antigen-Induced Allergic Rhinitis	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; AIRWAY INFLAMMATION; TSLP; INTERLEUKIN-33; EXPRESSION; RESPONSES; EXPOSURE; INNATE; ASTHMA; MODEL	Both interleukin (IL)-33 and IL-25 induce Th2 cytokine production by various cell types, suggesting that they contribute to development of allergic disorders. However, the precise roles of IL-33 and IL-25 in house dust mite (HDM)-induced allergic rhinitis (AR) remain unclear. Both IL-33 and IL-25 were produced mainly by nasal epithelial cells during HDM-induced AR. Eosinophil and goblet cell counts in the nose and IL-5 levels in lymph node cell culture supernatants were significantly decreased in IL-33-deficient, but not IL-25-deficient, mice compared with wild-type mice during HDM-induced AR, but the serum IgE and IgG1 levels did not differ. On the other hand, HDM-induced AR developed similarly in wild-type mice transferred with either IL-33-deficient BM cells or wild-type BM cells. IL-33, but not IL-25, produced by nasal epithelial cells was crucial for the development of murine HDM-induced AR. These observations suggest that IL-33 neutralization may be a potential approach for treatment of HDM-induced AR in humans.	[Nakanishi, Wakako; Kondo, Kenji; Yamasoba, Tatuya] Univ Tokyo, Dept Otolaryngol Head & Neck Surg, Tokyo, Japan; [Yamaguchi, Sachiko; Shibui, Akiko; Nambu, Aya; Nakae, Susumu] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Lab Syst Biol, Tokyo, Japan; [Matsuda, Akira] Juntendo Univ, Sch Med, Dept Ophthalmol, Tokyo 113, Japan; [Suto, Hajime] Juntendo Univ, Sch Med, Atopy Allergy Res Ctr, Tokyo 113, Japan; [Suzukawa, Maho] Teikyo Univ, Sch Med, Dept Med, Div Resp Med & Allergol, Tokyo 173, Japan; [Suzukawa, Maho] Natl Hosp Org, Tokyo Hosp, Tokyo, Japan; [Saito, Hirohisa; Matsumoto, Kenji] Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Tokyo, Japan; [Nakae, Susumu] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama, Japan	University of Tokyo; University of Tokyo; Juntendo University; Juntendo University; Teikyo University; National Center for Child Health & Development - Japan; Japan Science & Technology Agency (JST)	Nakae, S (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Lab Syst Biol, Tokyo, Japan.	snakae@ims.u-tokyo.ac.jp	Matsuda, Akira/A-9981-2010	Matsuda, Akira/0000-0002-0792-3663; Nambu, Aya/0000-0002-2797-6420; Shibui, Akiko/0000-0002-0428-5336; Suzukawa, Maho/0000-0002-2265-1950; Saito, Hirohisa/0000-0002-6630-8337	Global COE Program; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Ministry of Health, Labour and Welfare, Japan; Grant of National Center for Child Health and Development [23A-5]; Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [23390262] Funding Source: KAKEN	Global COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Grant of National Center for Child Health and Development; Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Global COE Program, "Center of Education and Research for Advanced Genome-Based Medicine-For Personalized medicine and the control of worldwide infectious disease," from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (WN), Grants-in-Aid for Young Scientists (A), MEXT (SN), Health Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare, Japan (HS and KM), The Grant of National Center for Child Health and Development (23A-5) (KM), and Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency (SN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shami A, 2005, J EXP MED, V202, P829, DOI 10.1084/jem.20050199; Ballantyne SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1324, DOI 10.1016/j.jaci.2007.07.051; Chu DK, 2013, J ALLERGY CLIN IMMUN, V131, P187, DOI 10.1016/j.jaci.2012.08.002; Ciprandi G, 2008, OTOLARYNG HEAD NECK, V138, P725, DOI 10.1016/j.otohns.2008.03.027; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Gregory LG, 2013, THORAX, V68, P82, DOI 10.1136/thoraxjnl-2012-202003; Haenuki Y, 2012, J ALLERGY CLIN IMMUN, V130, P184, DOI 10.1016/j.jaci.2012.02.013; Ishii Akina, 2010, Allergology International, V59, P399, DOI 10.2332/allergolint.10-OA-0218; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Kim YH, 2012, ALLERGY, V67, P183, DOI 10.1111/j.1398-9995.2011.02735.x; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Miyata M, 2008, EUR J IMMUNOL, V38, P1487, DOI 10.1002/eji.200737809; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Oboki Keisuke, 2010, Allergology International, V59, P143, DOI 10.2332/allergolint.10-RAI-0186; Ogita-Nakanishi Hiromi, 2009, Allergology International, V58, P171, DOI 10.2332/allergolint.08-OA-0021; Ohno T, 2012, ALLERGY, V67, P1203, DOI 10.1111/all.12004; Omori-Miyake M, 2012, ALLERGOL INT, V61, P27, DOI 10.2332/allergolint.11-RAI-0374; Phipps S, 2009, AM J RESP CRIT CARE, V179, P883, DOI 10.1164/rccm.200806-974OC; Reynolds JM, 2010, CYTOKINE GROWTH F R, V21, P413, DOI 10.1016/j.cytogfr.2010.10.002; Rydell-Tormanen K, 2008, AM J RESP CELL MOL, V39, P61, DOI 10.1165/rcmb.2007-0441OC; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Sakashita M, 2008, CLIN EXP ALLERGY, V38, P1875, DOI 10.1111/j.1365-2222.2008.03114.x; Seshasayee D, 2007, J CLIN INVEST, V117, P3868, DOI 10.1172/JCI33559; Shaaban R, 2008, LANCET, V372, P1049, DOI 10.1016/S0140-6736(08)61446-4; Skoner DR, 2001, J ALLERGY CLIN IMMUN, V108, pS2, DOI 10.1067/mai.2001.115569; Suzukawa M, 2012, J IMMUNOL, V189, P3641, DOI 10.4049/jimmunol.1200461; Swirski FK, 2002, J IMMUNOL, V169, P3499, DOI 10.4049/jimmunol.169.7.3499; Tamachi T, 2006, J ALLERGY CLIN IMMUN, V118, P606, DOI 10.1016/j.jaci.2006.04.051; van Cauwenberge P, 2000, ALLERGY, V55, P116, DOI 10.1034/j.1398-9995.2000.00526.x; Weckmann M, 2007, NAT MED, V13, P1308, DOI 10.1038/nm1660; Zhao CQ, 2010, ALLERGY, V65, P986, DOI 10.1111/j.1398-9995.2009.02295.x; Ziegler SF, 2010, CURR OPIN IMMUNOL, V22, P795, DOI 10.1016/j.coi.2010.10.020	33	42	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78099	10.1371/journal.pone.0078099	http://dx.doi.org/10.1371/journal.pone.0078099			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205109	gold, Green Submitted, Green Published			2022-12-27	WOS:000326155400071
J	Kostrzewa, E; van Elburg, AA; Sanders, N; Sternheim, L; Adan, RAH; Kas, MJH				Kostrzewa, Elzbieta; van Elburg, Annemarie A.; Sanders, Nicole; Sternheim, Lot; Adan, Roger A. H.; Kas, Martien J. H.			Longitudinal Changes in the Physical Activity of Adolescents with Anorexia Nervosa and Their Influence on Body Composition and Leptin Serum Levels after Recovery	PLOS ONE			English	Article							WEIGHT-GAIN; FAT DISTRIBUTION; EXCESSIVE EXERCISE; HYPERACTIVITY; WOMEN; GHRELIN; REDISTRIBUTION; GONADOTROPIN; UNDERWEIGHT; BALANCE	Objective: Patients with anorexia nervosa (AN) are often observed to have high levels of physical activity, which do not necessarily diminish after a successful therapy. Previous studies have shown that body fat tissue recovery in these patients is associated with a disproportional restoration of the adipocyte hormone, leptin. Therefore, we wondered whether the individual variation in physical activity in AN patients prior to treatment may be related to body fat percentage and plasma leptin level outcome. Method: Body fat percentage, leptin serum, and physical activity levels (accelerometer) were measured in adolescents with an (n=37, age 13 to 17.5 years) at initial assessment, at the end of study participation (median 12 months), and at one-year follow-up. Results: Accelerometer data were used to split the patients in two groups: those with low (n=26) and those with high levels of physical activity (HLPA, n=11). These groups did not differ in terms of age, IQ, presence of menses, BMI and season of admission. The HLPA group was characterized by a longer total duration of illness. Physical activity levels during therapy decreased for the group with initially HLPA and increased for the group with low levels of physical activity (to comparable levels). Physical activity remained stable after one year. The increase in body fat percentage and leptin levels were dependent on the recovery status; however, recovered patients with initially HLPA had significantly higher fat mass during the follow-up. Discussion: HLPA, an important modulator of AN progression in adolescents, can be successfully diminished by therapeutic intervention. Among recovered patients, those with initially HLPA had higher fat mass levels than those with low levels of physical activity. This finding suggests that HLPA are an important modulator of the body composition recovery mechanism.	[Kostrzewa, Elzbieta; Adan, Roger A. H.; Kas, Martien J. H.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Translat Neurosci, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [van Elburg, Annemarie A.; Sanders, Nicole; Sternheim, Lot] Altrecht Mental Hlth Inst, Rintveld Ctr Eating Disorders, Zeist, Netherlands	Utrecht University; Utrecht University Medical Center	Kas, MJH (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Dept Translat Neurosci, Brain Ctr Rudolf Magnus, Utrecht, Netherlands.	m.j.h.kas@umcutrecht.nl	Kas, Martien J./G-8269-2018; Kostrzewa, Elzbieta/K-1698-2015; Zamora, Cristina Cuesta/E-2864-2016	Kas, Martien J./0000-0002-4471-8618; Kostrzewa, Elzbieta/0000-0001-5304-0143; Zamora, Cristina Cuesta/0000-0003-1121-9561	ZonMW VIDI-grant from The Netherlands Organization for Scientific Research (NOW) [91786327]	ZonMW VIDI-grant from The Netherlands Organization for Scientific Research (NOW)	These studies were supported by a ZonMW VIDI-grant (91786327) from The Netherlands Organization for Scientific Research (NOW; http://www.nwo.nl/) to Dr. Martien Kas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti M, 2013, MED SCI SPORT EXER, V45, P1643, DOI 10.1249/MSS.0b013e31828e8f07; BEUMONT PJV, 1994, INT J EAT DISORDER, V15, P21, DOI 10.1002/1098-108X(199401)15:1&lt;21::AID-EAT2260150104&gt;3.0.CO;2-K; Bratland-Sanda S, 2010, INT J EAT DISORDER, V43, P88, DOI 10.1002/eat.20753; Carrera O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041851; Carter JC, 2004, PSYCHOL MED, V34, P671, DOI 10.1017/S0033291703001168; Casper RC, 1996, J YOUTH ADOLESCENCE, V25, P499, DOI 10.1007/BF01537545; DAVIS C, 1993, J BEHAV MED, V16, P611, DOI 10.1007/BF00844722; Davis C, 1995, J PSYCHOSOM RES, V39, P967, DOI 10.1016/0022-3999(95)00064-X; DAVIS C, 1994, PSYCHOL MED, V24, P957, DOI 10.1017/S0033291700029044; Djurovic M, 2004, J ENDOCRINOL INVEST, V27, P523, DOI 10.1007/BF03347473; Epling WF, 1992, SOLVING ANOREXIA PUZ; Exner C, 2000, MOL PSYCHIATR, V5, P476, DOI 10.1038/sj.mp.4000771; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Gelegen C, 2007, EUR NEUROPSYCHOPHARM, V17, P199, DOI 10.1016/j.euroneuro.2006.04.007; Grinspoon S, 2001, AM J CLIN NUTR, V73, P865; Gull WW, 1997, OBES RES, V5, P498, DOI 10.1002/j.1550-8528.1997.tb00677.x; Hebebrand J, 2007, MOL PSYCHIATR, V12, P23, DOI 10.1038/sj.mp.4001909; Hebebrand J, 2003, PHYSIOL BEHAV, V79, P25, DOI 10.1016/S0031-9384(03)00102-1; Hebebrand J, 1997, MOL PSYCHIATR, V2, P330, DOI 10.1038/sj.mp.4000282; Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568; Hillebrand JJG, 2005, BIOL PSYCHIAT, V58, P165, DOI 10.1016/j.biopsych.2005.03.011; Holtkamp K, 2004, INT J EAT DISORDER, V36, P163, DOI 10.1002/eat.20035; Holtkamp K, 2004, PSYCHONEUROENDOCRINO, V29, P791, DOI 10.1016/S0306-4530(03)00143-4; Holtkamp K, 2003, J CLIN ENDOCR METAB, V88, P5169, DOI 10.1210/jc.2003-030569; Holtkamp K, 2003, J PSYCHIATR RES, V37, P165, DOI 10.1016/S0022-3956(02)00100-0; Hubbard ST, 1998, EUR EAT DISORD REV, V6, P255, DOI 10.1002/(SICI)1099-0968(199812)6:4<255::AID-ERV262>3.0.CO;2-G; Hwa JJ, 1997, AM J PHYSIOL-REG I, V272, pR1204, DOI 10.1152/ajpregu.1997.272.4.R1204; Iketani T, 1999, INT J EAT DISORDER, V26, P275, DOI 10.1002/(SICI)1098-108X(199911)26:3&lt;275::AID-EAT4&gt;3.0.CO;2-I; Inoko K, 2005, PEDIATR INT, V47, P326, DOI 10.1111/j.1442-200x.2005.02072.x; Inui A, 2001, NAT REV NEUROSCI, V2, P551, DOI 10.1038/35086018; Kopp W, 1997, MOL PSYCHIATR, V2, P335, DOI 10.1038/sj.mp.4000287; KRON L, 1978, COMPR PSYCHIAT, V19, P433, DOI 10.1016/0010-440X(78)90072-X; Lee S, 2003, AM J PSYCHIAT, V160, P967, DOI 10.1176/appi.ajp.160.5.967; Malendowicz LK, 2007, INT REV CYTOL, V263, P63, DOI 10.1016/S0074-7696(07)63002-2; Mathiak K, 1999, HORM METAB RES, V31, P274, DOI 10.1055/s-2007-978732; Mayer L, 2005, AM J CLIN NUTR, V81, P1286; Mayer LES, 2009, AM J CLIN NUTR, V90, P1132, DOI 10.3945/ajcn.2009.27820; MAYOSMITH W, 1989, RADIOLOGY, V170, P515, DOI 10.1148/radiology.170.2.2911678; Mond JM, 2006, INT J EAT DISORDER, V39, P147, DOI 10.1002/eat.20214; Orphanidou CI, 1997, AM J CLIN NUTR, V65, P1034, DOI 10.1093/ajcn/65.4.1034; Otto B, 2001, Eur J Endocrinol, V145, P669; Pearce JMS, 2004, EUR NEUROL, V52, P191, DOI 10.1159/000082033; Popovic V, 2004, J CLIN ENDOCR METAB, V89, P1838, DOI 10.1210/jc.2003-031326; Probst M., 2010, OPEN COMPLEMENT MED, V2, P105, DOI [DOI 10.2174/1876391X010020010105, 10.2174/1876391X010020010105]; Puyau MR, 2002, OBES RES, V10, P150, DOI 10.1038/oby.2002.24; Scarpace PJ, 1997, AM J PHYSIOL-ENDOC M, V273, pE226, DOI 10.1152/ajpendo.1997.273.1.E226; Shroff H, 2006, INT J EAT DISORDER, V39, P454, DOI 10.1002/eat.20247; Soriano-Guillen L, 2004, J PEDIATR-US, V144, P36, DOI 10.1016/j.jpeds.2003.10.036; Strober M, 1997, INT J EAT DISORDER, V22, P339, DOI 10.1002/(SICI)1098-108X(199712)22:4&lt;339::AID-EAT1&gt;3.0.CO;2-N; Thome Jennifer L, 2007, Eat Behav, V8, P334, DOI 10.1016/j.eatbeh.2006.11.009; Tolle V, 2003, J CLIN ENDOCR METAB, V88, P109, DOI 10.1210/jc.2002-020645; van Dijk G, 2001, J NEUROENDOCRINOL, V13, P913, DOI 10.1046/j.1365-2826.2001.00707.x; van Elburg AA, 2007, J NEURAL TRANSM, V114, P1233, DOI 10.1007/s00702-007-0740-6; Verhagen LAW, 2011, EUR NEUROPSYCHOPHARM, V21, P274, DOI 10.1016/j.euroneuro.2010.11.006; Verhagen LAW, 2009, EUR NEUROPSYCHOPHARM, V19, P153, DOI 10.1016/j.euroneuro.2008.09.005; vonPrittwitz S, 1997, MOL PSYCHIATR, V2, P420, DOI 10.1038/sj.mp.4000300; Wabitsch M, 2001, J CLIN ENDOCR METAB, V86, P2982, DOI 10.1210/jc.86.7.2982	57	30	30	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78251	10.1371/journal.pone.0078251	http://dx.doi.org/10.1371/journal.pone.0078251			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205172	Green Published, Green Submitted, gold			2022-12-27	WOS:000326032600087
J	Manchukonda, NK; Naik, PK; Santoshi, S; Lopus, M; Joseph, S; Sridhar, B; Kantevari, S				Manchukonda, Naresh Kumar; Naik, Pradeep Kumar; Santoshi, Seneha; Lopus, Manu; Joseph, Silja; Sridhar, Balasubramanian; Kantevari, Srinivas			Rational Design, Synthesis, and Biological Evaluation of Third Generation alpha-Noscapine Analogues as Potent Tubulin Binding Anti-Cancer Agents	PLOS ONE			English	Article							MOLECULAR-ORBITAL METHODS; VALENCE BASIS-SETS; MICROTUBULE DYNAMICS; ACCURATE DOCKING; PERTURB MITOSIS; OVARIAN-CANCER; CELLS; POLYMERIZATION; COLCHICINE; APOPTOSIS	Systematic screening based on structural similarity of drugs such as colchicine and podophyllotoxin led to identification of noscapine, a microtubule-targeted agent that attenuates the dynamic instability of microtubules without affecting the total polymer mass of microtubules. We report a new generation of noscapine derivatives as potential tubulin binding anti-cancer agents. Molecular modeling experiments of these derivatives 5a, 6a-j yielded better docking score (-7.252 to -5.402 kCal/mol) than the parent compound, noscapine (-5.505 kCal/mol) and its existing derivatives (-5.563 to -6.412 kCal/mol). Free energy (Delta G(bind)) calculations based on the linear interaction energy (LIE) empirical equation utilizing Surface Generalized Born (SGB) continuum solvent model predicted the tubulin-binding affinities for the derivatives 5a, 6a-j (ranging from -4.923 to -6.189 kCal/mol). Compound 6f showed highest binding affinity to tubulin (-6.189 kCal/mol). The experimental evaluation of these compounds corroborated with theoretical studies. N-(3-brormobenzyl) noscapine (6f) binds tubulin with highest binding affinity (K-D, 38 +/- 4.0 mu M), which is similar to 4.0 times higher than that of the parent compound, noscapine (K-D, 144 +/- 1.0 mu M) and is also more potent than that of the first generation clinical candidate EM011, 9-bromonoscapine (K-D, 54 +/- 9.1 mu M). All these compounds exhibited substantial cytotoxicity toward cancer cells, with IC50 values ranging from 6.7 mu M to 72.9 mu M; compound 6f showed prominent anti-cancer efficacy with IC50 values ranging from 6.7 mu M to 26.9 mu M in cancer cells of different tissues of origin. These compounds perturbed DNA synthesis, delayed the cell cycle progression at G2/M phase, and induced apoptotic cell death in cancer cells. Collectively, the study reported here identified potent, third generation noscapinoids as new anti-cancer agents.	[Manchukonda, Naresh Kumar; Kantevari, Srinivas] Indian Inst Chem Technol, CSIR, Crop Protect Chem Div, Organ Chem Div 2, Hyderabad 500007, Andhra Pradesh, India; [Kantevari, Srinivas] Indian Inst Chem Technol, CSIR, Acad Sci & Innovat Res, Hyderabad 500007, Andhra Pradesh, India; [Sridhar, Balasubramanian] Indian Inst Chem Technol, CSIR, Xray Crystallog Lab, Hyderabad 500007, Andhra Pradesh, India; [Naik, Pradeep Kumar; Santoshi, Seneha] Jaypee Univ Informat Technol, Dept Biotechnol & Bioinformat, Solan, Himachal Prades, India; [Lopus, Manu; Joseph, Silja] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Lopus, Manu; Joseph, Silja] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Lopus, Manu] Univ Mumbai Campus, UM DAE Ctr Excellence Basic Sci, Bombay, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Jaypee University of Information Technology; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; UM-DAE Centre for Excellence in Basic Sciences	Naik, PK (corresponding author), Jaypee Univ Informat Technol, Dept Biotechnol & Bioinformat, Solan, Himachal Prades, India.	pknaik1973@gmail.com; kantevari@yahoo.com	Kantevari, Srinivas/B-3221-2008; Lopus, Manu/C-8470-2012; Kantevari, Srinivas/AAG-3892-2020; Santoshi, Seneha/ABI-5026-2020	Lopus, Manu/0000-0002-4829-3960; Santoshi, Seneha/0000-0001-8893-2221	MLP [0002]; CSIR [CSC0108-ORIGIN, CSC0205 - DENOVA]	MLP; CSIR(Council of Scientific & Industrial Research (CSIR) - India)	Financial assistance through MLP 0002 & CSIR 12th five year projects (CSC0108-ORIGIN & CSC0205 - DENOVA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Yahya M. A., 1982, ANAL PROFILES DRUG S, V11, P407, DOI DOI 10.1016/S0099-5428(08)60271-3; Anderson JT, 2005, J MED CHEM, V48, P7096, DOI 10.1021/jm050674q; Anderson JT, 2005, J MED CHEM, V48, P2756, DOI 10.1021/jm0494220; Aneja R, 2007, CANCER CHEMOTH PHARM, V60, P831, DOI 10.1007/s00280-007-0430-y; Aneja R, 2006, BIOCHEM PHARMACOL, V72, P415, DOI 10.1016/j.bcp.2006.05.004; Aneja R, 2006, BIOORGAN MED CHEM, V14, P8352, DOI 10.1016/j.bmc.2006.09.012; Aneja R, 2006, MOL PHARMACOL, V69, P1801, DOI 10.1124/mol.105.021899; Aneja R, 2010, INT J CANCER, V126, P256, DOI 10.1002/ijc.24765; [Anonymous], 2010, MED PLANT BIOTECHNOL; BECKE AD, 1993, J CHEM PHYS, V98, P1372, DOI 10.1063/1.464304; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BINKLEY JS, 1980, J AM CHEM SOC, V102, P939, DOI 10.1021/ja00523a008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bulduk I, 2013, J CHEM-NY, V2013, DOI 10.1155/2013/493870; Chandra R, 2012, CURR DRUG METAB, V13, P1476, DOI 10.2174/138920012803762756; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; DAHLSTROM B, 1982, EUR J CLIN PHARMACOL, V22, P535, DOI 10.1007/BF00609627; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeBono AJ, 2012, CHEMMEDCHEM, V7, P2122, DOI 10.1002/cmdc.201200365; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Fang ZZ, 2012, BRIT J PHARMACOL, V167, P1271, DOI 10.1111/j.1476-5381.2012.02067.x; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; GORDON MS, 1982, J AM CHEM SOC, V104, P2797, DOI 10.1021/ja00374a017; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; HAMEL E, 1981, ARCH BIOCHEM BIOPHYS, V209, P29, DOI 10.1016/0003-9861(81)90253-8; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Jackson T, 2008, CANCER CHEMOTH PHARM, V63, P117, DOI 10.1007/s00280-008-0720-z; Jhaveri N, 2011, CANCER LETT, V312, P245, DOI 10.1016/j.canlet.2011.08.015; Jordan MA, 1999, METHOD CELL BIOL, V61, P267; Ke Y, 2000, CANCER IMMUNOL IMMUN, V49, P217, DOI 10.1007/s002620000109; Landen JW, 2002, CANCER RES, V62, P4109; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Mahmoudian M, 2009, RECENT PAT ANTI-CANC, V4, P92, DOI 10.2174/157489209787002524; Manchukonda NK, 2012, BIOORG MED CHEM LETT, V22, P2983, DOI 10.1016/j.bmcl.2012.02.033; McCamley K, 2003, J ORG CHEM, V68, P9847, DOI 10.1021/jo035243z; Mishra RC, 2011, BIOCHEM PHARMACOL, V82, P110, DOI 10.1016/j.bcp.2011.03.029; Naik PK, 2011, J COMPUT AID MOL DES, V25, P443, DOI 10.1007/s10822-011-9430-4; Naik PK, 2011, J MOL GRAPH MODEL, V29, P947, DOI 10.1016/j.jmgm.2011.03.004; Panda D, 2000, BIOCHEMISTRY-US, V39, P5075, DOI 10.1021/bi992217f; PIETRO WJ, 1982, J AM CHEM SOC, V104, P5039, DOI 10.1021/ja00383a007; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Santoshi S, 2011, J BIOMOL SCREEN, V16, P1047, DOI 10.1177/1087057111418654; SEGAL MS, 1957, DIS CHEST, V32, P305; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Singh P, 2012, CURR DRUG METAB, DOI CDM-EPUB-20120824-11; Stanton RA, 2011, MED RES REV, V31, P443, DOI 10.1002/med.20242; Verma AK, 2006, BIOORGAN MED CHEM, V14, P6733, DOI 10.1016/j.bmc.2006.05.069; Ye KQ, 1998, P NATL ACAD SCI USA, V95, P1601, DOI 10.1073/pnas.95.4.1601; Zhou J, 2002, J BIOL CHEM, V277, P17200, DOI 10.1074/jbc.M110369200; Zhou J, 2003, MOL PHARMACOL, V63, P799, DOI 10.1124/mol.63.4.799; Zhou RH, 2001, J PHYS CHEM B, V105, P10388, DOI 10.1021/jp011480z	54	47	49	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77970	10.1371/journal.pone.0077970	http://dx.doi.org/10.1371/journal.pone.0077970			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205049	Green Published, Green Submitted, gold			2022-12-27	WOS:000326032600056
J	Valzachi, MC; Teodorov, E; Marcourakis, T; Bailey, A; Camarini, R				Valzachi, Maria Cristina; Teodorov, Elizabeth; Marcourakis, Tania; Bailey, Alexis; Camarini, Rosana			Enhancement of Behavioral Sensitization, Anxiety-Like Behavior, and Hippocampal and Frontal Cortical CREB Levels Following Cocaine Abstinence in Mice Exposed to Cocaine during Adolescence	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; MEDIAL PREFRONTAL CORTEX; ELEMENT-BINDING PROTEIN; NUCLEUS-ACCUMBENS; MEMORY RETRIEVAL; D-1 RECEPTOR; DOPAMINE; MODULATION; WITHDRAWAL; PHOSPHORYLATION	Adolescence has been linked to greater risk-taking and novelty-seeking behavior and a higher prevalence of drug abuse and risk of relapse. Decreases in cyclic adenosine monophosphate response element binding protein (CREB) and phosphorylated CREB (pCREB) have been reported after repeated cocaine administration in animal models. We compared the behavioral effects of cocaine and abstinence in adolescent and adult mice and investigated possible age-related differences in CREB and pCREB levels. Adolescent and adult male Swiss mice received one daily injection of saline or cocaine (10 mg/kg, i.p.) for 8 days. On day 9, the mice received a saline injection to evaluate possible environmental conditioning. After 9 days of withdrawal, the mice were tested in the elevated plus maze to evaluate anxiety-like behavior. Twelve days after the last saline/cocaine injection, the mice received a challenge injection of either cocaine or saline, and locomotor activity was assessed. One hour after the last injection, the brains were extracted, and CREB and pCREB levels were evaluated using Western blot in the prefrontal cortex (PFC) and hippocampus. The cocaine-pretreated mice during adolescence exhibited a greater magnitude of the expression of behavioral sensitization and greater cocaine withdrawal-induced anxiety-like behavior compared with the control group. Significant increases in CREB levels in the PFC and hippocampus and pCREB in the hippocampus were observed in cocaine-abstinent animals compared with the animals treated with cocaine in adulthood. Interestingly, significant negative correlations were observed between cocaine sensitization and CREB levels in both regions. These results suggest that the behavioral and neurochemical consequences of psychoactive substances in a still-developing nervous system can be more severe than in an already mature nervous system.	[Valzachi, Maria Cristina; Camarini, Rosana] Univ Sao Paulo, Inst Ciencias Biomed, Dept Farmacol, BR-05508 Sao Paulo, Brazil; [Teodorov, Elizabeth] Univ Fed ABC, Ctr Matemat Comp & Cognicao, Sao Paulo, Brazil; [Marcourakis, Tania] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Toxicol & Clin, Sao Paulo, Brazil; [Bailey, Alexis] Univ Surrey, Dept Biochem & Physiol, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England	Universidade de Sao Paulo; Universidade Federal do ABC (UFABC); Universidade de Sao Paulo; University of Surrey	Camarini, R (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Farmacol, BR-05508 Sao Paulo, Brazil.	camarini@icb.usp.br	Bailey, Alexis/AAI-1489-2020; Marcourakis, Tânia/D-6667-2012; Camarini, Rosana/D-2251-2012	Bailey, Alexis/0000-0003-1541-1964; Marcourakis, Tânia/0000-0002-0076-5017; Camarini, Rosana/0000-0002-8131-6108	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The work was funded by the following: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SL, 2008, TRENDS NEUROSCI, V31, P183, DOI 10.1016/j.tins.2008.01.004; Badanich KA, 2006, EUR J PHARMACOL, V550, P95, DOI 10.1016/j.ejphar.2006.08.034; Bailey A, 2007, J NEUROCHEM, V102, P1817, DOI 10.1111/j.1471-4159.2007.04661.x; Barco A, 2008, NEUROSCI BIOBEHAV R, V32, P831, DOI 10.1016/j.neubiorev.2008.01.002; Bartlett E, 1997, NEUROPSYCHOPHARMACOL, V16, P77, DOI 10.1016/S0893-133X(96)00164-9; Beyer CE, 2000, PSYCHOPHARMACOLOGY, V151, P211, DOI 10.1007/s002139900345; Bolla K, 2004, J NEUROPSYCH CLIN N, V16, P456, DOI 10.1176/appi.neuropsych.16.4.456; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brenhouse HC, 2008, BEHAV NEUROSCI, V122, P460, DOI 10.1037/0735-7044.122.2.460; Camarini R, 2008, BRAIN RES, V1193, P34, DOI 10.1016/j.brainres.2007.11.045; Camarini R, 2011, PHARMACOL BIOCHEM BE, V98, P173, DOI 10.1016/j.pbb.2010.12.017; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; CARLEZON WA, 1995, SYNAPSE, V20, P1, DOI 10.1002/syn.890200102; Casey BJ, 2005, CURR OPIN NEUROBIOL, V15, P239, DOI 10.1016/j.conb.2005.03.012; Chambers RA, 2003, AM J PSYCHIAT, V160, P1041, DOI 10.1176/appi.ajp.160.6.1041; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; COSTALL B, 1989, PHARMACOL BIOCHEM BE, V33, P197, DOI 10.1016/0091-3057(89)90450-4; Cito MDD, 2012, BEHAV BRAIN RES, V231, P116, DOI 10.1016/j.bbr.2012.01.056; DIANA M, 1992, EUR J PHARMACOL, V221, P403, DOI 10.1016/0014-2999(92)90734-L; Durston S, 2006, NEUROPSYCHOLOGIA, V44, P2149, DOI 10.1016/j.neuropsychologia.2005.10.010; Edwards S, 2007, EUR J NEUROSCI, V25, P2201, DOI 10.1111/j.1460-9568.2007.05473.x; El Hage C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043535; Fasano S, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.029.2009; Floresco SB, 2001, BEHAV NEUROSCI, V115, P934, DOI 10.1037/0735-7044.115.4.934; Haghparast A, 2011, BEHAV BRAIN RES, V220, P112, DOI 10.1016/j.bbr.2011.01.045; Homberg JR, 2002, EUR J NEUROSCI, V15, P1542, DOI 10.1046/j.1460-9568.2002.01976.x; Hotte M, 2005, NEUROBIOL LEARN MEM, V84, P85, DOI 10.1016/j.nlm.2005.04.002; Hotte M, 2006, BEHAV BRAIN RES, V171, P127, DOI 10.1016/j.bbr.2006.03.026; KALSBEEK A, 1988, J COMP NEUROL, V269, P58, DOI 10.1002/cne.902690105; Koob GF, 2008, PHILOS T R SOC B, V363, P3113, DOI 10.1098/rstb.2008.0094; Kroener S, 2010, NEUROPSYCHOPHARMACOL, V35, P2292, DOI 10.1038/npp.2010.107; Larson EB, 2011, J NEUROSCI, V31, P16447, DOI 10.1523/JNEUROSCI.3070-11.2011; Lejuez CW, 2008, BEHAV RES THER, V46, P811, DOI 10.1016/j.brat.2008.03.010; McDaid J, 2006, MOL PHARMACOL, V70, P2064, DOI 10.1124/mol.106.023051; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MISERENDINO MJD, 1995, BRAIN RES, V674, P299, DOI 10.1016/0006-8993(95)00030-T; Muschamp JW, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012005; Nestler EJ, 2004, TRENDS PHARMACOL SCI, V25, P210, DOI 10.1016/j.tips.2004.02.005; Nestler EJ, 2002, NEUROBIOL LEARN MEM, V78, P637, DOI 10.1006/nlme.2002.4084; Pandey SC, 1999, J PHARMACOL EXP THER, V288, P866; Pelloux Y, 2009, BEHAV BRAIN RES, V197, P311, DOI 10.1016/j.bbr.2008.08.029; Perrine SA, 2008, NEUROPHARMACOLOGY, V54, P355, DOI 10.1016/j.neuropharm.2007.10.007; Philpot RM, 1999, PHARMACOL BIOCHEM BE, V62, P465, DOI 10.1016/S0091-3057(98)00198-1; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Pryce CR, 2008, BRAIN RES REV, V57, P596, DOI 10.1016/j.brainresrev.2007.08.005; Robinson TE, 2000, ADDICTION, V95, pS91; ROGERIO R, 1992, PHARMACOL BIOCHEM BE, V43, P631, DOI 10.1016/0091-3057(92)90203-R; Rong YQ, 1996, J NEUROCHEM, V67, P662; Runyan JD, 2004, NEUROBIOL LEARN MEM, V82, P65, DOI 10.1016/j.nlm.2004.04.006; SHALABY IA, 1981, DEV BRAIN RES, V1, P434, DOI 10.1016/0165-3806(81)90082-1; SHIPPENBERG TS, 1991, PSYCHOPHARMACOLOGY, V103, P209, DOI 10.1007/BF02244205; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Steketee JD, 2011, PHARMACOL REV, V63, P348, DOI 10.1124/pr.109.001933; Stoker AK, 2011, BEHAV BRAIN RES, V223, P176, DOI 10.1016/j.bbr.2011.04.042; Tropea TF, 2008, J NEUROCHEM, V106, P1780, DOI 10.1111/j.1471-4159.2008.05518.x; Walters CL, 2001, J NEUROSCI, V21, P9438, DOI 10.1523/JNEUROSCI.21-23-09438.2001; Williams JM, 2005, NEUROPHARMACOLOGY, V48, P51, DOI 10.1016/j.neuropharm.2004.09.004; Zelcer I, 2006, CEREB CORTEX, V16, P460, DOI 10.1093/cercor/bhi125	60	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78317	10.1371/journal.pone.0078317	http://dx.doi.org/10.1371/journal.pone.0078317			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205196	Green Submitted, Green Published, gold			2022-12-27	WOS:000326032600092
J	Jawale, CV; Lee, JH				Jawale, Chetan V.; Lee, John Hwa			Development of a Biosafety Enhanced and Immunogenic Salmonella Enteritidis Ghost Using an Antibiotic Resistance Gene Free Plasmid Carrying a Bacteriophage Lysis System	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; EDWARDSIELLA-TARDA GHOSTS; ESCHERICHIA-COLI; VACCINE CANDIDATES; BACTERIAL GHOSTS; IMMUNE-RESPONSES; STAPHYLOCOCCAL NUCLEASE; PROTECTIVE EFFICACY; EXPRESSION SYSTEM; PROTEIN	In the development of genetically inactivated bacterial vaccines, plasmid retention often requires the antibiotic resistance gene markers, the presence of which can cause the potential biosafety hazards such as the horizontal spread of resistance genes. The new lysis plasmid was constructed by utilizing the approach of balanced-lethal systems based on auxotrophic gene Aspartate semialdehyde dehydrogenase (asd). The PhiX174 lysis gene E and.PR37-cI857 temperature-sensitive regulatory system was cloned in the asd gene positive plasmid and this novel approach allowed the production of antibiotic resistance marker free Salmonella Enteritidis (S. Enteritidis) ghost. The immunogenic potential of the biosafety enhanced antibiotic resistance gene free S. Enteritidis ghost was evaluated in chickens by employing the prime-boost vaccination strategy using a combination of oral and intramuscular routes. A total of 75 two-week-old chickens were equally divided into five groups: group A (non-immunized control), group B (intramuscularly primed and boosted), group C (primed intramuscularly and boosted orally), group D (primed and boosted orally), and group E (primed orally and boosted intramuscularly). Chickens from all immunized groups demonstrated significant increases in plasma IgG, intestinal secretory IgA levels, and antigen-specific lymphocyte proliferative response. After a virulent S. Enteritidis challenge, all immunized groups showed fewer gross lesions and decreased bacterial recovery from organs in comparison with the non-immunized control group. Among the immunized chickens, groups B and D chickens showed optimized protection, indicating that the prime-booster immunization with the ghost via intramuscular or oral route is efficient. Taken together, our results demonstrate that an antibiotic resistance gene free lysis plasmid was successfully constructed and utilized for production of safety enhanced S. Enteritidis ghost, which can be used as a safe and effective vaccine against virulent S. Enteritidis infections.	[Jawale, Chetan V.; Lee, John Hwa] Chonbuk Natl Univ, Coll Vet Med, Jeonju, South Korea	Jeonbuk National University	Lee, JH (corresponding author), Chonbuk Natl Univ, Coll Vet Med, Jeonju, South Korea.	johnhlee@jbnu.ac.kr	jawale, chetan/AAR-1894-2021		Mid-career Researcher Program through NRF; MEST in Republic of Korea [2012R1A2A4A01002318]	Mid-career Researcher Program through NRF(National Research Foundation of Korea); MEST in Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Mid-career Researcher Program through NRF grant funded by the MEST (No. 2012R1A2A4A01002318) in Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez J, 2004, J CLIN MICROBIOL, V42, P1734, DOI 10.1128/JCM.42.4.1734-1738.2004; Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8; Barrow PA, 2007, AVIAN PATHOL, V36, P1, DOI 10.1080/03079450601113167; BENTLEY WE, 1990, BIOTECHNOL BIOENG, V35, P668, DOI 10.1002/bit.260350704; Bernhardt TG, 2000, P NATL ACAD SCI USA, V97, P4297, DOI 10.1073/pnas.97.8.4297; BIELLMANN JF, 1980, EUR J BIOCHEM, V104, P53, DOI 10.1111/j.1432-1033.1980.tb04398.x; Bueno SM, 2007, IMMUNOL LETT, V111, P14, DOI 10.1016/j.imlet.2007.05.003; Cai K, 2013, VACCINE, V31, P334, DOI 10.1016/j.vaccine.2012.11.004; Chappell L, 2009, VET IMMUNOL IMMUNOP, V128, P53, DOI 10.1016/j.vetimm.2008.10.295; Chaudhari AA, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-44; Choi SH, 2010, MOL BIOTECHNOL, V46, P127, DOI 10.1007/s12033-010-9277-2; Davison J, 1999, PLASMID, V42, P73, DOI 10.1006/plas.1999.1421; EISENSTEIN TK, 1984, J INFECT DIS, V150, P425, DOI 10.1093/infdis/150.3.425; Gogal RM, 1997, AVIAN DIS, V41, P714, DOI 10.2307/1592166; Haidinger W, 2003, APPL ENVIRON MICROB, V69, P6106, DOI 10.1128/AEM.69.10.6106-6113.2003; Haslberger AG, 2000, J BIOTECHNOL, V83, P57, DOI 10.1016/S0168-1656(00)00298-4; Hensel A, 2000, VACCINE, V18, P2945, DOI 10.1016/S0264-410X(00)00107-9; Hu M, 2013, CLIN VACCIN IN PRESS; Jalava K, 2002, J CONTROL RELEASE, V85, P17, DOI 10.1016/S0168-3659(02)00267-5; Jawale CV, 2012, INFECT IMMUN, V80, P1502, DOI 10.1128/IAI.06264-11; Kang HY, 2002, INFECT IMMUN, V70, P1739, DOI 10.1128/IAI.70.4.1739-1749.2002; Kwon SR, 2009, MOL BIOTECHNOL, V42, P154, DOI 10.1007/s12033-009-9147-y; Kwon SR, 2005, AQUACULTURE, V250, P16, DOI 10.1016/j.aquaculture.2005.02.052; Lee DJ, 2008, DIS AQUAT ORGAN, V81, P249, DOI 10.3354/dao01964; Londono-Arcila P, 2002, INFECT IMMUN, V70, P5096, DOI 10.1128/IAI.70.9.5096-5106.2002; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Marchart J, 2003, VACCINE, V21, P3988, DOI 10.1016/S0264-410X(03)00383-9; Matsuda K, 2011, VACCINE, V29, P668, DOI 10.1016/j.vaccine.2010.11.039; Matsuda K, 2010, VET RES, V41, DOI 10.1051/vetres/2010031; Mayr UB, 2005, INFECT IMMUN, V73, P4810, DOI 10.1128/IAI.73.8.4810-4817.2005; McCluskie MJ, 2002, FEMS IMMUNOL MED MIC, V32, P179, DOI 10.1016/S0928-8244(01)00305-4; McSorley SJ, 2000, INFECT IMMUN, V68, P3344, DOI 10.1128/IAI.68.6.3344-3348.2000; NAKAYAMA K, 1988, BIO-TECHNOL, V6, P693, DOI 10.1038/nbt0688-693; Nandre RM, 2011, VET IMMUNOL IMMUNOP, V144, P299, DOI 10.1016/j.vetimm.2011.08.015; Ogra PL, 2001, CLIN MICROBIOL REV, V14, P430, DOI 10.1128/CMR.14.2.430-445.2001; Panthel K, 2003, INFECT IMMUN, V71, P109, DOI 10.1128/IAI.71.1.109-116.2003; Pasetti MF, 2011, IMMUNOL REV, V239, P125, DOI 10.1111/j.1600-065X.2010.00970.x; Peng W, 2011, IMMUNOBIOLOGY, V216, P558, DOI 10.1016/j.imbio.2010.10.001; Rana N, 2006, VET MICROBIOL, V115, P156, DOI 10.1016/j.vetmic.2006.01.011; SANGER F, 1977, NATURE, V265, P687, DOI 10.1038/265687a0; Smith AL, 2008, AVIAN IMMUNOLOGY, P243, DOI 10.1016/B978-012370634-8.50016-0; Szostak MP, 1996, J BIOTECHNOL, V44, P161, DOI 10.1016/0168-1656(95)00123-9; Thomas ME, 2009, APPL ENVIRON MICROB, V75, P6361, DOI 10.1128/AEM.00961-09; Uppington H, 2006, IMMUNOLOGY, V119, P147, DOI 10.1111/j.1365-2567.2006.02416.x; VILLAVERDE A, 1993, APPL ENVIRON MICROB, V59, P3485, DOI 10.1128/AEM.59.10.3485-3487.1993; Wang XP, 2009, VACCINE, V27, P1571, DOI 10.1016/j.vaccine.2009.01.002; WITTE A, 1992, ARCH MICROBIOL, V157, P381, DOI 10.1007/BF00248685; Yu SY, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-206	48	17	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78193	10.1371/journal.pone.0078193	http://dx.doi.org/10.1371/journal.pone.0078193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205152	Green Published, Green Submitted, gold			2022-12-27	WOS:000326029300147
J	Aguado-Llera, D; Hamidi, T; Domenech, R; Pantoja-Uceda, D; Gironella, M; Santoro, J; Velazquez-Campoy, A; Neira, JL; Iovanna, JL				Aguado-Llera, David; Hamidi, Tewfik; Domenech, Rosa; Pantoja-Uceda, David; Gironella, Meritxell; Santoro, Jorge; Velazquez-Campoy, Adrian; Neira, Jose L.; Iovanna, Juan L.			Deciphering the Binding between Nupr1 and MSL1 and Their DNA-Repairing Activity	PLOS ONE			English	Article							DOSAGE COMPENSATION COMPLEX; LETHAL COMPLEX; PROTEIN; MOF; STRESS; P8; IDENTIFICATION; ACETYLATION; RECRUITMENT; ACTIVATION	The stress protein Nupr1 is a highly basic, multifunctional, intrinsically disordered protein (IDP). MSL1 is a histone acetyl transferase-associated protein, known to intervene in the dosage compensation complex (DCC). In this work, we show that both Nupr1 and MSL1 proteins were recruited and formed a complex into the nucleus in response to DNA-damage, which was essential for cell survival in reply to cisplatin damage. We studied the interaction of Nupr1 and MSL1, and their binding affinities to DNA by spectroscopic and biophysical methods. The MSL1 bound to Nupr1, with a moderate affinity (2.8 mu M) in an entropically-driven process. MSL1 did not bind to non-damaged DNA, but it bound to chemically-damaged-DNA with a moderate affinity (1.2 mu M) also in an entropically-driven process. The Nupr1 protein bound to chemically-damaged-DNA with a slightly larger affinity (0.4 mu M), but in an enthalpically-driven process. Nupr1 showed different interacting regions in the formed complexes with Nupr1 or DNA; however, they were always disordered ("fuzzy"), as shown by NMR. These results underline a stochastic description of the functionality of the Nupr1 and its other interacting partners.	[Aguado-Llera, David; Domenech, Rosa; Neira, Jose L.] Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche, Alicante, Spain; [Hamidi, Tewfik; Gironella, Meritxell; Iovanna, Juan L.] Aix Marseille Univ, INSERM, U1068, CRCM,CNRS,U7258, Marseille, France; [Hamidi, Tewfik; Gironella, Meritxell; Iovanna, Juan L.] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Pantoja-Uceda, David; Santoro, Jorge] CSIC, IQFR, Madrid, Spain; [Gironella, Meritxell] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Velazquez-Campoy, Adrian; Neira, Jose L.] Univ Zaragoza, Inst Biocomp & Fis Sistemas Complejos BIFI, Unidad Asociada IQFR CSIC BIFI, Zaragoza, Spain; [Velazquez-Campoy, Adrian] Diputac Gen Aragon, Fdn Agencia Aragonesa Invest & Desarrollo ARAID, Zaragoza, Spain; [Velazquez-Campoy, Adrian] Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, Zaragoza, Spain	Universidad Miguel Hernandez de Elche; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Zaragoza; University of Zaragoza	Neira, JL (corresponding author), Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche, Alicante, Spain.	jlneira@umh.es; juan.iovanna@inserm.fr	Velazquez-Campoy, Adrian/E-7946-2012; Pantoja-Uceda, David/J-8097-2014; Neira, Jose/ABF-4210-2021; Llera, David Aguado/A-4349-2017; Iovanna, Juan/M-9805-2017	Velazquez-Campoy, Adrian/0000-0001-5702-4538; Llera, David Aguado/0000-0002-8333-2857; Iovanna, Juan/0000-0003-1822-2237; Neira, Jose Luis/0000-0002-4933-0428; Pantoja-Uceda, David/0000-0003-4390-6972; Gironella, Meritxell/0000-0003-4437-5181	Spanish Ministerio de Ciencia e Innovacion (MCINN) [CTQ2011-24393, CSD2008-00005, BFU2010-19451, CTQ2011-22514]; intramural BIFI projects; Generalitat Valenciana [Prometeo 018/2013]; La Ligue Contre le Cancer; INCa; Canceropole PACA; INSERM	Spanish Ministerio de Ciencia e Innovacion (MCINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); intramural BIFI projects; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); La Ligue Contre le Cancer(Ligue nationale contre le cancer); INCa(Institut National du Cancer (INCA) France); Canceropole PACA(Region Grand-Est); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by the Spanish Ministerio de Ciencia e Innovacion (MCINN) [CTQ2011-24393 to JLN, CSD2008-00005 to JLN, BFU2010-19451 to AVC, and CTQ2011-22514 to JS], intramural BIFI 2011 projects (to JLN and AVC), Generalitat Valenciana [Prometeo 018/2013] (to JLN) and by La Ligue Contre le Cancer, INCa, Canceropole PACA and INSERM (to JLI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado-Llera D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017068; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Bravo J, 2010, SCI WORLD J, V10, P1613; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Cano CE, 2011, J CELL PHYSIOL, V226, P1439, DOI 10.1002/jcp.22324; Carracedo A, 2006, CANCER RES, V66, P6748, DOI 10.1158/0008-5472.CAN-06-0169; Cavanagh J., 1996, PROTEIN NMR SPECTROS; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dmitriev RI, 2007, BIOCHEM BIOPH RES CO, V355, P1051, DOI 10.1016/j.bbrc.2007.02.073; Dyson HJ, 2011, Q REV BIOPHYS, V44, P467, DOI 10.1017/S0033583511000060; Encinar JA, 2001, J BIOL CHEM, V276, P2742, DOI 10.1074/jbc.M008594200; Fullgrabe J, 2013, NATURE, V500, P468, DOI 10.1038/nature12313; Fuxreiter M, 2012, ADV EXP MED BIOL, V725, P1, DOI 10.1007/978-1-4614-0659-4_1; Fuxreiter M, 2011, TRENDS BIOCHEM SCI, V36, P415, DOI 10.1016/j.tibs.2011.04.006; Gelbart ME, 2009, DEVELOPMENT, V136, P1399, DOI 10.1242/dev.029645; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gironella M, 2009, J CELL PHYSIOL, V221, P594, DOI 10.1002/jcp.21889; Goruppi S, 2010, J BIOL CHEM, V285, P1577, DOI 10.1074/jbc.R109.080887; Hallacli E, 2012, MOL CELL, V48, P587, DOI 10.1016/j.molcel.2012.09.014; Hamidi T, 2012, J CLIN INVEST, V122, P2092, DOI 10.1172/JCI60144; Hilfiker A, 1997, EMBO J, V16, P2054, DOI 10.1093/emboj/16.8.2054; Huang J, 2012, CELL RES, V22, P1078, DOI 10.1038/cr.2012.72; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kadlec J, 2011, NAT STRUCT MOL BIOL, V18, P142, DOI 10.1038/nsmb.1960; Khan H, 2013, J MOL BIOL, V425, P1011, DOI 10.1016/j.jmb.2013.01.005; Li XZ, 2010, MOL CELL BIOL, V30, P5335, DOI 10.1128/MCB.00350-10; Li XZ, 2010, EPIGENETICS-US, V5; Li XZ, 2009, MOL CELL, V36, P290, DOI 10.1016/j.molcel.2009.07.031; Malicet C, 2006, P NATL ACAD SCI USA, V103, P2671, DOI 10.1073/pnas.0508955103; Mallo GV, 1997, J BIOL CHEM, V272, P32360, DOI 10.1074/jbc.272.51.32360; Marin I, 2003, J MOL EVOL, V56, P527, DOI 10.1007/s00239-002-2422-1; Mendjan S, 2007, CHROMOSOMA, V116, P95, DOI 10.1007/s00412-006-0089-x; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Morales V, 2004, EMBO J, V23, P2258, DOI 10.1038/sj.emboj.7600235; Neira JL, 2013, PROTEIN PEPTIDE LETT, V20, P955, DOI 10.2174/09298665113209990040; Pantoja-Uceda D, 2008, J MAGN RESON, V195, P187, DOI 10.1016/j.jmr.2008.09.010; Pantoja-Uceda D, 2012, J BIOMOL NMR, V54, P145, DOI 10.1007/s10858-012-9665-y; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Raja SJ, 2010, MOL CELL, V38, P827, DOI 10.1016/j.molcel.2010.05.021; Sandi MJ, 2011, J CELL PHYSIOL, V226, P3442, DOI 10.1002/jcp.22702; Savvides SN, 2004, PROTEIN SCI, V13, P1942, DOI 10.1110/ps.04661904; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wu LP, 2011, MOL CELL, V43, P132, DOI 10.1016/j.molcel.2011.05.015	46	33	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78101	10.1371/journal.pone.0078101	http://dx.doi.org/10.1371/journal.pone.0078101			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205110	Green Published, gold, Green Submitted			2022-12-27	WOS:000326334500096
J	El Khatib, M; Bozko, P; Palagani, V; Malek, NP; Wilkens, L; Plentz, RR				El Khatib, Mona; Bozko, Przemyslaw; Palagani, Vindhya; Malek, Nisar P.; Wilkens, Ludwig; Plentz, Ruben R.			Activation of Notch Signaling Is Required for Cholangiocarcinoma Progression and Is Enhanced by Inactivation of p53 In Vivo (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							EPITHELIAL-MESENCHYMAL TRANSITION; EXTRAHEPATIC CHOLANGIOCARCINOMA; INTRAHEPATIC CHOLANGIOCARCINOMA; MUTATIONS; GALLBLADDER; EXPRESSION; LIVER; PROLIFERATION; CHEMOTHERAPY; CARCINOMA	Cholangiocacinoma (CC) is a cancer disease with rising incidence. Notch signaling has been shown to be deregulated in many cancers. However, the role of this signaling pathway in the carcinogenesis of CC is still not fully explored. In this study, we investigated the effects of Notch inhibition by gamma-secretase inhibitor IX (GSI IX) in cultured human CC cell lines and we established a transgenic mouse model with liver specific expression of the intracellular domain of Notch (Notch-ICD) and inactivation of tumor suppressor p53. GSI IX treatment effectively impaired cell proliferation, migration, invasion, epithelial to mesenchymal transition and growth of softagar colonies. In vivo overexpression of Notch-ICD together with an inactivation of p53 significantly increased tumor burden and showed CC characteristics. Conclusion: Our study highlights the importance of Notch signaling in the tumorigenesis of CC and demonstrates that additional inactivation of p53 in vivo.	[El Khatib, Mona; Bozko, Przemyslaw; Palagani, Vindhya; Malek, Nisar P.; Plentz, Ruben R.] Med Univ Hosp, Dept Internal Med 1, Tubingen, Germany; [Wilkens, Ludwig] Krankenhaus Nordstadt, Inst Pathol, Hannover, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf	Plentz, RR (corresponding author), Med Univ Hosp, Dept Internal Med 1, Tubingen, Germany.	Ruben.Plentz@med.uni-tuebingen.de	Udhane, Vindhya/Z-5947-2019		German Research Foundation [PL 468/4-1]	German Research Foundation(German Research Foundation (DFG))	Funding was provided by German Research Foundation (PL 468/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki K, 2011, BRIT J CANCER, V105, P1885, DOI 10.1038/bjc.2011.452; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; CARRIAGA MT, 1995, CANCER-AM CANCER SOC, V75, P171, DOI 10.1002/1097-0142(19950101)75:1+<171::AID-CNCR2820751306>3.0.CO;2-2; Claessen MMH, 2009, J HEPATOL, V50, P158, DOI 10.1016/j.jhep.2008.08.013; Deshpande V, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-60; Dill MT, 2013, HEPATOLOGY, V57, P1607, DOI 10.1002/hep.26165; Dormoy V, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-123; FALKSON G, 1984, CANCER, V54, P965, DOI 10.1002/1097-0142(19840915)54:6<965::AID-CNCR2820540603>3.0.CO;2-X; Fan B, 2012, J CLIN INVEST, V122, P2911, DOI 10.1172/JCI63212; Furubo S, 1999, HISTOPATHOLOGY, V35, P230; Gatto M, 2010, WORLD J GASTRO ONCOL, V2, P136, DOI 10.4251/wjgo.v2.i3.136; Geisler F, 2008, HEPATOLOGY, V48, P607, DOI 10.1002/hep.22381; Hezel AF, 2010, J CLIN ONCOL, V28, P3531, DOI 10.1200/JCO.2009.27.4787; Ishimura N, 2005, GASTROENTEROLOGY, V128, P1354, DOI 10.1053/j.gastro.2005.01.055; Jing YY, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-29; Kellendonk C, 2000, GENESIS, V26, P151, DOI 10.1002/(SICI)1526-968X(200002)26:2<151::AID-GENE17>3.0.CO;2-E; Khan SA, 2005, LANCET, V366, P1303, DOI 10.1016/S0140-6736(05)67530-7; Khan SA, 2005, LIVER INT, V25, P704, DOI 10.1111/j.1478-3231.2005.01106.x; Khan SA, 2012, GUT, V61, P1657, DOI 10.1136/gutjnl-2011-301748; Kiesslich T, 2009, PHOTOCH PHOTOBIO SCI, V8, P23, DOI 10.1039/b813183j; Koch U, 2010, CURR TOP DEV BIOL, V92, P411, DOI 10.1016/S0070-2153(10)92013-9; Lee QW, 2006, AM J CLIN ONCOL-CANC, V29, P127, DOI 10.1097/01.coc.0000203742.22828.bb; Lorent K, 2004, DEVELOPMENT, V131, P5753, DOI 10.1242/dev.01411; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Omenetti A, 2008, J CLIN INVEST, V118, P3331, DOI 10.1172/JCI35875; Ryan MJ, 2008, HEPATOLOGY, V48, P1989, DOI 10.1002/hep.22538; Sekiya S, 2012, J CLIN INVEST, V122, P3914, DOI 10.1172/JCI63065; Shaib Y, 2004, SEMIN LIVER DIS, V24, P115, DOI 10.1055/s-2004-828889; Tannapfel A, 2000, DIGEST DIS SCI, V45, P317, DOI 10.1023/A:1005412626515; Tannapfel A, 2000, GUT, V47, P721, DOI 10.1136/gut.47.5.721; Tannapfel A, 2003, GUT, V52, P706, DOI 10.1136/gut.52.5.706; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thongprasert S, 2005, ANN ONCOL, V16, P279, DOI 10.1093/annonc/mdi046; Tyson GL, 2011, HEPATOLOGY, V54, P173, DOI 10.1002/hep.24351; von Hahn T, 2011, SCAND J GASTROENTERO, V46, P1092, DOI 10.3109/00365521.2011.589472; Welzel TM, 2006, J NATL CANCER I, V98, P873, DOI 10.1093/jnci/djj234; Yoon HA, 2011, WORLD J GASTROENTERO, V17, P4023, DOI 10.3748/wjg.v17.i35.4023; Zender S, 2013, CANCER CELL, V23, P784, DOI 10.1016/j.ccr.2013.04.019; Zhou Q, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-244; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140	41	46	47	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77433	10.1371/journal.pone.0077433	http://dx.doi.org/10.1371/journal.pone.0077433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204826	gold, Green Published			2022-12-27	WOS:000326334500028
J	Steinberg, MW; Huang, YJ; Wang-Zhu, Y; Ware, CF; Cheroutre, H; Kronenberg, M				Steinberg, Marcos W.; Huang, Yujun; Wang-Zhu, Yiran; Ware, Carl F.; Cheroutre, Hilde; Kronenberg, Mitchell			BTLA Interaction with HVEM Expressed on CD8(+) T Cells Promotes Survival and Memory Generation in Response to a Bacterial Infection	PLOS ONE			English	Article							HERPESVIRUS ENTRY MEDIATOR; LYMPHOCYTE ATTENUATOR; B-LYMPHOCYTE; TNF SUPERFAMILY; CUTTING EDGE; IMMUNE-RESPONSES; LIGHT; ACTIVATION; MEMBERS; CD4(+)	The B and T lymphocyte attenuator (BTLA) is an Ig super family member that binds to the herpes virus entry mediator (HVEM), a TNF receptor super family (TNFRSF) member. Engagement of BTLA by HVEM triggers inhibitory signals, although recent evidence indicates that BTLA also may act as an activating ligand for HVEM. In this study, we reveal a novel role for the BTLA-HVEM pathway in promoting the survival of activated CD8(+) T cells in the response to an oral microbial infection. Our data show that both BTLA- and HVEM-deficient mice infected with Listeria monocytogenes had significantly reduced numbers of primary effector and memory CD8(+) T cells, despite normal proliferation and expansion compared to controls. In addition, blockade of the BTLA-HVEM interaction early in the response led to significantly reduced numbers of antigen-specific CD8(+) T cells. HVEM expression on the CD8(+) T cells as well as BTLA expression on a cell type other than CD8(+) T lymphocytes, was required. Collectively, our data demonstrate that the function of the BTLA-HVEM pathway is not limited to inhibitory signaling in T lymphocytes, and instead, that BTLA can provide crucial, HVEM-dependent signals that promote survival of antigen activated CD8(+) T cell during bacterial infection.	[Steinberg, Marcos W.; Huang, Yujun; Wang-Zhu, Yiran; Cheroutre, Hilde; Kronenberg, Mitchell] La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA USA; [Ware, Carl F.] Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA USA	La Jolla Institute for Immunology; Sanford Burnham Prebys Medical Discovery Institute	Kronenberg, M (corresponding author), La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA USA.	mitch@liai.org	Kronenberg, Mitchell/AAT-6078-2021		National Institutes of Health [RO1 AI61516, PO1 DK46763, AI064584, AI050265, R37AI33068, AI048073, AI067890]; Crohn's & Colitis Foundation of America; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI050265, R01AI050265, R01AI067890, R37AI033068, R01AI061516, R01AI048073, R01AI064584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK046763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's & Colitis Foundation of America; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health RO1 AI61516 and PO1 DK46763 to MK; AI064584 and AI050265 to HC; R37AI33068, AI048073 and AI067890 to CFW, and by a Research Fellowship Award from the Crohn's & Colitis Foundation of America to MWS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda R, 1997, J IMMUNOL, V158, P3464; Cai GF, 2008, NAT IMMUNOL, V9, P176, DOI 10.1038/ni1554; Cheung TC, 2005, P NATL ACAD SCI USA, V102, P13218, DOI 10.1073/pnas.0506172102; Cheung TC, 2009, J IMMUNOL, V183, P7286, DOI 10.4049/jimmunol.0902490; Cheung TC, 2009, P NATL ACAD SCI USA, V106, P6244, DOI 10.1073/pnas.0902115106; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Deppong C, 2008, J IMMUNOL, V181, P2973, DOI 10.4049/jimmunol.181.5.2973; Deppong C, 2006, J IMMUNOL, V176, P3909, DOI 10.4049/jimmunol.176.7.3909; DiMenna L, 2010, J IMMUNOL, V184, P5475, DOI 10.4049/jimmunol.0903808; Gonzalez LC, 2005, P NATL ACAD SCI USA, V102, P1116, DOI 10.1073/pnas.0409071102; Han P, 2004, J IMMUNOL, V172, P5931, DOI 10.4049/jimmunol.172.10.5931; Hurchla MA, 2007, J IMMUNOL, V178, P6073, DOI 10.4049/jimmunol.178.10.6073; Krieg C, 2007, NAT IMMUNOL; Lasaro MO, 2008, NAT MED, V14, P205, DOI 10.1038/nm1704; Liu JQ, 2003, INT IMMUNOL, V15, P861, DOI 10.1093/intimm/dxg082; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Miller ML, 2009, J IMMUNOL, V183, P32, DOI 10.4049/jimmunol.0900690; Musicki K, 2010, INT IMMUNOL, V22, P353, DOI 10.1093/intimm/dxq013; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Sakoda Y, 2011, BLOOD, V117, P2506, DOI 10.1182/blood-2010-08-301325; Scheu S, 2002, J EXP MED, V195, P1613, DOI 10.1084/jem.20020215; Sedgmen BJ, 2006, INT IMMUNOL, V18, P797, DOI 10.1093/intimm/dxl016; Sedy JR, 2008, NAT REV IMMUNOL, V8, P861, DOI 10.1038/nri2434; Soroosh P, 2011, J EXP MED, V208, P797, DOI 10.1084/jem.20101562; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Steinberg MW, 2008, J EXP MED, V205, P1463, DOI 10.1084/jem.20071160; Sun YL, 2009, J IMMUNOL, V183, P1946, DOI 10.4049/jimmunol.0801866; Tamada K, 2002, J IMMUNOL, V168, P4832, DOI 10.4049/jimmunol.168.10.4832; Tao R, 2005, J IMMUNOL, V175, P5774, DOI 10.4049/jimmunol.175.9.5774; Wang Y, 2005, J CLIN INVEST, V115, P711, DOI 10.1172/JCI200522982; Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944	32	42	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77992	10.1371/journal.pone.0077992	http://dx.doi.org/10.1371/journal.pone.0077992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205057	gold, Green Published, Green Submitted			2022-12-27	WOS:000326334500086
J	Chintapalli, VR; Al Bratty, M; Korzekwa, D; Watson, DG; Dow, JAT				Chintapalli, Venkateswara R.; Al Bratty, Mohammed; Korzekwa, Dominika; Watson, David G.; Dow, Julian A. T.			Mapping an Atlas of Tissue-Specific Drosophila melanogaster Metabolomes by High Resolution Mass Spectrometry	PLOS ONE			English	Article							HYDROPHILIC INTERACTION CHROMATOGRAPHY; HYPOXIA TOLERANCE; STRESS; MUSCLE; MUTANT; LIPIDS; LINKS	Metabolomics can provide exciting insights into organismal function, but most work on simple models has focussed on the whole organism metabolome, so missing the contributions of individual tissues. Comprehensive metabolite profiles for ten tissues from adult Drosophila melanogaster were obtained here by two chromatographic methods, a hydrophilic interaction (HILIC) method for polar metabolites and a lipid profiling method also based on HILIC, in combination with an Orbitrap Exactive instrument. Two hundred and forty two polar metabolites were putatively identified in the various tissues, and 251 lipids were observed in positive ion mode and 61 in negative ion mode. Although many metabolites were detected in all tissues, every tissue showed characteristically abundant metabolites which could be rationalised against specific tissue functions. For example, the cuticle contained high levels of glutathione, reflecting a role in oxidative defence; the alimentary canal (like vertebrate gut) had high levels of acylcarnitines for fatty acid metabolism, and the head contained high levels of ether lipids. The male accessory gland uniquely contained decarboxylated S-adenosylmethionine. These data thus both provide valuable insights into tissue function, and a reference baseline, compatible with the FlyAtlas.org transcriptomic resource, for further metabolomic analysis of this important model organism, for example in the modelling of human inborn errors of metabolism, aging or metabolic imbalances such as diabetes.	[Al Bratty, Mohammed; Watson, David G.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Chintapalli, Venkateswara R.; Korzekwa, Dominika; Dow, Julian A. T.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland	University of Strathclyde; University of Glasgow	Dow, JAT (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland.	Julian.Dow@glasgow.ac.uk	Dow, Julian/M-2371-2019; Albratty, Mohammed/AHD-1350-2022	Dow, Julian/0000-0002-9595-5146; 	Wellcome Trust; BBSRC (Biotechnology and Biological Sciences Research Council); University of Glasgow; University of Strathclyde; Biotechnology and Biological Sciences Research Council [BB/K019953/1, BB/J002143/1] Funding Source: researchfish; BBSRC [BB/J002143/1, BB/K019953/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC (Biotechnology and Biological Sciences Research Council)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Glasgow; University of Strathclyde; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Wellcome Trust, the BBSRC (Biotechnology and Biological Sciences Research Council), and by general funds of the Universities of Glasgow and Strathclyde. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Bratty M, 2011, METABOLOMICS, V7, P542, DOI 10.1007/s11306-011-0275-6; Andrews J, 2000, GENOME RES, V10, P2030, DOI 10.1101/gr.10.12.2030; BLOMQUIST GJ, 1987, ARCH INSECT BIOCHEM, V6, P227, DOI 10.1002/arch.940060404; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Buch S, 2009, FLY, V3, P74, DOI 10.4161/fly.3.1.7795; Carvalho M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.29; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Chintapalli VR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032577; Colinet H, 2012, FUNCT ECOL, V26, P711, DOI 10.1111/j.1365-2435.2012.01985.x; Coquin L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.71; Creek DJ, 2011, ANAL CHEM, V83, P8703, DOI 10.1021/ac2021823; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; ELIAS MS, 1983, J NEUROCHEM, V41, P562, DOI 10.1111/j.1471-4159.1983.tb04776.x; Feala JD, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100139; FRAENKEL G, 1948, NATURE, V161, P981, DOI 10.1038/161981a0; Green MM, 2010, GENETICS, V184, P3, DOI 10.1534/genetics.109.110015; HUBBY JL, 1962, GENETICS, V47, P109; Jackson AA, 1997, ARCH DIS CHILD-FETAL, V76, pF152, DOI 10.1136/fn.76.3.F152; Jeulin C, 1996, HUM REPROD UPDATE, V2, P87, DOI 10.1093/humupd/2.2.87; Kamleh A, 2008, RAPID COMMUN MASS SP, V22, P1912, DOI 10.1002/rcm.3564; Kamleh MA, 2008, FEBS LETT, V582, P2916, DOI 10.1016/j.febslet.2008.07.029; Kamleh MA, 2008, BRIEF FUNCT GENOMIC; Kamleh MA, 2009, FEBS J, V276, P6798, DOI 10.1111/j.1742-4658.2009.07397.x; Kostal V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025025; Malmendal A, 2006, AM J PHYSIOL-REG I, V291, pR205, DOI 10.1152/ajpregu.00867.2005; Malmendal A, 2013, NATURWISSENSCHAFTEN, V100, P417, DOI 10.1007/s00114-013-1040-7; Niewiadomska P, 1999, J CELL BIOL, V144, P533, DOI 10.1083/jcb.144.3.533; Overgaard J, 2007, J INSECT PHYSIOL, V53, P1218, DOI 10.1016/j.jinsphys.2007.06.012; Pan L, 2007, CELL STEM CELL, V1, P458, DOI 10.1016/j.stem.2007.09.010; Parisi Michael, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-198; Park JS, 2009, AGING-US, V1, P637, DOI 10.18632/aging.100054; Pedersen KS, 2008, GENETICS, V180, P1233, DOI 10.1534/genetics.108.089144; Quan GX, 2002, MOL GENET GENOMICS, V267, P1, DOI 10.1007/s00438-001-0629-2; Reisse S, 2001, BIOL REPROD, V64, P1689, DOI 10.1095/biolreprod64.6.1689; Rera M, 2012, P NATL ACAD SCI USA, V109, P21528, DOI 10.1073/pnas.1215849110; ROBITAILLE PA, 1986, J EXP ZOOL, V238, P89, DOI 10.1002/jez.1402380111; Shekhawat Prem S, 2013, J Crohns Colitis, V7, pe197, DOI 10.1016/j.crohns.2012.08.011; Simpson S. J., 2012, INSECTS STRUCTURE FU; SULLIVAN DT, 1980, BIOCHEM GENET, V18, P1109, DOI 10.1007/BF00484342; TEARLE R, 1991, GENET RES, V57, P257, DOI 10.1017/S0016672300029402; TREHERNE JE, 1957, J EXP BIOL, V34, P478; Vereshchagina N, 2006, DEVELOPMENT, V133, P4731, DOI 10.1242/dev.02659; Watson DG, 2013, COMPUT STRUCT BIOTEC, V4, DOI 10.5936/csbj.201301005; Wolfner MF, 1997, INSECT BIOCHEM MOLEC, V27, P179, DOI 10.1016/S0965-1748(96)00084-7; Zheng LA, 2010, RAPID COMMUN MASS SP, V24, P2074, DOI 10.1002/rcm.4618	45	50	51	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78066	10.1371/journal.pone.0078066	http://dx.doi.org/10.1371/journal.pone.0078066			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205093	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000326270700070
J	Martins, LA; Fogaca, AC; Bijovsky, AT; Carballar-Lejarazu, R; Marinotti, O; Cardoso, AF				Martins, Larissa A.; Fogaca, Andrea C.; Tania Bijovsky, A.; Carballar-Lejarazu, Rebeca; Marinotti, Osvaldo; Cardoso, Andre F.			Culex quinquefasciatus Storage Proteins	PLOS ONE			English	Article							WEST-NILE-VIRUS; INSECTICIDE RESISTANCE; MOLECULAR-CLONING; AEDES-AEGYPTI; FAT-BODY; VITELLOGENIN SYNTHESIS; ARTHROPOD HEMOCYANINS; VECTOR COMPETENCE; PIPIENS DIPTERA; MOSQUITO	Insect storage proteins accumulate at high levels during larval development of holometabolous insects. During metamorphosis they are degraded, supplying energy and amino acids for the completion of adult development. The genome of Culex quinquefasciatus contains eleven storage protein-coding genes. Their transcripts are more abundant in larvae than in pupae and in adults. In fact, only four of these genes are transcribed in adults, two of which in blood-fed adult females but not in adult males. Transcripts corresponding to all Cx. quinquefasciatus storage proteins were detected by RTPCR, while mass spectrometric analysis of larval and pupal proteins identified all storage proteins with the exception of one encoded by Cq LSP1.8. Our results indicate that the identified Cx. quinquefasciatus storage protein-coding genes are candidates for identifying regulatory sequences for the development of molecular tools for vector control.	[Martins, Larissa A.; Fogaca, Andrea C.; Tania Bijovsky, A.; Cardoso, Andre F.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, Brazil; [Carballar-Lejarazu, Rebeca; Marinotti, Osvaldo] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA	Universidade de Sao Paulo; University of California System; University of California Irvine	Cardoso, AF (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, Brazil.	andreculex@gmail.com	Fogaca, Andrea/C-1322-2012; Fogaca, Andrea C/M-4267-2013; Martins, Larissa Almeida/M-4748-2013	Martins, Larissa Almeida/0000-0001-8127-6276; Marinotti, Osvaldo/0000-0002-7173-7160; Fogaca, Andrea/0000-0002-0890-6136; Carballar Lejarazu, Rebeca/0000-0002-9338-8774	FAPESP [2010/51241-0, 13/09211-4]; FAPESP fellowship; CAPES fellowship	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP fellowship(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES fellowship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by FAPESP (2010/51241-0 and 13/09211-4). During this work LAM was supported by FAPESP fellowship. AFC was supported by FAPESP and CAPES fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Allen ML, 2001, J MED ENTOMOL, V38, P701, DOI 10.1603/0022-2585-38.5.701; Amenya DA, 2010, J INSECT PHYSIOL, V56, P1414, DOI 10.1016/j.jinsphys.2010.04.013; Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; BEINTEMA JJ, 1994, MOL BIOL EVOL, V11, P493; Bracco JE, 1999, MEM I OSWALDO CRUZ, V94, P115, DOI 10.1590/S0074-02761999000100022; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burmester T, 1999, EUR J ENTOMOL, V96, P213; Burmester T, 1996, J MOL EVOL, V42, P713, DOI 10.1007/BF02338804; Capurro MD, 2000, INSECT MOL BIOL, V9, P169, DOI 10.1046/j.1365-2583.2000.00173.x; Cardoso AF, 2010, MEM I OSWALDO CRUZ, V105, P254, DOI 10.1590/S0074-02762010000300003; Cruz CE, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-63; Davey K, 2007, J INSECT PHYSIOL, V53, P1, DOI 10.1016/j.jinsphys.2006.10.005; FALLON AM, 1974, J INSECT PHYSIOL, V20, P1815, DOI 10.1016/0022-1910(74)90211-X; FAY R. W., 1959, MOSQUITO NEWS, V19, P144; Federici BA, 2007, J AM MOSQUITO CONTR, V23, P164, DOI 10.2987/8756-971X(2007)23[164:DRBFCO]2.0.CO;2; Gordadze AV, 1999, INSECT MOL BIOL, V8, P55, DOI 10.1046/j.1365-2583.1999.810055.x; Gupta R, 2004, PREDICTION N GLYCOSY; Hall T, BIOEDIT; Hamer GL, 2008, J MED ENTOMOL, V45, P125, DOI 10.1603/0022-2585(2008)45[125:CPDCAB]2.0.CO;2; Haunerland NH, 1996, INSECT BIOCHEM MOLEC, V26, P755, DOI 10.1016/S0965-1748(96)00035-5; Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003; JONES G, 1990, J BIOL CHEM, V265, P8596; Korochkina SE, 1997, INSECT BIOCHEM MOLEC, V27, P813, DOI 10.1016/S0965-1748(97)00053-2; Lacey LA, 2007, J AM MOSQUITO CONTR, V23, P133, DOI 10.2987/8756-971X(2007)23[133:BTSIAB]2.0.CO;2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Levenbook L., 1985, P307; LINZEN B, 1989, NATURWISSENSCHAFTEN, V76, P206, DOI 10.1007/BF00627687; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahanta B., 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P804; Malafronte RD, 2003, INSECT BIOCHEM MOLEC, V33, P63, DOI 10.1016/S0965-1748(02)00168-6; Martins JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029006; Martins JR, 2008, J INSECT PHYSIOL, V54, P867, DOI 10.1016/j.jinsphys.2008.03.009; Megy K, 2012, NUCLEIC ACIDS RES, V40, pD729, DOI 10.1093/nar/gkr1089; MUNN EA, 1969, J INSECT PHYSIOL, V15, P1935, DOI 10.1016/0022-1910(69)90023-7; Nauen R, 2007, PEST MANAG SCI, V63, P628, DOI 10.1002/ps.1406; Paiva-Silva GO, 2006, P NATL ACAD SCI USA, V103, P8030, DOI 10.1073/pnas.0602224103; Pan M L, 2001, J Insect Sci, V1, P2; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; RAIKHEL AS, 1987, TISSUE CELL, V19, P515, DOI 10.1016/0040-8166(87)90045-0; Raikhel AS, 2002, INSECT BIOCHEM MOLEC, V32, P1275, DOI 10.1016/S0965-1748(02)00090-5; RAIKHEL AS, 1983, TISSUE CELL, V15, P281, DOI 10.1016/0040-8166(83)90023-X; REDFERN CPF, 1982, J INSECT PHYSIOL, V28, P97, DOI 10.1016/0022-1910(82)90117-2; ROBERTS DB, 1981, EXPERIENTIA, V37, P103, DOI 10.1007/BF01963174; Roy SG, 2007, INSECT BIOCHEM MOLEC, V37, P1317, DOI 10.1016/j.ibmb.2007.08.004; Sardelis MR, 2001, EMERG INFECT DIS, V7, P1018, DOI 10.3201/eid0706.010617; Seo SJ, 1998, ARCH INSECT BIOCHEM, V37, P115, DOI 10.1002/(SICI)1520-6327(1998)37:2&lt;115::AID-ARCH1&gt;3.0.CO;2-T; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Simons FER, 2001, INT ARCH ALLERGY IMM, V124, P403, DOI 10.1159/000053771; TELFER WH, 1991, ANNU REV ENTOMOL, V36, P205, DOI 10.1146/annurev.en.36.010191.001225; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vaidyanathan R, 2007, VECTOR-BORNE ZOONOT, V7, P193, DOI 10.1089/vbz.2006.0589; VAUGHAN A, 1995, J BIOL CHEM, V270, P17044, DOI 10.1074/jbc.270.28.17044; Wheeler DE, 1996, J INSECT PHYSIOL, V42, P961, DOI 10.1016/0022-1910(96)00049-2; Wheeler DE, 2000, J INSECT PHYSIOL, V46, P951, DOI 10.1016/S0022-1910(99)00202-4; WILLOTT E, 1989, J BIOL CHEM, V264, P19052; Zakharkin SO, 1997, EUR J BIOCHEM, V246, P719, DOI 10.1111/j.1432-1033.1997.t01-1-00719.x; Zakharkin SO, 2001, EUR J BIOCHEM, V268, P5713, DOI 10.1046/j.0014-2956.2001.02514.x	58	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77664	10.1371/journal.pone.0077664	http://dx.doi.org/10.1371/journal.pone.0077664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204911	gold, Green Published			2022-12-27	WOS:000326270700047
J	Moreno-Letelier, A; Ortiz-Medrano, A; Pinero, D				Moreno-Letelier, Alejandra; Ortiz-Medrano, Alejandra; Pinero, Daniel			Niche Divergence versus Neutral Processes: Combined Environmental and Genetic Analyses Identify Contrasting Patterns of Differentiation in Recently Diverged Pine Species	PLOS ONE			English	Article							CHLOROPLAST DNA-SEQUENCES; PHYLOGEOGRAPHIC STRUCTURE; NONCODING REGIONS; UNIVERSAL PRIMERS; MITOCHONDRIAL; DELIMITATION; DIVERSITY; NUCLEAR; MODELS; MICROSATELLITES	Background and Aims: Solving relationships of recently diverged taxa, poses a challenge due to shared polymorphism and weak reproductive barriers. Multiple lines of evidence are needed to identify independently evolving lineages. This is especially true of long-lived species with large effective population sizes, and slow rates of lineage sorting. North American pines are an interesting group to test this multiple approach. Our aim is to combine cytoplasmic genetic markers with environmental information to clarify species boundaries and relationships of the species complex of Pinus flexilis, Pinus ayacahuite, and Pinus strobiformis. Methods: Mitochondrial and chloroplast sequences were combined with previously obtained microsatellite data and contrasted with environmental information to reconstruct phylogenetic relationships of the species complex. Ecological niche models were compared to test if ecological divergence is significant among species. Key Results and Conclusion: Separately, both genetic and ecological evidence support a clear differentiation of all three species but with different topology, but also reveal an ancestral contact zone between P. strobiformis and P. ayacahuite. The marked ecological differentiation of P. flexilis suggests that ecological speciation has occurred in this lineage, but this is not reflected in neutral markers. The inclusion of environmental traits in phylogenetic reconstruction improved the resolution of internal branches. We suggest that combining environmental and genetic information would be useful for species delimitation and phylogenetic studies in other recently diverged species complexes.	[Moreno-Letelier, Alejandra; Ortiz-Medrano, Alejandra; Pinero, Daniel] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Moreno-Letelier, A (corresponding author), Imperial Coll London, Div Biol, Ascot, Berks, England.	a.moreno-letelier@imperial.ac.uk	Moreno-Letelier, Alejandra/AAF-8400-2020	Moreno-Letelier, Alejandra/0000-0001-7524-7639; Pinero, Daniel/0000-0002-2509-2445	CONACYT [0201/A1, 173276]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This project was funded by CONACYT (http://www.conacyt.mx), grant number 0201/A1 to Daniel Pinero and doctoral fellowship no. 173276 to Alejandra Moreno-Letelier. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anducho-Reyes MA, 2008, MOL PHYLOGENET EVOL, V49, P930, DOI 10.1016/j.ympev.2008.09.005; Ann W, 2007, MOL BIOL EVOL, V24, P90, DOI 10.1093/molbev/msl131; Bower AD, 2011, US FOR SERV RMRS-P, V63, P98; Bryson RW, 2011, J BIOGEOGR, V38, P697, DOI 10.1111/j.1365-2699.2010.02431.x; Arteaga MC, 2011, EVOLUTION, V65, P2470, DOI 10.1111/j.1558-5646.2011.01329.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Delgado P, 2007, INT J PLANT SCI, V168, P861, DOI 10.1086/518260; DEMESURE B, 1995, MOL ECOL, V4, P129, DOI 10.1111/j.1365-294X.1995.tb00201.x; Doyle J. J., 1987, PHYTOCHEM B, P11; Drouin G, 2008, MOL PHYLOGENET EVOL, V49, P827, DOI 10.1016/j.ympev.2008.09.009; Du FK, 2009, MOL ECOL, V18, P1396, DOI 10.1111/j.1365-294X.2009.04107.x; DumolinLapegue S, 1997, GENETICS, V146, P1475; Gernandt DS, 2008, INT J PLANT SCI, V169, P1086, DOI 10.1086/590472; Gernandt DS, 2005, TAXON, V54, P29, DOI 10.2307/25065300; GIBBARD P.L., 2005, GEOLOGIC TIME SCALE, P441, DOI DOI 10.1017/CBO9780511536045.023; Gonzalez-Rodriguez A, 2004, MOL ECOL, V13, P3467, DOI 10.1111/j.1365-294X.2004.02344.x; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Gugger PF, 2010, MOL ECOL, V19, P1877, DOI 10.1111/j.1365-294X.2010.04622.x; Gutierrez-Rodriguez C, 2011, MOL PHYLOGENET EVOL, V61, P603, DOI 10.1016/j.ympev.2011.08.023; Harrington RC, 2012, SYST BIOL, V61, P63, DOI 10.1093/sysbio/syr077; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jaramillo-Correa JP, 2006, MOL ECOL, V15, P2787, DOI 10.1111/j.1365-294X.2006.02974.x; Knowles LL, 2007, CURR BIOL, V17, P940, DOI 10.1016/j.cub.2007.04.033; Kozak KH, 2006, EVOLUTION, V60, P2604, DOI 10.1111/j.0014-3820.2006.tb01893.x; Leache AD, 2009, P NATL ACAD SCI USA, V106, P12418, DOI 10.1073/pnas.0906380106; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liston A, 2007, MOL ECOL, V16, P3926, DOI 10.1111/j.1365-294X.2007.03461.x; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Martinez M., 1948, PINOS MEXICANOS; McCormack JE, 2010, EVOLUTION, V64, P1231, DOI 10.1111/j.1558-5646.2009.00900.x; Mendoza CFV, 2006, CAN J BOT, V84, P172, DOI 10.1139/b05-138; Moreno-Letelier A, 2009, J BIOGEOGR, V36, P121, DOI 10.1111/j.1365-2699.2008.02001.x; Navascues M, 2005, MOL ECOL, V14, P1333, DOI 10.1111/j.1365-294X.2005.02504.x; Navascues M, 2006, MOL ECOL, V15, P2691, DOI 10.1111/j.1365-294X.2006.02960.x; Ortiz Medrano A, 2008, B SOC BOT MEX, V83, P25; Parducci L, 1999, THEOR APPL GENET, V98, P802, DOI 10.1007/s001220051137; Perez de la Rosa JA, 1993, THESIS COLEGIO POSTG; Perry JP., 1991, PINES MEXICO CENTRAL; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Provan J, 2001, TRENDS ECOL EVOL, V16, P142, DOI 10.1016/S0169-5347(00)02097-8; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; Reeves PA, 2011, SYST BIOL, V60, P45, DOI 10.1093/sysbio/syq056; Richardson BA, 2002, MOL ECOL, V11, P215, DOI 10.1046/j.1365-294X.2002.01435.x; Richardson David M., 1998, P3; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Rivera PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022199; Rosenberg NA, 2003, EVOLUTION, V57, P1465, DOI 10.1554/03-012; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Salas-Lizana R, 2012, MYCOL PROG, V11, P569, DOI 10.1007/s11557-011-0774-x; Samano S, 2003, ECOSCIENCE, V10, P319, DOI 10.1080/11956860.2003.11682780; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Strasburg JL, 2012, PHILOS T R SOC B, V367, P364, DOI 10.1098/rstb.2011.0199; Styles B.T., 1997, FLORA NEOTROPICA PIN; Syring J, 2005, AM J BOT, V92, P2086, DOI 10.3732/ajb.92.12.2086; Syring J, 2007, SYST BIOL, V56, P163, DOI 10.1080/10635150701258787; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Whittall JB, 2010, MOL ECOL, V19, P100, DOI 10.1111/j.1365-294X.2009.04474.x; Williams CG, 2010, AM J BOT, V97, P846, DOI 10.3732/ajb.0900255; Willyard A, 2009, MOL PHYLOGENET EVOL, V52, P498, DOI 10.1016/j.ympev.2009.02.011; Wu JY, 1998, GENETICS, V150, P1605; Zhang C, 2011, SYST BIOL, V60, P747, DOI 10.1093/sysbio/syr071	69	17	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78228	10.1371/journal.pone.0078228	http://dx.doi.org/10.1371/journal.pone.0078228			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205167	gold, Green Published, Green Submitted			2022-12-27	WOS:000326270700085
J	Ni, J; Reinhardt, JD; Zhang, X; Xiao, MY; Li, L; Jin, H; Zeng, XM; Li, JA				Ni, Jun; Reinhardt, Jan D.; Zhang, Xia; Xiao, Mingyue; Li, Ling; Jin, Hong; Zeng, Xianmin; Li, Jianan			Dysfunction and Post-Traumatic Stress Disorder in Fracture Victims 50 Months after the Sichuan Earthquake	PLOS ONE			English	Article							SPINAL-CORD-INJURY; QUALITY-OF-LIFE; MENTAL-HEALTH; PHYSICAL REHABILITATION; FUNCTIONAL OUTCOMES; ADULT SURVIVORS; FOLLOW-UP; EXERCISE; DISASTER; COMMUNITY	Background: This study aimed to evaluate the effectiveness of a rehabilitation intervention on physical dysfunction (PDF) and post-traumatic stress disorder (PTSD) in fracture victims 50 months after the Sichuan earthquake of 2008 and to identify risk factors for PTSD. Methods: This is a retrospective cohort study. Four hundred and fifty-nine earthquake-related fracture victims from Mianzhu city, Sichuan Province who did not qualify for disability pension participated. Two hundred and forty-five subjects received regular rehabilitation and 214 did not. Muscle strength, joint range of motion (ROM), sensory function, and sit-to-stand balance capacity were evaluated to assess PDF. The PTSD Checklist-Civilian Version (PCL-C) was administered to screen for PTSD. An ordinary least square regression was used to predict PTSD, and a logistic regression was used to predict PDF. In addition a Least Angle Regression (LARS) was carried out for PTSD to study the effects of rehabilitation and PDF at the same time. Results: Unadjusted and adjusted group differences in physical dysfunction (p<0.01) and PTSD prevalence (p<0.05) were significant in favor of the rehabilitation group. In addition, being female, average or above family income, having witnessed death and fearfulness were found risk factors for PTSD symptoms 50 months after the earthquake. Both PDF and rehabilitation were selected predictors by LARS demonstrating opposite effects. Conclusion: PDF and PTSD were significantly reduced by the rehabilitation intervention. Future medical intervention strategies should consider rehabilitation in order to assist survivors in dealing with both physical and psychological effects of natural disaster.	[Ni, Jun; Zhang, Xia; Xiao, Mingyue; Li, Ling; Li, Jianan] Nanjing Med Univ, Affiliated Hosp 1, Dept Rehabil Med, Nanjing, Jiangsu, Peoples R China; [Ni, Jun] Nantong Univ, Affiliated Hosp 1, Dept Rehabil Med, Nantong, Peoples R China; [Ni, Jun; Zhang, Xia; Xiao, Mingyue; Li, Ling] Caring Children Fdn, Hong Kong, Hong Kong, Peoples R China; [Reinhardt, Jan D.] Sichuan Univ, Inst Disaster Management & Reconstruct, Chengdu 610064, Peoples R China; [Reinhardt, Jan D.] Hong Kong Polytech Univ, Hong Kong, Hong Kong, Peoples R China; [Reinhardt, Jan D.; Zhang, Xia; Li, Jianan] Int Soc Phys & Rehabil Med, Comm Rehabil Disaster Relief, Geneva, Switzerland; [Reinhardt, Jan D.] Swiss Parapleg Res, Dept Human Functioning Sci, Nottwil, Switzerland; [Reinhardt, Jan D.] Univ Lucerne, Dept Hlth Sci & Hlth Policy, Luzern, Switzerland	Nanjing Medical University; Nantong University; Sichuan University; Hong Kong Polytechnic University; Swiss Paraplegic Research; University of Lucerne	Li, JA (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Rehabil Med, Nanjing, Jiangsu, Peoples R China.	lijianan@carm.org.cn			Hong Kong Caring for Children Foundation; Handicap International	Hong Kong Caring for Children Foundation; Handicap International	The study was supported by the Hong Kong Caring for Children Foundation and Handicap International. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTH J, 2005, PSYCHOSOC MED, V2; Blanchard EB, 1997, J TRAUMA STRESS, V10, P215, DOI 10.1023/A:1024826028483; Castillo RC, 2008, ARCH PHYS MED REHAB, V89, P1873, DOI 10.1016/j.apmr.2008.01.032; *CHIN SCIOO, 2008, UPD STAT REP WENCH E; Chou YJ, 2003, INT J EPIDEMIOL, V32, P1007, DOI 10.1093/ije/dyg296; Conybeare D, 2012, J CLIN PSYCHOL, V68, P699, DOI 10.1002/jclp.21845; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Fan F, 2011, J TRAUMA STRESS, V24, P44, DOI 10.1002/jts.20599; Gosney J, 2011, J REHABIL MED, V43, P965, DOI 10.2340/16501977-0890; Grubaugh AL, 2007, DEPRESS ANXIETY, V24, P124, DOI 10.1002/da.20226; Hu XR, 2012, J REHABIL MED, V44, P200, DOI 10.2340/16501977-0944; Jakupcak M, 2008, J NERV MENT DIS, V196, P425, DOI 10.1097/NMD.0b013e31817108ed; Jia ZB, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-172; Kun P, 2009, PUBLIC HEALTH, V123, P703, DOI 10.1016/j.puhe.2009.09.017; Kun P, 2009, DEPRESS ANXIETY, V26, P1134, DOI 10.1002/da.20612; Li YQ, 2012, J REHABIL MED, V44, P534, DOI 10.2340/16501977-1005; Ma XH, 2011, PSYCHIAT RES, V189, P385, DOI [10.1016/j.psychres.2010.12.016, 10.1016/j.psychres.2011.02.016]; Mayou R, 1997, PSYCHOSOM MED, V59, P578, DOI 10.1097/00006842-199711000-00004; Pandya A, 2013, CAN J PSYCHIAT, V58, P128, DOI 10.1177/070674371305800302; Phillips MR, 2013, LANCET, V381, P1964, DOI 10.1016/S0140-6736(13)61177-0; PRICE M, 2013, J TELEMED TELECARE; Rosenbaum S, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-115; Salcioglu E, 2007, DISASTERS, V31, P115, DOI 10.1111/j.1467-7717.2007.01000.x; Samuelkamaleshkumar S, 2010, ARCH PHYS MED REHAB, V91, P1117, DOI 10.1016/j.apmr.2010.04.005; Schulz KH, 2012, BUNDESGESUNDHEITSBLA, V55, P55, DOI 10.1007/s00103-011-1387-x; Stratta P, 2012, ANN I SUPER SANITA, V48, P132, DOI 10.4415/ANN_12_02_05; Tordeurs D, 2011, ENCEPHALE, V37, P345, DOI 10.1016/j.encep.2011.02.003; van Griensven F, 2006, JAMA-J AM MED ASSOC, V296, P537, DOI 10.1001/jama.296.5.537; Wang L, 2009, J TRAUMA STRESS, V22, P444, DOI 10.1002/jts.20439; Wen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043081; Xiao MY, 2011, J REHABIL MED, V43, P515, DOI 10.2340/16501977-0813; You CM, 2009, J PUBLIC HEALTH POL, V30, P379, DOI 10.1057/jphp.2009.30; Yzermans CJ, 2005, INT J EPIDEMIOL, V34, P820, DOI 10.1093/ije/dyi096; Zhang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053995; Zhang X, 2012, J REHABIL MED, V44, P206, DOI 10.2340/16501977-0945	35	16	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77535	10.1371/journal.pone.0077535	http://dx.doi.org/10.1371/journal.pone.0077535			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	242VF	24204861	gold, Green Published, Green Submitted			2022-12-27	WOS:000326270700036
J	Xiao, F; Liu, DR; Guo, YQ; Shi, B; Song, ZY; Tian, YC; Liang, CY				Xiao, Fei; Liu, Deruo; Guo, Yongqing; Shi, Bin; Song, Zhiyi; Tian, Yanchu; Liang, Chaoyang			Novel and Convenient Method to Evaluate the Character of Solitary Pulmonary Nodule-Comparison of Three Mathematical Prediction Models and Further Stratification of Risk Factors	PLOS ONE			English	Article							GUIDELINES 2ND EDITION; LUNG-CANCER; PROBABILITY; MALIGNANCY; CT; VALIDATION	Objective: To study risk factors that affect the evaluation of malignancy in patients with solitary pulmonary nodules (SPN) and verify different predictive models for malignant probability of SPN. Methods: Retrospectively analyzed 107 cases of SPN with definite post-operative histological diagnosis whom underwent surgical procedures in China-Japan Friendship Hospital from November of 2010 to February of 2013. Age, gender, smoking history, malignancy history of patients, imaging features of the nodule including maximum diameter, position, spiculation, lobulation, calcification and serum level of CEA and Cyfra21-1 were assessed as potential risk factors. Univariate analysis model was used to establish statistical correlation between risk factors and post-operative histological diagnosis. Receiver operating characteristic (ROC) curves were drawn using different predictive models for malignant probability of SPN to get areas under the curves (AUC values), sensitivity, specificity, positive predictive values, negative predictive values for each model, respectively. The predictive effectiveness of each model was statistically assessed subsequently. Results: In 107 patients, 78 cases were malignant (72.9%), 29 cases were benign (27.1%). Statistical significant difference was found between benign and malignant group in age, maximum diameter, serum level of Cyfra21-1, spiculation, lobulation and calcification of the nodules. The AUC values were 0.786 +/- 0.053 (Mayo model), 0.682 +/- 0.060 (VA model) and 0.810 +/- 0.051 (Peking University People's Hospital model), respectively. Conclusions: Serum level of Cyfra21-1, patient's age, maximum diameter of the nodule, spiculation, lobulation and calcification of the nodule are independent risk factors associated with the malignant probability of SPN. Peking University People's Hospital model is of high accuracy and clinical value for patients with SPN. Adding serum index (e. g. Cyfra21-1) into the prediction models as a new risk factor and adjusting the weight of age in the models might improve the accuracy of prediction for SPN.	[Xiao, Fei; Liu, Deruo; Guo, Yongqing; Shi, Bin; Song, Zhiyi; Tian, Yanchu; Liang, Chaoyang] China Japan Friendship Hosp, Dept Thorac Surg, Beijing, Peoples R China	China-Japan Friendship Hospital	Liang, CY (corresponding author), China Japan Friendship Hosp, Dept Thorac Surg, Beijing, Peoples R China.	chaoyangliang@hotmail.com						Albert RH, 2009, AM FAM PHYSICIAN, V80, P827; Ambrosini V, 2012, EUR J RADIOL, V81, P988, DOI 10.1016/j.ejrad.2011.03.020; Dela Cruz CS, 2011, CLIN CHEST MED, V32, P605, DOI 10.1016/j.ccm.2011.09.001; Gould MK, 2007, CHEST, V132, p108S, DOI 10.1378/chest.07-1353; Gould MK, 2007, CHEST, V131, P383, DOI 10.1378/chest.06-1261; Kupert E, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-513; Li Y, 2012, WORLD J SURG, V36, P830, DOI 10.1007/s00268-012-1449-8; Li Yun, 2011, Beijing Da Xue Xue Bao Yi Xue Ban, V43, P450; Mery CM, 2004, CHEST, V125, P2175, DOI 10.1378/chest.125.6.2175; Mikita K, 2012, EUR J RADIOL, V81, pE548, DOI 10.1016/j.ejrad.2011.06.032; Nair A, 2011, EUR RADIOL, V21, P2445, DOI 10.1007/s00330-011-2219-y; Schultz EM, 2008, THORAX, V63, P335, DOI 10.1136/thx.2007.084731; Shen J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-374; Swensen SJ, 1997, ARCH INTERN MED, V157, P849, DOI 10.1001/archinte.157.8.849; Swensen SJ, 2000, RADIOLOGY, V214, P73, DOI 10.1148/radiology.214.1.r00ja1473; Takashima S, 2003, AM J ROENTGENOL, V180, P955, DOI 10.2214/ajr.180.4.1800955; Tan BB, 2003, CHEST, V123, p89S, DOI 10.1378/chest.123.1_suppl.89S; Vineis P, 2006, INT J CANCER, V119, P169, DOI 10.1002/ijc.21801; Wahidi MM, 2007, CHEST, V132, p94S, DOI 10.1378/chest.07-1352; Yonemori K, 2007, RESPIROLOGY, V12, P856, DOI 10.1111/j.1440-1843.2007.01158.x	20	18	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78271	10.1371/journal.pone.0078271	http://dx.doi.org/10.1371/journal.pone.0078271			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205175	Green Published, gold, Green Submitted			2022-12-27	WOS:000326270700087
J	Gao, JL; McIntyre, MSF; D'Souza, CA; Zhang, L				Gao, Julia; McIntyre, Megan S. Ford; D'Souza, Cheryl A.; Zhang, Li			Pretransplant Infusion of Donor B Cells Enhances Donor-Specific Skin Allograft Survival	PLOS ONE			English	Article							REGULATORY T-CELLS; TRANSPLANTATION TOLERANCE; LYMPHOCYTE INFUSION; IN-VIVO; ANTIGEN; SUPPRESSION; COMBINATION; TRANSFUSIONS; CHIMERISM; MECHANISM	Pretransplant donor lymphocyte infusion (DLI) has been shown to enhance donor-specific allograft survival in rodents, primates and humans. However, the cell subset that is critical for the DLI effect and the mechanisms involved remain elusive. In this study, we monitored donor cell subsets after DLI in a murine MHC class I L-d-mismatched skin transplantation model. We found that donor B cells, but not DCs, are the major surviving donor APCs in recipients following DLI. Infusing donor B, but not non-B, cells resulted in significantly enhanced donor-specific skin allograft survival. Furthermore, mice that had received donor B cells showed higher expression of Ly6A and CD62L on antigen-specific TCR alpha beta(+)CD3(+)CD4(-)CD8(-)NK1.1(-) double negative (DN) regulatory T cells (Tregs). B cells presented alloantigen to DN Tregs and primed their proliferation in an antigen-specific fashion. Importantly, DN Tregs, activated by donor B cells, showed increased cytotoxicity toward anti-donor CD8(+) T cells. These data demonstrate that donor B cells can enhance skin allograft survival, at least partially, by increasing recipient DN Treg-mediated killing of anti-donor CD8(+) T cells. These findings provide novel insights into the mechanisms underlying DLI-induced transplant tolerance and suggest that DN Tregs have great potential as an antigen-specific immune therapy to enhance allograft survival.	[Gao, Julia; McIntyre, Megan S. Ford; D'Souza, Cheryl A.; Zhang, Li] Univ Hlth Network, Univ Toronto, Inst Transplantat, Toronto Gen Res Inst, Toronto, ON, Canada; [Gao, Julia; Zhang, Li] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [McIntyre, Megan S. Ford; Zhang, Li] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto	Zhang, L (corresponding author), Univ Hlth Network, Univ Toronto, Inst Transplantat, Toronto Gen Res Inst, Toronto, ON, Canada.	lzhang@uhnres.utoronto.ca			Canadian Institutes of Health Research [MOP 14431]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canadian Institutes of Health Research Grant (MOP 14431) to LZ. LZ is the Inaugural Maria H. Bacardi Chair in Transplantation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen W, 2003, TRANSPL P, V35, P2479, DOI 10.1016/j.transproceed.2003.08.030; Chen WH, 2005, J IMMUNOL, V175, P3409, DOI 10.4049/jimmunol.175.5.3409; Dugas V, 2010, J AUTOIMMUN, V35, P23, DOI 10.1016/j.jaut.2010.01.002; Fischer K, 2005, BLOOD, V105, P2828, DOI 10.1182/blood-2004-07-2583; Flye MW, 1995, TRANSPLANTATION, V60, P1395; Ford MS, 2007, EUR J IMMUNOL, V37, P2234, DOI 10.1002/eji.200636991; Ford MS, 2002, J EXP MED, V196, P261, DOI 10.1084/jem.20020029; FUCHS EJ, 1992, SCIENCE, V258, P1156, DOI 10.1126/science.1439825; Gao JF, 2011, EUR J IMMUNOL, V41, P2699, DOI 10.1002/eji.201141428; He KM, 2007, EUR J IMMUNOL, V37, P3455, DOI 10.1002/eji.200737408; Hengel RL, 2003, J IMMUNOL, V170, P28, DOI 10.4049/jimmunol.170.1.28; HILLHOUSE EE, 2012, J AUTOIMMUN, P45237; Hoerbelt R, 2005, TRANSPLANTATION, V80, P1275, DOI 10.1097/01.tp.0000177638.56260.23; JOHNSON LL, 1988, TRANSPLANTATION, V46, P167; Juvet SC, 2012, J MOL CELL BIOL, V4, P48, DOI 10.1093/jmcb/mjr043; Kirk AD, 2010, NAT REV NEPHROL, V6, P584, DOI 10.1038/nrneph.2010.111; Klinker MW, 2012, MOL MED, V18, P123, DOI 10.2119/molmed.2011.00333; Liu BL, 2006, AM J TRANSPLANT, V6, P933, DOI 10.1111/j.1600-6143.2006.01283.x; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; McIntyre MSF, 2008, J IMMUNOL, V181, P2271, DOI 10.4049/jimmunol.181.4.2271; McIntyre MSF, 2011, INT IMMUNOPHARMACOL, V11, P597, DOI 10.1016/j.intimp.2010.11.015; McIver Z, 2008, BRIT J HAEMATOL, V141, P170, DOI 10.1111/j.1365-2141.2008.07021.x; Minagawa R, 2004, TRANSPLANTATION, V78, P799, DOI 10.1097/01.TP.0000129799.96439.6F; Prigozhina TB, 2007, TRANSPL P, V39, P678, DOI 10.1016/j.transproceed.2007.01.055; Rademacher J, 2006, Minerva Chir, V61, P85; Redfield RR, 2011, CURR OPIN IMMUNOL, V23, P685, DOI 10.1016/j.coi.2011.07.011; Sheng BD, 1999, TRANSPLANTATION, V68, P1024, DOI 10.1097/00007890-199910150-00021; SHENGTANNER X, 1992, J EXP MED, V176, P407, DOI 10.1084/jem.176.2.407; Urakami H, 2006, TRANSPLANT P, V38, P3244, DOI 10.1016/j.transproceed.2006.10.042; Young KJ, 2002, BLOOD, V100, P3408, DOI 10.1182/blood-2002-01-0235; Zhang D, 2007, BLOOD, V109, P4071, DOI 10.1182/blood-2006-10-050625; ZHANG L, 1994, J IMMUNOL, V152, P2222; Zhang ZX, 2006, J IMMUNOL, V177, P6920, DOI 10.4049/jimmunol.177.10.6920; Zhang ZX, 2000, NAT MED, V6, P782, DOI 10.1038/77513; Zhang ZX, 2002, EUR J IMMUNOL, V32, P1584, DOI 10.1002/1521-4141(200206)32:6<1584::AID-IMMU1584>3.0.CO;2-2	35	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77761	10.1371/journal.pone.0077761	http://dx.doi.org/10.1371/journal.pone.0077761			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204953	Green Published, Green Submitted, gold			2022-12-27	WOS:000326241200038
J	Kenyon, NJ; Bratt, JM; Lee, J; Luo, JT; Franzi, LM; Zeki, AA; Lam, KS				Kenyon, Nicholas J.; Bratt, Jennifer M.; Lee, Joyce; Luo, Juntao; Franzi, Lisa M.; Zeki, Amir A.; Lam, Kit S.			Self-Assembling Nanoparticles Containing Dexamethasone as a Novel Therapy in Allergic Airways Inflammation	PLOS ONE			English	Article							EXHALED NITRIC-OXIDE; CLINICAL-PRACTICE; DRUG-DELIVERY; SEVERE ASTHMA; MURINE MODEL; OVALBUMIN; SYSTEM; MICE; ANTAGONIST; MECHANISMS	Nanocarriers can deliver a wide variety of drugs, target them to sites of interest, and protect them from degradation and inactivation by the body. They have the capacity to improve drug action and decrease undesirable systemic effects. We have previously developed a well-defined non-toxic PEG-dendritic block telodendrimer for successful delivery of chemotherapeutics agents and, in these studies, we apply this technology for therapeutic development in asthma. In these proof-of-concept experiments, we hypothesized that dexamethasone contained in self-assembling nanoparticles (Dex-NP) and delivered systemically would target the lung and decrease allergic lung inflammation and airways hyper-responsiveness to a greater degree than equivalent doses of dexamethasone (Dex) alone. We found that ovalbumin (Ova)-exposed mice treated with Dex-NP had significantly fewer total cells (2.78 +/- 0.44x10(5) (n = 18) vs. 5.98 +/- 1.3x10(5) (n = 13), P<0.05) and eosinophils (1.09 +/- 0.28x10(5) (n = 18) vs. 2.94 +/- 0.6x10(5) (n = 12), p<0.05) in the lung lavage than Ova-exposed mice alone. Also, lower levels of the inflammatory cytokines IL-4 (3.43 +/- 1.2 (n = 11) vs. 8.5662.1 (n = 8) pg/ml, p<0.05) and MCP-1 (13.1 +/- 3.6 (n = 8) vs. 28.8 +/- 8.7 (n = 10) pg/ml, p<0.05) were found in lungs of the Dex-NP compared to control, and they were not lower in the Dex alone group. In addition, respiratory system resistance was lower in the Dex-NP compared to the other Ova-exposed groups suggesting a better therapeutic effect on airways hyperresponsiveness. Taken together, these findings from early-stage drug development studies suggest that the encapsulation and protection of anti-inflammatory agents such as corticosteroids in nanoparticle formulations can improve efficacy. Further development of novel drugs in nanoparticles is warranted to explore potential treatments for chronic inflammatory diseases such as asthma.	[Kenyon, Nicholas J.; Bratt, Jennifer M.; Lee, Joyce; Franzi, Lisa M.; Zeki, Amir A.; Lam, Kit S.] Univ Calif Davis, Dept Internal Med, Davis, CA 95616 USA; [Luo, Juntao; Lam, Kit S.] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Kenyon, NJ (corresponding author), Univ Calif Davis, Dept Internal Med, Davis, CA 95616 USA.	njkenyon@ucdavis.edu	Zeki, Amir A./I-3930-2019		National Heart, Lung and Blood Institute (NHLBI) [HL105573]; National Institute of Biomedical Imaging and Bioengineering (NIBIB) [EB012569]; T32 training [HL-07013, ES-07059]; National Center for Advancing Translational Sciences (NCATS) CTSC KL2 [TR000134]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105573, K08HL114882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007059] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); T32 training; National Center for Advancing Translational Sciences (NCATS) CTSC KL2; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The funding for this work was through grants from National Heart, Lung and Blood Institute (NHLBI) (HL105573) to Nicholas J. Kenyon and National Institute of Biomedical Imaging and Bioengineering (NIBIB) (EB012569) to Kit S. Lam. Jennifer Bratt was supported by T32 training Grants (HL-07013 and ES-07059). Amir Zeki was supported by National Center for Advancing Translational Sciences (NCATS) CTSC KL2 grant (TR000134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow PG, 2008, CELL BIOL TOXICOL, V24, P243, DOI 10.1007/s10565-007-9033-y; Borish LC, 1999, AM J RESP CRIT CARE, V160, P1816, DOI 10.1164/ajrccm.160.6.9808146; Bratt JM, 2010, TOXICOL APPL PHARM, V242, P1, DOI 10.1016/j.taap.2009.09.018; Chatila TA, 2008, J ALLERGY CLIN IMMUN, V121, P812, DOI 10.1016/j.jaci.2008.02.025; Chirino YI, 2010, TOXICOL LETT, V193, P209, DOI 10.1016/j.toxlet.2010.01.009; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Corren J, 2010, AM J RESP CRIT CARE, V181, P788, DOI 10.1164/rccm.200909-1448OC; Craparo EF, 2011, CNS NEUROSCI THER, V17, P670, DOI 10.1111/j.1755-5949.2010.00199.x; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; Franzi LM, 2011, TOXICOL APPL PHARM, V257, P182, DOI 10.1016/j.taap.2011.09.003; Georen SK, 2009, ACTA OTO-LARYNGOL, V129, P182, DOI 10.1080/00016480802126561; Jackson JK, 2004, INT J PHARMACEUT, V270, P185, DOI 10.1016/j.ijpharm.2003.10.010; Kenyon NJ, 2008, TOXICOL APPL PHARM, V230, P269, DOI 10.1016/j.taap.2008.03.004; Kenyon NJ, 2009, EUR J PHARMACOL, V603, P138, DOI 10.1016/j.ejphar.2008.11.063; Kenyon NJ, 2003, TOXICOL APPL PHARM, V186, P90, DOI 10.1016/S0041-008X(02)00025-X; Korideck H, 2009, J PHARMACOL EXP THER, V329, P882, DOI 10.1124/jpet.108.147579; Lewis Christina C, 2009, J Allergy Clin Immunol, V123, P795, DOI 10.1016/j.jaci.2009.01.003; Lim SB, 2012, J CONTROL RELEASE; McFadden ER, 2003, AM J RESP CRIT CARE, V168, P740, DOI 10.1164/rccm.200208-902SO; McGeehan M, 2002, MED CLIN N AM, V86, P1073, DOI 10.1016/S0025-7125(02)00034-2; Noel A, 2012, TOXICOL LETT; Peng L, 2006, NAT CHEM BIOL, V2, P381, DOI 10.1038/nchembio798; Raemy DO, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-33; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Sahib MN, 2012, DRUG DES DEV THER, V6, P29, DOI 10.2147/DDDT.S28265; Sanchez-Moreno P, 2012, INT J MOL SCI, V13, P4906, DOI 10.3390/ijms13044906; SCHLEIMER RP, 1992, J IMMUNOL, V148, P1086; Silkoff PE, 1999, CHEST, V116, P754, DOI 10.1378/chest.116.3.754; Temelkovski J, 1998, THORAX, V53, P849, DOI 10.1136/thx.53.10.849; Warheit DB, 1997, TOXICOL APPL PHARM, V145, P10, DOI 10.1006/taap.1997.8102; Wegesser TC, 2008, TOXICOL APPL PHARM, V230, P159, DOI 10.1016/j.taap.2008.02.013; Wenzel SE, 2007, J ALLERGY CLIN IMMUN, V119, P14, DOI 10.1016/j.jaci.2006.10.025; Xiao K, 2011, J CONTROL RELEASE, V155, P272, DOI 10.1016/j.jconrel.2011.07.018; Xiao K, 2011, BIOMATERIALS, V32, P3435, DOI 10.1016/j.biomaterials.2011.01.021; Xiao K, 2009, BIOMATERIALS, V30, P6006, DOI 10.1016/j.biomaterials.2009.07.015; Zeki AA, 2009, AM J RESP CRIT CARE, V180, P731, DOI 10.1164/rccm.200901-0018OC	36	32	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77730	10.1371/journal.pone.0077730	http://dx.doi.org/10.1371/journal.pone.0077730			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204939	Green Submitted, Green Published, gold			2022-12-27	WOS:000326155400053
J	Offen, N; Kang, H; Meyer, A; Begemann, G				Offen, Nils; Kang, Hyoun; Meyer, Axel; Begemann, Gerrit			Retinoic Acid Is Involved in the Metamorphosis of the Anal Fin into an Intromittent Organ, the Gonopodium, in the Green Swordtail (Xiphophorus hellerii)	PLOS ONE			English	Article							GAMBUSIA-AFFINIS AFFINIS; SEXUALLY SELECTED TRAIT; PHYLOGENETIC ANALYSIS; MITOCHONDRIAL-DNA; LIMB DEVELOPMENT; SONIC-HEDGEHOG; CAUDAL FIN; ZEBRAFISH; GENES; EXPRESSION	In poeciliid fish the male anal fin has been transformed into a gonopodium, an intromittent organ required for internal fertilization. Elevated testosterone levels induce metamorphosis of a subset of anal fin rays to grow and form the specialized terminal structures of the gonopodium. The molecular mechanisms underlying these processes are largely unknown. Here, we investigated whether retinoic acid (RA) signaling is involved in gonopodium development in the swordtail Xiphophorus hellerii. We showed that aldh1a2, a RA synthesizing enzyme, and the RA receptors, rar-ga and rar-gb, are expressed in anal fins during metamorphosis. aldh1a2 expression is regulated by testosterone in a concentration-dependent manner and is up-regulated in both hormone-induced and naturally developing gonopodia. Androgen receptor (ar), a putative regulator of gonopodial development, is co-expressed with aldh1a2 and the RA receptors in gonopodial rays. Importantly, experimental increase of RA signaling promoted growth of the gonopodium and increased the number of new segments. Based on gene expression analyses and pharmacological manipulation of gonopodium development, we show that the RA signaling pathway is activated in response to androgen signaling and promotes fin ray growth and development during the metamorphosis of the anal fin into the gonopodium.	[Offen, Nils; Kang, Hyoun; Meyer, Axel; Begemann, Gerrit] Univ Konstanz, Lehrstuhl Zool & Evolut Biol, Dept Biol, Constance, Germany; [Offen, Nils] Lund Univ, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, Dept Lab Med, Lund, Sweden; [Kang, Hyoun; Meyer, Axel] Univ Konstanz, Konstanz Res Sch Chem Biol, Constance, Germany; [Begemann, Gerrit] Univ Bayreuth, Bayreuth, Germany	University of Konstanz; Lund University; University of Konstanz; University of Bayreuth	Begemann, G (corresponding author), Univ Konstanz, Lehrstuhl Zool & Evolut Biol, Dept Biol, Constance, Germany.	gerrit.begemann@uni-bayreuth.de	Begemann, Gerrit/C-6223-2011; Meyer, Axel/C-9826-2009	Begemann, Gerrit/0000-0001-7822-7617; Meyer, Axel/0000-0002-0888-8193	Konstanz Research School Chemical Biology (KoRS-CB); University of Konstanz; Landesgraduiertenforrderung Baden-Wurttemberg; Deutsche Forschungsgemeinschaft; German Research Foundation (DFG); University of Bayreuth	Konstanz Research School Chemical Biology (KoRS-CB); University of Konstanz; Landesgraduiertenforrderung Baden-Wurttemberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Bayreuth	Support for this study came from the Konstanz Research School Chemical Biology (KoRS-CB) (JK, AM), the University of Konstanz (AM), Landesgraduiertenforrderung Baden-Wurttemberg (NO) and Deutsche Forschungsgemeinschaft (GB, AM). This publication was funded by the German Research Foundation (DFG) and the University of Bayreuth in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; AKIMENKO MA, 1995, DEV BIOL, V170, P243, DOI 10.1006/dbio.1995.1211; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Begemann G, 2001, DEVELOPMENT, V128, P3081; Blum N, 2012, DEVELOPMENT, V139, P107, DOI 10.1242/dev.065391; Campo-Paysaa F, 2008, GENESIS, V46, P640, DOI 10.1002/dvg.20444; Chazaud C, 1999, DEVELOPMENT, V126, P2589; Cohn MJ, 2011, DEV DYNAM, V240, P1108, DOI 10.1002/dvdy.22631; Duester Gregg, 2007, Birth Defects Research, V81, P84, DOI 10.1002/bdrc.20092; Dzwillo M., 1964, KOSSWIG FESTSCHRIFT, V8, P15; DZWILLO M, 1962, VERH DTSCH ZOOL GESE, P151; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GERAUDIE J, 1995, INT J DEV BIOL, V39, P373; GERAUDIE J, 1993, PROG CLIN BIOL RES, V383, P803; Ghedotti MJ, 2000, ZOOL J LINN SOC-LOND, V130, P1, DOI 10.1006/zjls.1999.0213; Gibert Y, 2006, DEVELOPMENT, V133, P2649, DOI 10.1242/dev.02438; Gordon M., 1951, B AM MUS NAT HIST, V95, P413; Grandel H, 2002, DEVELOPMENT, V129, P2851; Grandel H, 2011, DEV DYNAM, V240, P1116, DOI 10.1002/dvdy.22461; GROBSTEIN C, 1948, J EXP ZOOL, V109, P215, DOI 10.1002/jez.1401090205; GROBSTEIN C, 1947, ANAT REC, V99, P569; Grobstein C, 1942, J EXP ZOOL, V89, P305, DOI 10.1002/jez.1400890208; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hayashi Hitomi, 2007, Journal of Toxicological Sciences, V32, P91, DOI 10.2131/jts.32.91; Herfeld S, 1998, HORM BEHAV, V34, P303, DOI 10.1006/hbeh.1998.1486; Huang HFS, 1997, ENDOCRINOLOGY, V138, P553, DOI 10.1210/en.138.2.553; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jones JC, 2013, MOL ECOL, V22, P2986, DOI 10.1111/mec.12269; Kang JH, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-25; Kuraku S, 2005, EVOL DEV, V7, P3, DOI 10.1111/j.1525-142X.2005.05002.x; Laforest L, 1998, DEVELOPMENT, V125, P4175; Langer W. F., 1913, Morphologisches Jahrbuch Leipzig, V47; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maden M, 2000, P NUTR SOC, V59, P65, DOI 10.1017/S0029665100000082; Maden M, 1996, DEV GENET, V19, P85; Mercader N, 2000, DEVELOPMENT, V127, P3961; Mercader N, 2005, DEVELOPMENT, V132, P4131, DOI 10.1242/dev.01976; Mercader N, 1999, NATURE, V402, P425, DOI 10.1038/46580; MEYER A, 1993, P ROY SOC B-BIOL SCI, V254, P153, DOI 10.1098/rspb.1993.0140; Mic FA, 2004, J BIOL CHEM, V279, P26698, DOI 10.1074/jbc.M401920200; Morriss-Kay GM, 1999, INT REV CYTOL, V188, P73; Offen N, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-98; Offen N, 2009, DEV DYNAM, V238, P1674, DOI 10.1002/dvdy.21983; Ogino Y, 2004, FEBS LETT, V575, P119, DOI 10.1016/j.febslet.2004.08.046; Parenti LR, 1981, B AM MUS NAT HIST, V168, P335, DOI DOI 10.1080/00222930210135631; Pickford G.E., 1957, PHYSL PITUITARY GLAN; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rosen D. E., 1963, Bulletin of the American Museum of Natural History, V126, P1; SANGSTER W, 1948, PHYSIOL ZOOL, V21, P134, DOI 10.1086/physzool.21.2.30151990; Shimozono S, 2013, NATURE, V496, P363, DOI 10.1038/nature12037; Stange D, 2012, AQUAT TOXICOL, V106, P20, DOI 10.1016/j.aquatox.2011.10.010; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner CL, 1941, J MORPHOL, V69, P161, DOI 10.1002/jmor.1050690107; Turner CL, 1941, BIOL BULL-US, V80, P371, DOI 10.2307/1537723; TURNER CL, 1947, J EXP ZOOL, V106, P125, DOI 10.1002/jez.1401060202; TURNER CL, 1947, ANAT REC, V97, P375; WHITE JA, 1994, DEVELOPMENT, V120, P1861; WOURMS JP, 1981, AM ZOOL, V21, P473; Zauner H, 2003, EVOL DEV, V5, P466, DOI 10.1046/j.1525-142X.2003.03053.x	65	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77580	10.1371/journal.pone.0077580	http://dx.doi.org/10.1371/journal.pone.0077580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204880	Green Published, gold, Green Submitted			2022-12-27	WOS:000326155400045
J	Lubbert, M; Kyereme, J; Schobel, N; Beltran, L; Wetzel, CH; Hatt, H				Luebbert, Matthias; Kyereme, Jessica; Schoebel, Nicole; Beltran, Leopoldo; Wetzel, Christian Horst; Hatt, Hanns			Transient Receptor Potential Channels Encode Volatile Chemicals Sensed by Rat Trigeminal Ganglion Neurons	PLOS ONE			English	Article							BACKGROUND K+ CHANNEL; CAPSAICIN RECEPTOR; SENSORY NEURONS; TRP CHANNELS; ION-CHANNEL; POTASSIUM CHANNELS; DIRECT ACTIVATION; HEAT; PAIN; SYSTEM	Primary sensory afferents of the dorsal root and trigeminal ganglia constantly transmit sensory information depicting the individual's physical and chemical environment to higher brain regions. Beyond the typical trigeminal stimuli (e. g. irritants), environmental stimuli comprise a plethora of volatile chemicals with olfactory components (odorants). In spite of a complete loss of their sense of smell, anosmic patients may retain the ability to roughly discriminate between different volatile compounds. While the detailed mechanisms remain elusive, sensory structures belonging to the trigeminal system seem to be responsible for this phenomenon. In order to gain a better understanding of the mechanisms underlying the activation of the trigeminal system by volatile chemicals, we investigated odorant-induced membrane potential changes in cultured rat trigeminal neurons induced by the odorants vanillin, heliotropyl acetone, helional, and geraniol. We observed the dose-dependent depolarization of trigeminal neurons upon application of these substances occurring in a stimulus-specific manner and could show that distinct neuronal populations respond to different odorants. Using specific antagonists, we found evidence that TRPA1, TRPM8, and/or TRPV1 contribute to the activation. In order to further test this hypothesis, we used recombinantly expressed rat and human variants of these channels to investigate whether they are indeed activated by the odorants tested. We additionally found that the odorants dose-dependently inhibit two-pore potassium channels TASK1 and TASK3 heterologously expressed In Xenopus laevis oocytes. We suggest that the capability of various odorants to activate different TRP channels and to inhibit potassium channels causes neuronal depolarization and activation of distinct subpopulations of trigeminal sensory neurons, forming the basis for a specific representation of volatile chemicals in the trigeminal ganglia.	[Luebbert, Matthias; Kyereme, Jessica; Beltran, Leopoldo; Hatt, Hanns] Ruhr Univ Bochum, Dept Cell Physiol, Bochum, Germany; [Schoebel, Nicole] Univ Dortmund, Leibniz Res Ctr Working Environm & Human Factors, D-44227 Dortmund, Germany; [Wetzel, Christian Horst] Univ Regensburg, Dept Psychiat & Psychotherapy, D-93053 Regensburg, Germany	Ruhr University Bochum; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); University of Regensburg	Lubbert, M (corresponding author), Ruhr Univ Bochum, Dept Cell Physiol, Univ Str 150, Bochum, Germany.	Matthias.luebbert@rub.de	Wetzel, Christian/C-2501-2009; Wetzel, Christian H/N-9880-2017; Wetzel, Christian/F-1366-2018	Wetzel, Christian/0000-0002-5762-0003; Wetzel, Christian H/0000-0002-5762-0003; 	Deutsche Forschungsgesellschaft [SFB 874]; Ruhr University Research School	Deutsche Forschungsgesellschaft(German Research Foundation (DFG)); Ruhr University Research School	This project was funded by grants from the Deutsche Forschungsgesellschaft [SFB 874 H. H.] and the Ruhr University Research School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern GP, 2005, J NEUROSCI, V25, P5109, DOI 10.1523/JNEUROSCI.0237-05.2005; Akopian AN, 2007, J PHYSIOL-LONDON, V583, P175, DOI 10.1113/jphysiol.2007.133231; Albrecht J, 2010, BRAIN RES REV, V62, P183, DOI 10.1016/j.brainresrev.2009.11.001; Baumann TK, 2004, EUR J NEUROSCI, V19, P1343, DOI 10.1111/j.1460-9568.2004.03097.x; Bautista D, 2008, NAT NEUROSCI, V11, P528, DOI 10.1038/nn0508-528; Bautista DM, 2008, NAT NEUROSCI, V11, P772, DOI 10.1038/nn.2143; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Behrendt HJ, 2004, BRIT J PHARMACOL, V141, P737, DOI 10.1038/sj.bjp.0705652; Beltran L, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00063; BEVAN S, 1992, BRIT J PHARMACOL, V107, P544, DOI 10.1111/j.1476-5381.1992.tb12781.x; Bohlen CJ, 2012, TOXICON, V60, P254, DOI 10.1016/j.toxicon.2012.04.336; Boyle JA, 2007, CHEM SENSES, V32, P343, DOI 10.1093/chemse/bjm004; Bridges D, 2003, NEUROSCIENCE, V119, P803, DOI 10.1016/S0306-4522(03)00200-8; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; Cometto-Muniz JE, 2005, CHEM SENSES, V30, P627, DOI 10.1093/chemse/bji056; Darian-Smith I, 1973, HDB SENSORY PHYSL SO, V2, P271; DAVIES AM, 1988, DEVELOPMENT, V103, P175; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; DOTY RL, 1978, PHYSIOL BEHAV, V20, P175, DOI 10.1016/0031-9384(78)90070-7; DOTY RL, 1975, PHYSIOL BEHAV, V14, P855, DOI 10.1016/0031-9384(75)90081-5; Dubner R, 1979, NEURAL BASIS ORAL FA, P1; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Edelmayer RM, 2012, PAIN, V153, P1949, DOI 10.1016/j.pain.2012.06.012; Eid S R, 2009, Handb Exp Pharmacol, P261, DOI 10.1007/978-3-540-79090-7_8; Eid SR, 2008, MOL PAIN, V10, P1; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Frasnelli J, 2007, INT J PSYCHOPHYSIOL, V65, P177, DOI 10.1016/j.ijpsycho.2007.03.007; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Hjerling-Leffler J, 2007, J NEUROSCI, V27, P2435, DOI 10.1523/JNEUROSCI.5614-06.2007; Hummel T, 2009, ANN NY ACAD SCI, V1170, P190, DOI 10.1111/j.1749-6632.2009.03910.x; Iwasaki Y, 2009, LIFE SCI, V85, P60, DOI 10.1016/j.lfs.2009.04.017; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Jung JY, 2004, J BIOL CHEM, V279, P7048, DOI 10.1074/jbc.M311448200; Kawai F, 1999, NEUROSCI LETT, V269, P45, DOI 10.1016/S0304-3940(99)00424-3; Kim AY, 2008, CELL, V133, P475, DOI 10.1016/j.cell.2008.02.053; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; Koo JY, 2007, EUR J NEUROSCI, V26, P1139, DOI 10.1111/j.1460-9568.2007.05743.x; Laska M, 1997, CHEM SENSES, V22, P447, DOI 10.1093/chemse/22.4.447; Lazarov NE, 2002, PROG NEUROBIOL, V66, P19, DOI 10.1016/S0301-0082(01)00021-1; Liu Y, 2007, TRANSIENT RECEPTOR P, P185; Luebbert M, 2010, PFLUG ARCH EUR J PHY, V459, P737, DOI 10.1007/s00424-009-0782-8; Lundstrom JN, 2011, ACS CHEM NEUROSCI, V2, P5, DOI 10.1021/cn1000843; Maingret F, 2001, EMBO J, V20, P47, DOI 10.1093/emboj/20.1.47; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Medhurst AD, 2001, MOL BRAIN RES, V86, P101, DOI 10.1016/S0169-328X(00)00263-1; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Morris JB, 2010, INFORM HEALTHCARE, V30; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Nilius B, 2012, PFLUG ARCH EUR J PHY, V464, P425, DOI 10.1007/s00424-012-1158-z; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; Ohkawara S, 2010, BIOL PHARM BULL, V33, P1434, DOI 10.1248/bpb.33.1434; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Pingle S, 2007, TRANSIENT RECEPTOR P, P156; Radil T, 1998, ANN NY ACAD SCI, V855, P641, DOI 10.1111/j.1749-6632.1998.tb10638.x; Riera CE, 2009, BRIT J PHARMACOL, V157, P1398, DOI 10.1111/j.1476-5381.2009.00307.x; Riera CE, 2009, J NEUROSCI, V29, P2654, DOI 10.1523/JNEUROSCI.4694-08.2009; Rothermel M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026158; Schobel N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048005; Sergeeva OA, 2010, J BIOL CHEM, V285, P23985, DOI 10.1074/jbc.M110.103309; SILVER WL, 1982, PHYSIOL BEHAV, V28, P927, DOI 10.1016/0031-9384(82)90216-5; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Stotz SC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002082; Szallasi A, 1999, PHARMACOL REV, V51, P159; Talley EM, 2003, NEUROSCIENTIST, V9, P46, DOI 10.1177/1073858402239590; Tang ZX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3179; Thuerauf N, 1999, PSYCHOPHARMACOLOGY, V142, P236, DOI 10.1007/s002130050885; Tucker D., 1971, P151; Vandewauw I, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-21; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809; Viana F, 2011, ACS CHEM NEUROSCI, V2, P38, DOI 10.1021/cn100102c; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yudin Y, 2012, MOL CELL ENDOCRINOL, V353, P68, DOI 10.1016/j.mce.2011.10.023; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	82	25	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77998	10.1371/journal.pone.0077998	http://dx.doi.org/10.1371/journal.pone.0077998			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205061	Green Submitted, Green Published, gold			2022-12-27	WOS:000326032600058
J	Rosa, IMD; Purves, D; Souza, C; Ewers, RM				Rosa, Isabel M. D.; Purves, Drew; Souza, Carlos, Jr.; Ewers, Robert M.			Predictive Modelling of Contagious Deforestation in the Brazilian Amazon	PLOS ONE			English	Article							LAND-USE; STATISTICAL-ANALYSIS; CARBON EMISSIONS; EXPANSION; DETERMINANTS; DYNAMICS; CONSERVATION; PROTECTION; REGRESSION; CONVERSION	Tropical forests are diminishing in extent due primarily to the rapid expansion of agriculture, but the future magnitude and geographical distribution of future tropical deforestation is uncertain. Here, we introduce a dynamic and spatially-explicit model of deforestation that predicts the potential magnitude and spatial pattern of Amazon deforestation. Our model differs from previous models in three ways: (1) it is probabilistic and quantifies uncertainty around predictions and parameters; (2) the overall deforestation rate emerges "bottom up", as the sum of local-scale deforestation driven by local processes; and (3) deforestation is contagious, such that local deforestation rate increases through time if adjacent locations are deforested. For the scenarios evaluated-pre- and post-PPCDAM ("Plano de Acao para Protecao e Controle do Desmatamento na Amazonia")-the parameter estimates confirmed that forests near roads and already deforested areas are significantly more likely to be deforested in the near future and less likely in protected areas. Validation tests showed that our model correctly predicted the magnitude and spatial pattern of deforestation that accumulates over time, but that there is very high uncertainty surrounding the exact sequence in which pixels are deforested. The model predicts that under pre-PPCDAM (assuming no change in parameter values due to, for example, changes in government policy), annual deforestation rates would halve between 2050 compared to 2002, although this partly reflects reliance on a static map of the road network. Consistent with other models, under the pre-PPCDAM scenario, states in the south and east of the Brazilian Amazon have a high predicted probability of losing nearly all forest outside of protected areas by 2050. This pattern is less strong in the post-PPCDAM scenario. Contagious spread along roads and through areas lacking formal protection could allow deforestation to reach the core, which is currently experiencing low deforestation rates due to its isolation.	[Rosa, Isabel M. D.; Ewers, Robert M.] Imperial Coll London, Dept Life Sci, Ascot, Berks, England; [Purves, Drew] Microsoft Res Cambridge, Computat Ecol & Environm Sci, Cambridge, England; [Souza, Carlos, Jr.] Imazon Amazon Inst People & Environm, Belem, Para, Brazil	Imperial College London; Microsoft	Rosa, IMD (corresponding author), Imperial Coll London, Dept Life Sci, Ascot, Berks, England.	i.rosa09@imperial.ac.uk	Rosa, Isabel/F-8600-2010; Souza, CARLOS/AAK-8207-2021	Rosa, Isabel/0000-0001-8257-1963; Souza, CARLOS/0000-0002-0205-6134	Grantham Institute for Climate Change; European Research Council [281986]; Fundo Vale grant; Microsoft Research Cambridge	Grantham Institute for Climate Change; European Research Council(European Research Council (ERC)European Commission); Fundo Vale grant; Microsoft Research Cambridge(Microsoft)	IMDR is supported by the Grantham Institute for Climate Change and Microsoft Research Cambridge, RME is supported by European Research Council Project number 281986, and CSJ is supported by Fundo Vale grant to Imazon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002142; Ahmed SE, 2013, REG ENVIRON CHANGE, V13, P927, DOI 10.1007/s10113-012-0397-z; Alves DS, 2002, INT J REMOTE SENS, V23, P2903, DOI 10.1080/01431160110096791; Angelsen A, 1999, WORLD BANK RES OBSER, V14, P73, DOI 10.1093/wbro/14.1.73; Arima EY, 2008, PHOTOGRAMM ENG REM S, V74, P699, DOI 10.14358/PERS.74.6.699; Asner GP, 2006, P NATL ACAD SCI USA, V103, P12947, DOI 10.1073/pnas.0604093103; Asner GP, 2009, CONSERV BIOL, V23, P1386, DOI 10.1111/j.1523-1739.2009.01333.x; Assuncao J., 2012, DEFORESTATION SLOWDO; Barlow J, 2011, BIOL REV, V86, P457, DOI 10.1111/j.1469-185X.2010.00155.x; Boakes EH, 2010, P ROY SOC B-BIOL SCI, V277, P1081, DOI 10.1098/rspb.2009.1771; Brandao AO, 2006, INT J REMOTE SENS, V27, P177, DOI 10.1080/01431160500353841; Carlson KM, 2012, P NATL ACAD SCI USA, V109, P7559, DOI 10.1073/pnas.1200452109; Chomitz KM, 2003, AM J AGR ECON, V85, P1016, DOI 10.1111/1467-8276.00504; Davies RG, 2006, P ROY SOC B-BIOL SCI, V273, P2127, DOI 10.1098/rspb.2006.3551; Aguiar APD, 2007, ECOL MODEL, V209, P169, DOI 10.1016/j.ecolmodel.2007.06.019; Etter A, 2006, LANDSCAPE URBAN PLAN, V77, P240, DOI 10.1016/j.landurbplan.2005.03.002; Evans TP, 2001, ECOL MODEL, V143, P95, DOI 10.1016/S0304-3800(01)00357-X; Ewers RM, 2008, ENVIRON CONSERV, V35, P303, DOI 10.1017/S0376892908005122; Fearnside PM, 2008, ECOL SOC, V13; Fearnside PM, 2005, CONSERV BIOL, V19, P680, DOI 10.1111/j.1523-1739.2005.00697.x; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Garcia RA, 2007, ECOL INDIC, V7, P719, DOI 10.1016/j.ecolind.2006.08.003; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Hastie T., 2009, ELEMENTS STAT LEARNI, P219; Houghton R.A., 2005, TROPICAL DEFORESTATI, P13; INPE, 2012, TAX AN DESM 1988 AT; IPAM, 2012, PLAN AC PREV CONTR D; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Lapola DM, 2011, EARTH INTERACT, V15, DOI 10.1175/2010EI333.1; Laurance WF, 2002, J BIOGEOGR, V29, P737, DOI 10.1046/j.1365-2699.2002.00721.x; Laurance WF, 2001, SCIENCE, V291, P438, DOI 10.1126/science.291.5503.438; Lewis DJ, 2009, AM J AGR ECON, V91, P1080, DOI 10.1111/j.1467-8276.2009.01310.x; Liu HP, 2013, INT J GREEN ENERGY, V10, P151, DOI 10.1080/15435075.2011.647170; LUDEKE AK, 1990, J ENVIRON MANAGE, V31, P247, DOI 10.1016/S0301-4797(05)80038-6; Maeda EE, 2011, INT J APPL EARTH OBS, V13, P435, DOI 10.1016/j.jag.2010.09.008; Malingreau JP, 2012, AMBIO, V41, P309, DOI 10.1007/s13280-011-0196-7; Moreira E, 2009, LANDSCAPE ECOL, V24, P1183, DOI 10.1007/s10980-009-9397-x; Morton DC, 2006, P NATL ACAD SCI USA, V103, P14637, DOI 10.1073/pnas.0606377103; Murray JD, 2002, MATH BIOL, P551; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Nepstad DC, 2006, CONSERV BIOL, V20, P1595, DOI 10.1111/j.1523-1739.2006.00510.x; Pereira D, 2010, FACTOS FLORESTAIS AM; Pfaff A, 2007, J REGIONAL SCI, V47, P109, DOI 10.1111/j.1467-9787.2007.00502.x; Pfaff ASP, 1999, J ENVIRON ECON MANAG, V37, P26, DOI 10.1006/jeem.1998.1056; Pontius RG, 2011, INT J REMOTE SENS, V32, P4407, DOI 10.1080/01431161.2011.552923; Rosa IMD, 2012, CONSERV BIOL, V26, P932, DOI 10.1111/j.1523-1739.2012.01901.x; Rudel TK, 2005, TROPICAL FORESTS REG, P240; Soares BS, 2002, ECOL MODEL, V154, P217, DOI 10.1016/S0304-3800(02)00059-5; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; Soler LD, 2007, INT GEOSCI REMOTE SE, P3462, DOI 10.1109/IGARSS.2007.4423591; Sombroek W, 2001, AMBIO, V30, P388, DOI 10.1639/0044-7447(2001)030[0388:SATPOA]2.0.CO;2; Vadez V, 2008, HUM ORGAN, V67, P384, DOI 10.17730/humo.67.4.45164623415rp7n8; Walker R, 2004, ECOL APPL, V14, pS299; Wassenaar T, 2007, GLOBAL ENVIRON CHANG, V17, P86, DOI 10.1016/j.gloenvcha.2006.03.007; Wearn OR, 2012, SCIENCE, V337, P228, DOI 10.1126/science.1219013; Wu TJ, 2013, SIGNAL PROCESS, V93, P49, DOI 10.1016/j.sigpro.2012.06.017	57	75	76	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77231	10.1371/journal.pone.0077231	http://dx.doi.org/10.1371/journal.pone.0077231			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204776	Green Submitted, Green Published, gold			2022-12-27	WOS:000326029300091
J	Antonio, T; Childers, SR; Rothman, RB; Dersch, CM; King, C; Kuehne, M; Bornmann, WG; Eshleman, AJ; Janowsky, A; Simon, ER; Reith, MEA; Alper, K				Antonio, Tamara; Childers, Steven R.; Rothman, Richard B.; Dersch, Christina M.; King, Christine; Kuehne, Martin; Bornmann, William G.; Eshleman, Amy J.; Janowsky, Aaron; Simon, Eric R.; Reith, Maarten E. A.; Alper, Kenneth			Effect of Iboga Alkaloids on mu-Opioid Receptor-Coupled G Protein Activation	PLOS ONE			English	Article							NALOXONE-PRECIPITATED WITHDRAWAL; NICOTINIC ACETYLCHOLINE-RECEPTOR; INDUCED LOCOMOTOR-ACTIVITY; MORPHINE-WITHDRAWAL; ANTINOCICEPTIVE ACTION; TABERNANTHE-IBOGA; ADENYLYL-CYCLASE; ACUTE SIGNS; NORIBOGAINE; BINDING	Objective: The iboga alkaloids are a class of small molecules defined structurally on the basis of a common ibogamine skeleton, some of which modify opioid withdrawal and drug self-administration in humans and preclinical models. These compounds may represent an innovative approach to neurobiological investigation and development of addiction pharmacotherapy. In particular, the use of the prototypic iboga alkaloid ibogaine for opioid detoxification in humans raises the question of whether its effect is mediated by an opioid agonist action, or if it represents alternative and possibly novel mechanism of action. The aim of this study was to independently replicate and extend evidence regarding the activation of mu-opioid receptor (MOR)-related G proteins by iboga alkaloids. Methods: Ibogaine, its major metabolite noribogaine, and 18-methoxycoronaridine (18-MC), a synthetic congener, were evaluated by agonist-stimulated guanosine-5'-O-(gamma-thio)-triphosphate ([S-35]GTP gamma S) binding in cells overexpressing the recombinant MOR, in rat thalamic membranes, and autoradiography in rat brain slices. Results And Significance: In rat thalamic membranes ibogaine, noribogaine and 18-MC were MOR antagonists with functional Ke values ranging from 3 uM (ibogaine) to 13 uM (noribogaine and 18MC). Noribogaine and 18-MC did not stimulate [S-35]GTP gamma S binding in Chinese hamster ovary cells expressing human or rat MORs, and had only limited partial agonist effects in human embryonic kidney cells expressing mouse MORs. Ibogaine did not did not stimulate [S-35]GTP gamma S binding in any MOR expressing cells. Noribogaine did not stimulate [S-35]GTP gamma S binding in brain slices using autoradiography. An MOR agonist action does not appear to account for the effect of these iboga alkaloids on opioid withdrawal. Taken together with existing evidence that their mechanism of action also differs from that of other non-opioids with clinical effects on opioid tolerance and withdrawal, these findings suggest a novel mechanism of action, and further justify the search for alternative targets of iboga alkaloids.	[Antonio, Tamara; King, Christine; Simon, Eric R.; Reith, Maarten E. A.; Alper, Kenneth] NYU, Sch Med, Dept Psychiat, New York, NY USA; [Antonio, Tamara; King, Christine; Simon, Eric R.; Reith, Maarten E. A.] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA; [Childers, Steven R.] Wake Forest Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC USA; [Rothman, Richard B.; Dersch, Christina M.] NIDA, Translat Pharmacol Res Sect, Intramural Res Program, Baltimore, MD USA; [Kuehne, Martin] Univ Vermont, Dept Chem, Burlington, VT 05405 USA; [Bornmann, William G.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Eshleman, Amy J.; Janowsky, Aaron] Oregon Hlth & Sci Univ, Res Serv, VA Med Ctr, Portland, OR 97201 USA; [Eshleman, Amy J.; Janowsky, Aaron] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA; [Eshleman, Amy J.; Janowsky, Aaron] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Alper, Kenneth] NYU, Dept Neurol, Sch Med, New York, NY 10016 USA	New York University; New York University; Wake Forest University; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of Vermont; University of Texas System; UTMD Anderson Cancer Center; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; New York University	Alper, K (corresponding author), NYU, Sch Med, Dept Psychiat, New York, NY USA.	Kenneth.Alper@nyumc.org	Alper, Kenneth/AAH-9613-2020; Reith, Maarten E./AAD-2303-2019	Reith, Maarten E./0000-0002-1900-842X; Alper, Kenneth/0000-0002-7014-1445	New York University School of Medicine Addiction Center of Excellence; Methamphetamine Abuse Research Center [P50 DA018165]; NIDA-VA [ADA12013]; VA Research Career Scientist and Merit Review programs NIDA grant, Intramural Research Program, NIDA, National Institute of health, Baltimore, MD [DA-06634]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA018165, P50DA006634] Funding Source: NIH RePORTER	New York University School of Medicine Addiction Center of Excellence; Methamphetamine Abuse Research Center; NIDA-VA; VA Research Career Scientist and Merit Review programs NIDA grant, Intramural Research Program, NIDA, National Institute of health, Baltimore, MD; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding was provided by New York University School of Medicine Addiction Center of Excellence (MEAR, KA, TA), The Methamphetamine Abuse Research Center (P50 DA018165), NIDA-VA Interagency agreement ADA12013, and VA Research Career Scientist and Merit Review programs (AJ, AJE) NIDA grant DA-06634 (SRC) Intramural Research Program, NIDA, National Institute of health, Baltimore, MD (RBR, CMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceto M D, 1992, NIDA Res Monogr, V119, P513; Alper K R, 2001, Alkaloids Chem Biol, V56, P1, DOI 10.1016/S0099-9598(01)56005-8; Alper KR, 2008, J ETHNOPHARMACOL, V115, P9, DOI 10.1016/j.jep.2007.08.034; Alper KR, 2012, J FORENSIC SCI, V57, P398, DOI 10.1111/j.1556-4029.2011.02008.x; Alper KR, 1999, AM J ADDICTION, V8, P234; AMATO L, 2009, COCHRANE DB SYST REV; Arias HR, 2010, INT J BIOCHEM CELL B, V42, P1525, DOI 10.1016/j.biocel.2010.05.011; Bagal AA, 1996, BRAIN RES, V741, P258, DOI 10.1016/S0006-8993(96)00938-9; BARTLETT MF, 1958, J AM CHEM SOC, V80, P126, DOI 10.1021/ja01534a036; Baumann MH, 2001, J PHARMACOL EXP THER, V297, P531; Bhargava HN, 1997, BRAIN RES, V771, P343, DOI 10.1016/S0006-8993(97)00914-1; Bhargava HN, 1997, BRAIN RES, V752, P234, DOI 10.1016/S0006-8993(96)01461-8; Bie BH, 2005, J NEUROSCI, V25, P3824, DOI 10.1523/JNEUROSCI.5010-04.2005; Bisaga A, 2001, PSYCHOPHARMACOLOGY, V157, P1, DOI 10.1007/s002130100739; BUNZOW JR, 1995, J NEUROCHEM, V64, P14; Cao YJ, 1997, BRAIN RES, V752, P250, DOI 10.1016/S0006-8993(96)01470-9; CAPPENDIJK SLT, 1994, BEHAV BRAIN RES, V65, P117, DOI 10.1016/0166-4328(94)90080-9; Cheng KJ, 2011, J MED CHEM, V54, P957, DOI 10.1021/jm1011676; Christie MJ, 2008, BRIT J PHARMACOL, V154, P384, DOI 10.1038/bjp.2008.100; Christoffers KH, 2002, REGUL PEPTIDES, V105, P9, DOI 10.1016/S0167-0115(01)00382-2; Corkery JM, 2004, HUM PSYCHOPHARM CLIN, V19, P565, DOI 10.1002/hup.630; DEECHER DC, 1992, BRAIN RES, V571, P242, DOI 10.1016/0006-8993(92)90661-R; DHAHIR HI, 1971, THESIS INDIANA U; DZOLJIC ED, 1988, ARCH INT PHARMACOD T, V294, P64; Fareed A, 2010, J ADDICT DIS, V29, P1, DOI 10.1080/10550880903436010; Fernandez J.W., 1982, BWITI ETHNOGRAPHY RE; Fichna J, 2006, BIOCHEM BIOPH RES CO, V345, P162, DOI 10.1016/j.bbrc.2006.04.079; FRANCES B, 1992, FUNDAM CLIN PHARM, V6, P327, DOI 10.1111/j.1472-8206.1992.tb00127.x; Fryer JD, 1999, J PHARMACOL EXP THER, V288, P88; GALLAGHER CA, 1995, BIOCHEM PHARMACOL, V49, P73, DOI 10.1016/0006-2952(94)00441-N; Glick S D, 2001, Alkaloids Chem Biol, V56, P39, DOI 10.1016/S0099-9598(01)56006-X; Glick SD, 1996, BRAIN RES, V713, P294, DOI 10.1016/0006-8993(95)01563-9; GLICK SD, 1992, NEUROPHARMACOLOGY, V31, P497, DOI 10.1016/0028-3908(92)90089-8; Glick SD, 2002, EUR J PHARMACOL, V448, P185, DOI 10.1016/S0014-2999(02)01944-1; Glick SD, 2002, EUR J PHARMACOL, V438, P99, DOI 10.1016/S0014-2999(02)01284-0; Gowing L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002025.pub4; Gowing L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002024.pub3; Holstein SE, 2013, BEHAV BRAIN RES, V237, P49, DOI 10.1016/j.bbr.2012.09.006; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; Jana GK, 2011, ORG PREP PROCED INT, V43, P541, DOI 10.1080/00304948.2011.629563; Ko MCH, 2003, J PHARMACOL EXP THER, V306, P179, DOI 10.1124/jpet.103.050625; Kontrimaviciute V, 2006, J ANAL TOXICOL, V30, P434, DOI 10.1093/jat/30.7.434; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Lamberts JT, 2011, NEUROPSYCHOPHARMACOL, V36, P2041, DOI 10.1038/npp.2011.91; Layer RT, 1996, EUR J PHARMACOL, V309, P159, DOI 10.1016/0014-2999(96)00304-4; Leal MB, 2003, PROG NEURO-PSYCHOPH, V27, P781, DOI 10.1016/S0278-5846(03)00109-X; Lester PA, 2006, BRAIN RES, V1073, P290, DOI 10.1016/j.brainres.2005.12.066; Levant B, 2004, BRAIN RES, V1003, P159, DOI 10.1016/j.brainres.2003.12.032; Maher CE, 2005, LIFE SCI, V77, P1140, DOI 10.1016/j.lfs.2005.03.004; MAISONNEUVE IM, 1992, BRAIN RES, V575, P69, DOI 10.1016/0006-8993(92)90424-8; MAISONNEUVE IM, 1991, EUR J PHARMACOL, V199, P35, DOI 10.1016/0014-2999(91)90634-3; Maisonneuve IM, 2003, PHARMACOL BIOCHEM BE, V75, P607, DOI 10.1016/S0091-3057(03)00119-9; Mash D C, 2001, Alkaloids Chem Biol, V56, P155, DOI 10.1016/S0099-9598(01)56012-5; *NAT I HLTH, 2013, ND EN STUD GMP SCAL; Nestler EJ, 2001, AM J ADDICTION, V10, P201, DOI 10.1080/105504901750532094; *NIDA, 1996, DET AC INT COMB IB M, V8, P1; Oka T, 1996, JPN J PHARMACOL, V71, P89, DOI 10.1254/jjp.71.89; Pablo JP, 1998, NEUROREPORT, V9, P109, DOI 10.1097/00001756-199801050-00022; Pace CJ, 2004, EUR J PHARMACOL, V492, P159, DOI 10.1016/j.ejphar.2004.03.062; Panchal V, 2005, EUR J PHARMACOL, V525, P98, DOI 10.1016/j.ejphar.2005.09.060; Parker LA, 2002, PROG NEURO-PSYCHOPH, V26, P293, DOI 10.1016/S0278-5846(01)00268-8; Pearl SM, 1996, NEUROPHARMACOLOGY, V35, P1779, DOI 10.1016/S0028-3908(96)00116-5; PEARL SM, 1995, PSYCHOPHARMACOLOGY, V121, P470, DOI 10.1007/BF02246495; Pearl SM, 1997, PHARMACOL BIOCHEM BE, V57, P809, DOI 10.1016/S0091-3057(96)00383-8; Peckham EM, 2005, BRAIN RES, V1058, P137, DOI 10.1016/j.brainres.2005.07.060; Pierre S, 2009, NAT REV DRUG DISCOV, V8, P321, DOI 10.1038/nrd2827; POPIK P, 1995, J PHARMACOL EXP THER, V275, P753; POPIK P, 1998, ALKALOIDS CHEM BIOL, V52, P197; Rabin RA, 1996, EUR J PHARMACOL, V316, P343, DOI 10.1016/S0014-2999(96)00690-5; *RES TRIANGL I, 1993, PHARM STUD TREATM DR, P1; Rho B, 1998, NEUROREPORT, V9, P1283, DOI 10.1097/00001756-199805110-00004; Romero DV, 1999, SYNAPSE, V34, P83, DOI 10.1002/(SICI)1098-2396(199911)34:2<83::AID-SYN1>3.3.CO;2-J; SCHNEIDER JA, 1956, EXPERIENTIA, V12, P323, DOI 10.1007/BF02159638; SCHNEIDER JA, 1957, TABERNANTHINE IBOGAI; Seifert R, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003466; Selley DE, 1997, MOL PHARMACOL, V51, P87, DOI 10.1124/mol.51.1.87; Sershen H, 2001, Alkaloids Chem Biol, V56, P115; Shaqura MA, 2004, J PHARMACOL EXP THER, V308, P712, DOI 10.1124/jpet.103.057257; SHARMA SK, 1975, P NATL ACAD SCI USA, V72, P3092, DOI 10.1073/pnas.72.8.3092; Sharma SS, 1998, PHARMACOLOGY, V57, P229, DOI 10.1159/000028246; Sharpe L G, 1990, Neuroreport, V1, P17, DOI 10.1097/00001756-199009000-00005; Sim L J, 1997, Methods Mol Biol, V83, P117; Sim-Selley LJ, 2007, BRIT J PHARMACOL, V151, P1324, DOI 10.1038/sj.bjp.0707328; Skolnick P, 2001, Alkaloids Chem Biol, V56, P55, DOI 10.1016/S0099-9598(01)56007-1; Staley JK, 1996, PSYCHOPHARMACOLOGY, V127, P10, DOI 10.1007/BF02805969; SWEETNAM PM, 1995, PSYCHOPHARMACOLOGY, V118, P369, DOI 10.1007/BF02245936; Taraschenko OD, 2005, EUR J PHARMACOL, V513, P207, DOI 10.1016/j.ejphar.2005.03.005; Tesmer JJG, 2000, BIOCHEMISTRY-US, V39, P14464, DOI 10.1021/bi0015562; Toll L, 1998, NIDA Res Monogr, V178, P440; TRUJILLO KA, 1994, BRAIN RES, V633, P178, DOI 10.1016/0006-8993(94)91538-5; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vigano D, 2003, NEUROSCIENCE, V117, P921, DOI 10.1016/S0306-4522(02)00825-4; Zhuo M, 2012, DRUG DISCOV TODAY, V17, P573, DOI 10.1016/j.drudis.2012.01.009	93	23	23	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77262	10.1371/journal.pone.0077262	http://dx.doi.org/10.1371/journal.pone.0077262			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24204784	Green Submitted, gold, Green Published			2022-12-27	WOS:000326019400097
J	Ding, Y; Hu, K; Wu, K; Zhao, ZL				Ding, Yi; Hu, Kai; Wu, Kai; Zhao, Zhenlong			Performance Monitoring and Analysis of Task-Based OpenMP	PLOS ONE			English	Article							DESIGN	OpenMP, a typical shared memory programming paradigm, has been extensively applied in high performance computing community due to the popularity of multicore architectures in recent years. The most significant feature of the OpenMP 3.0 specification is the introduction of the task constructs to express parallelism at a much finer level of detail. This feature, however, has posed new challenges for performance monitoring and analysis. In particular, task creation is separated from its execution, causing the traditional monitoring methods to be ineffective. This paper presents a mechanism to monitor task-based OpenMP programs with interposition and proposes two demonstration graphs for performance analysis as well. The results of two experiments are discussed to evaluate the overhead of monitoring mechanism and to verify the effects of demonstration graphs using the BOTS benchmarks.	[Ding, Yi; Hu, Kai; Wu, Kai; Zhao, Zhenlong] Beihang Univ, Sch Comp Sci & Engn, Beijing, Peoples R China	Beihang University	Ding, Y (corresponding author), Beihang Univ, Sch Comp Sci & Engn, Beijing, Peoples R China.	georgedingyi@cse.buaa.edu.cn			Aeronautical Science Foundation of China [2010ZA04001]; National Natural Science Foundation of China [61073013]	Aeronautical Science Foundation of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by Aeronautical Science Foundation of China (2010ZA04001) and National Natural Science Foundation of China (61073013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayguade E, 2009, IEEE T PARALL DISTR, V20, P404, DOI 10.1109/TPDS.2008.105; Curry T. W., 1994, P USENIX SUMM 1994 T, V1, P18; Ding Y, 2011, INT J ADV COMPUTING, V3, P64; Duran Alejandro, 2009, Proceedings of the 2009 International Conference on Parallel Processing (ICPP 2009), P124, DOI 10.1109/ICPP.2009.64; Furlinger K, 2009, LECT NOTES COMPUT SC, V5568, P132, DOI 10.1007/978-3-642-02303-3_11; Geimer M, 2010, CONCURR COMP-PRACT E, V22, P702, DOI 10.1002/cpe.1556; Hu K, 2012, CHINESE J AERONAUT, V25, P546, DOI 10.1016/S1000-9361(11)60418-4; Itzkowitz M., 2007, TECHNICAL REPORT; Lin Y, 2009, LECT NOTES COMPUT SC, V5568, P104, DOI 10.1007/978-3-642-02303-3_9; Lorenz D., 2012, 2012 41st International Conference on Parallel Processing Workshops (ICPPW 2012), P444, DOI 10.1109/ICPPW.2012.62; Lorenz D, 2010, LECT NOTES COMPUT SC, V6132, P109, DOI 10.1007/978-3-642-13217-9_9; Mohr B, 2002, J SUPERCOMPUT, V23, P105, DOI 10.1023/A:1015741304337; OpenMP Architecture Review Board, 2008, TECHNICAL REPORT; OpenMP Architecture Review Board, 2005, TECHNICAL REPORT; Rauber T, 2013, PARALLEL PROGRAMMING, P105; Schmidl D., 2012, IWOMP 2012, V7312, P196, DOI [10.1007/978-3- 642- 30961-8 15, DOI 10.1007/978-3-642-30961-815]; Shende SS, 2006, INT J HIGH PERFORM C, V20, P287, DOI 10.1177/1094342006064482	17	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77742	10.1371/journal.pone.0077742	http://dx.doi.org/10.1371/journal.pone.0077742			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204946	Green Submitted, Green Published, gold			2022-12-27	WOS:000326334500051
J	Kurzynska-Kokorniak, A; Koralewska, N; Tyczewska, A; Twardowski, T; Figlerowicz, M				Kurzynska-Kokorniak, Anna; Koralewska, Natalia; Tyczewska, Agata; Twardowski, Tomasz; Figlerowicz, Marek			A New Short Oligonucleotide-Based Strategy for the Precursor-Specific Regulation of microRNA Processing by Dicer	PLOS ONE			English	Article							POSTTRANSCRIPTIONAL REGULATION; RNA INTERFERENCE; MESSENGER-RNAS; BIOGENESIS; EXPRESSION; TARGETS; BINDING; INHIBITION; MODULATION; REVEALS	The precise regulation of microRNA (miRNA) biogenesis seems to be critically important for the proper functioning of all eukaryotic organisms. Even small changes in the levels of specific miRNAs can initiate pathological processes, including carcinogenesis. Accordingly, there is a great need to develop effective methods for the regulation of miRNA biogenesis and activity. In this study, we focused on the final step of miRNA biogenesis; i.e., miRNA processing by Dicer. To test our hypothesis that RNA molecules can function not only as Dicer substrates but also as Dicer regulators, we previously identified by SELEX a pool of RNA oligomers that bind to human Dicer. We found that certain of these RNA oligomers could selectively inhibit the formation of specific miRNAs. Here, we show that these specific inhibitors can simultaneously bind both Dicer and pre-miRNAs. These bifunctional riboregulators interfere with miRNA maturation by affecting pre-miRNA structure and sequestering Dicer. Based on these observations, we designed a set of short oligomers (12 nucleotides long) that were capable of influencing pre-miRNA processing in vitro, both in reactions involving recombinant human Dicer and in cytosolic extracts. We propose that the same strategy may be used to develop effective and selective regulators to control the production of any miRNA. Overall, our findings indicate that the interactions between pre-miRNAs and other RNAs may form very complex regulatory networks that modulate miRNA biogenesis and consequently gene expression.	[Kurzynska-Kokorniak, Anna; Koralewska, Natalia; Tyczewska, Agata; Twardowski, Tomasz; Figlerowicz, Marek] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland; [Figlerowicz, Marek] Poznan Univ Tech, Inst Comp Sci, Poznan, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Poznan University of Technology	Figlerowicz, M (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland.	marekf@ibch.poznan.pl	Tyczewska, Agata/L-8060-2013; Koralewska, Natalia/W-4886-2018; Figlerowicz, Marek/B-9550-2015; Tyczewska, Agata/L-4590-2019	Tyczewska, Agata/0000-0002-8819-1539; Koralewska, Natalia/0000-0001-7096-0128; Tyczewska, Agata/0000-0002-8819-1539; Figlerowicz, Marek/0000-0002-6392-0192; Kurzynska-Kokorniak, Anna/0000-0002-7034-3370	European Union Regional Development Fund within the PARENT-BRIDGE Programme of Foundation for Polish Science [Pomost/2011-3/5]; Polish Government through Ministry of Science and Higher Education [N301 265436]	European Union Regional Development Fund within the PARENT-BRIDGE Programme of Foundation for Polish Science; Polish Government through Ministry of Science and Higher Education	This work was supported by the European Union Regional Development Fund within the PARENT-BRIDGE Programme of Foundation for Polish Science (Pomost/2011-3/5 to A.K.-K.) and by the Polish Government through a grant from the Ministry of Science and Higher Education (N301 265436 to A.K.-K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Andersson MG, 2005, J VIROL, V79, P9556, DOI 10.1128/JVI.79.15.9556-9565.2005; Asirvatham AJ, 2008, MOL IMMUNOL, V45, P1995, DOI 10.1016/j.molimm.2007.10.035; Berkhout B, 2006, FEBS LETT, V580, P2896, DOI 10.1016/j.febslet.2006.02.070; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Chiosea S, 2007, CANCER RES, V67, P2345, DOI 10.1158/0008-5472.CAN-06-3533; Elbarbary RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005908; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Grelier G, 2009, BRIT J CANCER, V101, P673, DOI 10.1038/sj.bjc.6605193; Haasnoot J, 2006, HANDB EXP PHARM, V173, P117; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Henn A, 2008, CHEMBIOCHEM, V9, P2722, DOI 10.1002/cbic.200800271; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Hinkal GW, 2011, BRIT J CANCER, V104, P387, DOI 10.1038/sj.bjc.6606022; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Jackowiak P, 2011, NUCLEIC ACIDS RES, V39, P7361, DOI 10.1093/nar/gkr450; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kaul D, 2004, BIOCHEM BIOPH RES CO, V313, P552, DOI 10.1016/j.bbrc.2003.12.002; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kurzynska-Kokorniak A, 2009, MINI-REV MED CHEM, V9, P927, DOI 10.2174/138955709788681573; Lehrbach NJ, 2010, ADV EXP MED BIOL, V700, P67; Leuschner PJF, 2007, METHODS, V43, P105, DOI 10.1016/j.ymeth.2007.04.005; Lima WF, 2009, J BIOL CHEM, V284, P2535, DOI 10.1074/jbc.M803748200; Lunse CE, 2010, ANGEW CHEM INT EDIT, V49, P4674, DOI 10.1002/anie.200906919; Ma E, 2008, J MOL BIOL, V380, P237, DOI 10.1016/j.jmb.2008.05.005; Ma EB, 2012, J MOL BIOL, V422, P466, DOI 10.1016/j.jmb.2012.06.009; Macrae IJ, 2006, COLD SH Q B, V71, P73; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Nowacka M, 2013, PLANT MOL BIOL, V83, P191, DOI 10.1007/s11103-013-0079-3; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Olejniczak M, 2010, NUCLEIC ACIDS RES, V38, P1, DOI 10.1093/nar/gkp829; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Plante Isabelle, 2012, Frontiers in Genetics, V3, P99, DOI 10.3389/fgene.2012.00099; Singh S, 2005, BIOCHEM BIOPH RES CO, V335, P643, DOI 10.1016/j.bbrc.2005.07.138; Tili E, 2008, NAT CLIN PRACT RHEUM, V4, P534, DOI 10.1038/ncprheum0885; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Tyczewska A, 2011, NUCLEIC ACID THER, V21, P333, DOI 10.1089/nat.2011.0304; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Wiesen JL, 2009, MOL IMMUNOL, V46, P1222, DOI 10.1016/j.molimm.2008.11.012; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	51	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77703	10.1371/journal.pone.0077703	http://dx.doi.org/10.1371/journal.pone.0077703			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204924	gold, Green Published, Green Submitted			2022-12-27	WOS:000326270700050
J	Zanelli, J; Morgan, K; Dazzan, P; Morgan, C; Russo, M; Pilecka, I; Fearon, P; Demjaha, A; Doody, GA; Jones, PB; Murray, RM; Reichenberg, A				Zanelli, Jolanta; Morgan, Kevin; Dazzan, Paola; Morgan, Craig; Russo, Manuela; Pilecka, Izabela; Fearon, Paul; Demjaha, Arsime; Doody, Gill A.; Jones, Peter B.; Murray, Robin M.; Reichenberg, Abraham			Gender Differences in Neuropsychological Performance across Psychotic Disorders - a Multi-Centre Population Based Case-Control Study	PLOS ONE			English	Article							SEX-DIFFERENCES; SCHIZOPHRENIA; DEFICITS; 1ST-EPISODE; MEMORY	Background: Patients with schizophrenia and other psychoses exhibit a wide range of neuropsychological deficits. An unresolved question concerns whether there are gender differences in cognitive performance. Methods: Data were derived from a multi-centre population based case-control study of patients with first-episode psychosis. A neuropsychological test battery was administered to patients with a diagnosis of schizophrenia or schizoaffective disorder (N=70, 36% females), bipolar/mania (N=34, 60% females), depressive psychosis (N=36, 58% females) and healthy controls (N=148, 55% females). Generalized and specific cognitive deficits were compared. Results: There was strong evidence for disorder-specific gender differences in neuropsychological performance. Males and females with schizophrenia showed similar pervasive neuropsychological impairments. In psychotic depressive disorder females performed worse than males across neuropsychological measures. Differences in neuropsychological performance between males and females with bipolar/manic disorder were restricted to language functions. Symptom severity did not contribute to the observed gender differences. Conclusions: Early in the course of psychotic illness, gender related factors appear to moderate the severity of cognitive deficits in depressive psychosis and bipolar/mania patients.	[Zanelli, Jolanta; Dazzan, Paola; Russo, Manuela; Pilecka, Izabela; Fearon, Paul; Demjaha, Arsime; Murray, Robin M.; Reichenberg, Abraham] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, London, England; [Morgan, Kevin] Univ Westminster, Dept Psychol, London W1R 8AL, England; [Morgan, Craig] Kings Coll London, Inst Psychiat, Ctr Publ Mental Hlth, Hlth Serv & Populat Res Dept, London, England; [Jones, Peter B.] Univ Cambridge, Dept Psychiat, Cambridge, England; [Doody, Gill A.] Univ Nottingham, Div Psychiat, Nottingham NG7 2RD, England	University of London; King's College London; University of Westminster; University of London; King's College London; University of Cambridge; University of Nottingham	Zanelli, J (corresponding author), Kings Coll London, Inst Psychiat, Dept Psychosis Studies, London, England.	jolanta.w.zanelli@kcl.ac.uk	Morgan, Craig/B-2100-2010; Reichenberg, Abraham/GQB-1227-2022; murray, robin/F-8658-2012	Morgan, Craig/0000-0002-1386-2369; Pilecka, Izabela/0000-0001-7350-4873; Dazzan, Paola/0000-0002-8427-3617; murray, robin/0000-0003-0829-0519; doody, gillian/0000-0002-3494-438X; Jones, Peter Brian/0000-0002-0387-880X; demjaha, arsime/0000-0002-1870-6410; Morgan, Kevin/0000-0003-0172-2032	UK Medical Research Council [G0600972]; Medical Research Foundation [C0439] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the UK Medical Research Council (G0600972). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDIA AM, 1995, J NERV MENT DIS, V183, P522, DOI 10.1097/00005053-199508000-00005; Barrett SL, 2008, BIPOLAR DISORD, V10, P647, DOI 10.1111/j.1399-5618.2008.00592.x; Carrus D, 2010, PSYCHOL MED, V40, P1349, DOI 10.1017/S0033291709991644; Demjaha A, 2009, PSYCHOL MED, V39, P1943, DOI 10.1017/S0033291709990651; Dickinson D, 2008, BIOL PSYCHIAT, V64, P823, DOI 10.1016/j.biopsych.2008.04.005; GOLDBERG TE, 1995, AM J PSYCHIAT, V152, P883; Goldstein JM, 1998, AM J PSYCHIAT, V155, P1358, DOI 10.1176/ajp.155.10.1358; Gur RE, 2000, ARCH GEN PSYCHIAT, V57, P769, DOI 10.1001/archpsyc.57.8.769; HAAS GL, 1991, SCHIZOPHR RES, V4, P277, DOI 10.1016/0920-9964(91)90142-E; Hoff AL, 1998, AM J PSYCHIAT, V155, P1437, DOI 10.1176/ajp.155.10.1437; Knowles EEM, 2010, AM J PSYCHIAT, V167, P828, DOI 10.1176/appi.ajp.2010.09070937; KOPALA L, 1990, SCHIZOPHRENIA BULL, V16, P255, DOI 10.1093/schbul/16.2.255; Leung A, 2000, ACTA PSYCHIAT SCAND, V101, P3; Lewine RRJ, 1996, AM J PSYCHIAT, V153, P1178; Longenecker J, 2010, SCHIZOPHR RES, V120, P234, DOI 10.1016/j.schres.2009.12.009; Morgan C, 2006, WORLD PSYCHIATRY, V5, P40; Narr KL, 2001, BIOL PSYCHIAT, V50, P84, DOI 10.1016/S0006-3223(00)01120-3; Nelson HE., 1991, REVISED NATL ADULT R; PERLICK D, 1992, SCHIZOPHR RES, V8, P69, DOI 10.1016/0920-9964(92)90062-A; Reichenberg A, 2007, PSYCHOL BULL, V133, P833, DOI 10.1037/0033-2909.133.5.833; Reichenberg A, 2009, SCHIZOPHRENIA BULL, V35, P1022, DOI 10.1093/schbul/sbn044; Rubin LH, 2008, NEUROPSYCHOPHARMACOL, V33, P290, DOI 10.1038/sj.npp.1301395; Schwartz JE, 2000, ARCH GEN PSYCHIAT, V57, P593, DOI 10.1001/archpsyc.57.6.593; Seidman LJ, 1997, BIOL PSYCHIAT, V42, P104, DOI 10.1016/S0006-3223(96)00300-9; Shipman SL, 2009, PSYCHIAT RES, V166, P158, DOI 10.1016/j.psychres.2008.01.012; Strauss E, 2006, COMPENDIUM NEUROPSYC; Tost H, 2010, NAT NEUROSCI, V13, P920, DOI 10.1038/nn.2572; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Wechsler D., 1987, INSTRUCTION MANUAL W; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; World Health Organization (WHO) Division of Mental Health, 1994, SCHED CLIN ASS NEUR; Zanelli J, 2010, AM J PSYCHIAT, V167, P78, DOI 10.1176/appi.ajp.2009.09010118	32	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77318	10.1371/journal.pone.0077318	http://dx.doi.org/10.1371/journal.pone.0077318			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	242KW	24204806	Green Published, gold			2022-12-27	WOS:000326241200023
J	Tuval-Kochen, L; Paglin, S; Keshet, G; Lerenthal, Y; Nakar, C; Golani, T; Toren, A; Yahalom, J; Pfeffer, R; Lawrence, Y				Tuval-Kochen, Liron; Paglin, Shoshana; Keshet, Gilmor; Lerenthal, Yaniv; Nakar, Charles; Golani, Tamar; Toren, Amos; Yahalom, Joachim; Pfeffer, Raphael; Lawrence, Yaacov			Eukaryotic Initiation Factor 2 alpha - a Downstream Effector of Mammalian Target of Rapamycin - Modulates DNA Repair and Cancer Response to Treatment	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; MESSENGER-RNA; BREAST-CANCER; EIF2-ALPHA DEPHOSPHORYLATION; INDUCED AUTOPHAGY; UNFOLDED PROTEIN; MTOR INHIBITOR; TRANSLATION; PHOSPHORYLATION; MECHANISM	In an effort to circumvent resistance to rapamycin - an mTOR inhibitor - we searched for novel rapamycin-downstream-targets that may be key players in the response of cancer cells to therapy. We found that rapamycin, at nM concentrations, increased phosphorylation of eukaryotic initiation factor (eIF) 2 alpha in rapamycin-sensitive and estrogen-dependent MCF-7 cells, but had only a minimal effect on eIF2 alpha phosphorylation in the rapamycin-insensitive triple-negative MDA-MB-231 cells. Addition of salubrinal - an inhibitor of eIF2 alpha dephosphorylation decreased expression of a surface marker associated with capacity for self renewal, increased senescence and induced clonogenic cell death, suggesting that excessive phosphorylation of eIF2 alpha is detrimental to the cells' survival. Treating cells with salubrinal enhanced radiation-induced increase in eIF2 alpha phosphorylation and clonogenic death and showed that irradiated cells are more sensitive to increased eIF2 alpha phosphorylation than non-irradiated ones. Similar to salubrinal - the phosphomimetic eIF2 alpha variant - S51D - increased sensitivity to radiation, and both abrogated radiation-induced increase in breast cancer type 1 susceptibility gene, thus implicating enhanced phosphorylation of eIF2 alpha in modulation of DNA repair. Indeed, salubrinal inhibited non-homologous end joining as well as homologous recombination repair of double strand breaks that were induced by I-SceI in green fluorescent protein reporter plasmids. In addition to its effect on radiation, salubrinal enhanced eIF2 alpha phosphorylation and clonogenic death in response to the histone deacetylase inhibitor - vorinostat. Finally, the catalytic competitive inhibitor of mTOR - Ku-0063794 - increased phosphorylation of eIF2 alpha demonstrating further the involvement of mTOR activity in modulating eIF2 alpha phosphorylation. These experiments suggest that excessive phosphorylation of eIF2 alpha decreases survival of cancer cells; making eIF2 alpha a worthy target for drug development, with the potential to enhance the cytotoxic effects of established anti-neoplastic therapies and circumvent resistance to rapalogues and possibly to other drugs that inhibit upstream components of the mTOR pathway.	[Tuval-Kochen, Liron; Paglin, Shoshana; Keshet, Gilmor; Lerenthal, Yaniv; Golani, Tamar; Pfeffer, Raphael; Lawrence, Yaacov] Chaim Sheba Med Ctr, Canc Res Ctr, Ramat Gan, Israel; [Tuval-Kochen, Liron; Lerenthal, Yaniv] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Nakar, Charles; Yahalom, Joachim] Mem Sloan Kettering, Dept Oncol, New York, NY USA; [Toren, Amos] Safra Childrens Hosp, Dept Pediat Hematol Oncol, Ramat Gan, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Memorial Sloan Kettering Cancer Center	Paglin, S (corresponding author), Chaim Sheba Med Ctr, Canc Res Ctr, Ramat Gan, Israel.	shoshana.paglin@sheba.health.gov.il	lawrence, yaacov richard/AFP-1121-2022	lawrence, yaacov richard/0000-0002-9959-2485; Keshet, Gilmor/0000-0002-1907-3029	Medical Research Infrastructure Development Fund - Sheba Medical Center	Medical Research Infrastructure Development Fund - Sheba Medical Center	The research was supported by a generous donation from the estate of Miss HARAN ESTER of blessed memory through Keren Izvonot, Israel, Ministry of health (S.P) and by the Medical Research Infrastructure Development Fund - Sheba Medical Center (Y.L). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Chan CP, 2006, J VIROL, V80, P9279, DOI 10.1128/JVI.00659-06; Chen HH, 2011, RADIAT RES, V175, P214, DOI 10.1667/RR2323.1; Cnop M, 2007, J BIOL CHEM, V282, P3989, DOI 10.1074/jbc.M607627200; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Gaccioli F, 2006, J BIOL CHEM, V281, P17929, DOI 10.1074/jbc.M600341200; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Gatei M, 2000, CANCER RES, V60, P3299; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Keshet GI, 2008, BIOCHEM BIOPH RES CO, V368, P930, DOI 10.1016/j.bbrc.2008.02.022; Kim KW, 2010, ONCOGENE, V29, P3241, DOI 10.1038/onc.2010.74; Koren R, 2000, J STEROID BIOCHEM, V73, P105, DOI 10.1016/S0960-0760(00)00068-6; Kubota H, 2003, J BIOL CHEM, V278, P20457, DOI 10.1074/jbc.C300133200; Kwitkowski VE, 2010, ONCOLOGIST, V15, P428, DOI 10.1634/theoncologist.2009-0178; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Mansour WY, 2008, NUCLEIC ACIDS RES, V36, P4088, DOI 10.1093/nar/gkn347; Mehilli J, 2008, EUR HEART J, V29, P1975, DOI 10.1093/eurheartj/ehn253; Mounir Z, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001630; Moyal L, 2011, MOL CELL, V41, P529, DOI 10.1016/j.molcel.2011.02.015; Nika J, 2001, J BIOL CHEM, V276, P1051, DOI 10.1074/jbc.M007398200; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Ozpolat B, 2012, LEUKEMIA RES TREAT, V17; Paglin S, 2005, CANCER RES, V65, P11061, DOI 10.1158/0008-5472.CAN-05-1083; Paglin S, 2001, CANCER RES, V61, P439; Peidis P, 2011, CELL DEATH DIFFER, V18, P145, DOI 10.1038/cdd.2010.76; Peidis P, 2010, AGING-US, V2, P669, DOI 10.18632/aging.100216; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Puget N, 2005, DNA REPAIR, V4, P149, DOI 10.1016/j.dnarep.2004.08.010; Raven JF, 2008, J BIOL CHEM, V283, P3097, DOI 10.1074/jbc.M709677200; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Seluanov A., 2010, JOVE-J VIS EXP, V43, DOI [DOI 10.3791/2002, 10.3791/2002]; Shor B, 2008, CANCER RES, V68, P2934, DOI 10.1158/0008-5472.CAN-07-6487; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Yu K, 2001, ENDOCR-RELAT CANCER, V8, P249, DOI 10.1677/erc.0.0080249; Yuan RR, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-45; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	47	8	8	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77260	10.1371/journal.pone.0077260	http://dx.doi.org/10.1371/journal.pone.0077260			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204783	Green Submitted, gold, Green Published			2022-12-27	WOS:000326155400032
J	Lesting, J; Daldrup, T; Narayanan, V; Himpe, C; Seidenbecher, T; Pape, HC				Lesting, Joerg; Daldrup, Thiemo; Narayanan, Venu; Himpe, Christian; Seidenbecher, Thomas; Pape, Hans-Christian			Directional Theta Coherence in Prefrontal Cortical to Amygdalo-Hippocampal Pathways Signals Fear Extinction	PLOS ONE			English	Article							PARVALBUMIN-CONTAINING INTERNEURONS; CONDITIONED FEAR; BASOLATERAL AMYGDALA; VENTRAL HIPPOCAMPUS; PHASE SYNCHRONIZATION; NEURONAL CIRCUITS; LATERAL AMYGDALA; NEURAL CIRCUITS; FIRING PATTERNS; MOUSE MODEL	Theta oscillations are considered crucial mechanisms in neuronal communication across brain areas, required for consolidation and retrieval of fear memories. One form of inhibitory learning allowing adaptive control of fear memory is extinction, a deficit of which leads to maladaptive fear expression potentially leading to anxiety disorders. Behavioral responses after extinction training are thought to reflect a balance of recall from extinction memory and initial fear memory traces. Therefore, we hypothesized that the initial fear memory circuits impact behavioral fear after extinction, and more specifically, that the dynamics of theta synchrony in these pathways signal the individual fear response. Simultaneous multi-channel local field and unit recordings were obtained from the infralimbic prefrontal cortex, the hippocampal CA1 and the lateral amygdala in mice. Data revealed that the pattern of theta coherence and directionality within and across regions correlated with individual behavioral responses. Upon conditioned freezing, units were phase-locked to synchronized theta oscillations in these pathways, characterizing states of fear memory retrieval. When the conditioned stimulus evoked no fear during extinction recall, theta interactions were directional with prefrontal cortical spike firing leading hippocampal and amygdalar theta oscillations. These results indicate that the directional dynamics of theta-entrained activity across these areas guide changes in appraisal of threatening stimuli during fear memory and extinction retrieval. Given that exposure therapy involves procedures and pathways similar to those during extinction of conditioned fear, one therapeutical extension might be useful that imposes artificial theta activity to prefrontal cortical-amygdalo-hippocampal pathways that mimics the directionality signaling successful extinction recall.	[Lesting, Joerg; Daldrup, Thiemo; Narayanan, Venu; Seidenbecher, Thomas; Pape, Hans-Christian] Univ Munster, Inst Physiol 1, D-48149 Munster, Germany; [Daldrup, Thiemo] Univ Munster, Otto Creutzfeldt Ctr Cognit & Behav Neurosci, D-48149 Munster, Germany; [Himpe, Christian] Univ Munster, Inst Computat & Appl Math, D-48149 Munster, Germany	University of Munster; University of Munster; University of Munster	Pape, HC (corresponding author), Univ Munster, Inst Physiol 1, D-48149 Munster, Germany.	papechris@ukmuenster.de			German Research Foundation (DFG) [SFB-TRR58, TP A02]; Max-Planck Society; Humboldt Foundation; Otto Creutzfeldt Centre for Cognitive and Behavioral Neuroscience	German Research Foundation (DFG)(German Research Foundation (DFG)); Max-Planck Society(Max Planck Society); Humboldt Foundation(Alexander von Humboldt Foundation); Otto Creutzfeldt Centre for Cognitive and Behavioral Neuroscience	This work was supported by the German Research Foundation (DFG, SFB-TRR58, TP A02, to TS and HCP; http://sfbtrr58.uni-muenster.de), the Max-Planck Society and Humboldt Foundation (Research Award 2007 to HCP; http://www.humboldt-foundation.de/web/max-planck-preis.html), and the Otto Creutzfeldt Centre for Cognitive and Behavioral Neuroscience (scholarship to TD; http://www.uni-muenster.de/OCCMuenster/news/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2011, NEURON, V71, P898, DOI 10.1016/j.neuron.2011.07.027; Adhikari A, 2010, J NEUROSCI METH, V191, P191, DOI 10.1016/j.jneumeth.2010.06.019; Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; Amano T, 2010, NAT NEUROSCI, V13, P489, DOI 10.1038/nn.2499; Amir A, 2011, J NEUROPHYSIOL, V105, P3054, DOI 10.1152/jn.00136.2011; An B, 2012, J NEUROSCI, V32, P16845, DOI 10.1523/JNEUROSCI.3017-12.2012; Berens P., 2009, J STAT SOFTWARE, V31; Bienvenu TCM, 2012, NEURON, V74, P1059, DOI 10.1016/j.neuron.2012.04.022; Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; Busti D, 2011, J NEUROSCI, V31, P5131, DOI 10.1523/JNEUROSCI.6100-10.2011; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cammarota M, 2007, REV BRAS PSIQUIATR, V29, P80, DOI 10.1590/S1516-44462007000100019; Chauveau F, 2012, NEUROPSYCHOPHARMACOL, V37, P1588, DOI 10.1038/npp.2012.3; Delgado MR, 2008, NEURON, V59, P829, DOI 10.1016/j.neuron.2008.06.029; Ertl M, 2013, NEUROIMAGE, V81, P412, DOI 10.1016/j.neuroimage.2013.05.044; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Hartwich K, 2009, J NEUROSCI, V29, P9563, DOI 10.1523/JNEUROSCI.1397-09.2009; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Herry C, 2010, EUR J NEUROSCI, V31, P599, DOI 10.1111/j.1460-9568.2010.07101.x; Hyman JM, 2005, HIPPOCAMPUS, V15, P739, DOI 10.1002/hipo.20106; Johansen JP, 2012, BIOL PSYCHIAT, V71, P1053, DOI 10.1016/j.biopsych.2011.10.023; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Jungling K, 2008, NEURON, V59, P298, DOI 10.1016/j.neuron.2008.07.002; Knapska E, 2012, P NATL ACAD SCI USA, V109, P17093, DOI 10.1073/pnas.1202087109; Laxmi TR, 2003, BEHAV BRAIN RES, V145, P89, DOI 10.1016/S0166-4328(03)00101-3; Lesting J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021714; Lesting J, 2011, EPILEPSIA, V52, P337, DOI 10.1111/j.1528-1167.2010.02758.x; Likhtik E, 2008, NATURE, V454, P642, DOI 10.1038/nature07167; Livneh U, 2012, NEURON, V75, P133, DOI 10.1016/j.neuron.2012.05.016; Lubenov EV, 2009, NATURE, V459, P534, DOI 10.1038/nature08010; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 2011, NEURON, V70, P830, DOI 10.1016/j.neuron.2011.04.023; McDonald AJ, 2005, BRAIN RES, V1035, P32, DOI 10.1016/j.brainres.2004.11.052; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Milad MR, 2007, BIOL PSYCHIAT, V62, P1191, DOI 10.1016/j.biopsych.2007.04.032; Milad MR, 2012, ANNU REV PSYCHOL, V63, P129, DOI 10.1146/annurev.psych.121208.131631; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Narayanan RT, 2007, EUR J NEUROSCI, V25, P1823, DOI 10.1111/j.1460-9568.2007.05437.x; Narayanan RT, 2007, NEUROREPORT, V18, P1107, DOI 10.1097/WNR.0b013e3282004992; Narayanan V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022600; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Pape HC, 2005, HIPPOCAMPUS, V15, P874, DOI 10.1002/hipo.20120; Pinard CR, 2012, NEUROSCIENCE, V205, P112, DOI 10.1016/j.neuroscience.2011.12.036; Popa D, 2010, P NATL ACAD SCI USA, V107, P6516, DOI 10.1073/pnas.0913016107; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Rainnie DG, 2006, J COMP NEUROL, V498, P142, DOI 10.1002/cne.21049; Routtenberg A, 2005, TRENDS NEUROSCI, V28, P12, DOI 10.1016/j.tins.2004.11.006; Royer S, 2010, J NEUROSCI, V30, P1777, DOI 10.1523/JNEUROSCI.4681-09.2010; Sangha S, 2009, J NEUROSCI, V29, P15713, DOI 10.1523/JNEUROSCI.2620-09.2009; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Seidenbecher T, 2012, INSIGHTS AMYGDALA ST, P213; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sierra-Mercado D, 2011, NEUROPSYCHOPHARMACOL, V36, P529, DOI 10.1038/npp.2010.184; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; Sotres-Bayon F, 2012, NEURON, V76, P804, DOI 10.1016/j.neuron.2012.09.028; Uhlhaas PJ, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.017.2009	57	60	60	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77707	10.1371/journal.pone.0077707	http://dx.doi.org/10.1371/journal.pone.0077707			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204927	gold, Green Published, Green Submitted			2022-12-27	WOS:000326152300029
J	Sano, A; Matsushita, H; Wu, H; Jiao, JA; Kasinathan, P; Sullivan, EJ; Wang, ZD; Kuroiwa, Y				Sano, Akiko; Matsushita, Hiroaki; Wu, Hua; Jiao, Jin-An; Kasinathan, Poothappillai; Sullivan, Eddie J.; Wang, Zhongde; Kuroiwa, Yoshimi			Physiological Level Production of Antigen-Specific Human Immunoglobulin in Cloned Transchromosomic Cattle	PLOS ONE			English	Article							B-CELL RECEPTOR; INTRAVENOUS IMMUNOGLOBULIN; ANTIBODIES; DISEASE; PLASMA; CALVES; BETA	Therapeutic human polyclonal antibodies (hpAbs) derived from pooled plasma from human donors are Food and Drug Administration approved biologics used in the treatment of a variety of human diseases. Powered by the natural diversity of immune response, hpAbs are effective in treating diseases caused by complex or quickly-evolving antigens such as viruses. We previously showed that transchromosomic (Tc) cattle carrying a human artificial chromosome (HAC) comprising the entire unrearranged human immunoglobulin heavy-chain (hIGH) and kappa-chain (hIGK) germline loci (named as kappa HAC) are capable of producing functional hpAbs when both of the bovine immunoglobulin mu heavy-chains, bIGHM and bIGHML1, are homozygously inactivated (double knockouts or DKO). However, B lymphocyte development in these Tc cattle is compromised, and the overall production of hpAbs is low. Here, we report the construction of an improved HAC Delta, designated as cKSL-HAC Delta, by incorporating all of the human immunoglobulin germline loci into the HAC. Furthermore, for avoiding the possible human-bovine interspecies incompatibility between the human immunoglobulin mu chain protein (hIgM) and bovine transmembrane alpha and beta immunoglobulins (bIg alpha and bIg beta) in the pre-B cell receptor (pre-BCR) complex, we partially replaced (bovinized) the hIgM constant domain with the counterpart of bovine IgM (bIgM) that is involved in the interaction between bIgM and bIg alpha/Ig beta; human IgM bovinization would also improve the functionality of hIgM in supporting B cell activation and proliferation. We also report the successful production of DKO Tc cattle carrying the cKSL-HA Delta (cKSL-HAC Delta/DKO), the dramatic improvement of B cell development in these cattle and the high level production of hpAbs (as measured for the human IgG isotype) in the plasma. We further demonstrate that, upon immunization by tumor immunogens, high titer tumor immunogen-specific human IgG (hIgG) can be produced from such Tc cattle.	[Sano, Akiko; Kuroiwa, Yoshimi] Kyowa Hakko Kirin Co Ltd, Chiyoda Ku, Tokyo, Japan; [Matsushita, Hiroaki; Wu, Hua; Jiao, Jin-An; Sullivan, Eddie J.] Sanford Appl Biosci LLC, Sioux Falls, SD USA; [Wang, Zhongde] Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA; [Kasinathan, Poothappillai] Trans Ova Genet, Sioux Ctr, IA USA; [Sano, Akiko; Matsushita, Hiroaki; Wu, Hua; Jiao, Jin-An; Kasinathan, Poothappillai; Sullivan, Eddie J.; Wang, Zhongde; Kuroiwa, Yoshimi] Hematech Inc, Sioux Falls, SD USA	Kyowa Kirin Ltd; Utah System of Higher Education; Utah State University	Sullivan, EJ (corresponding author), Sanford Appl Biosci LLC, Sioux Falls, SD USA.	eddie.sullivan@sanfordhealth.org; zonda.wang@usu.edu		Sullivan, Eddie/0000-0001-7468-2006; Wang, Zhongde/0000-0003-2441-4729	Hematech, Inc.	Hematech, Inc.	This work was financed by internal funding of Hematech, Inc., which no longer exists and no longer has financial interest in the work. Hematech has transferred all of its business to Sanford Applied Biosciences, LLC. There are no current external funding sources for this study. Kyowa Hakko Kirin provided permission for the work to be published. Financial interest in this work is currently owned by Sanford Applied Biosciences who did have a role in the decision to publish as well as the preparation of the manuscript. While it is considered beneficial to the interests of Sanford Applied Biosciences to publish this work, this consideration played no role in the study design, data collection and analysis and preparation of the manuscript. This is evidenced by the inclusion of now independent authors with no affiliation to Sanford Applied Biosciences.	Ben-Nathan D, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-18; Bonagura VR, 2013, J CLIN IMMUNOL, V33, pS90, DOI 10.1007/s10875-012-9838-1; Boothpur R, 2010, AM J KIDNEY DIS, V55, P141, DOI 10.1053/j.ajkd.2009.06.017; Buchacher Andrea, 2006, Biotechnology Journal, V1, P148, DOI 10.1002/biot.200500037; Fuentes-Panana EM, 2004, J IMMUNOL, V173, P1000, DOI 10.4049/jimmunol.173.2.1000; Fuentes-Panana EM, 2004, IMMUNOL REV, V197, P26, DOI 10.1111/j.0105-2896.2004.0105.x; Kreil TR, 2012, TRANSFUSION, V52, P803, DOI 10.1111/j.1537-2995.2011.03347.x; Kuroiwa Y, 2004, NAT GENET, V36, P775, DOI 10.1038/ng1373; Kuroiwa Y, 2002, NAT BIOTECHNOL, V20, P889, DOI 10.1038/nbt727; Kuroiwa Y, 2009, NAT BIOTECHNOL, V27, P173, DOI 10.1038/nbt.1521; Lundquist AL, 2007, LIVER TRANSPLANT, V13, P647, DOI 10.1002/lt.21098; Martensson IL, 2007, CURR OPIN IMMUNOL, V19, P137, DOI 10.1016/j.coi.2007.02.006; Newcombe C, 2007, J CHROMATOGR B, V848, P2, DOI 10.1016/j.jchromb.2006.07.004; Perez-Vera P, 2011, BONE MARROW RES, DOI 10.1155/2011/502751; Radaev S, 2010, STRUCTURE, V18, P934, DOI 10.1016/j.str.2010.04.019; Rasmussen SK, 2012, ARCH BIOCHEM BIOPHYS, V526, P139, DOI 10.1016/j.abb.2012.07.001; Sellahewa K. H., 1994, Ceylon Medical Journal, V39, P173; Stiehm ER, 2008, BIOLOGICALS, V36, P363, DOI 10.1016/j.biologicals.2008.07.002; Sullivan EJ, 2004, BIOL REPROD, V70, P146, DOI 10.1095/biolreprod.103.021220; Yeh KM, 2005, J ANTIMICROB CHEMOTH, V56, P919, DOI 10.1093/jac/dki346; Yoshimi K, 2000, NAT BIOTECHNOL, V18, P1086, DOI 10.1038/80287	21	29	35	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78119	10.1371/journal.pone.0078119	http://dx.doi.org/10.1371/journal.pone.0078119			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205120	Green Published, gold, Green Submitted			2022-12-27	WOS:000326152300042
J	Becknell, B; Spencer, JD; Carpenter, AR; Chen, X; Singh, A; Ploeger, S; Kline, J; Ellsworth, P; Li, BR; Proksch, E; Schwaderer, AL; Hains, DS; Justice, SS; McHugh, KM				Becknell, Brian; Spencer, John David; Carpenter, Ashley R.; Chen, Xi; Singh, Aspinder; Ploeger, Suzanne; Kline, Jennifer; Ellsworth, Patrick; Li, Birong; Proksch, Ehrhardt; Schwaderer, Andrew L.; Hains, David S.; Justice, Sheryl S.; McHugh, Kirk M.			Expression and Antimicrobial Function of Beta-Defensin 1 in the Lower Urinary Tract	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; HUMAN BETA-DEFENSIN-1; DENDRITIC CELLS; RIBONUCLEASE 7; MURINE MODEL; IN-VITRO; PEPTIDE; BLADDER; INFECTION; MICE	Beta defensins (BDs) are cationic peptides with antimicrobial activity that defend epithelial surfaces including the skin, gastrointestinal, and respiratory tracts. However, BD expression and function in the urinary tract are incompletely characterized. The purpose of this study was to describe Beta Defensin-1 (BD-1) expression in the lower urinary tract, regulation by cystitis, and antimicrobial activity toward uropathogenic Escherichia coli (UPEC) in vivo. Human DEFB1 and orthologous mouse Defb1 mRNA are detectable in bladder and ureter homogenates, and human BD-1 protein localizes to the urothelium. To determine the relevance of BD-1 to lower urinary tract defense in vivo, we evaluated clearance of UPEC by Defb1 knockout (Defb1(-/-)) mice. At 6, 18, and 48 hours following transurethral UPEC inoculation, no significant differences were observed in bacterial burden in bladders or kidneys of Defb1(-/-) and wild type C57BL/6 mice. In wild type mice, bladder Defb1 mRNA levels decreased as early as two hours post-infection and reached a nadir by six hours. RT-PCR profiling of BDs identified expression of Defb3 and Defb14 mRNA in murine bladder and ureter, which encode for mBD-3 and mBD-14 protein, respectively. MBD-14 protein expression was observed in bladder urothelium following UPEC infection, and both mBD-3 and mBD-14 displayed dose-dependent bactericidal activity toward UPEC in vitro. Thus, whereas mBD-1 deficiency does not alter bladder UPEC burden in vivo, we have identified mBD-3 and mBD-14 as potential mediators of mucosal immunity in the lower urinary tract.	[Becknell, Brian; Spencer, John David; Schwaderer, Andrew L.; Hains, David S.] Nationwide Childrens Hosp, Nephrol Sect, Columbus, OH USA; [Becknell, Brian; Spencer, John David; Chen, Xi; Kline, Jennifer; Schwaderer, Andrew L.; Hains, David S.] Nationwide Childrens Hosp, Res Inst, Ctr Clin & Translat Res, Columbus, OH USA; [Carpenter, Ashley R.] Ohio State Univ, Coll Med, Biomed Sci Grad Program, Columbus, OH 43210 USA; [Carpenter, Ashley R.; McHugh, Kirk M.] Nationwide Childrens Hosp, Res Inst, Ctr Mol & Human Genet, Columbus, OH USA; [Singh, Aspinder; Ploeger, Suzanne] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Ellsworth, Patrick] Univ Rochester, Dept Internal Med & Pediat, Rochester, NY USA; [Li, Birong; Justice, Sheryl S.] Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH USA; [Proksch, Ehrhardt] Univ Kiel, Dept Dermatol, Kiel, Germany	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University of Rochester; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Kiel	Justice, SS (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH USA.	Sheryl.Justice@nationwidechildrens.org; Kirk.McHugh@nationwidechildrens.org	Schwaderer, Andrew/E-4049-2011; Becknell, Michael/E-6995-2014; Hains, David/AAR-1112-2020; Justice, Sheryl/E-3329-2011	Justice, Sheryl/0000-0002-7059-3759; Hains, David/0000-0001-6511-9561; Jackson, Ashley R./0000-0002-1571-3906	NIDDK [NIH R01 DK085242]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085242, K08DK094970] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is funded by the NIDDK (NIH R01 DK085242). There are no commercial or other sources of funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens K, 2011, J INVEST DERMATOL, V131, P443, DOI 10.1038/jid.2010.289; Ali ASM, 2009, J UROLOGY, V182, P21, DOI 10.1016/j.juro.2009.02.124; Bals R, 1999, INFECT IMMUN, V67, P3542, DOI 10.1128/IAI.67.7.3542-3547.1999; Bals R, 1998, INFECT IMMUN, V66, P1225, DOI 10.1128/IAI.66.3.1225-1232.1998; Barabas N, 2013, IMMUNOBIOLOGY, V218, P1005, DOI 10.1016/j.imbio.2012.11.007; Bates JM, 2004, KIDNEY INT, V65, P791, DOI 10.1111/j.1523-1755.2004.00452.x; BENSCH KW, 1995, FEBS LETT, V368, P331, DOI 10.1016/0014-5793(95)00687-5; Billips BK, 2008, INFECT IMMUN, V76, P3891, DOI 10.1128/IAI.00069-08; Billips BK, 2007, INFECT IMMUN, V75, P5353, DOI 10.1128/IAI.00922-07; Bolton M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033897; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Ganz T, 2001, Semin Respir Infect, V16, P4; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Ganz T, 2001, J INFECT DIS, V183, pS41, DOI 10.1086/318838; Hazlett L, 2011, CELL TISSUE RES, V343, P175, DOI 10.1007/s00441-010-1022-4; *HCUP NIS, 2010, HE HEALTHC COST UT P; Hinrichsen K, 2008, ANTIMICROB AGENTS CH, V52, P1876, DOI 10.1128/AAC.01308-07; Hiratsuka T, 2000, NEPHRON, V85, P34, DOI 10.1159/000045627; Hung CS, 2009, NAT PROTOC, V4, P1230, DOI 10.1038/nprot.2009.116; Hunstad DA, 2005, INFECT IMMUN, V73, P3999, DOI 10.1128/IAI.73.7.3999-4006.2005; Hunstad DA, 2010, ANNU REV MICROBIOL, V64, P203, DOI 10.1146/annurev.micro.112408.134258; Huttner KM, 1997, FEBS LETT, V413, P45, DOI 10.1016/S0014-5793(97)00875-2; Islam D, 2001, NAT MED, V7, P180, DOI 10.1038/84627; Jiang Yan, 2012, Antiviral Chemistry & Chemotherapy, V22, P255, DOI 10.3851/IMP2077; Kline KA, 2010, INFECT IMMUN, V78, P1943, DOI 10.1128/IAI.01235-09; Kraemer BF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002355; Mo L, 2004, AM J PHYSIOL-RENAL, V286, pF795, DOI 10.1152/ajprenal.00357.2003; Morrison G, 2002, INFECT IMMUN, V70, P3053, DOI 10.1128/IAI.70.6.3053-3060.2002; Morrison GM, 1998, MAMM GENOME, V9, P453, DOI 10.1007/s003359900795; Moser C, 2002, INFECT IMMUN, V70, P3068, DOI 10.1128/IAI.70.6.3068-3072.2002; Nitschke M, 2002, EXP NEPHROL, V10, P332, DOI 10.1159/000065296; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ragnarsdottir B, 2012, PEDIATR NEPHROL, V27, P2017, DOI 10.1007/s00467-011-2089-1; Ryan LK, 2011, J LEUKOCYTE BIOL, V90, P343, DOI 10.1189/jlb.0209079; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Semple F, 2010, EUR J IMMUNOL, V40, P1073, DOI 10.1002/eji.200940041; Soruri A, 2007, EUR J IMMUNOL, V37, P2474, DOI 10.1002/eji.200737292; SPENCER JD, 2013, PEDIATR NEPHROL, P32397; Spencer JD, 2011, KIDNEY INT, V80, P175, DOI 10.1038/ki.2011.109; Spencer JD, 2013, KIDNEY INT, V83, P615, DOI 10.1038/ki.2012.410; Spencer JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031712; Sperandio B, 2008, J EXP MED, V205, P1121, DOI 10.1084/jem.20071698; Storm DW, 2012, J UROLOGY, V188, P236, DOI 10.1016/j.juro.2012.03.025; THAI KH, 2010, JOVE-J VIS EXP, P29806; Townes CL, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2010.08.019; Underwood MA, 2010, PEDIATRICS, V125, P1237, DOI 10.1542/peds.2009-3289; Valore EV, 1998, J CLIN INVEST, V101, P1633, DOI 10.1172/JCI1861; Zaalouk TK, 2004, INFECT IMMUN, V72, P2772, DOI 10.1128/IAI.72.5.2772-2779.2004; Zasloff M, 2007, J AM SOC NEPHROL, V18, P2810, DOI 10.1681/ASN.2007050611; Zasloff M, 2013, KIDNEY INT, V83, P548, DOI 10.1038/ki.2012.467; Zucht H D, 1998, Eur J Med Res, V3, P315	53	32	33	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77714	10.1371/journal.pone.0077714	http://dx.doi.org/10.1371/journal.pone.0077714			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204930	Green Submitted, Green Published, gold			2022-12-27	WOS:000326032600043
J	Di Guardo, M; Tadiello, A; Farneti, B; Lorenz, G; Masuero, D; Vrhovsek, U; Costa, G; Velasco, R; Costa, F				Di Guardo, Mario; Tadiello, Alice; Farneti, Brian; Lorenz, Giorgia; Masuero, Domenico; Vrhovsek, Urska; Costa, Guglielmo; Velasco, Riccardo; Costa, Fabrizio			A Multidisciplinary Approach Providing New Insight into Fruit Flesh Browning Physiology in Apple (Malus x domestica Borkh.)	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; TOMATO POLYPHENOL OXIDASE; ASCORBIC-ACID; LINKAGE DISEQUILIBRIUM; PHENOLIC COMPOSITION; GENE; QTL; IDENTIFICATION; ORGANIZATION; BIOCHEMISTRY	In terms of the quality of minimally processed fruit, flesh browning is fundamentally important in the development of an aesthetically unpleasant appearance, with consequent off-flavours. The development of browning depends on the enzymatic action of the polyphenol oxidase (PPO). In the 'Golden Delicious' apple genome ten PPO genes were initially identified and located on three main chromosomes (2, 5 and 10). Of these genes, one element in particular, here called Md-PPO, located on chromosome 10, was further investigated and genetically mapped in two apple progenies ('Fuji x Pink Lady' and 'Golden Delicious x Braeburn'). Both linkage maps, made up of 481 and 608 markers respectively, were then employed to find QTL regions associated with fruit flesh browning, allowing the detection of 25 QTLs related to several browning parameters. These were distributed over six linkage groups with LOD values spanning from 3.08 to 4.99 and showed a rate of phenotypic variance from 26.1 to 38.6%. Anchoring of these intervals to the apple genome led to the identification of several genes involved in polyphenol synthesis and cell wall metabolism. Finally, the expression profile of two specific candidate genes, up and downstream of the polyphenolic pathway, namely phenylalanine ammonia lyase (PAL) and polyphenol oxidase (PPO), provided insight into flesh browning physiology. Md-PPO was further analyzed and two haplotypes were characterised and associated with fruit flesh browning in apple.	[Di Guardo, Mario; Tadiello, Alice; Lorenz, Giorgia; Masuero, Domenico; Vrhovsek, Urska; Velasco, Riccardo; Costa, Fabrizio] Fdn Edmund, Genom & Crop Biol Dept, Res & Innovat Ctr, San Michele All Adige, Trento, Italy; [Farneti, Brian; Costa, Guglielmo] Univ Bologna, Dept Fruit Trees & Woody Plant Sci, Bologna, Italy	Fondazione Edmund Mach; University of Bologna	Costa, F (corresponding author), Fdn Edmund, Genom & Crop Biol Dept, Res & Innovat Ctr, San Michele All Adige, Trento, Italy.	fabrizio.costa@fmach.it	Di Guardo, Mario/AAA-7498-2021	Farneti, Brian/0000-0001-7624-0084; Di Guardo, Mario/0000-0003-3339-2007; Velasco, Riccardo/0000-0002-8760-5031; Costa, Guglielmo/0000-0002-5036-3163; Costa, Fabrizio/0000-0003-1416-1078; Masuero, Domenico/0000-0003-0696-3206	Agroalimentare e Ricerca project (AGER) [2010-2119]	Agroalimentare e Ricerca project (AGER)	This work was supported by the Agroalimentare e Ricerca project (AGER grant no. 2010-2119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIOT MJ, 1992, J FOOD SCI, V57, P958, DOI 10.1111/j.1365-2621.1992.tb14333.x; Bagal UR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S3-S1; BOSS PK, 1995, PLANT MOL BIOL, V27, P429, DOI 10.1007/BF00020197; Buta JG, 1999, J AGR FOOD CHEM, V47, P1, DOI 10.1021/jf980712x; Chagne D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-212; Chagne D, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-12; Choi YJ, 2005, POSTHARVEST BIOL TEC, V37, P47, DOI 10.1016/j.postharvbio.2005.03.002; Chow YN, 2011, FOOD CHEM, V129, P761, DOI 10.1016/j.foodchem.2011.05.017; CONSTABEL CP, 1995, P NATL ACAD SCI USA, V92, P407, DOI 10.1073/pnas.92.2.407; COSETENG MY, 1987, J FOOD SCI, V52, P985, DOI 10.1111/j.1365-2621.1987.tb14257.x; Costa F, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-229; Costa F, 2010, J EXP BOT, V61, P3029, DOI 10.1093/jxb/erq130; Cova V, 2012, MOL BREEDING, V29, P699, DOI 10.1007/s11032-011-9584-8; Davey MW, 2006, PLANT PHYSIOL, V142, P343, DOI 10.1104/pp.106.083279; Demeke T, 2002, THEOR APPL GENET, V104, P813, DOI 10.1007/s00122-001-0847-3; Dunemann F, 2012, MOL BREEDING, V29, P609, DOI 10.1007/s11032-011-9577-7; Emanuelli F, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-241; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Folta Kevin M., 2009, V6, P315, DOI 10.1007/978-0-387-77491-6_15; Franck C, 2003, J AGR FOOD CHEM, V51, P4757, DOI 10.1021/jf026229a; Fridman E, 2000, P NATL ACAD SCI USA, V97, P4718, DOI 10.1073/pnas.97.9.4718; Giovannoni J, 2001, ANNU REV PLANT PHYS, V52, P725, DOI 10.1146/annurev.arplant.52.1.725; Gorny JR, 2002, POSTHARVEST BIOL TEC, V24, P271, DOI 10.1016/S0925-5214(01)00139-9; Gunes G, 2001, POSTHARVEST BIOL TEC, V22, P197, DOI 10.1016/S0925-5214(01)00083-7; Gupta PK, 2001, CURR SCI INDIA, V80, P524; Jorde LB, 2000, GENOME RES, V10, P1435, DOI 10.1101/gr.144500; JORDE LB, 1995, AM J HUM GENET, V56, P11; Kenis K, 2008, TREE GENET GENOMES, V4, P647, DOI 10.1007/s11295-008-0140-6; Krawczak M, 2000, HUM MUTAT, V15, P45, DOI 10.1002/(SICI)1098-1004(200001)15:1<45::AID-HUMU10>3.0.CO;2-T; Kumar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049321; Liebhard R, 2002, MOL BREEDING, V10, P217, DOI 10.1023/A:1020525906332; Liebhard R, 2003, THEOR APPL GENET, V106, P1497, DOI 10.1007/s00122-003-1209-0; Liebhard R, 2003, PLANT MOL BIOL, V52, P511, DOI 10.1023/A:1024886500979; Longhi S, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-37; Longhi S, 2012, J EXP BOT, V63, P1107, DOI 10.1093/jxb/err326; Lu YL, 2009, THEOR APPL GENET, V120, P93, DOI 10.1007/s00122-009-1162-7; MacDonald MJ, 2007, BIOCHEM CELL BIOL, V85, P273, DOI 10.1139/O07-018; MARTINEZ MV, 1995, TRENDS FOOD SCI TECH, V6, P195, DOI 10.1016/S0924-2244(00)89054-8; Mellidou I, 2012, PLANT PHYSIOL, V160, P1613, DOI 10.1104/pp.112.203786; Micheletti D, 2011, TREE GENET GENOMES, V7, P857, DOI 10.1007/s11295-011-0380-8; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Murata M, 2001, BIOSCI BIOTECH BIOCH, V65, P383, DOI 10.1271/bbb.65.383; MURATA M, 1995, J AGR FOODS CHEM, V43; Newcomb RD, 2006, PLANT PHYSIOL, V141, P147, DOI 10.1104/pp.105.076208; NEWMAN SM, 1993, PLANT MOL BIOL, V21, P1035, DOI 10.1007/BF00023601; NICOLAS JJ, 1994, CRIT REV FOOD SCI, V34, P109, DOI 10.1080/10408399409527653; Ogundiwin EA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-587; OHLSSON T, 1994, TRENDS FOOD SCI TECH, V5, P341, DOI 10.1016/0924-2244(94)90210-0; Pannala AS, 2001, BIOCHEM BIOPH RES CO, V282, P1161, DOI 10.1006/bbrc.2001.4705; Park S, 2006, PLANT PHYSIOL, V141, P811, DOI 10.1104/pp.106.080994; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Regev-Shoshani G, 2003, BIOCHEM J, V374, P157, DOI 10.1042/BJ20030141; Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249; Serpen A, 2007, FOOD CHEM, V104, P721, DOI 10.1016/j.foodchem.2006.11.073; SPANOS GA, 1990, J AGR FOOD CHEM, V38, P1572, DOI 10.1021/jf00097a031; Theodoridis G, 2012, METABOLOMICS, V8, P175, DOI 10.1007/s11306-011-0298-z; Thipyapong P, 1997, PLANT PHYSIOL, V115, P409, DOI 10.1104/pp.115.2.409; THYGESEN PW, 1995, PLANT PHYSIOL, V109, P525, DOI 10.1104/pp.109.2.525; Tran LT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-395; Treutter D, 2001, PLANT GROWTH REGUL, V34, P71, DOI 10.1023/A:1013378702940; Van der Hoeven R, 2002, PLANT CELL, V14, P1441, DOI 10.1105/tpc.010478; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Van Ooijen J. W, 2009, MAPQTL 6 SOFTW MAPP; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Vrhovsek U, 2012, J AGR FOOD CHEM, V60, P8831, DOI 10.1021/jf2051569; WILSON LM, 2004, PLANT CELL, DOI DOI 10.1105/TPC.P.104.025700; Yamamoto T, 2004, ACTA HORTIC, P51, DOI 10.17660/ActaHortic.2004.663.2	68	44	45	3	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78004	10.1371/journal.pone.0078004	http://dx.doi.org/10.1371/journal.pone.0078004			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205065	Green Published, gold			2022-12-27	WOS:000326029300132
J	Tan, XS; Ma, JY; Feng, R; Ma, C; Chen, WJ; Sun, YP; Fu, J; Huang, M; He, CY; Shou, JW; He, WY; Wang, Y; Jiang, JD				Tan, Xiang-Shan; Ma, Jing-Yi; Feng, Ru; Ma, Chao; Chen, Wen-Jing; Sun, Yu-Peng; Fu, Jie; Huang, Min; He, Chi-Yu; Shou, Jia-Wen; He, Wen-Yi; Wang, Yan; Jiang, Jian-Dong			Tissue Distribution of Berberine and Its Metabolites after Oral Administration in Rats	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; ION-TRAP-TIME; IN-VITRO; PROTEIN-KINASE; PLASMA; PHARMACOKINETICS; IDENTIFICATION; TRANSCRIPTION; TRANSPORT; URINE	Berberine (BBR) has been confirmed to have multiple bioactivities in clinic, such as cholesterol-lowering, anti-diabetes, cardiovascular protection and anti-inflammation. However, BBR's plasma level is very low; it cannot explain its pharmacological effects in patients. We consider that the in vivo distribution of BBR as well as of its bioactive metabolites might provide part of the explanation for this question. In this study, liquid chromatography coupled to ion trap time-of-flight mass spectrometry (LC/MSn-IT-TOF) as well as liquid chromatography that coupled with tandem mass spectrometry (LC-MS/MS) was used for the study of tissue distribution and pharmacokinetics of BBR in rats after oral administration (200 mg/kg). The results indicated that BBR was quickly distributed in the liver, kidneys, muscle, lungs, brain, heart, pancreas and fat in a descending order of its amount. The pharmacokinetic profile indicated that BBR's level in most of studied tissues was higher (or much higher) than that in plasma 4 h after administration. BBR remained relatively stable in the tissues like liver, heart, brain, muscle, pancreas etc. Organ distribution of BBR's metabolites was also investigated paralleled with that of BBR. Thalifendine (M1), berberrubine (M2) and jatrorrhizine (M4), which the metabolites with moderate bioactivity, were easily detected in organs like the liver and kidney. For instance, M1, M2 and M4 were the major metabolites in the liver, among which the percentage of M2 was up to 65.1%; the level of AUC((0-t)) (area under the concentration-time curve) for BBR or the metabolites in the liver was 10-fold or 30-fold higher than that in plasma, respectively. In summary, the organ concentration of BBR (as well as its bioactive metabolites) was higher than its concentration in the blood after oral administration. It might explain BBR's pharmacological effects on human diseases in clinic.	[Tan, Xiang-Shan; Ma, Jing-Yi; Feng, Ru; Ma, Chao; Chen, Wen-Jing; Sun, Yu-Peng; Fu, Jie; Huang, Min; He, Chi-Yu; Shou, Jia-Wen; He, Wen-Yi; Wang, Yan; Jiang, Jian-Dong] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China; [Tan, Xiang-Shan; Ma, Jing-Yi; Feng, Ru; Ma, Chao; Chen, Wen-Jing; Sun, Yu-Peng; Fu, Jie; Huang, Min; He, Chi-Yu; Shou, Jia-Wen; He, Wen-Yi; Wang, Yan; Jiang, Jian-Dong] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, Y (corresponding author), Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China.	wangyan@imm.ac.cn; jiang.jdong@163.com	Shou, JW/ABA-8850-2020		National Science and Technology Special Projects [2012ZX09301-002-001, 2012ZX09301-002006]; National Natural Science Foundation of China [30873115, 81072611]	National Science and Technology Special Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The project was supported by National Science and Technology Special Projects (2012ZX09301-002-001, 2012ZX09301-002006), and the financial support from the National Natural Science Foundation of China (No. 30873115and 81072611). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao T, 2000, J PHARM PHARMACOL, V52, P1563, DOI 10.1211/0022357001777621; Bahar M, 2011, BIOORG MED CHEM LETT, V21, P2606, DOI 10.1016/j.bmcl.2011.01.101; Chae HW, 2008, ARCH PHARM RES, V31, P103, DOI 10.1007/s12272-008-1127-4; CHEN CM, 1995, J CHROMATOGR B, V665, P117, DOI 10.1016/0378-4347(94)00517-9; CHEN Q-M, 1986, Yaoxue Xuebao, V21, P401; Chen W, 2011, AAPS PHARMSCITECH, V12, P705, DOI 10.1208/s12249-011-9632-z; Chu Y, 2013, J CHROMATOGR B, V919, P75, DOI 10.1016/j.jchromb.2012.12.022; Dong SF, 2011, EUR J PHARMACOL, V660, P368, DOI 10.1016/j.ejphar.2011.03.024; Feng LA, 2010, ARCH PHARM RES, V33, P1975, DOI 10.1007/s12272-010-1213-2; Feng R, 2012, J PHARMACEUT BIOMED, V62, P228, DOI 10.1016/j.jpba.2012.01.014; Fu J, 2012, J PHARMACEUT BIOMED, V71, P162, DOI 10.1016/j.jpba.2012.07.028; Gao L, 2011, MOLECULES, V16, P9218, DOI 10.3390/molecules16119218; Hong Y, 2003, LIFE SCI, V72, P2499, DOI 10.1016/S0024-3205(03)00144-9; Hua WY, 2007, J PHARMACEUT BIOMED, V44, P931, DOI 10.1016/j.jpba.2007.03.022; HUANG WM, 1992, CHINESE MED J-PEKING, V105, P1014; Kheir MM, 2010, FOOD CHEM TOXICOL, V48, P1105, DOI 10.1016/j.fct.2010.01.033; Ko BS, 2005, BIOL PHARM BULL, V28, P1431, DOI 10.1248/bpb.28.1431; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Lan TA, 2010, ARCH BIOCHEM BIOPHYS, V502, P112, DOI 10.1016/j.abb.2010.07.012; Lee JH, 2003, J ETHNOPHARMACOL, V84, P5, DOI 10.1016/S0378-8741(02)00222-2; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Li X, 1999, CHIN PHARM J, V34, P107; Li Y, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-62; Liu YT, 2010, DRUG METAB DISPOS, V38, P1779, DOI 10.1124/dmd.110.033936; Lu T, 2006, J PHARMACEUT BIOMED, V40, P1218, DOI 10.1016/j.jpba.2005.09.023; Ma BL, 2011, J ETHNOPHARMACOL, V137, P1395, DOI 10.1016/j.jep.2011.08.002; Mahata S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-39; MIYAZAKI H, 1978, J CHROMATOGR, V152, P79, DOI 10.1016/S0021-9673(00)85336-4; Shitan N, 2007, BIOSCI BIOTECH BIOCH, V71, P242, DOI 10.1271/bbb.60441; Stein TD, 2004, J NEUROSCI, V24, P7707, DOI 10.1523/JNEUROSCI.2211-04.2004; Tan G, 2009, RAPID COMMUNICATIONS, V24, P209; Wang XL, 2005, AM J CHINESE MED, V33, P935, DOI 10.1142/S0192415X05003557; WANG YX, 1994, J CARDIOVASC PHARM, V23, P716, DOI 10.1097/00005344-199405000-00005; Xia XA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016556; Xu SW, 2013, EXPERT OPIN THER PAT, V23, P149, DOI 10.1517/13543776.2013.743995; Zhang DF, 2010, AQUAC RES, V41, P1095, DOI 10.1111/j.1365-2109.2009.02399.x; Zhang H, 2010, MOL CELL ENDOCRINOL, V330, P25, DOI 10.1016/j.mce.2010.07.022; Zhang H, 2010, METABOLISM, V59, P285, DOI 10.1016/j.metabol.2009.07.029; Zhao J, 2012, J PHARMACEUT BIOMED, V64-65, P94, DOI 10.1016/j.jpba.2012.02.017; Zhu FQ, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-78; Zhu ZY, 2007, RAPID COMMUN MASS SP, V21, P1855, DOI 10.1002/rcm.3023	41	136	150	3	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e77969	10.1371/journal.pone.0077969	http://dx.doi.org/10.1371/journal.pone.0077969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24205048	Green Published, gold, Green Submitted			2022-12-27	WOS:000326373800011
J	Berlina, AN; Taranova, NA; Zherdev, AV; Sankov, MN; Andreev, IV; Martynov, AI; Dzantiev, BB				Berlina, Anna N.; Taranova, Nadezhda A.; Zherdev, Anatoly V.; Sankov, Mikhail N.; Andreev, Igor V.; Martynov, Alexandr I.; Dzantiev, Boris B.			Quantum-Dot-Based Immunochromatographic Assay for Total IgE in Human Serum	PLOS ONE			English	Article							ALLERGEN-SPECIFIC IGE; CHLORAMPHENICOL; IMMUNOASSAYS; NANOCRYSTALS; ANTIBODIES; CLUSTERS; PROTEIN; MILK	To rapidly quantify total immunoglobulin E levels in human serum, we developed a novel quantum-dot-based immunochromatographic assay that employs digital recording of fluorescence. It can detect IgE levels of 5-1000 kU/L, with a coefficient of variation ranging from 2.0 to 9.5%. The assay can be processed in 10 min. The developed assay was tested on 95 serum samples. The correlation coefficient between the IgE values obtained by the proposed assay and those obtained by a commercial ELISA kit was 0.9884. Our assay thus shows promise as a new diagnostic tool for IgE detection.	[Berlina, Anna N.; Taranova, Nadezhda A.; Zherdev, Anatoly V.; Dzantiev, Boris B.] Russian Acad Sci, AN Bach Inst Biochem, Moscow, Russia; [Sankov, Mikhail N.; Andreev, Igor V.; Martynov, Alexandr I.] Russian Fed Medicobiol Agcy, Inst Immunol, Moscow, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences; NRC Institute of Immunology FMBA of Russia	Dzantiev, BB (corresponding author), Russian Acad Sci, AN Bach Inst Biochem, Moscow, Russia.	dzantiev@inbi.ras.ru	Dzantiev, Boris B/C-6125-2014; Taranova, Nadezhda A./I-9872-2014; Berlina, Anna N./F-8900-2017; Zherdev, Anatoly V/G-2916-2013	Zherdev, Anatoly V/0000-0003-3008-2839; Berlina, Anna/0000-0002-3761-7472; Martynov, Alexandr/0000-0001-9761-8058	Ministry of Education and Science of the Russian Federation [8284]	Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation)	This work was supported by the Ministry of Education and Science of the Russian Federation (State Target Program "Research and scientific-pedagogical personnel of innovative Russia in 2009-2013, contract No. 8284). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algar WR, 2010, ANAL CHIM ACTA, V673, P1, DOI 10.1016/j.aca.2010.05.026; Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; BAZARAL M, 1972, J ALLERGY CLIN IMMUN, V49, P189, DOI 10.1016/0091-6749(72)90113-3; Beloglazova NV, 2011, MICROCHIM ACTA, V175, P361, DOI 10.1007/s00604-011-0682-4; Berlina AN, 2013, MEAS TECH+, V55, P1434, DOI 10.1007/s11018-013-0145-x; Berlina AN, 2013, ANAL BIOANAL CHEM, V405, P4997, DOI 10.1007/s00216-013-6876-3; Biotec Milenia, 2009, LAT FLOW IMM QUANT M; Blank U, 2011, ADV EXP MED BIOL, V716, P107, DOI 10.1007/978-1-4419-9533-9_7; Byzova NA, 2010, TALANTA, V81, P843, DOI 10.1016/j.talanta.2010.01.025; Byzova NA, 2010, IMMUNOLOGY, P47; Doekes G, 1996, OCCUP ENVIRON MED, V53, P63, DOI 10.1136/oem.53.1.63; GLEICH GJ, 1975, SCIENCE, V190, P1106, DOI 10.1126/science.1188389; GLEICH GJ, 1971, J LAB CLIN MED, V77, P690; Glovsky M Michael, 2007, Methods Mol Biol, V378, P205, DOI 10.1007/978-1-59745-323-3_15; Goldman ER, 2006, ANAL BIOANAL CHEM, V384, P560, DOI 10.1007/s00216-005-0212-5; Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1; IgE, 2013, IGE HUMAN ELISA KIT; Johansson SGO, 2011, CURR ALLERGY ASTHM R, V11, P173, DOI 10.1007/s11882-010-0174-3; Liskova M, 2011, ANAL BIOANAL CHEM, V400, P369, DOI 10.1007/s00216-011-4700-5; Liu GD, 2007, ANAL CHEM, V79, P7644, DOI 10.1021/ac070691i; Liu JM, 2012, J FLUORESC, V22, P419, DOI 10.1007/s10895-011-0975-3; Lowe PJ, 2011, BRIT J CLIN PHARMACO, V72, P306, DOI 10.1111/j.1365-2125.2011.03962.x; Mahmoud W, 2011, ANAL BIOCHEM, V416, P180, DOI 10.1016/j.ab.2011.05.018; Oleinikov VA, 2011, RUSS J BIOORG CHEM+, V37, P151, DOI 10.1134/S1068162011020117; Pyo D, 2012, J IMMUNOASS IMMUNOCH, V33, P203, DOI 10.1080/15321819.2011.618863; Sinclair D, 2004, J CLIN PATHOL, V57, P956, DOI 10.1136/jcp.2004.017681; STANWORTH DR, 1993, ALLERGY, V48, P67, DOI 10.1111/j.1398-9995.1993.tb00687.x; Sun BQ, 2008, J NANJING MED U, V22, P273; Urusov AE, 2011, J ANAL CHEM+, V66, P770, DOI 10.1134/S1061934811080144; Wang Y, 2011, IET NANOBIOTECHNOL, V5, P14, DOI 10.1049/iet-nbt.2010.0001; WHO Expert Committee on Biological Standartization, 1973, 25 WHO EXP COMM BIOL; Wong RC, 2009, LATERAL FLOW IMMUNOASSAY, P1, DOI 10.1007/978-1-59745-240-3; Yang H, 2010, NANOSCALE RES LETT, V5, P875, DOI 10.1007/s11671-010-9578-1; Yao JJ, 2012, ANAL CHEM, V84, P1645, DOI 10.1021/ac202910y	34	19	20	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77485	10.1371/journal.pone.0077485	http://dx.doi.org/10.1371/journal.pone.0077485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204841	Green Published, gold, Green Submitted			2022-12-27	WOS:000326334500030
J	Kwok, YH; Tuke, J; Nicotra, LL; Grace, PM; Rolan, PE; Hutchinson, MR				Kwok, Yuen H.; Tuke, Jonathan; Nicotra, Lauren L.; Grace, Peter M.; Rolan, Paul E.; Hutchinson, Mark R.			TLR 2 and 4 Responsiveness from Isolated Peripheral Blood Mononuclear Cells from Rats and Humans as Potential Chronic Pain Biomarkers	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; NEUROPATHIC PAIN; GLIAL ACTIVATION; OPIOID ANALGESIA; DRUG DEVELOPMENT; MODEL; HYPERSENSITIVITY; MECHANISMS; MORPHINE	Background: Chronic pain patients have increased peripheral blood mononuclear cell Interkeukin-1 beta production following TLR2 and TLR4 simulation. Here we have used a human-to-rat and rat-to-human approach to further investigate whether peripheral blood immune responses to TLR agonists might be suitable for development as possible systems biomarkers of chronic pain in humans. Methods and Results: Study 1: using a graded model of chronic constriction injury in rats, behavioral allodynia was assessed followed by in vitro quantification of TLR2 and TLR4 agonist-induced stimulation of IL-1 beta release by PBMCs and spinal cord tissues (n = 42; 6 rats per group). Statistical models were subsequently developed using the IL-1 beta responses, which distinguished the pain/no pain states and predicted the degree of allodynia. Study 2: the rat-derived statistical models were tested to assess their predictive utility in determining the pain status of a published human cohort that consists of a heterogeneous clinical pain population (n = 19) and a pain-free population (n = 11). The predictive ability of one of the rat models was able to distinguish pain patients from controls with a ROC AUC of 0.94. The rat model was used to predict the presence of pain in a new chronic pain cohort and was able to accurately predict the presence of pain in 28 out of the 34 chronic pain participants. Conclusions: These clinical findings confirm our previous discoveries of the involvement of the peripheral immune system in chronic pain. Given that these findings are reflected in the prospective graded rat data, it suggests that the TLR response from peripheral blood and spinal cord were related to pain and these clinical findings do indeed act as system biomarkers for the chronic pain state. Hence, they provide additional impetus to the neuroimmune interaction to be a drug target for chronic pain.	[Kwok, Yuen H.; Nicotra, Lauren L.; Grace, Peter M.; Rolan, Paul E.] Univ Adelaide, Sch Med Sci, Discipline Pharmacol, Adelaide, SA, Australia; [Tuke, Jonathan] Univ Adelaide, Sch Math Sci, Adelaide, SA, Australia; [Grace, Peter M.; Hutchinson, Mark R.] Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; [Grace, Peter M.; Hutchinson, Mark R.] Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA; [Rolan, Paul E.] Univ Adelaide, Pain & Anaesthesia Res Clin, Adelaide, SA, Australia; [Rolan, Paul E.] Royal Adelaide Hosp, Pain Management Unit, Adelaide, SA 5000, Australia; [Hutchinson, Mark R.] Univ Adelaide, Sch Med Sci, Discipline Physiol, Adelaide, SA, Australia	University of Adelaide; University of Adelaide; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Adelaide; Royal Adelaide Hospital; University of Adelaide	Kwok, YH (corresponding author), Univ Adelaide, Sch Med Sci, Discipline Pharmacol, Adelaide, SA, Australia.	yuen.kwok@adelaide.edu.au	Hutchinson, Mark/N-1815-2019; Hutchinson, Mark R/G-4147-2014; Grace, Peter/I-5507-2013	Hutchinson, Mark/0000-0003-2154-5950; Hutchinson, Mark R/0000-0003-2154-5950; Tuke, Jonathan/0000-0002-1688-8951; Grace, Peter/0000-0002-8999-1220; Kwok, Yuen/0000-0002-5336-9544	Pain and Anaesthesia Research Clinic, University of Adelaide; Australian Research Council (ARC) [DP110100297]	Pain and Anaesthesia Research Clinic, University of Adelaide; Australian Research Council (ARC)(Australian Research Council)	The study was funded by the Pain and Anaesthesia Research Clinic, University of Adelaide and was supported by Grant Number [DP110100297] from Australian Research Council (ARC). Its contents are solely the responsibility of the authors and the funders had no role in study design, date collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Borsook D, 2011, DISCOV MED, V11, P209; Borsook D, 2011, DISCOV MED, V11, P197; CHAO CC, 1991, CYTOKINE, V3, P292, DOI 10.1016/1043-4666(91)90497-2; Chizh BA, 2008, PAIN, V140, P249, DOI 10.1016/j.pain.2008.09.024; Davis KD, 2012, PAIN, V153, P1555, DOI 10.1016/j.pain.2012.02.037; de Leo JA, 2006, PAIN, V122, P17, DOI 10.1016/j.pain.2006.02.034; DeLeo JA, 2004, NEUROSCIENTIST, V10, P40, DOI 10.1177/1073858403259950; Dunne DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011343; Grace PM, 2011, BRAIN BEHAV IMMUN, V25, P1322, DOI 10.1016/j.bbi.2011.04.003; Grace PM, 2010, J NEUROSCI METH, V193, P47, DOI 10.1016/j.jneumeth.2010.08.025; Herr K, 2011, PAIN MANAG NURS, V12, P230, DOI 10.1016/j.pmn.2011.10.002; Hutchinson MR, 2008, BRAIN BEHAV IMMUN, V22, P1248, DOI 10.1016/j.bbi.2008.07.008; Hutchinson MR, 2008, EUR J NEUROSCI, V28, P20, DOI 10.1111/j.1460-9568.2008.06321.x; Hutchinson MR, 2011, PHARMACOL REV, V63, P772, DOI 10.1124/pr.110.004135; Hutchinson MR, 2009, BRAIN BEHAV IMMUN, V23, P240, DOI 10.1016/j.bbi.2008.09.012; Johnson JL, 2012, CEPHALALGIA, V33, P52; Kim D, 2007, J BIOL CHEM, V282, P14975, DOI 10.1074/jbc.M607277200; Kowalski ML, 2008, MEDIAT INFLAMM, V2008, DOI DOI 10.1155/2008/132732; Kwok YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044232; LEDEBOER A, 2007, NEURON GLIA BIOL, V2, P279; Lesko LJ, 2001, ANNU REV PHARMACOL, V41, P347, DOI 10.1146/annurev.pharmtox.41.1.347; Milligan ED, 2000, BRAIN RES, V861, P105, DOI 10.1016/S0006-8993(00)02050-3; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Miyake K, 2007, SEMIN IMMUNOL, V19, P3, DOI 10.1016/j.smim.2006.12.002; Nicotra L, 2011, EXP NEUROL, P316; Raghavendra V, 2003, J PHARMACOL EXP THER, V306, P624, DOI 10.1124/jpet.103.052407; Tanga FY, 2005, P NATL ACAD SCI USA, V102, P5856, DOI 10.1073/pnas.0501634102; Tawfik VL, 2005, J PHARMACOL EXP THER, V313, P1239, DOI 10.1124/jpet.104.082420; Tsujimoto H, 2006, CLIN IMMUNOL, V119, P180, DOI 10.1016/j.clim.2006.01.004; Venables WN., 2002, MODERN APPL STAT S 4; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471; Wartolowska K, 2009, NEUROTHERAPEUTICS, V6, P755, DOI 10.1016/j.nurt.2009.08.003; Watkins LR, 2003, NAT REV DRUG DISCOV, V2, P973, DOI 10.1038/nrd1251; Yassen A, 2012, J PHARMACOKINETICS P; Yoshikawa M, 1999, MULT SCLER J, V5, P126, DOI 10.1177/135245859900500210	38	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77799	10.1371/journal.pone.0077799	http://dx.doi.org/10.1371/journal.pone.0077799			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204973	Green Published, gold, Green Submitted			2022-12-27	WOS:000326334500063
J	Yang, RR; Yang, L; Qiu, FM; Zhang, LS; Wang, H; Yang, XR; Deng, JQ; Fang, WX; Zhou, YF; Lu, JC				Yang, Rongrong; Yang, Lei; Qiu, Fuman; Zhang, Lisha; Wang, Hui; Yang, Xiaorong; Deng, Jieqiong; Fang, Wenxiang; Zhou, Yifeng; Lu, Jiachun			Functional Genetic Polymorphisms in PP2A Subunit Genes Confer Increased Risks of Lung Cancer in Southern and Eastern Chinese	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; TUMOR-SUPPRESSOR PP2A; COPY-NUMBER VARIATION; REGULATORY SUBUNIT; BREAST-CANCER; DNA-REPAIR; NBS1 GENE; PHOSPHORYLATION; HAPLOTYPES; PATHWAYS	Protein phosphatase-2A (PP2A) is one of the major cellular serine-threonine phosphatases and functions as a tumor suppressor that negatively regulates the activity of some oncogenic kinases. Recent studies have reported that PP2A expression was suppressed during lung carcinogenesis, we there hypothesized that the single nucleotide polymorphisms (SNPs) in PP2A subunit genes may affect PP2A function and thus contribute to lung cancer susceptibility. In a two-stage case-control study with a total of 1559 lung cancer patients and 1679 controls, we genotyped eight putative functional SNPs and one identified functional SNP (i.e., rs11453459) in seven major PP2A subunits (i.e., PPP2R1A, PPP2R1B, PPP2CA, PPP2R2A, PPP2R2B, PPP2R5C, PPP2R5E) in southern and eastern Chinese. We found that rs11453459G (-G/GG) variant genotypes of PPP2R1A and the rs1255722AA variant genotype of PPP2R5E conferred increased risks of lung cancer (rs11453459, -G/GG vs. -: OR = 1.31, 95% CI = 1.13-1.51; rs1255722, AA vs. AG/GG: OR = 1.27, 95% CI = 1.07-1.51). After combined the two variants, the number of the adverse genotypes was positively associated with lung cancer risk in a dose-response manner (P-trend = 5.63x10(-6)). Further functional assay showed that lung cancer tissues carrying rs1255722AA variant genotype had a significantly lower mRNA level of PPP2R5E compared with tissues carrying GG/GA genotypes. However, such effect was not observed for the other SNPs and other combinations. Our findings suggested that the two functional variants in PPP2R1A and PPP2R5E and their combination are associated with lung cancer risk in Chinese, which may be valuable biomarkers to predict risk of lung cancer.	[Yang, Rongrong; Yang, Lei; Qiu, Fuman; Zhang, Lisha; Wang, Hui; Yang, Xiaorong; Fang, Wenxiang; Lu, Jiachun] Guangzhou Med Univ, State Key Lab Resp Dis, Inst Chem Carcinogenesis, Guangzhou, Guangdong, Peoples R China; [Deng, Jieqiong; Zhou, Yifeng] Soochow Univ, Lab Canc Mol Genet, Coll Med, Suzhou, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Soochow University - China	Lu, JC (corresponding author), Guangzhou Med Univ, State Key Lab Resp Dis, Inst Chem Carcinogenesis, Guangzhou, Guangdong, Peoples R China.	jcLu@gzhmc.edu.cn			National Natural Scientific Foundation of China [30671813, 30872178, 81072366, 81273149, 81001278, 81171895]; Guangdong Provincial High Level Experts Grants [2010-79]; Changjiang Scholars and Innovative Research Team in University [IRT0961]; Guangdong natural science foundation [10351012003000000]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial High Level Experts Grants; Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Guangdong natural science foundation(National Natural Science Foundation of Guangdong Province)	This study was supported by the National Natural Scientific Foundation of China grants 30671813, 30872178, 81072366, 81273149 (JL), and partly 81001278, 81171895 (YZ); Guangdong Provincial High Level Experts Grants 2010-79 (JL); Changjiang Scholars and Innovative Research Team in University grant IRT0961 (JW), Guangdong natural science foundation team grant 10351012003000000 (WL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; [Anonymous], 1998, CURR OPIN ONCOL, V10, P88; Calin GA, 2000, ONCOGENE, V19, P1191, DOI 10.1038/sj.onc.1203389; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Chen HG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007019; Cheng Y, 2011, CANCER GENET-NY, V204, P375, DOI 10.1016/j.cancergen.2011.05.002; Dong J, 2012, NAT GENET, V44, P895, DOI 10.1038/ng.2351; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Dupont WD, 2009, CANCER, V116, P8; Dupont WD, 2010, CANCER, V116, P8, DOI 10.1002/cncr.24702; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Ganesh B, 2011, ASIAN PAC J CANCER P, V12, P357; Grochola LF, 2009, CLIN CANCER RES, V15, P6301, DOI 10.1158/1078-0432.CCR-09-0797; Huang BF, 2012, INT J CANCER, V131, pE744, DOI 10.1002/ijc.27407; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Kalev P, 2012, CANCER RES, V72, P6414, DOI 10.1158/0008-5472.CAN-12-1667; Knol MJ, 2007, INT J EPIDEMIOL, V36, P1111, DOI 10.1093/ije/dym157; Kuhn E, 2012, JNCI-J NATL CANCER I, V104, P1503, DOI 10.1093/jnci/djs345; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Li HH, 2007, EMBO J, V26, P402, DOI 10.1038/sj.emboj.7601519; Liangpunsakul S, 2010, AM J PHYSIOL-GASTR L, V298, pG1004, DOI 10.1152/ajpgi.00482.2009; Lifschitz-Mercer B, 2001, HISTOCHEM CELL BIOL, V116, P31; Lin YC, 2011, MUTAT RES-FUND MOL M, V716, P66, DOI 10.1016/j.mrfmmm.2011.08.004; Liu B, 2012, AM J HUM GENET, V91, P384, DOI 10.1016/j.ajhg.2012.07.003; Lu JC, 2007, CARCINOGENESIS, V28, P988, DOI 10.1093/carcin/bgl225; Lu JC, 2006, CARCINOGENESIS, V27, P2209, DOI 10.1093/carcin/bgl077; Lu JC, 2011, HUM MUTAT, V32, P1299, DOI 10.1002/humu.21574; Mumby M, 2007, ACS CHEM BIOL, V2, P99, DOI 10.1021/cb700021z; Perrotti D, 2008, CANCER METAST REV, V27, P159, DOI 10.1007/s10555-008-9119-x; Ruediger R, 2001, ONCOGENE, V20, P1892, DOI 10.1038/sj.onc.1204279; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Shouse GP, 2010, ONCOGENE, V29, P3933, DOI 10.1038/onc.2010.161; Soprano KJ, 2006, ONCOGENE, V25, P5315, DOI 10.1038/sj.onc.1209679; Takakura S, 2001, INT J ONCOL, V18, P817; Uh H.W., 2007, BMC P S1, V1, pS114; Van Hoof C, 2003, BBA-MOL CELL RES, V1640, P97, DOI 10.1016/S0167-4889(03)00029-6; Vazquez A, 2011, INT J CANCER, V128, P2335, DOI 10.1002/ijc.25582; Wade R, 2011, HAEMATOL-HEMATOL J, V96, P1496, DOI 10.3324/haematol.2011.043471; Westermarck J, 2008, TRENDS MOL MED, V14, P152, DOI 10.1016/j.molmed.2008.02.001; Wysocki M, 2012, ANIM GENET, V43, P328, DOI 10.1111/j.1365-2052.2011.02251.x; Yang L, 2013, HUM MOL GENET, V22, P1886, DOI 10.1093/hmg/ddt019; Yang L, 2012, CARCINOGENESIS, V33, P338, DOI 10.1093/carcin/bgr272; Zhang M, 2012, CANCER RES, V72, P4178, DOI 10.1158/0008-5472.CAN-11-3983	47	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77285	10.1371/journal.pone.0077285	http://dx.doi.org/10.1371/journal.pone.0077285			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204789	Green Published, gold, Green Submitted			2022-12-27	WOS:000326270700023
J	Aoshima, K; Baba, A; Makino, Y; Okada, Y				Aoshima, Keisuke; Baba, Ai; Makino, Yoshinori; Okada, Yuki			Establishment of Alternative Culture Method for Spermatogonial Stem Cells Using Knockout Serum Replacement	PLOS ONE			English	Article								Since spermatogonial stem cells (SSCs) are capable of both self-renewal and differentiation to daughter cells for subsequent spermatogenesis, the development of an efficient in vitro culture system is essential for studies related to spermatogenesis. Although the currently available system is serum-free and contains only chemically-defined components, it highly relies upon bovine serum albumin (BSA), a component with batch-to-batch quality variations similar to those of fetal bovine serum. Thus, we searched for an alternative BSA-free culture system that preserved the properties of SSCs. In this study, we utilized Knockout Serum Replacement (KSR) in the SSC culture medium, as a substitute for BSA. The results demonstrated that KSR supported the continuous growth of SSCs in vitro and the SSC activity in vivo without BSA, in a feeder-cell combination with mouse embryonic fibroblasts. The addition of BSA to KSR further facilitated cell cycle progression, whereas a transplantation assay revealed that the addition of BSA did not affect the number of SSCs in vivo. The combination of KSR with BSA also allowed the elimination of GFRA1 and FGF2, and the reduction of the GDNF concentration from 20 ng/ml to 5 ng/ml, while maintaining the growth rate and the expression of SSC markers. Furthermore, KSR was also useful with SSCs from non-DBA/2 strains, such as C57BL/6 and ICR. These results suggested that KSR is an effective substitute for BSA for long-term in vitro cultures of SSCs. Therefore, this method is practical for various studies related to SSCs, including spermatogenesis and germ stem cell biology.	[Aoshima, Keisuke; Makino, Yoshinori; Okada, Yuki] Univ Tokyo, Lab Pathol & Dev, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo, Japan; [Aoshima, Keisuke; Baba, Ai; Makino, Yoshinori; Okada, Yuki] Kyoto Univ, Ctr Promot Interdisciplinary Educ & Res, Career Path Promot Unit Young Life Scientists, Sakyo Ku, Kyoto, Japan; [Aoshima, Keisuke] Hokkaido Univ, Ctr Zoonosis Control, Div Mol Pathobiol, Kita Ku, Sapporo, Hokkaido, Japan; [Baba, Ai] Kyoto Univ, Grad Sch Biostudies, Lab Bioimaging & Cell Signaling, Sakyo Ku, Kyoto, Japan; [Okada, Yuki] Japan Sci & Technol Agcy JST, PRESTO, Saitama, Japan	University of Tokyo; Kyoto University; Hokkaido University; Kyoto University; Japan Science & Technology Agency (JST)	Okada, Y (corresponding author), Univ Tokyo, Lab Pathol & Dev, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo, Japan.	ytokada@iam.u-tokyo.ac.jp		Aoshima, Keisuke/0000-0002-2987-0793	JST PRESTO program; Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan [22125007]; MEXT; Naito Foundation; MEXT in Japan; Grants-in-Aid for Scientific Research [22125007, 13J01051] Funding Source: KAKEN	JST PRESTO program; Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); MEXT in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the JST PRESTO program (Y.O.), a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan (22125007 to Y.O.), the Special Coordination Fund for Promoting Science and Technology of MEXT (Y.O.), the Naito Foundation Subsidy for Female Researchers after Maternity Leave (Y.O.), and the Program to Disseminate Tenure Tracking System of MEXT in Japan (Y.O.). K. A. is a Research Fellow of Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Hua JL, 2009, REPROD BIOMED ONLINE, V19, P238, DOI 10.1016/S1472-6483(10)60079-X; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kubota H, 2003, P NATL ACAD SCI USA, V100, P6487, DOI 10.1073/pnas.0631767100; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Kubota H, 2008, METHOD CELL BIOL, V86, P59, DOI 10.1016/S0091-679X(08)00004-6; Nagano M, 1998, TISSUE CELL, V30, P389, DOI 10.1016/S0040-8166(98)80053-0; Rajala K, 2011, STEM CELL STUDIES, V1; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Wang Qing Zhong, 2008, Fen Zi Xi Bao Sheng Wu Xue Bao, V41, P162; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001	12	41	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77715	10.1371/journal.pone.0077715	http://dx.doi.org/10.1371/journal.pone.0077715			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204931	gold, Green Submitted, Green Published			2022-12-27	WOS:000326241200037
J	Handke, LD; Hawkins, JC; Miller, AA; Jansen, KU; Anderson, AS				Handke, Luke D.; Hawkins, Julio C.; Miller, Alita A.; Jansen, Kathrin U.; Anderson, Annaliesa S.			Regulation of Staphylococcus aureus MntC Expression and Its Role in Response to Oxidative Stress	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; METAL SEQUESTRATION; RESISTANCE; VIRULENCE; GENE; BACTERIOPHAGE-L54A; ACQUISITION; MANGANESE; SEQUENCE; INTEGRATION	Staphylococcus aureus is a successful human pathogen that has developed several approaches to evade the immune system, including resistance strategies to prevent oxidative killing by immune cells. One mechanism by which this evasion occurs is by production of superoxide dismutase enzymes, which require manganese as a cofactor. Manganese is acquired by the manganese transporter MntABC. One component of this operon, MntC, has been proposed as a potential vaccine candidate due to its early in vivo expression and its ability to provide protection in preclinical models of staphylococcal infection. In the current study, we interrogate the role of this protein in protecting S. aureus from oxidative stress. We demonstrate that mutation of mntC in a number of invasive S. aureus clinical isolates results in increased sensitivity to oxidative stress. In addition, we show that while downregulation of mntC transcription is triggered upon exposure to physiological concentrations of manganese, MntC protein is still present on the bacterial surface at these same concentrations. Taken together, these results provide insight into the role of this antigen for the pathogen.	[Handke, Luke D.; Hawkins, Julio C.; Miller, Alita A.; Jansen, Kathrin U.; Anderson, Annaliesa S.] Pfizer Vaccine Res, Pearl River, NY USA	Pfizer	Handke, LD (corresponding author), Pfizer Vaccine Res, Pearl River, NY USA.	luke.handke@pfizer.com			Pfizer Vaccine Research	Pfizer Vaccine Research	This work was supported by Pfizer Vaccine Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AS, 2012, J INFECT DIS, V205, P1688, DOI 10.1093/infdis/jis272; Anderson AS, 2012, HUMAN VACCINES IMMUN, V8, P1; Ando M, 2003, INFECT IMMUN, V71, P2584, DOI 10.1128/IAI.71.5.2584-2590.2003; Broughan J, 2011, EXPERT REV VACCINES, V10, P695, DOI [10.1586/ERV.11.54, 10.1586/erv.11.54]; CARR RJG, 1986, APPL ENVIRON MICROB, V52, P1112, DOI 10.1128/AEM.52.5.1112-1116.1986; Cassat JE, 2012, SEMIN IMMUNOPATHOL, V34, P215, DOI 10.1007/s00281-011-0294-4; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Clements MO, 1999, J BACTERIOL, V181, P3898, DOI 10.1128/JB.181.13.3898-3903.1999; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; den Reijer PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053391; Deurenberg RH, 2008, INFECT GENET EVOL, V8, P747, DOI 10.1016/j.meegid.2008.07.007; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Gallagher S, 2008, CURRENT PROTOCOLS MO, DOI DOI 10.18.11-10.18.28; Gribenko A, J MOL BIOL IN PRESS; Haley KP, 2012, MICROBES INFECT, V14, P217, DOI 10.1016/j.micinf.2011.11.001; Hammer ND, 2012, CURR OPIN MICROBIOL, V15, P10, DOI 10.1016/j.mib.2011.11.004; HASSAN HM, 1978, J BIOL CHEM, V253, P8143; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Horsburgh MJ, 2002, MOL MICROBIOL, V44, P1269, DOI 10.1046/j.1365-2958.2002.02944.x; Iordanescu S, 1976, Arch Roum Pathol Exp Microbiol, V35, P111; JANZON L, 1990, EMBO J, V9, P1391, DOI 10.1002/j.1460-2075.1990.tb08254.x; Karavolos MH, 2003, MICROBIOL-SGM, V149, P2749, DOI 10.1099/mic.0.26353-0; Kehl-Fie TE, 2011, CELL HOST MICROBE, V10, P158, DOI 10.1016/j.chom.2011.07.004; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; LEE CY, 1991, GENE, V103, P101, DOI 10.1016/0378-1119(91)90399-V; LEE CY, 1989, J BACTERIOL, V171, P1652, DOI 10.1128/jb.171.3.1652-1657.1989; Malachowa N, 2011, VIRULENCE, V2, P567, DOI 10.4161/viru.2.6.17732; Maresso AW, 2006, BIOMETALS, V19, P193, DOI 10.1007/s10534-005-4863-7; McNamara Peter J., 2008, P89; NCCLS, 2012, M07A9 NCCLS; Niemeyer DM, 1996, J BACTERIOL, V178, P5464, DOI 10.1128/jb.178.18.5464-5471.1996; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; O'Neill AJ, 2010, LETT APPL MICROBIOL, V51, P358, DOI 10.1111/j.1472-765X.2010.02885.x; Sambrook J., 2001, MOL CLONING LAB MANU; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; Tseng HJ, 2002, INFECT IMMUN, V70, P1635, DOI 10.1128/IAI.70.3.1635-1639.2002; Tseng HJ, 2001, MOL MICROBIOL, V40, P1175, DOI 10.1046/j.1365-2958.2001.02460.x; Valderas MW, 2001, J BACTERIOL, V183, P3399, DOI 10.1128/JB.183.11.3399-3407.2001; Wichgers Schreur PJ, 2011, J BACTERIOL JB, P05305; YE ZH, 1990, J BACTERIOL, V172, P2568, DOI 10.1128/jb.172.5.2568-2575.1990; YE ZH, 1989, J BACTERIOL, V171, P4146, DOI 10.1128/JB.171.8.4146-4153.1989	42	30	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77874	10.1371/journal.pone.0077874	http://dx.doi.org/10.1371/journal.pone.0077874			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24205007	Green Published, gold, Green Submitted			2022-12-27	WOS:000326241200047
J	Jones, MR; Tellez-Plaza, M; Navas-Acien, A				Jones, Miranda R.; Tellez-Plaza, Maria; Navas-Acien, Ana			Smoking, Menthol Cigarettes and All-Cause, Cancer and Cardiovascular Mortality: Evidence from the National Health and Nutrition Examination Survey (NHANES) and a Meta-Analysis	PLOS ONE			English	Article							AFRICAN-AMERICAN SMOKERS; LUNG-CANCER; TOBACCO DEPENDENCE; UNITED-STATES; NICOTINE METABOLISM; SERUM CREATININE; RISK; ADOLESCENTS; DISPARITIES; CALIFORNIA	Background: The U.S. Food and Drug Administration has the authority to regulate tobacco product constituents, including menthol, if the scientific evidence indicates harm. Few studies, however, have evaluated the health effects of menthol cigarette use. Objective: To investigate associations of cigarette smoking and menthol cigarette use with all-cause, cancer and cardiovascular risk in U. S. adults. Methods: We studied 10,289 adults >= 20 years of age who participated in the National Health and Nutrition Examination Survey from 1999-2004 and were followed through December 2006. We also identified studies comparing risk of all-cause mortality, cardiovascular disease and cancer for menthol and nonmenthol cigarette smokers and estimates were pooled using random-effects models. Results: Fifty-five percent of participants were never smokers compared to 23%, 17% and 5% of former, current nonmenthol and current menthol cigarette smokers, respectively. The adjusted hazard ratios (95% CI) for former, current nonmenthol and current menthol cigarette smokers compared to never smokers were 1.24 (0.96, 1.62), 2.40 (1.56, 3.71) and 2.07 (1.20, 3.58), respectively, for all-cause mortality; 0.92 (0.62, 1.37), 2.10 (1.02, 4.31) and 3.48 (1.52, 7.99) for cardiovascular mortality; and 1.91 (1.21, 3.00), 3.82 (2.19, 6.68) and 2.03 (1.00, 4.13) for cancer mortality. Using data from 3 studies of all-cause mortality, 5 of cardiovascular disease and 13 of cancer, the pooled relative risks (95% CI) comparing menthol cigarette smokers to nonmenthol cigarette smokers was 0.94 (0.85, 1.05) for all-cause mortality, 1.28 (0.91, 1.80) for cardiovascular disease and 0.84 (0.76, 0.92) for any cancer. Conclusions: In a representative sample of U. S. adults, menthol cigarette smoking was associated with increased all-cause, cardiovascular and cancer mortality with no differences compared to nonmenthol cigarettes. In the systematic review, menthol cigarette use was associated with inverse risk of cancer compared to nonmenthol cigarette use with some evidence of an increased risk for cardiovascular disease.	[Jones, Miranda R.; Tellez-Plaza, Maria; Navas-Acien, Ana] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA; [Jones, Miranda R.; Tellez-Plaza, Maria; Navas-Acien, Ana] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Jones, Miranda R.; Tellez-Plaza, Maria; Navas-Acien, Ana] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Tellez-Plaza, Maria] Fdn Invest Hosp Clin Valencia INCLIVA, Valencia, Spain; [Navas-Acien, Ana] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Jones, MR (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA.	mijones@jhsph.edu	Tellez-Plaza, Maria/AAL-9820-2021	Tellez-Plaza, Maria/0000-0002-3850-1228	United States National Cancer Institute [R03CA153959]; Cardiovascular Epidemiology Institutional Training from the National Heart, Lung and Blood Institute [T32HL007024]; NATIONAL CANCER INSTITUTE [R03CA153959] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007024] Funding Source: NIH RePORTER	United States National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cardiovascular Epidemiology Institutional Training from the National Heart, Lung and Blood Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the United States National Cancer Institute (R03CA153959). Miranda R Jones was also supported by the Cardiovascular Epidemiology Institutional Training from the National Heart, Lung and Blood Institute (T32HL007024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SJ, 2011, TOB CONTROL, V20, pII20, DOI 10.1136/tc.2010.041939; Apostolou A, 2012, AM J PUBLIC HEALTH, V102, P714, DOI 10.2105/AJPH.2011.300161; Benowitz NL, 2004, J PHARMACOL EXP THER, V310, P1208, DOI 10.1124/jpet.104.066902; Blot WJ, 2011, JNCI-J NATL CANCER I, V103, P810, DOI 10.1093/jnci/djr102; Bover MT, 2008, INT J CLIN PRACT, V62, P182, DOI 10.1111/j.1742-1241.2007.01653.x; Brooks DR, 2003, AM J EPIDEMIOL, V158, P609, DOI 10.1093/aje/kwg182; Carpenter CL, 1999, ANN EPIDEMIOL, V9, P114, DOI 10.1016/S1047-2797(98)00042-8; Cooper R, 2000, CIRCULATION, V102, P3137; Cummings KM, 2002, TOB CONTROL, V11, pI5, DOI 10.1136/tc.11.suppl_1.i5; Etzel CJ, 2008, CANCER PREV RES, V1, P255, DOI 10.1158/1940-6207.CAPR-08-0082; Foulds J, 2006, AM J HEALTH BEHAV, V30, P400, DOI 10.5993/AJHB.30.4.6; Friedman GD, 1998, J EPIDEMIOL COMMUN H, V52, P202, DOI 10.1136/jech.52.3.202; Gandhi KK, 2009, INT J CLIN PRACT, V63, P360, DOI 10.1111/j.1742-1241.2008.01969.x; HEBERT JR, 1989, INT J EPIDEMIOL, V18, P37, DOI 10.1093/ije/18.1.37; Hersey JC, 2006, NICOTINE TOB RES, V8, P403, DOI 10.1080/14622200600670389; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; JARVIK ME, 1994, PHYSIOL BEHAV, V56, P563, DOI 10.1016/0031-9384(94)90302-6; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jemal A, 2008, AM J PREV MED, V34, P1, DOI 10.1016/j.amepre.2007.09.017; Jones MR, 2013, NICOTINE TOB RES, V15, P1183, DOI 10.1093/ntr/nts253; Jones MR, 2013, CANCER EPIDEM BIOMAR, V22, P224, DOI 10.1158/1055-9965.EPI-12-0912; KABAT GC, 1994, EPIDEMIOLOGY, V5, P183, DOI 10.1097/00001648-199403000-00008; KABAT GC, 1991, CANCER RES, V51, P6510; Kreslake JM, 2008, NICOTINE TOB RES, V10, P705, DOI 10.1080/14622200801979134; Lee PN, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-18; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Lumley T., 2011, SURVEY ANAL COMPLEX; Mai SK, 2007, HLTH CONS SMOK REP S, V2, P30; Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04; Murray RP, 2007, NICOTINE TOB RES, V9, P101, DOI 10.1080/14622200601078418; National Center for Health Statistics.Office of Analysis and Epidemiology, 2009, NAT HLTH NUTR EX SUR; Okuyemi KS, 2007, ADDICTION, V102, P1979, DOI 10.1111/j.1360-0443.2007.02010.x; Okuyemi KS, 2003, ADDICTION, V98, P1387, DOI 10.1046/j.1360-0443.2003.00443.x; Perez-Stable EJ, 1998, JAMA-J AM MED ASSOC, V280, P152, DOI 10.1001/jama.280.2.152; Pletcher MJ, 2006, ARCH INTERN MED, V166, P1915, DOI 10.1001/archinte.166.17.1915; Richter P, 2008, ETHNIC HEALTH, V13, P171, DOI 10.1080/13557850701784694; Roper Organization, 2009, STUD SMOK HAB ATT SP, VI; Rostron B, 2012, LUNG CANC MORTALITY; Selvin E, 2007, AM J KIDNEY DIS, V50, P918, DOI 10.1053/j.ajkd.2007.08.020; SIDNEY S, 1995, ARCH INTERN MED, V155, P727, DOI 10.1001/archinte.155.7.727; Stellman SD, 2003, ANN EPIDEMIOL, V13, P294, DOI 10.1016/S1047-2797(02)00420-9; Unger JB, 2010, NICOTINE TOB RES, V12, P398, DOI 10.1093/ntr/ntq016; Villanti AC, 2013, NICOTINE TOB RES, V15, P617, DOI 10.1093/ntr/nts176; Vozoris NT, 2012, ARCH INTERN MED, V172, P590, DOI 10.1001/archinternmed.2012.320; Wackowski O, 2007, ADDICT BEHAV, V32, P1964, DOI 10.1016/j.addbeh.2006.12.023; World Health Organization, 2007, INT CLASS DIS ICD 10	48	24	24	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77941	10.1371/journal.pone.0077941	http://dx.doi.org/10.1371/journal.pone.0077941			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	241GW	24205038	Green Published, gold, Green Submitted			2022-12-27	WOS:000326155400062
J	Ma, XW; Kang, F; Xu, F; Feng, AL; Zhao, Y; Lu, TJ; Yang, WD; Wang, Z; Lin, M; Wang, J				Ma, Xiaowei; Kang, Fei; Xu, Feng; Feng, Ailing; Zhao, Ying; Lu, Tianjian; Yang, Weidong; Wang, Zhe; Lin, Min; Wang, Jing			Enhancement of Cerenkov Luminescence Imaging by Dual Excitation of Er3+, Yb3+-Doped Rare-Earth Microparticles	PLOS ONE			English	Article							UP-CONVERSION; NANOPARTICLES; NANOPHOSPHORS; CELLS; PET	Cerenkov luminescence imaging (CLI) has been successfully utilized in various fields of preclinical studies; however, CLI is challenging due to its weak luminescent intensity and insufficient penetration capability. Here, we report the design and synthesis of a type of rare-earth microparticles (REMPs), which can be dually excited by Cerenkov luminescence (CL) resulting from the decay of radionuclides to enhance CLI in terms of intensity and penetration. Methods: Yb3+- and Er3+- codoped hexagonal NaYF4 hollow microtubes were synthesized via a hydrothermal route. The phase, morphology, and emission spectrum were confirmed for these REMPs by power X-ray diffraction (XRD), scanning electron microscopy (SEM), and spectrophotometry, respectively. A commercial CCD camera equipped with a series of optical filters was employed to quantify the intensity and spectrum of CLI from radionuclides. The enhancement of penetration was investigated by imaging studies of nylon phantoms and nude mouse pseudotumor models. Results: the REMPs could be dually excited by CL at the wavelengths of 520 and 980 nm, and the emission peaks overlaid at 660 nm. This strategy approximately doubled the overall detectable intensity of CLI and extended its maximum penetration in nylon phantoms from 5 to 15 mm. The penetration study in living animals yielded similar results. Conclusions: this study demonstrated that CL can dually excite REMPs and that the overlaid emissions in the range of 660 nm could significantly enhance the penetration and intensity of CL. The proposed enhanced CLI strategy may have promising applications in the future.	[Ma, Xiaowei; Kang, Fei; Yang, Weidong; Wang, Zhe; Wang, Jing] Fourth Mil Med Univ, Xijing Hosp, Dept Nucl Med, Xian 710032, Peoples R China; [Xu, Feng; Feng, Ailing; Zhao, Ying; Lu, Tianjian; Lin, Min] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Minist Educ, Key Lab Biomed Informat Engn, Xian 710049, Peoples R China; [Xu, Feng; Feng, Ailing; Zhao, Ying; Lu, Tianjian; Lin, Min] Xi An Jiao Tong Univ, Bioinspired Engn & Biomech Ctr, Xian 710049, Peoples R China	Air Force Military Medical University; Xi'an Jiaotong University; Xi'an Jiaotong University	Lin, M (corresponding author), Xi An Jiao Tong Univ, Sch Life Sci & Technol, Minist Educ, Key Lab Biomed Informat Engn, Xian 710049, Peoples R China.	minlin@mail.xjtu.edu.cn; wangjing@fmmu.edu.cn	Wang, Jing/G-5261-2018; Ma, Xiaowei/AAC-3232-2019; Lin, Min/F-1348-2018; Lu, Tian Jian/E-6063-2016; Xu, Feng/H-4468-2011; Xu, Feng/C-7430-2011	Ma, Xiaowei/0000-0002-3062-4063; Lin, Min/0000-0002-6198-9022; Xu, Feng/0000-0003-4351-0222; Kang, Fei/0000-0003-0267-7819	National Natural Science Foundation of China [81090270, 81230033]; Major International Joint Research Program of China [11120101002]; National 111 Project of China [B06024]; Fundamental Research Funds for the Central Universities [2012jdhz46]; China Young 1000-Talent Program; Shaanxi 100-Talent Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major International Joint Research Program of China; National 111 Project of China(Ministry of Education, China - 111 Project); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China Young 1000-Talent Program; Shaanxi 100-Talent Program	This work was supported by the National Natural Science Foundation of China (81090270, 81230033), the Major International Joint Research Program of China (11120101002), the National 111 Project of China (B06024), the Fundamental Research Funds for the Central Universities (2012jdhz46). F Xu was also partially supported by the China Young 1000-Talent Program and Shaanxi 100-Talent Program. No other potential conflict of interest relevant to this article was reported. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auzel F, 2004, CHEM REV, V104, P139, DOI 10.1021/cr020357g; BALTHAZAR EJ, 1991, AM J ROENTGENOL, V156, P23, DOI 10.2214/ajr.156.1.1898566; Boschi F, 2011, EUR J NUCL MED MOL I, V38, P120, DOI 10.1007/s00259-010-1630-y; Bouzigues C, 2011, ACS NANO, V5, P8488, DOI 10.1021/nn202378b; Carpenter CM, 2012, OPT EXPRESS, V20, P11598, DOI 10.1364/OE.20.011598; Chatteriee DK, 2008, BIOMATERIALS, V29, P937, DOI 10.1016/j.biomaterials.2007.10.051; Chen GY, 2012, ACS NANO, V6, P8280, DOI 10.1021/nn302972r; Cho JY, 2005, ULTRASOUND OBST GYN, V25, P253, DOI 10.1002/uog.1847; Gelovani JG, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013300, DOI 10.1371/J0URNAL.P0NE.0013300.PUBMED:20949021]; Holland JP, 2011, MOL IMAGING, V10, P177, DOI 10.2310/7290.2010.00047; Hu ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037623; Hu ZH, 2010, OPT EXPRESS, V18, P24441, DOI 10.1364/OE.18.024441; Idris NM, 2009, BIOMATERIALS, V30, P5104, DOI 10.1016/j.biomaterials.2009.05.062; Kircher MF, 2011, NAT REV CLIN ONCOL, V8, P677, DOI 10.1038/nrclinonc.2011.141; Kothapalli SR, 2012, BIOMED OPT EXPRESS, V3, P1215, DOI 10.1364/BOE.3.001215; Lee J, 2013, J NUCL MED, V54, P96, DOI 10.2967/jnumed.112.108043; Lewis MA, 2010, OPT LETT, V35, P3889, DOI 10.1364/OL.35.003889; Lin M, 2012, BIOTECHNOL ADV, V30, P1551, DOI 10.1016/j.biotechadv.2012.04.009; Liu HG, 2012, J NUCL MED, V53, P1579, DOI 10.2967/jnumed.111.098541; Liu HG, 2010, SMALL, V6, P1087, DOI 10.1002/smll.200902408; Liu HG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009470; Park YI, 2009, ADV MATER, V21, P4467, DOI 10.1002/adma.200901356; Robertson R, 2009, PHYS MED BIOL, V54, pN355, DOI 10.1088/0031-9155/54/16/N01; Robertson R, 2011, J NUCL MED, V52, P1764, DOI 10.2967/jnumed.111.091710; Ruggiero A, 2010, J NUCL MED, V51, P1123, DOI 10.2967/jnumed.110.076521; Spinelli AE, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.2.020502; Sudhagar S, 2011, BIOTECHNOL LETT, V33, P1891, DOI 10.1007/s10529-011-0641-5; Thorek DLJ, 2012, J NUCL MED, V53, P1438, DOI 10.2967/jnumed.112.104349; Thorek DLJ, 2012, AM J NUCL MED MOLEC, V2, P163; van der Ende BM, 2009, PHYS CHEM CHEM PHYS, V11, P11081, DOI 10.1039/b913877c; Wang XF, 2011, OPT LETT, V36, P4353, DOI 10.1364/OL.36.004353; Weissleder R, 2001, RADIOLOGY, V219, P316, DOI 10.1148/radiology.219.2.r01ma19316; Weissleder R, 2001, NAT BIOTECHNOL, V19, P316, DOI 10.1038/86684; Wu XJ, 2011, EUR J INORG CHEM, P2158, DOI 10.1002/ejic.201001149; Xiong LQ, 2009, BIOMATERIALS, V30, P5592, DOI 10.1016/j.biomaterials.2009.06.015; Xiong LQ, 2010, BIOMATERIALS, V31, P7078, DOI 10.1016/j.biomaterials.2010.05.065; Xu H, 2011, BIOMATERIALS, V32, P9364, DOI 10.1016/j.biomaterials.2011.08.053; Xu YD, 2011, J NUCL MED, V52, P2009, DOI 10.2967/jnumed.111.092965; Zhong J., 2011, INT J BIOMEDICAL IMA, V2011, P1	39	81	82	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77926	10.1371/journal.pone.0077926	http://dx.doi.org/10.1371/journal.pone.0077926			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205030	Green Submitted, Green Published, gold			2022-12-27	WOS:000326155400061
J	Neumann, S; Fuchs, A; Hummel, B; Frishman, D				Neumann, Sindy; Fuchs, Angelika; Hummel, Barbara; Frishman, Dmitrij			Classification of alpha-Helical Membrane Proteins Using Predicted Helix Architectures	PLOS ONE			English	Article							SECONDARY TRANSPORT PROTEINS; TRANSMEMBRANE PROTEINS; DATA-BANK; ESCHERICHIA-COLI; STRUCTURAL CLASS; GENE ONTOLOGY; HUMAN GENOME; TOPOLOGY; FAMILIES; DATABASE	Despite significant methodological advances in protein structure determination high-resolution structures of membrane proteins are still rare, leaving sequence-based predictions as the only option for exploring the structural variability of membrane proteins at large scale. Here, a new structural classification approach for alpha-helical membrane proteins is introduced based on the similarity of predicted helix interaction patterns. Its application to proteins with known 3D structure showed that it is able to reliably detect structurally similar proteins even in the absence of any sequence similarity, reproducing the SCOP and CATH classifications with a sensitivity of 65% at a specificity of 90%. We applied the new approach to enhance our comprehensive structural classification of alpha-helical membrane proteins (CAMPS), which is primarily based on sequence and topology similarity, in order to find protein clusters that describe the same fold in the absence of sequence similarity. The total of 151 helix architectures were delineated for proteins with more than four transmembrane segments. Interestingly, we observed that proteins with 8 and more transmembrane helices correspond to fewer different architectures than proteins with up to 7 helices, suggesting that in large membrane proteins the evolutionary tendency to re-use already available folds is more pronounced.	[Neumann, Sindy; Frishman, Dmitrij] Tech Univ Munich, Dept Genome Oriented Bioinformat, Wissensch Zentrum Weihenstephan, Freising Weihenstephan, Germany; [Fuchs, Angelika] Roche Diagnost GmbH, pRED, pRED Informat, Penzberg, Germany; [Hummel, Barbara] Univ Freiburg, Med Ctr, Dept Urol, Womens Hosp, Freiburg, Germany; [Hummel, Barbara] Univ Freiburg, Med Ctr, Clin Res Ctr, Freiburg, Germany; [Frishman, Dmitrij] German Res Ctr Environm Hlth GmbH, Helmholtz Ctr Munich, Inst Bioinformat & Syst Biol, Neuherberg, Germany	Technical University of Munich; Roche Holding; University of Freiburg; University of Freiburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Frishman, D (corresponding author), Tech Univ Munich, Dept Genome Oriented Bioinformat, Wissensch Zentrum Weihenstephan, Freising Weihenstephan, Germany.	d.frishman@wzw.tum.de	Frishman, Dmitrij/AAT-7815-2020	Hummel, Barbara/0000-0001-6563-3675	DFG [FR 1411/5-1]; DFG International Research Training Group 'Regulation and Evolution of Cellular Systems' [GRK 1563]	DFG(German Research Foundation (DFG)); DFG International Research Training Group 'Regulation and Evolution of Cellular Systems'	This work was supported by the DFG grant FR 1411/5-1 and the DFG International Research Training Group 'Regulation and Evolution of Cellular Systems' (GRK 1563). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Arai M, 2003, GENE, V304, P77, DOI 10.1016/S0378-1119(02)01181-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Choi S, 2008, PROTEINS, V71, P68, DOI 10.1002/prot.21656; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Elofsson A, 2007, ANNU REV BIOCHEM, V76, P125, DOI 10.1146/annurev.biochem.76.052705.163539; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Fuchs A, 2010, PROTEINS, V78, P2587, DOI 10.1002/prot.22768; Fuchs A, 2009, PROTEINS, V74, P857, DOI 10.1002/prot.22194; Granseth E, 2005, J MOL BIOL, V346, P377, DOI 10.1016/j.jmb.2004.11.036; Greene LH, 2007, NUCLEIC ACIDS RES, V35, pD291, DOI 10.1093/nar/gkl959; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hennerdal A, 2010, PROTEIN SCI, V19, P2305, DOI 10.1002/pro.510; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Jones DT, 1998, FEBS LETT, V423, P281, DOI 10.1016/S0014-5793(98)00095-7; Kim H, 2006, P NATL ACAD SCI USA, V103, P11142, DOI 10.1073/pnas.0604075103; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lolkema JS, 2003, J MOL BIOL, V327, P901, DOI 10.1016/S0022-2836(03)00214-6; Lolkema JS, 1998, MOL MEMBR BIOL, V15, P33, DOI 10.3109/09687689809027516; Lolkema JS, 2008, MOL MEMBR BIOL, V25, P567, DOI 10.1080/09687680802541177; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Martin-Galiano AJ, 2006, PROTEINS, V64, P906, DOI 10.1002/prot.21081; Neumann S, 2012, PROTEINS, V80, P839, DOI 10.1002/prot.23242; Neumann S, 2010, PROTEINS, V78, P1760, DOI 10.1002/prot.22692; Oberai A, 2006, PROTEIN SCI, V15, P1723, DOI 10.1110/ps.062109706; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Remm M, 2000, GENOME RES, V10, P1679, DOI 10.1101/gr.GR-1491R; Saaf A, 2001, J BIOL CHEM, V276, P18905, DOI 10.1074/jbc.M101716200; Saier MH, 2003, MOL MICROBIOL, V48, P1145, DOI 10.1046/j.1365-2958.2003.03499.x; SAIER MH, 1994, BIOESSAYS, V16, P23, DOI 10.1002/bies.950160104; SANSOM MSP, 1992, PROTEIN ENG, V5, P53, DOI 10.1093/protein/5.1.53; Shimizu T, 2004, J MOL BIOL, V339, P1, DOI 10.1016/j.jmb.2004.03.048; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; ter Horst R, 2012, BBA-BIOMEMBRANES, V1818, P72, DOI 10.1016/j.bbamem.2011.09.021; Theobald DL, 2010, NAT STRUCT MOL BIOL, V17, P2, DOI 10.1038/nsmb0110-2; Tusnady GE, 2008, NUCLEIC ACIDS RES, V36, pD234, DOI 10.1093/nar/gkm751; Tusnady GE, 2010, CURR PROTEIN PEPT SC, V11, P550; Tusnady GE, 2005, NUCLEIC ACIDS RES, V33, pD275, DOI 10.1093/nar/gki002; Tusnady GE, 2004, BIOINFORMATICS, V20, P2964, DOI 10.1093/bioinformatics/bth340; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Viklund H, 2006, J MOL BIOL, V361, P591, DOI 10.1016/j.jmb.2006.06.037; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; VONHEIJNE G, 1991, J MOL BIOL, V218, P499, DOI 10.1016/0022-2836(91)90695-3; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420	54	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77491	10.1371/journal.pone.0077491	http://dx.doi.org/10.1371/journal.pone.0077491			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204844	gold, Green Published, Green Submitted			2022-12-27	WOS:000326155400039
J	Caron, M; Grard, G; Paupy, C; Mombo, IM; Nso, BBB; Kassa, FRK; Nkoghe, D; Leroy, EM				Caron, Melanie; Grard, Gilda; Paupy, Christophe; Mombo, Illich Mamfred; Nso, Branly Bikie Bi; Kassa, Fabrice Roland Kassa; Nkoghe, Dieudonne; Leroy, Eric Maurice			First Evidence of Simultaneous Circulation of Three Different Dengue Virus Serotypes in Africa	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; AEDES-ALBOPICTUS; FEBRILE PATIENTS; CHIKUNGUNYA; IDENTIFICATION; PATHOGENESIS; ENHANCEMENT; EMERGENCE; SENEGAL; GABON	Gabon, in Central Africa, was affected for the first time in 2007 and then in 2010 by simultaneous outbreaks of chikungunya and Dengue serotype 2 (DENV-2) viruses. Through the national surveillance of dengue-like syndromes between 2007 and 2010, we observed continuous circulation of DENV-2 in a southward movement. This rapid spread of DENV-2 was associated with the emergence of DENV-1 in 2007 and DENV-3 in 2010. Interestingly, we detected six DENV-2 infected patients with hemorrhagic signs during the second outbreak in 2010. Although these cases do not meet all standard WHO criteria for severe Dengue with hemorrhage (formerly DHF), this is the first report of several dengue fever cases associated with hemorrhagic signs during a simultaneous circulation of different DENV serotypes in Africa. Together, these findings suggest that DENV is becoming more widely established on this continent and that DHF will likely become a serious public-health problem in the near future.	[Caron, Melanie; Grard, Gilda; Paupy, Christophe; Mombo, Illich Mamfred; Nso, Branly Bikie Bi; Kassa, Fabrice Roland Kassa; Nkoghe, Dieudonne; Leroy, Eric Maurice] Ctr Int Rech Med Franceville, Franceville, Gabon; [Caron, Melanie; Paupy, Christophe; Mombo, Illich Mamfred; Leroy, Eric Maurice] IRD, Montpellier, France; [Nkoghe, Dieudonne] Minist Sante Publ, Libreville, Gabon	Institut de Recherche pour le Developpement (IRD)	Caron, M (corresponding author), Ctr Int Rech Med Franceville, BP 769, Franceville, Gabon.	melaniecaron.cirmf@gmail.com	Paupy, Christophe/I-4847-2017; LEROY, Eric M/I-4347-2016	Paupy, Christophe/0000-0002-7122-2079; LEROY, Eric M/0000-0003-0022-0890; MOMBO, Illich Manfred/0000-0001-9292-7943	CIRMF; Gabonese Government; Total Gabon; French Foreign Ministry; Fondation Christophe et Rodolphe Merieux; Institut de France; IRD	CIRMF; Gabonese Government; Total Gabon(Total SA); French Foreign Ministry; Fondation Christophe et Rodolphe Merieux; Institut de France; IRD	This work was supported by CIRMF which is funded by the Gabonese Government, Total Gabon and the French Foreign Ministry. It was also partially financed by grants from Fondation Christophe et Rodolphe Merieux, Institut de France and IRD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasinghe A, 2011, EMERG INFECT DIS, V17, P1349, DOI 10.3201/eid1708.101515; [Anonymous], 2013, DENG DENG HAEM FEV; [Anonymous], WHOCDSCSRISR20001; Bharaj P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-1; CAREY DE, 1971, LANCET, V1, P105; Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530; Chen RB, 2011, VIRUSES-BASEL, V3, P1562, DOI 10.3390/v3091562; Cummings DAT, 2005, P NATL ACAD SCI USA, V102, P15259, DOI 10.1073/pnas.0507320102; Diallo M, 2003, EMERG INFECT DIS, V9, P362, DOI 10.3201/eid0903.020219; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Franco L, 2010, EUROSURVEILLANCE, V15; Franco L, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001251; Gaunt MW, 2005, J VIROL METHODS, V128, P113, DOI 10.1016/j.jviromet.2005.04.006; GONZALEZ JP, 1985, B SOC PATHOL EXOT, V78, P7; GUBLER DJ, 1986, AM J TROP MED HYG, V35, P1280, DOI 10.4269/ajtmh.1986.35.1280; GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55; HALSTEAD SB, 1970, YALE J BIOL MED, V42, P311; HALSTEAD SB, 1982, PROG ALLERGY, V31, P301; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Halstead SB, 2013, CLIN INFECT DIS, V56, P900, DOI 10.1093/cid/cis1047; Holmes EC, 2009, VIRUS RES, V143, P1, DOI 10.1016/j.virusres.2009.02.020; HYAMS KC, 1986, AM J TROP MED HYG, V35, P860, DOI 10.4269/ajtmh.1986.35.860; JOHNSON BK, 1982, LANCET, V2, P208; KANESATHASAN N, 1994, LANCET, V343, P678, DOI 10.1016/S0140-6736(94)92678-6; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Leparc-Goffart I, 2009, J CLIN VIROL, V45, P61, DOI 10.1016/j.jcv.2009.02.010; Leroy EM, 2009, EMERG INFECT DIS, V15, P591, DOI 10.3201/eid1504.080664; Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09; Morrison AC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000670; Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005; Pourrut X, 2011, EMERG INFECT DIS, V17, P1568, DOI 10.3201/eid1708.110153; Rodier GR, 1996, T ROY SOC TROP MED H, V90, P237, DOI 10.1016/S0035-9203(96)90228-X; SALUZZO JF, 1986, T ROY SOC TROP MED H, V80, P5, DOI 10.1016/0035-9203(86)90182-3; Sang R, 2006, DENGUE AFRICA REPORT, P50; SHARP TW, 1995, AM J TROP MED HYG, V53, P89, DOI 10.4269/ajtmh.1995.53.89; Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091; Srikiatkhachorn A, 2010, CLIN INFECT DIS, V50, P1135, DOI 10.1086/651268; TRAORELAMIZANA M, 1994, J MED ENTOMOL, V31, P623, DOI 10.1093/jmedent/31.4.623; Wang EY, 2000, J VIROL, V74, P3227, DOI 10.1128/JVI.74.7.3227-3234.2000; WHO, 2009, WKLY EPIDEMIOL REC, V11, P85	40	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78030	10.1371/journal.pone.0078030	http://dx.doi.org/10.1371/journal.pone.0078030			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205075	Green Published, Green Submitted, gold			2022-12-27	WOS:000326032600061
J	Fahlgren, N; Bollmann, SR; Kasschau, KD; Cuperus, JT; Press, CM; Sullivan, CM; Chapman, EJ; Hoyer, JS; Gilbert, KB; Grunwald, NJ; Carrington, JC				Fahlgren, Noah; Bollmann, Stephanie R.; Kasschau, Kristin D.; Cuperus, Josh T.; Press, Caroline M.; Sullivan, Christopher M.; Chapman, Elisabeth J.; Hoyer, J. Steen; Gilbert, Kerrigan B.; Gruenwald, Niklaus J.; Carrington, James C.			Phytophthora Have Distinct Endogenous Small RNA Populations That Include Short Interfering and microRNAs	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; GENOME SEQUENCE; PLANT; MECHANISMS; PATHOGEN; BIOGENESIS; EVOLUTION; INFESTANS; RECOGNITION	In eukaryotes, RNA silencing pathways utilize 20-30-nucleotide small RNAs to regulate gene expression, specify and maintain chromatin structure, and repress viruses and mobile genetic elements. RNA silencing was likely present in the common ancestor of modern eukaryotes, but most research has focused on plant and animal RNA silencing systems. Phytophthora species belong to a phylogenetically distinct group of economically important plant pathogens that cause billions of dollars in yield losses annually as well as ecologically devastating outbreaks. We analyzed the small RNA-generating components of the genomes of P. infestans, P. sojae and P. ramorum using bioinformatics, genetic, phylogenetic and high-throughput sequencing-based methods. Each species produces two distinct populations of small RNAs that are predominantly 21- or 25-nucleotides long. The 25-nucleotide small RNAs were primarily derived from loci encoding transposable elements and we propose that these small RNAs define a pathway of short-interfering RNAs that silence repetitive genetic elements. The 21-nucleotide small RNAs were primarily derived from inverted repeats, including a novel microRNA family that is conserved among the three species, and several gene families, including Crinkler effectors and type III fibronectins. The Phytophthora microRNA is predicted to target a family of amino acid/auxin permeases, and we propose that 21-nucleotide small RNAs function at the post-transcriptional level. The functional significance of microRNA-guided regulation of amino acid/auxin permeases and the association of 21-nucleotide small RNAs with Crinkler effectors remains unclear, but this work provides a framework for testing the role of small RNAs in Phytophthora biology and pathogenesis in future work.	[Fahlgren, Noah; Hoyer, J. Steen; Gilbert, Kerrigan B.; Carrington, James C.] Donald Danforth Plant Sci Ctr, St Louis, MO USA; [Fahlgren, Noah; Kasschau, Kristin D.; Cuperus, Josh T.; Sullivan, Christopher M.; Chapman, Elisabeth J.; Carrington, James C.] Oregon State Univ, Dept Bot & Plant Pathol, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA; [Bollmann, Stephanie R.; Press, Caroline M.; Gruenwald, Niklaus J.] USDA ARS, Hort Crops Res Lab, Corvallis, OR USA	Donald Danforth Plant Science Center; Oregon State University; United States Department of Agriculture (USDA)	Grunwald, NJ (corresponding author), USDA ARS, Hort Crops Res Lab, Corvallis, OR USA.	nik.grunwald@ars.usda.gov; JCarrington@danforthcenter.org	Grunwald, Niklaus` J/K-6041-2013; Carrington, James C/A-4656-2012; Fahlgren, Noah/D-4404-2011	Grunwald, Niklaus` J/0000-0003-1656-7602; Carrington, James C/0000-0003-3572-129X; Fahlgren, Noah/0000-0002-5597-4537; Hoyer, J. Steen/0000-0002-1338-8900; Gilbert, Kerrigan/0000-0002-7164-5821; Press, Caroline/0000-0003-4741-9776; Cuperus, Josh/0000-0002-8019-7733	National Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture [2008-35600-18780]; US Forest Service Pacific Southwest Research Station Sudden Oak Death research program; National Science Foundation [MCB-1231726]; National Institutes of Health [AI043288]; Direct For Biological Sciences [1231726] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI043288, R21AI043288, R01AI043288] Funding Source: NIH RePORTER	National Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture; US Forest Service Pacific Southwest Research Station Sudden Oak Death research program(United States Department of Agriculture (USDA)United States Forest Service); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by the National Research Initiative Competitive Grants Program grant 2008-35600-18780 from the USDA National Institute of Food and Agriculture to NJG and JCC, the US Forest Service Pacific Southwest Research Station Sudden Oak Death research program to NJG, and the National Science Foundation grant MCB-1231726 and the National Institutes of Health grant AI043288 to JCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaiz O, 2007, NUCLEIC ACIDS RES, V35, pD439, DOI 10.1093/nar/gkl777; Arnaiz O, 2011, NUCLEIC ACIDS RES, V39, pD632, DOI 10.1093/nar/gkq918; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Axtell MJ, 2013, RNA, V19, P740, DOI 10.1261/rna.035279.112; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Axtell MJ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-221; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Blair JE, 2008, FUNGAL GENET BIOL, V45, P266, DOI 10.1016/j.fgb.2007.10.010; Brasier C, 2010, NATURE, V466, P824, DOI 10.1038/466824a; Braun L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000920; Brown JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012759; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Cai PF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001256; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Chang SS, 2012, ANNU REV MICROBIOL, V66, P305, DOI 10.1146/annurev-micro-092611-150138; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Dong SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020172; Dou DL, 2010, MOL PLANT MICROBE IN, V23, P425, DOI 10.1094/MPMI-23-4-0425; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Ester M., 1996, P 2 INT C KNOWLEDGE, P226; Fahlgren N, 2010, METHODS MOL BIOL, V592, P51, DOI 10.1007/978-1-60327-005-2_4; Fahlgren N, 2009, RNA, V15, P992, DOI 10.1261/rna.1473809; Fong AMVA, 2003, MOL MICROBIOL, V50, P487, DOI 10.1046/j.1365-2958.2003.03735.x; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Fry W, 2008, MOL PLANT PATHOL, V9, P385, DOI [10.1111/j.1364-3703.2007.00465.x, 10.1111/J.1364-3703.2007.00465.X]; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Goss EM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000583; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grenville-Briggs LJ, 2008, PLANT CELL, V20, P720, DOI 10.1105/tpc.107.052043; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Grunwald NJ, 2008, MOL PLANT PATHOL, V9, P729, DOI [10.1111/j.1364-3703.2008.00500.x, 10.1111/J.1364-3703.2008.00500.X]; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hennig C, 2013, FPC FLEXIBLE PROCEDU; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Iyer LM, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-5; Ji LJ, 2012, CELL RES, V22, P624, DOI 10.1038/cr.2012.36; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Judelson HS, 2007, EUKARYOT CELL, V6, P1200, DOI 10.1128/EC.00311-06; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu C, 2006, GENOME RES, V16, P1276, DOI 10.1101/gr.5530106; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McCormick Kevin P, 2011, Silence, V2, P2, DOI 10.1186/1758-907X-2-2; Nunes CC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-288; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Poulsen C, 2013, PLANT CELL, V25, P22, DOI 10.1105/tpc.112.105643; Qutob D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2354; R Core Team, 2012, R LANG ENV STAT COMP; Raffaele S, 2010, SCIENCE, V330, P1540, DOI 10.1126/science.1193070; Raman V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-326; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stover NA, 2006, NUCLEIC ACIDS RES, V34, pD500, DOI 10.1093/nar/gkj054; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tyler BM, 2007, MOL PLANT PATHOL, V8, P1, DOI 10.1111/j.1364-3703.2006.00373.x; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van West P, 1999, MOL CELL, V3, P339, DOI 10.1016/S1097-2765(00)80461-X; van West P, 2008, MICROBIOL-SGM, V154, P1482, DOI 10.1099/mic.0.2007/015545-0; Vetukuri RR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051399; Vetukuri RR, 2011, MOL PLANT PATHOL, V12, P772, DOI [10.1111/J.1364-3703.2011.00710.X, 10.1111/j.1364-3703.2011.00710.x]; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Walker CA, 2008, FUNGAL GENET BIOL, V45, P954, DOI 10.1016/j.fgb.2008.03.004; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Whisson SC, 2005, MOL PLANT PATHOL, V6, P153, DOI 10.1111/J.1364-3703.2005.00272.X; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yoshida K, 2013, ELIFE, V2, DOI 10.7554/eLife.00731; Zhao W, 2011, FUNGAL GENET BIOL, V48, P241, DOI 10.1016/j.fgb.2010.11.006	94	46	47	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77181	10.1371/journal.pone.0077181	http://dx.doi.org/10.1371/journal.pone.0077181			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204767	Green Submitted, Green Published, gold			2022-12-27	WOS:000326032600024
J	Godiksen, S; Soendergaard, C; Friis, S; Jensen, JK; Bornholdt, J; Sales, KU; Huang, MD; Bugge, TH; Vogel, LK				Godiksen, Sine; Soendergaard, Christoffer; Friis, Stine; Jensen, Jan K.; Bornholdt, Jette; Sales, Katiuchia Uzzun; Huang, Mingdong; Bugge, Thomas H.; Vogel, Lotte K.			Detection of Active Matriptase Using a Biotinylated Chloromethyl Ketone Peptide	PLOS ONE			English	Article							TISSUE-PLASMINOGEN-ACTIVATOR; SERINE-PROTEASE MATRIPTASE; NEURAL-TUBE CLOSURE; ZYMOGEN ACTIVATION; PLACENTAL DEVELOPMENT; EPITHELIAL-CELLS; BARRIER FUNCTION; IN-VITRO; INHIBITOR; COMPLEX	Matriptase is a member of the family of type II transmembrane serine proteases that is essential for development and maintenance of several epithelial tissues. Matriptase is synthesized as a single-chain zymogen precursor that is processed into a two-chain disulfide-linked form dependent on its own catalytic activity leading to the hypothesis that matriptase functions at the pinnacle of several protease induced signal cascades. Matriptase is usually found in either its zymogen form or in a complex with its cognate inhibitor hepatocyte growth factor activator inhibitor 1 (HAI-1), whereas the active non-inhibited form has been difficult to detect. In this study, we have developed an assay to detect enzymatically active non-inhibitor-complexed matriptase by using a biotinylated peptide substrate-based chloromethyl ketone (CMK) inhibitor. Covalently CMK peptide-bound matriptase is detected by streptavidin pull-down and subsequent analysis by Western blotting. This study presents a novel assay for detection of enzymatically active matriptase in living human and murine cells. The assay can be applied to a variety of cell systems and species.	[Godiksen, Sine; Soendergaard, Christoffer; Friis, Stine; Bornholdt, Jette; Vogel, Lotte K.] Univ Copenhagen, Dept Cellular & Mol Med, Copenhagen, Denmark; [Godiksen, Sine] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Godiksen, Sine; Friis, Stine; Sales, Katiuchia Uzzun; Bugge, Thomas H.] Natl Inst Dent & Craniofacial Res, Proteases & Tissue Remodeling Unit, Bethesda, MD USA; [Jensen, Jan K.] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Jensen, Jan K.; Huang, Mingdong] Danish Chinese Ctr Proteases & Canc, Fuzhou, Fujian, Peoples R China; [Huang, Mingdong] Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou, Fujian, Peoples R China	University of Copenhagen; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Aarhus University; Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS	Vogel, LK (corresponding author), Univ Copenhagen, Dept Cellular & Mol Med, Copenhagen, Denmark.	vogel@sund.ku.dk	Huang, Mingdong/J-4278-2017; sales, katiuchia u/J-4880-2012	Huang, Mingdong/0000-0003-0085-9141; sales, katiuchia/0000-0002-3768-5790; Soendergaard, Christoffer/0000-0002-2943-6911; Vogel, Lotte K./0000-0001-9920-0982	Faculty of Science, University of Copenhagen; Grocer Kristian Kjaer and wife's Foundation; Kjaer-Foundation; Dagmar Marshalls Foundation; Master Cabinetmaker Sophus Jacobsen and wife Astrid Jacobsen's Foundation; Wholesale Dealer Valdemar Foersom and wife Thyra Foersom's Foundation; Manufacturer Einar Willumsen's Foundation; Lundbeck Foundation; Architect Holger Hjortenberg and wife Dagmar Hjortenberg's Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000699] Funding Source: NIH RePORTER	Faculty of Science, University of Copenhagen; Grocer Kristian Kjaer and wife's Foundation; Kjaer-Foundation; Dagmar Marshalls Foundation; Master Cabinetmaker Sophus Jacobsen and wife Astrid Jacobsen's Foundation; Wholesale Dealer Valdemar Foersom and wife Thyra Foersom's Foundation; Manufacturer Einar Willumsen's Foundation; Lundbeck Foundation(Lundbeckfonden); Architect Holger Hjortenberg and wife Dagmar Hjortenberg's Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Faculty of Science, University of Copenhagen, Architect Holger Hjortenberg and wife Dagmar Hjortenberg's Foundation; Grocer Kristian Kjaer and wife's Foundation, the Kjaer-Foundation; Dagmar Marshalls Foundation; Master Cabinetmaker Sophus Jacobsen and wife Astrid Jacobsen's Foundation; Wholesale Dealer Valdemar Foersom and wife Thyra Foersom's Foundation; Manufacturer Einar Willumsen's Foundation; and the Lundbeck Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PJ, 2001, ANAL BIOCHEM, V296, P254, DOI 10.1006/abio.2001.5302; Antalis TM, 2010, BIOCHEM J, V428, P325, DOI 10.1042/BJ20100046; Beliveau F, 2009, FEBS J, V276, P2213, DOI 10.1111/j.1742-4658.2009.06950.x; Benaud C, 2002, J BIOL CHEM, V277, P10539, DOI 10.1074/jbc.M109064200; BOOSE JA, 1989, BIOCHEMISTRY-US, V28, P635, DOI 10.1021/bi00428a033; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; Buzza MS, 2013, J BIOL CHEM, V288, P10328, DOI 10.1074/jbc.M112.443432; Buzza MS, 2010, P NATL ACAD SCI US; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; Carney TJ, 2007, DEVELOPMENT, V134, P3461, DOI 10.1242/dev.004556; Chen YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062826; Cho EG, 2001, J BIOL CHEM, V276, P44581, DOI 10.1074/jbc.M107059200; Darragh MR, 2010, CANCER RES, V70, P1505, DOI 10.1158/0008-5472.CAN-09-1640; Friis S, 2013, J BIOL CHEM, V288, P19028, DOI 10.1074/jbc.M113.469932; Friis S, 2011, J BIOL CHEM, V286, P5793, DOI 10.1074/jbc.M110.186874; Godiksen S, 2008, BIOCHEM J, V413, P251, DOI 10.1042/BJ20071496; Hung RJ, 2004, AM J PHYSIOL-CELL PH, V286, pC1159, DOI 10.1152/ajpcell.00400.2003; Inouye K, 2013, J BIOCHEM, V153, P51, DOI 10.1093/jb/mvs118; Inouye K, 2010, J BIOL CHEM, V285, P33394, DOI 10.1074/jbc.M110.115816; Inouye K, 2010, J BIOCHEM, V147, P485, DOI 10.1093/jb/mvp190; Kilpatrick LM, 2006, BLOOD, V108, P2616, DOI 10.1182/blood-2006-02-001073; Kiyomiya KI, 2006, AM J PHYSIOL-CELL PH, V291, pC40, DOI 10.1152/ajpcell.00351.2005; Larsen BR, 2013, EXP CELL RES, V319, P918, DOI 10.1016/j.yexcr.2013.01.008; Lee JW, 2005, HUM PATHOL, V36, P626, DOI 10.1016/j.humpath.2005.03.003; Lee MS, 2007, AM J PHYSIOL-CELL PH, V293, pC95, DOI 10.1152/ajpcell.00611.2006; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; List K, 2006, AM J PATHOL, V168, P1513, DOI 10.2353/ajpath.2006.051071; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; MADISON EL, 1993, SCIENCE, V262, P419, DOI 10.1126/science.8211162; Mathias JR, 2007, J CELL SCI, V120, P3372, DOI 10.1242/jcs.009159; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; RANBY M, 1982, THROMB RES, V27, P175, DOI 10.1016/0049-3848(82)90197-9; Sales KU, 2010, NAT GENET, V42, P676, DOI 10.1038/ng.629; Szabo R, 2007, ONCOGENE, V26, P1546, DOI 10.1038/sj.onc.1209966; Szabo R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002937; Szabo R, 2011, ANNU REV CELL DEV BI, V27, P213, DOI 10.1146/annurev-cellbio-092910-154247; Szabo R, 2009, DEVELOPMENT, V136, P2653, DOI 10.1242/dev.038430; Szabo R, 2009, AM J PATHOL, V174, P2015, DOI 10.2353/ajpath.2009.090053; Tachias K, 1996, J BIOL CHEM, V271, P28749, DOI 10.1074/jbc.271.46.28749; TACHIAS K, 1995, J BIOL CHEM, V270, P18319, DOI 10.1074/jbc.270.31.18319; Takeuchi T, 1999, P NATL ACAD SCI USA, V96, P11054, DOI 10.1073/pnas.96.20.11054; TATE KM, 1987, BIOCHEMISTRY-US, V26, P338, DOI 10.1021/bi00376a002; Tseng IC, 2010, J BIOL CHEM, V285, P3261, DOI 10.1074/jbc.M109.055640; VOGEL LK, 1995, J BIOL CHEM, V270, P22933, DOI 10.1074/jbc.270.39.22933; Wang JK, 2009, AM J PHYSIOL-CELL PH, V297, pC459, DOI 10.1152/ajpcell.00201.2009; Zhao BY, 2013, J BIOL CHEM, V288, P11155, DOI 10.1074/jbc.M113.454611	53	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77146	10.1371/journal.pone.0077146	http://dx.doi.org/10.1371/journal.pone.0077146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204759	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300085
J	Leung, V; Gillis, J; Raboud, J; Cooper, C; Hogg, RS; Loutfy, MR; Machouf, N; Montaner, JSG; Rourke, SB; Tsoukas, C; Klein, MB				Leung, Victor; Gillis, Jennifer; Raboud, Janet; Cooper, Curtis; Hogg, Robert S.; Loutfy, Mona R.; Machouf, Nima; Montaner, Julio S. G.; Rourke, Sean B.; Tsoukas, Chris; Klein, Marina B.		CANOC Collaboration	Predictors of CD4:CD8 Ratio Normalization and Its Effect on Health Outcomes in the Era of Combination Antiretroviral Therapy	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; T-CELL SUBSETS; LYMPHOCYTE-ACTIVATION; PROGNOSTIC VALUE; CD4-CD8 RATIO; CD4/CD8 RATIO; CD4+; CD8; DISEASE; COUNTS	Background: HIV leads to CD4:CD8 ratio inversion as immune dysregulation progresses. We examined the predictors of CD4:CD8 normalization after combination antiretroviral therapy (cART) and determined whether normalization is associated with reduced progression to AIDS-defining illnesses (ADI) and death. Methods: A Canadian cohort of HIV-positive adults with CD4:CD8<1.2 prior to starting cART from 2000-2010 were analyzed. Predictors of (1) reaching a CD4:CD8 >= 1.2 on two separate follow-up visits >30 days apart, and (2) ADI and death from all causes were assessed using adjusted proportional hazards models. Results: 4206 patients were studied for a median of 2.77 years and 306 (7.2%) normalized their CD4:CD8 ratio. Factors associated with achieving a normal CD4:CD8 ratio were: baseline CD4+ T-cells >350 cells/mm(3), baseline CD8+ T-cells <500 cells/mm(3), time-updated HIV RNA suppression, and not reporting sex with other men as a risk factor. There were 213 ADIs and 214 deaths in 13476 person-years of follow-up. Achieving a normal CD4:CD8 ratio was not associated with time to ADI/death. Conclusions: In our study, few individuals normalized their CD4:CD8 ratios within the first few years of initiating modern cART. This large study showed no additional short-term predictive value of the CD4:CD8 ratio for clinical outcomes after accounting for other risk factors including age and HIV RNA.	[Leung, Victor] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Gillis, Jennifer; Raboud, Janet] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [Raboud, Janet] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Cooper, Curtis] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Hogg, Robert S.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Hogg, Robert S.; Montaner, Julio S. G.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Loutfy, Mona R.] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [Loutfy, Mona R.] Maple Leaf Med Clin, Toronto, ON, Canada; [Loutfy, Mona R.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Machouf, Nima] Clin Med Actuel, Montreal, PQ, Canada; [Montaner, Julio S. G.] Univ British Columbia, Dept Med, Div Aids, Vancouver, BC, Canada; [Rourke, Sean B.] Ontario HIV Treatment Network, Toronto, ON, Canada; [Tsoukas, Chris; Klein, Marina B.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Tsoukas, Chris; Klein, Marina B.] McGill Univ Hlth Ctr, Montreal, PQ, Canada	University of British Columbia; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute; Simon Fraser University; B.C. Centre for Excellence in HIV/AIDS; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of British Columbia; McGill University; McGill University	Hogg, RS (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada.	rhogg@sfu.ca	Leung, Victor C.M./X-6823-2019; Leung, Victor C. M./AGU-2462-2022; Cooper, Curtis/M-9320-2019; Gillis, Jennifer/X-6384-2019	Leung, Victor C.M./0000-0003-3529-2640; Leung, Victor C. M./0000-0003-3529-2640; Gillis, Jennifer/0000-0001-5229-9911; Hogg, Robert/0000-0003-3463-5488; Klein, Marina/0000-0002-3063-8430	Canadian Institutes of Health Research (CIHR); CIHR Canadian HIV Trials Network [CTN 242]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Canadian HIV Trials Network(Canadian Institutes of Health Research (CIHR))	This work was supported by an Emerging Team Grant from the Canadian Institutes of Health Research (CIHR) and is supported by the CIHR Canadian HIV Trials Network (CTN 242). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CIHR: http://www.cihr-irsc.gc.ca/e/193.html CTN: http://www.hivnet.ubc.ca/home/	ABOULKER JP, 1992, J IMMUNOL METHODS, V154, P155, DOI 10.1016/0022-1759(92)90187-X; Adleman LM, 1996, J ACQ IMMUN DEF SYND, V11, P334, DOI 10.1097/00042560-199604010-00003; AMADORI A, 1995, NAT MED, V1, P1279, DOI 10.1038/nm1295-1279; Amadori A, 1996, IMMUNOL TODAY, V17, P414, DOI 10.1016/0167-5699(96)10049-9; Badura R, 2010, 10 INT C DRUG THER H; Bofill M, 1996, AIDS, V10, P827, DOI 10.1097/00002030-199607000-00005; BOFILL M, 1992, CLIN EXP IMMUNOL, V88, P243, DOI 10.1111/j.1365-2249.1992.tb03068.x; Bouscarat F, 1998, AIDS, V12, P1267, DOI 10.1097/00002030-199811000-00007; Clifford GM, 2009, BLOOD, V113, P5737, DOI 10.1182/blood-2009-02-204172; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; ECHANIZ P, 1993, CELL IMMUNOL, V150, P72, DOI 10.1006/cimm.1993.1179; Evans DM, 2004, GENES IMMUN, V5, P548, DOI 10.1038/sj.gene.6364126; FAHEY JL, 1987, ANN INST PASTEUR IMM, V138, P245, DOI 10.1016/S0769-2625(87)80075-2; FAHEY JL, 1990, NEW ENGL J MED, V322, P166, DOI 10.1056/NEJM199001183220305; GIORGI JV, 1993, J ACQ IMMUN DEF SYND, V6, P904; Grossman Z, 1998, J ACQ IMMUN DEF SYND, V17, P450, DOI 10.1097/00042560-199804150-00010; Gutierrez F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000089; Jiang WM, 2004, CLIN DIAGN LAB IMMUN, V11, P811, DOI 10.1128/CDLI.11.4.811-813.2004; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; Kulkarni H, 2011, JAIDS-J ACQ IMM DEF, V57, P387, DOI 10.1097/QAI.0b013e3182219113; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lang S, 2010, ARCH INTERN MED, V170, P1228, DOI 10.1001/archinternmed.2010.197; LAURENCE J, 1993, ANN INTERN MED, V119, P55, DOI 10.7326/0003-4819-119-1-199307010-00010; Lin H, 2002, MODELING SURVIVAL DA, V44, P85; Liu Z, 1998, J ACQ IMMUN DEF SYND, V18, P332, DOI 10.1097/00042560-199808010-00004; MARGOLICK JB, 1993, J ACQ IMMUN DEF SYND, V6, P153; Margolick JB, 2006, JAIDS-J ACQ IMM DEF, V42, P620, DOI 10.1097/01.qai.0000223028.55080.9d; Mendez-Lagares G, 2012, J ANTIMICROB CHEMOTH, V67, P1228, DOI 10.1093/jac/dkr594; Moore DM, 2006, AIDS, V20, P371, DOI 10.1097/01.aids.0000196180.11293.9a; MOSS AR, 1988, BRIT MED J, V296, P745, DOI 10.1136/bmj.296.6624.745; Naeger DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008886; Ndumbi P, 2011, 6 INT AIDS SOC C HIV; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Palmer AK, 2011, INT J EPIDEMIOL, V40, P25, DOI 10.1093/ije/dyp393; Plana M, 2000, AIDS, V14, P1921, DOI 10.1097/00002030-200009080-00007; Ratnam I, 2006, CLIN INFECT DIS, V42, P418, DOI 10.1086/499356; REICHERT T, 1991, CLIN IMMUNOL IMMUNOP, V60, P190, DOI 10.1016/0090-1229(91)90063-G; Schneider E, 2008, MORBIDITY MORTALITY, V57; Serrano-Villar S, 2013, J INFECTION, V66, P57, DOI 10.1016/j.jinf.2012.09.013; Shearer WT, 2007, J ALLERGY CLIN IMMUN, V120, P1449, DOI 10.1016/j.jaci.2007.08.037; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; SYRJALA H, 1991, CLIN EXP IMMUNOL, V83, P326; TAYLOR JMG, 1989, J ACQ IMMUN DEF SYND, V2, P114; Torti C, 2012, CLIN MICROBIOL INFEC, V18, P449, DOI 10.1111/j.1469-0691.2011.03650.x; Tuma RA, 2002, CURR OPIN IMMUNOL, V14, P348, DOI 10.1016/S0952-7915(02)00338-2; Wikby A, 1998, MECH AGEING DEV, V102, P187, DOI 10.1016/S0047-6374(97)00151-6; Wood E, 2003, AIDS, V17, P711, DOI 10.1097/00002030-200303280-00009; Zaman MM, 2000, AIDS PATIENT CARE ST, V14, P647, DOI 10.1089/10872910050206568	48	60	65	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77665	10.1371/journal.pone.0077665	http://dx.doi.org/10.1371/journal.pone.0077665			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204912	Green Published, gold, Green Submitted			2022-12-27	WOS:000326334500041
J	Tang, J; Ma, Y; Guo, Y; Ahmed, NI; Yu, YZ; Wang, JJ				Tang, Jie; Ma, Ying; Guo, Yong; Ahmed, Niman Isse; Yu, Yizhen; Wang, Jiaji			Association of Aggression and Non-Suicidal Self Injury: A School-Based Sample of Adolescents	PLOS ONE			English	Article							YOUNG-PEOPLE; RISK-FACTORS; HARM; SUICIDE; BEHAVIOR; PREVALENCE; HOSTILITY	Purpose: Non-suicidal self-injury (NSSI) in adolescent has drawn increasing attention because it is associated with subsequent depression, drug abuse, anxiety disorders, and suicide. In the present study, we aimed to estimate the prevalence of non-suicidal self-injury (NSSI) in a school-based sample of Chinese adolescents and to explore the association between aggression and NSSI. Methods: This study was part of a nationwide study on aggression among adolescents in urban areas of China. A sample of 2907 school students including 1436 boys and 1471 girls were randomly selected in Guangdong Province, with their age ranging from 10 to 18 years old. NSSI, aggression, emotional management and other factors were measured by self-administrated questionnaire. Multinomial logistic regression was used to estimate the association between aggression and NSSI, after adjustment for participants' emotional management, and other potential confounding variables. Results: The one year self-reported prevalence of NSSI was 33.6%. Of them, 21.7% engaged in 'minor NSSI', 11.9% in 'moderate/severe NSSI'. 96.9% of self-injuries engaged in one to five different types of NSSI in the past year. Hostility, verbal and indirect aggression was significantly associated with self-reported NSSI after adjusting for other potential factors both in 'minor NSSI' and 'moderate/severe NSSI'. Hostility, verbal and indirect aggression was significantly associated with greater risk of 'minor NSSI' and 'moderate/severe NSSI' in those who had poor emotional management ability. Conclusion: These findings highlight a high prevalence of NSSI and indicate the importance of hostility, verbal and indirect aggression as potentially risk factor for NSSI among Chinese adolescents.	[Tang, Jie; Wang, Jiaji] Guangzhou Med Univ, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Ma, Ying; Guo, Yong] Guangzhou Women & Childrens Med Ctr, Guangzhou, Guangdong, Peoples R China; [Tang, Jie; Ahmed, Niman Isse; Yu, Yizhen] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Child Adolescence & Woman Hlth Care, Wuhan 430074, Hubei, Peoples R China	Guangzhou Medical University; Huazhong University of Science & Technology	Yu, YZ (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Child Adolescence & Woman Hlth Care, Wuhan 430074, Hubei, Peoples R China.	yuyizhen650@163.com; wjiaji@163.com	Jie, Tang/AAS-7192-2021; WANG, Jia Ji/E-9059-2015	Tang, Jie/0000-0002-0568-8444	National Natural Science Foundation of China [30972496]; Supporting Program for Doctor of Guangzhou Medical College [L135025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Supporting Program for Doctor of Guangzhou Medical College	This work was supported by National Natural Science Foundation of China (Grant No 30972496) and was partially supported by research grants from the Supporting Program for Doctor of Guangzhou Medical College (Grant No L135025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander K, 2010, PSYCHIAT RES, V153, P274; Andover MS, 2010, PSYCHIAT RES, V178, P101, DOI 10.1016/j.psychres.2010.03.019; Ayers CD, 1999, J QUANT CRIMINOL, V15, P277; Barbui C, 2009, CAN MED ASSOC J, V180, P291, DOI 10.1503/cmaj.081514; Bhui K, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-336; Buss AH, 2010, AGGRESSION QUESTIONN; Catalano R. F, 2002, PREVENTION TREATMENT, V5, DOI [DOI 10.1037/1522-3736.5.1.515A, 10.1037/1522-3736.5.1.515a]; Chan WSC, 2009, SOC PSYCH PSYCH EPID, V44, P278, DOI 10.1007/s00127-008-0434-x; Felsten G, 1999, BEHAV RES THER, V37, P87, DOI 10.1016/S0005-7967(98)00104-1; Fisher HL, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2683; Fliege H, 2009, J PSYCHOSOM RES, V66, P477, DOI 10.1016/j.jpsychores.2008.10.013; Goleman D, 2020, EMOTIONAL INTELLIGEN, V25th; Gomes MM, 2009, J CHILD ADOL PS NURS, V22, P175, DOI 10.1111/j.1744-6171.2009.00196.x; Greydanus Donald E., 2009, Keio Journal of Medicine, V58, P144; Hawton K, 2002, BMJ-BRIT MED J, V325, P1207, DOI 10.1136/bmj.325.7374.1207; Hesketh T, 2002, SOC PSYCH PSYCH EPID, V37, P230, DOI 10.1007/s00127-002-0536-9; Isacsson G, 2001, BMJ-BRIT MED J, V322, P213, DOI 10.1136/bmj.322.7280.213; Ivan JP, 2012, PLOS ONE, V7; Jacobson CM, 2007, ARCH SUICIDE RES, V11, P129, DOI 10.1080/13811110701247602; Keilp JG, 2006, PSYCHOL MED, V36, P1779, DOI 10.1017/S0033291706008725; Kirkcaldy Bruce D, 2006, Int J Adolesc Med Health, V18, P597; Landstedt E, 2011, SCAND J PUBLIC HEALT, V39, P17, DOI 10.1177/1403494810382941; Lloyd E. E., 1997, ANN M SOC BEHAV MED; Lloyd-Richardson EE, 2007, PSYCHOL MED, V37, P1183, DOI 10.1017/S003329170700027X; Lowenstein Ludwig F, 2005, Int J Adolesc Med Health, V17, P225; Mann JJ, 1999, AM J PSYCHIAT, V156, P181; Maxwell JP, 2008, PERS INDIV DIFFER, V44, P943, DOI 10.1016/j.paid.2007.10.037; Maxwell JP, 2007, J PERS ASSESS, V88, P248; Nishina A, 2005, J CLIN CHILD ADOLESC, V34, P37, DOI 10.1207/s15374424jccp3401_4; Nock MK, 2009, CURR DIR PSYCHOL SCI, V18, P78, DOI 10.1111/j.1467-8721.2009.01613.x; Nock MK, 2005, J ABNORM PSYCHOL, V114, P140, DOI 10.1037/0021-843X.114.1.140; Portzky G, 2008, EUR CHILD ADOLES PSY, V17, P179, DOI 10.1007/s00787-007-0652-x; Shek DTL, 2012, SCI WORLD J, P1, DOI 10.1100/2012/932540; Skegg K, 2005, LANCET, V366, P1471, DOI 10.1016/S0140-6736(05)67600-3; Sourander A, 2006, J AFFECT DISORDERS, V93, P87, DOI 10.1016/j.jad.2006.02.015; Sun Y, 2008, CHINESE J SCH HLTH, V29, P424; Syed EU, 2008, CRISIS, V29, P159, DOI 10.1027/0227-5910.29.3.159; Taliaferro LA, 2012, ACAD PEDIATR, V12, P205, DOI 10.1016/j.acap.2012.01.008; Tang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017977; Vajani M, 2007, SUICIDE LIFE-THREAT, V37, P493, DOI 10.1521/suli.2007.37.5.493; Wedig MM, 2007, J AM ACAD CHILD PSY, V46, P1171, DOI 10.1097/chi.0b013e3180ca9aaf; Whitlock J, 2006, PEDIATRICS, V117, P1939, DOI 10.1542/peds.2005-2543; You JN, 2011, ARCH SUICIDE RES, V15, P75, DOI 10.1080/13811118.2011.540211; Zhang P., 2011, CHIN J SCH HLTH, V32, P897; Zhang P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031044	45	46	46	5	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78149	10.1371/journal.pone.0078149	http://dx.doi.org/10.1371/journal.pone.0078149			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243RL	24205132	Green Published, Green Submitted, gold			2022-12-27	WOS:000326334500100
J	Mehta, A; Luck, JM; Luk, CC; Syed, NI				Mehta, Anita; Luck, Jean-Marc; Luk, Collin C.; Syed, Naweed I.			Synaptic Metaplasticity Underlies Tetanic Potentiation in Lymnaea: A Novel Paradigm	PLOS ONE			English	Article							FORM	We present a mathematical model that explains and interprets a novel form of short-term potentiation, which was found to be use-, but not time-dependent, in experiments done on Lymnaea neurons. The high degree of potentiation is explained using a model of synaptic metaplasticity, while the use-dependence (which is critically reliant on the presence of kinase in the experiment) is explained using a model of a stochastic and bistable biological switch.	[Mehta, Anita] SN Bose Natl Ctr Basic Sci, Kolkata 700064, W Bengal, India; [Luck, Jean-Marc] CEA Saclay, Inst Phys Theor, F-91191 Gif Sur Yvette, France; [Luck, Jean-Marc] CNRS, URA 2306, Gif Sur Yvette, France; [Luk, Collin C.; Syed, Naweed I.] Univ Calgary, Fac Med, Hotchkiss Brain Inst, Calgary, AB T2N 1N4, Canada	Department of Science & Technology (India); SN Bose National Centre for Basic Science (SNBNCBS); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); University of Calgary	Mehta, A (corresponding author), SN Bose Natl Ctr Basic Sci, Kolkata 700064, W Bengal, India.	anita@bose.res.in		Luck, Jean-Marc/0000-0003-2151-5057				Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Brown MW, 1998, PROG NEUROBIOL, V55, P149, DOI 10.1016/S0301-0082(98)00002-1; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Fischer TM, 1997, NATURE, V389, P860, DOI 10.1038/39892; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; Luk CC, 2011, EUR J NEUROSCI, V34, P569, DOI 10.1111/j.1460-9568.2011.07784.x; Mehta A, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/09/P09025; Van Kampen NG, 1992, STOCHASTIC PROCESSES; Wixted JT, 1997, MEM COGNITION, V25, P731, DOI 10.3758/BF03211316; WIXTED JT, 1991, PSYCHOL SCI, V2, P409, DOI 10.1111/j.1467-9280.1991.tb00175.x	10	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78056	10.1371/journal.pone.0078056	http://dx.doi.org/10.1371/journal.pone.0078056			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205089	Green Submitted, gold, Green Published			2022-12-27	WOS:000326270700069
J	Mundra, V; Wu, H; Mahato, RI				Mundra, Vaibhav; Wu, Hao; Mahato, Ram I.			Genetically Modified Human Bone Marrow Derived Mesenchymal Stem Cells for Improving the Outcome of Human Islet Transplantation	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; IN-VITRO; PANCREATIC-ISLETS; GENE-TRANSFER; BETA-CELLS; CYTOKINES ACTIVATE; EXPRESSION; APOPTOSIS; DIFFERENTIATION; PROLIFERATION	The objective of this study was to determine the potential of human bone marrow derived mesenchymal stem cells (hBMSCs) as gene carriers for improving the outcome of human islet transplantation. hBMSCs were characterized for the expression of phenotypic markers and transduced with Adv-hVEGF-hIL-1Ra to overexpress human vascular endothelial growth factor (hVEGF) and human interleukin-1 receptor antagonist (hIL-1Ra). Human islets were co-cultured with hBMSCs overexpressing hVEGF and hIL-1Ra. Islet viability was determined by membrane fluorescent method and glucose stimulation test. Transduced hBMSCs and human islets were co-transplanted under the kidney capsule of NOD.Cg-Prkdc(scid) Il2rg(tm1Wjl)/SzJ (NSG) diabetic mice and blood glucose levels were measured over time to demonstrate the efficacy of genetically modified hBMSCs. At the end of study, immunofluorescent staining of kidney section bearing islets was performed for insulin and von Willebrand Factor (vWF). hBMSCs were positive for the expression of CD73, CD90, CD105, CD146 and Stro-1 surface markers as determined by flow cytometry. Transduction of hBMSCs with adenovirus did not affect their stemness and differentiation potential as confirmed by mRNA levels of stem cell markers and adipogenic differentiation of transduced hBMSCs. hBMSCs were efficiently transduced with Adv-hVEGF-hIL-1Ra to overexpress hVEGF and hIL-1Ra. Live dead cell staining and glucose stimulation test have shown that transduced hBMSCs improved the viability of islets against cytokine cocktail. Co-transplantation of human islets with genetically modified hBMSCs improved the glycemic control of diabetic NSG mice as determined by mean blood glucose levels and intraperitoneal glucose tolerance test. Immunofluorescent staining of kidney sections was positive for human insulin and vWF. In conclusion, our results have demonstrated that hBMSCs may be used as gene carriers and nursing cells to improve the outcome of islet transplantation.	[Mundra, Vaibhav; Wu, Hao; Mahato, Ram I.] Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Mahato, RI (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Memphis, TN 38163 USA.	ram.mahato@unmc.edu			National Institutes of Health (NIH) [RO1 DK69968]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069968] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the National Institutes of Health (NIH) for financial support (RO1 DK69968). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augstein P, 2004, J AUTOIMMUN, V23, P301, DOI 10.1016/j.jaut.2004.09.006; Barshes NR, 2005, J LEUKOCYTE BIOL, V77, P587, DOI 10.1189/jlb.1104649; Berman DM, 2010, DIABETES, V59, P2558, DOI 10.2337/db10-0136; Bertuzzi F, 2002, DIABETOLOGIA, V45, P77, DOI 10.1007/s125-002-8247-2; Biarnes M, 2002, DIABETES, V51, P66, DOI 10.2337/diabetes.51.1.66; Brissova M, 2004, DIABETES, V53, P1318, DOI 10.2337/diabetes.53.5.1318; Cai Q, 2012, DEV BIOL, V367, P40, DOI 10.1016/j.ydbio.2012.04.022; Delaney CA, 1997, ENDOCRINOLOGY, V138, P2610, DOI 10.1210/en.138.6.2610; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Duprez IR, 2011, UPSALA J MED SCI, V116, P8, DOI 10.3109/03009734.2010.524320; Garcia-Ocana A, 2003, J BIOL CHEM, V278, P343, DOI 10.1074/jbc.M207848200; Giannoukakis N, 1999, DIABETES, V48, P1730, DOI 10.2337/diabetes.48.9.1730; Go MJ, 2008, EXP CELL RES, V314, P1147, DOI 10.1016/j.yexcr.2007.11.021; GORES PF, 1993, ANN NY ACAD SCI, V696, P377; Grunnet LG, 2009, DIABETES, V58, P1807, DOI 10.2337/db08-0178; Han JH, 2012, STEM CELLS, V30, P2746, DOI 10.1002/stem.1223; HENDERSON JR, 1985, Q J EXP PHYSIOL CMS, V70, P347, DOI 10.1113/expphysiol.1985.sp002920; Hess D, 2003, NAT BIOTECHNOL, V21, P763, DOI 10.1038/nbt841; Ito T, 2010, TRANSPLANTATION, V89, P1438, DOI 10.1097/TP.0b013e3181db09c4; Johansson M, 2006, ENDOCRINOLOGY, V147, P2315, DOI 10.1210/en.2005-0997; Kim NY, 2010, J GENE MED, V12, P779, DOI 10.1002/jgm.1497; KURODA M, 1995, J CLIN ENDOCR METAB, V80, P3196, DOI 10.1210/jc.80.11.3196; Liu TM, 2009, STEM CELLS DEV, V18, P1013, DOI 10.1089/scd.2008.0335; Luo JZQ, 2011, BONE MARROW TRANSPL, V46, P1128, DOI 10.1038/bmt.2010.278; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Matsuda T, 2005, AM J TRANSPLANT, V5, P484, DOI 10.1046/j.1600-6143.2004.00716.x; McGinley L, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt53; McMahon JM, 2006, STEM CELLS DEV, V15, P87, DOI 10.1089/scd.2006.15.87; Milanesi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042177; Narang AS, 2006, PHARM RES, V23, P1970, DOI 10.1007/s11095-006-9065-7; Nyqvist D, 2011, DIABETES, V60, P2571, DOI 10.2337/db10-1711; Panakanti R, 2009, MOL PHARMACEUT, V6, P274, DOI 10.1021/mp800183b; Panakanti R, 2009, PHARM RES-DORDR, V26, P587, DOI 10.1007/s11095-008-9777-y; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Porada CD, 2010, ADV DRUG DELIVER REV, V62, P1156, DOI 10.1016/j.addr.2010.08.010; Psaltis PJ, 2010, J CELL PHYSIOL, V223, P530, DOI 10.1002/jcp.22081; Rosenberg L, 1999, SURGERY, V126, P393, DOI 10.1067/msy.1999.98783; Russell KC, 2010, STEM CELLS, V28, P788, DOI 10.1002/stem.312; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Sarkar SA, 2009, DIABETOLOGIA, V52, P1092, DOI 10.1007/s00125-009-1331-x; Schwarznau A, 2009, J CELL PHYSIOL, V220, P341, DOI 10.1002/jcp.21770; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Sordi V, 2010, STEM CELLS, V28, P140, DOI 10.1002/stem.259; Stiehler M, 2006, ADV EXP MED BIOL, V585, P31; Tondreau T, 2004, CYTOTHERAPY, V6, P372, DOI 10.1080/14653240410004943; Treacy O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042662; Wu H, 2011, J GENE MED, V13, P658, DOI 10.1002/jgm.1626; Wu H, 2011, MOL PHARMACEUT, V8, P1458, DOI 10.1021/mp200135e; Zhang N, 2003, AM J TRANSPLANT, V3, P1230, DOI 10.1046/j.1600-6143.2003.00215.x; Zhang N, 2004, DIABETES, V53, P963, DOI 10.2337/diabetes.53.4.963; Zheng YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041392	51	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77591	10.1371/journal.pone.0077591	http://dx.doi.org/10.1371/journal.pone.0077591			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204883	Green Published, gold, Green Submitted			2022-12-27	WOS:000326270700041
J	Hung, MJ; Hsu, KH; Hu, WS; Chang, NC; Hung, MY				Hung, Ming-Jui; Hsu, Kuang-Hung; Hu, Wei-Syun; Chang, Nen-Chung; Hung, Ming-Yow			C-Reactive Protein for Predicting Prognosis and Its Gender-Specific Associations with Diabetes Mellitus and Hypertension in the Development of Coronary Artery Spasm	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; SMOOTH-MUSCLE-CELLS; CARDIOVASCULAR-DISEASE; RISK-FACTORS; VASOSPASTIC ANGINA; NITRIC-OXIDE; FOLLOW-UP; RATS; INFLAMMATION; AGE	Background: While hypertension is negatively associated with coronary artery spasm (CAS), scarce data are available on diabetes mellitus in relation to CAS. In addition, outcome prediction in patients with CAS is challenging due to the lack of appropriate biomarkers. Therefore, we sought to identify the roles that gender, high-sensitivity C-reactive protein (hs-CRP), diabetes mellitus and hypertension play in CAS development and prognosis. Methodology/Prinicpal Findings: Patients (350 women and 547 men) undergoing diagnostic coronary angiography with or without proven CAS but without obstructive stenosis were evaluated at long-term follow-up (median 102 months). Diabetic women and diabetic men with low hs-CRP levels had a low and high risk of CAS (odds ratio [OR]: 0.16, 95% confidence interval [CI]: 0.01-1.88 and OR: 5.02, 95% CI: 1.03-24.54, respectively). The ORs of CAS in both women and men with the highest hs-CRP tertile (>3 mg/L) reduced from 4.41 to 1.45 and 2.98 to 1.52, respectively, if they had diabetes mellitus, and from 9.68 to 2.43 and 2.60 to 1.75, respectively, if they had hypertension. Hypertension had a more negative effect on CAS development in diabetic than non-diabetic women, which was not observed in men. The highest hs-CRP tertile was an independent predictor of adverse outcomes. Patients with the highest hs-CRP tertile had more coronary events than patients with the lowest hs-CRP tertitle (p = 0.021, log-rank test). Conclusions: Diabetes mellitus contributes to CAS development in men with low hs-CRP levels, but not in women. There are negative effects of diabetes mellitus and hypertension on CAS development in patients with high hs-CRP levels and especially in women. Elevated hs-CRP level independently predicts adverse outcomes.	[Hung, Ming-Jui] Chang Gung Mem Hosp, Dept Cardiol, Keelung, Taiwan; [Hung, Ming-Jui] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Hsu, Kuang-Hung] Chang Gung Univ, Dept Hlth Care Management, Lab Epidemiol, Tao Yuan, Taiwan; [Hsu, Kuang-Hung] Chang Gung Univ, Hlth Aging Res Ctr, Tao Yuan, Taiwan; [Hu, Wei-Syun; Hung, Ming-Yow] Taipei Med Univ, Shuang Ho Hosp, Div Cardiol, Dept Internal Med, New Taipei City, Taiwan; [Chang, Nen-Chung] Taipei Med Univ Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Hung, Ming-Yow] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Hung, Ming-Yow] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Chang Gung University; Taipei Medical University	Hung, MY (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Div Cardiol, Dept Internal Med, New Taipei City, Taiwan.	myhung6@ms77.hinet.net			Chang Gung Memorial Hospital at Keelung [23011, 250131]; National Science Council [95-2314-B-182A-058]; Healthy Aging Research Center of Chang Gung University, Taiwan [EMRPD1B0351, EMRPD1C0301]	Chang Gung Memorial Hospital at Keelung(Chang Gung Memorial Hospital); National Science Council(Ministry of Science and Technology, Taiwan); Healthy Aging Research Center of Chang Gung University, Taiwan	This work was supported by Chang Gung Medical Research Proposal grants 23011 and 250131 from Chang Gung Memorial Hospital at Keelung, National Science Council grant 95-2314-B-182A-058 and partly supported by the Healthy Aging Research Center of Chang Gung University (fund No. EMRPD1B0351 and EMRPD1C0301), Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajayi AA, 2003, DIABETES RES CLIN PR, V59, P11, DOI 10.1016/S0168-8227(02)00180-8; [Anonymous], 2010, CIRC J, V74, P1745; Best LG, 2005, CIRCULATION, V112, P1289, DOI 10.1161/CIRCULATIONAHA.104.489260; Bory M, 1996, EUR HEART J, V17, P1015; Chen KY, 2010, J HUM HYPERTENS, V24, P77, DOI 10.1038/jhh.2009.40; Crabos M, 1997, J MOL CELL CARDIOL, V29, P55, DOI 10.1006/jmcc.1996.0251; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Dumont T, 2009, NEUROCRIT CARE, V11, P183, DOI 10.1007/s12028-009-9232-x; Fernandez N, 2002, CLIN SCI LOND S48, p376S; Fukuda N, 1999, J HYPERTENS, V17, P1099, DOI 10.1097/00004872-199917080-00009; Gibbons RJ, 1999, CIRCULATION, V99, P2829, DOI 10.1161/01.CIR.99.21.2829; GRUNWALD JE, 1987, OPHTHALMOLOGY, V94, P1614; Hung MY, 2013, INT J MED SCI, V10, P255, DOI 10.7150/ijms.5383; Hung MY, 2010, EUR J CLIN INVEST, V40, P1094, DOI 10.1111/j.1365-2362.2010.02360.x; Karanian JW, 1996, J CARDIOVASC PHARM, V27, P312, DOI 10.1097/00005344-199603000-00002; KAUSER K, 1995, HYPERTENSION, V25, P517, DOI 10.1161/01.HYP.25.4.517; Kengne AP, 2012, DIABETES CARE, V35, P396, DOI 10.2337/dc11-1588; Konishi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060163; Kozakova M, 2000, HYPERTENSION, V36, P343, DOI 10.1161/01.HYP.36.3.343; Liu L, 2000, AM J PHYSIOL-HEART C, V278, pH1153, DOI 10.1152/ajpheart.2000.278.4.H1153; Lynch FM, 2012, J HYPERTENS, V30, P384, DOI 10.1097/HJH.0b013e32834e38a0; Miyao Y, 2000, J AM COLL CARDIOL, V36, P432, DOI 10.1016/S0735-1097(00)00729-4; Nakajima T, 1995, EUR J PHARMACOL, V294, P625, DOI 10.1016/0014-2999(95)00602-8; Nugent AG, 1996, DIABETES, V45, P105, DOI 10.2337/diabetes.45.1.105; ODriscoll G, 1997, J CLIN INVEST, V100, P678, DOI 10.1172/JCI119580; Oltman CL, 1997, CARDIOVASC RES, V34, P179, DOI 10.1016/S0008-6363(97)00016-3; Ong P, 2011, J AM COLL CARDIOL, V57, P147, DOI 10.1016/j.jacc.2010.08.626; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pieper GM, 1999, DIABETOLOGIA, V42, P204, DOI 10.1007/s001250051140; Ray KK, 2007, EUR HEART J, V28, P806, DOI 10.1093/eurheartj/ehm010; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Sanz E, 2003, LIFE SCI, V72, P1537, DOI 10.1016/S0024-3205(02)02444-X; SATO I, 1986, CHEST, V89, P12, DOI 10.1378/chest.89.1.12; Schofield I, 2002, CIRCULATION, V106, P3037, DOI 10.1161/01.CIR.0000041432.80615.A5; Sharaf BL, 1997, J AM COLL CARDIOL, V29, P78, DOI 10.1016/S0735-1097(96)00444-5; SUGIISHI M, 1993, CIRCULATION, V87, P76, DOI 10.1161/01.CIR.87.1.76; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P1121, DOI 10.1161/01.ATV.17.6.1121; TSCHUDI MR, 1995, CIRCULATION, V91, P2415, DOI 10.1161/01.CIR.91.9.2415; van Lennep JER, 2002, CARDIOVASC RES, V53, P538, DOI 10.1016/S0008-6363(01)00388-1; Yugar-Toledo JC, 2004, CHEST, V125, P823, DOI 10.1378/chest.125.3.823; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	41	29	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77655	10.1371/journal.pone.0077655	http://dx.doi.org/10.1371/journal.pone.0077655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204905	gold, Green Published, Green Submitted			2022-12-27	WOS:000326241200036
J	Oh, HY; Kim, MK; Lee, M; Kim, YO				Oh, Hea Young; Kim, Mi Kyung; Lee, Myoungsook; Kim, Young Ok			Macronutrient Composition and Sodium Intake of Diet Are Associated with Risk of Metabolic Syndrome and Hypertension in Korean Women	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; CORONARY-HEART-DISEASE; NATIONAL-HEALTH; PATTERNS; PREVALENCE; POPULATION; OBESITY; STROKE	Hypertension and hypertriglycemia are the most important contributors to metabolic syndrome (MetS) and cardiovascular disease risk in South Koreans with a relatively lean body mass. These major contributors differ from those identified in Western populations. This study aimed to identify the characteristics of the Korean diet associated with increased risk of MetS, whose prevalence has been steadily increasing in South Korea. On the basis of data collected from 5,320 subjects by the 2007-2008 Korean National Health and Nutrition Examination Survey, 3 dietary patterns were identified using factor analysis and their association with the risk of MetS and its components was examined. The balanced Korean diet, a typical Korean diet of rice and kimchi intake supplemented by a variety of foods had a desirable macronutrient composition and was associated with a lower risk of elevated blood pressure (OR=0.61, 95% CI=0.45-0.84) and hypertriglyceridemia (0.69, 0.49-0.88) in men and a lower risk of elevated blood pressure (0.59, 0.41-0.85) and MetS (0.67, 0.47-0.96) in women. The unbalanced Korean diet, characterized by a high intake of carbohydrates and sodium and little variety, was associated with a higher risk of MetS (1.44, 1.03-2.01) and elevated blood pressure (1.41, 1.00-1.98) in women. The semi-western diet, characterized by a relatively high intake of meat, poultry, and alcohol, was associated with a lower risk of low high-density lipoprotein cholesterol (0.70, 0.54-0.89) in women. Thus, macronutrient composition and sodium intake are associated with the risk of MetS and prehypertension in women. Maintaining a desirable macronutrient composition and avoiding excessive consumption of carbohydrates and sodium should be emphasized for prevention of MetS and hypertension in South Korean women.	[Oh, Hea Young; Kim, Mi Kyung] Natl Canc Ctr, Div Canc Epidemiol & Prevent, Translat Epidemiol Branch, Goyang, South Korea; [Lee, Myoungsook] Sungshin Womens Univ, Dept Food & Nutr, Seoul, South Korea; [Kim, Young Ok] Dongduk Womens Univ, Coll Nat Sci, Dept Food & Nutr, Seoul, South Korea	National Cancer Center - Korea (NCC); Sungshin Women's University; Dongduk Women's University	Kim, MK (corresponding author), Natl Canc Ctr, Div Canc Epidemiol & Prevent, Translat Epidemiol Branch, Goyang, South Korea.	alrud@ncc.re.kr		Lee, Myoungsook/0000-0003-1344-6979	National Cancer Center in Korea [1310361-1]; Korea Center for Disease Control and Prevention [2011E3500900]; Korean Food and Drug Administration [11162KFDA154]	National Cancer Center in Korea; Korea Center for Disease Control and Prevention; Korean Food and Drug Administration	This research was supported by grants from the National Cancer Center in Korea (1310361-1), the Korea Center for Disease Control and Prevention (2011E3500900), and the Korean Food and Drug Administration (11162KFDA154). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-61; Arai H, 2006, J ATHEROSCLER THROMB, V13, P202, DOI 10.5551/jat.13.202; Baxter AJ, 2006, ASIA PAC J CLIN NUTR, V15, P134; Beer-Borst S, 2000, EUR J CLIN NUTR, V54, P253, DOI 10.1038/sj.ejcn.1600934; Cho YA, 2011, NUTR METAB CARDIOVAS, V21, P893, DOI 10.1016/j.numecd.2010.02.018; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; Ford ES, 2005, DIABETES CARE, V28, P2745, DOI 10.2337/diacare.28.11.2745; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Halton TL, 2006, NEW ENGL J MED, V355, P1991, DOI 10.1056/NEJMoa055317; He YN, 2009, DIABETES CARE, V32, P1972, DOI 10.2337/dc09-0714; Hebert JR, 1997, AM J EPIDEMIOL, V146, P1046, DOI 10.1093/oxfordjournals.aje.a009233; Hu FB, 2007, J AM COLL CARDIOL, V50, P22, DOI 10.1016/j.jacc.2007.04.027; Jensen KO, 1999, EUR J CLIN NUTR, V53, P351, DOI 10.1038/sj.ejcn.1600767; Kim BK, 2012, BLOOD PRESS MONIT, V17, P120, DOI 10.1097/MBP.0b013e328354079b; Kim J, 2011, J AM DIET ASSOC, V111, P1141, DOI 10.1016/j.jada.2011.05.001; Korea Health Industry Development Institute Ministry of Health and Welfare, 2001, DEV NUTR DAT REC SIZ; Kris-Etherton PM, 2012, LIPIDS, V47, P931, DOI 10.1007/s11745-012-3704-z; Lee JH, 2011, J KOREAN MED SCI, V26, P1286, DOI 10.3346/jkms.2011.26.10.1286; Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109; Majane OHI, 2009, HYPERTENSION, V54, P1376, DOI 10.1161/HYPERTENSIONAHA.108.127514; Ministry of Health Welfare, 2010, KOR HLTH STAT 2009 K; Misra A, 2009, BRIT J NUTR, V101, P465, DOI 10.1017/S0007114508073649; Myong JP, 2012, INT J COLORECTAL DIS, V27, P1061, DOI 10.1007/s00384-012-1428-4; Okubo H, 2008, INT J OBESITY, V32, P541, DOI 10.1038/sj.ijo.0803737; Park SH, 2010, INT J CARDIOL, V139, P234, DOI 10.1016/j.ijcard.2008.10.011; Roos E, 1998, SOC SCI MED, V46, P1519, DOI 10.1016/S0277-9536(98)00032-X; Rural Development Administration, 2001, FOOD COMP TABL; Sherzai A, 2012, NUTR REV, V70, P423, DOI 10.1111/j.1753-4887.2012.00490.x; Shimazu T, 2007, INT J EPIDEMIOL, V36, P600, DOI 10.1093/ije/dym005; Silva ERDE, 2000, CIRCULATION, V102, P2347, DOI 10.1161/01.CIR.102.19.2347; Silventoinen K, 2005, INT J EPIDEMIOL, V34, P327, DOI 10.1093/ije/dyi007; Song Y, 2012, NUTR METAB CARDIOVAS, V22, P456, DOI 10.1016/j.numecd.2010.09.002; Stanley WC, 2009, HYPERTENSION, V54, P1209, DOI 10.1161/HYPERTENSIONAHA.109.128660; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567	34	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78088	10.1371/journal.pone.0078088	http://dx.doi.org/10.1371/journal.pone.0078088			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205105	gold, Green Published, Green Submitted			2022-12-27	WOS:000326155400070
J	Wang, JL; Li, C; Tao, HT; Cheng, Y; Han, L; Li, XY; Hu, Y				Wang, Jinliang; Li, Cheng; Tao, Haitao; Cheng, Yao; Han, Lu; Li, Xiaoyan; Hu, Yi			Statin Use and Risk of Lung Cancer: a Meta-Analysis of Observational Studies and Randomized Controlled Trials	PLOS ONE			English	Article							COA REDUCTASE INHIBITORS; FOLLOW-UP; PRIMARY PREVENTION; PANCREATIC-CANCER; POTENT INHIBITION; INDUCED APOPTOSIS; TUMOR FORMATION; CELL-GROWTH; IN-VITRO; LOVASTATIN	Clinical studies have shown that statin use may alter the risk of lung cancer. However, these studies yielded different results. To quantify the association between statin use and risk of lung cancer, we performed a detailed meta-analysis. A literature search was carried out using MEDLINE, EMBASE and COCHRANE database between January 1966 and November 2012. Before meta-analysis, between-study heterogeneity and publication bias were assessed using adequate statistical tests. Fixed-effect and random-effect models were used to calculate the pooled relative risks (RR) and corresponding 95% confidence intervals (CIs). Subgroup analyses, sensitivity analysis and cumulative meta-analysis were also performed. A total of 20 (five randomized controlled trials, eight cohorts, and seven case-control) studies contributed to the analysis. Pooled results indicated a non-significant decrease of total lung cancer risk among all statin users (RR = 0.89, 95% CI [0.78, 1.02]). Further, long-term statin use did not significantly decrease the risk of total lung cancer (RR = 0.80, 95% CI [0.39, 1.64]). In our subgroup analyses, the results were not substantially affected by study design, participant ethnicity, or confounder adjustment. Furthermore, sensitivity analysis confirmed the stability of results. The findings of this meta-analysis suggested that there was no significant association between statin use and risk of lung cancer. More studies, especially randomized controlled trials and high quality cohort studies are warranted to confirm this association.	[Wang, Jinliang; Li, Cheng; Tao, Haitao; Cheng, Yao; Han, Lu; Li, Xiaoyan; Hu, Yi] Chinese Peoples Liberat Army Gen Hosp, Dept Gen Oncol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Hu, Y (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Gen Oncol, Beijing, Peoples R China.	yihubj@163.com	wang, jinliang/AAA-2799-2021	wang, jinliang/0000-0001-6427-3487				Alonso DF, 1998, BREAST CANCER RES TR, V50, P83, DOI 10.1023/A:1006058409974; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Blais L, 2000, ARCH INTERN MED, V160, P2363, DOI 10.1001/archinte.160.15.2363; Chen J, 2012, EUR J PHARMACOL, V682, P161, DOI 10.1016/j.ejphar.2012.02.015; Chen J, 2012, MOL ONCOL, V6, P62, DOI 10.1016/j.molonc.2011.11.003; Cheng MH, 2012, LUNG CANCER, V75, P275, DOI 10.1016/j.lungcan.2011.08.014; Coogan PF, 2007, EPIDEMIOLOGY, V18, P213, DOI 10.1097/01.ede.0000254694.03027.a1; Cui XB, 2012, CANCER CAUSE CONTROL, V23, P1099, DOI 10.1007/s10552-012-9979-9; Dimitroulakos J, 2002, NEOPLASIA, V4, P337, DOI 10.1038/sj.neo.7900247; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Emberson JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029849; Farwell WR, 2008, JNCI-J NATL CANCER I, V100, P134, DOI 10.1093/jnci/djm286; Ford I, 2007, NEW ENGL J MED, V357, P1477, DOI 10.1056/NEJMoa065994; Friedman GD, 2008, PHARMACOEPIDEM DR S, V17, P27, DOI 10.1002/pds.1507; Friis S, 2005, INT J CANCER, V114, P643, DOI 10.1002/ijc.20758; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI 10.1001/jama.288.23.2998; Ghavami S, 2010, BBA-MOL CELL RES, V1803, P452, DOI 10.1016/j.bbamcr.2009.12.005; Goldstein MR, 2009, INT J CARDIOL, V135, P128, DOI 10.1016/j.ijcard.2008.01.023; Graaf MR, 2004, J CLIN ONCOL, V22, P2388, DOI 10.1200/JCO.2004.02.027; Hamelin BA, 1998, TRENDS PHARMACOL SCI, V19, P26, DOI 10.1016/S0165-6147(97)01147-4; Hanai J, 2012, J CELL PHYSIOL, V227, P1709, DOI 10.1002/jcp.22895; Haukka J, 2010, INT J CANCER, V126, P279, DOI 10.1002/ijc.24536; Hawk MA, 1996, CANCER LETT, V109, P217, DOI 10.1016/S0304-3835(96)04465-5; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hippisley-Cox Julia, 2010, BMJ, V340, pc2197, DOI 10.1136/bmj.c2197; Hwang KE, 2011, INVEST NEW DRUG, V29, P945, DOI 10.1007/s10637-010-9450-2; Jacobs EJ, 2011, CANCER RES, V71, P1763, DOI 10.1158/0008-5472.CAN-10-2953; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kaye JA, 2004, BRIT J CANCER, V90, P635, DOI 10.1038/sj.bjc.6601566; KEYOMARSI K, 1991, CANCER RES, V51, P3602; Khanzada UK, 2006, ONCOGENE, V25, P877, DOI 10.1038/sj.onc.1209117; Khurana V, 2007, CHEST, V131, P1282, DOI 10.1378/chest.06-0931; Kidera Yasuhiro, 2010, J Exp Clin Cancer Res, V29, P127, DOI 10.1186/1756-9966-29-127; Kusama T, 2002, GASTROENTEROLOGY, V122, P308, DOI 10.1053/gast.2002.31093; Lee KJ, 2010, CLIN EXP IMMUNOL, V161, P298, DOI 10.1111/j.1365-2249.2010.04170.x; Maksimova E, 2008, LUNG, V186, P45, DOI 10.1007/s00408-007-9053-7; Mausner-Fainberg K, 2008, ATHEROSCLEROSIS, V197, P829, DOI 10.1016/j.atherosclerosis.2007.07.031; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Mills EJ, 2008, J AM COLL CARDIOL, V52, P1769, DOI 10.1016/j.jacc.2008.08.039; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Newman TB, 1996, JAMA-J AM MED ASSOC, V275, P55, DOI 10.1001/jama.275.1.55; Park HJ, 2002, CIRC RES, V91, P143, DOI 10.1161/01.RES.0000028149.15986.4C; Park IH, 2011, INVEST NEW DRUG, V29, P883, DOI 10.1007/s10637-010-9439-x; Park IH, 2010, INVEST NEW DRUG, V28, P791, DOI 10.1007/s10637-009-9319-4; Pradelli D, 2013, EUR J CANCER PREV, V22, P229, DOI 10.1097/CEJ.0b013e328358761a; Raemer PC, 2009, EUR J IMMUNOL, V39, P1456, DOI 10.1002/eji.200838863; Sanli T, 2011, J THORAC ONCOL, V6, P439, DOI 10.1097/JTO.0b013e3182049d8b; Sato S, 2006, J EPIDEMIOL, V16, P201, DOI 10.2188/jea.16.201; Serruys PWJC, 2002, JAMA-J AM MED ASSOC, V287, P3215, DOI 10.1001/jama.287.24.3215; Setoguchi S, 2007, CIRCULATION, V115, P27, DOI 10.1161/CIRCULATIONAHA.106.650176; Strandberg TE, 2004, LANCET, V364, P771, DOI 10.1016/S0140-6736(04)16936-5; Undela K, 2012, BREAST CANCER RES TR, V135, P261, DOI 10.1007/s10549-012-2154-x; Vinogradova Y, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-409; Weis M, 2002, CIRCULATION, V105, P739, DOI 10.1161/hc0602.103393; Wong WWL, 2002, LEUKEMIA, V16, P508, DOI 10.1038/sj.leu.2402476	56	37	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77950	10.1371/journal.pone.0077950	http://dx.doi.org/10.1371/journal.pone.0077950			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205041	Green Submitted, Green Published, gold			2022-12-27	WOS:000326155400064
J	Vizeneux, A; Hilfiger, A; Bouligand, J; Pouillot, M; Brailly-Tabard, S; Bashamboo, A; McElreavey, K; Brauner, R				Vizeneux, Audrey; Hilfiger, Aude; Bouligand, Jerome; Pouillot, Monique; Brailly-Tabard, Sylvie; Bashamboo, Anu; McElreavey, Ken; Brauner, Raja			Congenital Hypogonadotropic Hypogonadism during Childhood: Presentation and Genetic Analyses in 46 Boys	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; INHIBIN B LEVELS; ANTIMULLERIAN HORMONE; GNRH REPLACEMENT; DEFICIENCY; MUTATIONS; PUBERTY; GROWTH; MALES; TESTOSTERONE	Background: The majority of the patients reported with mutations in isolated hypogonadotropic hypogonadism (HH) are adults. We analysed the presentation and the plasma inhibin B and anti-mullerian hormone (AMH) concentrations during childhood and adolescence, and compared them to the genetic results. Methods: This was a retrospective, single-center study of 46 boys with HH. Results: Fourteen (30.4%) had Kallmann syndrome (KS), 4 (8.7%) had CHARGE syndrome and 28 (60.9%) had HH without olfaction deficit nor olfactive bulb hypoplasia. Eighteen (39%) had an associated malformation or syndromes. At diagnosis, 22 (47.8%) boys were aged <one year, 9 (19%) 1-11 and 15 (32.6%) 11-17.6 years. They presented with micropenis (n = 32, 69.6%, including all those <one year), cryptorchidism (n = 32, 69.6%, unilateral in 8, bilateral in 24), and/or pubertal delay (n = 11). The plasma inhibin B concentrations were normal in 8 (3 KS including one CHARGE and 5 other HH), at the lower limit of the normal in 6 and decreased in 13 (48%) boys. The AMH concentrations were normal in 15 (6 KS including one CHARGE and 9 other HH) and decreased in 12 (44%) boys. In addition to the CHD7 gene mutations in 4 patients with CHARGE, mutations were found in 5/26 other boys analysed including one in KAL1 gene with STS, 2 in FGFR1 gene, one in PROKR2 gene and one in GnRHR gene. Conclusions: The presence of micropenis in neonate, particularly if associated with cryptorchidism, is an indication to look for gonadotropin deficiency isolated or associated with other hypothalamic-pituitary deficiencies. Inhibin B and AMH concentrations are suggestive if low, but they may be normal. Despite the high frequency of the associated malformations and excluding the patients with CHARGE or ichtyosis, the 4 patients with mutations had no family history or malformation. This suggests that many other genes are involved.	[Vizeneux, Audrey; Hilfiger, Aude; Pouillot, Monique; Brauner, Raja] Univ Paris 05, Paris, France; [Vizeneux, Audrey; Hilfiger, Aude; Pouillot, Monique; Brauner, Raja] Fdn Ophtalmol Adolphe de Rothschild, Pediat Endocrinol Unit, Paris, France; [Bouligand, Jerome; Brailly-Tabard, Sylvie] Univ Paris Sud, F-94275 Le Kremlin Bicetre, France; [Bouligand, Jerome; Brailly-Tabard, Sylvie] Hop Bicetre, AP HP, Serv Genet Mol, Le Kremlin Bicetre, France; [Bashamboo, Anu; McElreavey, Ken] Inst Pasteur, Paris, France	UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Brauner, R (corresponding author), Univ Paris 05, Paris, France.	raja.brauner@wanadoo.fr	BOULIGAND, Jérôme/S-5716-2018					Adan L, 2004, J PEDIATR ENDOCR MET, V17, P149; Adan L, 2010, MED SCI MONITOR, V16, pCR511; Anawalt BD, 1996, J CLIN ENDOCR METAB, V81, P3341, DOI 10.1210/jc.81.9.3341; Andersson AM, 1998, J CLIN ENDOCR METAB, V83, P675, DOI 10.1210/jc.83.2.675; Andersson AM, 1997, J CLIN ENDOCR METAB, V82, P3976, DOI 10.1210/jc.82.12.3976; Bergman JEH, 2012, J CLIN ENDOCR METAB, V97, pE858, DOI 10.1210/jc.2011-2652; Bin-Abbas B, 1999, J PEDIATR-US, V134, P579, DOI 10.1016/S0022-3476(99)70244-1; Bouligand J, 2009, NEW ENGL J MED, V360, P2742, DOI 10.1056/NEJMoa0900136; Brioude F, 2010, EUR J ENDOCRINOL, V162, P835, DOI 10.1530/EJE-10-0083; Chan YM, 2009, P NATL ACAD SCI USA, V106, P11703, DOI 10.1073/pnas.0903449106; Coutant R, 2010, J CLIN ENDOCR METAB, V95, P5225, DOI 10.1210/jc.2010-1535; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Dode C, 2010, ANN ENDOCRINOL-PARIS, V71, P149, DOI 10.1016/j.ando.2010.02.005; FELDMAN KW, 1975, J PEDIATR-US, V86, P395, DOI 10.1016/S0022-3476(75)80969-3; Francou B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025614; Fromantin M, 1973, Probl Actuels Endocrinol Nutr, V16, P179; Galeotti C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039828; Grumbach MM, 2005, J CLIN ENDOCR METAB, V90, P3122, DOI 10.1210/jc.2004-2465; Hanchate NK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002896; Harrington J, 2012, J CLIN ENDOCR METAB, V97, P3056, DOI 10.1210/jc.2012-1598; Jongmans MCJ, 2009, CLIN GENET, V75, P65, DOI 10.1111/j.1399-0004.2008.01107.x; Kim HG, 2008, AM J HUM GENET, V83, P511, DOI 10.1016/j.ajhg.2008.09.005; LEE PA, 1980, JOHNS HOPKINS MED J, V146, P156; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Nachtigall LB, 1997, NEW ENGL J MED, V336, P410, DOI 10.1056/NEJM199702063360604; Nachtigall LB, 1996, J CLIN ENDOCR METAB, V81, P3520, DOI 10.1210/jc.81.10.3520; Nimri R, 2011, J CLIN ENDOCR METAB, V96, pE536, DOI 10.1210/jc.2010-1676; Pham LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053189; Quinton R, 2001, CLIN ENDOCRINOL, V55, P163, DOI 10.1046/j.1365-2265.2001.01277.x; Rey RA, 1999, J CLIN ENDOCR METAB, V84, P627, DOI 10.1210/jc.84.2.627; Sarfati J, 2010, J CLIN ENDOCR METAB, V95, P659, DOI 10.1210/jc.2009-0843; Schonfeld WA, 1943, AM J DIS CHILD, V65, P535, DOI 10.1001/archpedi.1943.02010160019003; Seminara SB, 1996, J CLIN ENDOCR METAB, V81, P3692, DOI 10.1210/jc.81.10.3692; SHECKTER CB, 1988, J CLIN ENDOCR METAB, V67, P1221, DOI 10.1210/jcem-67-6-1221; Topaloglu AK, 2012, NEW ENGL J MED, V366, P629, DOI 10.1056/NEJMoa1111184; Topaloglu AK, 2009, NAT GENET, V41, P354, DOI 10.1038/ng.306; TOUBLANC JE, 1991, HORM RES, V36, P136, DOI 10.1159/000182147; Trarbach EB, 2006, J CLIN ENDOCR METAB, V91, P4006, DOI 10.1210/jc.2005-2793; VANDOP C, 1987, J PEDIATR-US, V111, P684, DOI 10.1016/S0022-3476(87)80243-3; Vinci G, 2007, MOL HUM REPROD, V13, P685, DOI 10.1093/molehr/gam045; Young J, 1999, J CLIN ENDOCR METAB, V84, P2696, DOI 10.1210/jc.84.8.2696; Young J, 2012, HUM REPROD, V27, P1460, DOI 10.1093/humrep/des022; Young J, 2012, J CLIN ENDOCR METAB, V97, P707, DOI 10.1210/jc.2011-1664	43	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77827	10.1371/journal.pone.0077827	http://dx.doi.org/10.1371/journal.pone.0077827			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204987	Green Submitted, Green Published, gold			2022-12-27	WOS:000326152300032
J	Jiang, FR; Tan, GL				Jiang, Fengrui; Tan, Guolong			Fabrication and Optical Properties of Water Soluble CdSeS Nanocrystals Using Glycerin as Stabilizing Agent	PLOS ONE			English	Article							LIGHT-EMITTING-DIODES; ONE-POT SYNTHESIS; HIGH-QUALITY CDS; QUANTUM DOTS; SEMICONDUCTOR NANOCRYSTALS; NONCOORDINATING SOLVENTS; ZNXCD1-XSE NANOCRYSTALS; LUMINESCENCE; SIZE; CDTE	Herein we present an unusual phosphine-free method to fabricate water soluble CdSeS nanocrystals in cubic structure. In this method, glycerin was used as a stabilizing agent replacing tri-n-octylphosphine oxide (TOPO). Water solution of Na2SeO3 in polyethylene glycol was utilized as Se source. 3-Mercaptopropionic acid (MPA) provides S source. The phosphine-free Se and S sources were found to be highly reactive and suitable for the synthesis of CdSeS nanocrystals. XRD and HRTEM images confirm the formation of CdSeS nanocrystals in zinc blende structure. The absorption peaks on UV-vis spectra of as-prepared CdSeS nanocrystals are tunable from 330 nm to 440 nm, which blue shifts to shorter wavelength side in comparison with that of pure CdSe nanocrystals. The cubic CdSeS nanocrystals demonstrate narrow PL emissions spectra between 464 and 615 nm. Transmission electron microscopy images show the uniformity for the size distribution of the ternary QDs. Series water soluble CdSe1-xSx (x = 0 similar to 1) nanocrystals have also been synthesized using Na2SeO3 and Na2S solution as the Se-S co-sources. Tunable band gap energies of CdSe1-xSx (x = 0 similar to 1) nanocrystals upon chemical composition x have been achieved, the gap ranges from 290 nm to 558 nm.	[Jiang, Fengrui; Tan, Guolong] Wuhan Univ Technol, State Key Lab Adv Technol Mat Synth & Proc, Wuhan 430070, Peoples R China	Wuhan University of Technology	Tan, GL (corresponding author), Wuhan Univ Technol, State Key Lab Adv Technol Mat Synth & Proc, Wuhan 430070, Peoples R China.	gltan@whut.edu.cn	Tan, Guolong/A-1098-2013	Tan, Guolong/0000-0003-0961-5506	Natural Science Foundation of Hubei Province [2010CDA078]	Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	The financial support is from the Natural Science Foundation of Hubei Province (2010CDA078). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Salim N, 2007, CHEM MATER, V19, P5185, DOI 10.1021/cm070818k; Alivisatos P, 2004, NAT BIOTECHNOL, V22, P47, DOI 10.1038/nbt927; Bailey RE, 2003, J AM CHEM SOC, V125, P7100, DOI 10.1021/ja035000o; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; BRUS L, 1986, J PHYS CHEM-US, V90, P2555, DOI 10.1021/j100403a003; Cao YC, 2004, J AM CHEM SOC, V126, P14336, DOI 10.1021/ja0459678; Caruge JM, 2008, NAT PHOTONICS, V2, P247, DOI 10.1038/nphoton.2008.34; Chen XF, 2010, MATER SCI ENG B-ADV, V166, P14, DOI 10.1016/j.mseb.2009.09.021; COLVIN VL, 1994, NATURE, V370, P354, DOI 10.1038/370354a0; Gur I, 2005, SCIENCE, V310, P462, DOI 10.1126/science.1117908; HERRON N, 1993, SCIENCE, V259, P1426, DOI 10.1126/science.259.5100.1426; Huynh WU, 2002, SCIENCE, V295, P2425, DOI 10.1126/science.1069156; Jang E, 2003, CHEM COMMUN, P2964, DOI 10.1039/b310853h; Jiang W, 2006, CHEM MATER, V18, P4845, DOI 10.1021/cm061311x; Kale RB, 2005, SEMICOND SCI TECH, V20, P1, DOI 10.1088/0268-1242/20/1/001; Kasuya A, 2004, NAT MATER, V3, P99, DOI 10.1038/nmat1056; Khanna PK, 2005, MATER CHEM PHYS, V94, P454, DOI 10.1016/j.matchemphys.2005.05.006; KRATSCHMER W, 1990, NATURE, V347, P354, DOI 10.1038/347354a0; Li JJ, 2003, J AM CHEM SOC, V125, P12567, DOI 10.1021/ja0363563; Liu TY, 2009, J PHYS CHEM C, V113, P2301, DOI 10.1021/jp809171f; Ma XD, 2002, J MATER CHEM, V12, P663, DOI 10.1039/b107173b; MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025; Ouyang JY, 2008, J PHYS CHEM C, V112, P4908, DOI 10.1021/jp710852q; Ouyang JY, 2007, J PHYS CHEM C, V111, P16261, DOI 10.1021/jp074416b; Ouyang JY, 2009, J PHYS CHEM C, V113, P5193, DOI 10.1021/jp8110138; Peng XG, 2000, NATURE, V404, P59, DOI 10.1038/35003535; Peng ZA, 2001, J AM CHEM SOC, V123, P183, DOI 10.1021/ja003633m; Ratcliffe CI, 2006, PHYS CHEM CHEM PHYS, V8, P3510, DOI 10.1039/b606507b; Riehle FS, 2009, NANO LETT, V9, P514, DOI 10.1021/nl080150o; Rizzo A, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2426899; Sedaghat Z, 2006, NANOTECHNOLOGY, V17, P3812, DOI 10.1088/0957-4484/17/15/034; Stampfl APJ, 1997, PHYS REV B, V55, P9679, DOI 10.1103/PhysRevB.55.9679; Steckel JS, 2006, ANGEW CHEM INT EDIT, V45, P5796, DOI 10.1002/anie.200600317; Swafford LA, 2006, J AM CHEM SOC, V128, P12299, DOI 10.1021/ja063939e; Wei YF, 2010, CHEM MATER, V22, P5672, DOI 10.1021/cm101308f; Yang YA, 2005, ANGEW CHEM INT EDIT, V44, P6712, DOI 10.1002/anie.200502279; Yang YJ, 2005, APPL PHYS A-MATER, V81, P1351, DOI 10.1007/s00339-005-3292-3; Yu WW, 2003, CHEM MATER, V15, P2854, DOI 10.1021/cm034081k; Yu WW, 2002, ANGEW CHEM INT EDIT, V41, P2368, DOI 10.1002/1521-3773(20020703)41:13<2368::AID-ANIE2368>3.0.CO;2-G; Zhong XH, 2004, J PHYS CHEM B, V108, P15552, DOI 10.1021/jp048071y; Zhong XH, 2004, J MATER CHEM, V14, P2790, DOI 10.1039/b407556k; Zhong XH, 2003, J AM CHEM SOC, V125, P13559, DOI 10.1021/ja036683a; Zhong XH, 2003, J AM CHEM SOC, V125, P8589, DOI 10.1021/ja035096m	43	0	0	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77253	10.1371/journal.pone.0077253	http://dx.doi.org/10.1371/journal.pone.0077253			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204781	Green Submitted, Green Published, gold			2022-12-27	WOS:000326032600025
J	Lu, GF; Matsuura, SE; Barrientos, A; Scott, WA				Lu, Gaofei; Matsuura, Suzanne E.; Barrientos, Antoni; Scott, Walter A.			HIV-1 Infection Is Blocked at an Early Stage in Cells Devoid of Mitochondrial DNA	PLOS ONE			English	Article							NONDIVIDING CELLS; PROTEIN P-32; VIRUS; RESPONSES; IDENTIFICATION; ENTRY; VISUALIZATION; TRANSDUCTION; RESTRICTION; EXPRESSION	Human immunodeficiency virus type I (HIV-1) exploits various host cellular pathways for efficient infection. Here we report that the absence of mitochondrial DNA (mtDNA) in rho(0) cells markedly attenuates HIV-1 infection. Importantly, reduced infection efficiency in rho(0) cells is not simply the result of impaired oxidative phosphorylation (OXPHOS) because pharmacological OXPHOS inhibition did not inhibit HIV-1 infection. Analysis of the early steps of virus infection by real-time PCR quantification of stage-specific HIV-1 DNA products in the infected rho(0) and parental cell line have allowed us to conclude that HIV-1 infection in rho(0) cells is blocked at the steps that occur after reverse transcription and prior to nuclear import. Additionally, confocal fluorescence microscope analysis showed that the majority of viral complexes containing HIV-1 p24 co-localize with mitochondria in target cells, suggesting an interaction between the two. Collectively, our data strongly indicate that mitochondria play an important role during early stages of HIV-1 infection, probably through direct association with HIV-1 intracellular complexes.	[Lu, Gaofei; Matsuura, Suzanne E.; Barrientos, Antoni; Scott, Walter A.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Barrientos, Antoni] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA	University of Miami; University of Miami	Barrientos, A (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA.	abarrientos@med.miami.edu			National Institutes of Health [AI-39973]; American Heart Association [09PRE2280106]; Miami Center for AIDS Research (CFAR) at the University of Miami Miller School of Medicine; National Institutes of Health (NIH) [P30AI073961]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039973, P30AI073961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071775] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Miami Center for AIDS Research (CFAR) at the University of Miami Miller School of Medicine; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Institutes of Health grant AI-39973 (to W. A. S.) and a predoctoral fellowship from the American Heart Association (09PRE2280106 to G. L.). The authors acknowledge support from the Miami Center for AIDS Research (CFAR) at the University of Miami Miller School of Medicine funded by a grant (P30AI073961) from the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken C, 1997, J VIROL, V71, P5871, DOI 10.1128/JVI.71.8.5871-5877.1997; ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5; Bayona-Bafaluy MP, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng100; Beatch MD, 2000, J VIROL, V74, P5569, DOI 10.1128/JVI.74.12.5569-5576.2000; Beatch MD, 2005, J VIROL, V79, P10807, DOI 10.1128/JVI.79.16.10807-10820.2005; Behan A, 2005, MITOCHONDRION, V5, P173, DOI 10.1016/j.mito.2005.03.002; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brun S, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-57; Brussel A, 2003, J VIROL, V77, P10119, DOI 10.1128/JVI.77.18.10119-10124.2003; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Castedo M, 2003, ANN NY ACAD SCI, V1010, P19, DOI 10.1196/annals.1299.004; Chevallet M, 2006, ELECTROPHORESIS, V27, P1574, DOI 10.1002/elps.200500704; Claus C, 2011, J VIROL, V85, P3881, DOI 10.1128/JVI.02492-10; Das SC, 2006, J VIROL, V80, P6368, DOI 10.1128/JVI.00211-06; Delsite Robert, 2002, Mol Cancer, V1, P6, DOI 10.1186/1476-4598-1-6; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Epstein CB, 2001, MOL BIOL CELL, V12, P297, DOI 10.1091/mbc.12.2.297; Fukumori T, 1998, FEBS LETT, V432, P17, DOI 10.1016/S0014-5793(98)00824-2; Gao GX, 1999, MOL BIOL CELL, V10, P1705, DOI 10.1091/mbc.10.6.1705; Goto M, 2003, J MED VIROL, V70, P497, DOI 10.1002/jmv.10423; Han M, 2008, ARCH PHARM RES, V31, P749, DOI 10.1007/s12272-001-1222-5; Hendrickson SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012862; Hendrickson SL, 2010, JAIDS-J ACQ IMM DEF, V53, P451, DOI 10.1097/QAI.0b013e3181cb8319; Joseph AM, 2004, AM J PHYSIOL-CELL PH, V286, pC867, DOI 10.1152/ajpcell.00191.2003; KAMEOKA M, 1993, FEBS LETT, V331, P182, DOI 10.1016/0014-5793(93)80322-L; Kim S, 2007, J VIROL, V81, P1714, DOI 10.1128/JVI.01863-06; King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4; King M P, 1996, Methods Enzymol, V264, P313, DOI 10.1016/S0076-6879(96)64030-0; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Lama J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-52; LANDAU NR, 1992, J VIROL, V66, P5110, DOI 10.1128/JVI.66.8.5110-5113.1992; LEBLONDLAROUCHE L, 1979, J GEN VIROL, V44, P323, DOI 10.1099/0022-1317-44-2-323; Liu L, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-94; Luo TC, 1998, VIROLOGY, V241, P224, DOI 10.1006/viro.1997.8966; Magda D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-521; Matthews DA, 1998, J GEN VIROL, V79, P1677, DOI 10.1099/0022-1317-79-7-1677; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Mineri R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005713; Moraes CT, 2001, METHOD CELL BIOL, V65, P397, DOI 10.1016/S0091-679X(01)65023-4; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Rappaport L, 1998, MOL CELL BIOCHEM, V184, P101, DOI 10.1023/A:1006843113166; Reiser J, 1996, P NATL ACAD SCI USA, V93, P15266, DOI 10.1073/pnas.93.26.15266; Reiser J, 2000, GENE THER, V7, P910, DOI 10.1038/sj.gt.3301188; Rojo G, 1998, J VIROL, V72, P7583, DOI 10.1128/JVI.72.9.7583-7588.1998; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Spear M, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-45; Warren K, 2012, P NATL ACAD SCI USA, V109, P9587, DOI 10.1073/pnas.1204673109; Xu LJ, 2009, P NATL ACAD SCI USA, V106, P1530, DOI 10.1073/pnas.0811029106; Yao ZQ, 2001, J IMMUNOL, V167, P5264, DOI 10.4049/jimmunol.167.9.5264; Yeung ML, 2009, J BIOL CHEM, V284, P19463, DOI 10.1074/jbc.M109.010033; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; Zheng Y-H, 2012, RETROVIROLOGY, V9, P1, DOI [10.1186/1742-4690-9-S1-I1., DOI 10.1186/1742-4690-9-S1-I1.PUBMED:22214232]; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	56	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78035	10.1371/journal.pone.0078035	http://dx.doi.org/10.1371/journal.pone.0078035			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205077	Green Published, Green Submitted, gold			2022-12-27	WOS:000326032600062
J	Wang, YI; Bettaieb, A; Sun, CX; DeVerse, JS; Radecke, CE; Mathew, S; Edwards, CM; Haj, FG; Passerini, AG; Simon, SI				Wang, Ying I.; Bettaieb, Ahmed; Sun, Chongxiu; DeVerse, J. Sherrod; Radecke, Christopher E.; Mathew, Steven; Edwards, Christina M.; Haj, Fawaz G.; Passerini, Anthony G.; Simon, Scott I.			Triglyceride-Rich Lipoprotein Modulates Endothelial Vascular Cell Adhesion Molecule (VCAM)-1 Expression via Differential Regulation of Endoplasmic Reticulum Stress	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; INDUCED ER STRESS; HOMOLOGOUS PROTEIN; NECROSIS; INFLAMMATION; HOMEOSTASIS; PALMITATE; OBESITY; GENES	Circulating triglyceride-rich lipoproteins (TGRL) from hypertriglyceridemic subjects exacerbate endothelial inflammation and promote monocyte infiltration into the arterial wall. We have recently reported that TGRL isolated from human blood after a high-fat meal can elicit a pro- or anti-atherogenic state in human aortic endothelial cells (HAEC), defined as up- or down-regulation of VCAM-1 expression in response to tumor necrosis factor alpha (TNF alpha) stimulation, respectively. A direct correlation was found between subjects categorized at higher risk for cardiovascular disease based upon serum triglycerides and postprandial production of TGRL particles that increased VCAM-1-dependent monocyte adhesion to inflamed endothelium. To establish how TGRL metabolism is linked to VCAM-1 regulation, we examined endoplasmic reticulum (ER) stress and the unfolded protein response (UPR) pathways. Regardless of its atherogenicity, the rate and extent of TGRL internalization and lipid droplet formation by HAEC were uniform. However, pro-atherogenic TGRL exacerbated ER membrane expansion and stress following TNF alpha stimulation, whereas anti-atherogenic TGRL ameliorated such effects. Inhibition of ER stress with a chemical chaperone 4-phenylbutyric acid decreased TNF alpha-induced VCAM-1 expression and abrogated TGRL's atherogenic effect. Activation of ER stress sensors PKR-like ER-regulated kinase (PERK) and inositol requiring protein 1 alpha (IRE1 alpha), and downstream effectors including eukaryotic initiation factor-2 alpha (eIF2 alpha), spliced X-box-binding protein 1 (sXBP1) and C/EBP homologous protein (CHOP), directly correlated with the atherogenic activity of an individual's TGRL. Modulation of ER stress sensors also correlated with changes in expression of interferon regulatory factor 1 (IRF-1), a transcription factor of Vcam-1 responsible for regulation of its expression. Moreover, knockdown studies using siRNA defined a causal relationship between the PERK/eIF2 alpha/CHOP pathway and IRF-1-mediated VCAM-1 expression. We conclude that ER stress and the UPR contribute to the regulation of Vcam-1 transcription as a function of the atherogenic nature of TGRL.	[Wang, Ying I.; Sun, Chongxiu; DeVerse, J. Sherrod; Radecke, Christopher E.; Mathew, Steven; Edwards, Christina M.; Passerini, Anthony G.; Simon, Scott I.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Bettaieb, Ahmed; Haj, Fawaz G.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Haj, Fawaz G.] Univ Calif Davis, Dept Internal Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Simon, SI (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	sisimon@ucdavis.edu	Wang, Ying/AAW-4053-2021	Wang, Ying/0000-0003-0236-5962; Passerini, Anthony/0000-0001-8007-4672; , ChongXiu/0000-0001-8425-5024	National Institutes of Health [HL082689, R01DK090492]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090492] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants HL082689 to SIS and AGP, and R01DK090492 to FGH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Boden G, 2009, DIABETES, V58, P518, DOI 10.2337/db08-1746; Civelek M, 2009, CIRC RES, V105, P453, DOI 10.1161/CIRCRESAHA.109.203711; Deguil J, 2011, TRAFFIC, V12, P349, DOI 10.1111/j.1600-0854.2010.01150.x; Diakogiannaki E, 2008, J ENDOCRINOL, V197, P553, DOI 10.1677/JOE-08-0041; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Gao JH, 2011, CIRCULATION, V124, P830, DOI 10.1161/CIRCULATIONAHA.110.014050; Gargalovic PS, 2006, ARTERIOSCL THROM VAS, V26, P2490, DOI 10.1161/01.ATV.0000242903.41158.a1; Gower RM, 2011, ARTERIOSCL THROM VAS, V31, P160, DOI 10.1161/ATVBAHA.110.215434; Guo Y, 2009, J CELL SCI, V122, P749, DOI 10.1242/jcs.037630; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hummasti S, 2010, ENDOPLASMIC RETICULU; Kannel WB, 2009, CURR OPIN CARDIOL, V24, P345, DOI 10.1097/HCO.0b013e32832c1284; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Namba T, 2009, AM J PATHOL, V174, P1786, DOI 10.2353/ajpath.2009.080864; Norata GD, 2007, ATHEROSCLEROSIS, V193, P321, DOI 10.1016/j.atherosclerosis.2006.09.015; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Peng G, 2011, ENDOCRINOLOGY, V152, P2206, DOI 10.1210/en.2010-1369; Pineau L, 2009, TRAFFIC, V10, P673, DOI 10.1111/j.1600-0854.2009.00903.x; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; RUS HG, 1991, ATHEROSCLEROSIS, V89, P247; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Sha HB, 2009, CELL METAB, V9, P556, DOI 10.1016/j.cmet.2009.04.009; SUN CT, 2012, FRACTURE MECHANICS, P1, DOI DOI 10.1161/CIRCRESAHA.112.270314; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Ting HJ, 2007, CIRC RES, V100, P381, DOI 10.1161/01.RES.0000258023.76515.a3; Wang YI, 2011, AM J PHYSIOL-HEART C, V300, pH784, DOI 10.1152/ajpheart.01036.2010; Xu GS, 2012, BLOOD, V119, P4205, DOI 10.1182/blood-2011-05-353300; Zhou J, 2005, CIRCULATION, V111, P1814, DOI 10.1161/01.CIR.0000160864.31351.C1	39	22	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78322	10.1371/journal.pone.0078322	http://dx.doi.org/10.1371/journal.pone.0078322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205197	gold, Green Submitted, Green Published			2022-12-27	WOS:000326032600093
J	Zhang, GH; Zhang, YQ; Chen, ZG				Zhang, Guanghua; Zhang, Yuqing; Chen, Zhenguo			Using Trust to Secure Geographic and Energy Aware Routing against Multiple Attacks	PLOS ONE			English	Article							SENSOR; PROTOCOLS	To address the vulnerability of geographic routing to multiple security threats such as false routing information, selective forwarding and the Sybil attack in wireless sensor networks, this paper proposes a trust-based defending model against above-mentioned multiple attacks. Considering the characteristics of resource-constrained sensor nodes, trust values of neighboring nodes on the routing path can be calculated through the Dirichlet distribution function, which is based on data packets' acknowledgements in a certain period instead of energy-consuming monitoring. Trust is combined with the cost of geographic and energy aware routing for selecting the next hop of routing. At the same time, the initial trust is dynamically determined, service requests are restricted for malicious nodes in accordance with trust values, and the impact of node mobility is weakened by the trust evolution. The simulation results and analysis show that the proposed model under multiple attacks has advantages in packet delivery ratio and network lifetime over the existing models.	[Zhang, Guanghua; Zhang, Yuqing] Xidian Univ, Minist Educ, Key Lab Comp Networks & Informat Secur, Xian, Shaanxi, Peoples R China; [Zhang, Guanghua] Hebei Univ Sci & Technol, Coll Informat Sci & Engn, Shijiazhuang, Hebei, Peoples R China; [Zhang, Yuqing] Natl Comp Network Intrus Protect Ctr, Beijing, Peoples R China; [Chen, Zhenguo] Northeastern Univ, Sch Informat Sci & Engn, Shenyang, Liaoning, Peoples R China; [Chen, Zhenguo] North China Inst Sci & Technol, Dept Comp Sci & Technol, Beijing, Peoples R China	Xidian University; Hebei University of Science & Technology; Northeastern University - China; North China Institute Science & Technology	Zhang, YQ (corresponding author), Xidian Univ, Minist Educ, Key Lab Comp Networks & Informat Secur, Xian, Shaanxi, Peoples R China.	zhangyq@nipc.org.cn; czhenguo@gmail.com	Chen, Zhi-Gang/D-1558-2010	Chen, Zhi-Gang/0000-0002-9309-7993	National Natural Science Foundation of China [61163050, 61272481, 61300120, 61301091]; Natural Science Foundation of Hebei Province of China [F2012208016]; Fundamental Research Funds for the Central Universities [3142013098, 3142013070]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei Province of China(Natural Science Foundation of Hebei Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The work was supported by the National Natural Science Foundation of China (61163050, 61272481, 61300120, 61301091), the Natural Science Foundation of Hebei Province of China (F2012208016), and Fundamental Research Funds for the Central Universities (3142013098, 3142013070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyildiz IF, 2002, IEEE COMMUN MAG, V40, P102, DOI 10.1109/MCOM.2002.1024422; Chen SS, 2010 INT C COMM MOB, P142; Cheng WF, 2006, LECT NOTES COMPUT SC, V4138, P478; Ganeriwal S, 2008, ACM T SENSOR NETWORK, V4, DOI 10.1145/1362542.1362546; Heinzelman WR., 2000, PROC 33 ANN HAWAII I, V1, P10, DOI [10.1109/HICSS.2000.926982, DOI 10.1109/HICSS.2000.926982]; Intanagonwiwat C, 2003, IEEE ACM T NETWORK, V11, P2, DOI 10.1109/TNET.2002.808417; Josang A, 2007, 15 BLED EL COMM C, P324; Josang A, 2007, ARES 2007: SECOND INTERNATIONAL CONFERENCE ON AVAILABILITY, RELIABILITY AND SECURITY, PROCEEDINGS, P112; Karlof C., 2003, AD HOC NETW, V1, P293, DOI DOI 10.1016/S1570-8705(03)00008-8; Kulik J, 2002, WIREL NETW, V8, P169, DOI 10.1023/A:1013715909417; Kulkarni RV, 2011, IEEE COMMUN SURV TUT, V13, P68, DOI 10.1109/SURV.2011.040310.00002; LAMPORT L, 1982, ACM T PROGR LANG SYS, V4, P382, DOI 10.1145/357172.357176; Maarouf I, 2009, IET COMMUN, V3, P846, DOI 10.1049/iet-com.2008.0324; Maarouf I, 2009, EURASIP J WIREL COMM, V1, P1; Nasser N, 2007, COMPUT COMMUN, V30, P2401, DOI 10.1016/j.comcom.2007.04.014; Ozdemir S, 2008, COMPUT COMMUN, V31, P3941, DOI 10.1016/j.comcom.2008.07.017; Perrig A, 2002, WIREL NETW, V8, P521, DOI 10.1023/A:1016598314198; Saaty TL., 1980, ANAL HIERARCHY PROCE; Satsiou A, 2010, IEEE T PARALL DISTR, V21, P466, DOI 10.1109/TPDS.2009.80; Varga A., 2008, P 1 INT C SIM TOOLS, P1, DOI DOI 10.1109/ITSC.2002.1041322; Wang WC, 2010, I C DEPEND SYS NETWO, P21, DOI 10.1109/DSN.2010.5545011; Wenjia Li, 2010, Proceedings 11th International Conference on Mobile Data Management (MDM 2010), P85, DOI 10.1109/MDM.2010.57; Yu Y., 2001, UCLACSDTR010023; Zahariadis T., 2010, Proceedings of the Third International Conference on Developments in eSystems Engineering (DESE 2010), P47, DOI 10.1109/DeSE.2010.15; Zhan GX, 2010, LECT NOTES COMPUT SC, V5970, P65, DOI 10.1007/978-3-642-11917-0_5	25	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77488	10.1371/journal.pone.0077488	http://dx.doi.org/10.1371/journal.pone.0077488			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204842	Green Submitted, Green Published, gold			2022-12-27	WOS:000326032600034
J	Chauhan, P; Reddy, PV; Singh, R; Jaisinghani, N; Gandotra, S; Tyagi, AK				Chauhan, Priyanka; Reddy, P. Vineel; Singh, Ramandeep; Jaisinghani, Neetika; Gandotra, Sheetal; Tyagi, Anil K.			Secretory Phosphatases Deficient Mutant of Mycobacterium tuberculosis Imparts Protection at the Primary Site of Infection in Guinea Pigs	PLOS ONE			English	Article							DELTA-RD1 DELTA-PANCD; ENHANCED PROTECTION; VACCINES; BCG; MODEL; MICE; DISRUPTION; IMMUNITY; GROWTH; IMMUNOCOMPETENT	Background: The failure of Mycobacterium bovis Bacille Calmette-Guerin to impart satisfactory protection against adult pulmonary tuberculosis has necessitated the development of more effective TB vaccines. The assumption that the vaccine strain should be antigenically as similar as possible to the disease causing pathogen has led to the evaluation of M. tuberculosis mutants as candidate tuberculosis vaccines. Methods/Principal Findings: In this study, we have generated a mutant of M. tuberculosis (Mtb Delta mms) by disrupting 3 virulence genes encoding a mycobacterial secretory acid phosphatase (sapM) and two phosphotyrosine protein phosphatases (mptpA and mptpB) and have evaluated its protective efficacy in guinea pigs. We observed that Mtb Delta mms was highly attenuated in THP-1 macrophages. Moreover, no bacilli were recovered from the lungs and spleens of guinea pigs after 10 weeks of Mtb Delta mms inoculation, although, initially, the mutant exhibited some growth in the spleens. Subsequently, when Mtb Delta mms was evaluated for its protective efficacy, we observed that similar to BCG vaccination, Mtb Delta mms exhibited a significantly reduced CFU in the lungs of guinea pigs when compared with the unvaccinated animals at 4 weeks after challenge. In addition, our observations at 12 weeks post challenge demonstrated that Mtb Delta mms exhibited a more sustainable and superior protection in lungs as compared to BCG. However, the mutant failed to control the hematogenous spread as the splenic bacillary load between Mtb Delta mms vaccinated and sham immunized animals was not significantly different. The gross pathological observations and histopathological observations corroborated the bacterial findings. Inspite of disruption of phosphatase genes in Mtb Delta mms, the lipid profiles of M. tuberculosis and Mtb Delta mms were identical indicating thereby that the phenotype of the mutant was ascribed to the loss of phosphatase genes and the influence was not related to any alteration in the lipid composition. Conclusions/Significance: This study highlights the importance of M. tuberculosis mutants in imparting protection against pulmonary TB.	[Chauhan, Priyanka; Reddy, P. Vineel; Singh, Ramandeep; Tyagi, Anil K.] Univ Delhi, Dept Biochem, New Delhi, India; [Jaisinghani, Neetika; Gandotra, Sheetal] CSIR Inst Genom & Integrat Biol, New Delhi, India	University of Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Tyagi, AK (corresponding author), Univ Delhi, Dept Biochem, South Campus, New Delhi, India.	aniltyagi@south.du.ac.in		Jaisinghani, Neetika/0000-0002-5469-594X; Singh, Ramandeep/0000-0003-2705-3826	Department of Biotechnology, Government of India, India; Council of Scientific and Industrial Research, Government of India	Department of Biotechnology, Government of India, India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a research grant from the Department of Biotechnology, Government of India, India. Council of Scientific and Industrial Research, Government of India is acknowledged for Junior/Senior research fellowships to PC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach H, 2008, CELL HOST MICROBE, V3, P316, DOI 10.1016/j.chom.2008.03.008; Baldwin SL, 1998, INFECT IMMUN, V66, P2951, DOI 10.1128/IAI.66.6.2951-2959.1998; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Beresford NJ, 2009, J ANTIMICROB CHEMOTH, V63, P928, DOI 10.1093/jac/dkp031; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; Brodin P, 2004, J INFECT DIS, V190, P115, DOI 10.1086/421468; Brosch R, 2007, P NATL ACAD SCI USA, V104, P5596, DOI 10.1073/pnas.0700869104; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Chambers MA, 2002, INFECT IMMUN, V70, P2159, DOI 10.1128/IAI.70.4.2159-2165.2002; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Copenhaver RH, 2004, INFECT IMMUN, V72, P7084, DOI 10.1128/IAI.72.12.7084-7095.2004; Festjens N, 2011, EMBO MOL MED, V3, P222, DOI 10.1002/emmm.201000125; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Giovannini D, 2012, MICROB PATHOGENESIS, V53, P135, DOI 10.1016/j.micpath.2012.06.002; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; Hou S, 2009, NUCLEOS NUCLEOT NUCL, V28, P725, DOI 10.1080/15257770903155493; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Jain R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003869; Kai M, 2007, FEBS LETT, V581, P3345, DOI 10.1016/j.febslet.2007.06.029; Kamath AT, 2005, VACCINE, V23, P3753, DOI 10.1016/j.vaccine.2005.03.001; Koul A, 2000, J BACTERIOL, V182, P5425, DOI 10.1128/JB.182.19.5425-5432.2000; Martin C, 2006, VACCINE, V24, P3408, DOI 10.1016/j.vaccine.2006.03.017; McMurray David N., 1994, P135; McMurray DN, 2001, TRENDS MOL MED, V7, P135, DOI 10.1016/S1471-4914(00)01901-8; McShane H, 2011, PHILOS T R SOC B, V366, P2782, DOI 10.1098/rstb.2011.0097; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Pando RH, 2006, TUBERCULOSIS, V86, P203, DOI 10.1016/j.tube.2006.01.022; Puri RV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070514; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Reddy PV, 2013, J INFECT DIS, V208, P1255, DOI 10.1093/infdis/jit250; Reddy PV, 2012, J BACTERIOL, V194, P567, DOI 10.1128/JB.05553-11; Saikolappan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036198; Saleh MT, 2000, J BACTERIOL, V182, P6850, DOI 10.1128/JB.182.23.6850-6853.2000; Sambandamurthy VK, 2006, VACCINE, V24, P6309, DOI 10.1016/j.vaccine.2006.05.097; Sambandamurthy VK, 2005, MICROBES INFECT, V7, P955, DOI 10.1016/j.micinf.2005.04.001; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; Shimono N, 2003, P NATL ACAD SCI USA, V100, P15918, DOI 10.1073/pnas.2433882100; Singh R, 2003, MOL MICROBIOL, V50, P751, DOI 10.1046/j.1365-2958.2003.03712.x; Slayden R A, 2001, Methods Mol Med, V54, P229, DOI 10.1385/1-59259-147-7:229; Tufariello JM, 2004, INFECT IMMUN, V72, P515, DOI 10.1128/IAI.72.1.515-526.2004; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Vilcheze C, 2007, CURR PROTOC MICROBIO, V10A; Walker K B, 2010, Vaccine, V28, P2259, DOI 10.1016/j.vaccine.2009.12.083; Waters WR, 2007, VACCINE, V25, P7832, DOI 10.1016/j.vaccine.2007.08.029; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wong D, 2013, TRENDS MICROBIOL, V21, P100, DOI 10.1016/j.tim.2012.09.002; Wong D, 2011, P NATL ACAD SCI USA, V108, P19371, DOI 10.1073/pnas.1109201108; Zhou B, 2010, P NATL ACAD SCI USA, V107, P4573, DOI 10.1073/pnas.0909133107	50	25	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77930	10.1371/journal.pone.0077930	http://dx.doi.org/10.1371/journal.pone.0077930			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205032	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300125
J	Egecioglu, E; Engel, JA; Jerlhag, E				Egecioglu, Emil; Engel, Jorgen A.; Jerlhag, Elisabet			The Glucagon-Like Peptide 1 Analogue Exendin-4 Attenuates the Nicotine-Induced Locomotor Stimulation, Accumbal Dopamine Release, Conditioned Place Preference as well as the Expression of Locomotor Sensitization in Mice	PLOS ONE			English	Article							GLP-1 RECEPTOR; NUCLEUS-ACCUMBENS; FOOD-INTAKE; RAT; ETHANOL; BRAIN; AMIDE; AMPHETAMINE; ANTAGONIST; DECREASES	The gastrointestinal peptide glucagon-like peptide 1 (GLP-1) is known to regulate consummatory behavior and is released in response to nutrient ingestion. Analogues of this peptide recently emerged as novel pharmacotherapies for treatment of type II diabetes since they reduce gastric emptying, glucagon secretion as well as enhance glucose-dependent insulin secretion. The findings that GLP-1 targets reward related areas including mesolimbic dopamine areas indicate that the physiological role of GLP-1 extends beyond food intake and glucose homeostasis control to include reward regulation. The present series of experiments was therefore designed to investigate the effects of the GLP-1 receptor agonist, Exendin-4 (Ex4), on established nicotine-induced effects on the mesolimbic dopamine system in mice. Specifically, we show that treatment with Ex4, at a dose with no effect per se, attenuate nicotine-induced locomotor stimulation, accumbal dopamine release as well as the expression of conditioned place preference in mice. In accordance, Ex4 also blocks nicotine-induced expression of locomotor sensitization in mice. Given that development of nicotine addiction largely depends on the effects of nicotine on the mesolimbic dopamine system these findings indicate that the GLP-1 receptor may be a potential target for the development of novel treatment strategies for nicotine cessations in humans.	[Egecioglu, Emil; Engel, Jorgen A.; Jerlhag, Elisabet] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Pharmacol, Gothenburg, Sweden	University of Gothenburg	Engel, JA (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Pharmacol, Gothenburg, Sweden.	jorgen.engel@pharm.gu.se			Swedish Research Council [K2006-21X-04247-33-3, 2009-2782, K2010-80X-21496-01-6]; Swedish brain foundation, LUA/ALF from the Sahlgrenska University Hospital, Alcohol research council of the Swedish alcohol retailing monopoly [148251]; foundation of Adlerbertska; foundation of Fredrik; foundation of Ingrid Thuring; Tore Nilsson; Langmanska; Torsten; Ragnar Soderberg; Wilhelm and Martina Lundgren; NovoNordisk; Knut and Alice Wallenberg; Magnus Bergvall; Aners; Jeansons; Ake Wiberg; Swedish Society of Medicine; Swedish Society for Medical Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish brain foundation, LUA/ALF from the Sahlgrenska University Hospital, Alcohol research council of the Swedish alcohol retailing monopoly; foundation of Adlerbertska; foundation of Fredrik; foundation of Ingrid Thuring; Tore Nilsson; Langmanska; Torsten; Ragnar Soderberg; Wilhelm and Martina Lundgren; NovoNordisk(Novo Nordisk); Knut and Alice Wallenberg(Knut & Alice Wallenberg Foundation); Magnus Bergvall; Aners; Jeansons; Ake Wiberg; Swedish Society of Medicine; Swedish Society for Medical Research	The research was supported by grants from the Swedish Research Council (grant no. K2006-21X-04247-33-3, 2009-2782 and K2010-80X-21496-01-6), The Swedish brain foundation, LUA/ALF (grant no. 148251) from the Sahlgrenska University Hospital, Alcohol research council of the Swedish alcohol retailing monopoly and the foundations of Adlerbertska, Fredrik and Ingrid Thuring, Tore Nilsson, Langmanska, Torsten and Ragnar Soderberg, Wilhelm and Martina Lundgren, NovoNordisk, Knut and Alice Wallenberg, Magnus Bergvall, Aners, Jeansons, Ake Wiberg, the Swedish Society of Medicine, Swedish Society for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhadeff AL, 2012, ENDOCRINOLOGY, V153, P647, DOI 10.1210/en.2011-1443; Alvarez E, 1996, J NEUROCHEM, V66, P920; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Barrera JG, 2009, DIABETES, V58, P2820, DOI 10.2337/db09-0281; Brubaker PL, 2003, CAN J PHYSIOL PHARM, V81, P1005, DOI 10.1139/Y03-107; Cagniard B, 2013, BEHAV BRAIN RES, V236, P289, DOI 10.1016/j.bbr.2012.08.021; Clifford PS, 2012, ADDICT BIOL, V17, P956, DOI 10.1111/j.1369-1600.2011.00339.x; Dickson SL, 2012, J NEUROSCI, V32, P4812, DOI 10.1523/JNEUROSCI.6326-11.2012; Dossat AM, 2011, J NEUROSCI, V31, P14453, DOI 10.1523/JNEUROSCI.3262-11.2011; Duaso Maria, 2012, Br J Community Nurs, V17, P356; Egecioglu E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069010; Egecioglu E, 2013, PSYCHONEUROENDOCRINO, V38, P1259, DOI 10.1016/j.psyneuen.2012.11.009; ENGEL JA, 1988, J NEURAL TRANSM, V74, P181, DOI 10.1007/BF01244784; Erreger K, 2012, PHYSIOL BEHAV, V106, P574, DOI 10.1016/j.physbeh.2012.03.014; Franklin K. B. J., 1996, MOUSE BRAIN STEREOTA; GOKE R, 1995, EUR J NEUROSCI, V7, P2294, DOI 10.1111/j.1460-9568.1995.tb00650.x; Graham DL, 2013, MOL PSYCHIATR, V18, P961, DOI 10.1038/mp.2012.141; GUTNIAK M, 1992, NEW ENGL J MED, V326, P1316, DOI 10.1056/NEJM199205143262003; Hayes MR, 2009, ENDOCRINOLOGY, V150, P2654, DOI 10.1210/en.2008-1479; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Holst JJ, 2009, MOL CELL ENDOCRINOL, V297, P127, DOI 10.1016/j.mce.2008.08.012; Jerlhag E, 2008, ADDICT BIOL, V13, P358, DOI 10.1111/j.1369-1600.2008.00125.x; Jerlhag E, 2006, ADDICT BIOL, V11, P45, DOI 10.1111/j.1369-1600.2006.00002.x; Jerlhag E, 2011, DRUG ALCOHOL DEPEN, V117, P126, DOI 10.1016/j.drugalcdep.2011.01.010; Kanoski SE, 2012, NEUROPHARMACOLOGY, V62, P1916, DOI 10.1016/j.neuropharm.2011.12.022; Kastin AJ, 2003, INT J OBESITY, V27, P313, DOI 10.1038/sj.ijo.0802206; KREYMANN B, 1987, LANCET, V2, P1300; Larsson A, 2004, NEUROSCI BIOBEHAV R, V27, P713, DOI 10.1016/j.neubiorev.2003.11.010; Malendowicz LK, 2003, INT J MOL MED, V12, P237; MATSUYAMA T, 1988, DIABETES RES CLIN PR, V5, P281, DOI 10.1016/S0168-8227(88)80063-9; McMahon LR, 1998, AM J PHYSIOL-REG I, V274, pR23, DOI 10.1152/ajpregu.1998.274.1.R23; Merchenthaler I, 1999, J COMP NEUROL, V403, P261, DOI 10.1002/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5; Morganstern Irene, 2011, Curr Drug Abuse Rev, V4, P163; Neugebauer NM, 2011, PHARMACOL BIOCHEM BE, V98, P87, DOI 10.1016/j.pbb.2010.12.015; NOVAK U, 1987, EUR J BIOCHEM, V164, P553, DOI 10.1111/j.1432-1033.1987.tb11162.x; Rasmussen K, 1996, NEUROREPORT, V7, P1050, DOI 10.1097/00001756-199604100-00019; Rinaman L, 2010, BRAIN RES, V1350, P18, DOI 10.1016/j.brainres.2010.03.059; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Ruttimann EB, 2009, ENDOCRINOLOGY, V150, P1174, DOI 10.1210/en.2008-1221; Sanchis-Segura C, 2006, ADDICT BIOL, V11, P2, DOI 10.1111/j.1369-1600.2006.00012.x; Sandoval DA, 2008, DIABETES, V57, P2046, DOI 10.2337/db07-1824; Schirra J, 1997, P ASSOC AM PHYSICIAN, V109, P84; SEGAL DS, 1974, PHARMACOL BIOCHEM BE, V2, P249, DOI 10.1016/0091-3057(74)90060-4; Shirazi R. H., 2013, PLOS ONE, V8, DOI [10.1371/joumal.pone.0061965, DOI 10.1371/JOUMAL.PONE.0061965]; Sonne DP, 2008, REGUL PEPTIDES, V146, P243, DOI 10.1016/j.regpep.2007.10.001; TangChristensen M, 1996, AM J PHYSIOL-REG I, V271, pR848, DOI 10.1152/ajpregu.1996.271.4.R848; THORENS B, 1993, DIABETES, V42, P1678, DOI 10.2337/diabetes.42.11.1678; Tupala E, 2004, PROG NEURO-PSYCHOPH, V28, P1221, DOI 10.1016/j.pnpbp.2004.06.022; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; Volkow ND, 2004, NAT REV NEUROSCI, V5, P963, DOI 10.1038/nrn1539; von der Goltz C, 2010, PSYCHONEUROENDOCRINO, V35, P570, DOI 10.1016/j.psyneuen.2009.09.005	51	68	70	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77284	10.1371/journal.pone.0077284	http://dx.doi.org/10.1371/journal.pone.0077284			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204788	Green Published, Green Submitted, gold			2022-12-27	WOS:000326029300094
J	Abramova, A; Sakaguchi, S; Schebesta, A; Hassan, H; Boucheron, N; Valent, P; Roers, A; Ellmeier, W				Abramova, Anastasia; Sakaguchi, Shinya; Schebesta, Alexandra; Hassan, Hammad; Boucheron, Nicole; Valent, Peter; Roers, Axel; Ellmeier, Wilfried			The Transcription Factor MAZR Preferentially Acts as a Transcriptional Repressor in Mast Cells and Plays a Minor Role in the Regulation of Effector Functions in Response to Fc epsilon RI Stimulation	PLOS ONE			English	Article							FINGER PROTEIN MAZR; LARGE GENE LISTS; TYROSINE KINASE; PATZ1 GENE; AT-HOOK; MITF; EXPRESSION; PHENOTYPE; FATE; MICE	Mast cells are key players in type I hypersensitivity reactions in humans and mice and their activity has to be tightly controlled. Previous studies implicated the transcription factor MAZR in the regulation of mast cell function. To study the role of MAZR in mast cells, we generated a conditional Mazr allele and crossed Mazr(F/F) mice with the Vav-iCre deleter strain, which is active in all hematopoietic cells. MAZR-null BM-derived mast cells (BMMC) were phenotypically indistinguishable from wild-type BMMCs, although the numbers of IL-3 generated Mazr(F/F)Vav-iCre BMMCs were reduced in comparison to Mazr(F/F) BMMCs, showing that MAZR is required for the efficient generation of BMMC in vitro. A gene expression analysis revealed that MAZR-deficiency resulted in the dysregulation of 128 genes, with more genes up-than down-regulated in the absence of MAZR, indicating that MAZR acts as a transcriptional repressor in mast cells. Among the up-regulated genes were the chemokines Ccl5, Cxcl10, Cxcl12, the chemokine receptor Ccr5 and the cytokine IL18, suggesting an immunoregulatory role for MAZR in mast cells. Enforced expression of MAZR in mature Mazr-deficient BMMCs rescued the altered expression pattern of some genes tested, suggesting direct regulation of these genes by MAZR. Upon Fc epsilon RI stimulation, Mazr expression was transiently down-regulated in BMMCs. However, early and late effector functions in response to Fc epsilon RI-mediated stimulation were not impaired in the absence of MAZR, with the exception of IL-6, which was slightly decreased. Taken together, out data indicate that MAZR preferentially acts as a transcriptional repressor in mast cells, however MAZR plays only a minor role in the transcriptional networks that regulate early and late effector functions in mast cells in response to Fc epsilon RI stimulation.	[Abramova, Anastasia; Sakaguchi, Shinya; Schebesta, Alexandra; Hassan, Hammad; Boucheron, Nicole; Ellmeier, Wilfried] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Div Immunobiol, Inst Immunol, Vienna, Austria; [Valent, Peter] Med Univ Vienna, Dept Internal Med 1, Div Hematol & Hemostaseol, Vienna, Austria; [Roers, Axel] Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Immunol, Dresden, Germany	Medical University of Vienna; Medical University of Vienna; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Ellmeier, W (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Div Immunobiol, Inst Immunol, Vienna, Austria.	wilfried.ellmeier@meduniwien.ac.at	Test, Test/Y-7921-2019; Hassan, Hammad/J-2125-2012; Valent, Peter/B-8533-2016; Gamperl, Susi/V-2715-2019; Test, PV/U-9451-2019	Valent, Peter/0000-0003-0456-5095; Gamperl, Susi/0000-0003-0456-5095; Boucheron, Nicole/0000-0002-4979-8311; Sakaguchi, Shinya/0000-0002-0591-2469; Ellmeier, Wilfried/0000-0001-8192-8481	Austrian Science Fund/Medical University of Vienna doctoral program [DK W1212]; Austrian Science Fund [P19930, P23641, I00698]; EU Marie Curie RTN Chromatin Plasticity; Vienna Science and Technology Fund (WWTF) [LS09-031]; FWF [P24265, P23669]; Austrian Science Fund (FWF) [P 23669, P 23641] Funding Source: researchfish	Austrian Science Fund/Medical University of Vienna doctoral program; Austrian Science Fund(Austrian Science Fund (FWF)); EU Marie Curie RTN Chromatin Plasticity; Vienna Science and Technology Fund (WWTF); FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work in the laboratory of W. E. was supported by the Austrian Science Fund/Medical University of Vienna doctoral program (DK W1212) "Inflammation and Immunity", by the Austrian Science Fund (P19930, P23641, I00698), by the EU Marie Curie RTN Chromatin Plasticity and by the Vienna Science and Technology Fund (WWTF; project LS09-031). N.B. and S. S. are funded by the FWF (P24265 and P23669, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilic I, 2006, NAT IMMUNOL, V7, P392, DOI 10.1038/ni1311; Bilic I, 2007, IMMUNOL LETT, V108, P1, DOI 10.1016/j.imlet.2006.09.007; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; Carmi I, 2007, IMMUNOL REV, V217, P280, DOI 10.1111/j.1600-065X.2007.00508.x; Cho JH, 2012, CELL DEATH DIFFER, V19, P703, DOI 10.1038/cdd.2011.142; Dawicki W, 2007, CURR OPIN IMMUNOL, V19, P31, DOI 10.1016/j.coi.2006.11.006; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Fedele M, 2008, J PATHOL, V215, P39, DOI 10.1002/path.2323; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Gurish MF, 2012, IMMUNITY, V37, P25, DOI 10.1016/j.immuni.2012.07.003; Hata D, 1998, J EXP MED, V187, P1235, DOI 10.1084/jem.187.8.1235; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kitamura Y, 2002, MOL IMMUNOL, V38, P1173, DOI 10.1016/S0161-5890(02)00058-5; Kitamura Y, 2002, INT ARCH ALLERGY IMM, V127, P106, DOI 10.1159/000048178; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; Levy C, 2002, J BIOL CHEM, V277, P1962, DOI 10.1074/jbc.M109236200; Morii E, 2002, J BIOL CHEM, V277, P8566, DOI 10.1074/jbc.M110392200; Pero R, 2012, J BIOL CHEM, V287, P18308, DOI 10.1074/jbc.M112.346270; Razin E, 1999, J BIOL CHEM, V274, P34272, DOI 10.1074/jbc.274.48.34272; Rodewald HR, 2012, IMMUNITY, V37, P13, DOI 10.1016/j.immuni.2012.07.007; Rozen S, 2000, Methods Mol Biol, V132, P365; Sakaguchi S, 2010, NAT IMMUNOL, V11, P442, DOI 10.1038/ni.1860; Schmidt U, 2009, EUR J IMMUNOL, V39, P3228, DOI 10.1002/eji.200838839; Scholten J, 2008, TRANSGENIC RES, V17, P307, DOI 10.1007/s11248-007-9153-4; Shahlaee AH, 2007, J IMMUNOL, V178, P378, DOI 10.4049/jimmunol.178.1.378; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tshori S, 2012, BBA-MOL BASIS DIS, V1822, P42, DOI 10.1016/j.bbadis.2010.12.024; Valentino T, 2013, J CELL PHYSIOL, V228, P646, DOI 10.1002/jcp.24174	29	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77677	10.1371/journal.pone.0077677	http://dx.doi.org/10.1371/journal.pone.0077677			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24204913	Green Submitted, Green Published, gold			2022-12-27	WOS:000326022200063
J	Liu, N; Zhou, LH; Hauger, JS				Liu, Ning; Zhou, Lihua; Hauger, J. Scott			How Sustainable Is Government-Sponsored Desertification Rehabilitation in China? Behavior of Households to Changes in Environmental Policies	PLOS ONE			English	Article							LAND CONVERSION PROGRAM; WILLINGNESS-TO-PAY; CHOICE; DESIGN; MODELS	This paper undertakes a direct, comprehensive assessment of the long-term sustainability of desertification rehabilitation in China under a plausible but worst case scenario where governmental interventions, in the form of payments for environmental services (PES), will cease. The analysis is based on household behavior as well as experimental data. Our econometric results highlight the main obstacles to the sustainability of rehabilitation programs subsequent to cessation of government intervention, including specific shortfalls in households' preference for a free ride, budget constraints, attitudes, tolerance of and responsibility for desertification, and dissatisfaction with governmental actions. We conclude that desertification rehabilitation is not sustainable in China without continued governmental intervention. The results of this study are intended to support policy makers as they consider future directions for rehabilitation sustainability.	[Liu, Ning; Zhou, Lihua] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Peoples R China; [Hauger, J. Scott] Asia Pacific Ctr Secur Studies, Honolulu, HI USA; [Liu, Ning] China Dev Bank Qinghai Branch, Xining, Peoples R China	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS	Zhou, LH (corresponding author), Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Peoples R China.	lhzhou@lzb.ac.cn	Zhou, Li/GSE-4531-2022		100 Talents Program of the Chinese Academy of Sciences; National Natural Science Foundation of China [40971278]; "Western Light" Project of the Chinese Academy of Sciences	100 Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Western Light" Project of the Chinese Academy of Sciences	This paper was financially supported by the 100 Talents Program of the Chinese Academy of Sciences, the National Natural Science Foundation of China (40971278), and the 2010 "Western Light" Project of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelgalil E, 2007, SOC EC PLANN SCI, V41, P107, DOI [10.1016/j.seps.2005.10.002, DOI 10.1016/J.SEPS.2005.10.002]; ADAMOWICZ W, 1994, J ENVIRON ECON MANAG, V26, P271, DOI 10.1006/jeem.1994.1017; Adamowicz W, 1997, J ENVIRON ECON MANAG, V32, P65, DOI 10.1006/jeem.1996.0957; [Anonymous], 1980, INTRO CHINESE DESERT; Bennett MT, 2008, ECOL ECON, V65, P699, DOI 10.1016/j.ecolecon.2007.09.017; Bureau of Statistics of Yanchi County, 2010, YNACH YB; Carlsson F, 2001, J ENVIRON ECON MANAG, V41, P179, DOI 10.1006/jeem.2000.1138; Chen G., 1996, EXPLORATION NATURE, V15, P1; Cheng Y., 2010, SOIL WATER CONSERVAT, V31, P34; Christie M, 2001, J ENVIRON MANAGE, V62, P255, DOI 10.1006/jema.2001.0439; Freeman III A, 1993, MEASUREMENT ENV RESO, P75; GUO HC, 1989, J APPL ECOL, V26, P787, DOI 10.2307/2403690; HANEMANN WM, 1991, AM ECON REV, V81, P635; Horowitz JK, 2003, J ECON BEHAV ORGAN, V51, P537, DOI 10.1016/S0167-2681(02)00216-0; Horowitz JK, 2002, J ENVIRON ECON MANAG, V44, P426, DOI 10.1006/jeem.2001.1215; Jia K. L., 2009, J DESERT RES, V29, P223; KNETSCH JL, 1990, J ENVIRON ECON MANAG, V18, P227, DOI 10.1016/0095-0696(90)90003-H; Kolstad CD, 1999, J ENVIRON ECON MANAG, V38, P66, DOI 10.1006/jeem.1999.1070; Li A, 2008, J DESERT RES, V28, P8; Li J, 2011, P NATL ACAD SCI USA, V108, P7721, DOI 10.1073/pnas.1101018108; [刘满仓 Liu Mancang], 2002, [草业科学, Pratacultural Science], V19, P5; Liu S, 1988, J DESERT RES, V8, P1; LOUVIERE JJ, 1983, J MARKETING RES, V20, P350, DOI 10.2307/3151440; LOUVIERE JJ, 1983, J CONSUM RES, V10, P348, DOI 10.1086/208974; [马永欢 MA Yonghuan], 2006, [中国软科学, China Soft Science], P53; Millennium-Ecosystem-Assessment, 2005, EC HUM WELL BEING DE; Ministry of Agriculture China, 2010, GREAT EFF HAS MAD GR; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; Rubio JL, 1998, J ARID ENVIRON, V39, P113, DOI 10.1006/jare.1998.0402; Sayman S, 2005, J ECON PSYCHOL, V26, P289, DOI 10.1016/j.joep.2004.07.002; State Forestry Administration of China (SFAC), 2005, REP DES CHIN; Su YZ, 2010, J ENVIRON MANAGE, V91, P2109, DOI 10.1016/j.jenvman.2009.12.014; TVERSKY A, 1991, Q J ECON, V106, P1039, DOI 10.2307/2937956; [王涛 Wang Tao], 2003, [中国沙漠, Journal of Desert Research], V23, P230; [王涛 WANG Tao], 2006, [中国沙漠, Journal of Desert Research], V26, P507; [王涛 Wang Tao], 2004, [中国沙漠, Journal of Desert Research], V24, P519; Wang XM, 2008, EARTH-SCI REV, V88, P188, DOI 10.1016/j.earscirev.2008.02.001; Xu ZG, 2006, WORLD DEV, V34, P130, DOI 10.1016/j.worlddev.2005.08.002; Xu ZG, 2004, INT FOREST REV, V6, P317, DOI 10.1505/ifor.6.3.317.59976; Yang T, 1994, ARID LAND GEOGRAPHY, V17, P21; Zha Y, 1997, J ARID ENVIRON, V37, P419, DOI 10.1006/jare.1997.0290; [张继平 ZHANG ji-ping], 2009, [干旱区研究, Arid Zone Research], V26, P39; [赵哈林 ZHAO Halin], 2008, [中国沙漠, Journal of Desert Research], V28, P8; Zhao JH, 2001, ECON LETT, V73, P293, DOI 10.1016/S0165-1765(01)00511-0; Zhong D., 1998, DYNAMIC EVOLUTION SA; Zhu Z., 1981, J DES RES, V1, P2; Zhu Z, 1982, PHYS GEOGRAPHY CHINA; Zhu Z.D., 1994, SANDY DESERTIFICATIO	48	9	12	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e77510	10.1371/journal.pone.0077510	http://dx.doi.org/10.1371/journal.pone.0077510			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	244FY	24204849	gold, Green Submitted, Green Published			2022-12-27	WOS:000326373800005
J	Prats, C; Gomez-Cabello, A; Nordby, P; Andersen, JL; Helge, JW; Dela, F; Baba, O; Ploug, T				Prats, Clara; Gomez-Cabello, Alba; Nordby, Pernille; Andersen, Jesper L.; Helge, Jorn W.; Dela, Flemming; Baba, Otto; Ploug, Thorkil			An Optimized Histochemical Method to Assess Skeletal Muscle Glycogen and Lipid Stores Reveals Two Metabolically Distinct Populations of Type I Muscle Fibers	PLOS ONE			English	Article							INTRAMYOCELLULAR LIPIDS; EXERCISE; DROPLETS; RED	Skeletal muscle energy metabolism has been a research focus of physiologists for more than a century. Yet, how the use of intramuscular carbohydrate and lipid energy stores are coordinated during different types of exercise remains a subject of debate. Controversy arises from contradicting data from numerous studies, which used different methodological approaches. Here we review the "pros and cons" of previously used histochemical methods and describe an optimized method to ensure the preservation and specificity of detection of both intramyocellular carbohydrate and lipid stores. For optimal preservation of muscle energy stores, air drying cryosections or cycles of freezing-thawing need to be avoided. Furthermore, optimization of the imaging settings in order to specifically image intracellular lipid droplets stained with oil red O or Bodipy-493/503 is shown. When co-staining lipid droplets with associated proteins, Bodipy-493/503 should be the dye of choice, since oil red O creates precipitates on the lipid droplets blocking the light. In order to increase the specificity of glycogen stain, an antibody against glycogen is used. The resulting method reveals the existence of two metabolically distinct myosin heavy chain I expressing fibers: I-1 fibers have a smaller crossectional area, a higher density of lipid droplets, and a tendency to lower glycogen content compared to I-2 fibers. Type I-2 fibers have similar lipid content than IIA. Exhaustive exercise lead to glycogen depletion in type IIA and IIX fibers, a reduction in lipid droplets density in both type I-1 and I-2 fibers, and a decrease in the size of lipid droplets exclusively in type I-1 fibers.	[Prats, Clara; Andersen, Jesper L.; Helge, Jorn W.; Dela, Flemming] Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark; [Nordby, Pernille; Ploug, Thorkil] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Gomez-Cabello, Alba] Univ Zaragoza, Fac Hlth & Sport Sci, Zaragoza, Spain; [Andersen, Jesper L.] Univ Copenhagen, Inst Sports Med, Bispebjerg Hosp, Copenhagen, Denmark; [Baba, Otto] Tokyo Med & Dent Univ, Tokyo, Japan	University of Copenhagen; University of Copenhagen; University of Zaragoza; University of Copenhagen; Bispebjerg Hospital; Tokyo Medical & Dental University (TMDU)	Prats, C (corresponding author), Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark.	cprats@sund.ku.dk	Dela, Flemming/AAU-1691-2021; Andersen, Jesper L/W-6813-2019; Dela, Flemming/B-3239-2008; Helge, Jørn Wulff/I-7096-2012; Gómez-Cabello, Alba/H-5891-2015; Prats, Clara/F-5993-2014	Dela, Flemming/0000-0001-9970-9535; Dela, Flemming/0000-0001-9970-9535; Helge, Jørn Wulff/0000-0001-9724-5423; Prats, Clara/0000-0001-6465-3068; Nordby, Pernille/0000-0002-3934-6952; Ploug, Thorkil/0000-0002-5375-6595	Nordea Foundation; Novonordisk Foundation	Nordea Foundation; Novonordisk Foundation(Novo Nordisk Foundation)	This work was financed by Nordea Foundation (https://www.nordeafonden.dk/om-fonden) and Novonordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JL, 2000, MUSCLE NERVE, V23, P1095; ANDERSEN P, 1985, J APPL PHYSIOL, V59, P1647, DOI 10.1152/jappl.1985.59.5.1647; Baba O, 1993, Kokubyo Gakkai Zasshi, V60, P264; BERGSTROM J, 1962, SCAND J CLIN LAB INV, V14, P1; BONILLA E, 1987, J HISTOCHEM CYTOCHEM, V35, P619, DOI 10.1177/35.5.3559182; COSTILL DL, 1971, J APPL PHYSIOL, V31, P353, DOI 10.1152/jappl.1971.31.3.353; Decombaz J, 2001, AM J PHYSIOL-REG I, V281, pR760, DOI 10.1152/ajpregu.2001.281.3.R760; Donsmark M, 2005, EXERC SPORT SCI REV, V33, P127, DOI 10.1097/00003677-200507000-00005; Fairchild TJ, 2004, MED SCI SPORT EXER, V36, P2053, DOI 10.1249/01.MSS.0000147586.85615.C4; GOCZE PM, 1994, CYTOMETRY, V17, P151, DOI 10.1002/cyto.990170207; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; Mackey AL, 2009, MUSCLE NERVE, V40, P455, DOI 10.1002/mus.21369; Nakamura-Tsuruta S, 2012, CARBOHYD RES, V350, P49, DOI 10.1016/j.carres.2011.12.029; Nordby P, 2010, EUR J APPL PHYSIOL, V109, P935, DOI 10.1007/s00421-010-1428-4; Oakes ND, 1997, DIABETES, V46, P2022, DOI 10.2337/diabetes.46.12.2022; Phillips SM, 1996, AM J PHYSIOL-ENDOC M, V270, pE265, DOI 10.1152/ajpendo.1996.270.2.E265; Prats C, 2009, J BIOL CHEM, V284, P15692, DOI 10.1074/jbc.M900845200; Shaw CS, 2008, HISTOCHEM CELL BIOL, V129, P65, DOI 10.1007/s00418-007-0349-8; Shaw C, 2009, HISTOCHEM CELL BIOL, V131, P575, DOI 10.1007/s00418-009-0558-4; Shepherd SO, 2012, EXP PHYSIOL, V97, P970, DOI 10.1113/expphysiol.2012.064592; Spangenburg EE, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/598358; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; Thompson SW, 1966, ELECTED HISTOCHEMICA; van Loon LJC, 2003, J PHYSIOL-LONDON, V553, P611, DOI 10.1113/jphysiol.2003.052431; Watt MJ, 2002, J PHYSIOL-LONDON, V541, P969, DOI 10.1113/jphysiol.2002.018820	25	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77774	10.1371/journal.pone.0077774	http://dx.doi.org/10.1371/journal.pone.0077774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204959	Green Submitted, gold, Green Published			2022-12-27	WOS:000326334500057
J	Robins, SC; Trudel, E; Rotondi, O; Liu, XH; Djogo, T; Kryzskaya, D; Bourque, CW; Kokoeva, MV				Robins, Sarah C.; Trudel, Eric; Rotondi, Olivia; Liu, Xiaohong; Djogo, Tina; Kryzskaya, Darya; Bourque, Charles W.; Kokoeva, Maia V.			Evidence for NG2-glia Derived, Adult-Born Functional Neurons in the Hypothalamus	PLOS ONE			English	Article							NEURAL STEM-CELLS; PROGENITOR CELLS; SYNAPTIC PLASTICITY; NG2 PROTEOGLYCAN; NEUROGENESIS; TANYCYTES; LINEAGE; MARKER; FATE; NEURODEGENERATION	Accumulating evidence suggests that the adult murine hypothalamus, a control site of several fundamental homeostatic processes, has neurogenic capacity. Correspondingly, the adult hypothalamus exhibits considerable cell proliferation that is ongoing even in the absence of external stimuli, and some of the newborn cells have been shown to mature into cells that express neuronal fate markers. However, the identity and characteristics of proliferating cells within the hypothalamic parenchyma have yet to be thoroughly investigated. Here we show that a subset of NG2-glia distributed throughout the mediobasal hypothalamus are proliferative and express the stem cell marker Sox2. We tracked the constitutive differentiation of hypothalamic NG2-glia by employing genetic fate mapping based on inducible Cre recombinase expression under the control of the NG2 promoter, demonstrating that adult hypothalamic NG2-glia give rise to substantial numbers of APC+ oligodendrocytes and a smaller population of HuC/D+ or NeuN+ neurons. Labelling with the cell proliferation marker BrdU confirmed that some NG2-derived neurons have proliferated shortly before differentiation. Furthermore, patch-clamp electrophysiology revealed that some NG2-derived cells display an immature neuronal phenotype and appear to receive synaptic input indicative of their electrical integration in local hypothalamic circuits. Together, our studies show that hypothalamic NG2-glia are able to take on neuronal fates and mature into functional neurons, indicating that NG2-glia contribute to the neurogenic capacity of the adult hypothalamus.	[Robins, Sarah C.; Rotondi, Olivia; Liu, Xiaohong; Djogo, Tina; Kryzskaya, Darya; Kokoeva, Maia V.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Trudel, Eric; Bourque, Charles W.] McGill Univ, Ctr Res Neurosci, Montreal, PQ H3A 2T5, Canada	McGill University; McGill University	Kokoeva, MV (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.	maia.kokoeva@mcgill.ca		Migaud, Martine/0000-0002-9496-0517; Bourque, Charles/0000-0002-1594-742X	Canadian Institute of Health Research (CIHR) [MOP-102511]	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was funded by the Canadian Institute of Health Research (CIHR, website: http://www.cihr-irsc.gc.ca/e/193.html) via grant number MOP-102511. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2010, TRENDS COGN SCI, V14, P325, DOI 10.1016/j.tics.2010.04.003; BARAMI K, 1995, J NEUROBIOL, V28, P82, DOI 10.1002/neu.480280108; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Clarke LE, 2012, J NEUROSCI, V32, P8173, DOI 10.1523/JNEUROSCI.0928-12.2012; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; GRAUS F, 1990, NEUROSCI LETT, V112, P14, DOI 10.1016/0304-3940(90)90314-Y; Guo FZ, 2010, J NEUROSCI, V30, P12036, DOI 10.1523/JNEUROSCI.1360-10.2010; Guo FZ, 2009, J NEUROSCI, V29, P7256, DOI 10.1523/JNEUROSCI.5653-08.2009; Haan N, 2013, J NEUROSCI, V33, P6170, DOI 10.1523/JNEUROSCI.2437-12.2013; Hughes EG, 2013, NAT NEUROSCI; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Kokoeva MV, 2007, J COMP NEUROL, V505, P209, DOI 10.1002/cne.21492; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Lee DA, 2012, NAT NEUROSCI, V15, P700, DOI 10.1038/nn.3079; Li JX, 2012, NAT CELL BIOL, V14, P999, DOI 10.1038/ncb2562; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MAGNUSON DSK, 1995, DEV BRAIN RES, V84, P130, DOI 10.1016/0165-3806(94)00166-W; Mangin JM, 2011, ASN NEURO, V3, P37, DOI 10.1042/AN20110001; Markakis EA, 2004, J NEUROSCI, V24, P2886, DOI 10.1523/JNEUROSCI.4161-03.2004; McNay DEG, 2012, J CLIN INVEST, V122, P142, DOI 10.1172/JCI43134; Mongiat LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005320; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Ozerdem U, 2001, DEV DYNAM, V222, P218, DOI 10.1002/dvdy.1200; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; Perez-Martin M, 2010, EUR J NEUROSCI, V31, P1533, DOI 10.1111/j.1460-9568.2010.07220.x; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Robins SC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3049; Robins SC, 2013, GLIA, V61, P1735, DOI 10.1002/glia.22554; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; STALLCUP WB, 1981, DEV BIOL, V83, P154, DOI 10.1016/S0012-1606(81)80018-8; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Trotter J, 2010, BRAIN RES REV, V63, P72, DOI 10.1016/j.brainresrev.2009.12.006; Wang S, 2000, J NEUROBIOL, V42, P248, DOI 10.1002/(SICI)1097-4695(20000205)42:2<248::AID-NEU8>3.3.CO;2-A; Xu AW, 2005, PLOS BIOL, V3, P2168, DOI 10.1371/journal.pbio.0030415; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951	48	62	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78236	10.1371/journal.pone.0078236	http://dx.doi.org/10.1371/journal.pone.0078236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205170	gold, Green Published, Green Submitted			2022-12-27	WOS:000326270700086
J	Schachtschabel, D; Arentshorst, M; Nitsche, BM; Morris, S; Nielsen, KF; van den Hondel, CAMJJ; Klis, FM; Ram, AFJ				Schachtschabel, Doreen; Arentshorst, Mark; Nitsche, Benjamin M.; Morris, Sam; Nielsen, Kristian F.; van den Hondel, Cees A. M. J. J.; Klis, Frans M.; Ram, Arthur F. J.			The Transcriptional Repressor TupA in Aspergillus niger Is Involved in Controlling Gene Expression Related to Cell Wall Biosynthesis, Development, and Nitrogen Source Availability	PLOS ONE			English	Article							CANDIDA-ALBICANS REVEALS; STRAIN IVIC PB9; SACCHAROMYCES-CEREVISIAE; ASEXUAL SPORULATION; FILAMENT FORMATION; IDENTIFICATION; PROTEIN; GROWTH; ALPHA-1,3-GLUCAN; TRANSFORMATION	The Tup1-Cyc8 (Ssn6) complex is a well characterized and conserved general transcriptional repressor complex in eukaryotic cells. Here, we report the identification of the Tup1 (TupA) homolog in the filamentous fungus Aspergillus niger in a genetic screen for mutants with a constitutive expression of the agsA gene. The agsA gene encodes a putative alpha-glucan synthase, which is induced in response to cell wall stress in A. niger. Apart from the constitutive expression of agsA, the selected mutant was also found to produce an unknown pigment at high temperatures. Complementation analysis with a genomic library showed that the tupA gene could complement the phenotypes of the mutant. Screening of a collection of 240 mutants with constitutive expression of agsA identified sixteen additional pigment-secreting mutants, which were all mutated in the tupA gene. The phenotypes of the tupA mutants were very similar to the phenotypes of a tupA deletion strain. Further analysis of the tupA-17 mutant and the DtupA mutant revealed that TupA is also required for normal growth and morphogenesis. The production of the pigment at 37 degrees C is nitrogen source-dependent and repressed by ammonium. Genome-wide expression analysis of the tupA mutant during exponential growth revealed derepression of a large group of diverse genes, including genes related to development and cell wall biosynthesis, and also protease-encoding genes that are normally repressed by ammonium. Comparison of the transcriptome of up-regulated genes in the tupA mutant showed limited overlap with the transcriptome of caspofungin-induced cell wall stress-related genes, suggesting that TupA is not a general suppressor of cell wall stress-induced genes. We propose that TupA is an important repressor of genes related to development and nitrogen metabolism.	[Schachtschabel, Doreen; Arentshorst, Mark; Morris, Sam; van den Hondel, Cees A. M. J. J.; Ram, Arthur F. J.] Leiden Univ, Inst Biol Leiden, Leiden, Netherlands; [Nitsche, Benjamin M.] Berlin Univ Technol, Inst Biotechnol, Berlin, Germany; [Nielsen, Kristian F.] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Klis, Frans M.] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Ram, Arthur F. J.] Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands	Leiden University; Leiden University - Excl LUMC; Technical University of Berlin; Technical University of Denmark; University of Amsterdam	Ram, AFJ (corresponding author), Leiden Univ, Inst Biol Leiden, Leiden, Netherlands.	a.f.j.ram@biology.leidenuniv.nl	Ram, Arthur FJ/S-4648-2017; Nielsen, Kristian Fog/C-7233-2011	Ram, Arthur FJ/0000-0002-2487-8016; Nielsen, Kristian Fog/0000-0002-5848-0911; Van den Hondel, Kees/0000-0003-4782-2725	Netherlands Genomics Initiative	Netherlands Genomics Initiative	The research group of A.F.J. Ram is part of the Kluyver Centre for Genomics of Industrial Fermentation (http://www.kluyvercentre.nl), which is supported by the Netherlands Genomics Initiative (http://www.genomics.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; [Anonymous], FUNGAL GENET BIOL, V49, P284; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bastos KP, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-29; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett J. W., 1991, MORE GENE MANIPULATI, P441; Biesebeke RT, 2005, APPL MICROBIOL BIOT, V67, P75, DOI 10.1007/s00253-004-1807-z; Boorsma A, 2004, YEAST, V21, P413, DOI 10.1002/yea.1109; BOS CJ, 1988, CURR GENET, V14, P437, DOI 10.1007/BF00521266; Braun BR, 2000, GENETICS, V155, P57; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; Carvalho NDSP, 2010, APPL MICROBIOL BIOT, V87, P1463, DOI 10.1007/s00253-010-2588-1; Damveld RA, 2005, FUNGAL GENET BIOL, V42, P873, DOI 10.1016/j.fgb.2005.06.006; Damveld RA, 2005, MOL MICROBIOL, V58, P305, DOI 10.1111/j.1365-2958.2005.04827.x; Damveld RA, 2005, FUNGAL GENET BIOL, V42, P165, DOI 10.1016/j.fgb.2004.11.006; Damveld RA, 2008, GENETICS, V178, P873, DOI 10.1534/genetics.107.073148; de Groot PWJ, 2001, COMP FUNCT GENOM, V2, P124, DOI 10.1002/cfg.85; Delmas S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002875; DERUITERJACOBS YMJT, 1989, CURR GENET, V16, P159, DOI 10.1007/BF00391472; Elias-Villalobos A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002235; Fontaine T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002372; Garcia I, 2008, FEMS MICROBIOL LETT, V289, P146, DOI 10.1111/j.1574-6968.2008.01379.x; Garcia R, 2004, J BIOL CHEM, V279, P15183, DOI 10.1074/jbc.M312954200; Gastebois A, 2009, FUTURE MICROBIOL, V4, P583, DOI 10.2217/FMB.09.29; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Green SR, 2005, MOL BIOL CELL, V16, P2605, DOI 10.1091/mbc.e05-02-0126; Heilmann CJ, 2011, MICROBIOL-SGM, V157, P2297, DOI 10.1099/mic.0.049395-0; Heintz-Buschart A, 2013, J BIOTECHNOL, V164, P137, DOI 10.1016/j.jbiotec.2012.12.004; Hicks J, 2001, MOL MICROBIOL, V39, P1482, DOI 10.1046/j.1365-2958.2001.02332.x; HOGAN LH, 1994, INFECT IMMUN, V62, P3543, DOI 10.1128/IAI.62.8.3543-3546.1994; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Janoo RTK, 2001, GENETICS, V157, P1205; JARAI G, 1994, CURR GENET, V26, P238, DOI 10.1007/BF00309554; Jorgensen TR, 2011, APPL ENVIRON MICROB, V77, P5270, DOI 10.1128/AEM.00118-11; Jorgensen TR, 2011, FUNGAL GENET BIOL, V48, P544, DOI 10.1016/j.fgb.2011.01.005; Jorgensen TR, 2010, APPL ENVIRON MICROB, V76, P5344, DOI 10.1128/AEM.00450-10; Jorgensen TR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-44; KELLY JM, 1985, EMBO J, V4, P475, DOI 10.1002/j.1460-2075.1985.tb03653.x; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Knight SAB, 2002, MICROBIOL-SGM, V148, P29, DOI 10.1099/00221287-148-1-29; Kobayashi A, 2007, BIOSCI BIOTECH BIOCH, V71, P1797, DOI 10.1271/bbb.70132; Kobayashi Y, 2008, BIOCHEM BIOPH RES CO, V368, P50, DOI 10.1016/j.bbrc.2008.01.033; Krijgsheld P, 2013, STUD MYCOL, P1, DOI 10.3114/sim0006; Krijgsheld P, 2013, J PROTEOME RES, V12, P1808, DOI 10.1021/pr301154w; Latge JP, 2010, CELL MICROBIOL, V12, P863, DOI 10.1111/j.1462-5822.2010.01474.x; Lee H, 2005, MOL MICROBIOL, V55, P1222, DOI 10.1111/j.1365-2958.2004.04458.x; Lee H, 2009, EUKARYOT CELL, V8, P1901, DOI 10.1128/EC.00256-09; Levdansky E, 2010, EUKARYOT CELL, V9, P1403, DOI 10.1128/EC.00126-10; Levin AM, 2007, EUKARYOT CELL, V6, P2311, DOI 10.1128/EC.00244-07; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Masloff S, 1999, GENETICS, V152, P191; Meyer V, 2007, J BIOL CHEM, V282, P32935, DOI 10.1074/jbc.M705856200; Meyer V, 2010, MANUAL OF INDUSTRIAL MICROBIOLOGY AND BIOTECHNOLOGY, THIRD EDITION, P318; MITCHELL LH, 1979, EXP CELL RES, V120, P167, DOI 10.1016/0014-4827(79)90547-0; Murad AMA, 2001, MOL MICROBIOL, V42, P981, DOI 10.1046/j.1365-2958.2001.02713.x; Nitsche BM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-486; Parnell EJ, 2011, GENE DEV, V25, P2429, DOI 10.1101/gad.181768.111; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Piper MDW, 2002, J BIOL CHEM, V277, P37001, DOI 10.1074/jbc.M204490200; Punt PJ, 2008, FUNGAL GENET BIOL, V45, P1591, DOI 10.1016/j.fgb.2008.09.007; Ram AFJ, 2004, MICROBIOL-SGM, V150, P3315, DOI 10.1099/mic.0.27249-0; Rappleye CA, 2004, MOL MICROBIOL, V53, P153, DOI 10.1111/j.1365-2958.2004.04131.x; Reese AJ, 2003, MOL MICROBIOL, V50, P1401, DOI 10.1046/j.1365-2958.2003.03780.x; Robledo-Briones M, 2013, FEMS YEAST RES, V13, P74, DOI 10.1111/1567-1364.12011; Ruiz-Herrera J, 2002, ARCH MICROBIOL, V178, P477, DOI 10.1007/s00203-002-0478-3; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SANBLAS F, 1976, J GEN MICROBIOL, V93, P209, DOI 10.1099/00221287-93-2-209; SANBLAS G, 1977, INFECT IMMUN, V15, P897, DOI 10.1128/IAI.15.3.897-902.1977; Shapiro RS, 2011, MICROBIOL MOL BIOL R, V75, P213, DOI 10.1128/MMBR.00045-10; Smith RL, 2000, TRENDS BIOCHEM SCI, V25, P325, DOI 10.1016/S0968-0004(00)01592-9; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Szabo R, 2002, FEMS MICROBIOL LETT, V206, P45, DOI 10.1111/j.1574-6968.2002.tb10984.x; Todd RB, 2003, MOL MICROBIOL, V48, P85, DOI 10.1046/j.1365-2958.2003.03426.x; Morales-Vargas AT, 2012, RES MICROBIOL, V163, P378, DOI 10.1016/j.resmic.2012.03.002; TREITEL MA, 1995, P NATL ACAD SCI USA, V92, P3132, DOI 10.1073/pnas.92.8.3132; Tsitsigiannis D, 2004, EUKARYOT CELL, V3, P1398, DOI 10.1128/EC.3.6.1398-1411.2004; Tsitsigiannis DI, 2004, J BIOL CHEM, V279, P11344, DOI 10.1074/jbc.M310840200; van den Hombergh JPTW, 1996, THESIS WAGENINGEN AG; VANGORCOM RFM, 1988, NUCLEIC ACIDS RES, V16, P9052, DOI 10.1093/nar/16.18.9052; VANHARTINGSVELDT W, 1987, MOL GEN GENET, V206, P71, DOI 10.1007/BF00326538; Vienken K, 2005, GENETICS, V169, P619, DOI 10.1534/genetics.104.030767; Wong KH, 2011, GENE DEV, V25, P2525, DOI 10.1101/gad.179275.111; WOSTEN HAB, 1991, J GEN MICROBIOL, V137, P2017, DOI 10.1099/00221287-137-8-2017	89	16	17	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78102	10.1371/journal.pone.0078102	http://dx.doi.org/10.1371/journal.pone.0078102			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205111	Green Published, Green Submitted, gold			2022-12-27	WOS:000326270700074
J	Wilson, BJ; Nicholas, FW; James, JW; Wade, CM; Thomson, PC				Wilson, Bethany J.; Nicholas, Frank W.; James, John W.; Wade, Claire M.; Thomson, Peter C.			Estimated Breeding Values for Canine Hip Dysplasia Radiographic Traits in a Cohort of Australian German Shepherd Dogs	PLOS ONE			English	Article							ESTRELA-MOUNTAIN-DOG; INHERITED DISORDERS; GENETIC-PARAMETERS; ELBOW DYSPLASIA; UNITED-KINGDOM; HERITABILITY; RETRIEVERS; SELECTION; SCORE; EPIDEMIOLOGY	Canine hip dysplasia (CHD) is a serious and common musculoskeletal disease of pedigree dogs and therefore represents both an important welfare concern and an imperative breeding priority. The typical heritability estimates for radiographic CHD traits suggest that the accuracy of breeding dog selection could be substantially improved by the use of estimated breeding values (EBVs) in place of selection based on phenotypes of individuals. The British Veterinary Association/Kennel Club scoring method is a complex measure composed of nine bilateral ordinal traits, intended to evaluate both early and late dysplastic changes. However, the ordinal nature of the traits may represent a technical challenge for calculation of EBVs using linear methods. The purpose of the current study was to calculate EBVs of British Veterinary Association/Kennel Club traits in the Australian population of German Shepherd Dogs, using linear (both as individual traits and a summed phenotype), binary and ordinal methods to determine the optimal method for EBV calculation. Ordinal EBVs correlated well with linear EBVs (r = 0.90-0.99) and somewhat well with EBVs for the sum of the individual traits (r = 0.58-0.92). Correlation of ordinal and binary EBVs varied widely (r = 0.24-0.99) depending on the trait and cut-point considered. The ordinal EBVs have increased accuracy (0.48-0.69) of selection compared with accuracies from individual phenotype-based selection (0.40-0.52). Despite the high correlations between linear and ordinal EBVs, the underlying relationship between EBVs calculated by the two methods was not always linear, leading us to suggest that ordinal models should be used wherever possible. As the population of German Shepherd Dogs which was studied was purportedly under selection for the traits studied, we examined the EBVs for evidence of a genetic trend in these traits and found substantial genetic improvement over time. This study suggests the use of ordinal EBVs could increase the rate of genetic improvement in this population.	[Wilson, Bethany J.; Nicholas, Frank W.; James, John W.; Wade, Claire M.; Thomson, Peter C.] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia	University of Sydney	Wilson, BJ (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	bethany.wilson@sydney.edu.au	Nicholas, Frank William/AAE-5566-2022; Nicholas, Frank/AGY-8318-2022; Thomson, Peter/V-7290-2019	Nicholas, Frank William/0000-0002-9178-3965; Nicholas, Frank/0000-0002-9178-3965; Thomson, Peter/0000-0003-4428-444X; Wade, Claire/0000-0003-3413-4771				Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; [Anonymous], 2010, R LANG ENV STAT COMP; Asher L, 2009, VET J, V182, P402, DOI 10.1016/j.tvjl.2009.08.033; Biery DN, 2006, BSAVA MANUAL CANINE, P119; Collins LM, 2011, VET J, V189, P147, DOI 10.1016/j.tvjl.2011.06.012; Demko J, 2005, VET CLIN N AM-SMALL, V35, P1111, DOI 10.1016/j.cvsm.2005.05.002; Dietschi E, 2003, J ANIM BREED GENET, V120, P150, DOI 10.1046/j.1439-0388.2003.00390.x; Everts RE, 2000, VET QUART, V22, P63, DOI 10.1080/01652176.2000.9695027; Falconer DS, 1996, INTRO QUANTITATIVE G, P160; Gibbs C, 1997, VET REC, V141, P275; Gilmour AR, 2009, ASREML USER GUIDE RE; Ginja MMD, 2008, ACTA VET HUNG, V56, P303, DOI 10.1556/AVet.56.2008.3.4; Janutta V, 2006, DEUT TIERARZTL WOCH, V113, P6; Janutta V, 2006, J HERED, V97, P13, DOI 10.1093/jhered/esi128; Janutta V, 2008, BERL MUNCH TIERARZTL, V121, P102, DOI 10.2376/0005-9366-121-102; Kapatkin AS, 2002, COMP CONT EDUC PRACT, V24, P681; Lawson DD, 2000, HEREDITARY BONE JOIN, P267; Leighton EA, 1997, J AM VET MED ASSOC, V210, P1474; Lewis TW, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-16; Lewis TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013610; Maki K, 2004, HEREDITY, V92, P402, DOI 10.1038/sj.hdy.6800434; Malm S, 2013, J ANIM BREED GENET, V130, P154, DOI 10.1111/j.1439-0388.2012.01013.x; Malm S, 2010, PREV VET MED, V93, P222, DOI 10.1016/j.prevetmed.2009.09.017; Paster ER, 2005, JAVMA-J AM VET MED A, V226, P387, DOI 10.2460/javma.2005.226.387; Pfahler S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049782; Silvestre AM, 2007, J ANIM SCI, V85, P1880, DOI 10.2527/jas.2007-0166; Smith GK, 1997, J AM VET MED ASSOC, V210, P1451; Stock KF, 2011, J ANIM BREED GENET, V128, P219, DOI 10.1111/j.1439-0388.2010.00901.x; Stock KF, 2010, J ANIM BREED GENET, V127, P42, DOI 10.1111/j.1439-0388.2009.00809.x; Thomson PC, 2010, VET J, V183, P243, DOI 10.1016/j.tvjl.2009.12.002; Todhunter RJ, 2003, J HERED, V94, P39, DOI 10.1093/jhered/esg006; Wilson BJ, 2011, J ANIM BREED GENET, V128, P230, DOI 10.1111/j.1439-0388.2010.00903.x; Wilson BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039620; Wood JLN, 2000, PREV VET MED, V46, P75, DOI 10.1016/S0167-5877(00)00140-9; Wood JLN, 2000, PREV VET MED, V46, P87, DOI 10.1016/S0167-5877(00)00141-0; Wood JLN, 2002, PREV VET MED, V55, P95, DOI 10.1016/S0167-5877(02)00090-9; Zhang ZW, 2009, AM J VET RES, V70, P483, DOI 10.2460/ajvr.70.4.483; Zhu L, 2009, VET J, V181, P97, DOI 10.1016/j.tvjl.2009.02.008	38	11	11	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77470	10.1371/journal.pone.0077470	http://dx.doi.org/10.1371/journal.pone.0077470			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204838	gold, Green Published, Green Submitted			2022-12-27	WOS:000326270700031
J	Xu, F; Han, Y; Sabbagh, MA; Wang, TF; Ren, XZ; Li, CH				Xu, Fen; Han, Yan; Sabbagh, Mark A.; Wang, Tengfei; Ren, Xuezhu; Li, Chunhua			Developmental Differences in the Structure of Executive Function in Middle Childhood and Adolescence	PLOS ONE			English	Article							COGNITIVE CONTROL; INHIBITION; PRESCHOOL; CHILDREN; MEMORY; INTELLIGENCE; DIVERSITY; SCHOOL; UNITY	Although it has been argued that the structure of executive function (EF) may change developmentally, there is little empirical research to examine this view in middle childhood and adolescence. The main objective of this study was to examine developmental changes in the component structure of EF in a large sample (N = 457) of 7-15 year olds. Participants completed batteries of tasks that measured three components of EF: updating working memory (UWM), inhibition, and shifting. Confirmatory factor analysis (CFA) was used to test five alternative models in 7-9 year olds, 10-12 year olds, and 13-15 year olds. The results of CFA showed that a single-factor EF model best explained EF performance in 7-9-year-old and 10-12-year-old groups, namely unitary EF, though this single factor explained different amounts of variance at these two ages. In contrast, a three-factor model that included UWM, inhibition, and shifting best accounted for the data from 13-15 year olds, namely diverse EF. In sum, during middle childhood, putative measures of UWM, inhibition, and shifting may rely on similar underlying cognitive processes. Importantly, our findings suggest that developmental dissociations in these three EF components do not emerge until children transition into adolescence. These findings provided empirical evidence for the development of EF structure which progressed from unity to diversity during middle childhood and adolescence.	[Xu, Fen] Zhejiang Sci Tech Univ, Dept Psychol, Hangzhou, Zhejiang, Peoples R China; [Xu, Fen; Han, Yan] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Sabbagh, Mark A.] Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada; [Wang, Tengfei; Ren, Xuezhu] Goethe Univ Frankfurt, D-60054 Frankfurt, Germany; [Li, Chunhua] Beijing 12 High Sch, Beijing, Peoples R China	Zhejiang Sci-Tech University; Beijing Normal University; Queens University - Canada; Goethe University Frankfurt	Xu, F (corresponding author), Zhejiang Sci Tech Univ, Dept Psychol, Hangzhou, Zhejiang, Peoples R China.	fenxu@zstu.edu.cn; hanyancathy@126.com	Ren, Xuezhu/Z-4616-2019; Wang, Tengfei/AAF-4268-2020	Ren, Xuezhu/0000-0002-3703-3194; Wang, Tengfei/0000-0002-1585-4143	National Natural Science Foundation of China [30528027, 31028010, 31170996]; Zhejiang Provincial Natural Science Foundation of China [Y2110369]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	The present study was supported by grants from the National Natural Science Foundation of China (30528027, 31028010, and 31170996) and Zhejiang Provincial Natural Science Foundation of China (Y2110369). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Brydges CR, 2012, INTELLIGENCE, V40, P458, DOI 10.1016/j.intell.2012.05.006; Burns P, 2012, J EXP CHILD PSYCHOL, V111, P501, DOI 10.1016/j.jecp.2011.10.003; Byrne M, 1989, PRIMER LISREL BASIC; Collette F, 2005, HUM BRAIN MAPP, V25, P409, DOI 10.1002/hbm.20118; Crone EA, 2006, P NATL ACAD SCI USA, V103, P9315, DOI 10.1073/pnas.0510088103; Curran PJ, 1996, PSYCHOL METHODS, V1, P16, DOI 10.1037//1082-989X.1.1.16; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; Diamond A, 2007, SCIENCE, V318, P1387, DOI 10.1126/science.1151148; Durston S, 2006, DEVELOPMENTAL SCI, V9, P1, DOI 10.1111/j.1467-7687.2005.00454.x; Eigsti IM, 2006, PSYCHOL SCI, V17, P478, DOI 10.1111/j.1467-9280.2006.01732.x; Espy KA, 2011, J CHILD PSYCHOL PSYC, V52, P33, DOI 10.1111/j.1469-7610.2010.02265.x; Farah MJ, 2006, BRAIN RES, V1110, P166, DOI 10.1016/j.brainres.2006.06.072; Fisk JE, 2004, J CLIN EXP NEUROPSYC, V26, P874, DOI 10.1080/13803390490510680; Friedman NP, 2006, PSYCHOL SCI, V17, P172, DOI 10.1111/j.1467-9280.2006.01681.x; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Garon N, 2008, PSYCHOL BULL, V134, P31, DOI 10.1037/0033-2909.134.1.31; Garrett HE, 1946, AM PSYCHOL, V1, P372, DOI 10.1037/h0056380; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Hughes C, 2010, DEV NEUROPSYCHOL, V35, P20, DOI 10.1080/87565640903325691; Huizinga M, 2006, NEUROPSYCHOLOGIA, V44, P2017, DOI 10.1016/j.neuropsychologia.2006.01.010; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Lehto JE, 2003, BRIT J DEV PSYCHOL, V21, P59, DOI 10.1348/026151003321164627; Leon-Carrion J, 2004, INT J NEUROSCI, V114, P1291, DOI 10.1080/00207450490476066; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Muthen L.K., 2010, MPLUS USERS GUIDE; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; Noble KG, 2005, DEVELOPMENTAL SCI, V8, P74, DOI 10.1111/j.1467-7687.2005.00394.x; Ren XZ, 2013, INTELLIGENCE, V41, P51, DOI 10.1016/j.intell.2012.10.006; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Senn TE, 2004, DEV NEUROPSYCHOL, V26, P445, DOI 10.1207/s15326942dn2601_5; Shing YL, 2010, DEV NEUROPSYCHOL, V35, P679, DOI 10.1080/87565641.2010.508546; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; St Clair-Thompson HL, 2006, Q J EXP PSYCHOL, V59, P745, DOI 10.1080/17470210500162854; Tucker-Drob EM, 2009, DEV PSYCHOL, V45, P1097, DOI 10.1037/a0015864; van der Sluis S, 2007, INTELLIGENCE, V35, P427, DOI 10.1016/j.intell.2006.09.001; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; Wiebe SA, 2008, DEV PSYCHOL, V44, P575, DOI 10.1037/0012-1649.44.2.575; Wiebe SA, 2011, J EXP CHILD PSYCHOL, V108, P436, DOI 10.1016/j.jecp.2010.08.008; Wu KK, 2011, DEV NEUROPSYCHOL, V36, P319, DOI 10.1080/87565641.2010.549979; Zhang HC, 1898, ACTA PSYCHOL SINICA, V21, P113	47	43	43	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77770	10.1371/journal.pone.0077770	http://dx.doi.org/10.1371/journal.pone.0077770			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	242VF	24204957	Green Published, gold, Green Submitted			2022-12-27	WOS:000326270700053
J	Zhang, L; Sun, XY; Tian, Y; Gong, XQ				Zhang, Lu; Sun, Xiangyang; Tian, Yun; Gong, Xiaoqiang			Composted Green Waste as a Substitute for Peat in Growth Media: Effects on Growth and Nutrition of Calathea insignis	PLOS ONE			English	Article							MUNICIPAL SOLID-WASTE; SEWAGE-SLUDGE; ORGANIC-MATTER; GROWING MEDIA; PLANT-GROWTH; COMPONENTS; EVOLUTION; COMMUNITY; BIOCHAR	Peat mined from endangered wetland ecosystems is generally used as a component in soilless potting media in horticulture but is a costly and non-renewable natural resource. The objective of this work was to study the feasibility of replacing peat with different percentages (0, 10, 30, 50, 70, 90, and 100%) of composted green waste (CGW) as growth media for the production of the ornamental plant Calathea insignis. Compared with 100% peat media, media containing CGW had improved physical and chemical characteristics to achieve the acceptable ranges. Moreover, CGW addition had increased the stability (i.e., reduced the decomposition rates) of growth media mixtures, as indicated by comparison of particle-size distribution at the start and end of a 7-month greenhouse experiment. Addition of CGW also supported increased plant growth (biomass production, root morphology, nutrient contents, and photosynthetic pigment contents). The physical and chemical characteristics of growth media and plant growth were best with a medium containing 70% CGW and were better in a medium with 100% CGW than in one with 100% peat media. These results indicate that CGW is a viable alternative to peat for the cultivation of Calathea insignis.	[Zhang, Lu; Sun, Xiangyang; Gong, Xiaoqiang] Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China; [Tian, Yun] Chinese Acad Forestry, Inst Desertificat Studies, Beijing, Peoples R China	Beijing Forestry University; Chinese Academy of Forestry; Institute of Desertification Studies, CAF	Sun, XY (corresponding author), Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China.	sunxy@bjfu.edu.cn			Fundamental Research Funds for the Central Universities [BLYJ201308]; Major Project of the Science and Technology of Beijing, China [D09040903780801]; Fund Project of the Agricultural Science and Technology Achievements transformation of China [2011GB23600002]; Promotion and Demonstration of the Agricultural and Forestry Wastes Production Flowers and Trees Growth Media Technology [39]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Major Project of the Science and Technology of Beijing, China; Fund Project of the Agricultural Science and Technology Achievements transformation of China; Promotion and Demonstration of the Agricultural and Forestry Wastes Production Flowers and Trees Growth Media Technology	This study was supported by the Fundamental Research Funds for the Central Universities (No. BLYJ201308); the Major Project of the Science and Technology of Beijing, China (D09040903780801); the Fund Project of the Agricultural Science and Technology Achievements transformation of China (2011GB23600002) "the Transformation and Demonstration of Flowers and Trees Peat Substitution Growth Media Production Key Technology"; and the Promotion and Demonstration of the Agricultural and Forestry Wastes Production Flowers and Trees Growth Media Technology (No. 39, 2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnolucci M, 2013, BIORESOURCE TECHNOL, V134, P10, DOI 10.1016/j.biortech.2013.02.022; Ahmed H. F. S., 2012, African Journal of Biotechnology, V11, P10079; Aklibasinda M, 2011, J ANIM PLANT SCI, V21, P535; Allgaier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008812; Belyaeva ON, 2012, ENVIRON EARTH SCI, V66, P1987, DOI 10.1007/s12665-011-1424-y; Benito M, 2005, BIORESOURCE TECHNOL, V96, P597, DOI 10.1016/j.biortech.2004.06.006; Bernal MP, 2009, BIORESOURCE TECHNOL, V100, P5444, DOI 10.1016/j.biortech.2008.11.027; Bustamante MA, 2008, RESOUR CONSERV RECY, V52, P792, DOI 10.1016/j.resconrec.2007.11.005; Cao ShiWei, 2012, African Journal of Biotechnology, V11, P3825; De Boodt M.A.V.O., 1972, ACTA HORTIC, V26, P37, DOI [10.17660/ActaHortic.1972.26.5, DOI 10.17660/ACTAHORTIC.1972.26.5]; Elhindi K. M., 2012, Australian Journal of Crop Science, V6, P1249; Farrell M, 2010, WASTE MANAGE, V30, P1495, DOI 10.1016/j.wasman.2010.01.032; Fornes F, 2012, BIORESOURCE TECHNOL, V118, P296, DOI 10.1016/j.biortech.2012.05.028; Gabhane J, 2012, BIORESOURCE TECHNOL, V114, P382, DOI 10.1016/j.biortech.2012.02.040; Grigatti M, 2004, BIORESOURCE TECHNOL, V91, P163, DOI 10.1016/S0960-8524(03)00170-6; Hicklenton PR, 2001, SCI HORTIC-AMSTERDAM, V91, P365, DOI 10.1016/S0304-4238(01)00251-5; Jahromi M. G., 2012, African Journal of Biotechnology, V11, P9036; Jayasinghe GY, 2012, CLEAN TECHNOL ENVIR, V14, P625, DOI 10.1007/s10098-011-0423-8; JIMENEZ EI, 1992, AGR ECOSYST ENVIRON, V38, P331, DOI 10.1016/0167-8809(92)90154-4; Khalil A, 2008, BIORESOURCE TECHNOL, V99, P6037, DOI 10.1016/j.biortech.2007.11.043; Khattak A. M., 2011, Sarhad Journal of Agriculture, V27, P201; Koberl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024452; Lallawmsanga, 2012, Annals of Biological Research, V3, P2268; Lazcano C, 2009, SPAN J AGRIC RES, V7, P944, DOI 10.5424/sjar/2009074-1107; Legind CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047002; Lindani N., 2012, African Journal of Plant Science, V6, P120; Medina E, 2009, BIORESOURCE TECHNOL, V100, P4227, DOI 10.1016/j.biortech.2009.03.055; Mininni C, 2012, HORTSCIENCE, V47, P1438, DOI 10.21273/HORTSCI.47.10.1438; Ostos JC, 2008, BIORESOURCE TECHNOL, V99, P1793, DOI 10.1016/j.biortech.2007.03.033; Pal A. K., 2005, Journal of Interacademicia, V9, P33; Pane C, 2011, BIOL CONTROL, V56, P115, DOI 10.1016/j.biocontrol.2010.10.002; Pascual I, 2008, PLANT SOIL, V310, P41, DOI 10.1007/s11104-008-9626-0; Paul-Victor C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006917; Perez-Murcia MD, 2006, BIORESOURCE TECHNOL, V97, P123, DOI 10.1016/j.biortech.2005.02.005; Redjala T, 2011, ENVIRON EXP BOT, V71, P241, DOI 10.1016/j.envexpbot.2010.12.010; Ribeiro HM, 2007, BIORESOURCE TECHNOL, V98, P3294, DOI 10.1016/j.biortech.2006.07.002; Segarra G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056075; Suo LN, 2011, J HORTIC SCI BIOTECH, V86, P366, DOI 10.1080/14620316.2011.11512775; Tian Y, 2012, SCI HORTIC-AMSTERDAM, V143, P15, DOI 10.1016/j.scienta.2012.05.018; Zhang L, 2013, BIORESOURCE TECHNOL, V131, P68, DOI 10.1016/j.biortech.2012.10.059; Zhao SL, 2013, BIORESOURCE TECHNOL, V129, P249, DOI 10.1016/j.biortech.2012.11.075	41	24	28	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78121	10.1371/journal.pone.0078121	http://dx.doi.org/10.1371/journal.pone.0078121			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205121	gold, Green Published, Green Submitted			2022-12-27	WOS:000326270700078
J	Jung, E; Perrone, EE; Brahmamdan, P; McDonough, JS; Leathersich, AM; Dominguez, JA; Clark, AT; Fox, AC; Dunne, WM; Hotchkiss, RS; Coopersmith, CM				Jung, Enjae; Perrone, Erin E.; Brahmamdan, Pavan; McDonough, Jacquelyn S.; Leathersich, Ann M.; Dominguez, Jessica A.; Clark, Andrew T.; Fox, Amy C.; Dunne, W. Michael; Hotchkiss, Richard S.; Coopersmith, Craig M.			Inhibition of Intestinal Epithelial Apoptosis Improves Survival in a Murine Model of Radiation Combined Injury	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; MULTIPLE-ORGAN-FAILURE; METHICILLIN-RESISTANT; IONIZING-RADIATION; CECAL LIGATION; MORTALITY; GUT; EXPOSURE; SEPSIS; MICE	World conditions place large populations at risk from ionizing radiation (IR) from detonation of dirty bombs or nuclear devices. In a subgroup of patients, ionizing radiation exposure would be followed by a secondary infection. The effects of radiation combined injury are potentially more lethal than either insult in isolation. The purpose of this study was to determine mechanisms of mortality and possible therapeutic targets in radiation combined injury. Mice were exposed to IR with 2.5 Gray (Gy) followed four days later by intratracheal methicillin-resistant Staphylococcus aureus (MRSA). While either IR or MRSA alone yielded 100% survival, animals with radiation combined injury had 53% survival (p = 0.01). Compared to IR or MRSA alone, mice with radiation combined injury had increased gut apoptosis, local and systemic bacterial burden, decreased splenic CD4 T cells, CD8 T cells, B cells, NK cells, and dendritic cells, and increased BAL and systemic IL-6 and G-CSF. In contrast, radiation combined injury did not alter lymphocyte apoptosis, pulmonary injury, or intestinal proliferation compared to IR or MRSA alone. In light of the synergistic increase in gut apoptosis following radiation combined injury, transgenic mice that overexpress Bcl-2 in their intestine and wild type mice were subjected to IR followed by MRSA. Bcl-2 mice had decreased gut apoptosis and improved survival compared to WT mice (92% vs. 42%; p<0.01). These data demonstrate that radiation combined injury results in significantly higher mortality than could be predicted based upon either IR or MRSA infection alone, and that preventing gut apoptosis may be a potential therapeutic target.	[Jung, Enjae; Perrone, Erin E.; Clark, Andrew T.; Fox, Amy C.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Brahmamdan, Pavan; McDonough, Jacquelyn S.; Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Leathersich, Ann M.; Dunne, W. Michael] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Dominguez, Jessica A.] Bastyr Univ Calif, Dept Basic Sci, San Diego, CA USA; [Coopersmith, Craig M.] Emory Univ, Sch Med, Emory Ctr Crit Care, Atlanta, GA 30322 USA; [Coopersmith, Craig M.] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Emory University; Emory University	Coopersmith, CM (corresponding author), Emory Univ, Sch Med, Emory Ctr Crit Care, Atlanta, GA 30322 USA.	cmcoop3@emory.edu		Dominguez Rieg, Jessica/0000-0001-6190-7464	National Institutes of Health [GM072808, GM66202, GM104323, GM008795, DK52574]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072808, R01GM066202, R01GM104323] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the National Institutes of Health (GM072808, GM66202, GM104323, GM008795, DK52574). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brook I, 2004, MIL MED, V169, P194, DOI 10.7205/MILMED.169.3.194; BROOK I, 1986, CAN J MICROBIOL, V32, P719, DOI 10.1139/m86-130; CARRICO CJ, 1986, ARCH SURG-CHICAGO, V121, P196; Chao NJ, 2007, EXP HEMATOL, V35, P24, DOI 10.1016/j.exphem.2007.01.008; Clark JA, 2008, SHOCK, V30, P36, DOI 10.1097/SHK.0b013e31815D0820; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; Clark JA, 2009, AM J PHYSIOL-GASTR L, V297, pG471, DOI 10.1152/ajpgi.00012.2009; Coopersmith CM, 1999, AM J PHYSIOL-GASTR L, V276, pG677, DOI 10.1152/ajpgi.1999.276.3.G677; DiCarlo AL, 2008, RADIAT RES, V169, P712, DOI 10.1667/RR1295.1; DiCarlo AL, 2010, HEALTH PHYS, V98, P863, DOI 10.1097/HP.0b013e3181a6ee32; Dominguez JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049159; Dominguez JA, 2011, SHOCK, V36, P381, DOI 10.1097/SHK.0b013e31822793c4; ERVIN FR, 1962, NEW ENGL J MED, V266, P1127, DOI 10.1056/NEJM196205312662204; Fox AC, 2012, SHOCK, V38, P508, DOI 10.1097/SHK.0b013e31826e47e8; Fox AC, 2010, CRIT CARE MED, V38, P886, DOI 10.1097/CCM.0b013e3181c8fdb1; Hassoun HT, 2001, SHOCK, V15, P1, DOI 10.1097/00024382-200115010-00001; Hiramatsu M, 1997, SHOCK, V7, P247, DOI 10.1097/00024382-199704000-00002; Hotchkiss RS, 2010, NEW ENGL J MED, V363, P87, DOI 10.1056/NEJMcibr1004371; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Jacob A, 2010, MOL MED, V16, P137, DOI 10.2119/molmed.2009.00154; Jung E, 2012, SHOCK, V37, P85, DOI 10.1097/SHK.0b013e3182360faf; KAPLAN HS, 1952, J LAB CLIN MED, V40, P682; Keller CE, 2003, COMPARATIVE MED, V53, P397; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Lee WJ, 2006, RADIAT RES, V165, P562, DOI 10.1667/RR3549.1; Manthous CA, 2007, CRIT CARE MED, V35, P716, DOI 10.1097/01.CCM.0000257328.31668.22; Mendoza AE, 2012, SHOCK, V38, P532, DOI 10.1097/SHK.0b013e31826c5b19; MERRITT AJ, 1994, CANCER RES, V54, P614; METTLER FA, 2001, MED MANAGEMENT RAD A, P53; Mettler FA, 2012, J RADIOL PROT, V32, pN9, DOI 10.1088/0952-4746/32/1/N9; Osuchowski MF, 2012, J IMMUNOL, V189, P4648, DOI 10.4049/jimmunol.1201806; Park E, 2008, BIOCHEM BIOPH RES CO, V372, P792, DOI 10.1016/j.bbrc.2008.05.140; Perrone EE, 2012, SHOCK, V38, P68, DOI 10.1097/SHK.0b013e318259abdb; Potten CS, 2004, RADIAT RES, V161, P123, DOI 10.1667/RR3104; Robertson CM, 2008, J SURG RES, V150, P278, DOI 10.1016/j.jss.2008.02.009; Shah KG, 2009, MOL MED, V15, P407, DOI 10.2119/molmed.2009.00100; Shorr AF, 2007, PHARMACOECONOMICS, V25, P751, DOI 10.2165/00019053-200725090-00004; Shurland S, 2007, INFECT CONT HOSP EP, V28, P273, DOI 10.1086/512627; Stromberg PE, 2009, FASEB J, V23, P1817, DOI 10.1096/fj.08-119024; Tajima G, 2013, RADIAT RES, V179, P101, DOI 10.1667/RR3120.1; Tessner TG, 2004, J CLIN INVEST, V114, P1676, DOI 10.1172/JCI200422218; Vyas D, 2007, HISTOL HISTOPATHOL, V22, P623, DOI 10.14670/HH-22.623; Wells CL, 2004, SHOCK, V22, P562, DOI 10.1097/01.shk.0000145935.24344.2d; Williams Jacqueline P, 2012, Radiat Res, V177, pe0025; Zou ZM, 2008, RADIAT RES, V169, P722, DOI 10.1667/RR1284.1	45	10	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77203	10.1371/journal.pone.0077203	http://dx.doi.org/10.1371/journal.pone.0077203			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204769	Green Published, Green Submitted, gold			2022-12-27	WOS:000326241200019
J	Jupelli, M; Shimada, K; Chiba, N; Slepenkin, A; Alsabeh, R; Jones, HD; Peterson, E; Chen, S; Arditi, M; Crother, TR				Jupelli, Madhulika; Shimada, Kenichi; Chiba, Norika; Slepenkin, Anatoly; Alsabeh, Randa; Jones, Heather D.; Peterson, Ellena; Chen, Shuang; Arditi, Moshe; Crother, Timothy R.			Chlamydia pneumoniae Infection in Mice Induces Chronic Lung Inflammation, iBALT Formation, and Fibrosis	PLOS ONE			English	Article							PULMONARY-FIBROSIS; STRAIN-TWAR; MACROPHAGE POLARIZATION; ALVEOLAR MACROPHAGES; BACTERIAL CLEARANCE; CURRENT KNOWLEDGE; MOUSE MODEL; ASSOCIATION; ASTHMA; REACTIVATION	Chlamydia pneumoniae (CP) lung infection can induce chronic lung inflammation and is associated with not only acute asthma but also COPD exacerbations. However, in mouse models of CP infection, most studies have investigated specifically the acute phase of the infection and not the longer-term chronic changes in the lungs. We infected C57BL/6 mice with 5x10(5) CP intratracheally and monitored inflammation, cellular infiltrates and cytokine levels over time to investigate the chronic inflammatory lung changes. While bacteria numbers declined by day 28, macrophage numbers remained high through day 35. Immune cell clusters were detected as early as day 14 and persisted through day 35, and stained positive for B, T, and follicular dendritic cells, indicating these clusters were inducible bronchus associated lymphoid tissues (iBALTs). Classically activated inflammatory M1 macrophages were the predominant subtype early on while alternatively activated M2 macrophages increased later during infection. Adoptive transfer of M1 but not M2 macrophages intratracheally 1 week after infection resulted in greater lung inflammation, severe fibrosis, and increased numbers of iBALTS 35 days after infection. In summary, we show that CP lung infection in mice induces chronic inflammatory changes including iBALT formations as well as fibrosis. These observations suggest that the M1 macrophages, which are part of the normal response to clear acute C. pneumoniae lung infection, result in an enhanced acute response when present in excess numbers, with greater inflammation, tissue injury, and severe fibrosis.	[Jupelli, Madhulika; Shimada, Kenichi; Chiba, Norika; Chen, Shuang; Arditi, Moshe; Crother, Timothy R.] Cedars Sinai Med Ctr, Dept Pediat, Div Pediat Infect Dis, Los Angeles, CA 90048 USA; [Slepenkin, Anatoly; Peterson, Ellena] Univ Calif Irvine, Dept Pathol, Irvine, CA 92717 USA; [Alsabeh, Randa] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90048 USA; [Jones, Heather D.] Cedars Sinai Med Ctr, Dept Med, Div Pulm & Crit Care Med, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; University of California System; University of California Irvine; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; Cedars Sinai Medical Center	Crother, TR (corresponding author), Cedars Sinai Med Ctr, Dept Pediat, Div Pediat Infect Dis, Los Angeles, CA 90048 USA.	timothy.crother@cshs.org	Crother, Timothy R/E-2879-2010	Crother, Timothy R/0000-0001-8465-6127	National Institutes of Health [HL-66436, AI-067995]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI067995, R01AI067995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health Grants HL-66436 and AI-067995 (to MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2004, TEX HEART I J, V31, P33; Anzai A, 2012, CIRCULATION, V125, P1234, DOI 10.1161/CIRCULATIONAHA.111.052126; Blasi F, 2002, THORAX, V57, P672, DOI 10.1136/thorax.57.8.672; Blasi F, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-83; Campbell Lee Ann, 2003, Semin Respir Infect, V18, P48, DOI 10.1053/srin.2003.50006; Crother TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048655; Duan M, 2012, J IMMUNOL, V189, P946, DOI 10.4049/jimmunol.1200660; Foo SY, 2010, MUCOSAL IMMUNOL, V3, P537, DOI 10.1038/mi.2010.52; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Gerard HC, 2013, NANOMEDICINE, DOI [10.1016/j.nano.2013.04.004, DOI 10.1016/J.NAN0.2013.04.004, http://dx.doi.org/10.1016/j.nano.2013.04.004]; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Grayston JT, 2000, J INFECT DIS, V181, pS402, DOI 10.1086/315596; GRAYSTON JT, 1989, EUR J CLIN MICROBIOL, V8, P191, DOI 10.1007/BF01965260; HAHN DL, 1991, JAMA-J AM MED ASSOC, V266, P225, DOI 10.1001/jama.266.2.225; Hammerschlag Margaret R, 2002, Semin Pediatr Infect Dis, V13, P239, DOI 10.1053/spid.2002.127201; He XB, 2010, J IMMUNOL, V184, P5743, DOI 10.4049/jimmunol.0903937; Hogan RJ, 2004, INFECT IMMUN, V72, P1843, DOI 10.1128/IAI.72.4.1843-1855.2004; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Johnston SL, 2005, AM J RESP CRIT CARE, V172, P1078, DOI 10.1164/rccm.200412-1743PP; Kalayoglu MV, 2002, JAMA-J AM MED ASSOC, V288, P2724, DOI 10.1001/jama.288.21.2724; KAUKORANTATOLVANEN SSE, 1993, MICROB PATHOGENESIS, V15, P293, DOI 10.1006/mpat.1993.1079; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; KUO CC, 1995, CLIN MICROBIOL REV, V8, P451, DOI 10.1128/CMR.8.4.451; Laitinen K, 1996, INFECT IMMUN, V64, P1488, DOI 10.1128/IAI.64.4.1488-1490.1996; Laurila AL, 1997, SCAND J INFECT DIS, P34; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Littman AJ, 2005, CANCER EPIDEM BIOMAR, V14, P773, DOI 10.1158/1055-9965.EPI-04-0599; MALINVERNI R, 1995, J INFECT DIS, V172, P593, DOI 10.1093/infdis/172.2.593; Mi S, 2011, J IMMUNOL, V187, P3003, DOI 10.4049/jimmunol.1004081; Mora AL, 2006, AM J RESP CELL MOL, V35, P466, DOI 10.1165/rcmb.2006-0121OC; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Naiki Y, 2005, J BIOL CHEM, V280, P29242, DOI 10.1074/jbc.M503225200; Naiki Y, 2008, J IMMUNOL, V181, P7176, DOI 10.4049/jimmunol.181.10.7176; Noble PW, 2012, J CLIN INVEST, V122, P2756, DOI 10.1172/JCI60323; Pechkovsky DV, 2010, CLIN IMMUNOL, V137, P89, DOI 10.1016/j.clim.2010.06.017; Prasse A, 2006, AM J RESP CRIT CARE, V173, P781, DOI 10.1164/rccm.200509-1518OC; Prasse A, 2007, J ALLERGY CLIN IMMUN, V119, P464, DOI 10.1016/j.jaci.2006.09.030; Qin HW, 2012, J IMMUNOL, V189, P3439, DOI 10.4049/jimmunol.1201168; Rahat MA, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00045; Rangel-Moreno J, 2006, J CLIN INVEST, V116, P3183, DOI 10.1172/JCI28756; Rangel-Moreno J, 2011, NAT IMMUNOL, V12, P639, DOI 10.1038/ni.2053; SAIKKU P, 1988, LANCET, V2, P983, DOI 10.1016/S0140-6736(88)90741-6; Schroeder NWJ, 2008, J ALLERGY CLIN IMMUN, V122, P595, DOI 10.1016/j.jaci.2008.06.038; Shah NR, 2005, SARCOIDOSIS VASC DIF, V22, P167; Shearer JD, 1997, AM J PHYSIOL-ENDOC M, V272, pE181, DOI 10.1152/ajpendo.1997.272.2.E181; Shimada K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000379; Song LH, 2013, INFECT IMMUN, V81, P636, DOI 10.1128/IAI.01305-12; Sutherland ER, 2007, CHEST, V132, P1962, DOI 10.1378/chest.06-2415; Teh B, 2012, CLIN MICROBIOL INFEC, V18, pE71, DOI 10.1111/j.1469-0691.2011.03759.x; Tighe RM, 2011, AM J RESP CELL MOL, V45, P781, DOI 10.1165/rcmb.2010-0471OC; Ulrichs T, 2004, J PATHOL, V204, P217, DOI 10.1002/path.1628; Watson C, 2008, CLIN SCI, V114, P509, DOI 10.1042/CS20070298; Webley WC, 2005, AM J RESP CRIT CARE, V171, P1083, DOI 10.1164/rccm.200407-917OC; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Wilson M, 2010, J PETROL, V51, P1, DOI 10.1093/petrology/egp099; YANG ZP, 1994, J INFECT DIS, V170, P464, DOI 10.1093/infdis/170.2.464; YANG ZP, 1993, INFECT IMMUN, V61, P2037, DOI 10.1128/IAI.61.5.2037-2040.1993	57	19	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77447	10.1371/journal.pone.0077447	http://dx.doi.org/10.1371/journal.pone.0077447			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204830	Green Published, Green Submitted, gold			2022-12-27	WOS:000326155400037
J	Polgar, E; Durrieux, C; Hughes, DI; Todd, AJ				Polgar, Erika; Durrieux, Camille; Hughes, David I.; Todd, Andrew J.			A Quantitative Study of Inhibitory Interneurons in Laminae I-III of the Mouse Spinal Dorsal Horn	PLOS ONE			English	Article							SUBSTANTIA-GELATINOSA NEURONS; GREEN FLUORESCENT PROTEIN; CONSTRICTION INJURY MODEL; CENTRAL-NERVOUS-SYSTEM; NITRIC-OXIDE SYNTHASE; NEUROPATHIC PAIN; ADULT-RAT; P RECEPTOR; INTRATHECAL SOMATOSTATIN; GABAERGIC NEURONS	Laminae I-III of the spinal dorsal horn contain many inhibitory interneurons that use GABA and/or glycine as a neurotransmitter. Distinct neurochemical populations can be recognised among these cells, and these populations are likely to have differing roles in inhibiting pain or itch. Quantitative studies in rat have shown that inhibitory interneurons account for 25-40% of all neurons in this region. The sst2A receptor is expressed by around half the inhibitory interneurons in laminae I-II, and is associated with particular neurochemically-defined populations. Although much of the work on spinal pain mechanisms has been performed on rat, the mouse is now increasingly used as a model, due to the availability of genetically altered lines. However, quantitative information on the arrangement of interneurons is lacking in the mouse, and it is possible that there are significant species differences in neuronal organisation. In this study, we show that as in the rat, nearly all neurons in laminae I-III that are enriched with glycine also contain GABA, which suggests that GABA-immunoreactivity can be used to identify inhibitory interneurons in this region. These cells account for 26% of the neurons in laminae I-II and 38% of those in lamina III. As in the rat, the sst2A receptor is only expressed by inhibitory interneurons in laminae I-II, and is present on just over half (54%) of these cells. Antibody against the neurokinin 1 receptor was used to define lamina I, and we found that although the receptor was concentrated in this lamina, it was expressed by many fewer cells than in the rat. By estimating the total numbers of neurons in each of these laminae in the L4 segment of the mouse, we show that there are around half as many neurons in each lamina as are present in the corresponding segment of the rat.	[Polgar, Erika; Durrieux, Camille; Hughes, David I.; Todd, Andrew J.] Univ Glasgow, Inst Neurosci & Psychol, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	University of Glasgow	Todd, AJ (corresponding author), Univ Glasgow, Inst Neurosci & Psychol, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	Andrew.Todd@glasgow.ac.uk	Hughes, David I/B-5692-2011; Todd, Andrew J/A-6855-2011	Hughes, David I/0000-0003-1260-3362; Todd, Andrew J/0000-0002-3007-6749	Biotechnology and Biological Sciences Research Council [BB/J001082/1]; Wellcome Trust [091505/Z/10/Z]; BBSRC [BB/J001082/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding provided by Biotechnology and Biological Sciences Research Council, grant ref: BB/J001082/1 URL: http://www.bbsrc.ac.uk/home/home.aspx and Wellcome Trust, grant ref: 091505/Z/10/Z URL: http://www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Ghamdi KS, 2009, NEUROSCIENCE, V164, P1794, DOI 10.1016/j.neuroscience.2009.09.071; Bencivinni I, 2011, EUR J PAIN, V15, P591, DOI 10.1016/j.ejpain.2010.11.001; BJUGN R, 1993, J COMP NEUROL, V328, P406, DOI 10.1002/cne.903280307; BLEAZARD L, 1994, J NEUROSCI, V14, P7655; Brohl D, 2008, DEV BIOL, V322, P381, DOI 10.1016/j.ydbio.2008.08.002; BROWN JL, 1995, J COMP NEUROL, V356, P327, DOI 10.1002/cne.903560302; CHAPMAN V, 1992, NEUROPEPTIDES, V23, P147, DOI 10.1016/0143-4179(92)90115-D; Chery N, 1999, J NEUROSCI, V19, P7342, DOI 10.1523/JNEUROSCI.19-17-07342.1999; Cheunsuang O, 2000, NEUROSCIENCE, V97, P335, DOI 10.1016/S0306-4522(00)00035-X; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; GAUMANN DM, 1988, ANESTHESIOLOGY, V68, P733, DOI 10.1097/00000542-198805000-00011; Graham BA, 2007, J NEUROPHYSIOL, V98, P1057, DOI 10.1152/jn.00581.2007; Grudt TJ, 2002, J PHYSIOL-LONDON, V540, P189, DOI 10.1113/jphysiol.2001.012890; Guillery RW, 2002, J COMP NEUROL, V447, P1, DOI 10.1002/cne.10221; Hantman AW, 2004, J NEUROSCI, V24, P836, DOI 10.1523/JNEUROSCI.4221-03.2004; Heinke B, 2004, J PHYSIOL-LONDON, V560, P249, DOI 10.1113/jphysiol.2004.070540; HOKFELT T, 1975, NEUROSCI LETT, V1, P231, DOI 10.1016/0304-3940(75)90066-X; Honore P, 2000, NEUROSCIENCE, V98, P585, DOI 10.1016/S0306-4522(00)00110-X; Huang MG, 2008, DEV BIOL, V322, P394, DOI 10.1016/j.ydbio.2008.06.031; Hughes DI, 2012, J PHYSIOL-LONDON, V590, P3927, DOI 10.1113/jphysiol.2012.235655; Hughes DI, 2003, J NEUROSCI, V23, P9491; HUNT SP, 1981, NEUROSCIENCE, V6, P1883, DOI 10.1016/0306-4522(81)90029-4; Imhof AK, 2011, ARTHRITIS RHEUM-US, V63, P2352, DOI 10.1002/art.30410; Jiang N, 2003, NEUROSCI RES, V47, P97, DOI 10.1016/S0168-0102(03)00183-4; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; Kim SJ, 2002, NEUROSCIENCE, V114, P1139, DOI 10.1016/S0306-4522(02)00245-2; Kline RH, 2008, J NEUROSCI, V28, P904, DOI 10.1523/JNEUROSCI.4452-07.2008; LAING I, 1994, NEUROSCIENCE, V61, P123, DOI 10.1016/0306-4522(94)90065-5; Lemons LL, 2011, NEUROPEPTIDES, V45, P377, DOI 10.1016/j.npep.2011.08.002; LITTLEWOOD NK, 1995, NEUROSCIENCE, V66, P597, DOI 10.1016/0306-4522(95)00039-L; Lyck L, 2008, J HISTOCHEM CYTOCHEM, V56, P201, DOI 10.1369/jhc.7A7187.2007; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; Malmberg AB, 1998, PAIN, V76, P215, DOI 10.1016/S0304-3959(98)00045-1; MANTYH PW, 1995, SCIENCE, V268, P1629, DOI 10.1126/science.7539937; MAXWELL DJ, 1987, TRENDS NEUROSCI, V10, P117, DOI 10.1016/0166-2236(87)90056-7; Meisner JG, 2010, J NEUROTRAUM, V27, P729, DOI 10.1089/neu.2009.1166; Mesnage B, 2011, J COMP NEUROL, V519, P3139, DOI 10.1002/cne.22668; MOLLENHOLT P, 1988, PAIN, V32, P95, DOI 10.1016/0304-3959(88)90028-0; MOLLENHOLT P, 1992, PAIN, V51, P343, DOI 10.1016/0304-3959(92)90220-6; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nakatsuka T, 2008, J PHYSIOL-LONDON, V586, P2511, DOI 10.1113/jphysiol.2007.146076; NAKAYA Y, 1994, J COMP NEUROL, V347, P249, DOI 10.1002/cne.903470208; OTTERSEN OP, 1987, TRENDS NEUROSCI, V10, P250, DOI 10.1016/0166-2236(87)90168-8; Polgar E, 2005, J NEUROSCI, V25, P6658, DOI 10.1523/JNEUROSCI.1490-05.2005; Polgar E, 1999, J NEUROSCI, V19, P2637; Polgar E, 2003, PAIN, V104, P229, DOI 10.1016/S0304-3959(03)00011-3; Polgar E, 2004, PAIN, V111, P144, DOI 10.1016/j.pain.2004.06.011; Polgar E, 2013, PAIN IN PRESS; Polgar E, 2011, J COMP NEUROL, V519, P1007, DOI 10.1002/cne.22570; POW DV, 1993, J NEUROSCI METH, V48, P51, DOI 10.1016/S0165-0270(05)80007-X; PROUDLOCK F, 1993, J COMP NEUROL, V327, P289, DOI 10.1002/cne.903270210; Ptak K, 2002, EUR J NEUROSCI, V16, P2245, DOI 10.1046/j.1460-9568.2002.02305.x; Puskar Z, 2001, NEUROSCIENCE, V102, P167, DOI 10.1016/S0306-4522(00)00445-0; RIBEIRODASILVA A, 1982, J COMP NEUROL, V209, P176, DOI 10.1002/cne.902090205; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Sardella TCP, 2011, NEUROSCIENCE, V192, P708, DOI 10.1016/j.neuroscience.2011.07.011; Sardella TCP, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-76; Schindler M, 1997, NEUROSCIENCE, V76, P225; Scholz J, 2005, J NEUROSCI, V25, P7317, DOI 10.1523/JNEUROSCI.1526-05.2005; Schulz S, 1998, NEUROSCI LETT, V257, P37, DOI 10.1016/S0304-3940(98)00803-9; Schulz S, 1998, EUR J NEUROSCI, V10, P3700, DOI 10.1046/j.1460-9568.1998.00386.x; SEYBOLD VS, 1982, PEPTIDES, V3, P49, DOI 10.1016/0196-9781(82)90141-3; Shimada IS, 2011, STROKE, V42, P3231, DOI 10.1161/STROKEAHA.111.623280; Sloviter RS, 2001, J COMP NEUROL, V430, P283; SOMOGYI P, 1985, J HISTOCHEM CYTOCHEM, V33, P240, DOI 10.1177/33.3.2579123; Spike RC, 2003, EUR J NEUROSCI, V18, P2433, DOI 10.1046/j.1460-9568.2003.02981.x; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Tiong SYX, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-36; Todd AJ, 1998, NEUROSCIENCE, V85, P459, DOI 10.1016/S0306-4522(97)00669-6; TODD AJ, 1990, J COMP NEUROL, V296, P496, DOI 10.1002/cne.902960312; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Torsney C, 2006, J NEUROSCI, V26, P1833, DOI 10.1523/JNEUROSCI.4584-05.2006; VIGNA SR, 1994, J NEUROSCI, V14, P834; Villeda SA, 2006, NEUROSCIENCE, V139, P1385, DOI 10.1016/j.neuroscience.2006.01.042; Wang XD, 2013, NEURON, V78, P312, DOI 10.1016/j.neuron.2013.03.001; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; WIESENFELDHALLIN Z, 1985, NEUROSCI LETT, V62, P69, DOI 10.1016/0304-3940(85)90286-1; WIESENFELDHALLIN Z, 1986, NEUROSCI LETT, V67, P319, DOI 10.1016/0304-3940(86)90329-0; Wildner H, 2013, J NEUROSCI, V33, P7299, DOI 10.1523/JNEUROSCI.0491-13.2013; Wiley RG, 2009, NEUROSCIENCE, V161, P139, DOI 10.1016/j.neuroscience.2008.12.017; Wiley RG, 2003, ADV DRUG DELIVER REV, V55, P1043, DOI 10.1016/S0169-409X(03)00102-9; WILLIAMS RW, 1988, J COMP NEUROL, V278, P344, DOI 10.1002/cne.902780305; Woodbury CJ, 2000, J COMP NEUROL, V417, P88, DOI 10.1002/(SICI)1096-9861(20000131)417:1<88::AID-CNE7>3.0.CO;2-U; Yang HW, 1997, EXP BRAIN RES, V114, P99, DOI 10.1007/PL00005627; Yasaka T, 2007, J PHYSIOL-LONDON, V581, P603, DOI 10.1113/jphysiol.2006.123919; Yasaka T, 2010, PAIN, V151, P475, DOI 10.1016/j.pain.2010.08.008; Yoshida T, 2006, J NEUROSCI, V26, P4740, DOI 10.1523/JNEUROSCI.0054-06.2006; YOSHIMURA M, 1995, J PHYSIOL-LONDON, V482, P29, DOI 10.1113/jphysiol.1995.sp020497; Zeilhofer HU, 2012, PHYSIOL REV, V92, P193, DOI 10.1152/physrev.00043.2010; Zeilhofer HU, 2005, J COMP NEUROL, V482, P123, DOI 10.1002/cne.20349; Zwick M, 2002, J NEUROSCI, V22, P4057, DOI 10.1523/JNEUROSCI.22-10-04057.2002	92	75	78	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78309	10.1371/journal.pone.0078309	http://dx.doi.org/10.1371/journal.pone.0078309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205193	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000326155400077
J	Shih, PC; Yang, YR; Wang, RY				Shih, Pei-Cheng; Yang, Yea-Ru; Wang, Ray-Yau			Effects of Exercise Intensity on Spatial Memory Performance and Hippocampal Synaptic Plasticity in Transient Brain Ischemic Rats	PLOS ONE			English	Article							CA3 PYRAMIDAL NEURONS; BDNF MESSENGER-RNA; TERM-MEMORY; VOLUNTARY EXERCISE; CEREBRAL-ISCHEMIA; DENDRITIC SPINES; DENTATE GYRUS; STRESS; PROTEIN; CORTICOSTERONE	Memory impairment is commonly noted in stroke survivors, and can lead to delay of functional recovery. Exercise has been proved to improve memory in adult healthy subjects. Such beneficial effects are often suggested to relate to hippocampal synaptic plasticity, which is important for memory processing. Previous evidence showed that in normal rats, low intensity exercise can improve synaptic plasticity better than high intensity exercise. However, the effects of exercise intensities on hippocampal synaptic plasticity and spatial memory after brain ischemia remain unclear. In this study, we investigated such effects in brain ischemic rats. The middle cerebral artery occlusion (MCAO) procedure was used to induce brain ischemia. After the MCAO procedure, rats were randomly assigned to sedentary (Sed), low-intensity exercise (Low-Ex), or high-intensity exercise (High-Ex) group. Treadmill training began from the second day post MCAO procedure, 30 min/ day for 14 consecutive days for the exercise groups. The Low-Ex group was trained at the speed of 8 m/min, while the High-Ex group at the speed of 20 m/min. The spatial memory, hippocampal brain-derived neurotrophic factor (BDNF), synapsin-I, postsynaptic density protein 95 (PSD-95), and dendritic structures were examined to document the effects. Serum corticosterone level was also quantified as stress marker. Our results showed the Low-Ex group, but not the High-Ex group, demonstrated better spatial memory performance than the Sed group. Dendritic complexity and the levels of BDNF and PSD-95 increased significantly only in the Low-Ex group as compared with the Sed group in bilateral hippocampus. Notably, increased level of corticosterone was found in the High-Ex group, implicating higher stress response. In conclusion, after brain ischemia, low intensity exercise may result in better synaptic plasticity and spatial memory performance than high intensity exercise; therefore, the intensity is suggested to be considered during exercise training.	[Shih, Pei-Cheng; Yang, Yea-Ru; Wang, Ray-Yau] Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol, Taipei 112, Taiwan; [Shih, Pei-Cheng] Mackay Mem Hosp, Dept Phys Therapy, Taipei, Taiwan	National Yang Ming Chiao Tung University; Mackay Memorial Hospital	Wang, RY (corresponding author), Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol, Taipei 112, Taiwan.	rywang@ym.edu.tw		Shih, Pei-Cheng/0000-0003-0017-752X	National Science Council [NSC 98-2314-B-010-004-MY3]; Ministry of Education, Aim for the Top University Plan [101AC-P508]	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	This work was funded by the National Science Council (NSC 98-2314-B-010-004-MY3) and a grant from the Ministry of Education, Aim for the Top University Plan (101AC-P508). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almli CR, 2000, EXP NEUROL, V166, P99, DOI 10.1006/exnr.2000.7492; Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; Bekinschtein P, 2008, P NATL ACAD SCI USA, V105, P2711, DOI 10.1073/pnas.0711863105; Briones TL, 2006, EXP NEUROL, V198, P530, DOI 10.1016/j.expneurol.2005.12.032; Charych EI, 2006, J NEUROSCI, V26, P10164, DOI 10.1523/JNEUROSCI.2379-06.2006; Diamond DM, 2006, HIPPOCAMPUS, V16, P571, DOI 10.1002/hipo.20188; Eadie BD, 2005, J COMP NEUROL, V486, P39, DOI 10.1002/cne.20493; El-Hussein AE, 2000, SCIENCE, V290, P1364; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Ho VM, 2011, SCIENCE, V334, P623, DOI 10.1126/science.1209236; Jacobsen JPR, 2006, BRAIN RES, V1110, P221, DOI 10.1016/j.brainres.2006.06.077; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Lambert KG, 1998, PHYSIOL BEHAV, V65, P43, DOI 10.1016/S0031-9384(98)00114-0; Leuner B, 2003, J NEUROSCI, V23, P659, DOI 10.1523/JNEUROSCI.23-02-00659.2003; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Magarinos AM, 1996, J NEUROSCI, V16, P3534; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; Numakawa Tadahiro, 2010, World J Biol Chem, V1, P133, DOI 10.4331/wjbc.v1.i5.133; Radecki DT, 2005, HIPPOCAMPUS, V15, P246, DOI 10.1002/hipo.20048; Schaaf MJM, 1998, BRAIN RES, V813, P112, DOI 10.1016/S0006-8993(98)01010-5; Shimada H, 2013, BEHAV BRAIN RES, V243, P21, DOI 10.1016/j.bbr.2012.12.018; SHOLL DA, 1953, J ANAT, V87, P387; Sim YJ, 2004, NEUROSCI LETT, V372, P256, DOI 10.1016/j.neulet.2004.09.060; Soya H, 2007, BIOCHEM BIOPH RES CO, V358, P961, DOI 10.1016/j.bbrc.2007.04.173; Stranahan AM, 2007, HIPPOCAMPUS, V17, P1017, DOI 10.1002/hipo.20348; Stranahan AM, 2009, HIPPOCAMPUS, V19, P951, DOI 10.1002/hipo.20577; Takamatsu Y, 2010, BRAIN RES, V1355, P165, DOI 10.1016/j.brainres.2010.07.070; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Tsai YW, 2013, J CEREBR BLOOD F MET, V33, P764, DOI 10.1038/jcbfm.2013.15; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Vaynman S, 2004, J NEUROSCI RES, V76, P356, DOI 10.1002/jnr.20077; Vinogradova OS, 2001, HIPPOCAMPUS, V11, P578, DOI 10.1002/hipo.1073; Wang RY, 2001, BRAIN RES, V922, P140, DOI 10.1016/S0006-8993(01)03154-7; WATANABE Y, 1992, HIPPOCAMPUS, V2, P431, DOI 10.1002/hipo.450020410; Xu XH, 2009, EXP BIOL MED, V234, P296, DOI 10.3181/0804-RM-128; Yang YR, 2012, J MOTOR BEHAV, V44, P97, DOI 10.1080/00222895.2012.654524; Yano H, 2006, NAT NEUROSCI, V9, P1009, DOI 10.1038/nn1730; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765; Zhang PY, 2013, INT J MOL SCI, V14, P6074, DOI 10.3390/ijms14036074	41	89	97	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78163	10.1371/journal.pone.0078163	http://dx.doi.org/10.1371/journal.pone.0078163			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205142	Green Published, gold, Green Submitted			2022-12-27	WOS:000326155400074
J	Hobden, MR; Martin-Morales, A; Guerin-Deremaux, L; Wils, D; Costabile, A; Walton, GE; Rowland, I; Kennedy, OB; Gibson, GR				Hobden, Mark R.; Martin-Morales, Agustin; Guerin-Deremaux, Laetitia; Wils, Daniel; Costabile, Adele; Walton, Gemma E.; Rowland, Ian; Kennedy, Orla B.; Gibson, Glenn R.			In Vitro Fermentation of NUTRIOSE (R) FB06, a Wheat Dextrin Soluble Fibre, in a Continuous Culture Human Colonic Model System	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; HUMAN GUT MICROBIOTA; DIET-INDUCED OBESITY; BACTERIAL-POPULATIONS; INSULIN-RESISTANCE; METABOLIC SYNDROME; WEIGHT-LOSS; OVERWEIGHT; SUPPLEMENTATION; ECOLOGY	Wheat dextrin soluble fibre may have metabolic and health benefits, potentially acting via mechanisms governed by the selective modulation of the human gut microbiota. Our aim was to examine the impact of wheat dextrin on the composition and metabolic activity of the gut microbiota. We used a validated in vitro three-stage continuous culture human colonic model (gut model) system comprised of vessels simulating anatomical regions of the human colon. To mimic human ingestion, 7 g of wheat dextrin (NUTRIOSE (R) FB06) was administered to three gut models, twice daily at 10.00 and 15.00, for a total of 18 days. Samples were collected and analysed for microbial composition and organic acid concentrations by 16S rRNA-based fluorescence in situ hybridisation and gas chromatography approaches, respectively. Wheat dextrin mediated a significant increase in total bacteria in vessels simulating the transverse and distal colon, and a significant increase in key butyrate-producing bacteria Clostridium cluster XIVa and Roseburia genus in all vessels of the gut model. The production of principal short-chain fatty acids, acetate, propionate and butyrate, which have been purported to have protective, trophic and metabolic host benefits, were increased. Specifically, wheat dextrin fermentation had a significant butyrogenic effect in all vessels of the gut model and significantly increased production of acetate (vessels 2 and 3) and propionate (vessel 3), simulating the transverse and distal regions of the human colon, respectively. In conclusion, wheat dextrin NUTRIOSE (R) FB06 is selectively fermented in vitro by Clostridium cluster XIVa and Roseburia genus and beneficially alters the metabolic profile of the human gut microbiota.	[Hobden, Mark R.; Martin-Morales, Agustin; Costabile, Adele; Walton, Gemma E.; Rowland, Ian; Kennedy, Orla B.; Gibson, Glenn R.] Univ Reading, Dept Food & Nutr Sci, Reading, Berks, England; [Guerin-Deremaux, Laetitia; Wils, Daniel] Roquette, Lestrem, France	University of Reading	Hobden, MR (corresponding author), Univ Reading, Dept Food & Nutr Sci, Reading, Berks, England.	m.r.hobden@reading.ac.uk		Costabile, Adele/0000-0003-3185-030X; Rowland, Ian/0000-0001-8738-4550	Roquette, France	Roquette, France	The study was funded by Roquette, France. The funders were involved in study design, decision to publish and preparation of the manuscript, however they had no role in running the experiments, data collection or analysis.	[Anonymous], 2009, FIBER INGREDIENTS FO; [Anonymous], APPL ENVIRON MICROB, V66, P4523, DOI [10.1128/AEM.66.10.4523-4527.2000, DOI 10.1128/AEM.66.10.4523-4527.2000.PUBMED:11010909]; Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2009, AM J CLIN NUTR, V90, P1236, DOI 10.3945/ajcn.2009.28095; Cats A, 1996, INT J ONCOL, V9, P1055; Correa P, 1978, Adv Cancer Res, V26, P1, DOI 10.1016/S0065-230X(08)60086-X; CUMMINGS JH, 1991, J APPL BACTERIOL, V70, P443, DOI 10.1111/j.1365-2672.1991.tb02739.x; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336; Fu BQ, 2008, J AOAC INT, V91, P614; Furet JP, 2010, DIABETES, V59, P3049, DOI 10.2337/db10-0253; Gibson G. R., 2010, Food Science and Technology Bulletin: Functional Foods, V7, P1; Guerin-Deremaux L, 2013, OBESITY SILVER SPRIN, V1; Guerin-Deremaux L, 2011, NUTR RES, V31, P665, DOI 10.1016/j.nutres.2011.09.004; Guerin-Deremaux L, 2011, INT J FOOD SCI NUTR, V62, P628, DOI 10.3109/09637486.2011.569492; Guerin-Deremaux L, 2010, NUTR RES PRACT, V4, P470, DOI 10.4162/nrp.2010.4.6.470; Haffner SM, 2006, OBESITY, V14, p121S, DOI 10.1038/oby.2006.291; Harmsen HJM, 1999, MICROB ECOL HEALTH D, V11, P3, DOI DOI 10.1080/089106099435862; Konstantinov S, 2005, HDB CLOSTRIDIA ECOLO, P986; Laitinen R, 2002, SYST APPL MICROBIOL, V25, P241, DOI 10.1078/0723-2020-00118; Lefranc-Millot C, 2012, J INT MED RES, V40, P211, DOI 10.1177/147323001204000122; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li SG, 2010, APPL PHYSIOL NUTR ME, V35, P773, DOI 10.1139/H10-074; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Liou AP, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005687; Macfarlane GT, 2008, J APPL MICROBIOL, V104, P305, DOI 10.1111/j.1365-2672.2007.03520.x; MACFARLANE GT, 1992, FEMS MICROBIOL ECOL, V101, P81, DOI 10.1111/j.1574-6968.1992.tb05764.x; Macfarlane GT, 1998, MICROB ECOL, V35, P180, DOI 10.1007/s002489900072; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Martin-Pelaez S, 2008, FEMS MICROBIOL ECOL, V66, P608, DOI 10.1111/j.1574-6941.2008.00610.x; Murphy KG, 2006, NATURE, V444, P854, DOI 10.1038/nature05484; Nazare JA, 2011, J AM COLL NUTR, V30, P63, DOI 10.1080/07315724.2011.10719945; Neyrinck AM, 2012, J NUTR BIOCHEM, V23, P51, DOI 10.1016/j.jnutbio.2010.10.008; Neyrinck AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020944; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Norris JM, 2012, ARTERIOSCL THROM VAS, V32, P2091, DOI 10.1161/ATVBAHA.112.255463; Parnell JA, 2009, AM J CLIN NUTR, V89, P1751, DOI 10.3945/ajcn.2009.27465; Pasman W, 2006, EUR J CLIN NUTR, V60, P1024, DOI 10.1038/sj.ejcn.1602418; Pereira DIA, 2002, APPL ENVIRON MICROB, V68, P4689, DOI 10.1128/AEM.68.9.4689-4693.2002; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; RICHARDSON AJ, 1989, LETT APPL MICROBIOL, V9, P5, DOI 10.1111/j.1472-765X.1989.tb00278.x; Rowland IR, 2009, CURR PHARM DESIGN, V15, P1524, DOI 10.2174/138161209788168191; SAKATA T, 1984, CAN J ANIM SCI, V64, P189, DOI 10.4141/cjas84-218; SAKATA T, 1987, BRIT J NUTR, V58, P95, DOI 10.1079/BJN19870073; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Sleeth ML, 2010, NUTR RES REV, V23, P135, DOI 10.1017/S0954422410000089; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; van den Heuvel EGHM, 2004, EUR J CLIN NUTR, V58, P1046, DOI 10.1038/sj.ejcn.1601930; Vulevic J, 2013, J NUTR, V143, P324, DOI 10.3945/jn.112.166132; Walker AW, 2005, APPL ENVIRON MICROB, V71, P3692, DOI 10.1128/AEM.71.7.3692-3700.2005; Walton G, 2013, PROKARYOTES, P25; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Woods M, 2001, CRC HDB DIETARY FIBR, P257; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	59	29	30	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77128	10.1371/journal.pone.0077128	http://dx.doi.org/10.1371/journal.pone.0077128			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204753	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000326152300016
J	Kang, CK; Moon, JY; Lee, SI; Jablonski, PG				Kang, Chang-ku; Moon, Jong-yeol; Lee, Sang-im; Jablonski, Piotr G.			Cryptically Patterned Moths Perceive Bark Structure When Choosing Body Orientations That Match Wing Color Pattern to the Bark Pattern	PLOS ONE			English	Article							RESTING SITE SELECTION; BACKGROUND SELECTIONS; DISRUPTIVE COLORATION; NOCTURNAL MOTHS; PREY; LEPIDOPTERA; CRYPSIS; FORMS; PALE	Many moths have wing patterns that resemble bark of trees on which they rest. The wing patterns help moths to become camouflaged and to avoid predation because the moths are able to assume specific body orientations that produce a very good match between the pattern on the bark and the pattern on the wings. Furthermore, after landing on a bark moths are able to perceive stimuli that correlate with their crypticity and are able to re-position their bodies to new more cryptic locations and body orientations. However, the proximate mechanisms, i.e. how a moth finds an appropriate resting position and orientation, are poorly studied. Here, we used a geometrid moth Jankowskia fuscaria to examine i) whether a choice of resting orientation by moths depends on the properties of natural background, and ii) what sensory cues moths use. We studied moths' behavior on natural (a tree log) and artificial backgrounds, each of which was designed to mimic one of the hypothetical cues that moths may perceive on a tree trunk (visual pattern, directional furrow structure, and curvature). We found that moths mainly used structural cues from the background when choosing their resting position and orientation. Our findings highlight the possibility that moths use information from one type of sensory modality (structure of furrows is probably detected through tactile channel) to achieve crypticity in another sensory modality (visual). This study extends our knowledge of how behavior, sensory systems and morphology of animals interact to produce crypsis.	[Kang, Chang-ku; Moon, Jong-yeol; Lee, Sang-im; Jablonski, Piotr G.] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Lee, Sang-im] Seoul Natl Univ, Inst Adv Machinery & Design, Seoul, South Korea; [Jablonski, Piotr G.] Polish Acad Sci, Ctr Ecol Res, Dziekanow Lesny, Poland	Seoul National University (SNU); Seoul National University (SNU); Polish Academy of Sciences	Jablonski, PG (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea.	SNULBEE@behecolpiotrsangim.org	Kang, Changku/S-3368-2019; Jablonski, Piotr G/A-2753-2015	/0000-0002-8333-0106	National Research Foundation of Korea [2010-0025546]; Brain Korea 21; Animal Behavior Society	National Research Foundation of Korea(National Research Foundation of Korea); Brain Korea 21(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Animal Behavior Society	This work was supported by National Research Foundation of Korea (grant no. 2010-0025546), Brain Korea 21 and Animal Behavior Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOARDMAN M, 1974, J ZOOL, V172, P343, DOI 10.1111/j.1469-7998.1974.tb04110.x; Brechbuhl R, 2010, P ROY SOC B-BIOL SCI, V277, P739, DOI 10.1098/rspb.2009.1632; Cook LM, 2012, BIOL LETTERS, V8, P609, DOI 10.1098/rsbl.2011.1136; Cott H.B., 1940, ADAPTIVE COLORATION; Cuthill IC, 2005, NATURE, V434, P72, DOI 10.1038/nature03312; Cuthill IC, 2009, PHILOS T R SOC B, V364, P489, DOI 10.1098/rstb.2008.0266; Kang CK, 2012, J EVOLUTION BIOL, V25, P1695, DOI 10.1111/j.1420-9101.2012.02557.x; Kang CK, 2013, ANIM BEHAV IN PRESS; KETTLEWELL HBD, 1955, NATURE, V175, P943, DOI 10.1038/175943a0; Land MF, 2002, ANIMAL EYES; LEES DR, 1975, J ZOOL, V176, P341, DOI 10.1111/j.1469-7998.1975.tb03206.x; PIETREWICZ AT, 1977, SCIENCE, V195, P580, DOI 10.1126/science.195.4278.580; Poulton E.B., 1890, COLOURS ANIMALS THEI, DOI [10.1126/science.ns-16.407.286.a, DOI 10.1126/SCIENCE.NS-16.407.286.A]; Ruxton GD, 2004, AVOIDING ATTACK EVOL; SARGENT T D, 1969, Journal of the Lepidopterists' Society, V23, P1; SARGENT TD, 1968, SCIENCE, V159, P100, DOI 10.1126/science.159.3810.100; SARGENT TD, 1969, ANIM BEHAV, V17, P670, DOI 10.1016/S0003-3472(69)80010-2; SARGENT TD, 1969, NATURE, V222, P585, DOI 10.1038/222585b0; SARGENT TD, 1966, SCIENCE, V154, P1674, DOI 10.1126/science.154.3757.1674; SCHNEIDER D, 1964, ANNU REV ENTOMOL, V9, P103, DOI 10.1146/annurev.en.09.010164.000535; Stevens M, 2007, P ROY SOC B-BIOL SCI, V274, P1457, DOI 10.1098/rspb.2007.0220; STEWARD RC, 1985, BIOL J LINN SOC, V24, P285, DOI 10.1111/j.1095-8312.1985.tb00375.x; Thayer G. H, 1918, CONCEALING COLORATIO; Wang Z, 2012, ECOL RES, V27, P107, DOI 10.1007/s11284-011-0877-5; Webster RJ, 2009, PHILOS T R SOC B, V364, P503, DOI 10.1098/rstb.2008.0215; Zar JH, 1999, BIOSTATISTICAL ANAL	26	8	8	10	128	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78117	10.1371/journal.pone.0078117	http://dx.doi.org/10.1371/journal.pone.0078117			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205118	Green Submitted, Green Published, gold			2022-12-27	WOS:000326152300041
J	Mitchell, A; Guan, WH; Staggs, R; Hamel, A; Hozayen, S; Adhikari, N; Grindle, S; Desir, S; John, R; Hall, JL; Eckman, P				Mitchell, Adam; Guan, Weihua; Staggs, Rodney; Hamel, Aimee; Hozayen, Sameh; Adhikari, Neeta; Grindle, Suzanne; Desir, Snider; John, Ranjit; Hall, Jennifer L.; Eckman, Peter			Identification of Differentially Expressed Transcripts and Pathways in Blood One Week and Six Months Following Implant of Left Ventricular Assist Devices	PLOS ONE			English	Article							MYOCARDIAL GENE-EXPRESSION; NECROSIS-FACTOR-ALPHA; HEART-FAILURE; CONTINUOUS-FLOW; RNA-SEQ; CELL-DEATH; PROTEIN; APOPTOSIS; SUPPORT; NIX	Introduction: Continuous-flow left ventricular assist devices (LVADs) are an established therapy for patients with end-stage heart failure. The short-and long-term impact of these devices on peripheral blood gene expression has not been characterized, and may provide insight into the molecular pathways mediated in response to left ventricular remodeling and an improvement in overall systemic circulation. We performed RNA sequencing to identify genes and pathways influenced by these devices. Methods: RNA was extracted from blood of 9 heart failure patients (8 male) prior to LVAD implantation, and at 7 and 180 days postoperatively. Libraries were sequenced on an Illumina HiSeq2000 and sequences mapped to the human Ensembl GRCh37.67 genome assembly. Results: A specific set of genes involved in regulating cellular immune response, antigen presentation, and T cell activation and survival were down-regulated 7 days after LVAD placement. 6 months following LVAD placement, the expression levels of these genes were significantly increased; yet importantly, remained significantly lower than age and sex-matched samples from healthy controls. Conclusions: In summary, this genomic analysis identified a significant decrease in the expression of genes that promote a healthy immune response in patients with heart failure that was partially restored 6 months following LVAD implant.	[Mitchell, Adam; Staggs, Rodney; Adhikari, Neeta; Grindle, Suzanne; Desir, Snider; Hall, Jennifer L.; Eckman, Peter] Univ Minnesota, Dept Med, Lillehei Heart Inst, Minneapolis, MN 55455 USA; [Guan, Weihua] Univ Minnesota, Div Biostat, Minneapolis, MN USA; [Mitchell, Adam; Staggs, Rodney; Hozayen, Sameh; Hall, Jennifer L.; Eckman, Peter] Univ Minnesota, Dept Med, Div Cardiol, Minneapolis, MN 55455 USA; [Hamel, Aimee] Univ Minnesota, Lillehei Clin Res Unit, Minneapolis, MN USA; [John, Ranjit] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Hall, JL (corresponding author), Univ Minnesota, Dept Med, Lillehei Heart Inst, Box 736 UMHC, Minneapolis, MN 55455 USA.	jlhall@umn.edu; eckmanp@umn.edu	Hozayen, Sameh/GQA-9754-2022	Hozayen, Sameh/0000-0002-4582-6530	Lillehei Heart Institute;  [1R21HL104596-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL104596] Funding Source: NIH RePORTER	Lillehei Heart Institute; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The study was funded by 1R21HL104596-01 awarded to JLH and the Lillehei Heart Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson KD, 2012, CIRCULATION, V125, P3191, DOI 10.1161/CIRCULATIONAHA.111.058412; Ankersmit HJ, 1999, LANCET, V354, P550, DOI 10.1016/S0140-6736(98)10359-8; Ankersmit HJ, 1999, CIRCULATION, V100, P211; Bartling B, 1999, CIRCULATION, V100, P216; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blaxall BC, 2003, J AM COLL CARDIOL, V41, P1096, DOI 10.1016/S0735-1097(03)00043-3; Chen YJ, 2003, PHYSIOL GENOMICS, V14, P251, DOI 10.1152/physiolgenomics.00022.2003; Chen Y, 2010, P NATL ACAD SCI USA, V107, P9035, DOI 10.1073/pnas.0914013107; Clark AL, 2001, EUR HEART J, V22, P2275, DOI 10.1053/euhj.2001.2693; Diwan A, 2008, CIRCULATION, V117, P396, DOI 10.1161/CIRCULATIONAHA.107.727073; Dorn GW, 2008, ONCOGENE, V27, pS158, DOI 10.1038/onc.2009.53; Dorn GW, 2011, J MOL CELL CARDIOL, V51, P497, DOI 10.1016/j.yjmcc.2010.09.011; Eckman PM, 2012, CIRCULATION, V125, P3038, DOI 10.1161/CIRCULATIONAHA.111.040246; Fermin DR, 2008, CIRC-CARDIOVASC GENE, V1, P117, DOI 10.1161/CIRCGENETICS.108.802652; Hall JL, 2007, EUR HEART J, V28, P613, DOI 10.1093/eurheartj/ehl365; Hall JL, 2004, PHYSIOL GENOMICS, V17, P283, DOI 10.1152/physiolgenomics.00004.2004; HARRIS TJ, 1995, J AM COLL CARDIOL, V26, P102, DOI 10.1016/0735-1097(95)00123-H; Hellawell JL, 2012, CARDIOVASC THER, V30, P172, DOI 10.1111/j.1755-5922.2010.00247.x; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Kimball P, 2006, TRANSPLANT P, V38, P3695, DOI 10.1016/j.transproceed.2006.10.153; Kimball PM, 2008, ANN THORAC SURG, V85, P1656, DOI 10.1016/j.athoracsur.2008.01.050; Kimura F, 2010, SURG TODAY, V40, P793, DOI 10.1007/s00595-010-4323-z; Lin ZY, 2005, CIRC RES, V96, pE48, DOI 10.1161/01.RES.0000159707.05637.a1; Lou XY, 2012, J CARDIOVASC TRANSL, V5, P345, DOI 10.1007/s12265-011-9321-z; MAISEL AS, 1994, CIRCULATION, V90, P1774, DOI 10.1161/01.CIR.90.4.1774; Mankad AK, 2012, J CARD FAIL, V18, P433, DOI 10.1016/j.cardfail.2012.03.003; Margulies KB, 2005, CIRC RES, V96, P592, DOI 10.1161/01.RES.0000159390.03503.c3; Martin CM, 2008, CIRC RES, V102, P1075, DOI 10.1161/CIRCRESAHA.107.161729; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Miller LW, 2007, NEW ENGL J MED, V357, P885, DOI 10.1056/NEJMoa067758; Razeghi P, 2002, CARDIOLOGY, V97, P203, DOI 10.1159/000063122; Razeghi P, 2001, ANN THORAC SURG, V72, P2044, DOI 10.1016/S0003-4975(01)03172-1; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Schleicher M, 2005, MOL CELL BIOL, V25, P8251, DOI 10.1128/MCB.25.18.8251-8258.2005; Sinha A, 2010, HUM IMMUNOL, V71, P164, DOI 10.1016/j.humimm.2009.10.012; Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938; SLY WS, 1995, ANNU REV BIOCHEM, V64, P375, DOI 10.1146/annurev.bi.64.070195.002111; Starling RC, 2011, J AM COLL CARDIOL, V57, P1890, DOI 10.1016/j.jacc.2010.10.062; Tang TT, 2010, CELL PHYSIOL BIOCHEM, V25, P451, DOI 10.1159/000303050; Torre-Amione G, 1999, CIRCULATION, V100, P1189, DOI 10.1161/01.CIR.100.11.1189; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turbpaiboon C, 2010, FRONT BIOSCI-LANDMRK, V15, P1, DOI 10.2741/3601; VanBuren P, 2011, PHYSIOL GENOMICS, V43, P392, DOI 10.1152/physiolgenomics.00175.2010; Vrtovec B, 2009, EUR J HEART FAIL, V11, P1000, DOI 10.1093/eurjhf/hfp110; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wohlschlaeger J, 2012, J HEART LUNG TRANSPL, V31, P318, DOI 10.1016/j.healun.2011.11.015; Yoshioka J, 2012, J CLIN INVEST, V122, P267, DOI 10.1172/JCI44927; Yu X, 2007, J CLIN INVEST, V117, P1856, DOI 10.1172/JCI31664; Yussman MG, 2002, NAT MED, V8, P725, DOI 10.1038/nm719	52	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77951	10.1371/journal.pone.0077951	http://dx.doi.org/10.1371/journal.pone.0077951			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205042	Green Submitted, Green Published, gold			2022-12-27	WOS:000326032600054
J	Ntie-Kang, F; Zofou, D; Babiaka, SB; Meudom, R; Scharfe, M; Lifongo, LL; Mbah, JA; Mbaze, LM; Sippl, W; Efange, SMN				Ntie-Kang, Fidele; Zofou, Denis; Babiaka, Smith B.; Meudom, Rolande; Scharfe, Michael; Lifongo, Lydia L.; Mbah, James A.; Mbaze, Luc Mevaa; Sippl, Wolfgang; Efange, Simon M. N.			AfroDb: A Select Highly Potent and Diverse Natural Product Library from African Medicinal Plants	PLOS ONE			English	Article							HERG K+ CHANNELS; DRUG DISCOVERY; ANTIMALARIAL ACTIVITY; FORCE-FIELD; PREDICTION; PERMEABILITY; SOLUBILITY; IDENTIFICATION; CONSTITUENTS; HYPOESTOXIDE	Computer-aided drug design (CADD) often involves virtual screening (VS) of large compound datasets and the availability of such is vital for drug discovery protocols. We assess the bioactivity and "drug-likeness" of a relatively small but structurally diverse dataset (containing >1,000 compounds) from African medicinal plants, which have been tested and proven a wide range of biological activities. The geographical regions of collection of the medicinal plants cover the entire continent of Africa, based on data from literature sources and information from traditional healers. For each isolated compound, the three dimensional (3D) structure has been used to calculate physico-chemical properties used in the prediction of oral bioavailability on the basis of Lipinski's "Rule of Five". A comparative analysis has been carried out with the "drug-like", "lead-like", and "fragment-like" subsets, as well as with the Dictionary of Natural Products. A diversity analysis has been carried out in comparison with the ChemBridge diverse database. Furthermore, descriptors related to absorption, distribution, metabolism, excretion and toxicity (ADMET) have been used to predict the pharmacokinetic profile of the compounds within the dataset. Our results prove that drug discovery, beginning with natural products from the African flora, could be highly promising. The 3D structures are available and could be useful for virtual screening and natural product lead generation programs.	[Ntie-Kang, Fidele; Lifongo, Lydia L.] Univ Buea, Fac Sci, Dept Chem, Chem & Bioact Informat Ctr, Buea, Cameroon; [Ntie-Kang, Fidele] Univ Douala, Fac Sci, Ctr Atom Mol Phys Opt & Quantum, Douala, Cameroon; [Ntie-Kang, Fidele; Scharfe, Michael; Sippl, Wolfgang] Univ Halle Wittenberg, Dept Pharmaceut Sci, D-06108 Halle, Saale, Germany; [Zofou, Denis] Univ Buea, Fac Sci, Dept Biochem & Mol Biol, Biotechnol Unit, Buea, Cameroon; [Babiaka, Smith B.; Meudom, Rolande; Mbah, James A.; Efange, Simon M. N.] Univ Buea, Fac Sci, Dept Chem, Buea, Cameroon; [Mbaze, Luc Mevaa] Univ Douala, Dept Chem, Fac Sci, Douala, Cameroon	Martin Luther University Halle Wittenberg	Ntie-Kang, F (corresponding author), Univ Buea, Fac Sci, Dept Chem, Chem & Bioact Informat Ctr, Buea, Cameroon.	ntiekfidele@gmail.com	Sippl, Wolfgang/P-5944-2014; Ntie-Kang, Fidele/B-5877-2013; Zofou, Denis/D-3538-2013	Sippl, Wolfgang/0000-0002-5985-9261; Ntie-Kang, Fidele/0000-0003-0795-394X; Zofou, Denis/0000-0002-3421-7609	Chemical and Bioactivity Information Centre, University of Buea; German Academic Exchange Service; ICTP [OEA-AC-071]; International Foundation for Science, Stockholm, Sweden/Organisation for the Prohibition of Chemical Weapons, The Hague, The Netherlands (IFS/OPCW) [F/5122-1]	Chemical and Bioactivity Information Centre, University of Buea; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); ICTP; International Foundation for Science, Stockholm, Sweden/Organisation for the Prohibition of Chemical Weapons, The Hague, The Netherlands (IFS/OPCW)	Financial support is acknowledged from the Chemical and Bioactivity Information Centre, University of Buea, through a Lhasa grant and also from the German Academic Exchange Service to FNK for his stay in Halle, Germany for part of his PhD, as well as from the ICTP through the OEA-AC-071 program. DZ acknowledges an International Foundation for Science, Stockholm, Sweden/Organisation for the Prohibition of Chemical Weapons, The Hague, The Netherlands (IFS/OPCW) grant (NoF/5122-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajay, 1999, J MED CHEM, V42, P4942, DOI 10.1021/jm990017w; Aronov MM, 2005, DRUG DISCOV TODAY, V10, P149, DOI 10.1016/S1359-6446(04)03278-7; Banzouzi JT, 2004, PHYTOMEDICINE, V11, P338, DOI 10.1078/0944711041495245; Bickii J, 2000, J ETHNOPHARMACOL, V69, P27, DOI 10.1016/S0378-8741(99)00117-8; Block S, 2005, ANTICANCER RES, V25, P363; BUZBEE B, 1993, SCIENCE, V261, P852, DOI 10.1126/science.261.5123.852; Cavalli A, 2002, J MED CHEM, V45, P3844, DOI 10.1021/jm0208875; ChemAxon, 2012, JCHEM SOFTW VERS 5 1; Chemical Computing Group Inc, 2010, MOL OP ENV SOFTW; Chibale K., 2012, DRUG DISCOVERY AFRIC, Vfirst; Chiesa N, 1997, J PHYSIOL-LONDON, V501, P313, DOI 10.1111/j.1469-7793.1997.313bn.x; Chin YW, 2006, AAPS J, V8, pE239, DOI 10.1007/BF02854894; Colmenarejo G, 2001, J MED CHEM, V44, P4370, DOI 10.1021/jm010960b; Couzin J, 1998, SCIENCE, V281, P762; De Ponti F, 2001, EUR J CLIN PHARMACOL, V57, P185, DOI 10.1007/s002280100290; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Duffy EM, 2000, J AM CHEM SOC, V122, P2878, DOI 10.1021/ja993663t; Efange S. M. N., 2002, Ethnomedicine and drug discovery, P61; Feher M, 2003, J CHEM INF COMP SCI, V43, P218, DOI 10.1021/ci0200467; Grabowski K, 2007, CURR CHEM BIOL, V1, P115, DOI DOI 10.2174/187231307779814066; Grabowski K, 2008, NAT PROD REP, V25, P892, DOI 10.1039/b715668p; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004; Hedley PL, 2009, HUM MUTAT, V30, P1486, DOI 10.1002/humu.21106; Hoet S, 2004, NAT PROD REP, V21, P353, DOI 10.1039/b311021b; Hoet S, 2004, PLANTA MED, V70, P407, DOI 10.1055/s-2004-818967; Holtje H.-D., 2008, MOL MODELING BASIC P; Hostettmann K, 2000, CURR ORG CHEM, V4, P973, DOI 10.2174/1385272003375923; Irvine JD, 1999, J PHARM SCI, V88, P28, DOI 10.1021/js9803205; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Jackson SJ, 2000, PLANTA MED, V66, P758, DOI 10.1055/s-2000-9778; Jorgensen WL, 2000, BIOORG MED CHEM LETT, V10, P1155, DOI 10.1016/S0960-894X(00)00172-4; Jorgensen WL, 2002, ADV DRUG DELIVER REV, V54, P355, DOI 10.1016/S0169-409X(02)00008-X; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kelder J, 1999, PHARMACEUT RES, V16, P1514, DOI 10.1023/A:1015040217741; Khanna V, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-30; Kubinyi H, 1998, Curr Opin Drug Discov Devel, V1, P16; Kuete V, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00123; Kuete V, 2010, PLANTA MED, V76, P1479, DOI 10.1055/s-0030-1250027; Lewell XQ, 1998, J CHEM INF COMP SCI, V38, P511, DOI 10.1021/ci970429i; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Luco JM, 1999, J CHEM INF COMP SCI, V39, P396, DOI 10.1021/ci980411n; Magadula JJ, 2009, NAT PROD REP, V26, P1535, DOI 10.1039/b906089h; Mahmoudi N, 2006, J ANTIMICROB CHEMOTH, V57, P489, DOI 10.1093/jac/dki470; Mdee LK, 1998, PHYTOCHEMISTRY, V49, P1107, DOI 10.1016/S0031-9422(97)01037-6; Newman DJ, 2008, J MED CHEM, V51, P2589, DOI 10.1021/jm0704090; Nkanwen ERS, 2013, FITOTERAPIA, V86, P108, DOI 10.1016/j.fitote.2013.02.003; Ntie-Kang F, 2013, RSC ADV UNPUB; Ntie-Kang F, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-147; Ntie-Kang F, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-88; Ojo-Amaize EA, 2002, CANCER RES, V62, P4007; Ojo-Amaize EA, 2001, CELL IMMUNOL, V209, P149, DOI 10.1006/cimm.2001.1798; OKOGUN JI, 1982, Z NATURFORSCH C, V37, P558; Oprea TI, 2002, J COMPUT AID MOL DES, V16, P325, DOI 10.1023/A:1020877402759; Potterat Olivier, 2008, V65; POTTS RO, 1995, PHARMACEUT RES, V12, P1628, DOI 10.1023/A:1016236932339; POTTS RO, 1992, PHARMACEUT RES, V9, P663, DOI 10.1023/A:1015810312465; Quinn RJ, 2008, J NAT PROD, V71, P464, DOI 10.1021/np070526y; R Core Team, 2012, R LANG ENV STAT COMP; Salama MM, 2012, NAT PROD RES, V26, P2057, DOI 10.1080/14786419.2011.606219; Schneider G, 2002, CURR MED CHEM, V9, P2095, DOI 10.2174/0929867023368755; Schrodinger, 2011, LIGPREP SOFTW VERS 2; Schrodinger, 2011, MAESTR VERS 9 2; Schrodinger, 2011, QIKPROP VERS 3 4; Schrodinger Press, 2011, QIKPROP 3 4 US MAN; Schwikkard S, 2002, NAT PROD REP, V19, P675, DOI 10.1039/b008980j; Shivakumar D, 2010, J CHEM THEORY COMPUT, V6, P1509, DOI 10.1021/ct900587b; Sob SVT, 2011, J ASIAN NAT PROD RES, V13, P1128, DOI 10.1080/10286020.2011.619182; Stenberg P, 2001, J MED CHEM, V44, P1927, DOI 10.1021/jm001101a; Teague SJ, 1999, ANGEW CHEM INT EDIT, V38, P3743, DOI 10.1002/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO;2-U; Titanji VPK, 2008, AFR J TRADIT COMPLEM, V5, P302; van de Waterbeemd H, 2003, NAT REV DRUG DISCOV, V2, P192, DOI 10.1038/nrd1032; Vandenberg JI, 2001, TRENDS PHARMACOL SCI, V22, P240, DOI 10.1016/S0165-6147(00)01662-X; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wetzel S, 2007, CHIMIA, V61, P355, DOI 10.2533/chimia.2007.355; World Health Organisation, 1993, HERBAL GRAM, V28, P13; Yazdanian M, 1998, PHARMACEUT RES, V15, P1490, DOI 10.1023/A:1011930411574; Zofou D, 2013, NAT PROD REP, V30, P1098, DOI 10.1039/c3np70030e	82	120	122	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78085	10.1371/journal.pone.0078085	http://dx.doi.org/10.1371/journal.pone.0078085			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205103	Green Published, Green Submitted, gold			2022-12-27	WOS:000326334500094
J	Saby, JN; Meltzoff, AN; Marshall, PJ				Saby, Joni N.; Meltzoff, Andrew N.; Marshall, Peter J.			Infants' Somatotopic Neural Responses to Seeing Human Actions: I've Got You under My Skin	PLOS ONE			English	Article							MU RHYTHM; MOTOR ACTIVATION; SOCIAL COGNITION; EEG; PREMOTOR; IMITATION; ATTENTION; DYNAMICS; SPECTRUM	Human infants rapidly learn new skills and customs via imitation, but the neural linkages between action perception and production are not well understood. Neuroscience studies in adults suggest that a key component of imitation-identifying the corresponding body part used in the acts of self and other-has an organized neural signature. In adults, perceiving someone using a specific body part (e. g., hand vs. foot) is associated with activation of the corresponding area of the sensory and/or motor strip in the observer's brain-a phenomenon called neural somatotopy. Here we examine whether preverbal infants also exhibit somatotopic neural responses during the observation of others' actions. 14-month-old infants were randomly assigned to watch an adult reach towards and touch an object using either her hand or her foot. The scalp electroencephalogram (EEG) was recorded and event-related changes in the sensorimotor mu rhythm were analyzed. Mu rhythm desynchronization was greater over hand areas of sensorimotor cortex during observation of hand actions and was greater over the foot area for observation of foot actions. This provides the first evidence that infants' observation of someone else using a particular body part activates the corresponding areas of sensorimotor cortex. We hypothesize that this somatotopic organization in the developing brain supports imitation and cultural learning. The findings connect developmental cognitive neuroscience, adult neuroscience, action representation, and behavioral imitation.	[Saby, Joni N.; Marshall, Peter J.] Temple Univ, Dept Psychol, Philadelphia, PA 19122 USA; [Meltzoff, Andrew N.] Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Washington; University of Washington Seattle	Saby, JN (corresponding author), Temple Univ, Dept Psychol, Philadelphia, PA 19122 USA.	joni.saby@temple.edu	Meltzoff, Andrew N/GPC-8807-2022	Meltzoff, Andrew N/0000-0001-8683-0547	NIH [HD-68734]; NSF [SMA-0835854]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD068734] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by an NIH (HD-68734) award to PJM and NSF (SMA-0835854) award to ANM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Berchicci M, 2011, DEV NEUROSCI-BASEL, V33, P130, DOI 10.1159/000329095; Blakemore SJ, 2005, BRAIN, V128, P1571, DOI 10.1093/brain/awh500; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Dawson G, 1998, CHILD DEV, V69, P1276, DOI 10.2307/1132265; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Frith CD, 2007, CURR BIOL, V17, pR724, DOI 10.1016/j.cub.2007.05.068; Fujii N, 2008, SOC NEUROSCI-UK, V3, P250, DOI 10.1080/17470910701434610; HAGNE I, 1972, ACTA PAEDIATR SCAND, P1; Hari R, 2009, PHYSIOL REV, V89, P453, DOI 10.1152/physrev.00041.2007; Jones SR, 2010, J NEUROSCI, V30, P13760, DOI 10.1523/JNEUROSCI.2969-10.2010; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Marshall PJ, 2011, DEVELOPMENTAL SCI, V14, P474, DOI 10.1111/j.1467-7687.2010.00991.x; Marshall PJ, 2011, DEV COGN NEUROS-NETH, V1, P110, DOI 10.1016/j.dcn.2010.09.001; Marshall PJ, 2002, CLIN NEUROPHYSIOL, V113, P1199, DOI 10.1016/S1388-2457(02)00163-3; Marshall PJ, 2013, INFANCY; MELTZOFF AN, 1988, DEV PSYCHOL, V24, P470, DOI 10.1037/0012-1649.24.4.470; Meltzoff AN, 1997, EARLY DEV PARENTING, V6, P179, DOI 10.1002/(SICI)1099-0917(199709/12)6:3/4<179::AID-EDP157>3.0.CO;2-R; Meltzoff AN, 2007, DEVELOPMENTAL SCI, V10, P126, DOI 10.1111/j.1467-7687.2007.00574.x; Meltzoff AN, 2013, ACTION SCIENCE: FOUNDATIONS OF AN EMERGING DISCIPLINE, P281; Meltzoff AN, 2009, SCIENCE, V325, P284, DOI 10.1126/science.1175626; Milh M, 2007, CEREB CORTEX, V17, P1582, DOI 10.1093/cercor/bhl069; Nystrom P, 2011, DEVELOPMENTAL SCI, V14, P327, DOI 10.1111/j.1467-7687.2010.00979.x; Pfurtscheller G, 2000, CLIN NEUROPHYSIOL, V111, P1873, DOI 10.1016/S1388-2457(00)00428-4; Pfurtscheller G, 2008, EUR J NEUROSCI, V28, P1419, DOI 10.1111/j.1460-9568.2008.06441.x; Pfurtscheller G, 1997, INT J PSYCHOPHYSIOL, V26, P121, DOI 10.1016/S0167-8760(97)00760-5; Pineda JA, 2005, BRAIN RES REV, V50, P57, DOI 10.1016/j.brainresrev.2005.04.005; Pineda Jaime A., 2009, P135, DOI 10.1007/978-1-59745-479-7_7; Reid VM, 2011, DEV COGN NEUROS-NETH, V1, P124, DOI 10.1016/j.dcn.2011.01.001; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Rogers SJ, 2006, IMITATION SOCIAL MIN; Saby JN, 2012, SOC NEUROSCI-UK, V7, P650, DOI 10.1080/17470919.2012.691429; Saby JN, 2012, DEV NEUROPSYCHOL, V37, P253, DOI 10.1080/87565641.2011.614663; Smith JR, 1941, J PSYCHOL, V11, P177, DOI 10.1080/00223980.1941.9917028; Southgate V, 2010, PSYCHOL SCI, V21, P355, DOI 10.1177/0956797610362058; Southgate V, 2009, BIOL LETTERS, V5, P769, DOI 10.1098/rsbl.2009.0474; Stapel JC, 2010, SOC NEUROSCI-UK, V5, P451, DOI 10.1080/17470919.2010.490667; Stroganova TA, 1999, CLIN NEUROPHYSIOL, V110, P997, DOI 10.1016/S1388-2457(98)00009-1; Toth K, 2006, J AUTISM DEV DISORD, V36, P993, DOI 10.1007/s10803-006-0137-7; von Hofsten C, 2007, DEVELOPMENTAL SCI, V10, P54, DOI 10.1111/j.1467-7687.2007.00564.x; Warreyn P, 2013, DEVELOPMENTAL SCI, V16, P173, DOI 10.1111/desc.12014; Wheaton KJ, 2004, NEUROIMAGE, V22, P277, DOI 10.1016/j.neuroimage.2003.12.043; Yuan H, 2010, NEUROIMAGE, V49, P2596, DOI 10.1016/j.neuroimage.2009.10.028	44	41	42	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77905	10.1371/journal.pone.0077905	http://dx.doi.org/10.1371/journal.pone.0077905			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205023	Green Published, gold, Green Submitted			2022-12-27	WOS:000326334500075
J	Flynn, R; Hutchinson, T; Murphy, KM; Ware, CF; Croft, M; Salek-Ardakani, S				Flynn, Rachel; Hutchinson, Tarun; Murphy, Kenneth M.; Ware, Carl F.; Croft, Michael; Salek-Ardakani, Shahram			CD8 T Cell Memory to a Viral Pathogen Requires Trans Cosignaling between HVEM and BTLA	PLOS ONE			English	Article							HERPESVIRUS ENTRY MEDIATOR; TNF SUPERFAMILY MEMBERS; LYMPHOCYTE ATTENUATOR; B-LYMPHOCYTE; VACCINIA VIRUS; FAMILY-MEMBERS; CUTTING EDGE; INHIBITORY RECEPTORS; ACTIVATION; IMMUNITY	Defining the molecular interactions required to program activated CD8 T cells to survive and become memory cells may allow us to understand how to augment anti-viral immunity. HVEM (herpes virus entry mediator) is a member of the tumor necrosis factor receptor (TNFR) family that interacts with ligands in the TNF family, LIGHT and Lymphotoxin-alpha, and in the Ig family, B and T lymphocyte attenuator (BTLA) and CD160. The Ig family members initiate inhibitory signaling when engaged with HVEM, but may also activate survival gene expression. Using a model of vaccinia virus infection, we made the unexpected finding that deficiency in HVEM or BTLA profoundly impaired effector CD8 T cell survival and development of protective immune memory. Mixed adoptive transfer experiments indicated that BTLA expressed in CD8 alpha+ dendritic cells functions as a trans-activating ligand that delivers positive co-signals through HVEM expressed in T cells. Our data demonstrate a critical role of HVEM-BTLA bidirectional cosignaling system in antiviral defenses by driving the differentiation of memory CD8 T cells.	[Flynn, Rachel; Hutchinson, Tarun; Salek-Ardakani, Shahram] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA; [Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; [Flynn, Rachel; Croft, Michael; Salek-Ardakani, Shahram] La Jolla Inst Allergy & Immunol, Div Immune Regulat, San Diego, CA USA; [Ware, Carl F.] Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, Lab Mol Immunol, La Jolla, CA USA	State University System of Florida; University of Florida; Howard Hughes Medical Institute; Washington University (WUSTL); La Jolla Institute for Immunology; Sanford Burnham Prebys Medical Discovery Institute	Salek-Ardakani, S (corresponding author), Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA.	ssalek@ufl.edu			National Institutes of Health [AI77079, AI087734, CA91837, AI67341, AI033068, AI048073, AI067890]; NATIONAL CANCER INSTITUTE [R01CA091837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048073, R01AI067341, R37AI033068, R56AI067341, R01AI067890, R21AI077079, R01AI087734, R01AI033068] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI77079 and AI087734 to SS-A, CA91837 and AI67341 to MC, AI033068, AI048073 and AI067890 to CFW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Cai GF, 2008, NAT IMMUNOL, V9, P176, DOI 10.1038/ni1554; Cai GF, 2009, IMMUNOL REV, V229, P244, DOI 10.1111/j.1600-065X.2009.00783.x; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Cheung TC, 2005, P NATL ACAD SCI USA, V102, P13218, DOI 10.1073/pnas.0506172102; Cheung TC, 2009, J IMMUNOL, V183, P7286, DOI 10.4049/jimmunol.0902490; Cheung TC, 2009, P NATL ACAD SCI USA, V106, P6244, DOI 10.1073/pnas.0902115106; Croft M, 2005, TRENDS IMMUNOL, V26, P292, DOI 10.1016/j.it.2005.03.010; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Davenport MP, 2009, TRENDS IMMUNOL, V30, P61, DOI 10.1016/j.it.2008.11.001; Deppong C, 2006, J IMMUNOL, V176, P3909, DOI 10.4049/jimmunol.176.7.3909; Gavrieli M, 2003, BIOCHEM BIOPH RES CO, V312, P1236, DOI 10.1016/j.bbrc.2003.11.070; Gavrieli M, 2006, BIOCHEM BIOPH RES CO, V345, P1440, DOI 10.1016/j.bbrc.2006.05.036; Gonzalez LC, 2005, P NATL ACAD SCI USA, V102, P1116, DOI 10.1073/pnas.0409071102; Gourley TS, 2004, SEMIN IMMUNOL, V16, P323, DOI 10.1016/j.smim.2004.08.013; Han P, 2004, J IMMUNOL, V172, P5931, DOI 10.4049/jimmunol.172.10.5931; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Hurchla MA, 2007, J IMMUNOL, V178, P6073, DOI 10.4049/jimmunol.178.10.6073; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Krieg C, 2005, J IMMUNOL, V175, P6420, DOI 10.4049/jimmunol.175.10.6420; Liu XK, 2009, J IMMUNOL, V182, P4516, DOI 10.4049/jimmunol.0803161; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215; Moutaftsi M, 2009, EUR J IMMUNOL, V39, P717, DOI 10.1002/eji.200838815; Murphy KM, 2006, NAT REV IMMUNOL, V6, P671, DOI 10.1038/nri1917; Murphy TL, 2010, ANNU REV IMMUNOL, V28, P389, DOI 10.1146/annurev-immunol-030409-101202; Sakoda Y, 2011, BLOOD, V117, P2506, DOI 10.1182/blood-2010-08-301325; Salek-Ardakani S, 2011, J CLIN INVEST, V121, P296, DOI 10.1172/JCI42056; Salek-Ardakani S, 2010, J INTERF CYTOK RES, V30, P205, DOI 10.1089/jir.2010.0026; Salek-Ardakani S, 2009, J IMMUNOL, V182, P2909, DOI 10.4049/jimmunol.0803545; Salek-Ardakani S, 2008, J IMMUNOL, V181, P7969, DOI 10.4049/jimmunol.181.11.7969; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Sedy JR, 2008, NAT REV IMMUNOL, V8, P861, DOI 10.1038/nri2434; Sedy JR, 2005, NAT IMMUNOL, V6, P90, DOI 10.1038/ni1144; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Steinberg MW, 2008, J EXP MED, V205, P1463, DOI 10.1084/jem.20071160; Tao R, 2005, J IMMUNOL, V175, P5774, DOI 10.4049/jimmunol.175.9.5774; Truong W, 2009, J LEUKOCYTE BIOL, V86, P41, DOI [10.1189/JLB.1107753, 10.1189/jlb.1107753]; Ware CF, 2008, IMMUNOL REV, V223, P186, DOI 10.1111/j.1600-065X.2008.00629.x; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; Ware CF, 2003, CYTOKINE GROWTH F R, V14, P181, DOI 10.1016/S1359-6101(03)00032-7; Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Wong P, 2003, ANNU REV IMMUNOL, V21, P29, DOI 10.1146/annurev.immunol.21.120601.141114; Zhao Y, 2009, J IMMUNOL, V182, P6278, DOI 10.4049/jimmunol.0803682	48	43	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77991	10.1371/journal.pone.0077991	http://dx.doi.org/10.1371/journal.pone.0077991			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205056	Green Published, Green Submitted, gold			2022-12-27	WOS:000326270700064
J	Cerminara, M; Campos, LA; Ramanathan, R; Munoz, V				Cerminara, Michele; Campos, Luis A.; Ramanathan, Ravishankar; Munoz, Victor			Slow Proton Transfer Coupled to Unfolding Explains the Puzzling Results of Single-Molecule Experiments on BBL, a Paradigmatic Downhill Folding Protein	PLOS ONE			English	Article							FREE-ENERGY BARRIERS; FLUORESCENCE SPECTROSCOPY; LANDSCAPE PERSPECTIVE; SPEED LIMIT; DYNAMICS; KINETICS; DOMAIN; 2-STATE; MODEL; RATES	A battery of thermodynamic, kinetic, and structural approaches has indicated that the small alpha-helical protein BBL folds-unfolds via the one-state downhill scenario. Yet, single-molecule fluorescence spectroscopy offers a more conflicting view. Single-molecule experiments at pH 6 show a unique half-unfolded conformational ensemble at mid denaturation, whereas other experiments performed at higher pH show a bimodal distribution, as expected for two-state folding. Here we use thermodynamic and laser T-jump kinetic experiments combined with theoretical modeling to investigate the pH dependence of BBL stability, folding kinetics and mechanism within the pH 6-11 range. We find that BBL unfolding is tightly coupled to the protonation of one of its residues with an apparent pK(a) of similar to 7. Therefore, in chemical denaturation experiments around neutral pH BBL unfolds gradually, and also converts in binary fashion to the protonated species. Moreover, under the single-molecule experimental conditions (denaturant midpoint and 279 K), we observe that proton transfer is much slower than the similar to 15 microseconds folding-unfolding kinetics of BBL. The relaxation kinetics is distinctly biphasic, and the overall relaxation time (i.e. 0.2-0.5 ms) becomes controlled by the proton transfer step. We then show that a simple theoretical model of protein folding coupled to proton transfer explains quantitatively all these results as well as the two sets of single-molecule experiments, including their more puzzling features. Interestingly, this analysis suggests that BBL unfolds following a one-state downhill folding mechanism at all conditions. Accordingly, the source of the bimodal distributions observed during denaturation at pH 7-8 is the splitting of the unique conformational ensemble of BBL onto two slowly inter-converting protonation species. Both, the unprotonated and protonated species unfold gradually (one-state downhill), but they exhibit different degree of unfolding at any given condition because the native structure is less stable for the protonated form.	[Cerminara, Michele; Campos, Luis A.; Ramanathan, Ravishankar; Munoz, Victor] CSIC, Ctr Nacl Biotecnol, Madrid, Spain; [Cerminara, Michele; Campos, Luis A.; Munoz, Victor] IMDEA Nanociencia, Madrid, Spain; [Munoz, Victor] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); IMDEA Nanociencia; University System of Maryland; University of Maryland College Park	Munoz, V (corresponding author), CSIC, Ctr Nacl Biotecnol, Madrid, Spain.	vmunoz@cnb.csic.es	Prieto, Luis Alberto Campos/A-1865-2019; Prieto, Luis Enrique/HFZ-7903-2022	Prieto, Luis Alberto Campos/0000-0003-4788-9102; Cerminara, Michele/0000-0002-2131-395X	Spanish Ministry of Economy and Competitiveness (MINECO) [BFU2008-03237, BIO2011-28092, CONSOLIDER CSD2009-00088]; European Research Council [MOLRHEOSTAT AG-ERC 323059]	Spanish Ministry of Economy and Competitiveness (MINECO); European Research Council(European Research Council (ERC)European Commission)	This work was supported by the grants BFU2008-03237, BIO2011-28092 and CONSOLIDER CSD2009-00088 from the Spanish Ministry of Economy and Competitiveness (MINECO) and the grant MOLRHEOSTAT AG-ERC 323059 from the European Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akmal A, 2004, PROTEINS, V57, P142, DOI 10.1002/prot.20172; Campos LA, 2009, P NATL ACAD SCI USA, V106, pE139, DOI 10.1073/pnas.0912057107; Arbely E, 2010, J MOL BIOL, V403, P313, DOI 10.1016/j.jmb.2010.08.052; Arbely E, 2009, J MOL BIOL, V387, P986, DOI 10.1016/j.jmb.2008.12.055; Bamford CH, 1977, PROTON TRANSFER; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Campos LA, 2013, P NATL ACAD SCI USA, V110, pE1242, DOI 10.1073/pnas.1219166110; Campos LA, 2011, NAT METHODS, V8, P143, DOI 10.1038/NMETH.1553; Cerminara M, 2012, J AM CHEM SOC, V134, P8010, DOI 10.1021/ja301092z; Chan HS, 1998, PROTEINS, V30, P2, DOI 10.1002/(SICI)1097-0134(19980101)30:1<2::AID-PROT2>3.0.CO;2-R; Cho SS, 2008, P NATL ACAD SCI USA, V105, P118, DOI 10.1073/pnas.0709376104; Crooks J. E., 1977, PROTON TRANSFER; De Sancho D, 2011, PHYS CHEM CHEM PHYS, V13, P17030, DOI 10.1039/c1cp20402e; De Sancho D, 2009, J AM CHEM SOC, V131, P2074, DOI 10.1021/ja808843h; Ferguson N, 2006, J MOL BIOL, V356, P1237, DOI 10.1016/j.jmb.2005.12.016; Fung A, 2008, J AM CHEM SOC, V130, P7489, DOI 10.1021/ja801401a; Garcia-Mira MM, 2002, SCIENCE, V298, P2191, DOI 10.1126/science.1077809; Garcia-Mira MM, 2001, BIOPHYS J, V81, P3489, DOI 10.1016/S0006-3495(01)75980-2; Hagen SJ, 1997, J PHYS CHEM B, V101, P2352, DOI 10.1021/jp9622997; Hao MH, 1998, ACCOUNTS CHEM RES, V31, P433, DOI 10.1021/ar960288q; Haran G, 2012, CURR OPIN STRUC BIOL, V22, P14, DOI 10.1016/j.sbi.2011.10.005; Huang F, 2013, P NATL ACAD SCI USA, V110, pE331, DOI 10.1073/pnas.1217840110; Huang F, 2009, P NATL ACAD SCI USA, V106, P16239, DOI 10.1073/pnas.0909126106; IKAI A, 1973, J MOL BIOL, V73, P145, DOI 10.1016/0022-2836(73)90320-3; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Lapidus LJ, 2002, J PHYS CHEM B, V106, P11628, DOI 10.1021/jp020829v; Li P, 2009, P NATL ACAD SCI USA, V106, P103, DOI 10.1073/pnas.0802986106; Liepinsh E, 1996, MAGNET RESON MED, V35, P30, DOI 10.1002/mrm.1910350106; Lin CW, 2013, J AM CHEM SOC, V135, P7668, DOI 10.1021/ja401473m; Liu JW, 2012, P NATL ACAD SCI USA, V109, P179, DOI 10.1073/pnas.1111164109; Munoz V, 2004, P NATL ACAD SCI USA, V101, P17646, DOI 10.1073/pnas.0405829101; Munoz V, 2002, INT J QUANTUM CHEM, V90, P1522, DOI 10.1002/qua.10384; Munoz V, 1997, NATURE, V390, P196, DOI 10.1038/36626; Munoz V, 2007, ANNU REV BIOPH BIOM, V36, P395, DOI 10.1146/annurev.biophys.36.040306.132608; Naganathan AN, 2005, J AM CHEM SOC, V127, P17970, DOI 10.1021/ja055996y; Naganathan AN, 2005, BIOCHEMISTRY-US, V44, P7435, DOI 10.1021/bi050118y; Naganathan AN, 2008, BIOCHEMISTRY-US, V47, P6752, DOI 10.1021/bi800336x; Naganathan AN, 2007, J AM CHEM SOC, V129, P5673, DOI 10.1021/ja0689740; Naganathan AN, 2006, BIOCHEMISTRY-US, V45, P8466, DOI 10.1021/bi060643c; Naganathan AN, 2011, PHYS CHEM CHEM PHYS, V13, P17064, DOI 10.1039/c1cp20156e; Naganathan AN, 2010, J AM CHEM SOC, V132, P11183, DOI 10.1021/ja103612q; Neuweiler H, 2009, J MOL BIOL, V387, P975, DOI 10.1016/j.jmb.2008.12.056; Oliva FY, 2004, J AM CHEM SOC, V126, P8596, DOI 10.1021/ja048309w; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; ROBIEN MA, 1992, BIOCHEMISTRY-US, V31, P3463, DOI 10.1021/bi00128a021; Sadqi M, 2003, P NATL ACAD SCI USA, V100, P12117, DOI 10.1073/pnas.2033863100; Sadqi M, 2007, NATURE, V445, pE17, DOI 10.1038/nature05645; Sadqi M, 2006, NATURE, V442, P317, DOI 10.1038/nature04859; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; Schuler B, 2008, CURR OPIN STRUC BIOL, V18, P16, DOI 10.1016/j.sbi.2007.12.003; Tanford C, 1968, Adv Protein Chem, V23, P121, DOI 10.1016/S0065-3233(08)60401-5; Williams S, 1996, BIOCHEMISTRY-US, V35, P691, DOI 10.1021/bi952217p; Yang WY, 2003, NATURE, V423, P193, DOI 10.1038/nature01609	54	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e78044	10.1371/journal.pone.0078044	http://dx.doi.org/10.1371/journal.pone.0078044			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24205082	Green Published, gold, Green Submitted			2022-12-27	WOS:000326241200051
J	Gottlich, M; Munte, TF; Heldmann, M; Kasten, M; Hagenah, J; Kramer, UM				Goettlich, Martin; Muente, Thomas F.; Heldmann, Marcus; Kasten, Meike; Hagenah, Johann; Kraemer, Ulrike M.			Altered Resting State Brain Networks in Parkinson's Disease	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; SMALL-WORLD; VISUAL HALLUCINATIONS; ANATOMICAL NETWORKS; CORTICAL AREAS; ORGANIZATION; CORTEX; ACTIVATION; IMPAIRMENT; RECEPTORS	Parkinson's disease (PD) is a neurodegenerative disorder affecting dopaminergic neurons in the substantia nigra leading to dysfunctional cortico-striato-thalamic-cortical loops. In addition to the characteristic motor symptoms, PD patients often show cognitive impairments, affective changes and other non-motor symptoms, suggesting system-wide effects on brain function. Here, we used functional magnetic resonance imaging and graph-theory based analysis methods to investigate altered whole-brain intrinsic functional connectivity in PD patients (n = 37) compared to healthy controls (n = 20). Global network properties indicated less efficient processing in PD. Analysis of brain network modules pointed to increased connectivity within the sensorimotor network, but decreased interaction of the visual network with other brain modules. We found lower connectivity mainly between the cuneus and the ventral caudate, medial orbitofrontal cortex and the temporal lobe. To identify regions of altered connectivity, we mapped the degree of intrinsic functional connectivity both on ROI- and on voxel-level across the brain. Compared to healthy controls, PD patients showed lower connectedness in the medial and middle orbitofrontal cortex. The degree of connectivity was also decreased in the occipital lobe (cuneus and calcarine), but increased in the superior parietal cortex, posterior cingulate gyrus, supramarginal gyrus and supplementary motor area. Our results on global network and module properties indicated that PD manifests as a disconnection syndrome. This was most apparent in the visual network module. The higher connectedness within the sensorimotor module in PD patients may be related to compensation mechanism in order to overcome the functional deficit of the striato-cortical motor loops or to loss of mutual inhibition between brain networks. Abnormal connectivity in the visual network may be related to adaptation and compensation processes as a consequence of altered motor function. Our analysis approach proved sensitive for detecting disease-related localized effects as well as changes in network functions on intermediate and global scale.	[Goettlich, Martin; Muente, Thomas F.; Heldmann, Marcus; Hagenah, Johann; Kraemer, Ulrike M.] Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany; [Kasten, Meike] Med Univ Lubeck, Dept Psychiat, D-23538 Lubeck, Germany; [Hagenah, Johann] Westkustenklinikum Heide, Dept Neurol, Heide, Germany	University of Lubeck; University of Lubeck	Gottlich, M (corresponding author), Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany.	martin.goettlich@neuro.uni-luebeck.de	Münte, Thomas/C-2077-2014; Krämer, Ulrike/AAF-2966-2020; Krämer, Ulrike M./A-8871-2019	Krämer, Ulrike M./0000-0002-3841-1812; Kasten, Meike/0000-0003-1910-6035; Gottlich, Martin/0000-0002-7668-0730	Deutsche Forschungsgemeinschaft [KA 3179/2-1]; Bundesministerium fur Bildung und Forschung; University of Lubeck	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); University of Lubeck	TFM has received support from the Deutsche Forschungsgemeinschaft and the Bundesministerium fur Bildung und Forschung. MK has received support from the Deutsche Forschungsgemeinschaft (KA 3179/2-1). This work was supported through intramural funding of the University of Lubeck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amick MM, 2006, NEUROPSYCHOLOGIA, V44, P339, DOI 10.1016/j.neuropsychologia.2005.06.002; Barnes J, 2001, J NEUROL NEUROSUR PS, V70, P727, DOI 10.1136/jnnp.70.6.727; Bassett DS, 2009, P NATL ACAD SCI USA, V106, P11747, DOI 10.1073/pnas.0903641106; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bodis-Wollner I G, 1999, Adv Neurol, V80, P383; BODISWOLLNER I, 1993, ADV NEUROL, V60, P390; BOYSON SJ, 1986, J NEUROSCI, V6, P3177; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cardoso EF, 2010, MOVEMENT DISORD, V25, P1590, DOI 10.1002/mds.23101; CHIODO LA, 1984, NEUROSCIENCE, V12, P1, DOI 10.1016/0306-4522(84)90133-7; Chumbley J, 2010, NEUROIMAGE, V49, P3057, DOI 10.1016/j.neuroimage.2009.10.090; Chumbley JR, 2009, NEUROIMAGE, V44, P62, DOI 10.1016/j.neuroimage.2008.05.021; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; Cronin-Golomb A, 2010, NEUROPSYCHOL REV, V20, P191, DOI 10.1007/s11065-010-9128-8; DIOP L, 1988, SYNAPSE, V2, P395, DOI 10.1002/syn.890020406; Eckert T, 2006, J NEUROL, V253, P199, DOI 10.1007/s00415-005-0956-z; Emre M, 2004, CURR OPIN NEUROL, V17, P399, DOI 10.1097/01.wco.0000137529.30750.ab; FROST JJ, 1993, ANN NEUROL, V34, P423, DOI 10.1002/ana.410340331; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Ginestet CE, 2011, NEUROIMAGE, V55, P688, DOI 10.1016/j.neuroimage.2010.11.030; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Gratton C, 2012, J COGNITIVE NEUROSCI, V24, P1275, DOI 10.1162/jocn_a_00222; Hacker CD, 2012, BRAIN, V135, P3699, DOI 10.1093/brain/aws281; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Helmich RC, 2010, CEREB CORTEX, V20, P1175, DOI 10.1093/cercor/bhp178; Helmich RC, 2009, J NEUROSCI, V29, P6105, DOI 10.1523/JNEUROSCI.0704-09.2009; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P91, DOI 10.1098/rstb.2000.0551; Hirano S, 2012, J NEUROL NEUROSUR PS, V83, P963, DOI 10.1136/jnnp-2011-301818; Jahanshahi M, 2002, J COGNITIVE NEUROSCI, V14, P298, DOI 10.1162/089892902317236911; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Katschnig P, 2011, J NEURAL TRANSM, V118, P783, DOI 10.1007/s00702-011-0621-x; Khoo TK, 2013, NEUROLOGY, V80, P276, DOI 10.1212/WNL.0b013e31827deb74; Kinnison J, 2012, J NEUROSCI, V32, P8361, DOI 10.1523/JNEUROSCI.0821-12.2012; Ko JH, 2012, HUMAN BRAIN MAPPING; Kudlicka A, 2011, MOVEMENT DISORD, V26, P2305, DOI 10.1002/mds.23868; Laatu S, 2004, PARKINSONISM RELAT D, V10, P227, DOI 10.1016/j.parkreldis.2004.02.001; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lewis SJG, 2003, J NEUROSCI, V23, P6351, DOI 10.1523/jneurosci.23-15-06351.2003; Mallol R, 2007, BRAIN RES, V1147, P265, DOI 10.1016/j.brainres.2007.02.046; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; MEADORWOODRUFF JH, 1989, P NATL ACAD SCI USA, V86, P7625, DOI 10.1073/pnas.86.19.7625; Mindham RHS, 2001, J NEUROL NEUROSUR PS, V70, P719; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Park CH, 2008, PHYSICA A, V387, P5958, DOI 10.1016/j.physa.2008.06.048; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rowe J, 2002, BRAIN, V125, P276, DOI 10.1093/brain/awf036; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sabatini U, 2000, BRAIN, V123, P394, DOI 10.1093/brain/123.2.394; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Skidmore F, 2011, NEUROSCI LETT, V499, P47, DOI 10.1016/j.neulet.2011.05.030; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2004, NEUROSCI LETT, V355, P25, DOI 10.1016/j.neulet.2003.10.063; Starkstein SE, 2012, AM J GERIAT PSYCHIAT, V20, P99, DOI 10.1097/JGP.0b013e318240f90a; Stephan KE, 2000, PHILOS T R SOC B, V355, P111, DOI 10.1098/rstb.2000.0552; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Svenningsson P, 2012, LANCET NEUROL, V11, P697, DOI 10.1016/S1474-4422(12)70152-7; TRICK GL, 1994, OPTOMETRY VISION SCI, V71, P242, DOI 10.1097/00006324-199404000-00002; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WILLIAMS SM, 1993, CEREB CORTEX, V3, P199, DOI 10.1093/cercor/3.3.199; Wu T, 2009, NEUROSCI LETT, V460, P6, DOI 10.1016/j.neulet.2009.05.046; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; Young DE, 2010, VISION RES, V50, P2495, DOI 10.1016/j.visres.2010.08.029; Yu H, 2007, NEUROIMAGE, V35, P222, DOI 10.1016/j.neuroimage.2006.11.047; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027	74	161	162	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77336	10.1371/journal.pone.0077336	http://dx.doi.org/10.1371/journal.pone.0077336			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204812	Green Published, gold, Green Submitted			2022-12-27	WOS:000326241200026
J	Fortune, B; Reynaud, J; Wang, L; Burgoyne, CF				Fortune, Brad; Reynaud, Juan; Wang, Lin; Burgoyne, Claude F.			Does Optic Nerve Head Surface Topography Change Prior to Loss of Retinal Nerve Fiber Layer Thickness: A Test of the Site of Injury Hypothesis in Experimental Glaucoma	PLOS ONE			English	Article							INTRAOCULAR-PRESSURE ELEVATION; SCANNING LASER TOMOGRAPHY; OPEN-ANGLE GLAUCOMA; LAMINA-CRIBROSA; GANGLION-CELLS; 3-D HISTOMORPHOMETRY; AXOPLASMIC-TRANSPORT; COHERENCE TOMOGRAPHY; CONNECTIVE-TISSUE; MONKEY	Purpose: To test the hypothesis that optic nerve head (ONH) deformation manifesting as changes in its mean surface height precedes thinning of the peripapillary retinal nerve fiber layer (RNFL) in experimental glaucoma (EG). Methods: 68 rhesus macaque monkeys each had three or more baseline imaging sessions under manometric intraocular pressure (IOP) control to obtain average RNFL thickness (RNFLT) and the ONH surface topography parameter mean position of the disc (MPD). Laser photocoagulation was then applied to the trabecular meshwork of one eye to induce chronic, mild-to-moderate IOP elevation and bi-weekly imaging continued. Event analysis was applied to determine for each parameter when an 'endpoint' occurred (signficant change from baseline) for eight different endpoint criteria. Specificity was assessed in the group of 68 fellow control eyes. Classical signal detection theory and survival analysis were used to compare MPD with RNFLT. Results: Regardless of the endpoint criterion, endpoints were always more frequent for MPD than for RNFLT. The discriminability index (d') was 2.7 +/- 0.2 for MPD and 1.9 +/- 0.2 for RNFLT (p<0.0001). Endpoints were reached by MPD an average of 1-2 months earlier than by RNFLT (p<0.01). At the onset of the first specific, detectable MPD change in EG eyes, there was still no significant change in RNFLT on average (p=0.29) and only 25% of individual eyes exhibited signficant reduction. In contrast, at onset of signficant RNFLT change, MPD had already changed an average of 101 mu m from baseline (p<0.0001) and 71% of the individual eyes had exhibited significant change. The magnitude of MPD change was more than could be explained on the basis of axon loss alone. Conclusions: This study demonstrates that the average surface height of the ONH changes prior to any detectable loss of average peripapillary RNFL thickness in non-human primate eyes with experimental glaucoma.	[Fortune, Brad] Legacy Hlth, Devers Eye Inst, Discoveries Sight Res Labs, Portland, OR USA; Legacy Hlth, Legacy Res Inst, Portland, OR USA	Devers Eye Institute; Legacy Health; Legacy Health	Fortune, B (corresponding author), Legacy Hlth, Devers Eye Inst, Discoveries Sight Res Labs, Portland, OR USA.	bfortune@deverseye.org		Wang, Lin/0000-0003-0385-8478; Burgoyne, Claude/0000-0002-2765-4739; Fortune, Brad/0000-0003-0284-5173	National Institutes of Health (NIH) of the U.S. Department of Health and Human Services [R01EY019327, R01-EY019939, R01-EY011610]; Heidelberg Engineering, GmbH, Heidelberg, Germany; NATIONAL EYE INSTITUTE [R01EY011610, R01EY019939, R01EY019327] Funding Source: NIH RePORTER	National Institutes of Health (NIH) of the U.S. Department of Health and Human Services; Heidelberg Engineering, GmbH, Heidelberg, Germany; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from The National Institutes of Health (NIH) of the U.S. Department of Health and Human Services: NIH R01EY019327 (BF), R01-EY019939 (LW), R01-EY011610 (CFB); http://www.nih.gov; as well as by The Legacy Good Samaritan Foundation. Additional support (equipment and unrestricted research support) was received from Heidelberg Engineering, GmbH, Heidelberg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DR, 1974, INVEST OPHTH VISUAL, V13, P771; Bellezza AJ, 2003, INVEST OPHTH VIS SCI, V44, P623, DOI 10.1167/iovs.01-1282; Bosco A, 2011, J COMP NEUROL, V519, P599, DOI 10.1002/cne.22516; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Burgoyne CF, 2011, EXP EYE RES, V93, P120, DOI 10.1016/j.exer.2010.09.005; Chauhan BC, 2002, INVEST OPHTH VIS SCI, V43, P2969; Chauhan BC, 2001, ARCH OPHTHALMOL-CHIC, V119, P1492; Chauhan BC, 2000, INVEST OPHTH VIS SCI, V41, P775; Chidlow G, 2011, ACTA NEUROPATHOL, V121, P737, DOI 10.1007/s00401-011-0807-1; Cull G, 2013, INVEST OPHTH VIS SCI, V54, P4271, DOI 10.1167/iovs.13-12013; Cull GA, 2012, INVEST OPHTH VIS SCI, V53, P7766, DOI 10.1167/iovs.12-10752; Dai C, 2012, GLIA, V60, P13, DOI 10.1002/glia.21242; Danesh-Meyer HV, 2009, INVEST OPHTHALMOL VI; EMERY JM, 1974, T AM ACAD OPHTHALMOL, V78, P290; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Fortune B, 2013, INVEST OPHTH VIS SCI, V54, P5653, DOI 10.1167/iovs.13-12219; Fortune B, 2012, INVEST OPHTH VIS SCI, V53, P3939, DOI 10.1167/iovs.12-9979; GAASTERLAND D, 1974, INVEST OPHTH VISUAL, V13, P455; GEIJSSEN HC, 1987, OPHTHALMIC SURG LAS, V18, P207; Grieshaber MC, 2007, SURV OPHTHALMOL, V52, pS144, DOI 10.1016/j.survophthal.2007.08.010; Heickell AG, 2001, J GLAUCOMA, V10, P369, DOI 10.1097/00061198-200110000-00002; Hernandez MR, 2008, PROG BRAIN RES, V173, P353, DOI 10.1016/S0079-6123(08)01125-4; Hernandez MR, 2000, PROG RETIN EYE RES, V19, P297, DOI 10.1016/S1350-9462(99)00017-8; Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181; Howell GR, 2013, EXP NEUROL, V246, P54, DOI 10.1016/j.expneurol.2012.01.014; Medeiros FA, 2013, OPHTHALMOLO IN PRESS; MINCKLER DS, 1977, INVEST OPHTH VIS SCI, V16, P426; Nickells RW, 2012, ANNU REV NEUROSCI, V35, P153, DOI 10.1146/annurev.neuro.051508.135728; Nicolela MT, 1996, OPHTHALMOLOGY, V103, P640, DOI 10.1016/S0161-6420(96)30640-4; Osborne NN, 2008, PROG BRAIN RES, V173, P339, DOI 10.1016/S0079-6123(08)01124-2; QUIGLEY HA, 1983, INVEST OPHTH VIS SCI, V24, P1305; QUIGLEY HA, 1976, INVEST OPHTH VISUAL, V15, P606; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; QUIGLEY HA, 1993, NEW ENGL J MED, V328, P1097, DOI 10.1056/NEJM199304153281507; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; QUIGLEY HA, 1980, INVEST OPHTH VIS SCI, V19, P505; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Roberts MD, 2009, INVEST OPHTH VIS SCI, V50, P681, DOI 10.1167/iovs.08-1792; Ryskamp DA, 2011, J NEUROSCI, V31, P7089, DOI 10.1523/JNEUROSCI.0359-11.2011; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Strouthidis NG, 2011, INVEST OPHTH VIS SCI, V52, P9431, DOI 10.1167/iovs.11-7922; Strouthidis NG, 2011, INVEST OPHTH VIS SCI, V52, P1206, DOI 10.1167/iovs.10-5599; VANBUSKIRK EM, 1992, AM J OPHTHALMOL, V113, P447, DOI 10.1016/S0002-9394(14)76171-9; VRABEC F, 1976, A GRAEF ARCH KLIN EX, V198, P223, DOI 10.1007/BF00410715; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Yang HL, 2007, INVEST OPHTH VIS SCI, V48, P5068, DOI 10.1167/iovs.07-0790; Yang HL, 2007, INVEST OPHTH VIS SCI, V48, P4597, DOI 10.1167/iovs.07-0349; Yang HL, 2011, INVEST OPHTH VIS SCI, V52, P7109, DOI 10.1167/iovs.11-7448; Yang HL, 2011, INVEST OPHTH VIS SCI, V52, P345, DOI 10.1167/iovs.09-5122	50	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77831	10.1371/journal.pone.0077831	http://dx.doi.org/10.1371/journal.pone.0077831			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204989	Green Published, Green Submitted, gold			2022-12-27	WOS:000326155400058
J	Fuchs, F; Bruyere, M; Senat, MV; Purenne, E; Benhamou, D; Fernandez, H				Fuchs, Florent; Bruyere, Marie; Senat, Marie-Victoire; Purenne, Emilien; Benhamou, Dan; Fernandez, Herve			Are Standard Intra-Abdominal Pressure Values Different during Pregnancy?	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; ABDOMINAL COMPARTMENT SYNDROME; HYPERTENSION; TERM	Background: Measurement of intra-abdominal pressure (IAP) is an important parameter in the surveillance of intensive care unit patients. Standard values of IAP during pregnancy have not been well defined. The aim of this study was to assess IAP values in pregnant women before and after cesarean delivery. Methods: This prospective study, carried out from January to December 2011 in a French tertiary care centre, included women with an uneventful pregnancy undergoing elective cesarean delivery at term. IAP was measured through a Foley catheter inserted in the bladder under spinal anaesthesia before cesarean delivery, and every 30 minutes during the first two hours in the immediate postoperative period. Results: The study included 70 women. Mean IAP before cesarean delivery was 14.2 mmHg (95% CI: 6.3-23). This value was significantly higher than in the postoperative period: 11.5 mmHg (95% CI: 5-19.7) for the first measurement (p = 0.002). IAP did not significantly change during the following two postoperative hours (p = 0.2). Obese patients (n = 25) had a preoperative IAP value significantly higher than non-obese patients: 15.7 vs. 12.4; p = 0.02. Conclusion: In term pregnancies, IAP values are significantly higher before delivery than in the post-partum period, where IAP values remain elevated for at least two hours at the level of postoperative classical abdominal surgery. The knowledge of these physiological changes in IAP values may help prevent organ dysfunction/failure when abdominal compartment syndrome occurs after cesarean delivery.	[Fuchs, Florent; Senat, Marie-Victoire; Fernandez, Herve] Hop Bicetre, Assistance Publ Hop Paris, Dept Obstet & Gynecol, Le Kremlin Bicetre, France; [Fuchs, Florent; Senat, Marie-Victoire; Fernandez, Herve] INSERM, Ctr Res Epidemiol & Populat Hlth, U1018, Villejuif, France; [Fuchs, Florent; Senat, Marie-Victoire; Fernandez, Herve] Univ Paris 11, Unit 1018, Villejuif, France; [Bruyere, Marie; Purenne, Emilien; Benhamou, Dan] Hop Bicetre, Assistance Publ Hop Paris, Dept Anesthesia, Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay	Fuchs, F (corresponding author), Hop Bicetre, Assistance Publ Hop Paris, Dept Obstet & Gynecol, Le Kremlin Bicetre, France.	florent.fuchs@bct.aphp.fr	Benhamou, Dan/ABG-7935-2021; FUCHS, Florent/AAA-5460-2019	FUCHS, Florent/0000-0003-3530-6328; FERNANDEZ, Herve/0000-0002-6463-1018				Abdel-Razeq SS, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.055; ACOG, 2009, OBSTET GYNECOL, V113, P443; Al-Khan A, 2011, J REPROD MED, V56, P53; Berghella V, 2005, AM J OBSTET GYNECOL, V193, P1607, DOI 10.1016/j.ajog.2005.03.063; Chun R, 2012, INT J OBSTET ANESTH, V21, P135, DOI 10.1016/j.ijoa.2011.10.010; Chun R, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-S1-S5; Cuppett C, 2008, AM J OBSTET GYNECOL, V199, pS151, DOI 10.1016/j.ajog.2008.09.544; De Keulenaer BL, 2009, INTENS CARE MED, V35, P969, DOI 10.1007/s00134-009-1445-0; Kirkpatrick AW, 2013, INTENS CARE MED, V39, P1190, DOI 10.1007/s00134-013-2906-z; KRON IL, 1984, ANN SURG, V199, P28, DOI 10.1097/00000658-198401000-00005; Malbrain MLNG, 2004, INTENS CARE MED, V30, P822, DOI 10.1007/s00134-004-2169-9; Malbrain MLNG, 2005, CRIT CARE MED, V33, P315, DOI 10.1097/01.CCM.0000153408.09806.1B; Sugerman HJ, 2011, MED HYPOTHESES, V77, P841, DOI 10.1016/j.mehy.2011.07.051; Sugrue M, 1999, ARCH SURG-CHICAGO, V134, P1082, DOI 10.1001/archsurg.134.10.1082; Sugrue M, 2005, CURR OPIN CRIT CARE, V11, P333, DOI 10.1097/01.ccx.0000170505.53657.48; Vidal MG, 2008, CRIT CARE MED, V36, P1823, DOI 10.1097/CCM.0b013e31817c7a4d; Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089; Wilkinson C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000120.pub2	18	27	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77324	10.1371/journal.pone.0077324	http://dx.doi.org/10.1371/journal.pone.0077324			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204808	gold, Green Submitted, Green Published			2022-12-27	WOS:000326155400034
J	Juntti, SA; Hu, CK; Fernald, RD				Juntti, Scott A.; Hu, Caroline K.; Fernald, Russell D.			Tol2-Mediated Generation of a Transgenic Haplochromine Cichlid, Astatotilapia burtoni	PLOS ONE			English	Article							TILAPIA OREOCHROMIS-NILOTICUS; TOL2 TRANSPOSABLE ELEMENT; EXPLOSIVE SPECIATION; AGGRESSIVE-BEHAVIOR; ADAPTIVE RADIATION; SOCIAL-BEHAVIOR; PARENTAL CARE; GENE-TRANSFER; MEDAKA FISH; ZEBRAFISH	Cichlid fishes represent one of the most species-rich and rapid radiations of a vertebrate family. These similar to 2200 species, predominantly found in the East African Great Lakes, exhibit dramatic differences in anatomy, physiology, and behavior. However, the genetic bases for this radiation, and for the control of their divergent traits, are unknown. A flood of genomic and transcriptomic data promises to suggest mechanisms underlying the diversity, but transgenic technology will be needed to rigorously test the hypotheses generated. Here we demonstrate the successful use of the Tol2 transposon system to generate transgenic Astatotilapia burtoni, a haplochromine cichlid from Lake Tanganyika, carrying the GFP transgene under the control of the ubiquitous EF1 alpha promoter. The transgene integrates into the genome, is successfully passed through the germline, and the widespread GFP expression pattern is stable across siblings and multiple generations. The stable inheritance and expression patterns indicate that the Tol2 system can be applied to generate A. burtoni transgenic lines. Transgenesis has proven to be a powerful technology for manipulating genes and cells in other model organisms and we anticipate that transgenic A. burtoni and other cichlids will be used to test the mechanisms underlying behavior and speciation.	[Juntti, Scott A.; Hu, Caroline K.; Fernald, Russell D.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Juntti, SA (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	sjuntti@stanford.edu		Juntti, Scott/0000-0001-7634-1395; Hu, Caroline/0000-0003-3772-5737	NIH [F32HD071755]; Gabilan Stanford Graduate Fellowship; NSF [IOS-0923588];  [NIH-NS 034950];  [MH 101373]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD071755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH101373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034950, R37NS034950, R56NS034950] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gabilan Stanford Graduate Fellowship; NSF(National Science Foundation (NSF)); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by funding from NIH F32HD071755 to SAJ, a Gabilan Stanford Graduate Fellowship to CKH, and NIH-NS 034950, MH 101373, and NSF IOS-0923588 to RDF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson RC, 2003, P NATL ACAD SCI USA, V100, P5252, DOI 10.1073/pnas.0930235100; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baier H, 2009, CURR OPIN NEUROBIOL, V19, P553, DOI 10.1016/j.conb.2009.08.001; BREM G, 1988, AQUACULTURE, V68, P209, DOI 10.1016/0044-8486(88)90354-7; Burket CT, 2008, TRANSGENIC RES, V17, P265, DOI 10.1007/s11248-007-9152-5; Burmeister SS, 2009, BRAIN BEHAV EVOLUT, V74, P110, DOI 10.1159/000235613; Carleton KL, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-22; Cooper WJ, 2010, PLOS ONE, V5, pA38, DOI 10.1371/journal.pone.0009551; DAVIS MR, 1990, J NEUROBIOL, V21, P1180, DOI 10.1002/neu.480210804; DEVLIN RH, 1994, NATURE, V371, P209, DOI 10.1038/371209a0; FERNALD RD, 1977, ANIM BEHAV, V25, P964, DOI 10.1016/0003-3472(77)90048-3; FERNALD RD, 1979, Z TIERPSYCHOL, V50, P180; FERNALD RD, 1985, J COMP NEUROL, V238, P202, DOI 10.1002/cne.902380207; Fernald RD, 2012, P NATL ACAD SCI USA, V109, P17194, DOI 10.1073/pnas.1202552109; Fernald RD, 2012, ANNU REV NEUROSCI, V35, P133, DOI 10.1146/annurev-neuro-062111-150520; FERNO A, 1987, BEHAVIOUR, V103, P241, DOI 10.1163/156853987X00189; FERNO A, 1986, BEHAV PROCESS, V13, P367, DOI 10.1016/0376-6357(86)90031-8; Fujimura K, 2007, DEV GROWTH DIFFER, V49, P301, DOI [10.1111/j.1440-169x.2007.00926.x, 10.1111/j.1440-169X.2007.00926.x]; Fujimura K, 2011, AQUACULTURE, V319, P342, DOI 10.1016/j.aquaculture.2011.07.021; Golan M, 2013, GEN COMP EN IN PRESS; Goodwin NB, 1998, P ROY SOC B-BIOL SCI, V265, P2265, DOI 10.1098/rspb.1998.0569; Greenwood AK, 2004, BIOL REPROD, V71, P909, DOI 10.1095/biolreprod.104.030072; Grosenick L, 2007, NATURE, V445, P429, DOI 10.1038/nature05511; Horn C, 2007, NAT GENET, V39, P933, DOI 10.1038/ng0807-933; Hosemann KE, 2004, BEHAVIOUR, V141, P1345, DOI 10.1163/1568539042948097; INOUE K, 1990, CELL DIFFER DEV, V29, P123, DOI 10.1016/0922-3371(90)90030-Z; Ivics Z, 2009, NAT METHODS, V6, P415, DOI [10.1038/NMETH.1332, 10.1038/nmeth.1332]; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kawakami K, 1998, GENE, V225, P17, DOI 10.1016/S0378-1119(98)00537-X; Kawakami K, 2000, P NATL ACAD SCI USA, V97, P11403, DOI 10.1073/pnas.97.21.11403; Kawakami K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S7; Kobayashi N, 2006, GENE, V373, P126, DOI 10.1016/j.gene.2006.01.016; Koblmuller S, 2008, MOL PHYLOGENET EVOL, V49, P153, DOI 10.1016/j.ympev.2008.05.045; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Kotani T, 2006, METHODS, V39, P199, DOI 10.1016/j.ymeth.2005.12.006; KUWAMURA T, 1986, J ETHOL, V4, P129, DOI 10.1007/BF02348115; Lang M, 2006, J EXP ZOOL PART B, V306B, P35, DOI 10.1002/jez.b.21068; LIEM KF, 1980, AM ZOOL, V20, P295; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; O'Connell LA, 2011, FRONT NEUROENDOCRIN, V32, P320, DOI 10.1016/j.yfrne.2010.12.004; Puertollano R, 2006, ENDOSOMES, P119; Rahman MA, 2000, TRANSGENIC RES, V9, P417, DOI 10.1023/A:1026517212807; Renn SCP, 2008, J EXP BIOL, V211, P3041, DOI 10.1242/jeb.018242; Salzburger W, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-17; Salzburger W, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-96; Salzburger W, 2009, MOL ECOL, V18, P169, DOI 10.1111/j.1365-294X.2008.03981.x; Sanetra M, 2009, GENETICS, V182, P387, DOI 10.1534/genetics.108.089367; STUART GW, 1988, DEVELOPMENT, V103, P403; Tasic B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033332; Theis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029878; Thummel R, 2006, THESCIENTIFICWORLDJO, V6, P65, DOI 10.1100/tsw.2006.328; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Turner GF, 2007, CURR BIOL, V17, pR827, DOI 10.1016/j.cub.2007.07.026; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Valenzano DR, 2011, G3-GENES GENOM GENET, V1, P531, DOI 10.1534/g3.111.001271; Van Staaden MJ, 2011, CURR ZOOL, V57, P237, DOI 10.1093/czoolo/57.2.237; Wagner CE, 2012, NATURE, V487, P366, DOI 10.1038/nature11144; Wang TL, 2010, TRAFFIC, V11, P1119, DOI 10.1111/j.1600-0854.2010.01098.x; Wang YP, 2001, CHINESE SCI BULL, V46, P1174	59	28	28	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77647	10.1371/journal.pone.0077647	http://dx.doi.org/10.1371/journal.pone.0077647			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204902	Green Published, Green Submitted, gold			2022-12-27	WOS:000326155400048
J	Libraty, DH; Zhang, L; Woda, M; Acosta, LP; Obcena, A; Brion, JD; Capeding, RZ				Libraty, Daniel H.; Zhang, Lei; Woda, Marcia; Acosta, Luz P.; Obcena, AnaMae; Brion, Job D.; Capeding, Rosario Z.			Toll-Like Receptor Induced Pro-Interleukin-1 beta and Interleukin-6 in Monocytes Are Lower in Healthy Infants Compared to Adults	PLOS ONE			English	Article								Infants have long been known to have higher infectious diseases morbidity and mortality and suboptimal vaccination responses compared to older children and adults. A variety of differences in innate and adaptive immune responses have been described between these two groups. We compared Toll-like receptor (TLR)-induced production of pro-interleukin (IL)-1 beta, IL-6, and tumor necrosis factor (TNF)-alpha between 2-month-old infants and adults. TLR 7/ 8-induced production of pro-IL-1 beta and IL-6 in monocytes was lower in 2-month-old infants compared to adults. There was no difference in TLR 7/8-induced production of TNF-alpha. Lower TLR-induced production of pro-IL-1 beta and IL-6 in innate immune cells during early infancy likely contributes to suboptimal vaccine responses and infectious diseases susceptibility.	[Libraty, Daniel H.; Zhang, Lei; Woda, Marcia] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Acosta, Luz P.] Res Inst Trop Med, Dept Immunol, Manila, Philippines; [Obcena, AnaMae; Capeding, Rosario Z.] Res Inst Trop Med, Dept Med, Manila, Philippines; [Brion, Job D.] San Pablo City Hlth Off, San Pablo, Philippines; [Capeding, Rosario Z.] Res Inst Trop Med, Dept Microbiol, Manila, Philippines	University of Massachusetts System; University of Massachusetts Worcester; Research Institute for Tropical Medicine - Philippines; Research Institute for Tropical Medicine - Philippines; Research Institute for Tropical Medicine - Philippines	Libraty, DH (corresponding author), Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA.	daniel.libraty@umassmed.edu			National Institutes of Health [NIH/NIAID R01 AI091820]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant NIH/NIAID R01 AI091820. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Corbett NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015041; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; Libraty DH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000171; Philbin VJ, 2009, PEDIATR RES, V65, p98R, DOI 10.1203/PDR.0b013e31819f195d; World Health Organization, 2011, WHO ANTHR PERS COMP	6	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78018	10.1371/journal.pone.0078018	http://dx.doi.org/10.1371/journal.pone.0078018			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205068	Green Published, gold, Green Submitted			2022-12-27	WOS:000326155400068
J	Ratti, S; Knoll, AH; Giordano, M				Ratti, Simona; Knoll, Andrew H.; Giordano, Mario			Grazers and Phytoplankton Growth in the Oceans: an Experimental and Evolutionary Perspective	PLOS ONE			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; MARINE-PHYTOPLANKTON; MACROEVOLUTIONARY CHANGE; CAMBRIAN RADIATION; ORGANISMS; AVAILABILITY; BIODIVERSITY; PATTERNS; ECOLOGY; STATE	The taxonomic composition of phytoplankton responsible for primary production on continental shelves has changed episodically through Earth history. Geological correlations suggest that major changes in phytoplankton composition correspond in time to changes in grazing and seawater chemistry. Testing hypotheses that arise from these correlations requires experimentation, and so we carried out a series of experiments in which selected phytoplankton species were grown in treatments that differed with respect to the presence or absence of grazers as well as seawater chemistry. Both protistan (Euplotes sp.) and microarthropod (Acartia tonsa) grazers changed the growth dynamics and biochemical composition of the green alga Tetraselmis suecica, the diatom Thalassiosira weissflogii, and the cyanobacterium Synechococcus sp., increasing the specific growth rate and palatability of the eukaryotic algae, while decreasing or leaving unchanged both parameters in the cyanobacteria. Synechococcus (especially) and Thalassiosira produced toxins effective against the copepod, but ciliate growth was unaffected. Acartia induced a 4-6 fold increase of Si cell quota in the diatom, but Euplotes had no similar effect. The differential growth responses of the eukaryotic algae and cyanobacteria to ciliate grazing may help to explain the apparently coeval radiation of eukaryophagic protists and rise of eukaryotes to ecological prominence as primary producers in Neoproterozoic oceans. The experimental results suggest that phytoplankton responses to the later radiation of microarthropod grazers were clade-specific, and included changes in growth dynamics, toxin synthesis, encystment, and (in diatoms) enhanced Si uptake.	[Ratti, Simona; Giordano, Mario] Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy; [Knoll, Andrew H.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Marche Polytechnic University; Harvard University	Giordano, M (corresponding author), Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy.	m.giordano@univpm.it	Giordano, Mario/A-8949-2008	Giordano, Mario/0000-0001-7754-0521	NASA Astrobiology Institute; Fondazione Cariverona; Ministero delle Politiche Agricole, Alimentari e Forestali; Assemble EU	NASA Astrobiology Institute; Fondazione Cariverona(Fondazione Cariverona); Ministero delle Politiche Agricole, Alimentari e Forestali; Assemble EU	This work was funded by NASA Astrobiology Institute (https://astrobiology.nasa.gov/nai/); Fondazione Cariverona (www.fondazionecariverona.org/); Ministero delle Politiche Agricole, Alimentari e Forestali (http://www.politicheagricole.it); and Assemble EU FP7 research infrastructure initiative (http://www.assemblemarine.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton AD, 2010, SCIENCE, V327, P1509, DOI 10.1126/science.1184961; Berges JA, 2001, J PHYCOL, V37, P1138, DOI 10.1046/j.1529-8817.2001.01052.x; Berney C, 2006, P ROY SOC B-BIOL SCI, V273, P1867, DOI 10.1098/rspb.2006.3537; Bradford-Grieve JM, 2002, HYDROBIOLOGIA, V485, P223, DOI 10.1023/A:1021373412738; Caron DA, 2013, J PLANKTON RES, V35, P235, DOI 10.1093/plankt/fbs091; Domenighini A, 2009, J PHYCOL, V45, P522, DOI 10.1111/j.1529-8817.2009.00662.x; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Fanesi A, 2013, PLANT CELL ENVIRON, DOI [10.1111/pce. 12176., DOI 10.1111/PCE.12176.PUBMED:23927015]; Finkel ZV, 2007, P NATL ACAD SCI USA, V104, P20416, DOI 10.1073/pnas.0709381104; Finkel ZV, 2010, GEOBIOLOGY, V8, P433, DOI 10.1111/j.1472-4669.2010.00250.x; Finkel ZV, 2010, GEOMICROBIOL J, V27, P596, DOI 10.1080/01490451003702941; Giordano M, 2001, J PHYCOL, V37, P271, DOI 10.1046/j.1529-8817.2001.037002271.x; Giordano M, 2013, PLANT SCI, V211, P92, DOI 10.1016/j.plantsci.2013.07.008; Hamm CE, 2003, NATURE, V421, P841, DOI 10.1038/nature01416; Harvey THP, 2012, P NATL ACAD SCI USA, V109, P1589, DOI 10.1073/pnas.1115244109; Hawlena D, 2010, P NATL ACAD SCI USA, V107, P15503, DOI 10.1073/pnas.1009300107; Knoll AH, 2006, PHILOS T R SOC B, V361, P1023, DOI 10.1098/rstb.2006.1843; Knoll AH, 2013, ORIGIN EVOL IN PRESS; Knoll Andrew H., 2007, P133; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; Leandro LF, 2010, J EXP MAR BIOL ECOL, V382, P88, DOI 10.1016/j.jembe.2009.11.002; NEJSTGAARD JC, 1995, ICES J MAR SCI, V52, P347, DOI 10.1016/1054-3139(95)80050-6; Norici A, 2005, PHOTOSYNTH RES, V86, P409, DOI 10.1007/s11120-005-3250-0; Palmucci M, 2011, J PHYCOL, V47, P313, DOI 10.1111/j.1529-8817.2011.00963.x; Parfrey LW, 2011, P NATL ACAD SCI USA, V108, P13624, DOI 10.1073/pnas.1110633108; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pondevan P, 2011, PROTIST, V158, P21; Porter S, 2011, GEOLOGY, V39, P607, DOI 10.1130/focus062011.1; Quigg A, 2003, NATURE, V425, P291, DOI 10.1038/nature01953; Ratti S, 2011, GEOBIOLOGY, V9, P301, DOI 10.1111/j.1472-4669.2011.00284.x; Raven JA, 2009, GEOBIOLOGY, V7, P140, DOI 10.1111/j.1472-4669.2008.00181.x; Saage A, 2009, J SEA RES, V62, P16, DOI 10.1016/j.seares.2009.01.002; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Selden PA, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1049; Smetacek V, 2012, J BIOSCIENCES, V37, P589, DOI 10.1007/s12038-012-9240-4; Sperling EA, 2013, P NATL ACAD SCI USA, V110, P13446, DOI 10.1073/pnas.1312778110; Stehfest K, 2005, PLANT PHYSIOL BIOCH, V43, P717, DOI 10.1016/j.plaphy.2005.07.001; Trommer G, 2012, MAR ECOL PROG SER, V449, P83, DOI 10.3354/meps09508; Vardi A, 2002, CURR BIOL, V12, P1767, DOI 10.1016/S0960-9822(02)01217-4; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075	40	34	35	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77349	10.1371/journal.pone.0077349	http://dx.doi.org/10.1371/journal.pone.0077349			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204815	Green Published, gold, Green Submitted			2022-12-27	WOS:000326152300021
J	Weixel, KM; Marciszyn, A; Alzamora, R; Li, H; Fischer, O; Edinger, RS; Hallows, KR; Johnson, JP				Weixel, Kelly M.; Marciszyn, Allison; Alzamora, Rodrigo; Li, Hui; Fischer, Oliver; Edinger, Robert S.; Hallows, Kenneth R.; Johnson, John P.			Resveratrol Inhibits the Epithelial Sodium Channel via Phopshoinositides and AMP-Activated Protein Kinase in Kidney Collecting Duct Cells	PLOS ONE			English	Article							UBIQUITIN LIGASE NEDD4-2; NA+ CHANNEL; PHOSPHOINOSITIDE 3-KINASE; TRANSPORT; ENAC; PHOSPHATIDYLINOSITIDES; SUBUNIT; MECHANISMS; EXPRESSION; MUTATIONS	Resveratrol, a naturally occurring phytoalexin, has reported cardioprotective, anti-inflammatory, chemopreventative and antidiabetic properties. Several studies indicate the multiple effects of resveratrol on cellular function are due to its inhibition of class 1A phosphoinositide 3-kinase (PI3K) mediated signaling pathways, but it also activates AMP-activated protein kinase (AMPK). As sodium transport in the kidney via the Epithelial Sodium Channel (ENaC) is highly sensitive to changes in phosphoinositide signaling in the membrane and AMPK, we employed resveratrol to probe the relative effects of phosphatidylinositol species in the plasma membrane and AMPK activity and their impact on ENaC activity in mouse cortical collecting duct (mpkCCD(c14)) cells. Here we demonstrate that resveratrol acutely reduces amiloride-sensitive current in mpkCCD(c14) cells. The time course and dose dependency of this inhibition paralleled depletion of the PI(3,4,5)P-3 reporter (AKT-PH) in live-cell microscopy, indicating the early inhibition is likely mediated by resveratrol's known effects on PI3K activity. Additionally, resveratrol induces a late inhibitory effect (4-24 hours) that appears to be mediated via AMPK activation. Resveratrol treatment induces significant AMPK activation compared with vehicle controls after 4 h, which persists through 16 h. Knockdown of AMPK or treatment with the AMPK inhibitor Compound C reduced the late phase of current reduction but had no effect on the early inhibitory activity of resveratrol. Collectively, these data demonstrate that resveratrol inhibits ENaC activity by a dual effect: an early reduction in activity seen within 5 minutes related to depletion of membrane PIP3, and a sustained late (4-24 h) effect secondary to activation of AMPK.	[Marciszyn, Allison; Alzamora, Rodrigo; Li, Hui; Fischer, Oliver; Edinger, Robert S.; Hallows, Kenneth R.; Johnson, John P.] Univ Pittsburgh, Dept Med, Renal Electrolyte Div, Pittsburgh, PA USA; [Hallows, Kenneth R.; Johnson, John P.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA USA; [Weixel, Kelly M.] Washington & Jefferson Univ, Dept Biol, Washington, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Weixel, KM (corresponding author), Washington & Jefferson Univ, Dept Biol, Washington, PA USA.	kweixel@washjeff.edu		Hallows, Kenneth/0000-0002-2964-2440	National Institutes of Health [R01 DK075048, R01 DK047874]; AHA [0825540D]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075048, R01DK047874] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (R01 DK075048 to KRH and R01 DK047874 to JPJ), and AHA #0825540D (to RA). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzamora R, 2010, AM J PHYSIOL-RENAL, V299, pF1308, DOI 10.1152/ajprenal.00423.2010; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; Blazer-Yost BL, 1999, AM J PHYSIOL-CELL PH, V277, pC531, DOI 10.1152/ajpcell.1999.277.3.C531; Butterworth MB, 2009, AM J PHYSIOL-RENAL, V296, pF10, DOI 10.1152/ajprenal.90248.2008; Carattino MD, 2005, J BIOL CHEM, V280, P17608, DOI 10.1074/jbc.M501770200; Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; Chen KH, 2011, CHEM-BIOL INTERACT, V190, P45, DOI 10.1016/j.cbi.2011.01.033; Chung JH, 2012, TRENDS CELL BIOL, V22, P546, DOI 10.1016/j.tcb.2012.07.004; Das S, 2006, FREE RADICAL RES, V40, P1066, DOI 10.1080/10715760600833085; Ding DF, 2010, AM J NEPHROL, V31, P363, DOI 10.1159/000300388; Dolinsky VW, 2013, BIOCH BIOPHYS ACTA; Faber AC, 2006, BIOCHEM PHARMACOL, V72, P1246, DOI 10.1016/j.bcp.2006.08.009; Frojdo S, 2007, BIOCHEM J, V406, P511, DOI 10.1042/BJ20070236; Gonzalez-Rodriguez E, 2007, KIDNEY INT, V71, P116, DOI 10.1038/sj.ki.5002018; Hallows KR, 2010, AM J PHYSIOL-RENAL, V298, pF1067, DOI 10.1152/ajprenal.00005.2010; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Kitada M, 2011, DIABETES, V60, P634, DOI 10.2337/db10-0386; Liu ML, 2010, J BIOL CHEM, V285, P36387, DOI 10.1074/jbc.M110.169284; Ooms Lisa M., 2009, V462, P223, DOI 10.1007/978-1-60327-115-8_15; Park CE, 2007, EXP MOL MED, V39, P222, DOI 10.1038/emm.2007.25; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Pervaiz S, 2009, ANTIOXID REDOX SIGN, V11, P2851, DOI [10.1089/ars.2008.2412, 10.1089/ARS.2008.2412]; Pochynyuk O, 2006, AM J PHYSIOL-RENAL, V290, pF949, DOI 10.1152/ajprenal.00386.2005; Pochynyuk O, 2008, CURR OPIN NEPHROL HY, V17, P533, DOI 10.1097/MNH.0b013e328308fff3; Pochynyuk O, 2007, J GEN PHYSIOL, V130, P399, DOI 10.1085/jgp.200709800; Pochynyuk O, 2007, J PHYSIOL-LONDON, V580, P365, DOI 10.1113/jphysiol.2006.127449; Record RD, 1998, AM J PHYSIOL-ENDOC M, V274, pE611, DOI 10.1152/ajpendo.1998.274.4.E611; Rimbaud S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026391; Sexton E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-45; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Staruschenko A, 2004, J BIOL CHEM, V279, P37771, DOI 10.1074/jbc.M402176200; Staruschenko A, 2007, J AM SOC NEPHROL, V18, P1652, DOI 10.1681/ASN.2007010020; Wang H, 2006, J BIOL CHEM, V281, P14129, DOI 10.1074/jbc.M512511200; Wang J, 2008, AM J PHYSIOL-RENAL, V295, pF843, DOI 10.1152/ajprenal.90348.2008; Weixel KM, 2007, J BIOL CHEM, V282, P36534, DOI 10.1074/jbc.M703970200; Xu Q, 2012, NUTR RES, V32, P648, DOI 10.1016/j.nutres.2012.07.002	40	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78019	10.1371/journal.pone.0078019	http://dx.doi.org/10.1371/journal.pone.0078019			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205069	Green Submitted, gold, Green Published			2022-12-27	WOS:000326152300039
J	Duan, JH; Hu, CH; Luo, SQ; Zhao, XY; Wang, TL				Duan, Jinghao; Hu, Chunhong; Luo, Shuqian; Zhao, Xinyan; Wang, Tailing			Microcomputed Tomography with Diffraction-Enhanced Imaging for Morphologic Characterization and Quantitative Evaluation of Microvessel of Hepatic Fibrosis in Rats	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; HIGH-RESOLUTION; LIVER FIBROSIS; BREAST; CT; SPECIMENS; VISUALIZATION; MAMMOGRAPHY; RADIATION; DIAGNOSIS	Backgroud: Hepatic fibrosis can lead to deformation of vessel morphology and structure. In the present feasibility study, high-resolution computed tomography (CT) using diffraction-enhanced imaging (DEI) was used to represent three-dimensional (3D) vessel microstructures of hepatic fibrosis in rats and to differentiate different stages of hepatic fibrosis using qualitative descriptions and quantitative measurement of microvessels. Material and Methods: Three typical specimens at different stages, i.e., mild, moderate and severe hepatic fibrosis, were imaged using DEI at 15 keV without contrast agents. The correspondence between DEI-CT images and histopathological findings was determined. The 3D visualizations from different stages of hepatic fibrosis were presented using DEI-CT. Additionally, Qualitative descriptions and quantitative evaluation of vessel features, such as vessel trend, vascular distortion deformation, thrombus formation and texture features on the inner wall of the vessel, were performed. Results: DEI-CT produced high-resolution images of the vessel microstructures in hepatic fibrosis that corresponded to information on actual structures observed from the histological sections. Combined with the 3D visualization technique, DEI-CT enabled the acquisition of an accurate description of the 3D vessel morphology from different stages of hepatic fibrosis. Qualitative descriptions and quantitative assessment of microvessels demonstrated clear differences between the different stages of hepatic fibrosis. The thrombus inside the vessel of severe liver fibrosis was accurately displayed, and corresponding analysis can provide an exact measurement of vessel stenosis rate. Conclusions: DEI-CT may allow morphologic descriptions and quantitative evaluation of vessel microstructures from different stages of hepatic fibrosis and can better characterize the various stages of fibrosis progression using high-resolution 3D vessel morphology.	[Duan, Jinghao; Hu, Chunhong] Tianjin Med Univ, Coll Biomed Engn, Tianjin, Peoples R China; [Luo, Shuqian] Capital Med Univ, Coll Biomed Engn, Beijing, Peoples R China; [Zhao, Xinyan] Capital Med Univ, Liver Res Ctr, Beijing Friendship Hosp, Beijing, Peoples R China; [Wang, Tailing] China Japan Friendship Hosp, Dept Pathol, Beijing, Peoples R China	Tianjin Medical University; Capital Medical University; Capital Medical University; China-Japan Friendship Hospital	Hu, CH (corresponding author), Tianjin Med Univ, Coll Biomed Engn, Tianjin, Peoples R China.	chunhong_hu@hotmail.com			National Natural Science Foundation of China [30900333, 81371549]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grants 30900333 and 81371549). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arfelli F, 2000, RADIOLOGY, V215, P286, DOI 10.1148/radiology.215.1.r00ap10286; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bonekamp S, 2009, J HEPATOL, V50, P17, DOI 10.1016/j.jhep.2008.10.016; Brankov JG, 2006, MED PHYS, V33, P278, DOI 10.1118/1.2150788; Bravin A, 2007, PHYS MED BIOL, V52, P2197, DOI 10.1088/0031-9155/52/8/011; Bravin A, 2013, PHYS MED BIOL, V58, pR1, DOI 10.1088/0031-9155/58/1/R1; CARO JJ, 1991, AM J ROENTGENOL, V156, P825, DOI 10.2214/ajr.156.4.1825900; Chapman D, 1997, PHYS MED BIOL, V42, P2015, DOI 10.1088/0031-9155/42/11/001; Coan P, 2010, PHYS MED BIOL, V55, P7649, DOI 10.1088/0031-9155/55/24/017; Connor DM, 2009, NEUROIMAGE, V46, P908, DOI 10.1016/j.neuroimage.2009.03.019; DAVIS TJ, 1995, NATURE, V373, P595, DOI 10.1038/373595a0; Diemoz PC, 2010, PHYS MED BIOL, V55, P7663, DOI 10.1088/0031-9155/55/24/018; Faulconer L, 2009, ACAD RADIOL, V16, P1329, DOI 10.1016/j.acra.2009.05.006; Gasilov S, 2013, BIOMED OPT EXPRESS, V4, P1512, DOI 10.1364/BOE.4.001512; Godfrey EM, 2013, SEMIN ULTRASOUND CT, V34, P81, DOI 10.1053/j.sult.2012.11.007; Hu CH, 2009, PROG NAT SCI-MATER, V19, P955, DOI 10.1016/j.pnsc.2008.06.031; Keyrilainen J, 2008, RADIOLOGY, V249, P321, DOI 10.1148/radiol.2491072129; Keyrilainen J, 2011, J SYNCHROTRON RADIAT, V18, P689, DOI 10.1107/S090904951102810X; Kottler C, 2010, J APPL PHYS, V108, DOI 10.1063/1.3512871; Li H, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3104860; Li XL, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-73; Liang KH, 1999, PORTAL HYPERTENSION; Lu JS, 1994, CHINESE J ANATOMY, V17, P220; Mannelli L, 2013, EUR RADIOL, V23, P367, DOI 10.1007/s00330-012-2623-y; Momose A, 1996, NAT MED, V2, P473, DOI 10.1038/nm0496-473; Muehleman C, 2006, J ANAT, V208, P115, DOI 10.1111/j.1469-7580.2006.00502.x; Muehleman C, 2010, CLIN ANAT, V23, P530, DOI 10.1002/ca.20993; Papatheodoridis GV, 2003, GUT, V52, P404, DOI 10.1136/gut.52.3.404; Parham C, 2009, ACAD RADIOL, V16, P911, DOI 10.1016/j.acra.2009.02.007; Patel KD, 2011, EXPERT REV GASTROENT, V5, P91, DOI [10.1586/egh.10.85, 10.1586/EGH.10.85]; Pisano ED, 2000, RADIOLOGY, V214, P895, DOI 10.1148/radiology.214.3.r00mr26895; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Seo SJ, 2012, PHYS MED BIOL, V57, P1251, DOI 10.1088/0031-9155/57/5/1251; Sztrokay A, 2012, PHYS MED BIOL, V57, P2931, DOI 10.1088/0031-9155/57/10/2931; Wernick MN, 2003, PHYS MED BIOL, V48, P3875, DOI 10.1088/0031-9155/48/23/006; Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0; Zhang L, 2011, EUR J RADIOL, V80, P158, DOI 10.1016/j.ejrad.2010.08.019; Zhang X, 2013, EUR RADIOL, V23, P417, DOI 10.1007/s00330-012-2630-z; Zhao XY, 2008, PATHOL INT, V58, P580, DOI 10.1111/j.1440-1827.2008.02274.x; Zhao XY, 2009, CLIN EXP PHARMACOL P, V36, P963, DOI 10.1111/j.1440-1681.2009.05194.x; Zhao YZ, 2012, P NATL ACAD SCI USA, V109, P18290, DOI 10.1073/pnas.1204460109	41	9	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78176	10.1371/journal.pone.0078176	http://dx.doi.org/10.1371/journal.pone.0078176			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205147	Green Submitted, Green Published, gold			2022-12-27	WOS:000326032600079
J	Ng, YL; Klopcic, B; Lloyd, F; Forrest, C; Greene, W; Lawrance, IC				Ng, Yoke-Leng; Klopcic, Borut; Lloyd, Frances; Forrest, Cynthia; Greene, Wayne; Lawrance, Ian C.			Secreted Protein Acidic and Rich in Cysteine (SPARC) Exacerbates Colonic Inflammatory Symptoms in Dextran Sodium Sulphate-Induced Murine Colitis	PLOS ONE			English	Article							NULL MICE EXHIBIT; INTESTINAL INFLAMMATION; MATRICELLULAR PROTEIN; ULCERATIVE-COLITIS; MEDIATED COLITIS; IMMUNE-RESPONSE; BOWEL-DISEASE; MOUSE MODELS; CELL-MATRIX; EXPRESSION	Background: Secreted Protein Acidic and Rich in Cysteine (SPARC) is expressed during tissue repair and regulates cellular proliferation, migration and cytokine expression. The aim was to determine if SPARC modifies intestinal inflammation. Methods: Wild-type (WT) and SPARC-null (KO) mice received 3% dextran sodium sulphate (DSS) for 7 days. Inflammation was assessed endoscopically, clinically and histologically. IL-1 beta, IL-4, IL-5, IL-6, IL-10, IL-13, IL-17A, IL-12/IL23p40, TNF-alpha, IFN-gamma, RANTES, MCP-1, MIP-1 alpha, MIP-1 beta, MIG and TGF-beta 1 levels were measured by ELISA and cytometric bead array. Inflammatory cells were characterised by CD68, Ly6G, F4/80 and CD11b immunofluorescence staining and regulatory T cells from spleen and mesenteric lymph nodes were assessed by flow cytometry. Results: KO mice had less weight loss and diarrhoea with less endoscopic and histological inflammation than WT animals. By day 35, all (n = 13) KO animals completely resolved the inflammation compared to 7 of 14 WT mice (p < 0.01). Compared to WTs, KO animals at day 7 had less IL1 beta (p = 0.025) and MIG (p = 0.031) with higher TGF beta 1 (p = 0.017) expression and a greater percentage of FoxP3+ regulatory T cells in the spleen and draining lymph nodes of KO animals (p, 0.01). KO mice also had fewer CD68+ and F4/80+ macrophages, Ly6G+ neutrophils and CD11b+ cells infiltrating the inflamed colon. Conclusions: Compared to WT, SPARC KO mice had less inflammation with fewer inflammatory cells and more regulatory T cells. Together, with increased TGF-beta 1 levels, this could aid in the more rapid resolution of inflammation and restoration of the intestinal mucosa suggesting that the presence of SPARC increases intestinal inflammation.	[Ng, Yoke-Leng; Klopcic, Borut; Lloyd, Frances; Lawrance, Ian C.] Univ Western Australia, Sch Med & Pharmacol, Ctr Inflammatory Bowel Dis, Fremantle, WA, Australia; [Ng, Yoke-Leng; Greene, Wayne] Murdoch Univ, Sch Vet & Biomed Sci, Perth, WA, Australia; [Forrest, Cynthia] Univ Western Australia, Sch Pathol & Lab Med, Fremantle, WA, Australia	University of Western Australia; Murdoch University; University of Western Australia	Ng, YL (corresponding author), Univ Western Australia, Sch Med & Pharmacol, Ctr Inflammatory Bowel Dis, Fremantle, WA, Australia.	yokeleng.ng@uwa.edu.au	Lawrance, Ian C/H-5252-2014	Greene, Wayne/0000-0002-5797-1356				Andres PG, 2000, J IMMUNOL, V164, P6303, DOI 10.4049/jimmunol.164.12.6303; Basu A, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-15; Becker C, 2005, GUT, V54, P950, DOI 10.1136/gut.2004.061283; Birgersdotter A, 2009, BRIT J CANCER, V101, P1393, DOI 10.1038/sj.bjc.6605238; Bradshaw AD, 2003, J INVEST DERMATOL, V120, P949, DOI 10.1046/j.1523-1747.2003.12241.x; Bradshaw AD, 2002, J HISTOCHEM CYTOCHEM, V50, P1; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Brekken RA, 2000, MATRIX BIOL, V19, P569, DOI 10.1016/S0945-053X(00)00105-0; Da Silva APB, 2006, J CELL PHYSIOL, V208, P629, DOI 10.1002/jcp.20701; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; DIGNASS AU, 1993, GASTROENTEROLOGY, V105, P1323, DOI 10.1016/0016-5085(93)90136-Z; Fae KC, 2013, INFLAMMATION; Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513; Guimbaud R, 1998, AM J GASTROENTEROL, V93, P2397, DOI 10.1016/S0002-9270(98)00575-9; Hall LJ, 2011, DIGEST DIS SCI, V56, P79, DOI 10.1007/s10620-010-1240-3; Jendraschak E, 1996, SEMIN CANCER BIOL, V7, P139, DOI 10.1006/scbi.1996.0019; Kurtovic Jelica, 2004, Trop Gastroenterol, V25, P9; Kwon KH, 2005, BIOCHEM BIOPH RES CO, V337, P647, DOI 10.1016/j.bbrc.2005.09.107; LANE TF, 1994, FASEB J, V8, P163, DOI 10.1096/fasebj.8.2.8119487; Latvala T, 1996, EXP EYE RES, V63, P579, DOI 10.1006/exer.1996.0148; Ludwiczek O, 2004, CLIN EXP IMMUNOL, V138, P323, DOI 10.1111/j.1365-2249.2004.02599.x; Mahler M, 1998, AM J PHYSIOL-GASTR L, V274, pG544, DOI 10.1152/ajpgi.1998.274.3.G544; McKaig BC, 1999, AM J PHYSIOL-GASTR L, V276, pG1087, DOI 10.1152/ajpgi.1999.276.5.G1087; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; Norose K, 2000, EXP EYE RES, V71, P295, DOI 10.1006/exer.2000.0884; Norose K, 1998, INVEST OPHTH VIS SCI, V39, P2674; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Rempel SA, 2007, GENES IMMUN, V8, P262, DOI 10.1038/sj.gene.6364388; Savani RC, 2000, AM J PHYSIOL-LUNG C, V279, pL743, DOI 10.1152/ajplung.2000.279.4.L743; Schonbeck U, 1998, J IMMUNOL, V161, P3340; Siegmund B, 2002, GASTROENTEROLOGY, V122, P2011, DOI 10.1053/gast.2002.33631; Socha MJ, 2007, AM J PATHOL, V171, P1104, DOI 10.2353/ajpath.2007.061273; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Tokuyama H, 2005, INT IMMUNOL, V17, P1023, DOI 10.1093/intimm/dxh284; TREMBLE PM, 1993, J CELL BIOL, V121, P1433, DOI 10.1083/jcb.121.6.1433; Wirtz S, 2007, ADV DRUG DELIVER REV, V59, P1073, DOI 10.1016/j.addr.2007.07.003; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Yan Q, 1999, J HISTOCHEM CYTOCHEM, V47, P1495, DOI 10.1177/002215549904701201; YOUNGMAN KR, 1993, GASTROENTEROLOGY, V104, P749, DOI 10.1016/0016-5085(93)91010-F	41	61	62	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77575	10.1371/journal.pone.0077575	http://dx.doi.org/10.1371/journal.pone.0077575			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204877	gold, Green Submitted, Green Published			2022-12-27	WOS:000326032600036
J	Raudabaugh, DB; Miller, AN				Raudabaugh, Daniel B.; Miller, Andrew N.			Nutritional Capability of and Substrate Suitability for Pseudogymnoascus destructans, the Causal Agent of Bat White-Nose Syndrome	PLOS ONE			English	Article							GEOMYCES-DESTRUCTANS; FUNGI; GROWTH; DEGRADATION; INFECTION; PH; PHYSIOLOGY; TOLERANCE; VIRULENCE; ECOLOGY	Pseudogymnoascus destructans, the causal agent of bat white-nose syndrome, has caused nearly six million deaths in North American bats since its introduction into the United States in 2006. Current research has shown that caves can harbor P. destructans even after the infected bats are removed and bats no longer visit or inhabit previously infected caves. Our research focuses on elucidating reservoir requirements by investigating the nutritional capabilities of and substrate suitability requirements for six different P. destructans isolates from various localities including Illinois, Indiana, New York (Type specimen), and Pennsylvania. Enzyme assays implicate that both urease and b-glucosidase appear to be constitutive, lipase and esterase activity were more rapid than proteinase activity on 6% gelatin, gelatin degradation was accompanied by medium alkalinization, the reduction of thiosulfate generated hydrogen sulfide gas, chitinase and manganese dependent peroxidase activity were not visually demonstrated within eight weeks, and keratinase activity was not evident at pH 8 within eight weeks. We demonstrate that all P. destructans isolates are capable of growth and sporulation on dead fish, insect, and mushroom tissues. Sole nitrogen source assays demonstrated that all P. destructans isolates exhibit Class 2 nitrogen utilization and that growth-dependent interactions occur among different pH and nitrogen sources. Substrate suitability assays demonstrated that all isolates could grow and sporulate on media ranging from pH 5-11 and tolerated media supplemented with 2000 mg/L of calcium and 700 mg/L of three separated sulfur compounds: thiosulfate L-cysteine, and sulfite. All isolates were intolerant to PEG-induced matric potential with delayed germination and growth at -2.5 MPa with no visible germination at -5 MPa. Interestingly, decreasing the surface tension with Tween 80 permitted germination and growth of P. destructans in -5 MPa PEG medium within 14 days suggesting a link between substrate suitability and aqueous surface tension altering substances.	[Raudabaugh, Daniel B.] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; [Raudabaugh, Daniel B.; Miller, Andrew N.] Univ Illinois, Illinois Nat Hist Survey, Champaign, IL 61820 USA	University of Illinois System; University of Illinois Urbana-Champaign; Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign	Raudabaugh, DB (corresponding author), Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA.	raudaba2@illinois.edu	Raudabaugh, Daniel/AAJ-8846-2020		Illinois Department of Natural Resources State Wildlife Grants Program [T-78-R-1]; Section 6 Endangered and Threatened Species Program [E-54-R-1]	Illinois Department of Natural Resources State Wildlife Grants Program; Section 6 Endangered and Threatened Species Program	This study was funded through awards given by the Illinois Department of Natural Resources State Wildlife Grants Program (Project NumberT-78-R-1) and the Section 6 Endangered and Threatened Species Program (Project Number E-54-R-1) to the Illinois Natural History Survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhila Rajan, 2011, International Journal of Biological Chemistry, V5, P116, DOI 10.3923/ijbc.2011.116.126; ANDERSEN SO, 1979, ANNU REV ENTOMOL, V24, P29, DOI 10.1146/annurev.en.24.010179.000333; Anthony SR, 2003, TROPICAL SOILS PROPE, P47; Biggs AR, 1997, PLANT DIS, V81, P399, DOI 10.1094/PDIS.1997.81.4.399; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Brock Matthias, 2008, V5, P63; Carissimi M., 2007, TECNOLOGICA, V11, P33; Casadevall A, 2003, CURR OPIN MICROBIOL, V6, P332, DOI 10.1016/S1369-5274(03)00082-1; Chaturvedi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010783; Cryan PM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-135; D'Amico S, 2006, EMBO REP, V7, P385, DOI 10.1038/sj.embor.7400662; Deacon JW, 2006, FUNGAL BIOL-UK; Gadd GM, 2007, MYCOL RES, V111, P3, DOI 10.1016/j.mycres.2006.12.001; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; Garraway MO, 1991, FUNGAL NUTR PHYSL; Ghaedian R, 1998, J FOOD ENG, V35, P323, DOI 10.1016/S0260-8774(98)00027-2; Gooday GW, 1990, BIODEGRADATION, V1, P177, DOI 10.1007/BF00058835; HACSKAYLO J, 1954, MYCOLOGIA, V46, P691, DOI 10.1080/00275514.1954.12024407; Hayes MA, 2012, BIOSCIENCE, V62, P819, DOI 10.1525/bio.2012.62.9.7; Hennicke F, 2013, EUKARYOT CELL, V12, P604, DOI 10.1128/EC.00336-12; Hillel D., 1998, ENV SOIL PHYS; Hung CY, 2007, ANN NY ACAD SCI, V1111, P225, DOI 10.1196/annals.1406.020; Hutton BJ, 1996, ANN BOT-LONDON, V77, P399, DOI 10.1006/anbo.1996.0048; Ito S, 2005, MICROBIAL ENZYMES BI; Klaus U, 1994, COMP ANIMAL BIOCH; KOUKER G, 1987, APPL ENVIRON MICROB, V53, P211, DOI 10.1128/AEM.53.1.211-213.1987; Kunert J., 2000, REV IBER MICOL, V1, P77; Latge J.P., 2006, GROWTH DIFFERENTIATI, P73; Liu YS, 2012, J IND MICROBIOL BIOT, V39, P623, DOI 10.1007/s10295-011-1066-9; LOCKWOOD GF, 1968, MYCOPATH MYCOL APPL, V35, P377, DOI 10.1007/BF02050753; Lorch JM, 2013, APPL ENVIRON MICROB, V79, P1293, DOI 10.1128/AEM.02939-12; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Marin S, 1995, CAN J MICROBIOL, V41, P1063, DOI 10.1139/m95-149; MATHBON G. E., 1964, ANN SOC BELG MED TROP, V44, P767; MCVEIGH I, 1969, MYCOPATH MYCOL APPL, V37, P349, DOI 10.1007/BF02129882; Meteyer CU, 2011, J WILDLIFE DIS, V47, P618, DOI 10.7589/0090-3558-47.3.618; MEXAL J, 1973, CAN J BOT, V51, P1579, DOI 10.1139/b73-201; MICHEL BE, 1983, PLANT PHYSIOL, V72, P66, DOI 10.1104/pp.72.1.66; Murthy NKS, 2012, INTERNET J MICROBIOL, V10, pe2bc3, DOI [10.5580/2bc3, DOI 10.5580/2BC3]; Nagai Koji, 1998, Mycoscience, V39, P293, DOI 10.1007/BF02464011; Northup DE, 2001, GEOMICROBIOL J, V18, P199, DOI 10.1080/01490450152467750; Overton BE, 2006, PHYTOPATHOL MEDITERR, V45, pS131; PICKETT MJ, 1991, J CLIN MICROBIOL, V29, P2322, DOI 10.1128/JCM.29.10.2322-2325.1991; Pointing Stephen B., 1999, Fungal Diversity, V2, P17; Power KC, 2008, GEOTECH TEST J, V31, P461, DOI 10.1520/GTJ101099; Ragab M. M. M., 2012, International Journal of Agriculture and Forestry, V2, P70, DOI 10.5923/j.ijaf.20120202.11; Raudabaugh DB, 2011, MYCOSPHERE, V2, P656, DOI 10.5943/mycosphere/2/6/6; ROBBINS CR, 2002, CHEM PHYS BEHAV HUMA; Rodde RH, 2008, CARBOHYD POLYM, V71, P388, DOI 10.1016/j.carbpol.2007.06.006; Rousk J, 2009, APPL ENVIRON MICROB, V75, P1589, DOI 10.1128/AEM.02775-08; Sancholle M, 2001, MYCOTA, VIX, P63; Sarojini T. S., 1947, PROC INDIAN ACAD SCI SECT B, V26, P69; Scott JA, 2004, MED MYCOL, V42, P239, DOI 10.1080/13693780310001644680; Shepherd D, 1983, FUNGAL DIFFERENTIATI, P515; SISK MARY O., 1957, J MORPH, V101, P425, DOI 10.1002/jmor.1051010303; Smyth C, 2013, BAT RES NEWS, V54, P17; STALINSKI J, 1994, ACTA THERIOL, V39, P1, DOI 10.4098/AT.arch.94-1; STEUTER AA, 1981, PLANT PHYSIOL, V67, P64, DOI 10.1104/pp.67.1.64; Verant ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046280; Warnecke L, 2012, P NATL ACAD SCI US; WAWRZKIEWICZ K, 1987, J MED VET MYCOL, V25, P261; Wibbelt G, 2010, EMERG INFECT DIS, V16, P1237, DOI 10.3201/eid1608.100002; Zabell R. A., 1992, WOOD MICROBIOLOGY DE, P90	63	39	39	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78300	10.1371/journal.pone.0078300	http://dx.doi.org/10.1371/journal.pone.0078300			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205191	Green Submitted, Green Published, gold			2022-12-27	WOS:000326032600091
J	Irague, R; Tarquis, L; Andre, I; Moulis, C; Morel, S; Monsan, P; Potocki-Veronese, G; Remaud-Simeon, M				Irague, Romain; Tarquis, Laurence; Andre, Isabelle; Moulis, Claire; Morel, Sandrine; Monsan, Pierre; Potocki-Veronese, Gabrielle; Remaud-Simeon, Magali			Combinatorial Engineering of Dextransucrase Specificity	PLOS ONE			English	Article							LACTOBACILLUS-REUTERI STRAIN-180; AUTOMATED PROTEIN-STRUCTURE; I-TASSER; STRUCTURAL-CHARACTERIZATION; LEUCONOSTOC-CITREUM; GLUCANSUCRASE; GLUCAN; REUTERANSUCRASE; CONSTRUCTION; ENZYMES	We used combinatorial engineering to investigate the relationships between structure and linkage specificity of the dextransucrase DSR-S from Leuconostoc mesenteroides NRRL B-512F, and to generate variants with altered specificity. Sequence and structural analysis of glycoside-hydrolase family 70 enzymes led to eight amino acids (D306, F353, N404, W440, D460, H463, T464 and S512) being targeted, randomized by saturation mutagenesis and simultaneously recombined. Screening of two libraries totaling 3.6.10(4) clones allowed the isolation of a toolbox comprising 81 variants which synthesize high molecular weight alpha-glucans with different proportions of alpha(1 -> 3) linkages ranging from 3 to 20 %. Mutant sequence analysis, biochemical characterization and molecular modelling studies revealed the previously unknown role of peptide (DYVHT464)-D-460 in DSR-S linkage specificity. This peptide sequence together with residue S512 contribute to defining +2 subsite topology, which may be critical for the enzyme regiospecificity.	[Irague, Romain; Tarquis, Laurence; Andre, Isabelle; Moulis, Claire; Morel, Sandrine; Monsan, Pierre; Potocki-Veronese, Gabrielle; Remaud-Simeon, Magali] UPS, Univ Toulouse, INSA, INP,LISBP, Toulouse, France; [Irague, Romain; Tarquis, Laurence; Andre, Isabelle; Moulis, Claire; Morel, Sandrine; Monsan, Pierre; Potocki-Veronese, Gabrielle; Remaud-Simeon, Magali] CNRS, UMR5504, Toulouse, France; [Irague, Romain; Tarquis, Laurence; Andre, Isabelle; Moulis, Claire; Morel, Sandrine; Monsan, Pierre; Potocki-Veronese, Gabrielle; Remaud-Simeon, Magali] INRA, Ingn Syst Biol & Proc UMR792, F-31931 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Remaud-Simeon, M (corresponding author), UPS, Univ Toulouse, INSA, INP,LISBP, Toulouse, France.	remaud@insa-toulouse.fr	Veronese, Gabrielle/GTF-3473-2022	MOULIS, Claire/0000-0002-1937-9052	French National Institute for Agricultural Research (INRA); French National Center for Scientific Research (CNRS); Region Midi-Pyrenees, France; European Regional Development Fund; INRA;  [CEPIA-AIC2007-2010]	French National Institute for Agricultural Research (INRA); French National Center for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Region Midi-Pyrenees, France(Region Occitanie); European Regional Development Fund(European Commission); INRA; 	This work was funded by the French National Institute for Agricultural Research (INRA) and the French National Center for Scientific Research (CNRS). Grant number : CEPIA-AIC2007-2010, http://www.inra.fr/, http://www.cnrs.fr/. ICEO is supported by grants from the Region Midi-Pyrenees, France, the European Regional Development Fund, and INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre I, 2010, TOP CURR CHEM, V294, P25, DOI 10.1007/128_2010_52; Arguello-Morales MA, 2000, FEMS MICROBIOL LETT, V182, P81, DOI 10.1016/S0378-1097(99)00572-8; Brison Y, 2012, J BIOL CHEM, V287, P7915, DOI 10.1074/jbc.M111.305078; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; COTE GL, 1982, CARBOHYD RES, V101, P57, DOI 10.1016/S0008-6215(00)80795-8; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Fabre E, 2005, J BACTERIOL, V187, P296, DOI 10.1128/JB.187.1.296-303.2005; Vidal RF, 2011, CURR MICROBIOL, V62, P1260, DOI 10.1007/s00284-010-9851-7; Funane K, 2004, BIOSCI BIOTECH BIOCH, V68, P1912, DOI 10.1271/bbb.68.1912; Hellmuth H, 2008, BIOCHEMISTRY-US, V47, P6678, DOI 10.1021/bi800563r; Herman A, 2007, PROTEIN ENG DES SEL, V20, P219, DOI 10.1093/protein/gzm014; Irague R, 2012, BIOMACROMOLECULES, V13, P187, DOI 10.1021/bm201453r; Irague R, 2011, ANAL CHEM, V83, P1202, DOI 10.1021/ac1032148; Ito K, 2011, J MOL BIOL, V408, P177, DOI 10.1016/j.jmb.2011.02.028; Ito K, 2010, ACTA CRYSTALLOGR F, V66, P1086, DOI 10.1107/S1744309110029714; Kang HK, 2011, J AGR FOOD CHEM, V59, P4148, DOI 10.1021/jf104629g; Kralj S, 2005, APPL ENVIRON MICROB, V71, P3942, DOI 10.1128/AEM.71.7.3942-3950.2005; Kralj S, 2005, BIOCHEMISTRY-US, V44, P9206, DOI 10.1021/bi050447q; Kralj S, 2004, MICROBIOL-SGM, V150, P2099, DOI 10.1099/mic.0.27105-0; Kralj S, 2008, FEBS J, V275, P6002, DOI 10.1111/j.1742-4658.2008.06729.x; Kralj S, 2006, FEBS J, V273, P3735, DOI 10.1111/j.1742-4658.2006.05376.x; Kramer B, 1999, PROTEINS, V37, P228, DOI 10.1002/(SICI)1097-0134(19991101)37:2<228::AID-PROT8>3.0.CO;2-8; Leemhuis H, 2013, J BIOTECHNOL, V163, P250, DOI 10.1016/j.jbiotec.2012.06.037; MacGregor EA, 1996, FEBS LETT, V378, P263, DOI 10.1016/0014-5793(95)01428-4; Maina NH, 2008, CARBOHYD RES, V343, P1446, DOI 10.1016/j.carres.2008.04.012; Monchois V, 2000, APPL ENVIRON MICROB, V66, P1923, DOI 10.1128/AEM.66.5.1923-1927.2000; Moulis C, 2006, J BIOL CHEM, V281, P31254, DOI 10.1074/jbc.M604850200; Moulis C, 2006, FEMS MICROBIOL LETT, V261, P203, DOI 10.1111/j.1574-6968.2006.00347.x; Pijning T, 2008, BIOCATAL BIOTRANSFOR, V26, P12, DOI 10.1080/10242420701789163; Pijning T, 2012, ACTA CRYSTALLOGR F, V68, P1448, DOI 10.1107/S1744309112044168; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEYMOUR FR, 1979, CARBOHYD RES, V74, P77, DOI 10.1016/S0008-6215(00)84766-7; SHIMAMURA A, 1994, J BACTERIOL, V176, P4845, DOI 10.1128/jb.176.16.4845-4850.1994; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sumner JB, 1935, J BIOL CHEM, V108, P51; van der Veen BA, 2004, FEBS LETT, V560, P91, DOI 10.1016/S0014-5793(04)00077-8; van Hijum SAFT, 2006, MICROBIOL MOL BIOL R, V70, P157, DOI 10.1128/MMBR.70.1.157-176.2006; van Leeuwen SS, 2008, BIOMACROMOLECULES, V9, P2251, DOI 10.1021/bm800410w; van Leeuwen SS, 2008, CARBOHYD RES, V343, P1237, DOI 10.1016/j.carres.2008.01.042; van Leeuwen SS, 2009, BIOMACROMOLECULES, V10, P580, DOI 10.1021/bm801240r; Vujicic-Zagar A, 2010, P NATL ACAD SCI USA, V107, P21406, DOI 10.1073/pnas.1007531107; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588	46	15	15	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77837	10.1371/journal.pone.0077837	http://dx.doi.org/10.1371/journal.pone.0077837			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204991	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300117
J	Opoku-Acheampong, AB; Unis, D; Henningson, JN; Beck, AP; Lindshield, BL				Opoku-Acheampong, Alexander B.; Unis, Dave; Henningson, Jamie N.; Beck, Amanda P.; Lindshield, Brian L.			Preventive and Therapeutic Efficacy of Finasteride and Dutasteride in TRAMP Mice	PLOS ONE			English	Article							AUTOCHTHONOUS PROSTATE-CANCER; STEROID 5-ALPHA-REDUCTASE; GENE-EXPRESSION; RISK; PROGRESSION; LESIONS; TOMATO; GROWTH; RAT	Background: The prostate cancer prevention trial (PCPT) and Reduction by dutasteride of Prostate Cancer Events (REDUCE) trial found that 5 alpha-reductase (5 alpha R) inhibitors finasteride and dutasteride respectively, decreased prostate cancer prevalence but also increased the incidence of high-grade tumors. 5 alpha R2 is the main isoenzyme in normal prostate tissue; however, most prostate tumors have high 5 alpha R1 and low 5 alpha R2 expression. Because finasteride inhibits only 5 alpha R2, we hypothesized that it would not be as efficacious in preventing prostate cancer development and/or progression in C57BL/6 TRAMP x FVB mice as dutasteride, which inhibits both 5 alpha R1 and 5 alpha R2. Method/Principal Findings: Six-week-old C57BL/6 TRAMP x FVB male mice were randomized to AIN93G control or pre- and post-finasteride and dutasteride diet (83.3 mg drug/kg diet) groups (n =30-33) that began at 6 and 12 weeks of age, respectively, and were terminated at 20 weeks of age. The pre-and post-finasteride and dutasteride groups were designed to test the preventive and therapeutic efficacy of the drugs, respectively. Final body weights, genitourinary tract weights, and genitourinary tract weights as percentage of body weights were significantly decreased in the Pre- and Post-dutasteride groups compared with the control. The Post-dutasteride group showed the greatest inhibition of prostatic intraepithelial neoplasia progression and prostate cancer development. Surprisingly, the Post-dutasteride group showed improved outcomes compared with the Pre-dutasteride group, which had increased incidence of high-grade carcinoma as the most common and most severe lesions in a majority of prostate lobes. Consistent with our hypothesis, we found little benefit from the finasteride diets, and they increased the incidence of high-grade carcinoma. Conclusion: Our findings have commonalities with previously reported PCPT, REDUCE, and the Reduction by dutasteride of Clinical Progression Events in Expectant Management (REDEEM) trial results. Our results may support the therapeutic use of dutasteride, but not finasteride, for therapeutic or preventive use.	[Opoku-Acheampong, Alexander B.; Unis, Dave; Lindshield, Brian L.] Kansas State Univ, Dept Human Nutr, Manhattan, KS 66506 USA; [Unis, Dave] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; [Henningson, Jamie N.] Kansas State Univ, Coll Vet Med, Manhattan, KS 66506 USA; [Beck, Amanda P.] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06510 USA	Kansas State University; Kansas State University; Kansas State University; Yale University	Lindshield, BL (corresponding author), Kansas State Univ, Dept Human Nutr, Manhattan, KS 66506 USA.	blindsh@k-state.edu	Beck, Amanda P/H-9573-2017	Beck, Amanda P/0000-0003-1867-4110; Opoku-Acheampong, Alexander/0000-0002-4589-3776	National Institute of Health COBRE Epithelial Function in Health & Disease (NIH-Grant from NCRR) [P20-RR017686]; Johnson Center for Basic Cancer Research at Kansas State University; Kansas State University Open Access Publishing Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017686] Funding Source: NIH RePORTER	National Institute of Health COBRE Epithelial Function in Health & Disease (NIH-Grant from NCRR); Johnson Center for Basic Cancer Research at Kansas State University; Kansas State University Open Access Publishing Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Institute of Health COBRE Epithelial Function in Health & Disease (NIH-Grant No: P20-RR017686 from NCRR) and the Johnson Center for Basic Cancer Research at Kansas State University. Publication of this article was funded in part by the Kansas State University Open Access Publishing Fund. This is contribution no. 13-370-J from the Kansas Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM CANC SOC, 2013, ANC FACTS FIG 2013, P57564; Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Andriole GL, 2004, UROLOGY, V64, P537, DOI 10.1016/j.urology.2004.04.084; Berman-Booty LD, 2012, TOXICOL PATHOL, V40, P5, DOI 10.1177/0192623311425062; Bjelfman C, 1997, J CLIN ENDOCR METAB, V82, P2210, DOI 10.1210/jc.82.7.2210; Canene-Adams K, 2007, CANCER RES, V67, P836, DOI 10.1158/0008-5472.CAN-06-3462; Cho YM, 2007, PROSTATE CANCER P D, V10, P378, DOI 10.1038/sj.pcan.4500971; Costello LC, 2011, CANCER BIOL THER, V12, P1078, DOI 10.4161/cbt.12.12.18367; Elliott CS, 2009, CLIN CANCER RES, V15, P4694, DOI 10.1158/1078-0432.CCR-08-2277; Fleshner NE, 2012, LANCET, V379, P1590, DOI 10.1016/S0140-6736(12)60678-3; Gingrich JR, 1999, PROSTATE CANCER P D, V2, P70, DOI 10.1038/sj/pcan/4500296; Gingrich JR, 1997, CANCER RES, V57, P4687; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Grossmann ME, 2001, JNCI-J NATL CANCER I, V93, P1687, DOI 10.1093/jnci/93.22.1687; Habib FK, 2003, CLIN CANCER RES, V9, P1815; Iehle C, 1999, J STEROID BIOCHEM, V68, P189, DOI 10.1016/S0960-0760(99)00030-8; Kaplan SA, 2009, UROLOGY, V73, P935, DOI 10.1016/j.urology.2008.09.079; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Ku JH, 2009, SCAND J UROL NEPHROL, V43, P445, DOI 10.3109/00365590903337896; Lucia MS, 2007, JNCI-J NATL CANCER I, V99, P1375, DOI 10.1093/jnci/djm117; Luo J, 2003, PROSTATE, V57, P134, DOI 10.1002/pros.10284; Nakamura Y, 2005, ENDOCR-RELAT CANCER, V12, P101, DOI 10.1677/erc.1.00914; Opoku-Acheampong AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029068; Pinsky P, 2008, CANCER PREV RES, V1, P182, DOI 10.1158/1940-6207.CAPR-07-0007; Pinsky PF, 2013, CANCER-AM CANCER SOC, V119, P593, DOI 10.1002/cncr.27774; Prahalada S, 1998, PROSTATE, V35, P157; Redman MW, 2008, CANCER PREV RES, V1, P174, DOI 10.1158/1940-6207.CAPR-08-0092; RUSSELL DW, 1994, ANNU REV BIOCHEM, V63, P25, DOI 10.1146/annurev.bi.63.070194.000325; Schmidt LJ, 2009, PROSTATE, V69, P1730, DOI 10.1002/pros.21022; Shao TC, 2007, J UROLOGY, V178, P1521, DOI 10.1016/j.juro.2007.05.118; Soderstrom TG, 2001, J CLIN ENDOCR METAB, V86, P855, DOI 10.1210/jc.86.2.855; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Tien A. H., 2013, ANDROGEN RESPONSIVE, P135; Titus MA, 2005, CLIN CANCER RES, V11, P4365, DOI 10.1158/1078-0432.CCR-04-0738; Xu Y, 2006, CLIN CANCER RES, V12, P4072, DOI 10.1158/1078-0432.CCR-06-0184; Zuniga KE, 2013, CANCER PREV RES, V6, P548, DOI 10.1158/1940-6207.CAPR-12-0443	36	11	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77738	10.1371/journal.pone.0077738	http://dx.doi.org/10.1371/journal.pone.0077738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204943	gold, Green Published			2022-12-27	WOS:000326029300112
J	Symonds, MRE; Elgar, MA				Symonds, Matthew R. E.; Elgar, Mark A.			The Evolution of Body Size, Antennal Size and Host Use in Parasitoid Wasps (Hymenoptera: Chalcidoidea): A Phylogenetic Comparative Analysis	PLOS ONE			English	Article							LIFE-HISTORY; MOLECULAR PHYLOGENY; BEHAVIORAL ECOLOGY; CLUTCH SIZE; PATTERNS; SENSILLA; FITNESS; TRAITS; SIGNAL; DISCRIMINATION	Chalcidoid wasps represent one of the most speciose superfamilies of animals known, with ca. 23,000 species described of which many are parasitoids. They are extremely diverse in body size, morphology and, among the parasitoids, insect hosts. Parasitic chalcidoids utilise a range of behavioural adaptations to facilitate exploitation of their diverse insect hosts, but how host use might influence the evolution of body size and morphology is not known in this group. We used a phylogenetic comparative analysis of 126 chalcidoid species to examine whether body size and antennal size showed evolutionary correlations with aspects of host use, including host breadth (specificity), host identity (orders of insects parasitized) and number of plant associates. Both morphological features and identity of exploited host orders show strong phylogenetic signal, but host breadth does not. Larger body size in these wasps was weakly associated with few plant genera, and with more specialised host use, and chalcidoid wasps that parasitize coleopteran hosts tend to be larger. Intriguingly, chalcidoid wasps that parasitize hemipteran hosts are both smaller in size in the case of those parasitizing the suborder Sternorrhyncha and have relatively larger antennae, particularly in those that parasitize other hemipteran suborders. These results suggest there are adaptations in chalcidoid wasps that are specifically associated with host detection and exploitation.	[Symonds, Matthew R. E.] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Burwood, Vic, Australia; [Symonds, Matthew R. E.; Elgar, Mark A.] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia	Deakin University; University of Melbourne	Symonds, MRE (corresponding author), Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Burwood, Vic, Australia.	matthew.symonds@deakin.edu.au	Symonds, Matthew R.E./I-6020-2018	Symonds, Matthew R.E./0000-0002-9785-6045; Elgar, Mark/0000-0003-0861-6064	Australian Research Council [DP0987360]	Australian Research Council(Australian Research Council)	Funding provided by Australian Research Council Discovery Project Grant DP0987360. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, LANG ENV STAT COMP; Auger-Rozenberg MA, 2006, SYST ENTOMOL, V31, P47, DOI 10.1111/j.1365-3113.2005.00310.x; BAKKER K, 1985, OECOLOGIA, V67, P572, DOI 10.1007/BF00790029; Belshaw R, 2003, ZOOL J LINN SOC-LOND, V139, P213, DOI 10.1046/j.1096-3642.2003.00078.x; Birch M.C., 1982, INSECT PHEROMONES; Bleeker MAK, 2004, MICROSC RES TECHNIQ, V63, P266, DOI 10.1002/jemt.20038; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; BRANDL R, 1987, BIOL J LINN SOC, V32, P351, DOI 10.1111/j.1095-8312.1987.tb00436.x; Burks RA, 2011, CLADISTICS, V27, P581, DOI 10.1111/j.1096-0031.2011.00358.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carrasco D, 2010, BEHAV ECOL SOCIOBIOL, V64, P1291, DOI 10.1007/s00265-010-0943-y; CHAPMAN RF, 1982, ADV INSECT PHYSIOL, V16, P247, DOI 10.1016/S0065-2806(08)60155-1; CHARNOV EL, 1984, FLA ENTOMOL, V67, P5, DOI 10.2307/3494101; Cloutier C, 2000, ENTOMOL EXP APPL, V97, P29, DOI 10.1023/A:1004056818645; Cohen JE, 2005, P NATL ACAD SCI USA, V102, P684, DOI 10.1073/pnas.0408780102; Conti Eric, 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/651015; Darling D. Christopher, 2005, Acta Societatis Zoologicae Bohemicae, V69, P49; Das P, 2011, MICROSC RES TECHNIQ, V74, P900, DOI 10.1002/jemt.20974; Ellers J, 1998, J ANIM ECOL, V67, P318, DOI 10.1046/j.1365-2656.1998.00195.x; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Fritz SA, 2010, CONSERV BIOL, V24, P1042, DOI 10.1111/j.1523-1739.2010.01455.x; Gibson G.A.P., 1997, ANNOTATED KEYS GENER, P279; Gibson GAP, 1999, ZOOL SCR, V28, P87, DOI 10.1046/j.1463-6409.1999.00016.x; Gols R, 2009, PHYTOCHEM REV, V8, P187, DOI 10.1007/s11101-008-9104-6; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Graham M. W. R. de Vere, 1998, ZOOLOGISCHE VERHANDA, V317, P1; GROSS P, 1993, ANNU REV ENTOMOL, V38, P251, DOI 10.1146/annurev.en.38.010193.001343; Guerrieri E, 2000, SYST ENTOMOL, V25, P147, DOI 10.1046/j.1365-3113.2000.00099.x; Harmon L, 2009, GEIGER ANAL EVOLUTIO; Harvey JA, 2006, ARCH INSECT BIOCHEM, V61, P170, DOI 10.1002/arch.20080; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hawkins B. A., 1994, PATTERN PROCESS HOST; HAWKINS BA, 1990, ECOL ENTOMOL, V15, P275, DOI 10.1111/j.1365-2311.1990.tb00809.x; HAWKINS BA, 1990, J ANIM ECOL, V59, P57, DOI 10.2307/5158; Heraty JM, 2007, MOL PHYLOGENET EVOL, V45, P480, DOI 10.1016/j.ympev.2007.06.021; Heraty JM, 2013, CLADISTICS, V29, P466, DOI 10.1111/cla.12006; Hunter MS, 2001, ANNU REV ENTOMOL, V46, P251, DOI 10.1146/annurev.ento.46.1.251; HURLBUTT B, 1987, BIOL J LINN SOC, V30, P63, DOI 10.1111/j.1095-8312.1987.tb00290.x; Jervis MA, 2003, FUNCT ECOL, V17, P375, DOI 10.1046/j.1365-2435.2003.00742.x; Jervis MA, 2001, J ANIM ECOL, V70, P442, DOI 10.1046/j.1365-2656.2001.00507.x; JOHNSON NF, 1987, SYST ENTOMOL, V12, P437, DOI 10.1111/j.1365-3113.1987.tb00216.x; Krasnov BR, 2011, ECOGRAPHY, V34, P114, DOI 10.1111/j.1600-0587.2010.06502.x; Kudo SI, 2000, EUR J ENTOMOL, V97, P137, DOI 10.14411/eje.2000.023; Lotfalizadeh H, 2007, ZOOL J LINN SOC-LOND, V151, P441, DOI 10.1111/j.1096-3642.2007.00308.x; Maddison W., 2018, MESQUITE MODULAR SYS; Mayhew PJ, 1999, J ANIM ECOL, V68, P906, DOI 10.1046/j.1365-2656.1999.00338.x; Moore J., 2002, PARASITES BEHAV ANIM; Munro JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027023; Murray EA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0495; Nicol CMY, 1999, ENTOMOL EXP APPL, V90, P83, DOI 10.1023/A:1003546731081; Noyes JS, 2021, UNIVERSAL CHALCIDOID; Ode PJ, 2006, ANNU REV ENTOMOL, V51, P163, DOI 10.1146/annurev.ento.51.110104.151110; Onagbola EO, 2008, MICRON, V39, P526, DOI 10.1016/j.micron.2007.08.001; Onagbola EO, 2009, ANN ENTOMOL SOC AM, V102, P523, DOI 10.1603/008.102.0324; Orme D, 2012, CAPER COMP ANAL PHYL; Owen AK, 2007, SYST ENTOMOL, V32, P227, DOI 10.1111/j.1365-3113.2006.00361.x; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pickett JA, 2007, APHIDS AS CROP PESTS, P235, DOI 10.1079/9780851998190.0235; Potting RPJ, 1997, ENTOMOL EXP APPL, V82, P341, DOI 10.1023/A:1002960625981; Poulin R, 2011, TRENDS PARASITOL, V27, P355, DOI 10.1016/j.pt.2011.05.003; Powell W, 2003, PEST MANAG SCI, V59, P149, DOI 10.1002/ps.550; PURVIS A, 1993, SYST BIOL, V42, P569, DOI 10.2307/2992489; Rasplus JY, 1998, CR ACAD SCI III-VIE, V321, P517, DOI 10.1016/S0764-4469(98)80784-1; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Santos AMC, 2011, ENTOMOL SCI, V14, P371, DOI 10.1111/j.1479-8298.2011.00481.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Spaethe J, 2007, NATURWISSENSCHAFTEN, V94, P733, DOI 10.1007/s00114-007-0251-1; Straub CS, 2011, AM NAT, V177, P389, DOI 10.1086/658177; Symonds MRE, 2012, ECOL EVOL, V2, P227, DOI 10.1002/ece3.81; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Symonds MRE, 2002, EVOLUTION, V56, P2330, DOI 10.1111/j.0014-3820.2002.tb00156.x; Traynor RE, 2005, OIKOS, V109, P305, DOI 10.1111/j.0030-1299.2005.13666.x; Triapitsyn SV, 2007, BIOL CONTROL, V41, P14, DOI 10.1016/j.biocontrol.2006.12.013; Van Baaren J., 2007, MODERN RES ED TOPICS, P345; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412	78	15	16	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e78297	10.1371/journal.pone.0078297	http://dx.doi.org/10.1371/journal.pone.0078297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24205189	gold, Green Submitted, Green Published			2022-12-27	WOS:000325887300119
J	Taylor, MP; Wedel, MJ				Taylor, Michael P.; Wedel, Mathew J.			The Effect of Intervertebral Cartilage on Neutral Posture and Range of Motion in the Necks of Sauropod Dinosaurs	PLOS ONE			English	Article							CERVICAL VERTEBRAL COLUMN; SPINAL-CORD; DOGS; EVOLUTION; ANIMALS; JOINT; HEAD	The necks of sauropod dinosaurs were a key factor in their evolution. The habitual posture and range of motion of these necks has been controversial, and computer-aided studies have argued for an obligatory sub-horizontal pose. However, such studies are compromised by their failure to take into account the important role of intervertebral cartilage. This cartilage takes very different forms in different animals. Mammals and crocodilians have intervertebral discs, while birds have synovial joints in their necks. The form and thickness of cartilage varies significantly even among closely related taxa. We cannot yet tell whether the neck joints of sauropods more closely resembled those of birds or mammals. Inspection of CT scans showed cartilage: bone ratios of 4.5% for Sauroposeidon and about 20% and 15% for two juvenile Apatosaurus individuals. In extant animals, this ratio varied from 2.59% for the rhea to 24% for a juvenile giraffe. It is not yet possible to disentangle ontogenetic and taxonomic signals, but mammal cartilage is generally three times as thick as that of birds. Our most detailed work, on a turkey, yielded a cartilage: bone ratio of 4.56%. Articular cartilage also added 11% to the length of the turkey's zygapophyseal facets. Simple image manipulation suggests that incorporating 4.56% of neck cartilage into an intervertebral joint of a turkey raises neutral posture by 15 degrees. If this were also true of sauropods, the true neutral pose of the neck would be much higher than has been depicted. An additional 11% of zygapophyseal facet length translates to 11% more range of motion at each joint. More precise quantitative results must await detailed modelling. In summary, including cartilage in our models of sauropod necks shows that they were longer, more elevated and more flexible than previously recognised.	[Taylor, Michael P.] Univ Bristol, Dept Earth Sci, Bristol, Avon, England; [Wedel, Mathew J.] Western Univ Hlth Sci, Coll Osteopath Med Pacific, Pomona, CA USA; [Wedel, Mathew J.] Western Univ Hlth Sci, Coll Podiatr Med, Pomona, CA USA	University of Bristol; Western University of Health Sciences; Western University of Health Sciences	Taylor, MP (corresponding author), Univ Bristol, Dept Earth Sci, Bristol, Avon, England.	dino@miketaylor.org.uk		Taylor, Mike/0000-0002-1003-5675				Bakker RT., 1986, DINOSAUR HERESIES; Baumel J.J, 1993, HDB AVIAN ANATOMY NO; Bonnan MF, 2010, ANAT REC, V293, P2044, DOI 10.1002/ar.21266; Burian Z, 1941, SNORKELLING BRACHIOS; Carpenter K., 2006, NEW MEXICO MUSEUM NA, V36, P131; Christian A, 2010, BIOL LETTERS, V6, P823, DOI 10.1098/rsbl.2010.0359; Cifelli R. L., 2005, OKLA GEOL NOTES, V65, P40; Cobley MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072187; da Costa RC, 2006, VET RADIOL ULTRASOUN, V47, P523, DOI 10.1111/j.1740-8261.2006.00180.x; Dzemski G, 2007, J MORPHOL, V268, P701, DOI 10.1002/jmor.10542; EMERSON CL, 1990, J ZOO WILDLIFE MED, V21, P345; Evans M., 1993, THESIS U COLL LONDON; Frey E, 1988, STUTTGARTER BEITRA A, V424, P1; Gilmore C. W., 1936, Memoirs of the Carnegie Museum, V11, P175; Glass K, 2003, CAMELID Q        JUN, P1; GRAF W, 1995, J ANAT, V186, P55; Haines T., 1999, WALKING DINOSAURS; Harvey E. B., 1968, ATLAS DOMESTIC TURKE; Hatcher JB., 1901, MEM CARNEGIE MUS, V1, P1, DOI [10.5962/p.234818, DOI 10.5962/P.234818]; Holliday CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013120; Hudson NPH, 2005, EQUINE VET EDUC, V17, P34, DOI 10.1111/j.2042-3292.2005.tb00333.x; HULTGREN BD, 1987, J WILDLIFE DIS, V23, P705, DOI 10.7589/0090-3558-23.4.705; Janensch W., 1950, PALAEONTOGRAPHICA, V3, P27; Kapandji IA, 2008, PHYSL JOINTS ANNOTAT, V3; Kimball S, 2010, GIMP GNU IMAGE MANIP; Knight CR, 1897, RESTORATION BRONTOSA; Levitski RE, 1999, VET RADIOL ULTRASOUN, V40, P332, DOI 10.1111/j.1740-8261.1999.tb02120.x; Liem KF., 2001, FUNCTIONAL ANATOMY V; Mallison H., 2010, PALAEONTOLOGIA ELECT, V13; Mallison H, 2010, SWISS J GEOSCI, V103, P211, DOI 10.1007/s00015-010-0024-2; Mallison H, 2010, ACTA PALAEONTOL POL, V55, P433, DOI 10.4202/app.2009.0075; Marsh O., 1883, AM J SCI, V26, P81; MARTIN J, 1987, OCCASIONAL PAPERS TY, V3, P154; Matthew W. D., 1905, American Museum Journal, V5; McIntosh J. S., 1981, BULL CARNEG MUS NAT, V18, P1; McKee WM, 1999, J SMALL ANIM PRACT, V40, P465, DOI 10.1111/j.1748-5827.1999.tb02997.x; McKenzie EC, 2010, JAVMA-J AM VET MED A, V237, P311, DOI 10.2460/javma.237.3.311; PAPAGEORGES M, 1987, VET RADIOLOGY, V28, P53, DOI 10.1111/j.1740-8261.1987.tb01725.x; Paul G.S., 1988, HUNTERIA, V2, P1; Paul GS., 2000, SCI AM BOOK DINOSAUR, P78; Sande, 1979, VET SURG, V8, P7, DOI DOI 10.1111/J.1532-950X.1979.TB00596.X; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Schwarz D, 2007, J GEOL SOC LONDON, V164, P61, DOI 10.1144/0016-76492006-019; Spielberg S., 1993, JURASSIC PARK; Stevens KA, 1999, SCIENCE, V284, P798, DOI 10.1126/science.284.5415.798; Stevens KA, 2005, LIFE O PAST, P212; Stevens KA, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P178; Stevens Kent A., 2002, Senckenbergiana Lethaea, V82, P23; Taylor MP, 2013, PEERJ, V1, DOI 10.7717/peerj.36; Taylor MP, 2009, J VERTEBR PALEONTOL, V29, P787, DOI 10.1671/039.029.0309; Taylor MP, 2009, ACTA PALAEONTOL POL, V54, P213, DOI 10.4202/app.2009.0007; Upchurch P., 2000, SCIENCE, V287, P547, DOI [10.1126/science.287.5453.547b, DOI 10.1126/SCIENCE.287.5453.547B]; VIDAL PP, 1986, EXP BRAIN RES, V61, P549; Wake M.H., 1992, HYMANS COMP VERTEBRA, V4th; Wedel MJ, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P201; Wedel Mathew J., 2002, Paleobios, V22, P1; Wedel MJ, 2003, J VERTEBR PALEONTOL, V23, P344, DOI 10.1671/0272-4634(2003)023[0344:TEOVPI]2.0.CO;2; Wedel MJ, 2000, ACTA PALAEONTOL POL, V45, P343; Wedel MJ, 2000, J VERTEBR PALEONTOL, V20, P109, DOI 10.1671/0272-4634(2000)020[0109:SPANSF]2.0.CO;2; WHITWELL KE, 1987, EQUINE VET J, V19, P8, DOI 10.1111/j.2042-3306.1987.tb02568.x; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Zallinger RF, 1947, AGE REPTILES	62	30	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78214	10.1371/journal.pone.0078214	http://dx.doi.org/10.1371/journal.pone.0078214			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205163	Green Submitted, Green Published, gold			2022-12-27	WOS:000326334500105
J	Yu, DG; Liu, FX; Liu, M; Zhao, X; Wang, XQ; Li, Y; Mao, YQ; Zhu, ZN				Yu, Degang; Liu, Fengxiang; Liu, Ming; Zhao, Xin; Wang, Xiaoqing; Li, Yang; Mao, Yuanqing; Zhu, Zhenan			The Inhibition of Subchondral Bone Lesions Significantly Reversed the Weight-Bearing Deficit and the Overexpression of CGRP in DRG Neurons, GFAP and Iba-1 in the Spinal Dorsal Horn in the Monosodium Iodoacetate Induced Model of Osteoarthritis Pain	PLOS ONE			English	Article							KNEE PAIN; OSTEOCHONDRAL JUNCTION; RAT MODEL; CARTILAGE; JOINT; PATHOPHYSIOLOGY; ANGIOGENESIS; ASSOCIATION; INNERVATION; PROGRESSION	Background: Chronic pain is the most prominent and disabling symptom of osteoarthritis (OA). Clinical data suggest that subchondral bone lesions contribute to the occurrence of joint pain. The present study investigated the effect of the inhibition of subchondral bone lesions on joint pain. Methods: Osteoarthritic pain was induced by an injection of monosodium iodoacetate (MIA) into the rat knee joint. Zoledronic acid (ZOL), a third generation of bisphosphonate, was used to inhibit subchondral bone lesions. Joint histomorphology was evaluated using X-ray micro computed tomography scanning and hematoxylin-eosin staining. The activity of osteoclast in subchondral bone was evaluated using tartrate-resistant acid phosphatase staining. Joint pain was evaluated using weight-bearing asymmetry, the expression of calcitonin gene-related peptide (CGRP) in the dorsal root ganglion (DRG), and spinal glial activation status using glial fibrillary acidic protein (GFAP) and ionized calcium binding adaptor molecule-1 (Iba-1) immunofluorescence. Afferent neurons in the DRGs that innervated the joints were identified using retrograde fluorogold labeling. Results: MIA injections induced significant histomorphological alterations and joint pain. The inhibition of subchondral bone lesions by ZOL significantly reduced the MIA-induced weight-bearing deficit and overexpression of CGRP in DRG neurons, GFAP and Iba-1 in the spinal dorsal horn at 3 and 6 weeks after MIA injection; however, joint swelling and synovial reaction were unaffected. Conclusions: The inhibition of subchondral bone lesions alleviated joint pain. Subchondral bone lesions should be a key target in the management of osteoarthritic joint pain.	[Yu, Degang; Liu, Fengxiang; Liu, Ming; Zhao, Xin; Wang, Xiaoqing; Li, Yang; Mao, Yuanqing; Zhu, Zhenan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Orthopaed, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Mao, YQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Orthopaed, Shanghai 200030, Peoples R China.	degangyu@yeah.net	ydg, nam/GNP-5078-2022		National Natural Science Foundation of China [81272036, 81171729]; Key Program of Basic Research of Science and Technology Commission of Shanghai [12JC1405600]; Fund for Key Disciplines of Shanghai Municipal Education Commission [J50206]; Program for the Shanghai Key Laboratory of Orthopedic Implants [08DZ2230330]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of Basic Research of Science and Technology Commission of Shanghai; Fund for Key Disciplines of Shanghai Municipal Education Commission; Program for the Shanghai Key Laboratory of Orthopedic Implants	This work was supported by grants from the National Natural Science Foundation of China (No. 81272036 and No. 81171729), Key Program of Basic Research of Science and Technology Commission of Shanghai (No. 12JC1405600), the Fund for Key Disciplines of Shanghai Municipal Education Commission (J50206) and the Program for the Shanghai Key Laboratory of Orthopedic Implants (Grant No. 08DZ2230330). The majority of this research was completed in the Shanghai Key Laboratory of Orthopedic Implants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arden N, 2006, BEST PRACT RES CL RH, V20, P3, DOI 10.1016/j.berh.2005.09.007; Arendt-Nielsen L, 2010, PAIN, V149, P573, DOI 10.1016/j.pain.2010.04.003; Bailey AJ, 2004, BIORHEOLOGY, V41, P349; Bellido M, 2011, OSTEOARTHR CARTILAGE, V19, P1228, DOI 10.1016/j.joca.2011.07.003; Beyreuther B, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2121; Bove SE, 2003, OSTEOARTHR CARTILAGE, V11, P821, DOI 10.1016/S1063-4584(03)00163-8; Burr David B, 2004, Osteoarthritis Cartilage, V12 Suppl A, pS20; Combe R, 2004, NEUROSCI LETT, V370, P236, DOI 10.1016/j.neulet.2004.08.023; Cook JL, 2010, OSTEOARTHR CARTILAGE, V18, pS66, DOI 10.1016/j.joca.2010.04.017; Dieppe PA, 2005, LANCET, V365, P965, DOI 10.1016/S0140-6736(05)71086-2; Dray A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2178; Ethgen O, 2004, J BONE JOINT SURG AM, V86A, P963, DOI 10.2106/00004623-200405000-00012; Felson DT, 2005, CURR OPIN RHEUMATOL, V17, P624, DOI 10.1097/01.bor.0000172800.49120.97; Fernihough J, 2004, PAIN, V112, P83, DOI 10.1016/j.pain.2004.08.004; Ferreira-Gomes J, 2010, ARTHRITIS RHEUM-US, V62, P3677, DOI 10.1002/art.27713; Hayami T, 2004, ARTHRITIS RHEUM-US, V50, P1193, DOI 10.1002/art.20124; Hernandez-Molina G, 2008, ANN RHEUM DIS, V67, P43, DOI 10.1136/ard.2007.070565; HOKFELT T, 1991, NEURON, V7, P867, DOI 10.1016/0896-6273(91)90333-U; Hui C, 2011, AM J SPORT MED, V39, P64, DOI 10.1177/0363546510377445; Hunter DJ, 2008, RHEUM DIS CLIN N AM, V34, P623, DOI 10.1016/j.rdc.2008.05.004; Im HJ, 2010, ARTHRITIS RHEUM-US, V62, P2995, DOI 10.1002/art.27608; Kadri A, 2008, ARTHRITIS RHEUM-US, V58, P2379, DOI 10.1002/art.23638; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kidd BL, 2006, PAIN, V123, P6, DOI 10.1016/j.pain.2006.04.009; Lee Y, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-39; Mach DB, 2002, NEUROSCIENCE, V113, P155, DOI 10.1016/S0306-4522(02)00165-3; Martel-Pelletier J, 2008, BEST PRACT RES CL RH, V22, P351, DOI 10.1016/j.berh.2008.02.001; Moisio K, 2009, ARTHRITIS RHEUM-US, V60, P3703, DOI 10.1002/art.25014; Nagy I, 2006, DRUG DISCOV TODAY, V3, P357; Nielsen RH, 2011, OSTEOARTHR CARTILAGE, V19, P466, DOI 10.1016/j.joca.2011.01.008; Orita S, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-134; Pomonis JD, 2005, PAIN, V114, P339, DOI 10.1016/j.pain.2004.11.008; Reichenbach S, 2011, ANN RHEUM DIS, V70, P293, DOI 10.1136/ard.2010.132985; Sagar DR, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-88; Schuelert N, 2009, NEUROSCI LETT, V465, P184, DOI 10.1016/j.neulet.2009.08.063; Sellam J, 2010, NAT REV RHEUMATOL, V6, P625, DOI 10.1038/nrrheum.2010.159; Sniekers YH, 2008, OSTEOARTHR CARTILAGE, V16, P533, DOI 10.1016/j.joca.2008.01.002; Steinmeyer J, 2006, ADV DRUG DELIVER REV, V58, P168, DOI 10.1016/j.addr.2006.01.007; Strassle BW, 2010, OSTEOARTHR CARTILAGE, V18, P1319, DOI 10.1016/j.joca.2010.06.007; Suri S, 2007, ANN RHEUM DIS, V66, P1423, DOI 10.1136/ard.2006.063354; Volker N, 2007, MOL PAIN, V3; Walsh DA, 2007, OSTEOARTHR CARTILAGE, V15, P743, DOI 10.1016/j.joca.2007.01.020; Walsh DA, 2010, RHEUMATOLOGY, V49, P1852, DOI 10.1093/rheumatology/keq188; Wenham CYJ, 2009, NAT CLIN PRACT RHEUM, V5, P149, DOI 10.1038/ncprheum1023; Yoneda T, 2011, BONE, V48, P100, DOI 10.1016/j.bone.2010.07.009; Yu DG, 2012, ACTA PHARMACOL SIN, V33, P924, DOI 10.1038/aps.2012.28; Yusuf E, 2011, ANN RHEUM DIS, V70, P60, DOI 10.1136/ard.2010.131904; Zhang YQ, 2011, ARTHRITIS RHEUM-US, V63, P691, DOI 10.1002/art.30148	48	14	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77824	10.1371/journal.pone.0077824	http://dx.doi.org/10.1371/journal.pone.0077824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204985	Green Published, Green Submitted, gold			2022-12-27	WOS:000326334500065
J	Lieberman, R; Wadwa, RP; Nguyen, N; Bishop, FK; Reinick, C; Snell-Bergeon, JK; Maahs, DM				Lieberman, Rachel; Wadwa, R. Paul; Nhung Nguyen; Bishop, Franziska K.; Reinick, Christina; Snell-Bergeon, Janet K.; Maahs, David M.			The Association between Vitamin D and Vascular Stiffness in Adolescents with and without Type 1 Diabetes	PLOS ONE			English	Article							25-HYDROXYVITAMIN D; ARTERIAL STIFFNESS; D DEFICIENCY; BLOOD-PRESSURE; E CONSUMPTION; RISK; SUPPLEMENTATION; CHILDREN; DISEASE; YOUTH	Objective: Vitamin D deficiency is common and associated with increased cardiovascular disease (CVD) risk. Pulse wave velocity (PWV) is a marker of vascular stiffness associated with CVD. We hypothesized that Vitamin D (25 (OH) D) levels would be inversely associated with PWV in youth with and without type 1 diabetes (T1D). Study Design: Comparisons were made between adolescents with T1D (n = 211; age = 17.5 +/- 2.3 years; diabetes duration = 10.9 +/- 3.2 years; A1c = 9.1 +/- 1.7%) and non-DM controls (n = 67; age = 16.9 +/- 1.9 years). PWV was measured in the carotid-femoral segment (Sphygmocor Vx, AtCor Medical, Lisle, IL). Results: Vitamin D levels were similar in adolescents with T1D and controls (27.7 +/- 0.7 v. 26.0 +/- 1.3 ng/ml; p = 0.26). Vitamin D was significantly inversely associated with PWV after adjusting for age, sex, quarter of the year, and race-ethnicity in adolescents with T1D (beta = -0.01 +/- 0.004, p = 0.02) but not in the non-DM adolescents (beta = -0.008 +/- 0.008, p = 0.32). Vitamin D remained significantly associated with PWV after additionally adjusting for hs-CRP in adolescents with T1D (-0.01 +/- 0.004, p = 0.01). After adjusting for BMI z-score, lipids, or blood pressure, the relationship of Vitamin D with PWV was not significant. Conclusions: Vitamin D levels were inversely associated with PWV in adolescents with T1D, but not independently of BMI, lipids, or blood pressure. Our data contrast with other reports and suggest further research is indicated to determine if Vitamin D supplementation would be beneficial to lower CVD risk in adolescents with T1D with vitamin D insufficiency or deficiency.	[Lieberman, Rachel] St Louis Univ, Sch Med, St Louis, MO USA; [Wadwa, R. Paul; Nhung Nguyen; Bishop, Franziska K.; Reinick, Christina; Snell-Bergeon, Janet K.; Maahs, David M.] Univ Colorado, Barbara Davis Ctr Childhood Diabet, Aurora, CO 80045 USA; [Wadwa, R. Paul; Maahs, David M.] Childrens Hosp Colorado, Aurora, CO USA; [Snell-Bergeon, Janet K.; Maahs, David M.] Univ Colorado Denver, Dept Epidemiol, Colorado Sch Publ Hlth, Aurora, CO USA	Saint Louis University; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Nguyen, N (corresponding author), Univ Colorado, Barbara Davis Ctr Childhood Diabet, Aurora, CO 80045 USA.	Nhung.Nguyen@ucdenver.edu		Maahs, David/0000-0002-4602-7909; Snell-Bergeon, Janet/0000-0002-9337-3740	NIDDK Medical Student Summer Research Program in Diabetes [3T32DK063687-10S1]; NIDDK [DK075360]; Juvenile Diabetes Research Foundation [11-2007-694]; American Diabetes Association [1-10-JF-50]; NIH/NCRR Colorado CTSI Grant [UL1 RR025780]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK075360, T32DK063687] Funding Source: NIH RePORTER	NIDDK Medical Student Summer Research Program in Diabetes; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); American Diabetes Association(American Diabetes Association); NIH/NCRR Colorado CTSI Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Ms. Lieberman and Ms. Reinick were supported by the NIDDK Medical Student Summer Research Program in Diabetes (3T32DK063687-10S1). Dr. Maahs was supported by a grant from NIDDK (DK075360); Dr. Wadwa by an early career award from the Juvenile Diabetes Research Foundation (11-2007-694); and Dr. Snell-Bergeon by a junior faculty career development award from the American Diabetes Association (1-10-JF-50). This project was supported by the Juvenile Diabetes Research Foundation (11-2007-694) and NIH/NCRR Colorado CTSI Grant Number UL1 RR025780. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemzadeh R, 2008, METABOLISM, V57, P183, DOI 10.1016/j.metabol.2007.08.023; Bierschenk L, 2009, DIABETES CARE, V32, P1977, DOI 10.2337/dc09-1089; Borkar VV, 2010, PEDIATR DIABETES, V11, P345, DOI 10.1111/j.1399-5448.2009.00589.x; Dong YB, 2010, J CLIN ENDOCR METAB, V95, P4584, DOI 10.1210/jc.2010-0606; Ghandchi Z, 2012, J HUM NUTR DIET, V25, P365, DOI 10.1111/j.1365-277X.2012.01228.x; Giallauria F, 2012, J CLIN ENDOCR METAB, V97, P3717, DOI 10.1210/jc.2012-1584; Janner M, 2010, SWISS MED WKLY, V140, DOI 10.4414/smw.2010.13091; Joergensen C, 2010, DIABETES CARE, V33, P2238, DOI 10.2337/dc10-0582; Jorde R, 2010, EUR J CLIN NUTR, V64, P1457, DOI 10.1038/ejcn.2010.176; Jorde R, 2011, PROG LIPID RES, V50, P303, DOI 10.1016/j.plipres.2011.05.001; Jorde R, 2010, HYPERTENSION, V55, P792, DOI 10.1161/HYPERTENSIONAHA.109.143990; Kumar J, 2009, PEDIATRICS, V124, pE362, DOI 10.1542/peds.2009-0051; Llaurado G, 2012, DIABETES CARE, V35, P1083, DOI 10.2337/dc11-1475; Looker Anne C, 2011, NCHS Data Brief, P1; Maahs DM, 2011, DIABETES CARE, V34, P2360, DOI 10.2337/dc11-0829; Mayer O, 2012, J HUM HYPERTENS, V26, P650, DOI 10.1038/jhh.2011.94; Mohr SB, 2008, DIABETOLOGIA, V51, P1391, DOI 10.1007/s00125-008-1061-5; Oh J, 2009, CIRCULATION, V120, P687, DOI 10.1161/CIRCULATIONAHA.109.856070; Palombo C, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-88; Parikh SJ, 2004, J CLIN ENDOCR METAB, V89, P1196, DOI 10.1210/jc.2003-031398; Reis JP, 2009, PEDIATRICS, V124, pE371, DOI 10.1542/peds.2009-0213; RIMM EB, 1993, NEW ENGL J MED, V328, P1450, DOI 10.1056/NEJM199305203282004; Rodriguez-Rodriguez E, 2011, EUR J NUTR, V50, P373, DOI 10.1007/s00394-010-0145-4; Sachs MC, 2013, DIABETES CARE, V36, P2423, DOI 10.2337/dc12-2020; Schwalfenberg GK, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/619381; Scragg R, 2007, AM J HYPERTENS, V20, P713, DOI 10.1016/j.amjhyper.2007.01.017; Snell-Bergeon JK, 2010, J CLIN ENDOCR METAB, V95, P2868, DOI 10.1210/jc.2009-1993; STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003; Svoren BM, 2009, J PEDIATR-US, V154, P132, DOI 10.1016/j.jpeds.2008.07.015; Urbina EM, 2010, J PEDIATR-US, V156, P731, DOI 10.1016/j.jpeds.2009.11.011; Urbina EM, 2009, HYPERTENSION, V54, P919, DOI 10.1161/HYPERTENSIONAHA.109.192639; Wang H, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-42; Young KA, 2011, DIABETES CARE, V34, P454, DOI 10.2337/dc10-0757; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302	34	23	23	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77272	10.1371/journal.pone.0077272	http://dx.doi.org/10.1371/journal.pone.0077272			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204786	Green Submitted, gold, Green Published			2022-12-27	WOS:000326270700022
J	Peters, BS; Perry, M; Wierzbicki, AS; Wolber, LE; Blake, GM; Patel, N; Hoile, R; Duncan, A; Kulasegaram, R; Williams, FMK				Peters, Barry S.; Perry, Melissa; Wierzbicki, Anthony S.; Wolber, Lisa E.; Blake, Glen M.; Patel, Nishma; Hoile, Richard; Duncan, Alastair; Kulasegaram, Ranjababu; Williams, Frances M. K.			A Cross-Sectional Randomised Study of Fracture Risk in People with HIV Infection in the Probono 1 Study	PLOS ONE			English	Article							BONE-MINERAL DENSITY; ANTIRETROVIRAL THERAPY; OSTEOPOROSIS; PREVALENCE; COHORT; RATES	Objective: To determine comparative fracture risk in HIV patients compared with uninfected controls. Design: A randomised cross-sectional study assessing bone mineral density (BMD), fracture history and risk factors in the 2 groups. Setting: Hospital Outpatients. Subbbjects: 222 HIV infected patients and an equal number of age-matched controls. Assessments: Fracture risk factors were assessed and biochemical, endocrine and bone markers measured. BMD was assessed at hip and spine. 10-year fracture probability (FRAX) and remaining lifetime fracture probability (RFLP) were calculated. Main Outcome Measures: BMD, and history of fractures. Results: Reported fractures occurred more frequently in HIV than controls, (45 vs. 16; 20.3 vs. 7%; OR=3.27; p=0.0001), and unsurprisingly in this age range, non-fragility fractures in men substantially contributed to this increase. Osteoporosis was more prevalent in patients with HIV (17.6% vs. 3.6%, p<0.0001). BMD was most reduced, and predicted fracture rates most increased, at the spine. Low BMD was associated with antiretroviral therapy (ART), low body mass index and PTH. 10-year FRAX risk was <5% for all groups. RLFP was greater in patients with HIV (OR=1.22; p=0.003) and increased with ART (2.4 vs. 1.50; OR=1.50; p=0.03). Conclusions: The increased fracture rate in HIV patients in our relatively youthful population is partly driven by fractures, including non-fragility fractures, in men. Nonetheless, these findings may herald a rise in osteoporotic fractures in HIV patients. An appropriate screening and management response is required to assess these risks and identify associated lifestyle factors that are also associated with other conditions such as cardiovascular disease and diabetes.	[Peters, Barry S.; Patel, Nishma] Kings Coll London, Dept Infect Dis, London, England; [Peters, Barry S.] Guys & St Thomas Fdn Hosp, London, England; [Perry, Melissa] Guys & St Thomas Fdn Hosp, Dept HIV & GU Med, London, England; [Wierzbicki, Anthony S.] Guys & St Thomas Fdn Hosp, Dept Chem Pathol, London, England; [Wolber, Lisa E.; Williams, Frances M. K.] Kings Coll London, Dept Rheumatol, Twins Res Unit, London, England; [Blake, Glen M.] Kings Coll London, Dept Nucl Med, London, England; [Hoile, Richard] Kings Coll London, Sch Med, London, England; [Duncan, Alastair] Guys & St Thomas Fdn Hosp, Dept Dietet, London, England; [Kulasegaram, Ranjababu] Guys & St Thomas NHS Trust, Dept HIV & GU Med, London, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust	Peters, BS (corresponding author), Kings Coll London, Dept Infect Dis, London, England.	Barry.Peters@kcl.ac.uk	Wierzbicki, Anthony/AAP-1735-2020	Wierzbicki, Anthony/0000-0003-2756-372X; Duncan, Alastair/0000-0002-6284-8192; Williams, Frances/0000-0002-2998-2744; Hoile, Richard/0000-0001-5003-1655	GlaxoSmithKline pharmaceuticals; ViiV pharmaceuticals; National Institute for Health Research [CDRF-2012-03-021] Funding Source: researchfish	GlaxoSmithKline pharmaceuticals(GlaxoSmithKline); ViiV pharmaceuticals; National Institute for Health Research(National Institute for Health Research (NIHR))	This project was in part supported by an unrestricted educational grant from GlaxoSmithKline pharmaceuticals. A subsequent unrestricted grant to look at prospective follow-up of patients described in this manuscript has been granted by ViiV pharmaceuticals and is in progress. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboud M, 2010, INT J CLIN PRACT, V64, P1252, DOI 10.1111/j.1742-1241.2010.02424.x; Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; Bolland MJ, 2007, J CLIN ENDOCR METAB, V92, P4522, DOI 10.1210/jc.2007-1660; Brown Todd T, 2006, Curr Infect Dis Rep, V8, P162, DOI 10.1007/s11908-006-0012-x; Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb; Brown TT, 2004, J CLIN ENDOCR METAB, V89, P1200, DOI 10.1210/jc.2003-031506; Elgalib A, 2011, CURR MED RES OPIN, V27, P63, DOI 10.1185/03007995.2010.537212; Grampp S, 1997, J BONE MINER RES, V12, P697, DOI 10.1359/jbmr.1997.12.5.697; Grund B, 2009, AIDS, V23, P1519, DOI 10.1097/QAD.0b013e32832c1792; Gullberg B, 1997, OSTEOPOROSIS INT, V7, P407, DOI 10.1007/PL00004148; Haskelberg H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038377; Hasse B, 2011, CLIN INFECT DIS, V53, P1130, DOI 10.1093/cid/cir626; Kanis JA, 2001, OSTEOPOROSIS INT, V12, P989, DOI 10.1007/s001980170006; Kearney F, 2010, AGE AGEING, V39, P536, DOI 10.1093/ageing/afq083; KELLY PJ, 1990, J BONE MINER RES, V5, P1169; Lippuner K, 2009, OSTEOPOROSIS INT, V20, P1131, DOI 10.1007/s00198-008-0779-8; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; *MEDSURF, 2000, REM LIF FRACT RISK P; Mondy K, 2005, JAIDS-J ACQ IMM DEF, V38, P426, DOI 10.1097/01.qai.0000145352.04440.1e; *NHS INF CTR, 2012, NAT HIP FRACT DAT; Ofotokun I, 2012, CURR HIV-AIDS REP, V9, P16, DOI 10.1007/s11904-011-0099-z; Ofotokun I, 2011, DISCOV MED, V11, P385; Ofotokun I, 2010, CURR OPIN ENDOCRINOL, V17, P523, DOI 10.1097/MED.0b013e32833f48d6; Peters B, 2013, HIV MED, V14, P1, DOI 10.1111/j.1468-1293.2012.01055.x; Triant VA, 2008, J CLIN ENDOCR METAB, V93, P3499, DOI 10.1210/jc.2008-0828; von Friesendorff M, 2011, J AM GERIATR SOC, V59, P806, DOI 10.1111/j.1532-5415.2011.03399.x; Wasnich R D, 1996, Hawaii Med J, V55, P141; WHO Expert Committee on Problems Related to Alcohol Consumption, 2007, World Health Organ Tech Rep Ser, P1; Wierzbicki AS, 2008, CURR MED RES OPIN, V24, P609, DOI 10.1185/030079908X272742; Womack JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017217; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; World Health Organization, 2011, FRAX WHO FRACT RISK; Yin MT, 2012, J CLIN ENDOCR METAB, V97, P554, DOI 10.1210/jc.2011-2197; Young B, 2011, CLIN INFECT DIS, V52, P1061, DOI 10.1093/cid/ciq242	34	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78048	10.1371/journal.pone.0078048	http://dx.doi.org/10.1371/journal.pone.0078048			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205086	Green Submitted, gold, Green Published			2022-12-27	WOS:000326270700068
J	Schwachmeyer, V; Damm, P; Bender, A; Dymke, J; Graichen, F; Bergmann, G				Schwachmeyer, Verena; Damm, Philipp; Bender, Alwina; Dymke, Joern; Graichen, Friedmar; Bergmann, Georg			In Vivo Hip Joint Loading during Post-Operative Physiotherapeutic Exercises	PLOS ONE			English	Article							CONTACT FORCES; SURGERY; MANAGEMENT; AMBULATION; FRACTURES; STABILITY; FIXATION	Introduction: After hip surgery, it is the orthopedist's decision to allow full weight bearing to prevent complications or to prescribe partial weight bearing for bone ingrowth or fracture consolidation. While most loading conditions in the hip joint during activities of daily living are known, it remains unclear how demanding physiotherapeutic exercises are. Recommendations for clinical rehabilitation have been established, but these guidelines vary and have not been scientifically confirmed. The aim of this study was to provide a basis for practical recommendations by determining the hip joint contact forces and moments that act during physiotherapeutic activities. Methods: Joint contact loads were telemetrically measured in 6 patients using instrumented hip endoprostheses. The resultant hip contact force, the torque around the implant stem, and the bending moment in the neck were determined for 13 common physiotherapeutic exercises, classified as weight bearing, isometric, long lever arm, or dynamic exercises, and compared to the loads during walking. Results: With peak values up to 441%BW, weight bearing exercises caused the highest forces among all exercises; in some patients they exceeded those during walking. During voluntary isometric contractions, the peak loads ranged widely and potentially reached high levels, depending on the intensity of the contraction. Long lever arms and dynamic exercises caused loads that were distributed around 50% of those during walking. Conclusion: Weight bearing exercises should be avoided or handled cautiously within the early post-operative period. The hip joint loads during isometric exercises depend strongly on the contraction intensity. Nonetheless, most physiotherapeutic exercises seem to be non-hazardous when considering the load magnitudes, even though the loads were much higher than expected. When deciding between partial and full weight bearing, physicians should consider the loads relative to those caused by activities of daily living.	[Schwachmeyer, Verena; Damm, Philipp; Bender, Alwina; Dymke, Joern; Graichen, Friedmar; Bergmann, Georg] Charite, Julius Wolff Inst, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schwachmeyer, V (corresponding author), Charite, Julius Wolff Inst, D-13353 Berlin, Germany.	verena.schwachmeyer@charite.de	Schwachmeyer, Verena/O-6745-2014	Bender, Alwina/0000-0002-4444-6309; Damm, Philipp/0000-0001-8471-7284	Deutsche Forschungsgemeinschaft [DFG - SFB 760, Be 804/19-1]; Deutsche Arthrose-Hilfe e.V.; ZVK-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Arthrose-Hilfe e.V.; ZVK-Stiftung	The study was funded by the Deutsche Forschungsgemeinschaft (project: DFG - SFB 760, Be 804/19-1), Deutsche Arthrose-Hilfe e.V. and the ZVK-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender A., 2011, COMPUTER METHODS BIO, P37; BERGMANN G, 1989, Z ORTHOP GRENZGEB, V127, P672, DOI 10.1055/s-2008-1040311; Bergmann G, 2001, J BIOMECH, V34, P859, DOI 10.1016/S0021-9290(01)00040-9; Bergmann G, 2004, LANGENBECK ARCH SURG, V389, P53, DOI 10.1007/s00423-003-0434-y; BERGMANN G, 1995, J BIOMECH, V28, P535, DOI 10.1016/0021-9290(94)00105-D; Bieger R, 2012, CLIN BIOMECH, V27, P158, DOI 10.1016/j.clinbiomech.2011.08.004; Bragdon CR, 1996, J ARTHROPLASTY, V11, P945, DOI 10.1016/S0883-5403(96)80136-7; BURKE DW, 1991, J BONE JOINT SURG BR, V73, P33, DOI 10.1302/0301-620X.73B1.1991771; Claes L, 2000, CLIN BIOMECH, V15, P750, DOI 10.1016/S0268-0033(00)00044-9; Damm P, 2010, MED ENG PHYS, V32, P95, DOI 10.1016/j.medengphy.2009.10.003; Fleischhauer M, 2006, LEITFADEN PHYSIOTHER; Heller MO, 2005, BIOMED TECH, V50, P394, DOI 10.1515/BMT.2005.054; Hol A, 2006, NEDERLANDS TIJSCHR E, V13e, P105; Jollenbeck T, 2005, Z ORTHOP, V143, P124; Kamel HK, 2003, J GERONTOL A-BIOL, V58, P1042; Knobe M, 2009, Z ORTHOP UNFALLCHIR, V147, P306, DOI 10.1055/s-0029-1185349; Lorich DG, 2004, J BONE JOINT SURG AM, V86A, P398, DOI 10.2106/00004623-200402000-00028; Oldmeadow LB, 2006, ANZ J SURG, V76, P607, DOI 10.1111/j.1445-2197.2006.03786.x; PILLIAR RM, 1986, CLIN ORTHOP RELAT R, P108; Thomas S, 2011, PHYS THER, V91, P1490, DOI 10.2522/ptj.20100310; Van Vugt AB, 2007, INJURY, V38S, P51; Vasarhelyi A, 2006, GAIT POSTURE, V23, P99, DOI 10.1016/j.gaitpost.2004.12.005; Yang Huan, 2011, Beijing Da Xue Xue Bao Yi Xue Ban, V43, P699; Zwartele RE, 2012, ARCH ORTHOP TRAUM SU, V132, P535, DOI 10.1007/s00402-011-1432-0	24	32	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77807	10.1371/journal.pone.0077807	http://dx.doi.org/10.1371/journal.pone.0077807			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204977	Green Published, gold, Green Submitted			2022-12-27	WOS:000326270700055
J	Sobarzo-Sanchez, E; Bilbao-Ramos, P; Dea-Ayuela, M; Gonzalez-Diaz, H; Yanez, M; Uriarte, E; Santana, L; Martinez-Sernandez, V; Bolas-Fernandez, F; Ubeira, FM				Sobarzo-Sanchez, Eduardo; Bilbao-Ramos, Pablo; Dea-Ayuela, Maria; Gonzalez-Diaz, Humberto; Yanez, Matilde; Uriarte, Eugenio; Santana, Lourdes; Martinez-Sernandez, Victoria; Bolas-Fernandez, Francisco; Ubeira, Florencio M.			Synthetic Oxoisoaporphine Alkaloids: In Vitro, In Vivo and In Silico Assessment of Antileishmanial Activities	PLOS ONE			English	Article							BETA-AMYLOID AGGREGATION; LEISHMANICIDAL ACTIVITY; TOPOISOMERASE-I; INHIBITORS; ACETYLCHOLINESTERASE; DERIVATIVES; COMPLEX; DRUGS	Leishmaniasis is a growing health problem worldwide. As there are certain drawbacks with the drugs currently used to treat human leishmaniasis and resistance to these drugs is emerging, there is a need to develop novel antileishmanial compounds, among which isoquinoline alkaloids are promising candidates. In this study, 18 novel oxoisoaporphine derivatives were synthesized and their possible antileishmanial activity was evaluated. The in vitro activity of these derivatives against Leishmania amazonensis axenic amastigotes was first evaluated, and the selected compounds were then tested in an inhibition assay with promastigotes of L. infantum, L. braziliensis, L. amazonensis and L. guyanensis, and with intracellular amastigotes of L. infantum and L. amazonensis. Finally, the most active compounds, OXO 1 (2,3-dihydro-7H-dibenzo[de,h]quinolin-7-one) and OXO 13 (2,3,8,9,10,11-hexahydro-7H-dibenzo[de,h]quinolin-7-one), were tested in BALB/c mice infected with L. infantum. Treatment of mice at a dose of 10 mg/kg with OXO 1 yielded significant reductions (p<0.05) in parasite burden in liver and spleen (99% and 78%, respectively) whereas with OXO 13 were not significant. Although previous reports suggest that this family of molecules displays inhibitory activity against monoamine oxidase A and acetylcholinesterase, these enzymes were not confirmed as targets for antileishmanial activity on the basis of the present results. However, after development of a new bioinformatics model to analyze the Leishmania proteome, we were able to identify other putative targets for these molecules. The most promising candidates were four proteins: two putative pteridine reductase 2 (1MXF and 1MXH), one N-myristoyltransferase (2WUU) and one type I topoisomerase (2B9S).	[Sobarzo-Sanchez, Eduardo] Univ Santiago de Compostela, Fac Farm, Dept Tecnol Farmaceut, Santiago De Compostela, Spain; [Sobarzo-Sanchez, Eduardo] Univ Autonoma Chile, Fac Ciencias Salud, Santiago, Chile; [Bilbao-Ramos, Pablo; Bolas-Fernandez, Francisco] Univ Complutense Madrid, Fac Farm, Dept Parasitol, Madrid, Spain; [Dea-Ayuela, Maria] Univ Cardenal Herrera, Dept Farm, Valencia, Spain; [Martinez-Sernandez, Victoria; Ubeira, Florencio M.] Univ Santiago de Compostela, Fac Farm, Dept Microbiol & Parasitol, Santiago De Compostela, Spain; [Yanez, Matilde] Univ Santiago de Compostela, Fac Farm, Dept Farmacol, Santiago De Compostela, Spain; [Uriarte, Eugenio; Santana, Lourdes] Univ Santiago de Compostela, Fac Farm, Dept Quim Organ, Santiago De Compostela, Spain	Universidade de Santiago de Compostela; Universidad Autonoma de Chile; Complutense University of Madrid; Universidad CEU Cardenal Herrera; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela	Ubeira, FM (corresponding author), Univ Santiago de Compostela, Fac Farm, Dept Microbiol & Parasitol, Santiago De Compostela, Spain.	fm.ubeira@usc.es	Santana, Lourdes/L-2981-2014; Uriarte, Eugenio EU/F-5691-2012; SOBARZO-SANCHEZ, EDUARDO/G-4126-2014; Sobarzo-Sánchez, Eduardo/B-1507-2012; Yañez, Matilde/ABC-5520-2020; Dea-Ayuela, M. Auxiliadora/AAA-7021-2019; Dea-Ayuela, M. Auxiliadora/ABG-5971-2020; , Humbert G. Díaz/A-6785-2012; Bolas Fernandez, Francisco/H-2514-2017	Santana, Lourdes/0000-0001-6056-8253; Uriarte, Eugenio EU/0000-0001-6218-2899; SOBARZO-SANCHEZ, EDUARDO/0000-0002-2790-2544; Sobarzo-Sánchez, Eduardo/0000-0002-2790-2544; Dea-Ayuela, M. Auxiliadora/0000-0002-5468-1863; , Humbert G. Díaz/0000-0002-9392-2797; Bolas Fernandez, Francisco/0000-0001-8062-2974; Ubeira, Florencio/0000-0001-7312-2752	Spanish Ministerio de Ciencia e Innovacion [AGL2011-30563-C03-01]; Spanish Agency for International Cooperation and Development (AECID) [A-024457/09]; Xunta de Galicia (Spain); MAEC-AECID	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Spanish Agency for International Cooperation and Development (AECID)(Spanish Government); Xunta de Galicia (Spain)(Xunta de Galicia); MAEC-AECID	This work was partially financed by grants AGL2011-30563-C03-01 from the Spanish Ministerio de Ciencia e Innovacion and A-024457/09 from the Spanish Agency for International Cooperation and Development (AECID). Eduardo Sobarzo-Sanchez is grateful to the Xunta de Galicia (Spain) for the "Isidro Parga Pondal" fellowship. Pablo Bilbao-Ramos is thankful to the MAEC-AECID for a PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dea-Ayuela MA, 2009, BIOORGAN MED CHEM, V17, P7449, DOI 10.1016/j.bmc.2009.09.030; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Bilbao-Ramos P, 2012, PARASITOL INT, V61, P604, DOI 10.1016/j.parint.2012.05.015; Bilbao-Ramos P, 2012, J MICROBIOL METH, V89, P8, DOI 10.1016/j.mimet.2012.01.013; Brannigan JA, 2010, J MOL BIOL, V396, P985, DOI 10.1016/j.jmb.2009.12.032; Camacho MD, 2000, PLANTA MED, V66, P478, DOI 10.1055/s-2000-8597; Castillo E, 2010, CURR MED CHEM, V17, P4027, DOI 10.2174/092986710793205345; Chan-Bacab MJ, 2001, NAT PROD REP, V18, P674, DOI 10.1039/b100455g; Chen ZF, 2012, J BIOL INORG CHEM, V17, P247, DOI 10.1007/s00775-011-0846-z; Costa EV, 2006, J NAT PROD, V69, P292, DOI 10.1021/np050422s; da Silva DB, 2009, PHYTOMEDICINE, V16, P1059, DOI 10.1016/j.phymed.2009.03.019; da Silva SM, 2012, ANTIMICROB AGENTS CH, V56, P2858, DOI 10.1128/AAC.00208-12; Davies DR, 2006, J MOL BIOL, V357, P1202, DOI 10.1016/j.jmb.2006.01.022; den Boer M, 2011, CLIN MICROBIOL INFEC, V17, P1471, DOI 10.1111/j.1469-0691.2011.03635.x; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Estevez Y, 2007, J ETHNOPHARMACOL, V114, P254, DOI 10.1016/j.jep.2007.08.007; Fabre JL, 1978, US patent, Patent No. [4128,650, 4128650, 4,128,650]; Gonzalez-Diaz H, 2008, CURR TOP MED CHEM, V8, P1676, DOI 10.2174/156802608786786543; HILL JO, 1983, INFECT IMMUN, V39, P1087, DOI 10.1128/IAI.39.3.1087-1094.1983; Hill T., 2006, STAT METHODS APPL CO; Mijares A, 2011, PARASITOL RES, V108, P1, DOI 10.1007/s00436-010-2032-6; Pearson RD, 1996, CLIN INFECT DIS, V22, P1, DOI 10.1093/clinids/22.1.1; Prado-Prado F, 2011, EUR J MED CHEM, V46, P5838, DOI 10.1016/j.ejmech.2011.09.045; Schormann N, 2005, J STRUCT BIOL, V152, P64, DOI 10.1016/j.jsb.2005.07.008; Sereno D, 1997, PARASITOL RES, V83, P401, DOI 10.1007/s004360050272; Sobarzo-Sanchez E, 2005, MAGN RESON CHEM, V43, P1080, DOI 10.1002/mrc.1703; Sobarzo-Sanchez E, 2003, SYNLETT, P1647, DOI 10.1055/s-2003-41422; Tang H, 2012, BIOORG MED CHEM LETT, V22, P2257, DOI 10.1016/j.bmcl.2012.01.090; Tang H, 2011, EUR J MED CHEM, V46, P4970, DOI 10.1016/j.ejmech.2011.08.002; Tang H, 2009, EUR J MED CHEM, V44, P2523, DOI 10.1016/j.ejmech.2009.01.021; TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x; Waechter AI, 1999, PHYTOTHER RES, V13, P175, DOI 10.1002/(SICI)1099-1573(199903)13:2&lt;175::AID-PTR395&gt;3.0.CO;2-N; Yanez M, 2006, BIOCHEM BIOPH RES CO, V344, P688, DOI 10.1016/j.bbrc.2006.03.190; Zhou BN, 2000, J NAT PROD, V63, P217, DOI 10.1021/np990442s	34	18	18	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77560	10.1371/journal.pone.0077560	http://dx.doi.org/10.1371/journal.pone.0077560			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204870	Green Published, Green Submitted, gold			2022-12-27	WOS:000326270700038
J	Costola-De-Souza, C; Ribeiro, A; Ferraz-De-Paula, V; Calefi, AS; Aloia, TPA; Gimenes, JA; de Almeida, VI; Pinheiro, ML; Palermo-Neto, J				Costola-de-Souza, Carolina; Ribeiro, Alison; Ferraz-de-Paula, Viviane; Calefi, Atilio Sersun; Arrais Aloia, Thiago Pinheiro; Gimenes-Junior, Joao Antonio; de Almeida, Vinicius Izidio; Pinheiro, Milena Lobao; Palermo-Neto, Joao			Monoacylglycerol Lipase (MAGL) Inhibition Attenuates Acute Lung Injury in Mice	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; CANNABINOID RECEPTOR AGONIST; MOLECULAR CHARACTERIZATION; ENDOGENOUS CANNABINOIDS; NEUTROPHIL AGGREGATION; INFLAMMATORY MEDIATORS; ACUTE-PANCREATITIS; ENDOTOXEMIC MICE; CB2 RECEPTORS; MODEL	Endocannabinoid signaling is terminated by enzymatic hydrolysis, a process that, for 2-Arachidonoylglycerol (2-AG), is mediated by monoacylglycerol lipase (MAGL). The piperidine carbamate, 4-nitrophenyl-4-(dibenzo[d] [ 1,3] dioxol-5-yl (hydroxy) methyl) piperidine-1-carboxylate (JZL184), is a drug that inhibits MAGL and presents high potency and selectivity. Thus, JZL184 increases the levels of 2-AG, an endocannabinoid that acts on the CB1 and CB2 cannabinoid receptors. Here, we investigated the effects of MAGL inhibition, with a single dose (16 mg/kg, intraperitoneally (i.p.)) of JZL184, in a murine model of lipopolysaccharide (LPS) -induced acute lung injury (ALI) 6, 24 and 48 hours after the inflammatory insult. Treatment with JZL184 decreased the leukocyte migration into the lungs as well as the vascular permeability measured through the bronchoalveolar lavage fluid (BAL) and histological analysis. JZL184 also reduced the cytokine and chemokine levels in the BAL and adhesion molecule expression in the blood and BAL. The CB1 and CB2 receptors were considered involved in the anti-inflammatory effects of JZL184 because the AM281 selective CB1 receptor antagonist (1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-4morpholinyl- 1H-pyrazole-3-carboxamide) and the AM630 selective CB2 receptor antagonist ([ 6-iodo-2-methyl-1-[2-(4-morpholinyl) ethyl]-1H-indol-3-yl](4-methoxyphenyl)-methanone) blocked the anti-inflammatory effects previously described for JZL184. It was concluded that MAGL inhibition, and consequently the increase in 2-AG levels, produced anti-inflammatory effects in a murine model of LPS-induced ALI, a finding that was considered a consequence of the activation of the CB1 and CB2 receptors.	[Costola-de-Souza, Carolina; Ribeiro, Alison; Calefi, Atilio Sersun; Arrais Aloia, Thiago Pinheiro; de Almeida, Vinicius Izidio; Pinheiro, Milena Lobao; Palermo-Neto, Joao] Univ Sao Paulo, Sch Vet Med, Dept Pathol, Neuroimmunomodulat Res Grp, Sao Paulo, Brazil; [Ferraz-de-Paula, Viviane] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Lab Expt Toxicol, Sao Paulo, Brazil; [Gimenes-Junior, Joao Antonio] Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Palermo-Neto, J (corresponding author), Univ Sao Paulo, Sch Vet Med, Dept Pathol, Neuroimmunomodulat Res Grp, Sao Paulo, Brazil.	jpalermo@usp.br	Calefi, Atilio/E-8085-2017; Gimenes-Junior, Joao A/F-4439-2014	Calefi, Atilio/0000-0002-1859-2046; Gimenes-Junior, Joao A/0000-0002-2958-1174; Pinheiro Arrais Aloia, Thiago/0000-0001-6913-8989	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2009/51886-3, 2011/10181-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [300764/2010-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was suppurted by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (Processes: 2009/51886-3 and 2011/10181-7) and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (Process: 300764/2010-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhouayek M, 2011, FASEB J, V25, P2711, DOI 10.1096/fj.10-176602; Asghari-Roodsari A, 2010, REPROD SCI, V17, P391, DOI 10.1177/1933719109358456; Balamayooran G, 2011, INFECT IMMUN, V79, P2567, DOI 10.1128/IAI.00067-11; Bhatia M, 2000, J PATHOL, V190, P117; Bhatia M., 2002, Current Drug Targets - Inflammation and Allergy, V1, P343; Bhatia M, 2004, J PATHOL, V202, P145, DOI 10.1002/path.1491; Bhatia M, 2001, Curr Opin Investig Drugs, V2, P496; Busquets-Garcia A, 2011, BIOL PSYCHIAT, V70, P479, DOI 10.1016/j.biopsych.2011.04.022; Campora L, 2012, AM J VET RES, V73, P988, DOI 10.2460/ajvr.73.7.988; Chouinard F, 2011, J IMMUNOL, V186, P3188, DOI 10.4049/jimmunol.1002853; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Conti S, 2002, BRIT J PHARMACOL, V135, P181, DOI 10.1038/sj.bjp.0704466; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; DELIMA WT, 1992, EUR J PHARMACOL, V213, P63, DOI 10.1016/0014-2999(92)90233-T; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2006, ANNU REV MED, V57, P553, DOI 10.1146/annurev.med.57.011205.135648; Faller S, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-26; Faller S, 2012, LAB INVEST, V92, P999, DOI 10.1038/labinvest.2012.55; Fukuda H, 2010, INT ARCH ALLERGY IMM, V152, P295, DOI 10.1159/000283042; Gamaleddin I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029900; Grommes J, MOL MED CAMB MASS, V17, P293; Guabiraba R, 2013, INFLAMM RES, V62, P811, DOI 10.1007/s00011-013-0638-8; Kim K, 2010, J TRAUMA, V68, P373, DOI 10.1097/TA.0b013e3181a73eea; Kinsey SG, 2011, J PHARMACOL EXP THER, V338, P795, DOI 10.1124/jpet.110.175778; KISHIMOTO TK, 1989, SCIENCE, V245, P1238, DOI 10.1126/science.2551036; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; LESER HG, 1991, GASTROENTEROLOGY, V101, P782, DOI 10.1016/0016-5085(91)90539-W; Ligeiro-Oliveira AP, 2004, NEUROIMMUNOMODULAT, V11, P181, DOI 10.1159/000076767; Long JZ, 2009, CHEM BIOL, V16, P744, DOI 10.1016/j.chembiol.2009.05.009; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Massi P, 2000, EUR J PHARMACOL, V387, P343, DOI 10.1016/S0014-2999(99)00860-2; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; McHugh D, 2008, MOL PHARMACOL, V73, P441, DOI 10.1124/mol.107.041863; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Oka S, 2006, J IMMUNOL, V177, P8796, DOI 10.4049/jimmunol.177.12.8796; Opdenakker G, 1998, IMMUNOL TODAY, V19, P182, DOI 10.1016/S0167-5699(97)01243-7; Park WY, 2001, AM J RESP CRIT CARE, V164, P1896, DOI 10.1164/ajrccm.164.10.2104013; Remick DG, 2002, SHOCK, V17, P463, DOI 10.1097/00024382-200206000-00004; Ribeiro A, 2012, EUR J PHARMACOL, V678, P78, DOI 10.1016/j.ejphar.2011.12.043; ROCHON YP, 1992, MED HYPOTHESES, V38, P132, DOI 10.1016/0306-9877(92)90086-R; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sacerdote P, 2000, J NEUROIMMUNOL, V109, P155, DOI 10.1016/S0165-5728(00)00307-6; SIMON SI, 1992, J IMMUNOL, V149, P2765; Smith SR, 2000, J PHARMACOL EXP THER, V293, P136; Smith SR, 2001, EUR J PHARMACOL, V425, P73, DOI 10.1016/S0014-2999(01)01142-6; Smith SR, 2001, EUR J PHARMACOL, V432, P107, DOI 10.1016/S0014-2999(01)01477-7; Tasaka S, 2002, PULM PHARMACOL THER, V15, P83, DOI 10.1006/pupt.2001.0325; Vaseghi G, 2012, BASIC CLIN PHARMACOL, V111, P161, DOI 10.1111/j.1742-7843.2012.00881.x; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Ware LB, 2006, SEMIN RESP CRIT CARE, V27, P337, DOI 10.1055/s-2006-948288; Weinacker AB, 2001, ANNU REV MED, V52, P221, DOI 10.1146/annurev.med.52.1.221; Zhao Y, 2010, J CARDIOVASC PHARM, V55, P292, DOI 10.1097/FJC.0b013e3181d2644d	53	52	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77706	10.1371/journal.pone.0077706	http://dx.doi.org/10.1371/journal.pone.0077706			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204926	Green Published, gold, Green Submitted			2022-12-27	WOS:000326155400052
J	Stohr, W; Fidler, S; McClure, M; Weber, J; Cooper, D; Ramjee, G; Kaleebu, P; Tambussi, G; Schechter, M; Babiker, A; Phillips, RE; Porter, K; Frater, J				Stoehr, Wolfgang; Fidler, Sarah; McClure, Myra; Weber, Jonathan; Cooper, David; Ramjee, Gita; Kaleebu, Pontiano; Tambussi, Giuseppe; Schechter, Mauro; Babiker, Abdel; Phillips, Rodney E.; Porter, Kholoud; Frater, John			Duration of HIV-1 Viral Suppression on Cessation of Antiretroviral Therapy in Primary Infection Correlates with Time on Therapy	PLOS ONE			English	Article							SEROCONVERSION; INTERRUPTION; COUNT; LOAD	Objective: A minority of HIV-1 positive individuals treated with antiretroviral therapy (ART) in primary HIV-1 infection (PHI) maintain viral suppression on stopping. Whether this is related to ART duration has not been explored. Design: And Methods: Using SPARTAC trial data from individuals recruited within 6 months of seroconversion, we present an observational analysis investigating whether duration of ART was associated with post-treatment viraemic control. Kaplan-Meier estimates, logistic regression and Cox models were used. Results: 165 participants reached plasma viral loads (VL) <400 copies/ml at the time of stopping therapy (ART stop). After ART stop, 159 experienced confirmed VL >= 400 copies/ml during median (IQR) follow-up of 167 (108,199) weeks. Most participants experienced VL rebound within 12 weeks from ART stop, however, there was a suggestion of a higher probability of remaining <400 copies/ml for those on ART >12 weeks compared to <= 12 weeks (p=0.061). Cumulative probabilities of remaining <400 copies/ml at 12, 52 and 104 weeks after ART stop were 21% (95% CI= 13,30), 4% (1,9), and 4% (1,9) for <= 12 weeks ART, and 32% (22,42), 14% (7,22), and 5% (2,11) for >12 weeks. In multivariable regression, ART for >12 weeks was independently associated with a lower probability of being >= 400 copies/ml within 12 weeks of ART stop (OR=0.11 (95% CI=0.03,0.34), p<0.001)). In Cox models of time to VL >= 400 after 12 weeks, we only found an association with female sex (OR=0.2, p=0.001). Conclusion: Longer ART duration in PHI was associated with a higher probability of viral control after ART stop.	[Stoehr, Wolfgang; Babiker, Abdel; Porter, Kholoud] MRC, Clin Trials Unit, London, England; [Fidler, Sarah; McClure, Myra; Weber, Jonathan] Univ London Imperial Coll Sci Technol & Med, London, England; [Cooper, David] Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia; [Cooper, David] Univ New S Wales, Sydney, NSW, Australia; [Ramjee, Gita] MRC, HIV Prevent Res Unit, Durban, South Africa; [Kaleebu, Pontiano] MRC, Uganda Virus Res Inst, Uganda Res Unit AIDS, Entebbe, Uganda; [Tambussi, Giuseppe] Ist Sci San Raffaele, Vaccine & Immunotherapy Res Ctr, I-20132 Milan, Italy; [Schechter, Mauro] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil; [Phillips, Rodney E.; Frater, John] Peter Medawar Bldg Pathogen Res, Nuffield Dept Clin Med, Oxford, England; [Phillips, Rodney E.; Frater, John] Peter Medawar Bldg Pathogen Res, Oxford Martin Sch, Oxford, England; [Phillips, Rodney E.; Frater, John] Oxford Natl Inst Hlth Res, Biomed Res Ctr, Oxford, England	Medical Research Council Clinical Trials Unit; Imperial College London; University of New South Wales Sydney; Kirby Institute; University of New South Wales Sydney; Uganda Virus Research Institute; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Universidade Federal do Rio de Janeiro; University of Oxford; University of Oxford; University of Oxford	Frater, J (corresponding author), Peter Medawar Bldg Pathogen Res, Nuffield Dept Clin Med, Oxford, England.	john.frater@ndm.ox.ac.uk	Schechter, Mauro/AAG-7445-2020	Porter, Kholoud/0000-0002-9226-6206; Fidler, Sarah/0000-0003-1676-7583; Tambussi, Giuseppe/0000-0002-0604-2960; McClure, Myra/0000-0002-5494-407X; Stohr, Wolfgang/0000-0002-6533-2888; Frater, John/0000-0001-7163-7277	Wellcome Trust [069598/Z/02/Z]; National Institute for Health Research Oxford Biomedical Research Centre; Oxford Martin School; Medical Research Council [MC_UU_12023/16, MC_U122886352, G108/626, MC_UU_12023/15, MC_U950080938] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10313] Funding Source: researchfish; MRC [G108/626, MC_UU_12023/16, MC_UU_12023/15, MC_U950080938, MC_U122886352] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Oxford Martin School; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The SPARTAC trial was funded by a grant from the Wellcome Trust (069598/Z/02/Z). JF is supported by the National Institute for Health Research Oxford Biomedical Research Centre and the Oxford Martin School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Easterbrook PJ, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-4; Fidler S, 2013, NEW ENGL J MED, V368, P207, DOI 10.1056/NEJMoa1110039; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Goujard C, 2012, ANTIVIR THER, V17, P1001, DOI 10.3851/IMP2273; Goujard C, 2009, CLIN INFECT DIS, V49, P982, DOI 10.1086/605504; Grijsen ML, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001196; Hocqueloux L, 2010, AIDS, V24, P1598, DOI 10.1097/QAD.0b013e32833b61ba; Lodi S, 2012, ARCH INTERN MED, V172, P1252, DOI 10.1001/archinternmed.2012.2719; Lyles RH, 2000, J INFECT DIS, V181, P872, DOI 10.1086/315339; Madec Y, 2005, AIDS, V19, P2001, DOI 10.1097/01.aids.0000194134.28135.cd; Pantazis N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032369; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Touloumi G, 2013, CLIN INFECT DIS, V56, P888, DOI 10.1093/cid/cis1000	15	55	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78287	10.1371/journal.pone.0078287	http://dx.doi.org/10.1371/journal.pone.0078287			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205183	Green Published, Green Submitted, gold			2022-12-27	WOS:000326155400076
J	Guo, YY; Zhang, JY; Li, XF; Luo, HY; Chen, F; Li, TJ				Guo, Yan-Yan; Zhang, Jian-Yun; Li, Xue-Fen; Luo, Hai-Yan; Chen, Feng; Li, Tie-Jun			PTCH1 Gene Mutations in Keratocystic Odontogenic Tumors: A Study of 43 Chinese Patients and a Systematic Review	PLOS ONE			English	Article							CELL CARCINOMA SYNDROME; STEROL-SENSING DOMAIN; HUMAN HOMOLOG; PATCHED PROTEIN; SUPPRESSOR GENE; RECEPTOR; APOPTOSIS; SPECTRUM; FEATURES; CYCLE	Background: The keratocystic odontogenic tumor (KCOT) is a locally aggressive cystic jaw lesion that occurs sporadically or in association with nevoid basal cell carcinoma syndrome (NBCCS). PTCH1, the gene responsible for NBCCS, may play an important role in sporadic KCOTs. In this study, we analyzed and compared the distribution pattern of PTCH1 mutations in patients with sporadic and NBCCS-associated KCOTs. Methods: We detected PTCH1 mutations in 14 patients with NBCCS-associated KCOTs and 29 patients with sporadic KCOTs by direct sequencing. In addition, five electronic databases were searched for studies detecting PTCH1 mutations in individuals with NBCCS-associated or sporadic KCOTs, published between January 1996 and June 2013 in English language. Results: We identified 15 mutations in 11 cases with NBCCS-associated KCOTs and 19 mutations in 13 cases with sporadic KCOTs. In addition, a total of 204 PTCH1 mutations (187 mutations from 210 cases with NBCCS-associated and 17 mutations from 57 cases with sporadic KCOTs) were compiled from 78 published papers. Conclusions: Our study indicates that mutations in transmembrane 2 (TM2) are closely related to the development of sporadic KCOTs. Moreover, for the early diagnosis of NBCCS, a genetic analysis of the PTCH1 gene should be included in the new diagnostic criteria.	[Guo, Yan-Yan; Zhang, Jian-Yun; Luo, Hai-Yan; Li, Tie-Jun] Peking Univ, Dept Oral Pathol, Sch & Hosp Stomatol, Beijing 100871, Peoples R China; [Li, Xue-Fen; Chen, Feng] Peking Univ, Cent Lab, Sch & Hosp Stomatol, Beijing 100871, Peoples R China	Peking University; Peking University	Chen, F (corresponding author), Peking Univ, Cent Lab, Sch & Hosp Stomatol, Beijing 100871, Peoples R China.	moleculecf@gmail.com; litiejun22@vip.sina.com			National Natural Science Foundation of China [81030018, 30872900, 30901680]; Ministry of Education of China [20120001110043]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This work was supported the National Natural Science Foundation of China (grant numbers 81030018, 30872900, 30901680) and the Doctoral Fund of Ministry of Education of China (grant number 20120001110043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SG, 2004, INT J ORAL MAX SURG, V33, P458, DOI 10.1016/j.ijom.2003.11.001; Barnes EA, 2001, EMBO J, V20, P2214, DOI 10.1093/emboj/20.9.2214; Barnes L., 2005, PATHOLOGY GENETICS H; Boutet N, 2003, J INVEST DERMATOL, V121, P478, DOI 10.1046/j.1523-1747.2003.12423.x; BROWNE RM, 1971, BRIT DENT J, V131, P249, DOI 10.1038/sj.bdj.4802732; EVANS DGR, 1993, J MED GENET, V30, P460, DOI 10.1136/jmg.30.6.460; Fujii K, 2013, FAM CANC IN PRESS; Fujii K, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9132; GAILANI MR, 1992, CELL, V69, P111, DOI 10.1016/0092-8674(92)90122-S; GORLIN RJ, 1987, MEDICINE, V66, P98, DOI 10.1097/00005792-198703000-00002; GORLIN RJ, 1995, DERMATOL CLIN, V13, P113, DOI 10.1016/S0733-8635(18)30114-1; GUTIERREZ MM, 1986, J AM ACAD DERMATOL, V15, P1023, DOI 10.1016/S0190-9622(86)70266-1; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Huang YS, 2013, J EUR ACAD DERMATOL, V27, P235, DOI 10.1111/j.1468-3083.2012.04453.x; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kijima C, 2012, FAM CANCER, V11, P565, DOI 10.1007/s10689-012-9548-0; Kimonis VE, 1997, AM J MED GENET, V69, P299, DOI 10.1002/(SICI)1096-8628(19970331)69:3<299::AID-AJMG16>3.0.CO;2-M; Klein RD, 2005, GENET MED, V7, P611, DOI 10.1097/01.gim.0000182879.57182.b4; LI TJ, 1994, J ORAL PATHOL MED, V23, P184, DOI 10.1111/j.1600-0714.1994.tb01110.x; Lindstrom E, 2006, HUM MUTAT, V27, P215, DOI 10.1002/humu.20296; Lo Muzio L, 1999, CLIN GENET, V55, P34, DOI 10.1034/j.1399-0004.1999.550106.x; Lo Muziol L, 1999, J DENT RES, V78, P1345, DOI 10.1177/00220345990780070901; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Martin V, 2001, CURR BIOL, V11, P601, DOI 10.1016/S0960-9822(01)00178-6; Matsuzawa N, 2006, J CLIN PATHOL, V59, P1084, DOI 10.1136/jcp.2005.029439; Ming JE, 2002, HUM GENET, V110, P297, DOI 10.1007/s00439-002-0695-5; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Pan S, 2009, ORAL ONCOL, V45, P861, DOI 10.1016/j.oraloncology.2009.02.003; Pastorino L, 2009, AM J MED GENET A, V149A, P1539, DOI 10.1002/ajmg.a.32944; Pastorino L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043827; Philipsen H.P, 1956, TANDLAEGEBLADET, V60, P963; Pietsch T, 1997, CANCER RES, V57, P2085; Ponti G, 2012, FAM CANC; Poulaki Vasiliki, 2009, Int Ophthalmol Clin, V49, P155, DOI 10.1097/IIO.0b013e3181924bc2; Savino Maria, 2004, Hum Mutat, V24, P441, DOI 10.1002/humu.9289; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Strutt H, 2001, CURR BIOL, V11, P608, DOI 10.1016/S0960-9822(01)00179-8; Suzuki M, 2012, J HUM GENET, V57, P422, DOI 10.1038/jhg.2012.45; Tanioka M, 2005, ARCH DERMATOL RES, V296, P303, DOI 10.1007/s00403-004-0520-1; Thibert C, 2003, SCIENCE, V301, P843, DOI 10.1126/science.1085405; Wicking C, 1997, AM J HUM GENET, V60, P21	43	48	51	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77305	10.1371/journal.pone.0077305	http://dx.doi.org/10.1371/journal.pone.0077305			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204797	Green Published, gold, Green Submitted			2022-12-27	WOS:000326032600028
J	McBane, JE; Vulesevic, B; Padavan, DT; McEwan, KA; Korbutt, GS; Suuronen, EJ				McBane, Joanne E.; Vulesevic, Branka; Padavan, Donna T.; McEwan, Kimberly A.; Korbutt, Gregory S.; Suuronen, Erik J.			Evaluation of a Collagen-Chitosan Hydrogel for Potential Use as a Pro-Angiogenic Site for Islet Transplantation	PLOS ONE			English	Article							PROGENITOR-CELL MOBILIZATION; PANCREATIC-ISLETS; DIABETES-MELLITUS; DEVICE; MICE; NEOVASCULARIZATION; SURVIVAL; PREIMPLANTATION; VASCULARIZATION; STREPTOZOTOCIN	Islet transplantation to treat type 1 diabetes (T1D) has shown varied long-term success, due in part to insufficient blood supply to maintain the islets. In the current study, collagen and collagen: chitosan (10: 1) hydrogels, +/-circulating angiogenic cells (CACs), were compared for their ability to produce a pro-angiogenic environment in a streptozotocin-induced mouse model of T1D. Initial characterization showed that collagen-chitosan gels were mechanically stronger than the collagen gels (0.7kPa vs. 0.4kPa elastic modulus, respectively), had more cross-links (9.2 vs. 7.4/mu m(2)), and were degraded more slowly by collagenase. After gelation with CACs, live/dead staining showed greater CAC viability in the collagen-chitosan gels after 18h compared to collagen (79% vs. 69%). In vivo, collagen-chitosan gels, subcutaneously implanted for up to 6 weeks in a T1D mouse, showed increased levels of pro-angiogenic cytokines over time. By 6 weeks, anti-islet cytokine levels were decreased in all matrix formulations +/- CACs. The 6-week implants demonstrated increased expression of VCAM-1 in collagen-chitosan implants. Despite this, infiltrating vWF(+) and CXCR4(+) angiogenic cell numbers were not different between the implant types, which may be due to a delayed and reduced cytokine response in a T1D versus non-diabetic setting. The mechanical, degradation and cytokine data all suggest that the collagen-chitosan gel may be a suitable candidate for use as a pro-angiogenic ectopic islet transplant site.	[McBane, Joanne E.; Vulesevic, Branka; Padavan, Donna T.; McEwan, Kimberly A.; Suuronen, Erik J.] Univ Ottawa, Inst Heart, Ottawa, ON, Canada; [McBane, Joanne E.; Vulesevic, Branka; Suuronen, Erik J.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [McEwan, Kimberly A.] Univ Ottawa, Fac Engn, Ottawa, ON, Canada; [Korbutt, Gregory S.] Univ Alberta, Alberta Diabet Inst, Edmonton, AB, Canada	University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; University of Ottawa; University of Alberta	Suuronen, EJ (corresponding author), Univ Ottawa, Inst Heart, Ottawa, ON, Canada.	esuuronen@ottawaheart.ca		McBane, Joanne/0000-0002-9053-4668; Vulesevic, Branka/0000-0003-2297-2209	JDRF [41-2009-771]; CIHR Doctoral Research Award; University of Ottawa Cardiovascular Research Endowment Fund Fellowship; Ontario Graduate Scholarship; Molecular Function & Imaging Program; HSF of Ontario Program Grant [PRG 6242]; JDRF postdoctoral fellowship; CDA postdoctoral fellowship incentive program award	JDRF(Juvenile Diabetes Research Foundation); CIHR Doctoral Research Award(Canadian Institutes of Health Research (CIHR)); University of Ottawa Cardiovascular Research Endowment Fund Fellowship; Ontario Graduate Scholarship(Ontario Graduate Scholarship); Molecular Function & Imaging Program; HSF of Ontario Program Grant; JDRF postdoctoral fellowship(Juvenile Diabetes Research Foundation); CDA postdoctoral fellowship incentive program award	This work was supported by operating grant number 41-2009-771 from JDRF (to GSK and EJS). BV was funded by a CIHR Doctoral Research Award, DTP was funded by a University of Ottawa Cardiovascular Research Endowment Fund Fellowship, KM was supported by an Ontario Graduate Scholarship, and JEM was supported first by a fellowship from the Molecular Function & Imaging Program, funded by a HSF of Ontario Program Grant (PRG 6242), and then by a JDRF postdoctoral fellowship and a CDA postdoctoral fellowship incentive program award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaci A, 1999, CIRCULATION, V99, P2239, DOI 10.1161/01.CIR.99.17.2239; Albiero M, 2012, CURR VASC PHARMACOL, V10, P310, DOI 10.2174/157016112799959387; Annabi N, 2010, TISSUE ENG PART B-RE, V16, P371, DOI [10.1089/ten.teb.2009.0639, 10.1089/ten.TEB.2009.0639]; Balamurugan AN, 2003, PANCREAS, V26, P279, DOI 10.1097/00006676-200304000-00012; Bowers DT, 2011, TRANSPL P, V43, P3285, DOI 10.1016/j.transproceed.2011.09.008; Cardozo AK, 2003, DIABETOLOGIA, V46, P255, DOI 10.1007/s00125-002-1017-0; Carlsson PO, 2011, UPSALA J MED SCI, V116, P1, DOI 10.3109/03009734.2010.548609; Chavakis E, 2005, J EXP MED, V201, P63, DOI 10.1084/jem.20041402; Deng C, 2011, J CONTROL RELEASE, V152, pE196, DOI 10.1016/j.jconrel.2011.09.005; Deng C, 2010, MACROMOL SYMP, V297, P138, DOI 10.1002/masy.200900149; Deng C, 2010, TISSUE ENG PT A, V16, P3099, DOI 10.1089/ten.tea.2009.0504; Dong L, 2011, MICROVASC RES, V82, P227, DOI 10.1016/j.mvr.2011.09.006; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fadini GP, 2005, CURR DIABETES REV, V1, P41, DOI 10.2174/1573399052952640; Forster NA, 2011, ISLETS, V3, P271, DOI 10.4161/isl.3.5.15942; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Ishiyama K, 2011, TRANSPLANTATION, V91, P952, DOI 10.1097/TP.0b013e3182139dc1; Jacobs-Tulleneers-Thevissen D, 2010, DIABETOLOGIA, V53, P1690, DOI 10.1007/s00125-010-1721-0; Kakabadze Z, 2011, TRANSPL INT, V24, P175, DOI 10.1111/j.1432-2277.2010.01160.x; Kaufman-Francis K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040741; Kim JS, 2012, J CONTROL RELEASE, V162, P382, DOI 10.1016/j.jconrel.2012.07.018; Kriz J, 2010, TRANSPL P, V42, P2097, DOI 10.1016/j.transproceed.2010.05.088; Kriz J, 2012, AM J SURG, V203, P793, DOI 10.1016/j.amjsurg.2011.02.009; Kuraitis D, 2011, J MOL CELL CARDIOL, V51, P187, DOI 10.1016/j.yjmcc.2011.04.011; Lin CC, 2011, BIOMATERIALS, V32, P9685, DOI 10.1016/j.biomaterials.2011.08.083; Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195; MANDRUPPOULSEN T, 1990, CURR TOP MICROBIOL, V164, P169; McEwan K, 2012, J BIOMAT SCI-POLYM E, V23, P1467, DOI 10.1163/092050611X584397; Merani S, 2008, BRIT J SURG, V95, P1449, DOI 10.1002/bjs.6391; Moore WV, 2002, CELL TRANSPLANT, V11, P707, DOI 10.3727/000000002783985369; Muthyala S, 2010, ISLETS, V2, P357, DOI 10.4161/isl.2.6.13765; PAIK SG, 1980, P NATL ACAD SCI-BIOL, V77, P6129, DOI 10.1073/pnas.77.10.6129; Pan SK, 2011, J ZHEJIANG UNIV-SC B, V12, P931, DOI 10.1631/jzus.B1100065; Pileggi A, 2006, TRANSPLANTATION, V81, P1318, DOI 10.1097/01.tp.0000203858.41105.88; Rafael E, 2003, CELL TRANSPLANT, V12, P407, DOI 10.3727/000000003108746957; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Sorenby AK, 2008, TRANSPLANTATION, V86, P364, DOI 10.1097/TP.0b013e31817efc78; Stamenovic D, 2000, J APPL PHYSIOL, V89, P2085, DOI 10.1152/jappl.2000.89.5.2085; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Trichet L, 2012, P NATL ACAD SCI USA, V109, P6933, DOI 10.1073/pnas.1117810109; Weber LM, 2009, J BIOMED MATER RES A, V90A, P720, DOI 10.1002/jbm.a.32134; Witkowski P, 2009, TRANSPLANTATION, V88, P1065, DOI 10.1097/TP.0b013e3181ba2e87; YAMADA K, 1993, BIOCHEM BIOPH RES CO, V197, P22, DOI 10.1006/bbrc.1993.2435; Yeung TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038189	46	40	42	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77538	10.1371/journal.pone.0077538	http://dx.doi.org/10.1371/journal.pone.0077538			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204863	Green Published, Green Submitted, gold			2022-12-27	WOS:000326029300103
J	Zhao, YY; Zhang, YH; Li, XC				Zhao, Yanyu; Zhang, Yanhua; Li, Xiaochen			Molecular Phylogeography and Population Genetic Structure of an Endangered Species Pachyhynobius shangchengensis (hynobiid Salamander) in a Fragmented Habitat of Southeastern China	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; MITOCHONDRIAL-DNA; LANDSCAPE GENETICS; CYTOCHROME-B; SKY ISLANDS; CONSEQUENCES; DIVERSITY; AMPHIBIA; CAUDATA; BIOGEOGRAPHY	The salamander Pachyhynobius shangchengensis (Hynobiidae) is a vulnerable species restricted to a patchy distribution associated with small mountain streams surrounded by forested slopes in the Mount Dabieshan region in southeastern China. However, molecular phylogeography and population genetic structure of P. shangchengensis remain poorly investigated. In this study, we explored the genetic structure and phylogeography of P. shangchengensis based on partial sequences of the mitochondrial DNA (mtDNA) cytochrome b and cytochrome c oxidase subunit I genes. Fifty-one haplotypes and four clades were found among 93 samples. Phylogenetic analyses revealed four deeply divergent and reciprocally monophyletic mtDNA lineages that approximately correspond to four geographic regions separated by complicated topography and long distances. The distinct geographic distributions of all lineages and the estimated divergence time suggest spatial and temporal separation coinciding with climatic changes during the Pleistocene. Analysis of molecular variance indicated that most of the observed genetic variation occurred among the four groups, implying long-term interruption of gene flow, and the possible separation of P. shangchengensis into four management units for conservation.	[Zhao, Yanyu; Li, Xiaochen] Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China; [Zhang, Yanhua] Jiangsu Normal Univ, Coll Life Sci, Xuzhou, Peoples R China	Shaanxi Normal University; Jiangsu Normal University	Zhao, YY (corresponding author), Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China.	xznuzhao@163.com			National Natural Science Foundation of China [31071888]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by the National Natural Science Foundation of China (No. 31071888). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, TRACER V1 6; [Anonymous], 1996, J APPL ECOL, DOI DOI 10.2307/2404927; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Axelrod D, 1998, FLORISTIC CHARACTERI; Bidlack AL, 2001, ANIM CONSERV, V4, P283, DOI 10.1017/S1367943001008885; Bryson RW, 2011, J BIOGEOGR, V38, P2299, DOI 10.1111/j.1365-2699.2011.02565.x; Bryson RW, 2011, J BIOGEOGR, V38, P697, DOI 10.1111/j.1365-2699.2010.02431.x; Cai San-yuan, 2001, Journal of Central China Normal University (Natural Sciences), V35, P203; Chen Xiao-Hong, 2001, Acta Zootaxonomica Sinica, V26, P383; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Craw D, 2008, J BIOGEOGR, V35, P1790, DOI 10.1111/j.1365-2699.2008.01936.x; DeChaine EG, 2004, EVOLUTION, V58, P113, DOI 10.1111/j.0014-3820.2004.tb01578.x; deMaynadier PG, 1999, J WILDLIFE MANAGE, V63, P441, DOI 10.2307/3802629; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; FEI L, 1985, Zoological Research, V6, P399; Fu YX, 1997, GENETICS, V147, P915; Funk WC, 2005, MOL ECOL, V14, P483, DOI 10.1111/j.1365-294X.2005.02426.x; Giordano AR, 2007, MOL ECOL, V16, P1625, DOI 10.1111/j.1365-294X.2006.03223.x; Hall T.A., 1999, BIOEDIT USER FRIENDL; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Knowles LL, 2000, EVOLUTION, V54, P1337, DOI 10.1111/j.0014-3820.2000.tb00566.x; Kraaijeveld-Smit FJL, 2005, MOL ECOL, V14, P3307, DOI 10.1111/j.1365-294X.2005.02614.x; [李吉均 Li Jijun], 2004, [冰川冻土, Journal of Glaciology and Geocryology], V26, P235; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lu B, 2012, MOL ECOL, V21, P3308, DOI 10.1111/j.1365-294X.2012.05606.x; Madison DM, 1998, COPEIA, P402; Malyarchuk B, 2010, MOL PHYLOGENET EVOL, V56, P562, DOI 10.1016/j.ympev.2010.04.005; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Martel C, 2004, J EXP MAR BIOL ECOL, V305, P155, DOI 10.1016/j.jembe.2003.11.011; Matsui M, 2008, MOL PHYLOGENET EVOL, V48, P84, DOI 10.1016/j.ympev.2008.04.010; Matsui M, 2007, MOL PHYLOGENET EVOL, V44, P204, DOI 10.1016/j.ympev.2006.11.031; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; NYLANDER J. A. A, 2004, MRMODELTEST V2 PROGR, V2, P2; Palo JU, 2003, MOL ECOL, V12, P1963, DOI 10.1046/j.1365-294X.2003.01865.x; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A., 2006, FIGTREE 1 1 1; Rambaut A., 2012, TRACER V1 5; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rothermel BB, 2002, CONSERV BIOL, V16, P1324, DOI 10.1046/j.1523-1739.2002.01085.x; Rowe G, 2000, OIKOS, V88, P641, DOI 10.1034/j.1600-0706.2000.880321.x; Sambrook J, 1989, MOL CLONING LAB MANU, V2; Shi Y, 2002, QUATERN INT, V97-8, P79, DOI 10.1016/S1040-6182(02)00053-8; Smith CI, 2005, MOL ECOL, V14, P3049, DOI 10.1111/j.1365-294X.2005.02647.x; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Spear SF, 2005, MOL ECOL, V14, P2553, DOI 10.1111/j.1365-294X.2005.02573.x; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; TAJIMA F, 1993, MECHANISMS OF MOLECULAR EVOLUTION, P37; Tajima F, 1996, GENETICS, V143, P1457; TAJIMA F, 1989, GENETICS, V123, P585; TALLMON DA, 2000, J INFO; Trenham PC, 2005, ECOL APPL, V15, P1158, DOI 10.1890/04-1150; Wang B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041579; Wang HW, 2006, MOL ECOL, V15, P4109, DOI 10.1111/j.1365-294X.2006.03086.x; Weisrock DW, 2001, MOL PHYLOGENET EVOL, V18, P434, DOI 10.1006/mpev.2000.0905; Wu Shuhui, 1994, Journal of Henan Normal University (Natural Science), V22, P106; Xiong JL, 2007, J HERPETOL, V41, P664, DOI 10.1670/07-054.1; Xiong JL, 2009, ANIMAL HUSBANDRY FEE, V30, P126; Yoshikawa N, 2008, MOL PHYLOGENET EVOL, V49, P249, DOI 10.1016/j.ympev.2008.07.016; Yuan SL, 2006, MOL ECOL, V15, P2119, DOI 10.1111/j.1365-294X.2006.02875.x; Zhang FF, 2006, MOL PHYLOGENET EVOL, V41, P313, DOI 10.1016/j.ympev.2006.05.024; Zhang MW, 2010, MOL PHYLOGENET EVOL, V54, P47, DOI 10.1016/j.ympev.2009.10.019; Zhang Rong-Zu, 2004, Acta Zoologica Sinica, V50, P841	71	8	8	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78064	10.1371/journal.pone.0078064	http://dx.doi.org/10.1371/journal.pone.0078064			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205092	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300137
J	Xie, XL; Sun, L; Pessetto, ZY; Zhao, Y; Zang, ZH; Zhong, L; Wu, M; Su, Q; Gao, XR; Zan, W; Sun, YY				Xie, Xingliang; Sun, Lin; Pessetto, Ziyan Yuan; Zhao, Yan; Zang, Zhihe; Zhong, Ling; Wu, Min; Su, Qing; Gao, Xiurong; Zan, Wang; Sun, Yiyi			Development of a Fluorescence Polarization Based High-Throughput Assay to Identify Casitas B-Lineage Lymphoma RING Domain Regulators	PLOS ONE			English	Article							INDUCED DIABETIC-RATS; CBL-FAMILY; V-CBL; PROTEINS; UBIQUITINATION; INHIBITORS; ONCOGENE; LIGASES	The E3 ubiquitin protein ligase Casitas B-lineage Lymphoma (Cbl) proteins and their binding partners play an important role in regulating signal transduction pathways. It is important to utilize regulators to study the protein-protein interactions (PPIs) between these proteins. However, finding specific small-molecule regulators of PPIs remains a significant challenge due to the fact that the interfaces involved in PPIs are not well suited for effective small molecule binding. We report the development of a competitive, homogeneous, high-throughput fluorescence polarization (FP) assay to identify small molecule regulators of Cbl (RING) domain. The FP assay was used to measure binding affinities and inhibition constants of UbCH7 peptides and small molecule regulators of Cbl (RING) domains, respectively. In order to rule out promiscuous, aggregation-based inhibition, two assay conditions were developed and compared side by side. Under optimized conditions, we screened a 10,000 natural compound library in detergent-free and detergent-present (0.01% Triton X-100) systems. The results indicate that the detergent-present system is more suitable for high-throughput screens. Three potential compounds, methylprotodioscin, leonuride and catalpol, have been identified that bind to Cbl (RING) domain and interfere with the Cbl (RING)-UbCH7 protein-protein interaction.	[Xie, Xingliang; Zhao, Yan; Zang, Zhihe; Zhong, Ling; Wu, Min; Su, Qing; Gao, Xiurong; Zan, Wang; Sun, Yiyi] Chengdu Med Coll, Dept Pharm, Chengdu, Sichuan Provinc, Peoples R China; [Sun, Lin] Sichuan Univ, West China Hosp, Chengdu, Sichuan Provinc, Peoples R China; [Pessetto, Ziyan Yuan] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA	Chengdu Medical College; Sichuan University; University of Kansas; University of Kansas Medical Center	Sun, YY (corresponding author), Chengdu Med Coll, Dept Pharm, Chengdu, Sichuan Provinc, Peoples R China.	yiyisun0363@gmail.com			National Natural Science Foundation of China (NSFC) [81102326]; Chengdu Medical College for Major Pharmacy Research Development Program [CYXK2012006]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Chengdu Medical College for Major Pharmacy Research Development Program	Project supported by the National Natural Science Foundation of China (NSFC, Grant No. 81102326) and by Chengdu Medical College for Major Pharmacy Research Development Program (Grant No. CYXK2012006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAKE TJ, 1991, ONCOGENE, V6, P653; Chan LL, 2009, IEEE ENG MED BIO, P788, DOI 10.1109/IEMBS.2009.5333796; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Deng YX, 2012, J ETHNOPHARMACOL, V144, P425, DOI 10.1016/j.jep.2012.09.039; Dong Z, 2013, PHYTOMEDICINE; Huang F, 2008, IMMUNOL REV, V224, P229, DOI 10.1111/j.1600-065X.2008.00655.x; Huang WJ, 2010, J NAT PROD, V73, P1170, DOI 10.1021/np9008317; Jadhav A, 2010, J MED CHEM, V53, P37, DOI 10.1021/jm901070c; Kumar EA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01639; Kumar EA, 2012, J MED CHEM, V55, P3583, DOI 10.1021/jm300078z; Kumar EA, 2011, ANAL BIOCHEM, V411, P254, DOI 10.1016/j.ab.2010.11.038; LANGDON WY, 1989, P NATL ACAD SCI USA, V86, P1168, DOI 10.1073/pnas.86.4.1168; Mahmoud MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063784; Miyake S, 1997, CRIT REV ONCOGENESIS, V8, P189, DOI 10.1615/CritRevOncog.v8.i2-3.30; Mohapatra B, 2013, BBA-MOL CELL RES, V1833, P122, DOI 10.1016/j.bbamcr.2012.10.010; Naramura M, 2011, ONCOTARGET, V2, P245; Pohjala L, 2012, MOLECULES, V17, P10774, DOI 10.3390/molecules170910774; SANJAY A, 2001, SCI STKE, pPE40; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Sun YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063354; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Wang G, 2006, CANCER LETT, V241, P102, DOI 10.1016/j.canlet.2005.10.050; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	25	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e78042	10.1371/journal.pone.0078042	http://dx.doi.org/10.1371/journal.pone.0078042			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24205080	Green Published, gold, Green Submitted			2022-12-27	WOS:000326373800013
J	Bi, WJ; Gu, ZY; Zheng, YN; Zhang, X; Guo, J; Wu, G				Bi, Wenjuan; Gu, Zhiyuan; Zheng, Yuanna; Zhang, Xiao; Guo, Jing; Wu, Gang			Heterodimeric BMP-2/7 Antagonizes the Inhibition of All-Trans Retinoic Acid and Promotes the Osteoblastogenesis	PLOS ONE			English	Article							OSTEOCLASTIC BONE-RESORPTION; OSTEOGENIC DIFFERENTIATION; RHBMP2/7 HETERODIMER; GENE-EXPRESSION; RECEPTOR-GAMMA; CELL-CYCLE; SMAD; ETHANOL; STIMULATION; MECHANISM	Objectives: Hypervitaminosis A and alcoholism can result in a low mineral density and compromised regenerative capacity of bone, thus delaying implant osteointegration. The inhibitory effect of all-trans retinoic acid on osteoblastogenesis is considered to be one of the mechanisms. We hypothesized that heterodimeric bone morphogenetic protein-2/7 could antagonize all-trans retinoic acid and enhance osteoblastogenesis, with an aim to accelerate and enhance bone regeneration and implant osteointegration. Materials and Methods: We applied 5 ng/ml or 50 ng/ml bone morphogenetic protein-2/7 to restore the osteoblastogenesis of pre-osteoblasts (MC3T3-E1 cell line) that was inhibited by 1 mu M all-trans retinoic acid. We evaluated the efficacy by assessing cell numbers (proliferation), alkaline phosphatase activity (a marker for early differentiation), osteocalcin (a marker for late differentiation), calcium deposition (a marker for final mineralization) and the expression of osteoblastogenic genes (such as Runx2, Collagen Ia, alkaline phosphatase and osteocalcin) at different time points. Results: All-trans retinoic acid significantly inhibited the expression of all the tested osteoblastogenic genes and proteins except alkaline phosphatase activity. In the presence of ATRA, 50 ng/ml bone morphogenetic protein-2/7 not only completely restored but also significantly enhanced all the osteoblastogenic genes and proteins. On the 28th day, mineralization was completely inhibited by all-trans retinoic acid. In contrast, 50 ng/ml BMP-2/7 could antagonize ATRA and significantly enhance the mineralization about 2.5 folds in comparison with the control treatment (no ATRA, no BMP2/7). Conclusions: Heterodimeric bone morphogenetic protein-2/7 bears a promising application potential to significantly promote bone regeneration and implant osteointegration for the patients with hypervitaminosis A and alcoholism.	[Bi, Wenjuan; Gu, Zhiyuan] Zhejiang Univ, Sch Hosp Stomatol, Hangzhou 310003, Zhejiang, Peoples R China; [Gu, Zhiyuan; Zheng, Yuanna] Zhejiang Chinese Med Univ, Sch Stomatol, Hangzhou, Zhejiang, Peoples R China; [Zhang, Xiao] Peking Univ, Dept Prosthodont, Sch & Hosp Stomatol, Beijing 100871, Peoples R China; [Guo, Jing] Vrije Univ Amsterdam, Res Inst MOVE, Dept Oral Cell Biol, Acad Ctr Dent Amsterdam ACTA, Amsterdam, Netherlands; [Guo, Jing; Wu, Gang] Univ Amsterdam, Amsterdam, Netherlands; [Wu, Gang] Vrije Univ Amsterdam, Res Inst MOVE, Acad Ctr Dent Amsterdam ACTA, Dept Oral Implantol & Prosthet Dent, Amsterdam, Netherlands	Zhejiang University; Zhejiang Chinese Medical University; Peking University; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam	Zheng, YN (corresponding author), Zhejiang Chinese Med Univ, Sch Stomatol, Hangzhou, Zhejiang, Peoples R China.	gzy@zju.edu.cn	wu, gang/C-5072-2012	wu, gang/0000-0001-8941-2500	Natural Science Foundation of Zhejiang Province [Y2111175, 17110008]; Research Foundation of Zhejiang Chinese Medical University	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Research Foundation of Zhejiang Chinese Medical University	This study is supported by the grants (No. Y2111175 and No. 17110008 to Dr. Y. Zheng) from Natural Science Foundation of Zhejiang Province and from Research Foundation of Zhejiang Chinese Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boden SD, 2002, SPINE, V27, P2662, DOI 10.1097/00007632-200212010-00005; Camilli JA, 2004, ARCH ORAL BIOL, V49, P747, DOI 10.1016/j.archoralbio.2004.02.009; Chen M, 2010, BIRTH DEFECTS RES A, V88, P965, DOI 10.1002/bdra.20723; Cohen-Tanugi A, 1998, DIFFERENTIATION, V63, P115, DOI 10.1046/j.1432-0436.1998.6330115.x; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Galindo M, 2005, J BIOL CHEM, V280, P20274, DOI 10.1074/jbc.M413665200; Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001; Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060; Hoffmann A, 2005, J BIOL CHEM, V280, P27271, DOI 10.1074/jbc.M503368200; Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190; Iwata T, 2002, J DENT RES, V81, P387, DOI 10.1177/154405910208100606; Jacobson A, 2004, BIOCHEM BIOPH RES CO, V322, P162, DOI 10.1016/j.bbrc.2004.07.092; Johansson S, 2002, BONE, V31, P685, DOI 10.1016/S8756-3282(02)00910-9; Kane MA, 2010, FASEB J, V24, P823, DOI 10.1096/fj.09-141572; Kaneko H, 2000, BONE, V27, P479, DOI 10.1016/S8756-3282(00)00358-6; Karakida T, 2011, CONNECT TISSUE RES, V52, P365, DOI 10.3109/03008207.2010.541309; Kitching R, 2002, J BONE MINER METAB, V20, P269, DOI 10.1007/s007740200039; Kuske B, 2011, METHODS MOL BIOL, V690, P195, DOI 10.1007/978-1-60761-962-8_14; Lima CC, 2011, BRAZ J BIOL, V71, P115, DOI 10.1590/S1519-69842011000100017; Liu Y, 2005, BONE, V36, P745, DOI 10.1016/j.bone.2005.02.005; LOHNES D, 1993, CELL, V73, P643, DOI 10.1016/0092-8674(93)90246-M; Massague J, 2003, GENE DEV, V17, P2993, DOI 10.1101/gad.1167003; Michaelsson K, 2003, NEW ENGL J MED, V348, P287, DOI 10.1056/NEJMoa021171; Miyazono K, 1999, BONE, V25, P91, DOI 10.1016/S8756-3282(99)00113-1; Nagasawa H, 2005, J NUTR SCI VITAMINOL, V51, P311, DOI 10.3177/jnsv.51.311; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Pratap J, 2003, CANCER RES, V63, P5357; Sampson HW, 1998, ALCOHOL HEALTH RES W, V22, P190; SANESHIGE S, 1995, BIOCHEM J, V309, P721, DOI 10.1042/bj3090721; Sheng NY, 2010, P NATL ACAD SCI USA, V107, P18886, DOI 10.1073/pnas.1009244107; Soares EV, 2010, J BONE MINER METAB, V28, P101, DOI 10.1007/s00774-009-0115-1; Suzuki A, 2006, J BONE MINER RES, V21, P674, DOI 10.1359/JBMR.020603; Trevisiol CH, 2007, BONE, V41, P175, DOI 10.1016/j.bone.2007.04.189; Turner RT, 2000, ALCOHOL CLIN EXP RES, V24, P1693, DOI 10.1111/j.1530-0277.2000.tb01971.x; Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1; Wang AX, 2008, BIOCHEM BIOPH RES CO, V375, P435, DOI 10.1016/j.bbrc.2008.08.036; Wang JR, 2008, J BIOL CHEM, V283, P4375, DOI 10.1074/jbc.M708471200; Wang JX, 2012, J CLIN PERIODONTOL, V39, P98, DOI 10.1111/j.1600-051X.2011.01807.x; Zheng YN, 2010, TISSUE ENG PT A, V16, P879, DOI [10.1089/ten.tea.2009.0312, 10.1089/ten.TEA.2009.0312]	39	17	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78198	10.1371/journal.pone.0078198	http://dx.doi.org/10.1371/journal.pone.0078198			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205156	gold, Green Published, Green Submitted			2022-12-27	WOS:000326334500101
J	Guo, JS; Yuan, YM; Liu, ZX; Zhu, J				Guo, Jiansheng; Yuan, Yongming; Liu, Zhixue; Zhu, Jian			Development and Structure of Internal Glands and External Glandular Trichomes in Pogostemon cablin	PLOS ONE			English	Article							ESSENTIAL OIL; LEONOTIS-LEONURUS; MULTIVESICULAR BODIES; ULTRASTRUCTURE; SECRETION; LEAVES; HISTOCHEMISTRY; IDENTIFICATION; BIOSYNTHESIS; CAPITATE	Pogostemon cablin possesses two morphologically and ontogenetically different types of glandular trichomes, one type of bristle hair on the surfaces of leaves and stems and one type of internal gland inside the leaves and stems. The internal gland originates from elementary meristem and is associated with the biosynthesis of oils present inside the leaves and stems. However, there is little information on mechanism for the oil biosynthesis and secretion inside the leaves and stems. In this study, we identified three kinds of glandular trichome types and two kinds of internal gland in the Pogostemon cablin. The oil secretions from internal glands of stems and leaves contained lipids, flavones and terpenes. Our results indicated that endoplasmic reticulum and plastids and vacuoles are likely involved in the biosynthesis of oils in the internal glands and the synthesized oils are transported from endoplasmic reticulum to the cell wall via connecting endoplasmic reticulum membranes to the plasma membrane. And the comparative analysis of the development, distribution, histochemistry and ultrastructures of the internal and external glands in Pogostemon cablin leads us to propose that the internal gland may be a novel secretory structure which is different from external glands.	[Guo, Jiansheng; Liu, Zhixue; Zhu, Jian] Tongji Univ, Sch Life Sci & Technol, Dept Mol & Cell Biol, Shanghai 200092, Peoples R China; [Yuan, Yongming] Firmenich Co, Shanghai, Peoples R China	Tongji University; Firmenich	Zhu, J (corresponding author), Tongji Univ, Sch Life Sci & Technol, Dept Mol & Cell Biol, Shanghai 200092, Peoples R China.	zhujian1@tongji.edu.cn						AMELUNXEN F, 1965, PLANTA MED, V13, P457, DOI 10.1055/s-0028-1100141; Ascensao L, 1998, ANN BOT-LONDON, V81, P263, DOI 10.1006/anbo.1997.0550; ASCENSAO L, 1995, ANN BOT-LONDON, V75, P619, DOI 10.1006/anbo.1995.1067; Ascensao L, 1997, INT J PLANT SCI, V158, P249, DOI 10.1086/297436; BOSABALIDIS A, 1982, PLANTA, V156, P496, DOI 10.1007/BF00392771; BOURETT TM, 1994, INT J PLANT SCI, V155, P623, DOI 10.1086/297202; Buer CS, 2010, J INTEGR PLANT BIOL, V52, P98, DOI 10.1111/j.1744-7909.2010.00905.x; Burbulis IE, 1999, P NATL ACAD SCI USA, V96, P12929, DOI 10.1073/pnas.96.22.12929; Cutter EG, 1980, PLANT ANATOMY EXPT 2; FAHN A, 1988, NEW PHYTOL, V108, P229, DOI 10.1111/j.1469-8137.1988.tb04159.x; Fahn A, 2000, ADV BOT RES, V31, P37, DOI 10.1016/S0065-2296(00)31006-0; FRANCESCHI VR, 1983, BOT GAZ, V144, P175, DOI 10.1086/337358; Gersbach PV, 2002, ANN BOT-LONDON, V89, P255, DOI 10.1093/aob/mcf033; Goodger JQD, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-20; Harborne J. B., 1993, INTRO ECOLOGICAL BIO, V4th; HEINRICH G, 1985, ISRAEL J BOT, V34, P205; HENDERSON W, 1970, PHYTOCHEMISTRY, V9, P1219, DOI 10.1016/S0031-9422(00)85312-1; Huang SS, 2008, J TORREY BOT SOC, V135, P155, DOI 10.3159/07-RA-045.1; Kelsey RG, 1984, BIOL CHEM PLANT TRIC, P187; Lawrence B.M., 1992, ADV LABIATE SCI, P399; Machado Silvia Rodrigues, 1995, Revista Brasileira de Botanica, V18, P197; Machado SR, 2006, ANN BOT-LONDON, V97, P357, DOI 10.1093/aob/mcj042; Maeda E, 1997, JPN J CROP SCI, V66, P307, DOI 10.1626/jcs.66.307; MEYBERG M, 1988, ANN BOT-LONDON, V62, P537, DOI 10.1093/oxfordjournals.aob.a087690; Moura MZD, 2005, BOT J LINN SOC, V148, P427, DOI 10.1111/j.1095-8339.2005.00426.x; NABETA K, 1993, DEV FOOD SCI, V32, P577; Plachno BJ, 2007, ANN BOT-LONDON, V100, P195, DOI 10.1093/aob/mcm109; Richardson PM, 1992, ADV LABIATAE SCI, P291; ROBARDS AW, 1988, PROTOPLASMA, V142, P79, DOI 10.1007/BF01290866; ROBINS RJ, 1980, NEW PHYTOL, V86, P279, DOI 10.1111/j.1469-8137.1980.tb00789.x; Rodriguez E., 1984, BIOL CHEM PLANT TRIC, V1st ed.; Sacchetti G, 1999, ANN BOT-LONDON, V83, P87, DOI 10.1006/anbo.1998.0778; SCHNEPF E, 1972, Biochemie und Physiologie der Pflanzen (BPP), V163, P113; Smaoui A, 2011, PROTOPLASMA, V248, P363, DOI 10.1007/s00709-010-0179-8; Spring O, 2000, ADV BOT RES, V31, P153, DOI 10.1016/S0065-2296(00)31009-6; Stpiczynska M, 2008, ANN BOT-LONDON, V101, P375, DOI 10.1093/aob/mcm297; SUGIMURA Y, 1991, JPN J CROP SCI, V60, P324, DOI 10.1626/jcs.60.324; TANCHAK MA, 1987, PROTOPLASMA, V138, P173, DOI 10.1007/BF01281026; Tse YC, 2004, PLANT CELL, V16, P672, DOI 10.1105/tpc.019703; Turner GW, 2000, PLANT PHYSIOL, V124, P665, DOI 10.1104/pp.124.2.665; Turner GW, 2004, PLANT PHYSIOL, V136, P4215, DOI 10.1104/pp.104.050229; VASSILYEV AE, 1988, ANN BOT-LONDON, V62, P329, DOI 10.1093/oxfordjournals.aob.a087665; VENKATACHALAM KV, 1984, PLANT PHYSIOL, V76, P148, DOI 10.1104/pp.76.1.148; WAGNER GJ, 1991, PLANT PHYSIOL, V96, P675, DOI 10.1104/pp.96.3.675; WERKER E, 1985, ISRAEL J BOT, V34, P31; WERKER E, 1993, ANN BOT-LONDON, V71, P43, DOI 10.1006/anbo.1993.1005; Werker E, 2000, ADV BOT RES, V31, P1, DOI 10.1016/S0065-2296(00)31005-9; Winkel-Shirley B, 1999, PHYSIOL PLANTARUM, V107, P142, DOI 10.1034/j.1399-3054.1999.100119.x; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; [郑宝江 Zheng Baojiang], 2002, [植物研究, Bulletin of Botanical Research], V22, P176	50	19	20	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77862	10.1371/journal.pone.0077862	http://dx.doi.org/10.1371/journal.pone.0077862			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205002	gold, Green Published, Green Submitted			2022-12-27	WOS:000326334500070
J	Peng, C; Wang, MH; Shen, Y; Feng, HQ; Li, A				Peng, Chen; Wang, Minghui; Shen, Yi; Feng, Huanqing; Li, Ao			Reconstruction and Analysis of Transcription Factor-miRNA Co-Regulatory Feed-Forward Loops in Human Cancers Using Filter-Wrapper Feature Selection	PLOS ONE			English	Article							EXPRESSION PROFILES; MICRORNA; NETWORK; GENE; DATABASE	Background: As one of the most common types of co-regulatory motifs, feed-forward loops (FFLs) control many cell functions and play an important role in human cancers. Therefore, it is crucial to reconstruct and analyze cancer-related FFLs that are controlled by transcription factor (TF) and microRNA (miRNA) simultaneously, in order to find out how miRNAs and TFs cooperate with each other in cancer cells and how they contribute to carcinogenesis. Current FFL studies rely on predicted regulation information and therefore suffer the false positive issue in prediction results. More critically, FFLs generated by existing approaches cannot represent the dynamic and conditional regulation relationship under different experimental conditions. Methodology/Principal Findings: In this study, we proposed a novel filter-wrapper feature selection method to accurately identify co-regulatory mechanism by incorporating prior information from predicted regulatory interactions with parallel miRNA/mRNA expression datasets. By applying this method, we reconstructed 208 and 110 TF-miRNA co-regulatory FFLs from human pan-cancer and prostate datasets, respectively. Further analysis of these cancer-related FFLs showed that the top-ranking TF STAT3 and miRNA hsa-let-7e are key regulators implicated in human cancers, which have regulated targets significantly enriched in cellular process regulations and signaling pathways that are involved in carcinogenesis. Conclusions/Significance: In this study, we introduced an efficient computational approach to reconstruct co-regulatory FFLs by accurately identifying gene co-regulatory interactions. The strength of the proposed feature selection method lies in the fact it can precisely filter out false positives in predicted regulatory interactions by quantitatively modeling the complex co-regulation of target genes mediated by TFs and miRNAs simultaneously. Moreover, the proposed feature selection method can be generally applied to other gene regulation studies using parallel expression data with respect to different biological contexts.	[Peng, Chen; Wang, Minghui; Shen, Yi; Feng, Huanqing; Li, Ao] Univ Sci & Technol China, Sch Informat Sci & Technol, Hefei 230026, Anhui, Peoples R China; [Wang, Minghui; Li, Ao] Univ Sci & Technol China, Res Ctr Biomed Engn, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Li, A (corresponding author), Univ Sci & Technol China, Sch Informat Sci & Technol, Hefei 230026, Anhui, Peoples R China.	aoli@ustc.edu.cn	Li, aoyu/GXV-4925-2022; Li, Ao/GRR-5311-2022		National Natural Science Foundation of China [61101061, 31100955]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Natural Science Foundation of China (61101061 to MW, 31100955 to AL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguda BD, 2013, ADV EXP MED BIOL, V774, P149, DOI 10.1007/978-94-007-5590-1_9; Alexiou P, 2010, NUCLEIC ACIDS RES, V38, pD137, DOI 10.1093/nar/gkp888; Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Bendoraite A, 2010, GYNECOL ONCOL, V116, P117, DOI 10.1016/j.ygyno.2009.08.009; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Budd WT, 2012, CHEM BIODIVERS, V9, P857, DOI 10.1002/cbdv.201100386; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Castillo SD, 2012, CANCER RES, V72, P176, DOI 10.1158/0008-5472.CAN-11-3506; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; CORONNELLO C, 2013, NUCL ACIDS RES; Ding C, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P523, DOI 10.1109/CSB.2003.1227396; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; Dong QC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010147; Esposito F, 2011, J PATHOL, V224, P110, DOI 10.1002/path.2846; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gu L, 2010, AM J PATHOL, V176, P1959, DOI 10.2353/ajpath.2010.090653; Guo AY, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-10; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Hoyos JM, 2009, ONCOGENE, V28, P876, DOI 10.1038/onc.2008.438; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Huang HF, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-2; Jiang C, 2007, NUCLEIC ACIDS RES, V35, pD137, DOI 10.1093/nar/gkl1041; JING N, 2011, DEV COMBINATION THER; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Keller A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-353; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu YM, 2011, BIOINFORMATICS, V27, P2406, DOI 10.1093/bioinformatics/btr410; MEYER PE, 2010, INFORM THEORETIC INF; Mitra D, 2011, J BIOL CHEM, V286, P40531, DOI 10.1074/jbc.M111.304865; Nazarov PV, 2013, NUCLEIC ACIDS RES, V41, P2817, DOI 10.1093/nar/gks1471; Powers D. M, 2011, ARXIV201016061; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Re A, 2009, MOL BIOSYST, V5, P854, DOI 10.1039/b900177h; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Shalgi R, 2009, AGING-US, V1, P762, DOI 10.18632/aging.100085; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sun JC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002488; Swami M, 2010, NAT REV CANCER, V10, DOI 10.1038/nrc2970; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Yan ZY, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks395; Ye HS, 2012, NUCLEIC ACIDS RES, V40, P5201, DOI 10.1093/nar/gks175; Yu H, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-61; Zhang HH, 2007, WORLD J GASTROENTERO, V13, P2883, DOI 10.3748/wjg.v13.i20.2883	47	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78197	10.1371/journal.pone.0078197	http://dx.doi.org/10.1371/journal.pone.0078197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205155	Green Published, gold, Green Submitted			2022-12-27	WOS:000326270700084
J	Ruwanpura, SM; McLeod, L; Lilja, AR; Brooks, G; Dousha, LF; Seow, HJ; Bozinovski, S; Vlahos, R; Hertzog, PJ; Anderson, GP; Jenkins, BJ				Ruwanpura, Saleela M.; McLeod, Louise; Lilja, Andrew R.; Brooks, Gavin; Dousha, Lovisa F.; Seow, Huei J.; Bozinovski, Steven; Vlahos, Ross; Hertzog, Paul J.; Anderson, Gary P.; Jenkins, Brendan J.			Non-Essential Role for TLR2 and Its Signaling Adaptor Mal/TIRAP in Preserving Normal Lung Architecture in Mice	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; OXIDATIVE STRESS; INDUCED EMPHYSEMA; CUTTING EDGE; EXPRESSION; ASSOCIATION; MYD88; COPD; RECOGNITION; TOLL-LIKE-RECEPTOR-2	Myeloid differentiation factor 88 (MyD88) and MyD88-adaptor like (Mal)/Toll-interleukin 1 receptor domain containing adaptor protein (TIRAP) play a critical role in transducing signals downstream of the Toll-like receptor (TLR) family. While genetic ablation of the TLR4/MyD88 signaling axis in mice leads to pulmonary cell death and oxidative stress culminating in emphysema, the involvement of Mal, as well as TLR2 which like TLR4 also signals via MyD88 and Mal, in the pathogenesis of emphysema has not been studied. By employing an in vivo genetic approach, we reveal here that unlike the spontaneous pulmonary emphysema which developed in Tlr4(-/-) mice by 6 months of age, the lungs of Tlr2(-/-) mice showed no physiological or morphological signs of emphysema. A more detailed comparative analysis of the lungs from these mice confirmed that elevated oxidative protein carbonylation levels and increased numbers of alveolar cell apoptosis were only detected in Tlr4(-/-) mice, along with up-regulation of NADPH oxidase 3 (Nox3) mRNA expression. With respect to Mal, the architecture of the lungs of Mal(-/-) mice was normal. However, despite normal oxidative protein carbonylation levels in the lungs of emphysema-free Mal(-/-) mice, these mice displayed increased levels of apoptosis comparable to those observed in emphysematous Tlr4(-/-) mice. In conclusion, our data provide in vivo evidence for the non-essential role for TLR2, unlike the related TLR4, in maintaining the normal architecture of the lung. In addition, we reveal that Mal differentially facilitates the anti-apoptotic, but not oxidant suppressive, activities of TLR4 in the lung, both of which appear to be essential for TLR4 to prevent the onset of emphysema.	[Ruwanpura, Saleela M.; McLeod, Louise; Brooks, Gavin; Hertzog, Paul J.; Jenkins, Brendan J.] Monash Univ, Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia; [Lilja, Andrew R.; Dousha, Lovisa F.; Seow, Huei J.; Bozinovski, Steven; Vlahos, Ross; Anderson, Gary P.] Univ Melbourne, Dept Med & Pharmacol, Parkville, Vic 3052, Australia	Monash University; University of Melbourne	Jenkins, BJ (corresponding author), Monash Univ, Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia.	Brendan.Jenkins@monash.edu	Hertzog, Paul J/I-7053-2013; Vlahos, Ross/AAM-3837-2020	Hertzog, Paul J/0000-0002-1373-8472; Vlahos, Ross/0000-0001-8443-7071; Ruwanpura, saleela/0000-0002-4074-2012; Seow, Huei/0000-0002-4790-4811; Jenkins, Brendan/0000-0002-7552-4656; Anderson, Gary/0000-0001-6580-3398; McLeod, Louise/0000-0002-7595-6432; Bozinovski, Steven/0000-0001-6533-8641	National Health and Medical Research Council (NHMRC, Australia); NHMRC Australian Biomedical Post-doctoral Fellowship; Senior Medical Research Fellowship; Sylvia and Charles Viertel Foundation; Victorian Government of Australia	National Health and Medical Research Council (NHMRC, Australia)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Australian Biomedical Post-doctoral Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Senior Medical Research Fellowship; Sylvia and Charles Viertel Foundation; Victorian Government of Australia	This study was supported by a research grant from the National Health and Medical Research Council (NHMRC, Australia), as well as the Operational Infrastructure Support Program by the Victorian Government of Australia. S.M. Ruwanpura is supported by NHMRC Australian Biomedical Post-doctoral Fellowship. B.J. Jenkins is supported by a Senior Medical Research Fellowship awarded by the Sylvia and Charles Viertel Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoshiba K, 2003, AM J RESP CELL MOL, V28, P555, DOI 10.1165/rcmb.2002-0090OC; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Baines KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018426; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Budulac SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043124; Chen JX, 2008, LAB INVEST, V88, P1316, DOI 10.1038/labinvest.2008.92; Chung KF, 2010, ANN NY ACAD SCI, V1203, P85, DOI 10.1111/j.1749-6632.2010.05600.x; Cole LE, 2010, J LEUKOCYTE BIOL, V87, P275, DOI 10.1189/jlb.0909619; Comer D, 2012, EUR RESP J; Demedts IK, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-53; Gill R, 2010, FREE RADICAL BIO MED, V48, P1121, DOI 10.1016/j.freeradbiomed.2010.01.006; Greenhill CJ, 2011, J IMMUNOL, V186, P1199, DOI 10.4049/jimmunol.1002971; Hantos Z, 2008, J APPL PHYSIOL, V105, P1864, DOI 10.1152/japplphysiol.90924.2008; Hoshino K, 1999, J IMMUNOL, V162, P3749; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kennedy C.L., 2013, ONCOGENE; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Kim WJ, 2011, EUR RESPIR J, V37, P39, DOI 10.1183/09031936.00173009; Kolls JK, 2006, J CLIN INVEST, V116, P860, DOI 10.1172/JCI28111; Ladhani SN, 2010, CLIN INFECT DIS, V51, P761, DOI 10.1086/656236; Laird MHW, 2009, J LEUKOCYTE BIOL, V85, P966, DOI 10.1189/jlb.1208763; Laroux FS, 2005, J IMMUNOL, V175, P5596, DOI 10.4049/jimmunol.175.9.5596; Lee SW, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-106; Lokke A, 2006, THORAX, V61, P935, DOI 10.1136/thx.2006.062802; Lugade AA, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00010; MacNee William, 2005, Proc Am Thorac Soc, V2, P50, DOI 10.1513/pats.200411-056SF; MacRedmond RE, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-84; Maes T, 2006, INT ARCH ALLERGY IMM, V141, P354, DOI 10.1159/000095462; Noble Paul W, 2006, Proc Am Thorac Soc, V3, P401, DOI 10.1513/pats.200604-097AW; O'Neill LAJ, 2005, NAT MED, V11, P1161, DOI 10.1038/nm1105-1161; Ochs M, 2006, J MICROSC-OXFORD, V222, P188, DOI 10.1111/j.1365-2818.2006.01587.x; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pabst S, 2009, LUNG, V187, P173, DOI 10.1007/s00408-009-9144-8; Pan Ming-Ming, 2008, Zhonghua Yi Xue Za Zhi, V88, P2103; Papadopoulos AI, 2012, CYTOKINE, V60, P104, DOI 10.1016/j.cyto.2012.05.008; Pons J, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-64; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Ruwanpura SM, 2012, AM J PHYSIOL-LUNG C, V302, P1627, DOI 10.1152/ajplung.00285.2011; Ruwanpura SM, 2011, AM J RESP CELL MOL, V45, P720, DOI 10.1165/rcmb.2010-0462OC; Sacre SM, 2007, AM J PATHOL, V170, P518, DOI 10.2353/ajpath.2007.060657; Schnare M, 2000, CURR BIOL, V10, P1139, DOI 10.1016/S0960-9822(00)00700-4; Sierra SS, 2009, EMBO J, V28, P2018, DOI 10.1038/emboj.2009.158; Song ZJ, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-168; Speletas M, 2009, CLIN DEV IMMUNOL, DOI 10.1155/2009/260286; Sukkar MB, 2006, J ALLERGY CLIN IMMUN, V118, P641, DOI 10.1016/j.jaci.2006.05.013; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tye H, 2012, CANCER CELL, V22, P466, DOI 10.1016/j.ccr.2012.08.010; Williams AS, 2007, J APPL PHYSIOL, V103, P1189, DOI 10.1152/japplphysiol.00172.2007; Wu Q, 2011, AM J PHYSIOL-LUNG C, V300, pL579, DOI 10.1152/ajplung.00336.2010; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Zhang XC, 2006, J CLIN INVEST, V116, P3050, DOI 10.1172/JCI28139	53	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78095	10.1371/journal.pone.0078095	http://dx.doi.org/10.1371/journal.pone.0078095			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205107	Green Published, gold, Green Submitted			2022-12-27	WOS:000326270700073
J	Salma, M; Rousseaux, S; Sequeira-Le Grand, A; Divol, B; Alexandre, H				Salma, Mohammad; Rousseaux, Sandrine; Sequeira-Le Grand, Anabelle; Divol, Benoit; Alexandre, Herve			Characterization of the Viable but Nonculturable (VBNC) State in Saccharomyces cerevisiae	PLOS ONE			English	Article							BOTRYTIS-AFFECTED WINE; MICROBIAL-POPULATIONS; ESCHERICHIA-COLI; VIBRIO-CHOLERAE; PLASMA-MEMBRANE; SULFUR-DIOXIDE; FLOW-CYTOMETRY; VIABILITY; SULFITE; RESUSCITATION	The Viable But Non Culturable (VBNC) state has been thoroughly studied in bacteria. In contrast, it has received much less attention in other microorganisms. However, it has been suggested that various yeast species occurring in wine may enter in VBNC following sulfite stress. In order to provide conclusive evidences for the existence of a VBNC state in yeast, the ability of Saccharomyces cerevisiae to enter into a VBNC state by applying sulfite stress was investigated. Viable populations were monitored by flow cytometry while culturable populations were followed by plating on culture medium. Twenty-four hours after the application of the stress, the comparison between the culturable population and the viable population demonstrated the presence of viable cells that were non culturable. In addition, removal of the stress by increasing the pH of the medium at different time intervals into the VBNC state allowed the VBNC S. cerevisiae cells to "resuscitate". The similarity between the cell cycle profiles of VBNC cells and cells exiting the VBNC state together with the generation rate of cells exiting VBNC state demonstrated the absence of cellular multiplication during the exit from the VBNC state. This provides evidence of a true VBNC state. To get further insight into the molecular mechanism pertaining to the VBNC state, we studied the involvement of the SSU1 gene, encoding a sulfite pump in S. cerevisiae. The physiological behavior of wild-type S. cerevisiae was compared to those of a recombinant strain overexpressing SSU1 and null Delta ssu1 mutant. Our results demonstrated that the SSU1 gene is only implicated in the first stages of sulfite resistance but not per se in the VBNC phenotype. Our study clearly demonstrated the existence of an SO2-induced VBNC state in S. cerevisiae and that the stress removal allows the "resuscitation" of VBNC cells during the VBNC state.	[Salma, Mohammad; Rousseaux, Sandrine; Alexandre, Herve] Univ Bourgogne, UMR PAM, AgroSup Dijon Lab, Inst Univ Vigne & Vin Jules Guyot, Dijon, France; [Divol, Benoit] Univ Stellenbosch, Inst Wine Biotechnol, ZA-7600 Stellenbosch, South Africa; [Sequeira-Le Grand, Anabelle] Univ Bourgogne, Dijon, France	Institut Agro; AgroSup Dijon; Universite de Bourgogne; Stellenbosch University; Universite de Bourgogne	Alexandre, H (corresponding author), Univ Bourgogne, UMR PAM, AgroSup Dijon Lab, Inst Univ Vigne & Vin Jules Guyot, Dijon, France.	rvalex@u-bourgogne.fr	alexandre, hervé/T-2101-2017; Rousseaux, Sandrine/L-3465-2016	Divol, Benoit/0000-0003-1506-3170; alexandre, herve/0000-0002-1316-7016				Agnolucci M, 2010, INT J FOOD MICROBIOL, V143, P76, DOI 10.1016/j.ijfoodmicro.2010.07.022; Ausubel F. M., 1999, SHORT PROTOCOLS MOL; Avram D, 1997, J BACTERIOL, V179, P5971, DOI 10.1128/jb.179.18.5971-5974.1997; Bleve G, 2003, APPL ENVIRON MICROB, V69, P4116, DOI 10.1128/AEM.69.7.4116-4122.2003; Bogosian G, 1998, APPL ENVIRON MICROB, V64, P1736; Bogosian G, 2001, EMBO REP, V2, P770, DOI 10.1093/embo-reports/kve182; Brachmann CB, 1998, YEAST, V14, P115; CASALONE E, 1992, CURR GENET, V22, P435, DOI 10.1007/BF00326407; Davey HM, 1996, MICROBIOL REV, V60, P641, DOI 10.1128/MMBR.60.4.641-696.1996; Dhiaf A, 2008, J WATER HEALTH, V6, P565, DOI 10.2166/wh.2008.131; Divol B, 2005, J APPL MICROBIOL, V99, P85, DOI 10.1111/j.1365-2672.2005.02578.x; du Toit WJ, 2005, J APPL MICROBIOL, V98, P862, DOI 10.1111/j.1365-2672.2004.02549.x; Gauthier MJ, 2000, NONCULTURABLE MICROORGANISMS IN THE ENVIRONMENT, P87; Giraffa G, 2004, FEMS MICROBIOL REV, V28, P251, DOI 10.1016/j.femsre.2003.10.005; Guillou S, 2003, INT J FOOD MICROBIOL, V88, P85, DOI 10.1016/S0168-1605(03)00112-0; Gundllapalli SB, 2006, ANN MICROBIOL, V56, P143, DOI 10.1007/BF03174996; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; Kell DB, 1998, ANTON LEEUW INT J G, V73, P169, DOI 10.1023/A:1000664013047; Lleo MD, 2000, APPL ENVIRON MICROB, V66, P4564; McDougald D, 1998, FEMS MICROBIOL ECOL, V25, P1, DOI 10.1111/j.1574-6941.1998.tb00455.x; Millard PJ, 1997, APPL ENVIRON MICROB, V63, P2897, DOI 10.1128/AEM.63.7.2897-2905.1997; Millet V, 2001, THESIS; Mills DA, 2002, APPL ENVIRON MICROB, V68, P4884, DOI 10.1128/AEM.68.10.4884-4893.2002; Minois N, 2009, AGING CELL, V8, P36, DOI 10.1111/j.1474-9726.2008.00446.x; NILSSON L, 1991, J BACTERIOL, V173, P5054, DOI 10.1128/jb.173.16.5054-5059.1991; Nystrom T, 2003, BIOESSAYS, V25, P204, DOI 10.1002/bies.10233; Oliver JD, 2005, J MICROBIOL, V43, P93; Park H, 2000, YEAST, V16, P881, DOI 10.1002/1097-0061(200007)16:10<881::AID-YEA576>3.0.CO;2-3; Park H, 2008, J MICROBIOL, V46, P542, DOI 10.1007/s12275-008-0053-y; Pozarowski Piotr, 2004, Methods Mol Biol, V281, P301; RAVEL J, 1995, MICROBIOL-UK, V141, P377, DOI 10.1099/13500872-141-2-377; ROLLINS DM, 1986, APPL ENVIRON MICROB, V52, P531, DOI 10.1128/AEM.52.3.531-538.1986; Romano P., 1993, WINE MICROBIOLOGY BI; ROSZAK DB, 1984, CAN J MICROBIOL, V30, P334, DOI 10.1139/m84-049; ROTH WG, 1988, APPL ENVIRON MICROB, V54, P3142, DOI 10.1128/AEM.54.12.3142-3146.1988; Sambrook J., 2002, MOL CLONING LAB MANU; SCHIMZ KL, 1980, ARCH MICROBIOL, V125, P89, DOI 10.1007/BF00403203; Serpaggi V, 2012, FOOD MICROBIOL, V30, P438, DOI 10.1016/j.fm.2011.12.020; Singleton VL, 1998, PRINCIPLES PRACTICES; Teixeira H, 2002, MICROBIAL ECOL, V43, P146, DOI 10.1007/s00248-001-0036-6; XU HS, 1982, MICROBIAL ECOL, V8, P313, DOI 10.1007/BF02010671; Yamamoto H, 2000, J Infect Chemother, V6, P112, DOI 10.1007/PL00012149; Zhong L, 2009, LETT APPL MICROBIOL, V48, P247, DOI 10.1111/j.1472-765X.2008.02522.x	43	57	60	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77600	10.1371/journal.pone.0077600	http://dx.doi.org/10.1371/journal.pone.0077600			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204887	Green Submitted, Green Published, gold			2022-12-27	WOS:000326270700042
J	Kopek, BG; Shtengel, G; Grimm, JB; Clayton, DA; Hess, HF				Kopek, Benjamin G.; Shtengel, Gleb; Grimm, Jonathan B.; Clayton, David A.; Hess, Harald F.			Correlative Photoactivated Localization and Scanning Electron Microscopy	PLOS ONE			English	Article							SUPERRESOLUTION FLUORESCENCE; MITOCHONDRIAL NUCLEOIDS; ULTRATHIN CRYOSECTIONS; PROTEIN; ACTIN; MOLECULES; REVEALS; LIGHT; TOOL; VISUALIZATION	The ability to localize proteins precisely within subcellular space is crucial to understanding the functioning of biological systems. Recently, we described a protocol that correlates a precise map of fluorescent fusion proteins localized using three-dimensional super-resolution optical microscopy with the fine ultrastructural context of three-dimensional electron micrographs. While it achieved the difficult simultaneous objectives of high photoactivated fluorophore preservation and ultrastructure preservation, it required a super-resolution optical and specialized electron microscope that is not available to many researchers. We present here a faster and more practical protocol with the advantage of a simpler two-dimensional optical (Photoactivated Localization Microscopy (PALM)) and scanning electron microscope (SEM) system that retains the often mutually exclusive attributes of fluorophore preservation and ultrastructure preservation. As before, cryosections were prepared using the Tokuyasu protocol, but the staining protocol was modified to be amenable for use in a standard SEM without the need for focused ion beam ablation. We show the versatility of this technique by labeling different cellular compartments and structures including mitochondrial nucleoids, peroxisomes, and the nuclear lamina. We also demonstrate simultaneous two-color PALM imaging with correlated electron micrographs. Lastly, this technique can be used with small-molecule dyes as demonstrated with actin labeling using phalloidin conjugated to a caged dye. By retaining the dense protein labeling expected for super-resolution microscopy combined with ultrastructural preservation, simplifying the tools required for correlative microscopy, and expanding the number of useful labels we expect this method to be accessible and valuable to a wide variety of researchers.	[Kopek, Benjamin G.; Shtengel, Gleb; Grimm, Jonathan B.; Clayton, David A.; Hess, Harald F.] Howard Hughes Med Inst, Ashburn, VA USA	Howard Hughes Medical Institute	Kopek, BG (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA.	kopekb@janelia.hhmi.org	Sauer, Markus/C-4378-2017	Sauer, Markus/0000-0002-1692-3219; Kopek, Benjamin/0000-0002-5288-3744	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by the Howard Hughes Medical Institute (www.hhmi.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beatty KE, 2006, ANGEW CHEM, V118, P7524, DOI DOI 10.1002/ANGE.200602114; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bos E, 2011, J STRUCT BIOL, V175, P62, DOI 10.1016/j.jsb.2011.03.022; Brown TA, 2011, MOL CELL BIOL, V31, P4994, DOI 10.1128/MCB.05694-11; Brown TA, 2010, METHODS, V51, P458, DOI 10.1016/j.ymeth.2010.01.001; Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Capani F, 2001, J HISTOCHEM CYTOCHEM, V49, P1351, DOI 10.1177/002215540104901103; CAPCO DG, 1982, CELL, V29, P847, DOI 10.1016/0092-8674(82)90446-9; Chudakov DM, 2004, NAT BIOTECHNOL, V22, P1435, DOI 10.1038/nbt1025; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Green MR, 2012, MOL CLONING LAB MANU, V1; GRIFFITHS G, 1984, J ULTRA MOL STRUCT R, V89, P65, DOI 10.1016/S0022-5320(84)80024-6; Grimm JB, 2013, ACS CHEM BIOL, V8, P1303, DOI 10.1021/cb4000822; Heilemann M, 2009, ANGEW CHEM INT EDIT, V48, P6903, DOI 10.1002/anie.200902073; Humbel BM, 1998, MICROSC RES TECHNIQ, V42, P43, DOI 10.1002/(SICI)1097-0029(19980701)42:1<43::AID-JEMT6>3.3.CO;2-4; Jao CY, 2008, P NATL ACAD SCI USA, V105, P15779, DOI 10.1073/pnas.0808480105; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Kopek BG, 2012, P NATL ACAD SCI USA, V109, P6136, DOI 10.1073/pnas.1121558109; Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108; Kukulski W, 2011, J CELL BIOL, V192, P111, DOI 10.1083/jcb.201009037; Lavis LD, 2008, ACS CHEM BIOL, V3, P142, DOI 10.1021/cb700248m; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; LOW I, 1974, FEBS LETT, V44, P340, DOI 10.1016/0014-5793(74)81173-7; Ma CL, 2011, J CELL BIOL, V193, P7, DOI 10.1083/jcb.201010022; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Mironov AA, 2009, J MICROSC-OXFORD, V235, P308, DOI 10.1111/j.1365-2818.2009.03222.x; Morphew MK, 2007, METHOD CELL BIOL, V79, P493, DOI 10.1016/S0091-679X(06)79019-7; Murphy GE, 2011, J STRUCT BIOL, V176, P268, DOI 10.1016/j.jsb.2011.08.013; Nanguneri S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038098; Puliti D, 2011, BIOORGAN MED CHEM, V19, P1023, DOI 10.1016/j.bmc.2010.07.011; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Shroff H, 2007, P NATL ACAD SCI USA, V104, P20308, DOI 10.1073/pnas.0710517105; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Sjollema KA, 2012, METHOD CELL BIOL, V111, P157, DOI 10.1016/B978-0-12-416026-2.00009-1; Small JV, 1999, MICROSC RES TECHNIQ, V47, P3; Takizawa T, 2003, J HISTOCHEM CYTOCHEM, V51, P31, DOI 10.1177/002215540305100105; Watanabe S, 2011, NAT METHODS, V8, P80, DOI 10.1038/NMETH.1537; Welch MD, 1998, METHOD ENZYMOL, V298, P52, DOI 10.1016/S0076-6879(98)98008-9; WULF E, 1979, P NATL ACAD SCI USA, V76, P4498, DOI 10.1073/pnas.76.9.4498; Wysocki LM, 2011, ANGEW CHEM INT EDIT, V50, P11206, DOI 10.1002/anie.201104571; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Xu K, 2012, NAT METHODS, V9, P185, DOI [10.1038/NMETH.1841, 10.1038/nmeth.1841]; Yao J, 2011, GENE DEV, V25, P569, DOI 10.1101/gad.2021411	51	52	52	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77209	10.1371/journal.pone.0077209	http://dx.doi.org/10.1371/journal.pone.0077209			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204771	Green Published, Green Submitted, gold			2022-12-27	WOS:000326155400030
J	Moura, A; Savageau, MA; Alves, R				Moura, Alexandra; Savageau, Michael A.; Alves, Rui			Relative Amino Acid Composition Signatures of Organisms and Environments	PLOS ONE			English	Article							HIGHLY EXPRESSED GENES; CODON USAGE BIAS; ESCHERICHIA-COLI; METABOLIC FLUXES; GENOMES; STOICHIOMETRY; EVOLUTION; PROTEOMES; SELECTION; SEQUENCE	Background: Identifying organism-environment interactions at the molecular level is crucial to understanding how organisms adapt to and change the chemical and molecular landscape of their habitats. In this work we investigated whether relative amino acid compositions could be used as a molecular signature of an environment and whether such a signature could also be observed at the level of the cellular amino acid composition of the microorganisms that inhabit that environment. Methodologies/Principal Findings: To address these questions we collected and analyzed environmental amino acid determinations from the literature, and estimated from complete genomic sequences the global relative amino acid abundances of organisms that are cognate to the different types of environment. Environmental relative amino acid abundances clustered into broad groups (ocean waters, host-associated environments, grass land environments, sandy soils and sediments, and forest soils), indicating the presence of amino acid signatures specific for each environment. These signatures correlate to those found in organisms. Nevertheless, relative amino acid abundance of organisms was more influenced by GC content than habitat or phylogeny. Conclusions: Our results suggest that relative amino acid composition can be used as a signature of an environment. In addition, we observed that the relative amino acid composition of organisms is not highly determined by environment, reinforcing previous studies that find GC content to be the major factor correlating to amino acid composition in living organisms.	[Moura, Alexandra; Alves, Rui] Univ Lleida, Dept Basic Med Sci, Lleida, Spain; [Moura, Alexandra; Alves, Rui] Univ Lleida, Inst Biomed Res, Lleida, Spain; [Moura, Alexandra] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Moura, Alexandra] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [Savageau, Michael A.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	Universitat de Lleida; Universitat de Lleida; Universidade de Aveiro; Universidade de Aveiro; University of California System; University of California Davis	Alves, R (corresponding author), Univ Lleida, Dept Basic Med Sci, Lleida, Spain.	ralves@cmb.udl.cat	Alves, Rui/C-5920-2009; Moura, Alexandra/C-8555-2009	Alves, Rui/0000-0002-8112-5184; Moura, Alexandra/0000-0003-0339-1230	Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BPD/72256/2010]; Ministerio de Ciencia e Innovacion (Spain) [BFU2010-17704]; Generalitat de Catalunya [2009SGR809]; US Public Health Service [RO1-GM30054]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030054] Funding Source: NIH RePORTER	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	AM was supported by Fundacao para a Ciencia e a Tecnologia, Portugal, through the postdoctoral grant SFRH/BPD/72256/2010. RA was partially supported by the Ministerio de Ciencia e Innovacion (Spain) through grant BFU2010-17704, and by the Generalitat de Catalunya through a grant for research group 2009SGR809. MAS was supported in part by a grant from the US Public Health Service (RO1-GM30054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2007, ENCY MEASUREMENT STA, DOI 10.4135/9781412952644; Akashi H, 2002, P NATL ACAD SCI USA, V99, P3695, DOI 10.1073/pnas.062526999; Alves R, 2005, MOL MICROBIOL, V56, P1017, DOI 10.1111/j.1365-2958.2005.04566.x; ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; Barrett T, 2012, NUCLEIC ACIDS RES, V40, pD57, DOI 10.1093/nar/gkr1163; Baudouin-Cornu P, 2001, SCIENCE, V293, P297, DOI 10.1126/science.1061052; Bernal A, 2012, NUCLEIC ACIDS RES, V29, P126; Botzman M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r109; Chowdhury AR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-236; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; CURRAN JF, 1989, J MOL BIOL, V209, P65, DOI 10.1016/0022-2836(89)90170-8; Foerstner KU, 2005, EMBO REP, V6, P1208, DOI 10.1038/sj.embor.7400538; Glass JI, 2000, NATURE, V407, P757, DOI 10.1038/35037619; Jollivet D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031150; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karlin S, 2000, J BACTERIOL, V182, P5238, DOI 10.1128/JB.182.18.5238-5250.2000; Karlin S, 2005, P NATL ACAD SCI USA, V102, P7303, DOI 10.1073/pnas.0502313102; Karlin S, 2003, P NATL ACAD SCI USA, V100, P7313, DOI 10.1073/pnas.1232298100; Karlin S, 1998, MOL MICROBIOL, V29, P1341, DOI 10.1046/j.1365-2958.1998.01008.x; Klumpp S, 2013, PLOS ONE, V7; Knight R. D., 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-4-RESEARCH0010; Ledoux S, 2008, MOL CELL, V31, P114, DOI 10.1016/j.molcel.2008.04.026; Lightfield J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017677; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Okayasu T, 1997, AMINO ACIDS, V13, P379, DOI 10.1007/BF01372601; Pramanik J, 1998, BIOTECHNOL BIOENG, V60, P230, DOI 10.1002/(SICI)1097-0290(19981020)60:2<230::AID-BIT10>3.0.CO;2-Q; Priestley M. B., 1988, NONLINEAR NONSTATION; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Quigg A, 2003, NATURE, V425, P291, DOI 10.1038/nature01953; Redfield A.C., 1934, J JOHNSTONE MEMORIAL, P177; REDFIELD AC, 1958, AM SCI, V46, P205; Rocha EPC, 2002, TRENDS GENET, V18, P291, DOI 10.1016/S0168-9525(02)02690-2; Roth A, 2012, CODON EVOLUTION: MECHANISMS AND MODELS, P189; Sanudo-Wilhelmy SA, 2004, NATURE, V432, P897, DOI 10.1038/nature03125; Sauer U, 1996, APPL ENVIRON MICROB, V62, P3687, DOI 10.1128/AEM.62.10.3687-3696.1996; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Taylor PG, 2010, NATURE, V464, P1178, DOI 10.1038/nature08985; Tekaia F, 2002, GENE, V297, P51, DOI 10.1016/S0378-1119(02)00871-5; Tekaia F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-307; Weber T, 2012, NATURE, V489, P419, DOI 10.1038/nature11357; Weber TS, 2010, NATURE, V467, P550, DOI 10.1038/nature09403; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578	42	54	56	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77319	10.1371/journal.pone.0077319	http://dx.doi.org/10.1371/journal.pone.0077319			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204807	Green Published, gold, Green Submitted			2022-12-27	WOS:000326155400033
J	Reddy, AP; Simmons, CW; D'haeseleer, P; Khudyakov, J; Burd, H; Hadi, M; Simmons, BA; Singer, SW; Thelen, MP; VanderGheynst, JS				Reddy, Amitha P.; Simmons, Christopher W.; D'haeseleer, Patrik; Khudyakov, Jane; Burd, Helcio; Hadi, Masood; Simmons, Blake A.; Singer, Steven W.; Thelen, Michael P.; VanderGheynst, Jean S.			Discovery of Microorganisms and Enzymes Involved in High-Solids Decomposition of Rice Straw Using Metagenomic Analyses	PLOS ONE			English	Article							SP-NOV.; BINDING MODULE; GEN. NOV.; CELLULOSE; SOIL; IDENTIFICATION; DIVERSITY; COMMUNITY; ALIGNMENT; RESOURCE	High-solids incubations were performed to enrich for microbial communities and enzymes that decompose rice straw under mesophilic (35 degrees C) and thermophilic (55 degrees C) conditions. Thermophilic enrichments yielded a community that was 7.5 times more metabolically active on rice straw than mesophilic enrichments. Extracted xylanase and endoglucanse activities were also 2.6 and 13.4 times greater, respectively, for thermophilic enrichments. Metagenome sequencing was performed on enriched communities to determine community composition and mine for genes encoding lignocellulolytic enzymes. Proteobacteria were found to dominate the mesophilic community while Actinobacteria were most abundant in the thermophilic community. Analysis of protein family representation in each metagenome indicated that cellobiohydrolases containing carbohydrate binding module 2 (CBM2) were significantly overrepresented in the thermophilic community. Micromonospora, a member of Actinobacteria, primarily housed these genes in the thermophilic community. In light of these findings, Micromonospora and other closely related Actinobacteria genera appear to be promising sources of thermophilic lignocellulolytic enzymes for rice straw deconstruction under high-solids conditions. Furthermore, these discoveries warrant future research to determine if exoglucanases with CBM2 represent thermostable enzymes tolerant to the process conditions expected to be encountered during industrial biofuel production.	[Reddy, Amitha P.; Simmons, Christopher W.; D'haeseleer, Patrik; Khudyakov, Jane; Burd, Helcio; Hadi, Masood; Simmons, Blake A.; Singer, Steven W.; Thelen, Michael P.; VanderGheynst, Jean S.] Joint BioEnergy Inst, Emeryville, CA USA; [Reddy, Amitha P.; Simmons, Christopher W.; VanderGheynst, Jean S.] Univ Calif Davis, Davis, CA 95616 USA; [Singer, Steven W.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA; [D'haeseleer, Patrik; Khudyakov, Jane; Thelen, Michael P.] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA USA; [Hadi, Masood; Simmons, Blake A.] Sandia Natl Labs, Biol & Mat Sci Ctr, Livermore, CA USA; [Burd, Helcio] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; University of California System; University of California Davis; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	VanderGheynst, JS (corresponding author), Joint BioEnergy Inst, Emeryville, CA USA.	jsvander@ucdavis.edu	Singer, STeven W/I-1851-2014; Thelen, Michael P/G-2032-2014; Khudyakov, Jane/C-1213-2014; Simmons, Blake/N-6022-2016; Thelen, Michael/C-6834-2008	Thelen, Michael P/0000-0002-2479-5480; Simmons, Blake/0000-0002-1332-1810; Thelen, Michael/0000-0002-2479-5480; Khudyakov, Jane/0000-0001-7038-102X	University of California Laboratory Fees Research Program [12-LR-237496]; DOE Joint BioEnergy Institute; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; U.S. Department of Energy	University of California Laboratory Fees Research Program; DOE Joint BioEnergy Institute; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by the University of California Laboratory Fees Research Program #12-LR-237496 and performed as part of the DOE Joint BioEnergy Institute (http://www.jbei.org) supported by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U.S. Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla HM, 2007, WASTE MANAGE, V27, P850, DOI 10.1016/j.wasman.2006.06.006; Allgaier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008812; Aslam DN, 2008, BIORESOURCE TECHNOL, V99, P8735, DOI 10.1016/j.biortech.2008.04.074; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beckham GT, 2010, J PHYS CHEM B, V114, P1447, DOI 10.1021/jp908810a; Blake AW, 2006, J BIOL CHEM, V281, P29321, DOI 10.1074/jbc.M605903200; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; Cheng YS, 2010, APPL BIOCHEM BIOTECH, V162, P1768, DOI 10.1007/s12010-010-8958-4; CHOWDHURY NA, 1991, WORLD J MICROB BIOT, V7, P603, DOI 10.1007/BF00452840; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; de Menezes AB, 2008, APPL ENVIRON MICROB, V74, P7080, DOI 10.1128/AEM.01092-08; DeAngelis KM, 2010, STRATEGIES ENHANCING; DeAngelis KM, 2010, BIOENERG RES, V3, P146, DOI 10.1007/s12155-010-9089-z; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Engelbrekston A, 2010, ISME J, V4; ERIKSON D, 1952, J GEN MICROBIOL, V6, P286, DOI 10.1099/00221287-6-3-4-286; Federal Agencies Environmental Protection Agency (EPA) National Highway Traffic Safety Administration (NHTSA) and Department of Transportation (DOT), 2017, FED REGISTER, V77; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FERGUS CL, 1969, MYCOLOGIA, V61, P120, DOI 10.2307/3757350; Gallagher J, 1996, BIOTECHNOL LETT, V18, P537, DOI 10.1007/BF00140199; Georgelis N, 2012, P NATL ACAD SCI USA, V109, P14830, DOI 10.1073/pnas.1213200109; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gladden John M, 2011, Appl Environ Microbiol, V77, P5804, DOI 10.1128/AEM.00032-11; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Haruta S, 2002, APPL MICROBIOL BIOT, V59, P529, DOI 10.1007/s00253-002-1026-4; Honein K, 2012, ENRGY PROCED, V18, P1271, DOI 10.1016/j.egypro.2012.05.143; Kadam KL, 2000, BIOMASS BIOENERG, V18, P369, DOI 10.1016/S0961-9534(00)00005-2; Kato S, 2005, APPL ENVIRON MICROB, V71, P7099, DOI 10.1128/AEM.71.11.7099-7106.2005; Kausar H, 2011, BIODEGRADATION, V22, P367, DOI 10.1007/s10532-010-9407-3; Kim BY, 2007, INT J SYST EVOL MICR, V57, P538, DOI 10.1099/ijs.0.64614-0; Kim S, 2004, BIOMASS BIOENERG, V26, P361, DOI 10.1016/j.biombioe.2003.08.002; Klein-Marcuschamer D, 2012, BIOTECHNOL BIOENG, V109, P1083, DOI 10.1002/bit.24370; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Markowitz VM, 2006, BIOINFORMATICS, V22, pE359, DOI 10.1093/bioinformatics/btl217; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Matteson GC, 2007, BIORESOURCE TECHNOL, V98, P3098, DOI 10.1016/j.biortech.2006.10.031; Mendu V, 2012, P NATL ACAD SCI USA, V109, P4014, DOI 10.1073/pnas.1112757109; Okeke BC, 2011, APPL BIOCHEM BIOTECH, V163, P869, DOI 10.1007/s12010-010-9091-0; Parker N, 2010, BIOMASS BIOENERG, V34, P1597, DOI 10.1016/j.biombioe.2010.06.007; Pati A, 2011, CLAMS CLASSIFIER MET; Ramin M, 2009, J RAPID METH AUT MIC, V17, P103, DOI 10.1111/j.1745-4581.2009.00160.x; Reddy AP, 2009, T ASABE, V52, P673, DOI 10.13031/2013.26806; Reddy AP, 2011, BIOTECHNOL BIOENG, V108, P2088, DOI 10.1002/bit.23176; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Simmons BA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-242; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Summers MD, 2001, 5 INT BIOM C AM ORL; Tuck CO, 2012, SCIENCE, V337, P695, DOI 10.1126/science.1218930; Wang H, 2009, INT J SYST EVOL MICR, V59, P2854, DOI 10.1099/ijs.0.010447-0; Wang Y, 2011, INT J SYST EVOL MICR, V61, P1554, DOI 10.1099/ijs.0.025221-0; Weon HY, 2006, INT J SYST EVOL MICR, V56, P1777, DOI 10.1099/ijs.0.64242-0; Weon HY, 2009, INT J SYST EVOL MICR, V59, P1282, DOI 10.1099/ijs.0.004333-0	60	18	21	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77985	10.1371/journal.pone.0077985	http://dx.doi.org/10.1371/journal.pone.0077985			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205054	Green Published, gold, Green Submitted			2022-12-27	WOS:000326155400065
J	Lee, KC; Chan, CC; Yang, YY; Hsieh, YC; Huang, YH; Lin, HC				Lee, Kuei-Chuan; Chan, Che-Chang; Yang, Ying-Ying; Hsieh, Yun-Cheng; Huang, Yi-Hsiang; Lin, Han-Chieh			Aliskiren Attenuates Steatohepatitis and Increases Turnover of Hepatic Fat in Mice Fed with a Methionine and Choline Deficient Diet	PLOS ONE			English	Article							NF-KAPPA-B; INCREASED ENERGY-EXPENDITURE; IMPROVES INSULIN-RESISTANCE; EFFECTIVE RENIN INHIBITOR; ACTIVATED PROTEIN-KINASE; MUSCLE GLUCOSE-TRANSPORT; STELLATE CELL ACTIVATION; ANGIOTENSIN-II; OXIDATIVE STRESS; LIVER-DISEASE	Background & Aims: Activation of the renin-angiotensin-system is known to play a role in nonalcoholic steatohepatitis. Renin knockout mice manifest decreased hepatic steatosis. Aliskiren is the first direct renin inhibitor to be approved for clinical use. Our study aims to evaluate the possible therapeutic effects and mechanism of the chronic administration of aliskiren in a dietary steatohepatitis murine model. Methods: Male C57BL/6 mice were fed with a methionine and choline-deficient (MCD) diet to induce steatohepatitis. After 8 weeks of feeding, the injured mice were randomly assigned to receive aliskiren (50 mg.kg(-1) per day) or vehicle administration for 4 weeks. Normal controls were also administered aliskiren (50 mg.kg(-1) per day) or a vehicle for 4 weeks. Results: In the MCD mice, aliskiren attenuated hepatic steatosis, inflammation and fibrosis. Aliskiren did not change expression of lipogenic genes but increase turnover of hepatic fat by up-regulating peroxisome proliferator-activated receptor alpha, carnitine palmitoyltransferase 1a, cytochrome P450-4A14 and phosphorylated AMP-activated protein kinase. Furthermore, aliskiren decreased the hepatic expression of angiotensin II and nuclear factor kappa B. The levels of oxidative stress, hepatocyte apoptosis, activation of Kupffer cells and hepatic stellate cells, and pro-fibrotic markers were also reduced in the livers of the MCD mice receiving aliskiren. Conclusions: Aliskiren attenuates steatohepatitis and fibrosis in mice fed with a MCD diet. Thus, the noted therapeutic effects might come from not only the reduction of angiotensin II but also the up-regulation of fatty acid oxidation-related genes.	[Lee, Kuei-Chuan; Chan, Che-Chang; Hsieh, Yun-Cheng; Huang, Yi-Hsiang; Lin, Han-Chieh] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan; [Lee, Kuei-Chuan; Chan, Che-Chang; Yang, Ying-Ying; Hsieh, Yun-Cheng; Huang, Yi-Hsiang; Lin, Han-Chieh] Natl Yang Ming Univ, Dept Med, Sch Med, Taipei 112, Taiwan; [Lee, Kuei-Chuan; Chan, Che-Chang; Huang, Yi-Hsiang] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Yang, Ying-Ying] Taipei Vet Gen Hosp, Dept Med, Div Gen Med, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Huang, YH (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan.	yhhuang@vghtpe.gov.tw; hclin@vghtpe.gov.tw		Huang, Yi-Hsiang/0000-0001-5241-5425; Yang, Ying-Ying/0000-0002-7719-0397	National Science Council of Taiwan [NSC 101-2314-B-075-017]; Taipei Veterans General Hospital, Taipei, Taiwan [V102B-017, V102C-014]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital, Taipei, Taiwan(Taipei Veterans General Hospital)	This work was supported by grant NSC 101-2314-B-075-017 from the National Science Council of Taiwan and grant V102B-017 and V102C-014 from the Taipei Veterans General Hospital, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara Y, 2013, HEPATOL RES IN PRESS; Arellano-Plancarte A, 2010, BIOCHEM PHARMACOL, V79, P733, DOI 10.1016/j.bcp.2009.10.014; Bataller R, 2003, AM J PHYSIOL-GASTR L, V285, pG642, DOI 10.1152/ajpgi.00037.2003; Bataller R, 2003, J CLIN INVEST, V112, P1383, DOI 10.1172/JCI200318212; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Canbay A, 2003, HEPATOLOGY, V38, P1188, DOI 10.1053/jhep.2003.50472; Canbay A, 2003, LAB INVEST, V83, P655, DOI 10.1097/01.LAB.0000069036.63405.5C; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chanda D, 2009, HEPATOLOGY, V50, P880, DOI 10.1002/hep.23049; Colombo SL, 2009, BIOCHEM J, V421, P163, DOI 10.1042/BJ20090613; Dela Pena A, 2005, GASTROENTEROLOGY, V129, P1663, DOI 10.1053/j.gastro.2005.09.004; Delerive P, 2001, J ENDOCRINOL, V169, P453, DOI 10.1677/joe.0.1690453; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Fisher NDL, 2008, CIRCULATION, V117, P3199, DOI 10.1161/CIRCULATIONAHA.108.767202; Gandhi S, 2013, J RENIN-ANGIO-ALDO S, V14, P3, DOI 10.1177/1470320312452766; George J, 2003, J HEPATOL, V39, P756, DOI 10.1016/S0168-8278(03)00376-3; Gradman AH, 2008, J AM COLL CARDIOL, V51, P519, DOI 10.1016/j.jacc.2007.10.027; Habibi J, 2008, ENDOCRINOLOGY, V149, P5643, DOI 10.1210/en.2008-0070; Hirose A, 2007, HEPATOLOGY, V45, P1375, DOI 10.1002/hep.21638; Ip E, 2004, HEPATOLOGY, V39, P1286, DOI 10.1002/hep.20170; Jaeschke H, 2011, J GASTROEN HEPATOL, V26, P173, DOI 10.1111/j.1440-1746.2010.06592.x; Jayasooriya AP, 2008, P NATL ACAD SCI USA, V105, P6531, DOI 10.1073/pnas.0802690105; Kang YS, 2011, NEPHROL DIAL TRANSPL, V26, P1194, DOI 10.1093/ndt/gfq579; Kishina M, 2013, HEPATOL RES IN PRESS; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lastra G, 2009, ENDOCRINOLOGY, V150, P2561, DOI 10.1210/en.2008-1391; Leclercq IA, 2007, LAB INVEST, V87, P56, DOI 10.1038/labinvest.3700489; LEE KS, 1995, J CLIN INVEST, V96, P2461, DOI 10.1172/JCI118304; Lee KC, 2012, EUR J CLIN INVEST, V42, P1261, DOI 10.1111/j.1365-2362.2012.02725.x; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lu H, 2008, J CLIN INVEST, V118, P984, DOI 10.1172/JCI32970; Marchionne EM, 2012, AM J PHYSIOL-REG I, V302, pR137, DOI 10.1152/ajpregu.00448.2011; Maziere C, 1999, BIOCHEM BIOPH RES CO, V265, P116, DOI 10.1006/bbrc.1999.1644; McAllister-Lucas LM, 2007, P NATL ACAD SCI USA, V104, P139, DOI 10.1073/pnas.0601947103; Nabeshima Y, 2009, J HEPATOL, V50, P1226, DOI 10.1016/j.jhep.2009.01.018; Paschos P, 2012, WORLD J HEPATOL, V4, P327, DOI 10.4254/wjh.v4.i12.327; Reinehr R, 2005, GASTROENTEROLOGY, V129, P2009, DOI 10.1053/j.gastro.2005.09.023; Rinella ME, 2004, J HEPATOL, V40, P47, DOI 10.1016/j.jhep.2003.09.020; Ruef T, 2001, BASIC RES CARDIOL, V96, P143, DOI 10.1007/s003950170064; Takahashi N, 2007, CELL METAB, V6, P506, DOI 10.1016/j.cmet.2007.10.011; Toyama T, 2004, BIOCHEM BIOPH RES CO, V324, P697, DOI 10.1016/j.bbrc.2004.09.110; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; Wei Y, 2008, J HEPATOL, V49, P417, DOI 10.1016/j.jhep.2008.03.018; Wiczer BM, 2009, BIOCHEM BIOPH RES CO, V387, P234, DOI 10.1016/j.bbrc.2009.06.114; Wood JM, 2003, BIOCHEM BIOPH RES CO, V308, P698, DOI 10.1016/S0006-291X(03)01451-7; Wood JM, 2005, J HYPERTENS, V23, P417, DOI 10.1097/00004872-200502000-00025	46	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77817	10.1371/journal.pone.0077817	http://dx.doi.org/10.1371/journal.pone.0077817			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204981	Green Published, gold, Green Submitted			2022-12-27	WOS:000326032600049
J	Alves, SP; Bessa, RJB; Quaresma, MAG; Kilminster, T; Scanlon, T; Oldham, C; Milton, J; Greeff, J; Almeida, AM				Alves, Susana P.; Bessa, Rui J. B.; Quaresma, Mario A. G.; Kilminster, Tanya; Scanlon, Tim; Oldham, Chris; Milton, John; Greeff, Johan; Almeida, Andre M.			Does the Fat Tailed Damara Ovine Breed Have a Distinct Lipid Metabolism Leading to a High Concentration of Branched Chain Fatty Acids in Tissues?	PLOS ONE			English	Article							SUBCUTANEOUS ADIPOSE-TISSUE; SHEEP; TRIACYLGLYCEROLS; ENERGY	Fat tailed sheep breeds are known for their adaptation to nutritional stress, among other harsh production conditions. Damara sheep, native to Southern Africa, have recently been exported to other areas of the world, particularly Australia, aiming to produce lamb in semi-arid regions. Damaras have a unique hanging fat tail, a fat depot able to be mobilized under nutritional stress. In this article we perform an in-depth characterization of the fatty acid profiles of the fat tail in underfed and control Damara rams. Profiles were very similar between experimental groups, with the exception of palmitic acid (16: 0) that was lower (P = 0.014) in underfed animals. However, the most striking result was the very high proportions of non-terminal branched chain fatty acids found in the fat tail adipose tissue, as well as the gastrocnemius muscle of Damara rams. The muscle of Dorper and Merino rams used in the same experiment did not present non-terminal branched chain fatty acids, suggesting that Damara rams have a unique lipid metabolism. Herein, we interpret this trait relating it to a higher ability of Damara sheep to digest fibrous fodder and to putative differences in the propionate metabolism by comparison to other sheep breeds.	[Alves, Susana P.; Bessa, Rui J. B.; Quaresma, Mario A. G.; Almeida, Andre M.] Univ Tecn Lisboa, Fac Med Vet, CIISA, Lisbon, Portugal; [Kilminster, Tanya; Scanlon, Tim; Oldham, Chris; Greeff, Johan] DAFWA, Perth, WA, Australia; [Milton, John] Univ Western Australia, Fac Nat & Agr Sci, Crawley, WA, Australia; [Almeida, Andre M.] IICT, Biotrop, Lisbon, Portugal; [Almeida, Andre M.] IBET, Oeiras, Portugal; [Almeida, Andre M.] UNL, ITQB, BCV, Oeiras, Portugal	Universidade de Lisboa; Government of Western Australia; Department of Agriculture & Food - Western Australia; University of Western Australia; Universidade Nova de Lisboa	Almeida, AM (corresponding author), Univ Tecn Lisboa, Fac Med Vet, CIISA, Lisbon, Portugal.	aalmeida@fmv.utl.pt	Bessa, Rui J. B./B-8006-2008; Alves, Susana/Q-3889-2019; Alves, Susana P/C-1447-2008; Almeida, Andre/I-4369-2013	Bessa, Rui J. B./0000-0003-4109-3488; Alves, Susana/0000-0002-3171-9566; Alves, Susana P/0000-0002-3171-9566; Almeida, Andre/0000-0002-7810-3988; Quaresma, Mario/0000-0002-6988-3935; Scanlon, Timothy/0000-0001-5706-5487	Department of Agriculture and Food WA (Perth, Western Australia); Fundacao para a Ciencia e a Tecnologia of the Ministerio da Ciencia, Tecnologia e do Ensino Superior (Lisbon, Portugal) [SFRH/BPD/76836/2011, SFRH/BPD/90916/2012]	Department of Agriculture and Food WA (Perth, Western Australia); Fundacao para a Ciencia e a Tecnologia of the Ministerio da Ciencia, Tecnologia e do Ensino Superior (Lisbon, Portugal)	Authors acknowledge financial support from the Department of Agriculture and Food WA (Perth, Western Australia). SP Alves was supported through the grant SFRH/BPD/76836/2011 and AM Almeida was financed by grant SFRH/BPD/90916/2012, and a Ciencia 2007 Research Contract, both from Fundacao para a Ciencia e a Tecnologia of the Ministerio da Ciencia, Tecnologia e do Ensino Superior (Lisbon, Portugal). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alipanah M, 2011, J FOOD AGRIC ENVIRON, V9, P416; Almeida AM, 2013, TROP ANIM H IN PRESS; Almeida AM, 2011, TROP ANIM HEALTH PRO, V43, P1427, DOI 10.1007/s11250-011-9868-3; ALSHABIBI MM, 1973, J AGR SCI-CAMBRIDGE, V80, P255, DOI 10.1017/S0021859600057725; Atti N, 2004, ANIM RES, V53, P165, DOI 10.1051/animres:2004012; Bas P, 2000, LIVEST PROD SCI, V64, P61, DOI 10.1016/S0301-6226(00)00176-7; Berthelot V, 2012, MEAT SCI, V90, P548, DOI 10.1016/j.meatsci.2011.09.014; Berthelot V, 2001, SMALL RUMINANT RES, V41, P29, DOI 10.1016/S0921-4488(01)00190-0; BUCKNER JS, 1978, ARCH BIOCHEM BIOPHYS, V186, P152, DOI 10.1016/0003-9861(78)90474-5; Cai QF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056189; Ciftci M, 2010, REV MED VET-TOULOUSE, V161, P432; DUNCAN WRH, 1978, BRIT J NUTR, V40, P29, DOI 10.1079/BJN19780092; FOLCH J, 1957, J BIOL CHEM, V226, P497; GARTON GA, 1972, BRIT J NUTR, V28, P409, DOI 10.1079/BJN19720050; Guler GO, 2011, AFR J BIOTECHNOL, V10, P7099; HORNING MG, 1961, J BIOL CHEM, V236, P669; KENNEDY DG, 1994, BRIT J NUTR, V71, P67, DOI 10.1079/BJN19940111; MARCHELLO JA, 1967, J ANIM SCI, V26, P294, DOI 10.2527/jas1967.262294x; Moharrery A, 2007, SMALL RUMINANT RES, V69, P208, DOI 10.1016/j.smallrumres.2005.12.021; Murphy R. C., 1993, MASS SPECTROMETRY LI; Pourlis AF, 2011, TROP ANIM HEALTH PRO, V43, P1267, DOI 10.1007/s11250-011-9853-x; Ran-Ressler RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029032; SCAIFE JR, 1978, BIOCHEM J, V176, P799, DOI 10.1042/bj1760799; Scanlon TT, 2013, SMALL RUMINANT RES, V109, P101, DOI 10.1016/j.smallrumres.2012.08.004; SMITH A, 1979, LIPIDS, V14, P953, DOI 10.1007/BF02533430; SMITH A, 1979, LIPIDS, V14, P350, DOI 10.1007/BF02533418; SMITH S, 1994, FASEB J, V8, P1248, DOI 10.1096/fasebj.8.15.8001737; Unsal M, 2003, MEAT SCI, V63, P235, DOI 10.1016/S0309-1740(02)00074-8; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; Wilkes MJ, 2012, ANIM PROD SCI, V52, P30, DOI 10.1071/AN11033; Wongtangtintharn S, 2004, J NUTR SCI VITAMINOL, V50, P137, DOI 10.3177/jnsv.50.137; Yilmaz MT, 2010, J THERM ANAL CALORIM, V101, P403, DOI 10.1007/s10973-009-0529-y	32	35	40	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77313	10.1371/journal.pone.0077313	http://dx.doi.org/10.1371/journal.pone.0077313			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204803	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300095
J	Henderson-Smith, A; Chow, D; Meechoovet, B; Aziz, M; Jacobson, SA; Shill, HA; Sabbagh, MN; Caviness, JN; Adler, CH; Driver-Dunckley, ED; Beach, TG; Yin, HW; Dunckley, T				Henderson-Smith, Adrienne; Chow, Donald; Meechoovet, Bessie; Aziz, Meraj; Jacobson, Sandra A.; Shill, Holly A.; Sabbagh, Marwan N.; Caviness, John N.; Adler, Charles H.; Driver-Dunckley, Erika D.; Beach, Thomas G.; Yin, Hongwei; Dunckley, Travis			SMG1 Identified as a Regulator of Parkinson's Disease-Associated alpha-Synuclein through siRNA Screening	PLOS ONE			English	Article							SERINE 129; PHOSPHORYLATION; RNA; KINASE; MUTATION; DUPLICATION; COMPLEX; SYSTEM	Synucleinopathies are a broad class of neurodegenerative disorders characterized by the presence of intracellular protein aggregates containing alpha-synuclein protein. The aggregated alpha-synuclein protein is hyperphosphorylated on serine 129 (S129) compared to the unaggregated form of the protein. While the precise functional consequences of S129 hyperphosphorylation are still being clarified, numerous in vitro and in vivo studies suggest that S129 phosphorylation is an early event in alpha-synuclein dysfunction and aggregation. Identifying the kinases and phosphatases that regulate this critical phosphorylation event may ultimately prove beneficial by allowing pharmacological mitigation of synuclein dysfunction and toxicity in Parkinson's disease and other synucleinopathies. We report here the development of a high-content, fluorescence-based assay to quantitate levels of total and S129 phosphorylated alpha-synuclein protein. We have applied this assay to conduct high-throughput loss-of-function screens with siRNA libraries targeting 711 known and predicted human kinases and 206 phosphatases. Specifically, knockdown of the phosphatidylinositol 3-kinase related kinase SMG1 resulted in significant increases in the expression of pS129 phosphorylated alpha-synuclein (p-syn). Moreover, SMG1 protein levels were significantly reduced in brain regions with high p-syn levels in both dementia with Lewy bodies (DLB) and Parkinson's disease with dementia (PDD). These findings suggest that SMG1 may play an important role in increased alpha-synuclein pathology during the course of PDD, DLB, and possibly other synucleinopathies.	[Henderson-Smith, Adrienne; Meechoovet, Bessie; Dunckley, Travis] Translat Genom Res Inst, Neurogen Div, Phoenix, AZ USA; [Chow, Donald; Aziz, Meraj; Yin, Hongwei] Translat Genom Res Inst, Canc & Cell Biol Div, Phoenix, AZ USA; [Jacobson, Sandra A.; Shill, Holly A.; Sabbagh, Marwan N.; Beach, Thomas G.] Banner Sun Hlth Res Inst, Sun City, AZ USA; [Caviness, John N.; Adler, Charles H.; Driver-Dunckley, Erika D.] Mayo Clin Scottsdale, Dept Neurol, Movement Disorders Div, Scottsdale, AZ USA	Translational Genomics Research Institute; Translational Genomics Research Institute; Banner Research; Banner Health; Banner Sun Health Research Institute; Mayo Clinic; Mayo Clinic Phoenix	Dunckley, T (corresponding author), Translat Genom Res Inst, Neurogen Div, Phoenix, AZ USA.	tdunckley@tgen.org	Adler, Charles/ABD-5276-2021; Yin, Hong/AAC-5784-2020		National Institute of Neurological Disorders and Stroke [U24 NS072026]; National Institute on Aging [P30 AG19610]; Arizona Department of Health Services [211002]; Arizona Biomedical Research Commission [4001, 0011, 05-901, 1001]; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS072026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG019610] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Arizona Department of Health Services; Arizona Biomedical Research Commission; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Brain and Body Donation Program is supported by the National Institute of Neurological Disorders and Stroke (U24 NS072026 National Brain and Tissue Resource for Parkinson's Disease and Related Disorders), the National Institute on Aging (P30 AG19610 Arizona Alzheimer's Disease Core Center), the Arizona Department of Health Services (contract 211002, Arizona Alzheimer's Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011, 05-901 and 1001 to the Arizona Parkinson's Disease Consortium) and the Michael J. Fox Foundation for Parkinson's Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Beach TG, 2009, ACTA NEUROPATHOL, V117, P169, DOI 10.1007/s00401-008-0450-7; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; Brown JAL, 2011, MOL CELL BIOL, V31, P4417, DOI 10.1128/MCB.05987-11; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chawla R, 2008, CYTOGENET GENOME RES, V122, P194, DOI 10.1159/000167804; Dickson DW, 1999, AM J PATHOL, V155, P1241, DOI 10.1016/S0002-9440(10)65226-1; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Gewandter JS, 2011, CELL CYCLE, V10, P2561, DOI 10.4161/cc.10.15.16347; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Inglis KJ, 2009, J BIOL CHEM, V284, P2598, DOI 10.1074/jbc.C800206200; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee KW, 2011, J NEUROSCI, V31, P6963, DOI 10.1523/JNEUROSCI.6513-10.2011; Lou HY, 2010, J BIOL CHEM, V285, P17648, DOI 10.1074/jbc.M110.100867; Lue LF, 2012, BRAIN PATHOL; Mbefo MK, 2010, J BIOL CHEM, V285, P2807, DOI 10.1074/jbc.M109.081950; Negro A, 2001, FASEB J, V15, P210, DOI 10.1096/fj.01-0517fje; Ohnishi T, 2003, MOL CELL, V12, P1187, DOI 10.1016/S1097-2765(03)00443-X; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Saito Y, 2003, J NEUROPATH EXP NEUR, V62, P644, DOI 10.1093/jnen/62.6.644; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Takahashi M, 2007, EUR J NEUROSCI, V26, P863, DOI 10.1111/j.1460-9568.2007.05736.x; Waxman EA, 2008, J NEUROPATH EXP NEUR, V67, P402, DOI 10.1097/NEN.0b013e31816fc995; Waxman EA, 2011, J NEUROSCI RES, V89, P231, DOI 10.1002/jnr.22537; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001; Yamashita A, 2005, BBA-PROTEINS PROTEOM, V1754, P305, DOI 10.1016/j.bbapap.2005.10.002; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	31	10	10	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77711	10.1371/journal.pone.0077711	http://dx.doi.org/10.1371/journal.pone.0077711			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204929	Green Published, gold, Green Submitted			2022-12-27	WOS:000326334500046
J	Lee, WY; Savage, JR; Zhang, JX; Jia, WJ; Oottamasathien, S; Prestwich, GD				Lee, Won Yong; Savage, Justin R.; Zhang, Jianxing; Jia, Wanjian; Oottamasathien, Siam; Prestwich, Glenn D.			Prevention of Anti-microbial Peptide LL-37-Induced Apoptosis and ATP Release in the Urinary Bladder by a Modified Glycosaminoglycan	PLOS ONE			English	Article							PAIN SYNDROME/INTERSTITIAL CYSTITIS; AMYLOID P-COMPONENT; RECEPTOR-LIKE 1; INTERSTITIAL CYSTITIS; CATHELICIDIN PEPTIDE; ANTIPROLIFERATIVE FACTOR; GENE-EXPRESSION; GROWTH-FACTOR; MOUSE MODEL; LL-37	Interstitial cystitis (IC), often referred to in combination with painful bladder syndrome, is a chronic inflammatory disease of the bladder. Current therapies primarily focus on replenishing urothelial glycosaminoglycan (GAG) layer using GAG analogs and managing pain with supportive therapies. However, the elusive etiology of IC and the lack of animal models to study the disease have been major hurdles developing more effective therapeutics. Previously, we showed an increased urinary concentration of antimicrobial peptide LL-37 in spina bifida patients and used LL-37 to develop a mouse model of cystitis that mimics important clinical findings of IC. Here we investigate (1) the molecular mechanism of LL-37 induced cystitis in cultured human urothelial cells and in mice, (2) the protective effects of GM-0111, a modified GAG, within the context of this mechanism, (3) the physiological and molecular markers that correlate with the severity of the inflammation, and (4) the protective effects of several GAGs using these biomarkers in our LL-37 induced cystitis model. We find that LL-37 quickly induces release of ATP and apoptosis in the urothelium. These changes can be inhibited by a chemically-modified GAG, GM-0111. Furthermore, we also find that GAG analogs provide varying degrees of protection against LL-37 challenge in mice. These findings suggest that GM-0111 and possibly GAG molecules prevent the development of cystitis by blocking the apoptosis and the concurrent release of ATP from the urothelium.	[Lee, Won Yong; Savage, Justin R.; Zhang, Jianxing; Prestwich, Glenn D.] GlycoMira Therapeut Inc, Salt Lake City, UT USA; [Zhang, Jianxing; Jia, Wanjian; Oottamasathien, Siam; Prestwich, Glenn D.] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; [Zhang, Jianxing; Jia, Wanjian; Oottamasathien, Siam; Prestwich, Glenn D.] Univ Utah, Ctr Therapeut Biomat, Salt Lake City, UT USA; [Oottamasathien, Siam] Univ Utah, Dept Surg, Salt Lake City, UT USA; [Oottamasathien, Siam] Univ Utah, Div Pediat Urol, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Lee, WY (corresponding author), GlycoMira Therapeut Inc, Salt Lake City, UT USA.	lee.wonyong@glycomira.com; glenn.prestwich@pharm.utah.edu	jia, wanjian/C-3266-2016	Lee, Won Yong/0000-0001-7915-1829	SBIR grant from National Institutes of Health (NIH) [R43DK093413]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001065, UL1TR001067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R43DK093413] Funding Source: NIH RePORTER	SBIR grant from National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an SBIR grant from the National Institutes of Health (NIH) (R43DK093413, GlycoMira Therapeutics, Inc). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow PG, 2010, AM J RESP CELL MOL, V43, P692, DOI 10.1165/rcmb.2009-0250OC; Berry SH, 2011, J UROLOGY, V186, P540, DOI 10.1016/j.juro.2011.03.132; Berry SH, 2010, J UROLOGY, V183, P1848, DOI 10.1016/j.juro.2009.12.103; Bhide AA, 2013, INT UROGYNECOL J, V24, P1065, DOI 10.1007/s00192-012-2027-1; Birder LA, 2010, NEUROUROL URODYNAM, V29, P88, DOI 10.1002/nau.20747; Blalock EM, 2012, J UROLOGY, V187, P725, DOI 10.1016/j.juro.2011.09.142; Brandao-Burch A, 2012, FRONT ENDOCRINOL, V3; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Crawley M.J., 2007, R BOOK; Cray C, 2009, COMPARATIVE MED, V59, P517; Davis EL, 2008, J UROLOGY, V179, P177, DOI 10.1016/j.juro.2007.08.170; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; den Hertog AL, 2005, BIOCHEM J, V388, P689, DOI 10.1042/BJ20042099; Dunning-Davies BM, 2013, BJU INT, V111, P505, DOI 10.1111/j.1464-410X.2012.11421.x; Engles CD, 2012, UROLOGY, V79, DOI 10.1016/j.urology.2011.10.010; Erickson DR, 2002, J UROLOGY, V167, P2461, DOI 10.1016/S0022-5347(05)65005-7; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Ford Anthony P D W, 2011, Handb Exp Pharmacol, P485, DOI 10.1007/978-3-642-16499-6_22; Girard BM, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00020; Green M, 2004, UROLOGY, V63, P688, DOI 10.1016/j.urology.2003.11.022; HAYES AW, 2008, PRINCIPLES METHODS T; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Hunstad DA, 2005, INFECT IMMUN, V73, P3999, DOI 10.1128/IAI.73.7.3999-4006.2005; Johnson DE, 1998, INFECT IMMUN, V66, P3059, DOI 10.1128/IAI.66.7.3059-3065.1998; Keay SK, 2004, P NATL ACAD SCI USA, V101, P11803, DOI 10.1073/pnas.0404509101; Keay S, 2012, BMC UROL, V12, DOI 10.1186/1471-2490-12-17; Kiuchi H, 2009, BJU INT, V104, P826, DOI 10.1111/j.1464-410X.2009.08467.x; Kutlu O, 2010, INT UROL NEPHROL, V42, P393, DOI 10.1007/s11255-009-9632-z; Lai L, 1998, J IMMUNOL, V160, P3861; Lee CC, 2011, BIOPHYS J, V100, P1688, DOI 10.1016/j.bpj.2011.02.018; Lee SJ, 2006, WORLD J UROL, V24, P33, DOI 10.1007/s00345-005-0046-y; Liu HT, 2012, UROLOGY, V80, DOI 10.1016/j.urology.2012.01.047; Mader JS, 2011, EXP CELL RES, V317, P531, DOI 10.1016/j.yexcr.2010.11.015; Mader JS, 2009, MOL CANCER RES, V7, P689, DOI 10.1158/1541-7786.MCR-08-0274; Madersbacher H, 2013, NEUROUROL URODYNAM, V32, P9, DOI 10.1002/nau.22256; Mantovani A, 2008, J CLIN IMMUNOL, V28, P1, DOI 10.1007/s10875-007-9126-7; Matsuo Tomohiro, 2011, Hinyokika Kiyo, V57, P513; Mochizuki T, 2009, J BIOL CHEM, V284, P21257, DOI 10.1074/jbc.M109.020206; Nagaoka I, 2006, J IMMUNOL, V176, P3044, DOI 10.4049/jimmunol.176.5.3044; Neregard P, 2012, ANN RHEUM DIS, V71, pA12, DOI 10.1136/annrheumdis-2011-201230.26; Nishii H, 2006, INT J UROL, V13, P1339, DOI 10.1111/j.1442-2042.2006.01536.x; Olza J, 2012, DIABETES CARE, V35, P2373, DOI 10.2337/dc12-0614; Oottamasathien S, 2013, J UROLOGY, V190, P1596, DOI 10.1016/j.juro.2013.01.002; Oottamasathien S, 2011, J UROLOGY, V186, P1684, DOI 10.1016/j.juro.2011.03.099; PARSONS CL, 1994, BRIT J UROL, V73, P504, DOI 10.1111/j.1464-410X.1994.tb07634.x; PEPYS MB, 1979, NATURE, V278, P259, DOI 10.1038/278259a0; Rao NV, 2010, AM J PHYSIOL-CELL PH, V299, pC97, DOI 10.1152/ajpcell.00009.2010; Ren SX, 2012, CANC RES; Russell AL, 1999, MED HYPOTHESES, V52, P297, DOI 10.1054/mehy.1997.0652; Saban MR, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-4; Sall J, 2013, J INNATE IMMUN, V5, P290, DOI 10.1159/000346587; Shao Y, 2013, WORLD J UROL, V31, P535, DOI 10.1007/s00345-012-0839-8; Shie JH, 2012, UROLOGY, V79, DOI 10.1016/j.urology.2011.09.049; Shie JH, 2011, BJU INT, V108, pE136, DOI 10.1111/j.1464-410X.2010.09911.x; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Slobodov G, 2004, J UROLOGY, V171, P1554, DOI 10.1097/01.ju.0000118938.09119.a5; Souza DG, 2009, AM J PATHOL, V174, P1309, DOI 10.2353/ajpath.2009.080240; Sun Y, 2006, AM J PHYSIOL-CELL PH, V290, pC27, DOI 10.1152/ajpcell.00552.2004; Suzuki K, 2011, INT IMMUNOL, V23, P185, DOI 10.1093/intimm/dxq471; Theoharides TC, 1998, ANN NY ACAD SCI, V840, P619, DOI 10.1111/j.1749-6632.1998.tb09601.x; Tseng LH, 2010, INT UROGYNECOL J, V21, P911, DOI 10.1007/s00192-010-1129-x; Van Molle W, 2000, INFECT IMMUN, V68, P5026, DOI 10.1128/IAI.68.9.5026-5029.2000; Vandamme D, 2012, CELL IMMUNOL, V280, P22, DOI 10.1016/j.cellimm.2012.11.009; Verhoef M, 2005, SPINAL CORD, V43, P331, DOI 10.1038/sj.sc.3101705; Vij M, 2012, EUR J OBSTET GYN R B, V161, P1, DOI 10.1016/j.ejogrb.2011.12.014; Yamada T, 2007, WORLD J UROL, V25, P407, DOI 10.1007/s00345-007-0174-7; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yoshimura N, 2006, J NEUROSCI, V26, P10847, DOI 10.1523/JNEUROSCI.3023-06.2006; You S, 2012, INT NEUROUROL J, V16, P159, DOI 10.5213/inj.2012.16.4.159; Zhang CO, 2005, J UROLOGY, V174, P2382, DOI 10.1097/01.ju.0000180417.11976.99; Zhang JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016658	71	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77854	10.1371/journal.pone.0077854	http://dx.doi.org/10.1371/journal.pone.0077854			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204996	gold, Green Published, Green Submitted			2022-12-27	WOS:000326334500068
J	Mazumdar, V; Amar, S; Segre, D				Mazumdar, Varun; Amar, Salomon; Segre, Daniel			Metabolic Proximity in the Order of Colonization of a Microbial Community	PLOS ONE			English	Article							GENOME-SCALE RECONSTRUCTION; KYOTO ENCYCLOPEDIA; BIOFILMS; NETWORK; MODEL; KEGG; RESISTANCE; EVOLUTION; BUTYRATE; BACTERIA	Microbial biofilms are often composed of multiple bacterial species that accumulate by adhering to a surface and to each other. Biofilms can be resistant to antibiotics and physical stresses, posing unresolved challenges in the fight against infectious diseases. It has been suggested that early colonizers of certain biofilms could cause local environmental changes, favoring the aggregation of subsequent organisms. Here we ask whether the enzyme content of different microbes in a well-characterized dental biofilm can be used to predict their order of colonization. We define a metabolic distance between different species, based on the overlap in their enzyme content. We next use this metric to quantify the average metabolic distance between neighboring organisms in the biofilm. We find that this distance is significantly smaller than the one observed for a random choice of prokaryotes, probably reflecting the environmental constraints on metabolic function of the community. More surprisingly, this metabolic metric is able to discriminate between observed and randomized orders of colonization of the biofilm, with the observed orders displaying smaller metabolic distance than randomized ones. By complementing these results with the analysis of individual vs. joint metabolic networks, we find that the tendency towards minimal metabolic distance may be counter-balanced by a propensity to pair organisms with maximal joint potential for synergistic interactions. The trade-off between these two tendencies may create a "sweet spot" of optimal inter-organism distance, with possible broad implications for our understanding of microbial community organization.	[Mazumdar, Varun; Amar, Salomon; Segre, Daniel] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Amar, Salomon] Boston Univ, Ctr Antiinflammatory Therapeut, Goldman Sch Dent Med, Boston, MA 02215 USA; [Segre, Daniel] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Segre, Daniel] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Boston University; Boston University; Boston University; Boston University	Segre, D (corresponding author), Boston Univ, Bioinformat Program, Boston, MA 02215 USA.	dsegre@bu.edu	Segre, Daniel/A-1993-2009	Segre, Daniel/0000-0003-4859-1914	United States Department of Energy [DE-SC0004962]; NIH [R01DE15345, R01HL6801, R0115989]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015345] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was partially funded by the United States Department of Energy, grant DE-SC0004962, and by NIH grants R01DE15345, R01HL6801 and R0115989. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 1998, J BIOCHEM, V123, P305; [Anonymous], [No title captured]; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Becker SA, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-8; Belda-Ferre P, 2011, ISME J, P1; Borenstein E, 2008, P NATL ACAD SCI USA, V105, P14482, DOI 10.1073/pnas.0806162105; Boussau B, 2004, P NATL ACAD SCI USA, V101, P9722, DOI 10.1073/pnas.0400975101; CANFIELD DE, 1991, SCIENCE, V251, P1471, DOI 10.1126/science.11538266; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Diaz-Torres ML, 2006, FEMS MICROBIOL LETT, V258, P257, DOI 10.1111/j.1574-6968.2006.00221.x; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Fu WL, 2010, ANTIMICROB AGENTS CH, V54, P397, DOI 10.1128/AAC.00669-09; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; HAWSER SP, 1994, INFECT IMMUN, V62, P915, DOI 10.1128/IAI.62.3.915-921.1994; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kauffman KJ, 2003, CURR OPIN BIOTECH, V14, P491, DOI 10.1016/j.copbio.2003.08.001; Klitgord N, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001002; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; KOLENBRANDER PE, 1986, J BACTERIOL, V168, P851, DOI 10.1128/jb.168.2.851-859.1986; Kolenbrander PE, 2002, MICROBIOL MOL BIOL R, V66, P486, DOI 10.1128/MMBR.66.3.486-505.2002; Lendenmann U, 2000, Adv Dent Res, V14, P22; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Li LN, 2010, INT J ORAL SCI, V2, P66, DOI 10.4248/IJOS10024; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Mazumdar V, 2009, J BACTERIOL, V191, P74, DOI 10.1128/JB.01123-08; NICKEL JC, 1985, ANTIMICROB AGENTS CH, V27, P619, DOI 10.1128/AAC.27.4.619; Nogales J, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-79; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; Olczak T, 2005, FEMS MICROBIOL REV, V29, P119, DOI 10.1016/j.femsre.2004.09.001; Oliveira AP, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-39; Palmer RJ, 2001, METHOD ENZYMOL, V337, P393, DOI 10.1016/S0076-6879(01)37028-3; Rickard AH, 2003, TRENDS MICROBIOL, V11, P94, DOI 10.1016/S0966-842X(02)00034-3; Roberts RJ, 2011, NUCLEIC ACIDS RES, V39, pD11, DOI 10.1093/nar/gkq1168; Senger RS, 2008, BIOTECHNOL BIOENG, V101, P1036, DOI 10.1002/bit.22010; SINGER RE, 1981, INFECT IMMUN, V32, P458, DOI 10.1128/IAI.32.2.458-463.1981; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Terzer M, 2008, BIOINFORMATICS, V24, P2229, DOI 10.1093/bioinformatics/btn401; Thiele I, 2005, J BACTERIOL, V187, P5818, DOI 10.1128/JB.187.16.5818-5830.2005; Tsuda H, 2010, J PERIODONTAL RES, V45, P626, DOI 10.1111/j.1600-0765.2010.01277.x; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2010, METAGENOMIC ANAL HUM, V1, P1; Valm AM, 2011, P NATL ACAD SCI USA, V108, P4152, DOI 10.1073/pnas.1101134108; Ward DM, 1998, MICROBIOL MOL BIOL R, V62, P1353, DOI 10.1128/MMBR.62.4.1353-1370.1998; Webb E. C., 1992, ENZYME NOMENCLATURE; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156	52	24	24	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77617	10.1371/journal.pone.0077617	http://dx.doi.org/10.1371/journal.pone.0077617			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204896	Green Published, Green Submitted, gold			2022-12-27	WOS:000326334500037
J	Ai, YC; Ai, HN; Meng, FM; Zhao, L				Ai, Yuncan; Ai, Hannan; Meng, Fanmei; Zhao, Lei			GenomeFingerprinter: The Genome Fingerprint and the Universal Genome Fingerprint Analysis for Systematic Comparative Genomics	PLOS ONE			English	Article							REPLICATION ORIGINS; REPRESENTATION; SEQUENCE; TOOL; IDENTIFICATION; ALIGNMENT; DATABASE; CURVES; BLAST	Background: No attention has been paid on comparing a set of genome sequences crossing genetic components and biological categories with far divergence over large size range. We define it as the systematic comparative genomics and aim to develop the methodology. Results: First, we create a method, GenomeFingerprinter, to unambiguously produce a set of three-dimensional coordinates from a sequence, followed by one three-dimensional plot and six two-dimensional trajectory projections, to illustrate the genome fingerprint of a given genome sequence. Second, we develop a set of concepts and tools, and thereby establish a method called the universal genome fingerprint analysis (UGFA). Particularly, we define the total genetic component configuration (TGCC) (including chromosome, plasmid, and phage) for describing a strain as a systematic unit, the universal genome fingerprint map (UGFM) of TGCC for differentiating strains as a universal system, and the systematic comparative genomics (SCG) for comparing a set of genomes crossing genetic components and biological categories. Third, we construct a method of quantitative analysis to compare two genomes by using the outcome dataset of genome fingerprint analysis. Specifically, we define the geometric center and its geometric mean for a given genome fingerprint map, followed by the Euclidean distance, the differentiate rate, and the weighted differentiate rate to quantitatively describe the difference between two genomes of comparison. Moreover, we demonstrate the applications through case studies on various genome sequences, giving tremendous insights into the critical issues in microbial genomics and taxonomy. Conclusions: We have created a method, GenomeFingerprinter, for rapidly computing, geometrically visualizing, intuitively comparing a set of genomes at genome fingerprint level, and hence established a method called the universal genome fingerprint analysis, as well as developed a method of quantitative analysis of the outcome dataset. These have set up the methodology of systematic comparative genomics based on the genome fingerprint analysis.	[Ai, Yuncan; Ai, Hannan; Meng, Fanmei; Zhao, Lei] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Ai, Yuncan] Guangzhou Med Univ, Affiliated Hosp 2, State Key Lab Resp Dis, Allergy Res Branch, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Ai, YC (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	Lssayc@mail.sysu.edu.cn		Ai, Hannan/0000-0002-1394-150X	National High Technology Research & Development Project (863 Project) [2006AA09Z420]; National Science and Technology Major Project of China [2014ZX0801105B002]; Guangzhou Municipal Science Ambassador Scholarship	National High Technology Research & Development Project (863 Project); National Science and Technology Major Project of China; Guangzhou Municipal Science Ambassador Scholarship	This work was supported in part by the grants to YA from the National High Technology Research & Development Project (863 Project) (No. 2006AA09Z420), National Science and Technology Major Project of China (No. 2014ZX0801105B002). HA was a recipient of the Guangzhou Municipal Science Ambassador Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron DE, 2010, PLOS ONE, V5; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Charkowski AO, 2004, PHYSIOL GENOMICS, V16, P180, DOI 10.1152/physiolgenomics.00199.2003; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Gao F, 2006, NUCLEIC ACIDS RES, V34, pW686, DOI 10.1093/nar/gkl040; GATES MA, 1986, J THEOR BIOL, V119, P319, DOI 10.1016/S0022-5193(86)80144-8; Guo FB, 2003, NUCLEIC ACIDS RES, V31, P1780, DOI 10.1093/nar/gkg254; HAMORI E, 1983, J BIOL CHEM, V258, P1318; HAMORI E, 1985, NATURE, V314, P585, DOI 10.1038/314585a0; Herisson J, 2006, CELL MOL BIOL, V52, P24, DOI 10.1170/T734; Herisson J, 2007, BIOINFORMATICS, V23, P680, DOI 10.1093/bioinformatics/btl669; LATHE R, 1984, NATURE, V311, P610, DOI 10.1038/311610b0; LATHE R, 1985, NATURE, V314, P585, DOI 10.1038/314585b0; Lobry JR, 1996, BIOCHIMIE, V78, P323, DOI 10.1016/0300-9084(96)84764-X; Nielsen CB, 2010, NAT METHODS, V7, pS5, DOI [10.1038/NMETH.1422, 10.1038/nmeth.1422]; Robinson NP, 2004, CELL, V116, P25, DOI 10.1016/S0092-8674(03)01034-1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Zhang CT, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041917; Zhang CT, 2003, BIOINFORMATICS, V19, P593, DOI 10.1093/bioinformatics/btg041; ZHANG R, 1994, J BIOMOL STRUCT DYN, V11, P767, DOI 10.1080/07391102.1994.10508031; Zhang R, 2003, BIOCHEM BIOPH RES CO, V302, P728, DOI 10.1016/S0006-291X(03)00252-3; Zhang R, 2002, BIOCHEM BIOPH RES CO, V297, P396, DOI 10.1016/S0006-291X(02)02214-3; Zheng WX, 2005, MOL PHYLOGENET EVOL, V36, P224, DOI 10.1016/j.ympev.2005.03.030; [No title captured]	26	1	1	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77912	10.1371/journal.pone.0077912	http://dx.doi.org/10.1371/journal.pone.0077912			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205026	Green Submitted, Green Published, gold			2022-12-27	WOS:000326270700060
J	Fry, EA; Taneja, P; Maglic, D; Zhu, SN; Sui, GC; Inoue, K				Fry, Elizabeth A.; Taneja, Pankaj; Maglic, Dejan; Zhu, Sinan; Sui, Guangchao; Inoue, Kazushi			Dmp1 alpha Inhibits HER2/neu-Induced Mammary Tumorigenesis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR DMP1; CELL-CYCLE ARREST; BREAST-CANCER; TRANSGENIC MICE; GENE-EXPRESSION; ERBB RECEPTORS; CRITICAL ROLES; ARF; P53; INDUCTION	Our recent study shows a pivotal role of Dmp1 in quenching hyperproliferative signals from HER2 to the Arf-p53 pathway as a safety mechanism to prevent breast carcinogenesis. To directly demonstrate the role of Dmp1 in preventing HER2/neu-driven oncogenic transformation, we established Flag-Dmp1 alpha transgenic mice (MDTG) under the control of the mouse mammary tumor virus (MMTV) promoter. The mice were viable but exhibited poorly developed mammary glands with markedly reduced milk production; thus more than half of parous females were unable to support the lives of new born pups. The mammary glands of the MDTG mice had very low Ki-67 expression but high levels of Arf, Ink4a, p53, and p21(Cip1), markers of senescence and accelerated aging. In all strains of generated MDTG;neu mice, tumor development was significantly delayed with decreased tumor weight. Tumors from MDTG;neu mice expressed Flag-Dmp1 alpha and Ki-67 in a mutually exclusive fashion indicating that transgenic Dmp1 alpha prevented tumor growth in vivo. Genomic DNA analyses showed that the Dmp1 alpha transgene was partially lost in half of the MDTG;neu tumors, and Western blot analyses showed Dmp1 alpha protein downregulation in 80% of the cases. Our data demonstrate critical roles of Dmp1 in preventing mammary tumorigenesis and raise the possibility of treating breast cancer by restoring Dmp1 alpha expression.	[Fry, Elizabeth A.; Taneja, Pankaj; Maglic, Dejan; Zhu, Sinan; Inoue, Kazushi] Wake Forest Univ Hlth Sci, Dept Pathol, Winston Salem, NC USA; [Fry, Elizabeth A.; Taneja, Pankaj; Maglic, Dejan; Zhu, Sinan; Sui, Guangchao; Inoue, Kazushi] Wake Forest Univ Hlth Sci, Dept Canc Biol, Winston Salem, NC USA; [Maglic, Dejan; Zhu, Sinan; Inoue, Kazushi] Wake Forest Univ Hlth Sci, Grad Program Mol Med, Winston Salem, NC USA	Wake Forest University; Wake Forest University School of Medicine; Wake Forest University; Wake Forest University School of Medicine; Wake Forest University; Wake Forest University School of Medicine	Sui, GC (corresponding author), Wake Forest Univ Hlth Sci, Dept Canc Biol, Winston Salem, NC USA.	gsui@wakehealth.edu; kinoue2@triad.rr.com		Sui, Guangchao/0000-0002-8164-5585	American Cancer Society [RSG-07-207-01-MGO, 5R01CA106314, 116403-RSG-09-082-01-MGO]; Wake Forest University Health Sciences [20595]; Susan G. Komen Foundation [KG080179]; Department of Defense (DOD) [BC100907];  [IRSC-GTS 37540]; NATIONAL CANCER INSTITUTE [R01CA106314] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Wake Forest University Health Sciences; Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Department of Defense (DOD)(United States Department of Defense); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	K. Inoue has been supported by the American Cancer Society RSG-07-207-01-MGO, 5R01CA106314, and by Director's Challenge Award #20595 from Wake Forest University Health Sciences. G. Sui has been supported by the American Cancer Society 116403-RSG-09-082-01-MGO and 5R01CA106314. P. Taneja was supported by the Susan G. Komen Foundation postdoctoral fellowship KG080179. D. Maglic has been supported by Department of Defense (DOD) pre-doctoral fellowship BC100907. S. Zhu was supported by institutional grant IRSC-GTS 37540. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarante MK, 2009, J CANCER RES CLIN, V135, P329, DOI 10.1007/s00432-008-0511-2; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BIECHE I, 1992, LANCET, V339, P139, DOI 10.1016/0140-6736(92)90208-K; Bodner SM, 1999, GENE, V229, P223, DOI 10.1016/S0378-1119(98)00591-5; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; Frazier DP, 2012, CANCER RES, V72, P1740, DOI 10.1158/0008-5472.CAN-11-2410; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hirai H, 1996, MOL CELL BIOL, V16, P6457; Holbro T, 2003, EXP CELL RES, V284, P99, DOI 10.1016/S0014-4827(02)00099-X; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Inoue K, 2007, ONCOGENE, V26, P4329, DOI 10.1038/sj.onc.1210226; Inoue K, 1999, P NATL ACAD SCI USA, V96, P3993, DOI 10.1073/pnas.96.7.3993; Inoue K, 2001, GENE DEV, V15, P2934, DOI 10.1101/gad.929901; Inoue K, 2000, GENE DEV, V14, P1797; Inoue K, 1998, MOL CELL BIOL, V18, P1590, DOI 10.1128/MCB.18.3.1590; Inoue K, 2008, CANCER RES, V68, P4487, DOI 10.1158/0008-5472.CAN-07-6791; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Kristjansson AK, 1997, ANTICANCER RES, V17, P93; Kwong KY, 1998, MOL CARCINOGEN, V23, P62, DOI 10.1002/(SICI)1098-2744(199810)23:2<62::AID-MC2>3.0.CO;2-O; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; Maglic D, 2013, ONCOGENE, V32, P4120, DOI 10.1038/onc.2012.423; Mallakin A, 2006, ONCOGENE, V25, P7703, DOI 10.1038/sj.onc.1209750; Mallakin A, 2007, CANCER CELL, V12, P381, DOI 10.1016/j.ccr.2007.08.034; Mallakin A, 2010, INT J CANCER, V126, P1403, DOI 10.1002/ijc.24938; Matheu A, 2004, GENE DEV, V18, P2736, DOI 10.1101/gad.310304; Morrow PKH, 2009, ANNU REV MED, V60, P153, DOI 10.1146/annurev.med.60.061107.145152; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Plante I, 2011, J VIS EXP, V21; Ross JS, 2003, EXPERT REV MOL DIAGN, V3, P573, DOI 10.1586/14737159.3.5.573; Ross JS, 2005, MOL ONCOLOGY BREAST; Saji S, 2000, P NATL ACAD SCI USA, V97, P337, DOI 10.1073/pnas.97.1.337; Sherr CJ, 2005, COLD SH Q B, V70, P129, DOI 10.1101/sqb.2005.70.004; Siegel PM, 1999, EMBO J, V18, P2149, DOI 10.1093/emboj/18.8.2149; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sreeramaneni R, 2005, MOL CELL BIOL, V25, P220, DOI 10.1128/MCB.25.1.220-232.2005; Sugiyama T, 2008, EXPERT REV MOL DIAGN, V8, P435, DOI 10.1586/14737159.8.4.435; Sugiyama T, 2008, CLIN MED INSIGHTS-ON, V2, P209; Taneja P, 2007, ONCOGENE, V26, P7457, DOI 10.1038/sj.onc.1210568; Taneja P, 2010, CANCER RES, V70, P9084, DOI 10.1158/0008-5472.CAN-10-0159; Taneja P, 2009, EXPERT REV MOL DIAGN, V9, P423, DOI 10.1586/ERM.09.31; Tschan MP, 2003, J BIOL CHEM, V278, P42750, DOI 10.1074/jbc.M307067200; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; Yang CW, 2004, AM J PATHOL, V164, P1031, DOI 10.1016/S0002-9440(10)63190-2; Zhou BP, 2003, SEMIN ONCOL, V30, P38, DOI 10.1053/j.seminoncol.2003.08.006; ZHU SY, 2013, HYPERFINE INTERACT, V220, P1, DOI DOI 10.1007/s10751-012-0749-6	48	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77870	10.1371/journal.pone.0077870	http://dx.doi.org/10.1371/journal.pone.0077870			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205004	Green Published, Green Submitted, gold			2022-12-27	WOS:000326270700056
J	Lin, DC				Lin, Der Chyan			Synchrony in Broadband Fluctuation and the 2008 Financial Crisis	PLOS ONE			English	Article							HERD BEHAVIOR; EMERGENCE; DYNAMICS; ORGANIZATION	We propose phase-like characteristics in scale-free broadband processes and consider fluctuation synchrony based on the temporal signature of significant amplitude fluctuation. Using wavelet transform, successful captures of similar fluctuation pattern between such broadband processes are demonstrated. The application to the financial data leading to the 2008 financial crisis reveals the transition towards a qualitatively different dynamical regime with many equity price in fluctuation synchrony. Further analysis suggests an underlying scale free "price fluctuation network" with large clustering coefficient.	Ryerson Univ, Dept Mech & Ind Engn, Toronto, ON, Canada	Toronto Metropolitan University	Lin, DC (corresponding author), Ryerson Univ, Dept Mech & Ind Engn, Toronto, ON, Canada.	derlin@ryerson.ca			Natural Science and Engineering Research Council of Canada	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Natural Science and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebron JA, 2005, REV MOD PHYS, V77, P137, DOI 10.1103/RevModPhys.77.137; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barclay MJ, 2003, REV FINANC STUD, V16, P1041, DOI 10.1093/rfs/hhg030; Bennett M, 2002, P ROY SOC A-MATH PHY, V458, P563, DOI 10.1098/rspa.2001.0888; Blasius B, 1999, NATURE, V399, P354, DOI 10.1038/20676; Boccaletti S, 2002, PHYS REP, V366, P1, DOI 10.1016/S0370-1573(02)00137-0; Cavagna A, 2010, P NATL ACAD SCI USA, V107, P11865, DOI 10.1073/pnas.1005766107; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; Cont R, 2000, MACROECON DYN, V4, P170; Corcos A., 2002, Quantitative Finance, V2, P264, DOI 10.1088/1469-7688/2/4/303; de la Lama MS, 2005, EUROPHYS LETT, V72, P851, DOI 10.1209/epl/i2005-10299-3; Eguiluz VM, 2005, AM J SOCIOL, V110, P977, DOI 10.1086/428716; Eguiluz VM, 2000, PHYS REV LETT, V85, P5659, DOI 10.1103/PhysRevLett.85.5659; Falconer F, 1990, FRACTAL GEOMETRY; Galam S, 2004, PHYSICA A, V333, P453, DOI 10.1016/j.physa.2003.10.041; GODE DK, 1993, J POLIT ECON, V101, P119, DOI 10.1086/261868; Hong H, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.054102; Ibarz B, 2011, PHYS REP, V501, P1, DOI 10.1016/j.physrep.2010.12.003; Kerner BS, 1998, PHYS REV LETT, V81, P3797, DOI 10.1103/PhysRevLett.81.3797; Krapivsky PL, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.238701; Lillo F, 2005, FLUCT NOISE LETT, V5, pL209, DOI 10.1142/S0219477505002574; Lillo F, 2003, NATURE, V421, P129, DOI 10.1038/421129a; Lin DC, 2006, BIOL CYBERN, V95, P401, DOI 10.1007/s00422-006-0094-4; Lin DC, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/40001; MALLAT S, 1992, IEEE T INFORM THEORY, V38, P617, DOI 10.1109/18.119727; Mallat S., 1999, WAVELET TOUR SIGNAL, DOI 10.1016/B978-012466606-1/50008-8; MANDELBROT B, 1967, J BUS, V40, P393, DOI 10.1086/295006; Moro E, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.066102; MUZY JF, 1991, PHYS REV LETT, V67, P3515, DOI 10.1103/PhysRevLett.67.3515; Plerou V, 2000, PHYSICA A, V279, P443, DOI 10.1016/S0378-4371(00)00010-8; RANTA E, 1995, P ROY SOC B-BIOL SCI, V262, P113, DOI 10.1098/rspb.1995.0184; Tass P, 1998, PHYS REV LETT, V81, P3291, DOI 10.1103/PhysRevLett.81.3291; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478	35	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77254	10.1371/journal.pone.0077254	http://dx.doi.org/10.1371/journal.pone.0077254			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	242KW	24204782	Green Published, gold, Green Submitted			2022-12-27	WOS:000326241200020
J	Zwolinska, K; Knysz, B; Gasiorowski, J; Pazgan-Simon, M; Gladysz, A; Sobczynski, M; Piasecki, E				Zwolinska, Katarzyna; Knysz, Brygida; Gasiorowski, Jacek; Pazgan-Simon, Monika; Gladysz, Andrzej; Sobczynski, Maciej; Piasecki, Egbert			Frequency of Human Endogenous Retroviral Sequences (HERV) K113 and K115 in the Polish Population, and Their Effect on HIV Infection	PLOS ONE			English	Article							INSERTIONAL POLYMORPHISMS; HUMAN GENOME; K HML-2; VIRUS TYPE-1; EXPRESSION; HERV-K113; ELEMENTS; PROTEIN; FAMILY; IDENTIFICATION	Background: The human genome contains about 8% of endogenous retroviral sequences originated from germ cell infections by exogenous retroviruses during evolution. Most of those sequences are inactive because of accumulation of mutations but some of them are still capable to be transcribed and translated. The latter are insertionally polymorphic HERV-K113 and HERV-K115. It has been suggested that their presence and expression was connected with several human diseases. It is also believed that they could interfere with the replication cycle of exogenous retroviruses, including HIV. Results: Prevalence of endogenous retroviral sequences HERV-K113 and HERV-K115 was determined in the Polish population. The frequencies were found as 11.8% for HERV-K113 and 7.92% for HERV-K115. To verify the hypothesis that the presence of these HERVs sequences could affect susceptibility to HIV infection, comparison of a control group (HIV-negative, not exposed to HIV; n = 303) with HIV-positive patients (n = 470) and exposed but uninfected (EU) individuals (n = 121) was performed. Prevalence of HERV-K113 and HERV-K115 in the EU group was 8.26% and 5.71%, respectively. In the HIV(+) group we detected HERV-K113 sequences in 12.98% of the individuals and HERV-K115 sequences in 7.23% of the individuals. There were no statistically significant differences between groups studied. Conclusion: The frequency of HERV-K113 and HERV-K115 sequences in Poland were found to be higher than usually shown for European populations. No relation between presence of the HERVs and HIV infection was detected.	[Zwolinska, Katarzyna; Piasecki, Egbert] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Virol Lab, Wroclaw, Poland; [Knysz, Brygida; Gasiorowski, Jacek; Pazgan-Simon, Monika; Gladysz, Andrzej] Wroclaw Med Univ, Dept & Clin Infect Dis Liver Dis & Acquired Immun, Wroclaw, Poland; [Sobczynski, Maciej] Univ Wroclaw, Fac Biotechnol, Dept Genom, PL-50138 Wroclaw, Poland; [Piasecki, Egbert] Jan Dlugosz Univ, Inst Chem Environm Protect & Biotechnol, Czestochowa, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Wroclaw Medical University; University of Wroclaw; Jan Dlugosz University	Zwolinska, K (corresponding author), Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Virol Lab, Wroclaw, Poland.	kjzwolinska@iitd.pan.wroc.pl	Pazgan-Simon, Monika/AAQ-9836-2020; Piasecki, Egbert/GSN-6297-2022	Piasecki, Egbert/0000-0003-2049-4602; Knysz, Brygida/0000-0003-2605-1079; Sobczynski, Maciej/0000-0003-2428-0927; Zwolinska, Katarzyna/0000-0002-5872-7806	Polish Ministry of Science and Higher Education [2 P05B 152 29]; Marshal Office of Lower Silesia Voivodeship	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Marshal Office of Lower Silesia Voivodeship	This work was part of the project entitled "The genetic factors influenced the susceptibility and the course of HIV-1 infection" and was supported by Polish Ministry of Science and Higher Education (Grant 2 P05B 152 29; www.nauka.gov.pl) and The Marshal Office of Lower Silesia Voivodeship (Grant for PhD students II/2009; http://www.umwd.dolnyslask.pl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An DS, 2001, J VIROL, V75, P3488, DOI 10.1128/JVI.75.7.3488-3489.2001; Bannert N, 2004, P NATL ACAD SCI USA, V101, P14572, DOI 10.1073/pnas.0404838101; Belshaw R, 2004, P NATL ACAD SCI USA, V101, P4894, DOI 10.1073/pnas.0307800101; Bock M, 2000, CURR OPIN GENET DEV, V10, P651, DOI 10.1016/S0959-437X(00)00138-6; Boller K, 2008, J GEN VIROL, V89, P567, DOI 10.1099/vir.0.83534-0; Burmeister T, 2004, AIDS RES HUM RETROV, V20, P1223, DOI 10.1089/aid.2004.20.1223; Cegolon L, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-4; Christensen T, 2010, J NEUROIMMUNE PHARM, V5, P326, DOI 10.1007/s11481-010-9214-y; Clausen J, 2003, Int MS J, V10, P22; Contreras-Galindo R, 2007, AIDS RES HUM RETROV, V23, P116, DOI 10.1089/aid.2006.0117; Contreras-Galindo R, 2006, AIDS RES HUM RETROV, V22, P979, DOI 10.1089/aid.2006.22.979; Contreras-Galindo R, 2006, J VIROL METHODS, V136, P51, DOI 10.1016/j.jviromet.2006.03.029; Contreras-Galindo R, 2012, J VIROL, V86, P262, DOI 10.1128/JVI.00602-11; de la Hera B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062090; Freimanis G, 2010, CLIN EXP IMMUNOL, V160, P340, DOI 10.1111/j.1365-2249.2010.04110.x; Garrison KE, 2007, PLOS PATHOG, V3, P1617, DOI 10.1371/journal.ppat.0030165; Gonzalez-Hernandez MJ, 2012, J VIROL, V86, P7790, DOI 10.1128/JVI.07215-11; Indik S, 2005, VIROLOGY, V337, P1, DOI 10.1016/j.virol.2005.03.040; Jha AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020234; Jha AR, 2009, MOL BIOL EVOL, V26, P2617, DOI 10.1093/molbev/msp180; Krzysztalowska-Wawrzyniak M, 2011, RHEUMATOLOGY, V50, P1310, DOI 10.1093/rheumatology/ker022; Lavie L, 2005, J VIROL, V79, P876, DOI 10.1128/JVI.79.2.876-883.2005; Lee WJ, 2003, MOL CELLS, V15, P75; Lee YN, 2007, PLOS PATHOG, V3, P119, DOI 10.1371/journal.ppat.0030010; Macfarlane C, 2004, J MOL EVOL, V59, P642, DOI 10.1007/s00239-004-2656-1; Malassine A, 2007, PLACENTA, V28, P185, DOI 10.1016/j.placenta.2006.03.001; Mayer J, 2004, VIROLOGY, V322, P190, DOI 10.1016/j.virol.2004.01.023; Moles JP, 2005, BRIT J DERMATOL, V153, P83, DOI 10.1111/j.1365-2133.2005.06555.x; Monde K, 2012, J VIROL, V86, P11194, DOI 10.1128/JVI.00301-12; Moyes D, 2007, TRENDS GENET, V23, P326, DOI 10.1016/j.tig.2007.05.004; Moyes DL, 2005, GENOMICS, V86, P337, DOI 10.1016/j.ygeno.2005.06.004; Muir A, 2004, PLACENTA, V25, pS16, DOI 10.1016/j.placenta.2004.01.012; Mullins CS, 2012, WORLD J GASTROENTERO, V18, P6027, DOI 10.3748/wjg.v18.i42.6027; Nelson PN, 2004, CLIN EXP IMMUNOL, V138, P1, DOI 10.1111/j.1365-2249.2004.02592.x; Nelson PN, 2003, J CLIN PATHOL-MOL PA, V56, P11, DOI 10.1136/mp.56.1.11; Noorali S, 2009, APPL IMMUNOHISTO M M, V17, P319, DOI 10.1097/PAI.0b013e31819640f9; Ormsby CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041021; Otowa T, 2006, NEUROSCI LETT, V408, P226, DOI 10.1016/j.neulet.2006.09.004; Paces J, 2013, NEW BIOTECHNOL, V30, P314, DOI 10.1016/j.nbt.2012.11.009; Padow M, 2000, AIDS RES HUM RETROV, V16, P1973, DOI 10.1089/088922200750054701; Reynier F, 2009, SCAND J IMMUNOL, V70, P295, DOI 10.1111/j.1365-3083.2009.02271.x; Tai AK, 2009, J CLIN VIROL, V46, P47, DOI 10.1016/j.jcv.2009.05.019; Towler EM, 1998, BIOCHEMISTRY-US, V37, P17137, DOI 10.1021/bi9818927; Tristem M, 2000, J VIROL, V74, P3715, DOI 10.1128/JVI.74.8.3715-3730.2000; Turcanova VL, 2009, J CLIN VIROL, V46, P15, DOI 10.1016/j.jcv.2009.05.015; Turner G, 2001, CURR BIOL, V11, P1531, DOI 10.1016/S0960-9822(01)00455-9; van der Kuyl AC, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-6; Yang J, 1999, P NATL ACAD SCI USA, V96, P13404, DOI 10.1073/pnas.96.23.13404; Yi JM, 2006, CANCER LETT, V231, P228, DOI 10.1016/j.canlet.2005.02.001; Zawada M, 2012, POSTEP HIG MED DOSW, V66, P758, DOI 10.5604/17322693.1015041; Zwolinska K, 2013, AIDS RES HUM RETROV, V29, P54, DOI [10.1089/aid.2011.0362, 10.1089/AID.2011.0362]; Zwolinska Katarzyna, 2006, Postepy Hig Med Dosw (Online), V60, P637; Zwolinska K, 2009, POSTEP HIG MED DOSW, V63, P73	53	8	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77820	10.1371/journal.pone.0077820	http://dx.doi.org/10.1371/journal.pone.0077820			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204983	Green Published, Green Submitted, gold			2022-12-27	WOS:000326241200043
J	Zhou, JH; Zhang, J; Sun, DJ; Ma, Q; Chen, HT; Ma, LN; Ding, YZ; Liu, YS				Zhou, Jian-hua; Zhang, Jie; Sun, Dong-jie; Ma, Qi; Chen, Hao-tai; Ma, Li-na; Ding, Yao-zhong; Liu, Yong-sheng			The Distribution of Synonymous Codon Choice in the Translation Initiation Region of Dengue Virus	PLOS ONE			English	Article							USAGE BIAS; HETEROLOGOUS EXPRESSION; MOLECULAR EVOLUTION; PREFERENTIAL USAGE; GENETIC-VARIATION; PESTIVIRUS GENUS; MINOR CODONS; TYPE-1 VIRUS; RNA VIRUSES; SEQUENCE	Dengue is the most common arthropod-borne viral (Arboviral) illness in humans. The genetic features concerning the codon usage of dengue virus (DENV) were analyzed by the relative synonymous codon usage, the effective number of codons and the codon adaptation index. The evolutionary distance between DENV and the natural hosts (Homo sapiens, Pan troglodytes, Aedes albopictus and Aedes aegypti) was estimated by a novel formula. Finally, the synonymous codon usage preference for the translation initiation region of this virus was also analyzed. The result indicates that the general trend of the 59 synonymous codon usage of the four genotypes of DENV are similar to each other, and this pattern has no link with the geographic distribution of the virus. The effect of codon usage pattern of Aedes albopictus and Aedes aegypti on the formation of codon usage of DENV is stronger than that of the two primates. Turning to the codon usage preference of the translation initiation region of this virus, some codons pairing to low tRNA copy numbers in the two primates have a stronger tendency to exist in the translation initiation region than those in the open reading frame of DENV. Although DENV, like other RNA viruses, has a high mutation to adapt its hosts, the regulatory features about the synonymous codon usage have been 'branded' on the translation initiation region of this virus in order to hijack the translational mechanisms of the hosts.	[Zhou, Jian-hua; Zhang, Jie; Sun, Dong-jie; Ma, Qi; Chen, Hao-tai; Ma, Li-na; Ding, Yao-zhong; Liu, Yong-sheng] Chinese Acad Agr Sci, State Key Lab Vet Etiol Biol, Lanzhou Vet Res Inst, Lanzhou, Gansu, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS	Liu, YS (corresponding author), Chinese Acad Agr Sci, State Key Lab Vet Etiol Biol, Lanzhou Vet Res Inst, Lanzhou, Gansu, Peoples R China.	liuyongshengvip8@163.com			International Science & Technology Cooperation Program of China [2010DFA32640, 2012DFG31890]; Gansu Provincial Funds for Distinguished Young Scientists [1111RJDA005]; National Natural Science foundation of China [31172335, 31072143]	International Science & Technology Cooperation Program of China; Gansu Provincial Funds for Distinguished Young Scientists; National Natural Science foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in parts by grants International Science & Technology Cooperation Program of China (No. 2010DFA32640 and No. 2012DFG31890) and Gansu Provincial Funds for Distinguished Young Scientists (1111RJDA005). This study was also supported by National Natural Science foundation of China (No. 31172335 and No. 31072143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahir I, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.71; Behura SK, 2010, INSECT MOL BIOL, V19, P49, DOI 10.1111/j.1365-2583.2009.00933.x; BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; Burns CC, 2006, J VIROL, V80, P3259, DOI 10.1128/JVI.80.7.3259-3272.2006; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; CHEN GFT, 1990, NUCLEIC ACIDS RES, V18, P1465, DOI 10.1093/nar/18.6.1465; Clarke TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003412; Das B, 2013, INFECT GENET EVOL, V16, P401, DOI 10.1016/j.meegid.2013.03.016; Dieng H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011790; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; Fredrick K, 2010, CELL, V141, P227, DOI 10.1016/j.cell.2010.03.033; FU JL, 1992, VIROLOGY, V188, P953, DOI 10.1016/0042-6822(92)90560-C; Gilchrist MA, 2009, GENETICS, V183, P1493, DOI 10.1534/genetics.109.108209; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Holmes EC, 2000, TRENDS MICROBIOL, V8, P74, DOI 10.1016/S0966-842X(99)01669-8; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X; Kim S, 2006, PROTEIN EXPRES PURIF, V50, P49, DOI 10.1016/j.pep.2006.07.014; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lavner Y, 2005, GENE, V345, P127, DOI 10.1016/j.gene.2004.11.035; Lee KS, 2012, INFECT GENET EVOL, V12, P77, DOI 10.1016/j.meegid.2011.10.012; Lobo FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006282; Ma MR, 2012, J ANIM VET ADV, V11, P3999; MONATH TP, 1986, VIROLOGY, V154, P313, DOI 10.1016/0042-6822(86)90457-5; Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068; Mueller S, 2006, J VIROL, V80, P9687, DOI 10.1128/JVI.00738-06; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Ohno H, 2001, GENE, V276, P107, DOI 10.1016/S0378-1119(01)00670-9; Parmley JL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000548; Patil JA, 2011, INFECT GENET EVOL, V11, P1443, DOI 10.1016/j.meegid.2011.05.011; Martins VEP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041386; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W; Rocha EPC, 2004, GENOME RES, V14, P2279, DOI 10.1101/gr.2896904; Rosano GL, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-41; Sanchez G, 2003, J VIROL, V77, P452, DOI 10.1128/JVI.77.1.452-459.2003; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P5125, DOI 10.1093/nar/14.13.5125; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; STANSSENS P, 1986, CELL, V44, P711, DOI 10.1016/0092-8674(86)90837-8; TRENT DW, 1983, VIROLOGY, V128, P271, DOI 10.1016/0042-6822(83)90255-6; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Twiddy SS, 2003, INFECT GENET EVOL, V3, P87, DOI 10.1016/S1567-1348(02)00153-3; Vasilakis N, 2008, ADV VIRUS RES, V72, P1, DOI 10.1016/S0065-3527(08)00401-6; Vervoort EB, 2000, NUCLEIC ACIDS RES, V28, P2069, DOI 10.1093/nar/28.10.2069; Weaver SC, 2006, CURR TOP MICROBIOL, V299, P285; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003; Welch M, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2008.0520.focus; Wong EHM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-253; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Zhou JH, 2013, INFECT GENET EVOL; Zhou JH, 2012, VIRUS GENES, V44, P475, DOI 10.1007/s11262-012-0731-z; Zhou JH, 2011, INFECT GENET EVOL, V11, P1815, DOI 10.1016/j.meegid.2011.07.014	53	61	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77239	10.1371/journal.pone.0077239	http://dx.doi.org/10.1371/journal.pone.0077239			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204777	Green Published, gold, Green Submitted			2022-12-27	WOS:000326155400031
J	Bigot, R; Bertaux, J; Frere, J; Berjeaud, JM				Bigot, Renaud; Bertaux, Joanne; Frere, Jacques; Berjeaud, Jean-Marc			Intra-Amoeba Multiplication Induces Chemotaxis and Biofilm Colonization and Formation for Legionella	PLOS ONE			English	Article							PATHOGEN-HOST INTERACTIONS; AUTOINDUCER SYNTHASE LQSA; ACANTHAMOEBA-CASTELLANII; INTRACELLULAR REPLICATION; NAEGLERIA-LOVANIENSIS; FLOATING BIOFILMS; WATER-SYSTEMS; POTABLE-WATER; PNEUMOPHILA; GROWTH	Legionella pneumophila, a facultative intracellular bacterium, is the causative agent of legionellosis. In the environment this pathogenic bacterium colonizes the biofilms as well as amoebae, which provide a rich environment for the replication of Legionella. When seeded on pre-formed biofilms, L. pneumophila was able to establish and survive and was only found at the surface of the biofilms. Different phenotypes were observed when the L. pneumophila, used to implement pre-formed biofilms or to form mono-species biofilms, were cultivated in a laboratory culture broth or had grown intracellulary within the amoeba. Indeed, the bacteria, which developed within the amoeba, formed clusters when deposited on a solid surface. Moreover, our results demonstrate that multiplication inside the amoeba increased the capacity of L. pneumophila to produce polysaccharides and therefore enhanced its capacity to establish biofilms. Finally, it was shown that the clusters formed by L. pneumophila were probably related to the secretion of a chemotaxis molecular agent.	[Bigot, Renaud; Frere, Jacques; Berjeaud, Jean-Marc] Univ Poitiers, CNRS, Equipe Microbiol Eau Ecol & Biol Interact, UMR 7267, Poitiers, France; [Bertaux, Joanne] Univ Poitiers, CNRS, Equipe Ecol Evolut Symbiose Ecol & Biol Interact, UMR 7267, Poitiers, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Poitiers	Berjeaud, JM (corresponding author), Univ Poitiers, CNRS, Equipe Microbiol Eau Ecol & Biol Interact, UMR 7267, Poitiers, France.	jean-marc.berjeaud@univ-poitiers.fr	Berjeaud, Jean-Marc/ABF-9966-2021; Berjeaud, Jean-Marc/GOP-0237-2022	Berjeaud, Jean-Marc/0000-0001-9013-8430; 	ministere de l'Enseignement Superieur et de la Recherche	ministere de l'Enseignement Superieur et de la Recherche	The ministere de l'Enseignement Superieur et de la Recherche is acknowledged for R. Bigot Ph.D. funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asare R, 2007, CELL MICROBIOL, V9, P1571, DOI 10.1111/j.1462-5822.2007.00894.x; Atlas RM, 1999, ENVIRON MICROBIOL, V1, P283, DOI 10.1046/j.1462-2920.1999.00046.x; BELLAMY W, 1992, J APPL BACTERIOL, V73, P472, DOI 10.1111/j.1365-2672.1992.tb05007.x; Besemer K, 2007, APPL ENVIRON MICROB, V73, P4966, DOI 10.1128/AEM.00588-07; BHOPAL RS, 1991, J INFECTION, V22, P97, DOI 10.1016/0163-4453(91)91178-Z; BOLLIN GE, 1985, J CLIN MICROBIOL, V21, P674, DOI 10.1128/JCM.21.5.674-677.1985; BOLLIN GE, 1985, APPL ENVIRON MICROB, V50, P1128, DOI 10.1128/AEM.50.5.1128-1131.1985; Byrne B, 1998, INFECT IMMUN, V66, P3029, DOI 10.1128/IAI.66.7.3029-3034.1998; Cazalet C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000851; Cheng K J, 1986, Soc Appl Bacteriol Symp Ser, V13, P239; Declerck P, 2007, J APPL MICROBIOL, V103, P2697, DOI 10.1111/j.1365-2672.2007.03530.x; Declerck P, 2005, MICROB ECOL, V50, P536, DOI 10.1007/s00248-005-0258-0; Declerck P, 2007, CURR MICROBIOL, V55, P435, DOI 10.1007/s00284-007-9006-7; Declerck P, 2007, WATER RES, V41, P3159, DOI 10.1016/j.watres.2007.04.011; Dupuy M, 2011, WATER RES, V45, P1087, DOI 10.1016/j.watres.2010.10.025; Ewann F, 2006, APPL ENVIRON MICROB, V72, P3993, DOI 10.1128/AEM.00684-06; Faulkner G, 2008, J BACTERIOL, V190, P7728, DOI 10.1128/JB.00751-08; Hagele S, 2000, CELL MICROBIOL, V2, P165, DOI 10.1046/j.1462-5822.2000.00044.x; Hilbi H, 2011, ENV MICROBIOL REP, V3, P286, DOI 10.1111/j.1758-2229.2011.00247.x; Huws SA, 2005, J APPL MICROBIOL, V98, P238, DOI 10.1111/j.1365-2672.2004.02449.x; Ibey BL, 2005, ANAL CHEM, V77, P7039, DOI 10.1021/ac0507901; JONAS D, 1995, J CLIN MICROBIOL, V33, P1247, DOI 10.1128/JCM.33.5.1247-1252.1995; Kessler A, 2013, ENVIRON MICROBIOL, V15, P646, DOI 10.1111/j.1462-2920.2012.02889.x; Kikuhara Hiroyuki, 1994, Journal of UOEH, V16, P263; Kim BR, 2002, WATER RES, V36, P4433, DOI 10.1016/S0043-1354(02)00188-4; Koubar M, 2013, CURR MICROBIOL, V66, P437, DOI 10.1007/s00284-012-0295-0; Koubar M, 2011, FEMS MICROBIOL LETT, V325, P10, DOI 10.1111/j.1574-6968.2011.02402.x; Kuiper MW, 2004, APPL ENVIRON MICROB, V70, P6826, DOI 10.1128/AEM.70.11.6826-6833.2004; Mampel J, 2006, APPL ENVIRON MICROB, V72, P2885, DOI 10.1128/AEM.72.4.2885-2895.2006; Mead TJ, 2009, P NATL ACAD SCI USA, V106, P14420, DOI 10.1073/pnas.0902306106; Molofsky AB, 2004, MOL MICROBIOL, V53, P29, DOI 10.1111/j.1365-2958.2004.04129.x; Murga R, 2001, MICROBIOL-SGM, V147, P3121, DOI 10.1099/00221287-147-11-3121; Nadell CD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2770; Neu TR, 2002, APPL ENVIRON MICROB, V68, P901, DOI 10.1128/AEM.68.2.901-909.2002; Neumeister B, 2000, APPL ENVIRON MICROB, V66, P914, DOI 10.1128/AEM.66.3.914-919.2000; Pecastaings S, 2010, BIOFOULING, V26, P809, DOI 10.1080/08927014.2010.520159; Piao ZY, 2006, APPL ENVIRON MICROB, V72, P1613, DOI 10.1128/AEM.72.2.1613-1622.2006; PRUCKLER JM, 1995, INFECT IMMUN, V63, P4928, DOI 10.1128/IAI.63.12.4928-4932.1995; ROGERS J, 1992, APPL ENVIRON MICROB, V58, P2326, DOI 10.1128/AEM.58.7.2326-2330.1992; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; Scott JE, 1996, EUR J ORAL SCI, V104, P2, DOI 10.1111/j.1600-0722.1996.tb00038.x; Spirig T, 2008, J BIOL CHEM, V283, P18113, DOI 10.1074/jbc.M801929200; Steinert M, 2002, FEMS MICROBIOL REV, V26, P149, DOI 10.1111/j.1574-6976.2002.tb00607.x; Stojek NM, 2011, ANN AGR ENV MED, V18, P330; Temmerman R, 2006, APPL ENVIRON MICROB, V72, P4323, DOI 10.1128/AEM.00070-06; Thomas V, 2004, J APPL MICROBIOL, V97, P950, DOI 10.1111/j.1365-2672.2004.02391.x; Tiaden A, 2008, J BACTERIOL, V190, P7532, DOI 10.1128/JB.01002-08; Tiaden A, 2007, CELL MICROBIOL, V9, P2903, DOI 10.1111/j.1462-5822.2007.01005.x; Tiaden A, 2010, ENVIRON MICROBIOL, V12, P1243, DOI 10.1111/j.1462-2920.2010.02167.x; Vervaeren H, 2006, FEMS MICROBIOL ECOL, V58, P583, DOI 10.1111/j.1574-6941.2006.00181.x	50	18	18	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77875	10.1371/journal.pone.0077875	http://dx.doi.org/10.1371/journal.pone.0077875			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205008	Green Published, gold, Green Submitted			2022-12-27	WOS:000326152300034
J	Sun, Y; Liang, DY; Sahbaie, P; Clark, JD				Sun, Yuan; Liang, Deyong; Sahbaie, Peyman; Clark, J. David			Effects of Methyl Donor Diets on Incisional Pain in Mice	PLOS ONE			English	Article							DNA METHYLATION; GENE; SUPPLEMENTATION; EXPRESSION; SPARC	Background: Dietary supplementation with methyl donors can influence the programming of epigenetic patterns resulting in persistent alterations in disease susceptibility and behavior. However, the dietary effects of methyl donors on pain have not been explored. In this study, we evaluated the effects of dietary methyl donor content on pain responses in mice. Methods: Male and female C57BL/6J mice were treated with high or low methyl donor diets either in the perinatal period or after weaning. Mechanical and thermal nociceptive sensitivity were measured before and after incision. Results: Mice fed high or low methyl donor diets displayed equal weight gain over the course of the experiments. When exposed to these dietary manipulations in the perinatal period, only male offspring of dams fed a high methyl donor diet displayed increased mechanical allodynia. Hindpaw incision in these animals caused enhanced nociceptive sensitization, but dietary history did not affect the duration of sensitization. For mice exposed to high or low methyl donor diets after weaning, no significant differences were observed in mechanical or thermal nociceptive sensitivity either at baseline or in response to hindpaw incision. Conclusions: Perinatal dietary factors such as methyl donor content may impact pain experiences in later life. These effects, however, may be specific to sex and pain modality.	[Sun, Yuan; Liang, Deyong; Sahbaie, Peyman; Clark, J. David] Stanford Univ, Sch Med, Dept Anesthesiol, Stanford, CA 94305 USA; [Sun, Yuan; Liang, Deyong; Sahbaie, Peyman; Clark, J. David] Vet Affairs Palo Alto Hlth Care Syst, Dept Anesthesiol, Palo Alto, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Clark, JD (corresponding author), Stanford Univ, Sch Med, Dept Anesthesiol, Stanford, CA 94305 USA.	djclark@stanford.edu	liang, dy/GZA-4770-2022		Department of Veterans Affairs Merit Review Award [1I01BX000881]	Department of Veterans Affairs Merit Review Award(US Department of Veterans Affairs)	The work was also supported by the Department of Veterans Affairs Merit Review Award 1I01BX000881. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burdge GC, 2009, J NUTR, V139, P1054, DOI 10.3945/jn.109.104653; Denk F, 2012, NEURON, V73, P435, DOI 10.1016/j.neuron.2012.01.012; Doehring A, 2013, PAIN, V154, P15, DOI 10.1016/j.pain.2012.06.011; Doehring A, 2011, EUR J PAIN, V15, P11, DOI 10.1016/j.ejpain.2010.06.004; Dominguez-Salas P, 2012, P NUTR SOC, V71, P154, DOI 10.1017/S0029665111003338; Gruber HE, 2005, J HISTOCHEM CYTOCHEM, V53, P1131, DOI 10.1369/jhc.5A6687.2005; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hollingsworth JW, 2008, J CLIN INVEST, V118, P3462, DOI 10.1172/JCI34378; Jacob RA, 1998, J NUTR, V128, P1204, DOI 10.1093/jn/128.7.1204; Liang DY, 2013, J PAIN RES, V6, P281, DOI 10.2147/JPR.S42561; Maloney CA, 2011, J NUTR, V141, P95, DOI 10.3945/jn.109.119453; Mathers JC, 2010, ADV GENET, V71, P3, DOI [10.1016/B978-0-12-380864-6.00001-8, 10.1016/S0065-2660(10)71001-4]; Mogil JS, 2012, TRENDS GENET, V28, P258, DOI 10.1016/j.tig.2012.02.004; Poree LR, 1998, ANESTH ANALG, V87, P941, DOI 10.1097/00000539-199810000-00037; Schaible TD, 2011, HUM MOL GENET, V20, P1687, DOI 10.1093/hmg/ddr044; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Sun Y, 2012, ANESTHESIOLOGY, V117, P626, DOI 10.1097/ALN.0b013e31826571aa; Suter MA, 2009, SEMIN REPROD MED, V27, P380, DOI 10.1055/s-0029-1237426; Tajerian M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-65; Turcot V, 2011, OBESITY, V19, P388, DOI 10.1038/oby.2010.198; Viet CT, 2011, PAIN, V152, P2323, DOI 10.1016/j.pain.2011.06.025; Wang Y, 2011, BRAIN RES, V1418, P64, DOI 10.1016/j.brainres.2011.08.040; Warner MJ, 2010, BIOCHEM J, V427, P333, DOI 10.1042/BJ20091861; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2003, J NUTR, V133, P238, DOI 10.1093/jn/133.1.238	25	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77881	10.1371/journal.pone.0077881	http://dx.doi.org/10.1371/journal.pone.0077881			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205011	Green Submitted, Green Published, gold			2022-12-27	WOS:000326152300035
J	Franzen, M; Nilsson, SG; Johansson, V; Ranius, T				Franzen, Markus; Nilsson, Sven G.; Johansson, Victor; Ranius, Thomas			Population Fluctuations and Synchrony of Grassland Butterflies in Relation to Species Traits	PLOS ONE			English	Article							SPATIAL SYNCHRONY; LIFE-HISTORY; EXTINCTION; DYNAMICS; LANDSCAPE; CLIMATE; RANGES; EDGES; RISK	Population fluctuations and synchrony influence population persistence; species with larger fluctuations and more synchronised population fluctuations face higher extinction risks. Here, we analyse the effect of diet specialisation, mobility, length of the flight period, and distance to the northern edge of the species' distribution in relation to between-year population fluctuations and synchrony of butterfly species. All butterfly species associated with grasslands were surveyed over five successive years at 19 grassland sites in a forest-dominated landscape (50 km(2)) in southern Sweden. At both the local and regional level, we found larger population fluctuations in species with longer flight periods. Population fluctuations were more synchronous among localities in diet specialists. Species with a long flight period might move more to track nectar resources compared to species with shorter flight period, and if nectar sources vary widely between years and localities it may explain that population fluctuations increase with increasing flight length. Diet generalists can use different resources (in this case host plants) at different localities and this can explain the lower synchrony in population fluctuations among generalist species. Higher degree of synchrony is one possible explanation for the higher extinction risks that have been observed for more specialised species. Therefore, diet specialists are more often threatened and require more conservation efforts than generalists.	[Franzen, Markus] Helmholtz Ctr Environm Res, UFZ, Dept Community Ecol, Halle, Germany; [Franzen, Markus; Nilsson, Sven G.] Lund Univ, Dept Biol Biodivers & Conservat Biol, Lund, Sweden; [Johansson, Victor; Ranius, Thomas] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Johansson, Victor] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Lund University; Swedish University of Agricultural Sciences; Stockholm University	Franzen, M (corresponding author), Helmholtz Ctr Environm Res, UFZ, Dept Community Ecol, Halle, Germany.	markus.franzen@ufz.de		Johansson, Victor/0000-0003-1369-9351	Formas, The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; European Commission [244090-STEP-CP-FP]	Formas, The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors thank Formas, The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning and the European Commission Framework Programme (FP) 7 via the Integrated Project STEP (grant 244090-STEP-CP-FP), for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, MODEL SELECTION MULT; Bellamy PE, 2003, ECOGRAPHY, V26, P338, DOI 10.1034/j.1600-0587.2003.03457.x; Eliasson C.U., 2005, NATIONALNYCKELN SVER; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; HANSKI I, 1993, J ANIM ECOL, V62, P656, DOI 10.2307/5386; Hanski I., 1999, METAPOPULATION ECOLO; Johst K, 2002, OIKOS, V98, P263, DOI 10.1034/j.1600-0706.2002.980208.x; Jones J, 2003, ECOLOGY, V84, P3024, DOI 10.1890/02-0639; Karsholt Ole, 1996, P1; Keith AB, 1990, ECOLOGY, V71, P1599, DOI [10.2307/1938295, DOI 10.2307/1938295]; Komonen A, 2004, OIKOS, V105, P41, DOI 10.1111/j.0030-1299.2004.12958.x; Korpimaki E, 2004, BIOSCIENCE, V54, P1071, DOI 10.1641/0006-3568(2004)054[1071:TPOPCA]2.0.CO;2; Kotiaho JS, 2005, P NATL ACAD SCI USA, V102, P1963, DOI 10.1073/pnas.0406718102; Kuussaari M, 2007, J INSECT CONSERV, V11, P351, DOI 10.1007/s10841-006-9052-7; Matter SF, 2010, P ROY SOC B-BIOL SCI, V277, P729, DOI 10.1098/rspb.2009.1520; MCARDLE BH, 1990, J ANIM ECOL, V59, P439, DOI 10.2307/4873; Nilsson Sven G., 2002, Entomologisk Tidskrift, V123, P193; Nilsson SG, 2008, INSECT CONSERV DIVER, V1, P197, DOI 10.1111/j.1752-4598.2008.00027.x; PIMM SL, 1988, AM NAT, V132, P757, DOI 10.1086/284889; POLLARD E, 1977, BIOL CONSERV, V12, P115, DOI 10.1016/0006-3207(77)90065-9; Powney GD, 2010, OIKOS, V119, P1690, DOI 10.1111/j.1600-0706.2010.18168.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ranta E, 1997, SCIENCE, V278, P1621, DOI 10.1126/science.278.5343.1621; Richards OW, 1968, TRE SOUTHWOOD, V4, P1; Saether BE, 2011, J ANIM ECOL, V80, P215, DOI 10.1111/j.1365-2656.2010.01751.x; Stefanescu C, 2013, ECOGRAPHY IN PRESS; Stoltze M, 1994, THESIS U COPENHAGEN; Sutcliffe OL, 1996, J ANIM ECOL, V65, P85, DOI 10.2307/5702; SVENSSON I, 1993, LEPIDOPTERA CALENDER; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; THOMAS JA, 1994, ECOGRAPHY, V17, P215, DOI 10.1111/j.1600-0587.1994.tb00096.x; THOMAS JA, 1984, BIOL BUTTERFLIES, P333; Van Dyck H, 2009, CONSERV BIOL, V23, P957, DOI 10.1111/j.1523-1739.2009.01175.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wilson Robert J., 2009, P81	35	10	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e78233	10.1371/journal.pone.0078233	http://dx.doi.org/10.1371/journal.pone.0078233			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24205169	Green Submitted, Green Published, gold			2022-12-27	WOS:000326034500070
J	Banu, S; Rahman, MT; Uddin, MKM; Khatun, R; Ahmed, T; Rahman, MM; Husain, MA; van Leth, F				Banu, Sayera; Rahman, Md. Toufiq; Uddin, Mohammad Khaja Mafij; Khatun, Razia; Ahmed, Tahmeed; Rahman, Md. Mojibur; Husain, Md. Ashaque; van Leth, Frank			Epidemiology of Tuberculosis in an Urban Slum of Dhaka City, Bangladesh	PLOS ONE			English	Article							LENGTH-POLYMORPHISM ANALYSIS; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; STRAIN DIFFERENTIATION; MOLECULAR EPIDEMIOLOGY; DIAGNOSIS; IDENTIFICATION; PREVALENCE	Background: The objectives of this study were to assess the tuberculosis (TB) burden and to provide an insight into the type of circulating M. tuberculosis species in urban slums of Bangladesh. We also aimed to test the feasibility of a larger transmission study in this setting. Methods: This cross-sectional study was conducted in an urban slum of Dhaka city. The household members were actively screened to assess the presence of TB-related signs and symptoms; cough >= 3 weeks and body mass index (BMI) <17 kg/m(2). Sputum specimens from suspects were collected for acid fast bacilli (AFB) microscopy, culture and drug susceptibility testing. Genotyping of M. tuberculosis was done using spoligotyping and variable number tandem repeats of mycobacterial interspersed repetitive units typing. Results: Among 9,877 adult screened for pulmonary TB (PTB), 25 were positive for AFB on microscopy and/or culture and the prevalence of new PTB cases was estimated to be 253/100,000. Only one child TB case was diagnosed among 5,147 child screened. Out of 26 cases, 21(81%) had cough for several duration and 5(19%) did not present with cough at the time of screening. One multidrug resistant case was found. Fifty two percent of all TB cases had BMI <17 kg/m(2) (p = <0.001). Among the 20 analyzed isolates, 13 different spoligotype patterns were identified in which 5 clusters contained 12 strains and 8 strains had unique pattern. Conclusions: The study revealed high prevalence of TB in urban slums. Screening using low BMI can be beneficial among risk group population. It is important to conduct larger study to validate clinical variables like cough <3 weeks and low BMI to define TB suspect and also to investigate the transmission of TB in slum settings.	[Banu, Sayera; Rahman, Md. Toufiq; Uddin, Mohammad Khaja Mafij; Khatun, Razia; Ahmed, Tahmeed] Int Ctr Diarrhoeal Dis Res, Ctr Communicable Dis, Dhaka 1000, Bangladesh; [Rahman, Md. Mojibur; Husain, Md. Ashaque] Directorate Gen Hlth Serv, Natl TB Control Program, Dhaka, Bangladesh; [van Leth, Frank] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands	International Centre for Diarrhoeal Disease Research (ICDDR); University of Amsterdam; Academic Medical Center Amsterdam	Banu, S (corresponding author), Int Ctr Diarrhoeal Dis Res, Ctr Communicable Dis, GPO Box 128, Dhaka 1000, Bangladesh.	sbanu@icddrb.org		van Leth, Frank/0000-0002-5490-8968; Banu, Sayera/0000-0002-5121-1962	KNCV Tuberculosis Foundation, The Netherlands	KNCV Tuberculosis Foundation, The Netherlands(Netherlands Government)	This work was supported by grants from the KNCV Tuberculosis Foundation, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, NATL GUIDELINES OPER; Asch S, 1998, AM J RESP CRIT CARE, V157, P1244, DOI 10.1164/ajrccm.157.4.9709071; Banu S, 2004, J CLIN MICROBIOL, V42, P674, DOI 10.1128/JCM.42.2.674-682.2004; Banu S, 2012, INT J TUBERC LUNG D, V16, P319, DOI 10.5588/ijtld.11.0426; Banu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010759; Banu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040545; Braden CR, 1997, J INFECT DIS, V175, P1446, DOI 10.1086/516478; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Cohen T, 2007, J R SOC INTERFACE, V4, P523, DOI 10.1098/rsif.2006.0193; (DGHS) DGoHS, 2011, TUB CONTR BANGL ANN; Ford CM, 2009, AM J TROP MED HYG, V81, P1097, DOI 10.4269/ajtmh.2009.08-0627; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Graham SM, 2012, J INFECT DIS, V205, pS199, DOI 10.1093/infdis/jis008; Hawkey PM, 2003, J CLIN MICROBIOL, V41, P3514, DOI 10.1128/JCM.41.8.3514-3520.2003; Hayward AC, 2003, INT J TUBERC LUNG D, V7, P751; Hossain S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044980; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Karim F, 2007, HEALTH POLICY PLANN, V22, P329, DOI 10.1093/heapol/czm026; Karyadi E, 2000, J NUTR, V130, P2953, DOI 10.1093/jn/130.12.2953; KOX LFF, 1994, J CLIN MICROBIOL, V32, P672, DOI 10.1128/JCM.32.3.672-678.1994; Mazars E, 2001, P NATL ACAD SCI USA, V98, P1901, DOI 10.1073/pnas.98.4.1901; Mehnaz Aisha, 2005, J Coll Physicians Surg Pak, V15, P543; Ngadaya ES, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-112; ONWUBALILI JK, 1988, EUR J CLIN NUTR, V42, P363; Petroff SA, 1915, J EXP MED, V21, P38, DOI 10.1084/jem.21.1.38; SAHA K, 1989, EUR J CLIN NUTR, V43, P117; Sola C, 2001, J MOL EVOL, V53, P680, DOI 10.1007/s002390010255; STEGEN G, 1969, PEDIATRICS, V43, P260; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 1997, MOL MICROBIOL, V26, P991, DOI 10.1046/j.1365-2958.1997.6361999.x; Tessier-Sherman B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-51; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1993, J CLIN MICROBIOL, V31, P1987, DOI 10.1128/JCM.31.8.1987-1995.1993; WHO, 2011, WHO GLOBAL TUBERCULO; Zaman K, 2012, EPIDEMIOL INFECT, V140, P1018, DOI 10.1017/S0950268811001609; Zaman K, 2011, EPIDEMIOL INFECT, P1	37	33	34	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77721	10.1371/journal.pone.0077721	http://dx.doi.org/10.1371/journal.pone.0077721			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204933	gold, Green Submitted, Green Published			2022-12-27	WOS:000326032600044
J	Chen, AJ; Tang, D; Zhou, YQ; Sun, BD; Li, XJ; Wang, LZ; Gao, WW				Chen, Amanda Juan; Tang, Dan; Zhou, Ying Qun; Sun, Bing Da; Li, Xiao Jin; Wang, Li Zhi; Gao, Wei Wei			Identification of Ochratoxin A Producing Fungi Associated with Fresh and Dry Liquorice	PLOS ONE			English	Article							ECOLOGICAL FARMS; POLISH CEREALS; RAW-MATERIALS; CONTAMINATION; PLANTS; FLORA	The presence of fungi on liquorice could contaminate the crop and result in elevated levels of mycotoxin. In this study, the mycobiota associated with fresh and dry liquorice was investigated in 3 producing regions of China. Potential toxigenic fungi were tested for ochratoxin A (OTA) and aflatoxin B1 (AFB1) production using liquid chromatography/mass spectrometry/mass spectrometry. Based on a polyphasic approach using morphological characters, beta-tubulin and RNA polymerase II second largest subunit gene phylogeny, a total of 9 genera consisting of 22 fungal species were identified, including two new Penicillium species (Penicillium glycyrrhizacola sp. nov. and Penicillium xingjiangense sp. nov.). The similarity of fungal communities associated with fresh and dry liquorice was low. Nineteen species belonging to 8 genera were detected from fresh liquorice with populations affiliated with P. glycyrrhizacola, P. chrysogenum and Aspergillus insuetus comprising the majority (78.74%, 33.33% and 47.06% of total) of the community from Gansu, Ningxia and Xinjiang samples, respectively. In contrast, ten species belonging to 4 genera were detected from dry liquorice with populations affiliated with P. chrysogenum, P. crustosum and Aspergillus terreus comprising the majority (64.00%, 52.38% and 90.91% of total) of the community from Gansu, Ningxia and Xinjiang samples, respectively. Subsequent LC/MS/MS analysis indicated that 5 fungal species were able to synthesize OTA in vitro including P. chrysogenum, P. glycyrrhizacola, P. polonicum, Aspergillus ochraceus and A. westerdijkiae, the OTA concentration varied from 12.99 to 39.03 mu g/kg. AFB1 was absent in all tested strains. These results demonstrate the presence of OTA producing fungi on fresh liquorice and suggest that these fungi could survive on dry liquorice after traditional sun drying. Penicillium chrysogenum derived from surrounding environments is likely to be a stable contributor to high OTA level in liquorice. The harvesting and processing procedure needs to be monitored in order to keep liquorice free of toxigenic fungi.	[Chen, Amanda Juan; Tang, Dan; Wang, Li Zhi; Gao, Wei Wei] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China; [Chen, Amanda Juan; Tang, Dan; Wang, Li Zhi; Gao, Wei Wei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhou, Ying Qun] China Natl Corp Traditional & Herbal Med, Beijing, Peoples R China; [Sun, Bing Da] Chinese Acad Sci, China Gen Microbiol Culture Collect Ctr, Inst Microbiol, Beijing, Peoples R China; [Li, Xiao Jin] Xinjiang Inst Tradit Chinese Med & Ethnicdrug, Urumqi, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Institute of Microbiology, CAS	Gao, WW (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China.	wwgao411@sina.com			National Natural Science Foundations of China [30973882, 81274071]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundations of China no. 30973882 and no 81274071. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accensi F, 2004, FOOD MICROBIOL, V21, P623, DOI 10.1016/j.fm.2003.12.003; Arino A, 2007, FOOD ADDIT CONTAM A, V24, P987, DOI 10.1080/02652030701317277; Arino A, 2007, INT J FOOD MICROBIOL, V114, P366, DOI 10.1016/j.ijfoodmicro.2006.08.005; BANNISTER P, 1968, J ECOL, V56, P27, DOI 10.2307/2258064; Bresch H, 2000, NAHRUNG, V44, P276, DOI [10.1002/1521-3803(20000701)44:4<276::AID-FOOD276>3.0.CO;2-A, 10.1002/1521-3803(20000701)44:4&lt;276::AID-FOOD276&gt;3.0.CO;2-A]; Carmichael J. W., 1980, Genera of Hyphomycetes.; Carmines EL, 2005, FOOD CHEM TOXICOL, V43, P1303, DOI 10.1016/j.fct.2005.01.012; Chen AJ, 2011, FOOD ADDIT CONTAM A, V28, P1091, DOI 10.1080/19440049.2011.576443; Chen AJ, 2010, MYCOSYSTEMA, V29, P335; Chinese Pharmacopoeia Council, 2005, CHINESE PHARMACOPOEI; Copetti MV, 2010, INT J FOOD MICROBIOL, V143, P67, DOI 10.1016/j.ijfoodmicro.2010.07.031; Creppy EE, 1999, J TOXICOL-TOXIN REV, V18, P277, DOI 10.3109/15569549909009258; Czerwiecki L, 2002, FOOD ADDIT CONTAM, V19, P1051, DOI 10.1080/02652030210156313; Czerwiecki L, 2002, FOOD ADDIT CONTAM, V19, P470, DOI 10.1080/02652030110113726; Efuntoye MO, 1996, MYCOPATHOLOGIA, V136, P115, DOI 10.1007/BF00437505; Esteban A, 2006, INT J FOOD MICROBIOL, V108, P188, DOI 10.1016/j.ijfoodmicro.2005.12.002; Frisvad JC, 2006, ADV EXP MED BIOL, V571, P33, DOI 10.1007/0-387-28391-9_2; FRISVAD JC, 1983, APPL ENVIRON MICROB, V46, P1301, DOI 10.1128/AEM.46.6.1301-1310.1983; Frisvad JC, 1985, ADV PENICILLIUM ASPE, P327; Gabriele D, 2001, J FOOD ENG, V48, P33, DOI 10.1016/S0260-8774(00)00140-0; Gil-Serna J, 2011, FOOD CONTROL, V22, P343, DOI 10.1016/j.foodcont.2010.06.018; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Gonzalez G, 2005, INT J FOOD MICROBIOL, V105, P1, DOI 10.1016/j.ijfoodmicro.2005.05.001; Herrera M, 2009, FOOD CHEM TOXICOL, V47, P2002, DOI 10.1016/j.fct.2009.05.009; HITOKOTO H, 1978, APPL ENVIRON MICROB, V36, P252, DOI 10.1128/AEM.36.2.252-256.1978; Houbraken J, 2011, STUD MYCOL, P1, DOI 10.3114/sim.2011.70.01; Kabelitz L, 2004, FOOD TECHNOL, V1, P25; Klich MA, 1988, LAB GUIDE COMMON ASP; Kornerup A., 1978, METHUEN HDB COLOUR, V3rd, P252; Majerus P, 2000, DEUT LEBENSM-RUNDSCH, V96, P451; Muller P, 2007, J STORED PROD RES, V43, P323, DOI 10.1016/j.jspr.2006.08.005; O'Brien E, 2005, CRIT REV TOXICOL, V35, P33, DOI 10.1080/10408440590905948; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Pietri A, 2010, TOXINS, V2, P758, DOI 10.3390/toxins2040758; Pitt J. I., 1979, The genus Penicillium and its teleomorphic states Eupenicillium and Talaromyces.; PITT JI, 1987, APPL ENVIRON MICROB, V53, P266, DOI 10.1128/AEM.53.2.266-269.1987; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAMSON RA, 2004, STUD MYCOL, V49, P1; Sanders T. H., 1993, Peanut Science, V20, P5, DOI 10.3146/i0095-3679-20-1-2; Singh P, 2008, MICROB ECOL, V56, P555, DOI 10.1007/s00248-008-9375-x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Varga J, 2001, CEREAL RES COMMUN, V29, P85; Wang LZ, 2013, FOOD CHEM, V138, P1048, DOI 10.1016/j.foodchem.2012.11.066; Wang YQ, 2002, J SHANXI AGR U, V22, P366; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yang L, 2010, FOOD ADDIT CONTAM A, V27, P989, DOI 10.1080/19440041003647122	47	24	28	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78285	10.1371/journal.pone.0078285	http://dx.doi.org/10.1371/journal.pone.0078285			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205182	Green Published, Green Submitted, gold			2022-12-27	WOS:000326032600090
J	Garcia-Bermudez, M; Lopez-Mejias, R; Genre, F; Castaneda, S; Gonzalez-Juanatey, C; Llorca, J; Corrales, A; Miranda-Filloy, JA; Rueda-Gotor, J; Gomez-Vaquero, C; Rodriguez-Rodriguez, L; Fernandez-Gutierrez, B; Pascual-Salcedo, D; Balsa, A; Lopez-Longo, FJ; Carreira, P; Blanco, R; Gonzalez-Alvaro, I; Martin, J; Gonzalez-Gay, MA				Garcia-Bermudez, Mercedes; Lopez-Mejias, Raquel; Genre, Fernanda; Castaneda, Santos; Gonzalez-Juanatey, Carlos; Llorca, Javier; Corrales, Alfonso; Miranda-Filloy, Jose A.; Rueda-Gotor, Javier; Gomez-Vaquero, Carmen; Rodriguez-Rodriguez, Luis; Fernandez-Gutierrez, Benjamin; Pascual-Salcedo, Dora; Balsa, Alejandro; Lopez-Longo, Francisco J.; Carreira, Patricia; Blanco, Ricardo; Gonzalez-Alvaro, Isidoro; Martin, Javier; Gonzalez-Gay, Miguel A.			SMAD3 rs17228212 Gene Polymorphism Is Associated with Reduced Risk to Cerebrovascular Accidents and Subclinical Atherosclerosis in Anti-CCP Negative Spanish Rheumatoid Arthritis Patients	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; ENVIRONMENTAL CONTRIBUTIONS; CARDIOVASCULAR EVENTS; DISEASE; CLASSIFICATION; INFLAMMATION; ANTIBODIES; PHENOTYPES; HLA-DRB1; CRITERIA	Rheumatoid arthritis (RA) is a complex polygenic inflammatory disease associated with accelerated atherosclerosis and increased risk of cardiovascular (CV) disease. Previous genome-wide association studies have described SMAD3 rs17228212 polymorphism as an important signal associated with CV events. The aim of the present study was to evaluate for the first time the relationship between this gene polymorphism and the susceptibility to CV manifestations and its potential association with the presence of subclinical atherosclerosis assessed by the evaluation of carotid intima-media thickness (cIMT) in patients with RA. Methods: One thousand eight hundred and ninety-seven patients fulfilling classification criteria for RA were genotyped for SMAD3 rs17228212 gene polymorphism through TaqMan genotyping assay. Also, subclinical atherosclerosis determined by the assessment of cIMT was analyzed in a subgroup of these patients by carotid ultrasonography. Results: No statistically significant differences were observed when allele frequencies of RA patients with or without CV events were compared. Nevertheless, when RA patients were stratified according to anti-cyclic citrullinated peptide (anti-CCP) status, we found that in RA patients who were negative for anti-CCP antibodies, the presence of C allele of SMAD3 rs17228212 polymorphism conferred a protective effect against the risk of cerebrovascular accident (CVA) after adjustment for demographic and classic CV risk factors (HR [95% CI]=0.36 [0.14-0.94], p=0.038) in a Cox regression model. Additionally, correlation between the presence of C allele of SMAD3 rs17228212 polymorphism and lower values of cIMT was found after adjustment for demographic and classic CV risk factors (p-value=0.0094) in the anti-CCP negative RA patients. Conclusions: Our results revealed that SMAD3 rs17228212 gene variant is associated with lower risk of CVA and less severe subclinical atherosclerosis in RA patients negative for anti-CCP antibodies. These findings may have importance to establish predictive models of CV disease in RA patients according to anti-CCP status.	[Martin, Javier] CSIC, IPBLN, Granada, Spain; [Lopez-Mejias, Raquel; Genre, Fernanda; Corrales, Alfonso; Rueda-Gotor, Javier; Blanco, Ricardo; Gonzalez-Gay, Miguel A.] Hosp Univ Marques de Valdecilla, Epidemiol Genet & Atherosclerosis Res Grp Syst In, Div Rheumatol, IFIMAV, Santander, Spain; [Castaneda, Santos; Gonzalez-Alvaro, Isidoro] Hosp Univ la Princesa, IIS Princesa, Dept Rheumatol, Madrid, Spain; [Gonzalez-Juanatey, Carlos] Hosp Lucus Augusti, Div Cardiol, Lugo, Spain; [Llorca, Javier] Univ Cantabria, Sch Med, Dept Epidemiol & Computat Biol, E-39005 Santander, Spain; [Llorca, Javier] IFIMAV, CIBERESP, Santander, Spain; [Miranda-Filloy, Jose A.] Hosp Xeral Calde, Div Rheumatol, Lugo, Spain; [Gomez-Vaquero, Carmen] Hosp Univ Bellvitge, Dept Rheumatol, Barcelona, Spain; [Rodriguez-Rodriguez, Luis; Fernandez-Gutierrez, Benjamin] Hosp Clin San Carlos, Dept Rheumatol, Madrid, Spain; [Pascual-Salcedo, Dora; Balsa, Alejandro] Hosp Univ la Paz, Dept Rheumatol, Madrid, Spain; [Lopez-Longo, Francisco J.] Hosp Univ Gregorio, Dept Rheumatol, Madrid, Spain; [Carreira, Patricia] Univ Hosp, Dept Rheumatol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Lucus Augusti-Lugo; Universidad de Cantabria; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Universitario Lucus Augusti-Lugo; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Hospital Clinico San Carlos; Hospital Universitario La Paz	Gonzalez-Gay, MA (corresponding author), Hosp Univ Marques de Valdecilla, Epidemiol Genet & Atherosclerosis Res Grp Syst In, Div Rheumatol, IFIMAV, Santander, Spain.	miguelaggay@hotmail.com	Martín, María/HDL-9512-2022; blanco, ricardo/AAA-1248-2020; González-Gay, Miguel A./B-2306-2008; Fernandez-Gutierrez, Benjamin/AAM-9063-2020; Carreira, Patricia E/D-4429-2018; Balsa, Alejandro/ABF-6456-2020; Martin, Javier/B-8141-2008; Rodriguez-Rodriguez, Luis/H-5880-2013; Llorca, Javier/F-7371-2011; García-Bermúdez, Mercedes/E-7708-2013; Martín, Javier/AAV-5209-2021	blanco, ricardo/0000-0003-2344-2285; González-Gay, Miguel A./0000-0002-7924-7406; Carreira, Patricia E/0000-0001-8279-3806; Martin, Javier/0000-0002-2202-0622; Rodriguez-Rodriguez, Luis/0000-0002-2869-7861; Llorca, Javier/0000-0001-8569-861X; García-Bermúdez, Mercedes/0000-0002-2643-5956; Rueda-Gotor, Javier/0000-0002-1970-541X	"Fondo de Investigaciones Sanitarias" (Spain) [PS09/00748, PI12/00060]; RETICS Program (RIER) from "Instituto de Salud Carlos III" (ISCIII) (Spain) [RD12/0009/0013, RD12/0009/0004]; European IMI BTCure Program; Fundacion Espanola de Reumatologia (FER).; Instituto de Salud Carlos III at the Spanish Ministry of Health (Spain); RETICS Program (RIER)	"Fondo de Investigaciones Sanitarias" (Spain)(Instituto de Salud Carlos III); RETICS Program (RIER) from "Instituto de Salud Carlos III" (ISCIII) (Spain); European IMI BTCure Program; Fundacion Espanola de Reumatologia (FER).; Instituto de Salud Carlos III at the Spanish Ministry of Health (Spain); RETICS Program (RIER)	This study was supported by grants from "Fondo de Investigaciones Sanitarias" PS09/00748 and PI12/00060 (Spain). This work was also partially supported by RETICS Program (RIER) RD12/0009/0013 and RD12/0009/0004 from "Instituto de Salud Carlos III" (ISCIII) (Spain). This work was supported in part by grants from the European IMI BTCure Program. MGB is a beneficiary of a grant from Fundacion Espanola de Reumatologia (FER). RLM is a recipient of a Sara Borrell postdoctoral fellowship from the Instituto de Salud Carlos III at the Spanish Ministry of Health (Spain). FG is supported by funds from the RETICS Program (RIER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Cheng X, 2008, CLIN IMMUNOL, V127, P89, DOI 10.1016/j.clim.2008.01.009; CORRALES A, 2013, ANN RHEUM DIS, P5241; Daha NA, 2011, NAT REV RHEUMATOL, V7, P203, DOI 10.1038/nrrheum.2011.28; Dessein PH, 2007, J RHEUMATOL, V34, P943; Fox CS, 2003, STROKE, V34, P397, DOI 10.1161/01.STR.0000048214.56981.6F; Garcia-Bermudez M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049214; Gonzalez-Gay MA, 2005, SEMIN ARTHRITIS RHEU, V35, P8, DOI 10.1016/j.semarthrit.2005.03.004; Gonzalez-Gay MA, 2007, ARTHRIT RHEUM-ARTHR, V57, P125, DOI 10.1002/art.22482; Gonzalez-Juanatey C, 2006, ARTHRIT RHEUM-ARTHR, V55, P150, DOI 10.1002/art.21707; Gonzalez-Juanatey C, 2009, SEMIN ARTHRITIS RHEU, V38, P366, DOI 10.1016/j.semarthrit.2008.01.012; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; HO KKL, 1993, J AM COLL CARDIOL, V22, pA6, DOI 10.1016/0735-1097(93)90455-A; Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385; Lopez-Longo FJ, 2009, ARTHRIT RHEUM-ARTHR, V61, P419, DOI 10.1002/art.24390; Juo SHH, 2004, STROKE, V35, P2243, DOI 10.1161/01.STR.0000142132.20442.d8; Kerekes G, 2012, NAT REV RHEUMATOL, V8, P224, DOI 10.1038/nrrheum.2012.16; Lees CW, 2011, GUT, V60, P1739, DOI 10.1136/gut.2009.199679; Lopez-Mejias R, 2012, ATHEROSCLEROSIS, V224, P426, DOI 10.1016/j.atherosclerosis.2012.06.008; Naredo E, 2011, RHEUMATOLOGY, V50, P1860, DOI 10.1093/rheumatology/ker206; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Rodriguez-Rodriguez L, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/574817; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Semb AG, 2013, J RHEUMATOL, V40, P359, DOI 10.3899/jrheum.120621; Shimizu C, 2011, CIRC-CARDIOVASC GENE, V4, P16, DOI 10.1161/CIRCGENETICS.110.940858; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Viatte S, 2013, NAT REV RHEUMATOL, V9, P141, DOI 10.1038/nrrheum.2012.237; Viatte S, 2012, ANN RHEUM DIS, V71, P1984, DOI 10.1136/annrheumdis-2011-201225; Willemze A, 2012, NAT REV RHEUMATOL, V8, P144, DOI 10.1038/nrrheum.2011.204	32	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77695	10.1371/journal.pone.0077695	http://dx.doi.org/10.1371/journal.pone.0077695			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204921	gold, Green Published, Green Submitted			2022-12-27	WOS:000326032600042
J	Goutte, S; Dubois, A; Legendre, F				Goutte, Sandra; Dubois, Alain; Legendre, Frederic			The Importance of Ambient Sound Level to Characterise Anuran Habitat	PLOS ONE			English	Article							ACOUSTIC COMMUNICATION; ANTIPREDATOR BEHAVIOR; ADVERTISEMENT CALLS; ANTHROPOGENIC NOISE; TRAFFIC NOISE; TORRENT FROG; FOREST; SIGNALS; DEGRADATION; ECOLOGY	Habitat characterisation is a pivotal step of any animal ecology study. The choice of variables used to describe habitats is crucial and need to be relevant to the ecology and behaviour of the species, in order to reflect biologically meaningful distribution patterns. In many species, acoustic communication is critical to individuals' interactions, and it is expected that ambient acoustic conditions impact their local distribution. Yet, classic animal ecology rarely integrates an acoustic dimension in habitat descriptions. Here we show that ambient sound pressure level (SPL) is a strong predictor of calling site selection in acoustically active frog species. In comparison to six other habitat-related variables (i.e. air and water temperature, depth, width and slope of the stream, substrate), SPL had the most important explanatory power in microhabitat selection for the 34 sampled species. Ambient noise was particularly useful in differentiating two stream-associated guilds: torrents and calmer streams dwelling species. Guild definitions were strongly supported by SPL, whereas slope, which is commonly used in stream-associated habitat, had a weak explanatory power. Moreover, slope measures are non-standardized across studies and are difficult to assess at small scale. We argue that including an acoustic descriptor will improve habitat-species analyses for many acoustically active taxa. SPL integrates habitat topology and temporal information (such as weather and hour of the day, for example) and is a simple and precise measure. We suggest that habitat description in animal ecology should include an acoustic measure such as noise level because it may explain previously misunderstood distribution patterns.	[Goutte, Sandra; Dubois, Alain; Legendre, Frederic] MNHN, Dept Systemat & Evolut, Paris, France	Museum National d'Histoire Naturelle (MNHN)	Goutte, S (corresponding author), MNHN, Dept Systemat & Evolut, Paris, France.	goutte@mnhn.fr	Dubois, Arnaud/C-1791-2014; goutte, sandra/M-2633-2014; Legendre, Frederic/B-5101-2013	Legendre, Frederic/0000-0001-5900-8048	Action Transversale du Museum "biodivesite actuelle et passee"; Ecole Normale Superieure de Lyon; Museum national d'Histoire naturelle (Paris); Societe des Amis du Museum; National University of Singapore	Action Transversale du Museum "biodivesite actuelle et passee"; Ecole Normale Superieure de Lyon(Grant Agency of the Czech Republic); Museum national d'Histoire naturelle (Paris); Societe des Amis du Museum; National University of Singapore(National University of Singapore)	This work was funded by the Action Transversale du Museum "biodivesite actuelle et passee", the Ecole Normale Superieure de Lyon (http://www.ens-lyon.eu), the Museum national d'Histoire naturelle (Paris) (http://www.mnhn.fr), the Societe des Amis du Museum (no website), and the National University of Singapore (http://www.nus.edu.sg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arch VS, 2008, BIOL LETTERS, V4, P19, DOI 10.1098/rsbl.2007.0494; Bee MA, 2008, J COMP PSYCHOL, V122, P235, DOI 10.1037/0735-7036.122.3.235; Bee MA, 2007, ANIM BEHAV, V74, P1765, DOI 10.1016/j.anbehav.2007.03.019; Biju SD, 2010, ZOOTAXA, P31; Blumenrath SH, 2004, BEHAVIOUR, V141, P935, DOI 10.1163/1568539042360152; Boeckle M, 2009, HERPETOLOGICA, V65, P154, DOI 10.1655/07-071R1.1; Boonman A, 2011, EVOL ECOL RES, V13, P197; Brumm H, 2005, COUST COMMUNICATION, P151; Byers BE, 2009, ANIM BEHAV, V77, P13, DOI 10.1016/j.anbehav.2008.10.003; Castellano S, 2003, BIOL J LINN SOC, V78, P11, DOI 10.1046/j.1095-8312.2003.00119.x; Chek AA, 2003, ECOL LETT, V6, P235, DOI 10.1046/j.1461-0248.2003.00420.x; Core R Team, 2012, R LANG ENV STAT COMP; DeRuiter SL, 2009, J EXP BIOL, V212, P3100, DOI 10.1242/jeb.030825; DUBOIS A, 1984, J ORNITHOL, V125, P455, DOI 10.1007/BF01640137; Dubois A, 1977, HIM EC ETHN C INT CN, P109; Dubois A, 1977, B SOC ZOOL FR, P163; Dubois Alain, 2001, Alytes (Paris), V19, P81; Ernst R, 2012, GLOBAL ECOL BIOGEOGR, V21, P704, DOI 10.1111/j.1466-8238.2011.00719.x; Feng AS, 2008, J COMP PHYSIOL A, V194, P159, DOI 10.1007/s00359-007-0267-1; Fichtel C, 2002, BEHAV ECOL SOCIOBIOL, V51, P262, DOI 10.1007/S00265-001-0436-0; FORREST TG, 1994, AM ZOOL, V34, P644; Frost DR, 2013, MPHIBIAN SPECIES WOR; Gerhardt H., 1983, ANIM BEHAV, V2, P82; GLAW F, 1994, FIELDGUIDE AMPHIBIAN; Godinho C, 2010, ECOL RES, V25, P283, DOI 10.1007/s11284-009-0655-9; Grafe TU, 2007, ETHOLOGY, V113, P772, DOI 10.1111/j.1439-0310.2007.01378.x; Griffin D. R., 1960, Animal Behaviour, V8, P141, DOI 10.1016/0003-3472(60)90022-1; Grosjean Stephane, 2006, Alytes (Paris), V23, P103; Halfwerk W, 2011, J APPL ECOL, V48, P210, DOI 10.1111/j.1365-2664.2010.01914.x; Halfwerk W, 2009, ANIM BEHAV, V78, P1301, DOI 10.1016/j.anbehav.2009.09.015; Hanna D, 2011, J EXP BIOL, V214, P3549, DOI 10.1242/jeb.060194; Hatch LT, 2012, CONSERV BIOL, V26, P983, DOI 10.1111/j.1523-1739.2012.01908.x; Hollen LI, 2009, ANIM BEHAV, V78, P791, DOI 10.1016/j.anbehav.2009.07.021; Hoskin CJ, 2009, J ZOOL, V278, P36, DOI 10.1111/j.1469-7998.2009.00550.x; Hoskin C. J., 2010, ROAD IMPACTS ABUNDAN; Husson F, 2012, FACTOMINER MULTIVARI; Husson F., 2010, PRINCIPAL COMPONENT; Keller A, 2009, J ANIM ECOL, V78, P305, DOI 10.1111/j.1365-2656.2008.01457.x; KELLOGG WN, 1953, SCIENCE, V117, P239, DOI 10.1126/science.117.3036.239; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Legendre F, 2012, ANIM BEHAV, V83, P361, DOI 10.1016/j.anbehav.2011.11.003; Li JT, 2011, ASIAN HERPETOL RES, V2, P1, DOI 10.3724/SP.J.1245.2011.00001; Lingnau R, 2007, J NAT HIST, V41, P1227, DOI 10.1080/00222930701395626; Lugli M, 2010, J COMP PHYSIOL A, V196, P439, DOI 10.1007/s00359-010-0528-2; Magrath RD, 2010, ADV STUD BEHAV, V41, P187, DOI 10.1016/S0065-3454(10)41006-2; MARTEN K, 1977, BEHAV ECOL SOCIOBIOL, V2, P271, DOI 10.1007/BF00299740; McNett GD, 2010, BEHAV ECOL SOCIOBIOL, V64, P2043, DOI 10.1007/s00265-010-1018-9; Moore SE, 2012, BIOSCIENCE, V62, P289, DOI 10.1525/bio.2012.62.3.10; MORTON ES, 1975, AM NAT, V109, P17, DOI 10.1086/282971; Moss CF, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00033; Narins PM, 2004, J ACOUST SOC AM, V115, P910, DOI 10.1121/1.1636851; Nemeth E, 2010, AM NAT, V176, P465, DOI 10.1086/656275; Nemeth E, 2009, ANIM BEHAV, V78, P637, DOI 10.1016/j.anbehav.2009.06.016; Nogueira SSC, 2012, ETHOLOGY, V118, P1001, DOI 10.1111/eth.12001; Owings DH, 2010, ADV STUD BEHAV, V41, P119, DOI 10.1016/S0065-3454(10)41004-9; Patricelli GL, 2006, AUK, V123, P639, DOI 10.1642/0004-8038(2006)123[639:ACIUNC]2.0.CO;2; Pearman PB, 2002, ECOL MONOGR, V72, P19, DOI 10.1890/0012-9615(2002)072[0019:TSOCSH]2.0.CO;2; Picciulin M, 2012, J ACOUST SOC AM, V132, P3118, DOI 10.1121/1.4756928; Pijanowski BC, 2011, BIOSCIENCE, V61, P203, DOI 10.1525/bio.2011.61.3.6; POULTER TC, 1963, SCIENCE, V139, P753, DOI 10.1126/science.139.3556.753; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reby D, 1999, CR ACAD SCI III-VIE, V322, P271, DOI 10.1016/S0764-4469(99)80063-8; Ryan M. J., 1985, TUNGARA FROG STUDY S; Shen JX, 2011, J COMP PHYSIOL A, V197, P1027, DOI 10.1007/s00359-011-0660-7; Shen JX, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1339; SIMBERLOFF D, 1991, ANNU REV ECOL SYST, V22, P115, DOI 10.1146/annurev.es.22.110191.000555; Skroblin A, 2012, AUSTRAL ECOL, V37, P874, DOI 10.1111/j.1442-9993.2011.02331.x; Urbina-Cardona JN, 2006, BIOL CONSERV, V132, P61, DOI 10.1016/j.biocon.2006.03.014; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wcislo WT, 1997, ARE BEHAV CLASSIFICA; WELLS KD, 1977, ANIM BEHAV, V25, P666, DOI 10.1016/0003-3472(77)90118-X; Wiens JA, 1989, LANDSCAPE ECOL, V3, P87, DOI 10.1007/BF00131172; ZIMMERMAN BL, 1983, HERPETOLOGICA, V39, P235	73	29	31	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78020	10.1371/journal.pone.0078020	http://dx.doi.org/10.1371/journal.pone.0078020			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205070	gold, Green Published, Green Submitted			2022-12-27	WOS:000326032600059
J	Salo, S; Bitu, C; Merkku, K; Nyberg, P; Bello, IO; Vuoristo, J; Sutinen, M; Vahanikkila, H; Costea, DE; Kauppila, J; Lehenkari, P; Dayan, D; Vered, M; Risteli, J; Salo, T				Salo, Sirpa; Bitu, Carolina; Merkku, Kalle; Nyberg, Pia; Bello, Ibrahim O.; Vuoristo, Jussi; Sutinen, Meeri; Vahanikkila, Hannu; Costea, Daniela E.; Kauppila, Joonas; Lehenkari, Petri; Dayan, Dan; Vered, Marilena; Risteli, Juha; Salo, Tuula			Human Bone Marrow Mesenchymal Stem Cells Induce Collagen Production and Tongue Cancer Invasion	PLOS ONE			English	Article							FETAL ANTIGEN-2 FA2; TUMOR MICROENVIRONMENT; BREAST-CANCER; STROMAL REACTION; PROSTATE-CANCER; I COLLAGEN; EXPRESSION; GROWTH; METASTASIS; FIBROBLASTS	Tumor microenvironment (TME) is an active player in carcinogenesis and changes in its composition modify cancer growth. Carcinoma-associated fibroblasts, bone marrow-derived multipotent mesenchymal stem cells (BMMSCs), and inflammatory cells can all affect the composition of TME leading to changes in proliferation, invasion and metastasis formation of carcinoma cells. In this study, we confirmed an interaction between BMMSCs and oral tongue squamous cell carcinoma (OTSCC) cells by analyzing the invasion progression and gene expression pattern. In a 3-dimensional myoma organotypic invasion model the presence of BMMSCs inhibited the proliferation but increased the invasion of OTSCC cells. Furthermore, the signals originating from OTSCC cells up-regulated the expression of inflammatory chemokines by BMMSCs, whereas BMMSC products induced the expression of known invasion linked molecules by carcinoma cells. Particularly, after the cell-cell interactions, the chemokine CCL5 was abundantly secreted from BMMSCs and a function blocking antibody against CCL5 inhibited BMMSC enhanced cancer invasion area. However, CCL5 blocking antibody did not inhibit the depth of invasion. Additionally, after exposure to BMMSCs, the expression of type I collagen mRNA in OTSCC cells was markedly up-regulated. Interestingly, also high expression of type I collagen N-terminal propeptide (PINP) in vivo correlated with the cancer-specific mortality of OTSCC patients, whereas there was no association between cancer tissue CCL5 levels and the clinical parameters. In conclusion, our results suggest that the interaction between BMMSC and carcinoma cells induce cytokine and matrix molecule expression, of which high level of type I collagen production correlates with the prognosis of OTSCC patients.	[Salo, Sirpa; Bitu, Carolina; Merkku, Kalle; Nyberg, Pia; Vuoristo, Jussi; Sutinen, Meeri; Salo, Tuula] Univ Oulu, Inst Dent, Dept Diagnost & Oral Med, Oulu, Finland; [Bello, Ibrahim O.] King Saud Univ, Coll Dent, Dept Oral Med & Diagnost Oral Sci, Riyadh, Saudi Arabia; [Vahanikkila, Hannu] Univ Oulu, Inst Dent, Dept Pedodont Cardiol & Endodontol, Oulu, Finland; [Costea, Daniela E.] Univ Bergen, Haukeland Hosp, Gade Inst, Sect Pathol, N-5021 Bergen, Norway; [Kauppila, Joonas] Univ Oulu, Dept Pathol, Oulu, Finland; [Kauppila, Joonas] Univ Oulu, Dept Surg, Oulu, Finland; [Kauppila, Joonas; Salo, Tuula] Oulu Univ Hosp, Oulu, Finland; [Lehenkari, Petri] Univ Oulu, Dept Anat, Oulu, Finland; [Dayan, Dan; Vered, Marilena] Tel Aviv Univ, Sch Dent, Dept Oral Pathol & Oral Med, IL-69978 Tel Aviv, Israel; [Vered, Marilena] Chaim Sheba Med Ctr, Inst Pathol, IL-52621 Tel Hashomer, Israel; [Risteli, Juha] Univ Oulu, Dept Clin Chem, Inst Diagnost, Oulu, Finland; [Risteli, Juha] Oulu Univ Hosp, NordLab, Oulu, Finland; [Salo, Tuula] Univ Helsinki, Inst Dent, Helsinki, Finland; [Salo, Tuula] Med Res Ctr, Oulu, Finland	University of Oulu; King Saud University; University of Oulu; University of Bergen; Haukeland University Hospital; University of Oulu; University of Oulu; University of Oulu; University of Oulu; Tel Aviv University; Chaim Sheba Medical Center; University of Oulu; University of Oulu; University of Helsinki	Salo, T (corresponding author), Univ Oulu, Inst Dent, Dept Diagnost & Oral Med, Oulu, Finland.	tuula.salo@oulu.fi	Kauppila, Joonas/P-1363-2015; , tuula/ABG-2051-2021; Costea, Daniela Elena/AAB-9705-2020; Bello, Ibrahim O./K-7274-2012; Lehenkari, Petri/O-3009-2016	Kauppila, Joonas/0000-0001-6740-3726; Bello, Ibrahim O./0000-0003-2085-3185; Lehenkari, Petri/0000-0002-0055-5183; Salo, Sirpa/0000-0002-4113-4000; Costea, Daniela-Elena/0000-0001-7673-0358; Salo, Tuula/0000-0001-6039-0088	Academy of Finland; Finnish Cancer Society; Sigrid Juselius Foundation; Finnish Dental Society Apollonia; Emil Aaltonen Foundation	Academy of Finland(Academy of Finland); Finnish Cancer Society; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Dental Society Apollonia; Emil Aaltonen Foundation	This study has been supported by the Academy of Finland, the Finnish Cancer Society, the Sigrid Juselius Foundation, the Finnish Dental Society Apollonia, and the Emil Aaltonen Foundation grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M, 2011, J PATHOL, V223, P162, DOI 10.1002/path.2803; Amaral TMP, 2004, ORAL ONCOL, V40, P780, DOI 10.1016/j.oraloncology.2003.10.009; Ame-Thomas P, 2007, BLOOD, V109, P693, DOI 10.1182/blood-2006-05-020800; Barkan D, 2010, CANCER RES, V70, P5706, DOI 10.1158/0008-5472.CAN-09-2356; Bello IO, 2011, ORAL ONCOL, V47, P33, DOI 10.1016/j.oraloncology.2010.10.013; Benelli R, 2013, PROSTATE, V73, P941, DOI 10.1002/pros.22640; Camacho DF, 2012, CLIN CANCER RES, V18, P2801, DOI 10.1158/1078-0432.CCR-12-0366; Cambien B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028842; Cheng WL, 2011, ANN ONCOL, V22, P2267, DOI 10.1093/annonc/mdq739; Chuang JY, 2009, J CELL PHYSIOL, V220, P418, DOI 10.1002/jcp.21783; Dayan D, 2012, CANCER MED-US, V1, P128, DOI 10.1002/cam4.24; Fox JM, 2007, BRIT J HAEMATOL, V137, P491, DOI 10.1111/j.1365-2141.2007.06610.x; Guo XY, 2008, J BIOL CHEM, V283, P19864, DOI 10.1074/jbc.M800798200; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hogan NM, 2012, INT J CANCER, V131, P1, DOI 10.1002/ijc.27458; Jensen BV, 2002, INT J CANCER, V98, P582, DOI 10.1002/ijc.10187; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Nguyen-Ngoc KV, 2012, P NATL ACAD SCI USA, V109, pE2595, DOI 10.1073/pnas.1212834109; Klopp AH, 2011, STEM CELLS, V29, P11, DOI 10.1002/stem.559; Koh BI, 2012, EMBO REP, V13, P412, DOI 10.1038/embor.2012.41; Kulasekara KK, 2009, ARCH ORAL BIOL, V54, P924, DOI 10.1016/j.archoralbio.2009.07.004; Kuo PL, 2012, CARCINOGENESIS, V33, P2477, DOI 10.1093/carcin/bgs299; Kylmaniemi M, 1996, J DENT RES, V75, P919, DOI 10.1177/00220345960750030901; Leskela HV, 2003, BIOCHEM BIOPH RES CO, V311, P1008, DOI 10.1016/j.bbrc.2003.10.095; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Marin L, 2011, ANN CLIN BIOCHEM, V48, P447, DOI 10.1258/acb.2011.011040; Mishra PJ, 2008, CANCER RES, V68, P4331, DOI 10.1158/0008-5472.CAN-08-0943; Nurmenniemi S, 2010, EXP CELL RES, V316, P2676, DOI 10.1016/j.yexcr.2010.05.024; Nurmenniemi S, 2009, AM J PATHOL, V175, P1281, DOI 10.2353/ajpath.2009.081110; Ohtani H, 1998, PATHOL INT, V48, P1, DOI 10.1111/j.1440-1827.1998.tb03820.x; Parikka V, 2005, MATRIX BIOL, V24, P438, DOI 10.1016/j.matbio.2005.06.009; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; RASMUSSEN HB, 1991, TUMOR BIOL, V12, P330; RASMUSSEN HB, 1992, APMIS, V100, P39, DOI 10.1111/j.1699-0463.1992.tb00837.x; RISTELI J, 1993, CLIN CHEM, V39, P635; Shen YF, 2012, INT J GYNECOL CANCER, V22, P1316, DOI 10.1097/IGC.0b013e318263ef34; Shinagawa K, 2010, INT J CANCER, V127, P2323, DOI 10.1002/ijc.25440; Shintani S, 2004, ONCOLOGY-BASEL, V66, P316, DOI 10.1159/000078333; Simojoki M, 2003, GYNECOL ONCOL, V88, P358, DOI 10.1016/S0090-8258(02)00139-7; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Teppo S, 2013, EXP CELL RES, V319, P376, DOI 10.1016/j.yexcr.2012.12.010; TORNEHAVE D, 1992, ANAT EMBRYOL, V186, P271; Velasco-Velazquez M, 2012, CANCER RES, V72, P3839, DOI 10.1158/0008-5472.CAN-11-3917; Vered M, 2011, NAT REV CANCER, V11, P382, DOI 10.1038/nrc2982-c1; Vered M, 2010, INT J CANCER, V127, P1356, DOI 10.1002/ijc.25358; Vered M, 2010, CANCER SCI, V101, P274, DOI 10.1111/j.1349-7006.2009.01357.x; Wang SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035101; Waterman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045590; Yamada S, 2010, INT J ORAL MAX SURG, V39, P61, DOI 10.1016/j.ijom.2009.10.003; Ye H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-69; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang YM, 2009, ONCOL REP, V21, P1113, DOI 10.3892/or_00000331	54	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77692	10.1371/journal.pone.0077692	http://dx.doi.org/10.1371/journal.pone.0077692			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204919	Green Published, gold, Green Submitted			2022-12-27	WOS:000326032600041
J	Yi, J; Xiong, W; Gong, X; Bellister, S; Ellis, LM; Liu, QY				Yi, Jing; Xiong, Wei; Gong, Xing; Bellister, Seth; Ellis, Lee M.; Liu, Qingyun			Analysis of LGR4 Receptor Distribution in Human and Mouse Tissues	PLOS ONE			English	Article							WNT/BETA-CATENIN; STEM-CELLS; POSTNATAL-DEVELOPMENT; DOWN-REGULATION; HAIR FOLLICLE; GENE; GPR48; WNT; DIFFERENTIATION; EXPRESSION	LGR4 is an R-spondin receptor with strong positive effect on Wnt signaling. It plays a critical role in development as its ablation in the mouse led to total embryonic/neonatal lethality with profound defects in multiple organs. Haplotype insufficiency of LGR4 in human was associated with several diseases, including increased risk of squamous cell carcinoma of the skin, reduced birth weights, electrolyte imbalance, and decreased levels of testosterone, which are similar to the phenotypes of LGR4-hypomorphic mice. Tissue distribution of LGR4 was extensively analyzed in the mouse using gene-trap reporter enzyme alleles. However, its expression pattern in human tissues remained largely unknown. We have developed LGR4-specific monoclonal antibodies and used them to examine the expression of LGR4 in selected adult human and mouse tissues by immunohistochemical analysis. Intense LGR4-like immunoreactivity was observed in the epidermis and hair follicle of the skin, pancreatic islet cells, and epithelial cells in both the male and female reproductive organs. Of particular interest is that LGR4 is highly expressed in germ cells and pancreatic islet cells, which have important implications given the role of R-spondin-LGR4 signaling in the survival of adult stem cells. In addition, the majority of colon tumors showed elevated levels of LGR4 receptor. Overall, the expression pattern of LGR4 in human tissues mapped by this IHC analysis is similar to that in the mouse as revealed from gene trap alleles. Importantly, the pattern lends strong support to the important role of LGR4 in the development and maintenance of skin, kidney, reproductive systems, and other organs.	[Yi, Jing; Xiong, Wei; Gong, Xing; Liu, Qingyun] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX 77030 USA; [Yi, Jing; Xiong, Wei; Gong, Xing; Liu, Qingyun] Univ Texas Hlth Sci Ctr Houston, Texas Therapeut Inst, Houston, TX 77030 USA; [Bellister, Seth; Ellis, Lee M.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Liu, QY (corresponding author), Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX 77030 USA.	Qingyun.Liu@uth.tmc.edu	Yi, Jing/S-2586-2016	Yi, Jing/0000-0001-5037-1924	Cancer Prevention and Research Institute of Texas [RP100678]; National Institute of Health [R01GM102485]; Janice Davis Gordon Endowment for Bowel Cancer Research from the University of Texas Health Science Center at Houston; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102485] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Janice Davis Gordon Endowment for Bowel Cancer Research from the University of Texas Health Science Center at Houston; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Grant RP100678 from the Cancer Prevention and Research Institute of Texas (http://www.cprit.state.tx.us/), Grant R01GM102485 form the National Institute of Health (http://www.nih.gov/), and the Janice Davis Gordon Endowment for Bowel Cancer Research from the University of Texas Health Science Center at Houston. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Cheng Y, 2013, FASEB J, V27, P2175, DOI 10.1096/fj.12-223412; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Gao Y, 2006, CANCER RES, V66, P11623, DOI 10.1158/0008-5472.CAN-06-2629; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Gong X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037137; Hoshii T, 2007, BIOL REPROD, V76, P303, DOI 10.1095/biolreprod.106.054619; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Kato S, 2006, NEPHRON EXP NEPHROL, V104, pE63, DOI 10.1159/000093999; Klauzinska M, 2012, J CELL PHYSIOL, V227, P1960, DOI 10.1002/jcp.22924; Liu SJ, 2013, J BIOL CHEM, V288, P8794, DOI 10.1074/jbc.M112.436204; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; Mendive F, 2006, DEV BIOL, V290, P421, DOI 10.1016/j.ydbio.2005.11.043; Mohri Y, 2008, DEV DYNAM, V237, P2235, DOI 10.1002/dvdy.21639; Mohri Y, 2010, FERTIL STERIL, V94, P2878, DOI 10.1016/j.fertnstert.2010.05.050; Mustata RC, 2011, EMBO REP, V12, P558, DOI 10.1038/embor.2011.52; Nusse R, 2008, COLD SH Q B, V73, P59, DOI 10.1101/sqb.2008.73.035; Oyama K, 2011, SEX DEV, V5, P205, DOI 10.1159/000329476; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Qian Y, 2013, DEVELOPMENT, V140, P1751, DOI 10.1242/dev.093641; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Ruffner H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040976; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Srinivasan V, 2002, ACTA CRYSTALLOGR D, V58, P867, DOI 10.1107/S0907444902005012; Styrkarsdottir U, 2013, NATURE, V497, P517, DOI 10.1038/nature12124; Theodorou V, 2007, NAT GENET, V39, P759, DOI 10.1038/ng2034; Van Schoore G, 2005, HISTOCHEM CELL BIOL, V124, P35, DOI 10.1007/s00418-005-0002-3; Wang J, 2012, J AM SOC NEPHROL, V23, P281, DOI 10.1681/ASN.2011040351; Wang Y, 2013, STEM CELLS, V31, P1921, DOI 10.1002/stem.1438; Weng JS, 2008, P NATL ACAD SCI USA, V105, P6081, DOI 10.1073/pnas.0708257105; Wong VSC, 2010, J BIOL CHEM, V285, P21292, DOI 10.1074/jbc.M110.129874; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yamashita R, 2009, DEV DYNAM, V238, P993, DOI 10.1002/dvdy.21900	40	39	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78144	10.1371/journal.pone.0078144	http://dx.doi.org/10.1371/journal.pone.0078144			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205130	Green Submitted, Green Published, gold			2022-12-27	WOS:000326032600074
J	Liu, SQ; Roberts, D; Zhang, B; Ren, YP; Zhang, LQ; Wu, YH				Liu, Shu Q.; Roberts, Derek; Zhang, Brian; Ren, Yupeng; Zhang, Li-Qun; Wu, Yu H.			Trefoil Factor 3 as an Endocrine Neuroprotective Factor from the Liver in Experimental Cerebral Ischemia/Reperfusion Injury	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ARTERIAL ELASTIC LAMINAE; TNF-ALPHA; TRANSFORMING GROWTH-FACTOR-BETA-1; EXPERIMENTAL COLITIS; INCREASED EXPRESSION; ISCHEMIC-STROKE; RAT HIPPOCAMPUS; GENE-EXPRESSION; BRAIN	Cerebral ischemia, while causing neuronal injury, can activate innate neuroprotective mechanisms, minimizing neuronal death. In this report, we demonstrate that experimental cerebral ischemia/reperfusion injury in the mouse causes upregulation of the secretory protein trefoil factor 3 (TFF3) in the hepatocyte in association with an increase in serum TFF3. Partial hepatectomy (similar to 60% liver resection) immediately following cerebral injury significantly lowered the serum level of TFF3, suggesting a contribution of the liver to the elevation of serum TFF3. Compared to wild-type mice, TFF3(-/-) mice exhibited a significantly higher activity of caspase 3 and level of cell death in the ischemic cerebral lesion, a larger fraction of cerebral infarcts, and a smaller fraction of the injured cerebral hemisphere, accompanied by severer forelimb motor deficits. Intravenous administration of recombinant TFF3 reversed changes in cerebral injury and forelimb motor function due to TFF3 deficiency. These observations suggest an endocrine neuroprotective mechanism involving TFF3 from the liver in experimental cerebral ischemia/reperfusion injury.	[Liu, Shu Q.; Roberts, Derek; Zhang, Brian; Wu, Yu H.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Ren, Yupeng; Zhang, Li-Qun] Rehabil Inst Chicago, Chicago, IL 60611 USA	Northwestern University; Shirley Ryan AbilityLab	Liu, SQ (corresponding author), Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.	sliu@northwestern.edu	Liu, Shu Q/B-7626-2009; Wu, Ying/B-7283-2009		National Science Foundation [0932131]; Div Of Chem, Bioeng, Env, & Transp Sys [0932131] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This research was supported by the National Science Foundation (grant number 0932131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2009, J CEREBR BLOOD F MET, V29, P66, DOI 10.1038/jcbfm.2008.88; Acalovschi D, 2003, STROKE, V34, P1864, DOI 10.1161/01.STR.0000079815.38626.44; Ali C, 2001, J CEREBR BLOOD F MET, V21, P820, DOI 10.1097/00004647-200107000-00007; Alison M, 1998, PHILOS T R SOC B, V353, P877, DOI 10.1098/rstb.1998.0252; Ata KA, 1999, ACTA NEUROPATHOL, V97, P447, DOI 10.1007/s004010051013; Babyatsky MW, 1996, GASTROENTEROLOGY, V110, P489, DOI 10.1053/gast.1996.v110.pm8566596; Bhuiyan Mohammad Iqbal Hossain, 2010, Int Neurourol J, V14, P203, DOI 10.5213/inj.2010.14.4.203; Bohm F, 2010, EMBO MOL MED, V2, P294, DOI 10.1002/emmm.201000085; BUCHAN AM, 1992, STROKE, V23, P273, DOI 10.1161/01.STR.23.2.273; Burmeister M, 1997, MAMM GENOME, V8, P223, DOI 10.1007/s003359900637; Chinery R, 1996, GENE, V171, P249, DOI 10.1016/0378-1119(96)00074-1; CHINERY R, 1995, PEPTIDES, V16, P749, DOI 10.1016/0196-9781(95)00045-L; COYLE P, 1982, STROKE, V13, P855, DOI 10.1161/01.STR.13.6.855; Dave KR, 2005, J NEUROSCI RES, V82, P665, DOI 10.1002/jnr.20674; Dirnagl U, 2003, TRENDS NEUROSCI, V26, P248, DOI 10.1016/S0166-2236(03)00071-7; Dobolyi A, 2012, INT J MOL SCI, V13, P8219, DOI 10.3390/ijms13078219; Doyle KP, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-62; Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6; Forbes S, 2002, J PATHOL, V197, P510, DOI 10.1002/path.1163; Goldman J, 2003, AM J PHYSIOL-HEART C, V284, pH1839, DOI 10.1152/ajpheart.00470.2002; Gott P, 1996, EUR J HUM GENET, V4, P308; Gustafsson AB, 2007, AM J PHYSIOL-CELL PH, V292, pC45, DOI 10.1152/ajpcell.00229.2006; He X, 2012, CELL MOL LIFE SCI; Hertel SC, 2004, PEPTIDES, V25, P755, DOI 10.1016/j.peptides.2003.11.021; Huang J, 2006, SURG NEUROL, V66, P232, DOI 10.1016/j.surneu.2005.12.028; Jander S, 2001, J CEREBR BLOOD F MET, V21, P218, DOI 10.1097/00004647-200103000-00005; Kariko K, 2004, J CEREBR BLOOD F MET, V24, P1288, DOI 10.1097/01.WCB.0000145666.68576.71; Kinoshita K, 2000, MOL CELL BIOL, V20, P4680, DOI 10.1128/MCB.20.13.4680-4690.2000; Kjellev S, 2007, DIGEST DIS SCI, V52, P1050, DOI 10.1007/s10620-006-9256-4; Krupinski J, 1996, STROKE, V27, P852, DOI 10.1161/01.STR.27.5.852; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; Larsson E, 1999, J CEREBR BLOOD F MET, V19, P1220, DOI 10.1097/00004647-199911000-00006; Lee JC, 2013, BRAIN RES, V1510, P78, DOI 10.1016/j.brainres.2013.03.008; Li B, 2010, BRAIN RES, V1327, P91, DOI 10.1016/j.brainres.2010.02.030; Li XL, 2004, EXP NEUROL, V187, P94, DOI 10.1016/j.expneurol.2004.01.004; Liu D, 1997, LAB INVEST, V77, P557; Liu J, 2000, AM J PHYSIOL-CELL PH, V278, pC144, DOI 10.1152/ajpcell.2000.278.1.C144; Liu SQ, 2008, MATRIX BIOL, V27, P282, DOI 10.1016/j.matbio.2008.01.001; Liu SQ, 2012, AM J PHYSIOL-HEART C, V303, pH1446, DOI 10.1152/ajpheart.00362.2012; Liu Shu Q, 2010, Front Biosci (Elite Ed), V2, P711, DOI 10.2741/e131; Liu SQ, 2005, J BIOL CHEM, V280, P39294, DOI 10.1074/jbc.M503866200; Liu SQ, 2009, CURRENT TOPICS BIOCH, V11, P65; Liu SQ, 2012, J CLIN EXP CARDIOL S, VS7; Liu XQ, 2009, ACTA PHARMACOL SIN, V30, P1071, DOI 10.1038/aps.2009.105; Mahmood A, 2005, ALIMENT PHARM THER, V21, P1357, DOI 10.1111/j.1365-2036.2005.02436.x; Martins PNA, 2008, LIVER INT, V28, P3, DOI 10.1111/j.1478-3231.2007.01628.x; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Noguchi CT, 2007, CRIT REV ONCOL HEMAT, V64, P159, DOI 10.1016/j.critrevonc.2007.03.001; Obrenovitch TP, 2008, PHYSIOL REV, V88, P211, DOI 10.1152/physrev.00039.2006; Ohtsuki T, 1996, J CEREBR BLOOD F MET, V16, P1137, DOI 10.1097/00004647-199611000-00007; OSYPIW JC, 1994, BIOCHEM J, V304, P617, DOI 10.1042/bj3040617; Perez-Pinzon MA, 2007, COMP BIOCHEM PHYS A, V147, P291, DOI 10.1016/j.cbpa.2006.08.032; Poirier JL, 2000, NEUROSCIENCE, V97, P59, DOI 10.1016/S0306-4522(00)00026-9; Poulsen SS, 2005, REGUL PEPTIDES, V126, P163, DOI 10.1016/j.regpep.2004.09.007; Prass K, 2003, STROKE, V34, P1981, DOI 10.1161/01.STR.0000080381.76409.B2; Probst JC, 1996, FASEB J, V10, P1518, DOI 10.1096/fasebj.10.13.8940297; Riehle KJ, 2011, J GASTROEN HEPATOL, V26, P203, DOI 10.1111/j.1440-1746.2010.06539.x; Saito K, 1996, NEUROSCI LETT, V206, P149, DOI 10.1016/S0304-3940(96)12460-5; Schindl MJ, 2005, GUT, V54, P289, DOI 10.1136/gut.2004.046524; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schroeter M, 2003, MOL BRAIN RES, V117, P1, DOI 10.1016/S0169-328X(03)00255-9; Smith CJ, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-2; Sommer C, 2003, ACTA NEUROPATHOL, V105, P197, DOI 10.1007/s00401-002-0632-7; Sun FY, 2005, J NEUROSCI RES, V79, P180, DOI 10.1002/jnr.20321; Suzuki S, 2009, J CEREBR BLOOD F MET, V29, P464, DOI 10.1038/jcbfm.2008.141; Tan XD, 1997, BIOCHEM BIOPH RES CO, V237, P673, DOI 10.1006/bbrc.1997.7144; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Taupin D, 1999, GASTROENTEROLOGY, V116, P1072, DOI 10.1016/S0016-5085(99)70010-7; Taupin DR, 2000, P NATL ACAD SCI USA, V97, P799, DOI 10.1073/pnas.97.2.799; Teng X, 2009, INFLAMMATION, V32, P120, DOI 10.1007/s10753-009-9110-x; Truettner J, 2002, MOL BRAIN RES, V103, P106, DOI 10.1016/S0169-328X(02)00191-2; Vandenbroucke K, 2004, GASTROENTEROLOGY, V127, P502, DOI 10.1053/j.gastro.2004.05.020; Vincze C, 2010, J COMP NEUROL, V518, P3752, DOI 10.1002/cne.22422; Waje-Andreassen U, 2005, ACTA NEUROL SCAND, V111, P360, DOI 10.1111/j.1600-0404.2005.00416.x; Wong WM, 1999, GUT, V44, P890, DOI 10.1136/gut.44.6.890; Zhang Y, 2001, LIFE SCI, V68, P1013, DOI 10.1016/S0024-3205(00)01004-3; Zhou AM, 2004, NEUROSCI RES, V48, P397, DOI 10.1016/j.neures.2003.12.010; Zhu Y, 2001, NEUROSCIENCE, V107, P593, DOI 10.1016/S0306-4522(01)00357-8	80	21	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77732	10.1371/journal.pone.0077732	http://dx.doi.org/10.1371/journal.pone.0077732			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204940	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300111
J	Vidal, F; Simon, C; Cristini, C; Arnaud, C; Parant, O				Vidal, Fabien; Simon, Caroline; Cristini, Christelle; Arnaud, Catherine; Parant, Olivier			Instrumental Rotation for Persistent Fetal Occiput Posterior Position: A Way to Decrease Maternal and Neonatal Injury?	PLOS ONE			English	Article							OPERATIVE VAGINAL DELIVERY; INTRAPARTUM SONOGRAPHY; FORCEPS DELIVERY; OUTCOMES; EPISIOTOMY; MORBIDITY; RISK	Objective: To evaluate immediate perineal and neonatal morbidity associated with instrumental rotations performed with Thierry's spatulas for the management of persistent posterior occiput (OP) positions. Methods: Retrospective study including all persistent occiput posterior positions with vaginal OP delivery, from August 2006 to September 2007. Occiput anterior deliveries following successful instrumental rotation were included as well. We compared maternal and neonatal immediate outcomes between spontaneous deliveries, rotational and non rotational assisted deliveries, using chi(2) and Anova tests. Results: 157 patients were enrolled, comprising 46 OP spontaneous deliveries, 58 assisted OP deliveries and 53 deliveries after rotational procedure. Instrumental rotation failed in 9 cases. Mean age and parity were significantly higher in the spontaneous delivery group, while labor duration was shorter. There were no significant differences in the rate of severe perineal tears and neonatal adverse outcomes between the 3 groups. Conclusion: Instrumental rotation using Thierry's spatulas was not associated with a reduced risk of maternal and neonatal morbidity for persistent OP deliveries. Further studies are required to define the true interest of such procedure in modern obstetrics.	[Vidal, Fabien; Simon, Caroline; Parant, Olivier] Hop Paule de Viguier, CHU Toulouse, Toulouse, France; [Cristini, Christelle; Arnaud, Catherine] CHU Purpan, Unite Soutien Rech, Toulouse, France; [Arnaud, Catherine; Parant, Olivier] INSERM, U1027, F-75654 Paris 13, France; [Arnaud, Catherine; Parant, Olivier] Univ Toulouse 3, F-31062 Toulouse, France	CHU de Toulouse; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Vidal, F (corresponding author), Hop Paule de Viguier, CHU Toulouse, Toulouse, France.	dox_94@yahoo.fr	ARNAUD, Catherine/AAC-5646-2019	ARNAUD, Catherine/0000-0002-4002-802X	Purpan Medical School; Toulouse Academic Hospital	Purpan Medical School; Toulouse Academic Hospital	The sources of funding that have supported this study are: Purpan Medical School and Toulouse Academic Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akmal S, 2004, ULTRASOUND OBST GYN, V24, P425, DOI 10.1002/uog.1064; Al-Suhel R, 2009, AUST NZ J OBSTET GYN, V49, P510, DOI 10.1111/j.1479-828X.2009.01060.x; [Anonymous], 1994, Int J Gynaecol Obstet, V47, P179; BAERTHLEIN WC, 1986, OBSTET GYNECOL, V67, P594; Benavides L, 2005, AM J OBSTET GYNECOL, V192, P1702, DOI 10.1016/j.ajog.2004.11.047; Cheng YW, 2006, OBSTET GYNECOL, V107, P837, DOI 10.1097/01.AOG.0000206217.07883.a2; CNGOF, 2006, Gynecol Obstet Fertil, V34, P275; College national des gynecologues et obstetriciens francais (CNGOF), 2008, J Gynecol Obstet Biol Reprod (Paris), V37 Suppl 8, pS297; Courtois L, 2008, J GYNECOL OBST BIO R, V37, P276, DOI 10.1016/j.jgyn.2007.10.006; Feldman DM, 1999, AM J OBSTET GYNECOL, V181, P1185, DOI 10.1016/S0002-9378(99)70105-5; Gardberg M, 1998, OBSTET GYNECOL, V91, P746, DOI 10.1016/S0029-7844(98)00074-X; Guyomar J, 1965, Rev Fr Gynecol Obstet, V60, P775; Hankins GDV, 1999, AM J OBSTET GYNECOL, V180, P231, DOI 10.1016/S0002-9378(99)70180-8; JAIN V, 1993, INT J GYNECOL OBSTET, V43, P129, DOI 10.1016/0020-7292(93)90319-R; Macleod M, 2008, BJOG-INT J OBSTET GY, V115, P1688, DOI 10.1111/j.1471-0528.2008.01961.x; Macleod M, 2008, EUR J OBSTET GYN R B, V136, P178, DOI 10.1016/j.ejogrb.2007.03.004; Maisonnette-Escot Y, 2005, Gynecol Obstet Fertil, V33, P208, DOI 10.1016/j.gyobfe.2005.03.007; MENTICOGLOU SM, 1995, OBSTET GYNECOL, V86, P589, DOI 10.1016/S0029-7844(95)80022-0; Murphy DJ, 2008, BJOG, V115, P1693; Parant O, 2009, GYNECOL OBSTET FERTI, V37, P780, DOI 10.1016/j.gyobfe.2009.07.010; Parant O, 2007, J Gynecol Obstet Biol Reprod (Paris), V36, P582; RAMIN SM, 1993, OBSTET GYNECOL, V81, P307; Shaffer BL, 2010, J MATERN FETAL NEONA; Society of Obstetricians and Gynaecologists of Canada, 2005, Int J Gynaecol Obstet, V89, P319; Vanlieferinghen S, 2009, J GYNECOL OBST BIO R, V38, P648, DOI 10.1016/j.jgyn.2009.09.015; Vayssiere C, 2011, EUR J OBSTET GYN R B, V159, P43, DOI 10.1016/j.ejogrb.2011.06.043; Wu X, 2001, Zhonghua Fu Chan Ke Za Zhi, V36, P468; Yancey MK, 2001, OBSTET GYNECOL, V97, P608, DOI 10.1016/S0029-7844(00)01230-8	28	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78124	10.1371/journal.pone.0078124	http://dx.doi.org/10.1371/journal.pone.0078124			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205122	Green Published, Green Submitted, gold			2022-12-27	WOS:000326029300140
J	Voorhees, JL; Powell, ND; Moldovan, L; Mo, XK; Eubank, TD; Marsh, CB				Voorhees, Jeffrey L.; Powell, Nicole D.; Moldovan, Leni; Mo, Xiaokui; Eubank, Timothy D.; Marsh, Clay B.			Chronic Restraint Stress Upregulates Erythropoiesis through Glucocorticoid Stimulation	PLOS ONE			English	Article							VULGARIS PROPHYLACTIC TREATMENT; GENE-EXPRESSION; PSYCHOLOGICAL STRESS; ERYTHROID-CELLS; ADRENAL AXIS; STEM-CELL; DEPRESSION; RECEPTOR; MICE; BLOOD	In response to elevated glucocorticoid levels, erythroid progenitors rapidly expand to produce large numbers of young erythrocytes. Previous work demonstrates hematopoietic changes in rodents exposed to various physical and psychological stressors, however, the effects of chronic psychological stress on erythropoiesis has not be delineated. We employed laboratory, clinical and genomic analyses of a murine model of chronic restraint stress (RST) to examine the influence of psychological stress on erythropoiesis. Mice exposed to RST demonstrated markers of early erythroid expansion involving the glucocorticoid receptor. In addition, these RST-exposed mice had increased numbers of circulating reticulocytes and increased erythropoiesis in primary and secondary erythroid tissues. Mice also showed increases in erythroid progenitor populations and elevated expression of the erythroid transcription factor KLF1 in these cells. Together this work reports some of the first evidence of psychological stress affecting erythroid homeostasis through glucocorticoid stimulation.	[Voorhees, Jeffrey L.; Moldovan, Leni; Eubank, Timothy D.; Marsh, Clay B.] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Voorhees, Jeffrey L.; Moldovan, Leni; Eubank, Timothy D.; Marsh, Clay B.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Powell, Nicole D.] Ohio State Univ, Coll Dent, Sect Oral Biol, Columbus, OH 43210 USA; [Mo, Xiaokui] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Eubank, TD (corresponding author), Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA.	Tim.Eubank@osumc.edu; Clay.Marsh@osumc.edu		Moldovan, Leni/0000-0003-1967-2408; Eubank, Tim/0000-0002-8225-7824	National Institutes of Health (NIH) [T32 HL07946, NIH R01 HL067176, NIH R01 HL102464]; TDE; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000090] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102464, R01HL067176, T32HL007946] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TDE; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) T32 HL07946, NIH R01 HL067176, NIH R01 HL102464, and startup funds from TDE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 2010, AM J PHYSIOL-REG I, V299, pR889, DOI 10.1152/ajpregu.00296.2010; Anisman H, 1998, BRAIN RES, V779, P177, DOI 10.1016/S0006-8993(97)01114-1; Bauer A, 1999, GENE DEV, V13, P2996, DOI 10.1101/gad.13.22.2996; Bauer ME, 2001, PHYSIOL BEHAV, V73, P525, DOI 10.1016/S0031-9384(01)00503-0; Borges L, 2012, BLOOD, V119, P5417, DOI 10.1182/blood-2011-11-391896; Boyle MP, 2005, P NATL ACAD SCI USA, V102, P473, DOI 10.1073/pnas.0406458102; Bredel M, 2005, CANCER RES, V65, P8679, DOI 10.1158/0008-5472.CAN-05-1204; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Cao YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020634; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dumitriu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012088; Dygai AM, 2011, B EXP BIOL MED+, V151, P171, DOI 10.1007/s10517-011-1282-3; Flygare J, 2011, BLOOD, V117, P3435, DOI 10.1182/blood-2010-07-295550; Fowden AL, 1998, P NUTR SOC, V57, P113, DOI 10.1079/PNS19980017; Ganguli G, 2002, EMBO REP, V3, P569, DOI 10.1093/embo-reports/kvf114; GOLDE DW, 1976, J CLIN INVEST, V57, P57, DOI 10.1172/JCI108269; Gregory T, 1999, BLOOD, V94, P87, DOI 10.1182/blood.V94.1.87.413k41_87_96; Hattangadi SM, 2011, BLOOD, V118, P6258, DOI 10.1182/blood-2011-07-356006; HOLM S, 1979, SCAND J STAT, V6, P65; Kelly JJ, 2000, J HUM HYPERTENS, V14, P195, DOI 10.1038/sj.jhh.1000959; Kerenyi MA, 2010, J EXP MED, V207, P2537, DOI 10.1084/jem.20102260; Kiank C, 2006, BRAIN BEHAV IMMUN, V20, P359, DOI 10.1016/j.bbi.2005.10.151; Klinsey SG, 2007, BRAIN BEHAV IMMUN, V21, P458, DOI 10.1016/j.bbi.2006.11.001; Laakko T, 2002, IMMUNOLOGY, V105, P111, DOI 10.1046/j.1365-2567.2002.01346.x; Landmark-Hoyvik H, 2009, PHARMACOGENOMICS J, V9, P333, DOI 10.1038/tpj.2009.27; Li YJ, 2012, BIOL TRACE ELEM RES, V147, P285, DOI 10.1007/s12011-011-9319-z; Lim GB, 1996, ENDOCRINOLOGY, V137, P1658, DOI 10.1210/en.137.5.1658; Maccari S, 2007, PSYCHONEUROENDOCRINO, V32, pS10, DOI 10.1016/j.psyneuen.2007.06.005; Maes M, 1996, J AFFECT DISORDERS, V40, P23, DOI 10.1016/0165-0327(96)00038-9; Malacrida SA, 1997, IMMUNOPHARM IMMUNOT, V19, P523; Malacrida SA, 1997, INT J IMMUNOPHARMACO, V19, P227, DOI 10.1016/S0192-0561(97)00029-5; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Moritz KM, 1997, AM J PHYSIOL-REG I, V273, pR1829, DOI 10.1152/ajpregu.1997.273.6.R1829; Patel S, 2006, P NATL ACAD SCI USA, V103, P18668, DOI 10.1073/pnas.0608658103; Quadrini KJ, 2008, EXP CELL RES, V314, P1595, DOI 10.1016/j.yexcr.2008.01.033; Queiroz JD, 2004, IMMUNOPHARM IMMUNOT, V26, P455, DOI 10.1081/IPH-200026914; Queiroz JD, 2008, BRAIN BEHAV IMMUN, V22, P1056, DOI 10.1016/j.bbi.2008.03.002; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; Sato S, 2010, INT J LAB HEMATOL, V32, pE137, DOI 10.1111/j.1751-553X.2009.01148.x; Siatecka M, 2011, BLOOD, V118, P2044, DOI 10.1182/blood-2011-03-331371; Solomon MB, 2011, NEUROSCIENCE; Tallack MR, 2010, GENOME RES, V20, P1052, DOI 10.1101/gr.106575.110; Tang JI, 2011, ENDOCRINOLOGY, V152, P2716, DOI 10.1210/en.2010-1443; Tiedt R, 2008, BLOOD, V111, P3931, DOI 10.1182/blood-2007-08-107748; Tripathy SK, 1996, P NATL ACAD SCI USA, V93, P10876, DOI 10.1073/pnas.93.20.10876; Trottier MD, 2008, P NATL ACAD SCI USA, V105, P2028, DOI 10.1073/pnas.0712003105; Turner J, 1998, EMBO J, V17, P5129, DOI 10.1093/emboj/17.17.5129; TURNEY TH, 1984, PHYSIOL BEHAV, V33, P559, DOI 10.1016/0031-9384(84)90371-8; UDUPA KB, 1986, BRIT J HAEMATOL, V62, P705, DOI 10.1111/j.1365-2141.1986.tb04094.x; van West Dirk, 1999, Neuro Endocrinol Lett, V20, P11; Voorhees JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058488; Wei CL, 2008, INT J HEMATOL, V88, P52, DOI 10.1007/s12185-008-0105-4; Wohleb ES, 2011, J NEUROSCI, V31, P6277, DOI 10.1523/JNEUROSCI.0450-11.2011; Zhao W, 2006, BLOOD, V107, P907, DOI 10.1182/blood-2005-06-2516	55	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77935	10.1371/journal.pone.0077935	http://dx.doi.org/10.1371/journal.pone.0077935			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205034	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300126
J	Willeboordse, M; van den Bersselaar, DLCM; van de Kant, KDG; Muris, JWM; van Schayck, OCP; Dompeling, E				Willeboordse, Maartje; van den Bersselaar, Donna L. C. M.; van de Kant, Kim D. G.; Muris, Jean W. M.; van Schayck, Onno C. P.; Dompeling, Edward			Sex Differences in the Relationship between Asthma and Overweight in Dutch Children: a Survey Study	PLOS ONE			English	Article							BODY-MASS INDEX; NUTRITION EXAMINATION; INCIDENT ASTHMA; NATIONAL-HEALTH; OBESITY; CHILDHOOD; RISK; METAANALYSIS; PREVALENCE; ADOLESCENCE	Objective: Obesity has been identified as a risk factor for asthma in children. However, in the Netherlands, the obesity prevalence is rising while the asthma prevalence in children is stabilising. The aim of this study is to clarify the association between asthma and Body Mass Index (BMI) in children and whether this association is influenced by sex. Study Design: Parents of 39,316 children (6-16 years) in the south of the Netherlands were invited to complete an online questionnaire on respiratory symptoms, anthropometric variables and several potential confounding factors for asthma and obesity (including sex, birth weight and breastfeeding). Data was analysed by multivariable logistic regression models and an ordinal regression model. Results: The response rate was 24% (n boys=4,743, n girls=4,529). The prevalence of asthma, overweight and obesity was 8%, 15% and 2% respectively. Body mass index -standard deviation Score (BMI-SDS) was related to current asthma (adjusted OR: 1.29; 95% CI: 1.14-1.45, p=0.001). When stratified for sex, asthma and BMI-SDS were only related in girls (Girls: adjusted OR: 1.31; 95% CI: 1.13-1.51, p=0.001. Boys: adjusted OR: 1.01; 95% CI: 0.91-1.14, p=0.72). Conclusions: The positive association between BMI-SDS and asthma is only present in girls, not boys. Future studies into obesity and asthma should correct for sex in their analyses.	[Willeboordse, Maartje; van den Bersselaar, Donna L. C. M.; van de Kant, Kim D. G.; Dompeling, Edward] MUMC, Sch Publ Hlth & Primary Care CAPHRI, Dept Pediat Resp Med, Maastricht, Netherlands; [Muris, Jean W. M.; van Schayck, Onno C. P.] MUMC, CAPHRI, Dept Family Med, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC)	Willeboordse, M (corresponding author), MUMC, Sch Publ Hlth & Primary Care CAPHRI, Dept Pediat Resp Med, Maastricht, Netherlands.	m.willeboordse@mumc.nl		Muris, Jean/0000-0002-8780-476X; Willeboordse, Maartje/0000-0002-9695-9755	Dutch Lung Foundation [DLF 3.4.09.002]	Dutch Lung Foundation	The Dutch Lung Foundation (grant DLF 3.4.09.002) sponsored this study (https://www.longfonds.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 2003, THORAX, V58, P846, DOI 10.1136/thorax.58.10.846; Anandan C, 2010, ALLERGY, V65, P152, DOI 10.1111/j.1398-9995.2009.02244.x; Anto JM, 2012, CURR ALLERGY ASTHM R, V12, P192, DOI 10.1007/s11882-012-0254-7; Arriba-Mendez S, 2008, ALLERGOL IMMUNOPATH, V36, P259, DOI 10.1016/S0301-0546(08)75220-0; Assad NA, 2012, BIOCHIMIE, V94, P2180, DOI 10.1016/j.biochi.2012.03.006; Axinn WG, 2011, DEMOGRAPHY, V48, P1127, DOI 10.1007/s13524-011-0044-1; Beuther DA, 2007, AM J RESP CRIT CARE, V175, P661, DOI 10.1164/rccm.200611-1717OC; Bonds RS, 2013, CURR OPIN ALLERGY CL, V13, P92, DOI 10.1097/ACI.0b013e32835a6dd6; Castro-Rodriguez LA, 2001, AM J RESP CRIT CARE, V163, P1344, DOI 10.1164/ajrccm.163.6.2006140; Chen YC, 2013, OBES REV, V14, P222, DOI 10.1111/j.1467-789X.2012.01055.x; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cole TJ, 1999, ANN HUM BIOL, V26, P303, DOI 10.1080/030144699282633; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flaherman V, 2006, ARCH DIS CHILD, V91, P334, DOI 10.1136/adc.2005.080390; Fredriks AM, 2000, ARCH DIS CHILD, V82, P107, DOI 10.1136/adc.82.2.107; Jensen ME, 2011, PAEDIATR RESPIR REV, V12, P152, DOI 10.1016/j.prrv.2011.01.009; Keizer-Schrama SMPFD, 2001, HUM REPROD UPDATE, V7, P287; Kratzsch J, 2002, J CLIN ENDOCR METAB, V87, P4587, DOI 10.1210/jc.2002-020001; Lamberts P, 2010, GEZONDE KIJK ZUID LI; Mahut B, 2012, EUR RESPIR J, V39, P1120, DOI 10.1183/09031936.00103311; Matricardi PM, 2007, CLIN EXP ALLERGY, V37, P476, DOI 10.1111/j.1365-2222.2007.02664.x; Noal RB, 2011, OBES REV, V12, P93, DOI 10.1111/j.1467-789X.2010.00741.x; Peroni DG, 2010, INT J OBESITY, V34, P599, DOI 10.1038/ijo.2009.273; Rodriguez MA, 2002, ARCH PEDIAT ADOL MED, V156, P269, DOI 10.1001/archpedi.156.3.269; Santillan AA, 2003, INT J OBESITY, V27, P1430, DOI 10.1038/sj.ijo.0802395; Schonbeck Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027608; Shore SA, 2008, J ALLERGY CLIN IMMUN, V121, P1087, DOI 10.1016/j.jaci.2008.03.004; Sood A, 2011, EXERC SPORT SCI REV, V39, P48, DOI 10.1097/JES.0b013e318201f0c4; Su MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030694; van Merode T, 2007, PEDIATR ALLERGY IMMU, V18, P196, DOI 10.1111/j.1399-3038.2006.00513.x; van Schayck CP, 2005, EUR RESPIR J, V26, P647, DOI 10.1183/09031936.05.00019805; Varraso R, 2005, AM J RESP CRIT CARE, V171, P334, DOI 10.1164/rccm.200405-674OC; von Mutius E, 2001, THORAX, V56, P835, DOI 10.1136/thorax.56.11.835	33	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77574	10.1371/journal.pone.0077574	http://dx.doi.org/10.1371/journal.pone.0077574			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24204876	Green Submitted, gold, Green Published			2022-12-27	WOS:000326022200047
J	Choudhary, AK; Rennie, J; Cairns, C; Borthwick, G; Hughes, J; Morton, NM; Kluth, D; Conway, BR				Choudhary, Abhijeet K.; Rennie, Jillian; Cairns, Carolynn; Borthwick, Gary; Hughes, Jeremy; Morton, Nicholas M.; Kluth, David; Conway, Bryan R.			Administration of Heme Arginate Ameliorates Murine Type 2 Diabetes Independently of Heme Oxygenase Activity	PLOS ONE			English	Article							PANCREATIC BETA-CELL; METABOLISM	Amelioration of rodent type 2 diabetes by hemin has been linked to increased heme oxygenase (HO) activity, however alternative mechanisms have recently been proposed for its anti-diabetic effect. We sought to determine the anti-diabetic efficacy of heme arginate (HA), a clinically licensed preparation of heme, and whether its predominant mode of action is via increased HO activity. Intravenous administration of HA reduced hyperglycemia in diabetic (db/db) mice. Co-administration of the HO inhibitor stannous (IV) mesoporphyrin IX dichloride (SM) resulted unexpectedly in a further improvement in glycaemic control despite restoring HO activity to baseline levels. The anti-diabetic effects of HA+/-SM were associated with increased adiposity, increased serum adiponectin levels, reduced adipose tissue and islet inflammation and preservation of islet beta-cell function. HO activity independent effects of HA on adipogenesis and beta-cell inflammation were further confirmed in cell culture models using the 3T3-L1 pre-adipocyte and MIN6 beta-cell lines, respectively. In conclusion, our work demonstrates that the heme component of HA ameliorates experimental type 2 diabetes by promoting metabolically favourable adipogenesis and preserving islet beta-cell function, but this is not mediated via increased HO activity.	[Choudhary, Abhijeet K.; Borthwick, Gary; Hughes, Jeremy; Kluth, David; Conway, Bryan R.] Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Rennie, Jillian; Cairns, Carolynn; Morton, Nicholas M.; Conway, Bryan R.] Univ Edinburgh, Queens Med Res Inst, British Heart Fdn, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Conway, BR (corresponding author), Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland.	bryan.conway@ed.ac.uk	Morton, NICHOLAS/ABF-3774-2020	Hughes, Jeremy/0000-0002-3470-0422	Clinician Scientist Fellowship from the Medical Research Council [Mrc G0501900]; University of Edinburgh Centre for Inflammation Research; MTEM Ltd, a University of Edinburgh spin-out company; Medical Research Council [G0501900] Funding Source: researchfish	Clinician Scientist Fellowship from the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Edinburgh Centre for Inflammation Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MTEM Ltd, a University of Edinburgh spin-out company; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	BC was supported by a Clinician Scientist Fellowship from the Medical Research Council (Mrc G0501900, www.mrc.ac.uk). AC was supported by a studentship from the University of Edinburgh Centre for Inflammation Research (www.cir.ed.ac.uk) and a scholarship from MTEM Ltd, a University of Edinburgh spin-out company. The funders of the current work had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Donath MY, 2009, PHYSIOLOGY, V24, P325, DOI 10.1152/physiol.00032.2009; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Grochot-Przeczek A, 2012, CLIN SCI, V122, P93, DOI 10.1042/CS20110147; Huang JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038626; Kato Y, 2003, DIABETOLOGIA, V46, P1228, DOI 10.1007/s00125-003-1173-x; Kumar N, 2010, ENDOCRINOLOGY, V151, P3015, DOI 10.1210/en.2009-0800; LAZAR MA, 1999, J ANIM SCI S3, V77, P16, DOI DOI 10.2527/1999.77SUPPL_316X; Li M, 2008, DIABETES; McNally SJ, 2004, ANAL BIOCHEM, V332, P398, DOI 10.1016/j.ab.2004.06.024; Ndisang JF, 2009, ENDOCRINOLOGY, V150, P2627, DOI 10.1210/en.2008-1370; Ndisang JF, 2009, ENDOCRINOLOGY, V150, P2098, DOI 10.1210/en.2008-0239; Ndisang JF, 2009, AM J PHYSIOL-ENDOC M, V296, pE1029, DOI 10.1152/ajpendo.90241.2008; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; TENHUNEN R, 1987, J PHARM PHARMACOL, V39, P780, DOI 10.1111/j.2042-7158.1987.tb05119.x; Thomas HE, 2002, DIABETES, V51, P311, DOI 10.2337/diabetes.51.2.311; TOKOLA O, 1986, BRIT J CLIN PHARMACO, V22, P331, DOI 10.1111/j.1365-2125.1986.tb02895.x; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Vieira E, 2012, ENDOCRINOLOGY, V153, P592, DOI 10.1210/en.2011-1595; Wang YH, 2006, J NUTR, V136, P2953, DOI 10.1093/jn/136.12.2953; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179	20	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78209	10.1371/journal.pone.0078209	http://dx.doi.org/10.1371/journal.pone.0078209			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205160	Green Published, gold, Green Submitted			2022-12-27	WOS:000326334500103
J	Peterson, SW; Jurjevic, Z				Peterson, Stephen W.; Jurjevic, Zeljko			Talaromyces columbinus sp nov., and Genealogical Concordance Analysis in Talaromyces Clade 2a	PLOS ONE			English	Article							PENICILLIUM-PICEUM; TAXONOMY	During the course of mold surveys, a set of Talaromyces isolates were obtained that did not fit any described species. Phenotypic examination of these isolates showed that they were similar to T. piceus but differed in some growth characteristics. Multilocus DNA sequence data were obtained for the new isolates and some related species in the broader, more inclusive clade, and the data were analyzed using genealogical concordance. The new isolates are described as Talaromyces columbinus. From analysis of the related species, Penicillium rugulosum var. atricolum is given species status in Talaromyces as T. atricola. Penicillium tardum and P. chrysitis were showed to be synonyms of T. rugulosus. Penicillium scorteum and T. phialosporus were showed to be conspecific and under the rule of priority T. scorteus is the proper name for isolates previously known as T. phialosporus. Talaromyces wortmanii was showed to be distinct from Penicillium concavorugulosum and T. variabilis but the relationship of the latter two species remains unresolved. Examination of ITS sequences from GenBank showed that T. columbinus has previously been reported from human lung infections under the name Penicillium piceum.	[Peterson, Stephen W.] USDA, Bacterial Foodborne Pathogens & Mycol Res Unit, Peoria, IL USA; [Jurjevic, Zeljko] EMSL Analyt Inc, Cinnaminson, NJ USA	United States Department of Agriculture (USDA)	Peterson, SW (corresponding author), USDA, Bacterial Foodborne Pathogens & Mycol Res Unit, Peoria, IL USA.	Stephen.Peterson@ars.usda.gov						BERBEE ML, 1995, MYCOLOGIA, V87, P210, DOI 10.2307/3760907; De Ravin SS, 2011, CLIN INFECT DIS, V52, pE136, DOI 10.1093/cid/ciq250; Dettman JR, 2003, EVOLUTION, V57, P2703, DOI 10.1554/03-073; Eremin AN, 2008, APPL BIOCHEM MICRO+, V44, P590, DOI 10.1134/S0003683808060069; FRISVAD JC, 1990, NATO ADV SCI I A-LIF, V185, P83; Horn BW, 2013, MYCOLOGIA, V105, P1153, DOI 10.3852/13-101; Horre R, 2001, MYCOSES, V44, P502, DOI 10.1046/j.1439-0507.2001.00710.x; Hubka V, 2012, PERSOONIA, V29, P1, DOI 10.3767/003158512X658123; Manoch L, 2013, MYCOSCIENCE; McNeill J, 2012, REGNUM VEG, V154, P1; ODonnell K, 1997, MOL PHYLOGENET EVOL, V7, P103, DOI 10.1006/mpev.1996.0376; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pitt J.I., 2000, INTEGRATION MODERN T, P9; Pitt J. I., 1980, GENUS PENICILLIUM IT; Pitt JI, 1993, NAMES CURRENT USE FA, P13; Raper KB, 1949, MANUAL PENICILLIA; Ridgway R., 1912, COLOR STANDARDS COLO; Samson RA, 2011, STUD MYCOL, P159, DOI 10.3114/sim.2011.70.04; Samson R. A., 2010, CBS LAB MANUAL SERIE, V2; Santos PE, 2006, MED MYCOL, V44, P749, DOI 10.1080/13693780600967089; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Sidrim JJC, 2010, J APPL MICROBIOL, V108, P1751, DOI 10.1111/j.1365-2672.2009.04573.x; Soares C, 2012, MYCOLOGIA, V104, P682, DOI 10.3852/11-088; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Thom C, 1930, PENICILLIA; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trehane P., 1994, REGNUM VEGETABILE, V131; Ugaki N, 2012, J ANTIBIOT, V65, P15, DOI 10.1038/ja.2011.105; Visagie CM, 2012, PERSOONIA, V28, P14, DOI 10.3767/003158512X632455; Yilmaz N, 2012, PERSOONIA, V29, P39, DOI 10.3767/003158512X659500	30	39	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78084	10.1371/journal.pone.0078084	http://dx.doi.org/10.1371/journal.pone.0078084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205102	Green Submitted, Green Published, gold			2022-12-27	WOS:000326334500093
J	Rasmussen, JM; Entringer, S; Nguyen, A; van Erp, TGM; Guijarro, A; Oveisi, F; Swanson, JM; Piomelli, D; Wadhwa, PD; Buss, C; Potkin, SG				Rasmussen, Jerod M.; Entringer, Sonja; Nguyen, Annie; van Erp, Theo G. M.; Guijarro, Ana; Oveisi, Fariba; Swanson, James M.; Piomelli, Daniele; Wadhwa, Pathik D.; Buss, Claudia; Potkin, Steven G.			Brown Adipose Tissue Quantification in Human Neonates Using Water-Fat Separated MRI	PLOS ONE			English	Article							3-POINT DIXON METHOD; IDENTIFICATION; RELIABILITY; MICE	There is a major resurgence of interest in brown adipose tissue (BAT) biology, particularly regarding its determinants and consequences in newborns and infants. Reliable methods for non-invasive BAT measurement in human infants have yet to be demonstrated. The current study first validates methods for quantitative BAT imaging of rodents post mortem followed by BAT excision and re-imaging of excised tissues. Identical methods are then employed in a cohort of in vivo infants to establish the reliability of these measures and provide normative statistics for BAT depot volume and fat fraction. Using multi-echo water-fat MRI, fat-and water-based images of rodents and neonates were acquired and ratios of fat to the combined signal from fat and water (fat signal fraction) were calculated. Neonatal scans (n = 22) were acquired during natural sleep to quantify BAT and WAT deposits for depot volume and fat fraction. Acquisition repeatability was assessed based on multiple scans from the same neonate. Intra-and inter-rater measures of reliability in regional BAT depot volume and fat fraction quantification were determined based on multiple segmentations by two raters. Rodent BAT was characterized as having significantly higher water content than WAT in both in situ as well as ex vivo imaging assessments. Human neonate deposits indicative of bilateral BAT in spinal, supraclavicular and axillary regions were observed. Pairwise, WAT fat fraction was significantly greater than BAT fat fraction throughout the sample (Delta(WAT-BAT) = 38%, p<10(-4)). Repeated scans demonstrated a high voxelwise correlation for fat fraction (R-all = 0.99). BAT depot volume and fat fraction measurements showed high intra-rater (ICCBAT,VOL = 0.93, ICCBAT,FF = 0.93) and inter-rater reliability (ICCBAT,VOL = 0.86, ICCBAT,FF = 0.93). This study demonstrates the reliability of using multi-echo water-fat MRI in human neonates for quantification throughout the torso of BAT depot volume and fat fraction measurements.	[Rasmussen, Jerod M.; van Erp, Theo G. M.; Wadhwa, Pathik D.; Potkin, Steven G.] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA; [Entringer, Sonja; Nguyen, Annie; Swanson, James M.; Wadhwa, Pathik D.; Buss, Claudia] Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA; [Guijarro, Ana; Oveisi, Fariba; Piomelli, Daniele] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA; [Wadhwa, Pathik D.] Univ Calif Irvine, Dept Obstet & Gynecol, Irvine, CA 92717 USA; [Wadhwa, Pathik D.] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA; [Piomelli, Daniele] Inst Italiano Tecnol Italian, Genoa, Italy; [Buss, Claudia] Charite, Dept Med Psychol, Berlin, Germany	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Buss, C (corresponding author), Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA.	claudia.buss@charite.de; sgpotkin@uci.edu	Entringer, Sonja/ABB-9405-2020; Buss, Claudia/ABC-3687-2020	GUIJARRO ANTON, Ana Isabel/0000-0002-1595-2173; Potkin, Steven/0000-0003-1028-1013; Entringer, Sonja/0000-0002-9926-7076; Buss, Claudia/0000-0002-8738-3133	National Institutes of Health [RO1 MH-091351, RO1 HD-065825, R21 DK-098765]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK098765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding for this project was supported by National Institutes of Health grants RO1 MH-091351 to CB, RO1 HD-065825 to SE, and R21 DK-098765 to SE and CB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHERNE W, 1964, P ROY SOC MED, V57, P1172, DOI 10.1177/003591576405701226; Bartness TJ, 2010, INT J OBESITY, V34, pS36, DOI 10.1038/ijo.2010.182; Berglund J, 2010, MAGN RESON MED, V63, P1659, DOI 10.1002/mrm.22385; Carter Brett W, 2008, Proc (Bayl Univ Med Cent), V21, P328; Chen YI, 2012, OBESITY, V20, P1519, DOI 10.1038/oby.2012.22; Chen YF, 2011, J MAGN RESON IMAGING, V33, P940, DOI 10.1002/jmri.22345; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DAWKINS MJR, 1965, NATURE, V206, P201, DOI 10.1038/206201b0; GLOVER GH, 1991, MAGNET RESON MED, V18, P371, DOI 10.1002/mrm.1910180211; Hamilton G, 2011, J MAGN RESON IMAGING, V34, P468, DOI 10.1002/jmri.22623; Holstila M, 2013, METABOLISM, V62, P1189, DOI 10.1016/j.metabol.2013.03.002; Hu HH, 2011, FRONT ENDOCRINOL, V2, P1; Hu HCH, 2013, J MAGN RESON IMAGING, V38, P885, DOI 10.1002/jmri.24053; Hu HH, 2013, AM J ROENTGENOL, V200, P177, DOI 10.2214/AJR.12.8996; Hu HCH, 2012, J MAGN RESON IMAGING, V35, P938, DOI 10.1002/jmri.23531; Hu HH, 2012, MAGN RESON IMAGING, V20, P323, DOI 10.1016/j.mri.2011.12.004; Hu HH, 2010, J MAGN RESON IMAGING, V31, P1195, DOI 10.1002/jmri.22162; Hu HH, 2012, MAGN RESON MED, V68, P378, DOI 10.1002/mrm.24369; Jahng GH, 2005, RADIOLOGY, V234, P909, DOI 10.1148/radiol.2343031499; Khanna A, 2012, MAGN RESON MED, V68, P1285, DOI 10.1002/mrm.24118; Lau AZ, 2014, INT J OBESITY, V38, P126, DOI 10.1038/ijo.2013.58; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Lunati E, 1999, J LIPID RES, V40, P1395; Ma JF, 2004, MAGN RESON MED, V52, P415, DOI 10.1002/mrm.20146; Ma JF, 2008, J MAGN RESON IMAGING, V28, P543, DOI 10.1002/jmri.21492; Peng XG, 2013, AM J PHYSIOL-ENDOC M, V304, pE160, DOI 10.1152/ajpendo.00401.2012; Rofsky NM, 1999, RADIOLOGY, V212, P876, DOI 10.1148/radiology.212.3.r99se34876; Rutkowski JM, 2009, FEBS J, V276, P5738, DOI 10.1111/j.1742-4658.2009.07303.x; RYLANDER E, 1972, ACTA PAEDIATR SCAND, V61, P42, DOI 10.1111/j.1651-2227.1972.tb15901.x; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Steidle G, 2011, MAGN RESON MED, V65, P1119, DOI 10.1002/mrm.22699; Symonds ME, 2012, DIABETOLOGIA, V55, P1597, DOI 10.1007/s00125-012-2505-5; van Rooijen BD, 2013, INVEST RADIOL, V48, P708, DOI 10.1097/RLI.0b013e31829363b8; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang Y, 1998, JMRI-J MAGN RESON IM, V8, P703, DOI 10.1002/jmri.1880080329; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	37	54	55	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77907	10.1371/journal.pone.0077907	http://dx.doi.org/10.1371/journal.pone.0077907			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205024	Green Published, gold			2022-12-27	WOS:000326334500076
J	Campbell, N; Sinagra, G; Jones, KL; Slavov, D; Gowan, K; Merlo, M; Carniel, E; Fain, PR; Aragona, P; Di Lenarda, A; Mestroni, L; Taylor, MRG				Campbell, Nzali; Sinagra, Gianfranco; Jones, Kenneth L.; Slavov, Dobromir; Gowan, Katherine; Merlo, Marco; Carniel, Elisa; Fain, Pamela R.; Aragona, Pierluigi; Di Lenarda, Andrea; Mestroni, Luisa; Taylor, Matthew R. G.			Whole Exome Sequencing Identifies a Troponin T Mutation Hot Spot in Familial Dilated Cardiomyopathy	PLOS ONE			English	Article							GENE; VARIANTS; FREQUENCY; DIAGNOSIS; CAPTURE	Dilated cardiomyopathy (DCM) commonly causes heart failure and shows extensive genetic heterogeneity that may be amenable to newly developed next-generation DNA sequencing of the exome. In this study we report the successful use of exome sequencing to identify a pathogenic variant in the TNNT2 gene using segregation analysis in a large DCM family. Exome sequencing was performed on three distant relatives from a large family with a clear DCM phenotype. Missense, nonsense, and splice variants were analyzed for segregation among the three affected family members and confirmed in other relatives by direct sequencing. A c.517T C>T, Arg173Trp TNNT2 variant segregated with all affected family members and was also detected in one additional DCM family in our registry. The inclusion of segregation analysis using distant family members markedly improved the bioinformatics filtering process by removing from consideration variants that were not shared by all affected subjects. Haplotype analysis confirmed that the variant found in both DCM families was located on two distinct haplotypes, supporting the notion of independent mutational events in each family. In conclusion, an exome sequencing strategy that includes segregation analysis using distant affected relatives within a family represents a viable diagnostic strategy in a genetically heterogeneous disease like DCM.	[Campbell, Nzali; Slavov, Dobromir; Carniel, Elisa; Mestroni, Luisa; Taylor, Matthew R. G.] Univ Colorado, Cardiovasc Inst & Adult Med Genet, Aurora, CO 80045 USA; [Sinagra, Gianfranco; Merlo, Marco; Di Lenarda, Andrea] Osped Riuniti, Cardiovasc Dept, Trieste, Italy; [Sinagra, Gianfranco; Merlo, Marco; Di Lenarda, Andrea] Univ Trieste, Trieste, Italy; [Jones, Kenneth L.; Gowan, Katherine] Univ Colorado, Sch Med, Ctr Canc, Aurora, CO USA; [Jones, Kenneth L.; Gowan, Katherine] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO USA; [Fain, Pamela R.] Univ Colorado, Sch Med, Human Med Genet & Genom Program, Aurora, CO USA; [Aragona, Pierluigi] Osped Trebisacce, Cardiol Unit, Cosenza, Italy	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Trieste; University of Trieste; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Mestroni, L (corresponding author), Univ Colorado, Cardiovasc Inst & Adult Med Genet, Aurora, CO 80045 USA.	Luisa.Mestroni@ucdenver.edu; matthew.taylor@ucdenver.edu	Di Lenarda, Andrea/AAC-2377-2022; sinagra, gianfranco gs/P-7643-2014; Jones, Kenneth/GXF-4945-2022; Sinagra, Gianfranco/AAE-3943-2020	Di Lenarda, Andrea/0000-0001-8482-4872; SINAGRA, GIANFRANCO/0000-0003-2700-8478; Mestroni, Luisa/0000-0003-1116-2286	NIH [1R01HL109209]; NIH/NCRR Colorado CTSI [UL1 RR025780]; AHA [12GRNT11770055];  [R01HL69071]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069071, R01HL109209] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCRR Colorado CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This publication was supported by NIH 1R01HL109209 (MT), R01HL69071, NIH/NCRR Colorado CTSI Grant Number UL1 RR025780, and AHA 12GRNT11770055 (LM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfares A, 2011, J MED GENET, V48, P602, DOI 10.1136/jmedgenet-2011-100230; Bick AG, 2012, AM J HUM GENET, V91, P513, DOI 10.1016/j.ajhg.2012.07.017; Bonnefond A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013630; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; CODD MB, 1989, CIRCULATION, V80, P564, DOI 10.1161/01.CIR.80.3.564; Galmiche L, 2011, HUM MUTAT, V32, P1225, DOI 10.1002/humu.21562; Gotz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006; Grunig E, 1998, J AM COLL CARDIOL, V31, P186, DOI 10.1016/S0735-1097(97)00434-8; HENRY WL, 1980, CIRCULATION, V62, P1054, DOI 10.1161/01.CIR.62.5.1054; Hershberger RE, 2009, CIRC-CARDIOVASC GENE, V2, P306, DOI 10.1161/CIRCGENETICS.108.846733; Jachymova M, 2012, PHYSIOL RES, V61, P169, DOI 10.33549/physiolres.932157; Jefferies JL, 2010, LANCET, V375, P752, DOI 10.1016/S0140-6736(09)62023-7; Jordan DM, 2011, AM J HUM GENET, V88, P183, DOI 10.1016/j.ajhg.2011.01.011; Judge DP, 2009, JAMA-J AM MED ASSOC, V302, P2471, DOI 10.1001/jama.2009.1787; Lakdawala NK, 2012, J CARD FAIL, V18, P296, DOI 10.1016/j.cardfail.2012.01.013; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Majewski J, 2011, J MED GENET, V48, P593, DOI 10.1136/jmedgenet-2011-100288; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mestroni L, 1999, EUR HEART J, V20, P93, DOI 10.1053/euhj.1998.1145; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; Montenegro G, 2011, ANN NEUROL, V69, P464, DOI 10.1002/ana.22235; Morimoto S, 2007, ADV EXP MED BIOL, V592, P227; Norton N, 2011, AM J HUM GENET, V88, P273, DOI 10.1016/j.ajhg.2011.01.016; Schrader KA, 2011, J PATHOL, V225, P12, DOI 10.1002/path.2941; Stefanelli CB, 2004, MOL GENET METAB, V83, P188, DOI 10.1016/j.ymgme.2004.04.013; Sun N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003552; Theis JL, 2011, CIRC-CARDIOVASC GENE, V4, P585, DOI 10.1161/CIRCGENETICS.111.961052; Van Acker H, 2010, INT J CARDIOL, V144, P307, DOI 10.1016/j.ijcard.2009.03.003; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Watkins D, 2011, J MED GENET, V48, P590, DOI 10.1136/jmedgenet-2011-100286; Worthey EA, 2011, GENET MED, V13, P255, DOI 10.1097/GIM.0b013e3182088158; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057	33	18	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78104	10.1371/journal.pone.0078104	http://dx.doi.org/10.1371/journal.pone.0078104			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205113	gold, Green Published, Green Submitted			2022-12-27	WOS:000326270700075
J	Leung, YY; McGrath, C; Cheung, LK				Leung, Yiu Yan; McGrath, Colman; Cheung, Lim Kwong			Trigeminal Neurosensory Deficit and Patient Reported Outcome Measures: The Effect on Quality of Life	PLOS ONE			English	Article							SURGERY	Objectives: To investigate the effect of persistent neurosensory disturbance of the lingual nerve (LN) or inferior alveolar nerve (IAN) on general health and oral health-related quality of life (QoL). Methods: The study design was a case-control study. Patients with persistent neurosensory deficit of LN or IAN after lower third molar surgery (for 12 months or more) were the study group. The control group was an age and gender matched sample of patients who had dental extractions or lower third molar surgeries without trigeminal neurosensory deficit. The outcome variables were the general health and oral health-related QoL. General health-related QoL was assessed using the 36-item Short Form Health Survey (SF-36) and oral health-related QoL using the 14-item Short Form Oral Health Impact Profile (OHIP-14). Differences in SF-36 scores and OHIP-14 scores between the groups were compared. Results: Forty-eight subjects (24 cases and 24 controls) were recruited. When compared to the control group, patients with neurosensory deficits had poorer Mental-Health Component Scores (MCS) (p = 0.005), General Health (p = 0.023), Vitality (p = 0.048), Social Functioning (p = 0.003), Role-emotion (p = 0.008) and Mental Health (p = 0.022). The OHIP-14 scores were also significantly worse in this patients with neurosensory deficits compared with the control group (p = 0.002). When compared within the study group, older patient with neurosensory deficit was found to correlate with worse Physical Health Component Scores (PCS) (p = 0.02) and OHIP-14 scores (p = 0.02), while more severe visualized analog scaling rating of numbness was correlated with a worse PCS (p = 0.034). Conclusions: Patients with persistent LN or IAN deficit after lower third molar surgery have poorer health-related QoL and poorer oral health-related QoL than those without such deficits.	[Leung, Yiu Yan; McGrath, Colman; Cheung, Lim Kwong] Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Leung, YY (corresponding author), Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China.	mikeyyleung@hku.hk		Cheung, Lim Kwong/0000-0002-2248-286X; McGrath, Colman Patrick Joseph/0000-0001-9379-0889; /0000-0001-7038-3279				Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Cheung LK, 2009, INT J ORAL MAXILLOF, V108, P821; Cohen J.E., 1988, STAT POWER ANAL BEHA; Hupp James R, 2007, Oral Maxillofac Surg Clin North Am, V19, P129, DOI 10.1016/j.coms.2006.11.008; Lam CLK, 2005, J CLIN EPIDEMIOL, V58, P815, DOI 10.1016/j.jclinepi.2004.12.008; Leung YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072891; Locker D, 2007, COMMUNITY DENT ORAL, V35, P401, DOI 10.1111/j.1600-0528.2007.00418.x; McGrath C, 2001, Community Dent Health, V18, P138; McGrath C, 2003, BRIT J ORAL MAX SURG, V41, P43, DOI 10.1016/S0266-4356(02)00289-9; McGrath C, 1999, Prim Dent Care, V6, P53; Pogrel MA, 2011, J ORAL MAXIL SURG, V69, P2284, DOI 10.1016/j.joms.2011.02.023; Reisine S, 2012, INT J ORAL MAX SURG, V41, P1558, DOI 10.1016/j.ijom.2012.04.019; Rustemeyer J, 2012, J CRANIO MAXILL SURG, V40, P400, DOI 10.1016/j.jcms.2011.07.009; SANDSTEDT P, 1995, J ORAL MAXIL SURG, V53, P498, DOI 10.1016/0278-2391(95)90055-1; Ware J.E., 1994, SF 36 PHYS MENTAL HL; Wong W, 2012, QUAL LIFE RES, V21, P873, DOI 10.1007/s11136-011-9987-3	16	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77391	10.1371/journal.pone.0077391	http://dx.doi.org/10.1371/journal.pone.0077391			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204820	Green Submitted, Green Published, gold			2022-12-27	WOS:000326270700028
J	Gowda, NM; Wu, XZ; Kumar, S; Febbraio, M; Gowda, DC				Gowda, Nagaraj M.; Wu, Xianzhu; Kumar, Sanjeev; Febbraio, Maria; Gowda, D. Channe			CD36 Contributes to Malaria Parasite-Induced Pro-Inflammatory Cytokine Production and NK and T Cell Activation by Dendritic Cells	PLOS ONE			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; PLASMODIUM-FALCIPARUM; CHONDROITIN SULFATE; PROTECTIVE IMMUNITY; MEMBRANE PROTEIN-1; RECEPTOR; ADHESION; INNATE; ADHERENCE; RESPONSES	The scavenger receptor CD36 plays important roles in malaria, including the sequestration of parasite-infected erythrocytes in microvascular capillaries, control of parasitemia through phagocytic clearance by macrophages, and immunity. Although the role of CD36 in the parasite sequestration and clearance has been extensively studied, how and to what extent CD36 contributes to malaria immunity remains poorly understood. In this study, to determine the role of CD36 in malaria immunity, we assessed the internalization of CD36-adherent and CD36-nonadherent Plasmodium falciparum-infected red blood cells (IRBCs) and production of pro-inflammatory cytokines by DCs, and the ability of DCs to activate NK, and T cells. Human DCs treated with anti-CD36 antibody and CD36 deficient murine DCs internalized lower levels of CD36-adherent IRBCs and produced significantly decreased levels of pro-inflammatory cytokines compared to untreated human DCs and wild type mouse DCs, respectively. Consistent with these results, wild type murine DCs internalized lower levels of CD36-nonadherent IRBCs and produced decreased levels of pro-inflammatory cytokines than wild type DCs treated with CD36-adherent IRBCs. Further, the cytokine production by NK and T cells activated by IRBC-internalized DCs was significantly dependent on CD36. Thus, our results demonstrate that CD36 contributes significantly to the uptake of IRBCs and pro-inflammatory cytokine responses by DCs, and the ability of DCs to activate NK and T cells to produce IFN-gamma. Given that DCs respond to malaria parasites very early during infection and influence development of immunity, and that CD36 contributes substantially to the cytokine production by DCs, NK and T cells, our results suggest that CD36 plays an important role in immunity to malaria. Furthermore, since the contribution of CD36 is particularly evident at low doses of infected erythrocytes, the results imply that the effect of CD36 on malaria immunity is imprinted early during infection when parasite load is low.	[Gowda, Nagaraj M.; Wu, Xianzhu; Kumar, Sanjeev; Gowda, D. Channe] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Febbraio, Maria] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Cleveland Clinic Foundation	Gowda, DC (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA.	gowda@psu.edu		Gowda, Channe/0000-0002-6860-5108	National Institute of Infectious Diseases and Allergy, National Institutes of Health [AI41139]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041139] Funding Source: NIH RePORTER	National Institute of Infectious Diseases and Allergy, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by grant AI41139 from the National Institute of Infectious Diseases and Allergy, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2000, NATURE, V405, P1015, DOI 10.1038/35016636; Alkhalil A, 2000, J BIOL CHEM, V275, P40357, DOI 10.1074/jbc.M006399200; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BARNWELL JW, 1989, J CLIN INVEST, V84, P765, DOI 10.1172/JCI114234; Baruch DI, 1996, P NATL ACAD SCI USA, V93, P3497, DOI 10.1073/pnas.93.8.3497; Beeson JG, 2002, CELL MOL LIFE SCI, V59, P258, DOI 10.1007/s00018-002-8421-y; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Brasel Kenneth, 2000, Blood, V96, P3029; Buffet PA, 1999, P NATL ACAD SCI USA, V96, P12743, DOI 10.1073/pnas.96.22.12743; Chen K, 2008, CIRC RES, V102, P1512, DOI 10.1161/CIRCRESAHA.108.172064; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Davis SP, 2012, FASEB J, V26, P1119, DOI 10.1096/fj.11-196923; Deitsch KW, 2004, TRENDS PARASITOL, V20, P562, DOI 10.1016/j.pt.2004.09.002; Diallo TO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012764; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; El Khoury JB, 2003, J EXP MED, V197, P1657, DOI 10.1084/jem.20021546; Elliott SR, 2007, INFECT IMMUN, V75, P3621, DOI 10.1128/IAI.00095-07; Erdman LK, 2009, J IMMUNOL, V183, P6452, DOI 10.4049/jimmunol.0901374; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Fesel C, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-5; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Gowda NM, 2012, J IMMUNOL, V188, P5073, DOI 10.4049/jimmunol.1102143; Gowda NM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020398; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Heddini A, 2001, INFECT IMMUN, V69, P5849, DOI 10.1128/IAI.69.9.5849-5856.2001; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844; Janes JH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002032; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Langhorne J, 2004, IMMUNOL REV, V201, P35, DOI 10.1111/j.0105-2896.2004.00182.x; Leitner WW, 1997, PARASITE IMMUNOL, V19, P103, DOI 10.1046/j.1365-3024.1997.d01-188.x; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; Mach N, 2000, CANCER RES, V60, P3239; Muthusamy A, 2007, AM J PATHOL, V170, P1989, DOI 10.2353/ajpath.2007.061238; Ned RM, 2008, J INFECT DIS, V198, P1609, DOI 10.1086/593066; Newman KC, 2006, PLOS PATHOG, V2, P1120, DOI 10.1371/journal.ppat.0020118; Ochola LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014741; OCKENHOUSE CF, 1992, J EXP MED, V176, P1183, DOI 10.1084/jem.176.4.1183; Omi K, 2003, AM J HUM GENET, V72, P364, DOI 10.1086/346091; Omi Kazuya, 2002, Southeast Asian J Trop Med Public Health, V33 Suppl 3, P1; Pain A, 2001, LANCET, V357, P1502, DOI 10.1016/S0140-6736(00)04662-6; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Patel SN, 2007, J IMMUNOL, V178, P3954, DOI 10.4049/jimmunol.178.6.3954; Patel SN, 2004, J INFECT DIS, V189, P204, DOI 10.1086/380764; Pichyangkul S, 2004, J IMMUNOL, V172, P4926, DOI 10.4049/jimmunol.172.8.4926; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; SCHWARZER E, 1992, J EXP MED, V176, P1033, DOI 10.1084/jem.176.4.1033; Seixas E, 2001, EUR J IMMUNOL, V31, P2970, DOI 10.1002/1521-4141(2001010)31:10&lt;2970::AID-IMMU2970&gt;3.0.CO;2-S; Senczuk AM, 2001, BLOOD, V98, P3132, DOI 10.1182/blood.V98.10.3132; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Su Z, 2005, INFECT IMMUN, V73, P3531, DOI 10.1128/IAI.73.6.3531-3539.2005; Urban BC, 2001, P NATL ACAD SCI USA, V98, P8750, DOI 10.1073/pnas.151028698; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; Wagner H, 2004, TRENDS IMMUNOL, V25, P381, DOI 10.1016/j.it.2004.04.011; Wu XZ, 2010, J IMMUNOL, V184, P4338, DOI 10.4049/jimmunol.0903824; Yipp BG, 2003, BLOOD, V101, P2850, DOI 10.1182/blood-2002-09-2841; Zhu JZ, 2009, J BIOL CHEM, V284, P15750, DOI 10.1074/jbc.M901111200	62	20	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77604	10.1371/journal.pone.0077604	http://dx.doi.org/10.1371/journal.pone.0077604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204889	Green Published, gold, Green Submitted			2022-12-27	WOS:000326241200034
J	Brown, RS; Deng, ZD; Cook, KV; Pflugrath, BD; Li, XY; Fu, T; Martinez, JJ; Li, HD; Trumbo, BA; Ahmann, ML; Seaburg, AG				Brown, Richard S.; Deng, Z. Daniel; Cook, Katrina V.; Pflugrath, Brett D.; Li, Xinya; Fu, Tao; Martinez, Jayson J.; Li, Huidong; Trumbo, Bradly A.; Ahmann, Martin L.; Seaburg, Adam G.			A Field Evaluation of an External and Neutrally Buoyant Acoustic Transmitter for Juvenile Salmon: Implications for Estimating Hydroturbine Passage Survival	PLOS ONE			English	Article							HYDRO-TURBINE PASSAGE; CHINOOK SALMON; SWIMMING PERFORMANCE; SNAKE RIVER; COLUMBIA RIVER; TELEMETRY TRANSMITTERS; ATTACHED TRANSMITTERS; ANADROMOUS SALMONIDS; AVIAN PREDATION; SMALLMOUTH BASS	Turbine-passed fish are exposed to rapid decreases in pressure which can cause barotrauma. The presence of an implanted telemetry tag increases the likelihood of injury or death from exposure to pressure changes, thus potentially biasing studies evaluating survival of turbine-passed fish. Therefore, a neutrally buoyant externally attached tag was developed to eliminate this bias in turbine passage studies. This new tag was designed not to add excess mass in water or take up space in the coelom, having an effective tag burden of zero with the goal of reducing pressure related biases to turbine survival studies. To determine if this new tag affects fish performance or susceptibility to predation, it was evaluated in the field relative to internally implanted acoustic transmitters (JSATS; Juvenile Salmon Acoustic Telemetry System) used widely for survival studies of juvenile salmonids. Survival and travel time through the study reach was compared between fish with either tag type in an area of high predation in the Snake and Columbia rivers, Washington. An additional group of fish affixed with neutrally-buoyant dummy external tags were implanted with passive integrated transponder (PIT) tags and recovered further downstream to assess external tag retention and injury. There were no significant differences in survival to the first detection site, 12 river kilometers (rkm) downstream of release. Travel times were also similar between groups. Conversely, externally-tagged fish had reduced survival (or elevated tag loss) to the second detection site, 65 rkm downstream. In addition, the retention study revealed that tag loss was first observed in fish recaptured approximately 9 days after release. Results suggest that this new tag may be viable for short term (< 8 days) single-dam turbine-passage studies and under these situations, may alleviate the turbine passage-related bias encountered when using internal tags, however further research is needed to confirm this.	[Brown, Richard S.; Cook, Katrina V.; Pflugrath, Brett D.] Pacific NW Natl Lab, Ecol Grp, Richland, WA 99352 USA; [Deng, Z. Daniel; Li, Xinya; Fu, Tao; Martinez, Jayson J.; Li, Huidong] Pacific NW Natl Lab, Hydrol Grp, Richland, WA 99352 USA; [Trumbo, Bradly A.; Ahmann, Martin L.] US Army, Corps Engineers, Walla Walla, WA USA; [Seaburg, Adam G.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; University of Washington; University of Washington Seattle	Brown, RS (corresponding author), Pacific NW Natl Lab, Ecol Grp, Richland, WA 99352 USA.	rich.brown@pnnl.gov	Deng, Zhiqun Daniel/A-9536-2011	Deng, Zhiqun Daniel/0000-0002-8300-8766; Li, Huidong/0000-0002-0096-2117	U.S. Army corps of Engineers, Walla Walla district (Walla Walla Washington State) [W912EF-08-D-0004]	U.S. Army corps of Engineers, Walla Walla district (Walla Walla Washington State)	This study was funded by the U.S. Army corps of Engineers, Walla Walla district (Walla Walla Washington State) under contract number W912EF-08-D-0004. Funders were involved in study design and preparation of the manuscript (authors BAT and MLA).	Absolon RF, 2000, ANN REPORT US ARMY C; BERGMAN PK, 1992, FISHERIES, V17, P20, DOI 10.1577/1548-8446(1992)017<0020:PODUAM>2.0.CO;2; Bridger CJ, 2003, REV FISH SCI, V11, P13, DOI 10.1080/16226510390856510; Brown RS, 2012, FISH RES, V121, P43, DOI 10.1016/j.fishres.2012.01.006; Brown RS, 2012, T AM FISH SOC, V141, P147, DOI 10.1080/00028487.2011.650274; Brown RS, 2012, J RENEW SUSTAIN ENER, V4, DOI 10.1063/1.3682062; Brown RS, 2009, T AM FISH SOC, V138, P1285, DOI 10.1577/T08-122.1; Brown RS, FISHERIES IN PRESS; Brown RS, 2012, HYDROREVIEW      DEC, V31, P48; Carlson TJ, 2012, N AM J FISH MANAGE, V32, P249, DOI 10.1080/02755947.2012.661384; Connor WP, 2004, N AM J FISH MANAGE, V24, P545, DOI 10.1577/M02-161.1; Cooke SJ, 2011, REV FISH BIOL FISHER, V21, P11, DOI 10.1007/s11160-010-9184-4; CORMACK RM, 1964, BIOMETRIKA, V51, P429, DOI 10.1093/biomet/51.3-4.429; Counihan TD, 1999, T AM FISH SOC, V128, P965, DOI 10.1577/1548-8659(1999)128<0965:IOEATO>2.0.CO;2; DeHart M, 2012, ANN REPORT BONNEVILL; Deng ZD, 2012, FISH RES, V113, P94, DOI 10.1016/j.fishres.2011.08.018; Deng ZQ, 2007, SENSORS-BASEL, V7, P3399, DOI 10.3390/s7123399; Deng ZQ, 2010, J RENEW SUSTAIN ENER, V2, DOI 10.1063/1.3501336; Deters KA, 2012, T AM FISH SOC, V141, P1, DOI 10.1080/00028487.2011.638594; Deters KA, 2010, T AM FISH SOC, V139, P888, DOI 10.1577/T09-043.1; Evans AF, 2012, T AM FISH SOC, V141, P975, DOI 10.1080/00028487.2012.676809; Evans AF, 2011, N AM J FISH MANAGE, V31, P79, DOI 10.1080/02755947.2011.562429; FOLMAR LC, 1981, AQUACULTURE, V23, P309, DOI 10.1016/0044-8486(81)90024-7; GALLEPP GW, 1972, T AM FISH SOC, V101, P507, DOI 10.1577/1548-8659(1972)101<507:EONBOT>2.0.CO;2; Giorgi A. E., 1997, North American Journal of Fisheries Management, V17, P268, DOI 10.1577/1548-8675(1997)017<0268:FTITDM>2.3.CO;2; Janak JM, 2012, T AM FISH SOC, V141, P1424, DOI 10.1080/00028487.2012.688915; JOLLY GM, 1965, BIOMETRIKA, V52, P225, DOI 10.2307/2333826; Li HD, 2012, SENSORS-BASEL, V12, P9098, DOI 10.3390/s120709098; MCCLEAVE JD, 1975, J FISH RES BOARD CAN, V32, P559, DOI 10.1139/f75-071; McMichael GA, 2006, PNWD3604; McMichael GA, 2010, FISHERIES, V35, P9, DOI 10.1577/1548-8446-35.1.9; Meduri P, 2011, ELECTROCHEM COMMUN, V13, P1344, DOI 10.1016/j.elecom.2011.08.006; MELLAS EJ, 1985, CAN J FISH AQUAT SCI, V42, P488, DOI 10.1139/f85-066; Monzyk FR, 2009, T AM FISH SOC, V138, P1093, DOI 10.1577/T08-108.1; MORGAN RIG, 1976, J FISH BIOL, V8, P289, DOI 10.1111/j.1095-8649.1976.tb03951.x; MUIR WD, 1994, AQUACULTURE, V127, P69, DOI 10.1016/0044-8486(94)90193-7; Naughton GP, 2004, N AM J FISH MANAGE, V24, P534, DOI 10.1577/M02-177.1; Panther JL, 2011, T AM FISH SOC, V140, P1492, DOI 10.1080/00028487.2011.637003; Peake S, 1997, T AM FISH SOC, V126, P707, DOI 10.1577/1548-8659(1997)126<0707:IOTAPO>2.3.CO;2; Perry RW, 2001, T AM FISH SOC, V130, P46, DOI 10.1577/1548-8659(2001)130&lt;0046:BCOJCS&gt;2.0.CO;2; Peven C, 2005, GUIDELINES RECOMMEND; Plumb JM, 2006, N AM J FISH MANAGE, V26, P438, DOI 10.1577/M04-177.1; POE TP, 1991, T AM FISH SOC, V120, P405, DOI 10.1577/1548-8659(1991)120<0405:FOPFOO>2.3.CO;2; ROSS MJ, 1981, PROG FISH CULT, V43, P67, DOI 10.1577/1548-8659(1981)43[67:EOERTO]2.0.CO;2; SEBER GAF, 1965, BIOMETRIKA, V52, P249; Stephenson JR, 2010, FISH RES, V106, P271, DOI 10.1016/j.fishres.2010.08.006; Summerfelt R.C., 1990, P213; Tabor Roger A., 1993, North American Journal of Fisheries Management, V13, P831, DOI 10.1577/1548-8675(1993)013<0831:POJSBS>2.3.CO;2; Titzler PS, 2010, N AM J FISH MANAGE, V30, P853, DOI 10.1577/M09-143.1; Walsh MG, 2000, T AM FISH SOC, V129, P539, DOI 10.1577/1548-8659(2000)129<0539:EOIMAT>2.0.CO;2; WEDEMEYER GA, 1980, US NMFS MAR FISH REV, V42, P1; Weiland MA, 2011, SENSORS-BASEL, V11, P5645, DOI 10.3390/s110605645; Zabel Richard W., 1997, North American Journal of Fisheries Management, V17, P93, DOI 10.1577/1548-8675(1997)017<0093:AMOTTT>2.3.CO;2; ZAUGG WS, 1985, AQUACULTURE, V51, P33, DOI 10.1016/0044-8486(85)90238-8; ZIMMERMAN MP, 1995, NORTHWEST SCI, V69, P19	55	6	6	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77744	10.1371/journal.pone.0077744	http://dx.doi.org/10.1371/journal.pone.0077744			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204947	Green Submitted, Green Published, gold			2022-12-27	WOS:000326155400054
J	Helfer, CM; Wang, RR; You, JX				Helfer, Christine M.; Wang, Ranran; You, Jianxin			Analysis of the Papillomavirus E2 and Bromodomain Protein Brd4 Interaction Using Bimolecular Fluorescence Complementation	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATION; INTRAEPITHELIAL NEOPLASIA; EPISOMAL MAINTENANCE; BINDING; DNA; CHROMATIN; COMPLEX; VACCINE; CHROMOSOMES; ASSOCIATION	The human papillomavirus (HPV) vaccines effectively protect against new infections of up to four HPV subtypes. However, these vaccines are not protective against many other clinically relevant HPV subtypes and are ineffective at treating established HPV infections. There is therefore a significant need for antiviral treatments for persistent HPV infections. A promising anti-HPV drug target is the interaction between the HPV E2 protein and cellular bromodomain-containing protein 4 (Brd4) since this protein complex mediates several processes important for the viral life cycle including viral genome maintenance, replication, and transcription. Using bimolecular fluorescence complementation (BiFC) technology, we demonstrate the E2 and Brd4 interaction on both interphase chromatin and mitotic chromosomes throughout mitosis. The E2-Brd4 BiFC was significantly diminished by mutating the Brd4 binding sites in E2 or by a dominant negative inhibitor of the E2-Brd4 interaction, demonstrating the potential of BiFC for identifying inhibitors of this important virus-host interaction. Importantly, when Brd4 was released from chromatin using the bromodomain inhibitor JQ1(+), the E2-Brd4 interacting complex relocated into foci that no longer associate with mitotic chromosomes, pointing to JQ1(+) as a promising antiviral inhibitor of HPV genome maintenance during HPV persistent infection.	[Helfer, Christine M.; Wang, Ranran; You, Jianxin] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	You, JX (corresponding author), Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	jianyou@mail.med.upenn.edu		Wang, Ranran/0000-0002-7920-0704	HIV-Associated Malignancies Pilot Project Award (National Cancer Institute); National Institutes of Health (NIH) [R01CA148768, R01CA142723]; NATIONAL CANCER INSTITUTE [R01CA148768, R01CA142723] Funding Source: NIH RePORTER	HIV-Associated Malignancies Pilot Project Award (National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the HIV-Associated Malignancies Pilot Project Award (National Cancer Institute), and National Institutes of Health (NIH) Grants R01CA148768 and R01CA142723. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate EA, 2006, MOL CELL, V24, P877, DOI 10.1016/j.molcel.2006.11.002; Ault KA, 2007, GYNECOL ONCOL, V107, pS31, DOI 10.1016/j.ygyno.2007.08.059; Bastien N, 2000, VIROLOGY, V270, P124, DOI 10.1006/viro.2000.0265; Baxter MK, 2005, J VIROL, V79, P4806, DOI 10.1128/JVI.79.8.4806-4818.2005; Brannon AR, 2005, P NATL ACAD SCI USA, V102, P2998, DOI 10.1073/pnas.0407818102; Cardenas-Mora J, 2008, J VIROL, V82, P7298, DOI 10.1128/JVI.00772-08; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dillner J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3493; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; DOSTATNI N, 1988, EMBO J, V7, P3807, DOI 10.1002/j.1460-2075.1988.tb03265.x; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Flores ER, 1999, VIROLOGY, V262, P344, DOI 10.1006/viro.1999.9868; Gagnon D, 2009, J VIROL, V83, P4127, DOI 10.1128/JVI.02468-08; Ilves I, 2006, J VIROL, V80, P3660, DOI 10.1128/JVI.80.7.3660-3665.2006; Ilves I, 1999, J VIROL, V73, P4404, DOI 10.1128/JVI.73.5.4404-4412.1999; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kim J, 2003, BIOCHEM BIOPH RES CO, V305, P1008, DOI 10.1016/S0006-291X(03)00880-5; Kjaer SK, 2009, CANCER PREV RES, V2, P868, DOI 10.1158/1940-6207.CAPR-09-0031; Kodama Y, 2010, BIOTECHNIQUES, V49, P793, DOI 10.2144/000113519; Kumar RA, 2007, J VIROL, V81, P2213, DOI 10.1128/JVI.01746-06; Lee D, 2000, J BIOL CHEM, V275, P7045, DOI 10.1074/jbc.275.10.7045; Lee D, 2002, J BIOL CHEM, V277, P6483, DOI 10.1074/jbc.M105085200; Lehman CW, 1998, P NATL ACAD SCI USA, V95, P4338, DOI 10.1073/pnas.95.8.4338; MCBRIDE AA, 1991, J BIOL CHEM, V266, P18411; McPhillips MG, 2006, J VIROL, V80, P9530, DOI 10.1128/JVI.01105-06; McPhillips MG, 2005, J VIROL, V79, P8920, DOI 10.1128/JVI.79.14.8920-8932.2005; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nakagawa C, 2011, BIOSCI BIOTECH BIOCH, V75, P1399, DOI 10.1271/bbb.110189; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Piirsoo M, 1996, EMBO J, V15, P1; Schweiger MR, 2007, J VIROL, V81, P9612, DOI 10.1128/JVI.00447-07; Schweiger MR, 2006, J VIROL, V80, P4276, DOI 10.1128/JVI.80.9.4276-4285.2006; Senechal H, 2007, VIROLOGY, V358, P10, DOI 10.1016/j.virol.2006.08.035; Skiadopoulos MH, 1998, J VIROL, V72, P2079, DOI 10.1128/JVI.72.3.2079-2088.1998; Smith JA, 2010, P NATL ACAD SCI USA, V107, P3752, DOI 10.1073/pnas.0914818107; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; SPALHOLZ BA, 1985, CELL, V42, P183, DOI 10.1016/S0092-8674(85)80114-8; Stanley MA, 2012, J GEN VIROL, V93, P681, DOI 10.1099/vir.0.039677-0; TAN SH, 1994, J VIROL, V68, P6411, DOI 10.1128/JVI.68.10.6411-6420.1994; Trimble CL, 2009, CLIN CANCER RES, V15, P361, DOI 10.1158/1078-0432.CCR-08-1725; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang R, 2012, J BIOL CHEM; Wang X, 2013, J VIROL, V87, P3871, DOI 10.1128/JVI.03068-12; White PW, 2011, CURR TOP MICROBIOL, V348, P61, DOI 10.1007/82_2010_92; White PW, 2005, ANTIMICROB AGENTS CH, V49, P4834, DOI 10.1128/AAC.49.12.4834-4842.2005; Wu SY, 2006, GENE DEV, V20, P2383, DOI 10.1101/gad.1448206; Wu SY, 2013, MOL CELL, V49, P843, DOI 10.1016/j.molcel.2012.12.006; Yan JP, 2011, J BIOL CHEM, V286, P27663, DOI 10.1074/jbc.M111.246975; Yan JP, 2010, J VIROL, V84, P76, DOI 10.1128/JVI.01647-09; You J, 2004, CELL, V117, P349, DOI 10.1016/S0092-8674(04)00402-7; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	51	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77994	10.1371/journal.pone.0077994	http://dx.doi.org/10.1371/journal.pone.0077994			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205059	Green Published, gold, Green Submitted			2022-12-27	WOS:000326155400066
J	Joo, D; Kwan, YS; Song, J; Pinho, C; Hey, J; Won, YJ				Joo, Deokjin; Kwan, Ye-seul; Song, Jongwoo; Pinho, Catarina; Hey, Jody; Won, Yong-Jin			Identification of Cichlid Fishes from Lake Malawi Using Computer Vision	PLOS ONE			English	Article							ECOLOGICAL CHARACTER DISPLACEMENT; SEXUAL SELECTION; SPECIES FLOCK; GENE FLOW; AUTOMATED CLASSIFICATION; MICROSATELLITE LOCI; MALE COLORATION; SPECIATION; POPULATION; POLYMORPHISM	Background: The explosively radiating evolution of cichlid fishes of Lake Malawi has yielded an amazing number of haplochromine species estimated as many as 500 to 800 with a surprising degree of diversity not only in color and stripe pattern but also in the shape of jaw and body among them. As these morphological diversities have been a central subject of adaptive speciation and taxonomic classification, such high diversity could serve as a foundation for automation of species identification of cichlids. Methodology/Principal Finding: Here we demonstrate a method for automatic classification of the Lake Malawi cichlids based on computer vision and geometric morphometrics. For this end we developed a pipeline that integrates multiple image processing tools to automatically extract informative features of color and stripe patterns from a large set of photographic images of wild cichlids. The extracted information was evaluated by statistical classifiers Support Vector Machine and Random Forests. Both classifiers performed better when body shape information was added to the feature of color and stripe. Besides the coloration and stripe pattern, body shape variables boosted the accuracy of classification by about 10%. The programs were able to classify 594 live cichlid individuals belonging to 12 different classes (species and sexes) with an average accuracy of 78%, contrasting to a mere 42% success rate by human eyes. The variables that contributed most to the accuracy were body height and the hue of the most frequent color. Conclusions: Computer vision showed a notable performance in extracting information from the color and stripe patterns of Lake Malawi cichlids although the information was not enough for errorless species identification. Our results indicate that there appears an unavoidable difficulty in automatic species identification of cichlid fishes, which may arise from short divergence times and gene flow between closely related species.	[Joo, Deokjin] Seoul Natl Univ, Dept Elect Engn & Comp Sci, Seoul, South Korea; [Kwan, Ye-seul; Won, Yong-Jin] Ewha Womans Univ, Div EcoSci, Seoul, South Korea; [Song, Jongwoo] Ewha Womans Univ, Dept Stat, Seoul, South Korea; [Pinho, Catarina] Univ Porto, CIBIO, Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal; [Hey, Jody] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA	Seoul National University (SNU); Ewha Womans University; Ewha Womans University; Universidade do Porto; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Won, YJ (corresponding author), Ewha Womans Univ, Div EcoSci, Seoul, South Korea.	won@ewha.ac.kr	Pinho, Catarina/A-7541-2010	Pinho, Catarina/0000-0001-5150-2850	Ewha Global Top5 Grant of Ewha Womans University, Korea; Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) [PTDC/BIA-BDE/66210/2006]; FCT [SFRH/BPD/28869/2006]	Ewha Global Top5 Grant of Ewha Womans University, Korea; Fundacao para a Ciencia e a Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the Ewha Global Top5 Grant 2013 of Ewha Womans University, Korea. Field work was supported by grant PTDC/BIA-BDE/66210/2006 from Fundacao para a Ciencia e a Tecnologia (FCT, Portugal). CP is supported by a post-doc fellowship (SFRH/BPD/28869/2006) from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2000, P NATL ACAD SCI USA, V97, P4106, DOI 10.1073/pnas.97.8.4106; Albertson RC, 1999, P NATL ACAD SCI USA, V96, P5107, DOI 10.1073/pnas.96.9.5107; Allender CJ, 2003, P NATL ACAD SCI USA, V100, P14074, DOI 10.1073/pnas.2332665100; Animal Behaviour Society, 2006, ANIM BEHAV, V71, P245, DOI DOI 10.1016/J.ANBEHAV.2005.10.001; Barlow GW, 2000, CICHLID FISHES; Benson B, 2009, FIELD PROGRAMMABLE G, P1; Bhanu Bir, 2008, American Entomologist, V54, P228; Bosch A, 2007, IEEE I CONF COMP VIS, P1863; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; BROWN WL, 1956, SYST ZOOL, V5, P49, DOI 10.2307/2411924; Bruzzone L, 2006, IEEE T GEOSCI REMOTE, V44, P3363, DOI 10.1109/TGRS.2006.877950; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen AH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-274; Chen YW, 2006, STUD FUZZ SOFT COMP, V207, P315; Collobert R., 2004, P 21 INT C MACHINE L, P23, DOI [10.1145/1015330.1015415, DOI 10.1145/1015330.1015415]; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Danley PD, 2001, MOL ECOL, V10, P1075, DOI 10.1046/j.1365-294X.2001.01283.x; Danley PD, 2000, EVOLUTION, V54, P1725; Dayan T, 2005, ECOL LETT, V8, P875, DOI 10.1111/j.1461-0248.2005.00791.x; Delvaux D, 1996, MUS R AFR CENT TERVA, V1995-1996, P99; Deutsch JC, 1997, BIOL J LINN SOC, V62, P1; ENDLER JA, 1973, SCIENCE, V179, P243, DOI 10.1126/science.179.4070.243; Gaston KJ, 2004, PHILOS T R SOC B, V359, P655, DOI 10.1098/rstb.2003.1442; Goldstein HM, 2009, THESIS PENNSYLVANIA, P1; Grosjean P, 2004, ICES J MAR SCI, V61, P518, DOI 10.1016/j.icesjms.2004.03.012; HERT E, 1991, J FISH BIOL, V38, P951, DOI 10.1111/j.1095-8649.1991.tb03634.x; Hey J, 2004, MOL ECOL, V13, P909, DOI 10.1046/j.1365-294X.2003.02031.x; Huang K, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-78; Hulsey CD, 2007, P ROY SOC B-BIOL SCI, V274, P1867, DOI 10.1098/rspb.2007.0444; Joyce DA, 2011, CURR BIOL, V21, pR108, DOI 10.1016/j.cub.2010.11.029; Kang SH, 2012, J ASIA-PAC ENTOMOL, V15, P437, DOI 10.1016/j.aspen.2012.05.005; Kassam DD, 2003, ANIM BIOL, V53, P59, DOI 10.1163/157075603769682585; KIRYATI N, 1991, PATTERN RECOGN, V24, P303, DOI 10.1016/0031-3203(91)90073-E; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Knight ME, 1999, ANIM BEHAV, V58, P761, DOI 10.1006/anbe.1999.1206; Knight ME, 2004, P ROY SOC B-BIOL SCI, V271, P675, DOI 10.1098/rspb.2003.2639; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Konings A., 2001, MALAWI CICHLIDS THEI; Kornfield I, 2000, ANNU REV ECOL SYST, V31, P163, DOI 10.1146/annurev.ecolsys.31.1.163; KORNFIELD IL, 1978, EXPERIENTIA, V34, P335, DOI 10.1007/BF01923020; Kornfield Irv, 1997, P25, DOI 10.1016/B978-012417540-2/50004-X; Larios N, 2008, MACH VISION APPL, V19, P105, DOI 10.1007/s00138-007-0086-y; Larsen R, 2009, LECT NOTES COMPUT SC, V5575, P745; Loh YHE, 2013, MOL BIOL EVOL, V30, P906, DOI 10.1093/molbev/mss326; Loso JB, 2000, P NATL ACAD SCI USA, V97, P5693, DOI 10.1073/pnas.97.11.5693; Maan ME, 2004, P ROY SOC B-BIOL SCI, V271, P2445, DOI 10.1098/rspb.2004.2911; Markert JA, 2001, TRENDS ECOL EVOL, V16, P100, DOI 10.1016/S0169-5347(00)02064-4; Mayo M, 2007, KNOWL-BASED SYST, V20, P195, DOI 10.1016/j.knosys.2006.11.012; McCulloch W. S., 1943, B MATH BIOPHYS, VBMB-5, P115, DOI DOI 10.1007/BF02478259; MCELROY DM, 1991, NETH J ZOOL, V41, P250; MCKAYE ER, 1982, ZOOL J LINN SOC-LOND, V76, P91, DOI 10.1111/j.1096-3642.1982.tb01956.x; MCKAYE KR, 1984, EVOLUTION, V38, P215, DOI 10.1111/j.1558-5646.1984.tb00273.x; MORAN P, 1993, MOL BIOL EVOL, V10, P1015; Nagashima Y., 1998, Proceedings of IAPR Workshop on Machine Vision Applications, P306; Nicodemus KK, 2010, HUM GENET, V127, P441, DOI 10.1007/s00439-009-0782-y; Parker A, 1997, J MOL EVOL, V45, P70, DOI 10.1007/PL00006204; RICE WR, 1993, EVOLUTION, V47, P1637, DOI [10.2307/2410209, 10.1111/j.1558-5646.1993.tb01257.x]; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ, 2001, TPSDIG32 GEOMETRIC M; Rother C, 2004, ACM T GRAPHIC, V23, P309, DOI 10.1145/1015706.1015720; Rova A., 2007, IAPR C MACHINE VISIO, P404; Rowley HA, 2006, VISAPP 2006: PROCEEDINGS OF THE FIRST INTERNATIONAL CONFERENCE ON COMPUTER VISION THEORY AND APPLICATIONS, VOL 1, P290; SCHLUTER D, 1992, AM NAT, V140, P85, DOI 10.1086/285404; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Seehausen O, 2004, P ROY SOC B-BIOL SCI, V271, P1345, DOI 10.1098/rspb.2004.2737; Seehausen O, 1998, BEHAV ECOL SOCIOBIOL, V42, P1, DOI 10.1007/s002650050405; Seehausen O, 1999, ECOL LETT, V2, P367; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Seo TK, 2010, J MOL EVOL, V71, P250, DOI 10.1007/s00239-010-9380-9; Smith PF, 2003, MOL ECOL, V12, P2497, DOI 10.1046/j.1365-294X.2003.01905.x; Stauffer JR, 1996, COPEIA, P203, DOI 10.2307/1446959; Stelkens RB, 2008, PHILOS T R SOC B, V363, P2861, DOI 10.1098/rstb.2008.0049; Storbeck F, 2001, FISH RES, V51, P11, DOI 10.1016/S0165-7836(00)00254-X; Streelman JT, 2004, MOL ECOL, V13, P2471, DOI 10.1111/j.1365-294X.2004.02240.x; Talbot JF, 2006, IMPLEMENTING GRABCUT; Trewavas E, 1984, REV FRANCAISE AQUARI, V10, P97; VanOppen MJH, 1997, MOL ECOL, V6, P387, DOI 10.1046/j.1365-294X.1997.00188.x; Won YJ, 2006, MOL BIOL EVOL, V23, P828, DOI 10.1093/molbev/msj101; Won YJ, 2005, P NATL ACAD SCI USA, V102, P6581, DOI 10.1073/pnas.0502127102; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310	81	10	10	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77686	10.1371/journal.pone.0077686	http://dx.doi.org/10.1371/journal.pone.0077686			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204918	gold, Green Published, Green Submitted			2022-12-27	WOS:000326155400049
J	Liao, XG; Fang, WG; Lin, LC; Lu, HL; St Leger, RJ				Liao, Xinggang; Fang, Weiguo; Lin, Liangcai; Lu, Hsiao-Ling; St Leger, Raymond J.			Metarhizium robertsii Produces an Extracellular Invertase (MrINV) That Plays a Pivotal Role in Rhizospheric Interactions and Root Colonization	PLOS ONE			English	Article							CUTICLE-DEGRADING PROTEASES; TRICHODERMA-VIRENS; ENTOMOPATHOGENIC FUNGI; BIOLOGICAL-CONTROL; SEED TREATMENT; ANISOPLIAE; BIOCONTROL; MECHANISMS; FIELD; GENE	As well as killing pest insects, the rhizosphere competent insect-pathogenic fungus Metarhizium robertsii also boosts plant growth by providing nitrogenous nutrients and increasing resistance to plant pathogens. Plant roots secrete abundant nutrients but little is known about their utilization by Metarhizium spp. and the mechanistic basis of Metarhizium-plant associations. We report here that M. robertsii produces an extracellular invertase (MrInv) on plant roots. Deletion of MrInv (Delta MrInv) reduced M. robertsii growth on sucrose and rhizospheric exudates but increased colonization of Panicum virgatum and Arabidopsis thaliana roots. This could be accounted for by a reduction in carbon catabolite repression in Delta MrInv increasing production of plant cell wall-degrading depolymerases. A non-rhizosphere competent scarab beetle specialist Metarhizium majus lacks invertase which suggests that rhizospheric competence may be related to the sugar metabolism of different Metarhizium species.	[Liao, Xinggang; Lu, Hsiao-Ling; St Leger, Raymond J.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Fang, Weiguo] Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China; [Lin, Liangcai] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China	University System of Maryland; University of Maryland College Park; Zhejiang University; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS	St Leger, RJ (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	stleger@umd.edu	St. Leger, Raymond/N-3219-2013; Fang, Weiguo/G-6680-2012	Fang, Weiguo/0000-0002-8431-8256; Lin, Liangcai/0000-0003-0645-1446	United States Department of Agriculture National Institute of Food and Agriculture [2011-33522-30742]	United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This work was supported by Biotechnology Risk Assessment Grant Program competitive grant 2011-33522-30742 from the United States Department of Agriculture National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare C, 1999, APPL ENVIRON MICROB, V65, P2926; Contreras-Cornejo HA, 2009, PLANT PHYSIOL, V149, P1579, DOI 10.1104/pp.108.130369; Baudoin E, 2003, SOIL BIOL BIOCHEM, V35, P1183, DOI 10.1016/S0038-0717(03)00179-2; Behie SW, 2012, SCIENCE, V336, P1576, DOI 10.1126/science.1222289; Bischoff JF, 2009, MYCOLOGIA, V101, P512, DOI 10.3852/07-202; Chacon MR, 2007, INT MICROBIOL, V10, P19, DOI 10.2436/20.1501.01.4; Chaudhuri A, 1999, FEMS MICROBIOL LETT, V177, P39, DOI 10.1111/j.1574-6968.1999.tb13711.x; Clarkson JM, 1996, TRENDS MICROBIOL, V4, P197, DOI 10.1016/0966-842X(96)10022-6; de Faria MR, 2007, BIOL CONTROL, V43, P237, DOI 10.1016/j.biocontrol.2007.08.001; De Weert S, 2006, PLANT-ASSOCIATED BACTERIA, P317; Fang WG, 2006, CAN J MICROBIOL, V52, P623, DOI 10.1139/W06-014; Fang WG, 2010, PLANT PHYSIOL, V154, P1549, DOI 10.1104/pp.110.163014; Fang WG, 2010, ENVIRON MICROBIOL, V12, P810, DOI 10.1111/j.1462-2920.2009.02127.x; Fang W, 2009, FUNGAL GENET BIOL, V46, P277, DOI 10.1016/j.fgb.2008.12.001; Fernandez J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002673; Gao QA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001264; Goetz M, 2000, J PLANT PHYSIOL, V157, P581, DOI 10.1016/S0176-1617(00)80115-7; Harman GE, 2006, PHYTOPATHOLOGY, V96, P190, DOI 10.1094/PHYTO-96-0190; Herrera-Estrella A, 1999, EXS, V87, P171; Hu G, 2002, APPL ENVIRON MICROB, V68, P6383, DOI 10.1128/AEM.68.12.6383-6387.2002; Jaeger CH, 1999, APPL ENVIRON MICROB, V65, P2685; Kabaluk JT, 2007, AGRON J, V99, P1377, DOI 10.2134/agronj2007.0017N; Liao XG, 2008, CURR MICROBIOL, V57, P121, DOI 10.1007/s00284-008-9163-3; Lin LC, 2011, J MICROBIOL METH, V87, P241, DOI 10.1016/j.mimet.2011.07.018; Lomer CJ, 2001, ANNU REV ENTOMOL, V46, P667, DOI 10.1146/annurev.ento.46.1.667; Lorito M, 2010, ANNU REV PHYTOPATHOL, V48, P395, DOI 10.1146/annurev-phyto-073009-114314; Mach RL, 1996, MOL MICROBIOL, V21, P1273, DOI 10.1046/j.1365-2958.1996.00094.x; Mahmood T, 2002, PLANTA, V214, P887, DOI 10.1007/s00425-001-0697-x; Maniania NK, 2003, CROP PROT, V22, P553, DOI 10.1016/S0261-2194(02)00221-1; Mastouri F, 2010, PHYTOPATHOLOGY, V100, P1213, DOI 10.1094/PHYTO-03-10-0091; Miche L, 2001, APPL ENVIRON MICROB, V67, P3046, DOI 10.1128/AEM.67.7.3046-3052.2001; Mukherjee P. K., 2008, V15, P243; Mukherjee PK, 2012, MICROBIOL-SGM, V158, P155, DOI 10.1099/mic.0.052159-0; OBRIENT, 2009, THESIS U MARYLAND CO; Ownley BH, 2010, BIOCONTROL, V55, P113, DOI 10.1007/s10526-009-9241-x; Pava-Ripoll M, 2011, MICROBIOL-SGM, V157, P47, DOI 10.1099/mic.0.042200-0; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Prade RA, 1999, BIOTECHNOL GENET ENG, V16, P361, DOI 10.1080/02648725.1999.10647984; Rubio MC, 2006, ENZYME MICROB TECH, V39, P601, DOI 10.1016/j.enzmictec.2005.11.011; Ruijter GJG, 1997, FEMS MICROBIOL LETT, V151, P103, DOI 10.1016/S0378-1097(97)00161-4; SAMUELS RI, 1995, COMP BIOCHEM PHYS B, V110, P661, DOI 10.1016/0305-0491(94)00205-9; Sasan RK, 2012, AM J BOT, V99, P101, DOI 10.3732/ajb.1100136; Shah PA, 2003, APPL MICROBIOL BIOT, V61, P413, DOI 10.1007/s00253-003-1240-8; STLEGER RJ, 1987, ARCH BIOCHEM BIOPHYS, V253, P221, DOI 10.1016/0003-9861(87)90655-2; STLEGER RJ, 1986, J GEN MICROBIOL, V132, P1509; Vargas WA, 2009, PLANT PHYSIOL, V151, P792, DOI 10.1104/pp.109.141291; Viterbo A, 2005, APPL ENVIRON MICROB, V71, P6241, DOI 10.1128/AEM.71.10.6241-6246.2005; Viterbo A, 2006, MOL PLANT PATHOL, V7, P249, DOI 10.1111/J.1364-3703.2006.00335.X; Voegele RT, 2006, MOL PLANT MICROBE IN, V19, P625, DOI 10.1094/MPMI-19-0625; Wang CS, 2007, EUKARYOT CELL, V6, P808, DOI 10.1128/EC.00409-06; Wyrebek M, 2011, MICROBIOL-SGM, V157, P2904, DOI 10.1099/mic.0.051102-0; Yedidia I, 1999, APPL ENVIRON MICROB, V65, P1061	52	26	33	4	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78118	10.1371/journal.pone.0078118	http://dx.doi.org/10.1371/journal.pone.0078118			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205119	Green Submitted, Green Published, gold			2022-12-27	WOS:000326032600073
J	Odone, A; Crampin, AC; Mwinuka, V; Malema, S; Mwaungulu, JN; Munthali, L; Glynn, JR				Odone, Anna; Crampin, Amelia C.; Mwinuka, Venance; Malema, Simon; Mwaungulu, J. Nimrod; Munthali, Lumbani; Glynn, Judith R.			Association between Socioeconomic Position and Tuberculosis in a Large Population-Based Study in Rural Malawi	PLOS ONE			English	Article							SOCIAL DETERMINANTS; RISK-FACTORS; HIV-INFECTION; PREVALENCE; COUNTRY; DISEASE; EPIDEMIOLOGY; AFRICA; BURDEN; TRENDS	Setting: There is increasing interest in social structural interventions for tuberculosis. The association between poverty and tuberculosis is well established in many settings, but less clear in rural Africa. In Karonga District, Malawi, we found an association between higher socioeconomic status and tuberculosis from 1986-1996, independent of HIV status and other factors. Objective: To investigate the relationship in the same area in 1997-2010. Design: All adults in the district with new laboratory-confirmed tuberculosis were included. They were compared with community controls, selected concurrently and frequency-matched for age, sex and area. Results: 1707 cases and 2678 controls were interviewed (response rates >95%). The odds of TB were increased in those working in the cash compared to subsistence economy (p<0.001), and with better housing (p-trend=0.006), but decreased with increased asset ownership (p-trend=0.003). The associations with occupation and housing were partly mediated by HIV status, but remained significant. Conclusion: Different socioeconomic measures capture different pathways of the association between socioeconomic status and tuberculosis. Subsistence farmers may be relatively unexposed whereas those in the cash economy travel more, and may be more likely to come forward for diagnosis. In this setting "better houses" may be less well ventilated and residents may spend more time indoors.	[Odone, Anna; Crampin, Amelia C.; Glynn, Judith R.] London Sch Hyg & Trop Med, London WC1, England; [Odone, Anna] Univ Parma, Sch Med, I-43100 Parma, Italy; [Crampin, Amelia C.; Mwinuka, Venance; Malema, Simon; Mwaungulu, J. Nimrod; Munthali, Lumbani] Karonga Prevent Study, Chilumba, Malawi; [Odone, Anna] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA	University of London; London School of Hygiene & Tropical Medicine; University of Parma; Malawi Epidemiology and Intervention Research Unit; Harvard University; Harvard Medical School	Odone, A (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	anna.odone@mail.harvard.edu	Odone, Anna/AAC-4715-2022	Odone, Anna/0000-0002-5657-9774; Crampin, Amelia/0000-0002-1513-4330	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	The study was funded by the Wellcome Trust, with contributions from the British Leprosy Relief Association (LEPRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar I, 2012, J INFECT DIS, V205, pS293, DOI 10.1093/infdis/jir886; Aparicio JP, 2002, J THEOR BIOL, V215, P227, DOI 10.1006/jtbi.2001.2489; Blaas SH, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-60; Boccia D, 2013, INT J TUBERC LUNG D, V17, P39, DOI 10.5588/ijtld.11.0387; Boccia D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020824; Boccia D, 2009, AM J TROP MED HYG, V80, P1004, DOI 10.4269/ajtmh.2009.80.1004; *CHATH HOUS, 2012, CTR GLOB HLTH SEC SO; Crampin A, 2011, TROP MED INT HEALTH, V16, P811, DOI 10.1111/j.1365-3156.2011.02763.x; Crampin AC, 2008, INT J TUBERC LUNG D, V12, P612; Crampin AC, 2009, INT J TUBERC LUNG D, V13, P153; Crampin AC, 2004, INT J TUBERC LUNG D, V8, P194; Crampin AC, 2001, T ROY SOC TROP MED H, V95, P481, DOI 10.1016/S0035-9203(01)90009-4; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Ximenes RAD, 2009, INT J EPIDEMIOL, V38, P1285, DOI 10.1093/ije/dyp224; Glynn JR, 2004, AIDS, V18, P1459, DOI 10.1097/01.aids.0000131336.15301.06; Glynn JR, 2000, T ROY SOC TROP MED H, V94, P500, DOI 10.1016/S0035-9203(00)90065-8; Grundy E, 2005, INT J EPIDEMIOL, V34, P529, DOI 10.1093/ije/dyh272; Hafeman DM, 2009, INT J EPIDEMIOL, V38, P838, DOI 10.1093/ije/dyn372; Hargreaves JR, 2011, AM J PUBLIC HEALTH, V101, P654, DOI 10.2105/AJPH.2010.199505; Harling G, 2008, SOC SCI MED, V66, P492, DOI 10.1016/j.socscimed.2007.08.026; Hill PC, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-156; Holtgrave DR, 2004, AM J PREV MED, V26, P159, DOI 10.1016/j.amepre.2003.10.014; Howe LD, 2012, INT J EPIDEMIOL, V41, P871, DOI 10.1093/ije/dys037; Jackson S, 2006, INT J TUBERC LUNG D, V10, P1104; Jaramillo E., 2011, International Journal of Tuberculosis and Lung Disease, V15, pS1; Kemp JR, 2007, B WORLD HEALTH ORGAN, V85, P580, DOI 10.2471/BLT.06.033167; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Lienhardt C, 2001, EPIDEMIOL REV, V23, P288, DOI 10.1093/oxfordjournals.epirev.a000807; Lonnroth K, 2009, INT J TUBERC LUNG D, V13, P171; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Msyamboza KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020316; Oxlade O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047533; Ploubidis GB, 2012, EUR RESPIR J, V40, P925, DOI 10.1183/09031936.00184011; Prost MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002684; Rajeswari R, 1999, INT J TUBERC LUNG D, V3, P869; Rasanathan K, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P30, DOI 10.5588/ijtld.10.0691; RIEDER H, 1999, EPIDEMIOLOGICAL BASI, P50; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Wanyeki I, 2006, SOC SCI MED, V63, P501, DOI 10.1016/j.socscimed.2005.12.015; Wojcicki JM, 2005, J BIOSOC SCI, V37, P1, DOI 10.1017/S0021932004006534	40	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77740	10.1371/journal.pone.0077740	http://dx.doi.org/10.1371/journal.pone.0077740			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239NN	24204945	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000326032600046
J	Pocquet, N; Milesi, P; Makoundou, P; Unal, S; Zumbo, B; Atyame, C; Darriet, F; Dehecq, JS; Thiria, J; Bheecarry, A; Iyaloo, DP; Weill, M; Chandre, F; Labbe, P				Pocquet, Nicolas; Milesi, Pascal; Makoundou, Patrick; Unal, Sandra; Zumbo, Betty; Atyame, Celestine; Darriet, Frederic; Dehecq, Jean-Sebastien; Thiria, Julien; Bheecarry, Ambicadutt; Iyaloo, Diana P.; Weill, Mylene; Chandre, Fabrice; Labbe, Pierrick			Multiple Insecticide Resistances in the Disease Vector Culex p. Quinquefasciatus from Western Indian Ocean	PLOS ONE			English	Article							RIFT-VALLEY FEVER; PIPIENS-QUINQUEFASCIATUS; ANOPHELES-GAMBIAE; PYRETHROID INSECTICIDES; BANCROFTIAN-FILARIASIS; GROWTH-REGULATOR; SINGLE MOSQUITOS; CULICIDAE; DIPTERA; GENE	Several mosquito-borne diseases affect the Western Indian Ocean islands. Culex pipiens quinquefasciatus is one of these vectors and transmits filariasis, Rift Valley and West Nile viruses and the Japanese encephalitis. To limit the impact of these diseases on public health, considerable vector control efforts have been implemented since the 50s, mainly through the use of neurotoxic insecticides belonging to Organochlorines (OC), Organophosphates (OP) and pyrethroids (PYR) families. However, mosquito control failures have been reported on site, and they were probably due to the selection of resistant individuals in response to insecticide exposure. In this study, we used different approaches to establish a first regional assessment of the levels and mechanisms of resistance to various insecticides. Bioassays were used to evaluate resistance to various insecticides, enzyme activity was measured to assess the presence of metabolic resistances through elevated detoxification, and molecular identification of known resistance alleles was investigated to determine the frequency of target-site mutations. These complementary approaches showed that resistance to the most used insecticides families (OC, OP and PYR) is widespread at a regional scale. However, the distribution of the different resistance genes is quite heterogeneous among the islands, some being found at high frequencies everywhere, others being frequent in some islands and absent in others. Moreover, two resistance alleles displayed clinal distributions in Mayotte and La Reunion, probably as a result of a heterogeneous selection due to local treatment practices. These widespread and diverse resistance mechanisms reduce the capacity of resistance management through classical strategies (e. g. insecticide rotation). In case of a disease outbreak, it could undermine the efforts of the vector control services, as only few compounds could be used. It thus becomes urgent to find alternatives to control populations of Cx. p. quinquefasciatus in the Indian Ocean.	[Pocquet, Nicolas; Darriet, Frederic; Chandre, Fabrice] IRD CNRS UM1 UM2 224 5290, UMR MIVEGEC, Inst Rech Dev, Montpellier, France; [Milesi, Pascal; Makoundou, Patrick; Unal, Sandra; Atyame, Celestine; Weill, Mylene; Labbe, Pierrick] Univ Montpellier 2, CNRS IRD UM2, Inst Sci Evolut Montpellier, UMR 5554, Montpellier, France; [Zumbo, Betty; Dehecq, Jean-Sebastien] Agence Sante Ocean Indien ARS OI, St Denis, La Reunion Isla, France; [Thiria, Julien] DASS Nouvelle Caledonie, Sante Environm, Noumea, New Caledonia; [Bheecarry, Ambicadutt; Iyaloo, Diana P.] Minist Hlth & Qual Life, Vector Biol & Control Div, Port Louis, Mauritius	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Labbe, P (corresponding author), Univ Montpellier 2, CNRS IRD UM2, Inst Sci Evolut Montpellier, UMR 5554, Montpellier, France.	pierrick.labbe@univ-montp2.fr	Labbé, Pïerrick/AAL-5806-2020; Milesi, Pascal/K-3234-2019; Chandre, Fabrice/Q-3429-2019	Labbé, Pïerrick/0000-0003-0806-1919; Chandre, Fabrice/0000-0002-1994-9705; Darriet, Frederic/0000-0003-2486-5968; Iyaloo, Diana Pillay/0000-0001-5871-301X; Weill, Mylene/0000-0002-4043-1601; Pocquet, Nicolas/0000-0003-3928-6803	ANSES (Agence nationale de securite sanitaire de l'alimentation, de l'environnement et du travail) [IRD-ARS-ANSES 2009-CRD-38]	ANSES (Agence nationale de securite sanitaire de l'alimentation, de l'environnement et du travail)(French National Research Agency (ANR))	This work was supported by ANSES (Agence nationale de securite sanitaire de l'alimentation, de l'environnement et du travail) convention IRD-ARS-ANSES 2009-CRD-38. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anyamba A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001465; Atyame CM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001440; Ben Cheikh H, 1998, J MED ENTOMOL, V35, P251, DOI 10.1093/jmedent/35.3.251; Berticat C, 2000, PEST MANAG SCI, V56, P727, DOI 10.1002/1526-4998(200009)56:9<727::AID-PS214>3.3.CO;2-9; Berticat C, 2002, GENET RES, V79, P41, DOI 10.1017/S001667230100547X; Berticat C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-104; Bourguet D, 2004, EVOLUTION, V58, P128, DOI 10.1111/j.0014-3820.2004.tb01579.x; Bourguet D, 1996, PESTIC BIOCHEM PHYS, V55, P122, DOI 10.1006/pest.1996.0041; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brogdon WG, 1997, J AM MOSQUITO CONTR, V13, P233; Cetre-Sossah C, 2012, EMERG INFECT DIS, V18, P969, DOI 10.3201/eid1806.110994; CLARK AG, 1984, PESTIC BIOCHEM PHYS, V22, P249, DOI 10.1016/0048-3575(84)90018-X; CNEV, 2012, CIRC WUCH BANCR MAYO; Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005; Delatte H, 2011, INFECT GENET EVOL, V11, P1769, DOI 10.1016/j.meegid.2011.07.016; Djogbenou L, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-70; Duron O, 2006, EVOLUTION, V60, P303, DOI 10.1111/j.0014-3820.2006.tb01108.x; ffrench-Constant RH, 1998, PHILOS T R SOC B, V353, P1685, DOI 10.1098/rstb.1998.0319; Ffrench-Constant RH, 2000, ANNU REV ENTOMOL, V45, P449, DOI 10.1146/annurev.ento.45.1.449; Finney DJ, 1971, ROBIT ANAL CAMB, P333; Fonseca-Gonzalez I, 2011, PEST MANAG SCI, V67, P430, DOI 10.1002/ps.2081; GEORGHIOU GP, 1966, B WORLD HEALTH ORGAN, V35, P691; Hardstone MC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-42; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hemingway J, 1998, WHOCDSCPCMAL986; Hollingworth RM, 2008, GLOBAL PESTICIDE RES, P169; HOLM S, 1979, SCAND J STAT, V6, P65; Jambulingam P, 2008, ACTA TROP, V107, P20, DOI 10.1016/j.actatropica.2008.04.005; Jones CM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-78; Julvez J, 1998, B SOC PATHOL EXOT, V91, P99; Labbe P, 2005, J EVOLUTION BIOL, V18, P1471, DOI 10.1111/j.1420-9101.2005.00938.x; Labbe P, 2011, EVOLUTION RESISTANCE, p[14, 409]; Labbe P, 2007, MOL BIOL EVOL, V24, P1056, DOI 10.1093/molbev/msm025; Labbe P, 2009, GENETICS, V182, P303, DOI 10.1534/genetics.109.101444; Lenormand T, 1999, NATURE, V400, P861, DOI 10.1038/23685; Lenormand T, 1998, GENETICS, V149, P1383; Liu HQ, 2004, J MED ENTOMOL, V41, P408, DOI 10.1603/0022-2585-41.3.408; Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989; Marina CF, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-95; Martinez-Torres D, 1999, PESTIC SCI, V55, P1012, DOI 10.1002/(SICI)1096-9063(199910)55:10&lt;1012::AID-PS39&gt;3.0.CO;2-5; METCALF RL, 1967, ANNU REV ENTOMOL, V12, P229, DOI 10.1146/annurev.en.12.010167.001305; Ministry of Health and Quality of Life Mauritius, 2009, OP PLAN PREV CONTR C, P94; Ministry of Health and Quality of Life Mauritius World Health Organization University of California San Francisco, 2012, EL MAL CAS STUD 4, P75; Namountougou M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048412; NASH RG, 1967, SCIENCE, V157, P924, DOI 10.1126/science.157.3791.924; Nkya TE, 2013, INSECT BIOCHEM MOLEC, V43, P407, DOI 10.1016/j.ibmb.2012.10.006; Oakeshott JG, 2005, CHEM-BIOL INTERACT, V157, P269, DOI 10.1016/j.cbi.2005.10.041; Pasteur N, 1999, J MED ENTOMOL, V36, P794, DOI 10.1093/jmedent/36.6.794; PASTEUR N, 1987, MANUEL TECHNIQUE GEN; PENNELL JT, 1964, B WORLD HEALTH ORGAN, V31, P669; PERRY AS, 1970, LIFE SCI 2-BIOCH GEN, V9, P335, DOI 10.1016/0024-3205(70)90178-5; PERRY AS, 1953, BIOL BULL, V104, P426, DOI 10.2307/1538495; Poupardin R, 2008, INSECT BIOCHEM MOLEC, V38, P540, DOI 10.1016/j.ibmb.2008.01.004; Poupardin R, 2012, AQUAT TOXICOL, V114, P49, DOI 10.1016/j.aquatox.2012.02.001; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; RAYMOND M, 1989, GENETICS, V123, P543; RAYMOND M, 1991, NATURE, V350, P151, DOI 10.1038/350151a0; RAYMOND M, 1986, J ECON ENTOMOL, V79, P1452, DOI 10.1093/jee/79.6.1452; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Receveur M C, 2004, Bull Soc Pathol Exot, V97, P265; Renault P, 2012, MED MALADIES INFECT, V42, P93, DOI 10.1016/j.medmal.2011.12.002; Richards SL, 2010, AM J TROP MED HYG, V83, P126, DOI 10.4269/ajtmh.2010.09-0776; Ridley M., 2004, EVOLUTION; Robert V, 2009, MISSION CONSEIL APPU, P53; Rogers SO., 1988, EXTRACTION DNA PLANT; SABATINELLI G, 1994, PARASITE, V1, P71, DOI 10.1051/parasite/1994011071; Sadanandane C, 2012, INDIAN J MED RES, V136, P783; Sakuma M, 1998, APPL ENTOMOL ZOOL, V33, P339, DOI 10.1303/aez.33.339; Sang R, 2010, AM J TROP MED HYG, V83, P28, DOI 10.4269/ajtmh.2010.09-0319; Sissoko D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014141; Sissoko D, 2009, EMERG INFECT DIS, V15, P568, DOI 10.3201/eid1504.081045; StatSoft, 2011, STATISTICA LOG AN DO; Tantely ML, 2010, INSECT BIOCHEM MOLEC, V40, P317, DOI 10.1016/j.ibmb.2010.02.005; Tchen J, 2006, Med Trop (Mars), V66, P295; Fossog BT, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/429817; Tomlin CDS, 2009, PESTICIDE MANUAL WOR; Vinogradova E.B., 2000, CULEX PIPIENS PIPIEN; Weill M, 2004, CURR BIOL, V14, pR552, DOI 10.1016/j.cub.2004.07.008; Weill M, 2004, INSECT MOL BIOL, V13, P1, DOI 10.1111/j.1365-2583.2004.00452.x; Weill M, 2003, NATURE, V423, P136, DOI 10.1038/423136b; Yebakima A, 2004, J MED ENTOMOL, V41, P718, DOI 10.1603/0022-2585-41.4.718	81	29	29	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77855	10.1371/journal.pone.0077855	http://dx.doi.org/10.1371/journal.pone.0077855			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204997	Green Published, Green Submitted, gold			2022-12-27	WOS:000326032600051
J	Forrester, HB; Ivashkevich, A; McKay, MJ; Leong, T; de Kretser, DM; Sprung, CN				Forrester, Helen B.; Ivashkevich, Alesia; McKay, Michael J.; Leong, Trevor; de Kretser, David M.; Sprung, Carl N.			Follistatin Is Induced by Ionizing Radiation and Potentially Predictive of Radiosensitivity in Radiation-Induced Fibrosis Patient Derived Fibroblasts	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; IDIOPATHIC PULMONARY-FIBROSIS; ACTIVIN-BINDING PROTEIN; CANCER-PATIENTS; TISSUE-REPAIR; TIME-LAPSE; CELLS; PIRFENIDONE; HALOFUGINONE; INHIBITION	Follistatin is a potent regulator of the inflammatory response and binds to and inhibits activin A action. Activin A is a member of the TGF beta protein superfamily which has regulatory roles in the inflammatory response and in the fibrotic process. Fibrosis can occur following cell injury and cell death induced by agents such as ionizing radiation (IR). IR is used to treat cancer and marked fibrotic response is a normal tissue (non-tumour) consequence in a fraction of patients under the current dose regimes. The discovery and development of a therapeutic to abate fibrosis in these radiosensitive patients would be a major advance for cancer radiotherapy. Likewise, prediction of which patients are susceptible to fibrosis would enable individualization of treatment and provide an opportunity for pre-emptive fibrosis control and better tumour treatment outcomes. The levels of activin A and follistatin were measured in fibroblasts derived from patients who developed severe radiation-induced fibrosis following radiotherapy and compared to fibroblasts from patients who did not. Both follistatin and activin A gene expression levels were increased following IR and the follistatin gene expression level was lower in the fibroblasts from fibrosis patients compared to controls at both basal levels and after IR. The major follistatin transcript variants were found to have a similar response to IR and both were reduced in fibrosis patients. Levels of follistatin and activin A secreted in the fibroblast culture medium also increased in response to IR and the relative follistatin protein levels were significantly lower in the samples derived from fibrosis patients. The decrease in the follistatin levels can lead to an increased bioactivity of activin A and hence may provide a useful measurement to identify patients at risk of a severe fibrotic response to IR. Additionally, follistatin, by its ability to neutralise the actions of activin A may be of value as an anti-fibrotic for radiation induced fibrosis.	[Forrester, Helen B.; Ivashkevich, Alesia; Sprung, Carl N.] Monash Univ, Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia; [McKay, Michael J.] North Coast Canc Inst, Lismore, NSW, Australia; [Leong, Trevor] Peter MacCallum Canc Ctr, Div Radiat Oncol & Canc Imaging, East Melbourne, Vic, Australia; [de Kretser, David M.] Monash Inst Med Res, Ctr Reprod & Dev, Clayton, Vic, Australia; [de Kretser, David M.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia	Monash University; Peter Maccallum Cancer Center; Monash University; Monash University	Sprung, CN (corresponding author), Monash Univ, Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia.	carl.sprung@monash.edu	McKay, Michael/ABA-9029-2021		National Institute of Health [5U19AI067773-07]; 2010 round of the priority-driven Collaborative Cancer Research Scheme [1002743]; Australian Government Department of Health and Ageing; Australian National Health and Medical Research Council; Australian National Breast Cancer Foundation [PG-08-06]; Victorian Government's Operational Infrastructure Support Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067773] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 2010 round of the priority-driven Collaborative Cancer Research Scheme; Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian National Breast Cancer Foundation; Victorian Government's Operational Infrastructure Support Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported through National Institute of Health [grant 5U19AI067773-07] and the 2010 round of the priority-driven Collaborative Cancer Research Scheme (grant 1002743) and funded by the Australian Government Department of Health and Ageing with the assistance of Cancer Australia. Also, this work was supported by the Australian National Health and Medical Research Council; and the Australian National Breast Cancer Foundation [grant PG-08-06; http://www.nbcf.org.au/]. Support was also provided by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsbeih G, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-125; Alsner J, 2008, SEMIN RADIAT ONCOL, V18, P126, DOI 10.1016/j.semradonc.2007.10.004; Andreassen CN, 2010, RADIOTHER ONCOL, V97, P1, DOI 10.1016/j.radonc.2010.07.018; Anscher MS, 2008, INT J RADIAT ONCOL, V71, P829, DOI 10.1016/j.ijrobp.2008.02.046; Anscher MS, 2006, INT J RADIAT ONCOL, V65, P876, DOI 10.1016/j.ijrobp.2006.02.051; Aoki F, 2005, AM J RESP CRIT CARE, V172, P713, DOI 10.1164/rccm.200412-1620OC; Azuma A, 2005, AM J RESP CRIT CARE, V171, P1040, DOI 10.1164/rccm.200404-571OC; Bentzen SM, 2006, NAT REV CANCER, V6, P702, DOI 10.1038/nrc1950; Bian YS, 2009, CANCER RES, V69, P5918, DOI 10.1158/0008-5472.CAN-08-4623; de Jonge MJA, 2006, EUR J CANCER, V42, P1768, DOI 10.1016/j.ejca.2005.12.027; de Kretser David M, 2013, Methods Mol Biol, V927, P531; de Kretser DM, 2012, MOL CELL ENDOCRINOL, V359, P101, DOI 10.1016/j.mce.2011.10.009; DEKRETSER DM, 1989, BIOL REPROD, V40, P33, DOI 10.1095/biolreprod40.1.33; Denton CP, 2007, ARTHRITIS RHEUM-US, V56, P323, DOI 10.1002/art.22289; Distel LVR, 2006, RADIOTHER ONCOL, V81, P257, DOI 10.1016/j.radonc.2006.10.012; Fields SZ, 2013, EXPERT OPIN INV DRUG, V22, P87, DOI 10.1517/13543784.2013.738666; Forrester HB, 1999, CANCER RES, V59, P931; Forrester HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053358; GRANOT I, 1993, BIOCHIM BIOPHYS ACTA, V1156, P107, DOI 10.1016/0304-4165(93)90123-P; Hedger MP, 2011, VITAM HORM, V85, P255, DOI 10.1016/B978-0-12-385961-7.00013-5; HEDGER MP, 1989, MOL CELL ENDOCRINOL, V61, P133, DOI 10.1016/0303-7207(89)90198-6; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hinz Boris, 2010, F1000 Biol Rep, V2, P78, DOI 10.3410/B2-78; HURWITZ C, 1969, BIOPHYS J, V9, P607, DOI 10.1016/S0006-3495(69)86407-6; INOUYE S, 1991, ENDOCRINOLOGY, V129, P815, DOI 10.1210/endo-129-2-815; Ishii H, 2009, INT J ONCOL, V35, P315, DOI 10.3892/ijo_00000342; Ismail SM, 2004, RADIOTHER ONCOL, V72, P325, DOI 10.1016/j.radonc.2004.07.003; Knight PG, 1996, J ENDOCRINOL, V148, P267, DOI 10.1677/joe.0.1480267; Lepparanta O, 2013, AM J RESP CELL MOL, V48, P448, DOI 10.1165/rcmb.2012-0201OC; Li ZB, 2012, J CELL SCI, V125, P3957, DOI 10.1242/jcs.090365; Lin SY, 2003, REPRODUCTION, V126, P133, DOI 10.1530/rep.0.1260133; Maher TM, 2010, DRUG TODAY, V46, P473, DOI 10.1358/dot.2010.46.7.1488336; MICHEL U, 1990, BIOCHEM BIOPH RES CO, V173, P401, DOI 10.1016/S0006-291X(05)81072-1; Morrissey J, 2002, J AM SOC NEPHROL, V13, pS14; Nagai S, 2002, INTERNAL MED, V41, P1118, DOI 10.2169/internalmedicine.41.1118; Nagashio Y, 2004, LAB INVEST, V84, P1610, DOI 10.1038/labinvest.3700191; NAKAMURA T, 1991, J BIOL CHEM, V266, P19432; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; Nishioka A, 2004, INT J RADIAT ONCOL, V58, P1235, DOI 10.1016/j.ijrobp.2003.11.006; O'Connor AE, 1999, HUM REPROD, V14, P827, DOI 10.1093/humrep/14.3.827; Ohga E, 1996, BIOCHEM BIOPH RES CO, V228, P391, DOI 10.1006/bbrc.1996.1672; Ohga E, 2000, LIFE SCI, V66, P1603, DOI 10.1016/S0024-3205(00)00480-X; Oku H, 2008, EUR J PHARMACOL, V590, P400, DOI 10.1016/j.ejphar.2008.06.046; Parliament MB, 2012, LANCET ONCOL, V13, P7, DOI 10.1016/S1470-2045(11)70331-X; Patella S, 2006, AM J PHYSIOL-GASTR L, V290, pG137, DOI 10.1152/ajpgi.00080.2005; Phillips DJ, 1998, FRONT NEUROENDOCRIN, V19, P287, DOI 10.1006/frne.1998.0169; Rabbani ZN, 2003, INT J RADIAT ONCOL, V57, P563, DOI 10.1016/S0360-3016(03)00639-4; Raghu G, 1999, AM J RESP CRIT CARE, V159, P1061, DOI 10.1164/ajrccm.159.4.9805017; Schultze-Mosgau S, 2004, RADIOTHER ONCOL, V70, P249, DOI 10.1016/j.radonc.2004.01.010; Severin DM, 2001, INT J RADIAT ONCOL, V50, P1323, DOI 10.1016/S0360-3016(01)01608-X; SHIMASAKI S, 1988, P NATL ACAD SCI USA, V85, P4218, DOI 10.1073/pnas.85.12.4218; Simone NL, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-19; Sprung CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025758; Sprung CN, 2005, CLIN CANCER RES, V11, P6352, DOI 10.1158/1078-0432.CCR-04-1931; Sprung CN, 2008, CANC BIOL THER, V7; Sugino Hiromu, 1997, Journal of Medical Investigation, V44, P1; Tsuchida K, 2008, ENDOCR J, V55, P11, DOI 10.1507/endocrj.KR-110; Vasireddy RS, 2010, BRIT J CANCER, V102, P1511, DOI 10.1038/sj.bjc.6605666; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; Werner S, 2006, CYTOKINE GROWTH F R, V17, P157, DOI 10.1016/j.cytogfr.2006.01.001; West CML, 1998, INT J RADIAT BIOL, V73, P409, DOI 10.1080/095530098142248; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xavier S, 2004, J BIOL CHEM, V279, P15167, DOI 10.1074/jbc.M309798200; Yarnold J, 2010, RADIOTHER ONCOL, V97, P149, DOI 10.1016/j.radonc.2010.09.002; Zhou PK, 1998, RADIOTHER ONCOL, V47, P271, DOI 10.1016/S0167-8140(97)00200-4; Zion O, 2009, PANCREAS, V38, P427, DOI 10.1097/MPA.0b013e3181967670	67	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77119	10.1371/journal.pone.0077119	http://dx.doi.org/10.1371/journal.pone.0077119			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204752	Green Published, Green Submitted, gold			2022-12-27	WOS:000326029300083
J	Fujimoto, S; Itsumura, N; Tsuji, T; Anan, Y; Tsuji, N; Ogra, Y; Kimura, T; Miyamae, Y; Masuda, S; Nagao, M; Kambe, T				Fujimoto, Shigeyuki; Itsumura, Naoya; Tsuji, Tokuji; Anan, Yasumi; Tsuji, Natsuko; Ogra, Yasumitsu; Kimura, Tomoki; Miyamae, Yusaku; Masuda, Seiji; Nagao, Masaya; Kambe, Taiho			Cooperative Functions of ZnT1, Metallothionein and ZnT4 in the Cytoplasm Are Required for Full Activation of TNAP in the Early Secretory Pathway	PLOS ONE			English	Article							ZINC TRANSPORT COMPLEXES; ALKALINE-PHOSPHATASES; CONFERS RESISTANCE; SIGNALING PATHWAYS; VERTEBRATE CELLS; COPPER; EXPRESSION; PROTEINS; ACCUMULATION; PATHOGENESIS	The activation process of secretory or membrane-bound zinc enzymes is thought to be a highly coordinated process involving zinc transport, trafficking, transfer and coordination. We have previously shown that secretory and membrane-bound zinc enzymes are activated in the early secretory pathway (ESP) via zinc-loading by the zinc transporter 5 (ZnT5)-ZnT6 hetero-complex and ZnT7 homo-complex (zinc transport complexes). However, how other proteins conducting zinc metabolism affect the activation of these enzymes remains unknown. Here, we investigated this issue by disruption and re-expression of genes known to be involved in cytoplasmic zinc metabolism, using a zinc enzyme, tissue non-specific alkaline phosphatase (TNAP), as a reporter. We found that TNAP activity was significantly reduced in cells deficient in ZnT1, Metallothionein (MT) and ZnT4 genes (ZnT1(-/-) MT-/- ZnT4(-/-) cells), in spite of increased cytosolic zinc levels. The reduced TNAP activity in ZnT1(-/-) MT-/- ZnT4(-/-) cells was not restored when cytosolic zinc levels were normalized to levels comparable with those of wild-type cells, but was reversely restored by extreme zinc supplementation via zinc-loading by the zinc transport complexes. Moreover, the reduced TNAP activity was adequately restored by re-expression of mammalian counterparts of ZnT1, MT and ZnT4, but not by zinc transport-incompetent mutants of ZnT1 and ZnT4. In ZnT1(-/-) MT-/- ZnT4(-/-) cells, the secretory pathway normally operates. These findings suggest that cooperative zinc handling of ZnT1, MT and ZnT4 in the cytoplasm is required for full activation of TNAP in the ESP, and present clear evidence that the activation process of zinc enzymes is elaborately controlled.	[Fujimoto, Shigeyuki; Itsumura, Naoya; Tsuji, Tokuji; Tsuji, Natsuko; Miyamae, Yusaku; Masuda, Seiji; Nagao, Masaya; Kambe, Taiho] Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto, Japan; [Anan, Yasumi; Ogra, Yasumitsu] Showa Pharmaceut Univ, Lab Chem Toxicol & Environm Hlth, Machida, Tokyo, Japan; [Ogra, Yasumitsu] Showa Pharmaceut Univ, High Technol Res Ctr, Machida, Tokyo, Japan; [Kimura, Tomoki] Setsunan Univ, Fac Pharmaceut Sci, Dept Toxicol, Hirakata, Osaka 57301, Japan	Kyoto University; Showa Pharmaceutical University; Showa Pharmaceutical University; Setsunan University	Kambe, T (corresponding author), Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto, Japan.	kambe1@kais.kyoto-u.ac.jp	Miyamae, Yusaku/F-3543-2018; Miyamae, Yusaku/S-3665-2019; Kimura, Tomoki/B-4363-2010; Ogra, Yasumitsu/A-2747-2017	Miyamae, Yusaku/0000-0002-8102-4391; Kimura, Tomoki/0000-0002-5138-5882; Ogra, Yasumitsu/0000-0002-8268-1828; Kambe, Taiho/0000-0001-9757-063X	Ministry of Education, Culture, Sports, Science and Technology of Japan; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Suzuken Memorial Foundation; Takeda Science Foundation; Japan Foundation for Applied Enzymology; Grants-in-Aid for Scientific Research [23380059] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Suzuken Memorial Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Foundation for Applied Enzymology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Suzuken Memorial Foundation, the Takeda Science Foundation and the Japan Foundation for Applied Enzymology (to T. Kambe). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Andreini C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026325; Aydemir TB, 2009, J LEUKOCYTE BIOL, V86, P337, DOI 10.1189/jlb.1208759; Colvin RA, 2010, METALLOMICS, V2, P306, DOI 10.1039/b926662c; Costello LC, 2011, J INORG BIOCHEM, V105, P589, DOI 10.1016/j.jinorgbio.2011.02.002; Dutta A, 2011, NUTR RES, V31, P404, DOI 10.1016/j.nutres.2011.05.001; Eichelsdoerfer JL, 2010, J BIOL CHEM, V285, P34304, DOI 10.1074/jbc.C110.165480; El Meskini R, 2003, J BIOL CHEM, V278, P12278, DOI 10.1074/jbc.M211413200; Falcon-Perez JM, 2007, EXP CELL RES, V313, P1473, DOI 10.1016/j.yexcr.2007.02.006; Fukada T, 2011, METALLOMICS, V3, P662, DOI 10.1039/c1mt00011j; Fukada T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003642; Fukunaka A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227173; Fukunaka A, 2009, J BIOL CHEM, V284, P30798, DOI 10.1074/jbc.M109.026435; Gao SY, 2002, BRIT J PHARMACOL, V137, P749, DOI 10.1038/sj.bjp.0704939; Hamza I, 2001, P NATL ACAD SCI USA, V98, P6848, DOI 10.1073/pnas.111058498; Hirooka T, 2010, TOXICOL IN VITRO, V24, P835, DOI 10.1016/j.tiv.2009.12.009; Ishihara K, 2006, J BIOL CHEM, V281, P17743, DOI 10.1074/jbc.M602470200; Itsumura N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064045; Jeney V, 2005, CIRC RES, V96, P723, DOI 10.1161/01.RES.0000162001.57896.66; Jeong J, 2012, P NATL ACAD SCI USA, V109, pE3530, DOI 10.1073/pnas.1211775110; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Kambe T, 2009, MOL CELL BIOL, V29, P129, DOI 10.1128/MCB.00963-08; Kambe T, 2008, GENESIS, V46, P214, DOI 10.1002/dvg.20382; Kambe T, 2012, CURR TOP MEMBR, V69, P199, DOI 10.1016/B978-0-12-394390-3.00008-2; Kambe T, 2011, BIOSCI BIOTECH BIOCH, V75, P1036, DOI 10.1271/bbb.110056; Kimura T, 2008, BIOCHEM J, V415, P477, DOI 10.1042/BJ20081025; Lazarczyk M, 2008, J EXP MED, V205, P35, DOI 10.1084/jem.20071311; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Maret W, 2012, J INORG BIOCHEM, V111, P110, DOI 10.1016/j.jinorgbio.2011.11.018; Maret W, 2011, J BIOL INORG CHEM, V16, P1079, DOI 10.1007/s00775-011-0800-0; Maret W, 2011, BIOMETALS, V24, P411, DOI 10.1007/s10534-010-9406-1; Maret W, 2009, CHEM REV, V109, P4682, DOI 10.1021/cr800556u; MILLAN JL, 1995, CRIT REV CL LAB SCI, V32, P1, DOI 10.3109/10408369509084680; Miyayama T, 2010, BIOCHEM J, V429, P53, DOI 10.1042/BJ20100223; Miyayama T, 2009, TOXICOL APPL PHARM, V237, P205, DOI 10.1016/j.taap.2009.03.024; Nam DH, 2007, COMP BIOCHEM PHYS C, V145, P295, DOI 10.1016/j.cbpc.2006.10.012; Ohana E, 2009, J BIOL CHEM, V284, P17677, DOI 10.1074/jbc.M109.007203; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Palmiter RD, 1996, EMBO J, V15, P1784, DOI 10.1002/j.1460-2075.1996.tb00527.x; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Suzuki T, 2005, J BIOL CHEM, V280, P637, DOI 10.1074/jbc.M411247200; Suzuki T, 2005, J BIOL CHEM, V280, P30956, DOI 10.1074/jbc.M506902200; Taniguchi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058022; Taylor KM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002585; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Wang YF, 2011, ADV NUTR, V2, P129, DOI 10.3945/an.110.000273; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Yamasaki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039654	51	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77445	10.1371/journal.pone.0077445	http://dx.doi.org/10.1371/journal.pone.0077445			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204829	Green Submitted, Green Published, gold			2022-12-27	WOS:000326029300096
J	Ibrahim, Z; Ebenezer, G; Christensen, JM; Sarhane, KA; Hauer, P; Cooney, DS; Sacks, JM; Schneeberger, S; Lee, WPA; Polydefkis, M; Brandacher, G				Ibrahim, Zuhaib; Ebenezer, Gigi; Christensen, Joani M.; Sarhane, Karim A.; Hauer, Peter; Cooney, Damon S.; Sacks, Justin M.; Schneeberger, Stefan; Lee, W. P. Andrew; Polydefkis, Michael; Brandacher, Gerald			Cutaneous Collateral Axonal Sprouting Re-Innervates the Skin Component and Restores Sensation of Denervated Swine Osteomyocutaneous Alloflaps	PLOS ONE			English	Article							SOCIETIES/PERIPHERAL NERVE SOCIETY; JOINT TASK-FORCE; NEUROLOGICAL SOCIETIES; EUROPEAN FEDERATION; REINNERVATION; REGENERATION; GRAFTS; FIBERS; GUIDELINE; RECOVERY	Reconstructive transplantation such as extremity and face transplantation is a viable treatment option for select patients with devastating tissue loss. Sensorimotor recovery is a critical determinant of overall success of such transplants. Although motor function recovery has been extensively studied, mechanisms of sensory re-innervation are not well established. Recent clinical reports of face transplants confirm progressive sensory improvement even in cases where optimal repair of sensory nerves was not achieved. Two forms of sensory nerve regeneration are known. In regenerative sprouting, axonal outgrowth occurs from the transected nerve stump while in collateral sprouting, reinnervation of denervated tissue occurs through growth of uninjured axons into the denervated tissue. The latter mechanism may be more important in settings where transected sensory nerves cannot be re-apposed. In this study, denervated osteomyocutaneous alloflaps (hind-limb transplants) from Major Histocompatibility Complex (MHC)-defined MGH miniature swine were performed to specifically evaluate collateral axonal sprouting for cutaneous sensory re-innervation. The skin component of the flap was externalized and serial skin sections extending from native skin to the grafted flap were biopsied. In order to visualize regenerating axonal structures in the dermis and epidermis, 50um frozen sections were immunostained against axonal and Schwann cell markers. In all alloflaps, collateral axonal sprouts from adjacent recipient skin extended into the denervated skin component along the dermal-epidermal junction from the periphery towards the center. On day 100 post-transplant, regenerating sprouts reached 0.5 cm into the flap centripetally. Eight months following transplant, epidermal fibers were visualized 1.5 cm from the margin (rate of regeneration 0.06 mm per day). All animals had pinprick sensation in the periphery of the transplanted skin within 3 months post-transplant. Restoration of sensory input through collateral axonal sprouting can revive interaction with the environment; restore defense mechanisms and aid in cortical re-integration of vascularized composite allografts.	[Ibrahim, Zuhaib; Christensen, Joani M.; Sarhane, Karim A.; Cooney, Damon S.; Sacks, Justin M.; Schneeberger, Stefan; Lee, W. P. Andrew; Brandacher, Gerald] Johns Hopkins Univ, Sch Med, Dept Plast & Reconstruct Surg, Baltimore, MD USA; [Ebenezer, Gigi; Hauer, Peter; Polydefkis, Michael] Johns Hopkins Univ, Sch Med, Dept Neurol & Neurosci, Baltimore, MD 21218 USA; [Schneeberger, Stefan] Med Univ Innsbruck, Dept Visceral Transplant & Thorac Surg, Ctr Operat Med, A-6020 Innsbruck, Austria	Johns Hopkins University; Johns Hopkins University; Medical University of Innsbruck	Polydefkis, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol & Neurosci, Baltimore, MD 21218 USA.	mpolyde@jhmi.edu; brandacher@jhmi.edu	Cooney, Damon/J-4762-2014; Schneeberger, Stefan/S-9329-2019; Brandacher, Gerald/L-7540-2016; Furtmüller, Georg J/D-8119-2019; Sarhane, Karim/CAG-5222-2022	Cooney, Damon/0000-0002-2786-287X; Schneeberger, Stefan/0000-0002-2619-8639; Furtmüller, Georg J/0000-0001-8286-0968; Sarhane, Karim/0000-0003-4458-4047; Brandacher, Gerald/0000-0001-7790-441X	US Armed Forces Institute of Regenerative Medicine AFIRM [DoD W8IXWH-08-2-0032]; Open Access Promotion Fund of the Johns Hopkins University Libraries	US Armed Forces Institute of Regenerative Medicine AFIRM; Open Access Promotion Fund of the Johns Hopkins University Libraries	This work was supported by the US Armed Forces Institute of Regenerative Medicine AFIRM (DoD W8IXWH-08-2-0032). Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayramicli M, 2000, BRIT J PLAST SURG, V53, P130, DOI 10.1054/bjps.1999.3204; DIAMOND J, 1992, J NEUROSCI, V12, P1467; DIAMOND J, 1992, J NEUROSCI, V12, P1454; Ebenezer GJ, 2007, J NEUROPATH EXP NEUR, V66, P1059, DOI 10.1097/nen.0b013e31815c8989; Ebenezer GJ, 2007, BRAIN, V130, P2703, DOI 10.1093/brain/awm199; Ebenezer GJ, 2011, BRAIN, V134, P1853, DOI 10.1093/brain/awr086; Glaus SW, 2011, HAND CLIN, V27, P495, DOI 10.1016/j.hcl.2011.07.002; Gordon T, 2008, NEUROL RES, V30, P1012, DOI 10.1179/174313208X362488; Hahn K, 2006, J PERIPHER NERV SYST, V11, P142, DOI 10.1111/j.1085-9489.2006.00079.x; HENRY EW, 1985, EXP NEUROL, V90, P652, DOI 10.1016/0014-4886(85)90162-1; Landin L, 2008, J PLAST RECONSTR AES, V61, P1034, DOI 10.1016/j.bjps.2007.12.084; Lauria G, 2010, EUR J NEUROL, V17, P903, DOI 10.1111/j.1468-1331.2010.03023.x; Lauria G, 2012, CURR DIABETES REP, V12, P384, DOI 10.1007/s11892-012-0280-9; LEE WPA, 1991, PLAST RECONSTR SURG, V87, P401, DOI 10.1097/00006534-199103000-00001; McArthur JC, 2005, ANN NEUROL, V57, P163, DOI 10.1002/ana.20383; Navarro X, 1997, J COMP NEUROL, V380, P164, DOI 10.1002/(SICI)1096-9861(19970407)380:2<164::AID-CNE2>3.0.CO;2-1; Petruzzo P, 2010, TRANSPLANTATION, V90, P1590, DOI 10.1097/TP.0b013e3181ff1472; Polydefkis M, 2004, BRAIN, V127, P1606, DOI 10.1093/brain/awh175; Price RD, 2003, BRIT J PHARMACOL, V140, P825, DOI 10.1038/sj.bjp.0705522; Rajan B, 2003, J COMP NEUROL, V457, P24, DOI 10.1002/cne.10460; Ro LS, 1998, J FORMOS MED ASSOC, V97, P247; SAMULACK DD, 1986, NEUROSCI LETT, V72, P1, DOI 10.1016/0304-3940(86)90608-7; Santanelli F, 2011, PLAST RECONSTR SURG, V127, P1790, DOI 10.1097/PRS.0b013e31820cf1c6; SANTONIRUGIU P, 1966, PLAST RECONSTR SURG, V38, P98, DOI 10.1097/00006534-196608000-00003; Sarhane KA, 2013, CURR SURG REP, V1, P40, DOI 10.1007/s40137-012-0008-4; Siemionow M, 2011, PLAST RECONSTR SURG, V127, P1875, DOI 10.1097/PRS.0b013e31820e90c3; Van den Bergh PYK, 2010, EUR J NEUROL, V17, P356, DOI 10.1111/j.1468-1331.2009.02930.x; WARIS T, 1983, PLAST RECONSTR SURG, V72, P439, DOI 10.1097/00006534-198310000-00001; Washington KM, 2009, PLAST RECONSTR SURG, V123, p26S, DOI 10.1097/PRS.0b013e318191bca2	29	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77646	10.1371/journal.pone.0077646	http://dx.doi.org/10.1371/journal.pone.0077646			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204901	gold, Green Published, Green Submitted			2022-12-27	WOS:000326029300108
J	Nogueira, SV; Backstedt, BT; Smith, AA; Qin, JH; Wunder, EA; Ko, A; Pal, U				Nogueira, Sarah Veloso; Backstedt, Brian T.; Smith, Alexis A.; Qin, Jin-Hong; Wunder, Elsio A., Jr.; Ko, Albert; Pal, Utpal			Leptospira interrogans Enolase Is Secreted Extracellularly and Interacts with Plasminogen	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; BORRELIA-BURGDORFERI; ALPHA-ENOLASE; BINDS PLASMINOGEN; SURFACE PROTEIN; IDENTIFICATION; INSIGHTS; LIPL32; ACQUISITION; COMPLEXES	Leptospira interrogans is the agent for leptospirosis, an important zoonosis in humans and animals across the globe. Surface proteins of invading pathogens, such as L. interrogans, are thought to be responsible for successful microbial persistence in vivo via interaction with specific host components. In particular, a number of invasive infectious agents exploit host proteolytic pathways, such as one involving plasminogen (Pg), which aid in efficient pathogen dissemination within the host. Here we show that L. interrogans serovar Lai binds host Pg and that the leptospiral gene product LA1951, annotated as enolase, is involved in this interaction. Interestingly, unlike in related pathogenic Spirochetes, such as Borrelia burgdorferi, LA1951 is not readily detectable in the L. interrogans outer membrane. We show that the antigen is indeed secreted extracellularly; however, it can reassociate with the pathogen surface, where it displays Pg-binding and measurable enzymatic activity. Hamsters infected with L. interrogans also develop readily detectable antibody responses against enolase. Taken together, our results suggest that the L. interrogans enolase has evolved to play a role in pathogen interaction with host molecules, which may contribute to the pathogenesis of leptospirosis.	[Nogueira, Sarah Veloso; Backstedt, Brian T.; Smith, Alexis A.; Qin, Jin-Hong; Pal, Utpal] Univ Maryland, Dept Vet Med, College Pk, MD 20742 USA; [Nogueira, Sarah Veloso; Backstedt, Brian T.; Smith, Alexis A.; Qin, Jin-Hong; Pal, Utpal] Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA; [Wunder, Elsio A., Jr.; Ko, Albert] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Yale University	Pal, U (corresponding author), Univ Maryland, Dept Vet Med, College Pk, MD 20742 USA.	upal@umd.edu	Pal, Utpal/I-5265-2015; Wunder, Elsio Augusto/C-2733-2013; Ko, Albert/P-2343-2015	Wunder, Elsio Augusto/0000-0002-5239-8511; Ko, Albert/0000-0001-9023-2339	National Institutes of Health [AI080615, AI088752, AI052473]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI080615, R01AI080615, U01AI088752, R01AI052473] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by funding from National Institutes of Health (AI080615, AI088752 and AI052473). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler B, 2011, VET MICROBIOL, V153, P73, DOI 10.1016/j.vetmic.2011.02.055; Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; Agarwal S, 2008, BBA-PROTEINS PROTEOM, V1784, P986, DOI 10.1016/j.bbapap.2008.03.017; Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Bergmann S, 2007, THROMB HAEMOSTASIS, V98, P512, DOI 10.1160/TH07-02-0117; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Chang YF, 2007, VACCINE, V25, P8190, DOI 10.1016/j.vaccine.2007.09.020; Chhatwal GS, 2002, TRENDS MICROBIOL, V10, P205, DOI 10.1016/S0966-842X(02)02351-X; Cinco M, 2010, NEW MICROBIOL, V33, P283; COLEMAN JL, 1995, INFECT IMMUN, V63, P2478, DOI 10.1128/IAI.63.7.2478-2484.1995; Coleman JL, 1997, CELL, V89, P1111, DOI 10.1016/S0092-8674(00)80298-6; Crowe JD, 2003, MOL MICROBIOL, V47, P1637, DOI 10.1046/j.1365-2958.2003.03390.x; Cullen PA, 2005, INFECT IMMUN, V73, P4853, DOI 10.1128/IAI.73.8.4853-4863.2005; Cullen PA, 2004, FEMS MICROBIOL REV, V28, P291, DOI 10.1016/j.femsre.2003.10.004; Cullen PA, 2002, INFECT IMMUN, V70, P2311, DOI 10.1128/IAI.70.5.2311-2318.2002; Faisal SM, 2008, VACCINE, V26, P277, DOI 10.1016/j.vaccine.2007.10.029; Fenno JC, 2000, INFECT IMMUN, V68, P1884, DOI 10.1128/IAI.68.4.1884-1892.2000; Floden AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027502; Goto H, 1998, P NATL ACAD SCI USA, V95, P10224, DOI 10.1073/pnas.95.17.10224; Grassmann AA, 2012, CLIN VACCINE IMMUNOL, V19, P740, DOI 10.1128/CVI.05720-11; Haake DA, 2000, MICROBIOL-SGM, V146, P1491, DOI 10.1099/00221287-146-7-1491; Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000; Haake DA, 2002, CLIN INFECT DIS, V34, pE40, DOI 10.1086/339942; Jong AY, 2003, J MED MICROBIOL, V52, P615, DOI 10.1099/jmm.0.05060-0; Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9; Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208; Kornblatt MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028481; Lee SH, 2002, INFECT IMMUN, V70, P315, DOI 10.1128/IAI.70.1.315-322.2002; Levett PN, 2001, CLIN DIAGN LAB IMMUN, V8, P349, DOI 10.1128/CDLI.8.2.349-351.2001; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lopez-Villar E, 2006, PROTEOMICS, V6, pS107, DOI 10.1002/pmic.200500479; Merien F, 2000, FEMS MICROBIOL LETT, V185, P17, DOI 10.1111/j.1574-6968.2000.tb09034.x; MILES LA, 1991, BIOCHEMISTRY-US, V30, P1682, DOI 10.1021/bi00220a034; Mundodi V, 2008, INFECT IMMUN, V76, P523, DOI 10.1128/IAI.01352-07; Murray GL, 2009, INFECT IMMUN, V77, P952, DOI 10.1128/IAI.01370-08; Nally JE, 2007, INFECT IMMUN, V75, P766, DOI 10.1128/IAI.00741-06; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; Nogueira SV, 2012, INFECT IMMUN, V80, P82, DOI 10.1128/IAI.05671-11; Nogueira SV, 2010, INFECT IMMUN, V78, P4040, DOI 10.1128/IAI.00221-10; Pal U, 2008, J EXP MED, V205, P133, DOI 10.1084/jem.20070962; Palaniappan RUM, 2007, CURR OPIN INFECT DIS, V20, P284, DOI 10.1097/QCO.0b013e32814a5729; Palaniappan RUM, 2005, MOL CELL PROBE, V19, P111, DOI 10.1016/j.mcp.2004.10.002; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; PLOW EF, 1995, FASEB J, V9, P939, DOI 10.1096/fasebj.9.10.7615163; Promnares K, 2009, MOL MICROBIOL, V74, P112, DOI 10.1111/j.1365-2958.2009.06853.x; Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Rijken DC, 2009, J THROMB HAEMOST, V7, P4, DOI 10.1111/j.1538-7836.2008.03220.x; Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097; Siqueira GH, 2013, AM J TROP MED HYG; Stie J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005780; Toledo A, 2012, INFECT IMMUN, V80, P359, DOI 10.1128/IAI.05836-11; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; Velineni S, 2006, Indian J Med Microbiol, V24, P339; Verma A, 2010, INFECT IMMUN, V78, P2053, DOI 10.1128/IAI.01282-09; Vieira ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011259; Vieira Monica L, 2009, Open Microbiol J, V3, P69, DOI 10.2174/1874285800903010069; Vieira ML, 2009, INFECT IMMUN, V77, P4092, DOI 10.1128/IAI.00353-09; Yang CK, 2011, J BACTERIOL, V193, P5607, DOI 10.1128/JB.05897-11; Yang XL, 2011, J PROTEOME RES, V10, P4556, DOI 10.1021/pr200395b; Zeng L, 2013, OMICS, DOI [10.1089/omi.2013.0043, DOI 10.1089/0MI.2013.0043.PUBMED:23895271]	63	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78150	10.1371/journal.pone.0078150	http://dx.doi.org/10.1371/journal.pone.0078150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205133	Green Published, Green Submitted, gold			2022-12-27	WOS:000326029300144
J	Hosseinzadeh, A; Urban, CF				Hosseinzadeh, Ava; Urban, Constantin F.			Novel Insight into Neutrophil Immune Responses by Dry Mass Determination of Candida albicans Morphotypes	PLOS ONE			English	Article							IN-VITRO; DENDRITIC CELLS; MORPHOGENESIS; GRANULOCYTES; RECOGNITION; INFECTIONS; DECTIN-1; OXIDASE; YEAST; ASSAY	The common fungal pathogen Candida albicans has the ability to grow as a yeast or as a hypha and can alternate between these morphotypes. The overall biomass of both morphotypes increases with growth. However, only yeasts, but not hyphae, exist as discrete cellular entities. Multiplicity of infection (MOI) is a useful parameter to determine the initial inoculum of yeasts for in vitro infection assays. Since the amount of hyphae is difficult to quantify, comparable starting conditions in such assays cannot be determined accurately for yeasts and hyphae using MOI. To circumvent this problem, we have established a set of correlation coefficients to convert fungal metabolic activity and optical density to dry mass. Using these correlations, we were able to accurately compare ROS production and IL-8 release by polymorphonuclear neutrophils upon infection with equal dry mass amounts of yeast and hyphal morphotypes. Neutrophil responses depended on the initial form of infection, irrespective of C. albicans wild-type yeasts transforming to hyphal growth during the assay. Infection with a high mass of live C. albicans yeasts resulted in lower neutrophil ROS and this decrease stems from efficient ROS detoxification by C. albicans without directly affecting the phagocyte ROS machinery. Moreover, we show that dead C. albicans induces significantly less ROS and IL-8 release than live fungi, but thimerosal-killed C. albicans were still able to detoxify neutrophil ROS. Thus, the dry mass approach presented in this study reveals neutrophil responses to different amounts and morphotypes of C. albicans and serves as a template for studies that aim to identify morphotype-specific responses in a variety of immune cells.	[Urban, Constantin F.] Umea Univ, Dept Clin Microbiol, Umea, Sweden; [Hosseinzadeh, Ava; Urban, Constantin F.] Umea Univ, Dept Mol Biol, Umea, Sweden; [Hosseinzadeh, Ava] Umea Ctr Microbial Res, Umea, Sweden	Umea University; Umea University	Urban, CF (corresponding author), Umea Univ, Dept Clin Microbiol, Umea, Sweden.	constantin.urban@mims.umu.se	Urban, Constantin/H-5121-2019	Urban, Constantin/0000-0003-1438-1134; hosseinzadeh, ava/0000-0003-3069-0295	Swedish Research Council VR-M [K2012-99X-21961-01-3]; Laboratory for Molecular Medicine Sweden (MIMS); Medial Faculty Umea [316-886-10]; J.C. Kempes Memorial Fund	Swedish Research Council VR-M(Swedish Research Council); Laboratory for Molecular Medicine Sweden (MIMS); Medial Faculty Umea; J.C. Kempes Memorial Fund	This work was supported by grants from the Swedish Research Council VR-M (K2012-99X-21961-01-3), the Laboratory for Molecular Medicine Sweden (MIMS) and the Medial Faculty Umea (316-886-10). AH acknowledges financial support from the J.C. Kempes Memorial Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aga E, 2002, J IMMUNOL, V169, P898, DOI 10.4049/jimmunol.169.2.898; Behnsen J, 2007, PLOS PATHOG, V3, P138, DOI 10.1371/journal.ppat.0030013; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; Bryan AK, 2010, P NATL ACAD SCI USA, V107, P999, DOI 10.1073/pnas.0901851107; Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7; Cassatella MA, 1997, ANN NY ACAD SCI, V832, P233, DOI 10.1111/j.1749-6632.1997.tb46251.x; Chauhan N, 2006, NAT REV MICROBIOL, V4, P435, DOI 10.1038/nrmicro1426; Cheng SC, J LEUKOC BIOL, V90, P357; Cottier F, 2009, FEMS MICROBIOL LETT, V295, P1, DOI 10.1111/j.1574-6968.2009.01564.x; d'Ostiani CF, 2000, J EXP MED, V191, P1661, DOI 10.1084/jem.191.10.1661; DINAUER MC, 1993, CRIT REV CL LAB SCI, V30, P329, DOI 10.3109/10408369309082591; Donini M, 2007, EUR J IMMUNOL, V37, P1194, DOI 10.1002/eji.200636532; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; Frohner IE, 2009, MOL MICROBIOL, V71, P240, DOI 10.1111/j.1365-2958.2008.06528.x; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; GOW NAR, 1987, CRIT REV MICROBIOL, V15, P73, DOI 10.3109/10408418709104449; HADDAD SA, 1953, APPL MICROBIOL, V1, P153, DOI 10.1128/AEM.1.3.153-156.1953; Hajjeh RA, 2004, J CLIN MICROBIOL, V42, P1519, DOI 10.1128/JCM.42.4.1519-1527.2004; Kruppa M, 2011, GLYCOBIOLOGY, V21, P1173, DOI 10.1093/glycob/cwr051; LIOCHEV SI, 1994, FREE RADICAL BIO MED, V16, P29, DOI 10.1016/0891-5849(94)90239-9; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Losse J, 2011, MOL IMMUNOL, V48, P2135, DOI 10.1016/j.molimm.2011.07.007; MESHULAM T, 1995, J INFECT DIS, V172, P1153, DOI 10.1093/infdis/172.4.1153; MILLER MD, 1992, CRIT REV IMMUNOL, V12, P17; Miramon P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052850; Moyes DL, 2010, CELL HOST MICROBE, V8, P225, DOI 10.1016/j.chom.2010.08.002; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Netea MG, 2010, CELL HOST MICROBE, V8, P219, DOI 10.1016/j.chom.2010.08.008; ODDS FC, 1987, CRC CR REV MICROBIOL, V15, P1; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Soloviev DA, 2011, INFECT IMMUN, V79, P1546, DOI 10.1128/IAI.00650-10; Stoldt VR, 1997, EMBO J, V16, P1982, DOI 10.1093/emboj/16.8.1982; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; Wellington M, 2009, INFECT IMMUN, V77, P405, DOI 10.1128/IAI.00860-08; Wellington M, 2013, MBIO, V4, DOI 10.1128/mBio.00433-12; Whiteway M, 2007, ANNU REV MICROBIOL, V61, P529, DOI 10.1146/annurev.micro.61.080706.093341; Wozniok I, 2008, CELL MICROBIOL, V10, P807, DOI 10.1111/j.1462-5822.2007.01086.x; YOUNG G, 1958, J INFECT DIS, V102, P114, DOI 10.1093/infdis/102.2.114; Zavrel M, 2012, EUKARYOT CELL, V11, P129, DOI 10.1128/EC.05206-11	40	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77993	10.1371/journal.pone.0077993	http://dx.doi.org/10.1371/journal.pone.0077993			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205058	Green Submitted, Green Published, gold			2022-12-27	WOS:000326334500087
J	Masson, M; Molnar, E; Donoghue, HD; Besra, GS; Minnikin, DE; Wu, HHT; Lee, OYC; Bull, ID; Palfi, G				Masson, Muriel; Molnar, Erika; Donoghue, Helen D.; Besra, Gurdyal S.; Minnikin, David E.; Wu, Houdini H. T.; Lee, Oona Y-C.; Bull, Ian D.; Palfi, Gyoergy			Osteological and Biomolecular Evidence of a 7000-Year-Old Case of Hypertrophic Pulmonary Osteopathy Secondary to Tuberculosis from Neolithic Hungary	PLOS ONE			English	Article							RADIOCARBON AGE CALIBRATION; SKELETAL; ANCIENT; OSTEOARTHROPATHY; DNA; SETTLEMENTS; COLLECTION; LIGURIA; REMAINS	Seventy-one individuals from the late Neolithic population of the 7000-year-old site of Hodmezovasarhely-Gorzsa were examined for their skeletal palaeopathology. This revealed numerous cases of infections and non-specific stress indicators in juveniles and adults, metabolic diseases in juveniles, and evidence of trauma and mechanical changes in adults. Several cases showed potential signs of tuberculosis, particularly the remains of the individual HGO-53. This is an important finding that has significant implications for our understanding of this community. The aim of the present study was to seek biomolecular evidence to confirm this diagnosis. HGO-53 was a young male with a striking case of hypertrophic pulmonary osteopathy (HPO), revealing rib changes and cavitations in the vertebral bodies. The initial macroscopic diagnosis of HPO secondary to tuberculosis was confirmed by analysis of Mycobacterium tuberculosis complex specific cell wall lipid biomarkers and corroborated by ancient DNA (aDNA) analysis. This case is the earliest known classical case of HPO on an adult human skeleton and is one of the oldest palaeopathological and palaeomicrobiological tuberculosis cases to date.	[Masson, Muriel] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Masson, Muriel; Molnar, Erika; Palfi, Gyoergy] Univ Szeged, Dept Biol Anthropol, Szeged, Hungary; [Donoghue, Helen D.] UCL, Ctr Clin Microbiol, London, England; [Donoghue, Helen D.] UCL, Ctr Hist Med, London, England; [Besra, Gurdyal S.; Minnikin, David E.; Wu, Houdini H. T.; Lee, Oona Y-C.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Bull, Ian D.] Univ Bristol, Sch Chem, Organ Geochem Unit, Bristol, Avon, England	University of Edinburgh; Szeged University; University of London; University College London; University of London; University College London; University of Birmingham; University of Bristol	Masson, M (corresponding author), Univ Edinburgh, Edinburgh, Midlothian, Scotland.	murielmasson@gmail.com	Donoghue, Helen D./D-6805-2013; Molnar, Erika/A-8780-2015; Bull, Ian/AAV-1474-2020; Pálfi, György/M-3555-2018; Pálfi, György/AAL-7268-2020	Donoghue, Helen D./0000-0003-3918-5252; Molnar, Erika/0000-0001-6660-9239; Bull, Ian/0000-0002-5881-5654; Pálfi, György/0000-0003-0989-4090; Besra, Gurdyal/0000-0002-5605-0395	Leverhulme Trust [F/00094/BL]; United Kingdom National Environmental Research Council [R8/H12/15]; Hungarian Scientific Research Fund [78555]; NERC [lsmsf010001] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1239307] Funding Source: researchfish; Natural Environment Research Council [lsmsf010001] Funding Source: researchfish	Leverhulme Trust(Leverhulme Trust); United Kingdom National Environmental Research Council; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The study was supported by Leverhulme Trust Project Grant F/00094/BL (GSB, DEM, OY-CL, HHTW). The United Kingdom National Environmental Research Council provided funding for the mass spectrometry facilities at Bristol (Contract no. R8/H12/15; www.lsmsf.co.uk). Additionally funding was provided by the Hungarian Scientific Research Fund Grant no. 78555. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assis S, 2011, INT J PALEOPATHOL, V1, P155, DOI 10.1016/j.ijpp.2012.02.009; Aufderheide A. C., 1998, HUMAN PALEOPATHOLOGY; Blondiaux J., 1992, INT J OSTEOARCHAEOL, V2, P241, DOI [10.1002/oa.1390020308, DOI 10.1002/OA.1390020308]; Canci A, 1996, INT J OSTEOARCHAEOL, V6, P497, DOI 10.1002/(SICI)1099-1212(199612)6:5<497::AID-OA291>3.0.CO;2-O; Donoghue HD, 2011, CLIN MICROBIOL INFEC, V17, P821, DOI 10.1111/j.1469-0691.2011.03554.x; Donoghue HD, 1998, LETT APPL MICROBIOL, V27, P265; Donoghue HD, 2004, LANCET INFECT DIS, V4, P584, DOI 10.1016/S1473-3099(04)01133-8; Donoghue HD, 2010, P R SOC B, V277, P51, DOI 10.1098/rspb.2009.1484; Farkas G, 2005, SZAKVELEMENY HODMEZO; FORMICOLA V, 1987, AM J PHYS ANTHROPOL, V72, P1, DOI 10.1002/ajpa.1330720102; Gazdapusztai G, 1957, ARCHAEOLOGIAI ERTESI, V84, P3; Gazdapusztai G, 1963, KESONEOLITKORI TELEP, P21; Gernaey A.M., 1999, TUBERCULOSIS PAST PR, P275; Gernaey AM, 2001, TUBERCULOSIS, V81, P259, DOI 10.1054/tube.2001.0295; Gladykowska-Rzeczycka J., 1993, J PALEOPATHOLOGY, V5, P159; Gladykowska-Rzeczycka JJ, 1999, TUBERCULOSIS PRESENT, P561; Grubezy E, 1998, CR ACAD SCI III-VIE, V321, P941; Hajdu T, 2012, SPINE, V37, pE1598, DOI 10.1097/BRS.0b013e31827300dc; Hershkovitz I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003426; HERTELENDI E, 1992, RADIOCARBON, V34, P859, DOI 10.1017/S0033822200064171; Hertelendi E, 1998, RADIOCARBON, V40, P659; HERTELENDI E, 1998, ARCHAEOMETRICAL RES, V2, P61; Horvath F, 2005, HETKOZNAPOK VENUSZAI, P67; Horvath F, 1987, LATE NEOLITHIC TISZA, P31; Horvath F, 2003, HUNGARIAN ARCHEOLOGY, P100; Horvath F, 2005, EVERYDAY VENUSES LAT, P27; Horvath F, 2003, HUNGARIAN ARCHAEOLOG, P106; Horvath F, 1982, ARCHEOLOGIAI ERTESIT, V1, P201; Kohler K, 2012, INT J OSTEOARCHAEOL, DOI [10.1002/oa.2254, DOI 10.1002/0A.2254]; Lee OYC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041923; Maczel M., 2003, TRACES TUBERCULOSIS; Martinez-Lavin Manuel, 1997, Current Opinion in Rheumatology, V9, P83, DOI 10.1097/00002281-199701000-00016; Masson M, 2009, LESIONS MODERN DIAGN, P80; Matos V, 2006, AM J PHYS ANTHROPOL, V130, P190, DOI 10.1002/ajpa.20309; Mays S, 2002, J ARCHAEOL SCI, V29, P1267, DOI 10.1006/jasc.2001.0769; Minnikin DE, 2012, UNDERSTANDING TUBERCULOSIS - DECIPHERING THE SECRET LIFE OF THE BACILLI, P3; Minnikin DE, 2002, CHEM BIOL, V9, P545, DOI 10.1016/S1074-5521(02)00142-4; Ortner D., 2003, IDENTIFICATIONS PATH; Posa Annamaria, 2012, Acta Biologica Szegediensis, V56, P125; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Redman JE, 2009, TUBERCULOSIS, V89, P267, DOI 10.1016/j.tube.2009.04.001; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Roberts C.A., 1999, TUBERCULOSIS PRESENT, P311; Rothschild B. M., 1999, TUBERCULOSIS PRESENT, P293; Rothschild BM, 1998, J RHEUMATOL, V25, P2221; Santos AL, 2001, AM J PHYS ANTHROPOL, V115, P38, DOI 10.1002/ajpa.1054; Spekker Olga, 2012, Acta Biologica Szegediensis, V56, P115; Spigelman M, 2002, INT J OSTEOARCHAEOL, V12, P393, DOI 10.1002/oa.638; Taylor GM, 2007, MICROBIOL-SGM, V153, P1243, DOI 10.1099/mic.0.2006/002154-0; WEBB JG, 1986, TUBERCLE, V67, P225, DOI 10.1016/S0041-3879(86)80029-0; Yerkes RW, 2009, RADIOCARBON, V51, P1071, DOI 10.1017/S0033822200034123; Zink AR, 2007, INT J OSTEOARCHAEOL, V17, P380, DOI 10.1002/oa.909	53	32	32	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78252	10.1371/journal.pone.0078252	http://dx.doi.org/10.1371/journal.pone.0078252			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205173	Green Submitted, Green Published, gold			2022-12-27	WOS:000326334500107
J	Naharudin, MN; Yusof, A				Naharudin, Mohamed Nashrudin; Yusof, Ashril			Fatigue Index and Fatigue Rate during an Anaerobic Performance under Hypohydrations	PLOS ONE			English	Article							RESISTANCE EXERCISE; MUSCULAR STRENGTH; HYDRATION STATE; MOTOR UNITS; WEIGHT-LOSS; MUSCLE; POWER; HYPERTHERMIA; DEHYDRATION	Background: Since hypohydration commonly occurs in sports, studies on anaerobic exercise performance under this condition have been extensively carried out. When describing anaerobic performance, authors usually refer to a drop in anaerobic performance as fatigue index (FI) which is conventionally calculated using peak and low power data points. Meanwhile, another possible method in explaining anaerobic fatigue is using the rate constant which is derived from the exponential decline of power output known as fatigue rate (FR). Few studies have demonstrated that there was no change in anaerobic performance under mild hypohydrations. Purpose: This study aimed to compare the kinetics of power output using FI and FR of an anaerobic performance (Wingate test) under 2, 3 and 4% state of hypohydrations. Method: Thirty two collegiate cyclists (age = 22 +/- 2 years; body weight = 71.45 +/- 3.43 kg; height = 173.23 +/- 0.04 cm) were matched using their baseline anaerobic peak power (APP) then randomly divided into 4 groups of EU (euhydrated), 2H, 3H and 4H respectively. Results: As expected the, FI, APP, anaerobic lower power (ALP) and rating of perceived exertion (RPE) did not show significant differences between and within the groups. However, the FR in 3H (0.018 +/- 0.005s(-1)) and 4H (0.019 +/- 0.010s(-1)) were significantly lower than EU (0.033 +/- 0.012s(-1)). Post-test FR also showed significant reduction in 3H and 4H compared to their pre-test values (p<0.05). Conclusion: Despite the lack of changes in APP and RPE, subjects in 3H and 4H showed evidence of lower reduction of power output over time. The findings support earlier reports which showed no change in anaerobic performance under mild hypohydrations. The relatively lower FR suggests higher drive in maintaining power output under hypohydrations of 3 and 4% body weight.	[Naharudin, Mohamed Nashrudin; Yusof, Ashril] Univ Malaya, Sports Ctr, Kuala Lumpur, Malaysia	Universiti Malaya	Naharudin, MN (corresponding author), Univ Malaya, Sports Ctr, Kuala Lumpur, Malaysia.	nashrudin@um.edu.my	Naharudin, Mohamed Nashrudin/ABD-1540-2020; YUSOF, ASHRIL/B-8252-2010	Naharudin, Mohamed Nashrudin/0000-0002-1408-7966; YUSOF, ASHRIL/0000-0002-8117-6440	University of Malaya's Institute of Research Management and Monitoring research fund [RG367/11HTM]	University of Malaya's Institute of Research Management and Monitoring research fund	The work is supported by University of Malaya's Institute of Research Management and Monitoring research fund (RG367/11HTM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam A, 2005, J APPL PHYSIOL, V99, P268, DOI 10.1152/japplphysiol.01344.2004; Adam GM, 2002, EXERCISE PHYSL LAB M, P107; Ball D, 1999, EUR J APPL PHYSIOL, V79, P360, DOI 10.1007/s004210050521; BAROR O, 1977, ISRAEL J MED SCI, V13, P326; Carpentier A, 2001, J PHYSIOL-LONDON, V534, P903, DOI 10.1111/j.1469-7793.2001.00903.x; Cheuvront SN, 2006, MED SCI SPORT EXER, V38, P1093, DOI 10.1249/01.mss.0000222838.74015.15; De Luca CJ, 1996, J NEUROPHYSIOL, V76, P1503, DOI 10.1152/jn.1996.76.3.1503; Dotan R, 2006, EUR J APPL PHYSIOL, V98, P113, DOI 10.1007/s00421-006-0251-4; Drust B, 2005, ACTA PHYSIOL SCAND, V183, P181, DOI 10.1111/j.1365-201X.2004.01390.x; ENOKA RM, 1989, J NEUROPHYSIOL, V62, P1344, DOI 10.1152/jn.1989.62.6.1344; FOGELHOLM GM, 1993, MED SCI SPORT EXER, V25, P371, DOI 10.1249/00005768-199303000-00012; Gonzalez-Alonso J, 1999, J PHYSIOL-LONDON, V520, P577, DOI 10.1111/j.1469-7793.1999.00577.x; Greiwe JS, 1998, MED SCI SPORT EXER, V30, P284, DOI 10.1097/00005768-199802000-00017; Hedley AM, 2002, J STRENGTH COND RES, V16, P353; Houston M E, 1981, Phys Sportsmed, V9, P73, DOI 10.1080/00913847.1981.11711208; Inbar O, 1996, WINGATE ANAEROBIC TE, P1; JACOBS I, 1982, MED SCI SPORT EXER, V14, P457, DOI 10.1249/00005768-198206000-00009; Jones LC, 2008, J STRENGTH COND RES, V22, P455, DOI 10.1519/JSC.0b013e3181635ba5; Judelson DA, 2007, SPORTS MED, V37, P907, DOI 10.2165/00007256-200737100-00006; Judelson DA, 2007, MED SCI SPORT EXER, V39, P1817, DOI 10.1249/mss.0b013e3180de5f22; King RFGJ, 2008, J SPORT SCI, V26, P1361, DOI 10.1080/02640410802192768; Kraemer WJ, 2001, MED SCI SPORT EXER, V33, P1367, DOI 10.1097/00005768-200108000-00019; Kraft JA, 2011, J STRENGTH COND RES, V25, P778, DOI 10.1519/JSC.0b013e3181c1f79d; Laurent CM, 2007, EUR J APPL PHYSIOL, V100, P645, DOI 10.1007/s00421-007-0454-3; Marquardt JA., 1993, RES Q EXERCISE SPORT, V64, pA33; Montain SJ, 1998, J APPL PHYSIOL, V84, P1889, DOI 10.1152/jappl.1998.84.6.1889; Morrison S, 2004, EUR J APPL PHYSIOL, V91, P729, DOI 10.1007/s00421-004-1063-z; Nielsen B., 1981, SCAND J MED SCI SPOR, V3, P2; VIITASALO JT, 1987, INT J SPORTS MED, V8, P281, DOI 10.1055/s-2008-1025670; WEBSTER S, 1990, MED SCI SPORT EXER, V22, P229; Yamamoto LM, 2008, J STRENGTH COND RES, V22, P1387, DOI 10.1519/JSC.0b013e3181739403	31	12	13	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77290	10.1371/journal.pone.0077290	http://dx.doi.org/10.1371/journal.pone.0077290			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204790	Green Published, Green Submitted, gold			2022-12-27	WOS:000326334500022
J	Lai, PMR; Dasenbrock, H; Lin, N; Du, R				Lai, Pui Man Rosalind; Dasenbrock, Hormuzdiyar; Lin, Ning; Du, Rose			The Impact of Insurance Status on the Outcomes after Aneurysmal Subarachnoid Hemorrhage	PLOS ONE			English	Article							UNRUPTURED INTRACRANIAL ANEURYSMS; UNITED-STATES; TRAUMA MORTALITY; PAYER STATUS; SURGERY; REPAIR; RACE; NEUROSURGERY; DISPARITIES; MORBIDITY	Investigation into the association of insurance status with the outcomes of patients undergoing neurosurgical intervention has been limited: this is the first nationwide study to analyze the impact of primary payer on the outcomes of patients with aneurysmal subarachnoid hemorrhage who underwent endovascular coiling or microsurgical clipping. The Nationwide Inpatient Sample (2001-2010) was utilized to identify patients; those with both an ICD-9 diagnosis codes for subarachnoid hemorrhage and a procedure code for aneurysm repair (either via an endovascular or surgical approach) were included. Hierarchical multivariate regression analyses were utilized to evaluate the impact of primary payer on in-hospital mortality, hospital discharge disposition, and length of hospital stay with hospital as the random effects variable. Models were adjusted for patient age, sex, race, comorbidities, socioeconomic status, hospital region, location (urban versus rural), and teaching status, procedural volume, year of admission, and the proportion of patients who underwent ventriculostomy. Subsequent models were also adjusted for time to aneurysm repair and time to ventriculostomy; subgroup analyses evaluated for those who underwent endovascular and surgical procedures separately. 15,557 hospitalizations were included. In the initial model, the adjusted odds of in-hospital mortality were higher for Medicare (OR 1.23, p<0.001), Medicaid (OR 1.23, p<0.001), and uninsured patients (OR 1.49, p<0.001) compared to those with private insurance. After also adjusting for timing of intervention, Medicaid and uninsured patients had a reduced odds of non-routine discharge (OR 0.75, p<0.001 and OR 0.42, p<0.001) despite longer hospital stays (by 8.35 days, p<0.001 and 2.45 days, p = 0.005). Variations in outcomes by primary payer-including in-hospital post-procedural mortality-were more pronounced for patients of all insurance types who underwent microsurgical clipping. The observed differences by primary payer are likely multifactorial, attributable to varied socioeconomic factors and the complexities of the American healthcare delivery system.	[Du, Rose] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Du, R (corresponding author), Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA.	rdu@partners.org	Lin, Ning/AAP-7745-2020; Du, Rose/AAJ-2873-2020; Lai, Rosalind/AAG-3680-2021; Du, Rose/I-5402-2012	Lin, Ning/0000-0002-3638-4814; Du, Rose/0000-0003-2641-6496				Abdo A, 2012, INT UROL NEPHROL, V44, P343, DOI 10.1007/s11255-011-0056-1; Alosh H, 2009, SPINE, V34, P1956, DOI 10.1097/BRS.0b013e3181ab930e; Boxer LK, 2003, SURGERY, V134, P142, DOI 10.1067/msy.2003.214; Brinjikji W, 2011, STROKE, V42, P1320, DOI 10.1161/STROKEAHA.110.607986; Dasenbrock HH, 2012, CANCER-AM CANCER SOC, V118, P4833, DOI 10.1002/cncr.27388; El-Sayed AM, 2011, WORLD NEUROSURG, V76, P459, DOI 10.1016/j.wneu.2011.03.051; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Haider AH, 2008, ARCH SURG-CHICAGO, V143, P945, DOI 10.1001/archsurg.143.10.945; Kelz RR, 2004, CANCER-AM CANCER SOC, V101, P2187, DOI 10.1002/cncr.20624; Komotar RJ, 2008, NEUROSURGERY, V62, P183, DOI 10.1227/01.NEU.0000311076.64109.2E; LaPar DJ, 2010, ANN SURG, V252, P544, DOI 10.1097/SLA.0b013e3181e8fd75; Lemaire A, 2008, J VASC SURG, V47, P1172, DOI 10.1016/j.jvs.2008.01.033; Lin N, 2011, WORLD NEUROSURG, V76, P398, DOI 10.1016/j.wneu.2011.05.011; Mannix R, 2012, J PEDIATR-US, V161, P536, DOI 10.1016/j.jpeds.2012.03.013; Momin EN, 2012, ARCH SURG-CHICAGO, V147, P1017, DOI 10.1001/archsurg.2012.1459; Moser JW, 2012, J AM COLL RADIOL, V9, P50, DOI 10.1016/j.jacr.2011.08.006; Murphy EH, 2010, J VASC SURG, V51, p14S, DOI 10.1016/j.jvs.2009.11.079; Nirula R, 2009, J TRAUMA, V66, P255, DOI 10.1097/TA.0b013e31815ede46; PLEIS JR, 2006, VITAL HLTH STAT, V10, P1; Rinkel GJE, 2008, J NEURORADIOLOGY, V35, P99, DOI 10.1016/j.neurad.2007.11.004; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; Rosen H, 2009, ARCH SURG-CHICAGO, V144, P1006, DOI 10.1001/archsurg.2009.195; Rosen H, 2009, J PEDIATR SURG, V44, P1952, DOI 10.1016/j.jpedsurg.2008.12.026; Salim A, 2010, J TRAUMA, V68, P211, DOI 10.1097/TA.0b013e3181a0e659; Shen JJ, 2007, STROKE, V38, P1010, DOI 10.1161/01.STR.0000257312.12989.af; Slatore CG, 2010, AM J RESP CRIT CARE, V182, P1195, DOI 10.1164/rccm.2009-038ST; Trinh QD, 2012, CANCER-AM CANCER SOC, V118, P1803, DOI 10.1002/cncr.26475; Wong GKC, 2012, WORLD NEUROSURG, V77, P311, DOI 10.1016/j.wneu.2011.09.025	28	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78047	10.1371/journal.pone.0078047	http://dx.doi.org/10.1371/journal.pone.0078047			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205085	Green Published, Green Submitted, gold			2022-12-27	WOS:000326270700067
J	Leardini, A; Berti, L; Begon, M; Allard, P				Leardini, Alberto; Berti, Lisa; Begon, Mickael; Allard, Paul			Effect of Trunk Sagittal Attitude on Shoulder, Thorax and Pelvis Three-Dimensional Kinematics in Able-Bodied Subjects during Gait	PLOS ONE			English	Article							ADOLESCENT IDIOPATHIC SCOLIOSIS; LUMBAR SPINE; WALKING; MOVEMENTS; CLASSIFICATION; DEFORMITY; STANCE; SWAY; MEN	It has been shown that an original attitude in forward or backward inclination of the trunk is maintained at gait initiation and during locomotion, and that this affects lower limb loading patterns. However, no studies have shown the extent to which shoulder, thorax and pelvis three-dimensional kinematics are modified during gait due to this sagittal inclination attitude. Thirty young healthy volunteers were analyzed during level walking with video-based motion analysis. Reflecting markers were mounted on anatomical landmarks to form a two-marker shoulder line segment, and a four-marker thorax and pelvis segments. Absolute and relative spatial rotations were calculated, for a total of 11 degrees of freedom. The subjects were divided into two groups of 15 according to the median of mean thorax inclination angle over the gait cycle. Preliminary MANOVA analysis assessed whether gender was an independent variable. Then two-factor nested ANOVA was used to test the possible effect of thorax inclination on body segments, planes of motion and gait periods, separately. There was no significant difference in all anthropometric and spatio-temporal parameters between the two groups, except for subject mass. The three-dimensional kinematics of the thorax and pelvis were not affected by gender. Nested ANOVA revealed group effect in all segment rotations apart those at the pelvis, in the sagittal and frontal planes, and at the push-off. Attitudes in sagittal thorax inclination altered trunk segments kinematics during gait. Subjects with a backward thorax showed less thorax-to-pelvis motion, but more shoulder-to-thorax and thorax-to-laboratory motion, less motion in flexion/extension and in lateral bending, and also less motion during push-off. This contributes to the understanding of forward propulsion and sideways load transfer mechanisms, fundamental for the maintenance of balance and the risk of falling.	[Leardini, Alberto; Berti, Lisa] Ist Ortoped Rizzoli, MovementAnal Lab, Bologna, Italy; [Begon, Mickael] Univ Montreal, Dept Kinesiol, Lab Ingn Mouvement, Montreal, PQ, Canada; [Allard, Paul] Univ Montreal, Dept Kinesiol, Montreal, PQ, Canada; [Allard, Paul] St Justine Hosp, Res Ctr, Human Movement Lab, Montreal, PQ, Canada	IRCCS Istituto Ortopedico Rizzoli; Universite de Montreal; Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Leardini, A (corresponding author), Ist Ortoped Rizzoli, MovementAnal Lab, Bologna, Italy.	leardini@ior.it	Allard, Paul/ABA-3257-2021; Leardini, Alberto/C-8189-2019; BEGON, Mickael/M-9574-2013; Begon, Mickaël/AAH-9887-2019	Leardini, Alberto/0000-0003-3547-7370; BEGON, Mickael/0000-0002-4107-9160; Begon, Mickaël/0000-0002-4107-9160; BERTI, LISA/0000-0002-0840-6617	NSERC; Regione Emilia-Romagna	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Regione Emilia-Romagna(Regione Emilia Romagna)	NSERC and Regione Emilia-Romagna for funding this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkin AL, 2005, GAIT POSTURE, V22, P240, DOI 10.1016/j.gaitpost.2004.09.009; Bruyneel AV, 2008, NEUROSCI LETT, V447, P158, DOI 10.1016/j.neulet.2008.10.007; CHRISTIE HJ, 1995, ARCH PHYS MED REHAB, V76, P218, DOI 10.1016/S0003-9993(95)80604-0; Chung CY, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-9; Crosbie J, 1997, GAIT POSTURE, V5, P6, DOI 10.1016/S0966-6362(96)01066-1; Dalleau G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036755; ENG JJ, 1995, J BIOMECH, V28, P753, DOI 10.1016/0021-9290(94)00124-M; Engsberg JR, 2001, SPINE, V26, P2020, DOI 10.1097/00007632-200109150-00016; Evcik D, 2003, RHEUMATOL INT, V23, P163, DOI 10.1007/s00296-002-0268-x; Goh JH, 1998, CLIN BIOMECH, V13, pS26, DOI 10.1016/S0268-0033(97)00071-5; Grood E, 1983, J BIOMECHANICAL ENG, V105, P2; Heyrman L, 2013, GAIT POSTURE; Hurt CP, 2010, GAIT POSTURE, V31, P461, DOI 10.1016/j.gaitpost.2010.02.001; Leardini A, 2011, CLIN BIOMECH, V26, P562, DOI 10.1016/j.clinbiomech.2011.01.015; Leardini A, 2009, CLIN BIOMECH, V24, P542, DOI 10.1016/j.clinbiomech.2009.05.005; Leroux A, 2002, GAIT POSTURE, V15, P64, DOI 10.1016/S0966-6362(01)00181-3; Leteneur S, 2009, CLIN BIOMECH, V24, P190, DOI 10.1016/j.clinbiomech.2008.10.005; Leteneur S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055256; Linley HS, 2010, CLIN BIOMECH, V25, P1003, DOI 10.1016/j.clinbiomech.2010.07.012; Mansfield A, 2010, PHYS THER, V90, P476, DOI 10.2522/ptj.20090070; Menz HB, 2003, AGE AGEING, V32, P137, DOI 10.1093/ageing/32.2.137; Moe-Nilssen R, 2005, GAIT POSTURE, V21, P164, DOI 10.1016/j.gaitpost.2004.01.013; Mundermann A, 2008, J BIOMECH, V41, P165, DOI 10.1016/j.jbiomech.2007.07.001; Saha D, 2008, GAIT POSTURE, V27, P653, DOI 10.1016/j.gaitpost.2007.08.009; Stylianides GA, 2012, EUR SPINE J, V21, P725, DOI 10.1007/s00586-011-2070-5; Takahashi T, 2005, OSTEOPOROSIS INT, V16, P273, DOI 10.1007/s00198-004-1669-3; Taylor NF, 1999, GAIT POSTURE, V9, P88, DOI 10.1016/S0966-6362(99)00004-1; THORSTENSSON A, 1984, ACTA PHYSIOL SCAND, V121, P9, DOI 10.1111/j.1748-1716.1984.tb10452.x; Vardaxis VG, 1998, HUM MOVEMENT SCI, V17, P121, DOI 10.1016/S0167-9457(97)00024-9; Vogt L, 2002, CLIN BIOMECH, V17, P162, DOI 10.1016/S0268-0033(01)00111-5; Watelain E, 2000, ARCH PHYS MED REHAB, V81, P579, DOI 10.1053/mr.2000.4415; Whittle MW, 1999, HUM MOVEMENT SCI, V18, P681, DOI 10.1016/S0167-9457(99)00032-9; WOLTRING HJ, 1986, ADV ENG SOFTW WORKST, V8, P104, DOI 10.1016/0141-1195(86)90098-7	33	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77168	10.1371/journal.pone.0077168	http://dx.doi.org/10.1371/journal.pone.0077168			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204763	Green Published, gold, Green Submitted			2022-12-27	WOS:000326270700021
J	Nunes, MP; Fortes, B; Silva, JL; Terra-Granado, E; Santos, L; Conde, L; Oliveira, ID; Freire-de-Lima, L; Martins, MV; Pinheiro, AAS; Takyia, CM; Freire-de-Lima, CG; Todeschini, AR; DosReis, GA; Morrot, A				Nunes, Marise Pinheiro; Fortes, Barbara; Silva-Filho, Joao Luiz; Terra-Granado, Eugenia; Santos, Leonardo; Conde, Luciana; Oliveira, Isadora de Araujo; Freire-de-Lima, Leonardo; Martins, Marina Vieira; Sa Pinheiro, Ana Acacia; Takyia, Christina Maeda; Freire-de-Lima, Celio Geraldo; Todeschini, Adriane Regina; DosReis, George Alexandre; Morrot, Alexandre			Inhibitory Effects of Trypanosoma cruzi Sialoglycoproteins on CD4(+) T Cells Are Associated with Increased Susceptibility to Infection	PLOS ONE			English	Article							MEMBRANE GLYCOPROTEIN AGC10; TRANS-SIALIDASE; CHAGAS-DISEASE; INDUCED IMMUNOSUPPRESSION; DENDRITIC CELLS; MSIGLEC-E; ACTIVATION; IL-2; TRANSCRIPTION; PERSISTENCE	Background: The Trypanosoma cruzi infection is associated with severe T cell unresponsiveness to antigens and mitogens characterized by decreased IL-2 synthesis. Trypanosoma cruzi mucin (Tc Muc) has been implicated in this phenomenom. These molecules contain a unique type of glycosylation consisting of several sialylated O-glycans linked to the protein backbone via N-acetylglucosamine residues. Methodology/Principal Findings: In this study, we evaluated the ability of Tc Muc to modulate the activation of CD4(+) T cells. Our data show that cross-linking of CD3 on naive CD4(+) T cells in the presence of Tc Muc resulted in the inhibition of both cytokine secretion and proliferation. We further show that the sialylated O-Linked Glycan residues from tc mucin potentiate the suppression of T cell response by inducing G1-phase cell cycle arrest associated with upregulation of mitogen inhibitor p27(kip1). These inhibitory effects cannot be reversed by the addition of exogenous IL-2, rendering CD4(+) T cells anergic when activated by TCR triggering. Additionally, in vivo administration of Tc Muc during T. cruzi infection enhanced parasitemia and aggravated heart damage. Analysis of recall responses during infection showed lower frequencies of IFN-gamma producing CD4(+) T cells in the spleen of Tc Muc treated mice, compared to untreated controls. Conclusions/Significance: Our results indicate that Tc Muc mediates inhibitory efects on CD4(+) T expansion and cytokine production, by blocking cell cycle progression in the G1 phase. We propose that the sialyl motif of Tc Muc is able to interact with sialic acid-binding Ig-like lectins (Siglecs) on CD4(+) T cells, which may allow the parasite to modulate the immune system.	[Nunes, Marise Pinheiro; Santos, Leonardo; Conde, Luciana; Martins, Marina Vieira] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil; [Fortes, Barbara; Morrot, Alexandre] Univ Fed Rio de Janeiro, Inst Microbiol, BR-21941 Rio De Janeiro, Brazil; [Silva-Filho, Joao Luiz; Oliveira, Isadora de Araujo; Freire-de-Lima, Leonardo; Sa Pinheiro, Ana Acacia; Takyia, Christina Maeda; Freire-de-Lima, Celio Geraldo; Todeschini, Adriane Regina; DosReis, George Alexandre] Univ Fed Rio de Janeiro, Carlos Chagas Filho Inst Biophys, Rio De Janeiro, Brazil; [Terra-Granado, Eugenia] Natl Canc Inst, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; National Cancer Institute (Inca)	Nunes, MP (corresponding author), Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.	mnunes@ioc.fiocruz.br; morrot@micro.ufrj.br	de Lima, Celio Geraldo Freire/A-9057-2012; Todeschini, Adriane Regina/ABC-9165-2020; Todeschini, Adriane/AAG-8128-2020; Silva-Filho, João Luiz/I-5704-2016; Freire-de-Lima, Leonardo/I-1894-2012	Todeschini, Adriane Regina/0000-0002-6049-2751; Silva-Filho, João Luiz/0000-0003-4762-2205; Freire-de-Lima, Leonardo/0000-0003-3013-3173; Oliveira, Isadora/0000-0003-0269-1450; DosReis, George/0000-0002-8924-4727; Pinheiro, Ana Acacia/0000-0002-3894-1645; Terra-Granado, Eugenia/0000-0002-3616-140X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico do Brasil (CNPq); Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTv/CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fundacao Oswaldo Cruz	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico do Brasil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTv/CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao Oswaldo Cruz	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico do Brasil (CNPq), Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTv/CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Fundacao Oswaldo Cruz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSOHN IA, 1995, J IMMUNOL, V155, P3955; Alcaide P, 2004, INT IMMUNOL, V16, P1365, DOI 10.1093/intimm/dxh138; Allavena P, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/547179; Anandkumar A, 2013, SCAND J IMMUNOL; Barry MA, 2013, PEDIATR CLIN N AM, V60, P471, DOI 10.1016/j.pcl.2012.12.011; Bermejo DA, 2013, NAT IMMUNOL, V14, P514, DOI 10.1038/ni.2569; Camargo MM, 1997, J IMMUNOL, V159, P6131; Campos MA, 2004, J IMMUNOL, V172, P1711, DOI 10.4049/jimmunol.172.3.1711; Carlin AF, 2009, BLOOD, V113, P3333, DOI 10.1182/blood-2008-11-187302; Charvet C, 2006, J IMMUNOL, V177, P5024, DOI 10.4049/jimmunol.177.8.5024; CHUENKOVA M, 1995, J EXP MED, V181, P1693, DOI 10.1084/jem.181.5.1693; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Cuervo H, 2011, J IMMUNOL, V187, P2656, DOI 10.4049/jimmunol.1002928; de Araujo FF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000992; DINOIA JM, 1995, J BIOL CHEM, V270, P24146, DOI 10.1074/jbc.270.41.24146; DosReis GA, 2005, TRENDS PARASITOL, V21, P237, DOI 10.1016/j.pt.2005.03.008; Erdmann H, 2009, CELL MICROBIOL, V11, P1600, DOI 10.1111/j.1462-5822.2009.01350.x; Fernandes MC, 2012, FEMS MICROBIOL REV, V36, P734, DOI 10.1111/j.1574-6976.2012.00333.x; Fiuza JA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000512; Freire T, 2011, J BIOL CHEM, V286, P7797, DOI 10.1074/jbc.M110.209742; Garcia ES, 2010, TRENDS PARASITOL, V26, P499, DOI 10.1016/j.pt.2010.07.003; GAZZINELLI RT, 1991, PARASITE IMMUNOL, V13, P345, DOI 10.1111/j.1365-3024.1991.tb00288.x; Giorgi ME, 2011, CARBOHYD RES, V346, P1389, DOI 10.1016/j.carres.2011.04.006; Gutierrez FRS, 2009, PARASITE IMMUNOL, V31, P673, DOI 10.1111/j.1365-3024.2009.01108.x; Jacobs T, 2010, EUR J CELL BIOL, V89, P113, DOI 10.1016/j.ejcb.2009.10.006; Jatzek A, 2012, J IMMUNOL, V189, P5119, DOI 10.4049/jimmunol.1201482; JOINER K, 1986, P NATL ACAD SCI USA, V83, P6593, DOI 10.1073/pnas.83.17.6593; Junqueira C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001560; Kierszenbaum F, 1999, EUR J IMMUNOL, V29, P1684, DOI 10.1002/(SICI)1521-4141(199905)29:05&lt;1684::AID-IMMU1684&gt;3.0.CO;2-7; Kierszenbaum F, 2002, MOL BIOCHEM PARASIT, V125, P91, DOI 10.1016/S0166-6851(02)00217-7; Kipnis TL, 1991, P NATL ACAD SCI USA, V78, P602; LIEW FY, 1987, J IMMUNOL, V139, P2452; Lopes MF, 1996, INFECT IMMUN, V64, P1559, DOI 10.1128/IAI.64.5.1559-1564.1996; Majumder S, 1996, J IMMUNOL, V156, P3866; MARKS DC, 1992, LEUKEMIA RES, V16, P1165, DOI 10.1016/0145-2126(92)90114-M; Mendonca-Previato L, 2013, GLYCOCONJ J; Mucci J, 2006, CELL MICROBIOL, V8, P1086, DOI 10.1111/j.1462-5822.2006.00689.x; Muia RP, 2010, GLYCOBIOLOGY, V20, P833, DOI 10.1093/glycob/cwq037; Nagajyothi F, 2012, CELL MICROBIOL, V14, P634, DOI 10.1111/j.1462-5822.2012.01764.x; Nardy AFFR, 2013, MICROBES INFECT, V15, P365, DOI 10.1016/j.micinf.2013.02.003; Ohta M, 2010, BIOCHEM BIOPH RES CO, V402, P663, DOI 10.1016/j.bbrc.2010.10.079; Padilla AM, 2009, J IMMUNOL, V183, P1245, DOI 10.4049/jimmunol.0901178; Pereira-Chioccola VL, 2000, J CELL SCI, V113, P1299; Pillai S, 2012, ANNU REV IMMUNOL, V30, P357, DOI 10.1146/annurev-immunol-020711-075018; Pinazo MJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001965; Prata A, 2001, Lancet Infect Dis, V1, P92, DOI 10.1016/S1473-3099(01)00065-2; PREVIATO JO, 1995, J BIOL CHEM, V270, P7241, DOI 10.1074/jbc.270.13.7241; Ribeiro AL, 2012, NAT REV CARDIOL, V9, P576, DOI 10.1038/nrcardio.2012.109; Rosenberg CS, 2010, J IMMUNOL, V185, P560, DOI 10.4049/jimmunol.1000432; Sawai CM, 2012, CANCER CELL, V22, P452, DOI 10.1016/j.ccr.2012.09.016; SCHENKMAN S, 1991, CELL, V65, P1117, DOI 10.1016/0092-8674(91)90008-M; SCHENKMAN S, 1994, ANNU REV MICROBIOL, V48, P499, DOI 10.1146/annurev.mi.48.100194.002435; SOONG L, 1992, J IMMUNOL, V149, P2095; Soto CDA, 2003, INFECT IMMUN, V71, P1194, DOI 10.1128/IAI.71.3.1194-1199.2003; Talvani A, 2009, PARASITOL RES, V104, P1141, DOI 10.1007/s00436-008-1300-1; Tarleton RL, 2003, TRENDS PARASITOL, V19, P447, DOI 10.1016/j.pt.2003.08.008; Tarleton RL, 1999, PARASITOL TODAY, V15, P94, DOI 10.1016/S0169-4758(99)01398-8; Tarleton RL, 2001, INT J PARASITOL, V31, P550, DOI 10.1016/S0020-7519(01)00158-8; Tinder TL, 2008, J IMMUNOL, V181, P3116, DOI 10.4049/jimmunol.181.5.3116; Van Overtvelt L, 2002, INT IMMUNOL, V14, P1135, DOI 10.1093/intimm/dxf077; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Yu ZB, 2001, BIOCHEM J, V353, P483, DOI 10.1042/0264-6021:3530483; Zhang JQQ, 2004, EUR J IMMUNOL, V34, P1175, DOI 10.1002/eji.200324723; Zuniga E, 2000, CLIN EXP IMMUNOL, V119, P507, DOI 10.1046/j.1365-2249.2000.01150.x	65	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77568	10.1371/journal.pone.0077568	http://dx.doi.org/10.1371/journal.pone.0077568			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204874	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000326241200032
J	Dougal, K; de la Fuente, G; Harris, PA; Girdwood, SE; Pinloche, E; Newbold, CJ				Dougal, Kirsty; de la Fuente, Gabriel; Harris, Patricia A.; Girdwood, Susan E.; Pinloche, Eric; Newbold, C. Jamie			Identification of a Core Bacterial Community within the Large Intestine of the Horse	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; HAY-GRAIN RATIOS; MICROBIAL DISORDERS; METAGENOMIC ANALYSIS; MOLECULAR ANALYSIS; GUT MICROBIOME; IN-VITRO; DIVERSITY; GENE; ABUNDANT	The horse has a rich and complex microbial community within its gastrointestinal tract that plays a central role in both health and disease. The horse receives much of its dietary energy through microbial hydrolysis and fermentation of fiber predominantly in the large intestine/hindgut. The presence of a possible core bacterial community in the equine large intestine was investigated in this study. Samples were taken from the terminal ileum and 7 regions of the large intestine from ten animals, DNA extracted and the V1-V2 regions of 16SrDNA 454-pyrosequenced. A specific group of OTUs clustered in all ileal samples and a distinct and different signature existed for the proximal regions of the large intestine and the distal regions. A core group of bacterial families were identified in all gut regions with clear differences shown between the ileum and the various large intestine regions. The core in the ileum accounted for 32% of all sequences and comprised of only seven OTUs of varying abundance; the core in the large intestine was much smaller (5-15% of all sequences) with a much larger number of OTUs present but in low abundance. The most abundant member of the core community in the ileum was Lactobacillaceae, in the proximal large intestine the Lachnospiraceae and in the distal large intestine the Prevotellaceae. In conclusion, the presence of a core bacterial community in the large intestine of the horse that is made up of many low abundance OTUs may explain in part the susceptibility of horses to digestive upset.	[Dougal, Kirsty; de la Fuente, Gabriel; Girdwood, Susan E.; Pinloche, Eric; Newbold, C. Jamie] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Ceredigion, Wales	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Newbold, CJ (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Ceredigion, Wales.	cjn@aber.ac.uk	de la Fuente Oliver, Gabriel/B-3793-2015; de la Fuente Oliver, Gabriel/M-6981-2019	de la Fuente Oliver, Gabriel/0000-0003-0083-776X; de la Fuente Oliver, Gabriel/0000-0003-0083-776X	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G017271/1]; WALTHAM Centre for Pet Nutrition, Melton Mowbray, Leicestershire	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); WALTHAM Centre for Pet Nutrition, Melton Mowbray, Leicestershire	This research was funded by a Biotechnology and Biological Sciences Research Council (BBSRC) Case studentship (BB/G017271/1) and the WALTHAM Centre for Pet Nutrition, Melton Mowbray, Leicestershire. LE14 4RT. The funders (with the exception of Patricia A. Harris, co-author and collaborator) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGENZIO RA, 1974, AM J PHYSIOL, V226, P1043, DOI 10.1152/ajplegacy.1974.226.5.1043; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bailey SR, 2009, VET IMMUNOL IMMUNOP, V129, P167, DOI 10.1016/j.vetimm.2008.11.009; Bailey SR, 2002, J ANIM SCI, V80, P2656; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Blackmore TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075079; BOCHRODER B, 1994, EQUINE VET J, V26, P131, DOI 10.1111/j.2042-3306.1994.tb04351.x; Booijink CCGM, 2010, ENVIRON MICROBIOL, V12, P3213, DOI 10.1111/j.1462-2920.2010.02294.x; COHEN ND, 1995, J AM VET MED ASSOC, V206, P667; Costa MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041484; Cotta M, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P1002, DOI 10.1007/0-387-30744-3_35; Daly K, 2003, FEMS MICROBIOL ECOL, V44, P243, DOI 10.1016/S0168-6496(03)00032-1; Daly K, 2001, FEMS MICROBIOL ECOL, V38, P141, DOI 10.1111/j.1574-6941.2001.tb00892.x; de Fombelle A, 2001, J EQUINE VET SCI, V21, P439, DOI 10.1016/S0737-0806(01)70018-4; Dougal K, 2012, FEMS MICROBIOL ECOL, V82, P642, DOI 10.1111/j.1574-6941.2012.01441.x; Drogoul C, 2001, J EQUINE VET SCI, V21, P487, DOI 10.1016/S0737-0806(01)70211-0; Durso LM, 2010, APPL ENVIRON MICROB, V76, P4858, DOI 10.1128/AEM.00207-10; Earing J.E., 2012, ADV MICROBIOL-IRVINE, V2, P79, DOI DOI 10.4236/AIM.2012.22010; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hayashi H, 2005, J MED MICROBIOL, V54, P1093, DOI 10.1099/jmm.0.45935-0; Hillyer MH, 2001, EQUINE VET J, V33, P380, DOI 10.2746/042516401776249499; Holodniy M, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014764, 10.1371/journal.pone.0025792]; Hudson JM, 2001, J AM VET MED ASSOC, V219, P1419, DOI 10.2460/javma.2001.219.1419; Jalanka-Tuovinen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023035; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; Julliand V, 2001, J EQUINE VET SCI, V21, P543, DOI 10.1016/S0737-0806(01)70159-1; Kolmeder CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029913; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li WZ, 2012, BRIEF BIOINFORM, V13, P656, DOI 10.1093/bib/bbs035; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Lopes MAF, 2004, AM J VET RES, V65, P687, DOI 10.2460/ajvr.2004.65.687; Lopes MAF, 2000, HISTOL HISTOPATHOL, V15, P983, DOI 10.14670/HH-15.983; Lowe BA, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-20; Maeda H, 2003, FEMS IMMUNOL MED MIC, V39, P81, DOI 10.1016/S0928-8244(03)00224-4; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Medina B, 2002, J ANIM SCI, V80, P2600; Menzies-Gow NJ, 2010, VET REC, V167, P690, DOI 10.1136/vr.c5177; Milinovich GJ, 2008, ISME J, V2, P1089, DOI 10.1038/ismej.2008.67; Perkins GA, 2012, APPL ENVIRON MICROB, V78, P2522, DOI 10.1128/AEM.06252-11; PROUDMAN CJ, 1992, EQUINE VET J, V24, P90, DOI 10.1111/j.2042-3306.1992.tb02789.x; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sekelja M, 2011, ISME J, V5, P519, DOI 10.1038/ismej.2010.129; Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x; Shepherd ML, 2012, FEMS MICROBIOL LETT, V326, P62, DOI 10.1111/j.1574-6968.2011.02434.x; Shirazi-Beechey SP, 2008, EQUINE VET J, V40, P414, DOI 10.2746/042516408X314075; Skrivanova E, 2010, VET MICROBIOL, V144, P334, DOI 10.1016/j.vetmic.2010.01.013; Steelman SM, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-231; Sturgeon A, 2013, VET MICROBIOL, V162, P891, DOI 10.1016/j.vetmic.2012.11.018; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; USDA, 2006, HIGHL EQ 2005 1; Varloud M, 2004, ANIM SCI, V79, P61, DOI 10.1017/S1357729800054539; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Willing B, 2009, EQUINE VET J, V41, P908, DOI 10.2746/042516409X447806; Wylie CE, 2013, EQUINE VET J, V45, P681, DOI 10.1111/evj.12047; Yamano H, 2008, ANIM SCI J, V79, P234, DOI 10.1111/j.1740-0929.2008.00522.x; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	68	94	97	2	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77660	10.1371/journal.pone.0077660	http://dx.doi.org/10.1371/journal.pone.0077660			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204908	Green Published, Green Submitted, gold			2022-12-27	WOS:000326152300028
J	Jang, MY; Chun, SI; Mun, CW; Hong, KS; Shin, JW				Jang, Moo-Young; Chun, Song-I; Mun, Chi-Woong; Hong, Kwan Soo; Shin, Jung-Woog			Evaluation of Metabolomic Changes as a Biomarker of Chondrogenic Differentiation in 3D-cultured Human Mesenchymal Stem Cells Using Proton (H-1) Nuclear Magnetic Resonance Spectroscopy	PLOS ONE			English	Article							IN-VITRO; ARTICULAR CHONDROCYTES; REGENERATIVE MEDICINE; CYTIDINE COENZYMES; SEEDING DENSITY; ALGINATE BEADS; STROMAL CELLS; PROLIFERATION; CULTURE; VIVO	Purpose: The purpose of this study was to evaluate the metabolomic changes in 3D-cultured human mesenchymal stem cells (hMSCs) in alginate beads, so as to identify biomarkers during chondrogenesis using H-1 nuclear magnetic resonance (NMR) spectroscopy. Materials and Methods: hMSCs (2x10(6) cells/mL) were seeded into alginate beads, and chondrogenesis was allowed to progress for 15 days. NMR spectra of the chondrogenic hMSCs were obtained at 4, 7, 11, and 15 days using a 14.1-T (600-MHz) NMR with the water suppression sequence, zgpr. Real-Time polymerase chain reaction (PCR) was performed to confirm that that the hMSCs differentiated into chondrocytes and to analyze the metabolomic changes indicated by the NMR spectra. Results: During chondrogenesis, changes were detected in several metabolomes as hMSC chondrogenesis biomarkers, e. g., fatty acids, alanine, glutamate, and phosphocholine. The metabolomic changes were compared with the Real-Time PCR results, and significant differences were determined using statistical analysis. We found that changes in metabolomes were closely related to biological reactions that occurred during the chondrogenesis of hMSCs. Conclusions: In this study, we confirm that metabolomic changes detected by H-1-NMR spectroscopy during chondrogenic differentiation of 3D-cultured hMSCs in alginate beads can be considered as biomarkers of stem cell differentiation.	[Jang, Moo-Young; Chun, Song-I; Mun, Chi-Woong; Shin, Jung-Woog] Inje Univ, Dept Biomed Engn UHRC, Gimhae, Gyeongnam, South Korea; [Mun, Chi-Woong; Shin, Jung-Woog] Inje Univ, Grad Sch Hlth Sci & Technol, Gimhae, Gyeongnam, South Korea; [Hong, Kwan Soo] Korea Basic Sci Inst, Ochang, Chungbuk, South Korea	Inje University; Inje University; Korea Basic Science Institute (KBSI)	Mun, CW (corresponding author), Inje Univ, Dept Biomed Engn UHRC, Gimhae, Gyeongnam, South Korea.	mcw@inje.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012R1A1A4A01013961]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (Grant No. 2012R1A1A4A01013961). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billings PC, 2008, J BONE MINER RES, V23, P305, DOI 10.1359/JBMR.071030; Bohari SPM, 2011, BIO-MED MATER ENG, V21, P159, DOI 10.3233/BME-2011-0665; BORKENHAGEN LF, 1957, J BIOL CHEM, V227, P951; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Campbell MK, 2006, BIOCHEMISTRY; Chun SI, 2012, TISSUE ENG REGEN MED, V9, P101, DOI 10.1007/s13770-012-0016-6; Di Vito M, 2001, BBA-MOL CELL BIOL L, V1530, P47, DOI 10.1016/S1388-1981(00)00165-7; Gagne TA, 2000, J ORTHOPAED RES, V18, P882, DOI 10.1002/jor.1100180606; Greenwood Heather L., 2006, International Journal of Biotechnology, V8, P60, DOI 10.1504/IJBT.2006.008964; HALARNKAR PP, 1989, COMP BIOCHEM PHYS B, V92, P227, DOI 10.1016/0305-0491(89)90270-8; HAUSELMANN HJ, 1994, J CELL SCI, V107, P17; Holy CE, 2000, J BIOMED MATER RES, V51, P376, DOI 10.1002/1097-4636(20000905)51:3<376::AID-JBM11>3.0.CO;2-G; Indrawattana N, 2004, BIOCHEM BIOPH RES CO, V320, P914, DOI 10.1016/j.bbrc.2004.06.029; Jackowski S, 1996, J BIOL CHEM, V271, P20219, DOI 10.1074/jbc.271.34.20219; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; KEMP GJ, 1994, J THEOR BIOL, V170, P239, DOI 10.1006/jtbi.1994.1184; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kim DE, 2004, STROKE, V35, P952, DOI 10.1161/01.STR.0000120308.21946.5D; Kim HJ, 2009, TISSUE ENG REGEN MED, V6, P1343; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Koh CJ, 2004, J AM SOC NEPHROL, V15, P1113, DOI 10.1097/01.ASN.0000119683.59068.F0; Lin YJ, 2009, J BIOMED MATER RES A, V88A, P23, DOI 10.1002/jbm.a.31841; Lisignoli G, 2005, BIOMATERIALS, V26, P5677, DOI 10.1016/j.biomaterials.2005.02.031; Lundberg P, 2007, BIOCHEM BIOPH RES CO, V352, P444, DOI 10.1016/j.bbrc.2006.11.057; Ma HL, 2003, J BIOMED MATER RES A, V64A, P273, DOI 10.1002/jbm.a.10370; Martinez-Bisbal MC, 2004, NMR BIOMED, V17, P191, DOI 10.1002/nbm.888; Mirbahai L, 2011, INT J BIOCHEM CELL B, V43, P990, DOI 10.1016/j.biocel.2010.07.002; Mironov V, 2004, EXPERT OPIN BIOL TH, V4, P773, DOI 10.1517/14712598.4.6.773; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Payne GS, 2006, BRIT J RADIOL, V79, pS16, DOI 10.1259/bjr/84072695; Rudin M, 2007, EUR RADIOL, V17, P2441, DOI 10.1007/s00330-007-0619-9; Rudin M, 2009, CURR OPIN CHEM BIOL, V13, P360, DOI 10.1016/j.cbpa.2009.03.025; Shi CM, 2008, J TISSUE ENG REGEN M, V2, P482, DOI 10.1002/term.120; Soares DP, 2009, CLIN RADIOL, V64, P12, DOI 10.1016/j.crad.2008.07.002; Srere PA, 1969, CITRIC ACID CYCLE, p[13, 3]; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Wang JS, 2000, J THORAC CARDIOV SUR, V120, P999, DOI 10.1067/mtc.2000.110250; WILLIAMSASHMAN HG, 1956, J BIOL CHEM, V223, P509; Xu JP, 2008, TISSUE ENG PT A, V14, P667, DOI 10.1089/tea.2007.0272; YEAGLE PL, 1989, FASEB J, V3, P1833, DOI 10.1096/fasebj.3.7.2469614; Yen CN, 2008, BIOTECHNOL PROGR, V24, P452, DOI 10.1021/bp0702828	42	13	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78325	10.1371/journal.pone.0078325	http://dx.doi.org/10.1371/journal.pone.0078325			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205199	gold, Green Published, Green Submitted			2022-12-27	WOS:000326032600095
J	Rui, YY; Zhang, D; Zhou, ZG; Wang, C; Yang, L; Yu, YY; Chen, HN				Rui, Yuan-Yi; Zhang, Dan; Zhou, Zong-Guang; Wang, Cun; Yang, Lie; Yu, Yong-Yang; Chen, Hai-Ning			Can K-ras Gene Mutation Be Utilized as Prognostic Biomarker for Colorectal Cancer Patients Receiving Chemotherapy? A Meta-Analysis and Systematic Review	PLOS ONE			English	Review							COLON-CANCER; ADJUVANT CHEMOTHERAPY; KRAS MUTATION; STAGE-II; CETUXIMAB; THERAPY; FLUOROURACIL; OXALIPLATIN; SURVIVAL; BEHAVIOR	Introduction: K-ras gene mutations were common in colorectal patients, but their relationship with prognosis was unclear. Objective: Verify prognostic differences between patient with and without mutant K-ras genes by reviewing the published evidence. Method: Systematic reviews and data bases were searched for cohort/case-control studies of prognosis of colorectal cancer patients with detected K-ras mutations versus those without mutant K-ras genes, both of whom received chemotherapy. Number of patients, regimens of chemotherapy, and short-term or long-term survival rate (disease-free or overall) were extracted. Quality of studies was also evaluated. Principal Findings: 7 studies of comparisons with a control group were identified. No association between K-ras gene status with neither short-term disease free-survival (OR=1.01, 95% CI, 0.73-1.38, P=0.97) nor overall survival (OR=1.06, 95% CI, 0.82-1.36, P=0.66) in CRC patients who received chemotherapy was indicated. Comparison of long-term survival between two groups also indicated no significant difference after heterogeneity was eliminated (OR=1.09, 95% CI, 0.85-1.40, P=0.49). Conclusions: K-ras gene mutations may not be a prognostic index for colorectal cancer patients who received chemotherapy.	[Rui, Yuan-Yi; Zhang, Dan; Zhou, Zong-Guang; Wang, Cun; Yang, Lie; Yu, Yong-Yang; Chen, Hai-Ning] Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, Chengdu, Sichuan, Peoples R China; [Rui, Yuan-Yi; Zhang, Dan; Zhou, Zong-Guang; Chen, Hai-Ning] Sichuan Univ, West China Hosp, Inst Digest Surg, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University	Zhou, ZG (corresponding author), Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, Chengdu, Sichuan, Peoples R China.	zhou767@163.com	rui, yuanyi/ABB-4050-2021; Chen, Hai-Ning/AAR-8059-2021; Wang, Cun/C-5600-2015	Chen, Hai-Ning/0000-0003-0104-8498; , Zongguang/0000-0002-7616-1199	Ministry of Education [2007B66]	Ministry of Education	This study was supported by Doctoral thesis special fund of Ministry of Education, number 2007B66. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnen DJ, 1998, CANCER RES, V58, P1149; Andreyev HJN, 2001, BRIT J CANCER, V85, P692, DOI 10.1054/bjoc.2001.1964; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bleeker WA, 2001, DIS COLON RECTUM, V44, P358, DOI 10.1007/BF02234733; Boughdady I S, 1992, Surg Oncol, V1, P269, DOI 10.1016/0960-7404(92)90087-2; Chang MH, 2011, CANCER CHEMOTH PHARM, V68, P317, DOI 10.1007/s00280-010-1496-5; Chen MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045388; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FINKELSTEIN SD, 1993, CANCER, V71, P3827, DOI 10.1002/1097-0142(19930615)71:12<3827::AID-CNCR2820711207>3.0.CO;2-N; Gnanasampanthan G, 2001, J PATHOL, V195, P543, DOI 10.1002/path.990; Hutchins G, 2011, J CLIN ONCOL, V29, P1261, DOI 10.1200/JCO.2010.30.1366; Imamura Y, 2012, CLIN CANCER RES, V18, P4753, DOI 10.1158/1078-0432.CCR-11-3210; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Liao XY, 2012, CLIN CANCER RES, V18, P2257, DOI 10.1158/1078-0432.CCR-11-2410; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Macara IG, 1996, FASEB J, V10, P625, DOI 10.1096/fasebj.10.5.8621061; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Network National Comprehensive Cancer Network, 2013, CLIN PRACT GUID ONC; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; Ogino S, 2009, CLIN CANCER RES, V15, P7322, DOI 10.1158/1078-0432.CCR-09-1570; Ren JJ, 2012, DIS COLON RECTUM, V55, P913, DOI 10.1097/DCR.0b013e318251d8d9; Roth AD, 2010, J CLIN ONCOL, V28, P466, DOI 10.1200/JCO.2009.23.3452; Rui YY, HEPATO GAST IN PRESS; Sargent DJ, 2010, J CLIN ONCOL, V28, P3219, DOI 10.1200/JCO.2009.27.1825; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Stec R, 2012, CANCER BIOL THER, V13, P1235, DOI 10.4161/cbt.21813; Tejpar S, 2012, J CLIN ONCOL, V30, P3570, DOI 10.1200/JCO.2012.42.2592; Tournigand C, 2012, J CLIN ONCOL, V30, P3353, DOI 10.1200/JCO.2012.42.5645; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Wells G SB, 2013, NEWCASTLE OTTAWA SCA; Yang L, 2004, BRIT J CANCER, V90, P2157, DOI 10.1038/sj.bjc.6601813	32	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77901	10.1371/journal.pone.0077901	http://dx.doi.org/10.1371/journal.pone.0077901			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205021	Green Published, Green Submitted, gold			2022-12-27	WOS:000326032600053
J	van den Bergh, JPW; Bouts, ME; van der Veer, E; van der Velde, RY; Janssen, MJW; Geusens, PP; Winkens, B; Oldenhof, NJJ; van Geel, TACM				van den Bergh, Joop P. W.; Bouts, Marian E.; van der Veer, Eveline; van der Velde, Robert Y.; Janssen, Marcel J. W.; Geusens, Piet P.; Winkens, Bjorn; Oldenhof, Nico J. J.; van Geel, Tineke A. C. M.			Comparing Tolerability and Efficacy of Generic versus Brand Alendronate: A Randomized Clinical Study in Postmenopausal Women with a Recent Fracture	PLOS ONE			English	Article							BONE TURNOVER MARKERS; LIAISON SERVICES; SODIUM TABLETS; OSTEOPOROSIS; DISINTEGRATION; IMPLEMENTATION; SUBSTITUTION; COPIES; SCALE	Introduction: An increasing number of generic alendronate formulations have become available. Although expected to have the same tolerability and efficacy, head-to head comparison of generic and brand alendronate was never performed. Therefore, we compared the tolerability and efficacy of generic and brand alendronate. Methods: In a randomized double-blinded single centre cross-over study in 37 postmenopausal women (mean age 65.4+/-6.4 years) with osteoporosis were treated with generic and branded alendronate during 24 (2x12) weeks. Tolerance was evaluated by the Gastro intestinal Symptom Rating Scale (GSRS) and self-reported side effects. Efficacy was assessed by serum bone turnover markers, carboxy terminal telopeptide (CTX) and procollagen type I N-terminal propeptide (PINP). No wash out period was allowed (ethical reasons). Because of possible carry over effect only data of the first 12 weeks were analyzed using linear mixed models. Results: There were no significant differences in overall tolerance (GSRS) between treatment groups. However, for subscale abdominal pain, patients using generic had a significantly higher mean GSRS score at week 4 (estimated mean difference (B): 0.40; 95% CI: 0.05 to 0.74, p = 0.024). The level of bone turnover markers significantly decreased over 12 weeks of follow-up for generic and branded alendronate (p < 0.001). Mean level of CTX was significantly lower with branded at week 4 (B: 121.3; 95% CI: 52.0 to 190.5), but not at week 12 (B: 53.6; 95% CI:-3.7 to 110.9). No significant differences were found for PINP at week 4 or 12. Conclusions: Bone turnover markers were significantly reduced with branded and generic alendronate. With branded, CTX was significantly lower at 4 weeks. Generic caused significantly higher abdominal pain scores in the first 4 weeks of treatment. Therefore, generic alendronate may not have the same tolerability and efficacy as branded alendronate in the first weeks after starting treatment in patients with a recent fracture. Trial Registration: Dutch Trial Register NTR number 1867 http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=1867	[van den Bergh, Joop P. W.; Bouts, Marian E.; van der Velde, Robert Y.] VieCuri Med Ctr Noord Limburg, Dept Internal Med, Venlo, Netherlands; [van den Bergh, Joop P. W.; Geusens, Piet P.] Maastricht Univ, Med Ctr, Dept Internal Med, Maastricht, Netherlands; [van den Bergh, Joop P. W.; van Geel, Tineke A. C. M.] Maastricht Univ, NUTRIM Sch Nutr Toxicol & Metab, Maastricht, Netherlands; [van den Bergh, Joop P. W.; Geusens, Piet P.] Univ Hasselt, Biomed Res Ctr, Diepenbeek, Belgium; [van der Veer, Eveline] Univ Groningen, Univ Med Ctr Groningen, Lab Med, NL-9713 AV Groningen, Netherlands; [Janssen, Marcel J. W.] VieCuri Med Ctr Noord Limburg, Lab Clin Chem & Haematol, Venlo, Netherlands; [Geusens, Piet P.; Winkens, Bjorn; van Geel, Tineke A. C. M.] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Maastricht, Netherlands; [Winkens, Bjorn] Maastricht Univ, Dept Methodol & Stat, Maastricht, Netherlands; [Oldenhof, Nico J. J.] VieCuri Med Ctr Noord Limburg, Hosp Pharm, Venlo, Netherlands; [van Geel, Tineke A. C. M.] Maastricht Univ, Dept Family Med, Maastricht, Netherlands	VieCuri Medical Center; Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Hasselt University; University of Groningen; VieCuri Medical Center; Maastricht University; Maastricht University; VieCuri Medical Center; Maastricht University	van Geel, TACM (corresponding author), Maastricht Univ, NUTRIM Sch Nutr Toxicol & Metab, Maastricht, Netherlands.	tineke.vangeel@maastrichtuniversity.nl		Winkens, Bjorn/0000-0002-6747-6228; van Geel, Tineke/0000-0003-2022-6552; van den Bergh, Joop/0000-0003-3984-2232; van der Veer, Eveline/0000-0002-4825-9981	Stichting Wetenschappelijk onderzoek Interne Geneeskunde (WOIG)	Stichting Wetenschappelijk onderzoek Interne Geneeskunde (WOIG)	This study was funded by Stichting Wetenschappelijk onderzoek Interne Geneeskunde (WOIG). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arends S, 2011, OSTEOPOROSIS INT, V22, P1431, DOI 10.1007/s00198-010-1338-7; Bauer DC, 2004, J BONE MINER RES, V19, P1250, DOI 10.1359/JBMR.040512; Boudou L, 2011, OSTEOPOROSIS INT, V22, P2099, DOI 10.1007/s00198-011-1638-6; Bours SPG, 2011, J CLIN ENDOCR METAB, V96, P1360, DOI 10.1210/jc.2010-2135; Dansereau RJ, 2008, CURR MED RES OPIN, V24, P1137, DOI 10.1185/030079908X280725 ; Eisman JA, 2012, J BONE MINER RES, V27, P2039, DOI 10.1002/jbmr.1698; Epstein S, 2003, CURR MED RES OPIN, V19, P781, DOI 10.1185/030079903125002577; Epstein S, 2005, J APPL RES, V2, P1; Greenspan SL, 2000, J CLIN ENDOCR METAB, V85, P3537, DOI 10.1210/jc.85.10.3537; Grima DT, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-68; Huntjens KMB, 2011, OSTEOPOROSIS INT, V22, P2129, DOI 10.1007/s00198-010-1442-8; Huntjens KMB, 2011, INJURY, V42, pS39, DOI 10.1016/S0020-1383(11)70011-0; Institute Dutchfor Healthcare Improvement (CBO), 2011, GUID OST FRACT PREV; Ivaska KK, 2007, J BONE MINER RES, V22, P1155, DOI 10.1359/JBMR.070505; Lai PSM, 2012, CURR MED RES OPIN, V28, P1347, DOI 10.1185/03007995.2012.708326; Landfeldt E, 2012, BONE, V51, P637, DOI 10.1016/j.bone.2012.07.009; McLellan AR, 2011, OSTEOPOROSIS INT, V22, P2083, DOI 10.1007/s00198-011-1534-0; Perkins AC, 2008, CLIN THER, V30, P834, DOI 10.1016/j.clinthera.2008.04.018; Revicki DA, 1998, QUAL LIFE RES, V7, P75; Ringe JD, 2009, RHEUMATOL INT, V30, P213, DOI 10.1007/s00296-009-0940-5; Risser J, 2007, J NURS MEAS, V15, P203, DOI 10.1891/106137407783095757; Rosner B., 2006, FUNDAMENTALS BIOSTAT; Strom O, 2012, OSTEOPOROSIS INT, V23, P2201, DOI 10.1007/s00198-011-1850-4; Svarstad BL, 1999, PATIENT EDUC COUNS, V37, P113, DOI 10.1016/S0738-3991(98)00107-4; Szulc P, 2012, CLIN BIOCHEM, V45, P907, DOI 10.1016/j.clinbiochem.2012.01.022; van den Bergh JP, 2012, NAT REV RHEUMATOL, V8, P163, DOI 10.1038/nrrheum.2011.217; van Geel TACM, 2010, MATURITAS, V65, P143, DOI 10.1016/j.maturitas.2009.12.007; Vasikaran S, 2011, OSTEOPOROSIS INT, V22, P391, DOI 10.1007/s00198-010-1501-1; Wells G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004523.pub3; Wells GA, 2008, COCHRANE DB SYST REV	30	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78153	10.1371/journal.pone.0078153	http://dx.doi.org/10.1371/journal.pone.0078153			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205135	gold, Green Published			2022-12-27	WOS:000326032600075
J	Keller, A; Grimmer, G; Steffan-Dewenter, I				Keller, Alexander; Grimmer, Gudrun; Steffan-Dewenter, Ingolf			Diverse Microbiota Identified in Whole Intact Nest Chambers of the Red Mason Bee Osmia bicornis (Linnaeus 1758)	PLOS ONE			English	Article							APIS-MELLIFERA HYMENOPTERA; HONEY-BEE; PAENIBACILLUS-LARVAE; SPIROPLASMA-MELLIFERUM; BACTERIAL COMMUNITIES; CORNUTA HYMENOPTERA; SYMBIOTIC BACTERIA; HYGIENIC BEHAVIOR; FLORAL NECTAR; ACID BACTERIA	Microbial activity is known to have profound impact on bee ecology and physiology, both by beneficial and pathogenic effects. Most information about such associations is available for colony-building organisms, and especially the honey bee. There, active manipulations through worker bees result in a restricted diversity of microbes present within the colony environment. Microbial diversity in solitary bee nests remains unstudied, although their larvae face a very different situation compared with social bees by growing up in isolated compartments. Here, we assessed the microbiota present in nests and pre-adults of Osmia bicornis, the red mason bee, by culture-independent pyrosequencing. We found high bacterial diversity not comparable with honey bee colonies. We identified a variety of bacteria potentially with positive or negative interactions for bee larvae. However, most of the other diverse bacteria present in the nests seem to originate from environmental sources through incorporated nest building material and stored pollen. This diversity of microorganisms may cause severe larval mortality and require specific physiological or symbiotic adaptations against microbial threats. They may however also profit from such a diverse environment through gain of mutualistic partners. We conclude that further studies of microbiota interaction in solitary bees will improve the understanding of fitness components and populations dynamics.	[Keller, Alexander; Grimmer, Gudrun; Steffan-Dewenter, Ingolf] Univ Wurzburg, Dept Anim Ecol & Trop Biol, Bioctr, D-97070 Wurzburg, Germany; [Keller, Alexander; Grimmer, Gudrun] Univ Wurzburg, DNA Analyt Core Facil, Bioctr, D-97070 Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Keller, A (corresponding author), Univ Wurzburg, Dept Anim Ecol & Trop Biol, Bioctr, D-97070 Wurzburg, Germany.	a.keller@biozentrum.uni-wuerzburg.de	Keller, Alexander/D-1221-2009	Keller, Alexander/0000-0001-5716-3634; Steffan-Dewenter, Ingolf/0000-0003-1359-3944	University of Wurzburg; German Research Foundation (DFG); University of Wuerzburg	University of Wurzburg; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	We are grateful for financial support of this study regarding consumables and staff by the University of Wurzburg. This publication was further funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi A, 2011, TRENDS ECOL EVOL, V26, P494, DOI 10.1016/j.tree.2011.06.008; Alippi AM, 2006, J INVERTEBR PATHOL, V91, P141, DOI 10.1016/j.jip.2005.12.002; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarado I, 2013, J BACTERIOL, V195, P1005, DOI 10.1128/JB.01958-12; Alvarez-Perez S, 2012, FEMS MICROBIOL ECOL; Alvarez-Perez S, 2013, FEMS MICROBIOL ECOL, V83, P685, DOI 10.1111/1574-6941.12027; Anderson KE, 2011, INSECT SOC, V58, P431, DOI 10.1007/s00040-011-0194-6; Bevivino A, 1998, FEMS MICROBIOL ECOL, V27, P225, DOI 10.1111/j.1574-6941.1998.tb00539.x; Bosch J, 2004, APIDOLOGIE, V35, P469, DOI 10.1051/apido:2004035; Bosch J, 2002, B ENTOMOL RES, V92, P3, DOI 10.1079/BER2001139; Brown SE, 2004, J BIOL CHEM, V279, P14595, DOI 10.1074/jbc.M309859200; BULLA LA, 1975, ANNU REV MICROBIOL, V29, P163, DOI 10.1146/annurev.mi.29.100175.001115; Burgett D. M., 1997, HONEY BEE PEST PREDA, P455; CANO RJ, 1994, APPL ENVIRON MICROB, V60, P2164, DOI 10.1128/AEM.60.6.2164-2167.1994; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Audisio MC, 2011, MICROBIOL RES, V166, P1, DOI 10.1016/j.micres.2010.01.003; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; CLARK TB, 1985, INT J SYST BACTERIOL, V35, P296, DOI 10.1099/00207713-35-3-296; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cordaux R, 2007, APPL ENVIRON MICROB, V73, P5045, DOI 10.1128/AEM.00378-07; Crotti E, 2010, APPL ENVIRON MICROB, V76, P6963, DOI 10.1128/AEM.01336-10; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Evans Jay D., 2006, BMC Ecology, V6, P4, DOI 10.1186/1472-6785-6-4; Evison SEF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030641; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Fridman S, 2012, ENV MICROBIOL REP, V4, P97, DOI 10.1111/j.1758-2229.2011.00309.x; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; GILLIAM M, 1987, J INVERTEBR PATHOL, V49, P70, DOI 10.1016/0022-2011(87)90127-3; GILLIAM M, 1971, ANN ENTOMOL SOC AM, V64, P315, DOI 10.1093/aesa/64.1.315; GILLIAM M, 1974, J INVERTEBR PATHOL, V23, P38, DOI 10.1016/0022-2011(74)90069-X; GILLIAM M, 1990, APIDOLOGIE, V21, P99, DOI 10.1051/apido:19900202; GILLIAM M, 1988, MICROBIOS, V55, P95; Gilliam M, 1997, FEMS MICROBIOL LETT, V155, P1; Gilliam M., 1990, Proceedings and abstracts, Vth International Colloquium on Invertebrate Pathology and Microbial Control, Adelaide, Australia, 20-24 August 1990., P398; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hendriksma HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059589; Herrera CM, 2008, ECOLOGY, V89, P2369, DOI 10.1890/08-0241.1; Jeong G, 2009, J MICROBIOL, V47, P28, DOI 10.1007/s12275-009-0198-3; Junker RR, 2011, PLANT BIOLOGY, V13, P918, DOI 10.1111/j.1438-8677.2011.00454.x; Kaltenpoth M, 2005, CURR BIOL, V15, P475, DOI 10.1016/j.cub.2004.12.084; Kaltenpoth M, FUNCT ECOL IN PRESS; Kaltenpoth M, 2011, MOL ECOL, V20, P439, DOI 10.1111/j.1365-294X.2010.04960.x; Kikuchi Y, 2005, APPL ENVIRON MICROB, V71, P4035, DOI 10.1128/AEM.71.7.4035-4043.2005; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; Kluge R, 1962, Z BIENENFORSCHUNG, V6, P141; Koch H, 2012, J ANIM ECOL, V81, P1202, DOI 10.1111/j.1365-2656.2012.02004.x; Krunic Miloje, 2005, Bulletin of Insectology, V58, P141; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Ladurner E, 2004, J APICULT RES, V43, P118, DOI 10.1080/00218839.2004.11101121; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lo WS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-22; Mahar Ali Nawaz, 2005, J Zhejiang Univ Sci B, V6, P457, DOI 10.1631/jzus.2005.B0457; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; McCauley DE, 2007, AM J BOT, V94, P1333, DOI 10.3732/ajb.94.8.1333; McCutcheon JP, 2010, GENOME BIOL EVOL, V2, P708, DOI 10.1093/gbe/evq055; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; NAKANO H, 1994, INT J FOOD MICROBIOL, V21, P247, DOI 10.1016/0168-1605(94)90031-0; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Parker BJ, 2013, APPL ENVIRON MICROB, V79, P2455, DOI 10.1128/AEM.03193-12; Reynaldi F. J., 2004, Rev. argent. microbiol., V36, P52; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Sabate DC, 2009, RES MICROBIOL, V160, P193, DOI 10.1016/j.resmic.2009.03.002; Schokraie E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009502; Shade A, 2013, MBIO, V4, DOI 10.1128/mBio.00602-12; Simone M, 2009, EVOLUTION, V63, P3016, DOI 10.1111/j.1558-5646.2009.00772.x; Simone-Finstrom MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034601; Spivak M, 2003, J NEUROBIOL, V55, P341, DOI 10.1002/neu.10219; Spivak M, 1998, J ECON ENTOMOL, V91, P64, DOI 10.1093/jee/91.1.64; STANDIFER LN, 1980, APIDOLOGIE, V11, P163, DOI 10.1051/apido:19800206; Steffan-Dewenter I, 2008, ECOLOGY, V89, P1375, DOI 10.1890/06-1323.1; Sugar DR, 2012, ENVIRON MICROBIOL, V14, P924, DOI 10.1111/j.1462-2920.2011.02663.x; Swanson JAI, 2009, J CHEM ECOL, V35, P1108, DOI 10.1007/s10886-009-9683-8; Torbeck Lynn, 2011, PDA J Pharm Sci Technol, V65, P535, DOI 10.5731/pdajpst.2011.00793; TULLY JG, 1993, INT J SYST BACTERIOL, V43, P378, DOI 10.1099/00207713-43-2-378; Vallet-Gely I, 2010, CELL MICROBIOL, V12, P1666, DOI 10.1111/j.1462-5822.2010.01501.x; Vicens N, 2000, ENVIRON ENTOMOL, V29, P235, DOI 10.1603/0046-225X(2000)029[0235:PEOOCA]2.0.CO;2; Vojvodic S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072106; Vorburger C, 2010, BIOL LETTERS, V6, P109, DOI 10.1098/rsbl.2009.0642; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07	81	30	33	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78296	10.1371/journal.pone.0078296	http://dx.doi.org/10.1371/journal.pone.0078296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205188	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300151
J	Kim, JH; Kim, GE; Cho, GS; Kwon, HJ; Joo, CH; Kim, HS; Jang, YJ				Kim, Ji Heui; Kim, Gye Eun; Cho, Gye Song; Kwon, Hyung-Joon; Joo, Chul Hyun; Kim, Hun Sik; Jang, Yong Ju			Natural Killer Cells from Patients with Chronic Rhinosinusitis Have Impaired Effector Functions	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; INNATE IMMUNITY; RECALCITRANT RHINOSINUSITIS; CHRONIC SINUSITIS; NK CELLS; EXPRESSION; ACTIVATION; ASTHMA; POLARIZATION; PATHOGENESIS	Natural killer (NK) cells are multicompetent lymphocytes of the innate immune system that play a central role in host defense and immune regulation. Although increasing evidence suggests that innate immunity plays a key role in the pathogenesis of chronic rhinosinusitis (CRS), the role of NK cells in CRS has been poorly studied. This study aimed to characterize the peripheral blood NK cells from patients with CRS, and to compare the functions of these cells with those from non-CRS controls. The correlation between NK cell functional activity and prognosis was also assessed. Eighteen CRS patients and 19 healthy non-CRS controls were included. The patients with CRS were classified into two subgroups, namely a treatment-responsive group and recalcitrant group. NK cell degranulation was determined by measuring the cell surface expression of CD107a against 721.221 and K562 cells. Intracytoplasmic cytokine production was determined by flow cytometry. Compared to the controls, the NK cells of CRS group had an impaired ability to degranulate and to produce cytokines such as IFN-gamma and TNF-alpha. The recalcitrant subgroup showed the most severe defects in NK cell effector functions. Moreover, the decreased NK cell functions in patients with CRS were associated with poor prognostic factors such as concomitant asthma and peripheral blood eosinophilia. NK cells, which were originally named for their ability to mediate spontaneous cytotoxicity towards diseased cells including infected cells, may play an important role in regulating the inflammatory process in CRS pathogenesis.	[Kim, Ji Heui; Cho, Gye Song; Jang, Yong Ju] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Otolaryngol, Seoul, South Korea; [Kim, Gye Eun; Kwon, Hyung-Joon; Kim, Hun Sik] Univ Ulsan, Coll Med, Grad Sch, Dept Med, Seoul, South Korea; [Joo, Chul Hyun; Kim, Hun Sik] Univ Ulsan, Coll Med, Dept Microbiol, Seoul, South Korea; [Kim, Hun Sik] Univ Ulsan, Coll Med, Cellular Dysfunct Res Ctr, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; University of Ulsan; University of Ulsan	Kim, HS (corresponding author), Univ Ulsan, Coll Med, Grad Sch, Dept Med, Seoul, South Korea.	hunkim@amc.seoul.kr; jangyj@amc.seoul.kr			Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A110893]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This work was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A110893). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnon TI, 2001, EUR J IMMUNOL, V31, P2680, DOI 10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A; Brandt CS, 2009, J EXP MED, V206, P1495, DOI 10.1084/jem.20090681; Bresciani M, 2001, J ALLERGY CLIN IMMUN, V107, P73, DOI 10.1067/mai.2001.111593; Bryceson YT, 2005, J EXP MED, V202, P1001, DOI 10.1084/jem.20051143; Cao PP, 2009, J ALLERGY CLIN IMMUN, V124, P478, DOI 10.1016/j.jaci.2009.05.017; Dupuy S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002486; El-Shazly AE, 2013, CLIN EXP ALLERGY, V43, P322, DOI 10.1111/cea.12022; El-Shazly AE, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/373589; Fairclough L, 2008, CLIN SCI, V114, P533, DOI 10.1042/CS20070356; Fokkens WJ, 2010, RHINOLOGY, V48, P257, DOI 10.4193/Rhin10.300; Hamilos DL, 2011, J ALLERGY CLIN IMMUN, V128, P693, DOI 10.1016/j.jaci.2011.08.004; HAMILOS DL, 1995, J ALLERGY CLIN IMMUN, V96, P537, DOI 10.1016/S0091-6749(95)70298-9; Hsu J, 2011, AM J RHINOL ALLERGY, V25, P285, DOI 10.2500/ajra.2011.25.3680; Jiang DH, 2004, J CLIN INVEST, V114, P291, DOI 10.1172/JCI200416861; Jyonouchi H, 2001, ARCH OTOLARYNGOL, V127, P1488, DOI 10.1001/archotol.127.12.1488; KAVATHAS P, 1980, P NATL ACAD SCI-BIOL, V77, P4251, DOI 10.1073/pnas.77.7.4251; Kim HS, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002754; Korsgren M, 1999, J EXP MED, V189, P553, DOI 10.1084/jem.189.3.553; Lane AP, 2009, CURR ALLERGY ASTHM R, V9, P205, DOI 10.1007/s11882-009-0030-5; Lane AP, 2006, AM J RHINOL, V20, P138, DOI 10.1177/194589240602000203; Lee Stella, 2011, Curr Infect Dis Rep, V13, P159, DOI 10.1007/s11908-011-0166-z; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Lopez-Verges S, 2010, BLOOD, V116, P3865, DOI 10.1182/blood-2010-04-282301; Matsubara S, 2007, AM J RESP CELL MOL, V36, P324, DOI 10.1165/rcmb.2006-0231OC; Matsuwaki Y, 2008, INT ARCH ALLERGY IMM, V146, P77, DOI 10.1159/000126066; Mesdaghi M, 2010, INT ARCH ALLERGY IMM, V153, P234, DOI 10.1159/000314363; Ombrello MJ, 2012, NEW ENGL J MED, V366, P330, DOI 10.1056/NEJMoa1102140; Ozdemir O, 2005, J ALLERGY CLIN IMMUN, V116, P1165, DOI 10.1016/j.jaci.2005.08.007; Papakosta D, 2009, RESPIRATION, V78, P177, DOI 10.1159/000203989; Parolini S, 2000, J EXP MED, V192, P337, DOI 10.1084/jem.192.3.337; Payne SC, 2011, J ALLERGY CLIN IMMUN, V128, P710, DOI 10.1016/j.jaci.2011.05.022; Prieto A, 2001, AM J RESP CRIT CARE, V163, P1578, DOI 10.1164/ajrccm.163.7.2002015; Ramanathan M, 2007, OTOLARYNG HEAD NECK, V136, P348, DOI 10.1016/j.otohns.2006.11.011; Rosenfeld RM, 2007, OTOLARYNG HEAD NECK, V137, pS1, DOI 10.1016/j.otohns.2007.06.726; Schierloh P, 2005, IMMUNOLOGY, V116, P541, DOI 10.1111/j.1365-2567.2005.02259.x; Strieter RM, 2004, J CLIN INVEST, V114, P165, DOI 10.1172/JCI200422398; Turvey SE, 2010, J ALLERGY CLIN IMMUN, V125, pS24, DOI 10.1016/j.jaci.2009.07.016; Vankayalapati R, 2002, J IMMUNOL, V168, P3451, DOI 10.4049/jimmunol.168.7.3451; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Wei HM, 2005, J ALLERGY CLIN IMMUN, V115, P841, DOI 10.1016/j.jaci.2004.11.026; Wesselkamper SC, 2008, J IMMUNOL, V181, P5481, DOI 10.4049/jimmunol.181.8.5481	41	19	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77177	10.1371/journal.pone.0077177	http://dx.doi.org/10.1371/journal.pone.0077177			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204766	gold, Green Submitted, Green Published			2022-12-27	WOS:000326029300088
J	King, AJF; Guo, YJ; Cai, DS; Hollister-Lock, J; Morris, B; Salvatori, A; Corbett, JA; Bonner-Weir, S; Shoelson, SE; Weir, GC				King, Aileen J. F.; Guo, Yongjing; Cai, Dongsheng; Hollister-Lock, Jennifer; Morris, Brooke; Salvatori, Alison; Corbett, John A.; Bonner-Weir, Susan; Shoelson, Steven E.; Weir, Gordon C.			Sustained NF-kappa B Activation and Inhibition in beta-Cells Have Minimal Effects on Function and Islet Transplant Outcomes	PLOS ONE			English	Article							OXIDE SYNTHASE EXPRESSION; STIMULATED-INSULIN-SECRETION; TRANSCRIPTION FACTOR; PANCREATIC-ISLETS; IKK-BETA; CHRONIC HYPERGLYCEMIA; SODIUM-SALICYLATE; DIABETES-MELLITUS; RANDOMIZED-TRIAL; APOPTOSIS	The activation of the transcription factor NF-kappa B leads to changes in expression of many genes in pancreatic beta-cells. However, the role of NF-kappa B activation in islet transplantation has not been fully elucidated. The aim of the present study was to investigate whether the state of NF-kappa B activation would influence the outcome of islet transplantation. Transgenic mice expressing a dominant active IKK beta (constitutively active) or a non-degradable form of I kappa B alpha (constitutive inhibition) under control of the rat insulin promoter were generated. Islets from these mice were transplanted into streptozotocin diabetic mice in suboptimal numbers. Further, the effects of salicylate (an inhibitor of NF-kappa B) treatment of normal islets prior to transplantation, and the effects of salicylate administration to mice prior to and after islet implantation were evaluated. Transplantation outcomes were not affected using islets expressing a non-degradable form of I kappa B alpha when compared to wild type controls. However, the transplantation outcomes using islets isolated from mice expressing a constitutively active mutant of NF-kappa B were marginally worse, although no aberrations of islet function in vitro could be detected. Salicylate treatment of normal islets or mice had no effect on transplantation outcome. The current study draws attention to the complexities of NF-kappa B in pancreatic beta cells by suggesting that they can adapt with normal or near normal function to both chronic activation and inhibition of this important transcription factor.	[King, Aileen J. F.] Kings Coll London, Diabet Res Grp, London, England; [King, Aileen J. F.; Hollister-Lock, Jennifer; Morris, Brooke; Bonner-Weir, Susan; Shoelson, Steven E.; Weir, Gordon C.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Islet Cell & Regenerat Biol, Boston, MA 02115 USA; [Guo, Yongjing; Cai, Dongsheng] Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Pathophysiol & Mol Pharmacol, Boston, MA 02115 USA; [Salvatori, Alison] St Louis Univ, Dept Physiol & Pharmacol, St Louis, MO 63103 USA; [Corbett, John A.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	University of London; King's College London; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Saint Louis University; Medical College of Wisconsin	Weir, GC (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Islet Cell & Regenerat Biol, Boston, MA 02115 USA.	gordon.weir@joslin.harvard.edu	King, Aileen/I-5935-2013	King, Aileen/0000-0001-5759-7985; Bonner-Weir, Susan/0000-0003-4682-0656	Juvenile Diabetes Research Foundation; National Institutes of Health [R01 DK 66056, DK 93909, R01 DK 45943, DK 51729]; Joslin Diabetes Research Center (DRC) Advanced Microscopy Core [P30 DK36836]; Diabetes Research and Wellness Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK051729, R01DK066056, P30DK036836, R01DK045943, R01DK051729, R01DK093909] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joslin Diabetes Research Center (DRC) Advanced Microscopy Core; Diabetes Research and Wellness Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the Juvenile Diabetes Research Foundation (GCW), grants from the National Institutes of Health: R01 DK 66056 and DK 93909 (SBW) and R01 DK 45943 and DK 51729 (SES), P30 DK36836 Joslin Diabetes Research Center (DRC) Advanced Microscopy Core, as well as the Diabetes Research and Wellness Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelli S, 2004, DIABETES, V53, P2815, DOI 10.2337/diabetes.53.11.2815; ANDERSSON A, 1983, CRYOBIOLOGY, V20, P161, DOI 10.1016/0011-2240(83)90005-6; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Borthwick GM, 2006, FASEB J, V20, P2009, DOI 10.1096/fj.06-5987com; Bottino R, 2004, DIABETES, V53, P2559, DOI 10.2337/diabetes.53.10.2559; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cardozo AK, 2001, J BIOL CHEM, V276, P48879, DOI 10.1074/jbc.M108658200; Chang I, 2003, DIABETES, V52, P1169, DOI 10.2337/diabetes.52.5.1169; Chen C, 2011, AM J TRANSPLANT, V11, P215, DOI 10.1111/j.1600-6143.2010.03390.x; Collier JJ, 2006, DIABETES, V55, P1398, DOI 10.2337/db05-1000; Davalli AM, 1996, DIABETES, V45, P1161, DOI 10.2337/diabetes.45.9.1161; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Ding XM, 2012, ARTIF ORGANS, V36, pE21, DOI 10.1111/j.1525-1594.2011.01395.x; Eldor R, 2006, P NATL ACAD SCI USA, V103, P5072, DOI 10.1073/pnas.0508166103; Eldor R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056924; Fiorina P, 2008, AM J TRANSPLANT, V8, P1990, DOI 10.1111/j.1600-6143.2008.02353.x; Giannoukakis N, 2000, J BIOL CHEM, V275, P36509, DOI 10.1074/jbc.M005943200; Goldfine AB, 2013, ANN INTERN MED, V159, P1, DOI 10.7326/0003-4819-159-1-201307020-00003; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Hammar EB, 2005, J BIOL CHEM, V280, P30630, DOI 10.1074/jbc.M502493200; Hawley SA, 2012, SCIENCE; Heimberg H, 2001, DIABETES, V50, P2219, DOI 10.2337/diabetes.50.10.2219; Heitmeier MR, 1997, J BIOL CHEM, V272, P13697, DOI 10.1074/jbc.272.21.13697; Heitmeier MR, 1999, J BIOL CHEM, V274, P29266, DOI 10.1074/jbc.274.41.29266; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; KWON G, 1995, ENDOCRINOLOGY, V136, P4790, DOI 10.1210/en.136.11.4790; Laybutt DR, 2003, J BIOL CHEM, V278, P2997, DOI 10.1074/jbc.M210581200; Laybutt DR, 2002, DIABETES, V51, P413, DOI 10.2337/diabetes.51.2.413; Mabley JG, 2002, J ENDOCRINOL, V173, DOI 10.1677/joe.0.1730457; MandrupPoulsen T, 1996, DIABETOLOGIA, V39, P1005, DOI 10.1007/BF00400649; McCall MD, 2011, ISLETS, V3; MONTANA E, 1993, J CLIN INVEST, V91, P780, DOI 10.1172/JCI116297; Norlin S, 2005, DIABETES, V54, P125, DOI 10.2337/diabetes.54.1.125; Padgett LE, 2013, ANN NY ACAD SCI, V1281, P16, DOI 10.1111/j.1749-6632.2012.06826.x; Papaccio G, 2005, J CELL PHYSIOL, V204, P124, DOI 10.1002/jcp.20276; Rabinovitch A, 1998, BIOCHEM PHARMACOL, V55, P1139, DOI 10.1016/S0006-2952(97)00492-9; Rink JS, 2012, SURGERY, V151, P330, DOI 10.1016/j.surg.2011.07.011; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; SoRelle JA, 2013, DIABETOLOGIA, V56, P814, DOI 10.1007/s00125-012-2813-9; Steer SA, 2006, PLOS MED, V3, P253, DOI 10.1371/journal.pmed.0030017; Takahashi T, 2010, J SURG RES, V163, pE23, DOI 10.1016/j.jss.2010.04.044; Tillmar L, 2002, J BIOL CHEM, V277, P1099, DOI 10.1074/jbc.M108340200; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zeender E, 2004, J CLIN ENDOCR METAB, V89, P5059, DOI 10.1210/jc.2004-0446	48	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77452	10.1371/journal.pone.0077452	http://dx.doi.org/10.1371/journal.pone.0077452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204831	gold, Green Published, Green Submitted			2022-12-27	WOS:000326029300097
J	Meng, LP; Xu, HQ; Liu, AL; van Raaij, J; Bemelmans, W; Hu, XQ; Zhang, Q; Du, SM; Fang, HY; Ma, J; Xu, GF; Li, Y; Guo, HW; Du, L; Ma, GS				Meng, Liping; Xu, Haiquan; Liu, Ailing; van Raaij, Joop; Bemelmans, Wanda; Hu, Xiaoqi; Zhang, Qian; Du, Songming; Fang, Hongyun; Ma, Jun; Xu, Guifa; Li, Ying; Guo, Hongwei; Du, Lin; Ma, Guansheng			The Costs and Cost-Effectiveness of a School-Based Comprehensive Intervention Study on Childhood Obesity in China	PLOS ONE			English	Article							BODY-MASS INDEX; PHYSICAL-ACTIVITY; CONTROLLED-TRIAL; CHILDREN; OVERWEIGHT; NUTRITION; PROGRAM; PREVENTION; HEALTH; YOUTH	Background: The dramatic rise of overweight and obesity among Chinese children has greatly affected the social economic development. However, no information on the cost-effectiveness of interventions in China is available. The objective of this study is to evaluate the cost and the cost-effectiveness of a comprehensive intervention program for childhood obesity. We hypothesized the integrated intervention which combined nutrition education and physical activity (PA) is more cost-effective than the same intensity of single intervention. Methods: And Findings: A multi-center randomized controlled trial conducted in six large cities during 2009-2010. A total of 8301 primary school students were categorized into five groups and followed one academic year. Nutrition intervention, PA intervention and their shared common control group were located in Beijing. The combined intervention and its' control group were located in other 5 cities. In nutrition education group, 'nutrition and health classes' were given 6 times for the students, 2 times for the parents and 4 times for the teachers and health workers. "Happy 10" was carried out twice per day in PA group. The comprehensive intervention was a combination of nutrition and PA interventions. BMI and BAZ increment was 0.65 kg/m(2) (SE 0.09) and 0.01 (SE 0.11) in the combined intervention, respectively, significantly lower than that in its' control group (0.82 +/- 0.09 for BMI, 0.10 +/- 0.11 for BAZ). No significant difference were found neither in BMI nor in BAZ change between the PA intervention and its' control, which is the same case in the nutrition intervention. The single intervention has a relative lower intervention costs compared with the combined intervention. Labor costs in Guangzhou, Shanghai and Jinan was higher compared to other cities. The cost-effectiveness ratio was $120.3 for BMI and $249.3 for BAZ in combined intervention, respectively. Conclusions: The school-based integrated obesity intervention program was cost-effectiveness for children in urban China.	[Meng, Liping; Xu, Haiquan; Liu, Ailing; Hu, Xiaoqi; Zhang, Qian; Du, Songming; Fang, Hongyun; Ma, Guansheng] Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Food Safety, Beijing, Peoples R China; [van Raaij, Joop; Bemelmans, Wanda] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Ma, Jun] Beijing Univ, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Xu, Guifa] Shandong Univ, Jinan 250100, Peoples R China; [Li, Ying] Harbin Med Univ, Coll Publ Hlth, Harbin, Peoples R China; [Guo, Hongwei] Fudan Univ, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Du, Lin] Guangzhou Ctr Dis Prevent & Control, Guangzhou, Guangdong, Peoples R China	Chinese Center for Disease Control & Prevention; Netherlands National Institute for Public Health & the Environment; Peking University; Shandong University; Harbin Medical University; Fudan University	Ma, GS (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Food Safety, Beijing, Peoples R China.	mags@chinacdc.cn	Ma, Guansheng/AAD-6767-2020; meng, li/GVT-2063-2022		China Ministry of Science Technology [2008BAI58B05]	China Ministry of Science Technology(Ministry of Science and Technology, China)	This project has been funded by China Ministry of Science & Technology as "Key Projects in the National Science & Technology Pillar Program during the Eleventh Five-Year Plan Period", grant number 2008BAI58B05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell K, 2001, Obes Rev, V2, P149, DOI 10.1046/j.1467-789x.2001.00035.x; Carter R, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-419; DARCA AS, 1986, PUBLIC HEALTH, V100, P166, DOI 10.1016/S0033-3506(86)80030-0; Doak CM, 2006, OBES REV, V7, P111, DOI 10.1111/j.1467-789X.2006.00234.x; Donnelly JE, 1996, OBES RES, V4, P229, DOI 10.1002/j.1550-8528.1996.tb00541.x; Goldfield GS, 2001, INT J OBESITY, V25, P1843, DOI 10.1038/sj.ijo.0801838; Gortmaker SL, 1999, ARCH PEDIAT ADOL MED, V153, P409, DOI 10.1001/archpedi.153.4.409; Group of China Obesity Task Force, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P97; GUO SS, 1994, AM J CLIN NUTR, V59, P810, DOI 10.1093/ajcn/59.4.810; Harris KC, 2009, CAN MED ASSOC J, V180, P719, DOI 10.1503/cmaj.080966; Howe CA, 2011, J OBES, V2011, DOI 10.1155/2011/358581; Jiang J, 2007, CHILD CARE HLTH DEV, V33, P641, DOI 10.1111/j.1365-2214.2007.00738.x; Li YP, 2008, ASIA PAC J CLIN NUTR, V17, P131; Li YP, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-229; Liu A, 2008, OBES REV, V9, P130, DOI 10.1111/j.1467-789X.2007.00454.x; Liu Y, 2006, ASIA PAC J CLIN NUTR, V15, P72; Ma G, 2009, HLTH SCH, V1; Manios Y, 1999, PREV MED, V28, P149, DOI 10.1006/pmed.1998.0388; Ministry of Health Singapore, 2001, STAT HLTH REP 2000 R; *NAT BUR STAT CHIN, 2000, CHIN STAT YB 2000; PISUNYER FX, 1993, ANN INTERN MED, V119, P655, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00006; Popkin BM, 2006, OBES REV, V7, P271, DOI 10.1111/j.1467-789X.2006.00230.x; Primary Health Division Ministry of Health Singapore, 1993, ANN REP 1993 SCH HLT; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Tudor-Locke C, 2003, INT J OBESITY, V27, P1093, DOI 10.1038/sj.ijo.0802377; Wake M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3308; Wang LY, 2008, J SCHOOL HEALTH, V78, P619, DOI 10.1111/j.1746-1561.2008.00357.x; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Wu XiuJuan, 2010, Modern Preventive Medicine, V37, P2225; Zhai Feng-ying, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P485	30	31	31	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77971	10.1371/journal.pone.0077971	http://dx.doi.org/10.1371/journal.pone.0077971			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205050	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300129
J	Stevens, H; Bertelsen, MF; Sijmons, S; Van Ranst, M; Maes, P				Stevens, Hans; Bertelsen, Mads Frost; Sijmons, Steven; Van Ranst, Marc; Maes, Piet			Characterization of a Novel Polyomavirus Isolated from a Fibroma on the Trunk of an African Elephant (Loxodonta africana)	PLOS ONE			English	Article							ROLLING-CIRCLE AMPLIFICATION; MERKEL CELL POLYOMAVIRUS; LARGE T-ANTIGEN; VIRUS; DNA; REPLICATION; INFECTION; BINDING; GENOME; SV40	Viruses of the family Polyomaviridae infect a wide variety of avian and mammalian hosts with a broad spectrum of outcomes including asymptomatic infection, acute systemic disease, and tumor induction. In this study a novel polyomavirus, the African elephant polyomavirus 1 (AelPyV-1) found in a protruding hyperplastic fibrous lesion on the trunk of an African elephant (Loxodonta africana) was characterized. The AelPyV-1 genome is 5722 bp in size and is one of the largest polyomaviruses characterized to date. Analysis of the AelPyV-1 genome reveals five putative open-reading frames coding for the classic small and large T antigens in the early region, and the VP1, VP2 and VP3 capsid proteins in the late region. In the area preceding the VP2 start codon three putative open-reading frames, possibly coding for an agnoprotein, could be localized. A regulatory, non-coding region separates the 2 coding regions. Unique for polyomaviruses is the presence of a second 854 bp long non-coding region between the end of the early region and the end of the late region. Based on maximum likelihood phylogenetic analyses of the large T antigen of the AelPyV-1 and 61 other polyomavirus sequences, AelPyV-1 clusters within a heterogeneous group of polyomaviruses that have been isolated from bats, new world primates and rodents.	[Stevens, Hans; Sijmons, Steven; Van Ranst, Marc; Maes, Piet] Katholieke Univ Leuven, Rega Inst, Dept Microbiol & Immunol, Lab Clin Virol, Louvain, Belgium; [Bertelsen, Mads Frost] Copenhagen Zoo, Ctr Zoo & Wild Anim Hlth, Frederiksberg, Denmark	KU Leuven	Maes, P (corresponding author), Katholieke Univ Leuven, Rega Inst, Dept Microbiol & Immunol, Lab Clin Virol, Louvain, Belgium.	piet.maes@rega.kuleuven.be	Van Ranst, Marc/P-7522-2017; Maes, Piet/P-7782-2017; Bertelsen, Mads/AAA-5746-2022	Van Ranst, Marc/0000-0002-1674-4157; Maes, Piet/0000-0002-4571-5232; Bertelsen, Mads/0000-0001-9201-7499; Sijmons, Steven/0000-0003-3520-636X	Research Foundation Flanders (FWO - 'Fonds voor Wetenschappelijk Onderzoek, Vlaanderen')	Research Foundation Flanders (FWO - 'Fonds voor Wetenschappelijk Onderzoek, Vlaanderen')(FWO)	Steven Sijmons and Piet Maes are supported by the Research Foundation Flanders (FWO - 'Fonds voor Wetenschappelijk Onderzoek, Vlaanderen' - www.fwo.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; Alley M, 2013, NZ VET J; ARTHUR RR, 1986, NEW ENGL J MED, V315, P230, DOI 10.1056/NEJM198607243150405; Bennett MD, 2008, VIROLOGY, V376, P173, DOI 10.1016/j.virol.2008.03.014; Egli A, 2009, J INFECT DIS, V199, P837, DOI 10.1086/597126; Fagrouch Z, 2012, J GEN VIROL, V93, P2652, DOI 10.1099/vir.0.044149-0; Fang NX, 1999, VIRUS RES, V60, P113, DOI 10.1016/S0168-1702(98)00117-8; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; FRISQUE RJ, 1984, J VIROL, V51, P458, DOI 10.1128/JVI.51.2.458-469.1984; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Gerits N, 2012, VIROLOGY, V432, P316, DOI 10.1016/j.virol.2012.05.024; Groenewoud MJ, 2010, J GEN VIROL, V91, P653, DOI 10.1099/vir.0.017673-0; Imperiale M.J., 2007, FIELDS VIROLOGY, V2, P2263; JACOBSON ER, 1986, J AM VET MED ASSOC, V189, P1075; Johne R, 2005, J VIROL, V79, P3883, DOI 10.1128/JVI.79.6.3883-3887.2005; Johne R, 2007, J VIROL, V81, P11554, DOI 10.1128/JVI.01178-07; Johne R, 2011, ARCH VIROL, V156, P1627, DOI 10.1007/s00705-011-1008-x; Johne R, 2009, TRENDS MICROBIOL, V17, P205, DOI 10.1016/j.tim.2009.02.004; Korup S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058021; Kreuter A, 2008, ARCH DERMATOL, V144, P1393, DOI 10.1001/archderm.144.10.1393; LI L, 1995, J VIROL, V69, P7570, DOI 10.1128/JVI.69.12.7570-7578.1995; Lim ES, 2013, VIROLOGY, V436, P295, DOI 10.1016/j.virol.2012.12.005; Literak I, 2006, AVIAN DIS, V50, P120, DOI 10.1637/7395-061605R.1; LOEBER G, 1989, J VIROL, V63, P94, DOI 10.1128/JVI.63.1.94-100.1989; Miksch K, 2002, BERL MUNCH TIERARZTL, V115, P390; Misra V, 2009, J GEN VIROL, V90, P2015, DOI 10.1099/vir.0.010694-0; Orba Y, 2011, J GEN VIROL, V92, P789, DOI 10.1099/vir.0.027854-0; PADGETT BL, 1971, LANCET, V1, P1257; PIPAS JM, 1992, J VIROL, V66, P3979, DOI 10.1128/JVI.66.7.3979-3985.1992; Rector A, 2004, J VIROL, V78, P4993, DOI 10.1128/JVI.78.10.4993-4998.2004; Renshaw RW, 2012, J VIROL, V86, P8903, DOI 10.1128/JVI.01261-12; Ronaghi M, 2001, GENOME RES, V11, P3, DOI 10.1101/gr.11.1.3; SCHMIDT M, 1989, J VIROL, V63, P429, DOI 10.1128/JVI.63.1.429-431.1989; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; Scuda N, 2011, J VIROL, V85, P4586, DOI 10.1128/JVI.02602-10; Siebrasse EA, 2012, J VIROL, V86, P10321, DOI 10.1128/JVI.01210-12; Spurgeon ME, 2013, VIROLOGY, V435, P118, DOI 10.1016/j.virol.2012.09.029; Stevens H., 2010, COLD SPRING HARB PRO; Stevens H, 2008, VET MICROBIOL, V129, P108, DOI 10.1016/j.vetmic.2007.11.037; Sullivan CS, 2002, MICROBIOL MOL BIOL R, V66, P179, DOI 10.1128/MMBR.66.2.179-202.2002; SWEET BH, 1960, P SOC EXP BIOL MED, V105, P420, DOI 10.3181/00379727-105-26128; Tao Y, 2013, J GEN VIROL, V94, P738, DOI 10.1099/vir.0.047928-0; van der Meijden E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001024; Verschoor EJ, 2008, J GEN VIROL, V89, P130, DOI 10.1099/vir.0.83287-0; Walther AP, 1999, BIOCHEMISTRY-US, V38, P3963, DOI 10.1021/bi982370u; Williams CK, 2012, ARCH BIOCHEM BIOPHYS, V518, P111, DOI 10.1016/j.abb.2011.12.014; Woolford L, 2008, VET PATHOL, V45, P95, DOI 10.1354/vp.45-1-95; WYCHOWSKI C, 1986, EMBO J, V5, P2569, DOI 10.1002/j.1460-2075.1986.tb04536.x; Yu GX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049449	49	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77884	10.1371/journal.pone.0077884	http://dx.doi.org/10.1371/journal.pone.0077884			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205012	Green Published, Green Submitted, gold			2022-12-27	WOS:000326029300122
J	Dai, CM; Zhang, J; Zhang, YL; Zhou, XF; Liu, SG				Dai, Chaomeng; Zhang, Juan; Zhang, Yalei; Zhou, Xuefei; Liu, Shuguang			Application of Molecularly Imprinted Polymers to Selective Removal of Clofibric Acid from Water	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING COMPOUNDS; PERSONAL CARE PRODUCTS; PHARMACEUTICAL RESIDUES; AQUATIC ENVIRONMENT; MUNICIPAL SEWAGE; AQUEOUS-SOLUTION; DRINKING-WATER; DICLOFENAC; SURFACE; FATE	A new molecularly imprinted polymer (MIP) adsorbent for clofibric acid (CA) was prepared by a non-covalent protocol. Characterization of the obtained MIP was achieved by scanning electron microscopy (SEM) and nitrogen sorption. Sorption experimental results showed that the MIP had excellent binding affinity for CA and the adsorption of CA by MIP was well described by pseudo-second-order model. Scatchard plot analysis revealed that two classes of binding sites were formed in the MIP with dissociation constants of 7.52 +/- 0.46 mg L-1 and 114 +/- 4.2 mg L-1, respectively. The selectivity of MIP demonstrated higher affinity for CA over competitive compound than that of non-imprinted polymers (NIP). The MIP synthesized was used to remove CA from spiked surface water and exhibited significant binding affinity towards CA in the presence of total dissolved solids (TDS). In addition, MIP reusability was demonstrated for at least 12 repeated cycles without significant loss in performance.	[Dai, Chaomeng; Liu, Shuguang] Tongji Univ, Coll Civil Engn, Shanghai 200092, Peoples R China; [Dai, Chaomeng; Zhang, Juan; Zhang, Yalei; Zhou, Xuefei] Tongji Univ, State Key Lab Pollut Control & Resource Reuse, Shanghai 200092, Peoples R China; [Zhang, Yalei] Tongji Univ, UNEP Tongji Inst Environm Sustainable Dev, Shanghai 200092, Peoples R China	Tongji University; Tongji University; Tongji University	Zhang, YL (corresponding author), Tongji Univ, State Key Lab Pollut Control & Resource Reuse, Shanghai 200092, Peoples R China.	zhangyalei@tongji.edu.cn	ZHOU, XUE/F-6129-2013		Natural Science Foundation of China [41101480, 358 41070641]; State Key Laboratory of Pollution Control and Resource Reuse Foundation [PCRRY11015]; China Postdoctoral Science Foundation [20110490698, 2013M531217]; Shanghai Postdoctoral Scientific Program [13R21416000]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Pollution Control and Resource Reuse Foundation; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shanghai Postdoctoral Scientific Program	This study was financed by the Natural Science Foundation of China (41101480, 358 41070641), State Key Laboratory of Pollution Control and Resource Reuse Foundation (PCRRY11015), China Postdoctoral Science Foundation funded project (20110490698, 2013M531217) and Shanghai Postdoctoral Scientific Program (13R21416000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreozzi R, 2003, J HAZARD MATER, V103, P233, DOI 10.1016/j.jhazmat.2003.07.001; APHA A., 1999, STANDARD METHODS EXA; Boyd GR, 2003, SCI TOTAL ENVIRON, V311, P135, DOI 10.1016/S0048-9697(03)00138-4; Buser HR, 1998, ENVIRON SCI TECHNOL, V32, P3449, DOI 10.1021/es980301x; Byun HS, 2010, SEP PURIF TECHNOL, V74, P144, DOI 10.1016/j.seppur.2010.05.017; Debska J, 2004, CRIT REV ANAL CHEM, V34, P51, DOI 10.1080/10408340490273753; Doll TE, 2005, WATER RES, V39, P403, DOI 10.1016/j.watres.2004.09.016; Dunne M., 2000, ADVOCATE; Gao YH, 2011, ENVIRON TECHNOL, V32, P1719, DOI 10.1080/09593330.2011.554888; Heberer T, 2002, J HYDROL, V266, P175, DOI 10.1016/S0022-1694(02)00165-8; Heberer T, 2002, TOXICOL LETT, V131, P5, DOI 10.1016/S0378-4274(02)00041-3; Krupadam RJ, 2010, WATER RES, V44, P681, DOI 10.1016/j.watres.2009.09.044; Le Noir M, 2007, WATER RES, V41, P2825, DOI 10.1016/j.watres.2007.03.023; Le Noir M, 2007, J CHROMATOGR A, V1154, P158, DOI 10.1016/j.chroma.2007.03.064; Le Noir M, 2009, ACS SYM SER, V1022, P25; Le Noir M, 2009, J SEP SCI, V32, P1471, DOI 10.1002/jssc.200800670; Li Y, 2009, BIOSENS BIOELECTRON, V25, P306, DOI 10.1016/j.bios.2009.07.001; Li Y, 2009, ENVIRON POLLUT, V157, P1879, DOI 10.1016/j.envpol.2009.01.014; Lopez C, 2011, ANAL CHIM ACTA, V683, P198, DOI 10.1016/j.aca.2010.09.051; Meng ZH, 2005, ENVIRON SCI TECHNOL, V39, P8958, DOI 10.1021/es0505292; Mestre AS, 2010, CARBON, V48, P972, DOI 10.1016/j.carbon.2009.11.013; Pan JM, 2010, CHEM ENG J, V162, P910, DOI 10.1016/j.cej.2010.06.039; Peng XZ, 2008, SCI TOTAL ENVIRON, V397, P158, DOI 10.1016/j.scitotenv.2008.02.059; Sun Z, 2008, ANAL CHIM ACTA, V620, P73, DOI 10.1016/j.aca.2008.05.020; Ternes TA, 2002, ENVIRON SCI TECHNOL, V36, P3855, DOI 10.1021/es015757k; Ternes TA, 1998, WATER RES, V32, P3245, DOI 10.1016/S0043-1354(98)00099-2; Weigel S, 2002, SCI TOTAL ENVIRON, V295, P131, DOI 10.1016/S0048-9697(02)00064-5; Yoon Y, 2007, DESALINATION, V202, P16, DOI 10.1016/j.desal.2005.12.033; Yu Q, 2008, WATER RES, V42, P3089, DOI 10.1016/j.watres.2008.02.024; Zorita S, 2009, SCI TOTAL ENVIRON, V407, P2760, DOI 10.1016/j.scitotenv.2008.12.030; Zwiener C, 2003, SCI TOTAL ENVIRON, V309, P201, DOI 10.1016/S0048-9697(03)00002-0	31	17	17	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e78167	10.1371/journal.pone.0078167	http://dx.doi.org/10.1371/journal.pone.0078167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24205143	Green Published, gold, Green Submitted			2022-12-27	WOS:000326373800015
J	O'Brien, K; Forrest, W; Lynott, D; Daly, M				O'Brien, Kerry; Forrest, Walter; Lynott, Dermot; Daly, Michael			Racism, Gun Ownership and Gun Control: Biased Attitudes in US Whites May Influence Policy Decisions	PLOS ONE			English	Article							SYMBOLIC RACISM; IMPLICIT; CRIME; RACE; VALIDITY; DISCRIMINATION; OPPOSITION; PREJUDICE; HOMICIDE; SUICIDE	Objective: Racism is related to policies preferences and behaviors that adversely affect blacks and appear related to a fear of blacks (e. g., increased policing, death penalty). This study examined whether racism is also related to gun ownership and opposition to gun controls in US whites. Method: The most recent data from the American National Election Study, a large representative US sample, was used to test relationships between racism, gun ownership, and opposition to gun control in US whites. Explanatory variables known to be related to gun ownership and gun control opposition (i.e., age, gender, education, income, conservatism, anti-government sentiment, southern vs. other states, political identification) were entered in logistic regression models, along with measures of racism, and the stereotype of blacks as violent. Outcome variables included; having a gun in the home, opposition to bans on handguns in the home, support for permits to carry concealed handguns. Results: After accounting for all explanatory variables, logistic regressions found that for each 1 point increase in symbolic racism there was a 50% increase in the odds of having a gun at home. After also accounting for having a gun in the home, there was still a 28% increase in support for permits to carry concealed handguns, for each one point increase in symbolic racism. The relationship between symbolic racism and opposition to banning handguns in the home (OR1.27 CI 1.03,1.58) was reduced to non-significant after accounting for having a gun in the home (OR1.17 CI. 94,1.46), which likely represents self-interest in retaining property (guns). Conclusions: Symbolic racism was related to having a gun in the home and opposition to gun control policies in US whites. The findings help explain US whites' paradoxical attitudes towards gun ownership and gun control. Such attitudes may adversely influence US gun control policy debates and decisions.	[O'Brien, Kerry; Forrest, Walter] Monash Univ, Melbourne, Vic 3004, Australia; [O'Brien, Kerry] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England; [Lynott, Dermot] Univ Lancaster, Dept Psychol, Lancaster LA1 4YF, England; [Daly, Michael] Univ Stirling, Inst Sociomanagement, Stirling FK9 4LA, Scotland	Monash University; University of Manchester; Lancaster University; University of Stirling	O'Brien, K (corresponding author), Monash Univ, Melbourne, Vic 3004, Australia.	kerrykez@gmail.com	Lynott, Dermot/A-9661-2011; O'Brien, Kerry/K-9975-2013; Forrest, Walter/E-7328-2015; Daly, Michael/AAD-7703-2019	Lynott, Dermot/0000-0001-7338-0567; O'Brien, Kerry/0000-0003-3145-6038; Forrest, Walter/0000-0001-5817-2807; Daly, Michael/0000-0003-1557-8326				Barkan SE, 2005, SOC PROBL, V52, P300, DOI 10.1525/sp.2005.52.2.300; Benforado A, 2010, OR L REV, V89, P1; Berg JA, 2013, SOCIOL INQ, V83, P1, DOI 10.1111/j.1475-682x.2012.00437.x; Blanton H, 2009, J APPL PSYCHOL, V94, P567, DOI 10.1037/a0014665; Campbell Colin., 1971, SOCIOLOGY IRRELIGION; Chapman S, 2006, INJURY PREV, V12, P365, DOI 10.1136/ip.2006.013714; Chiricos T, 2004, CRIMINOLOGY, V42, P359; CROSBY F, 1980, PSYCHOL BULL, V87, P546, DOI 10.1037/0033-2909.87.3.546; Davies E, 2013, BMJ-BRIT MED J, V346, pf1058; DeBell M., 2010, METHODOLOGY REPORT U; Felson RB, 2010, SOC SCI RES, V39, P272, DOI 10.1016/j.ssresearch.2009.07.004; Green EGT, 2006, LAW HUMAN BEHAV, V30, P435, DOI 10.1007/s10979-006-9020-5; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Heloma A, 2003, ADDICTION, V98, P1111, DOI 10.1046/j.1360-0443.2003.00429.x; Henderson M, 2011, J HEALTH POLIT POLIC, V36, P945, DOI 10.1215/03616878-1460533; Henry PJ, 2002, POLIT PSYCHOL, V23, P253, DOI 10.1111/0162-895X.00281; Hoyert Donna L, 2012, Natl Vital Stat Rep, V61, P1; Hurwitz J, 1997, AM J POLIT SCI, V41, P375, DOI 10.2307/2111769; Kahan DM, 2003, U PENN LAW REV, V151, P1291, DOI 10.2307/3312930; KELLERMANN AL, 1992, NEW ENGL J MED, V327, P467, DOI 10.1056/NEJM199208133270705; KELLERMANN AL, 1993, NEW ENGL J MED, V329, P1084, DOI 10.1056/NEJM199310073291506; Kinder DR, 2012, ANN M AM POL SCI ASS; Kleck G, 1996, AM BEHAV SCI, V39, P387, DOI 10.1177/0002764296039004004; Kleck G, 2011, J CRIM JUST, V39, P312, DOI 10.1016/j.jcrimjus.2011.03.002; Klinesmith J, 2006, PSYCHOL SCI, V17, P568, DOI 10.1111/j.1467-9280.2006.01745.x; Knowles ED, 2010, J EXP SOC PSYCHOL, V46, P420, DOI 10.1016/j.jesp.2009.10.011; Lane KA, 2007, ANNU REV LAW SOC SCI, V3, P427, DOI 10.1146/annurev.lawsocsci.3.081806.112748; Leenaars AA, 2003, DEATH STUD, V27, P103, DOI 10.1080/07481180302890; Leigh A, 2012, AM LAW ECON REV, V12, P462; Lott, 2010, MORE GUNS LESS CRIME; McCarthy M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f980; McConahay JB., 1986, PREJUDICE DISCRIMINA, P91; Mitchell Gregory, OHIO ST L J, V67, P1023, DOI DOI 10.1037/XGE0000234; Nicholson SP, 2012, POLIT BEHAV, V34, P369, DOI 10.1007/s11109-011-9162-0; Pew Research Center, 2013, PERSP GUN OWN NON WH; Pew Research Center, 2013, GUN CONTR DEB SEV OP; Rabinowitz JL, 2009, POLIT PSYCHOL, V30, P805, DOI 10.1111/j.1467-9221.2009.00726.x; Rezaei AR, 2011, COMPUT HUM BEHAV, V27, P1937, DOI 10.1016/j.chb.2011.04.018; Rothermund K, 2005, J EXP PSYCHOL GEN, V134, P426, DOI 10.1037/0096-3445.134.3.426; Sabin JA, 2009, J HEALTH CARE POOR U, V20, P896, DOI 10.1353/hpu.0.0185; Sears DO, 2005, ADV EXP SOC PSYCHOL, V37, P95, DOI 10.1016/S0065-2601(05)37002-X; Sears DO, 2003, J PERS SOC PSYCHOL, V85, P259, DOI 10.1037/0022-3514.85.2.259; Sears DO, 1997, PUBLIC OPIN QUART, V61, P16, DOI 10.1086/297785; Smith, 2001, NATL GUN POLICY SURV; Tang H, 2003, AM J PUBLIC HEALTH, V93, P611, DOI 10.2105/AJPH.93.4.611; Tarman C, 2005, J POLIT, V67, P731, DOI 10.1111/j.1468-2508.2005.00337.x; UN Office on Drugs and Crimes, UN SURV CRIM TRENDS; Vanman EJ, 2004, PSYCHOL SCI, V15, P711, DOI 10.1111/j.0956-7976.2004.00746.x; Winkler, 2011, GUN FIGHT BATTLE RIG	49	59	59	4	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e77552	10.1371/journal.pone.0077552	http://dx.doi.org/10.1371/journal.pone.0077552			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	244FY	24204867	gold, Green Published, Green Accepted			2022-12-27	WOS:000326373800006
J	Liu, Y; Xu, HB; Yan, QJ; Yang, SQ; Duan, XJ; Jiang, ZQ				Liu, Yu; Xu, Haibo; Yan, Qiaojuan; Yang, Shaoqing; Duan, Xiaojie; Jiang, Zhengqiang			Biochemical Characterization of a First Fungal Esterase from Rhizomucor miehei Showing High Efficiency of Ester Synthesis	PLOS ONE			English	Article							SOLVENT-TOLERANT ESTERASE; THERMOSTABLE ESTERASE; FAMILY; LIPASE; PURIFICATION; CLASSIFICATION; EXPRESSION; ENZYMES; CLONING	Background: Esterases with excellent merits suitable for commercial use in ester production field are still insufficient. The aim of this research is to advance our understanding by seeking for more unusual esterases and revealing their characterizations for ester synthesis. Methodology/Principal Findings: A novel esterase-encoding gene from Rhizomucor miehei (RmEstA) was cloned and expressed in Escherichia coli. Sequence analysis revealed a 975-bp ORF encoding a 324-amino-acid polypeptide belonging to the hormone-sensitive lipase (HSL) family IV and showing highest similarity (44%) to the Paenibacillus mucilaginosus esterase/lipase. Recombinant RmEstA was purified to homogeneity: it was 34 kDa by SDS-PAGE and showed optimal pH and temperature of 6.5 and 45 degrees C, respectively. The enzyme was stable to 50 degrees C, under a broad pH range (5.0-10.6). RmEstA exhibited broad substrate specificity toward p-nitrophenol esters and short-acyl-chain triglycerols, with highest activities (1,480 U mg(-1) and 228 U mg(-1)) for p-nitrophenyl hexanoate and tributyrin, respectively. RmEstA efficiently synthesized butyl butyrate (92% conversion yield) when immobilized on AOT-based organogel. Conclusion: RmEstA has great potential for industrial applications. RmEstA is the first reported esterase from Rhizomucor miehei.	[Liu, Yu; Yan, Qiaojuan] China Agr Univ, Coll Engn, Bioresource Utilizat Lab, Beijing 100094, Peoples R China; [Xu, Haibo; Yang, Shaoqing; Duan, Xiaojie; Jiang, Zhengqiang] China Agr Univ, Coll Food Sci & Nutr Engn, Dept Biotechnol, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University	Yan, QJ (corresponding author), China Agr Univ, Coll Engn, Bioresource Utilizat Lab, Beijing 100094, Peoples R China.	yanqj@cau.edu.cn; zhqjiang@cau.edu.cn	Yan, Qiaojuan/C-1669-2017					Ahmed EH, 2010, BIORESOURCE TECHNOL, V101, P3628, DOI 10.1016/j.biortech.2009.12.107; Al Khudary R, 2010, EXTREMOPHILES, V14, P273, DOI 10.1007/s00792-010-0306-7; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4; Chen MB, 2011, AFR J BIOTECHNOL, V10, P5166; Cieslinski H, 2007, ARCH MICROBIOL, V188, P27, DOI 10.1007/s00203-007-0220-2; Dandavate V, 2009, BIORESOURCE TECHNOL, V100, P3374, DOI 10.1016/j.biortech.2009.02.011; Dandavate V, 2007, ENZYME MICROB TECH, V41, P265, DOI 10.1016/j.enzmictec.2007.01.019; De Barros DPC, 2012, J FOOD BIOCHEM, V36, P275, DOI 10.1111/j.1745-4514.2010.00535.x; Eggert T, 2000, EUR J BIOCHEM, V267, P6459, DOI 10.1046/j.1432-1327.2000.01736.x; Fahmy AS, 2008, BIORESOURCE TECHNOL, V99, P437, DOI 10.1016/j.biortech.2006.11.062; Fan XL, 1999, BIOTECHNOL LETT, V21, P1071, DOI 10.1023/A:1005601030076; Jiang XW, 2012, EXTREMOPHILES, V13, P769; Jin P, 2012, BIORESOURCE TECHNOL, V116, P234, DOI 10.1016/j.biortech.2011.10.087; Kang CH, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-41; Karpushova A, 2005, APPL MICROBIOL BIOT, V67, P59, DOI 10.1007/s00253-004-1780-6; Kumar L, 2012, PROCESS BIOCHEM, V47, P983, DOI 10.1016/j.procbio.2012.03.020; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee MH, 2006, APPL ENVIRON MICROB, V72, P7406, DOI 10.1128/AEM.01157-06; Levisson M, 2007, FEBS J, V274, P2832, DOI 10.1111/j.1742-4658.2007.05817.x; Linke D, 2013, APPL MICROBIOL BIOT, V97, P7241, DOI 10.1007/s00253-012-4598-7; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma BD, 2013, BIORESOURCE TECHNOL, V133, P354, DOI 10.1016/j.biortech.2013.01.089; MARTINELLE M, 1995, BBA-LIPID LIPID MET, V1258, P272, DOI 10.1016/0005-2760(95)00131-U; Oh KH, 2012, J MOL CATAL B-ENZYM, V80, P67, DOI 10.1016/j.molcatb.2012.04.015; Pandey A, 1999, BIOTECHNOL APPL BIOC, V29, P119; Preetha S, 1997, WORLD J MICROB BIOT, V13, P573, DOI 10.1023/A:1018525711573; PURDY RE, 1975, BIOCHEMISTRY-US, V14, P2832, DOI 10.1021/bi00684a007; Rao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060645; Rao L, 2011, BBA-PROTEINS PROTEOM, V1814, P1695, DOI 10.1016/j.bbapap.2011.08.013; Rose TM, 2003, NUCLEIC ACIDS RES, V31, P3763, DOI 10.1093/nar/gkg524; Sambrook J., 2001, MOL CLONING LAB MANU; Sumby KM, 2009, APPL ENVIRON MICROB, V75, P6729, DOI 10.1128/AEM.01563-09; Tang YB, 2012, J AGR FOOD CHEM, V60, P2354, DOI 10.1021/jf2049799; Torres S, 2009, FOOD RES INT, V42, P454, DOI 10.1016/j.foodres.2008.12.005; Verger R, 1997, TRENDS BIOTECHNOL, V15, P32, DOI 10.1016/S0167-7799(96)10064-0; Virk AP, 2011, J MICROBIOL BIOTECHN, V21, P667, DOI 10.4014/jmb.1103.03008; Yang ZX, 2013, J BIOSCI BIOENG, V115, P133, DOI 10.1016/j.jbiosc.2012.08.016; Yassine BA, 2006, BIOCHEMISTRY-US, V45, P14183	39	18	18	5	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77856	10.1371/journal.pone.0077856	http://dx.doi.org/10.1371/journal.pone.0077856			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204998	Green Published, gold, Green Submitted			2022-12-27	WOS:000326334500069
J	van Ittersum, K; Wansink, B				van Ittersum, Koert; Wansink, Brian			Extraverted Children Are More Biased by Bowl Sizes than Introverts	PLOS ONE			English	Article							ILLUSIONS BIAS; PORTION SIZES; PERSONALITY; CONSUMPTION; DIMENSIONS; EXTROVERTS; OVERWEIGHT; BEHAVIOR; OBESITY; TRAITS	Extraverted children are hypothesized to be most at risk for over-serving and overeating due to environmental cues - such as the size of dinnerware. A within-subject field study of elementary school students found that extraverted children served themselves 33.1% more cereal in larger bowls (16-oz) than in smaller (12-oz) bowls, whereas introverted children were unaffected by bowl size (+5.6%, ns). However, when children were asked by adults how much cereal they wanted to eat, both extraverted and introverted children requested more cereal when given a large versus small bowl. Insofar as extraverted children appear to be more biased by environmental cues, this pilot study suggests different serving styles are recommended for parents and other caregivers. They should serve extraverts, but allow introverts to serve themselves. Still, since the average child still served 23.2% more when serving themselves than when served by an adult, it might be best for caregivers to do the serving whenever possible - especially for extraverted children.	[van Ittersum, Koert] Univ Groningen, Dept Mkt, Groningen, Netherlands; [Wansink, Brian] Cornell Univ, Charles H Dyson Sch Appl Econ & Management, Ithaca, NY 14850 USA	University of Groningen; Cornell University	Wansink, B (corresponding author), Cornell Univ, Charles H Dyson Sch Appl Econ & Management, Ithaca, NY 14850 USA.	foodandbrandlab@cornell.edu		Van Ittersum, Koert/0000-0002-3584-089X	Unilever	Unilever(Unilever)	Brian Wansink received funding during the analysis stage of "Happier Meals: New Children's Meals Lead to Fewer Purchased Calories" from September 2012 through December 2012. Brian Wansink became a member of the McDonald's Advisory Council in January 2012. He received royalties from the Bantam Dell book, Mindless Eating. He was part of the Blue Zones Keynote & Panel Project in Los Angeles; gave paid lectures on food psychology research conducted over the past 20 years. PKF Consulting: Brian Wansink acted as paid consultant on a project that PKF conducted for the Department of Defense related to improving overall health of military bases. Unilever: He gave paid lectures on food psychology research conducted over the past 20 years. In regards to the Mindless Products and Mindless Method mentioned in PLOS ONE's email to the authors, Dr. Wansink is not affiliated with either. Both projects were private ventures based upon Dr. Wansink's prior studies, but he is not connected to them and receives no royalties or payment.	Craeynest M, 2008, J BEHAV THER EXP PSY, V39, P354, DOI 10.1016/j.jbtep.2007.09.002; Doucet C, 1997, PERS INDIV DIFFER, V23, P775, DOI 10.1016/S0191-8869(97)00104-9; Eysenck H.J., 1967, BIOL BASIS PERSONALI; Eysenck H.J., 1990, HDB PERSONALITY THEO, P244; Faith MS, 2001, OBES RES, V9, P647, DOI 10.1038/oby.2001.86; Ferguson E, 2001, BRIT J HEALTH PSYCH, V6, P311, DOI 10.1348/135910701169232; Golan M, 2004, NUTR REV, V62, P39, DOI 10.1111/j.1753-4887.2004.tb00005.x; Grant T, 2003, PERS INDIV DIFFER, V35, P633, DOI 10.1016/S0191-8869(02)00241-6; GRAYDON J, 1995, PERS INDIV DIFFER, V19, P265, DOI 10.1016/0191-8869(95)00052-8; Gudjonsson GH, 2004, EUR J PERSONALITY, V18, P435, DOI 10.1002/per.514; HALLSTROM T, 1981, J PSYCHOSOM RES, V25, P75, DOI 10.1016/0022-3999(81)90093-3; Harrington R, 2001, J PSYCHOL, V135, P439, DOI 10.1080/00223980109603710; Herman CP, 2005, APPETITE, V45, P108, DOI 10.1016/j.appet.2005.03.013; Kakizaki M, 2008, J PSYCHOSOM RES, V64, P71, DOI 10.1016/j.jpsychores.2007.07.008; Martsh CT, 1997, PERS INDIV DIFFER, V23, P153, DOI 10.1016/S0191-8869(97)00015-9; Pierobon A, 2008, SLEEP MED, V9, P882, DOI 10.1016/j.sleep.2007.10.017; Rustin RM, 1978, J PSYCHOSOM RES, V22, P145; Selby EC, 2004, J CREATIVE BEHAV, V38, P221, DOI 10.1002/j.2162-6057.2004.tb01242.x; van Ittersum K, 2007, J AM DIET ASSOC, V107, P1107, DOI 10.1016/j.jada.2007.05.020; Van Ittersum K, 2012, J CONSUM RES, V39, P215, DOI 10.1086/662615; Wansink B, 2004, ANNU REV NUTR, V24, P455, DOI 10.1146/annurev.nutr.24.012003.132140; Wansink B, 2014, J EXP PSYCHOL APPL; Wansink B, 2006, AM J PREV MED, V31, P240, DOI 10.1016/j.amepre.2006.04.003; Young LR, 2002, AM J PUBLIC HEALTH, V92, P246, DOI 10.2105/AJPH.92.2.246	25	17	17	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78224	10.1371/journal.pone.0078224	http://dx.doi.org/10.1371/journal.pone.0078224			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243RL	24205166	Green Published, gold			2022-12-27	WOS:000326334500106
J	Volberg, V; Heggeseth, B; Harley, K; Huen, K; Yousefi, P; Dave, V; Tyler, K; Vedar, M; Eskenazi, B; Holland, N				Volberg, Vitaly; Heggeseth, Brianna; Harley, Kim; Huen, Karen; Yousefi, Paul; Dave, Veronica; Tyler, Kristin; Vedar, Michelle; Eskenazi, Brenda; Holland, Nina			Adiponectin and Leptin Trajectories in Mexican-American Children from Birth to 9 Years of Age	PLOS ONE			English	Article							BODY-MASS INDEX; FOR-GESTATIONAL-AGE; CORD BLOOD; DEVELOPMENTAL TRAJECTORIES; SERUM ADIPONECTIN; INSULIN-RESISTANCE; PROSPECTIVE COHORT; CHILDHOOD; WEIGHT; GROWTH	Objectives: To address molecular mechanisms underlying obesity development, we examined patterns of critical metabolism-related hormones, adiponectin and leptin (adipokines), over childhood. Subjects and Design: Plasma adiponectin and leptin were measured in 80 Mexican-American children at birth and again at 2, 5, and 9 years from the ongoing prospective cohort followed by the Center for the Health Assessment of Mothers and Children of Salinas (CHAMACOS). We used a mixture modeling approach to identify patterns in adipokine trajectories from birth to 9 years. Results: Leptin was positively related to child body size within all ages, however adiponectin had inverse and weaker associations with BMI at 2, 5, and 9 years. Correlations between adipokine levels over the 0-2, 2-5, and 5-9-year periods increased for both leptin (r = 0.06, 0.31 and 0.62) and adiponectin (r = 0.25, 0.41 and 0.46). Our mixture modeling approach identified three trajectory clusters for both leptin (1L [slowly-rising], 2L [rapidly-rising], and 3L [stable]) and adiponectin (1A [steep-dropping and rebounding], 2A [moderately-dropping], and 3A [stable]). While leptin groups were most separated over the 2-9-year period, adiponectin trajectories displayed greatest heterogeneity from birth to 2 years. Children in the rapidly-rising 2L group had highest BMI and waist circumference at 9 years. Further, children with greater birth weight had increased odds of belonging to this high risk group (OR = 1.21 95% CI 1.03, 1.43, compared to stable group 3L). Children whose mothers consumed more sugar-sweetened beverages during pregnancy were at risk of being in the steep-dropping 1A group (OR = 1.08, 95% CI 1.01, 1.17, compared to stable group 3A). Conclusion: Our results highlight developmental differences in leptin and adiponectin over the childhood period. Leptin closely reflects child body size however factors affecting adiponectin and long-term consequences of its changes over infancy need to be further explored.	[Volberg, Vitaly; Harley, Kim; Huen, Karen; Yousefi, Paul; Dave, Veronica; Tyler, Kristin; Vedar, Michelle; Eskenazi, Brenda; Holland, Nina] Univ Calif Berkeley, Sch Publ Hlth, CERCH, Berkeley, CA 94720 USA; [Heggeseth, Brianna] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Volberg, V (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, CERCH, Berkeley, CA 94720 USA.	vvolberg@gmail.com		Huen, Karen/0000-0003-3604-2096; Dave, Veronica/0000-0002-3791-192X	Environmental Protection Agency (EPA) [RD83273401, RD83171001]; National Institute of Environmental Health Sciences (NIEHS) [PO1ES009605, RO1ES012503-03]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012503, P01ES009605, R01ES021369] Funding Source: NIH RePORTER	Environmental Protection Agency (EPA)(United States Environmental Protection Agency); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Environmental Protection Agency (EPA) Grants RD83273401 and RD83171001, and the National Institute of Environmental Health Sciences (NIEHS) Grants PO1ES009605 and RO1ES012503-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ay L, 2009, J CLIN ENDOCR METAB, V94, P2023, DOI 10.1210/jc.2008-2045; BLOCK G, 1990, J CLIN EPIDEMIOL, V43, P1327, DOI 10.1016/0895-4356(90)90099-B; Bottner A, 2004, J CLIN ENDOCR METAB, V89, P4053, DOI 10.1210/jc.2004-0303; Bozzola E, 2010, ITAL J PEDIATR, V36, DOI 10.1186/1824-7288-36-26; Butte NF, 2005, J CLIN ENDOCR METAB, V90, P4170, DOI 10.1210/jc.2004-2328; Carter MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047065; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Cruz M, 2004, DIABETES CARE, V27, P1451, DOI 10.2337/diacare.27.6.1451; Dabelea D, 2007, DIABETES CARE, V30, pS169, DOI 10.2337/dc07-s211; Dadson Keith, 2011, Front Endocrinol (Lausanne), V2, P62, DOI 10.3389/fendo.2011.00062; Eskenazi B, 2005, ENVIRON HEALTH PERSP, V113, P1419, DOI 10.1289/ehp.7670; Eskenazi B, 2004, ENVIRON HEALTH PERSP, V112, P1116, DOI 10.1289/ehp.6789; Freedman DS, 2005, PEDIATRICS, V115, P22, DOI 10.1542/peds.2004-0220; Giapros V, 2007, CLIN ENDOCRINOL, V66, P353, DOI 10.1111/j.1365-2265.2006.02736.x; Harley K, 2005, PAEDIATR PERINAT EP, V19, P125, DOI 10.1111/j.1365-3016.2005.00640.x; Harley KG, 2013, ENV HLTH PERSPECT; Hediger ML, 1999, PEDIATRICS, V104, part. no., DOI 10.1542/peds.104.3.e33; Heggeseth B, 2013, 308 UC BERK DIV BIOS; Ibanez L, 2006, J CLIN ENDOCR METAB, V91, P2153, DOI 10.1210/jc.2005-2778; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Lammi N, 2009, DIABETOLOGIA, V52, P408, DOI 10.1007/s00125-008-1244-0; Li CY, 2007, OBESITY, V15, P760, DOI 10.1038/oby.2007.585; Lindsay RS, 2003, DIABETES CARE, V26, P2244, DOI 10.2337/diacare.26.8.2244; Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2; Lustig RH, 2011, ENDOCR UPDAT, P1, DOI 10.1007/978-1-4419-7034-3_1; Mantzoros C, 2004, EUR J ENDOCRINOL, V151, P741, DOI 10.1530/eje.0.1510741; Mantzoros CS, 2011, AM J PHYSIOL-ENDOC M, V301, pE567, DOI 10.1152/ajpendo.00315.2011; Mantzoros CS, 2010, CLIN NUTR, V29, P622, DOI 10.1016/j.clnu.2010.03.004; Mantzoros CS, 2009, PEDIATRICS, V123, P682, DOI 10.1542/peds.2008-0343; Margetic S, 2002, INT J OBESITY, V26, P1407, DOI 10.1038/sj.ijo.0802142; Muthen B, 2001, DECADE BEHAV, P291, DOI 10.1037/10409-010; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Nagin DS, 1999, PSYCHOL METHODS, V4, P139, DOI 10.1037/1082-989X.4.2.139; Nishimura R, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-30; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Ong KKL, 1999, ACTA PAEDIATR, V88, P95, DOI 10.1111/j.1651-2227.1999.tb14413.x; Ortega-Senovilla H, 2011, DIABETES CARE, V34, P2061, DOI 10.2337/dc11-0715; Overpeck MD, 1999, OBSTET GYNECOL, V93, P943, DOI 10.1016/S0029-7844(98)00553-5; Pryor LE, 2011, ARCH PEDIAT ADOL MED, V165, P906, DOI 10.1001/archpediatrics.2011.153; Shaibi GQ, 2007, J CLIN ENDOCR METAB, V92, P1809, DOI 10.1210/jc.2006-2294; Sharrock KCB, 2008, AM J HUM BIOL, V20, P392, DOI 10.1002/ajhb.20765; Sivan E, 2003, J CLIN ENDOCR METAB, V88, P5656, DOI 10.1210/jc.2003-031174; Veldhuis JD, 2005, ENDOCR REV, V26, P114, DOI 10.1210/er.2003-0038; Volberg V, 2013, PEDIAT OBES; Warner ML, 2006, OBESITY, V14, P1966, DOI 10.1038/oby.2006.230; Wen XZ, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-38; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301	47	41	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77964	10.1371/journal.pone.0077964	http://dx.doi.org/10.1371/journal.pone.0077964			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205046	Green Published, gold, Green Submitted			2022-12-27	WOS:000326334500083
J	Huang, SG; Zhang, LL; Niu, Q; Xiang, GM; Liu, LL; Jiang, DN; Liu, F; Li, Y; Pu, XY				Huang, Shao-guang; Zhang, Le-le; Niu, Qin; Xiang, Gui-ming; Liu, Lin-lin; Jiang, Dong-neng; Liu, Fei; Li, Yi; Pu, Xiaoyun			Hypoxia Promotes Epithelial - Mesenchymal Transition of Hepatocellular Carcinoma Cells via Inducing GLIPR-2 Expression	PLOS ONE			English	Article							PATHOGENESIS-RELATED PROTEIN; PROGRESSION; METASTASIS; PATHWAYS; INVASION	Glioma pathogenesis related-2 (GLIPR-2) belongs to pathogenesis related-1 (PR-1) family whose function remains unknown. In our previous studies, GLIPR-2 was found to be a novel potent stimulator of epithelial-to-mesenchymal transition (EMT) in renal fibrosis which has been classified as type 2 EMT. However, whether GLIPR-2 could induce type 3 EMT in carcinogenesis needs further investigation. In this study, we showed that GLIPR-2 was expressed in hepatocellular carcinoma (HCC) tissues, hypoxia could upregulate the expression of GLIPR-2 in HepG2 and PLC/PRF/5 cells in vitro, overexpression of this protein promoted migration and invasion via EMT, knockdown of GLIPR-2 attenuated migration and invasion of HepG2 and PLC/PRF/5 cells in hypoxia. Moreover, extracellular signal-regulated kinases 1 and 2 (ERK1/2) are positively regulated by GLIPR-2. Taken together, we provide evidence for a hypoxia/GLIPR-2/EMT/migration and invasion axis in HCC cells and it provides novel insights into the mechanism of migration and invasion of hepatocellular carcinoma cells in hypoxia condition.	[Huang, Shao-guang; Zhang, Le-le; Xiang, Gui-ming; Liu, Lin-lin; Jiang, Dong-neng; Liu, Fei; Li, Yi; Pu, Xiaoyun] Third Mil Med Univ, Xin Qiao Hosp, Dept Clin Lab, Chongqing, Peoples R China; [Niu, Qin] Third Mil Med Univ, Inst Pathol, Southwest Hosp, Chongqing, Peoples R China	Army Medical University; Army Medical University	Pu, XY (corresponding author), Third Mil Med Univ, Xin Qiao Hosp, Dept Clin Lab, Chongqing, Peoples R China.	puxiaoyong@yahoo.com			National Natural Science Foundation of China [2009ZX10601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by contract grant sponsor National Natural Science Foundation of China, contract grant no. 2009ZX10601. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter RM, 2007, MATRIX BIOL, V26, P20, DOI 10.1016/j.matbio.2006.09.005; Bermudez O, 2011, J CELL PHYSIOL, V226, P276, DOI 10.1002/jcp.22339; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Eberle HB, 2002, J CELL SCI, V115, P827; Eisenberg I, 2002, GENE, V293, P141, DOI 10.1016/S0378-1119(02)00703-5; Gedaly R, 2012, J SURG RES, V176, P542, DOI 10.1016/j.jss.2011.10.045; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Harrison L, 2004, ONCOLOGIST, V9, P31, DOI 10.1634/theoncologist.9-90005-31; Huang SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058574; Hulit J, 2007, CANCER RES, V67, P3106, DOI 10.1158/0008-5472.CAN-06-3401; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Li X, 2012, EXP PHYSIOL, V97, P257, DOI 10.1113/expphysiol.2011.061382; Lin SC, 2012, J CLIN ENDOCRINOL ME; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Sabbah M, 2008, DRUG RESIST UPDATE, V11, P123, DOI 10.1016/j.drup.2008.07.001; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Sphyris N, 2011, JNCI-J NATL CANCER I, V103, P1644, DOI 10.1093/jnci/djr421; Subarsky P, 2003, CLIN EXP METASTAS, V20, P237, DOI 10.1023/A:1022939318102; Szyperski T, 1998, P NATL ACAD SCI USA, V95, P2262, DOI 10.1073/pnas.95.5.2262; Tafani M, 2011, CARCINOGENESIS, V32, P1167, DOI 10.1093/carcin/bgr101; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; VANLOON LC, 1970, VIROLOGY, V40, P199, DOI 10.1016/0042-6822(70)90395-8; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	26	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77497	10.1371/journal.pone.0077497	http://dx.doi.org/10.1371/journal.pone.0077497			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204846	Green Submitted, Green Published, gold			2022-12-27	WOS:000326270700032
J	Kwak, N; Choi, SM; Lee, J; Park, YS; Lee, CH; Lee, SM; Yoo, CG; Kim, YW; Han, SK; Yim, JJ				Kwak, Nakwon; Choi, Sun Mi; Lee, Jinwoo; Park, Young Sik; Lee, Chang-Hoon; Lee, Sang-Min; Yoo, Chul-Gyu; Kim, Young Whan; Han, Sung Koo; Yim, Jae-Joon			Diagnostic Accuracy and Turnaround Time of the Xpert MTB/RIF Assay in Routine Clinical Practice	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; RIFAMPIN RESISTANCE; RAPID DETECTION; MICROSCOPY; SPUTUM	The Xpert MTB/RIF assay was introduced for timely and accurate detection of tuberculosis (TB). The aim of this study was to determine the diagnostic accuracy and turnaround time (TAT) of Xpert MTB/RIF assay in clinical practice in South Korea. We retrospectively reviewed the medical records of patients in whom Xpert MTB/RIF assay using sputum were requested. The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) for the diagnosis of pulmonary tuberculosis (PTB) and detection of rifampicin resistance were calculated. In addition, TAT of Xpert MTB/RIF assay was compared with those of other tests. Total 681 patients in whom Xpert MTB/RIF assay was requested were included in the analysis. The sensitivity, specificity, PPV and NPV of Xpert MTB/RIF assay for diagnosis of PTB were 79.5% (124/156), 100.0% (505/505), 100.0% (124/124) and 94.0% (505/537), respectively. Those for the detection of rifampicin resistance were 57.1% (8/14), 100.0% (113/113), 100.0% (8/8) and 94.9% (113/119), respectively. The median TAT of Xpert MTB/RIF assay to the report of results and results confirmed by physicians in outpatient settings were 0 (0-1) and 6 (3-7) days, respectively. Median time to treatment after initial evaluation was 7 (4-9) days in patients with Xpert MTB/RIF assay, but was 21 (7-33.5) days in patients without Xpert MTB/RIF assay. Xpert MTB/RIF assay showed acceptable sensitivity and excellent specificity for the diagnosis of PTB and detection of rifampicin resistance in areas with intermediate TB burden. Additionally, the assay decreased time to the initiation of anti-TB drugs through shorter TAT.	[Kwak, Nakwon; Choi, Sun Mi; Lee, Jinwoo; Park, Young Sik; Lee, Chang-Hoon; Lee, Sang-Min; Yoo, Chul-Gyu; Kim, Young Whan; Han, Sung Koo; Yim, Jae-Joon] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Pulm & Crit Care Med, Seoul 151, South Korea	Seoul National University (SNU)	Yim, JJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Div Pulm & Crit Care Med, Seoul 151, South Korea.	yimjj@snu.ac.kr	Lee, Chang-Hoon/AAC-7650-2021; Trajman, Anete/C-7679-2016	Trajman, Anete/0000-0002-4000-4984; Yim, Jae-Joon/0000-0002-9605-0074	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C0844]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C0844). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmann JS, 1999, J CLIN MICROBIOL, V37, P1419, DOI 10.1128/JCM.37.5.1419-1425.1999; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Chang K, 2012, J INFECTION, V64, P580, DOI 10.1016/j.jinf.2012.02.012; Colebunders R, 2000, INT J TUBERC LUNG D, V4, P97; Foulds J, 1998, INT J TUBERC LUNG D, V2, P778; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Joh JS, 2007, J KOREAN MED SCI, V22, P26, DOI 10.3346/jkms.2007.22.1.26; Koh WJ, 2006, INT J TUBERC LUNG D, V10, P1001; LIPSKY BA, 1984, REV INFECT DIS, V6, P214; Organization WH, 2011, RAP IMPL XPERT MTB R, V978, P4; Park YS, 2010, INT J TUBERC LUNG D, V14, P1069; Park YS, 2012, TUBERC RESPIR DIS, V73, P48, DOI 10.4046/trd.2012.73.1.48; Perkins MD, 2007, J INFECT DIS, V196, pS15, DOI 10.1086/518656; Scott LE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001061; Steingart KR, 2007, EXPERT REV ANTI-INFE, V5, P327, DOI 10.1586/14787210.5.3.327; Van Rie A, 2012, INT J TUBERC LUNG D, V16, P206, DOI 10.5588/ijtld.11.0395; Watterson SA, 1998, J CLIN MICROBIOL, V36, P1969, DOI 10.1128/JCM.36.7.1969-1973.1998; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	19	49	52	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77456	10.1371/journal.pone.0077456	http://dx.doi.org/10.1371/journal.pone.0077456			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204834	Green Published, gold, Green Submitted			2022-12-27	WOS:000326270700030
J	Mathot, S; Van der Linden, L; Grainger, J; Vitu, F				Mathot, Sebastiaan; Van der Linden, Lotje; Grainger, Jonathan; Vitu, Francoise			The Pupillary Light Response Reveals the Focus of Covert Visual Attention	PLOS ONE			English	Article							EYE-MOVEMENTS; DILATION; SEARCH; SIZE; MICROSTIMULATION; STIMULATION; DYNAMICS; STIMULUS; REFLEX	The pupillary light response is often assumed to be a reflex that is not susceptible to cognitive influences. In line with recent converging evidence, we show that this reflexive view is incomplete, and that the pupillary light response is modulated by covert visual attention: Covertly attending to a bright area causes a pupillary constriction, relative to attending to a dark area under identical visual input. This attention-related modulation of the pupillary light response predicts cuing effects in behavior, and can be used as an index of how strongly participants attend to a particular location. Therefore, we suggest that pupil size may offer a new way to continuously track the focus of covert visual attention, without requiring a manual response from the participant. The theoretical implication of this finding is that the pupillary light response is neither fully reflexive, nor under complete voluntary control, but is instead best characterized as a stereotyped response to a voluntarily selected target. In this sense, the pupillary light response is similar to saccadic and smooth pursuit eye movements. Together, eye movements and the pupillary light response maximize visual acuity, stabilize visual input, and selectively filter visual information as it enters the eye.	[Mathot, Sebastiaan; Van der Linden, Lotje; Grainger, Jonathan; Vitu, Francoise] Aix Marseille Univ, CNRS, Lab Psychol Cognit, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Mathot, S (corresponding author), Aix Marseille Univ, CNRS, Lab Psychol Cognit, Marseille, France.	s.mathot@cogsci.nl	Grainger, Jonathan/C-9299-2009	Vitu, Francoise/0000-0002-0627-8295; Mathot, Sebastiaan/0000-0003-3379-8584	ERC [230313]; French ministry of research	ERC(European Research Council (ERC)European Commission); French ministry of research(Ministry of Research, FranceEuropean Commission)	SM, JG, and FV were supported by ERC grant 230313. (http://erc.europa.eu..) LL was supported by a grant ("allocation de recherche") from the French ministry of research (2012-2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, SIMPLE WAY RECONSTRU; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; BARANY EH, 1948, J NEUROPHYSIOL, V11, P25, DOI 10.1152/jn.1948.11.1.25; BARBUR JL, 1992, OPHTHAL PHYSL OPT, V12, P137, DOI 10.1111/j.1475-1313.1992.tb00276.x; Barbur JL, 1995, VISION RES; BEATTY J, 1982, PSYCHOL BULL, V91, P276, DOI 10.1037/0033-2909.91.2.276; Betts JG, 2013, ANATOMY PHYSL; Binda P, 2013, J VISION, V13, DOI 10.1167/13.6.8; Binda P, 2013, J NEUROSCI, V33, P2199, DOI 10.1523/JNEUROSCI.3440-12.2013; Bitsios P, 1996, AGE AGEING, V25, P432, DOI 10.1093/ageing/25.6.432; BRENNER RL, 1969, ARCH OPHTHALMOL-CHIC, V82, P23; Broadbent D.E., 1958, PERCEPTION COMMUNICA; Buschman TJ, 2009, NEURON, V63, P386, DOI 10.1016/j.neuron.2009.06.020; CAMPBELL FW, 1960, NATURE, V187, P1121, DOI 10.1038/1871121c0; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Carrasco M, 2011, VISION RES, V51, P1484, DOI 10.1016/j.visres.2011.04.012; ELLIS CJK, 1981, BRIT J OPHTHALMOL, V65, P754, DOI 10.1136/bjo.65.11.754; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Fahle MW, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00120; GOLDWATER BC, 1972, PSYCHOL BULL, V77, P340, DOI 10.1037/h0032456; Harms H., 1937, GRAEFES ARCH CLIN EX, V138, P149, DOI [10.1007/BF01854538, DOI 10.1007/BF01854538]; HESS EH, 1960, SCIENCE, V132, P349, DOI 10.1126/science.132.3423.349; Jainta Stephanie, 2011, Front Hum Neurosci, V5, P97, DOI 10.3389/fnhum.2011.00097; JUST MA, 1993, CAN J EXP PSYCHOL, V47, P310, DOI 10.1037/h0078820; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kowler E, 2011, VISION RES, V51, P1457, DOI 10.1016/j.visres.2010.12.014; Krauzlis RJ, 2004, J NEUROPHYSIOL, V91, P591, DOI 10.1152/jn.00801.2003; Laeng B, 2012, P NATL ACAD SCI USA, V109, P2162, DOI 10.1073/pnas.1118298109; Laeng B, 2012, PERSPECT PSYCHOL SCI, V7, P18, DOI 10.1177/1745691611427305; Land MF, 1999, J COMP PHYSIOL A, V185, P341, DOI 10.1007/s003590050393; LOEWENFELD I. E., 1958, DOCUMENTA OPHTHALMOL, V12, P185, DOI 10.1007/BF00913471; LOWE SW, 1966, ARCH OPHTHALMOL-CHIC, V75, P395; LOWENSTEIN O, 1950, ARCH NEURO PSYCHIATR, V64, P313, DOI 10.1001/archneurpsyc.1950.02310270002001; Mack A., 1998, INATTENTIONAL BLINDN; Mathot S, 2013, THESIS VU U AMSTERDA; Mathot S, 2012, BEHAV RES METHODS, V44, P314, DOI 10.3758/s13428-011-0168-7; Mathot S, 2011, PHILOS T R SOC B, V366, P516, DOI 10.1098/rstb.2010.0187; Naber M, 2013, J VISION, V13, DOI 10.1167/13.6.7; Naber M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020910; Netser S, 2010, J NEUROPHYSIOL, V104, P108, DOI 10.1152/jn.01142.2009; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Porter G, 2007, Q J EXP PSYCHOL, V60, P211, DOI 10.1080/17470210600673818; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Prettyman R, 1997, J NEUROL NEUROSUR PS, V62, P665, DOI 10.1136/jnnp.62.6.665; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; ROBINSON DA, 1968, SCIENCE, V161, P1219, DOI 10.1126/science.161.3847.1219; Sahraie A, 1997, GRAEF ARCH CLIN EXP, V235, P494, DOI 10.1007/BF00947006; SLOOTER J, 1980, INVEST OPHTH VIS SCI, V19, P105; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Tanaka T, 2005, INVEST OPHTH VIS SCI, V46, P4267, DOI 10.1167/iovs.05-0088; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; UKAI K, 1985, J OPT SOC AM A, V2, P1094, DOI 10.1364/JOSAA.2.001094; WALLS GL, 1962, VISION RES, V2, P69, DOI 10.1016/0042-6989(62)90064-0; Wang CA, 2012, J NEUROSCI, V32, P3629, DOI 10.1523/JNEUROSCI.5512-11.2012; Wierda SM, 2012, P NATL ACAD SCI USA, V109, P8456, DOI 10.1073/pnas.1201858109; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; WOODHOUSE JM, 1975, VISION RES, V15, P649, DOI 10.1016/0042-6989(75)90279-5; WOODHOUSE JM, 1975, VISION RES, V15, P645, DOI 10.1016/0042-6989(75)90278-3; WYATT HJ, 1995, VISION RES, V35, P2021, DOI 10.1016/0042-6989(94)00268-Q; Zylberberg A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00316	63	104	104	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78168	10.1371/journal.pone.0078168	http://dx.doi.org/10.1371/journal.pone.0078168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205144	Green Published, Green Submitted, gold			2022-12-27	WOS:000326270700080
J	Zheng, JS; Arnett, DK; Lee, YC; Shen, J; Parnell, LD; Smith, CE; Richardson, K; Li, D; Borecki, IB; Ordovas, JM; Lai, CQ				Zheng, Ju-Sheng; Arnett, Donna K.; Lee, Yu-Chi; Shen, Jian; Parnell, Laurence D.; Smith, Caren E.; Richardson, Kris; Li, Duo; Borecki, Ingrid B.; Ordovas, Jose M.; Lai, Chao-Qiang			Genome-Wide Contribution of Genotype by Environment Interaction to Variation of Diabetes-Related Traits	PLOS ONE			English	Article							COMMON SNPS EXPLAIN; INSULIN-RESISTANCE; FATTY-ACIDS; LARGE PROPORTION; BREAST-CANCER; LIFE-STYLE; ASSOCIATION; RISK; LOCI; HERITABILITY	While genome-wide association studies (GWAS) and candidate gene approaches have identified many genetic variants that contribute to disease risk as main effects, the impact of genotype by environment (GxE) interactions remains rather under-surveyed. To explore the importance of GxE interactions for diabetes-related traits, a tool for Genome-wide Complex Trait Analysis (GCTA) was used to examine GxE variance contribution of 15 macronutrients and lifestyle to the total phenotypic variance of diabetes-related traits at the genome-wide level in a European American population. GCTA identified two key environmental factors making significant contributions to the GxE variance for diabetes-related traits: carbohydrate for fasting insulin (25.1% of total variance, P-nominal = 0.032) and homeostasis model assessment of insulin resistance (HOMA-IR) (24.2% of total variance, P-nominal = 0.035), n-6 polyunsaturated fatty acid (PUFA) for HOMA-beta-cell-function (39.0% of total variance, P-nominal = 0.005). To demonstrate and support the results from GCTA, a GxE GWAS was conducted with each of the significant dietary factors and a control E factor (dietary protein), which contributed a non-significant GxE variance. We observed that GxE GWAS for the environmental factor contributing a significant GxE variance yielded more significant SNPs than the control factor. For each trait, we selected all significant SNPs produced from GxE GWAS, and conducted anew the GCTA to estimate the variance they contributed. We noted the variance contributed by these SNPs is higher than that of the control. In conclusion, we utilized a novel method that demonstrates the importance of genome-wide GxE interactions in explaining the variance of diabetes-related traits.	[Zheng, Ju-Sheng; Li, Duo] Zhejiang Univ, Dept Food Sci & Nutr, Hangzhou 310027, Zhejiang, Peoples R China; [Zheng, Ju-Sheng; Lee, Yu-Chi; Shen, Jian; Parnell, Laurence D.; Smith, Caren E.; Richardson, Kris; Ordovas, Jose M.; Lai, Chao-Qiang] Tufts Univ, Jean Mayer USDA, Human Nutr Res Ctr, Boston, MA 02111 USA; [Arnett, Donna K.] Univ Alabama, Dept Epidemiol, Birmingham, MA USA; [Shen, Jian] Oregon Hlth & Sci Univ, Div Endocrinol, Bone & Mineral Unit, Portland, OR 97201 USA; [Borecki, Ingrid B.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Zhejiang University; Tufts University; United States Department of Agriculture (USDA); University of Alabama System; University of Alabama Birmingham; Oregon Health & Science University; Washington University (WUSTL)	Li, D (corresponding author), Zhejiang Univ, Dept Food Sci & Nutr, Hangzhou 310027, Zhejiang, Peoples R China.	duoli@zju.edu.cn; chaoqiang.lai@ars.usda.gov	; Li, Duo/N-3682-2013; Ordovas, Jose/B-8727-2013; Zheng, Ju-Sheng/J-3970-2015	Lai, Chao-Qiang/0000-0003-1107-8375; Li, Duo/0000-0001-5227-5565; Ordovas, Jose/0000-0002-7581-5680; Zheng, Ju-Sheng/0000-0001-6560-4890	National Natural Science Foundation of China [81273054]; Ph.D. Programs Foundation of Ministry of Education of China [20120101110107]; National Program on Key Basic Research Project of China (973 Program) [2011CB504002]; NHLBI [HL54776, HL078885]; US Department of Agriculture, Agriculture Research Service [53-K06-5-10, 58-1950-9-001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072524, K08HL112845, R01HL091357] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); National Program on Key Basic Research Project of China (973 Program)(National Basic Research Program of China); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US Department of Agriculture, Agriculture Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by the National Natural Science Foundation of China (81273054); by the Ph.D. Programs Foundation of Ministry of Education of China (20120101110107); by the National Program on Key Basic Research Project of China (973 Program: 2011CB504002); by NHLBI grant number HL54776 and HL078885; by contracts 53-K06-5-10 and 58-1950-9-001 from the US Department of Agriculture, Agriculture Research Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlqvist E, 2011, CLIN CHEM, V57, P241, DOI 10.1373/clinchem.2010.157016; Akinkuolie AO, 2011, CLIN NUTR; Aslibekyan S, 2012, PHARMACOGENET GENOM, V22, P191, DOI 10.1097/FPC.0b013e32834fdd41; Billings LK, 2010, ANN NY ACAD SCI, V1212, P59, DOI 10.1111/j.1749-6632.2010.05838.x; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Chen MH, 2010, BIOINFORMATICS, V26, P580, DOI 10.1093/bioinformatics/btp710; Chen R, 2012, PLOS GENET, V8, P100, DOI 10.1371/journal.pgen.1002621; Corella D, 2007, CLIN CHEM, V53, P1144, DOI 10.1373/clinchem.2006.084863; Corella D, 2006, DIABETES CARE, V29, P1313, DOI 10.2337/dc06-0045; Cornelis MC, 2012, ANNU REV NUTR, V32, P245, DOI 10.1146/annurev-nutr-071811-150648; Fedor D, 2009, CURR OPIN CLIN NUTR, V12, P138, DOI 10.1097/MCO.0b013e3283218299; Florez JC, 2008, DIABETOLOGIA, V51, P1100, DOI 10.1007/s00125-008-1025-9; Hartweg J, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003205.pub2; He K, 2009, PROG CARDIOVASC DIS, V52, P95, DOI 10.1016/j.pcad.2009.06.003; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Kim EHJ, 2006, AM J EPIDEMIOL, V164, P990, DOI 10.1093/aje/kwj309; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lai CQ, 2007, ARTERIOSCL THROM VAS, V27, P1417, DOI 10.1161/ATVBAHA.107.140103; Lai CQ, 2012, PROG MOL BIOL TRANSL, V108, P461, DOI 10.1016/B978-0-12-398397-8.00018-6; Lee YC, 2011, J DATA MINING GENOMI, V2; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Manco M, 2004, DIABETES OBES METAB, V6, P402, DOI 10.1111/j.1462-8902.2004.00356.x; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Nettleton JA, 2010, DIABETES CARE, V33, P2684, DOI 10.2337/dc10-1150; Norlin S, 2005, DIABETES, V54, P125, DOI 10.2337/diabetes.54.1.125; Pala V, 2001, J NATL CANCER I, V93, P1088, DOI 10.1093/jnci/93.14.1088; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Qi L, 2009, AM J CLIN NUTR, V89, P1453, DOI 10.3945/ajcn.2008.27249; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smith CE, 2012, NUTR METAB CARDIOVAS, V22, P449, DOI 10.1016/j.numecd.2010.09.003; Subar AF, 2001, AM J EPIDEMIOL, V154, P1089, DOI 10.1093/aje/154.12.1089; Thompson FE, 2002, J AM DIET ASSOC, V102, P212, DOI 10.1016/S0002-8223(02)90050-7; Villegas R, 2011, AM J CLIN NUTR, V94, P543, DOI 10.3945/ajcn.111.013193; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Visscher PM, 2010, TWIN RES HUM GENET, V13, P517, DOI 10.1375/twin.13.6.517; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Xun PC, 2012, DIABETES CARE, V35, P930, DOI 10.2337/dc11-1869; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zheng JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044525; Zheng JS, 2012, PUBLIC HEALTH NUTR, V15, P725, DOI 10.1017/S1368980011002254	45	29	30	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77442	10.1371/journal.pone.0077442	http://dx.doi.org/10.1371/journal.pone.0077442			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204828	Green Published, Green Submitted, gold			2022-12-27	WOS:000326241200028
J	Hartley, I; Elkhoury, FF; Shin, JH; Xie, B; Gu, XQ; Gao, Y; Zhou, D; Haddad, GG				Hartley, Iain; Elkhoury, Fuad F.; Shin, Joo Heon; Xie, Bin; Gu, Xiangqun; Gao, Yuan; Zhou, Dan; Haddad, Gabriel G.			Long-Lasting Changes in DNA Methylation Following Short-Term Hypoxic Exposure in Primary Hippocampal Neuronal Cultures	PLOS ONE			English	Article							CDNA MICROARRAY ANALYSIS; CREB-BINDING PROTEIN; GENE-EXPRESSION; EPIGENETIC REGULATION; BETA-CATENIN; CELL-DEATH; IDENTIFICATION; ACTIVATION; BRAIN; HYPOMETHYLATION	While the effects of hypoxia on gene expression have been investigated in the CNS to some extent, we currently do not know what role epigenetics plays in the transcription of many genes during such hypoxic stress. To start understanding the role of epigenetic changes during hypoxia, we investigated the long-term effect of hypoxia on gene expression and DNA methylation in hippocampal neuronal cells. Primary murine hippocampal neuronal cells were cultured for 7 days. Hypoxic stress of 1% O2, 5% CO2 for 24 hours was applied on Day 3, conditions we found to maximize cellular hypoxic stress response without inducing cell death. Cells were returned to normoxia for 4 days following the period of hypoxic stress. On Day 7, Methyl-Sensitive Cut Counting (MSCC) was used to identify a genome-wide methylation profile of the hippocampal cell lines to assess methylation changes resulting from hypoxia. RNA-Seq was also done on Day 7 to analyze changes in gene transcription. Phenotypic analysis showed that neuronal processes were significantly shorter after 1 day of hypoxia, but there was a catch-up growth of these processes after return to normoxia. Transcriptome profiling using RNA-Seq revealed 369 differentially expressed genes with 225 being upregulated, many of which form networks shown to affect CNS development and function. Importantly, the expression level of 59 genes could be correlated to the changes in DNA methylation in their promoter regions. CpG islands, in particular, had a strong tendency to remain hypomethylated long after hypoxic stress was removed. From this study, we conclude that short-term, sub-lethal hypoxia results in long-lasting changes to genome wide DNA methylation status and that some of these changes can be highly correlated with transcriptional modulation in a number of genes involved in functional pathways that have been previously implicated in neural growth and development.	[Hartley, Iain; Elkhoury, Fuad F.; Gu, Xiangqun; Zhou, Dan; Haddad, Gabriel G.] Univ Calif San Diego, Dept Pediat, Div Resp Med, La Jolla, CA 92093 USA; [Hartley, Iain; Elkhoury, Fuad F.; Gu, Xiangqun; Zhou, Dan; Haddad, Gabriel G.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA USA; [Shin, Joo Heon; Xie, Bin; Gao, Yuan] Lieber Inst Brain Dev, Div Genom Epigen & Bioinformat, Baltimore, MD USA; [Haddad, Gabriel G.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Haddad, Gabriel G.] Rady Childrens Hosp, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Haddad, GG (corresponding author), Univ Calif San Diego, Dept Pediat, Div Resp Med, La Jolla, CA 92093 USA.	ghaddad@ucsd.edu		Zhou, Dan/0000-0001-6401-9040	National Institutes of Health [HL098053]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098053, T35HL007491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a National Institutes of Health grant HL098053 to GGH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amicarelli F, 2003, FREE RADICAL BIO MED, V35, P856, DOI 10.1016/S0891-5849(03)00438-6; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ara J, 2011, NEUROBIOL DIS, V43, P473, DOI 10.1016/j.nbd.2011.04.021; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Burgula S, 2010, J MOL NEUROSCI, V41, P36, DOI 10.1007/s12031-009-9275-7; Carrero P, 2000, MOL CELL BIOL, V20, P402, DOI 10.1128/MCB.20.1.402-415.2000; Colaneri A, 2011, P NATL ACAD SCI USA, V108, P9715, DOI 10.1073/pnas.1105713108; Curristin SM, 2002, P NATL ACAD SCI USA, V99, P15729, DOI 10.1073/pnas.232568799; Donker RB, 2007, MOL HUM REPROD, V13, P273, DOI 10.1093/molehr/gam006; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; Fath T, 2009, NAT PROTOC, V4, P78, DOI 10.1038/nprot.2008.199; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Grant GR, 2011, BIOINFORMATICS, V27, P2518, DOI 10.1093/bioinformatics/btr427; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Huang W, 2013, NAT NEUROSCI, V16, P441, DOI 10.1038/nn.3351; Jin K, 2002, NEUROCHEM RES, V27, P1105, DOI 10.1023/A:1020913123054; Jogi A, 2002, P NATL ACAD SCI USA, V99, P7021, DOI 10.1073/pnas.102660199; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Lin JS, 2008, J PHYSIOL-LONDON, V586, P5757, DOI 10.1113/jphysiol.2008.160887; Lu YH, 2011, MOL CELL BIOL, V31, P3339, DOI 10.1128/MCB.01121-10; MacLennan A, 1999, BMJ-BRIT MED J, V319, P1054, DOI 10.1136/bmj.319.7216.1054; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Nakamura T, 1998, GENES CELLS, V3, P395, DOI 10.1046/j.1365-2443.1998.00198.x; Nanduri J, 2012, P NATL ACAD SCI USA, V109, P2515, DOI 10.1073/pnas.1120600109; Obstetricians ACo, 2003, NEONATAL ENCEPHALOPA; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pocock R, 2008, NAT NEUROSCI, V11, P894, DOI 10.1038/nn.2152; Ragel BT, 2007, NEUROSURG REV, V30, P181, DOI 10.1007/s10143-007-0070-z; Ralph GS, 2004, J CEREBR BLOOD F MET, V24, P245, DOI 10.1097/01.WCB.0000110532.48786.46; Raspaglio G, 2008, GENE, V409, P100, DOI 10.1016/j.gene.2007.11.015; Rossler J, 2004, J CELL BIOCHEM, V93, P153, DOI 10.1002/jcb.20133; Ruas JL, 2005, J CELL SCI, V118, P301, DOI 10.1242/jcs.01617; Ruas JL, 2002, J BIOL CHEM, V277, P38723, DOI 10.1074/jbc.M205051200; Sekiya T, 2002, CANCER RES, V62, P3322; Shahrzad S, 2007, EPIGENETICS-US, V2, P119, DOI 10.4161/epi.2.2.4613; Sharp Frank R, 2004, NeuroRx, V1, P26, DOI 10.1602/neurorx.1.1.26; Spires TL, 2005, CEREB CORTEX, V15, P385, DOI 10.1093/cercor/bhh141; Tang YL, 2009, CIRC RES, V104, P1209, DOI 10.1161/CIRCRESAHA.109.197723; Watson JA, 2009, HUM MOL GENET, V18, P3594, DOI 10.1093/hmg/ddp307; Wenger RH, 1998, EUR J BIOCHEM, V253, P771, DOI 10.1046/j.1432-1327.1998.2530771.x; Yoder JA, 1997, J MOL BIOL, V270, P385, DOI 10.1006/jmbi.1997.1125; Zhou D, 2008, PHYSIOL GENOMICS, V32, P370, DOI 10.1152/physiolgenomics.00147.2007	44	40	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77859	10.1371/journal.pone.0077859	http://dx.doi.org/10.1371/journal.pone.0077859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205000	gold, Green Submitted, Green Published			2022-12-27	WOS:000326155400059
J	Jia, L; Xing, J; Ding, Y; Shen, YC; Shi, XH; Ren, W; Wan, M; Guo, JJ; Zheng, SJ; Liu, Y; Liang, XB; Su, DM				Jia, Lu; Xing, Jing; Ding, Ying; Shen, Yachen; Shi, Xuhui; Ren, Wei; Wan, Meng; Guo, Jianjin; Zheng, Shujing; Liu, Yun; Liang, Xiubin; Su, Dongming			Hyperuricemia Causes Pancreatic beta-Cell Death and Dysfunction through NF-kappa B Signaling Pathway	PLOS ONE			English	Article							SERUM URIC-ACID; NITRIC-OXIDE PRODUCTION; METABOLIC SYNDROME; INSULIN-SECRETION; INDUCED APOPTOSIS; EXPRESSION; ISLETS; RELEASE; STRESS; MICE	Accumulating clinical evidence suggests that hyperuricemia is associated with an increased risk of type 2 diabetes. However, it is still unclear whether elevated levels of uric acid can cause direct injury of pancreatic beta-cells. In this study, we examined the effects of uric acid on beta-cell viability and function. Uric acid solution or normal saline was administered intraperitoneally to mice daily for 4 weeks. Uric acid-treated mice exhibited significantly impaired glucose tolerance and lower insulin levels in response to glucose challenge than did control mice. However, there were no significant differences in insulin sensitivity between the two groups. In comparison to the islets in control mice, the islets in the uric acid-treated mice were markedly smaller in size and contained less insulin. Treatment of beta-cells in vitro with uric acid activated the NF-kappa B signaling pathway through I kappa B alpha phosphorylation, resulting in upregulated inducible nitric oxide synthase (iNOS) expression and excessive nitric oxide (NO) production. Uric acid treatment also increased apoptosis and downregulated Bcl-2 expression in Min6 cells. In addition, a reduction in insulin secretion under glucose challenge was observed in the uric acid-treated mouse islets. These deleterious effects of uric acid on pancreatic beta-cells were attenuated by benzbromarone, an inhibitor of uric acid transporters, NOS inhibitor L-NMMA, and Bay 11-7082, an NF-kappa B inhibitor. Further investigation indicated that uric acid suppressed levels of MafA protein through enhancing its degradation. Collectively, our data suggested that an elevated level of uric acid causes beta-cell injury via the NF-kappa B-iNOS-NO signaling axis.	[Jia, Lu; Xing, Jing; Ding, Ying; Shen, Yachen; Shi, Xuhui; Zheng, Shujing; Liu, Yun; Liang, Xiubin; Su, Dongming] Nanjing Med Univ, Ctr Metab Dis Res, Nanjing, Jiangsu, Peoples R China; [Su, Dongming] Nanjing Med Univ, Ctr Cellular Therapy, Affiliated Hosp 2, Nanjing, Jiangsu, Peoples R China; [Ren, Wei; Guo, Jianjin] Shanghai Jiao Tong Univ, Dept Endocrinol & Metab, Affiliated Peoples Hosp 6, Shanghai Diabet Inst, Shanghai 200030, Peoples R China; [Ren, Wei; Guo, Jianjin] Shanghai Clin Ctr Diabet, Shanghai, Peoples R China; [Wan, Meng] Nanjing Med Univ, Nanjing Hosp 1, Dept Pharm, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Shanghai Jiao Tong University; Nanjing Medical University	Su, DM (corresponding author), Nanjing Med Univ, Ctr Metab Dis Res, Nanjing, Jiangsu, Peoples R China.	sudongming@njmu.edu.cn	Shen, Yachen/HGE-6370-2022	Shen, Yachen/0000-0003-2614-3387	National Basic Research Program of China [2011CB504000]; National Natural Science Foundation of China [81070656, 81171589]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding from the National Basic Research Program of China (2011CB504000, 973 Program) and the National Natural Science Foundation of China (81070656, 81171589). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu Estela, 2011, Acta Med Port, V24 Suppl 2, P565; Baldwin W, 2011, DIABETES, V60, P1258, DOI 10.2337/db10-0916; Banakh I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048977; Cai K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019559; Chen F, 2011, ENDOCRINOLOGY, V152, P1779, DOI 10.1210/en.2010-1048; Conen D, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-9; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P8992, DOI 10.1073/pnas.90.19.8992; CORBETT JA, 1995, J EXP MED, V181, P559, DOI 10.1084/jem.181.2.559; Dehghan A, 2008, DIABETES CARE, V31, P361, DOI 10.2337/dc07-1276; Han HJ, 2007, AM J PHYSIOL-RENAL, V292, pF373, DOI 10.1152/ajprenal.00104.2006; Han X, 2001, DIABETES, V50, P1047, DOI 10.2337/diabetes.50.5.1047; Harmon JS, 2005, J BIOL CHEM, V280, P11107, DOI 10.1074/jbc.M410345200; HEDESKOV CJ, 1975, BIOCHEM J, V152, P571, DOI 10.1042/bj1520571; Ishizaka N, 2005, ARTERIOSCL THROM VAS, V25, P1038, DOI 10.1161/01.ATV.0000161274.87407.26; Kanellis J, 2003, HYPERTENSION, V41, P1287, DOI 10.1161/01.HYP.0000072820.07472.3B; Kanter M, 2009, J MOL HISTOL, V40, P379, DOI 10.1007/s10735-009-9251-0; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kataoka K, 2002, J BIOL CHEM, V277, P49903, DOI 10.1074/jbc.M206796200; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Krishnan E, 2012, AM J EPIDEMIOL, V176, P108, DOI 10.1093/aje/kws002; Lin Shi-Dou, 2006, J Chin Med Assoc, V69, P512; Maier B, 2010, J CLIN INVEST, V120, P2156, DOI 10.1172/JCI38924; Matsuoka T, 2010, DIABETES, V59, P1709, DOI 10.2337/db08-0693; Meisinger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037180; Melloul D, 2008, BIOCHEM SOC T, V36, P334, DOI 10.1042/BST0360334; Nan HR, 2008, DIABETES RES CLIN PR, V80, P321, DOI 10.1016/j.diabres.2008.01.002; Oda E, 2009, DIABETES CARE, V32, pauthor; Oda Eiji, 2009, Diabetes Care, V32, pe126, DOI 10.2337/dc09-1244; Onat A, 2006, AM J HYPERTENS, V19, P1055, DOI 10.1016/j.amjhyper.2006.02.014; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Rabadi MM, 2012, AM J PHYSIOL-RENAL, V302, pF730, DOI 10.1152/ajprenal.00520.2011; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Roehrich ME, 2003, J BIOL CHEM, V278, P18368, DOI 10.1074/jbc.M300102200; Salehi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002165; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; Simental-Mendia LE, 2009, DIABETES-METAB RES, V25, P535, DOI 10.1002/dmrr.988; So A, 2010, J CLIN INVEST, V120, P1791, DOI 10.1172/JCI42344; Su DM, 2007, DIABETES, V56, P2274, DOI 10.2337/db07-0371; Thomas HE, 2002, DIABETES, V51, P311, DOI 10.2337/diabetes.51.2.311; Wang TG, 2011, ENDOCRINE, V40, P109, DOI 10.1007/s12020-011-9449-2; ZHANG HJ, 1989, DIABETES, V38, P44, DOI 10.2337/diabetes.38.1.44; Zhang XF, 2009, ENDOCRINOLOGY, V150, P4065, DOI 10.1210/en.2009-0343; Zhao ZS, 2009, ENDOCRINOLOGY, V150, P2569, DOI 10.1210/en.2008-1342; Zhou Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039738; Zhou Y, 2010, AM J PHYSIOL-RENAL, V299, pF336, DOI 10.1152/ajprenal.00053.2010; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520; Zhu YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056386	47	63	67	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78284	10.1371/journal.pone.0078284	http://dx.doi.org/10.1371/journal.pone.0078284			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205181	Green Published, Green Submitted, gold			2022-12-27	WOS:000326155400075
J	Scranton, MA; Fowler, JH; Girke, T; Walling, LL				Scranton, Melissa A.; Fowler, Jonathan H.; Girke, Thomas; Walling, Linda L.			Microarray Analysis of Tomato's Early and Late Wound Response Reveals New Regulatory Targets for Leucine Aminopeptidase A	PLOS ONE			English	Article							MG-PROTOPORPHYRIN IX; NUCLEAR GENE-EXPRESSION; SYRINGAE PV. TOMATO; ABSCISIC-ACID; SIGNAL-TRANSDUCTION; DEFENSE RESPONSES; METHYL JASMONATE; 9-LIPOXYGENASE-DERIVED OXYLIPINS; ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTORS	Wounding due to mechanical injury or insect feeding causes a wide array of damage to plant cells including cell disruption, desiccation, metabolite oxidation, and disruption of primary metabolism. In response, plants regulate a variety of genes and metabolic pathways to cope with injury. Tomato (Solanum lycopersicum) is a model for wound signaling but few studies have examined the comprehensive gene expression profiles in response to injury. A cross-species microarray approach using the TIGR potato 10-K cDNA array was analyzed for large-scale temporal (early and late) and spatial (locally and systemically) responses to mechanical wounding in tomato leaves. These analyses demonstrated that tomato regulates many primary and secondary metabolic pathways and this regulation is dependent on both timing and location. To determine if LAP-A, a known modulator of wound signaling, influences gene expression beyond the core of late wound-response genes, changes in RNAs from healthy and wounded Leucine aminopeptidase A-silenced (LapA-SI) and wild-type (WT) leaves were examined. While most of the changes in gene expression after wounding in LapA-SI leaves were similar to WT, overall responses were delayed in the LapA-SI leaves. Moreover, two pathogenesis-related 1 (PR-1c and PR-1a2) and two dehydrin (TAS14 and Dhn3) genes were negatively regulated by LAP-A. Collectively, this study has shown that tomato wound responses are complex and that LAP-A's role in modulation of wound responses extends beyond the well described late-wound gene core.	[Scranton, Melissa A.; Fowler, Jonathan H.; Girke, Thomas; Walling, Linda L.] Univ Calif Riverside, Dept Bot & Plant Sci, Ctr Plant Cell Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Walling, LL (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Ctr Plant Cell Biol, Riverside, CA 92521 USA.	linda.walling@ucr.edu		Scranton, Melissa/0000-0003-1910-3117; Girke, Thomas/0000-0003-0710-3777	National Science Foundation [IOS 0725093, DGE 0504249]	National Science Foundation(National Science Foundation (NSF))	This work and JF were supported by the National Science Foundation grant (IOS 0725093) to LLW. MS was supported by supported in part by the National Science Foundation-funded ChemIGERT program (DGE 0504249) and IOS 0725093. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie B, 2007, J PLANT GROWTH REGUL, V26, P160, DOI 10.1007/s00344-007-0012-6; Allagulova CR, 2003, BIOCHEMISTRY-MOSCOW+, V68, P945, DOI 10.1023/A:1026077825584; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bagnaresi P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-176; Bar-Or C, 2007, GENOMICS, V90, P636, DOI 10.1016/j.ygeno.2007.06.008; Bar-Or C, 2007, TRENDS GENET, V23, P200, DOI 10.1016/j.tig.2007.02.003; Bar-Or C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-110; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernards Mark A., 2008, P189; Bilgin DD, 2010, PLANT CELL ENVIRON, V33, P1597, DOI 10.1111/j.1365-3040.2010.02167.x; Birkenmeier GF, 1998, PLANT PHYSIOL, V117, P687, DOI 10.1104/pp.117.2.687; Bottcher C, 2009, FEBS J, V276, P4693, DOI 10.1111/j.1742-4658.2009.07195.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonaventure Gustavo, 2010, Commun Integr Biol, V3, P313; Bostock RM, 2005, ANNU REV PHYTOPATHOL, V43, P545, DOI 10.1146/annurev.phyto.41.052002.095505; BOSTOCK RM, 1989, ANNU REV PHYTOPATHOL, V27, P343, DOI 10.1146/annurev.py.27.090189.002015; Bown AW, 2006, TRENDS PLANT SCI, V11, P424, DOI 10.1016/j.tplants.2006.07.002; Campos ML, 2009, J EXP BOT, V60, P4346, DOI 10.1093/jxb/erp270; Chao WS, 1999, PLANT PHYSIOL, V120, P979, DOI 10.1104/pp.120.4.979; Chao WS, 2000, PLANTA, V210, P563, DOI 10.1007/s004250050045; Chen H, 2005, P NATL ACAD SCI USA, V102, P19237, DOI 10.1073/pnas.0509026102; Chen H, 2006, FEBS LETT, V580, P2540, DOI 10.1016/j.febslet.2006.03.070; Chen Hui, 2008, P271, DOI 10.1007/978-1-4020-8182-8_13; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; CHOI D, 1994, P NATL ACAD SCI USA, V91, P2329, DOI 10.1073/pnas.91.6.2329; Cona A, 2006, TRENDS PLANT SCI, V11, P80, DOI 10.1016/j.tplants.2005.12.009; Dargeviciute A, 1998, PLANT CELL PHYSIOL, V39, P993, DOI 10.1093/oxfordjournals.pcp.a029311; Dempsey DM, 2011, SALICYLIC ACID BIOSY; Dobbin K, 2002, BIOINFORMATICS, V18, P1438, DOI 10.1093/bioinformatics/18.11.1438; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Edreva AM, 2007, RUSS J PLANT PHYSL+, V54, P287, DOI 10.1134/S1021443707030016; Erb M, 2012, TRENDS PLANT SCI, V17, P250, DOI 10.1016/j.tplants.2012.01.003; Estavillo GM, 2012, FRON PLANT SCI, V3, P1; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; FELTON GW, 1989, J CHEM ECOL, V15, P2667, DOI 10.1007/BF01014725; Ferreira RB, 2007, MOL PLANT PATHOL, V8, P677, DOI 10.1111/J.1364-3703.2007.00419.X; Fowler JH, 2009, PLANT CELL, V21, P1239, DOI 10.1105/tpc.108.065029; Galvez-Valdivieso G, 2010, PHYSIOL PLANTARUM, V138, P430, DOI 10.1111/j.1399-3054.2009.01331.x; Gatz C, 2013, MOL PLANT MICROBE IN, V26, P151, DOI 10.1094/MPMI-04-12-0078-IA; GODOY JA, 1990, PLANT MOL BIOL, V15, P695, DOI 10.1007/BF00016120; Gu YQ, 2000, EUR J BIOCHEM, V267, P1178, DOI 10.1046/j.1432-1327.2000.01116.x; Halitschke R, 2003, PLANT J, V36, P794, DOI 10.1046/j.1365-313X.2003.01921.x; Hare JD, 2011, ANNU REV ENTOMOL, V56, P161, DOI 10.1146/annurev-ento-120709-144753; Hartl M, 2008, NEW PHYTOL, V179, P356, DOI 10.1111/j.1469-8137.2008.02479.x; Heil M, 2009, TRENDS PLANT SCI, V14, P356, DOI 10.1016/j.tplants.2009.04.002; Howe GA, 2000, PLANT PHYSIOL, V123, P711, DOI 10.1104/pp.123.2.711; Howe GA, 2004, J PLANT GROWTH REGUL, V23, P223, DOI 10.1007/s00344-004-0030-6; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Leon-Morcillo RJ, 2012, J EXP BOT, V63, P3545, DOI 10.1093/jxb/ers010; Jung C, 2007, PLANT CELL REP, V26, P1053, DOI 10.1007/s00299-007-0311-1; Kachroo A, 2009, ANNU REV PHYTOPATHOL, V47, P153, DOI 10.1146/annurev-phyto-080508-081820; Kang JH, 2010, PLANT PHYSIOL, V154, P262, DOI 10.1104/pp.110.160192; Kant MR, 2004, PLANT PHYSIOL, V135, P483, DOI 10.1104/pp.103.038315; Kaur H, 2010, PLANT PHYSIOL, V152, P1731, DOI 10.1104/pp.109.151738; Keller T, 1998, PLANT CELL, V10, P255, DOI 10.1105/tpc.10.2.255; Kempema LA, 2007, PLANT PHYSIOL, V143, P849, DOI 10.1104/pp.106.090662; Kerchev PI, 2012, PLANT CELL ENVIRON, V35, P441, DOI 10.1111/j.1365-3040.2011.02399.x; Kindgren P, 2011, PHYSIOL PLANTARUM, V141, P310, DOI 10.1111/j.1399-3054.2010.01440.x; Koizumi N, 2001, PLANT PHYSIOL, V127, P949, DOI 10.1104/pp.010636; Korth KL, 1997, PLANT PHYSIOL, V115, P1299, DOI 10.1104/pp.115.4.1299; Krause K, 2012, INT J MOL SCI, V13, P11085, DOI 10.3390/ijms130911085; Kusano T, 2008, PLANTA, V228, P367, DOI 10.1007/s00425-008-0772-7; Lawrence SD, 2008, J CHEM ECOL, V34, P1013, DOI 10.1007/s10886-008-9507-2; Li CY, 2009, INSECT BIOCHEM MOLEC, V39, P726, DOI 10.1016/j.ibmb.2009.08.008; Li CY, 2003, PLANT CELL, V15, P1646, DOI 10.1105/tpc.012237; Li L, 2004, PLANT CELL, V16, P126, DOI 10.1105/tpc.017954; Lopez MA, 2011, PLANT J, V67, P447, DOI 10.1111/j.1365-313X.2011.04608.x; Ludwig-Muller J, 2011, J EXP BOT, V62, P1757, DOI 10.1093/jxb/erq412; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; Major IT, 2006, NEW PHYTOL, V172, P617, DOI 10.1111/j.1469-8137.2006.01877.x; Maruta T, 2012, J BIOL CHEM, V287, P11717, DOI 10.1074/jbc.M111.292847; Matsui K, 2006, CURR OPIN PLANT BIOL, V9, P274, DOI 10.1016/j.pbi.2006.03.002; Mithoe SC, 2011, PHYTOCHEMISTRY, V72, P997, DOI 10.1016/j.phytochem.2010.12.009; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Mochizuki N, 2008, P NATL ACAD SCI USA, V105, P15184, DOI 10.1073/pnas.0803245105; Moulin M, 2008, P NATL ACAD SCI USA, V105, P15178, DOI 10.1073/pnas.0803054105; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Narvaez-Vasquez J, 1999, PLANT CELL, V11, P2249, DOI 10.1105/tpc.11.11.2249; Narvaez-Vasquez J, 2008, PLANTA, V227, P341, DOI 10.1007/s00425-007-0621-0; NIDERMAN T, 1995, PLANT PHYSIOL, V108, P17, DOI 10.1104/pp.108.1.17; ODonnell PJ, 1996, SCIENCE, V274, P1914, DOI 10.1126/science.274.5294.1914; Orozco-Cardenas ML, 2001, PLANT CELL, V13, P179, DOI 10.1105/tpc.13.1.179; Padmanabhan MS, 2010, MOL PLANT MICROBE IN, V23, P1368, DOI 10.1094/MPMI-05-10-0113; Pautot V, 2001, MOL PLANT MICROBE IN, V14, P214, DOI 10.1094/MPMI.2001.14.2.214; Pearce G, 2011, CURR PROTEIN PEPT SC, V12, P399, DOI 10.2174/138920311796391106; PenaCortes H, 1996, PLANTA, V198, P447, DOI 10.1007/BF00620062; PENACORTES H, 1991, PLANT CELL, V3, P963, DOI 10.1105/tpc.3.9.963; Pfannschmidt T, 2009, ANN BOT-LONDON, V103, P599, DOI 10.1093/aob/mcn081; Pfannschmidt T, 2010, TRENDS PLANT SCI, V15, P427, DOI 10.1016/j.tplants.2010.05.009; Ramel F, 2012, P NATL ACAD SCI USA, V109, P5535, DOI 10.1073/pnas.1115982109; Reymond P, 2000, PLANT CELL, V12, P707, DOI 10.1105/tpc.12.5.707; Rietz S, 2004, PLANTA, V219, P743, DOI 10.1007/s00425-004-1275-9; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P1; Rotter A, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-10; Rozen S, 2000, Methods Mol Biol, V132, P365; Ryan CA, 2000, BBA-PROTEIN STRUCT M, V1477, P112, DOI 10.1016/S0167-4838(99)00269-1; Sanchez-Hernandez C, 2006, PLANT CELL ENVIRON, V29, P546, DOI 10.1111/j.1365-3040.2005.01431.x; Sasidharan R, 2011, CRIT REV PLANT SCI, V30, P548, DOI 10.1080/07352689.2011.615706; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schaller A, 2004, PLANTA, V220, P183, DOI 10.1007/s00425-004-1407-2; Scranton MA, 2013, ELUCIDATION ROLE LEU; Scranton MA, 2012, J BIOL CHEM, V287, P18408, DOI 10.1074/jbc.M111.309500; Seo S, 1997, PHYSIOL PLANTARUM, V101, P740, DOI 10.1111/j.1399-3054.1997.tb01058.x; Shi LF, 1998, PLANT MOL BIOL, V38, P1053, DOI 10.1023/A:1006007315718; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Steinbrenner AD, 2011, J CHEM ECOL, V37, P1294, DOI 10.1007/s10886-011-0042-1; Strand A, 2003, NATURE, V421, P79, DOI 10.1038/nature01204; Strassner J, 2002, PLANT J, V32, P585, DOI 10.1046/j.1365-313X.2002.01449.x; Sun JQ, 2011, MOL PLANT, V4, P607, DOI 10.1093/mp/ssr008; Suza WP, 2010, PLANTA, V231, P717, DOI 10.1007/s00425-009-1080-6; TAYLOR BH, 1993, PLANT MOL BIOL, V23, P1005, DOI 10.1007/BF00021815; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Thompson AJ, 2000, PLANT J, V23, P363, DOI 10.1046/j.1365-313x.2000.00789.x; Tian ZD, 2003, ACTA BOT SIN, V45, P959; TORNERO P, 1994, MOL GEN GENET, V243, P47, DOI 10.1007/BF00283875; Tornero P, 1997, MOL PLANT MICROBE IN, V10, P624, DOI 10.1094/MPMI.1997.10.5.624; Tu CJ, 2003, PLANT PHYSIOL, V132, P243, DOI 10.1104/pp.102.013854; Uppalapati SR, 2005, PLANT J, V42, P201, DOI 10.1111/j.1365-313X.2005.02366.x; Uppalapati SR, 2008, MOL PLANT MICROBE IN, V21, P383, DOI 10.1094/MPMI-21-4-0383; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; van der Hoorn RAL, 2004, CURR OPIN PLANT BIOL, V7, P400, DOI 10.1016/j.pbi.2004.04.003; van der Hoorn RAL, 2008, ANNU REV PLANT BIOL, V59, P191, DOI 10.1146/annurev.arplant.59.032607.092835; VANKAN JAL, 1995, PLANT MOL BIOL, V27, P1205, DOI 10.1007/BF00020894; Vellosillo T, 2013, PLANT PHYSIOL, V161, P617, DOI 10.1104/pp.112.207514; Vranova E, 2012, MOL PLANT, V5, P318, DOI 10.1093/mp/sss015; Walley JW, 2007, PLOS GENET, V3, P1800, DOI 10.1371/journal.pgen.0030172; Walling LL, 2009, ADV BOT RES, V51, P551, DOI 10.1016/S0065-2296(09)51013-0; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Woodson JD, 2008, NAT REV GENET, V9, P383, DOI 10.1038/nrg2348; Woodson JD, 2012, CURR BIOL, V22, pR690, DOI 10.1016/j.cub.2012.07.028; Woodson JD, 2011, CURR BIOL, V21, P897, DOI 10.1016/j.cub.2011.04.004; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Zarate SI, 2007, PLANT PHYSIOL, V143, P866, DOI 10.1104/pp.106.090035; Zegzouti H, 1997, PLANT MOL BIOL, V35, P847, DOI 10.1023/A:1005860302313; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	137	17	19	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77889	10.1371/journal.pone.0077889	http://dx.doi.org/10.1371/journal.pone.0077889			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205013	Green Published, gold, Green Submitted			2022-12-27	WOS:000326152300036
J	Bonnell, TR; Campenni, M; Chapman, CA; Gogarten, JF; Reyna-Hurtado, RA; Teichroeb, JA; Wasserman, MD; Sengupta, R				Bonnell, Tyler R.; Campenni, Marco; Chapman, Colin A.; Gogarten, Jan F.; Reyna-Hurtado, Rafael A.; Teichroeb, Julie A.; Wasserman, Michael D.; Sengupta, Raja			Emergent Group Level Navigation: An Agent-Based Evaluation of Movement Patterns in a Folivorous Primate	PLOS ONE			English	Article							FORAGING PATTERNS; SPATIAL MEMORY; MONKEYS; HYPOTHESES; MAPS	The foraging activity of many organisms reveal strategic movement patterns, showing efficient use of spatially distributed resources. The underlying mechanisms behind these movement patterns, such as the use of spatial memory, are topics of considerable debate. To augment existing evidence of spatial memory use in primates, we generated movement patterns from simulated primate agents with simple sensory and behavioral capabilities. We developed agents representing various hypotheses of memory use, and compared the movement patterns of simulated groups to those of an observed group of red colobus monkeys (Procolobus rufomitratus), testing for: the effects of memory type (Euclidian or landmark based), amount of memory retention, and the effects of social rules in making foraging choices at the scale of the group (independent or leader led). Our results indicate that red colobus movement patterns fit best with simulated groups that have landmark based memory and a follow the leader foraging strategy. Comparisons between simulated agents revealed that social rules had the greatest impact on a group's step length, whereas the type of memory had the highest impact on a group's path tortuosity and cohesion. Using simulation studies as experimental trials to test theories of spatial memory use allows the development of insight into the behavioral mechanisms behind animal movement, developing case-specific results, as well as general results informing how changes to perception and behavior influence movement patterns.	[Bonnell, Tyler R.; Sengupta, Raja] McGill Univ, Deptartment Geog, Montreal, PQ, Canada; [Campenni, Marco] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Chapman, Colin A.; Wasserman, Michael D.] McGill Univ, Deptartment Anthropol, Montreal, PQ, Canada; [Chapman, Colin A.] McGill Univ, McGill Sch Environm, Montreal, PQ, Canada; [Chapman, Colin A.] Wildlife Conservat Soc, Bronx, NY USA; [Gogarten, Jan F.] McGill Univ, Deptartment Biol, Montreal, PQ, Canada; [Reyna-Hurtado, Rafael A.] ECOSUR Campeche, Lerma, Cempeche, Mexico; [Teichroeb, Julie A.] Univ Calif Santa Cruz, Dept Anthropol, Santa Cruz, CA 95064 USA	McGill University; Max Planck Society; McGill University; McGill University; Wildlife Conservation Society; McGill University; El Colegio de la Frontera Sur (ECOSUR); University of California System; University of California Santa Cruz	Bonnell, TR (corresponding author), McGill Univ, Deptartment Geog, Montreal, PQ, Canada.	Tyler.Bonnell@mail.McGill.ca	Wasserman, Michael/AAR-7279-2020; Chapman, Colin/S-1911-2019; Gogarten, Jan Frederik/A-4430-2014; Reyna-Hurtado, Rafael/M-7204-2019; Reyna-Hurtado, Rafael A/B-6223-2015	Wasserman, Michael/0000-0003-1611-024X; Chapman, Colin/0000-0002-8827-8140; Gogarten, Jan Frederik/0000-0003-1889-4113; Reyna-Hurtado, Rafael/0000-0003-4382-642X; Reyna-Hurtado, Rafael A/0000-0003-4382-642X; Sengupta, Raja/0000-0003-4914-5844	Canada Research Chairs Program; Natural Science and Engineering Research Council of Canada; National Science Foundation; National Geographic; Fonds de Recherche Nature et Technologies; Graduate Research Fellowship from the National Science Foundation; Explorers Club - Eddie Bauer Youth Grant; McGill University's Tomlinson Postdoctoral Fellowship; Government of Canada Postdoctoral Research Fellowship (PDRF)	Canada Research Chairs Program(Canada Research Chairs); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Science Foundation(National Science Foundation (NSF)); National Geographic(National Geographic Society); Fonds de Recherche Nature et Technologies; Graduate Research Fellowship from the National Science Foundation; Explorers Club - Eddie Bauer Youth Grant; McGill University's Tomlinson Postdoctoral Fellowship; Government of Canada Postdoctoral Research Fellowship (PDRF)	Funding for the research in Kibale was provided by the Canada Research Chairs Program, Natural Science and Engineering Research Council of Canada, National Science Foundation, and National Geographic. TB received support from Fonds de Recherche Nature et Technologies. Permission to conduct the research in Uganda was given by the National Council for Science and Technology and the Uganda Wildlife Authority. JFG was supported by a Graduate Research Fellowship from the National Science Foundation and the Explorers Club - Eddie Bauer Youth Grant. MDW received funding from McGill University's Tomlinson Postdoctoral Fellowship. MC was supported by Government of Canada Postdoctoral Research Fellowship (PDRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod R, 2006, HANDB ECON, V13, P1565; Bankes SC, 2002, P NATL ACAD SCI USA, V99, P7199, DOI 10.1073/pnas.072081299; Bennett DA, 2006, INT J GEOGR INF SCI, V20, P1039, DOI 10.1080/13658810600830806; Boinski S, 2000, ON THE MOVE HOW AND; Bonnell TR, 2013, ANIM BEHAV, V85, P483, DOI 10.1016/j.anbehav.2012.12.014; Bonnell TR, 2010, ECOL MODEL, V221, P2491, DOI 10.1016/j.ecolmodel.2010.07.020; Boyer D, 2006, P ROY SOC B-BIOL SCI, V273, P1743, DOI 10.1098/rspb.2005.3462; Boyer D, 2010, PHILOS T R SOC A, V368, P5645, DOI 10.1098/rsta.2010.0275; Bryson JJ, 2007, PHILOS T R SOC B, V362, P1685, DOI 10.1098/rstb.2007.2061; Byrne RW, 2000, ON THE MOVE HOW AND; CHAPMAN CA, 2000, DETERMINANTS GROUP S, P24; Conradt L, 2009, AM NAT, V173, P304, DOI 10.1086/596532; Cunningham E, 2007, ANIM COGN, V10, P273, DOI 10.1007/s10071-007-0078-3; Di Fiore A, 2007, ANIM COGN, V10, P317, DOI 10.1007/s10071-006-0067-y; GARBER PA, 1989, AM J PRIMATOL, V19, P203, DOI 10.1002/ajp.1350190403; GARBER PA, 1993, INT J PRIMATOL, V14, P827, DOI 10.1007/BF02220255; Getz WM, 2008, P NATL ACAD SCI USA, V105, P19066, DOI 10.1073/pnas.0801732105; Goldstone RL, 2005, TRENDS COGN SCI, V9, P424, DOI 10.1016/j.tics.2005.07.009; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; HEINRICH B, 1988, BEHAV ECOL SOCIOBIOL, V23, P141, DOI 10.1007/BF00300349; Janmaat KRL, 2006, ANIM BEHAV, V72, P797, DOI 10.1016/j.anbehav.2005.12.009; Janson CH, 2007, ANIM COGN, V10, P357, DOI 10.1007/s10071-007-0080-9; Janson CH, 2007, ANIM COGN, V10, P341, DOI 10.1007/s10071-007-0079-2; Milton K, 2000, ON THE MOVE: HOW AND WHY ANIMALS TRAVEL IN GROUPS, P375; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Normand E, 2009, ANIM BEHAV, V77, P1195, DOI 10.1016/j.anbehav.2009.01.025; POUCET B, 1993, PSYCHOL REV, V100, P163, DOI 10.1037/0033-295X.100.2.163; Prescott TJ, 2007, PHILOS T R SOC B, V362, P1521, DOI 10.1098/rstb.2007.2050; Prete FR, 2005, COMPLEX WORLDS FROM; Ramos-Fernandez G, 2006, BEHAV ECOL SOCIOBIOL, V60, P536, DOI 10.1007/s00265-006-0197-x; Sellers WI, 2007, PHILOS T R SOC B, V362, P1699, DOI 10.1098/rstb.2007.2064; Snaith TV, 2008, BEHAV ECOL, V19, P1289, DOI 10.1093/beheco/arn076; Struhsaker TT, 1975, THE RED COLOBUS MONK; Tang WW, 2010, GEOGR COMPASS, V4, pCP7, DOI 10.1111/j.1749-8198.2010.00337.x; TEBOEKHORST IJA, 1994, BEHAVIOUR, V130, P229, DOI 10.1163/156853994X00541; Tombak KJ, 2012, PRIMATES, V53, P57, DOI 10.1007/s10329-011-0274-2; VANSCHAIK CP, 1983, BEHAVIOUR, V85, P91, DOI 10.1163/156853983X00057; Whittington J, 2004, ECOL SOC, V9	38	15	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78264	10.1371/journal.pone.0078264	http://dx.doi.org/10.1371/journal.pone.0078264			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205174	Green Published, gold			2022-12-27	WOS:000326032600088
J	Choy, A; Severo, MS; Sun, RB; Girke, T; Gillespie, JJ; Pedra, JHF				Choy, Anthony; Severo, Maiara S.; Sun, Ruobai; Girke, Thomas; Gillespie, Joseph J.; Pedra, Joao H. F.			Decoding the Ubiquitin-Mediated Pathway of Arthropod Disease Vectors	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; PROTEIN; IMPROVEMENTS; INSECTICIDES; MECHANISMS; PROTEOMICS; EVOLUTION; INFECTION; RESOURCE; HOMOLOGY	Protein regulation by ubiquitin has been extensively described in model organisms. However, characterization of the ubiquitin machinery in disease vectors remains mostly unknown. This fundamental gap in knowledge presents a concern because new therapeutics are needed to control vector-borne diseases, and targeting the ubiquitin machinery as a means for disease intervention has been already adopted in the clinic. In this study, we employed a bioinformatics approach to uncover the ubiquitin-mediated pathway in the genomes of Anopheles gambiae, Aedes aegypti, Culex quinquefasciatus, Ixodes scapularis, Pediculus humanus and Rhodnius prolixus. We observed that (1) disease vectors encode a lower percentage of ubiquitin-related genes when compared to Drosophila melanogaster, Mus musculus and Homo sapiens but not Saccharomyces cerevisiae; (2) overall, there are more proteins categorized as E3 ubiquitin ligases when compared to E2-conjugating or E1-activating enzymes; (3) the ubiquitin machinery within the three mosquito genomes is highly similar; (4) ubiquitin genes are more than doubled in the Chagas disease vector (R. prolixus) when compared to other arthropod vectors; (5) the deer tick I. scapularis and the body louse (P. humanus) genomes carry low numbers of E1-activating enzymes and HECT-type E3 ubiquitin ligases; (6) R. prolixus have low numbers of RING-type E3 ubiquitin ligases; and (7) C. quinquefasciatus present elevated numbers of predicted F-box E3 ubiquitin ligases, JAB and UCH deubiquitinases. Taken together, these findings provide novel opportunities to study the interaction between a pathogen and an arthropod vector.	[Choy, Anthony; Severo, Maiara S.; Pedra, Joao H. F.] Univ Calif Riverside, Ctr Dis Vector Res, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Choy, Anthony; Severo, Maiara S.; Pedra, Joao H. F.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Sun, Ruobai; Girke, Thomas] Univ Calif Riverside, Dept Bot & Plant Sci, Ctr Plant Cell Biol, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Gillespie, Joseph J.; Pedra, Joao H. F.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; University System of Maryland; University of Maryland Baltimore	Pedra, JHF (corresponding author), Univ Calif Riverside, Ctr Dis Vector Res, Inst Integrat Genome Biol, Riverside, CA 92521 USA.	jpedra@som.umaryland.edu		Severo, Maiara/0000-0001-5972-0035; Gillespie, Joseph/0000-0002-5447-7264; Girke, Thomas/0000-0003-0710-3777; Pedra, Joao/0000-0001-8740-2667	University of California, Riverside; National Institutes of Health [NIH R01AI043006, NIH AI093653]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093653, R01AI043006] Funding Source: NIH RePORTER	University of California, Riverside(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the University of California, Riverside and the National Institutes of Health NIH R01AI043006 and NIH AI093653. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bade VN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038294; Baron M, 2012, SEMIN CELL DEV BIOL, V23, P437, DOI 10.1016/j.semcdb.2012.01.008; Bartholomay LC, 2010, SCIENCE, V330, P88, DOI 10.1126/science.1193162; Bateman A, 1999, NUCLEIC ACIDS RES, V27, P260, DOI 10.1093/nar/27.1.260; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; *CDCP, 2010, LYMPH FIL; Centers for Disease Control and Prevention, 2010, LYM DIS; Chatterjee A, 2008, CELL CYCLE, V7, P1231, DOI 10.4161/cc.7.9.5795; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Collins CA, 2010, TRENDS CELL BIOL, V20, P205, DOI 10.1016/j.tcb.2010.01.002; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Cooper PS, 2010, BRIEF BIOINFORM, V11, P563, DOI 10.1093/bib/bbq022; Correa RL, 2013, INT J MOL SCI, V14, P4030, DOI 10.3390/ijms14024030; David JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-216; de la Fuente J, 2007, GENOMICS, V90, P712, DOI 10.1016/j.ygeno.2007.08.009; Dinglasan RR, 2008, TRENDS PARASITOL, V24, P364, DOI 10.1016/j.pt.2008.05.002; Evans PC, 2003, J BIOL CHEM, V278, P23180, DOI 10.1074/jbc.M301863200; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; Furukawa K, 2000, J BIOL CHEM, V275, P7462, DOI 10.1074/jbc.275.11.7462; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Hjerpe R, 2012, J MOL BIOL, V421, P27, DOI 10.1016/j.jmb.2012.05.013; Hofmann K, 1998, J MOL BIOL, V282, P195, DOI 10.1006/jmbi.1998.1998; Huang B, 2012, FEMS IMMUNOL MED MIC, V64, P32, DOI 10.1111/j.1574-695X.2011.00873.x; Inagawa T, 2009, P NATL ACAD SCI USA, V106, P7927, DOI 10.1073/pnas.0812323106; Jaiswal M, 2012, ANNU REV GENET, V46, P371, DOI 10.1146/annurev-genet-110711-155456; JIN J, 2012, FRONT ONCOL, V2; Johnston SC, 1997, EMBO J, V16, P3787, DOI 10.1093/emboj/16.13.3787; Kang SH, 2007, J BIOL CHEM, V282, P5256, DOI 10.1074/jbc.M610590200; Komatsu M, 2001, J BIOL CHEM, V276, P9846, DOI 10.1074/jbc.M007737200; Kraft C, 2012, EMBO J, V31, P3691, DOI 10.1038/emboj.2012.225; KUMAR S, 1993, BIOCHEM BIOPH RES CO, V195, P393, DOI 10.1006/bbrc.1993.2056; Larsen CN, 1998, BIOCHEMISTRY-US, V37, P3358, DOI 10.1021/bi972274d; Low TY, 2013, PROTEOMICS, V13, P526, DOI 10.1002/pmic.201200244; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P42, DOI 10.1016/j.ibmb.2007.09.003; Marin I, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-331; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; Matsumoto M, 2005, PROTEOMICS, V5, P4145, DOI 10.1002/pmic.200401280; Mauri PL, 2006, FEBS J, V273, P4277, DOI 10.1111/j.1742-4658.2006.05419.x; McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968; Megy K, 2012, NUCLEIC ACIDS RES, V40, pD729, DOI 10.1093/nar/gkr1089; Mishra SK, 2011, NATURE, V474, P173, DOI 10.1038/nature10143; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Neafsey DE, 2013, G3-GENES GENOM GENET, V3, P1191, DOI 10.1534/g3.113.006247; Patramool S, 2012, PROTEOMICS, V12, P3510, DOI 10.1002/pmic.201200300; Patterson-Fortin J, 2010, J BIOL CHEM, V285, P30971, DOI 10.1074/jbc.M110.135319; Peng JM, 2005, METHOD ENZYMOL, V399, P367, DOI 10.1016/S0076-6879(05)99025-3; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Ponts N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002386; Semple CAM, 2003, GENOME RES, V13, P1389, DOI 10.1101/gr.980303; Severo MS, 2013, CELL MICROBIOL, V15, P1070, DOI 10.1111/cmi.12128; SEVERO MS, 2013, J INFECT DIS; Severson DW, 2012, ANNU REV ENTOMOL, V57, P143, DOI 10.1146/annurev-ento-120710-100651; Su D, 2010, MOL CELL BIOL, V30, P3734, DOI 10.1128/MCB.00673-10; World Health Organization, 2004, WORLD HLTH REP 2004	56	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78077	10.1371/journal.pone.0078077	http://dx.doi.org/10.1371/journal.pone.0078077			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205097	Green Submitted, Green Published, gold			2022-12-27	WOS:000326032600068
J	Duddempudi, PK; Goyal, R; Date, SS; Jansen, M				Duddempudi, Phaneendra Kumar; Goyal, Raman; Date, Swapneeta Sanjay; Jansen, Michaela			Delineating the Extracellular Water-Accessible Surface of the Proton-Coupled Folate Transporter	PLOS ONE			English	Article							PROTEIN HOMOLOGY DETECTION; FUNCTIONAL ROLES; GLUCOSE-TRANSPORTER; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MALABSORPTION; PCFT-SLC46A1; MECHANISM; MUTATION; GENE	The proton-coupled folate transporter (PCFT) was recently identified as the major uptake route for dietary folates in humans. The three-dimensional structure of PCFT and its detailed interplay with function remain to be determined. We screened the water-accessible extracellular surface of HsPCFT using the substituted-cysteine accessibility method, to investigate the boundaries between the water-accessible surface and inaccessible buried protein segments. Single-cysteines, engineered individually at 40 positions in a functional cysteine-less HsPCFT background construct, were probed for plasma-membrane expression in Xenopus oocytes with a bilayer-impermeant primary-amine-reactive biotinylating agent (sulfosuccinimidyl 6-(biotinamido) hexanoate), and additionally for water-accessibility of the respective engineered cysteine with the sulfhydryl-selective biotinylating agent 2-((biotinoyl)amino)ethyl methanethiosulfonate. The ratio between Cys-selective over amine-selective labeling was further used to evaluate three-dimensional models of HsPCFT generated by homology / threading modeling. The closest homologues of HsPCFT with a known experimentally-determined three-dimensional structure are all members of one of the largest membrane protein super-families, the major facilitator superfamily (MFS). The low sequence identity - 14% or less - between HsPCFT and these templates necessitates experiment-based evaluation and model refinement of homology / threading models. With the present set of single-cysteine accessibilities, the models based on GlpT and PepT(St) are most promising for further refinement.	[Duddempudi, Phaneendra Kumar] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Dept Pharmacol & Neurosci, Lubbock, TX 79430 USA; [Duddempudi, Phaneendra Kumar; Goyal, Raman; Date, Swapneeta Sanjay; Jansen, Michaela] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Ctr Membrane Prot Res, Lubbock, TX 79430 USA; [Goyal, Raman; Date, Swapneeta Sanjay; Jansen, Michaela] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Jansen, M (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Sch Med, Ctr Membrane Prot Res, Lubbock, TX 79430 USA.	michaela.jansen@ttuhsc.edu	Duddempudi, Phaneendra/AAL-8015-2020; Goyal, Raman/AAG-8507-2019	Duddempudi, Phaneendra/0000-0002-2625-8179; Jansen, Michaela/0000-0003-1325-9700	Center for Membrane Protein Research, TTUHSC (Texas Tech University Health Sciences Center); seed-grant program of the Office of Research, TTUHSC	Center for Membrane Protein Research, TTUHSC (Texas Tech University Health Sciences Center); seed-grant program of the Office of Research, TTUHSC	This work was supported, in part, by grants provided by the Center for Membrane Protein Research, TTUHSC (Texas Tech University Health Sciences Center)(to MJ), and by the seed-grant program of the Office of Research, TTUHSC (to MJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; ANTONY AC, 1992, BLOOD, V79, P2807; ANTONY AC, 1981, J BIOL CHEM, V256, P9684; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Atabay B, 2010, PEDIATR HEMAT ONCOL, V27, P614, DOI 10.3109/08880018.2010.481705; Bao XY, 2004, J BIOL CHEM, V279, P9689, DOI 10.1074/jbc.M311438200; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; Britto PJ, 2002, J BIOL CHEM, V277, P29018, DOI 10.1074/jbc.M204263200; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; Desmoulin SK, 2010, MOL PHARMACOL, V78, P577, DOI 10.1124/mol.110.065896; Duddempudi PK, 2013, FEBS J, V280, P2900, DOI 10.1111/febs.12293; Duthie SJ, 1999, BRIT MED BULL, V55, P578, DOI 10.1258/0007142991902646; GAN ZR, 1990, ARCH BIOCHEM BIOPHYS, V282, P110, DOI 10.1016/0003-9861(90)90093-E; HENDERSON GB, 1990, ANNU REV NUTR, V10, P319, DOI [10.1146/annurev.nutr.10.1.319, 10.1146/annurev.nu.10.070190.001535]; Holstead RG, 2011, J MEMBRANE BIOL, V243, P15, DOI 10.1007/s00232-011-9388-0; Hou ZJ, 2012, J BIOL CHEM, V287, P4982, DOI 10.1074/jbc.M111.306860; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; Kasahara T, 2010, J BIOL CHEM, V285, P26263, DOI 10.1074/jbc.M110.149716; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Lasry I, 2008, BLOOD, V112, P2055, DOI 10.1182/blood-2008-04-150276; Lasry I, 2009, BIOCHEM BIOPH RES CO, V386, P426, DOI 10.1016/j.bbrc.2009.06.007; Leng XH, 1999, J BIOL CHEM, V274, P14655, DOI 10.1074/jbc.274.21.14655; Meyer E, 2010, MOL GENET METAB, V99, P325, DOI 10.1016/j.ymgme.2009.11.004; Min SH, 2008, J PEDIATR-US, V153, P435, DOI 10.1016/j.jpeds.2008.04.009; Mirza O, 2006, EMBO J, V25, P1177, DOI 10.1038/sj.emboj.7601028; Mueckler M, 2005, J BIOL CHEM, V280, P39562, DOI 10.1074/jbc.M509050200; Newstead S, 2011, EMBO J, V30, P417, DOI 10.1038/emboj.2010.309; Parikh RB, 2011, J BIOL CHEM, V286, P14098, DOI 10.1074/jbc.M111.221895; Pedersen BP, 2013, NATURE, V496, P533, DOI 10.1038/nature12042; Qiu A, 2007, AM J PHYSIOL-CELL PH, V293, pC1669, DOI 10.1152/ajpcell.00202.2007; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; Shin D.S., 2012, AM J PHYSL CELL PHYS; Shin DS, 2012, AM J PHYSIOL-CELL PH, V303, pC834, DOI 10.1152/ajpcell.00171.2012; Shin DS, 2012, AM J PHYSIOL-CELL PH, V302, pC1405, DOI 10.1152/ajpcell.00435.2011; Shin DS, 2011, MOL GENET METAB, V103, P33, DOI 10.1016/j.ymgme.2011.01.008; Shin DS, 2010, BLOOD, V116, P5162, DOI 10.1182/blood-2010-06-291237; Smith AD, 2008, AM J CLIN NUTR, V87, P517; SMITHELLS RW, 1976, ARCH DIS CHILD, V51, P944, DOI 10.1136/adc.51.12.944; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Solcan N, 2012, EMBO J, V31, P3411, DOI 10.1038/emboj.2012.157; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Unal ES, 2009, J BIOL CHEM, V284, P17846, DOI 10.1074/jbc.M109.008060; Unal ES, 2008, BBA-BIOMEMBRANES, V1778, P1407, DOI 10.1016/j.bbamem.2008.03.009; UNDERHILL TM, 1989, MOL CELL BIOL, V9, P1754, DOI 10.1128/MCB.9.4.1754; Yan HC, 2013, CELL REP, V3, P716, DOI 10.1016/j.celrep.2013.03.007; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; Zhao R, 2007, BLOOD, V110, P1147, DOI 10.1182/blood-2007-02-077099; Zhao RB, 2011, BBA-BIOMEMBRANES, V1808, P1140, DOI 10.1016/j.bbamem.2011.01.008; Zhao RB, 2010, BIOCHEMISTRY-US, V49, P2925, DOI 10.1021/bi9021439; Zhao RB, 2009, J BIOL CHEM, V284, P4267, DOI 10.1074/jbc.M807665200	53	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78301	10.1371/journal.pone.0078301	http://dx.doi.org/10.1371/journal.pone.0078301			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205192	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300152
J	Hublin, JSYN; Ryan, U; Trengove, R; Maker, G				Hublin, Josephine S. Y. Ng; Ryan, Una; Trengove, Robert; Maker, Garth			Metabolomic Profiling of Faecal Extracts from Cryptosporidium parvum Infection in Experimental Mouse Models	PLOS ONE			English	Article							BENZOIC-ACID; GENOME; MICE; RESPONSES; OOCYSTS; RATS	Cryptosporidiosis is a gastrointestinal disease in humans and animals caused by infection with the protozoan parasite Cryptosporidium. In healthy individuals, the disease manifests mainly as acute self-limiting diarrhoea, but may be chronic and life threatening for those with compromised immune systems. Control and treatment of the disease is challenged by the lack of sensitive diagnostic tools and broad-spectrum chemotherapy. Metabolomics, or metabolite profiling, is an emerging field of study, which enables characterisation of the end products of regulatory processes in a biological system. Analysis of changes in metabolite patterns reflects changes in biochemical regulation, production and control, and may contribute to understanding the effects of Cryptosporidium infection in the host environment. In the present study, metabolomic analysis of faecal samples from experimentally infected mice was carried out to assess metabolite profiles pertaining to the infection. Gas-chromatography mass spectrometry (GC-MS) carried out on faecal samples from a group of C. parvum infected mice and a group of uninfected control mice detected a mean total of 220 compounds. Multivariate analyses showed distinct differences between the profiles of C. parvum infected mice and uninfected control mice, identifying a total of 40 compounds, or metabolites that contributed most to the variance between the two groups. These metabolites consisted of amino acids (n = 17), carbohydrates (n = 8), lipids (n = 7), organic acids (n = 3) and other various metabolites (n = 5), which showed significant differences in levels of metabolite abundance between the infected and uninfected mice groups (p < 0.05). The metabolites detected in this study as well as the differences in abundance between the C. parvum infected and the uninfected control mice, highlights the effects of the infection on intestinal permeability and the fate of the metabolites as a result of nutrient scavenging by the parasite to supplement its streamlined metabolism.	[Hublin, Josephine S. Y. Ng; Ryan, Una; Maker, Garth] Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA 6150, Australia; [Hublin, Josephine S. Y. Ng; Trengove, Robert] Murdoch Univ, Separat Sci & Metab Lab, Murdoch, WA 6150, Australia; [Trengove, Robert; Maker, Garth] Murdoch Univ Node, Metab Australia, Perth, WA, Australia	Murdoch University; Murdoch University; Murdoch University	Hublin, JSYN (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA 6150, Australia.	J.Ng-Hublin@outlook.com	Maker, Garth/T-6222-2019	Ryan, Una/0000-0003-2710-9324; Maker, Garth/0000-0003-1666-9377; Trengove, Robert/0000-0003-2454-0477	NCRIS Bioplatforms Australia	NCRIS Bioplatforms Australia	Financial support was provided by NCRIS Bioplatforms Australia. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; BRIDGES JW, 1970, BIOCHEM J, V118, P47, DOI 10.1042/bj1180047; Capet C, 1999, EXP PARASITOL, V91, P119, DOI 10.1006/expr.1998.4358; Ehrenman K, 2013, CELL MICROBIOL, V15, P1182, DOI 10.1111/cmi.12107; Fall A, 2003, J PARASITOL, V89, P399, DOI 10.1645/0022-3395(2003)089[0399:MINART]2.0.CO;2; Fayer R, 2000, INT J PARASITOL, V30, P1305, DOI 10.1016/S0020-7519(00)00135-1; Fiehn O, 2001, COMP FUNCT GENOM, V2, P155, DOI 10.1002/cfg.82; Frltzler JM, 2007, EUKARYOT CELL, V6, P2018, DOI 10.1128/EC.00210-07; Gookin JL, 2002, J VET INTERN MED, V16, P12, DOI 10.1892/0891-6640(2002)016&lt;0012:HRTCI&gt;2.3.CO;2; Krahenbuhl L, 1997, HEPATOLOGY, V25, P278, DOI 10.1053/jhep.1997.v25.pm0009021934; Leav BA, 2003, CLIN INFECT DIS, V36, P903, DOI 10.1086/368194; Li JV, 2008, J PROTEOME RES, V7, P3948, DOI 10.1021/pr800209d; Mauzy MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031715; Meloni BP, 1996, J PARASITOL, V82, P757, DOI 10.2307/3283888; Ng JSY, 2012, MOL BIOCHEM PARASIT, V185, P145, DOI 10.1016/j.molbiopara.2012.08.006; Rider SD, 2010, EXP PARASITOL, V124, P2, DOI 10.1016/j.exppara.2008.12.014; Rossignol JF, 2010, EXP PARASITOL, V124, P45, DOI 10.1016/j.exppara.2009.07.005; Saric J, 2008, J PROTEOME RES, V7, P352, DOI 10.1021/pr070340k; Scheltema RA, 2010, PARASITOLOGY, V137, P1291, DOI 10.1017/S0031182009992022; Topouchian A, 2005, PARASITOL RES, V96, P326, DOI 10.1007/s00436-005-1369-8; Topouchian A, 2003, PARASITOL RES, V91, P197, DOI 10.1007/s00436-003-0956-9; Vanee N, 2010, CHEM BIODIVERS, V7, P1026, DOI 10.1002/cbdv.200900323; Vejchapipat P, 2000, J PEDIATR SURG, V35, P759, DOI 10.1053/jpsu.2000.6062; Wang YL, 2004, P NATL ACAD SCI USA, V101, P12676, DOI 10.1073/pnas.0404878101; Watson DG, 2010, PARASITOLOGY, V137, P1409, DOI 10.1017/S0031182009991648; WEBER R, 1991, J CLIN MICROBIOL, V29, P1323, DOI 10.1128/JCM.29.7.1323-1327.1991; Xiao Lihua, 2007, P119; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977; Xu T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S11-S13; Zhu Guan, 2007, P57, DOI 10.1201/9781420052275.ch3	31	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77803	10.1371/journal.pone.0077803	http://dx.doi.org/10.1371/journal.pone.0077803			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204976	Green Published, gold			2022-12-27	WOS:000326029300115
J	Lapp, SA; Korir-Morrison, C; Jiang, JL; Bai, YH; Corredor, V; Galinski, MR				Lapp, Stacey A.; Korir-Morrison, Cindy; Jiang, Jianlin; Bai, Yaohui; Corredor, Vladimir; Galinski, Mary R.			Spleen-Dependent Regulation of Antigenic Variation in Malaria Parasites: Plasmodium knowlesi SICAvar Expression Profiles in Splenic and Asplenic Hosts	PLOS ONE			English	Article							VARIANT SURFACE-ANTIGENS; FALCIPARUM-VAR GENES; DEEP VASCULAR SCHIZOGONY; INFECTED ERYTHROCYTES; MEMBRANE; IDENTIFICATION; FAMILY; PROTEINS; REVEALS; CYTOADHERENCE	Background: Antigenic variation by malaria parasites was first described in Plasmodium knowlesi, which infects humans and macaque monkeys, and subsequently in P. falciparum, the most virulent human parasite. The schizont-infected cell agglutination (SICA) variant proteins encoded by the SICAvar multigene family in P. knowlesi, and Erythrocyte Membrane Protein-1 (EMP-1) antigens encoded by the SICAvar multigene family in P. falciparum, are expressed at the surface of infected erythrocytes, are associated with virulence, and serve as determinants of naturally acquired immunity. A parental P. knowlesi clone, Pk1(A+), and a related progeny clone, Pk1(B+)1+, derived by an in vivo induced variant antigen switch, were defined by the expression of distinct SICA variant protein doublets of 210/190 and 205/200 kDa, respectively. Passage of SICA[+] infected erythrocytes through splenectomized rhesus monkeys results in the SICA[-] phenotype, defined by the lack of surface expression and agglutination with variant specific antisera. Principal Findings: We have investigated SICAvar RNA and protein expression in Pk1(A+), Pk1(B+) 1+, and SICA[-] parasites. The Pk1(A+) and Pk1(B+) 1+ parasites express different distinct SICAvar transcript and protein repertoires. By comparison, SICA[-] parasites are characterized by a vast reduction in SICAvar RNA expression, the lack of full-length SICAvar transcript signals on northern blots, and correspondingly, the absence of any SICA protein detected by mass spectrometry. Significance: SICA protein expression may be under transcriptional as well as post-transcriptional control, and we show for the first time that the spleen, an organ central to blood-stage immunity in malaria, exerts an influence on these processes. Furthermore, proteomics has enabled the first in-depth characterization of SICA[+] protein phenotypes and we show that the in vivo switch from Pk1(A+) to Pk1(B+) 1+ parasites resulted in a complete change in SICA profiles. These results emphasize the importance of studying antigenic variation in the context of the host environment.	[Lapp, Stacey A.; Korir-Morrison, Cindy; Jiang, Jianlin; Bai, Yaohui; Galinski, Mary R.] Emory Univ, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Corredor, Vladimir] Univ Nacl Colombia, Fac Med, Dept Salud Publ, Bogota, Colombia; [Galinski, Mary R.] Emory Univ, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA	Emory University; Universidad Nacional de Colombia; Emory University	Galinski, MR (corresponding author), Emory Univ, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.	Mary.Galinski@gmail.com		CORREDOR, Vladimir/0000-0002-8597-8125	US National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [R01 R01-AI065961, HHSN272201200031C]; National Center for Research Resources [P51RR165]; Office of Research Infrastructure Programs/OD [P51OD11132]; Emory Center for AIDS Research [P30 AI050409]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409, R01AI065961] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	US National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs/OD; Emory Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was funded in whole or in part by federal funds from the US National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under grant # R01 R01-AI065961 and contract # HHSN272201200031C and supported by the National Center for Research Resources P51RR165 and the Office of Research Infrastructure Programs/OD P51OD11132. Some qRT-PCR experiments were outsourced to the CFAR Core Service Center, which is funded by the Emory Center for AIDS Research (P30 AI050409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinyi S, 2012, MOL MICROBIOL, V84, P816, DOI 10.1111/j.1365-2958.2012.08060.x; Al-Khedery B, 1999, MOL CELL, V3, P131, DOI 10.1016/S1097-2765(00)80304-4; ALEY SB, 1984, MOL BIOCHEM PARASIT, V12, P69, DOI 10.1016/0166-6851(84)90045-8; Amulic B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000256; Arnot DE, 2011, ADV APPL MICROBIOL, V74, P77, DOI 10.1016/B978-0-12-387022-3.00007-0; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bachmann A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049540; Bachmann A, 2011, CELL MICROBIOL, V13, P1397, DOI 10.1111/j.1462-5822.2011.01629.x; Bachmann A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007459; BARNWELL JW, 1982, J IMMUNOL, V128, P224; BARNWELL JW, 1983, CIBA F SYMP, V94, P117; BARNWELL JW, 1983, INFECT IMMUN, V40, P985, DOI 10.1128/IAI.40.3.985-994.1983; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; BIGGS BA, 1992, J IMMUNOL, V149, P2047; Blomqvist K, 2010, MOL BIOCHEM PARASIT, V170, P74, DOI 10.1016/j.molbiopara.2009.12.002; Borst P, 2006, NATURE, V439, P926, DOI 10.1038/439926b; Borst P, 2002, CELL, V109, P5, DOI 10.1016/S0092-8674(02)00711-0; BORST P, 1995, CELL, V82, P1, DOI 10.1016/0092-8674(95)90044-6; Braks JAM, 2008, NUCLEIC ACIDS RES, V36, P1176, DOI 10.1093/nar/gkm1142; Broadbent KM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r56; BROWN KN, 1965, NATURE, V208, P1286, DOI 10.1038/2081286a0; BROWN KN, 1974, T ROY SOC TROP MED H, V68, P139, DOI 10.1016/0035-9203(74)90187-4; BROWN KN, 1973, NATURE, V242, P49, DOI 10.1038/242049a0; Calderwood MS, 2003, J BIOL CHEM, V278, P34125, DOI 10.1074/jbc.M213065200; Corredor V, 2004, MOL BIOCHEM PARASIT, V138, P37, DOI 10.1016/j.molbiopara.2004.05.017; Cortes A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002943; Daily JP, 2005, J INFECT DIS, V191, P1196, DOI 10.1086/428289; DAVID PH, 1983, P NATL ACAD SCI-BIOL, V80, P5075, DOI 10.1073/pnas.80.16.5075; Deitsch KW, 2012, P NATL ACAD SCI USA, V109, P10130, DOI 10.1073/pnas.1207174109; Deitsch KW, 2001, NATURE, V412, P875, DOI 10.1038/35091146; Demar M, 2004, AM J TROP MED HYG, V71, P290, DOI 10.4269/ajtmh.2004.71.290; DESOWITZ RS, 1969, T ROY SOC TROP MED H, V63, P198, DOI 10.1016/0035-9203(69)90147-3; Dzikowski R, 2009, CURR GENET, V55, P103, DOI 10.1007/s00294-009-0233-2; Eaton MD, 1938, J EXP MED, V67, P857, DOI 10.1084/jem.67.6.857; Epp C, 2009, RNA, V15, P116, DOI 10.1261/rna.1080109; Fastman Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034168; Frank M, 2010, WIEN KLIN WOCHENSCHR, V122, P7, DOI 10.1007/s00508-010-1326-0; Frech C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-427; Fried M, 2004, PROTEOMICS, V4, P1086, DOI 10.1002/pmic.200300666; Galinski MR, 2004, MOL BIOCHEM PARASIT, V134, P17, DOI 10.1016/j.molbiopara.2003.09.013; Gatton ML, 2003, TRENDS PARASITOL, V19, P202, DOI 10.1016/S1471-4922(03)00067-9; Guizetti J, 2013, CELL MICROBIOL, V15, P718, DOI 10.1111/cmi.12115; HANDUNNETTI SM, 1987, J EXP MED, V165, P1269, DOI 10.1084/jem.165.5.1269; HOMMEL M, 1983, J EXP MED, V157, P1137, DOI 10.1084/jem.157.4.1137; HOWARD RJ, 1984, J CELL BIOCHEM, V24, P297, DOI 10.1002/jcb.240240310; HOWARD RJ, 1984, PHILOS T R SOC B, V307, P141, DOI 10.1098/rstb.1984.0115; HOWARD RJ, 1988, MOL BIOCHEM PARASIT, V27, P207, DOI 10.1016/0166-6851(88)90040-0; HOWARD RJ, 1985, PARASITOLOGY, V91, P245, DOI 10.1017/S0031182000057346; HOWARD RJ, 1983, P NATL ACAD SCI-BIOL, V80, P4129, DOI 10.1073/pnas.80.13.4129; HOWARD RJ, 1984, PARASITOLOGY, V88, P27, DOI 10.1017/S0031182000054317; Hviid L, 2010, HUM VACCINES, V6, P84, DOI 10.4161/hv.6.1.9602; Jiang LB, 2013, NATURE, V499, P223, DOI 10.1038/nature12361; Joergensen L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001083; Kaestli M, 2004, J INFECT DIS, V189, P1942, DOI 10.1086/383250; Korir CC, 2006, INFECT GENET EVOL, V6, P75, DOI 10.1016/j.meegid.2005.01.003; Kyes SA, 1999, P NATL ACAD SCI USA, V96, P9333, DOI 10.1073/pnas.96.16.9333; Kyes SA, 2007, EUKARYOT CELL, V6, P1511, DOI 10.1128/EC.00173-07; Lapp SA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-181; Leech J H, 1984, Prog Clin Biol Res, V155, P63; LEECH JH, 1984, J CELL BIOL, V98, P1256, DOI 10.1083/jcb.98.4.1256; LEECH JH, 1984, J EXP MED, V159, P1567, DOI 10.1084/jem.159.6.1567; Mair GR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000767; Melcher M, 2010, CELL MICROBIOL, V12, P1446, DOI 10.1111/j.1462-5822.2010.01481.x; Merrick CJ, 2012, J INFECT DIS, V205, P1593, DOI 10.1093/infdis/jis239; MILLER LH, 1971, AM J TROP MED HYG, V20, P816, DOI 10.4269/ajtmh.1971.20.816; Mitsui H, 2010, GENE, V450, P32, DOI 10.1016/j.gene.2009.10.001; Mok BW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001982; Munasinghe A, 2009, SCAND J INFECT DIS, V41, P538, DOI 10.1080/00365540902971195; Pain A, 2008, NATURE, V455, P799, DOI 10.1038/nature07306; Patankar S, 2001, MOL BIOL CELL, V12, P3114, DOI 10.1091/mbc.12.10.3114; Peng JM, 2001, J MASS SPECTROM, V36, P1083, DOI 10.1002/jms.229; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Peters J, 2002, P NATL ACAD SCI USA, V99, P10689, DOI 10.1073/pnas.162349899; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; RUDZINSKA MA, 1968, J PROTOZOOL, V15, P73, DOI 10.1111/j.1550-7408.1968.tb02091.x; Shock JL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r134; Sierra-Miranda M, 2012, MOL BIOCHEM PARASIT, V185, P36, DOI 10.1016/j.molbiopara.2012.06.005; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Staalsoe T, 2002, J INFECT DIS, V186, P719, DOI 10.1086/342390; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Urban BC, 2005, INFECT IMMUN, V73, P1986, DOI 10.1128/IAI.73.4.1986-1994.2005; Vargas-Serrato E, 2003, INFECT GENET EVOL, V3, P67, DOI 10.1016/S1567-1348(03)00007-8; Wang CW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-147; Wang CW, 2009, PARASITOL INT, V58, P478, DOI 10.1016/j.parint.2009.07.004; Wunderlich Gerhard, 2005, Rev. Inst. Med. trop. S. Paulo, V47, P195, DOI 10.1590/S0036-46652005000400004	85	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78014	10.1371/journal.pone.0078014	http://dx.doi.org/10.1371/journal.pone.0078014			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205067	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300133
J	Liu, GB; Liu, RZ; Li, QQ; Tang, XH; Yu, M; Li, XY; Cao, JH; Zhao, SH				Liu, Guangbin; Liu, Ruize; Li, Qinqun; Tang, Xiaohui; Yu, Mei; Li, Xinyun; Cao, Jianhua; Zhao, Shuhong			Identification of microRNAs in Wool Follicles during Anagen, Catagen, and Telogen Phases in Tibetan Sheep	PLOS ONE			English	Article							HAIR CYCLE; DIFFERENTIATION; STEM; EXPRESSION; ACTIVATION; PREDICTION; MECHANISM; EPIDERMIS; PROGRAMS; MIRBASE	Background: Wool quality is one of the most important economic traits in sheep. The wool fiber is derived from specialized skin cells that are referred to as wool follicles. To understand the roles of microRNAs (miRNAs) in wool fiber growth, we detected the expression patterns of miRNAs in wool follicles at the anagen, catagen, and telogen stages from Tibetan sheep through Solexa sequencing. Results: A total of 244 mature miRNAs were identified. Of these, only five miRNAs are listed in the database of sheep miRNAs (miRBase Database V19), and the other 239 miRNAs have not been previously described in this species. Further analyses indicated that 204 miRNAs are evolutionarily conserved among mammal species, whereas 35 of the identified miRNAs were first found specifically in sheep. The expression pattern analyses showed that the expression levels of 39, 34, and 20 of the miRNAs significantly change between anagen and catagen, between anagen and telogen, and between catagen and telogen, respectively. The results of the bioinformatics analysis show that these differentially expressed miRNAs might regulate wool follicle development by targeting genes in many different pathways, such as the MAPK and Wnt pathways, as well as the pathways that regulate the actin cytoskeleton, focal adhesion, and tight junctions. Furthermore, we identified six differentially expressed miRNAs (oar-miR-103-3P, oar-miR-148b-3P, oar-miR-320-3P, oar-miR-31-5P, oar-novel-1-5P, and oar-novel-2-3P) that might target the key genes of the Wnt pathway. It has been reported that the Wnt pathway is critical for wool follicle development. Therefore, these miRNAs may regulate wool development through the Wnt pathway. Conclusions: Our results provide new information on the identification and expression pattern of miRNAs in wool follicles. Our data might therefore aid in the understanding of the mechanisms of wool follicle development in sheep.	[Liu, Guangbin; Liu, Ruize; Li, Qinqun; Yu, Mei; Li, Xinyun; Cao, Jianhua; Zhao, Shuhong] Huazhong Agr Univ, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Hubei, Peoples R China; [Tang, Xiaohui] Agr & Anim Husb Coll Tibet, Linzhi, Tibet, Peoples R China	Huazhong Agricultural University; Tibet Agriculture & Animal Husbandry University	Cao, JH (corresponding author), Huazhong Agr Univ, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Hubei, Peoples R China.	jhcao@mail.hzau.edu.cn; shzhao@mail.hzau.edu.cn			National Program of Transgenic Variety Development of China [2011ZX08009-004]; National Natural Science Foundation of China [30960163]	National Program of Transgenic Variety Development of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant (2011ZX08009-004) from the National Program of Transgenic Variety Development of China and Regional project of the National Natural Science Foundation (30960163) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Aubin-Houzelstein G, 2012, ADV EXP MED BIOL, V727, P142, DOI 10.1007/978-1-4614-0899-4_11; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Celso CL, 2004, DEVELOPMENT, V131, P1787, DOI DOI 10.1242/DEV.01052.PUBMED:15084463; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Duan HH, 2010, TOXICOL IN VITRO, V24, P928, DOI 10.1016/j.tiv.2009.11.013; Foitzik K, 2000, FASEB J, V14, P752, DOI 10.1096/fasebj.14.5.752; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo SL, 2011, INT J BIOL SCI, V7, P567, DOI 10.7150/ijbs.7.567; He Y, 2012, CELL SIGNAL; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Hung PS, 2010, J DENT RES, V89, P252, DOI 10.1177/0022034509357411; Iyer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044789; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kukreja RC, 2011, MOL PHARMACOL, V80, P558, DOI 10.1124/mol.111.073528; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lin HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019135; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mardaryev AN, 2010, FASEB J, V24, P3869, DOI 10.1096/fj.10-160663; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Moncini S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020038; Niemann C, 2002, DEVELOPMENT, V129, P95; Ning MS, 2012, CELL MOL LIFE SCI, P1; Park PJ, 2012, LIFE SCI; Petersson M, 2011, EMBO J, V30, P3004, DOI 10.1038/emboj.2011.199; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rogers GE, 2006, EXP DERMATOL, V15, P931, DOI 10.1111/j.1600-0625.2006.00512.x; Rusca Nicole, 2011, Mol Biol Int, V2011, P437301, DOI 10.4061/2011/437301; Schoolmeesters A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005605; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Van Mater D, 2003, GENE DEV, V17, P1219, DOI 10.1101/gad.1076103; Wu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045761; Wu ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045825; Yang GH, 2009, J CELL BIOCHEM, V107, P548, DOI 10.1002/jcb.22156; Yang LL, 2012, J EXP MED, V209, P1655, DOI 10.1084/jem.20112218; Zhang Y, 2008, DEVELOPMENT, V135, P2161, DOI 10.1242/dev.017459; ZHOU PB, 1995, GENE DEV, V9, P700, DOI 10.1101/gad.9.6.700	49	27	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77801	10.1371/journal.pone.0077801	http://dx.doi.org/10.1371/journal.pone.0077801			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24204975	gold, Green Published, Green Submitted			2022-12-27	WOS:000326022200077
J	Herold, C; Ramirez, A; Drichel, D; Lacour, A; Vaitsiakhovich, T; Nothen, MM; Jessen, F; Maier, W; Becker, T				Herold, Christine; Ramirez, Alfredo; Drichel, Dmitriy; Lacour, Andre; Vaitsiakhovich, Tatsiana; Noethen, Markus M.; Jessen, Frank; Maier, Wolfgang; Becker, Tim			A One-Degree-of-Freedom Test for Supra-Multiplicativity of SNP Effects	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ALZHEIMERS-DISEASE; MISSING HERITABILITY; IDENTIFIES VARIANTS; COMMON VARIANTS; LIABILITY; INTERSNP; MODELS; ONSET; CD2AP	Deviation from multiplicativity of genetic risk factors is biologically plausible and might explain why Genome-wide association studies (GWAS) so far could unravel only a portion of disease heritability. Still, evidence for SNP-SNP epistasis has rarely been reported, suggesting that 2-SNP models are overly simplistic. In this context, it was recently proposed that the genetic architecture of complex diseases could follow limiting pathway models. These models are defined by a critical risk allele load and imply multiple high-dimensional interactions. Here, we present a computationally efficient one-degree-of-freedom "supra-multiplicativity-test" (SMT) for SNP sets of size 2 to 500 that is designed to detect risk alleles whose joint effect is fortified when they occur together in the same individual. Via a simulation study we show that the SMT is powerful in the presence of threshold models, even when only about 30-45% of the model SNPs are available. In addition, we demonstrate that the SMT outperforms standard interaction analysis under recessive models involving just a few SNPs. We apply our test to 10 consensus Alzheimer's disease (AD) susceptibility SNPs that were previously identified by GWAS and obtain evidence for supra-multiplicativity (p = 0.008) that is not attributable to either two-way or three-way interaction.	[Herold, Christine; Drichel, Dmitriy; Lacour, Andre; Jessen, Frank; Maier, Wolfgang; Becker, Tim] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Herold, Christine] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Vaitsiakhovich, Tatsiana; Becker, Tim] Univ Bonn, Inst Med Biometry Informat & Epidemiol, Bonn, Germany; [Ramirez, Alfredo; Jessen, Frank; Maier, Wolfgang] Univ Bonn, Dept Psychiat & Psychotherapy, Bonn, Germany; [Ramirez, Alfredo; Noethen, Markus M.] Univ Bonn, Inst Human Genet, Bonn, Germany; [Noethen, Markus M.] Univ Bonn, Dept Genom, Life & Brain Ctr, Bonn, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Harvard University; Harvard T.H. Chan School of Public Health; University of Bonn; University of Bonn; University of Bonn; University of Bonn	Becker, T (corresponding author), German Ctr Neurodegenerat Dis DZNE, Bonn, Germany.	Tim.Becker@dzne.de	Ramirez, Alfredo/S-5126-2019; Jessen, Frank/AAK-6170-2020	Ramirez, Alfredo/0000-0003-4991-763X; Nothen, Markus/0000-0002-8770-2464; Lacour, Andre/0000-0003-2692-2583; Drichel, Dmitriy/0000-0001-5978-3458; Becker, Tim/0000-0002-6573-1109	Deutsche Forschungsgemeinschaft [BE 3828/3-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	TV was supported by the Deutsche Forschungsgemeinschaft grant BE 3828/3-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Clayton D, 2012, GENET EPIDEMIOL, V36, P409, DOI 10.1002/gepi.21635; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; FALCONER DS, 1967, ANN HUM GENET, V31, P1; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Herold C, 2012, HUM HERED, V73, P63, DOI 10.1159/000336196; Herold C, 2009, BIOINFORMATICS, V25, P3275, DOI 10.1093/bioinformatics/btp596; Hindorffi L, 2012, CATALOG PUBLISHED GE; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Li XY, 2012, BEHAV GENET, V42, P268, DOI 10.1007/s10519-011-9506-x; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mechanic LE, 2012, GENET EPIDEMIOL, V36, P22, DOI 10.1002/gepi.20652; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Phillips PC, 1998, GENETICS, V149, P1167; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; THOMPSON WD, 1991, J CLIN EPIDEMIOL, V44, P221, DOI 10.1016/0895-4356(91)90033-6; Wan XA, 2010, AM J HUM GENET, V87, P325, DOI 10.1016/j.ajhg.2010.07.021; Wray NR, 2010, GENOME MED, V2, DOI 10.1186/gm131; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	24	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78038	10.1371/journal.pone.0078038	http://dx.doi.org/10.1371/journal.pone.0078038			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205078	Green Submitted, gold, Green Published			2022-12-27	WOS:000326334500091
J	Hyde, ER; Haarmann, DP; Lynne, AM; Bucheli, SR; Petrosino, JF				Hyde, Embriette R.; Haarmann, Daniel P.; Lynne, Aaron M.; Bucheli, Sibyl R.; Petrosino, Joseph F.			The Living Dead: Bacterial Community Structure of a Cadaver at the Onset and End of the Bloat Stage of Decomposition	PLOS ONE			English	Article							ACCUMULATED DEGREE-DAYS; TIME; INDICATOR	Human decomposition is a mosaic system with an intimate association between biotic and abiotic factors. Despite the integral role of bacteria in the decomposition process, few studies have catalogued bacterial biodiversity for terrestrial scenarios. To explore the microbiome of decomposition, two cadavers were placed at the Southeast Texas Applied Forensic Science facility and allowed to decompose under natural conditions. The bloat stage of decomposition, a stage easily identified in taphonomy and readily attributed to microbial physiology, was targeted. Each cadaver was sampled at two time points, at the onset and end of the bloat stage, from various body sites including internal locations. Bacterial samples were analyzed by pyrosequencing of the 16S rRNA gene. Our data show a shift from aerobic bacteria to anaerobic bacteria in all body sites sampled and demonstrate variation in community structure between bodies, between sample sites within a body, and between initial and end points of the bloat stage within a sample site. These data are best not viewed as points of comparison but rather additive data sets. While some species recovered are the same as those observed in culture-based studies, many are novel. Our results are preliminary and add to a larger emerging data set; a more comprehensive study is needed to further dissect the role of bacteria in human decomposition.	[Hyde, Embriette R.; Petrosino, Joseph F.] Baylor Coll Med, Alkek Ctr Metagen & Microbiome Res, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Haarmann, Daniel P.; Lynne, Aaron M.; Bucheli, Sibyl R.] Sam Houston State Univ, Dept Biol Sci, Huntsville, TX 77340 USA	Baylor College of Medicine; Texas State University System; Sam Houston State University	Bucheli, SR (corresponding author), Sam Houston State Univ, Dept Biol Sci, Huntsville, TX 77340 USA.	bucheli@shsu.edu	Petrosino, Joseph F./AAF-1621-2019		Sam Houston State University; Baylor College of Medicine through the Alkek Foundation	Sam Houston State University; Baylor College of Medicine through the Alkek Foundation	Funding for this project was provided by Sam Houston State University in the form of an Enhancement Research Grant and by Baylor College of Medicine through the Alkek Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; Butzbach DM, 2013, J FORENSIC SCI, V58, P90, DOI 10.1111/j.1556-4029.2012.02280.x; Byrd JH, 2000, INSECTS FORENSIC IMP, P43; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carter DO, 2008, FACULTY PUBLICATIONS; Catts EP, 1990, ENTOMOLOGY DEATH PRO; Dickson GC, 2011, FORENSIC SCI INT, V209, P1, DOI 10.1016/j.forsciint.2010.10.016; Evans W.E.D, 1963, CHEM DEATH; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x; Galloway A, 1996, PROCESS DECOMPOSITIO; Haskell N. H., 2008, ENTOMOLOGY DEATH PRO; HEWADIKARAM KA, 1991, AM J FOREN MED PATH, V12, P235, DOI 10.1097/00000433-199109000-00013; Hopkins DW, 2000, APPL SOIL ECOL, V14, P283, DOI 10.1016/S0929-1393(00)00063-9; Howard GT, 2010, INT BIODETER BIODEGR, V64, P300, DOI 10.1016/j.ibiod.2010.02.006; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Janaway Robert C., 2009, P313, DOI 10.1007/978-1-59745-327-1_14; Kakizaki E, 2008, FORENSIC SCI INT, V176, P236, DOI 10.1016/j.forsciint.2007.09.018; Lamendella R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-103; Lenz EJ, 2010, J FORENSIC SCI, V55, P1437, DOI 10.1111/j.1556-4029.2010.01464.x; Lindgren NK, 2011, FORENSIC SCI INT, V204, pE1, DOI 10.1016/j.forsciint.2010.05.016; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Megyesi MS, 2005, J FORENSIC SCI, V50, P618; MELVIN JR, 1984, J FORENSIC SCI, V29, P412; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Meyers MS, 2008, J FORENSIC SCI, V53, P652, DOI 10.1111/j.1556-4029.2008.00728.x; Michaud JP, 2011, J FORENSIC SCI, V56, P229, DOI 10.1111/j.1556-4029.2010.01559.x; Micozzi MS, 1996, FROZEN ENV SOFT TISS; Myburgh J, 2013, FORENSIC SCI INT, V229, DOI 10.1016/j.forsciint.2013.03.037; Ogden Cynthia L, 2004, Adv Data, P1; Parkinson RA, 2009, CRIMINAL AND ENVIRONMENTAL SOIL FORENSICS, P379, DOI 10.1007/978-1-4020-9204-6_24; Payen G, 1988, Acta Med Leg Soc (Liege), V38, P145; Pechal JL, 2014, INT J LEGAL MED, V128, P193, DOI 10.1007/s00414-013-0872-1; Petrosino JF, 2009, CLIN CHEM, V55, P856, DOI 10.1373/clinchem.2008.107565; Pless JE, 1996, POSTMORTEM CHANGES S; Schoenen D, 2013, FORENSIC SCI INT, V226, DOI 10.1016/j.forsciint.2013.01.023; Schoenly KG, 2006, AM BIOL TEACH, V68, P402, DOI 10.1662/0002-7685(2006)68[402:RDAITS]2.0.CO;2; Simmons T, 2010, J FORENSIC SCI, V55, P8, DOI 10.1111/j.1556-4029.2009.01206.x; Stearns JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00170; Stokes KL, 2013, J FORENSIC SCI, V58, P583, DOI 10.1111/1556-4029.12115; Stokes KL, 2009, FORENSIC SCI INT, V183, P6, DOI 10.1016/j.forsciint.2008.08.013; Tuomisto S, 2013, J FORENSIC SCI, V58, P910, DOI 10.1111/1556-4029.12124; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Vass A.A., 2001, MICROBIOL TODAY, V28, P190	45	128	138	2	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77733	10.1371/journal.pone.0077733	http://dx.doi.org/10.1371/journal.pone.0077733			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204941	Green Published, gold, Green Submitted			2022-12-27	WOS:000326334500048
J	Mizuta, T; Ando, K; Uemura, T; Kawata, Y; Mizobata, T				Mizuta, Toshifumi; Ando, Kasumi; Uemura, Tatsuya; Kawata, Yasushi; Mizobata, Tomohiro			Probing the Dynamic Process of Encapsulation in Escherichia coli GroEL	PLOS ONE			English	Article							INDUCED ALLOSTERIC TRANSITIONS; INDUCED CONFORMATIONAL-CHANGES; SINGLE-RING MUTANT; CHAPERONIN GROEL; CIRCULAR PERMUTATION; CRYSTAL-STRUCTURE; KINETIC-ANALYSIS; EFFICIENT ENCAPSULATION; ANGSTROM RESOLUTION; APICAL DOMAIN	Kinetic analyses of GroE-assisted folding provide a dynamic sequence of molecular events that underlie chaperonin function. We used stopped-flow analysis of various fluorescent GroEL mutants to obtain details regarding the sequence of events that transpire immediately after ATP binding to GroEL and GroEL with prebound unfolded proteins. Characterization of GroEL CP86, a circularly permuted GroEL with the polypeptide ends relocated to the vicinity of the ATP binding site, showed that GroES binding and protection of unfolded protein from solution is achieved surprisingly early in the functional cycle, and in spite of greatly reduced apical domain movement. Analysis of fluorescent GroEL SR-1 and GroEL D398A variants suggested that among other factors, the presence of two GroEL rings and a specific conformational rearrangement of Helix M in GroEL contribute significantly to the rapid release of unfolded protein from the GroEL apical domain.	[Mizuta, Toshifumi; Ando, Kasumi; Kawata, Yasushi; Mizobata, Tomohiro] Grad Sch Engn, Dept Biotechnol, Tottori, Japan; [Uemura, Tatsuya; Kawata, Yasushi; Mizobata, Tomohiro] Tottori Univ, Grad Sch Med Sci, Dept Biomed Sci, Tottori 680, Japan	Tottori University	Mizobata, T (corresponding author), Grad Sch Engn, Dept Biotechnol, Tottori, Japan.	mizobata@bio.tottori-u.ac.jp	Mizobata, Tomohiro/V-6672-2019; Kawata, Yasushi/ABA-9608-2021	Mizobata, Tomohiro/0000-0002-7808-2099; Kawata, Yasushi/0000-0002-2744-1506	Japan Society for the Promotion of Science (JSPS) of Japan [22570119]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [22020025]; Faculty of Engineering, Tottori University; Venture Business Laboratory, Tottori University	Japan Society for the Promotion of Science (JSPS) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Faculty of Engineering, Tottori University; Venture Business Laboratory, Tottori University	This study was partially supported by a Grant-in-Aid for Scientific Research (C) (No. 22570119 to TM) from the Japan Society for the Promotion of Science (JSPS) of Japan, a Grant-in-Aid for Scientific Research on Priority Areas (No. 22020025 to YK) from The Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, and also by grants to TM from the Faculty of Engineering, Tottori University and the Venture Business Laboratory, Tottori University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BURSTON SG, 1995, J MOL BIOL, V249, P138, DOI 10.1006/jmbi.1995.0285; Chatellier J, 2000, J MOL BIOL, V304, P897, DOI 10.1006/jmbi.2000.4278; Chaudhry C, 2004, J MOL BIOL, V342, P229, DOI 10.1016/j.jmb.2004.07.015; Chen DH, 2013, CELL, V153, P1354, DOI 10.1016/j.cell.2013.04.052; Clare DK, 2012, CELL, V149, P113, DOI 10.1016/j.cell.2012.02.047; Cliff MJ, 2006, J BIOL CHEM, V281, P21266, DOI 10.1074/jbc.M601605200; Cliff MJ, 1999, J MOL BIOL, V293, P667, DOI 10.1006/jmbi.1999.3138; Fei X, 2013, P NATL ACAD SCI USA, V110, pE2958, DOI 10.1073/pnas.1311996110; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hayer-Hartl M, 2000, METH MOL B, V140, P127; Heinemann U, 1995, PROG BIOPHYS MOL BIO, V64, P121, DOI 10.1016/0079-6107(95)00013-5; Hennecke J, 1999, J MOL BIOL, V286, P1197, DOI 10.1006/jmbi.1998.2531; Horwich AL, 2009, Q REV BIOPHYS, V42, P83, DOI 10.1017/S0033583509004764; Iwakura M, 2000, NAT STRUCT BIOL, V7, P580, DOI 10.1038/76811; Kovacs E, 2010, J MOL BIOL, V396, P1271, DOI 10.1016/j.jmb.2009.11.074; KUBO T, 1993, J BIOL CHEM, V268, P19346; Lin Z, 2004, MOL CELL, V16, P23, DOI 10.1016/j.molcel.2004.09.003; Liu H, 2009, FEBS LETT, V583, P2365, DOI 10.1016/j.febslet.2009.06.027; Machida K, 2009, BBA-PROTEINS PROTEOM, V1794, P1344, DOI 10.1016/j.bbapap.2008.12.003; MILLER DM, 1992, BIOCHIM BIOPHYS ACTA, V1121, P286, DOI 10.1016/0167-4838(92)90158-A; MIZOBATA T, 1994, BBA-PROTEIN STRUCT M, V1209, P83, DOI 10.1016/0167-4838(94)90140-6; Mizobata T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026462; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poso D, 2004, J MOL BIOL, V338, P969, DOI 10.1016/j.jmb.2004.03.010; Ranson NA, 2001, CELL, V107, P869, DOI 10.1016/S0092-8674(01)00617-1; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Shtilerman M, 1999, SCIENCE, V284, P822, DOI 10.1126/science.284.5415.822; Taniguchi M, 2004, J BIOL CHEM, V279, P16368, DOI 10.1074/jbc.M311806200; Thirumalai D, 2001, ANNU REV BIOPH BIOM, V30, P245, DOI 10.1146/annurev.biophys.30.1.245; Tyagi NK, 2009, P NATL ACAD SCI USA, V106, P20264, DOI 10.1073/pnas.0911556106; Wang J, 2003, J MOL BIOL, V327, P843, DOI 10.1016/S0022-2836(03)00184-0; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Yifrach O, 1998, BIOCHEMISTRY-US, V37, P7083, DOI 10.1021/bi980370o; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001; Yifrach O, 2000, P NATL ACAD SCI USA, V97, P1521, DOI 10.1073/pnas.040449997; Yoshimi T, 2006, J BIOCHEM, V139, P407, DOI 10.1093/jb/mvj043	41	0	0	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78135	10.1371/journal.pone.0078135	http://dx.doi.org/10.1371/journal.pone.0078135			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205127	gold, Green Published, Green Submitted			2022-12-27	WOS:000326334500097
J	Vu, BG; Gourronc, FA; Bernlohr, DA; Schlievert, PM; Klingelhutz, AJ				Vu, Bao G.; Gourronc, Francoise A.; Bernlohr, David A.; Schlievert, Patrick M.; Klingelhutz, Aloysius J.			Staphylococcal Superantigens Stimulate Immortalized Human Adipocytes to Produce Chemokines	PLOS ONE			English	Article							TOXIC-SHOCK-SYNDROME; NECROSIS-FACTOR-ALPHA; INNATE IMMUNE-SYSTEM; INSULIN-RESISTANCE; ATOPIC-DERMATITIS; EPITHELIAL-CELLS; ADIPOSE-TISSUE; HLA-DR; AUREUS; OBESITY	Background: Human adipocytes may have significant functions in wound healing and the development of diabetes through production of pro-inflammatory cytokines after stimulation by gram-negative bacterial endotoxin. Diabetic foot ulcers are most often associated with staphylococcal infections. Adipocyte responses in the area of the wound may play a role in persistence and pathology. We studied the effect of staphylococcal superantigens (SAgs) on immortalized human adipocytes, alone and in the presence of bacterial endotoxin or staphylococcal alpha-toxin. Methodology/Principal Findings: Primary non-diabetic and diabetic human preadipocytes were immortalized by the reverse transcriptase component of telomerase (TERT) and the E6/E7 genes of human papillomavirus. The immortal cells were demonstrated to have properties of non-immortalized pre-adipocytes and could be differentiated into mature and functional adipocytes. Differentiated adipocytes exposed to staphylococcal SAgs produced robust levels of cytokines IL-6 and IL-8, but there were no significant differences in levels between the non-diabetic and diabetic cells. Cytokine production was increased by co-incubation of adipocytes with SAgs and endotoxin together. In contrast, alpha-toxin alone was cytotoxic at high concentrations, but, at sub-cytotoxic doses, did not stimulate production of IL-6 and IL-8. Conclusions/Significance: Endotoxin has been proposed to contribute to diabetes through enhanced insulin resistance after chronic exposure and stimulation of adipocytes to produce cytokines. Our data indicate staphylococcal SAgs TSST-1 and SEB alone and in combination with bacterial endotoxin also stimulate adipocytes to produce cytokines and thus may contribute to the inflammatory response found in chronic diabetic ulcers and in the systemic inflammation that is associated with the development and persistence of diabetes. The immortal human pre-adipocytes reported here will be useful for studies to understand further the mechanism by which toxins are involved in wound healing and the development and clinical manifestations of obesity and diabetes.	[Vu, Bao G.; Gourronc, Francoise A.; Schlievert, Patrick M.; Klingelhutz, Aloysius J.] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA; [Bernlohr, David A.] Univ Minnesota, Sch Med, Dept Biochem & Mol Biol Biophys, Minneapolis, MN 55455 USA	University of Iowa; University of Minnesota System; University of Minnesota Twin Cities	Klingelhutz, AJ (corresponding author), Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA.	aloysius-klingelhutz@uiowa.edu	Klingelhutz, Aloysius/L-9081-2018	Klingelhutz, Aloysius/0000-0003-4258-5046; Schlievert, Patrick/0000-0001-8314-9369	University of Iowa Department of Microbiology Development Grant; United States Public Health Service [AI074283]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084669] Funding Source: NIH RePORTER	University of Iowa Department of Microbiology Development Grant; United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a University of Iowa Department of Microbiology Development Grant (AJK) and United States Public Health Service research grant AI074283 (PMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia A, 2000, DIABETIC MED, V17, P487; Armani A, 2010, J CELL BIOCHEM, V110, P564, DOI 10.1002/jcb.22598; BERMAN DS, 1987, J INFECT DIS, V155, P829, DOI 10.1093/infdis/155.4.829-a; Bes-Houtmann S, 2007, HISTOCHEM CELL BIOL, V127, P131, DOI 10.1007/s00418-006-0230-1; BLOMSTERHAUTAMAA DA, 1988, METHOD ENZYMOL, V165, P37; Cani PD, 2008, PATHOL BIOL, V56, P305, DOI 10.1016/j.patbio.2007.09.008; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cheng HC, 2011, MOL BIOL REP, V38, P5161, DOI 10.1007/s11033-010-0665-2; CHINTAGUMPALA MM, 1991, J IMMUNOL, V147, P3876; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; Dali-Youcef N, 2013, ANN MED, V45, P242, DOI 10.3109/07853890.2012.705015; Darbro BW, 2006, ONCOGENE, V25, P7421, DOI 10.1038/sj.onc.1209729; Darimont C, 2003, CELL DEATH DIFFER, V10, P1025, DOI 10.1038/sj.cdd.4401273; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Dinges MM, 2001, INFECT IMMUN, V69, P7169, DOI 10.1128/IAI.69.11.7169-7172.2001; Gourronc FA, 2010, EXP DERMATOL, V19, P279, DOI 10.1111/j.1600-0625.2009.00916.x; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; HALBERT CL, 1991, J VIROL, V65, P473, DOI 10.1128/JVI.65.1.473-478.1991; Hanses F, 2011, ENDOCRINOLOGY, V152, P4148, DOI 10.1210/en.2011-0103; Henry SL, 2012, INT J BIOCHEM CELL B, V44, P435, DOI 10.1016/j.biocel.2011.12.011; Hoch M, 2008, CYTOKINE, V41, P29, DOI 10.1016/j.cyto.2007.10.008; Kim SJ, 2012, J NUTR BIOCHEM, V23, P113, DOI 10.1016/j.jnutbio.2010.10.012; Kobayashi SD, 2011, J INFECT DIS, V204, P937, DOI 10.1093/infdis/jir441; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leyvraz C, 2010, DIABETES OBES METAB, V12, P195, DOI 10.1111/j.1463-1326.2009.01149.x; Lin YC, 2011, BIOCHEMISTRY-US, V50, P7157, DOI 10.1021/bi200435n; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; MARRACK P, 1990, SCIENCE, V248, P1066; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; Meijer K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017154; Nguyen MTA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034976; Peterson ML, 2005, INFECT IMMUN, V73, P2164, DOI 10.1128/IAI.73.4.2164-2174.2005; Piya MK, 2013, J ENDOCRINOL, V216, pT1, DOI 10.1530/JOE-12-0498; Poggi M, 2009, DIABETOLOGIA, V52, P1152, DOI 10.1007/s00125-009-1267-1; Poulos SP, 2010, EXP BIOL MED, V235, P1185, DOI 10.1258/ebm.2010.010063; Prevention CDC, 2011, NAT DIAB FACT SHEET; Purohit JS, 2013, OBESITY, V21, P737, DOI [10.1002/oby.20275, 10.1038/oby.2012.155]; ROODYN LEONARD, 1960, JOUR HYG, V58, P11; Schaffaler A, 2010, TRENDS IMMUNOL, V31, P228, DOI 10.1016/j.it.2010.03.001; Schlievert PM, 2008, CLIN INFECT DIS, V46, P1562, DOI 10.1086/586746; Schlievert PM, 2007, BIOCHEMISTRY-US, V46, P14349, DOI 10.1021/bi701202w; Schlievert PM, 2010, J ALLERGY CLIN IMMUN, V125, P39, DOI 10.1016/j.jaci.2009.10.039; SCHLIEVERT PM, 1982, INFECT IMMUN, V36, P123, DOI 10.1128/IAI.36.1.123-128.1982; SCHLIEVERT PM, 1982, ANN INTERN MED, V96, P937, DOI 10.7326/0003-4819-96-6-937; Schmidt BA, 2013, DEVELOPMENT, V140, P1517, DOI 10.1242/dev.087593; SCHOLL PR, 1989, J IMMUNOL, V143, P2583; Spaulding AR, 2013, CLIN MICROBIOL REV, V26, P422, DOI 10.1128/CMR.00104-12; Spaulding AR, 2012, VACCINE, V30, P5099, DOI 10.1016/j.vaccine.2012.05.067; Taura D, 2009, FEBS LETT, V583, P1029, DOI 10.1016/j.febslet.2009.02.031; Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x; Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109; TUAZON CU, 1975, JAMA-J AM MED ASSOC, V231, P1272, DOI 10.1001/jama.231.12.1272; WESTPHAL O, 1952, Z NATURFORSCH B, V7, P148, DOI 10.1515/znb-1952-0303; Wukich DK, 2013, FOOT ANKLE INT, V34, P351, DOI 10.1177/1071100712467980; Zabner J, 2003, AM J PHYSIOL-LUNG C, V284, pL844, DOI 10.1152/ajplung.00355.2002	55	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77988	10.1371/journal.pone.0077988	http://dx.doi.org/10.1371/journal.pone.0077988			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205055	Green Published, Green Submitted, gold			2022-12-27	WOS:000326334500085
J	Wang, YD; Chu, XW; Meng, XJ; Zou, F				Wang, Yadong; Chu, Xinwei; Meng, Xiaojing; Zou, Fei			Association of X-ray Repair Cross Complementing Group 1 Arg399Gln Polymorphisms with the Risk of Squamous Cell Carcinoma of the Head and Neck: Evidence from an Updated Meta-Analysis	PLOS ONE			English	Article							BASE-EXCISION-REPAIR; GENETIC POLYMORPHISMS; XRCC1 POLYMORPHISMS; LUNG-CANCER; DNA; SUSCEPTIBILITY; VARIANTS; SMOKING; PATHWAY; XPD	Background: Epidemiologic studies have reported the association of X-ray repair cross-complementary group 1 (XRCC1) Arg399Gln polymorphisms with susceptibility to squamous cell carcinoma of the head and neck (HNSCC). However, the results were conflictive rather than conclusive. The purpose of this study was to clarify the association of XRCC1 Arg399Gln variants with HNSCC risk. Methods: Systematic searches were performed through the search engines of PubMed, Elsevier, Science Direct, CNKI and Chinese Biomedical Literature Database. Summary odds ratio (OR) with 95% confidence intervals (CI) was computed to estimate the strength association. Results: Overall, we did not observe any association of XRCC1 Arg399Gln polymorphisms with HNSCC risk in total population (OR = 0.95, 95% CI: 0.76-1.19 for Gln/Gln vs. Arg/Arg, OR = 1.05, 95% CI: 0.92-1.20 for Arg/Gln vs. Arg/Arg, and OR = 1.03, 95% CI: 0.90-1.18 for Gln/Gln+Arg/Gln vs. Arg/Arg) based on 18 studies including 3917 cases and 4560 controls. In subgroup analyses, we observed an increased risk of XRCC1 399 Arg/Gln genotype for HNSCC in Caucasians (OR = 1.20, 95% CI: 1.00-1.44) and Gln/Gln genotype for larynx squamous cell carcinoma (OR = 1.63, 95% CI: 1.10-2.40). We did not observe any association between XRCC1 Arg399Gln variants and HNSCC risk in additional subgroup analyses. Conclusion: The results from this present meta-analysis suggest that XRCC1 Arg399Gln variants may contribute to HNSCC risk among Caucasians and to the risk of larynx squamous cell carcinoma. Further, well-designed studies with larger sample sizes are required to verify our findings.	[Wang, Yadong] Henan Ctr Dis Control & Prevent, Zhengzhou, Peoples R China; [Chu, Xinwei] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Nutr Hlth, Guangzhou, Guangdong, Peoples R China; [Wang, Yadong; Meng, Xiaojing; Zou, Fei] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Occupat Hlth & Occupat Med, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Zou, F (corresponding author), Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Occupat Hlth & Occupat Med, Guangzhou, Guangdong, Peoples R China.	zoufei0616@163.com			National Basic Research Program of China [2012CB518200]; National Nature Science Foundation of China [81272180]	National Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Basic Research Program of China (No. 2012CB518200) and National Nature Science Foundation of China (No. 81272180). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; Applebaum KM, 2009, INT J CANCER, V124, P2690, DOI 10.1002/ijc.24256; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bogela Aersilan, 2011, Journal of Xinjiang Medical University, V34, P1247; Csejtei A, 2009, ANTICANCER RES, V29, P4169; Demokan S, 2005, PATHOL ONCOL RES, V11, P22, DOI 10.1007/BF03032401; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; dos Reis MB, 2013, J ORAL PATHOL MED, V42, P180, DOI 10.1111/j.1600-0714.2012.01192.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Foulkes WD, 1996, BMJ-BRIT MED J, V313, P716, DOI 10.1136/bmj.313.7059.716; Gugatschka M, 2011, EXP MOL PATHOL, V91, P331, DOI 10.1016/j.yexmp.2011.03.004; Harth V, 2008, J TOXICOL ENV HEAL A, V71, P887, DOI 10.1080/15287390801988160; Huang GL, 2011, ASIAN PAC J CANCER P, V12, P2329; Jiang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055597; Khlifi R, 2012, J GENET, V91, P375, DOI 10.1007/s12041-012-0193-z; Kietthubthew S, 2006, INT J HYG ENVIR HEAL, V209, P21, DOI 10.1016/j.ijheh.2005.06.002; Kiyohara C, 2006, LUNG CANCER, V54, P267, DOI 10.1016/j.lungcan.2006.08.009; Kostrzewska-Poczekaj M, 2013, EUR ARCH OTO-RHINO-L, V270, P271, DOI 10.1007/s00405-012-1993-8; Kowalski M, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-37; Krupa R., 2011, Experimental Oncology, V33, P55; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Kumar A, 2012, MUTAT RES-FUND MOL M, V729, P24, DOI 10.1016/j.mrfmmm.2011.09.001; Li CY, 2007, CANCER-AM CANCER SOC, V110, P867, DOI 10.1002/cncr.22861; Li HH, 2009, BREAST, V18, P183, DOI 10.1016/j.breast.2009.03.008; Liu YF, 2013, STAT INTERFACE, V6, P1; Long XD, 2004, J GUANGXI MED U, V21, P313; Majumder M, 2007, INT J CANCER, V120, P2148, DOI 10.1002/ijc.22547; Olshan AF, 2002, CANCER LETT, V178, P181, DOI 10.1016/S0304-3835(01)00822-9; Salanti G, 2005, EUR J HUM GENET, V13, P840, DOI 10.1038/sj.ejhg.5201410; Shen MR, 1998, CANCER RES, V58, P604; Tae K, 2004, INT J CANCER, V111, P805, DOI 10.1002/ijc.20338; Thibaudeau E, 2013, INT J OTOLARYNGOL, V2013, P437815, DOI DOI 10.1155/2013/43781; Varzim G, 2003, EUR J CANCER PREV, V12, P495, DOI 10.1097/00008469-200312000-00008; Vidal AE, 2001, EMBO J, V20, P6530, DOI 10.1093/emboj/20.22.6530; Yang Yuan, 2008, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V25, P211; Yin JY, 2007, LUNG CANCER, V56, P153, DOI 10.1016/j.lungcan.2006.12.012; Yu HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041853; Zhang CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056294; Zhang YW, 2006, CANCER EPIDEM BIOMAR, V15, P353, DOI 10.1158/1055-9965.EPI-05-0653; Zienolddiny S, 2006, CARCINOGENESIS, V27, P560, DOI 10.1093/carcin/bgi232	40	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77898	10.1371/journal.pone.0077898	http://dx.doi.org/10.1371/journal.pone.0077898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205020	Green Published, gold, Green Submitted			2022-12-27	WOS:000326334500073
J	Choi, HF; Blemker, SS				Choi, Hon Fai; Blemker, Silvia S.			Skeletal Muscle Fascicle Arrangements Can Be Reconstructed Using a Laplacian Vector Field Simulation	PLOS ONE			English	Article							HUMAN LOWER-LIMB; FIBER TRACKING; IN-VIVO; ARCHITECTURE; REPRESENTATION; ORIENTATION; GEOMETRIES; MODELS	Skeletal muscles are characterized by a large diversity in anatomical architecture and function. Muscle force and contraction are generated by contractile fiber cells grouped in fascicle bundles, which transmit the mechanical action between origin and insertion attachments of the muscle. Therefore, an adequate representation of fascicle arrangements in computational models of skeletal muscles is important, especially when investigating three-dimensional muscle deformations in finite element models. However, obtaining high resolution in vivo measurements of fascicle arrangements in skeletal muscles is currently still challenging. This motivated the development of methods in previous studies to generate numerical representations of fascicle trajectories using interpolation templates. Here, we present an alternative approach based on the hypothesis of a rotation and divergence free (Laplacian) vector field behavior which reflects observed physical characteristics of fascicle trajectories. To obtain this representation, the Laplace equation was solved in anatomical reconstructions of skeletal muscle shapes based on medical images using a uniform flux boundary condition on the attachment areas. Fascicle tracts were generated through a robust flux based tracing algorithm. The concept of this approach was demonstrated in two-dimensional synthetic examples of typical skeletal muscle architectures. A detailed evaluation was performed in an example of the anatomical human tibialis anterior muscle which showed an overall agreement with measurements from the literature. The utility and capability of the proposed method was further demonstrated in other anatomical examples of human skeletal muscles with a wide range of muscle shapes and attachment morphologies.	[Choi, Hon Fai; Blemker, Silvia S.] Univ Virginia, Dept Mech & Aerosp Engn, Charlottesville, VA 22903 USA; [Blemker, Silvia S.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA	University of Virginia; University of Virginia	Blemker, SS (corresponding author), Univ Virginia, Dept Mech & Aerosp Engn, Charlottesville, VA 22903 USA.	ssblemker@virginia.edu	Blemker, Silvia/A-1661-2009		Belgian American Educational Foundation; National Institutes of Health [R01-AR056201]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056201] Funding Source: NIH RePORTER	Belgian American Educational Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Hon Fai Choi is a postdoctoral research fellow supported by the Belgian American Educational Foundation (www.BAEF.be). This work was also partially supported by the National Institutes of Health Grant R01-AR056201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agur AM, 2003, CLIN ANAT, V16, P285, DOI 10.1002/ca.10112; Arnold EM, 2011, PHILOS T R SOC B, V366, P1530, DOI 10.1098/rstb.2010.0345; Benard MR, 2009, MUSCLE NERVE, V39, P652, DOI 10.1002/mus.21287; Blemker SS, 2006, J BIOMECH, V39, P1383, DOI 10.1016/j.jbiomech.2005.04.012; Blemker SS, 2005, ANN BIOMED ENG, V33, P661, DOI 10.1007/s10439-005-1433-7; Dobrzynski C, 2008, PROCEEDINGS OF THE 17TH INTERNATIONAL MESHING ROUNDTABLE, P177, DOI 10.1007/978-3-540-87921-3_11; FRIEDERICH JA, 1990, J BIOMECH, V23, P91, DOI 10.1016/0021-9290(90)90373-B; Froeling M, 2012, J MAGN RESON IMAGING, V36, P237, DOI 10.1002/jmri.23608; Garabedian PR, 1966, PARTIAL DIFFERENTIAL; Geuzaine C, 2009, INT J NUMER METH ENG, V79, P1309, DOI 10.1002/nme.2579; Heemskerk AM, 2010, NMR BIOMED, V23, P294, DOI 10.1002/nbm.1463; Heemskerk AM, 2009, MAGN RESON MED, V61, P467, DOI 10.1002/mrm.21819; Holzapfel G., 2000, NONLINEAR SOLID MECH; Kermarrec E, 2010, AM J ROENTGENOL, V195, pW352, DOI 10.2214/AJR.09.3368; Kim SY, 2007, CLIN ANAT, V20, P648, DOI 10.1002/ca.20469; Klausen RA, 2012, COMPUTAT GEOSCI, V16, P261, DOI 10.1007/s10596-011-9256-0; Klimstra M, 2007, J ELECTROMYOGR KINES, V17, P504, DOI 10.1016/j.jelekin.2006.04.011; Lansdown DA, 2007, J APPL PHYSIOL, V103, P673, DOI 10.1152/japplphysiol.00290.2007; Leon LM, 2006, COMPUT METHOD BIOMEC, V20, P648; Levin DIW, 2011, MED IMAGE ANAL, V15, P340, DOI 10.1016/j.media.2011.01.005; Lu YT, 2011, COMPUT METHOD BIOMEC, V14, P1079, DOI 10.1080/10255842.2010.509100; Maganaris CN, 2006, J BIOMECH, V39, P1663, DOI 10.1016/j.jbiomech.2005.04.025; Marchandise E, 2011, INT J NUMER METH ENG, V86, P1303, DOI 10.1002/nme.3099; Marchandise E, 2010, INT J NUMER METH BIO, V26, P876, DOI 10.1002/cnm.1388; Muramatsu T, 2002, J APPL PHYSIOL, V92, P129, DOI 10.1152/jappl.2002.92.1.129; Netter FH, 2006, ATLAS HUMAN ANATOMY; Pandy MG, 2010, ANNU REV BIOMED ENG, V12, P401, DOI 10.1146/annurev-bioeng-070909-105259; Remacle JF, 2010, INT J NUMER METH ENG, V83, P403, DOI 10.1002/nme.2824; Standring S, 2008, GRAYS ANATOMY; Ward SR, 2009, CLIN ORTHOP RELAT R, V467, P1074, DOI 10.1007/s11999-008-0594-8; Weller HG, 1998, COMPUT PHYS, V12, P620, DOI 10.1063/1.168744; WICKIEWICZ TL, 1983, CLIN ORTHOP RELAT R, P275, DOI 10.1097/00003086-198310000-00042; Wu FTH, 2007, COMPUT METH PROG BIO, V88, P112, DOI 10.1016/j.cmpb.2007.07.012; Zienkiewicz OC, 2005, FINITE ELEMENT METHOD FOR FLUID DYNAMICS, 6TH EDITION, P1	34	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77576	10.1371/journal.pone.0077576	http://dx.doi.org/10.1371/journal.pone.0077576			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204878	Green Published, gold, Green Submitted			2022-12-27	WOS:000326155400044
J	Friedrich-Rust, M; Meyer, G; Dauth, N; Berner, C; Bogdanou, D; Herrmann, E; Zeuzem, S; Bojunga, J				Friedrich-Rust, Mireen; Meyer, Gesine; Dauth, Nina; Berner, Christian; Bogdanou, Dimitra; Herrmann, Eva; Zeuzem, Stefan; Bojunga, Joerg			Interobserver Agreement of Thyroid Imaging Reporting and Data System (TIRADS) and Strain Elastography for the Assessment of Thyroid Nodules	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; REAL-TIME ELASTOGRAPHY; ULTRASOUND ELASTOGRAPHY; DIFFERENTIAL-DIAGNOSIS; PREDICTING MALIGNANCY; US-ELASTOGRAPHY; CANCER-RISK; MANAGEMENT; BENIGN; METAANALYSIS	Background: Thyroid Imaging Reporting and Data System (TIRADS) was developed to improve patient management and cost-effectiveness by avoiding unnecessary fine needle aspiration biopsy (FNAB) in patients with thyroid nodules. However, its clinical use is still very limited. Strain elastography (SE) enables the determination of tissue elasticity and has shown promising results for the differentiation of thyroid nodules. Methods: The aim of the present study was to evaluate the interobserver agreement (IA) of TIRADS developed by Horvath et al. and SE. Three blinded observers independently scored stored images of TIRADS and SE in 114 thyroid nodules (114 patients). Cytology and/or histology was available for all benign (n = 99) and histology for all malignant nodules (n = 15). Results: The IA between the 3 observers was only fair for TIRADS categories 2-5 (Cohens kappa = 0.27, p = 0.000001) and TIRADS categories 2/3 versus 4/5 (ck = 0.25, p = 0.0020). The IA was substantial for SE scores 1-4 (ck = 0.66, p<0.000001) and very good for SE scores 1/2 versus 3/4 (ck = 0.81, p<0.000001). 92-100% of patients with TIRADS-2 had benign lesions, while 28-42% with TIRADS-5 had malignant cytology/histology. The negative-predictive-value (NPV) was 92-100% for TIRADS using TIRADS-categories 4&5 and 96-98% for SE using score ES-3&4 for the diagnosis of malignancy, respectively. However, only 11-42% of nodules were in TIRADS-categories 2&3, as compared to 58-60% with ES-1&2. Conclusions: IA of TIRADS developed by Horvath et al. is only fair. TIRADS and SE have high NPV for excluding malignancy in the diagnostic work-up of thyroid nodules.	[Friedrich-Rust, Mireen; Meyer, Gesine; Dauth, Nina; Berner, Christian; Bogdanou, Dimitra; Zeuzem, Stefan; Bojunga, Joerg] JW Goethe Univ Hosp, Dept Internal Med 1, Frankfurt, Germany; [Herrmann, Eva] Goethe Univ Frankfurt, Fac Med, Inst Biostat & Math Modelling, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt	Friedrich-Rust, M (corresponding author), JW Goethe Univ Hosp, Dept Internal Med 1, Frankfurt, Germany.	Mireen.Friedrich-Rust@kgu.de	Zeuzem, Stefan/AAE-7435-2019; Meyer, Gesine/ABD-7219-2021					Asteria C, 2008, THYROID, V18, P523, DOI 10.1089/thy.2007.0323; Bojunga J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042735; Bojunga J, 2010, THYROID, V20, P1145, DOI 10.1089/thy.2010.0079; Dietlein M, 2003, EUR J ENDOCRINOL, V148, P377, DOI 10.1530/eje.0.1480377; Ding JR, 2011, J ULTRAS MED, V30, P1259, DOI 10.7863/jum.2011.30.9.1259; Friedrich-Rust M, 2010, EXP CLIN ENDOCR DIAB, V118, P602, DOI 10.1055/s-0029-1237701; Gharib H, 2010, J ENDOCRINOL INVEST, V33, P1, DOI 10.4158/10024.GL; Hegedus L, 2004, NEW ENGL J MED, V351, P1764, DOI 10.1056/NEJMcp031436; Hong YR, 2009, J ULTRAS MED, V28, P861, DOI 10.7863/jum.2009.28.7.861; Horvath E, 2009, J CLIN ENDOCR METAB, V94, P1748, DOI 10.1210/jc.2008-1724; Iannuccilli JD, 2004, J ULTRAS MED, V23, P1455, DOI 10.7863/jum.2004.23.11.1455; Kwak JY, 2011, RADIOLOGY, V260, P892, DOI 10.1148/radiol.11110206; LAROSA GL, 1991, CANCER, V67, P2137, DOI 10.1002/1097-0142(19910415)67:8<2137::AID-CNCR2820670822>3.0.CO;2-Y; Lim DJ, 2012, AM J ROENTGENOL, V198, P896, DOI 10.2214/AJR.11.7009; Lippolis PV, 2011, J CLIN ENDOCR METAB, V96, pE1826, DOI 10.1210/jc.2011-1021; Lyshchik A, 2005, RADIOLOGY, V237, P202, DOI 10.1148/radiol.2363041248; Moon HJ, 2012, RADIOLOGY, V262, P1002, DOI 10.1148/radiol.11110839; Ning CP, 2012, EUR J RADIOL, V81, P286, DOI 10.1016/j.ejrad.2010.12.010; Oertel YC, 2007, THYROID, V17, P1061, DOI 10.1089/thy.2007.0159; Pacini F, 2006, EUR J ENDOCRINOL, V154, P787, DOI 10.1530/eje.1.02158; Park JY, 2009, THYROID, V19, P1257, DOI 10.1089/thy.2008.0021; Peng Y, 2008, DIAGN CYTOPATHOL, V36, P916, DOI 10.1002/dc.20943; Ragazzoni F, 2012, ULTRASOUND MED BIOL, V38, P1154, DOI 10.1016/j.ultrasmedbio.2012.02.025; Rago T, 2007, J CLIN ENDOCR METAB, V92, P2917, DOI 10.1210/jc.2007-0641; Reiners C, 2004, THYROID, V14, P926, DOI 10.1089/thy.2004.14.926; Rubaltelli L, 2009, ULTRASCHALL MED, V30, P175, DOI 10.1055/s-2008-1027442; Russ G, 2013, EUR J ENDOCRINOL, V168, P649, DOI 10.1530/EJE-12-0936; Smith BR, 2006, THYROID, V16, P109, DOI 10.1089/thy.2006.16.109; Tee YY, 2007, ANN SURG, V246, P714, DOI 10.1097/SLA.0b013e3180f61adc; Trimboli P, 2012, J CLIN ENDOCR METAB, V97, P4524, DOI 10.1210/jc.2012-2951; Unluturk U, 2012, THYROID, V22, P1031, DOI 10.1089/thy.2011.0502; Vorlander C, 2010, LANGENBECK ARCH SURG, V395, P865, DOI 10.1007/s00423-010-0685-3	32	50	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77927	10.1371/journal.pone.0077927	http://dx.doi.org/10.1371/journal.pone.0077927			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205031	Green Published, gold			2022-12-27	WOS:000326152300037
J	Huang, JG; Stadt, KJ; Dawson, A; Comeau, PG				Huang, Jian-Guo; Stadt, Kenneth J.; Dawson, Andria; Comeau, Philip G.			Modelling Growth-Competition Relationships in Trembling Aspen and White Spruce Mixed Boreal Forests of Western Canada	PLOS ONE			English	Article							LODGEPOLE PINE; BRITISH-COLUMBIA; INCREMENT MODEL; HEIGHT-GROWTH; LIGHT; UNDERSTORY; INDEXES; DIAMETER; AGE; MIXTURES	We examined the effect of competition on stem growth of Picea glauca and Populus tremuloides in boreal mixedwood stands during the stem exclusion stage. We combined traditional approaches of collecting competition data with dendrochronology to provide retrospective measurements of stem diameter growth. Several competition indices including stand basal area (BA), the sum of stem diameter at breast height (SDBH), and density (N) for the broadleaf and coniferous species, as well as similar indices considering only trees with diameters greater than each subject (BAGR, SDBHGR, and NGR), were evaluated. We used a nonlinear mixed model to characterize the basal area increment over the past 5, 10, 15, 20, 25, 30, and 35 years as a function of growth of nearby dominant trees, the size of the subject trees, deciduous and coniferous competition indices, and ecoregions. SDBHGR and BAGR were better predictors for spruce, and SDBHGR and NGR were better for aspen, respectively, than other indices. Results showed strongest correlations with long-term stem growth, as the best models integrated growth for 10-25 years for aspen and >= 25 for spruce. Our model demonstrated a remarkable capability (adjusted R-2>0.67) to represent this complex variation in growth as a function of site, size and competition.	[Huang, Jian-Guo; Dawson, Andria; Comeau, Philip G.] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [Stadt, Kenneth J.] Sustainable Resource Dev, Forest Management Branch, Edmonton, AB, Canada	University of Alberta	Huang, JG (corresponding author), Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada.	jianguo.huang@ualberta.ca	Comeau, Phil/AAB-6481-2020	Comeau, Phil/0000-0003-2578-4289	Natural Science and Engineering Research Council of Canada; Mixedwood Management Association; Forest Resource Improvement Association of Alberta	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Mixedwood Management Association; Forest Resource Improvement Association of Alberta	This project was funded by the Natural Science and Engineering Research Council of Canada, the Mixedwood Management Association, and the Forest Resource Improvement Association of Alberta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AESRD, 2012, PHAS 3 FOR INV; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alberta Sustainable Resource Development, 2006, ALB FOR MAN PLANN ST, P114; [Anonymous], 2006, SAS MIXED MODELS; Beckingham J. D., 1996, 9 CAN FOR SERV N FOR; Beckingham JD, 1996, 5 CAN FOR SERV N FOR; BIGING GS, 1995, FOREST SCI, V41, P360; Biondi F, 1999, ECOL APPL, V9, P216, DOI 10.1890/1051-0761(1999)009[0216:CTRCAR]2.0.CO;2; Bokalo M, 2007, FOREST ECOL MANAG, V242, P175, DOI 10.1016/j.foreco.2007.01.038; Bokalo M, 2013, FORESTS, V4, P1, DOI 10.3390/f4010001; BURTON P, 1993, CAN J FOREST RES, V23, P2141, DOI 10.1139/x93-267; Canham CD, 2004, CAN J FOREST RES, V34, P778, DOI [10.1139/x03-232, 10.1139/X03-232]; Chen Han Y. H., 2002, Environmental Reviews, V10, P137, DOI 10.1139/a02-007; Comeau PG, 1998, CAN J FOREST RES, V28, P1843, DOI 10.1139/cjfr-28-12-1843; Comeau PG, 2003, CAN J FOREST RES, V33, P1962, DOI 10.1139/X03-117; Comeau PG, 2009, FOREST CHRON, V85, P583, DOI 10.5558/tfc85583-4; Cortini F, 2012, FOREST ECOL MANAG, V277, P67, DOI 10.1016/j.foreco.2012.04.022; Cumming SG, 2000, ECOL APPL, V10, P744; Environment Canada, 2012, CAN CLIM NORM AV 197; Feng ZL, 2006, CAN J FOREST RES, V36, P3173, DOI 10.1139/X06-192; Filipescu CN, 2007, CAN J FOREST RES, V37, P1701, DOI 10.1139/X07-011; Filipescu CN, 2007, FOREST ECOL MANAG, V247, P175, DOI 10.1016/j.foreco.2007.04.038; Friend AD, 1993, VEGETATION DYNAMICS; Fritts H. C., 1976, TREE RINGS CLIMATE; Gutsell SL, 2002, J ECOL, V90, P153, DOI 10.1046/j.0022-0477.2001.00646.x; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Huang S, 1994, 1 ALB ENV PROT; HUANG SM, 1995, CAN J FOREST RES, V25, P1455, DOI 10.1139/x95-158; LANNER RM, 1985, FOREST ECOL MANAG, V13, P143, DOI 10.1016/0378-1127(85)90030-1; LIEFFERS VJ, 1994, CAN J FOREST RES, V24, P1193, DOI 10.1139/x94-157; Lieffers VJ, 1996, CAN J FOREST RES, V26, P1002, DOI 10.1139/x26-110; Lieffers VJ, 2002, FOREST CHRON, V78, P137, DOI 10.5558/tfc78137-1; LORIMER CG, 1983, FOREST ECOL MANAG, V6, P343, DOI 10.1016/0378-1127(83)90042-7; MacDonald GB, 1995, FOREST CHRON, V71, P725, DOI 10.5558/tfc71725-6; MacFarlane DW, 2006, CAN J FOREST RES, V36, P1695, DOI 10.1139/X06-054; MacPherson DM, 2001, FOREST CHRON, V77, P351, DOI 10.5558/tfc77351-2; Man R, 1999, FOREST CHRON, V75, P505; Metsaranta JM, 2009, FORESTRY, V82, P163, DOI 10.1093/forestry/cpn051; MORRIS DM, 1991, FOREST CHRON, V67, P403, DOI 10.5558/tfc67403-4; Newsome TA, 2006, 029 BC MIN FOR RES B; Newsome TA, 2010, FOREST ECOL MANAG, V259, P1170, DOI 10.1016/j.foreco.2010.01.003; Nunifu TK, 2009, CAN J FOREST RES, V39, P180, DOI 10.1139/X08-168; Osika DE, 2013, CAN J FOREST RES, V43, P139, DOI 10.1139/cjfr-2012-0169; Peters VS, 2005, ECOLOGY, V86, P1744, DOI 10.1890/03-0656; Peterson EB, 1992, 1 FOR CAN N FOR CENT, V1; Pritchard JM, 2004, FOREST ECOL MANAG, V200, P119, DOI 10.1016/j.foreco.2004.06.002; Pukkala T., 1989, Silva Fennica, V23, P101; Reid DEB, 2003, TREE PHYSIOL, V23, P833, DOI 10.1093/treephys/23.12.833; Stadt KJ, 2007, ANN FOREST SCI, V64, P477, DOI 10.1051/forest:2007025; Vanclay J. K., 1994, Modelling forest growth and yield: applications to mixed tropical forests.; WARING RH, 1982, CAN J FOREST RES, V12, P556, DOI 10.1139/x82-086; Wimberly MC, 1996, FOREST ECOL MANAG, V89, P1, DOI 10.1016/S0378-1127(96)03870-4; Wright EF, 1998, CAN J FOREST RES, V28, P871, DOI 10.1139/cjfr-28-6-871; Yang YQ, 2009, CAN J FOREST RES, V39, P2203, DOI 10.1139/X09-123	54	29	33	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77607	10.1371/journal.pone.0077607	http://dx.doi.org/10.1371/journal.pone.0077607			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204891	Green Published, Green Submitted, gold			2022-12-27	WOS:000326152300026
J	Sengupta, A; Sarkar, A; Priya, P; Dastidar, SG; Das, S				Sengupta, Anindita; Sarkar, Anindya; Priya, Prerna; Dastidar, Shubhra Ghosh; Das, Sampa			New Insight to Structure-Function Relationship of GalNAc Mediated Primary Interaction between Insecticidal Cry1Ac Toxin and HaALP Receptor of Helicoverpa armigera	PLOS ONE			English	Article							MANDUCA-SEXTA AMINOPEPTIDASE; BRUSH-BORDER MEMBRANE; BACILLUS-THURINGIENSIS TOXIN; DELTA-ENDOTOXIN; DOMAIN III; ALKALINE-PHOSPHATASE; HELIOTHIS-VIRESCENS; PORE FORMATION; N-ACETYLGALACTOSAMINE; PROTEIN STRUCTURES	Over the last few decades Cry1Ac toxin has been widely used in controlling the insect attack due to its high specificity towards target insects. The pore-forming toxin undergoes a complex mechanism in the insect midgut involving sequential interaction with specific glycosylated receptors in which terminal GalNAc molecule plays a vital role. Recent studies on Cry toxins interactions with specific receptors revealed the importance of several amino acid residues in domain III of Cry1Ac, namely Q509, N510, R511, Y513 and W545, serve as potential binding sites that surround the putative GalNAc binding pocket and mediate the toxin-receptor interaction. In the present study, alanine substitution mutations were generated in the Cry1Ac domain III region and functional significance of those key residues was monitored by insect bioassay on Helicoverpa armigera larvae. In addition, ligand blot analysis and SPR binding assay was performed to monitor the binding characteristics of Cry1Ac wild type and mutant toxins towards HaALP receptor isolated from Helicoverpa armigera. Mutagenesis data revealed that, alanine substitutions in R511, Y513 and W545 substantially impacted the relative affinity towards HaALP receptor and toxicity toward target insect. Furthermore, in silico study of GalNAc-mediated interaction also confirmed the important roles of these residues. This structural analysis will provide a detail insight for evaluating and engineering new generation Cry toxins to address the problem of change in insect behavioral patterns.	[Sengupta, Anindita; Sarkar, Anindya; Das, Sampa] Bose Inst, Div Plant Biol, Kolkata, W Bengal, India; [Priya, Prerna; Dastidar, Shubhra Ghosh] Bose Inst, Bioinformat Ctr, Kolkata, W Bengal, India	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute	Das, S (corresponding author), Bose Inst, Div Plant Biol, Kolkata, W Bengal, India.	sampa@jcbose.ac.in			Department of Biotechnology, Govt of India [BT/PR5426/BID/07/086/2004]; University Grant Commission, India [F.2-8/2002]	Department of Biotechnology, Govt of India(Department of Biotechnology (DBT) India); University Grant Commission, India(University Grants Commission, India)	This work was supported by the grant provided to A. Sengupta by Department of Biotechnology, Govt of India (Sanction number: BT/PR5426/BID/07/086/2004) and to PP by University Grant Commission, India (Sanction number: F.2-8/2002 (SA-I) dated 30.03.2012. Authors are thankful to Bose Institute for providing infrastructure facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas I, 2010, J BIOL CHEM, V285, P12497, DOI 10.1074/jbc.M109.085266; ARONSON AI, 1995, J BACTERIOL, V177, P4059, DOI 10.1128/jb.177.14.4059-4065.1995; Banerjee S, 2004, J BIOL CHEM, V279, P23782, DOI 10.1074/jbc.M401405200; BEEGLE CC, 1992, CAN ENTOMOL, V124, P587, DOI 10.4039/Ent124587-4; Beegle CC, 1990, BIOASSAY METHODS QUA, P14; Burton SL, 1999, J MOL BIOL, V287, P1011, DOI 10.1006/jmbi.1999.2649; Cantor C.R., 1980, BIOPHYSICAL CHEM 2; Chi H, 1997, COMPUTER PROGRAM PRO; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Daniel A, 2002, APPL ENVIRON MICROB, V68, P2106, DOI 10.1128/AEM.68.5.2106-2112.2002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Maagd RA, 1999, MOL MICROBIOL, V31, P463, DOI 10.1046/j.1365-2958.1999.01188.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; deMaagd RA, 1996, APPL ENVIRON MICROB, V62, P1537, DOI 10.1128/AEM.62.5.1537-1543.1996; Derbyshire DJ, 2001, ACTA CRYSTALLOGR D, V57, P1938, DOI 10.1107/S090744490101040X; Escobar BF, 2013, APPL ENVIRON MICROB, DOI [10.1128/AEM.01062-13, DOI 10.1128/AEM.01062-13]; Fernandez LE, 2006, BIOCHEM J, V394, P77, DOI 10.1042/BJ20051517; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; GAZIT E, 1993, BIOCHEMISTRY-US, V32, P3429, DOI 10.1021/bi00064a029; GE AZ, 1991, J BIOL CHEM, V266, P17954; George Z., 2012, INBACILLUS THURINGIE, P19, DOI 10.1007/978-94-007-3021-2_2; Gomez I, 2002, FEBS LETT, V513, P242, DOI 10.1016/S0014-5793(02)02321-9; Griffitts JS, 2005, SCIENCE, V307, P922, DOI 10.1126/science.1104444; GROCHULSKI P, 1995, J MOL BIOL, V254, P447, DOI 10.1006/jmbi.1995.0630; HOFMANN C, 1988, P NATL ACAD SCI USA, V85, P7844, DOI 10.1073/pnas.85.21.7844; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ingle SS, 2001, CURR MICROBIOL, V43, P255, DOI 10.1007/s002840010297; Jenkins JL, 1999, FEBS LETT, V462, P373, DOI 10.1016/S0014-5793(99)01559-8; Jenkins JL, 2000, J BIOL CHEM, V275, P14423, DOI 10.1074/jbc.275.19.14423; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Jurat-Fuentes JL, 2006, J INVERTEBR PATHOL, V92, P166, DOI 10.1016/j.jip.2006.01.010; Kegley SE, 1998, PESTICIDES FRUIT VEG; KNIGHT PJK, 1994, MOL MICROBIOL, V11, P429, DOI 10.1111/j.1365-2958.1994.tb00324.x; KNOWLES BH, 1991, P ROY SOC B-BIOL SCI, V245, P31, DOI 10.1098/rspb.1991.0084; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lee MK, 1999, APPL ENVIRON MICROB, V65, P4513; LI JD, 1991, NATURE, V353, P815, DOI 10.1038/353815a0; Liao CY, 2002, J INVERTEBR PATHOL, V80, P55, DOI 10.1016/S0022-2011(02)00035-6; Lu YJ, 1996, INSECT BIOCHEM MOLEC, V26, P33, DOI 10.1016/0965-1748(95)00058-5; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nayak P, 1997, P NATL ACAD SCI USA, V94, P2111, DOI 10.1073/pnas.94.6.2111; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Pacheco S, 2009, J BIOL CHEM, V284, P32750, DOI 10.1074/jbc.M109.024968; Pardo-Lopez L, 2006, BIOCHEMISTRY-US, V45, P10329, DOI 10.1021/bi060297z; Perera OP, 2009, INSECT BIOCHEM MOLEC, V39, P294, DOI 10.1016/j.ibmb.2009.01.006; PERLAK FJ, 1990, BIO-TECHNOL, V8, P939, DOI 10.1038/nbt1090-939; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Rajamohan F, 1996, J BIOL CHEM, V271, P2390, DOI 10.1074/jbc.271.5.2390; SANGADALA S, 1994, J BIOL CHEM, V269, P10088; Sangadala S, 2001, INSECT BIOCHEM MOLEC, V32, P97, DOI 10.1016/S0965-1748(01)00086-8; Saraswathy N, 2004, ELECTRON J BIOTECHN, V7, P178; Sarkar A, 2009, J PROTEOME RES, V8, P1838, DOI 10.1021/pr8006528; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; SCHWARTZ JL, 1993, J MEMBRANE BIOL, V132, P53, DOI 10.1007/BF00233051; Sharma H. C., 2001, CROP PROTECTION COMP; Sivakumar S, 2007, J BIOL CHEM, V282, P7312, DOI 10.1074/jbc.M607442200; Soberon M, 2010, ADV EXP MED BIOL, V677, P127; VADLAMUDI RK, 1993, J BIOL CHEM, V268, P12334; Valaitis AP, 2001, ARCH INSECT BIOCHEM, V46, P186, DOI 10.1002/arch.1028; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3144, DOI 10.1021/ci300363c; Vassal Jean-Michel, 2008, Commun Agric Appl Biol Sci, V73, P433; Vie V, 2001, J MEMBRANE BIOL, V180, P195, DOI 10.1007/s002320010070; Wang GR, 2005, SCI CHINA SER C, V48, P346, DOI 10.1360/03yc0273; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wolfersberger MG, 1996, APPL ENVIRON MICROB, V62, P279, DOI 10.1128/AEM.62.1.279-282.1996; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103; Zhuang MB, 2002, J BIOL CHEM, V277, P13863, DOI 10.1074/jbc.M110057200	70	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78249	10.1371/journal.pone.0078249	http://dx.doi.org/10.1371/journal.pone.0078249			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205171	Green Published, Green Submitted, gold			2022-12-27	WOS:000326152300046
J	van der Velden, PG; Bosmans, MWG; Scherpenzeel, AC				van der Velden, Peter G.; Bosmans, Mark W. G.; Scherpenzeel, Annette C.			The Burden of Research on Trauma for Respondents: A Prospective and Comparative Study on Respondents Evaluations and Predictors	PLOS ONE			English	Article							SELF-EFFICACY MEASURE; RESEARCH PARTICIPATION; FOCUSED RESEARCH; EVENT SCALE; STRESS; PERSONALITY; VALIDATION; PERCEPTIONS; SURVIVORS; DISASTER	The possible burden of participating in trauma research is an important topic for Ethical Committees (EC's), Review Boards (RB's) and researchers. However, to what extent research on trauma is more burdensome than non-trauma research is unknown. Little is known about which factors explain respondents evaluations on the burden: to what extent are they trauma-related or dependent on other factors such as personality and how respondents evaluate research in general? Data of a large probability based multi-wave internet panel, with surveys on politics and values, personality and health in 2009 and 2011, and a survey on trauma in 2012 provided the unique opportunity to address these questions. Results among respondents confronted with these events in the past 2 years (N = 950) showed that questions on trauma were significantly and systematically evaluated as less pleasant (enjoyed less), more difficult, but also stimulated respondents to think about things more than almost all previous non-trauma surveys. Yet, the computed effect sizes indicated that the differences were (very) small and often meaningless. No differences were found between users and non-users of mental services, in contrast to posttraumatic stress symptoms. Evaluations of the burden of previous surveys in 2011 on politics and values, personality and health most strongly, systematically and independently predicted the burden of questions on trauma, and not posttraumatic stress symptoms, event-related coping self-efficacy and personality factors. For instance, multiple linear regression analyses showed that 30% of the variance of how (un) pleasant questions on trauma and life-events were evaluated, was explained by how (un) pleasant the 3 surveys in 2011 were evaluated, in contrast to posttraumatic stress symptoms (not significant) and coping self-efficacy (5%). Findings question why EC's, RB's and researchers should be more critical of the possible burden of trauma research than of the possible burden of other non-trauma research.	[van der Velden, Peter G.; Bosmans, Mark W. G.] Tilburg Univ, INTERVICT, NL-5000 LE Tilburg, Netherlands; [Scherpenzeel, Annette C.] Tilburg Univ, CentERdata, NL-5000 LE Tilburg, Netherlands	Tilburg University; Tilburg University	van der Velden, PG (corresponding author), Tilburg Univ, INTERVICT, NL-5000 LE Tilburg, Netherlands.	pg.vandervelden@tilburguniversity.edu		van der Velden, Peter G./0000-0002-0221-6281; Bosmans, Mark/0000-0001-9479-8604	Victim Support Fund (Fonds Slachtofferhulp), The Netherlands	Victim Support Fund (Fonds Slachtofferhulp), The Netherlands	This study is part of a large research project on coping self-efficacy, granted by the Victim Support Fund (Fonds Slachtofferhulp), The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Benight CC, 2004, J TRAUMA STRESS, V17, P505, DOI 10.1007/s10960-004-5799-3; Benight CC, 1999, J TRAUMA STRESS, V12, P379, DOI 10.1023/A:1024792913301; Boscarino JA, 2004, J NERV MENT DIS, V192, P515, DOI 10.1097/01.nmd.0000135476.20580.ae; De Vos K., 2009, WORKING PAPER; Deprince AP., 2006, J TRAUMA PRACTICE, V3, P23, DOI [DOI 10.1300/J189V03N04_02, 10.1300/J189v03n04_02]; DILL DL, 1991, COMPR PSYCHIAT, V32, P166, DOI 10.1016/0010-440X(91)90009-2; Galea S, 2005, J TRAUMA STRESS, V18, P461, DOI 10.1002/jts.20053; Goldberg L.R., 1999, PERSONALITY PSYCHOL, V7, P7; Goldberg L. R., 1992, PSYCHOL ASSESSMENT, V4, P26, DOI [10.1037/1040-3590.4.1.26, DOI 10.1037/1040-3590.4.1.26]; Goldberg LR, 2006, J RES PERS, V40, P84, DOI 10.1016/j.jrp.2005.08.007; GOLDBERG LR, 1990, J PERS SOC PSYCHOL, V59, P1216, DOI 10.1037/0022-3514.59.6.1216; Gow AJ, 2005, PERS INDIV DIFFER, V39, P317, DOI 10.1016/j.paid.2005.01.011; Griffin MG, 2003, J TRAUMA STRESS, V16, P221, DOI 10.1023/A:1023735821900; Grubaugh AL, 2012, PSYCHIAT RES, V200, P1071, DOI 10.1016/j.psychres.2012.07.039; Hebenstreit CL, 2012, J EMPIR RES HUM RES, V7, P60, DOI 10.1525/jer.2012.7.2.60; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Johnson LE, 2003, J TRAUMA STRESS, V16, P567, DOI 10.1023/B:JOTS.0000004080.50361.f3; Lugtig P., 2010, 2 PAN SURV METH WORK; Naemi BD, 2009, J PERS, V77, P261, DOI 10.1111/j.1467-6494.2008.00545.x; Newman E, 2004, J TRAUMA STRESS, V17, P383, DOI 10.1023/B:JOTS.0000048951.02568.3a; Newman E, 2009, J TRAUMA STRESS, V22, P595, DOI 10.1002/jts.20465; Pfefferbaum B, 2001, PSYCHIATRY, V64, P202, DOI 10.1521/psyc.64.3.202.18462; Pfefferbaum B, 2000, PSYCHIATRY, V63, P358, DOI 10.1080/00332747.2000.11024929; Pfefferbaum Betty, 2003, Ann Clin Psychiatry, V15, P1, DOI 10.1023/A:1023293824492; Resick PA, 2009, J TRAUMA STRESS, V22, P316, DOI 10.1002/jts.20428; Ruzek JI, 2000, GEN HOSP PSYCHIAT, V22, P27, DOI 10.1016/S0163-8343(99)00041-9; Scherpenzeel A., 2011, START LISS PANEL SAM; Smid GE, 2012, PSYCHOL MED, V42, P1675, DOI 10.1017/S0033291711002765; van der Ploeg E, 2004, PSYCHOL ASSESSMENT, V16, P16, DOI 10.1037/1040-3590.16.1.16	30	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77266	10.1371/journal.pone.0077266	http://dx.doi.org/10.1371/journal.pone.0077266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239NN	24204785	Green Published, gold, Green Submitted			2022-12-27	WOS:000326032600026
J	Grgic, H; Poljak, Z; Sharif, S; Nagy, E				Grgic, Helena; Poljak, Zvonimir; Sharif, Shayan; Nagy, Eva			Pathogenicity and Cytokine Gene Expression Pattern of a Serotype 4 Fowl Adenovirus Isolate	PLOS ONE			English	Article							INCLUSION-BODY HEPATITIS; TERMINAL HEAD DOMAIN; HYDROPERICARDIUM SYNDROME; MAREKS-DISEASE; IN-VITRO; VERTICAL TRANSMISSION; BROILER BREEDERS; INTERFERON-GAMMA; IFN-GAMMA; VIRUS	Hydropericardium-hepatitis syndrome (HHS), a recently emerged disease of chickens, is caused by some strains of fowl adenovirus serotype 4 (FAdV-4). In this study, a Canadian FAdV-4 isolate, designated as FAdV-4 ON1, was evaluated for pathogenicity after oral and intramuscular (im) infection of specific pathogen free (SPF) chickens. Pathogenicity was evaluated by observation of clinical signs and gross and histological lesions. The highest viral DNA copy numbers, irrespective of the inoculation route, were detected in the cecal tonsils. Virus titers in cloacal swabs collected over the entire study period were compared between the orally and im inoculated chickens, and the difference in titers between the two groups was significant (P<0.001), the oral group had a higher rank. The antibody response of infected chickens tested by an adenovirus-specific ELISA showed a statistically significant (P<0.001) difference between the orally and im inoculated chickens. The im inoculated chickens had higher values than birds inoculated orally (P<0.001). Serum samples from both groups collected at 14 days post-infection completely neutralized FAdV-4 ON1. In addition, the effects of FAdV-4 ON1 infection on transcription of a number of avian cytokines were studied in vivo. The expression of interferon (IFN)-gamma and interleukin (IL)-10 in the liver was induced at early times after infection. This FAdV-4 ON1 potentially could be used as a live vaccine against HHS and developed as vaccine vector. The GenBank/EMBL/DDBJ accession number for the FAdV-4 ON1 sequence is GU188428.	[Grgic, Helena; Sharif, Shayan; Nagy, Eva] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON N1G 2W1, Canada; [Poljak, Zvonimir] Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON N1G 2W1, Canada	University of Guelph; University of Guelph	Nagy, E (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON N1G 2W1, Canada.	enagy@uoguelph.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Poultry Research Council (CPRC); Ontario Ministry of Agriculture and Food (OMAF)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Poultry Research Council (CPRC); Ontario Ministry of Agriculture and Food (OMAF)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC), the Canadian Poultry Research Council (CPRC) and the Ontario Ministry of Agriculture and Food (OMAF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Careem MF, 2006, VIRAL IMMUNOL, V19, P167, DOI 10.1089/vim.2006.19.167; Abdul-Careem MF, 2007, VACCINE, V25, P424, DOI 10.1016/j.vaccine.2006.08.006; Abe T, 1998, AVIAN DIS, V42, P606, DOI 10.2307/1592690; Alexander HS, 1998, J VIROL METHODS, V74, P9, DOI 10.1016/S0166-0934(98)00062-7; ANJUM AD, 1990, AVIAN PATHOL, V19, P655, DOI 10.1080/03079459008418721; Cheema A E, 1989, Rev Sci Tech, V8, P789, DOI 10.20506/rst.8.3.420; Corredor JC, 2010, NONESSENTIAL LEFT EN, P9; Corredor JC, 2010, J GEN VIROL, V91, P51, DOI 10.1099/vir.0.013839-0; COWEN BS, 1992, WORLD POULTRY SCI J, V48, P247, DOI 10.1079/WPS19920019; Deng L, 2013, CLIN VACCINE IMMUNOL, V20, P1189, DOI 10.1128/CVI.00187-13; El Bakkouri M, 2008, VIROLOGY, V378, P169, DOI 10.1016/j.virol.2008.05.011; ERNY K, 1995, ARCH VIROL, V140, P491, DOI 10.1007/BF01718426; Fitzgerald SD., 2008, DIS POULTRY, V12th, P251; Gerosa F, 1996, J EXP MED, V183, P2559, DOI 10.1084/jem.183.6.2559; Grgic H, 2006, CAN J VET RES, V70, P230; Grgic H, 2013, VIRAL IMMUNOL, V26, P143, DOI 10.1089/vim.2012.0078; Grgic H, 2011, VIRUS RES, V156, P91, DOI 10.1016/j.virusres.2011.01.002; Griffin BD, 2011, J GEN VIROL, V92, P1260, DOI 10.1099/vir.0.030064-0; Guardado-Calvo P, 2007, J GEN VIROL, V88, P2407, DOI 10.1099/vir.0.82845-0; Hess M, 1999, AVIAN PATHOL, V28, P433, DOI 10.1080/03079459994443; Johnsen CK, 2002, VIRAL IMMUNOL, V15, P549, DOI 10.1089/088282402320914494; Johnson MA, 2003, VACCINE, V21, P2730, DOI 10.1016/S0264-410X(03)00227-5; Khawaja D. A., 1988, Pakistan Journal of Veterinary Research, V1, P2; Lillehoj HS, 1998, AVIAN DIS, V42, P307, DOI 10.2307/1592481; Mansoor MK, 2011, TROP ANIM HEALTH PRO, V43, P331, DOI 10.1007/s11250-010-9694-z; Mazaheri A, 1998, AVIAN PATHOL, V27, P269, DOI 10.1080/03079459808419335; Nakamura K, 1999, AVIAN DIS, V43, P414, DOI 10.2307/1592638; Ojkic D, 2003, VACCINE, V22, P42, DOI 10.1016/S0264-410X(03)00544-9; Ojkic D, 2001, VIROLOGY, V283, P197, DOI 10.1006/viro.2000.0890; Parvizi P, 2009, VET IMMUNOL IMMUNOP, V132, P209, DOI 10.1016/j.vetimm.2009.06.009; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Philippe C, 2005, J APPL POULTRY RES, V14, P588, DOI 10.1093/japr/14.3.588; Philippe C, 2007, CAN J VET RES, V71, P98; Plachy J, 1999, VIROLOGY, V256, P85, DOI 10.1006/viro.1999.9602; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; SAIFUDDIN M, 1991, ARCH VIROL, V116, P33, DOI 10.1007/BF01319229; Schonewille E, 2010, AVIAN DIS, V54, P905, DOI 10.1637/8999-072309-Reg.1; Sheppard M, 1998, ARCH VIROL, V143, P915, DOI 10.1007/s007050050342; Sung RS, 2001, MOL THER, V3, P757, DOI 10.1006/mthe.2001.0318; Toro H, 1999, AVIAN DIS, V43, P262, DOI 10.2307/1592616; Xing Z, 2000, J VIROL, V74, P3605, DOI 10.1128/JVI.74.8.3605-3612.2000	41	40	46	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77601	10.1371/journal.pone.0077601	http://dx.doi.org/10.1371/journal.pone.0077601			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204888	Green Submitted, Green Published, gold			2022-12-27	WOS:000326029300105
J	Marcombe, S; Paris, M; Paupy, C; Bringuier, C; Yebakima, A; Chandre, F; David, JP; Corbel, V; Despres, L				Marcombe, Sebastien; Paris, Margot; Paupy, Christophe; Bringuier, Charline; Yebakima, Andre; Chandre, Fabrice; David, Jean-Philippe; Corbel, Vincent; Despres, Laurence			Insecticide-Driven Patterns of Genetic Variation in the Dengue Vector Aedes aegypti in Martinique Island	PLOS ONE			English	Article							SODIUM-CHANNEL GENE; PYRETHROID RESISTANCE; POPULATION-STRUCTURE; GENOME SCANS; F-STATISTICS; SPACE SPRAYS; MOSQUITO; METABOLISM; SULFOTRANSFERASES; PHYLOGEOGRAPHY	Effective vector control is currently challenged worldwide by the evolution of resistance to all classes of chemical insecticides in mosquitoes. In Martinique, populations of the dengue vector Aedes aegypti have been intensively treated with temephos and deltamethrin insecticides over the last fifty years, resulting in heterogeneous levels of resistance across the island. Resistance spreading depends on standing genetic variation, selection intensity and gene flow among populations. To determine gene flow intensity, we first investigated neutral patterns of genetic variability in sixteen populations representative of the many environments found in Martinique and experiencing various levels of insecticide pressure, using 6 microsatellites. Allelic richness was lower in populations resistant to deltamethrin, and consanguinity was higher in populations resistant to temephos, consistent with a negative effect of insecticide pressure on neutral genetic diversity. The global genetic differentiation was low, suggesting high gene flow among populations, but significant structure was found, with a pattern of isolation-by-distance at the global scale. Then, we investigated adaptive patterns of divergence in six out of the 16 populations using 319 single nucleotide polymorphisms (SNPs). Five SNP outliers displaying levels of genetic differentiation out of neutral expectations were detected, including the kdr-V1016I mutation in the voltage-gated sodium channel gene. Association tests revealed a total of seven SNPs associated with deltamethrin resistance. Six other SNPs were associated with temephos resistance, including two non-synonymous substitutions in an alkaline phosphatase and in a sulfotransferase respectively. Altogether, both neutral and adaptive patterns of genetic variation in mosquito populations appear to be largely driven by insecticide pressure in Martinique.	[Marcombe, Sebastien; Paupy, Christophe; Chandre, Fabrice; Corbel, Vincent] IRD, UMR MIVEGEC IRD 224 CNRS 5290 UM1 UM2, Montpellier, France; [Paris, Margot; Bringuier, Charline; David, Jean-Philippe; Despres, Laurence] Grenoble Alpes Univ, Lab Ecol Alpine LECA, CNRS, UMR 5553, Grenoble, France; [Paupy, Christophe] Ctr Int Rech Med Franceville CIRMF, Franceville, Gabon; [Yebakima, Andre] Conseil Gen Martinique, Ctr Demousticat, Fort De France, Martinique, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie	Despres, L (corresponding author), Grenoble Alpes Univ, Lab Ecol Alpine LECA, CNRS, UMR 5553, Grenoble, France.	laurence.despres@ujf-grenoble.fr	Chandre, Fabrice/Q-3429-2019; Corbel, VIncent/G-9576-2016; Despres, Laurence/AAC-9518-2021; Paris, Margot/AAD-1971-2020; Paupy, Christophe/I-4847-2017; Paris, Margot/C-8076-2012; DAVID, jean-philippe/F-3077-2012	Chandre, Fabrice/0000-0002-1994-9705; Despres, Laurence/0000-0002-0660-6260; Paris, Margot/0000-0001-7328-3820; Paupy, Christophe/0000-0002-7122-2079; DAVID, jean-philippe/0000-0002-3950-5909; corbel, vincent/0000-0003-0995-3257	Conseil General de la Martinique University J. Fourier	Conseil General de la Martinique University J. Fourier	Funding came from the Conseil General de la Martinique University J. Fourier. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, GUIDELINES LAB FIELD; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x; Chen QX, 2000, INT J BIOCHEM CELL B, V32, P879, DOI 10.1016/S1357-2725(00)00026-1; Choi J, 2002, PESTIC BIOCHEM PHYS, V74, P117, DOI 10.1016/S0048-3575(02)00154-2; David JP, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0429; ElMousadik A, 1996, MOL ECOL, V5, P547, DOI 10.1046/j.1365-294X.1996.00123.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Gamage N, 2006, TOXICOL SCI, V90, P5, DOI 10.1093/toxsci/kfj061; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623; Hemingway J, 2000, INSECT BIOCHEM MOLEC, V30, P1009, DOI 10.1016/S0965-1748(00)00079-5; Hodgson E, 2003, J BIOCHEM MOL TOXIC, V17, P201, DOI 10.1002/jbt.10080; HOLM S, 1979, SCAND J STAT, V6, P65; Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005; San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346; Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989; Marcombe S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001202; Marcombe S, 2009, AM J TROP MED HYG, V80, P745, DOI 10.4269/ajtmh.2009.80.745; Morlais I, 2004, AM J TROP MED HYG, V71, P795, DOI 10.4269/ajtmh.2004.71.795; Nkya TE, 2013, INSECT BIOCHEM MOLEC, V43, P407, DOI 10.1016/j.ibmb.2012.10.006; Paris M, 2013, EVOL APPL, V6, P1012, DOI 10.1111/eva.12082; Paris M, 2012, MOL ECOL, V21, P1672, DOI 10.1111/j.1365-294X.2012.05499.x; Paris M, 2012, J INVERTEBR PATHOL, V109, P201, DOI 10.1016/j.jip.2011.11.004; Paupy C, 2008, J MED ENTOMOL, V45, P391, DOI 10.1603/0022-2585(2008)45[391:GFBDAS]2.0.CO;2; Paupy C, 2012, INFECT GENET EVOL, V12, P1260, DOI 10.1016/j.meegid.2012.04.012; Paupy C, 2010, INFECT GENET EVOL, V10, P473, DOI 10.1016/j.meegid.2010.03.001; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rousset F, 1997, GENETICS, V145, P1219; Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x; Soper, 1977, VENTURES WORLD HLTH; Team RDC, 2019, R LANG ENV STAT COMP; Van Dyk JS, 2011, CHEMOSPHERE, V82, P291, DOI 10.1016/j.chemosphere.2010.10.033; Wang LQ, 2006, CURR DRUG METAB, V7, P83, DOI 10.2174/138920006774832596; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Yebakima A, 2004, TROP MED INT HEALTH, V9, P582, DOI 10.1111/j.1365-3156.2004.01241.x	39	18	19	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77857	10.1371/journal.pone.0077857	http://dx.doi.org/10.1371/journal.pone.0077857			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204999	Green Published, gold			2022-12-27	WOS:000326029300119
J	Antosova, B; Smolikova, J; Borkovcova, R; Strnad, H; Lachova, J; Machon, O; Kozmik, Z				Antosova, Barbora; Smolikova, Jana; Borkovcova, Romana; Strnad, Hynek; Lachova, Jitka; Machon, Ondrej; Kozmik, Zbynek			Ectopic Activation of Wnt/beta-Catenin Signaling in Lens Fiber Cells Results in Cataract Formation and Aberrant Fiber Cell Differentiation	PLOS ONE			English	Article							BETA-CATENIN; CRYSTALLIN GENE; C-MAF; TRANSCRIPTION FACTOR; TRANSGENIC MICE; CYCLIN D1; EXPRESSION; MORPHOGENESIS; PAX6; GROWTH	The Wnt/beta-catenin signaling pathway controls many processes during development, including cell proliferation, cell differentiation and tissue homeostasis, and its aberrant regulation has been linked to various pathologies. In this study we investigated the effect of ectopic activation of Wnt/beta-catenin signaling during lens fiber cell differentiation. To activate Wnt/beta-catenin signaling in lens fiber cells, the transgenic mouse referred to as alpha A-CLEF was generated, in which the transactivation domain of beta-catenin was fused to the DNA-binding protein LEF1, and expression of the transgene was controlled by alpha A-crystallin promoter. Constitutive activation of Wnt/beta-catenin signaling in lens fiber cells of alpha A-CLEF mice resulted in abnormal and delayed fiber cell differentiation. Moreover, adult alpha A-CLEF mice developed cataract, microphthalmia and manifested downregulated levels of gamma-crystallins in lenses. We provide evidence of aberrant expression of cell cycle regulators in embryonic lenses of alpha A-CLEF transgenic mice resulting in the delay in cell cycle exit and in the shift of fiber cell differentiation to the central fiber cell compartment. Our results indicate that precise regulation of the Wnt/beta-catenin signaling activity during later stages of lens development is essential for proper lens fiber cell differentiation and lens transparency.	[Antosova, Barbora; Smolikova, Jana; Borkovcova, Romana; Strnad, Hynek; Lachova, Jitka; Machon, Ondrej; Kozmik, Zbynek] Acad Sci Czech Republ, Inst Mol Genet, Prague, Czech Republic; [Antosova, Barbora] Charles Univ Prague, Fac Sci, Dept Genet & Microbiol, Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Charles University Prague	Kozmik, Z (corresponding author), Acad Sci Czech Republ, Inst Mol Genet, Prague, Czech Republic.	kozmik@img.cas.cz	Kozmik, Zbynek/I-8807-2014; Strnad, Hynek/B-7361-2008; Kozmik, Zbynek/G-3581-2014; Machon, Ondrej/G-3587-2014	Strnad, Hynek/0000-0002-0141-8340; Kozmik, Zbynek/0000-0002-5850-2105	Grant Agency of the Czech Republic [P305/11/2198, P305/12/2042]; Grant Agency of Charles University in Prague [GAUK 243-253051]; Czech Ministry of Education [LK11214]; OP EC CZ [1.07/2.3.00/30.0027]; Ministry of Education, Youth and Sports, Czech Republic+European Social Fund; IMG [RVO68378050]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Grant Agency of Charles University in Prague; Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); OP EC CZ; Ministry of Education, Youth and Sports, Czech Republic+European Social Fund; IMG	This study was supported by the Grant Agency of the Czech Republic (P305/11/2198 and P305/12/2042), Grant Agency of Charles University in Prague (GAUK 243-253051), by Czech Ministry of Education (LK11214), by OP EC CZ 1.07/2.3.00/30.0027 "Founding the Centre of Transgenic Technologies" (Operational Program Education for Competitiveness by Ministry of Education, Youth and Sports, Czech Republic+European Social Fund), and by IMG institutional support RVO68378050. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2013, DEVELOPMENT, V140, P237, DOI 10.1242/dev.084111; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; BASSNETT S, 1992, DEV DYNAM, V194, P85, DOI 10.1002/aja.1001940202; Belecky-Adams TL, 2002, DEVELOPMENT, V129, P3795; Blixt A, 2000, GENE DEV, V14, P245; Boswell BA, 2008, DEV BIOL, V324, P202, DOI 10.1016/j.ydbio.2008.09.003; Brownell I, 2000, GENESIS, V27, P81, DOI 10.1002/1526-968X(200006)27:2<81::AID-GENE50>3.0.CO;2-N; Cain S, 2008, DEV BIOL, V321, P420, DOI 10.1016/j.ydbio.2008.07.002; Chen Q, 2000, INVEST OPHTH VIS SCI, V41, P4223; Chen Q, 2004, J BIOL CHEM, V279, P17667, DOI 10.1074/jbc.M311678200; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cvekl A, 2007, PROG RETIN EYE RES, V26, P555, DOI 10.1016/j.preteyeres.2007.07.002; de Longh RU, 2001, DEVELOPMENT, V128, P3995; Duncan MK, 2000, J CELL SCI, V113, P3173; Duncan MK, 2004, INVEST OPHTH VIS SCI, V45, P3589, DOI 10.1167/iovs.04-0151; Faber SC, 2002, DEVELOPMENT, V129, P3727; Faber SC, 2001, DEVELOPMENT, V128, P4425; Galceran J, 2001, P NATL ACAD SCI USA, V98, P8668, DOI 10.1073/pnas.151258098; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Gerido DA, 2003, INVEST OPHTH VIS SCI, V44, P2669, DOI 10.1167/iovs.02-1311; Graw J, 2004, INT J DEV BIOL, V48, P1031, DOI 10.1387/ijdb.041854jg; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Griep AE, 2006, SEMIN CELL DEV BIOL, V17, P686, DOI 10.1016/j.semcdb.2006.10.004; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Kawauchi S, 1999, J BIOL CHEM, V274, P19254, DOI 10.1074/jbc.274.27.19254; Kim JI, 1999, P NATL ACAD SCI USA, V96, P3781, DOI 10.1073/pnas.96.7.3781; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kralova J, 2002, GENE, V286, P271, DOI 10.1016/S0378-1119(02)00425-0; Kreslova J, 2007, GENESIS, V45, P157, DOI 10.1002/dvg.20277; Lovicu FJ, 2005, DEV BIOL, V280, P1, DOI 10.1016/j.ydbio.2005.01.020; Lovicu FJ, 1998, DEVELOPMENT, V125, P3365; Machon O, 2007, DEV BIOL, V311, P223, DOI 10.1016/j.ydbio.2007.08.038; Machon O, 2010, GENESIS, V48, P86, DOI 10.1002/dvg.20583; Martinez G, 2009, INVEST OPHTH VIS SCI, V50, P4794, DOI 10.1167/iovs.09-3567; McAvoy JW, 1999, EYE, V13, P425, DOI 10.1038/eye.1999.117; MCAVOY JW, 1978, J EMBRYOL EXP MORPH, V45, P271; Miller LAD, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-14; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Niehrs C, 2012, EMBO J, V31, P2705, DOI 10.1038/emboj.2012.124; Nielsen PA, 2003, MOL BIOL CELL, V14, P2470, DOI 10.1091/mbc.E02-10-0637; Nishiguchi S, 1998, GENE DEV, V12, P776, DOI 10.1101/gad.12.6.776; OVERBEEK PA, 1985, P NATL ACAD SCI USA, V82, P7815, DOI 10.1073/pnas.82.23.7815; Piatigorsky J, 1980, Curr Top Eye Res, V3, P1; Ring BZ, 2000, DEVELOPMENT, V127, P307; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Smith AN, 2005, DEV BIOL, V285, P477, DOI 10.1016/j.ydbio.2005.07.019; Stump RJW, 2003, DEV BIOL, V259, P48, DOI 10.1016/S0012-1606(03)00179-9; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Wigle JT, 1999, NAT GENET, V21, P318, DOI 10.1038/6844; Xie Q, 2011, J BIOL CHEM, V286, P43259, DOI 10.1074/jbc.M111.264580; Xu L, 2002, EXP EYE RES, V74, P753, DOI 10.1006/exer.2002.1175; Yamamoto N, 2008, MED MOL MORPHOL, V41, P83, DOI 10.1007/s00795-008-0395-x; Yang Y, 2005, J MOL BIOL, V351, P453, DOI 10.1016/j.jmb.2005.05.072; Yang Y, 2004, J MOL BIOL, V344, P351, DOI 10.1016/j.jmb.2004.07.102; Zhang PM, 1998, GENE DEV, V12, P3162, DOI 10.1101/gad.12.20.3162; Zhao HT, 2008, DEV BIOL, V318, P276, DOI 10.1016/j.ydbio.2008.03.028	57	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78279	10.1371/journal.pone.0078279	http://dx.doi.org/10.1371/journal.pone.0078279			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205179	Green Published, Green Submitted, gold			2022-12-27	WOS:000326334500108
J	Rana, T; Chakrabarti, A; Freeman, M; Biswas, S				Rana, Tapasi; Chakrabarti, Anwesa; Freeman, Michael; Biswas, Swati			Doxorubicin-Mediated Bone Loss in Breast Cancer Bone Metastases Is Driven by an Interplay between Oxidative Stress and Induction of TGF beta	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; I RECEPTOR KINASE; SUPEROXIDE-DISMUTASE SOD1; NF-KAPPA-B; MINERAL DENSITY; OSTEOBLASTIC DIFFERENTIATION; OSTEOCLAST DIFFERENTIATION; CHEMOTHERAPEUTIC-AGENTS; ADJUVANT CHEMOTHERAPY; STEM-CELLS	Breast cancer patients, who are already at increased risk of developing bone metastases and osteolytic bone damage, are often treated with doxorubicin. Unfortunately, doxorubicin has been reported to induce damage to bone. Moreover, we have previously reported that doxorubicin treatment increases circulating levels of TGF beta in murine pre-clinical models. TGF beta has been implicated in promoting osteolytic bone damage, a consequence of increased osteoclast-mediated resorption and suppression of osteoblast differentiation. Therefore, we hypothesized that in a preclinical breast cancer bone metastasis model, administration of doxorubicin would accelerate bone loss in a TGF beta-mediated manner. Administration of doxorubicin to 4T1 tumor-bearing mice produced an eightfold increase in osteolytic lesion areas compared untreated tumor-bearing mice (P = 0.002) and an almost 50% decrease in trabecular bone volume expressed in BV/TV (P = 0.0005), both of which were rescued by anti-TGF beta antibody (1D11). Doxorubicin, which is a known inducer of oxidative stress, decreased osteoblast survival and differentiation, which was rescued by N-acetyl cysteine (NAC). Furthermore, doxorubicin treatment decreased Cu-ZnSOD (SOD1) expression and enzyme activity in vitro, and treatment with anti-TGF beta antibody was able to rescue both. In conclusion, a combination therapy using doxorubicin and anti-TGFb antibody might be beneficial for preventing therapy-related bone loss in cancer patients.	[Rana, Tapasi; Freeman, Michael; Biswas, Swati] Vanderbilt Univ, Sch Med, Dept Radiat Oncol, Nashville, TN 37212 USA; [Freeman, Michael; Biswas, Swati] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Chakrabarti, Anwesa] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Memphis, TN 38163 USA	Vanderbilt University; Vanderbilt University; University of Tennessee System; University of Tennessee Health Science Center	Biswas, S (corresponding author), Vanderbilt Univ, Sch Med, Dept Radiat Oncol, Nashville, TN 37212 USA.	swati.biswas@vanderbilt.edu			Building Interdisciplinary Research Careers in Women's Health (BIRCWH) grant; American Physical Society funding; Academic Project Support (APS)	Building Interdisciplinary Research Careers in Women's Health (BIRCWH) grant; American Physical Society funding; Academic Project Support (APS)	This work was supported by Building Interdisciplinary Research Careers in Women's Health (BIRCWH) grant, American Physical Society funding and Academic Project Support (APS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Altindag O, 2008, RHEUMATOL INT, V28, P317, DOI 10.1007/s00296-007-0452-0; Anderson PH, 2008, J BONE MINER RES, V23, P1789, DOI 10.1359/JBMR.080616; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bai XC, 2005, J BIOL CHEM, V280, P17497, DOI 10.1074/jbc.M409332200; Bai XC, 2004, BIOCHEM BIOPH RES CO, V314, P197, DOI 10.1016/j.bbrc.2003.12.073; Balooch G, 2005, P NATL ACAD SCI USA, V102, P18813, DOI 10.1073/pnas.0507417102; Bandyopadhyay A, 2006, CANCER RES, V66, P6714, DOI 10.1158/0008-5472.CAN-05-3565; Bandyopadhyay A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010365; Basu S, 2001, BIOCHEM BIOPH RES CO, V288, P275, DOI 10.1006/bbrc.2001.5747; BELLOWS CG, 1989, CELL TISSUE RES, V256, P145; Beyer TA, 2008, CELL CYCLE, V7, P874, DOI 10.4161/cc.7.7.5617; Biswas S, 2007, J CLIN INVEST, V117, P1305, DOI 10.1172/JCI30740; Biswas S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027090; Borton AJ, 2001, J BONE MINER RES, V16, P1754, DOI 10.1359/jbmr.2001.16.10.1754; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Buijs JT, 2011, CANCER MICROENVIRON, V4, P261, DOI 10.1007/s12307-011-0075-6; BUTLER WT, 1989, CONNECT TISSUE RES, V23, P123, DOI 10.3109/03008208909002412; Buttiglieri S, 2011, EXP HEMATOL, V39, P1171, DOI 10.1016/j.exphem.2011.08.009; Campbell JP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001363; Chen JH, 2005, ENDOCR-RELAT CANCER, V12, P93, DOI 10.1677/erc.1.00871; Choi YJ, 2012, INT J NANOMED, V7, P5091, DOI 10.2147/IJN.S31723; Delmas PD, 1998, EUR J CANCER, V34, P260, DOI 10.1016/S0959-8049(97)10135-6; Dittmar M., 2008, OPEN ANTHR J, V1, P38, DOI [10.2174/1874912700801010038, DOI 10.2174/1874912700801010038]; Edwards JR, 2010, J BONE MINER RES, V25, P2419, DOI 10.1002/jbmr.139; Emerit J, 2006, BIOMED PHARMACOTHER, V60, P1, DOI 10.1016/j.biopha.2005.09.002; Erlebacher A, 1996, J CELL BIOL, V132, P195, DOI 10.1083/jcb.132.1.195; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FRIEDLAENDER GE, 1984, J BONE JOINT SURG AM, V66A, P602, DOI 10.2106/00004623-198466040-00016; Gallwitz WE, 2002, J CLIN INVEST, V110, P1559, DOI 10.1172/JCI200211936; GARRETT IR, 1990, J CLIN INVEST, V85, P632, DOI 10.1172/JCI114485; Geiser AG, 1998, BONE, V23, P87, DOI 10.1016/S8756-3282(98)00078-7; Gevorgyan A, 2008, PLAST RECONSTR SURG, V122, P1025, DOI 10.1097/PRS.0b013e3181845931; GLACKIN CA, 1992, BIOCHEM INT, V28, P67; Guest I, 2000, IMMUNOPHARMACOLOGY, V46, P103, DOI 10.1016/S0162-3109(99)00168-X; Guise TA, 2006, ONCOLOGIST, V11, P1121, DOI 10.1634/theoncologist.11-10-1121; Hadji P, 2009, EUR J CANCER, V45, P3205, DOI 10.1016/j.ejca.2009.09.026; HOEKSTRA HJ, 1984, ARCH ORTHOP TRAUM SU, V103, P224, DOI 10.1007/BF00435559; Hussain SP, 2004, CANCER RES, V64, P2350, DOI 10.1158/0008-5472.CAN-2287-2; Isomura H, 2004, TOXICOLOGY, V197, P93, DOI 10.1016/j.tox.2003.12.006; Jacot W, 2012, BREAST CANCER RES TR, V134, P709, DOI 10.1007/s10549-012-2084-7; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Li JH, 2006, J AM SOC NEPHROL, V17, P2799, DOI 10.1681/ASN.2006020130; Lian N, 2012, J BIOL CHEM, V287, P35975, DOI 10.1074/jbc.M112.372458; Maggio D, 2003, J CLIN ENDOCR METAB, V88, P1523, DOI 10.1210/jc.2002-021496; Mody N, 2001, FREE RADICAL BIO MED, V31, P509, DOI 10.1016/S0891-5849(01)00610-4; Mohammad KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005275; Morinobu M, 2003, J BONE MINER RES, V18, P1706, DOI 10.1359/jbmr.2003.18.9.1706; Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036; Mundy GR, 1997, AM J MED, V103, P134, DOI 10.1016/S0002-9343(97)80047-2; MUNDY GR, 1978, NATURE, V275, P132, DOI 10.1038/275132a0; Mundy GR, 1997, CANCER-AM CANCER SOC, V80, P1546, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.3.CO;2-R; Nojiri H, 2011, J BONE MINER RES, V26, P2682, DOI 10.1002/jbmr.489; Noor Rana, 2002, Med Sci Monit, V8, pRA210; Ostman B, 2009, FREE RADICAL BIO MED, V47, P668, DOI 10.1016/j.freeradbiomed.2009.05.031; PFEILSCHIFTER J, 1990, ENDOCRINOLOGY, V127, P69, DOI 10.1210/endo-127-1-69; Proell Verena, 2007, Comp Hepatol, V6, P1, DOI 10.1186/1476-5926-6-1; ROBEY PG, 1985, CALCIFIED TISSUE INT, V37, P453, DOI 10.1007/BF02557826; Rock E, 2003, J NUTR, V133, p3785S, DOI 10.1093/jn/133.11.3785S; Rose AAN, 2007, MOL CANCER RES, V5, P1001, DOI 10.1158/1541-7786.MCR-07-0119; ROSENSTOCK JG, 1978, EUR J CANCER, V14, P799, DOI 10.1016/0014-2964(78)90012-9; Sanchez-Rodriguez MA, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-124; Sawyer JS, 2003, J MED CHEM, V46, P3953, DOI 10.1021/jm0205705; Shusterman S, 2000, CURR OPIN HEMATOL, V7, P217, DOI 10.1097/00062752-200007000-00004; Singh J, 2003, BIOORG MED CHEM LETT, V13, P4355, DOI 10.1016/j.bmcl.2003.09.028; Sledge GW, 2003, J CLIN ONCOL, V21, P588, DOI 10.1200/JCO.2003.08.013; Smietana MJ, 2010, BIOCHEM BIOPH RES CO, V403, P149, DOI 10.1016/j.bbrc.2010.11.006; van Leeuwen BL, 2000, ANN ONCOL, V11, P1121, DOI 10.1023/A:1008352620870; Vozenin-Brotons MC, 2001, FREE RADICAL BIO MED, V30, P30, DOI 10.1016/S0891-5849(00)00431-7; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wu CY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007061; Yalin S, 2005, CLIN EXP RHEUMATOL, V23, P689; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486; YOUNG DM, 1975, CALC TISS RES, V18, P47, DOI 10.1007/BF02546226; Zhou SY, 2001, TOXICOL LETT, V121, P151, DOI 10.1016/S0378-4274(01)00329-0; Zhu H, 2006, FREE RADICAL BIO MED, V41, P132, DOI 10.1016/j.freeradbiomed.2006.03.020	80	36	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78043	10.1371/journal.pone.0078043	http://dx.doi.org/10.1371/journal.pone.0078043			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205081	Green Published, gold			2022-12-27	WOS:000326334500092
J	Chun, S; Plunkett, J; Teramo, K; Muglia, LJ; Fay, JC				Chun, Sung; Plunkett, Jevon; Teramo, Kari; Muglia, Louis J.; Fay, Justin C.			Fine-Mapping an Association of FSHR with Preterm Birth in a Finnish Population	PLOS ONE			English	Article							STIMULATING-HORMONE RECEPTOR; GENETIC CONTRIBUTIONS; REGULATORY ELEMENTS; DNA-BINDING; IN-VITRO; PREGNANCIES; PROTEIN; FERTILIZATION; EXPRESSION; MYOMETRIAL	Preterm birth is a complex disorder defined by gestations of less than 37 weeks. While preterm birth is estimated to have a significant genetic component, relative few genes have been associated with preterm birth. Polymorphism in one such gene, follicle-stimulating hormone receptor (FSHR), has been associated with preterm birth in Finnish and African American mothers but not other populations. To refine the genetic association of FSHR with preterm birth we conducted a fine-mapping study at the FSHR locus in a Finnish cohort. We sequenced a total of 44 kb, including protein-coding and conserved non-coding regions, in 127 preterm and 135 term mothers. Overall, we identified 288 single nucleotide variants and 65 insertion/deletions of 1-2 bp across all subjects. While no common SNPs in protein-coding regions were associated with preterm birth, including one previously associated with timing of fertilization, multiple SNPs spanning the first and second intron showed the strongest associations. Analysis of the associated SNPs revealed that they form both a protective (OR = 0.50, 95% CI = 0.25-0.93) as well as a risk (OR = 1.89, 95% CI = 1.08-3.39) haplotype with independent effects. In these haplotypes, two SNPs, rs12052281 and rs72822025, were predicted to disrupt ZEB1 and ELF3 transcription factor binding sites, respectively. Our results show that multiple haplotypes at FSHR are associated with preterm birth and we discuss the frequency and structure of these haplotypes outside of the Finnish population as a potential explanation for the absence of FSHR associations in some populations.	[Chun, Sung; Fay, Justin C.] Washington Univ, Computat & Syst Biol Program, St Louis, MO 63130 USA; [Plunkett, Jevon] Washington Univ, Program Human & Stat Genet, St Louis, MO USA; [Teramo, Kari] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland; [Muglia, Louis J.] Cincinnati Childrens Hosp Med Ctr, Ctr Prevent Preterm Birth, Cincinnati, OH 45229 USA; [Fay, Justin C.] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Fay, Justin C.] Washington Univ, Ctr Genome Sci & Syst Biol, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); University of Helsinki; Helsinki University Central Hospital; Cincinnati Children's Hospital Medical Center; Washington University (WUSTL); Washington University (WUSTL)	Fay, JC (corresponding author), Washington Univ, Computat & Syst Biol Program, St Louis, MO 63130 USA.	jfay@genetics.wustl.edu	Chun, Sung/I-2212-2015	Chun, Sung/0000-0003-3440-1913; Fay, Justin/0000-0003-1893-877X	National Institutes of Health [GM080669]; Children's Discovery Institute of Washington University; St. Louis Children's Hospital; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080669] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Discovery Institute of Washington University; St. Louis Children's Hospital; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a National Institutes of Health Grant (GM080669) to JCF and by the Children's Discovery Institute of Washington University and St. Louis Children's Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MM, 2000, JAMA-J AM MED ASSOC, V283, P1591, DOI 10.1001/jama.283.12.1591; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; AITTOMAKI K, 1995, CELL, V82, P959, DOI 10.1016/0092-8674(95)90275-9; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bethin KE, 2003, MOL ENDOCRINOL, V17, P1454, DOI 10.1210/me.2003-0007; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Celik O, 2008, FERTIL STERIL, V90, P1348, DOI 10.1016/j.fertnstert.2007.07.1391; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Clausson B, 2000, BRIT J OBSTET GYNAEC, V107, P375, DOI 10.1111/j.1471-0528.2000.tb13234.x; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Courbiere B, 2011, FERTIL STERIL, V95, P1629, DOI 10.1016/j.fertnstert.2010.12.015; Doherty E, 2002, J CLIN ENDOCR METAB, V87, P1151, DOI 10.1210/jc.87.3.1151; Dolan SM, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-S1-S4; Druley TE, 2009, NAT METHODS, V6, P263, DOI [10.1038/NMETH.1307, 10.1038/nmeth.1307]; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; George JW, 2011, BIOL REPROD, V84, P7, DOI 10.1095/biolreprod.110.085043; Greb RR, 2005, J CLIN ENDOCR METAB, V90, P4866, DOI 10.1210/jc.2004-2268; Gromoll J, 2005, TRENDS ENDOCRIN MET, V16, P368, DOI 10.1016/j.tem.2005.05.011; GROMOLL J, 1994, MOL CELL ENDOCRINOL, V102, P93, DOI 10.1016/0303-7207(94)90102-3; Hascalik S, 2010, MOL HUM REPROD, V16, P200, DOI 10.1093/molehr/gap076; Hermann BP, 2005, MOL ENDOCRINOL, V19, P2112, DOI 10.1210/me.2004-0244; Hermann BP, 2007, MOL CELL ENDOCRINOL, V260, P49, DOI 10.1016/j.mce.2006.01.017; Holdsworth-Carson SJ, 2009, PLACENTA, V30, P176, DOI 10.1016/j.placenta.2008.11.013; Howson CP, 2012, BORN SOON GLOBAL ACT; IKEDA K, 1995, EUR J BIOCHEM, V233, P73, DOI 10.1111/j.1432-1033.1995.073_1.x; Kistka ZA, 2008, AM J OBSTET GYNECOL, V199, pe1, DOI DOI 10.1016/J.AJ0G.2007.12.014; Kistka ZAF, 2007, AM J OBSTET GYNECOL, V196, P241, DOI [10.1016/j.ajog.2006.10.873, 10.1016/j.ajog.2006.06.093]; Kornyei JL, 1996, EUR J ENDOCRINOL, V134, P225, DOI 10.1530/eje.0.1340225; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Lalioti MD, 2011, CURR OPIN OBSTET GYN, V23, P158, DOI 10.1097/GCO.0b013e3283455288; Li Y, 2011, GENOME RES, V21, P940, DOI 10.1101/gr.117259.110; Lussiana C, 2008, OBSTET GYNECOL SURV, V63, P785, DOI 10.1097/OGX.0b013e31818957eb; Martin Joyce A, 2010, NCHS Data Brief, P1; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mitra RD, 2003, P NATL ACAD SCI USA, V100, P5926, DOI 10.1073/pnas.0936399100; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Omigbodun AO, 1997, J NATL MED ASSOC, V89, P617; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Patel RR, 2004, INT J EPIDEMIOL, V33, P107, DOI 10.1093/ije/dyg238; Plunkett J, 2008, ANN MED, V40, P167, DOI 10.1080/07853890701806181; Plunkett J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001365; Plunkett J, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-44; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Renthal NE, 2010, P NATL ACAD SCI USA, V107, P20828, DOI 10.1073/pnas.1008301107; Romundstad LB, 2008, LANCET, V372, P737, DOI 10.1016/S0140-6736(08)61041-7; Rozen S, 2000, Methods Mol Biol, V132, P365; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Shemesh M, 2001, SEMIN REPROD MED, V19, P87, DOI 10.1055/s-2001-13915; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Treloar S A, 2000, Twin Res, V3, P80, DOI 10.1375/twin.3.2.80; Urato AC, 2011, BEST PRACT RES CL OB, V25, P367, DOI 10.1016/j.bpobgyn.2011.01.003; Uzun A, 2013, GENOMICS, V101, P163, DOI 10.1016/j.ygeno.2012.12.005; Vallania F, 2012, JOVE-J VIS EXP, V64, P3943; Vallania FLM, 2010, GENOME RES, V20, P1711, DOI 10.1101/gr.109157.110; Ward K, 2005, OBSTET GYNECOL, V106, P1235, DOI 10.1097/01.AOG.0000189091.35982.85; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; York TP, 2009, TWIN RES HUM GENET, V12, P333, DOI 10.1375/twin.12.4.333	57	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78032	10.1371/journal.pone.0078032	http://dx.doi.org/10.1371/journal.pone.0078032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205076	Green Submitted, Green Published, gold			2022-12-27	WOS:000326270700066
J	Cruz, SA; Lin, CH; Chao, PL; Hwang, PP				Cruz, Shelly Abad; Lin, Chia-Hao; Chao, Pei-Lin; Hwang, Pung-Pung			Glucocorticoid Receptor, but Not Mineralocorticoid Receptor, Mediates Cortisol Regulation of Epidermal Ionocyte Development and Ion Transport in Zebrafish (Danio Rerio)	PLOS ONE			English	Article							TILAPIA OREOCHROMIS-MOSSAMBICUS; MITOCHONDRIA-RICH CELLS; MESSENGER-RNA LEVELS; RAINBOW-TROUT; ONCORHYNCHUS-MYKISS; IN-VITRO; GILL EPITHELIUM; CHLORIDE CELLS; JAPANESE EEL; PROTON PUMP	Cortisol is the major endogenous glucocorticoid (GC) both in human and fish, mediated by corticosteroid receptors. Due to the absence of aldosterone production in teleost fish, cortisol is also traditionally accepted to function as mineralocorticoid (MC); but whether it acts through the glucocorticoid receptor (GR) or the mineralocorticoid receptor (MR) remains a subject of debate. Here, we used loss-of-function and rescue assays to determine whether cortisol affects zebrafish epidermal ionocyte development and function via the GR and/or the MR. GR knockdown morphants displayed a significant decrease in the major ionocytes, namely Na+-K+-ATPase-rich cells (NaRCs) and H+-ATPase-rich cells (HRCs), as well as other cells, including epidermal stem cells (ESCs), keratinocytes, and mucus cells; conversely, cell numbers were unaffected in MR knockdown morphants. In agreement, GR morphants, but not MR morphants, exhibited decreased NaRC-mediated Ca2+ uptake and HRC-mediated H+ secretion. Rescue via GR capped mRNA injection or exogenous cortisol incubation normalized the number of epidermal ionocytes in GR morphants. We also provide evidence for GR localization in epidermal cells. At the transcript level, GR mRNA is ubiquitously expressed in gill sections and present in both NaRCs and HRCs, supporting the knockdown and functional assay results in embryo. Altogether, we have provided solid molecular evidence that GR is indeed present on ionocytes, where it mediates the effects of cortisol on ionocyte development and function. Hence, cortisol-GR axis performs the roles of both GC and MC in zebrafish skin and gills.	[Cruz, Shelly Abad; Lin, Chia-Hao; Chao, Pei-Lin; Hwang, Pung-Pung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan	Academia Sinica - Taiwan	Hwang, PP (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan.	pphwang@gate.sinica.edu.tw	hwang, pp/A-3641-2011; Hwang, Pung-Pung/AAH-1538-2022; Lin, Chia-Hao/AHC-6514-2022; Hwang, Pung-Pung/AEQ-4633-2022		National Science Council; Academia Sinica, Taiwan, ROC	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica, Taiwan, ROC(Academia Sinica - Taiwan)	This study was financially supported by grants to P. P. Hwang from the National Science Council, and Academia Sinica, Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Fifi Z. I. A., 2006, Biotechnology, V5, P455; Alderman SL, 2009, GEN COMP ENDOCR, V164, P61, DOI 10.1016/j.ygcen.2009.04.007; Alsop D, 2008, AM J PHYSIOL-REG I, V294, pR711, DOI 10.1152/ajpregu.00671.2007; Aruna A, 2012, GEN COMP ENDOCR, V179, P465, DOI 10.1016/j.ygcen.2012.08.028; BOHN MC, 1994, ANN NY ACAD SCI, V746, P243; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Bury NR, 2003, J MOL ENDOCRINOL, V31, P141, DOI 10.1677/jme.0.0310141; Carroll SM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002117; Chandrasekar G, 2007, J COMP NEUROL, V505, P337, DOI 10.1002/cne.21496; Chang WJ, 2011, BIRTH DEFECTS RES C, V93, P205, DOI 10.1002/bdrc.20215; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; Colombe L, 2000, STEROIDS, V65, P319, DOI 10.1016/S0039-128X(00)00090-8; COLOMBO L, 1972, ENDOCRINOLOGY, V91, P450, DOI 10.1210/endo-91-2-450; Cruz SA, 2010, COMP BIOCHEM PHYS A, V156, P190, DOI 10.1016/j.cbpa.2010.01.019; Cruz SA, 2013, COMP BIOCHEM PHYS A, V164, P249, DOI 10.1016/j.cbpa.2012.09.011; Deane EE, 2005, BIOCHEM BIOPH RES CO, V331, P1229, DOI 10.1016/j.bbrc.2005.04.038; Delyani JA, 2000, KIDNEY INT, V57, P1408, DOI 10.1046/j.1523-1755.2000.00983.x; EDWARDS CRW, 1988, LANCET, V2, P986, DOI 10.1016/S0140-6736(88)90742-8; Esaki M, 2007, AM J PHYSIOL-REG I, V292, pR470, DOI 10.1152/ajpregu.00200.2006; Evans DH, 2005, PHYSIOL REV, V85, P97, DOI 10.1152/physrev.00050.2003; Farman N, 2001, AM J PHYSIOL-RENAL, V280, pF181, DOI 10.1152/ajprenal.2001.280.2.F181; Frindt G, 2012, AM J PHYSIOL-RENAL, V302, pF20, DOI 10.1152/ajprenal.00480.2011; Fuller PJ, 2012, J ENDOCRINOL, V213, P15, DOI 10.1530/JOE-11-0372; FUNDER JW, 1988, SCIENCE, V242, P583, DOI 10.1126/science.2845584; GALAVERNA O, 1992, BRAIN RES BULL, V28, P89, DOI 10.1016/0361-9230(92)90234-O; Hadley ME, 2000, ENDOCRINOLOGY; Heitzer MD, 2007, REV ENDOCR METAB DIS, V8, P321, DOI 10.1007/s11154-007-9059-8; Hellal-Levy C, 2000, KIDNEY INT, V57, P1250, DOI 10.1046/j.1523-1755.2000.00958.x; Herzog W, 2004, MOL ENDOCRINOL, V18, P1185, DOI 10.1210/me.2003-0376; Hiroi J, 1999, J EXP BIOL, V202, P3485; Horng JL, 2007, AM J PHYSIOL-REG I, V292, pR2068, DOI 10.1152/ajpregu.00578.2006; Hsiao CD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000302; Hwang PP, 2007, COMP BIOCHEM PHYS A, V148, P479, DOI 10.1016/j.cbpa.2007.06.416; Hwang PP, 2013, PFLUG ARCH EUR J PHY, V465, P1233, DOI 10.1007/s00424-013-1269-1; Hwang PP, 2011, AM J PHYSIOL-REG I, V301, pR28, DOI 10.1152/ajpregu.00047.2011; Hwang PP, 2010, FISH PHYSIOL, V29, P311, DOI 10.1016/S1546-5098(10)02908-0; Janicke M, 2007, DEV BIOL, V307, P258, DOI 10.1016/j.ydbio.2007.04.044; Jiang JQ, 1998, MOL CELL ENDOCRINOL, V146, P207, DOI 10.1016/S0303-7207(98)00147-6; Katoh F, 2003, J EXP BIOL, V206, P793, DOI 10.1242/jeb.00159; Kiilerich P, 2007, J ENDOCRINOL, V194, P417, DOI 10.1677/JOE-07-0185; Kiilerich P, 2011, J ENDOCRINOL, V209, P221, DOI 10.1530/JOE-10-0371; Kiilerich P, 2011, J ENDOCRINOL, V209, P115, DOI 10.1530/JOE-10-0326; Kumai Y, 2012, MOL CELL ENDOCRINOL, V364, P113, DOI 10.1016/j.mce.2012.08.017; LAURENT P, 1994, FISH PHYSIOL BIOCHEM, V13, P353, DOI 10.1007/BF00003415; Liao BK, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-354; Lin CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045650; Lin CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023689; Lin GR, 1999, PHYSIOL BIOCHEM ZOOL, V72, P397, DOI 10.1086/316682; LIN H, 1993, J EXP BIOL, V180, P163; Lin LY, 2006, AM J PHYSIOL-CELL PH, V290, pC371, DOI 10.1152/ajpcell.00281.2005; Liu NA, 2003, MOL ENDOCRINOL, V17, P959, DOI 10.1210/me.2002-0392; Lohr H, 2011, ANNU REV PHYSIOL, V73, P183, DOI 10.1146/annurev-physiol-012110-142320; Mathew LK, 2007, J BIOL CHEM, V282, P35202, DOI 10.1074/jbc.M706640200; MCCORMICK SD, 1990, AM J PHYSIOL, V259, pR857, DOI 10.1152/ajpregu.1990.259.4.R857; McCormick SD, 2006, GEN COMP ENDOCR, V147, P3, DOI 10.1016/j.ygcen.2005.12.009; McCormick SD, 2001, AM ZOOL, V41, P781, DOI 10.1668/0003-1569(2001)041[0781:ECOOIT]2.0.CO;2; McCormick SD, 2008, GEN COMP ENDOCR, V157, P35, DOI 10.1016/j.ygcen.2008.03.024; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; Pan TC, 2005, AM J PHYSIOL-REG I, V289, pR1202, DOI 10.1152/ajpregu.00816.2004; Pascual-Le Tallec L, 2005, MOL ENDOCRINOL, V19, P2211, DOI 10.1210/me.2005-0089; PERRY SF, 1989, J EXP BIOL, V147, P147; Prunet P, 2006, GEN COMP ENDOCR, V147, P17, DOI 10.1016/j.ygcen.2006.01.015; Rashid S, 2005, CLIN BIOCHEM, V38, P401, DOI 10.1016/j.clinbiochem.2004.11.009; Schaaf MJM, 2008, ENDOCRINOLOGY, V149, P1591, DOI 10.1210/en.2007-1364; Scott GR, 2001, J COMP PHYSIOL B, V175, P499; Shahsavarani A, 2006, AM J PHYSIOL-REG I, V291, pR1490, DOI 10.1152/ajpregu.00026.2006; Shih TH, 2013, AM J PHYSL REGUL INT; Shrimpton JM, 1999, J EXP BIOL, V202, P987; Sloman KA, 2001, J EXP BIOL, V204, P3953; STEPHENSON G, 1984, AM J PHYSIOL, V247, pF665, DOI 10.1152/ajprenal.1984.247.4.F665; Sturm A, 2005, ENDOCRINOLOGY, V146, P47, DOI 10.1210/en.2004-0128; To TT, 2007, MOL ENDOCRINOL, V21, P472, DOI 10.1210/me.2006-0216; Uchida K, 1998, GEN COMP ENDOCR, V109, P175, DOI 10.1006/gcen.1997.7019; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Wong CKC, 1999, AM J PHYSIOL-REG I, V277, pR517, DOI 10.1152/ajpregu.1999.277.2.R517; Wong CKC, 2001, J ENDOCRINOL, V168, P185, DOI 10.1677/joe.0.1680185; Yan JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1814, DOI 10.1152/ajpcell.00358.2007	78	60	60	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77997	10.1371/journal.pone.0077997	http://dx.doi.org/10.1371/journal.pone.0077997			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205060	Green Submitted, gold, Green Published			2022-12-27	WOS:000326270700065
J	Merkado, G; Holzmann, M; Apotheloz-Perret-Gentil, L; Pawlowski, J; Abdu, U; Almogi-Labin, A; Hyams-Kaphzan, O; Bakhrat, A; Abramovich, S				Merkado, Gily; Holzmann, Maria; Apotheloz-Perret-Gentil, Laure; Pawlowski, Jan; Abdu, Uri; Almogi-Labin, Ahuva; Hyams-Kaphzan, Orit; Bakhrat, Anna; Abramovich, Sigal			Molecular Evidence for Lessepsian Invasion of Soritids (Larger Symbiont Bearing Benthic Foraminifera)	PLOS ONE			English	Article							MEDITERRANEAN SEA; SHELF; AMPHISTEGINA	The Mediterranean Sea is considered as one of the hotspots of marine bioinvasions, largely due to the influx of tropical species migrating through the Suez Canal, so-called Lessepsian migrants. Several cases of Lessepsian migration have been documented recently, however, little is known about the ecological characteristics of the migrating species and their aptitude to colonize the new areas. This study focused on Red Sea soritids, larger symbiont-bearing benthic foraminifera (LBF) that are indicative of tropical and subtropical environments and were recently found in the Israeli coast of the Eastern Mediterranean. We combined molecular phylogenetic analyses of soritids and their algal symbionts as well as network analysis of Sorites orbiculus Forskal to compare populations from the Gulf of Elat (northern Red Sea) and from a known hotspot in Shikmona (northern Israel) that consists of a single population of S. orbiculus. Our phylogenetic analyses show that all specimens found in Shikmona are genetically identical to a population of S. orbiculus living on a similar shallow water pebbles habitat in the Gulf of Elat. Our analyses also show that the symbionts found in Shikmona and Elat soritids belong to the Symbiodinium clade F5, which is common in the Red Sea and also present in the Indian Ocean and Caribbean Sea. Our study therefore provides the first genetic and ecological evidences that indicate that modern population of soritids found on the Mediterranean coast of Israel is probably Lessepsian, and is less likely the descendant of a native ancient Mediterranean species.	[Merkado, Gily; Abdu, Uri; Bakhrat, Anna; Abramovich, Sigal] Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel; [Holzmann, Maria; Apotheloz-Perret-Gentil, Laure; Pawlowski, Jan] Univ Geneva, Dept Genet & Evolut, Geneva, Switzerland; [Almogi-Labin, Ahuva; Hyams-Kaphzan, Orit] Geol Survey Israel, IL-95501 Jerusalem, Israel	Ben Gurion University; University of Geneva; Geological Survey Israel	Abramovich, S (corresponding author), Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel.	sigalabr@bgu.ac.il	Abramovich, Sigal/AAR-5034-2021; Pawlowski, Jan/AAO-3306-2021	Abramovich, Sigal/0000-0003-3124-1387; Pawlowski, Jan/0000-0003-2421-388X; Almogi-Labin, Ahuva/0000-0002-4082-7120	Israel Science Foundation [587/2013]; Israeli Ministry of National Infrastructure [27-17-005]; Swiss National Science Foundation [31003A_140766]; G. & A. Claraz Donation	Israel Science Foundation(Israel Science Foundation); Israeli Ministry of National Infrastructure; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); G. & A. Claraz Donation	The research was supported by the Israel Science Foundation grant No 587/2013, by the Israeli Ministry of National Infrastructure grant no. 27-17-005 and by the Swiss National Science Foundation grant 31003A_140766 and by a G. & A. Claraz Donation (JP, MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arieli RN, 2011, MAR POLLUT BULL, V62, P1002, DOI 10.1016/j.marpolbul.2011.02.036; AVITAL A, 2002, THESIS BENGURION U N; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Galil BS, 2008, HYDROBIOLOGIA, V606, P105, DOI 10.1007/s10750-008-9342-z; Garcia-Cuetos L, 2005, PROTIST, V156, P399, DOI 10.1016/j.protis.2005.08.003; GELABERT ER, 2007, MARINE COASTAL ENV E, P208; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gruber Limor, 2007, Rapport du Congress de la CIESM, V38, P491; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Herut B, 2000, OCEANOL ACTA, V23, P771, DOI 10.1016/S0399-1784(00)01118-X; Holzmann M, 2001, MAR MICROPALEONTOL, V43, P57, DOI 10.1016/S0377-8398(01)00021-4; Hottinger L., 1993, DELA SLOVENSKA AKAD, V33, P179; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hyams Orit, 2002, Israel Journal of Earth Sciences, V51, P169, DOI 10.1560/QAE1-KTEE-2K2L-QPCH; Hyams-Kaphzan O, 2008, NEUES JAHRB GEOL P-A, V248, P315, DOI 10.1127/0077-7749/2008/0248-0315; Koukousioura O, 2010, MEDITERR MAR SCI, V11, P155, DOI 10.12681/mms.98; Langer M.R., 1991, MEDITERRANEAN FORAMI; Langer M.R., 2008, AQABA EILAT IMPROBAB, P397; Langer MR, 2012, J FORAMIN RES, V42, P234, DOI 10.2113/gsjfr.42.3.234; Langer MR, 2000, MICROPALEONTOLOGY, V46, P105; Lazar S., 2007, GSI082007; Meric E, 2010, AQUAT INVASIONS, V5, P191, DOI 10.3391/ai.2010.5.2.10; Pawlowski J, 2000, MICROPALEONTOLOGY, V46, P1; Perelis-Grossowicz L., 2008, AQABA EILAT IMPROBAB, P439; Por FD, 2010, INTEGR ZOOL, V5, P112, DOI 10.1111/j.1749-4877.2010.00194.x; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Reiss Z., 1984, GULF AQABA ECOLOGICA; Reiss Z, 1961, GEOLOGICAL SURVEY IS, V32, P10; RENEMA W., 2002, SCRIPTA GEOLOGICA, V124, P1, DOI DOI 10.1016/S0016-6995(95)80209-6; Rilov G, 2002, MAR ENVIRON RES, V54, P85, DOI 10.1016/S0141-1136(02)00096-X; Rilov G, 2009, ECOLOGICAL STUDIES S; Rilov Gil, 2009, V204, P549; Schmidt C, 2011, LIMNOL OCEANOGR, V56, P1587, DOI 10.4319/lo.2011.56.5.1587; SPANIER E, 1991, ENDEAVOUR, V15, P102, DOI 10.1016/0160-9327(91)90152-2; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; STIPS AK, 2006, GEOPH RES ABSTR, V8; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Toueg R., 1996, THESIS U HAIFA HAIFA; VERA JD, 2006, MED SEA LEV AN 1992; Williams DE, 2004, MAR BIOL, V145, P641, DOI 10.1007/s00227-004-1351-5; Zenetos A, 2010, MEDITERR MAR SCI, V11, P381, DOI 10.12681/mms.87	41	16	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77725	10.1371/journal.pone.0077725	http://dx.doi.org/10.1371/journal.pone.0077725			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204936	Green Published, Green Submitted, gold			2022-12-27	WOS:000326270700052
J	Fuentes, TI; Appleby, N; Tsay, E; Martinez, JJ; Bailey, L; Hasaniya, N; Kearns-Jonker, M				Fuentes, Tania I.; Appleby, Nancy; Tsay, Eric; Martinez, J. Julian; Bailey, Leonard; Hasaniya, Nahidh; Kearns-Jonker, Mary			Human Neonatal Cardiovascular Progenitors: Unlocking the Secret to Regenerative Ability	PLOS ONE			English	Article							CARDIAC STEM-CELLS; CARDIOSPHERE-DERIVED CELLS; RANDOMIZED PHASE-1 TRIAL; HEART-FAILURE; MYOCARDIAL-INFARCTION; CANCER-CELLS; INVASION; SENESCENCE; EXPRESSION; MICRORNAS	Although clinical benefit can be achieved after cardiac transplantation of adult c-kit+ or cardiosphere-derived cells for myocardial repair, these stem cells lack the regenerative capacity unique to neonatal cardiovascular stem cells. Unraveling the molecular basis for this age-related discrepancy in function could potentially transform cardiovascular stem cell transplantation. In this report, clonal populations of human neonatal and adult cardiovascular progenitor cells were isolated and characterized, revealing the existence of a novel subpopulation of endogenous cardiovascular stem cells that persist throughout life and co-express both c-kit and isl1. Epigenetic profiling identified 41 microRNAs whose expression was significantly altered with age in phenotypically-matched clones. These differences were correlated with reduced proliferation and a limited capacity to invade in response to growth factor stimulation, despite high levels of growth factor receptor on progenitors isolated from adults. Further understanding of these differences may provide novel therapeutic targets to enhance cardiovascular regenerative capacity.	[Fuentes, Tania I.; Appleby, Nancy; Tsay, Eric; Martinez, J. Julian; Kearns-Jonker, Mary] Loma Linda Univ, Sch Med, Dept Pathol & Human Anat, Loma Linda, CA 92350 USA; [Bailey, Leonard; Hasaniya, Nahidh] Loma Linda Univ, Sch Med, Dept Cardiothorac Surg, Loma Linda, CA USA	Loma Linda University; Loma Linda University	Kearns-Jonker, M (corresponding author), Loma Linda Univ, Sch Med, Dept Pathol & Human Anat, Loma Linda, CA 92350 USA.	mkearnsjonker@llu.edu		Kearns-Jonker, Mary/0000-0002-8989-3698	Loma Linda University Medical Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060507] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006988] Funding Source: NIH RePORTER	Loma Linda University Medical Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The work was supported using Loma Linda University Medical Center start-up funds to MKJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner A, 2011, J MOL MED, V89, P445, DOI 10.1007/s00109-010-0716-0; Amir G, 2008, ANN THORAC SURG, V86, P1311, DOI 10.1016/j.athoracsur.2008.06.058; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Bondue A, 2011, J CELL BIOL, V192, P751, DOI 10.1083/jcb.201007063; Campaner S, 2010, NAT CELL BIOL, V12, P54, DOI 10.1038/ncb2004; Cesselli D, 2011, AM J PATHOL, V179, P349, DOI 10.1016/j.ajpath.2011.03.036; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Coller HA, 2007, PLOS GENET, V3, P1319, DOI 10.1371/journal.pgen.0030146; D'Amario D, 2011, CIRC RES, V108, P1467, DOI 10.1161/CIRCRESAHA.111.240648; D'Amario D, 2011, CIRC RES, V108, P857, DOI 10.1161/CIRCRESAHA.111.241380; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eulalio A, 2012, NATURE, V492, P376, DOI 10.1038/nature11739; Ferreira-Martins J, 2012, CIRC RES, V110, P701, DOI 10.1161/CIRCRESAHA.111.259507; Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329; Hidaka K, 2010, CIRC RES, V106, P111, DOI 10.1161/CIRCRESAHA.109.209478; Hong LX, 2010, CANCER RES, V70, P8547, DOI 10.1158/0008-5472.CAN-10-1938; Hou X., 2012, J CLIN EXPT CARDIOLO, VS6; Itzhaki-Alfia A, 2009, CIRCULATION, V120, P2559, DOI 10.1161/CIRCULATIONAHA.109.849588; Jesty SA, 2012, P NATL ACAD SCI USA, V109, P13380, DOI 10.1073/pnas.1208114109; Kearns-Jonker M, 2012, J STEM CELL RES TH S, VS1; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Li BQ, 2011, PROSTATE, V71, P567, DOI 10.1002/pros.21272; Li SJ, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-24; Liu H, 2010, TUMORI J, V96, P751, DOI 10.1177/030089161009600518; Liu XH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-348; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Malliaras K, 2012, CIRCULATION, V125, P100, DOI 10.1161/CIRCULATIONAHA.111.042598; Mishra R, 2011, CIRCULATION, V123, P364, DOI 10.1161/CIRCULATIONAHA.110.971622; Montgomery RL, 2011, CIRCULATION, V124, P1537, DOI 10.1161/CIRCULATIONAHA.111.030932; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Peng SB, 2005, MOL CANCER RES, V3, P227; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Pickering MT, 2009, ONCOGENE, V28, P140, DOI 10.1038/onc.2008.372; Pietra BA, 2000, J CLIN INVEST, V106, P1003, DOI 10.1172/JCI10467; Qian L, 2011, J EXP MED, V208, P549, DOI 10.1084/jem.20101547; Robinson K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005951; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Serradifalco C, 2011, EUR J HISTOCHEM, V55, P229, DOI 10.4081/ejh.2011.e41; Simpson DL, 2012, CIRCULATION, V126, pS46, DOI 10.1161/CIRCULATIONAHA.111.084699; Sirish P, 2012, J MOL CELL CARDIOL, V52, P264, DOI 10.1016/j.yjmcc.2011.10.012; Smits AM, 2009, NAT PROTOC, V4, P232, DOI 10.1038/nprot.2008.229; Sussman MA, 2012, CIRC RES, V110, P1267, DOI 10.1161/CIRCRESAHA.112.268995; Tang JM, 2011, CARDIOVASC RES, V91, P402, DOI 10.1093/cvr/cvr053; Tang YL, 2009, CIRC RES, V104, P1209, DOI 10.1161/CIRCRESAHA.109.197723; Tarnowski M, 2010, EUR J HAEMATOL, V85, P472, DOI 10.1111/j.1600-0609.2010.01531.x; Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50; Trompeter HI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016138; Ucar A, 2010, NAT GENET, V42, P1101, DOI 10.1038/ng.709; Van Slambrouck S, 2007, BIOCHEM J, V401, P689, DOI 10.1042/BJ20060944; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Yu DQ, 2012, ONCOL LETT, V3, P1221, DOI 10.3892/ol.2012.638; Yu T, 2011, MOL CANCER RES, V9, P161, DOI 10.1158/1541-7786.MCR-10-0386	57	18	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77464	10.1371/journal.pone.0077464	http://dx.doi.org/10.1371/journal.pone.0077464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204836	Green Published, gold, Green Submitted			2022-12-27	WOS:000326241200029
J	Teo, BG; Dhillon, SK; Lim, LHS				Teo, Bee Guan; Dhillon, Sarinder Kaur; Lim, Lee Hong Susan			A Deformable Generic 3D Model of Haptoral Anchor of Monogenean	PLOS ONE			English	Article							ARIID FISHES; ANCYROCEPHALIDAE; POLYSTOMATIDAE; BYCHOWSKY; YAMAGUTI; NAGIBINA; NURBS	In this paper, a digital 3D model which allows for visualisation in three dimensions and interactive manipulation is explored as a tool to help us understand the structural morphology and elucidate the functions of morphological structures of fragile microorganisms which defy live studies. We developed a deformable generic 3D model of haptoral anchor of dactylogyridean monogeneans that can subsequently be deformed into different desired anchor shapes by using direct manipulation deformation technique. We used point primitives to construct the rectangular building blocks to develop our deformable 3D model. Point primitives are manually marked on a 2D illustration of an anchor on a Cartesian graph paper and a set of Cartesian coordinates for each point primitive is manually extracted from the graph paper. A Python script is then written in Blender to construct 3D rectangular building blocks based on the Cartesian coordinates. The rectangular building blocks are stacked on top or by the side of each other following their respective Cartesian coordinates of point primitive. More point primitives are added at the sites in the 3D model where more structural variations are likely to occur, in order to generate complex anchor structures. We used Catmull-Clark subdivision surface modifier to smoothen the surface and edge of the generic 3D model to obtain a smoother and more natural 3D shape and antialiasing option to reduce the jagged edges of the 3D model. This deformable generic 3D model can be deformed into different desired 3D anchor shapes through direct manipulation deformation technique by aligning the vertices (pilot points) of the newly developed deformable generic 3D model onto the 2D illustrations of the desired shapes and moving the vertices until the desire 3D shapes are formed. In this generic 3D model all the vertices present are deployed for displacement during deformation.	[Teo, Bee Guan; Dhillon, Sarinder Kaur; Lim, Lee Hong Susan] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia	Universiti Malaya	Lim, LHS (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia.	susan@um.edu.my	Lim, Susan Lee Hong/B-1075-2009; Dhillon, Sarinder Kaur/B-5320-2009	Dhillon, Sarinder Kaur/0000-0003-1922-2044	Sustainability Science Research Cluster, University of Malaya, Kuala Lumpur [FL001-2011]	Sustainability Science Research Cluster, University of Malaya, Kuala Lumpur	This project is funded by grant no. FL001-2011 provided by the Sustainability Science Research Cluster, University of Malaya, Kuala Lumpur (http://susci.um.edu.my/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GR, 2012, 2012965 AIAA; Bates KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004532; Berry RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010771; Chen Li, 2012, Proceedings of the 2012 International Conference on Wavelet Analysis and Pattern Recognition (ICWAPR), P62, DOI 10.1109/ICWAPR.2012.6294756; Chinthamani S., 2010, International Journal of Research and Reviews in Computer Science, V1, P29; COQUILLART S., 1990, COMPUT GRAPH, V24, P187, DOI [DOI 10.1145/97880.97900, DOI 10.1145/97879.97900]; CROW F, 1987, IEEE COMPUT GRAPH, V7, P8, DOI 10.1109/MCG.1987.277023; Dohnalkova A, 2007, MICROSC MICROANAL, V13, P1338; du Preez LH, 2000, FOLIA PARASIT, V47, P11, DOI 10.14411/fp.2000.003; du Preez LH, 2003, AFRICAN ZOOLOGY, V39, P225; Dunn F., 2011, 3D MATH PRIMER GRAPH, V2nd; Fu CS, 2010, INT ARCH PHOTOGRAMME, V37, P203; Galli P, 2006, J PARASITOL, V92, P395, DOI 10.1645/GE-3544RN.1; Gusev A.V., 1976, INDIAN J HELMINTH, V25, P1; Halton DW, 2004, CAN J ZOOL, V82, P316, DOI [10.1139/z03-221, 10.1139/Z03-221]; HSU WM, 1992, COMP GRAPH, V26, P177, DOI 10.1145/142920.134036; Johnson K, 2008, ILAR J, V49, P27, DOI 10.1093/ilar.49.1.27; Kamisaka Y, 2011, MAR BIOL, V158, P233, DOI 10.1007/s00227-010-1554-x; Kara LB, 2008, COMPUT AIDED DESIGN, V5, P867, DOI DOI 10.3722/CADAPS.2008.867-876; Karciauskas K, 2012, GRAPH MODELS, V74, P351, DOI 10.1016/j.gmod.2012.05.005; Kelley DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001119; Kitamura A, 2006, SYST PARASITOL, V65, P151, DOI 10.1007/s11230-006-9046-6; KRAEVOY V., 2009, P 6 EUR S SKETCH BAS, P37, DOI DOI 10.1145/1572741.1572749]; Leadbeater BSC, 2009, P R SOC B, V276, P3, DOI 10.1098/rspb.2008.0844; Li L, 2013, COMPUT AIDED DESIGN, V45, P134, DOI 10.1016/j.cad.2012.08.007; Lim LHS, 2007, SYST PARASITOL, V67, P101, DOI 10.1007/s11230-006-9075-1; Lim LHS, 2009, SYST PARASITOL, V73, P13, DOI 10.1007/s11230-008-9167-1; Lim L.H.S., 1989, Malayan Nature Journal, V43, P59; Lim LHS, 1998, INT J PARASITOL, V28, P1495, DOI 10.1016/S0020-7519(98)00061-7; LIM LHS, 1994, SYST PARASITOL, V28, P99, DOI 10.1007/BF00009590; Lim LHS, 1996, SYST PARASITOL, V33, P53, DOI 10.1007/BF01526634; LIM LHS, 1995, SYST PARASITOL, V32, P211, DOI 10.1007/BF00008830; LIM LHS, 1995, SYST PARASITOL, V30, P141, DOI 10.1007/BF00010167; Lim LHS, 2001, SYST PARASITOL, V49, P223, DOI 10.1023/A:1010600804482; McGurk L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000834; Mortenson M., 1989, COMPUTER GRAPHICS IN; Moustakides G, 2000, ADV ENG SOFTW, V31, P955, DOI 10.1016/S0965-9978(00)00060-0; Murakawa Jun, 2006, P EUR C SKETCH BAS I, P67, DOI [10.2312/SBM/SBM06/067-074, DOI 10.2312/SBM/SBM06/067-074]; Pourazady M, 2000, ADV ENG SOFTW, V31, P107, DOI 10.1016/S0965-9978(99)00026-5; Sederberg T. W., 1986, Computer Graphics, V20, P151, DOI 10.1145/15886.15903; Serra M, 2008, DISCOVERING GEOMETRY; Silva FG, 2009, P ACM SIGGRAPH ASIA, P1; Teo BG, 2010, TROP BIOMED, V27, P254; Wickes R, 2009, FDN BLENDER COMPOSIT; Wright R. S., 2010, OPENGL SUPERBIBLE CO; YAMAGUTI S, 1963, SYSTEMA HELMINTHIUM; Yuk-Ming T, 2011, COMPUT AIDED DESIGN, V43, P1841, DOI 10.1016/j.cad.2011.08.005	47	4	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77650	10.1371/journal.pone.0077650	http://dx.doi.org/10.1371/journal.pone.0077650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204903	Green Published, gold, Green Submitted			2022-12-27	WOS:000326241200035
J	Pappas, JL; Miller, DJ				Pappas, Janice L.; Miller, Daniel J.			A Generalized Approach to the Modeling and Analysis of 3D Surface Morphology in Organisms	PLOS ONE			English	Article							THEORETICAL MORPHOSPACE; MORPHOGENESIS; GEOMETRY; QUANTIFY; GROWTH	The surface geometry of an organism represents the boundary of its three-dimensional (3D) form and can be used as a proxy for the phenotype. A mathematical approach is presented that describes surface morphology using parametric 3D equations with variables expressed as x, y, z in terms of parameters u, v. Partial differentiation of variables with respect to parameters yields elements of the Jacobian representing tangent lines and planes of every point on the surface. Jacobian elements provide a compact size-free summary of the entire surface, and can be used as variables in principal components analysis to produce a morphospace. Mollusk and echinoid models are generated to demonstrate that whole organisms can be represented in a common morphospace, regardless of differences in size, geometry, and taxonomic affinity. Models can be used to simulate theoretical forms, novel morphologies, and patterns of phenotypic variation, and can also be empirically-based by designing them with reference to actual forms using reverse engineering principles. Although this study uses the Jacobian to summarize models, they can also be analyzed with 3D methods such as eigensurface, spherical harmonics, wavelet analysis, and geometric morphometrics. This general approach should prove useful for exploring broad questions regarding morphological evolution and variation.	[Pappas, Janice L.; Miller, Daniel J.] Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Pappas, JL (corresponding author), Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA.	jlpappas@umich.edu	Pappas, Janice L./H-7020-2019	Pappas, Janice/0000-0002-1207-8388				Abbott R. T., 1986, COMPENDIUM SEASHELLS; Abou Chakra M, 2011, J THEOR BIOL, V285, P113, DOI 10.1016/j.jtbi.2011.06.019; ACKERLY SC, 1989, PALEOBIOLOGY, V15, P147, DOI 10.1017/S0094837300009337; [Anonymous], 1991, SEASHELLS NO HEMISPH; Baxandall PR, 1981, DIFFERENTIAL VECTOR; Bayer U., 1978, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V156, P226; Boettiger A, 2009, P NATL ACAD SCI USA, V106, P6837, DOI 10.1073/pnas.0810311106; Boyer DM, 2011, P NATL ACAD SCI USA, V108, P18221, DOI 10.1073/pnas.1112822108; Bronstein AM, 2010, INT J COMPUT VISION, V89, P266, DOI 10.1007/s11263-009-0301-6; CHECA A, 1991, LETHAIA, V24, P97, DOI 10.1111/j.1502-3931.1991.tb01183.x; CORTIE MB, 1993, COMPUT GRAPH, V17, P79, DOI 10.1016/0097-8493(93)90054-D; Darboux G., 1896, LECONS THEORIE GEN S, V4; Darboux G, 1894, LECONS THEORIE GEN S, VIII; Darboux G., 1889, LECONS THEORIE GEN S, VII; Darboux G, 1887, LECONS THEORIE GEN S, VI; Davies A, 1996, INTRO COMPUTATIONAL; Dera G, 2008, PALEOBIOLOGY, V34, P301, DOI 10.1666/07070.1; Do Carmo P., 1976, DIFFERENTIAL GEOMETR; Foote M, 1997, ANNU REV ECOL SYST, V28, P129, DOI 10.1146/annurev.ecolsys.28.1.129; Frenet F., 1852, J MATH PURES APPL, V17, P437; GOULD SJ, 1991, PALEOBIOLOGY, V17, P411, DOI 10.1017/S0094837300010745; GOULD SJ, 1969, B MAR SCI, V19, P432; Gray Alfred., 1998, MODERN DIFFERENTIAL; Hammer O, 2005, LETHAIA, V38, P111, DOI 10.1080/00241160510013222; Kaplan W, 1971, CALCULUS LINEAR ALGE, V2; Kaplan W., 2003, ADV CALCULUS, V5th; Laga H, 2006, P IEEE INT C SHAP MO, P15, DOI [10.1109/SMI.2006.39, DOI 10.1109/SMI.2006.39]; MacLeod N, 2008, SYST ASSOC SPEC VOL, V76, P143; McGhee GR, 1999, PERS PALEOB; Memoli F, 2005, FOUND COMPUT MATH, V5, P313, DOI 10.1007/s10208-004-0145-y; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Moseley H., 1838, PHILOS T ROYAL SOC L, V128, P351; Moseley H, PHILOS MAG, V21, P300; Moulton DE, 2012, J THEOR BIOL, V311, P69, DOI 10.1016/j.jtbi.2012.07.009; OKAMOTO T, 1988, PALEOBIOLOGY, V14, P272, DOI 10.1017/S0094837300012008; OKAMOTO T, 1988, PALAEONTOLOGY, V31, P35; Pappas JL, 2008, J BIOL SYST, V16, P119, DOI 10.1142/S0218339008002460; Pappas JL, 2011, J BIOL SYST, V19, P47, DOI 10.1142/S0218339011003816; Pappas JL, 2005, J BIOL SYST, V13, P385, DOI 10.1142/S0218339005001586; Pappas JL, 2005, J NANOSCI NANOTECHNO, V5, P120, DOI 10.1166/jnn.2005.009; Polly PD, 2008, EVOL BIOL, V35, P83, DOI 10.1007/s11692-008-9020-0; Polly PD, 2008, PALAEONTOL ELECTRON, V11; Pressley Andrew, 2001, ELEMENTARY DIFFERENT; Prusinkiewicz P, 1995, ALGORITHMIC BEAUTY S, P163; RAUP DAVID M., 1966, J PALEONTOL, V40, P1178; RAUP DM, 1965, SCIENCE, V147, P1294, DOI 10.1126/science.147.3663.1294; RAUP DM, 1961, P NATL ACAD SCI USA, V47, P602, DOI 10.1073/pnas.47.4.602; RAUP DM, 1962, SCIENCE, V138, P150, DOI 10.1126/science.138.3537.150; Roy K, 1997, TRENDS ECOL EVOL, V12, P277, DOI 10.1016/S0169-5347(97)81026-9; SAVAZZI E, 1990, LETHAIA, V23, P195, DOI 10.1111/j.1502-3931.1990.tb01360.x; Serret J., 1851, J MATH PURES APPL, V16, P193; Shen L, 2009, EVOLUTION, V63, P1003, DOI 10.1111/j.1558-5646.2008.00557.x; Spivak M., 1979, COMPREHENSIVE INTRO, VIII; Spivak M., 1979, COMPREHENSIVE INTRO, VII; Struik Dirk Jan, 1961, LECT CLASSICAL DIFFE, P7; Thompson D. W., 1917, GROWTH FORM; Ubukata T, 2005, PALEOBIOLOGY, V31, P643, DOI 10.1666/04075.1; Varady T, 1997, COMPUT AIDED DESIGN, V29, P255, DOI 10.1016/S0010-4485(96)00054-1; Villarceau Y., 1848, NOUVELLES ANN MATH, V7, P345; Zachos LG, 2011, COMPUTATIONAL PALEONTOLOGY, P75, DOI 10.1007/978-3-642-16271-8_5	60	7	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77551	10.1371/journal.pone.0077551	http://dx.doi.org/10.1371/journal.pone.0077551			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204866	gold, Green Published			2022-12-27	WOS:000326155400043
J	Lau, SM; Cha, KM; Karunatillake, A; Stokes, RA; Cheng, K; McLean, M; Cheung, NW; Gonzalez, FJ; Gunton, JE				Lau, Sue Mei; Cha, Kuan Minn; Karunatillake, Ayesha; Stokes, Rebecca A.; Cheng, Kim; McLean, Mark; Cheung, N. W.; Gonzalez, Frank J.; Gunton, Jenny E.			Beta-Cell ARNT Is Required for Normal Glucose Tolerance in Murine Pregnancy	PLOS ONE			English	Article							GESTATIONAL DIABETES-MELLITUS; PLACENTAL-LACTOGEN; ENDOCRINE PANCREAS; INSULIN-SECRETION; GENE-EXPRESSION; ISLET MASS; PROLIFERATION; PROLACTIN; ADAPTATION; RECEPTORS	Aims: Insulin secretion increases in normal pregnancy to meet increasing demands. Inability to increase beta-cell function results in gestational diabetes mellitus (GDM). We have previously shown that the expression of the transcription factor ARNT (Aryl-hydrocarbon Receptor Nuclear Translocator) is reduced in the islets of humans with type 2 diabetes. Mice with a beta-cell specific deletion of ARNT (beta-ARNT mice) have impaired glucose tolerance secondary to defective insulin secretion. We hypothesised that ARNT is required to increase beta-cell function during pregnancy, and that beta-ARNT mice would be unable to compensate for the beta-cell stress of pregnancy. The aims of this study were to investigate the mechanisms of ARNT regulation of beta-cell function and glucose tolerance in pregnancy. Methods: beta-ARNT females were mated with floxed control (FC) males and FC females with beta-ARNT males. Results: During pregnancy, beta-ARNT mice had a marked deterioration in glucose tolerance secondary to defective insulin secretion. There was impaired beta-cell proliferation in late pregnancy, associated with decreased protein and mRNA levels of the islet cell-cycle regulator cyclinD2. There was also reduced expression of Irs2 and G6PI. In contrast, in control mice, pregnancy was associated with a 2.1-fold increase in ARNT protein and a 1.6-fold increase in cyclinD2 protein, and with increased beta-cell proliferation. Conclusions: Islet ARNT increases in normal murine pregnancy and beta-cell ARNT is required for cyclinD2 induction and increased beta-cell proliferation in pregnancy.	[Lau, Sue Mei; Cha, Kuan Minn; Karunatillake, Ayesha; Stokes, Rebecca A.; Cheng, Kim; Gunton, Jenny E.] Garvan Inst Med Res, Diabet & Transcript Factors Grp, Sydney, NSW, Australia; [Lau, Sue Mei] Univ New S Wales, Fac Med, Prince Wales Clin Sch, Sydney, NSW, Australia; [McLean, Mark; Cheung, N. W.; Gunton, Jenny E.] Westmead Hosp, Dept Endocrinol & Diabet, Sydney, NSW, Australia; [McLean, Mark] Univ Western Sydney, Fac Med, Sydney, NSW, Australia; [Cheung, N. W.; Gunton, Jenny E.] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia; [Gonzalez, Frank J.] NCI, Lab Metab, Bethesda, MD 20892 USA; [Gunton, Jenny E.] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney; University of Sydney; Western Sydney University; University of Sydney; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of New South Wales Sydney	Gunton, JE (corresponding author), Garvan Inst Med Res, Diabet & Transcript Factors Grp, Sydney, NSW, Australia.	j.gunton@garvan.org.au	Gunton, Jenny E/AAH-7719-2021	Cheung, Ngai Wah/0000-0001-6323-8006	National Health and Medical Research Council; Diabetes Australia Research Trust; Australasian Diabetes in Pregnancy Society; NATIONAL CANCER INSTITUTE [ZIABC005708] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia Research Trust; Australasian Diabetes in Pregnancy Society; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The funders were peer-reviewed granting bodies: National Health and Medical Research Council, Diabetes Australia Research Trust, and Australasian Diabetes in Pregnancy Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral MEC, 2004, J ENDOCRINOL, V183, P469, DOI 10.1677/joe.1.05547; Avril I, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740215; Butler AE, 2010, DIABETOLOGIA, V53, P2167, DOI 10.1007/s00125-010-1809-6; CATALANO PM, 1991, AM J OBSTET GYNECOL, V165, P1667, DOI 10.1016/0002-9378(91)90012-G; Cheng K, 2010, J CLIN INVEST, V120, P2171, DOI 10.1172/JCI35846; DAHRI S, 1995, P NUTR SOC, V54, P345, DOI 10.1079/PNS19950003; Galsgaard ED, 1999, J BIOL CHEM, V274, P18686, DOI 10.1074/jbc.274.26.18686; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Homko C, 2001, J CLIN ENDOCR METAB, V86, P568, DOI 10.1210/jc.86.2.568; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Lau SM, 2011, DIABETOLOGIA, V54, P910, DOI 10.1007/s00125-010-1998-z; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Nielsen JH, 1999, J MOL MED-JMM, V77, P62; OSULLIVAN JB, 1964, DIABETES, V13, P278; PARSONS JA, 1992, ENDOCRINOLOGY, V130, P1459, DOI 10.1210/en.130.3.1459; READING AJ, 1966, J MAMMAL, V47, P111, DOI 10.2307/1378075; Rieck S, 2009, MOL ENDOCRINOL, V23, P1702, DOI 10.1210/me.2009-0144; Sacks DA, 2012, DIABETES CARE, V35, P526, DOI 10.2337/dc11-1641; Stokes RA, 2013, CELL TRANSPLANT, V22, P253, DOI 10.3727/096368912X647180; Tomita S, 2000, MOL ENDOCRINOL, V14, P1674, DOI 10.1210/me.14.10.1674; VANASSCHE FA, 1980, DIABETOLOGIA, V18, P487, DOI 10.1007/BF00261705; VANASSCHE FA, 1978, BRIT J OBSTET GYNAEC, V85, P818; Vasavada RC, 2000, J BIOL CHEM, V275, P15399, DOI 10.1074/jbc.275.20.15399; Weinhaus AJ, 1996, ENDOCRINOLOGY, V137, P1640, DOI 10.1210/en.137.5.1640; Zhang L, 2010, INT J OBESITY, V34, P357, DOI 10.1038/ijo.2009.232	25	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77419	10.1371/journal.pone.0077419	http://dx.doi.org/10.1371/journal.pone.0077419			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204824	Green Published, Green Submitted, gold			2022-12-27	WOS:000326152300024
J	Qian, JX; Luo, YZ; Gu, XQ; Zhan, W; Wang, X				Qian, Jianxin; Luo, Yizhou; Gu, Xiaoqiang; Zhan, Wang; Wang, Xi			Twist1 Promotes Gastric Cancer Cell Proliferation through Up-Regulation of FoxM1	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR FOXM1; FORKHEAD BOX M1; BREAST-CANCER; TUMOR-METASTASIS; LUNG-CANCER; STEM-CELLS; EXPRESSION; IDENTIFICATION; PROGRESSION	Twist-related protein 1 (Twist1), also known as class A basic helix-loop-helix protein 38 (bHLHa38), has been implicated in cell lineage determination and differentiation. Previous studies demonstrate that Twist1 expression is up-regulated in gastric cancer with poor clinical outcomes. Besides, Twist1 is suggested to be involved in progression of human gastric cancer. However, its biological functions remain largely unexplored. In the present study, we show that Twist 1 overexpression leads to a significant up-regulation of FoxM1, which plays a key role in cell cycle progression in gastric cancer cells. In contrast, knockdown of Twist 1 reduces FoxM1 expression, suggesting that FoxM1 might be a direct transcriptional target of Twist 1. At the molecular level, we further reveal that Twist 1 could bind to the promoter region of FoxM1, and subsequently recruit p300 to induce FoxM1 mRNA transcription. Therefore, our results uncover a previous unknown Twist 1/FoxM1 regulatory pathway, which may help to understand the mechanisms of gastric cancer proliferation.	[Qian, Jianxin; Gu, Xiaoqiang; Zhan, Wang; Wang, Xi] Changzheng Hosp, Dept Med Oncol, Shanghai, Peoples R China; [Luo, Yizhou] PLA, Hosp 454, Dept Hematol & Oncol, Nanjing, Jiangsu, Peoples R China	Naval Medical University	Qian, JX (corresponding author), Changzheng Hosp, Dept Med Oncol, Shanghai, Peoples R China.	Jianxinqiancz@hotmail.com						Cheng GZ, 2008, CANCER RES, V68, P957, DOI 10.1158/0008-5472.CAN-07-5067; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Feng Y, 2013, MOL CANC RES; Gong AH, 2012, CANCER RES, V72, P5658, DOI 10.1158/0008-5472.CAN-12-0953; Gort EH, 2008, CANCER EPIDEM BIOMAR, V17, P3325, DOI 10.1158/1055-9965.EPI-08-0472; Horikawa T, 2007, CANCER RES, V67, P1970, DOI 10.1158/0008-5472.CAN-06-3933; Horimoto Y, 2011, AM J PATHOL, V179, P1148, DOI 10.1016/j.ajpath.2011.05.052; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Karadedou CT, 2012, ONCOGENE, V31, P1845, DOI 10.1038/onc.2011.368; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; Kong X, 2013, CANC RES; Li JP, 2012, FEBS LETT, V586, P3761, DOI 10.1016/j.febslet.2012.09.016; Li Q, 2009, CANCER RES, V69, P3501, DOI 10.1158/0008-5472.CAN-08-3045; Luo GQ, 2011, PATHOLOGY, V43, P697, DOI 10.1097/PAT.0b013e32834bf632; Michel L, 2013, BLOOD, V121, P1477, DOI 10.1182/blood-2012-10-460535; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Pan DN, 2009, CELL, V137, P73, DOI 10.1016/j.cell.2009.01.051; Qin Q, 2012, CELL RES, V22, P90, DOI 10.1038/cr.2011.144; Radhakrishnan SK, 2006, CANCER RES, V66, P9731, DOI 10.1158/0008-5472.CAN-06-1576; Rosivatz E, 2002, AM J PATHOL, V161, P1881, DOI 10.1016/S0002-9440(10)64464-1; Stasinopoulos IA, 2005, J BIOL CHEM, V280, P2294, DOI 10.1074/jbc.M411018200; Sullivan C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051277; Sung CO, 2011, AM J PATHOL, V179, P1827, DOI 10.1016/j.ajpath.2011.06.032; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; VanDusen NJ, 2012, DIFFERENTIATION, V84, DOI 10.1016/j.diff.2012.03.002; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Xia LM, 2012, CARCINOGENESIS, V33, P2250, DOI 10.1093/carcin/bgs249; Xue ZF, 2012, J CELL BIOCHEM, V113, P302, DOI 10.1002/jcb.23356; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2006, CANCER RES, V66, P4549, DOI 10.1158/0008-5472.CAN-05-3850; Zeng JP, 2009, J PATHOL, V218, P419, DOI 10.1002/path.2530	32	40	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77625	10.1371/journal.pone.0077625	http://dx.doi.org/10.1371/journal.pone.0077625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204899	gold, Green Published, Green Submitted			2022-12-27	WOS:000326152300027
J	Chuang, JY; Chang, AC; Chiang, IP; Tsai, MH; Tang, CH				Chuang, Jing-Yuan; Chang, An-Chen; Chiang, I-Ping; Tsai, Ming-Hsui; Tang, Chih-Hsin			Apoptosis Signal-Regulating Kinase 1 Is Involved in WISP-1-Promoted Cell Motility in Human Oral Squamous Cell Carcinoma Cells	PLOS ONE			English	Article							HUMAN CHONDROSARCOMA CELLS; INFLAMMATORY BREAST-CANCER; GROWTH-FACTOR; ADHESION MOLECULES; CCN FAMILY; INCREASES MIGRATION; HUMAN OSTEOSARCOMA; ICAM-1 EXPRESSION; UP-REGULATION; LUNG-CANCER	Oral squamous cell carcinoma (OSCC) has a tendency to migrate and metastasize. WNT1-inducible signaling pathway protein 1 (WISP-1) is a cysteine-rich protein that belongs to the Cyr61, CTGF, Nov (CCN) family of matrix cellular proteins. The effect of WISP-1 on human OSCC cells, however, is unknown. Here, we showed that WISP-1 increased cell migration and intercellular adhesion molecule-1 (ICAM-1) expression in OSCC cells. Pretreatment of cells with integrin avb3 monoclonal antibody (mAb) significantly abolished WISP-1-induced cell migration and ICAM-1 expression. On the other hand, WISP-1-mediated cell motility and ICAM-1 upregulation were attenuated by ASK1, JNK, and p38 inhibitor. Furthermore, WISP-1 also enhanced activator protein 1 (AP-1) activation, and the integrin avb3 mAb, and ASK1, JNK, and p38 inhibitors reduced WISP-1-mediated AP-1 activation. Moreover, WISP-1 and ICAM-1 expression correlated with the tumor stage of patients with OSCC. Our results indicate that WISP-1 enhances the migration of OSCC cells by increasing ICAM-1 expression through the avb3 integrin receptor and the ASK1, JNK/p38, and AP-1 signal transduction pathways.	[Chuang, Jing-Yuan; Chang, An-Chen] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan; [Chiang, I-Ping] China Med Univ Hosp, Dept Pathol, Taichung, Taiwan; [Tsai, Ming-Hsui] China Med Univ Hosp, Dept Otolaryngol, Taichung, Taiwan; [Tang, Chih-Hsin] China Med Univ, Sch Med, Dept Pharmacol, Taichung, Taiwan; [Tang, Chih-Hsin] Asia Univ, Coll Hlth Sci, Dept Biotechnol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Asia University Taiwan	Tang, CH (corresponding author), China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan.	chtang@mail.cmu.edu.tw	Tang, Chih Hsin/O-5212-2015; Chang, An-Chen/ABB-6915-2021	Tang, Chih Hsin/0000-0002-7113-8352; Chang, An-Chen/0000-0002-9544-9980	National Science Council of Taiwan [NSC99-2320-B-039-003-MY3, NSC100-2320-B-039-028-MY3]; Taiwan Department of Health, China Medical University Hospital Cancer Research of Excellence [DOH102-TD-C-111-005]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taiwan Department of Health, China Medical University Hospital Cancer Research of Excellence	This work was supported by grants from the National Science Council of Taiwan (NSC99-2320-B-039-003-MY3 and NSC100-2320-B-039-028-MY3); Taiwan Department of Health, China Medical University Hospital Cancer Research of Excellence (DOH102-TD-C-111-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Chen LM, 2011, J CELL BIOCHEM, V112, P933, DOI 10.1002/jcb.23009; Chen PP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000534; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Croci S, 2004, CANCER RES, V64, P1730, DOI 10.1158/0008-5472.CAN-3502-02; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Duperray A, 1997, J BIOL CHEM, V272, P435; Fong YC, 2012, J CELL PHYSIOL, V227, P223, DOI 10.1002/jcp.22720; Greenberg JS, 2003, CANCER, V98, P508, DOI 10.1002/cncr.11526; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Hou CH, 2011, BIOCHEM PHARMACOL, V81, P1286, DOI 10.1016/j.bcp.2011.03.016; Hsia TC, 2013, MOL PHARMACOL, V83, P857, DOI 10.1124/mol.112.082743; Huang CY, 2012, ARTHRITIS RHEUM-US, V64, P3344, DOI 10.1002/art.34557; Kleer CG, 2004, NEOPLASIA, V6, P179, DOI 10.1593/neo.03316; Kleer CG, 2002, ONCOGENE, V21, P3172, DOI 10.1038/sj.onc.1205462; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Lin MT, 2004, J BIOL CHEM, V279, P24015, DOI 10.1074/jbc.M402305200; Lin YM, 2013, CANCER LETT, V328, P135, DOI 10.1016/j.canlet.2012.08.029; Lu KW, 2011, HUM EXP TOXICOL, V30, P406, DOI 10.1177/0960327110372405; Lyons AJ, 2007, INT J ORAL MAX SURG, V36, P671, DOI 10.1016/j.ijom.2007.04.002; Makrilia N, 2009, CANCER INVEST, V27, P1023, DOI 10.3109/07357900902769749; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Perbal B, 2001, J CLIN PATHOL-MOL PA, V54, P57, DOI 10.1136/mp.54.2.57; Rosette C, 2005, CARCINOGENESIS, V26, P943, DOI 10.1093/carcin/bgi070; Sampath D, 2001, J CLIN ENDOCR METAB, V86, P1707, DOI 10.1210/jc.86.4.1707; Takeda K, 2008, ANNU REV PHARMACOL, V48, P199, DOI 10.1146/annurev.pharmtox.48.113006.094606; Tan TW, 2009, CARCINOGENESIS, V30, P258, DOI 10.1093/carcin/bgn284; Tang CH, 2012, BIOMEDICINE-TAIWAN, V2, P92, DOI 10.1016/j.biomed.2012.01.001; Tang CH, 2010, ARTHRITIS RHEUM-US, V62, P3615, DOI 10.1002/art.27755; Thomas GJ, 2001, CRIT REV ORAL BIOL M, V12, P479, DOI 10.1177/10454411010120060301; Tsou HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053974; Tzeng HE, 2013, BIOCHEM PHARMACOL, V85, P531, DOI 10.1016/j.bcp.2012.11.021; VANDE SA, 1996, J MOL MED, V74, P13, DOI DOI 10.1007/BF00202069; Wu MH, 2012, J CELL PHYSIOL, V227, P3016, DOI 10.1002/jcp.23043; Xie D, 2004, CLIN CANCER RES, V10, P2072, DOI 10.1158/1078-0432.CCR-0659-03; Xu LF, 2000, GENE DEV, V14, P585; Yang SF, 2010, J BIOL CHEM, V285, P29808, DOI 10.1074/jbc.M110.108183; Yu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061362; Zhang R, 2003, J CLIN INVEST, V111, P1933, DOI 10.1172/JCI200317790; Zimmerman T, 2008, CURR PHARM DESIGN, V14, P2128, DOI 10.2174/138161208785740225	40	34	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78022	10.1371/journal.pone.0078022	http://dx.doi.org/10.1371/journal.pone.0078022			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205072	gold, Green Published, Green Submitted			2022-12-27	WOS:000326032600060
J	Dong, WP; Xu, C; Cheng, T; Zhou, SL				Dong, Wenpan; Xu, Chao; Cheng, Tao; Zhou, Shiliang			Complete Chloroplast Genome of Sedum sarmentosum and Chloroplast Genome Evolution in Saxifragales	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; DISTINCT PLASTID GENOMES; SPECIES DIVERSIFICATION; INDEPENDENT TRANSFERS; PHYLOGENETIC ANALYSIS; SUBSECTION OENOTHERA; GENE; LOSSES; NUCLEAR; RATES	Comparative chloroplast genome analyses are mostly carried out at lower taxonomic levels, such as the family and genus levels. At higher taxonomic levels, chloroplast genomes are generally used to reconstruct phylogenies. However, little attention has been paid to chloroplast genome evolution within orders. Here, we present the chloroplast genome of Sedum sarmentosum and take advantage of several available (or elucidated) chloroplast genomes to examine the evolution of chloroplast genomes in Saxifragales. The chloroplast genome of S. sarmentosum is 150,448 bp long and includes 82,212 bp of a large single-copy (LSC) region, 16.670 bp of a small single-copy (SSC) region, and a pair of 25,783 bp sequences of inverted repeats (IRs). The genome contains 131 unique genes, 18 of which are duplicated within the IRs. Based on a comparative analysis of chloroplast genomes from four representative Saxifragales families, we observed two gene losses and two pseudogenes in Paeonia obovata, and the loss of an intron was detected in the rps16 gene of Penthorum chinense. Comparisons among the 72 common protein-coding genes confirmed that the chloroplast genomes of S. sarmentosum and Paeonia obovata exhibit accelerated sequence evolution. Furthermore, a strong correlation was observed between the rates of genome evolution and genome size. The detected genome size variations are predominantly caused by the length of intergenic spacers, rather than losses of genes and introns, gene pseudogenization or IR expansion or contraction. The genome sizes of these species are negatively correlated with nucleotide substitution rates. Species with shorter duration of the life cycle tend to exhibit shorter chloroplast genomes than those with longer life cycles.	[Dong, Wenpan; Xu, Chao; Cheng, Tao; Zhou, Shiliang] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Xu, Chao; Cheng, Tao] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhou, SL (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	slzhou@ibcas.ac.cn	董, 文攀/D-1297-2015; Dong, Wenpan/C-8167-2013	Dong, Wenpan/0000-0002-8371-3246	National Natural Science Foundation of China [30930010]; Ministry of Science and Technology [2012BAC01B05-6, 2011FY120200-6]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was partly supported by the National Natural Science Foundation of China (30930010) and the Ministry of Science and Technology (2012BAC01B05-6 and 2011FY120200-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2012, GENOME BIOL EVOL, V4, P1316, DOI 10.1093/gbe/evs110; Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; Barraclough TG, 1996, P ROY SOC B-BIOL SCI, V263, P589, DOI 10.1098/rspb.1996.0088; BOUSQUET J, 1992, P NATL ACAD SCI USA, V89, P7844, DOI 10.1073/pnas.89.16.7844; Cahoon AB, 2010, AM J BOT, V97, P49, DOI 10.3732/ajb.0900008; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Comeron JM, 2001, CURR OPIN GENET DEV, V11, P652, DOI 10.1016/S0959-437X(00)00249-5; Daniell H, 2008, THEOR APPL GENET, V116, P723, DOI 10.1007/s00122-007-0706-y; Daniell H, 2006, THEOR APPL GENET, V112, P1503, DOI 10.1007/s00122-006-0254-x; Delannoy E, 2011, MOL BIOL EVOL, V28, P2077, DOI 10.1093/molbev/msr028; Diekmann K, 2009, DNA RES, V16, P165, DOI 10.1093/dnares/dsp008; Dong WP, 2013, GENOME BIOL EVOL, V5, P989, DOI 10.1093/gbe/evt063; Doorduin L, 2011, DNA RES, V18, P93, DOI 10.1093/dnares/dsr002; DOWNIE SR, 1991, EVOLUTION, V45, P1245, DOI [10.2307/2409731, 10.1111/j.1558-5646.1991.tb04390.x]; Downie SR, 1996, SYST BOT, V21, P135, DOI 10.2307/2419744; Drouin G, 2008, MOL PHYLOGENET EVOL, V49, P827, DOI 10.1016/j.ympev.2008.09.009; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Funk HT, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-45; Goremykin V, 2003, PLANT SYST EVOL, V242, P119, DOI 10.1007/s00606-003-0056-4; Greiner S, 2008, MOL BIOL EVOL, V25, P2019, DOI 10.1093/molbev/msn149; Greiner S, 2008, NUCLEIC ACIDS RES, V36, P2366, DOI 10.1093/nar/gkn081; Guisinger MM, 2010, J MOL EVOL, V70, P149, DOI 10.1007/s00239-009-9317-3; Guisinger MM, 2008, P NATL ACAD SCI USA, V105, P18424, DOI 10.1073/pnas.0806759105; Haberle RC, 2008, J MOL EVOL, V66, P350, DOI 10.1007/s00239-008-9086-4; Hong D., 2010, PEONIES WORLD TAXONO; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Jansen RK, 2011, MOL BIOL EVOL, V28, P835, DOI 10.1093/molbev/msq261; Jian SG, 2008, SYST BIOL, V57, P38, DOI 10.1080/10635150801888871; Jo YD, 2011, PLANT CELL REP, V30, P217, DOI 10.1007/s00299-010-0929-2; Kim KJ, 2005, MOL CELLS, V19, P104; [李金璐 Li Jinlu], 2013, [植物学报, Chinese Bulletin of Botany], V48, P72; Lin CP, 2010, GENOME BIOL EVOL, V2, P504, DOI 10.1093/gbe/evq036; Magee AM, 2010, GENOME RES, V20, P1700, DOI 10.1101/gr.111955.110; Matsuoka Y, 2002, MOL BIOL EVOL, V19, P2084, DOI 10.1093/oxfordjournals.molbev.a004033; Mccoy SR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-130; McDonald MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000622; McNeal JR, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-57; Millen RS, 2001, PLANT CELL, V13, P645, DOI 10.1105/tpc.13.3.645; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Mort ME, 2002, SYST BOT, V27, P271; Neuhaus HE, 2000, ANNU REV PLANT PHYS, V51, P111, DOI 10.1146/annurev.arplant.51.1.111; Rambaut A., 1996, SEQUENCE ALIGNMENT E; Raubeson LA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-174; Ravi V, 2008, PLANT SYST EVOL, V271, P101, DOI 10.1007/s00606-007-0608-0; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schmitz-Linneweber C, 2001, PLANT MOL BIOL, V45, P307, DOI 10.1023/A:1006478403810; Selosse MA, 2001, TRENDS ECOL EVOL, V16, P135, DOI 10.1016/S0169-5347(00)02084-X; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Sloan DB, 2012, GENOME BIOL EVOL, V4, P294, DOI 10.1093/gbe/evs006; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; TAJIMA F, 1993, GENETICS, V135, P599; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tangphatsornruang S, 2011, GENE, V475, P104, DOI 10.1016/j.gene.2011.01.002; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ueda M, 2007, GENE, V402, P51, DOI 10.1016/j.gene.2007.07.019; Wang RJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-36; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; WOLFE KH, 1992, P NATL ACAD SCI USA, V89, P10648, DOI 10.1073/pnas.89.22.10648; Wu CS, 2011, GENOME BIOL EVOL, V3, P309, DOI 10.1093/gbe/evr026; Wu CS, 2009, MOL PHYLOGENET EVOL, V52, P115, DOI 10.1016/j.ympev.2008.12.026; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xue JH, 2012, J SYST EVOL, V50, P477, DOI 10.1111/j.1759-6831.2012.00224.x; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yi X, 2013, GENOME BIOL EVOL, V5, P688, DOI 10.1093/gbe/evt042; Young HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023980	70	79	80	12	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77965	10.1371/journal.pone.0077965	http://dx.doi.org/10.1371/journal.pone.0077965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205047	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300128
J	Zhang, YS; Yang, LF; Lin, YT; Rong, ZX; Liu, XW; Li, D				Zhang, Yunsheng; Yang, Lifang; Lin, Yiting; Rong, Zhuoxian; Liu, Xiaowen; Li, Dan			SPATA12 and Its Possible Role in DNA Damage Induced by Ultraviolet-C	PLOS ONE			English	Article							TRANSCRIPTION FACTOR DECOY; SIGNALING PATHWAYS; BINDING PROTEIN-2; GENE-EXPRESSION; AP-1; P53; PHOSPHORYLATION; ACTIVATION; STRESS; FAMILY	Our previous studies indicated that SPATA12, a novel spermatogenesis-associated gene, might be an inhibitor involved in spermatogenesis and tumorigenesis. To obtain a better understanding of the functions of SPATA12, a yeast two-hybrid screening system was used to search for interacting proteins, and chromodomain helicase DNA binding protein 2 (CHD2) was successfully identified. Bimolecular fluorescence complementation (BiFC) and subcellular co-localization assays further suggested a possible interaction between SPATA12 and CHD2 in the nuclei. CHD2 is known to be involved in the later stage of the DNA damage response pathway by influencing the transcriptional activity of p53. Thus, our hypothesis is that SPATA12 might play a role in DNA damage signaling. Western blotting results showed that SPATA12 expression could be induced in ultraviolet-C (UV-C) irradiated cells. Through reporter gene assays and the activator protein-1 (AP-1) decoy oligodeoxynucleotide method, we demonstrated that SPATA12 promoter activity could be up-regulated in response to UV-C radiation exposure and an AP-1 binding site in the SPATA12 promoter may have a role in transcriptional regulation of SPATA12. Using colony formation and host cell reactivation assays, it was demonstrated that SPATA12 might lead to inhibition of cellular proliferation in UV-C-irradiated DNA damage. Furthermore, SPATA12 was transfected into H1299, MCF-7 and HeLa cells, and flow cytometry (FCM) results suggested that there are some biological association between SPATA12 and p53 in UV-C-irradiated DNA damage. In addition, we investigated whether SPATA12 could up-regulate the expression of p53. Taken together, these findings indicate that SPATA12 could be induced under UV-C stress. During DNA damage process, AP-1 involves in the transcriptional up-regulation of SPATA12 in response to UV-C radiation and p53 involves in growth inhibitory effects of SPATA12 on UV-C irradiated cells.	[Zhang, Yunsheng; Lin, Yiting; Rong, Zhuoxian; Liu, Xiaowen; Li, Dan] Hunan Univ, Coll Biol, Dept Life Sci, Changsha 410082, Hunan, Peoples R China; [Yang, Lifang] Cent South Univ, Xiangya Sch Med, Canc Res Inst, Changsha, Hunan, Peoples R China	Hunan University; Central South University	Li, D (corresponding author), Hunan Univ, Coll Biol, Dept Life Sci, Changsha 410082, Hunan, Peoples R China.	lidanie@hotmail.com	Yunsheng, ZHANG/K-8565-2013	Yunsheng, ZHANG/0000-0002-4748-1548	National Natural Science Foundation of China [30872763, 81270735]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (nos. 30872763, 81270735). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JD, 2002, CIRC RES, V90, P1325, DOI 10.1161/01.RES.0000023200.19316.D5; Ahn JD, 2001, DIABETOLOGIA, V44, P713, DOI 10.1007/s001250051680; Aitken RJ, 2006, MOL CELL ENDOCRINOL, V250, P66, DOI 10.1016/j.mce.2005.12.026; Bode Ann M, 2003, Sci STKE, V2003, pRE2, DOI 10.1126/stke.2003.167.re2; Costelloe T, 2006, EXP CELL RES, V312, P2677, DOI 10.1016/j.yexcr.2006.06.031; Dzau VJ, 2002, CIRC RES, V90, P1234, DOI 10.1161/01.RES.0000025209.24283.73; Farnebo M, 2010, BIOCHEM BIOPH RES CO, V396, P85, DOI 10.1016/j.bbrc.2010.02.152; Huang CS, 2000, MOL CARCINOGEN, V27, P65, DOI 10.1002/(SICI)1098-2744(200002)27:2<65::AID-MC2>3.0.CO;2-E; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Li D, 2007, J ANDROL, V28, P502, DOI 10.2164/jandrol.106.001560; Li D, 2012, GENE, V511, P18, DOI 10.1016/j.gene.2012.08.047; Li H, 2008, MECH AGEING DEV, V129, P416, DOI 10.1016/j.mad.2008.02.002; Li ZX, 2008, ASIAN J ANDROL, V10, P749, DOI 10.1111/j.1745-7262.2008.00400.x; Liu YG, 2001, CARCINOGENESIS, V22, P851, DOI 10.1093/carcin/22.6.851; Liu Zhiwen, 2012, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V37, P222, DOI 10.3969/j.issn.1672-7347.2012.03.002; Lopez-Camarillo C, 2012, INT J MOL SCI, V13, P142, DOI 10.3390/ijms13010142; Marfella CGA, 2007, MUTAT RES-FUND MOL M, V618, P30, DOI 10.1016/j.mrfmmm.2006.07.012; Marfella CGA, 2006, J CELL PHYSIOL, V209, P162, DOI 10.1002/jcp.20718; Morishita R, 1998, CIRC RES, V82, P1023, DOI 10.1161/01.RES.82.10.1023; Nagarajan P, 2009, ONCOGENE, V28, P1053, DOI 10.1038/onc.2008.440; Olsen Ann-Karin, 2005, Toxicol Appl Pharmacol, V207, P521, DOI 10.1016/j.taap.2005.01.060; Pandita TK, 2009, NUCLEIC ACIDS RES, V37, P1363, DOI 10.1093/nar/gkn1071; Qiao YW, 2002, MUTAT RES-FUND MOL M, V509, P165, DOI 10.1016/S0027-5107(02)00219-1; Rajagopalan S, 2012, ENVIRON MOL MUTAGEN, V53, P44, DOI 10.1002/em.20674; Rastogi RP, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/592980; SACHSENMAIER C, 1994, CELL, V78, P963, DOI 10.1016/0092-8674(94)90272-0; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Zhang YG, 2001, DNA CELL BIOL, V20, P769, DOI 10.1089/104454901753438589; Zhong JL, 2011, PHOTOCHEM PHOTOBIOL, V87, P1092, DOI 10.1111/j.1751-1097.2011.00963.x; Zhou H, 2007, CELL PROLIFERAT, V40, P431, DOI 10.1111/j.1365-2184.2007.00444.x	33	5	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78201	10.1371/journal.pone.0078201	http://dx.doi.org/10.1371/journal.pone.0078201			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205157	Green Submitted, gold, Green Published			2022-12-27	WOS:000326029300148
J	Koyama, A; Wallenstein, MD; Simpson, RT; Moore, JC				Koyama, Akihiro; Wallenstein, Matthew D.; Simpson, Rodney T.; Moore, John C.			Carbon-Degrading Enzyme Activities Stimulated by Increased Nutrient Availability in Arctic Tundra Soils	PLOS ONE			English	Article							BACTERIAL COMMUNITY STRUCTURE; LEAF-LITTER DECOMPOSITION; MICROBIAL ACTIVITY; NITROGEN ADDITION; ORGANIC-MATTER; ECOENZYMATIC STOICHIOMETRY; PERMAFROST THAW; CLIMATE-CHANGE; N DEPOSITION; TEMPERATURE	Climate-induced warming of the Arctic tundra is expected to increase nutrient availability to soil microbes, which in turn may accelerate soil organic matter (SOM) decomposition. We increased nutrient availability via fertilization to investigate the microbial response via soil enzyme activities. Specifically, we measured potential activities of seven enzymes at four temperatures in three soil profiles (organic, organic/mineral interface, and mineral) from untreated native soils and from soils which had been fertilized with nitrogen (N) and phosphorus (P) since 1989 (23 years) and 2006 (six years). Fertilized plots within the 1989 site received annual additions of 10 g N.m(-2).year(-1) and 5 g P.m(-2).year(-1). Within the 2006 site, two fertilizer regimes were established - one in which plots received 5 g N.m(-2).year(-1) and 2.5 g P.m(-2).year(-1) and one in which plots received 10 g N.m(-2).year(-1) and 5 g P.m(-2).year(-1). The fertilization treatments increased activities of enzymes hydrolyzing carbon (C)-rich compounds but decreased phosphatase activities, especially in the organic soils. Activities of two enzymes that degrade N-rich compounds were not affected by the fertilization treatments. The fertilization treatments increased ratios of enzyme activities degrading C-rich compounds to those for N-rich compounds or phosphate, which could lead to changes in SOM chemistry over the long term and to losses of soil C. Accelerated SOM decomposition caused by increased nutrient availability could significantly offset predicted increased C fixation via stimulated net primary productivity in Arctic tundra ecosystems.	[Koyama, Akihiro; Wallenstein, Matthew D.; Simpson, Rodney T.; Moore, John C.] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Koyama, Akihiro] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Wallenstein, Matthew D.; Moore, John C.] Colorado State Univ, Dept Ecosyst Sci & Sustainabil, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University; Colorado State University	Koyama, A (corresponding author), Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA.	akihiro.koyama@colostate.edu	Koyama, Akihiro/E-4868-2019; Wallenstein, Matthew/C-6441-2008; Wallenstein, Matthew D/S-3512-2016; Moore, John/E-9802-2011	Koyama, Akihiro/0000-0002-3854-1035; Wallenstein, Matthew/0000-0002-6219-1442; Wallenstein, Matthew D/0000-0002-6219-1442; 	National Science Foundation [OPP-0909507];  [DEB-0423385]; Division Of Environmental Biology [1026843] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); ; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this research was provided by the National Science Foundation (OPP-0909507 to J.C.M), and grants to the Marine Biological Laboratory at Woods Hole, MA in support of the Arctic LTER (DEB-0423385). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajwa HA, 1999, SOIL BIOL BIOCHEM, V31, P769, DOI 10.1016/S0038-0717(98)00177-1; Allison SD, 2005, SOIL BIOL BIOCHEM, V37, P937, DOI 10.1016/j.soilbio.2004.09.014; Allison SD, 2008, GLOBAL CHANGE BIOL, V14, P1156, DOI 10.1111/j.1365-2486.2008.01549.x; Allison SD, 2011, SOIL BIOL, V22, P229, DOI 10.1007/978-3-642-14225-3_12; Allison SD, 2010, SOIL BIOL BIOCHEM, V42, P1157, DOI 10.1016/j.soilbio.2010.03.026; Allison SD, 2010, NAT GEOSCI, V3, P336, DOI 10.1038/NGEO846; Arrhenius S., 1889, Z PHYS CHEM, V4U, P226, DOI [10.1515/zpch-1889-0416, DOI 10.1515/ZPCH-1889-0416]; BALDRIAN P, 2009, ADVANCES IN FUNGAL B, P109; Blok D, 2010, GLOBAL CHANGE BIOL, V16, P1296, DOI 10.1111/j.1365-2486.2009.02110.x; Boyd S. A., 1990, Soil biochemistry. Volume 6., P1; BURNS RG, 1982, SOIL BIOL BIOCHEM, V14, P423, DOI 10.1016/0038-0717(82)90099-2; Burns RG, 2013, SOIL BIOL BIOCHEM, V58, P216, DOI 10.1016/j.soilbio.2012.11.009; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; CHAPIN FS, 1985, ECOLOGY, V66, P564, DOI 10.2307/1940405; CHAPIN FS, 1988, ECOLOGY, V69, P693; Chu HY, 2007, SOIL BIOL BIOCHEM, V39, P2971, DOI 10.1016/j.soilbio.2007.05.031; CLARHOLM M, 1993, BIOL FERT SOILS, V16, P287, DOI 10.1007/BF00369306; Cornelissen JHC, 2007, ECOL LETT, V10, P619, DOI 10.1111/j.1461-0248.2007.01051.x; Cotrufo MF, 2013, GLOBAL CHANGE BIOL, V19, P988, DOI 10.1111/gcb.12113; DeForest JL, 2004, SOIL SCI SOC AM J, V68, P132, DOI 10.2136/sssaj2004.1320; Development Core Team R, 2011, R LANG ENV STAT COMP; Di Nardo C, 2004, SOIL BIOL BIOCHEM, V36, P1539, DOI 10.1016/j.soilbio.2004.07.013; Enwall K, 2007, SOIL BIOL BIOCHEM, V39, P106, DOI 10.1016/j.soilbio.2006.06.015; GIANFREDA L, 1995, SOIL SCI SOC AM J, V59, P811, DOI 10.2136/sssaj1995.03615995005900030025x; GIANFREDA L, 1995, SOIL SCI SOC AM J, V59, P805, DOI 10.2136/sssaj1995.03615995005900030024x; GIBLIN AE, 1991, ECOL MONOGR, V61, P415, DOI 10.2307/2937049; Glazer AN., 2007, MICROBIOTECHNOL FUND, DOI [10.1017/CBO9780511811227, DOI 10.1017/CBO9780511811227]; Gough L, 2007, OIKOS, V116, P407, DOI 10.1111/j.0030-1299.2007.15449.x; Grogan P, 1999, ECOSYSTEMS, V2, P451, DOI 10.1007/s100219900093; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; Henry HAL, 2005, GLOBAL CHANGE BIOL, V11, P1808, DOI 10.1111/j.1365-2486.2005.001007.x; Henry HAL, 2012, SOIL BIOL BIOCHEM, V47, P53, DOI 10.1016/j.soilbio.2011.12.026; Hobbie SE, 2004, OECOLOGIA, V140, P113, DOI 10.1007/s00442-004-1556-9; Hobbie SE, 2002, PLANT SOIL, V242, P163, DOI 10.1023/A:1019670731128; Hobbie SE, 1996, ECOL MONOGR, V66, P503, DOI 10.2307/2963492; Jangid K, 2008, SOIL BIOL BIOCHEM, V40, P2843, DOI 10.1016/j.soilbio.2008.07.030; Joanisse GD, 2007, NEW PHYTOL, V175, P535, DOI 10.1111/j.1469-8137.2007.02113.x; Jonasson S, 1999, APPL SOIL ECOL, V11, P135, DOI 10.1016/S0929-1393(98)00145-0; Keeler BL, 2009, ECOSYSTEMS, V12, P1, DOI 10.1007/s10021-008-9199-z; Kirschbaum MUF, 2000, BIOGEOCHEMISTRY, V48, P21, DOI 10.1023/A:1006238902976; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; Lang E, 2000, J BASIC MICROB, V40, P33, DOI 10.1002/(SICI)1521-4028(200002)40:1&lt;33::AID-JOBM33&gt;3.0.CO;2-Q; Mack MC, 2004, NATURE, V431, P440, DOI 10.1038/nature02887; Marklein AR, 2012, NEW PHYTOL, V193, P696, DOI 10.1111/j.1469-8137.2011.03967.x; Marschner P, 2001, SOIL BIOL BIOCHEM, V33, P1437, DOI 10.1016/S0038-0717(01)00052-9; Marx MC, 2005, SOIL BIOL BIOCHEM, V37, P35, DOI 10.1016/j.soilbio.2004.05.024; MAYER LM, 1989, LIMNOL OCEANOGR, V34, P973, DOI 10.4319/lo.1989.34.6.0973; McKane RB, 1997, ECOLOGY, V78, P1170, DOI 10.1890/0012-9658(1997)078[1170:CEOTCS]2.0.CO;2; Mikan CJ, 2002, SOIL BIOL BIOCHEM, V34, P1785, DOI 10.1016/S0038-0717(02)00168-2; Myers-Smith IH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045509; NADELHOFFER KJ, 1991, ECOLOGY, V72, P242, DOI 10.2307/1938918; Naidja A, 2000, J ENVIRON QUAL, V29, P677, DOI 10.2134/jeq2000.00472425002900030002x; NANNIPIERI P, 1988, SOIL BIOL BIOCHEM, V20, P683, DOI 10.1016/0038-0717(88)90153-8; Nannipieri P., 1996, HUMIC SUBSTANCES TER, P293, DOI DOI 10.1016/B978-044481516-3/50008-6; Nemergut DR, 2008, ENVIRON MICROBIOL, V10, P3093, DOI 10.1111/j.1462-2920.2008.01735.x; Nicolaus B, 2010, ENVIRON TECHNOL, V31, P1145, DOI 10.1080/09593330903552094; Nowinski NS, 2008, ECOSYSTEMS, V11, P16, DOI 10.1007/s10021-007-9104-1; Oechel W. C, 1992, ARCTIC ECOSYSTEMS CH, P139; OECHEL WC, 1993, NATURE, V361, P520, DOI 10.1038/361520a0; Olander LP, 2000, BIOGEOCHEMISTRY, V49, P175, DOI 10.1023/A:1006316117817; Parham JA, 2000, SOIL BIOL BIOCHEM, V32, P1183, DOI 10.1016/S0038-0717(00)00034-1; Ping CL, 1998, J GEOPHYS RES-ATMOS, V103, P28917, DOI 10.1029/98JD02024; Qin GK, 2007, MICROBIOL-SGM, V153, P1566, DOI 10.1099/mic.0.2006/003327-0; REJ R, 1981, CLIN CHEM, V27, P213; Saiya-Cork KR, 2002, SOIL BIOL BIOCHEM, V34, P1309, DOI 10.1016/S0038-0717(02)00074-3; Schimel JP, 2004, SOIL BIOL BIOCHEM, V36, P217, DOI 10.1016/j.soilbio.2003.09.008; Schimel JP, 2003, SOIL BIOL BIOCHEM, V35, P549, DOI 10.1016/S0038-0717(03)00015-4; Schmidt IK, 1999, APPL SOIL ECOL, V11, P147, DOI 10.1016/S0929-1393(98)00147-4; Schuur EAG, 2009, NATURE, V459, P556, DOI 10.1038/nature08031; SHAVER GR, 1991, ECOL MONOGR, V61, P1, DOI 10.2307/1942997; SINSABAUGH RL, 1994, BIOL FERT SOILS, V17, P69, DOI 10.1007/BF00418675; Sinsabaugh RL, 2012, ANNU REV ECOL EVOL S, V43, P313, DOI 10.1146/annurev-ecolsys-071112-124414; Sinsabaugh RL, 2009, NATURE, V462, P795, DOI 10.1038/nature08632; Sistla SA, 2013, NATURE, V497, P615, DOI 10.1038/nature12129; Steinweg JM, 2012, SOIL BIOL BIOCHEM, V55, P85, DOI 10.1016/j.soilbio.2012.06.015; Stone MM, 2012, GLOBAL CHANGE BIOL, V18, P1173, DOI 10.1111/j.1365-2486.2011.02545.x; Sturm M, 2005, BIOSCIENCE, V55, P17, DOI 10.1641/0006-3568(2005)055[0017:WBPCHC]2.0.CO;2; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; Sturm M, 2001, J CLIMATE, V14, P336, DOI 10.1175/1520-0442(2001)014<0336:SSIIAT>2.0.CO;2; Stursova M, 2006, MICROB ECOL, V51, P90, DOI 10.1007/s00248-005-5156-y; TAN KH, 2011, PRINCIPLES OF SOIL C; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Tiquia SM, 2002, APPL SOIL ECOL, V21, P31, DOI 10.1016/S0929-1393(02)00040-9; Wahren CHA, 2005, GLOBAL CHANGE BIOL, V11, P537, DOI 10.1111/j.1365-2486.2005.00927.x; Waldrop MP, 2004, ECOL APPL, V14, P1172, DOI 10.1890/03-5120; Wallenstein M, 2011, SOIL BIOL, V22, P245, DOI 10.1007/978-3-642-14225-3_13; Wallenstein MD, 2008, SOIL BIOL BIOCHEM, V40, P2098, DOI 10.1016/j.soilbio.2008.01.024; Wallenstein MD, 2009, GLOBAL CHANGE BIOL, V15, P1631, DOI 10.1111/j.1365-2486.2008.01819.x; WALLENSTEIN MD, 2011, ECOLOGY OF EXTRACELL, P35; WEBER CF, 2013, FRONT MICROBIOL, P4; Zeglin LH, 2007, OECOLOGIA, V154, P349, DOI 10.1007/s00442-007-0836-6; Zimmerman AR, 2011, SOIL BIOL, V22, P271, DOI 10.1007/978-3-642-14225-3_15	92	37	41	4	156	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77212	10.1371/journal.pone.0077212	http://dx.doi.org/10.1371/journal.pone.0077212			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24204773	Green Published, gold			2022-12-27	WOS:000325894100048
J	Nakabayashi, K; Liu, CH				Nakabayashi, Kazuyo; Liu, Chang Hong			Developmental Differences in Holistic Interference of Facial Part Recognition	PLOS ONE			English	Article							FACE RECOGNITION; WORKING-MEMORY; CHILDREN; VERBALIZATION; PSYCHOLOGY; FEATURES; WHOLES; VIEWS	Research has shown that adults' recognition of a facial part can be disrupted if the part is learnt without a face context but tested in a whole face. This has been interpreted as the holistic interference effect. The present study investigated whether children of 6- and 9-10-year-olds would show a similar effect. Participants were asked to judge whether a probe part was the same as or different from a test part whereby the part was presented either in isolation or in a whole face. The results showed that while all the groups were susceptible to a holistic interference, the youngest group was most severely affected. Contrary to the view that piecemeal processing precedes holistic processing in the cognitive development, our findings demonstrate that holistic processing is already present at 6 years of age. It is the ability to inhibit the influence of holistic information on piecemeal processing that seems to require a longer period of development into at an older and adult age.	[Nakabayashi, Kazuyo] Univ Hull, Dept Psychol, Kingston Upon Hull HU6 7RX, N Humberside, England; [Liu, Chang Hong] Bournemouth Univ, Sch Design Engn & Comp, Poole BH12 5BB, Dorset, England	University of Hull; Bournemouth University	Nakabayashi, K (corresponding author), Univ Hull, Dept Psychol, Kingston Upon Hull HU6 7RX, N Humberside, England.	k.nakabayashi@hull.ac.uk						Baddeley A. D, 1986, WORKING MEMORY; Baddeley AD, 1974, RECENT ADV LEARNING, V8, P47, DOI DOI 10.1016/S0079-7421(08)60452-1; Brown C, 2010, AM J PSYCHOL, V123, P51; CAREY S, 1977, SCIENCE, V195, P312, DOI 10.1126/science.831281; Cragg L, 2009, DEV PSYCHOBIOL, V51, P533, DOI 10.1002/dev.20391; de Heering A, 2007, J EXP CHILD PSYCHOL, V96, P57, DOI 10.1016/j.jecp.2006.07.001; DONALDSON W, 1993, B PSYCHONOMIC SOC, V31, P271; DONALDSON W, 1992, J EXP PSYCHOL GEN, V121, P275, DOI 10.1037/0096-3445.121.3.275; Hay DC, 2000, INFANT CHILD DEV, V9, P199, DOI 10.1002/1522-7219(200012)9:4<199::AID-ICD231>3.0.CO;2-K; Klingberg T, 2006, NEUROPSYCHOLOGIA, V44, P2171, DOI 10.1016/j.neuropsychologia.2005.11.019; Leder H, 2005, Q J EXP PSYCHOL-A, V58, P235, DOI 10.1080/02724980343000936; Mondloch CJ, 2007, VIS COGN, V15, P564, DOI 10.1080/13506280600859383; Nakabayashi K, 2012, J EXP PSYCHOL LEARN, V38, P376, DOI 10.1037/a0025782; Nakabayashi K, 2012, J EXP PSYCHOL LEARN, V38, P61, DOI 10.1037/a0024853; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; PEDELTY L, 1985, J EXP CHILD PSYCHOL, V39, P421, DOI 10.1016/0022-0965(85)90050-5; Pellicano E, 2003, PSYCHOL SCI, V14, P618, DOI 10.1046/j.0956-7976.2003.psci_1474.x; Pellicano E, 2006, DEVELOPMENTAL SCI, V9, P270, DOI 10.1111/j.1467-7687.2006.00489.x; Seitz K, 2002, J EXP CHILD PSYCHOL, V82, P367, DOI 10.1016/S0022-0965(02)00106-6; Simmering VR, 2012, COGNITIVE DEV, V27, P419, DOI 10.1016/j.cogdev.2012.08.001; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Tanaka JW, 1997, MEM COGNITION, V25, P583, DOI 10.3758/BF03211301; Tanaka JW, 1998, VIS COGN, V5, P479, DOI 10.1080/713756795; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; WELSH MC, 1988, DEV NEUROPSYCHOL, V4, P199, DOI 10.1080/87565648809540405	26	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e77504	10.1371/journal.pone.0077504	http://dx.doi.org/10.1371/journal.pone.0077504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	244FY	24204847	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000326373800004
J	Gena, P; Mastrodonato, M; Portincasa, P; Fanelli, E; Mentino, D; Rodriguez, A; Marinelli, RA; Brenner, C; Fruhbeck, G; Svelto, M; Calamita, G				Gena, Patrizia; Mastrodonato, Maria; Portincasa, Piero; Fanelli, Elena; Mentino, Donatella; Rodriguez, Amaia; Marinelli, Raul A.; Brenner, Catherine; Fruehbeck, Gema; Svelto, Maria; Calamita, Giuseppe			Liver Glycerol Permeability and Aquaporin-9 Are Dysregulated in a Murine Model of Non-Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							EXPRESSION; AQP9; METABOLISM; CHANNELS; AQUAGLYCEROPORINS; HEPATOCYTES; MANAGEMENT; ADIPOSE; OBESITY; ROLES	One form of liver steatosis, namely Non-Alcoholic Fatty Liver Disease (NAFLD), is a worrisome health problem worldwide characterized by intrahepatic triacylglycerol (TG) overaccumulation. NAFLD is a common feature of metabolic syndrome being often associated with obesity, dyslipidemia and diabetes and mostly closely linked to insulin resistance. The mechanism of NAFLD pathogenesis is object of intense investigation especially regarding complex systems ultimately resulting in excessive TG deposition in hepatocytes. However, scarce is the attention about the relevance of hepatic import of glycerol, the other primary source (as glycerol-3-phosphate) of increased TG in hepatocytes. Obese leptin-deficient (ob/ob) mice, an animal model of NAFLD, were used to evaluate the functional involvement of Aquaporin-9 (AQP9), the major pathway of liver glycerol entry, in hepatosteatosis. By RT-PCR and qPCR, the level of Aqp9 mRNA in the liver of starved obese mice was comparable with the corresponding control lean littermates. By immunoblotting, the AQP9 protein at the hepatocyte sinusoidal plasma membrane of obese mice was markedly lower (33%) than lean mice, a finding fully confirmed by immunohistochemistry. By stopped-flow light scattering, the liver glycerol permeability of ob/ob mice was significantly lower (53%) than lean mice, a finding consistent with both the observed down-regulation of AQP9 protein and increased level of plasma glycerol characterizing obese mice. In summary, our results suggest implication of AQP9 in liver steatosis. The reduction of hepatocyte AQP9 and, consequently, glycerol permeability might be a defensive mechanism to counteract further fat infiltration in liver parenchyma.	[Gena, Patrizia; Fanelli, Elena; Svelto, Maria; Calamita, Giuseppe] Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy; [Mastrodonato, Maria; Mentino, Donatella] Univ Bari Aldo Moro, Dept Biol, Bari, Italy; [Portincasa, Piero] Univ Bari Aldo Moro, Dept Biomed Sci & Human Oncol, Bari, Italy; [Rodriguez, Amaia; Fruehbeck, Gema] Univ Navarra Clin, Metab Res Lab, Spanish Biomed Res Ctr Physiopathol Obes & Nutr, Pamplona, Spain; [Marinelli, Raul A.] Univ Nacl Rosario, Inst Fisiol Expt, CONICET, RA-2000 Rosario, Santa Fe, Argentina; [Brenner, Catherine] Univ Paris 11, INSERM, U769, LabEx LERMIT, Chatenay Malabry, France; [Svelto, Maria; Calamita, Giuseppe] Ctr Eccellenza Genom Campo Biomed & Agr, Bari, Italy; [Calamita, Giuseppe] Network Apulian Publ Res Labs WAFITECH, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; University of Navarra; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Calamita, G (corresponding author), Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy.	giuseppe.calamita@uniba.it	Gena, patrizia/AAC-3396-2022; Svelto, Maria/P-6186-2014; brenner, catherine/AAE-8632-2020; mastrodonato, Maria/P-4513-2016; Fanelli, Elena/C-1712-2015; Rodriguez, Amaia/D-3044-2019	mastrodonato, Maria/0000-0002-0799-8032; portincasa, piero/0000-0001-5359-1471; Mentino, Donatella/0000-0002-0680-5251; Rodriguez, Amaia/0000-0002-2180-461X; Fanelli, Elena/0000-0002-3132-3908; Svelto, Maria/0000-0002-5584-9541; Calamita, Giuseppe/0000-0003-4666-9546	Ministero dell'Istruzione, dell'Universita e della Ricerca [PRIN20089SRS2X_003]; Regione Puglia (Rete di Laboratori Pubblici di Ricerca WAFITECH)	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Regione Puglia (Rete di Laboratori Pubblici di Ricerca WAFITECH)	Funding from Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN20089SRS2X_003) and Regione Puglia (Rete di Laboratori Pubblici di Ricerca WAFITECH) to GC is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agre P, 2004, ANGEW CHEM INT EDIT, V43, P4278, DOI 10.1002/anie.200460804; Badaut J, 2004, NEUROSCIENCE, V129, P971, DOI 10.1016/j.neuroscience.2004.06.035; Basaranoglu M, 2013, WORLD J GASTROENTERO, V19, P1166, DOI 10.3748/wjg.v19.i8.1166; Blomme B, 2009, J HEPATOL, V50, P592, DOI 10.1016/j.jhep.2008.12.010; Cai C, 2013, INT IMMUNOPHARMACOL, V15, P550, DOI 10.1016/j.intimp.2013.01.020; Calamita G, 2005, J BIOL CHEM, V280, P17149, DOI 10.1074/jbc.C400595200; Calamita G, 2008, AM J PHYSIOL-GASTR L, V295, pG682, DOI 10.1152/ajpgi.90226.2008; Calamita G, 2007, EXPERT OPIN THER TAR, V11, P1231, DOI 10.1517/14728222.11.9.1231; Calamita G, 2012, BIOL CELL, V104, P342, DOI 10.1111/boc.201100061; Carbrey JM, 2003, P NATL ACAD SCI USA, V100, P2945, DOI 10.1073/pnas.0437994100; Catalan V, 2008, OBES SURG, V18, P695, DOI 10.1007/s11695-008-9453-7; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Dunn W, 2008, AM J GASTROENTEROL, V103, P2263, DOI 10.1111/j.1572-0241.2008.02034.x; Elkjaer ML, 2000, BIOCHEM BIOPH RES CO, V276, P1118, DOI 10.1006/bbrc.2000.3505; Gena P, 2011, FOOD BIOPHYS, V6, P241, DOI 10.1007/s11483-010-9193-9; Grattagliano I, 2013, ANN HEPATOL, V12, P70, DOI 10.1016/S1665-2681(19)31387-0; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hara-Chikuma M, 2006, CELL MOL LIFE SCI, V63, P1386, DOI 10.1007/s00018-006-6028-4; Jelen S, 2012, AM J PHYSIOL-GASTR L, V303, pG1279, DOI 10.1152/ajpgi.00153.2012; Jelen S, 2011, J BIOL CHEM, V286, P44319, DOI 10.1074/jbc.M111.297002; Krawczyk M, 2010, BEST PRACT RES CL GA, V24, P695, DOI 10.1016/j.bpg.2010.08.005; Kuriyama H, 2002, DIABETES, V51, P2915, DOI 10.2337/diabetes.51.10.2915; Lebeck J, 2012, AM J PHYSIOL-GASTR L, V302, pG365, DOI 10.1152/ajpgi.00437.2011; Lee CS, 2013, FEBS J, V280, P3609, DOI 10.1111/febs.12350; Lee DH, 2005, METABOLISM, V54, P1282, DOI 10.1016/j.metabol.2005.04.015; LI CC, 1983, J CELL PHYSIOL, V117, P230, DOI 10.1002/jcp.1041170214; Liquori GE, 2009, HISTOL HISTOPATHOL, V24, P49, DOI 10.14670/HH-24.49; Love-Osborne KA, 2008, J ADOLESCENT HEALTH, V42, P543, DOI 10.1016/j.jadohealth.2007.11.136; Maeda N, 2012, MOL ASPECTS MED, V33, P665, DOI 10.1016/j.mam.2012.02.004; Miranda M, 2009, METABOLISM, V58, P1762, DOI 10.1016/j.metabol.2009.06.004; Pastor-Soler N, 2001, BIOL REPROD, V65, P384, DOI 10.1095/biolreprod65.2.384; Portois L, 2012, INT J MOL MED, V29, P1121, DOI 10.3892/ijmm.2012.943; Rodriguez A, 2006, FEBS LETT, V580, P4771, DOI 10.1016/j.febslet.2006.07.080; Rodriguez A, 2011, J CLIN ENDOCR METAB, V96, pE586, DOI 10.1210/jc.2010-1408; Rojek A, 2013, AM J PHYSIOL-GASTR L, V304, pG501, DOI 10.1152/ajpgi.00208.2012; Rojek AM, 2007, P NATL ACAD SCI USA, V104, P3609, DOI 10.1073/pnas.0610894104; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Yang SQ, 1997, P NATL ACAD SCI USA, V94, P2557, DOI 10.1073/pnas.94.6.2557; Yang SQ, 2001, HEPATOLOGY, V34, P694, DOI 10.1053/jhep.2001.28054; Younossi ZM, 2008, ALIMENT PHARM THER, V28, P2, DOI 10.1111/j.1365-2036.2008.03710.x	40	37	37	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78139	10.1371/journal.pone.0078139	http://dx.doi.org/10.1371/journal.pone.0078139			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205128	Green Published, gold			2022-12-27	WOS:000326334500098
J	Wohrle, S; Weiss, A; Ito, M; Kauffmann, A; Murakami, M; Jagani, Z; Thuery, A; Bauer-Probst, B; Reimann, F; Stamm, C; Pornon, A; Romanet, V; Guagnano, V; Mmendorf, TB; Sellers, WR; Hofmann, F; Roberts, CWM; Porta, DG				Woehrle, Simon; Weiss, Andreas; Ito, Moriko; Kauffmann, Audrey; Murakami, Masato; Jagani, Zainab; Thuery, Anne; Bauer-Probst, Beatrice; Reimann, Flavia; Stamm, Christelle; Pornon, Astrid; Romanet, Vincent; Guagnano, Vito; Mmendorf, Thomas Bru; Sellers, William R.; Hofmann, Francesco; Roberts, Charles W. M.; Porta, Diana Graus			Fibroblast Growth Factor Receptors as Novel Therapeutic Targets in SNF5-Deleted Malignant Rhabdoid Tumors	PLOS ONE			English	Article							CHROMATIN-REMODELING COMPLEX; SOFT-TISSUE SARCOMAS; CELL-CYCLE ARREST; SYNOVIAL SARCOMA; SWI/SNF COMPLEX; SUPPRESSOR GENE; ONCOGENIC TRANSFORMATION; FAMILIAL SCHWANNOMATOSIS; SMARCB1/INI1 PROTEIN; INI1	Malignant rhabdoid tumors (MRTs) are aggressive pediatric cancers arising in brain, kidney and soft tissues, which are characterized by loss of the tumor suppressor SNF5/SMARCB1. MRTs are poorly responsive to chemotherapy and thus a high unmet clinical need exists for novel therapies for MRT patients. SNF5 is a core subunit of the SWI/SNF chromatin remodeling complex which affects gene expression by nucleosome remodeling. Here, we report that loss of SNF5 function correlates with increased expression of fibroblast growth factor receptors (FGFRs) in MRT cell lines and primary tumors and that re-expression of SNF5 in MRT cells causes a marked repression of FGFR expression. Conversely, siRNA-mediated impairment of SWI/SNF function leads to elevated levels of FGFR2 in human fibroblasts. In vivo, treatment with NVP-BGJ398, a selective FGFR inhibitor, blocks progression of a murine MRT model. Hence, we identify FGFR signaling as an aberrantly activated oncogenic pathway in MRTs and propose pharmacological inhibition of FGFRs as a potential novel clinical therapy for MRTs.	[Woehrle, Simon; Weiss, Andreas; Ito, Moriko; Kauffmann, Audrey; Murakami, Masato; Thuery, Anne; Bauer-Probst, Beatrice; Reimann, Flavia; Stamm, Christelle; Pornon, Astrid; Romanet, Vincent; Guagnano, Vito; Mmendorf, Thomas Bru; Hofmann, Francesco; Porta, Diana Graus] Novartis Inst BioMed Res, Basel, Switzerland; [Jagani, Zainab; Sellers, William R.] Novartis Inst BioMed Res, Cambridge, MA USA; [Roberts, Charles W. M.] Childrens Hosp Boston, Div Hematol Oncol, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA USA	Novartis; Novartis; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute	Porta, DG (corresponding author), Novartis Inst BioMed Res, Basel, Switzerland.	diana.graus_porta@novartis.com	Roberts, Charles/N-2541-2018	Roberts, Charles/0000-0003-1135-1896	NATIONAL CANCER INSTITUTE [R01CA113794] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA113794] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arnold MA, 2013, HUM PATHOL, V44, P881, DOI 10.1016/j.humpath.2012.08.014; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Betz BL, 2002, ONCOGENE, V21, P5193, DOI 10.1038/sj.onc.1205706; Biegel JA, 1999, CANCER RES, V59, P74; Boyd C, 2008, CLIN GENET, V74, P358, DOI 10.1111/j.1399-0004.2008.01060.x; Cheng SWG, 1999, NAT GENET, V22, P102, DOI 10.1038/8811; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; Christiaans I, 2011, J MED GENET, V48, P93, DOI 10.1136/jmg.2010.082420; Garcia CB, 2012, ONCOGENE, V31, P2323, DOI 10.1038/onc.2011.418; Gresh L, 2005, EMBO J, V24, P3313, DOI 10.1038/sj.emboj.7600802; Guagnano V, 2012, CANC DISCOV; Guagnano V, 2011, J MED CHEM, V54, P7066, DOI 10.1021/jm2006222; Hadfield KD, 2008, J MED GENET, V45, P332, DOI 10.1136/jmg.2007.056499; Hulsebos TJM, 2007, AM J HUM GENET, V80, P805, DOI 10.1086/513207; Isakoff MS, 2005, P NATL ACAD SCI USA, V102, P17745, DOI 10.1073/pnas.0509014102; Ishibe T, 2005, CLIN CANCER RES, V11, P2702, DOI 10.1158/1078-0432.CCR-04-2057; Jackson EM, 2009, CLIN CANCER RES, V15, P1923, DOI 10.1158/1078-0432.CCR-08-2091; Jagani Z, 2010, NAT MED, V16, P1429, DOI 10.1038/nm.2251; Kohashi K, 2008, AM J SURG PATHOL, V32, P1168, DOI 10.1097/PAS.0b013e318161781a; Kohashi K, 2010, MODERN PATHOL, V23, P981, DOI 10.1038/modpathol.2010.71; Kreiger PA, 2009, MODERN PATHOL, V22, P142, DOI 10.1038/modpathol.2008.185; Kuwahara Y, 2010, CANCER RES, V70, P1854, DOI 10.1158/0008-5472.CAN-09-1922; Lee D, 2002, J BIOL CHEM, V277, P22330, DOI 10.1074/jbc.M111987200; Lee RS, 2012, J CLIN INVEST, V122, P2983, DOI 10.1172/JCI64400; Lee S, 2011, CANCER RES, V71, P3225, DOI 10.1158/0008-5472.CAN-10-2167; Lorch Y, 2010, P NATL ACAD SCI USA, V107, P3458, DOI 10.1073/pnas.1000398107; Mobley BC, 2010, ACTA NEUROPATHOL, V120, P745, DOI 10.1007/s00401-010-0767-x; Modena P, 2005, CANCER RES, V65, P4012, DOI 10.1158/0008-5472.CAN-04-3050; Morozov A, 2007, CLIN CANCER RES, V13, P4721, DOI 10.1158/1078-0432.CCR-07-0054; Oruetxebarria I, 2004, J BIOL CHEM, V279, P3807, DOI 10.1074/jbc.M309333200; PARHAM DM, 1994, AM J SURG PATHOL, V18, P1010, DOI 10.1097/00000478-199410000-00005; Roberts CWM, 2000, P NATL ACAD SCI USA, V97, P13796, DOI 10.1073/pnas.250492697; Roberts CWM, 2002, CANCER CELL, V2, P415, DOI 10.1016/S1535-6108(02)00185-X; Rousseau-Merck MF, 1999, CANCER RES, V59, P3152; Rozenblatt-Rosen O, 1998, P NATL ACAD SCI USA, V95, P4152, DOI 10.1073/pnas.95.8.4152; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Schmitz U, 2001, BRIT J CANCER, V84, P199, DOI 10.1054/bjoc.2000.1583; Schneppenheim R, 2010, AM J HUM GENET, V86, P279, DOI 10.1016/j.ajhg.2010.01.013; Sevenet N, 1999, AM J HUM GENET, V65, P1342, DOI 10.1086/302639; Sif S, 1998, GENE DEV, V12, P2842, DOI 10.1101/gad.12.18.2842; Sudarsanam P, 2000, P NATL ACAD SCI USA, V97, P3364, DOI 10.1073/pnas.050407197; Trobaugh-Lotrario AD, 2011, PEDIATR BLOOD CANCER, V57, P423, DOI 10.1002/pbc.22857; Trobaugh-Lotrario AD, 2009, PEDIATR BLOOD CANCER, V52, P328, DOI 10.1002/pbc.21834; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; van den Heuvel-Eibrink MM, 2011, PEDIATR BLOOD CANCER, V56, P733, DOI 10.1002/pbc.22922; Versteege I, 2002, ONCOGENE, V21, P6403, DOI 10.1038/sj.onc.1205841; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; WICK MR, 1995, SEMIN DIAGN PATHOL, V12, P233; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006; Wu DY, 2002, J BIOL CHEM, V277, P27706, DOI 10.1074/jbc.M200955200; Zhang ZK, 2002, MOL CELL BIOL, V22, P5975, DOI 10.1128/MCB.22.16.5975-5988.2002	52	40	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77652	10.1371/journal.pone.0077652	http://dx.doi.org/10.1371/journal.pone.0077652			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204904	gold, Green Published, Green Submitted			2022-12-27	WOS:000326334500038
J	Yao, YL; Shao, J; Zhang, CF; Wu, JH; Zhang, QH; Wang, JJ; Zhu, W				Yao, Yong-Liang; Shao, Jie; Zhang, Chunfu; Wu, Jian-Hong; Zhang, Qing-Hui; Wang, Jian-Jun; Zhu, Wei			Proliferation of Colorectal Cancer Is Promoted by Two Signaling Transduction Expression Patterns: ErbB2/ErbB3/AKT and MET/ErbB3/MAPK	PLOS ONE			English	Article							CELL LUNG-CANCER; BREAST-CANCER; COLON-CANCER; PREOPERATIVE CHEMOTHERAPY; MET; RESISTANCE; INHIBITORS; MUTATIONS; RECEPTOR; PATHWAY	One of the recent breakthroughs in cancer research is the identification of activating mutations in various receptor tyrosine kinase(RTK) pathways in many cancers including colorectal cancer(CRC). We hypothesize that, alternative to mutations, overexpression of various oncogenic RTKs may also underpin CRC pathogenesis, and different RTK may couple with distinct downstream signaling pathways in different subtypes of human CRC. By immunohistochemistry, we show here that RTK members ErbB2, ErbB3 and c-Met were in deed differentially overexpressed in colorectal cancer patient samples leading to constitutive activation of RTK signaling pathways. Using ErbB2 specific inhibitor Lapatinib and c-Met specific inhibitor PHA-665752, we further demonstrated that this constitutive activation of RTK signaling is necessary for the survival of colorectal cancer cells. Furthermore, we show that RTK overexpression pattern dictates the use of downstream AKT and/or MAPK pathways. Our data are important additions to current oncogenic mutation models, and further explain the clinical variation in therapeutic responses of colorectal cancer. Our findings advocate for more personalized therapy tailored to individual patients based on their type of RTK expression in addition to their mutation status.	[Yao, Yong-Liang; Wu, Jian-Hong; Zhang, Qing-Hui; Wang, Jian-Jun] Jiangsu Univ, Kunshan Peoples Hosp 1, Dept Clin Lab, Kunshan, Jiangsu, Peoples R China; [Zhu, Wei] Jiangsu Univ, Sch Med Sci & Lab Med, Zhenjiang, Jiangsu, Peoples R China; [Shao, Jie] PLA, Hosp 359, Dept Clin Lab, Zhenjiang, Jiangsu, Peoples R China; [Zhang, Chunfu] Second Peoples Hosp Kunshan, Dept Clin Lab, Kunshan, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University	Zhu, W (corresponding author), Jiangsu Univ, Sch Med Sci & Lab Med, Zhenjiang, Jiangsu, Peoples R China.	zhuwei@ujs.edu.cn	Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507	Social Development Foundation of Kunshan [KS1130]; Scientific Research Foundation of Jiangsu University [11JGD0090]	Social Development Foundation of Kunshan; Scientific Research Foundation of Jiangsu University	This work was supported by the Social Development Foundation of Kunshan (no. KS1130) and the Scientific Research Foundation of Jiangsu University (no. 11JGD0090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio LA, 2012, CANCER METAST REV, V31, P375, DOI 10.1007/s10555-012-9348-x; Ballard-Barbash R, 2012, JNCI-J NATL CANCER I, V104, P815, DOI 10.1093/jnci/djs207; Benson AB, 2013, J NATL COMPR CANC NE, V11, P141, DOI 10.6004/jnccn.2013.0022; Bentivegna S, 2008, HUM MUTAT, V29, P441, DOI 10.1002/humu.20672; Brugger W, 2012, LUNG CANCER, V77, P2, DOI 10.1016/j.lungcan.2011.12.014; Cecchi F, 2012, EXPERT OPIN THER TAR, V16, P553, DOI 10.1517/14728222.2012.680957; Cervantes A, 2012, LANCET ONCOL, V13, P1073, DOI 10.1016/S1470-2045(12)70389-3; Chow A, 2011, J MAMMARY GLAND BIOL, V16, P81, DOI 10.1007/s10911-011-9206-4; Fafalios A, 2011, NAT MED, V17, P1577, DOI 10.1038/nm.2531; Fan WW, 2011, CANCER RES, V71, P4494, DOI 10.1158/0008-5472.CAN-10-2668; Gajria D, 2011, EXPERT REV ANTICANC, V11, P263, DOI 10.1586/ERA.10.226; Gan HK, 2012, CANCER RES, V72, P2924, DOI 10.1158/0008-5472.CAN-11-3898; Gao JJ, 2011, DRUG DISCOV THER, V5, P2, DOI 10.5582/ddt.2011.v5.1.2; Gutierrez C, 2011, ARCH PATHOL LAB MED, V135, P55, DOI 10.1043/2010-0454-RAR.1; Huang SD, 2012, CELL, V151, P937, DOI 10.1016/j.cell.2012.10.035; Jaiswal BS, 2013, CANCER CELL, V23, P603, DOI 10.1016/j.ccr.2013.04.012; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Kielbowna L, 2012, FOLIA BIOL-KRAKOW, V60, P107, DOI 10.3409/fb60_3-4.107-119; Lefebvre J, 2012, FASEB J, V26, P1387, DOI 10.1096/fj.11-197723; Liu XD, 2011, EXPERT OPIN INV DRUG, V20, P1225, DOI 10.1517/13543784.2011.600687; Miller TW, 2011, J CLIN ONCOL, V29, P4452, DOI 10.1200/JCO.2010.34.4879; Morton UKD, 2012, LANCET ONCOL, V13, P1152, DOI 10.1016/S1470-2045(12)70348-0; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Peters S, 2012, NAT REV CLIN ONCOL, V9, P314, DOI 10.1038/nrclinonc.2012.71; Romagnolo Donato F., 2012, Journal of Nutrition in Gerontology and Geriatrics, V31, P206, DOI 10.1080/21551197.2012.702534; Sgambato A, 2012, CURR PHARM DESIGN, V18, P6155, DOI 10.2174/138161212803582478; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yap TA, 2011, CURR DRUG TARGETS, V12, P2045; Yue P, 2012, ONCOGENE, V31, P2309, DOI 10.1038/onc.2011.409; Zhang LM, 2011, ANAL BIOCHEM, V412, P1, DOI 10.1016/j.ab.2011.01.028	32	20	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78086	10.1371/journal.pone.0078086	http://dx.doi.org/10.1371/journal.pone.0078086			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205104	gold, Green Published, Green Submitted			2022-12-27	WOS:000326334500095
J	Zeng, H; Sun, MX; Zhou, CH; Yin, F; Wang, ZY; Hua, YQ; Cai, ZD				Zeng, Hui; Sun, Mengxiong; Zhou, Chenghao; Yin, Fei; Wang, Zhuoying; Hua, Yingqi; Cai, Zhengdong			Hematoporphyrin Monomethyl Ether-Mediated Photodynamic Therapy Selectively Kills Sarcomas by Inducing Apoptosis	PLOS ONE			English	Article							ACRIDINE-ORANGE; CANCER; CELLS; PATHWAYS; SURGERY	We investigated the antitumor effect and mechanism of hematoporphyrin monomethyl ether-mediated photodynamic therapy (HMME-PDT) in sarcomas. Intracellular uptake of HMME by osteosarcoma cells (LM8 and K7) was time-and dose-dependent, while this was not observed for myoblast cells (C2C12) and fibroblast cells (NIH/3T3). HMME-PDT markedly inhibited the proliferation of sarcoma cell lines (LM8, MG63, Saos-2, SW1353, TC71, and RD) (P<0.05), and the killing effect was improved with increased HMME concentration and energy intensity. Flow cytometry analysis revealed that LM8, MG63, and Saos-2 cells underwent apoptosis after treatment with HMME-PDT. Additionally, apoptosis was induced after HMME-PDT in a three-dimensional culture of osteosarcoma cells. Hoechst 33342 staining confirmed apoptosis. Cell death caused by PDT was rescued by an irreversible inhibitor (Z-VAD-FMK) of caspase. However, cell viability was not markedly decreased compared with the HMME-PDT group. Expression levels of caspase-1, caspase-3, caspase-6, caspase-9, and poly (ADP-ribose) polymerase (PARP) proteins were markedly up-regulated in the treatment groups and increased with HMME concentration as determined by western blot analysis. In vivo, tumor volume markedly decreased at 7-16 days post-PDT. Hematoxylin and eosin staining revealed widespread necrotic and infiltrative inflammatory cells in the HMME-PDT group. Immunohistochemistry analysis also showed that caspase-1, caspase-3, caspase-6, caspase-9, and PARP proteins were significantly increased in the HMME-PDT group. These results indicate that HMME-PDT has a potent killing effect on osteosarcoma cells in vitro and significantly inhibits tumor growth in vivo, which is associated with the caspase-dependent pathway.	[Zeng, Hui; Yin, Fei; Wang, Zhuoying; Hua, Yingqi; Cai, Zhengdong] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Orthoped, Shanghai 200030, Peoples R China; [Sun, Mengxiong; Zhou, Chenghao; Hua, Yingqi; Cai, Zhengdong] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Orthoped, Shanghai 200092, Peoples R China; [Hua, Yingqi] Tongji Univ, Adv Inst Translat Med, Shanghai 200092, Peoples R China	Shanghai Jiao Tong University; Tongji University; Tongji University	Hua, YQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Orthoped, Shanghai 200030, Peoples R China.	yingqi.hua@yahoo.com; zhdcai@gmail.com	Fan, Lin/L-3606-2014		Shanghai Science and Technology Commission [11JC1410100]	Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the Basic Research Project of Shanghai Science and Technology Commission (NO. 11JC1410100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinis P, 2004, PHOTOCH PHOTOBIO SCI, V3, P721, DOI 10.1039/b315237e; Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; Akeda K, 2009, ONCOL REP, V22, P997, DOI 10.3892/or_00000527; Buytaert E, 2007, BBA-REV CANCER, V1776, P86, DOI 10.1016/j.bbcan.2007.07.001; Cai H, 2011, PHOTODERMATOL PHOTO, V27, P90, DOI 10.1111/j.1600-0781.2011.00577.x; Chan YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038961; Chen XH, 2011, LASER MED SCI, V26, P69, DOI 10.1007/s10103-010-0810-0; Ding XM, 2004, CANCER LETT, V216, P43, DOI 10.1016/j.canlet.2004.07.005; Hashiguchi S, 2002, ONCOLOGY-BASEL, V62, P85, DOI 10.1159/000048251; Hsieh YJ, 2003, J CELL PHYSIOL, V194, P363, DOI 10.1002/jcp.10273; Huang CP, 2009, LAB CHIP, V9, P1740, DOI 10.1039/b818401a; Kusuzaki K, 2005, PHOTOCHEM PHOTOBIOL, V81, P705, DOI 10.1562/2004-06-27-RA-218.1; Lawen A, 2003, BIOESSAYS, V25, P888, DOI 10.1002/bies.10329; Liu TC, 2010, INT J ONCOL, V36, P777, DOI 10.3892/ijo_00000553; Liu Y, 2011, VET J, V188, P325, DOI 10.1016/j.tvjl.2010.05.013; Master A, 2013, MOL PHARMACEUT, V10, P1988, DOI 10.1021/mp400007k; Matsubara T, 2009, ONCOL REP, V21, P89, DOI 10.3892/or_00000193; Moan J, 2003, ANTICANCER RES, V23, P3591; Moon YH, 2009, ONCOL REP, V22, P1085, DOI 10.3892/or_00000540; Nakamura T, 2008, J SURG ONCOL, V97, P523, DOI 10.1002/jso.21025; Nowak-Sliwinska P, 2010, ANGIOGENESIS, V13, P281, DOI 10.1007/s10456-010-9185-x; Reiners JJ, 2010, AUTOPHAGY, V6, P7, DOI 10.4161/auto.6.1.10220; Satonaka H, 2011, ANTICANCER RES, V31, P4163; Su XM, 2013, CANCER BIOTHER RADIO, V28, P207, DOI 10.1089/cbr.2012.1190; Takeda K, 2008, CLIN ORTHOP RELAT R, V466, P1726, DOI 10.1007/s11999-008-0284-6; Tan PHS, 2011, BIOMATERIALS, V32, P6131, DOI 10.1016/j.biomaterials.2011.04.084; Tang PMK, 2009, CANCER BIOL THER, V8, P533, DOI 10.4161/cbt.8.6.7694; Vittar NBR, 2010, INT J BIOCHEM CELL B, V42, P1123, DOI 10.1016/j.biocel.2010.03.019; Wang XL, 2010, J PHARMACOL EXP THER, V334, P847, DOI 10.1124/jpet.110.168856; Won E, 2010, BREAST CANCER RES TR, V124, P111, DOI 10.1007/s10549-009-0712-7; Yanase S, 2009, PHOTOMED LASER SURG, V27, P791, DOI 10.1089/pho.2008.2329; Zhan Q, 2011, PHOTODIAGN PHOTODYN, V8, P314, DOI 10.1016/j.pdpdt.2011.04.002; Zhou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058855	33	24	25	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77727	10.1371/journal.pone.0077727	http://dx.doi.org/10.1371/journal.pone.0077727			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204937	gold, Green Submitted, Green Published			2022-12-27	WOS:000326334500047
J	Stich, M; Ghoshal, G; Perez-Mercader, J				Stich, Michael; Ghoshal, Gourab; Perez-Mercader, Juan			Parametric Pattern Selection in a Reaction-Diffusion Model	PLOS ONE			English	Article							GRAY-SCOTT MODEL; STATIC SPIKE AUTOSOLITONS; SELF-REPLICATING SPOTS; GAS-DISCHARGE SYSTEM; CHEMICAL-SYSTEMS; TURBULENCE; STABILITY; DYNAMICS	We compare spot patterns generated by Turing mechanisms with those generated by replication cascades, in a model one-dimensional reaction-diffusion system. We determine the stability region of spot solutions in parameter space as a function of a natural control parameter (feed-rate) where degenerate patterns with different numbers of spots coexist for a fixed feed-rate. While it is possible to generate identical patterns via both mechanisms, we show that replication cascades lead to a wider choice of pattern profiles that can be selected through a tuning of the feed-rate, exploiting hysteresis and directionality effects of the different pattern pathways.	[Stich, Michael; Ghoshal, Gourab; Perez-Mercader, Juan] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Perez-Mercader, Juan] Santa Fe Inst, Santa Fe, NM 87501 USA	Harvard University; The Santa Fe Institute	Stich, M (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	mstich@fas.harvard.edu		Ghoshal, Gourab/0000-0001-7593-5626	Repsol S. A.	Repsol S. A.	This work was carried out with support from Repsol S. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astrov YA, 1997, PHYS REV LETT, V79, P2983, DOI 10.1103/PhysRevLett.79.2983; Astrov YA, 2006, PHYS LETT A, V358, P404, DOI 10.1016/j.physleta.2006.05.047; Avila K, 2011, SCIENCE, V333, P192, DOI 10.1126/science.1203223; Barkley D, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016309; CASTETS V, 1990, PHYS REV LETT, V64, P2953, DOI 10.1103/PhysRevLett.64.2953; Cross M, 2009, PATTERN FORMATION DY, DOI 10.1017/CBO9780511627200; De Wit A, 1999, ADV CHEM PHYS, V109, P435, DOI 10.1002/9780470141687.ch5; Doelman A, 1997, NONLINEARITY, V10, P523, DOI 10.1088/0951-7715/10/2/013; Ei S, 2001, JPN J IND APPL MATH, V18, P181, DOI 10.1007/BF03168570; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; GRAY P, 1983, CHEM ENG SCI, V38, P29, DOI 10.1016/0009-2509(83)80132-8; Grzybowski B.A., 2009, CHEM MOTION REACTION; Kolokolnikov T, 2005, PHYSICA D, V202, P258, DOI 10.1016/j.physd.2005.02.009; LEE KJ, 1994, NATURE, V369, P215, DOI 10.1038/369215a0; Lesmes F, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.238301; Manneville P, 2012, EPL-EUROPHYS LETT, V98, DOI 10.1209/0295-5075/98/64001; Mazin W, 1996, MATH COMPUT SIMULAT, V40, P371, DOI 10.1016/0378-4754(95)00044-5; Mikhailov A. S., 1994, FDN SYNERGETICS, VI; Mikhailov AS, 2006, PHYS REP, V425, P79, DOI 10.1016/j.physrep.2005.11.003; Morgan DS, 2000, METH APPL ANAL, V7, P105; Muratov CB, 2002, SIAM J APPL MATH, V62, P1463, DOI 10.1137/S0036139901384285; Muratov CB, 2000, J PHYS A-MATH GEN, V33, P8893, DOI 10.1088/0305-4470/33/48/321; Nishiura Y, 1999, PHYSICA D, V130, P73, DOI 10.1016/S0167-2789(99)00010-X; OUYANG Q, 1991, NATURE, V352, P610, DOI 10.1038/352610a0; PEARSON JE, 1993, SCIENCE, V261, P189, DOI 10.1126/science.261.5118.189; PRIGOGIN.I, 1968, J CHEM PHYS, V48, P1695, DOI 10.1063/1.1668896; Reynolds WN, 1997, PHYS REV E, V56, P185, DOI 10.1103/PhysRevE.56.185; SELKOV EE, 1968, EUR J BIOCHEM, V4, P79, DOI 10.1111/j.1432-1033.1968.tb00175.x; Shi L, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.204502; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Walgraef D, 1997, SPATIO TEMPORAL PATT; Wei JC, 2008, J MATH BIOL, V57, P53, DOI 10.1007/s00285-007-0146-y	32	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77337	10.1371/journal.pone.0077337	http://dx.doi.org/10.1371/journal.pone.0077337			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204813	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000326270700026
J	Fergus, P; Cheung, P; Hussain, A; Al-Jumeily, D; Dobbins, C; Iram, S				Fergus, Paul; Cheung, Pauline; Hussain, Abir; Al-Jumeily, Dhiya; Dobbins, Chelsea; Iram, Shamaila			Prediction of Preterm Deliveries from EHG Signals Using Machine Learning	PLOS ONE			English	Article							UTERINE EMG; ELECTRICAL-ACTIVITY; APPROXIMATE ENTROPY; ABDOMINAL SURFACE; EARLY-DIAGNOSIS; TERM; CLASSIFICATION; PREGNANCY; LABOR; BIRTH	There has been some improvement in the treatment of preterm infants, which has helped to increase their chance of survival. However, the rate of premature births is still globally increasing. As a result, this group of infants are most at risk of developing severe medical conditions that can affect the respiratory, gastrointestinal, immune, central nervous, auditory and visual systems. In extreme cases, this can also lead to long-term conditions, such as cerebral palsy, mental retardation, learning difficulties, including poor health and growth. In the US alone, the societal and economic cost of preterm births, in 2005, was estimated to be $26.2 billion, per annum. In the UK, this value was close to (sic)2.95 billion, in 2009. Many believe that a better understanding of why preterm births occur, and a strategic focus on prevention, will help to improve the health of children and reduce healthcare costs. At present, most methods of preterm birth prediction are subjective. However, a strong body of evidence suggests the analysis of uterine electrical signals (Electrohysterography), could provide a viable way of diagnosing true labour and predict preterm deliveries. Most Electrohysterography studies focus on true labour detection during the final seven days, before labour. The challenge is to utilise Electrohysterography techniques to predict preterm delivery earlier in the pregnancy. This paper explores this idea further and presents a supervised machine learning approach that classifies term and preterm records, using an open source dataset containing 300 records (38 preterm and 262 term). The synthetic minority oversampling technique is used to oversample the minority preterm class, and cross validation techniques, are used to evaluate the dataset against other similar studies. Our approach shows an improvement on existing studies with 96% sensitivity, 90% specificity, and a 95% area under the curve value with 8% global error using the polynomial classifier.	[Fergus, Paul; Cheung, Pauline; Hussain, Abir; Al-Jumeily, Dhiya; Dobbins, Chelsea; Iram, Shamaila] Liverpool John Moores Univ, Appl Comp Res Grp, Liverpool L3 5UX, Merseyside, England	Liverpool John Moores University	Fergus, P (corresponding author), Liverpool John Moores Univ, Appl Comp Res Grp, Liverpool L3 5UX, Merseyside, England.	P.Fergus@ljmu.ac.uk	Dobbins, Chelsea/Q-9789-2019; Al-Jumeily, Dhiya/AAE-8272-2020; Dobbins, Chelsea/AAF-8786-2021	Dobbins, Chelsea/0000-0001-9420-2452; Al-Jumeily, Dhiya/0000-0002-9170-0568; Iram, Shamaila/0000-0003-0217-500X; Fergus, Paul/0000-0002-7070-4447				[Anonymous], P IEEE 8 INT S MECH, DOI [10.1109/ISMA.2012.6215191, DOI 10.1109/ISMA.2012.6215191]; Baghamoradi S, 2011, 18 IR C BIOM ENG, P1; Buhimschi C, 1997, OBSTET GYNECOL, V90, P102, DOI 10.1016/S0029-7844(97)83837-9; Buhimschi C, 1996, AM J OBSTET GYNECOL, V174, P744, DOI 10.1016/S0002-9378(96)70459-3; Buhimschi C, 1998, AM J OBSTET GYNECOL, V178, P811, DOI 10.1016/S0002-9378(98)70498-3; Carre P, 1998, IEEE T BIO-MED ENG, V45, P1104, DOI 10.1109/10.709554; CHARNIAK E, 1991, AI MAG, V12, P50; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Diab A, 2012, IEEE ENG MED BIO, P1045, DOI 10.1109/EMBC.2012.6346113; Diab Mohamad O., 2010, Journal of Biomedical Science & Engineering, V3, P837, DOI 10.4236/jbise.2010.39113; Diab M.O., 2007, INT J COMPUT COGNIT, V5, P8; Diab MO, 2012, IEEE MEDITERR ELECT, P335, DOI 10.1109/MELCON.2012.6196443; Doret M, 2005, OBSTET GYNECOL, V105, P822, DOI 10.1097/01.AOG.0000157110.62926.d7; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fele-Zorz G, 2008, MED BIOL ENG COMPUT, V46, P911, DOI 10.1007/s11517-008-0350-y; Frey B., 2020, STAT PEOPLE WHO THIN; Garfield RE, 2005, BJOG-INT J OBSTET GY, V112, P103, DOI 10.1111/j.1471-0528.2005.00596.x; Garfield RE, 2007, SEMIN CELL DEV BIOL, V18, P289, DOI 10.1016/j.semcdb.2007.05.004; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gondry Jean, 1993, Biomedical Instrumentation and Technology, V27, P318; Greenough A, 2012, SEMIN FETAL NEONAT M, V17, P73, DOI 10.1016/j.siny.2012.01.009; Hassan M, 2011, MED ENG PHYS, V33, P980, DOI 10.1016/j.medengphy.2011.03.010; Hassan M, 2013, IEEE T BIO-MED ENG, V60, P1160, DOI 10.1109/TBME.2012.2229279; Kenny LC., 2011, OBSTET 10 TEACHERS, V19, P225; Lammers WJEP, 2013, REPROD SCI, V20, P182, DOI 10.1177/1933719112446082; Lasko TA, 2005, J BIOMED INFORM, V38, P404, DOI 10.1016/j.jbi.2005.02.008; Leman H, 1999, IEEE T BIO-MED ENG, V46, P1222, DOI 10.1109/10.790499; Lin WJ, 2013, BRIEF BIOINFORM, V14, P13, DOI 10.1093/bib/bbs006; Lucovnik M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.09.024; Lusa, 2013, BMC BIOINFORMATICS, V14, P1; Maner WL, 2007, ANN BIOMED ENG, V35, P465, DOI 10.1007/s10439-006-9248-8; Maner WL, 2006, MED BIOL ENG COMPUT, V44, P117, DOI 10.1007/s11517-005-0011-3; Maner WL, 2003, OBSTET GYNECOL, V101, P1254, DOI 10.1016/S0029-7844(03)00341-7; Mangham LJ, 2009, PEDIATRICS, V123, pE312, DOI 10.1542/peds.2008-1827; March of Dimes PMNCH Save The Children WHO, 2012, GLOB ACT REP PRET BI, DOI DOI 10.1016/S0140-6736(12)61970-9; Marque Catherine K, 2007, BMC Pregnancy Childbirth, V7 Suppl 1, pS5, DOI 10.1186/1471-2393-7-S1-S5; McPheeters ML, 2005, AM J OBSTET GYNECOL, V192, P1325, DOI 10.1016/j.ajog.2004.12.055; Moslem B., 2011, 2011 18th IEEE International Conference on Electronics, Circuits and Systems (ICECS 2011), P631, DOI 10.1109/ICECS.2011.6122354; Moslem B., 2011, 2011 18th IEEE International Conference on Electronics, Circuits and Systems (ICECS 2011), P93, DOI 10.1109/ICECS.2011.6122222; Moslem B, 2011, IEEE ENG MED BIO, P2602, DOI 10.1109/IEMBS.2011.6090718; Moslem B, 2011, IEEE ENG MED BIO, P3371, DOI 10.1109/IEMBS.2011.6090913; Moslem B, 2012, IEEE MEDITERR ELECT, P331, DOI 10.1109/MELCON.2012.6196442; Moslem B, 2011, IEEE WRK SIG PRO SYS, P267, DOI 10.1109/SiPS.2011.6088987; Muglia LJ, 2010, NEW ENGL J MED, V362, P529, DOI 10.1056/NEJMra0904308; Nahar J, 2012, EXPERT SYST APPL, V39, P12371, DOI 10.1016/j.eswa.2012.04.045; Rabotti C, 2010, IEEE T BIO-MED ENG, V57, P2178, DOI 10.1109/TBME.2010.2049111; Rattihalli R, 2012, FETAL NEONATAL, V97, P160; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Russell SP, 2010, ARTIFICIAL INTELLIGE; Sun T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063559; Taft LM, J BIOMEDICAL INFORM, V42, P356; Tong LI, 2011, EXPERT SYST APPL, V38, P4222, DOI 10.1016/j.eswa.2010.09.087; van der Heijde F, 2005, CLASSIFICATION PARAM; Verdenik I, 2001, EUR J OBSTET GYN R B, V95, P149, DOI 10.1016/S0301-2115(00)00418-8; Vinken MPGC, 2009, OBSTET GYNECOL SURV, V64, P529, DOI 10.1097/OGX.0b013e3181a8c6b1; Wang YJ, 2012, IEEE T INF TECHNOL B, V16, P383, DOI 10.1109/TITB.2012.2187458	56	90	90	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77154	10.1371/journal.pone.0077154	http://dx.doi.org/10.1371/journal.pone.0077154			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204760	Green Published, Green Accepted, gold			2022-12-27	WOS:000326241200018
J	Gerstl, S; Sauter, J; Kasanda, J; Kinzelbach, A				Gerstl, Sibylle; Sauter, Justin; Kasanda, Joseph; Kinzelbach, Alfred			Who Can Afford Health Care? Evaluating the Socio-Economic Conditions and the Ability to Contribute to Health Care in a Post-Conflict Area in DR Congo	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; SEEKING BEHAVIOR; USER FEES; INSURANCE; SERVICES; POVERTY; COUNTRIES; COVERAGE; COST	Introduction: The Democratic Republic of the Congo is today one of the poorest countries in the world; the health status of the population ranks among the worst in Sub-Saharan Africa. Public health services charge user fees and drug prices. Since 2008, north-eastern Congo is facing a guerrilla war. Malteser International is assisting with free health care for internally displaced persons as well as the general population. Before the incursion the health system was based on user fees. The aim of this study was to determine the socio-economic conditions of the population and to assess their ability to contribute to health care. Methodology: Heads of 552 randomly selected households in 23 clusters in two health zones were interviewed using a standardised questionnaire. Findings: The demographic description and socio-economic conditions of the study population were homogenous. Major source of income was agriculture (57%); 47% of the households earned less than US$ 5.5/week. Ninety-two percent of the interviewed households estimated that they would be able to contribute to consultation fees (maximum amount of US$ 0.27) and 79% to the drug prices (maximum amount of US$ 1.10). Six percent opted for free consultations and 19% for free drugs. Conclusions: Living conditions were very basic; the estimated income of the study population was low. Almost half of the population perceived their current living situation as fairly good/good. More than 90% of the study population estimated to be able to contribute to consultation fees and 80% to drug prices. As a result Malteser International suggested introducing flat-rates for health care services. Once the project ends, the population will have to pay again for their health service. One solution would be the introduction of a health care financing system with the goal to reach universal coverage to health care.	[Gerstl, Sibylle] Malteser Int, Cologne, Germany; [Sauter, Justin; Kasanda, Joseph] Malteser Int, Ariwara, Aru Territory, DEM REP CONGO; [Kinzelbach, Alfred] Malteser Int, Kampala, Uganda		Gerstl, S (corresponding author), Malteser Int, Cologne, Germany.	sgerstl@aol.com			European Commission's Humanitarian Aid and Civil Protection Department (ECHO)	European Commission's Humanitarian Aid and Civil Protection Department (ECHO)	The study was carried out by Malteser International. It was funded within a grant of the European Commission's Humanitarian Aid and Civil Protection Department (ECHO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This document has been produced with the financial assistance of the European Commission. The views expressed herein should not be taken, in any way, to reflect the official opinion of the European Commission.	Alkire S, 2010, 38 U OXF OXF POV HUM; Baiphethi MN, 2009, AGREKON, V48, P459, DOI 10.1080/03031853.2009.9523836; Bank World, 2005, 35626ZR BANK WORLD; Bank World, 2009, 6 STEPS AB PRIM SCH; Bank World, 2009, AB SCH FEES AFR LESS; Basinga P, 2011, LANCET, V377, P1421, DOI 10.1016/S0140-6736(11)60177-3; Bonu S, 2003, HEALTH POLICY PLANN, V18, P370, DOI 10.1093/heapol/czg045; Chen S, 2008, 4703 DEV RES GROUP W; Chuma J, 2007, TROP MED INT HEALTH, V12, P673, DOI 10.1111/j.1365-3156.2007.01825.x; DASGUPTA P, 1992, WORLD DEV, V20, P119, DOI 10.1016/0305-750X(92)90141-H; Dasgupta P, 2000, 0024 RES FUT; de la Sante Ministere, 2003, SNIS SYST NAT INF SA; Deaton A., 1997, The analysis of household surveys: a microeconometric approach to development policy.; Democratic Republic of the Congo-Ministry of Health, 2006, EALTH SYST STRENGTH; Donfouet HPP, 2011, INT J HEALTH CARE FI, V11, P209, DOI 10.1007/s10754-011-9097-3; Dong HJ, 2003, HEALTH ECON, V12, P849, DOI 10.1002/hec.771; Falkingham J, 2004, SOC SCI MED, V58, P247, DOI 10.1016/S0277-9536(03)00008-X; Foster N, 2012, 89 EQUINET UCT; GEC (Groupe d'?tude sur le Congo), 2020, EB RDC SYST SANT PAR; Global Health Facts, 2009, DEM REP CONG HIGHL; HENDERSON RH, 1982, B WORLD HEALTH ORGAN, V60, P253; Hentschel J, 1996, CONSTRUCTING INDICAT; Howe LD, 2012, INT J EPIDEMIOL, V41, P871, DOI 10.1093/ije/dys037; Howe LD, 2011, HEALTH POLICY PLANN, V26, P223, DOI 10.1093/heapol/czq043; Human Rights Watch, 2011, US CENTR AFR PROT CI; Konde-Lule J, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-29; Lagomarsino G, 2012, LANCET, V380, P933, DOI 10.1016/S0140-6736(12)61147-7; Larson CP, 2006, INT J EPIDEMIOL, V35, P1430, DOI 10.1093/ije/dyl167; MDF-AC, 2009, ENQ SOC ACC SOINS SA; Moser K, 2007, INT J EPIDEMIOL, V36, P1285, DOI 10.1093/ije/dym176; MSF, 2009, TOP 10 HUM CRIS 2009; Muela SH, 2000, HEALTH POLICY PLANN, V15, P296, DOI 10.1093/heapol/15.3.296; Noor Aizuddin A., 2012, BMC PUBLIC HEALTH, V12, pA37, DOI [10.1186/1471-2458-12-s2-a37, DOI 10.1186/1471-2458-12-S2-A37, 10.1186/1471-2458-12-S2-A37]; OCHA, 2011, ACT HUM PROV OR RAPP; OCHA, 2011, LRA REG UPD DRC CAR; Onwujekwe O, 2010, HEALTH POLICY PLANN, V25, P155, DOI 10.1093/heapol/czp046; Osubor KM, 2006, MATERN CHILD HLTH J, V10, P159, DOI 10.1007/s10995-005-0037-z; Oxfam, 2010, GHOSTS CHRISTM PROT; Pradhan M, 1998, MEASURING POVERTY US; Pretty J, 2001, REDUCING FOOD POVERT; Ravallion M, 1996, WORLD BANK RES OBSER, V11, P199, DOI 10.1093/wbro/11.2.199; Ravallion M, 2009, WORLD BANK ECON REV, V23, P163, DOI 10.1093/wber/lhp007; Ridde V, 2011, HEALTH POLICY PLANN, V26, P1, DOI 10.1093/heapol/czq021; Russell S, 1996, HEALTH POLICY PLANN, V11, P219, DOI 10.1093/heapol/11.3.219; Stewart Q, 2005, REASSETS VALID PROXY; SWAMINATHAN M, 1995, ENVIRON URBAN, V7, P133, DOI 10.1177/095624789500700117; the Global Alliance for Vaccination and Immunization, 2009, HLTH SYST STRENGTH T; UNDP, 2012, INT HUM DEV IND; UNHCR, 2010, UNHCR FIELD OFF REP; USAID, 2006, PUBL HLTH TRAIN DEM; Van Herp M, 2003, DISASTERS, V27, P141, DOI 10.1111/1467-7717.00225; WHO, 2010, WOR HEALT REP, P1; Zarocostas, 2009, BMJ-BRIT MED J, V338, pb2652, DOI [10.1136/bmj.b2652, DOI 10.1136/BMJ.B2652.PUBMED:19567465]	53	6	6	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77382	10.1371/journal.pone.0077382	http://dx.doi.org/10.1371/journal.pone.0077382			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	241FR	24204819	Green Published, gold, Green Submitted			2022-12-27	WOS:000326152300022
J	Janovsky, Z; Mikat, M; Hadrava, J; Horcickova, E; Kmecova, K; Pozarova, D; Smycka, J; Herben, T				Janovsky, Zdenek; Mikat, Michael; Hadrava, Jiri; Horcickova, Eva; Kmecova, Katerina; Pozarova, Doubravka; Smycka, Jan; Herben, Tomas			Conspecific and Heterospecific Plant Densities at Small-Scale Can Drive Plant-Pollinator Interactions	PLOS ONE			English	Article							ANIMAL MUTUALISTIC NETWORKS; LOCAL-DENSITY; SIZE; LANDSCAPE; COMMUNITY; BUMBLEBEES; DIVERSITY; REPRODUCTION; VISITATION; CONSTANCY	Generalist pollinators are important in many habitats, but little research has been done on small-scale spatial variation in interactions between them and the plants that they visit. Here, using a spatially explicit approach, we examined whether multiple species of flowering plants occurring within a single meadow showed spatial structure in their generalist pollinator assemblages. We report the results for eight plant species for which at least 200 individual visits were recorded. We found that for all of these species, the proportions of their general pollinator assemblages accounted for by particular functional groups showed spatial heterogeneity at the scale of tens of metres. This heterogeneity was connected either with no or only subtle changes of vegetation and flowering species composition. In five of these species, differences in conspecific plant density influenced the pollinator communities (with greater dominance of main pollinators at low-conspecific plant densities). The density of heterospecific plant individuals influenced the pollinator spectrum in one case. Our results indicate that the picture of plant-pollinator interactions provided by averaging data within large plots may be misleading and that within-site spatial heterogeneity should be accounted for in terms of sampling effort allocation and analysis. Moreover, spatially structured plant-pollinator interactions may have important ecological and evolutionary consequences, especially for plant population biology.	[Janovsky, Zdenek; Mikat, Michael; Hadrava, Jiri; Horcickova, Eva; Smycka, Jan; Herben, Tomas] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic; [Kmecova, Katerina] Secondary Grammar Sch Znojmo, Znojmo, Czech Republic; [Pozarova, Doubravka] Secondary Grammar Sch Rakovnik, Rakovnik, Czech Republic; [Herben, Tomas] Acad Sci Czech Republic, Inst Bot, Pruhonice By Prague, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Janovsky, Z (corresponding author), Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic.	zdenekjanovsky@seznam.cz	Hadrava, Jiří/R-9347-2017; Herben, Tomas/G-1804-2014; Mikát, Michael/S-3418-2017; Janovský, Zdeněk/M-9818-2014; Horcickova, Eva/W-4247-2017	Hadrava, Jiří/0000-0003-3247-6399; Herben, Tomas/0000-0002-6636-0012; Mikát, Michael/0000-0001-5364-7180; Janovský, Zdeněk/0000-0002-0438-6778; Horcickova, Eva/0000-0003-2915-548X	Grant Agency of the Czech Republic [GACR P505/11/1589]; British Ecological Society [3298/4077]; Roman-Catholic Parish in Uhlirske Janovice, Czech Republic	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); British Ecological Society; Roman-Catholic Parish in Uhlirske Janovice, Czech Republic	The research was supported by Grant Agency of the Czech Republic (project no. GACR P505/11/1589; www.gacr.cz), British Ecological Society (Field Experience Grant 3298/4077; www.britishecologicalsociety.org) and Roman-Catholic Parish in Uhlirske Janovice, Czech Republic (www.farnostjanovice.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartomeus I, 2010, J ECOL, V98, P440, DOI 10.1111/j.1365-2745.2009.01629.x; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Bluthgen N, 2010, BASIC APPL ECOL, V11, P185, DOI 10.1016/j.baae.2010.01.001; Bosch M, 2001, OECOLOGIA, V126, P76, DOI 10.1007/s004420000488; Bosch M, 1999, AM J BOT, V86, P871, DOI 10.2307/2656707; Brunet J, 2006, EVOLUTION, V60, P234, DOI 10.1111/j.0014-3820.2006.tb01102.x; Chacoff NP, 2012, J ANIM ECOL, V81, P190, DOI 10.1111/j.1365-2656.2011.01883.x; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chytry M, 2007, VEGETACE CESKE REPUB; Dorado J, 2011, ECOLOGY, V92, P19, DOI 10.1890/10-0794.1; Forup ML, 2008, J APPL ECOL, V45, P742, DOI 10.1111/j.1365-2664.2007.01390.x; Forup ML, 2005, ECOL ENTOMOL, V30, P47, DOI 10.1111/j.0307-6946.2005.00660.x; Ghazoul J, 2006, J ECOL, V94, P295, DOI 10.1111/j.1365-2745.2006.01098.x; Gibson RH, 2011, OIKOS, V120, P822, DOI 10.1111/j.1600-0706.2010.18927.x; Goulson D, 2009, BUMBLEBEES BEHAV ECO; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Greig-Smith P., 1983, QUANTITATIVE PLANT E; Hegland SJ, 2006, ECOL ENTOMOL, V31, P532, DOI 10.1111/j.1365-2311.2006.00812.x; Hegland SJ, 2009, ECOL RES, V24, P929, DOI 10.1007/s11284-008-0572-3; Herrera CM, 2005, AM J BOT, V92, P13, DOI 10.3732/ajb.92.1.13; Jakobsson A, 2009, OECOLOGIA, V160, P707, DOI 10.1007/s00442-009-1346-5; Kirchner F, 2005, OIKOS, V111, P130, DOI 10.1111/j.0030-1299.2005.14022.x; KLINKHAMER PGL, 1990, OIKOS, V57, P399, DOI 10.2307/3565970; KUNIN WE, 1993, ECOLOGY, V74, P2145, DOI 10.2307/1940859; Kunin WE, 1997, J ECOL, V85, P225, DOI 10.2307/2960653; Larsson M, 2005, OECOLOGIA, V146, P394, DOI 10.1007/s00442-005-0217-y; Lazaro A, 2008, OECOLOGIA, V157, P249, DOI 10.1007/s00442-008-1066-2; Lazaro A, 2009, OIKOS, V118, P691, DOI 10.1111/j.1600-0706.2008.17168.x; Legendre P., 2003, NUMERICAL ECOLOGY, VSecond; Leps J, 2003, MULTIVARIATE ANAL EC; Memmott J, 1999, ECOL LETT, V2, P276, DOI 10.1046/j.1461-0248.1999.00087.x; Morales JM, 2008, OIKOS, V117, P1362, DOI 10.1111/j.0030-1299.2008.16737.x; Olesen JM, 2008, ECOLOGY, V89, P1573, DOI 10.1890/07-0451.1; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Olesen JM, 2002, ECOLOGY, V83, P2416, DOI 10.1890/0012-9658(2002)083[2416:GPIPPM]2.0.CO;2; Osborne JL, 1999, J APPL ECOL, V36, P519, DOI 10.1046/j.1365-2664.1999.00428.x; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; Rader R, 2009, J APPL ECOL, V46, P1080, DOI 10.1111/j.1365-2664.2009.01700.x; Schuett EM, 2010, EVOL BIOL, V37, P19, DOI 10.1007/s11692-010-9082-7; SOWIG P, 1989, OECOLOGIA, V78, P550, DOI 10.1007/BF00378747; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Tolasz R., 2007, ATLAS PODNEBI CESKA; Vazquez DP, 2009, ANN BOT-LONDON, V103, P1445, DOI 10.1093/aob/mcp057; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; WASER NM, 1986, AM NAT, V127, P593, DOI 10.1086/284507; Westphal C, 2006, ECOL ENTOMOL, V31, P389, DOI 10.1111/j.1365-2311.2006.00801.x; Williams NM, 2007, ECOL APPL, V17, P910, DOI 10.1890/06-0269	47	11	11	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77361	10.1371/journal.pone.0077361	http://dx.doi.org/10.1371/journal.pone.0077361			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204818	Green Submitted, gold, Green Published			2022-12-27	WOS:000326032600032
J	Liu, JY; Chen, YC; Lin, CH; Kao, SH				Liu, Jer-Yuh; Chen, Yi-Ching; Lin, Chun-Hsiang; Kao, Shao-Hsuan			Perilla frutescens Leaf Extract Inhibits Mite Major Allergen Der p 2-induced Gene Expression of Pro-Allergic and Pro-Inflammatory Cytokines in Human Bronchial Epithelial Cell BEAS-2B	PLOS ONE			English	Article							NF-KAPPA-B; OBSTRUCTIVE PULMONARY-DISEASE; P38 MAPK; ACTIVATION; ASTHMA; IL-6; INTERLEUKIN-8; RELEASE; HYPERRESPONSIVENESS; PATHOGENESIS	Perilla frutescens has been used in traditional medicine for respiratory diseases due to its anti-bacterial and anti-inflammatory activity. This study aimed to investigate effects of Perilla frutescens leaf extract (PFE) on expression of pro-allergic and pro-inflammatory cytokines in airway epithelial cells exposed to mite major allergen Der p 2 (DP2) and the underlying mechanisms. Our results showed that PFE up to 100 mg/mL had no cytotoxic effect on human bronchial epithelial cell BEAS-2B. Further investigations revealed that PFE dose-dependently diminished mRNA expression of pro-allergic cytokine IL-4, IL-5, IL-13 and GM-CSF, as well as pro-inflammatory cytokine IL-6, IL-8 and MCP-1 in BEAS-2B cells treated with DP2. In parallel to mRNA, the DP-2-elevated levels of the tested cytokines were decreased. Further investigation showed that DP2-indued phosphorylation of p38 MAPK (P38) and JNK, but not Erk1/2, was also suppressed by PFE. In addition, PFE elevated cytosolic I kappa B alpha level and decreased nuclear NF-kappa B level in DP2-stimulated BEAS-2B cells. Taken together, these findings revealed that PFE significantly diminished both mRNA expression and protein levels of pro-allergic and pro-inflammatory cytokines in response to DP2 through inhibition of P38/JNK and NK-kappa B activation. These findings suggest that PFE should be beneficial to alleviate both allergic and inflammatory responses on airway epithelium in response to aeroallergens.	[Liu, Jer-Yuh] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Liu, Jer-Yuh] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan; [Chen, Yi-Ching; Lin, Chun-Hsiang; Kao, Shao-Hsuan] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan; [Kao, Shao-Hsuan] Chung Shan Med Univ Hosp, Clin Lab, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Kao, SH (corresponding author), Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan.	kaosh@csmu.edu.tw	Kao, Shao-Hsuan/I-3875-2019		National Science Council [NSC99-2320-B040-003-MY3, NSC99-2632-B040-001-MY3]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council (NSC99-2320-B040-003-MY3, NSC99-2632-B040-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asokananthan N, 2002, J IMMUNOL, V168, P3577, DOI 10.4049/jimmunol.168.7.3577; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; BARNES PJ, 1989, J ALLERGY CLIN IMMUN, V83, P1013, DOI 10.1016/0091-6749(89)90441-7; Benson M, 1999, PEDIATR ALLERGY IMMU, V10, P178; Bhat RK, 2003, CLIN EXP ALLERGY, V33, P35, DOI 10.1046/j.1365-2222.2002.01481.x; Blau H, 2007, AM J PHYSIOL-LUNG C, V292, pL343, DOI 10.1152/ajplung.00030.2006; Chow AWM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012091; Douillet CD, 2006, AM J PHYSIOL-LUNG C, V291, pL734, DOI 10.1152/ajplung.00389.2005; Garcia-Lafuente A, 2009, INFLAMM RES, V58, P537, DOI 10.1007/s00011-009-0037-3; Graness A, 2002, J BIOL CHEM, V277, P18440, DOI 10.1074/jbc.M200468200; Heo JC, 2011, INT J MOL MED, V28, P733, DOI 10.3892/ijmm.2011.763; Hill AT, 1999, AM J RESP CRIT CARE, V160, P893, DOI 10.1164/ajrccm.160.3.9901091; Holgate Stephen T, 2008, Allergol Int, V57, P1, DOI 10.2332/allergolint.R-07-154; Ingram JL, 2012, J ALLERGY CLIN IMMUN, V130, P829, DOI 10.1016/j.jaci.2012.06.034; Jeffery Peter K, 2004, Proc Am Thorac Soc, V1, P176, DOI 10.1513/pats.200402-009MS; Lee HC, 2007, P NATL ACAD SCI USA, V104, P914, DOI 10.1073/pnas.0607305104; Liu K, 2008, J BIOL CHEM, V283, P9977, DOI 10.1074/jbc.M710257200; Liu YH, 2005, INT ARCH ALLERGY IMM, V138, P161, DOI 10.1159/000088438; Makarov SS, 2000, MOL MED TODAY, V6, P441, DOI 10.1016/S1357-4310(00)01814-1; Makino T, 1999, NEPHRON, V83, P40, DOI 10.1159/000045471; Martin Thomas R, 2005, Proc Am Thorac Soc, V2, P403, DOI 10.1513/pats.200508-090JS; Moghaddam SJ, 2008, AM J RESP CELL MOL, V38, P629, DOI 10.1165/rcmb.2007-0366OC; Moore BB, 2001, J IMMUNOL, V167, P4368, DOI 10.4049/jimmunol.167.8.4368; Natarajan R, 2002, FREE RADICAL BIO MED, V32, P1033, DOI 10.1016/S0891-5849(02)00813-4; Oh HA, 2011, EXP BIOL MED, V236, P99, DOI 10.1258/ebm.2010.010252; Osterlund C, 2009, CLIN EXP ALLERGY, V39, P1199, DOI 10.1111/j.1365-2222.2009.03284.x; Park SY, 2009, J BIOL CHEM, V284, P20099, DOI 10.1074/jbc.M109.010017; Platts-Mills TAE, 1997, J ALLERGY CLIN IMMUN, V100, pS2, DOI 10.1016/S0091-6749(97)70292-6; Profita M, 2008, EUR J PHARMACOL, V582, P145, DOI 10.1016/j.ejphar.2007.12.029; Rahman I, 2004, BIOCHEM PHARMACOL, V68, P1255, DOI 10.1016/j.bcp.2004.05.042; Roschmann KIL, 2011, CLIN EXP ALLERGY, V41, P830, DOI 10.1111/j.1365-2222.2011.03713.x; Saetta M, 1998, AM J RESP CRIT CARE, V157, P822, DOI 10.1164/ajrccm.157.3.9709027; Schneider D, 2013, AM J PHYSIOL-LUNG C, V304, pL162, DOI 10.1152/ajplung.00182.2012; Scott M, 2012, THORAX, V67, P1046, DOI 10.1136/thoraxjnl-2012-202150; Shin TY, 2000, IMMUNOPHARM IMMUNOT, V22, P489, DOI 10.3109/08923970009026007; SOLOPERTO M, 1991, AM J PHYSIOL, V260, pL530, DOI 10.1152/ajplung.1991.260.6.L530; Strieter RM, 2002, J CLIN INVEST, V109, P699, DOI 10.1172/JCI200215277; Thomas WR, 1998, ALLERGY, V53, P821, DOI 10.1111/j.1398-9995.1998.tb03987.x; Ueda H, 2001, BIOSCI BIOTECH BIOCH, V65, P1673, DOI 10.1271/bbb.65.1673; Ueda H, 1997, BIOSCI BIOTECH BIOCH, V61, P1292, DOI 10.1271/bbb.61.1292; Wang CB, 2005, ALLERGY, V60, P1378, DOI 10.1111/j.1398-9995.2005.00884.x; Wang WC, 2011, J CELL BIOCHEM, V112, P1544, DOI 10.1002/jcb.23067; Zhu Z, 2002, J IMMUNOL, V168, P2953, DOI 10.4049/jimmunol.168.6.2953	45	13	14	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77458	10.1371/journal.pone.0077458	http://dx.doi.org/10.1371/journal.pone.0077458			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204835	gold, Green Submitted, Green Published			2022-12-27	WOS:000326029300098
J	Liu, X; Zhu, W; Guan, SH; Feng, RH; Zhang, H; Liu, QH; Sun, P; Lin, DH; Zhang, NX; Shen, J				Liu, Xia; Zhu, Wei; Guan, Shuhong; Feng, Ruihong; Zhang, Hui; Liu, Qiuhong; Sun, Peng; Lin, Donghai; Zhang, Naixia; Shen, Jun			Metabolomic Analysis of Anti-Hypoxia and Anti-anxiety Effects of Fu Fang Jin Jing Oral Liquid	PLOS ONE			English	Article							PLUS-MAZE; DEPRESSION; STRESS; MICE; RATS; SPECTROSCOPY; ADAPTATION; EXPRESSION; RECEPTORS; RESPONSES	Background: Herba Rhodiolae is a traditional Chinese medicine used by the Tibetan people for treating hypoxia related diseases such as anxiety. Based on the previous work, we developed and patented an anti-anxiety herbal formula Fu Fang Jin Jing Oral Liquid (FJJOL) with Herba Rhodiolae as a chief ingredient. In this study, the anti-hypoxia and anti-anxiety effects of FJJOL in a high altitude forced-swimming mouse model with anxiety symptoms will be elucidated by NMR-based metabolomics. Methods: In our experiments, the mice were divided randomly into four groups as flatland group, high altitude saline-treated group, high altitude FJJOL-treated group, and high altitude diazepam-treated group. To cause anxiety effects and hypoxic defects, a combination use of oxygen level decreasing (hypobaric cabin) and oxygen consumption increasing (exhaustive swimming) were applied to mice. After a three-day experimental handling, aqueous metabolites of mouse brain tissues were extracted and then subjected to NMR analysis. The therapeutic effects of FJJOL on the hypobaric hypoxia mice with anxiety symptoms were verified. Results: Upon hypoxic exposure, both energy metabolism defects and disorders of functional metabolites in brain tissues of mice were observed. PCA, PLS-DA and OPLS-DA scatter plots revealed a clear group clustering for metabolic profiles in the hypoxia versus normoxia samples. After a three-day treatment with FJJOL, significant rescue effects on energy metabolism were detected, and levels of ATP, fumarate, malate and lactate in brain tissues of hypoxic mice recovered. Meanwhile, FJJOL also up-regulated the neurotransmitter GABA, and the improvement of anxiety symptoms was highly related to this effect. Conclusions: FJJOL ameliorated hypobaric hypoxia effects by regulating energy metabolism, choline metabolism, and improving the symptoms of anxiety. The anti-anxiety therapeutic effects of FJJOL were comparable to the conventional anti-anxiety drug diazepam on the hypobaric hypoxia mice. FJJOL might serve as an alternative therapy for the hypoxia and anxiety disorders.	[Zhu, Wei; Zhang, Hui; Liu, Qiuhong; Shen, Jun] Naval Med Res Inst, Shanghai, Peoples R China; [Liu, Xia; Sun, Peng; Zhang, Naixia] Chinese Acad Sci, Shanghai Inst Mat Med, Dept Analyt Chem, Shanghai 200031, Peoples R China; [Guan, Shuhong; Feng, Ruihong] Chinese Acad Sci, Shanghai Inst Mat Med, Natl Engn Lab TCM Standardizat Technol, Shanghai 200031, Peoples R China; [Lin, Donghai] Xiamen Univ, Coll Chem & Chem Engn, Key Lab Chem Biol Fujian Prov, Xiamen, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Xiamen University	Lin, DH (corresponding author), Xiamen Univ, Coll Chem & Chem Engn, Key Lab Chem Biol Fujian Prov, Xiamen, Peoples R China.	dhlin@xmu.edu.cn; nxzhang@mail.shcnc.ac.cn; zhu_wei2002@163.com			National Natural Science Foundation of China [30900662]; Shanghai Foundation for Development of Science and Technology [08411965600]; "100 Talents Program" of Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Foundation for Development of Science and Technology; "100 Talents Program" of Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was financially supported by the National Natural Science Foundation of China (Grant No. 30900662), the Shanghai Foundation for Development of Science and Technology (Grant No. 08411965600), and the "100 Talents Program" of Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglin RE, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.107; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Beyoglu D, 2012, BIOCHEM PHARMACOL, V85, P12; Chen PJ, 2011, J MED FOOD, V14, P610, DOI 10.1089/jmf.2010.1209; Chen QG, 2009, PHYTOMEDICINE, V16, P830, DOI 10.1016/j.phymed.2009.03.011; CONNETT RJ, 1990, J APPL PHYSIOL, V68, P833, DOI 10.1152/jappl.1990.68.3.833; CzyzykKrzeska MF, 1997, RESP PHYSIOL, V110, P99, DOI 10.1016/S0034-5687(97)00076-5; D'Alessandro A, 2012, DRUG DISCOV TODAY, V17, P3, DOI 10.1016/j.drudis.2011.09.017; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Frey BN, 2007, BIPOLAR DISORD, V9, P119, DOI 10.1111/j.1399-5618.2007.00454.x; Hirani K, 2005, PSYCHOPHARMACOLOGY, V180, P267, DOI 10.1007/s00213-005-2169-7; Holmes A, 2000, PHYSIOL BEHAV, V71, P509, DOI 10.1016/S0031-9384(00)00373-5; Hwang GS, 2010, AM J PHYSIOL-RENAL, V298, pF461, DOI 10.1152/ajprenal.00389.2009; Kang M, 2005, AM J CHINESE MED, V33, P205, DOI 10.1142/S0192415X05002874; Kash SF, 1999, P NATL ACAD SCI USA, V96, P1698, DOI 10.1073/pnas.96.4.1698; Klimova T, 2008, CELL DEATH DIFFER, V15, P660, DOI 10.1038/sj.cdd.4402307; Lau AA, 2008, BEHAV BRAIN RES, V191, P130, DOI 10.1016/j.bbr.2008.03.024; Li T, 2008, CHEM PHARM BULL, V56, P807, DOI 10.1248/cpb.56.807; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Liu J, 2011, INT J MOL SCI, V12, P6469, DOI 10.3390/ijms12106469; Liu J, 2010, BIOMED ENVIRON SCI, V23, P312, DOI 10.1016/S0895-3988(10)60069-4; Lu XM, 2011, TALANTA, V83, P700, DOI 10.1016/j.talanta.2010.09.026; McClintock DS, 2002, MOL CELL BIOL, V22, P94, DOI 10.1128/MCB.22.1.94-104.2002; Mole DR, 2008, PEDIATR NEPHROL, V23, P681, DOI 10.1007/s00467-007-0632-x; MONTELEONE P, 1990, J AFFECT DISORDERS, V20, P1, DOI 10.1016/0165-0327(90)90043-8; Nakanishi K, 1999, LAB INVEST, V79, P679; Nicholson G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002270; Nicholson G, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.57; Nikolaus S, 2010, REV NEUROSCIENCE, V21, P119; Przegalinski E, 1997, NEUROPHARMACOLOGY, V36, P31, DOI 10.1016/S0028-3908(96)00157-8; RAGO L, 1988, N-S ARCH PHARMACOL, V337, P675; Raud S, 2009, NEUROSCI LETT, V460, P138, DOI 10.1016/j.neulet.2009.05.054; Rojas P, 2011, NEUROCHEM INT, V59, P628, DOI 10.1016/j.neuint.2011.05.007; Semenza GL, 2000, GENE DEV, V14, P1983; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Sheridan H, 2012, J ETHNOPHARMACOL, V140, P482, DOI 10.1016/j.jep.2012.01.050; Solomon D, 2011, AUST NZ J PSYCHIAT, V45, P123, DOI 10.3109/00048674.2010.526094; Tan GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034157; Tan GG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027683; van Patot MCT, 2010, AM J PHYSIOL-REG I, V298, pR166, DOI 10.1152/ajpregu.00383.2009; Vasilyev KY, 2007, B EXP BIOL MED+, V144, P695, DOI 10.1007/s10517-007-0408-0; Weljie AM, 2007, J PROTEOME RES, V6, P3456, DOI 10.1021/pr070123j; Weljie AM, 2011, J BIOMOL NMR, V49, P185, DOI 10.1007/s10858-011-9486-4; YANG YC, 1991, ZANG YAO ZHI, P34; Zhang AH, 2013, ANALYST, V138, P353, DOI 10.1039/c2an36382h; Zhang LB, 2011, MAR ENVIRON RES, V72, P33, DOI 10.1016/j.marenvres.2011.04.002; Zhong F, 2012, NEPHROL DIAL TRANSPL, V27, P556, DOI 10.1093/ndt/gfr368	47	24	26	4	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78281	10.1371/journal.pone.0078281	http://dx.doi.org/10.1371/journal.pone.0078281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205180	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300150
J	Di Luigi, L; Sottili, M; Antinozzi, C; Vannelli, GB; Romanelli, F; Riccieri, V; Valesini, G; Lenzi, A; Crescioli, C				Di Luigi, Luigi; Sottili, Mariangela; Antinozzi, Cristina; Vannelli, Gabriella Barbara; Romanelli, Francesco; Riccieri, Valeria; Valesini, Guido; Lenzi, Andrea; Crescioli, Clara			The Vitamin D Receptor Agonist BXL-01-0029 as a Potential New Pharmacological Tool for the Treatment of Inflammatory Myopathies	PLOS ONE			English	Article							CELL-ADHESION MOLECULES; SKELETAL-MUSCLE CELLS; NECROSIS-FACTOR-ALPHA; TNF-ALPHA; CLASS-I; HUMAN MYOBLASTS; D ANALOG; EXPRESSION; CHEMOKINES; CYTOKINES	Objective: This study aims to investigate in vitro the effect of the VDR agonist BXL-01-0029 onto IFN gamma/TNF alpha-induced CXCL10 secretion by human skeletal muscle cells compared to elocalcitol (VDR agonist), methylprednisolone, methotrexate, cyclosporin A, infliximab and leflunomide; to assess in vivo circulating CXCL10 level in subjects at time of diagnosis with IMs, before therapy, together with TNF alpha, IFN gamma, IL-8, IL-6, MCP-1, MIP-1 beta and IL-10, vs. healthy subjects. Methods: Human fetal skeletal muscle cells were used for in vitro studies; ELISA and Bio-Plex were used to measure cell supernatant and IC50 determination or serum cytokines; Western blot and Bio-Plex were for cell signaling analysis. Results: BXL-01-0029 decreased with the highest potency IFN gamma/TNF alpha-induced CXCL10 protein secretion and targeted cell signaling downstream of TNF alpha in human skeletal muscle cells; CXCL10 level was the highest in sera of subjects diagnosed with IMs before therapy and the only one significantly different vs. healthy controls. Conclusions: Our in vitro and in vivo data, while confirm the relevance of CXCL10 in IMs, suggested BXL-01-0029 as a novel pharmacological tool for IM treatment, hypothetically to be used in combination with the current immunosuppressants to minimize side effects.	[Di Luigi, Luigi; Antinozzi, Cristina; Crescioli, Clara] Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy; [Sottili, Mariangela] Univ Florence, Excellence Ctr Res Transfer & High Educ Novo Ther, Florence, Italy; [Vannelli, Gabriella Barbara] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [Romanelli, Francesco; Lenzi, Andrea] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Riccieri, Valeria; Valesini, Guido] Univ Roma La Sapienza, Dept Internal Med & Clin Special, I-00185 Rome, Italy	Foro Italico University of Rome; University of Florence; University of Florence; Sapienza University Rome; Sapienza University Rome	Crescioli, C (corresponding author), Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy.	clara.crescioli@uniroma4.it	Romanelli, Francesco/A-7925-2012; Lenzi, Andrea/I-7711-2015; Riccieri, Valeria/AAC-6079-2022	Lenzi, Andrea/0000-0002-7711-0465; Riccieri, Valeria/0000-0002-7507-5483	M.I.U.R. (Ministero dell'Istruzione, dell'Universita e della Ricerca)	M.I.U.R. (Ministero dell'Istruzione, dell'Universita e della Ricerca)(Ministry of Education, Universities and Research (MIUR))	This study was supported by M.I.U.R. (Ministero dell'Istruzione, dell'Universita e della Ricerca) (www.miur.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorini L, 2005, CELL IMMUNOL, V233, P115, DOI 10.1016/j.cellimm.2005.04.013; Adorini L, 2007, J STEROID BIOCHEM, V103, P689, DOI 10.1016/j.jsbmb.2006.12.065; Aggarwal R, 2012, CURR OPIN RHEUMATOL, V24, P635, DOI 10.1097/BOR.0b013e328358ac72; Arnson Y, 2007, ANN RHEUM DIS, V66, P1137, DOI 10.1136/ard.2007.069831; Baudy AR, 2009, INT IMMUNOPHARMACOL, V9, P1209, DOI 10.1016/j.intimp.2009.07.001; Campbell J. Darren, 2004, FASEB Journal, V18, P329; Chinoy H, 2007, RHEUMATOLOGY, V46, P1411, DOI 10.1093/rheumatology/kem145; Codner E, 2001, METABOLISM, V50, P830, DOI 10.1053/meta.2001.24929; Crescioli C, 2008, ENDOCRINOLOGY, V149, P3626, DOI 10.1210/en.2008-0078; Crescioli C, 2007, J ENDOCRINOL, V195, P145, DOI 10.1677/JOE-07-0240; Crescioli C, 2004, EUR J ENDOCRINOL, V150, P591, DOI 10.1530/eje.0.1500591; Crescioli C, 2008, EXP CELL RES, V314, P1337, DOI 10.1016/j.yexcr.2007.12.016; Crescioli C, 2012, EUR J CELL BIOL, V91, P139, DOI 10.1016/j.ejcb.2011.09.011; Dalakas MC, 2003, LANCET, V362, P971, DOI 10.1016/S0140-6736(03)14368-1; De Paepe B, 2005, MUSCLE NERVE, V31, P621, DOI 10.1002/mus.20294; De Paepe B, 2009, CURR OPIN RHEUMATOL, V21, P610, DOI 10.1097/BOR.0b013e3283317b31; Dekel B, 2004, EXPERT OPIN BIOL TH, V4, P443, DOI 10.1517/eobt.4.4.443.29789; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; Dold S, 2007, CLIN RHEUMATOL, V26, P1186, DOI 10.1007/s10067-006-0325-z; Efthimiou P, 2006, SEMIN ARTHRITIS RHEU, V36, P168, DOI 10.1016/j.semarthrit.2006.07.003; Fall N, 2005, ARTHRITIS RHEUM-US, V52, P3175, DOI 10.1002/art.21303; Fichera A, 2007, J SURG RES, V142, P239, DOI 10.1016/j.jss.2007.02.038; Figarella-Branger D, 2003, MUSCLE NERVE, V28, P659, DOI 10.1002/mus.10462; FOGLIA RP, 1986, ANN SURG, V204, P402, DOI 10.1097/00000658-198610000-00008; Forsgren S, 2012, INT J RHEUMATOL, V2012, DOI 10.1155/2012/637452; Frasca L, 2008, J IMMUNOL, V180, P1471, DOI 10.4049/jimmunol.180.3.1471; Gotherstrom C, 2005, HAEMATOLOGICA, V90, P1017; Gregori S, 2002, DIABETES, V51, P1367, DOI 10.2337/diabetes.51.5.1367; Grundtman C, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2139; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Hodgetts S, 2006, NEUROMUSCULAR DISORD, V16, P591, DOI 10.1016/j.nmd.2006.06.011; HOHLFELD R, 1990, AM J PATHOL, V136, P503; Hohlfeld Reinhard, 1997, Current Opinion in Rheumatology, V9, P520, DOI 10.1097/00002281-199711000-00007; Keller CW, 2011, J BIOL CHEM, V286, P3970, DOI 10.1074/jbc.M110.159392; Lange U, 2006, AUTOIMMUNITY, V39, P261, DOI 10.1080/08916930600623874; Lee EY, 2009, AUTOIMMUN REV, V8, P379, DOI 10.1016/j.autrev.2008.12.002; LINDBERG C, 1995, SCAND J IMMUNOL, V41, P421, DOI 10.1111/j.1365-3083.1995.tb03587.x; Liu ZG, 2003, MOL CELL, V12, P795, DOI 10.1016/S1097-2765(03)00399-X; Luigi Luigi Di, MEDIATORS I IN PRESS; Lundberg I, 1995, J NEUROIMMUNOL, V63, P9, DOI 10.1016/0165-5728(95)00122-0; Lundberg I, 1997, ARTHRITIS RHEUM, V40, P865, DOI 10.1002/art.1780400514; MANTEGAZZA R, 1991, NEUROLOGY, V41, P1128, DOI 10.1212/WNL.41.7.1128; MICHAELIS D, 1993, AM J PATHOL, V143, P1142; Nagaraju K, 1998, CLIN EXP IMMUNOL, V113, P407; Nyberg P, 2000, J RHEUMATOL, V27, P940; O'Herrin JK, 2002, AM J NEPHROL, V22, P515, DOI 10.1159/000065289; Pavlath GK, 2002, J NEUROIMMUNOL, V125, P42, DOI 10.1016/S0165-5728(02)00026-7; Pillon NJ, 2013, AM J PHYSIOL-ENDOC M, V304, pE453, DOI 10.1152/ajpendo.00553.2012; Plomgaard P, 2005, EXERC IMMUNOL REV, V11, P53; Raju R, 2003, J NEUROIMMUNOL, V141, P125, DOI 10.1016/S0165-5728(03)00218-2; Romagnani P, 2012, CLIN CHIM ACTA, V413, P1364, DOI 10.1016/j.cca.2012.02.009; Sagrinati C, 2010, TRANSPL INT, V23, P914, DOI 10.1111/j.1432-2277.2010.01078.x; Schmidt J, 2008, BRAIN, V131, P1228, DOI 10.1093/brain/awn053; SCHUTZE S, 1992, SEMIN ONCOL, V19, P16; Sottili M, 2009, EXP CELL RES, V315, P264, DOI 10.1016/j.yexcr.2008.10.025; Suvannavejh GC, 2000, CELL IMMUNOL, V205, P24, DOI 10.1006/cimm.2000.1706; Szelenyi ER, 2012, MUSCLE NERVE, V45, P552, DOI 10.1002/mus.22323; Szodoray P, 2010, RHEUMATOLOGY, V49, P1867, DOI 10.1093/rheumatology/keq151; Tournadre A, 2010, JOINT BONE SPINE, V77, P390, DOI 10.1016/j.jbspin.2010.04.007; Xiong Z, 2006, J CLIN PATHOL, V59, P855, DOI 10.1136/jcp.2005.032961	60	18	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77745	10.1371/journal.pone.0077745	http://dx.doi.org/10.1371/journal.pone.0077745			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204948	Green Published, Green Submitted, gold			2022-12-27	WOS:000326334500052
J	Gasche, L; Mahevas, S; Marchal, P				Gasche, Loic; Mahevas, Stephanie; Marchal, Paul			Supporting Fisheries Management by Means of Complex Models: Can We Point out Isles of Robustness in a Sea of Uncertainty?	PLOS ONE			English	Article							SENSITIVITY-ANALYSIS; ISIS-FISH; CONSERVATION BIOLOGY; DECISION-MAKING; INFERENCE; IMPACT; RECRUITMENT; DEFINITION; STRATEGIES; FRAMEWORK	Ecosystems are usually complex, nonlinear and strongly influenced by poorly known environmental variables. Among these systems, marine ecosystems have high uncertainties: marine populations in general are known to exhibit large levels of natural variability and the intensity of fishing efforts can change rapidly. These uncertainties are a source of risks that threaten the sustainability of both fish populations and fishing fleets targeting them. Appropriate management measures have to be found in order to reduce these risks and decrease sensitivity to uncertainties. Methods have been developed within decision theory that aim at allowing decision making under severe uncertainty. One of these methods is the information-gap decision theory. The info-gap method has started to permeate ecological modelling, with recent applications to conservation. However, these practical applications have so far been restricted to simple models with analytical solutions. Here we implement a deterministic approach based on decision theory in a complex model of the Eastern English Channel. Using the ISIS-Fish modelling platform, we model populations of sole and plaice in this area. We test a wide range of values for ecosystem, fleet and management parameters. From these simulations, we identify management rules controlling fish harvesting that allow reaching management goals recommended by ICES (International Council for the Exploration of the Sea) working groups while providing the highest robustness to uncertainties on ecosystem parameters.	[Gasche, Loic; Mahevas, Stephanie] IFREMER, Ctr Atlantique, Unite Ecol & Modeles Halieut, F-44311 Nantes 03, France; [Marchal, Paul] IFREMER, Ctr Manche Mer Nord, Lab Ressources Halieut, F-62321 Boulogne Sur Mer, France	Ifremer; Ifremer	Gasche, L (corresponding author), IFREMER, Ctr Atlantique, Unite Ecol & Modeles Halieut, F-44311 Nantes 03, France.	loic.gasche@ifremer.fr		Marchal, Paul/0000-0003-2047-4599; MAHEVAS, Stephanie/0000-0001-7707-2502	European Community [266445]; Region des Pays de la Loire	European Community(European Commission); Region des Pays de la Loire(Region Pays de la Loire)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007 2013) within the Ocean of Tomorrow call under Grant Agreement No. 266445 for the project Vectors of Change in Oceans and Seas Marine Life, Impact on Economic Sectors (VECTORS) and the Region des Pays de la Loire. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Haim Y., 2006, INFO GAP DECISION TH, V33, P368; BenHaim Y, 2006, INFO GAP DECISION TH, DOI DOI 10.1016/B978-0-12-373552-2.X5000-0; Biseau A, 1998, AQUAT LIVING RESOUR, V11, P119, DOI 10.1016/S0990-7440(98)80109-5; Breiman L., 1984, CLASSIFICATION REGRE; Caddy JF, 1995, TECHNICAL REPORT; Cariboni J, 2007, ECOL MODEL, V203, P167, DOI 10.1016/j.ecolmodel.2005.10.045; Carpentier A., 2009, CHANNEL HABITAT ATLA, P626; Charles AT, 1998, FISH RES, V37, P37, DOI 10.1016/S0165-7836(98)00125-8; CLARK CW, 1986, J ENVIRON ECON MANAG, V13, P235, DOI 10.1016/0095-0696(86)90024-0; Cressie N, 2009, ECOL APPL, V19, P553, DOI 10.1890/07-0744.1; Deporte N, 2012, ICES J MAR SCI, V69, P331, DOI 10.1093/icesjms/fsr197; Dorazio RM, 2003, ECOL APPL, V13, P556, DOI 10.1890/1051-0761(2003)013[0556:BIADTA]2.0.CO;2; Drouineau H, 2006, AQUAT LIVING RESOUR, V19, P15, DOI 10.1051/alr:2006002; FranceAgriMer, 2010, TECHNICAL REPORT; Francis RICC, 1997, CAN J FISH AQUAT SCI, V54, P982, DOI 10.1139/cjfas-54-4-982; Francis RICC, 1997, CAN J FISH AQUAT SCI, V54, P1699, DOI 10.1139/cjfas-54-8-1699; Harwood J, 2003, TRENDS ECOL EVOL, V18, P617, DOI 10.1016/j.tree.2003.08.001; Hayes KR, 2013, METHODS ECOL EVOL, V4, P601, DOI 10.1111/2041-210X.12046; Helton JC, 2003, RELIAB ENG SYST SAFE, V81, P23, DOI 10.1016/S0951-8320(03)00058-9; Hilborn R, 1997, FISHERIES, V22, P19; HILBORN R, 1987, North American Journal of Fisheries Management, V7, P1, DOI 10.1577/1548-8659(1987)7<1:LWUIRM>2.0.CO;2; Holland D.S, 2010, OECD FOOD AGR FISHER, V25; Homma T, 1996, RELIAB ENG SYST SAFE, V52, P1, DOI 10.1016/0951-8320(96)00002-6; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; ICES, 2012, TECHNICAL REPORT; Leblond E, 2011, TECHNICAL REPORT; LUDWIG D, 1993, SCIENCE, V260, P17, DOI 10.1126/science.260.5104.17; Mahevas S, 2004, ECOL MODEL, V171, P65, DOI 10.1016/j.ecolmodel.2003.04.001; Mangel M, 1996, ECOL APPL, V6, P338, DOI 10.2307/2269369; Marchal P, 2011, ICES J MAR SCI, V68, P1580, DOI 10.1093/icesjms/fsr096; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Moilanen A, 2006, ECOL MODEL, V199, P115, DOI 10.1016/j.ecolmodel.2006.07.004; Pelletier D, 2005, FISH FISH, V6, P307, DOI 10.1111/j.1467-2979.2005.00199.x; Pelletier D, 2001, SPATIAL PROCESSES MA; Pelletier D, 2009, ECOL MODEL, V220, P1013, DOI 10.1016/j.ecolmodel.2009.01.007; Post van der Burg M, 2011, ECOL APPL, V21, P303, DOI 10.1890/09-0973.1; Pujol G, 2008, SENSITIVITY SENSITIV; Punt AE, 1997, REV FISH BIOL FISHER, V7, P35, DOI 10.1023/A:1018419207494; R Development Core Team, 2012, R LANG ENV STAT COMP; Regan HM, 2005, ECOL APPL, V15, P1471, DOI 10.1890/03-5419; Regan HM, 2002, ECOL APPL, V12, P618, DOI 10.2307/3060967; RIJNSDORP AD, 1992, NETH J SEA RES, V29, P173, DOI 10.1016/0077-7579(92)90018-A; Sainsbury KJ, 2000, ICES J MAR SCI, V57, P731, DOI 10.1006/jmsc.2000.0737; Saltelli A, 2000, STAT SCI, V15, P377, DOI 10.1214/ss/1009213004; Saltelli A., 2008, GLOBAL SENSITIVITY A; Saltelli A., 2004, SENSITIVITY ANAL PRA, V1, DOI 10.1002/0470870958; Saltelli A, 2006, RELIAB ENG SYST SAFE, V91, P1109, DOI 10.1016/j.ress.2005.11.014; Sethi SA, 2010, FISH FISH, V11, P341, DOI 10.1111/j.1467-2979.2010.00363.x; Sniedovich M., 2007, DECISION MAKING MANU, V1, P111, DOI [https://doi.org/10.7494/dmms.2007.1.2.111, DOI 10.7494/DMMS.2007.1.2.111]; Sniedovich M, 2010, J RISK FINANC, V11, P268, DOI 10.1108/15265941011043648; Sobol IM, 2001, MATH COMPUT SIMULAT, V55, P271, DOI 10.1016/S0378-4754(00)00270-6; van der Veer HW, 2000, ICES J MAR SCI, V57, P202, DOI 10.1006/jmsc.1999.0523; von Neumann J, 1955, THEORY GAMES EC BEHA; Wade PR, 2000, CONSERV BIOL, V14, P1308, DOI 10.1046/j.1523-1739.2000.99415.x; WALD A, 1949, ANN MATH STAT, V20, P165, DOI 10.1214/aoms/1177730030; Walters C, 1986, ADAPTATIVE MANAGEMEN; WGNSSK, 2008, TECHNICAL REPORT; WGNSSK, 2009, TECHNICAL REPORT; WGNSSK, 2010, TECHNICAL REPORT; WGNSSK, 2012, REP WORK GROUP ASS D; WGNSSK, 2011, TECHNICAL REPORT	62	10	10	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77566	10.1371/journal.pone.0077566	http://dx.doi.org/10.1371/journal.pone.0077566			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204873	Green Published, Green Submitted, gold			2022-12-27	WOS:000326334500035
J	Li, ZH; Xu, HY; Zheng, WL; Lam, SH; Gong, ZY				Li, Zhi-Hua; Xu, Hongyan; Zheng, Weiling; Lam, Siew Hong; Gong, Zhiyuan			RNA-Sequencing Analysis of TCDD-Induced Responses in Zebrafish Liver Reveals High Relatedness to In Vivo Mammalian Models and Conserved Biological Pathways	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; GENE-EXPRESSION PROFILES; APOPTOTIC CELL-DEATH; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; DIOXIN; PROTEIN; AHR; REPRODUCIBILITY; IDENTIFICATION; ACTIVATION	TCDD is one of the most persistent environmental toxicants in biological systems and its effect through aryl hydrocarbon receptor (AhR) has been well characterized. However, the information on TCDD-induced toxicity in other molecular pathways is rather limited. To fully understand molecular toxicity of TCDD in an in vivo animal model, adult zebrafish were exposed to TCDD at 10 nM for 96 h and the livers were sampled for RNA-sequencing based transcriptomic profiling. A total of 1,058 differently expressed genes were identified based on fold-change >2 and TPM (transcripts per million) >10. Among the top 20 up-regulated genes, 10 novel responsive genes were identified and verified by RT-qPCR analysis on independent samples. Transcriptomic analysis indicated several deregulated pathways associated with cell cycle, endocrine disruptors, signal transduction and immune systems. Comparative analyses of TCDD-induced transcriptomic changes between fish and mammalian models revealed that proteomic pathway is consistently up-regulated while calcium signaling pathway and several immune-related pathways are generally down-regulated. Finally, our study also suggested that zebrafish model showed greater similarity to in vivo mammalian models than in vitro models. Our study indicated that the zebrafish is a valuable in vivo model in toxicogenomic analyses for understanding molecular toxicity of environmental toxicants relevant to human health. The expression profiles associated with TCDD could be useful for monitoring environmental dioxin and dioxin-like contamination.	[Li, Zhi-Hua; Xu, Hongyan; Zheng, Weiling; Lam, Siew Hong; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Li, Zhi-Hua] Chinese Acad Fishery Sci, Yangtze River Fisheries Res Inst, Wuhan, Peoples R China	National University of Singapore; Chinese Academy of Fishery Sciences; Yangtze River Fisheries Research Institute, CAFS	Gong, ZY (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsgzy@nus.edu.sg	Li, ZhiHua/GYU-9914-2022; Gong, Zhiyuan/H-8794-2012; LI, ZHIHUA/G-2896-2015; Lam, Siew Hong/H-8483-2012	Gong, Zhiyuan/0000-0002-9660-5260; LI, ZHIHUA/0000-0002-6484-657X; 	Singapore National Research Foundation; Environment & Water Industry Programme Office (EWI) of the PUB [R-154-000-328-272]	Singapore National Research Foundation(National Research Foundation, Singapore); Environment & Water Industry Programme Office (EWI) of the PUB	This work was supported by the Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme and administered by the Environment & Water Industry Programme Office (EWI) of the PUB (grant number R-154-000-328-272). The funders had no role in study design, data collection and analysis, decision to publish, or reparation of the manuscript.	Black MB, 2012, TOXICOL SCI, V127, P199, DOI 10.1093/toxsci/kfs069; Boverhof DR, 2005, TOXICOL SCI, V85, P1048, DOI 10.1093/toxsci/kfi162; Cantrell SM, 1996, TOXICOL APPL PHARM, V141, P23; Cao ZJ, 2003, AQUAT TOXICOL, V63, P271, DOI 10.1016/S0166-445X(02)00184-4; Chen YH, 1996, J BIOL CHEM, V271, P26261, DOI 10.1074/jbc.271.42.26261; Consonni D, 2012, ENVIRON INT, V44, P151, DOI 10.1016/j.envint.2012.01.004; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Dearstyne EA, 2002, TOXICOLOGY, V170, P139, DOI 10.1016/S0300-483X(01)00542-X; Dere E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-80; Dong W, 2002, TOXICOL SCI, V69, P191, DOI 10.1093/toxsci/69.1.191; Falahatpisheh H, 2007, CELL STRESS CHAPERON, V12, P209, DOI 10.1379/CSC-259.1; Forgacs AL, 2012, TOXICOL SCI, V125, P41, DOI 10.1093/toxsci/kfr262; Gentile CL, 2011, ANTIOXID REDOX SIGN, V15, P505, DOI 10.1089/ars.2010.3790; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; Handley-Goldstone HM, 2005, TOXICOL SCI, V85, P683, DOI 10.1093/toxsci/kfi116; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Jo H, 2013, HEPATOLOGY, V57, P1366, DOI 10.1002/hep.26126; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kim S, 2009, TOXICOL SCI, V112, P229, DOI 10.1093/toxsci/kfp189; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169; Ma Q, 2000, J BIOL CHEM, V275, P8432, DOI 10.1074/jbc.275.12.8432; Mandal PK, 2005, J COMP PHYSIOL B, V175, P221, DOI 10.1007/s00360-005-0483-3; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Marlowe JL, 2004, J BIOL CHEM, V279, P29013, DOI 10.1074/jbc.M404315200; MAY BK, 1995, PROG NUCLEIC ACID RE, V51, P1, DOI 10.1016/S0079-6603(08)60875-2; MCCONKEY DJ, 1988, SCIENCE, V242, P256, DOI 10.1126/science.3262923; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Ovando BJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-583; Pichler FB, 2003, NAT BIOTECHNOL, V21, P879, DOI 10.1038/nbt852; Puga A, 1997, BIOCHEM PHARMACOL, V54, P1287, DOI 10.1016/S0006-2952(97)00417-6; Ruiz-Aracama A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-251; Ryu YM, 2005, MOL CELL TOXICOL, V1, P164; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Su ZQ, 2011, CHEM RES TOXICOL, V24, P1486, DOI 10.1021/tx200103b; Teraoka H, 2008, INTERDISCIPLINARY ST, P61; Toomey BH, 2001, AQUAT TOXICOL, V53, P127, DOI 10.1016/S0166-445X(00)00161-2; Venkatesh B, 2003, CURR OPIN GENET DEV, V13, P588, DOI 10.1016/j.gde.2003.09.001; Volz DC, 2005, TOXICOL SCI, V85, P572, DOI 10.1093/toxsci/kfi109; Xu SH, 2010, AM J PHYSIOL-GASTR L, V299, pG126, DOI 10.1152/ajpgi.00522.2010; Zheng WL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024019; Zodrow JM, 2004, AQUAT TOXICOL, V66, P25, DOI 10.1016/j.aquatox.2003.07.002	43	27	27	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77292	10.1371/journal.pone.0077292	http://dx.doi.org/10.1371/journal.pone.0077292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204792	Green Published, Green Submitted, gold			2022-12-27	WOS:000326334500023
J	Wang, P; Knosche, TR				Wang, Peng; Knoesche, Thomas R.			A Realistic Neural Mass Model of the Cortex with Laminar-Specific Connections and Synaptic Plasticity - Evaluation with Auditory Habituation	PLOS ONE			English	Article							GILL-WITHDRAWAL REFLEX; SHORT-TERM PLASTICITY; EVOKED-POTENTIALS; PYRAMIDAL NEURONS; VISUAL-CORTEX; INTRACELLULAR-RECORDINGS; BAYESIAN-ESTIMATION; SPECTRAL RESPONSES; MATHEMATICAL-MODEL; CORTICAL DYNAMICS	In this work we propose a biologically realistic local cortical circuit model (LCCM), based on neural masses, that incorporates important aspects of the functional organization of the brain that have not been covered by previous models: (1) activity dependent plasticity of excitatory synaptic couplings via depleting and recycling of neurotransmitters and (2) realistic inter-laminar dynamics via laminar-specific distribution of and connections between neural populations. The potential of the LCCM was demonstrated by accounting for the process of auditory habituation. The model parameters were specified using Bayesian inference. It was found that: (1) besides the major serial excitatory information pathway (layer 4 to layer 2/3 to layer 5/6), there exists a parallel "short-cut" pathway (layer 4 to layer 5/6), (2) the excitatory signal flow from the pyramidal cells to the inhibitory interneurons seems to be more intra-laminar while, in contrast, the inhibitory signal flow from inhibitory interneurons to the pyramidal cells seems to be both intra-and inter-laminar, and (3) the habituation rates of the connections are unsymmetrical: forward connections (from layer 4 to layer 2/3) are more strongly habituated than backward connections (from Layer 5/6 to layer 4). Our evaluation demonstrates that the novel features of the LCCM are of crucial importance for mechanistic explanations of brain function. The incorporation of these features into a mass model makes them applicable to modeling based on macroscopic data (like EEG or MEG), which are usually available in human experiments. Our LCCM is therefore a valuable building block for future realistic models of human cognitive function.	[Wang, Peng] Max Planck Inst Human Cognit & Brain Sci, MEG Network, Leipzig, Germany; Max Planck Inst Human Cognit & Brain Sci, Cort Network, Leipzig, Germany	Max Planck Society; Max Planck Society	Wang, P (corresponding author), Max Planck Inst Human Cognit & Brain Sci, MEG Network, Leipzig, Germany.	pengwang@cbs.mpg.de		Wang, Peng/0000-0002-3609-7954	IMPRS NEUROCOM	IMPRS NEUROCOM	Funder: IMPRS NEUROCOM http://imprs-neurocom.mpg.de/main.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Ahveninen J, 2006, P NATL ACAD SCI USA, V103, P14608, DOI 10.1073/pnas.0510480103; Bojak I, 2010, BRAIN TOPOGR, V23, P139, DOI 10.1007/s10548-010-0140-3; Braitenberg V, 1991, ANATOMY CORTEX STAT; Bureau I, 2006, PLOS BIOL, V4, P2361, DOI 10.1371/journal.pbio.0040382; BURTON H, 1976, J COMP NEUROL, V168, P249, DOI 10.1002/cne.901680204; Cao YQ, 2012, NEURAL NETWORKS, V26, P75, DOI 10.1016/j.neunet.2011.10.010; CASTELLUCCI V, 1970, SCIENCE, V167, P1745, DOI 10.1126/science.167.3926.1745; CASTELLUCCI VF, 1974, P NATL ACAD SCI USA, V71, P5004, DOI 10.1073/pnas.71.12.5004; Chen CC, 2008, NEUROIMAGE, V41, P1293, DOI 10.1016/j.neuroimage.2008.03.026; David O, 2005, NEUROIMAGE, V25, P756, DOI 10.1016/j.neuroimage.2004.12.030; David O, 2003, NEUROIMAGE, V20, P1743, DOI 10.1016/j.neuroimage.2003.07.015; David O, 2008, NEUROIMAGE, V39, P1633, DOI 10.1016/j.neuroimage.2007.11.005; David O, 2006, NEUROIMAGE, V30, P1255, DOI 10.1016/j.neuroimage.2005.10.045; Deco G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000092; DeFelipe J, 2002, J NEUROCYTOL, V31, P299, DOI 10.1023/A:1024130211265; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Feldmeyer D, 2005, J NEUROSCI, V25, P3423, DOI 10.1523/JNEUROSCI.5227-04.2005; Feldmeyer D, 2002, J PHYSIOL-LONDON, V538, P803, DOI 10.1113/jphysiol.2001.012959; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; FitzHugh R., 1955, B MATH BIOPHYS, V17, P257, DOI [10.1007/BF02477753, DOI 10.1007/BF02477753, 10.1007/bf02477753]; Freeman W, 1978, ELECTROENCEPHALOGR S, V9; Friston KJ, 2002, NEUROIMAGE, V16, P513, DOI 10.1006/nimg.2001.1044; FRUHSTOR.H, 1970, ELECTROEN CLIN NEURO, V28, P153, DOI 10.1016/0013-4694(70)90183-5; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Garrido MI, 2007, NEUROIMAGE, V36, P571, DOI 10.1016/j.neuroimage.2007.03.014; Garrido MI, 2009, NEUROIMAGE, V48, P269, DOI 10.1016/j.neuroimage.2009.06.034; GILBERT CD, 1983, PROG BRAIN RES, V58, P209, DOI 10.1016/S0079-6123(08)60022-9; Grossberg S, 2004, VISION RES, V44, P1147, DOI 10.1016/j.visres.2003.12.009; Grossberg S, 2003, CEREB CORTEX, V13, P852, DOI 10.1093/cercor/13.8.852; Grossberg S, 2000, J INT NEUROPSYCH SOC, V6, P583, DOI 10.1017/S135561770065508X; Grossberg S, 2008, PSYCHOL REV, V115, P677, DOI 10.1037/a0012618; Grossberg S, 2008, BRAIN RES, V1218, P278, DOI 10.1016/j.brainres.2008.04.024; Grossberg S, 2011, J ACOUST SOC AM, V130, P440, DOI 10.1121/1.3589258; Haeusler S, 2007, CEREB CORTEX, V17, P149, DOI 10.1093/cercor/bhj132; Hanlon FM, 2005, PSYCHOPHYSIOLOGY, V42, P417, DOI 10.1111/j.1469-8986.2005.00299.x; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Huang CL, 2000, J COMP NEUROL, V427, P302, DOI 10.1002/1096-9861(20001113)427:2<302::AID-CNE10>3.0.CO;2-J; Jaaskelainen IP, 2004, P NATL ACAD SCI USA, V101, P6809, DOI 10.1073/pnas.0303760101; JANSEN BH, 1993, BIOL CYBERN, V68, P275, DOI 10.1007/BF00224863; JANSEN BH, 1995, BIOL CYBERN, V73, P357, DOI 10.1007/BF00199471; JONES EG, 1976, J COMP NEUROL, V168, P197, DOI 10.1002/cne.901680203; Kiebel SJ, 2007, NEUROIMAGE, V36, P332, DOI 10.1016/j.neuroimage.2007.02.046; Kiebel SJ, 2008, COGN NEURODYNAMICS, V2, P121, DOI 10.1007/s11571-008-9038-0; Laxminarayan S, 2012, BIOL CYBERN, P1; Lopes da Silva F H, 1976, Prog Brain Res, V45, P281; Lopes da Silva F. H., 1974, BIOL CYBERN, V15, P27, DOI [10.1007/BF00270757, DOI 10.1007/BF00270757]; Lopes Da Silva FH, 1998, ELECTROENCEPHALOGRAP, P93; LU ZL, 1992, SCIENCE, V258, P1668, DOI 10.1126/science.1455246; Lubke J, 2007, BRAIN STRUCT FUNCT, V212, P3, DOI 10.1007/s00429-007-0144-2; LUND JS, 1979, J COMP NEUROL, V184, P599, DOI 10.1002/cne.901840402; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; MARTIN KAC, 1984, J PHYSIOL-LONDON, V353, P463, DOI 10.1113/jphysiol.1984.sp015347; May PJC, 2010, PSYCHOPHYSIOLOGY, V47, P66, DOI 10.1111/j.1469-8986.2009.00856.x; MITANI A, 1987, J COMP NEUROL, V257, P105, DOI 10.1002/cne.902570108; Moran RJ, 2008, NEUROIMAGE, V42, P272, DOI 10.1016/j.neuroimage.2008.01.025; Moran RJ, 2007, NEUROIMAGE, V37, P706, DOI 10.1016/j.neuroimage.2007.05.032; Morrison A, 2008, BIOL CYBERN, V98, P459, DOI 10.1007/s00422-008-0233-1; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; NUNEZ P L, 1974, Mathematical Biosciences, V21, P279, DOI 10.1016/0025-5564(74)90020-0; Penny WD, 2004, NEUROIMAGE, V22, P1157, DOI 10.1016/j.neuroimage.2004.03.026; Penny WD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000709; Petersen CCH, 2002, J NEUROPHYSIOL, V87, P2904, DOI 10.1152/jn.2002.87.6.2904; Pilly PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060599; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Raizada RDS, 2001, VIS COGN, V8, P431, DOI 10.1080/13506280143000070; Rennie CJ, 2002, BIOL CYBERN, V86, P457, DOI 10.1007/s00422-002-0310-9; Robinson PA, 1997, PHYS REV E, V56, P826, DOI 10.1103/PhysRevE.56.826; ROGERS RL, 1990, ELECTROEN CLIN NEURO, V77, P237, DOI 10.1016/0168-5597(90)90043-D; Rosburg T, 2006, PSYCHOPHYSIOLOGY, V43, P137, DOI 10.1111/j.1469-8986.2006.00391.x; Rosburg T, 2004, CLIN NEUROPHYSIOL, V115, P906, DOI 10.1016/j.clinph.2003.11.039; Rosburg T, 2010, EXP BRAIN RES, V205, P559, DOI 10.1007/s00221-010-2391-3; SAMS M, 1993, J COGNITIVE NEUROSCI, V5, P363, DOI 10.1162/jocn.1993.5.3.363; Sara Y, 2002, J NEUROSCI, V22, P1608, DOI 10.1523/JNEUROSCI.22-05-01608.2002; Schubert D, 2006, CEREB CORTEX, V16, P223, DOI 10.1093/cercor/bhi100; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Shepherd GMG, 2005, J NEUROSCI, V25, P5670, DOI 10.1523/JNEUROSCI.1173-05.2005; Silberberg G, 2005, TRENDS NEUROSCI, V28, P541, DOI 10.1016/j.tins.2005.08.004; SOININEN HS, 1995, PHYSIOL BEHAV, V57, P927, DOI 10.1016/0031-9384(94)00393-J; Spiegler A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002298; Spiegler A, 2010, NEUROIMAGE, V52, P1041, DOI 10.1016/j.neuroimage.2009.12.081; Taulu S, 2004, PHYSICS0401166; THOMPSON RF, 1966, PSYCHOL REV, V73, P16, DOI 10.1037/h0022681; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; Thomson AM, 1998, NEUROSCIENCE, V84, P669, DOI 10.1016/S0306-4522(97)00557-5; Todorovic A, 2011, J NEUROSCI, V31, P9118, DOI 10.1523/JNEUROSCI.1425-11.2011; Trong MN, 2012, NEUROIMAGE; Tsodyks M, 2000, J NEUROSCI, V20; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; VANDERKLOOT W, 1994, PHYSIOL REV, V74, P899, DOI 10.1152/physrev.1994.74.4.899; Varela JA, 1997, J NEUROSCI, V17, P7926; VELASCO M, 1985, ELECTROEN CLIN NEURO, V61, P519, DOI 10.1016/0013-4694(85)90971-X; Velasco M, 1986, NEUROPHYSIOLOGY, V63, P62; Wang W, 1996, NEUROLOGY, V46, P1404, DOI 10.1212/WNL.46.5.1404; WATSON AB, 1977, VISION RES, V17, P893, DOI 10.1016/0042-6989(77)90063-3; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; Weiler N, 2008, NAT NEUROSCI, V11, P360, DOI 10.1038/nn2049; Wendling F, 2002, EUR J NEUROSCI, V15, P1499, DOI 10.1046/j.1460-9568.2002.01985.x; Wendling F, 2000, BIOL CYBERN, V83, P367, DOI 10.1007/s004220000160; WILSON HR, 1973, KYBERNETIK, V13, P55, DOI 10.1007/BF00288786; Wright JJ, 1996, BEHAV BRAIN SCI, V19, P285, DOI 10.1017/S0140525X00042679; Wu LG, 1998, BIOPHYS J, V74, P3003, DOI 10.1016/S0006-3495(98)78007-5; Zavaglia M, 2010, COMPUTATIONAL INTELL, V2010, P5; Zavaglia M, 2006, J NEUROSCI METH, V157, P317, DOI 10.1016/j.jneumeth.2006.04.022; Zouridakis G, 1998, BRAIN TOPOGR, V10, P183, DOI 10.1023/A:1022246825461; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	109	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77876	10.1371/journal.pone.0077876	http://dx.doi.org/10.1371/journal.pone.0077876			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205009	Green Submitted, Green Published, gold			2022-12-27	WOS:000326334500071
J	Chapleur, O; Wu, TD; Guerquin-Kern, JL; Mazeas, L; Bouchez, T				Chapleur, Olivier; Wu, Ting-Di; Guerquin-Kern, Jean-Luc; Mazeas, Laurent; Bouchez, Theodore			SIMSISH Technique Does Not Alter the Apparent Isotopic Composition of Bacterial Cells	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; CATALYZED REPORTER DEPOSITION; MICROBIAL ECOLOGY; NANOSIMS; IDENTIFICATION; IDENTITY; FISH; TOOL	In order to identify the function of uncultured microorganisms in their environment, the SIMSISH method, combining in situ hybridization (ISH) and nanoscale secondary ion mass spectrometry (nanoSIMS) imaging, has been proposed to determine the quantitative uptake of specific labelled substrates by uncultured microbes at the single cell level. This technique requires the hybridization of rRNA targeted halogenated DNA probes on fixed and permeabilized microorganisms. Exogenous atoms are introduced into cells and endogenous atoms removed during the experimental procedures. Consequently differences between the original and the apparent isotopic composition of cells may occur. In the present study, the influence of the experimental procedures of SIMSISH on the isotopic composition of carbon in E. coli cells was evaluated with nanoSIMS and compared to elemental analyser-isotopic ratio mass spectrometer (EA-IRMS) measurements. Our results show that fixation and hybridization have a very limited, reproducible and homogeneous influence on the isotopic composition of cells. Thereby, the SIMSISH procedure minimizes the contamination of the sample by exogenous atoms, thus providing a means to detect the phylogenetic identity and to measure precisely the carbon isotopic composition at the single cell level. This technique was successfully applied to a complex sample with double bromine iodine labelling targeting a large group of bacteria and a specific archaea to evaluate their specific C-13 uptake during labelled methanol anaerobic degradation.	[Chapleur, Olivier; Mazeas, Laurent; Bouchez, Theodore] Irstea, UR HBAN, Antony, France; [Wu, Ting-Di; Guerquin-Kern, Jean-Luc] Univ Paris 11, INSERM, U759, F-91405 Orsay, France; [Wu, Ting-Di; Guerquin-Kern, Jean-Luc] Inst Curie, Lab Microscopie Ion, F-91405 Orsay, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Chapleur, O (corresponding author), Irstea, UR HBAN, Antony, France.	olivier.chapleur@irstea.fr	BOUCHEZ, Théodore/AAC-4652-2021; Bouchez, Theodore/B-5383-2016; Guerquin-Kern, Jean-Luc/M-5000-2018	BOUCHEZ, Théodore/0000-0002-2236-8282; Bouchez, Theodore/0000-0002-2236-8282; Guerquin-Kern, Jean-Luc/0000-0002-8610-0146; WU, Ting-Di/0000-0002-6398-0363; Chapleur, Olivier/0000-0001-9460-921X				Amann R, 1996, J BACTERIOL, V178, P3496, DOI 10.1128/jb.178.12.3496-3500.1996; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Behrens S, 2008, APPL ENVIRON MICROB, V74, P3143, DOI 10.1128/AEM.00191-08; Davission ML, 2008, DEV STANDARDS NANOSI; Halm H, 2009, ENVIRON MICROBIOL, V11, P1945, DOI 10.1111/j.1462-2920.2009.01917.x; Huang WE, 2007, ENVIRON MICROBIOL, V9, P1878, DOI 10.1111/j.1462-2920.2007.01352.x; Lee N, 1999, APPL ENVIRON MICROB, V65, P1289; Li T., 2007, THESIS; Li T, 2008, ENVIRON MICROBIOL, V10, P580, DOI 10.1111/j.1462-2920.2007.01478.x; Musat N, 2012, FEMS MICROBIOL REV, V36, P486, DOI 10.1111/j.1574-6976.2011.00303.x; Musat N, 2008, P NATL ACAD SCI USA, V105, P17861, DOI 10.1073/pnas.0809329105; Ouverney CC, 1999, APPL ENVIRON MICROB, V65, P1746; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Radajewski S, 2000, NATURE, V403, P646, DOI 10.1038/35001054	14	5	5	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77522	10.1371/journal.pone.0077522	http://dx.doi.org/10.1371/journal.pone.0077522			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204855	Green Published, Green Submitted, gold			2022-12-27	WOS:000326270700033
J	Chen, L; Yang, ZF; Chen, B				Chen, Liang; Yang, Zhifeng; Chen, Bin			Scenario Analysis and Path Selection of Low-Carbon Transformation in China Based on a Modified IPAT Model	PLOS ONE			English	Article							ECONOMIC-GROWTH; DRIVING FORCES; STIRPAT MODEL; POPULATION; DECOMPOSITION; CONSUMPTION; AFFLUENCE; SCIENCE; IMPACT	This paper presents a forecast and analysis of population, economic development, energy consumption and CO2 emissions variation in China in the short- and long-term steps before 2020 with 2007 as the base year. The widely applied IPAT model, which is the basis for calculations, projections, and scenarios of greenhouse gases (GHGs) reformulated as the Kaya equation, is extended to analyze and predict the relations between human activities and the environment. Four scenarios of CO2 emissions are used including business as usual (BAU), energy efficiency improvement scenario (EEI), low carbon scenario (LC) and enhanced low carbon scenario (ELC). The results show that carbon intensity will be reduced by 40-45% as scheduled and economic growth rate will be 6% in China under LC scenario by 2020. The LC scenario, as the most appropriate and the most feasible scheme for China's low-carbon development in the future, can maximize the harmonious development of economy, society, energy and environmental systems. Assuming China's development follows the LC scenario, the paper further gives four paths of low-carbon transformation in China: technological innovation, industrial structure optimization, energy structure optimization and policy guidance.	[Chen, Liang; Yang, Zhifeng; Chen, Bin] Beijing Normal Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100875, Peoples R China	Beijing Normal University	Yang, ZF (corresponding author), Beijing Normal Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100875, Peoples R China.	zfyang@bnu.edu.cn; chenb@bnu.edu.cn	Chen, Bin/A-6951-2012	Chen, Bin/0000-0002-5488-6850	Fund for Creative Research Groups of the National Natural Science Foundation of China [51121003]; Key Program of National Natural Science Foundation [50939001]; National Key Technology RD Program [2012BAK30B03]	Fund for Creative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program)	This study was supported by Fund for Creative Research Groups of the National Natural Science Foundation of China (No. 51121003), Key Program of National Natural Science Foundation (No. 50939001), and National Key Technology R&D Program (No. 2012BAK30B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnolucci P, 2009, ECOL ECON, V68, P1652, DOI 10.1016/j.ecolecon.2007.09.005; Anderson K, 2004, 8 SCENARIOS DEV TYND; Ang BW, 2004, ENERG ECON, V26, P757, DOI 10.1016/j.eneco.2004.02.002; Ang BW, 2001, ENERGY, V26, P537, DOI 10.1016/S0360-5442(01)00022-6; Cai WJ, 2007, ENERG POLICY, V35, P6445, DOI 10.1016/j.enpol.2007.08.026; Center for Clean Air Policy, 2006, GREENH GAS MIT CHIN; Center for Clean Air Policy, 2006, GREENH GAS MIT BRAZ; Chertow RM, 2001, J IND ECOL, V4, P13; China Council for International Cooperation on Environment and Development (CCICED), 2009, CHIN PATHW LOW CARB; Dietz T, 1997, P NATL ACAD SCI USA, V94, P175, DOI 10.1073/pnas.94.1.175; Dietz T., 1994, HUM ECOL REV, V1, P277, DOI [10.2307/24706840, DOI 10.2307/24706840]; Ehrlich P R, 1972, B ATOM SCI, V28, P16, DOI DOI 10.1080/00963402.1972.11457930; EHRLICH PR, 1971, SCIENCE, V171, P1212, DOI 10.1126/science.171.3977.1212; Feng KS, 2009, ECOL ECON, V69, P145, DOI 10.1016/j.ecolecon.2009.08.007; Gao CK, 2010, PROCEDIA ENVIRON SCI, V2, P1335, DOI 10.1016/j.proenv.2010.10.144; Guan D, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036540; Harrison Paul, 1993, 3 REVOLUTION; Hubacek K, 2007, FUTURES, V39, P1084, DOI 10.1016/j.futures.2007.03.010; Hubacek K, 2012, ENERGIES, V5, P22, DOI 10.3390/en5010022; IEA, 2009, CO2 EMISSIONS FUEL C; International Energy Agency (EIA), 2011, INT EN STAT; IPCC, 2001, IPCC SPECIAL REPORT; Jia JS, 2009, ECOL ECON, V68, P2818, DOI 10.1016/j.ecolecon.2009.05.012; Kaya Y, 1989, IMPACT CARBON DIOXID; Martin N., 1999, ENERGY EFFICIENCY CA; Menz T, 2011, POPUL ENVIRON, V33, P55, DOI 10.1007/s11111-011-0132-6; MNP (Netherlands Environmental Assessment Agency), 2007, CHIN NOW 1 CO2 EM US; Nakicenovic N, 2004, SCOPE SER, V62, P225; Raskin PD, 1995, ECOL ECON, V15, P225, DOI 10.1016/0921-8009(95)00047-X; Research Team of China Climate Change Country Study, 1999, CHIN CLIM CHANG COUN; Roberts TD, 2011, APPL GEOGR, V31, P731, DOI 10.1016/j.apgeog.2010.06.010; Rosa EA, 1998, INT SOCIOL, V13, P421, DOI 10.1177/026858098013004002; Shrestha RM, 2007, ENERG POLICY, V35, P3179, DOI 10.1016/j.enpol.2006.11.007; Sinton JE, 2000, ENERGY CARBON SCENAR; Song ML, 2011, RENEW SUST ENERG REV, V15, P5129, DOI 10.1016/j.rser.2011.07.043; State Council of the People's Republic of China, 2011, 12 5 YEAR PLAN FRAM; State Council of the People's Republic of China, 2006, 11 5 YEAR PLAN FRAM; Study Group for Sustainable Development Strategy of CAS, 2009, CHIN APPR LOW CARB F; Su W, 2010, CHINAS PLEDGE COP15; Tao ZP, 2010, ENERGY, V35, P168, DOI 10.1016/j.energy.2009.09.007; Waggoner PE, 2002, P NATL ACAD SCI USA, V99, P7860, DOI 10.1073/pnas.122235999; Wang C, 2007, ENERG CONVERS MANAGE, V48, P2110, DOI 10.1016/j.enconman.2006.12.022; Wang CM, 2010, PROCEDIA ENVIRON SCI, V2, P1701, DOI 10.1016/j.proenv.2010.10.181; Wang K, 2007, ENERG POLICY, V35, P2320, DOI 10.1016/j.enpol.2006.08.007; York R, 2003, ECOL ECON, V46, P351, DOI 10.1016/S0921-8009(03)00188-5; York R, 2002, SOC SCI QUART, V83, P18, DOI 10.1111/1540-6237.00068; Zhou D., 2003, CHINAS SUSTAINABLE E	47	11	13	6	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77699	10.1371/journal.pone.0077699	http://dx.doi.org/10.1371/journal.pone.0077699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204922	Green Published, gold, Green Submitted			2022-12-27	WOS:000326270700049
J	Delgado, MD; Caferri, E; Mendez, M; Godoy, JA; Campioni, L; Penteriani, V				del Mar Delgado, Maria; Caferri, Eleonora; Mendez, Maria; Godoy, Jose A.; Campioni, Letizia; Penteriani, Vincenzo			Population Characteristics May Reduce the Levels of Individual Call Identity	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; PHENOTYPIC PLASTICITY; MICROSATELLITE MARKERS; REPRODUCTIVE SUCCESS; BREEDING PERFORMANCE; BOTAURUS-STELLARIS; VOCAL DISPLAYS; REACTION NORMS; STRIX-ALUCO; EAGLE	Individual variability influences the demographic and evolutionary dynamics of spatially structured populations, and conversely ecological and evolutionary dynamics provide the context under which variations at the individual level occur. Therefore, it is essential to identify and characterize the importance of the different factors that may promote or hinder individual variability. Animal signaling is a prime example of a type of behavior that is largely dependent on both the features of individuals and the characteristics of the population to which they belong. After 10 years studying the dynamics of a population of a long-lived species, the eagle owl (Bubo bubo), we investigated the emergence and maintenance of traits that reveal individual identity by focusing on vocal features. We found that individuals inhabiting a high density population characterized by a relative lack of heterogeneity (in terms of prey availability and breeding success) among breeding sites might be selected for reducing the levels of identity. Two non-mutually exclusive hypotheses may explain the structural call patterns we detected: (1) similarity in calls may be principally a consequence of the particular characteristics of the population; and (2) high density may encourage individuals to mimic each other's vocalizations in a cascade effect, leading to a widespread and unique communication network.	[del Mar Delgado, Maria] Univ Helsinki, Dept Biosci, Metapopulat Res Grp, Helsinki, Finland; [del Mar Delgado, Maria; Caferri, Eleonora; Mendez, Maria; Campioni, Letizia; Penteriani, Vincenzo] CSIC, Dept Conservat Biol, Estn Biol Donana, E-41080 Seville, Spain; [Godoy, Jose A.] CSIC, Integrat Ecol Grp, Estn Biol Donana, E-41080 Seville, Spain; [Penteriani, Vincenzo] Univ Helsinki, Finnish Museum Nat Hist, Zool Museum, Helsinki, Finland	University of Helsinki; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Helsinki	Delgado, MD (corresponding author), Univ Helsinki, Dept Biosci, Metapopulat Res Grp, Helsinki, Finland.	maria.delgado@helsinki.fi	Godoy, José Antonio/B-9288-2008; campioni, letizia/AAZ-2888-2020	Godoy, José Antonio/0000-0001-7502-9471; campioni, letizia/0000-0002-6319-6931	Spanish Ministry of Economy and Competitiveness [CGL2012-33240]; FEDER; Spanish Ministry of Science and Innovation [CGL2004-02780/BOS, CGL2008-02871/BOS]; Junta of Andalucia [RNM-5090]; Academy of Finland [140367]; Spanish Secretaria General de Universidades, Ministry of Education (Salvador de Madariaga Program)	Spanish Ministry of Economy and Competitiveness(Spanish Government); FEDER(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta of Andalucia(Junta de Andalucia); Academy of Finland(Academy of Finland); Spanish Secretaria General de Universidades, Ministry of Education (Salvador de Madariaga Program)	The work was funded by one research project of the Spanish Ministry of Economy and Competitiveness (CGL2012-33240; with FEDER co-financing), two research projects of the Spanish Ministry of Science and Innovation (CGL2004-02780/BOS and CGL2008-02871/BOS; with FEDER co-financing) and the Junta of Andalucia (Excellence Project, RNM-5090). M. D. received a postdoctoral fellowship from the Spanish Ministry of Science and Innovation and a postdoctoral grant (no. 140367) from the Academy of Finland. V. P. was the recipient of a grant from the Spanish Secretaria General de Universidades, Ministry of Education (Salvador de Madariaga Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; Anderson DP, 2005, LANDSCAPE ECOL, V20, P257, DOI 10.1007/s10980-005-0062-8; Appleby BM, 1997, IBIS, V139, P152, DOI 10.1111/j.1474-919X.1997.tb04515.x; BELETSKY LD, 1992, BEHAVIOUR, V123, P290, DOI 10.1163/156853992X00066; Bradbury Jack W., 1998, pi; Burton T, 2011, P ROY SOC B-BIOL SCI, V278, P3465, DOI 10.1098/rspb.2011.1778; Cam E, 2002, AM NAT, V159, P96, DOI 10.1086/324126; Campioni L, 2013, OECOLOGIA, V172, P371, DOI 10.1007/s00442-012-2493-7; Campioni L, 2010, IBIS, V152, P569, DOI 10.1111/j.1474-919X.2010.01030.x; Catchpole CK, 1995, BIRD SONG BIOL THEME; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; Delgado MD, 2010, J ANIM ECOL, V79, P620, DOI 10.1111/j.1365-2656.2009.01655.x; Delgado MD, 2009, ARDEA, V97, P7, DOI 10.5253/078.097.0102; Delgado MM, 2007, J ZOOL, V271, P3, DOI 10.1111/j.1469-7998.2006.00205.x; Donovan TM, 1995, CONSERV BIOL, V9, P1380, DOI 10.1046/j.1523-1739.1995.09061380.x; Elkie P, 1999, PATCH ANAL USERS MAN; Ellis JMS, 2008, CONDOR, V110, P648, DOI 10.1525/cond.2008.8592; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Feng AS, 2009, ETHOLOGY, V115, P851, DOI 10.1111/j.1439-0310.2009.01666.x; Fisher J., 1954, P71; GALEOTTI P, 1991, ETHOL ECOL EVOL, V3, P113, DOI 10.1080/08927014.1991.9525378; Galeotti P, 2001, J AVIAN BIOL, V32, P256, DOI 10.1111/j.0908-8857.2001.320308.x; Gilbert G, 2002, IBIS, V144, P51, DOI 10.1046/j.0019-1019.2001.00012.x; Grava T, 2008, IBIS, V150, P279, DOI 10.1111/j.1474-919X.2007.00776.x; HOUSTON AI, 1992, EVOL ECOL, V6, P243, DOI 10.1007/BF02214164; Hsu YC, 2003, MOL ECOL NOTES, V3, P595, DOI 10.1046/j.1471-8286.2003.00523.x; Huber H, 2004, AM NAT, V163, P548, DOI 10.1086/382549; Husby A, 2010, EVOLUTION, V64, P2221, DOI 10.1111/j.1558-5646.2010.00991.x; Isaksson M, 2002, MOL ECOL NOTES, V2, P91, DOI 10.1046/j.1471-8286.2002.00156.x; KAWECKI TJ, 1993, EVOL ECOL, V7, P155, DOI 10.1007/BF01239386; Kie JG, 2002, ECOLOGY, V83, P530, DOI 10.1890/0012-9658(2002)083[0530:LHADSE]2.0.CO;2; King EG, 2010, AM NAT, V175, P702, DOI 10.1086/652434; Koehl M.A.R., 1989, P39; Kuparinen A, 2011, OECOLOGIA, V167, P435, DOI 10.1007/s00442-011-1989-x; Laiolo P, 2005, J APPL ECOL, V42, P1183, DOI 10.1111/j.1365-2664.2005.01093.x; Laiolo P, 2007, FRONT ECOL ENVIRON, V5, P68, DOI 10.1890/1540-9295(2007)5[68:EOACIF]2.0.CO;2; Lengagne T, 2001, BEHAVIOUR, V138, P1407, DOI 10.1163/156853901317367663; Lyytinen A, 2004, P ROY SOC B-BIOL SCI, V271, P279, DOI 10.1098/rspb.2003.2571; McGregor Peter K., 1996, P409; Mennill DJ, 2011, IBIS, V153, P235, DOI 10.1111/j.1474-919X.2011.01119.x; Morita K, 2002, J FISH BIOL, V61, P1230, DOI [10.1006/jfbi.2002.2138, 10.1111/j.1095-8649.2002.tb02467.x]; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Otte D., 1974, Annual Rev Ecol Syst, V5, P385, DOI 10.1146/annurev.es.05.110174.002125; Ouyang JQ, 2011, P ROY SOC B-BIOL SCI, V278, P2537, DOI 10.1098/rspb.2010.2490; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Penteriani V, 2003, IBIS, V145, pE127, DOI 10.1046/j.1474-919X.2003.00173.x; Penteriani V, 2002, ETHOL ECOL EVOL, V14, P275; Penteriani V, 2005, IBIS, V147, P155, DOI 10.1111/j.1474-919x.2004.00381.x; Penteriani V, 2004, POPUL ECOL, V46, P185, DOI 10.1007/s10144-004-0178-8; Penteriani V, 2002, J ZOOL, V257, P365, DOI 10.1017/S0952836902000961; Penteriani V, 2011, ANIM BEHAV, V82, P413, DOI 10.1016/j.anbehav.2011.05.027; Penteriani V, 2011, ECOGRAPHY, V34, P729, DOI 10.1111/j.1600-0587.2010.06773.x; Perez-Garcia JM, 2012, BIRD STUDY, V59, P22, DOI 10.1080/00063657.2011.613111; Puglisi L, 2004, AUK, V121, P541, DOI 10.1642/0004-8038(2004)121[0541:DOIVIM]2.0.CO;2; R Development Core Team, 2009, R LANG ENV STAT COMP; Saether BE, 1997, TRENDS ECOL EVOL, V12, P143, DOI 10.1016/S0169-5347(96)10068-9; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Specht R, 2003, AVISOFT SASLABPRO SO; STEARNS SC, 1986, EVOLUTION, V40, P893, DOI 10.1111/j.1558-5646.1986.tb00560.x; Terry Andrew M.R., 2005, Frontiers in Zoology, V2, P1; Thode AB, 2002, MOL ECOL NOTES, V2, P446, DOI 10.1046/j.1471-8286.2002.00267.x; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Van Dyck H, 2005, BASIC APPL ECOL, V6, P535, DOI 10.1016/j.baae.2005.03.005; WIENS JA, 1990, REV CHIL HIST NAT, V63, P309	67	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77557	10.1371/journal.pone.0077557	http://dx.doi.org/10.1371/journal.pone.0077557			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204869	Green Published, gold			2022-12-27	WOS:000326270700037
J	Li, MY; Zhao, J; Shen, Y; Li, T; He, L; Xu, HL; Yu, YF; Zhou, XT				Li, Meiyan; Zhao, Jing; Shen, Yang; Li, Tao; He, Li; Xu, Hailin; Yu, Yongfu; Zhou, Xingtao			Comparison of Dry Eye and Corneal Sensitivity between Small Incision Lenticule Extraction and Femtosecond LASIK for Myopia	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; NEUROTROPHIC EPITHELIOPATHY; HINGE POSITION; OCULAR SURFACE; REFRACTIVE SURGERY; LASER; SENSATION; DISEASE; SMILE	Purpose: To investigate the changes in dry eye symptoms and clinical signs and corneal sensitivity after small incision lenticule extraction (SMILE) and femtosecond LASIK (femto-LASIK). Design: Prospective, non-randomized comparative study. Methods: The study included a total of 71 eyes of 71 patients; the SMILE group comprised 38 eyes of 38 patients, and the femto-LASIK group comprised 33 eyes of 33 patients. Ocular Surface Disease Index (OSDI), Tear film breakup time (TBUT), the Schirmer test without anesthesia (S1T), corneal fluorescein staining, and central corneal sensation were evaluated before surgery and at 1 week, 1 month, 3 months, and 6 months after surgery. Results: OSDI scores in both groups were increased immediately and returned to preoperative level at 1 month after surgeries. The TBUT values in both groups were reduced after surgeries relative to their preoperative scores. Patients in SMILE group were less likely to have corneal staining compared with those in the femto-LASIK group ([odds ratio] OR = 0.50, 95% [confidence interval] CI 0.28 to 0.93, P = 0.03). Central corneal sensitivity was decreased at all postoperative time points in both groups. However, the central corneal sensation scores in the SMILE group were greater than that in the femto-LASIK group at all of the postoperative time points (all P<0.05). Conclusions: SMILE surgeries resulted in a short-term increase in dry eye symptoms, tear film instability, and loss of corneal sensitivity. Furthermore, SMILE surgeries have superiority over femto-LASIK in lower risk of postoperative corneal staining and less reduction of corneal sensation.	[Li, Meiyan; Zhao, Jing; Shen, Yang; Li, Tao; He, Li; Xu, Hailin; Zhou, Xingtao] Fudan Univ, Dept Ophthalmol, Eye & Ear Nose & Throat Hosp, Myopia Key Lab,Hlth Minist, Shanghai 200433, Peoples R China; [Yu, Yongfu] Fudan Univ, Sch Publ Hlth, Dept Biostat, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Zhou, XT (corresponding author), Fudan Univ, Dept Ophthalmol, Eye & Ear Nose & Throat Hosp, Myopia Key Lab,Hlth Minist, Shanghai 200433, Peoples R China.	doctzhouxingtao@163.com	Yu, Yongfu/GLR-9881-2022; Shen, Yang/R-3539-2016; Yu, Yongfu/W-7557-2019; zhou, xt/GWZ-9212-2022	Shen, Yang/0000-0002-5859-0790; Yu, Yongfu/0000-0003-4208-9480; 	Natural Science Foundation of China [11074052]; Key Project of Science and Technology of Shanghai [11JC1402000]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Science and Technology of Shanghai	Funding provided by Natural Science Foundation of China (Grant No. 11074052) and The Key Project of Science and Technology of Shanghai (Grant No. 11JC1402000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albietz JM, 2004, J CATARACT REFR SURG, V30, P675, DOI 10.1016/j.jcrs.2003.07.003; Ambrosio R, 2008, J REFRACT SURG, V24, P396, DOI 10.3928/1081597X-20080401-14; Battat L, 2001, OPHTHALMOLOGY, V108, P1230, DOI 10.1016/S0161-6420(01)00623-6; Chen F, 2010, INVEST OPHTH VIS SCI, V51, P5571, DOI 10.1167/iovs.09-5097; De Paiva CS, 2004, AM J OPHTHALMOL, V137, P109, DOI 10.1016/S0002-9394(03)00897-3; Donnenfeld ED, 2003, OPHTHALMOLOGY, V110, P1023, DOI 10.1016/S0161-6420(03)00100-3; Golas L, 2011, J CATARACT REFR SURG, V37, P1476, DOI 10.1016/j.jcrs.2011.03.035; Hammond MD, 2005, OPHTHALMOLOGY, V112, P184, DOI 10.1016/j.ophtha.2004.08.014; Horwath-Winter J, 2004, J CATARACT REFR SURG, V30, P2316, DOI 10.1016/j.jcrs.2004.03.042; Konomi K, 2008, INVEST OPHTH VIS SCI, V49, P168, DOI 10.1167/iovs.07-0337; Mertzanis P, 2005, INVEST OPHTH VIS SCI, V46, P46, DOI 10.1167/iovs.03-0915; Mian SI, 2007, J CATARACT REFR SURG, V33, P1190, DOI 10.1016/j.jcrs.2007.03.031; Mian SI, 2009, J CATARACT REFR SURG, V35, P2092, DOI 10.1016/j.jcrs.2009.07.009; Muller LJ, 2003, EXP EYE RES, V76, P521, DOI 10.1016/S0014-4835(03)00050-2; Nichols KK, 2004, CORNEA, V23, P762, DOI 10.1097/01.ico.0000133997.07144.9e; Salomao MQ, 2009, J CATARACT REFR SURG, V35, P1756, DOI 10.1016/j.jcrs.2009.05.032; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; Sekundo W, 2011, BRIT J OPHTHALMOL, V95, P335, DOI 10.1136/bjo.2009.174284; Toda I, 2001, AM J OPHTHALMOL, V132, P1, DOI 10.1016/S0002-9394(01)00959-X; Toda I, 2007, COMPR OPHTHALMOL UPD, V8, P87; Toda Ikuko, 2007, Compr Ophthalmol Update, V8, P79; Tuisku IS, 2007, J REFRACT SURG, V23, P338; Vitale Susan, 2004, Health Qual Life Outcomes, V2, P44, DOI 10.1186/1477-7525-2-44; Wei SS, 2013, GRAEF ARCH CLIN EXP, V251, P1645, DOI 10.1007/s00417-013-2272-0; Wilson SE, 2001, AM J OPHTHALMOL, V132, P405, DOI 10.1016/S0002-9394(01)00995-3; Wilson SE, 2001, OPHTHALMOLOGY, V108, P1082, DOI 10.1016/S0161-6420(01)00587-5; 2007, OCUL SURF, V5, P93	27	90	101	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77797	10.1371/journal.pone.0077797	http://dx.doi.org/10.1371/journal.pone.0077797			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204971	Green Published, Green Submitted, gold			2022-12-27	WOS:000326270700054
J	Gorse, P; Nordon, C; Rouillon, F; Pham-Scottez, A; Revah-Levy, A				Gorse, Pauline; Nordon, Clementine; Rouillon, Frederic; Pham-Scottez, Alexandra; Revah-Levy, Anne			Subjective Motives for Requesting In-Patient Treatment in Female with Anorexia Nervosa: A Qualitative Study	PLOS ONE			English	Article							EATING-DISORDERS; TREATMENT ACCEPTANCE; PREDICTORS; MORTALITY; READINESS; COMMUNITY; ADMISSION; TRIAL	Background: Anorexia nervosa is a severe psychiatric disorder mainly affecting women. Its treatment is long and accepted with much difficulty, in particular in-patient treatment. Aims: To describe the subjective motives of women with anorexia nervosa for requesting in-patient admission, from a qualitative analysis of application letters. Methods: Participants were adult women (18 years and older) with anorexia nervosa who were admitted as inpatients in a referral hospital unit in France from January 2008 to December 2010. The application letters, prerequisites to admission, were studied by the interpretative phenomenological method of content analysis. Results: 63 letters have been analysed, allowing the identification of six themes related to requests for in-patient care: loss of control of behaviour, and of thoughts, mental exhaustion, isolation, inner struggle and fear of recovery. Conclusions: Requests for in-patient admission were motivated by very personal, subjective experiences, unrelated to medical reasons for admission. These results may help improve pre-admission motivational work with individuals, by basing it on their subjective experience.	[Gorse, Pauline; Rouillon, Frederic; Pham-Scottez, Alexandra] St Anne Univ Hosp, CMME, Dept Adult Psychiat, Paris, France; [Nordon, Clementine; Revah-Levy, Anne] Univ Paris 11, INSERM, Res Unit 669, Paris, France; [Nordon, Clementine; Revah-Levy, Anne] Paris Descartes Univ, Paris, France; [Revah-Levy, Anne] Argenteuil Hosp Ctr, Argenteuil, France	GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite	Revah-Levy, A (corresponding author), Univ Paris 11, INSERM, Res Unit 669, Paris, France.	anne.revah-levy@ch-argenteuil.fr		revah-levy, anne/0000-0003-1805-6275	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This study was funded by INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2006, PRACT GUID TREATM PA; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ametller L, 2005, J CHILD PSYCHOL PSYC, V46, P394, DOI 10.1111/j.1469-7610.2004.00360.x; Arcelus J, 2011, ARCH GEN PSYCHIAT, V68, P724, DOI 10.1001/archgenpsychiatry.2011.74; Dupont Marie-Estelle, 2008, Rev Prat, V58, P141; Espeset EMS, 2012, CLIN PSYCHOL PSYCHOT, V19, P518, DOI 10.1002/cpp.760; Espindola CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056275; Espindola CR, 2009, ANN CLIN PSYCHIATRY, V21, P38; Feld R, 2001, INT J EAT DISORDER, V29, P393, DOI 10.1002/eat.1035; Fox JRE, 2009, CLIN PSYCHOL PSYCHOT, V16, P240, DOI 10.1002/cpp.626; Geller J, 2002, INT J EAT DISORDER, V31, P251, DOI 10.1002/eat.10045; Geller J, 2002, INT J EAT DISORDER, V32, P344, DOI 10.1002/eat.10083; Guarda AS, 2008, PHYSIOL BEHAV, V94, P113, DOI 10.1016/j.physbeh.2007.11.020; Guarda AS, 2007, AM J PSYCHIAT, V164, P108, DOI 10.1176/appi.ajp.164.1.108; Halmi KA, 2005, ARCH GEN PSYCHIAT, V62, P776, DOI 10.1001/archpsyc.62.7.776; Huas C, 2011, ACTA PSYCHIAT SCAND, V123, P62, DOI 10.1111/j.1600-0447.2010.01627.x; Jenkins J, 2012, EUR EAT DISORD REV, V20, pe23, DOI 10.1002/erv.1085; Keski-Rahkonen A, 2007, AM J PSYCHIAT, V164, P1259, DOI 10.1176/appi.ajp.2007.06081388; Miller WR, 2003, J CONSULT CLIN PSYCH, V71, P754, DOI 10.1037/0022-006X.71.4.754; Miotto P, 2002, ACTA PSYCHIAT SCAND, V105, P372, DOI 10.1034/j.1600-0447.2002.1o186.x; Morse J. M., 1995, QUALITATIVE RES METH; Mosher Catherine E, 2008, Eat Behav, V9, P497, DOI 10.1016/j.eatbeh.2008.04.002; Murnen SK, 1997, INT J EAT DISORDER, V22, P231, DOI 10.1002/(SICI)1098-108X(199711)22:3&lt;231::AID-EAT2&gt;3.0.CO;2-O; National Institute of Clinical Excellence, 2004, EAT DIS COR INT TREA, V9; Nordbo RHS, 2006, INT J EAT DISORDER, V39, P556, DOI 10.1002/eat.20276; Papadopoulos FC, 2009, BRIT J PSYCHIAT, V194, P10, DOI 10.1192/bjp.bp.108.054742; Paulson-Karlsson G, 2012, J MULTIDISCIP HEALTH, V5, P169, DOI 10.2147/JMDH.S33658; Qsr International Pty Ltd, 2012, NVIVO QUAL DAT AN SO; Reid M, 2008, J HEALTH PSYCHOL, V13, P956, DOI 10.1177/1359105308095070; Serpell L, 1999, INT J EAT DISORDER, V25, P177, DOI 10.1002/(SICI)1098-108X(199903)25:2<177::AID-EAT7>3.3.CO;2-4; Smith J, 2008, PRACTICAL GUIDE RES, V2nd ed.; Steinhausen HC, 2002, AM J PSYCHIAT, V159, P1284, DOI 10.1176/appi.ajp.159.8.1284; Strober M, 1997, INT J EAT DISORDER, V22, P339, DOI 10.1002/(SICI)1098-108X(199712)22:4&lt;339::AID-EAT1&gt;3.0.CO;2-N; Strother L, 2010, CONSCIOUS COGN, V19, P12, DOI 10.1016/j.concog.2009.12.007; Swanson SA, 2011, ARCH GEN PSYCHIAT, V68, P714, DOI 10.1001/archgenpsychiatry.2011.22; Tan J, 2003, INT J LAW PSYCHIAT, V26, P697, DOI 10.1016/j.ijlp.2003.09.010; Tasca GA, 2012, EUR EAT DISORD REV, V20, P155, DOI 10.1002/erv.1133; Treasure JL, 1997, CLIN GUIDE MANAGEMEN; Vitousek K, 1998, CLIN PSYCHOL REV, V18, P391, DOI 10.1016/S0272-7358(98)00012-9; Wallier J, 2009, INT J EAT DISORDER, V42, P636, DOI 10.1002/eat.20609; Yager J, 2012, PRACTICE GUIDELINE T, P2012	41	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77757	10.1371/journal.pone.0077757	http://dx.doi.org/10.1371/journal.pone.0077757			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	241GW	24204951	Green Published, Green Submitted, gold			2022-12-27	WOS:000326155400055
J	Lin, HH; Chiang, YT; Chuang, JH; Yang, SL; Chang, HY; Ezzati, M; Murray, M				Lin, Hsien-Ho; Chiang, Yi-Ting; Chuang, Jen-Hsiang; Yang, Shiang-Lin; Chang, Hsing-Yi; Ezzati, Majid; Murray, Megan			Exposure to Secondhand Smoke and Risk of Tuberculosis: Prospective Cohort Study	PLOS ONE			English	Article							PASSIVE SMOKING; TAIWAN; ADULTS	Background: Prospective evidence on the association between secondhand-smoke exposure and tuberculosis is limited. Methods: We included 23,827 never smokers from two rounds (2001 and 2005) of Taiwan National Health Interview Survey. Information on exposure to secondhand smoke at home as well as other sociodemographic and behavioral factors was collected through in-person interview. The participants were prospectively followed for incidence of tuberculosis through cross-matching the survey database to the national tuberculosis registry of Taiwan. Results: A total of 85 cases of active tuberculosis were identified after a median follow-up of 7.0 years. The prevalence of exposure to secondhand smoke at home was 41.8% in the study population. In the multivariable Cox proportional hazards analysis, secondhand smoke was not associated with active tuberculosis (adjusted hazard ratio [HR], 1.03; 95% CI, 0.64 to 1.64). In the subgroup analysis, the association between secondhand smoke and tuberculosis decreased with increasing age; the adjusted HR for those <18, >= 18 and <40, >= 40 and <60, and >= 60 years old was 8.48 (0.77 to 93.56), 2.29 (0.75 to 7.01), 1.33 (0.58 to 3.01), and 0.66 (0.35 to 1.23) respectively. Results from extensive sensitivity analyses suggested that potential misclassification of secondhand-smoke exposure would not substantially affect the observed associations. Conclusions: The results from this prospective cohort study did not support an overall association between secondhand smoke and tuberculosis. However, the finding that adolescents might be particularly susceptible to secondhand smoke's effect warrants further investigation.	[Lin, Hsien-Ho; Chiang, Yi-Ting] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Chuang, Jen-Hsiang; Yang, Shiang-Lin] Ctr Dis Control, Dept Hlth, Taipei, Taiwan; [Chang, Hsing-Yi] Natl Hlth Res Inst, Inst Populat Hlth Sci, Miaoli, Taiwan; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, Sch Publ Hlth, London, England; [Murray, Megan] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	National Taiwan University; Centers For Disease Control - Taiwan; National Health Research Institutes - Taiwan; Imperial College London; Harvard University; Harvard T.H. Chan School of Public Health	Lin, HH (corresponding author), Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	hsienho@ntu.edu.tw	Chang, Hsing-Yi/E-3973-2010; Chuang, Jen-Hsiang/G-4356-2010	Chuang, Jen-Hsiang/0000-0002-7114-3418; LIN, HSIEN-HO/0000-0002-7481-6016	National Science Council of Taiwan [NSC99-2314-B-002-144-MY2]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was funded by a grant from the National Science Council of Taiwan (NSC99-2314-B-002-144-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide J, 1996, TUBERCLE LUNG DIS, V77, P112, DOI 10.1016/S0962-8479(96)90024-6; Altet MN, 1996, TUBERCLE LUNG DIS, V77, P537, DOI 10.1016/S0962-8479(96)90052-0; [Anonymous], 1999, EPIDEMIOLOGIC BASIS; Ariyothai Niorn, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P219; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Bureau of Health Promotion, 2012, REP AD SMOK BEH SURV; Leung CC, 2010, ARCH INTERN MED, V170, P287, DOI 10.1001/archinternmed.2009.506; Lienhardt C, 2001, EPIDEMIOL REV, V23, P288, DOI 10.1093/oxfordjournals.epirev.a000807; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Lo HY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-915; Lo HY, 2011, J FORMOS MED ASSOC, V110, P501, DOI 10.1016/S0929-6646(11)60076-4; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Luh K-T, 2011, TAIWAN GUIDELINES TB; Shih Y-T, 2003, TAIWAN J PUBLIC HEAL, V22, P419; Slama K, 2007, INT J TUBERC LUNG D, V11, P612; STIEHM E, 2004, IMMUNOLOGIC DISORDER; Tipayamongkholgul Mathuros, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P145; U. S. Department of Health and Human Services, 2006, HLTH CONS INV EXP TO; WHO, 2011, WHO GLOBAL TUBERCULO; World Health Organization, 2007, WHO UN MON TB TOB CO; Yeh YP, 2005, T ROY SOC TROP MED H, V99, P509, DOI 10.1016/j.trstmh.2005.03.001	21	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77333	10.1371/journal.pone.0077333	http://dx.doi.org/10.1371/journal.pone.0077333			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204811	Green Published, Green Submitted, gold			2022-12-27	WOS:000326155400035
J	Tang, CW; Colagiuri, B				Tang, Chi Wang; Colagiuri, Ben			Can an Educational Handout Enhance Placebo Analgesia for Experimentally-Induced Pain?	PLOS ONE			English	Article							VERBAL EXPECTANCY; MAJOR DEPRESSION; CONTROLLED-TRIAL; EXPERIENCE	The placebo effect is an interesting phenomenon whereby a dummy treatment can produce therapeutic benefit, such as, pain relief. While evidence for the placebo effect is growing, relatively few studies have explored ways of enhancing placebo effects. To address this, the current study tested whether placebo-induced analgesia could be enhanced by providing an educational handout about the efficacy of analgesics. Fifty university students were allocated to receive placebo treatment under the guise of a new analgesic formula, either with or without an educational handout, or to a no treatment control group before undergoing electrical and cold pressor pain tests. There was a placebo effect for electrically-induced pain with those receiving placebo treatment reporting significantly less pain compared with those who received no treatment. There was also some evidence of enhancement of this placebo-induced analgesia for electrically-induced pain as a result of the educational handout. No differences were found on cold pressor-induced pain. These findings suggest that providing educational information about a treatment could enhance its efficacy via the placebo effect. Future studies should test different methods of providing educational information in order to determine which elicit the strongest effects.	[Tang, Chi Wang; Colagiuri, Ben] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Colagiuri, Ben] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia	University of New South Wales Sydney; University of Sydney	Colagiuri, B (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.	ben.colagiuri@sydney.edu.au		Colagiuri, Ben/0000-0003-2157-2641	University of New South Wales	University of New South Wales	Dr. Ben Colagiuri was a recipient of a University of New South Wales Vice-Chancellor's Postdoctoral Research Fellowship from January 2011 to June 2012, during which time some of the current data were collected. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austan F, 1997, AM J CLIN HYPN, V39, P182, DOI 10.1080/00029157.1997.10403383; Bae EH, 2011, EPILEPSY BEHAV, V20, P355, DOI 10.1016/j.yebeh.2010.12.005; Benedetti F, 2003, J NEUROSCI, V23, P4315; Benedetti F, 2003, PREVENT TREAT, V6, P1; Bingel U, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001244; Brunoni AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004824; BUCKALEW LW, 1981, PSYCHOL REP, V49, P955, DOI 10.2466/pr0.1981.49.3.955; CLARK WC, 1969, J ABNORM PSYCHOL, V74, P363, DOI 10.1037/h0027509; Colagiuri B, 2012, J PSYCHOPHARMACOL, V26, P1540, DOI 10.1177/0269881112458730; Colagiuri B, 2011, PSYCHON B REV, V18, P399, DOI 10.3758/s13423-010-0041-1; Colagiuri B, 2010, CLIN TRIALS, V7, P246, DOI 10.1177/1740774510367916; Colagiuri B, 2010, PSYCHOPHARMACOLOGY, V208, P433, DOI 10.1007/s00213-009-1743-9; Colloca L, 2006, PAIN, V124, P126, DOI 10.1016/j.pain.2006.04.005; de Craen AJM, 1999, BRIT J CLIN PHARMACO, V48, P853, DOI 10.1046/j.1365-2125.1999.00094.x; DeSantana Josimari M, 2008, Curr Rheumatol Rep, V10, P492; Di Blasi Z, 2001, LANCET, V357, P757, DOI 10.1016/S0140-6736(00)04169-6; DOWNING RW, 1979, ACTA PSYCHIAT SCAND, V60, P438, DOI 10.1111/j.1600-0447.1979.tb00554.x; GOTTLIEB AM, 1987, J CONSULT CLIN PSYCH, V55, P606, DOI 10.1037/0022-006X.55.4.606; Kaptchuk TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015591; Kaptchuk TJ, 2006, BMJ-BRIT MED J, V332, P391, DOI 10.1136/bmj.38726.603310.55; Kelley JM, 2012, PSYCHOTHER PSYCHOSOM, V81, P312, DOI 10.1159/000337053; KIRSCH I, 1985, AM PSYCHOL, V40, P1189, DOI 10.1037/0003-066X.40.11.1189; KNOX VJ, 1979, PSYCHOSOM MED, V41, P477; Koban L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049784; Lee C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026016; Lewis T, 1930, HEART-J STUD CIRC, V15, P177; Louhiala P, 2008, Med Humanit, V34, P107, DOI 10.1136/jmh.2008.000307; Moerman DE, 2002, ANN INTERN MED, V136, P471, DOI 10.7326/0003-4819-136-6-200203190-00011; Montgomery GH, 1997, PAIN, V72, P107, DOI 10.1016/S0304-3959(97)00016-X; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Pollo A, 2002, NEUROREPORT, V13, P1383, DOI 10.1097/00001756-200208070-00006; Rose JP, 2012, J BEHAV MED, V35, P462, DOI 10.1007/s10865-011-9374-0; Shelke AR, 2008, J PAIN SYMPTOM MANAG, V35, P381, DOI 10.1016/j.jpainsymman.2007.05.008; Siegel S, 2002, SCI PLACEBO EFFECT I, P108; Stewart-Williams S, 2004, PSYCHOL BULL, V130, P324, DOI 10.1037/0033-2909.130.2.324; Suetsugi M, 2007, PROG NEURO-PSYCHOPH, V31, P839, DOI 10.1016/j.pnpbp.2007.01.019; ter Riet G, 1998, PAIN, V76, P273, DOI 10.1016/S0304-3959(98)00057-8; VOUDOURIS NJ, 1990, PAIN, V43, P121, DOI 10.1016/0304-3959(90)90057-K; Walsh BT, 2002, JAMA-J AM MED ASSOC, V287, P1840, DOI 10.1001/jama.287.14.1840; Wolf S, 1941, J CLIN INVEST, V20, P521, DOI 10.1172/JCI101245	40	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77544	10.1371/journal.pone.0077544	http://dx.doi.org/10.1371/journal.pone.0077544			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	241GW	24204865	Green Submitted, Green Published, gold			2022-12-27	WOS:000326155400042
J	Miyata, R; Ota, K; Aonishi, T				Miyata, Ryota; Ota, Keisuke; Aonishi, Toru			Optimal Design for Hetero-Associative Memory: Hippocampal CA1 Phase Response Curve and Spike-Timing-Dependent Plasticity	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; THETA-RHYTHM; REPLAY; SEQUENCES; SLEEP; EXPERIENCE; STORAGE; COMPRESSION; RETRIEVAL; NETWORKS	Recently reported experimental findings suggest that the hippocampal CA1 network stores spatio-temporal spike patterns and retrieves temporally reversed and spread-out patterns. In this paper, we explore the idea that the properties of the neural interactions and the synaptic plasticity rule in the CA1 network enable it to function as a hetero-associative memory recalling such reversed and spread-out spike patterns. In line with Lengyel's speculation (Lengyel et al., 2005), we firstly derive optimally designed spike-timing-dependent plasticity (STDP) rules that are matched to neural interactions formalized in terms of phase response curves (PRCs) for performing the hetero-associative memory function. By maximizing object functions formulated in terms of mutual information for evaluating memory retrieval performance, we search for STDP window functions that are optimal for retrieval of normal and doubly spread-out patterns under the constraint that the PRCs are those of CA1 pyramidal neurons. The system, which can retrieve normal and doubly spread-out patterns, can also retrieve reversed patterns with the same quality. Finally, we demonstrate that purposely designed STDP window functions qualitatively conform to typical ones found in CA1 pyramidal neurons.	[Miyata, Ryota; Aonishi, Toru] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Tokyo, Kanagawa, Japan; [Miyata, Ryota] Japan Soc Promot Sci, Tokyo, Japan; [Ota, Keisuke] RIKEN, Brain Sci Inst, Saitama, Japan	Tokyo Institute of Technology; Japan Society for the Promotion of Science; RIKEN	Aonishi, T (corresponding author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Tokyo, Kanagawa, Japan.	aonishi@dis.titech.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [12J09230, 23500375]; Grants-in-Aid for Scientific Research [12J09230] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by a Grant-in-Aid for Japan Society for the Promotion of Science Fellows [No. 12J09230 (RM)] and a Grant-in-Aid for Scientific Research (C) [No. 23500375 (TA)] from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Aihara T, 2007, NEUROSCIENCE, V145, P80, DOI 10.1016/j.neuroscience.2006.11.025; Andersen P., 2007, HIPPOCAMPUS BOOK; Aonishi T, 2006, J PHYS SOC JPN, V75, DOI 10.1143/JPSJ.75.114802; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Brandalise F, 2012, NEUROSCIENCE2012 ANN; Buchanan Katherine A, 2010, Front Synaptic Neurosci, V2, P11, DOI 10.3389/fnsyn.2010.00011; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cutsuridis V, 2010, SPR SER COMPUT NEURO, V5, P1, DOI 10.1007/978-1-4419-0996-1; Cutsuridis V, 2011, NEURAL NETWORKS, V24, P29, DOI 10.1016/j.neunet.2010.08.005; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Graham BP, 2001, NETWORK-COMP NEURAL, V12, P473, DOI 10.1088/0954-898X/12/4/304; Hasselmo ME, 2002, NEURAL COMPUT, V14, P793, DOI 10.1162/089976602317318965; Hasselmo ME, 1996, HIPPOCAMPUS, V6, P693, DOI 10.1002/(SICI)1098-1063(1996)6:6<693::AID-HIPO12>3.0.CO;2-W; Hertz JA, 2018, INTRO THEORY NEURAL; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Karlsson MP, 2009, NAT NEUROSCI, V12, P913, DOI 10.1038/nn.2344; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lengyel M, 2005, NAT NEUROSCI, V8, P1677, DOI 10.1038/nn1561; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Marr D., 1982, VISION COMPUTATIONAL; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Netoff TI, 2005, J NEUROPHYSIOL, V93, P1197, DOI 10.1152/jn.00982.2004; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; Ota K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050232; Ota K, 2012, SPR SER COMPUT NEURO, V6, P179, DOI 10.1007/978-1-4614-0739-3_8; Ota K, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.041902; Ota K, 2009, J PHYS CONF SER, V197, DOI 10.1088/1742-6596/197/1/012016; Ota K, 2009, J COMPUT NEUROSCI, V26, P185, DOI 10.1007/s10827-008-0104-8; Shouval HZ, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00019; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Teramae JN, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.248105; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Tsukada M, 2005, HIPPOCAMPUS, V15, P104, DOI 10.1002/hipo.20035; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Wittenberg GM, 2006, J NEUROSCI, V26, P6610, DOI 10.1523/JNEUROSCI.5388-05.2006	46	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77395	10.1371/journal.pone.0077395	http://dx.doi.org/10.1371/journal.pone.0077395			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204822	gold, Green Submitted, Green Published			2022-12-27	WOS:000326152300023
J	Dirks-Hofmeister, ME; Kolkenbrock, S; Moerschbacher, BM				Dirks-Hofmeister, Mareike E.; Kolkenbrock, Stephan; Moerschbacher, Bruno M.			Parameters That Enhance the Bacterial Expression of Active Plant Polyphenol Oxidases	PLOS ONE			English	Article							SODIUM DODECYL-SULFATE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; ACTIVATION; CLONING; PURIFICATION; ISOFORM; PROTEIN	Polyphenol oxidases (PPOs, EC 1.10.3.1) are type-3 copper proteins that enzymatically convert diphenolic compounds into their corresponding quinones. Although there is significant interest in these enzymes because of their role in food deterioration, the lack of a suitable expression system for the production of soluble and active plant PPOs has prevented detailed investigations of their structure and activity. Recently we developed a bacterial expression system that was sufficient for the production of PPO isoenzymes from dandelion (Taraxacum officinale). The system comprised the Escherichia coli Rosetta 2 (DE3) [pLysSRARE2] strain combined with the pET-22b(+)-vector cultivated in auto-induction medium at a constant low temperature (26 degrees C). Here we describe important parameters that enhance the production of active PPOs using dandelion PPO-2 for proof of concept. Low-temperature cultivation was essential for optimal yields, and the provision of CuCl2 in the growth medium was necessary to produce an active enzyme. By increasing the copper concentration in the production medium to 0.2 mM, the yield in terms of PPO activity per mol purified protein was improved 2.7-fold achieving a v(max) of 0.48 +/- 0.1 mu kat per mg purified PPO-2 for 4-methylcatechol used as a substrate. This is likely to reflect the replacement of an inactive apo-form of the enzyme with a correctly-folded, copper-containing counterpart. We demonstrated the transferability of the method by successfully expressing a PPO from tomato (Solanum lycopersicum) showing that our optimized system is suitable for the analysis of further plant PPOs. Our new system therefore provides greater opportunities for the future of research into this economically-important class of enzymes.	[Dirks-Hofmeister, Mareike E.; Kolkenbrock, Stephan; Moerschbacher, Bruno M.] Univ Munster, Dept Plant Biol & Biotechnol, D-48149 Munster, Germany	University of Munster	Dirks-Hofmeister, ME (corresponding author), Univ Munster, Dept Plant Biol & Biotechnol, D-48149 Munster, Germany.	m.dirks-hofmeister@uni-muenster.de	Moerschbacher, Bruno M/C-2012-2017	Dirks-Hofmeister, Mareike E./0000-0002-9634-6932				BACHEM CWB, 1994, BIO-TECHNOL, V12, P1101, DOI 10.1038/nbt1194-1101; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Claus H, 2006, SYST APPL MICROBIOL, V29, P3, DOI 10.1016/j.syapm.2005.07.012; Decker H, 2000, J EXP BIOL, V203, P1777; Decker H, 2007, GENE, V398, P183, DOI 10.1016/j.gene.2007.02.051; Dirks-Hofmeister ME, 2012, PLANT MOL BIOL, V80, P203, DOI 10.1007/s11103-012-9943-9; Espin JC, 1999, J AGR FOOD CHEM, V47, P3518, DOI 10.1021/jf981275p; Flurkey WH, 2008, J INORG BIOCHEM, V102, P2160, DOI 10.1016/j.jinorgbio.2008.08.007; Francis D, 2010, CURRENT PROTOCOLS PR, V61; Harrison MD, 2000, TRENDS BIOCHEM SCI, V25, P29, DOI 10.1016/S0968-0004(99)01492-9; Haruta M, 1998, BIOSCI BIOTECH BIOCH, V62, P358, DOI 10.1271/bbb.62.358; Klabunde T, 1998, NAT STRUCT BIOL, V5, P1084, DOI 10.1038/4193; Koussevitzky S, 2008, PHYSIOL PLANTARUM, V133, P266, DOI 10.1111/j.1399-3054.2008.01074.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu JW, 2010, J SCI FOOD AGR, V90, P2490, DOI 10.1002/jsfa.4111; MARTINEZ MV, 1995, TRENDS FOOD SCI TECH, V6, P195, DOI 10.1016/S0924-2244(00)89054-8; Marusek CM, 2006, J INORG BIOCHEM, V100, P108, DOI 10.1016/j.jinorgbio.2005.10.008; Mayer AM, 2006, PHYTOCHEMISTRY, V67, P2318, DOI 10.1016/j.phytochem.2006.08.006; MAYER AM, 1979, PHYTOCHEMISTRY, V18, P193, DOI 10.1016/0031-9422(79)80057-6; MOORE BM, 1990, J BIOL CHEM, V265, P4982; Rasband W., 2006, IMAGEJ; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Richter C, 2012, MOL PLANT MICROBE IN, V25, P200, DOI 10.1094/MPMI-04-11-0082; Shin CS, 1998, APPL MICROBIOL BIOT, V49, P364, DOI 10.1007/s002530051183; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sullivan ML, 2004, PLANT PHYSIOL, V136, P3234, DOI 10.1104/pp.104.047449; Telgmann L, 2011, METALLOMICS, V3, P1035, DOI 10.1039/c1mt00054c; Tran LT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-395; Virador VM, 2010, J AGR FOOD CHEM, V58, P1189, DOI 10.1021/jf902939q; Voulgaridou GP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056582; Wu YL, 2010, J BIOTECHNOL, V145, P66, DOI 10.1016/j.jbiotec.2009.10.008; Zhao PC, 2007, INSECT BIOCHEM MOLEC, V37, P952, DOI 10.1016/j.ibmb.2007.05.001	32	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77291	10.1371/journal.pone.0077291	http://dx.doi.org/10.1371/journal.pone.0077291			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204791	Green Published, gold, Green Submitted			2022-12-27	WOS:000326032600027
J	Kalashikam, RR; Battula, KK; Kirlampalli, V; Friedman, JM; Nappanveettil, G				Kalashikam, Rajender Rao; Battula, Kiran Kumar; Kirlampalli, Veerababu; Friedman, Jeffrey M.; Nappanveettil, Giridharan			Obese Locus in WNIN/Obese Rat Maps on Chromosome 5 Upstream of Leptin Receptor	PLOS ONE			English	Article							ANIMAL-MODELS; INDUCED HYPERCHOLESTEROLEMIA; PREVALENCE; DISEASE; TRENDS	WNIN/Obese (WNIN/Ob) rat a new mutant model of metabolic syndrome was identified in 1996 from an inbred Wistar rat strain, WNIN. So far several papers are published on this model highlighting its physical, biochemical and metabolic traits. WNIN/Ob is leptin resistant with unaltered leptin or its receptor coding sequences - the two well-known candidate genes for obesity. Genotyping analysis of F2 progeny (raised from WNIN/Ob x Fisher - 344) in the present study localized the mutation to a recombinant region of 14.15cM on chromosome 5. This was further corroborated by QTL analysis for body weight, which narrowed this region to 4.43 cM with flanking markers D5Rat256 & D5Wox37. Interval mapping of body weight QTL shows that the LOD score peak maps upstream of leptin receptor and shows an additive effect suggesting this as a novel mutation and signifying the model as a valuable resource for studies on obesity and metabolic syndrome.	[Kalashikam, Rajender Rao; Battula, Kiran Kumar; Kirlampalli, Veerababu; Nappanveettil, Giridharan] Natl Inst Nutr, NCLAS, Hyderabad 500007, Andhra Pradesh, India; [Friedman, Jeffrey M.] Rockefeller Univ, Howard Hughes Med Inst, Mol Genet Lab, New York, NY 10021 USA	Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN); Howard Hughes Medical Institute; Rockefeller University	Friedman, JM (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Mol Genet Lab, New York, NY 10021 USA.	Jeffrey.Friedman@rockefeller.edu; nappanveettil@yahoo.com			ICMR, INDIA; National Institutes of Health, USA [63/2/INDO-US/2005-RHN]	ICMR, INDIA(Indian Council of Medical Research (ICMR)); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by ICMR, INDIA and National Institutes of Health, USA (No.63/2/INDO-US/2005-RHN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Artinano AA, 2009, BRIT J NUTR, V102, P1246, DOI 10.1017/S0007114509990729; Amann K, 2013, SEMIN NEPHROL, V33, P23, DOI 10.1016/j.semnephrol.2012.12.003; [Anonymous], 2013, RAT GENOME DATABASE; Asahina M, 2005, J LIPID RES, V46, P2289, DOI 10.1194/jlr.M500257-JLR200; Bandaru P, 2011, VACCINE, V29, P3038, DOI 10.1016/j.vaccine.2011.01.107; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Casper RC, 2008, PSYCHOPHARMACOLOGY, V199, P313, DOI 10.1007/s00213-008-1102-2; Dixon JB, 2010, MOL CELL ENDOCRINOL, V316, P104, DOI 10.1016/j.mce.2009.07.008; DOHERTY G.H., 2011, CURR GERONTOL GERIAT, V2011; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; Giridharan N., 1996, Scandinavian Journal of Laboratory Animal Science, V23, P131; Giridharan NV, 1998, INDIAN J MED RES, V108, P225; Harishankar N, 2011, ENDOCRINOLOGIST, V2011; Harishankar N, 2011, INDIAN J MED RES, V134, P330; Herrera VLM, 2007, J HYPERTENS, V25, P1608, DOI 10.1097/HJH.0b013e328182df1a; Jayaraman KS, 2005, NAT MED, V11, P108, DOI 10.1038/nm0205-108a; Jayaraman KS, 1997, NAT MED, V3, P823, DOI 10.1038/nm0897-823a; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Leibel RL, 1997, J BIOL CHEM, V272, P31937, DOI 10.1074/jbc.272.51.31937; Lutz Thomas A, 2012, Curr Protoc Pharmacol, VChapter 5, DOI 10.1002/0471141755.ph0561s58; Margarido GRA, 2007, HEREDITAS, V144, P78, DOI 10.1111/j.2007.0018-0661.02000.x; Nobrega MA, 2009, PHYSIOL GENOMICS, V39, P38, DOI 10.1152/physiolgenomics.90389.2008; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Reddy GB, 2009, INVEST OPHTH VIS SCI, V50, P3456, DOI 10.1167/iovs.08-2498; Speakman J, 2007, OBES REV, V8, P55, DOI 10.1111/j.1467-789X.2007.00319.x; Speakman J, 2008, LAB ANIM-UK, V42, P413, DOI 10.1258/la.2007.006067; Strachan T, 1999, HUMAN MOL GENETICS; Tschop M, 2001, EXP CLIN ENDOCR DIAB, V109, P307, DOI 10.1055/s-2001-17297; Ueno T, 2004, PHYSIOL GENOMICS, V17, P38, DOI 10.1152/physiolgenomics.00043.2003	30	19	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77679	10.1371/journal.pone.0077679	http://dx.doi.org/10.1371/journal.pone.0077679			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204914	Green Published, gold, Green Submitted			2022-12-27	WOS:000326032600040
J	Schaumburg, F; Mugisha, L; Kappeller, P; Fichtel, C; Kock, R; Kondgen, S; Becker, K; Boesch, C; Peters, G; Leendertz, F				Schaumburg, Frieder; Mugisha, Lawrence; Kappeller, Peter; Fichtel, Claudia; Koeck, Robin; Koendgen, Sophie; Becker, Karsten; Boesch, Christophe; Peters, Georg; Leendertz, Fabian			Evaluation of Non-Invasive Biological Samples to Monitor Staphylococcus aureus Colonization in Great Apes and Lemurs	PLOS ONE			English	Article							METHICILLIN-RESISTANT; SANCTUARY APES; NASAL CARRIAGE; NATIONAL-PARK; AMPLIFICATION; CHIMPANZEES; POPULATION; PREVALENCE; GORILLAS; DISEASE	Introduction: Reintroduction of endangered animals as part of conservational programs bears the risk of importing human pathogens from the sanctuary to the natural habitat. One bacterial pathogen that serves as a model organism to analyze this transmission is Staphylococcus aureus as it can colonize and infect both humans and animals. The aim of this study was to evaluate the utility of various biological samples to monitor S. aureus colonization in great apes and lemurs. Methods: Mucosal swabs from wild lemurs (n=25, Kirindy, Madagascar), feces, oral and genital swabs from captive chimpanzees (n=58, Ngamba and Entebbe, Uganda) and fruit wadges and feces from wild chimpanzees (n=21, Ta National Parc, Cote d'Ivoire) were screened for S. aureus. Antimicrobial resistance and selected virulence factors were tested for each isolate. Sequence based genotyping (spa typing, multilocus sequence typing) was applied to assess the population structure of S. aureus. Results: Oro-pharyngeal carriage of S. aureus was high in lemurs (72%, n=18) and captive chimpanzees (69.2%, n=27 and 100%, n=6, respectively). Wild chimpanzees shed S. aureus through feces (43.8, n=7) and fruit wadges (54.5, n=12). Analysis of multiple sampling revealed that two samples are sufficient to detect those animals which shed S. aureus through feces or fruit wadges. Genotyping showed that captive animals are more frequently colonized with human-associated S. aureus lineages. Conclusion: Oro-pharyngeal swabs are useful to screen for S. aureus colonization in apes and lemurs before reintroduction. Duplicates of stool and fruit wadges reliably detect S. aureus shedding in wild chimpanzees. We propose to apply these sampling strategies in future reintroduction programs to screen for S. aureus colonization. They may also be useful to monitor S. aureus in wild populations.	[Schaumburg, Frieder; Becker, Karsten; Peters, Georg] Univ Hosp Munster, Inst Med Microbiol, Munster, Germany; [Mugisha, Lawrence] Makerere Univ, Coll Vet Med Anim Resources & Biosecur, Kampala, Uganda; [Mugisha, Lawrence] Conservat & Ecosyst Hlth Alliance, Kampala, Uganda; [Kappeller, Peter; Fichtel, Claudia] German Primate Ctr, Behav Ecol & Sociobiol Unit, Gottingen, Germany; [Koeck, Robin] Univ Hosp Munster, Inst Hyg, Munster, Germany; [Koendgen, Sophie; Leendertz, Fabian] Robert Koch Inst, Project Grp Epidemiol Highly Pathogen Microorgani, Berlin, Germany; [Boesch, Christophe] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany	University of Munster; Makerere University; Deutsches Primatenzentrum (DPZ); University of Munster; Robert Koch Institute; Max Planck Society	Schaumburg, F (corresponding author), Univ Hosp Munster, Inst Med Microbiol, Munster, Germany.	frieder.schaumburg@ukmuenster.de	Mugisha, Lawrence/N-4916-2017; Schaumburg, Frieder/E-4464-2016; Köck, Robin/AAC-1552-2019; Leendertz, Fabian Hubertus/H-8902-2019; Becker, Karsten/O-2302-2018	Mugisha, Lawrence/0000-0003-4932-3356; Becker, Karsten/0000-0002-6391-1341	'Deutsche Forschungsgemeinschaft' [PAK296, EI 247/8, LE 1813/4-1]	'Deutsche Forschungsgemeinschaft'(German Research Foundation (DFG))	This study was funded by the 'Deutsche Forschungsgemeinschaft' (Infection Biology and Epidemiology of Staphylococci and Staphylococcal Diseases in Central and South Africa, PAK296, EI 247/8 and LE 1813/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton DS, 2009, EUR J CLIN MICROBIOL, V28, P115, DOI 10.1007/s10096-008-0602-7; Becker K, 1998, J CLIN MICROBIOL, V36, P2548, DOI 10.1128/JCM.36.9.2548-2553.1998; BLAKESLEE JR, 1987, CANCER LETT, V37, P1, DOI 10.1016/0304-3835(87)90139-X; BRAKSTAD OG, 1992, J CLIN MICROBIOL, V30, P1654, DOI 10.1128/JCM.30.7.1654-1660.1992; Eckmanns T, 2004, J HOSP INFECT, V57, P93, DOI 10.1016/j.jhin.2004.01.021; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Faust LJ, 2011, INT J PRIMATOL, V32, P849, DOI 10.1007/s10764-011-9505-z; Gillespie TR, 2008, YEARB PHYS ANTHROPOL, V51, P53, DOI 10.1002/ajpa.20949; Kondgen S, 2010, ECOHEALTH, V7, P332, DOI 10.1007/s10393-010-0340-z; Kumar S, 2012, J MED PRIMATOL, V41, P266, DOI 10.1111/j.1600-0684.2012.00547.x; Leendertz FH, 2006, BIOL CONSERV, V131, P325, DOI 10.1016/j.biocon.2006.05.002; Leendertz FH, 2004, J GEN VIROL, V85, P3305, DOI 10.1099/vir.0.80052-0; Lilenbaum W, 2006, AM J PRIMATOL, V68, P825, DOI 10.1002/ajp.20282; Mellmann A, 2006, PLOS MED, V3, P348, DOI 10.1371/journal.pmed.0030033; Nagel M, 2012, CLIN MICROBIOL INFEC; Ruimy R, 2008, J BACTERIOL, V190, P3962, DOI 10.1128/JB.01947-07; Rwego IB, 2008, CONSERV BIOL, V22, P1600, DOI 10.1111/j.1523-1739.2008.01018.x; Schaumburg F, 2012, ENV MICROBIOL REP, V4, P141, DOI 10.1111/j.1758-2229.2011.00316.x; Schaumburg F, 2011, CLIN MICROBIOL INFEC, V17, P1507, DOI 10.1111/j.1469-0691.2011.03534.x; Schaumburg F, 2012, AM J PRIMATOL, V74, P1071, DOI 10.1002/ajp.22067; Unwin S, 2012, AM J PRIMATOL, V74, P1076, DOI 10.1002/ajp.22069; van den Berg S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026170; von Eiff C, 2004, DIAGN MICR INFEC DIS, V49, P157, DOI 10.1016/j.diagmicrobio.2004.03.009; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4	24	29	29	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78046	10.1371/journal.pone.0078046	http://dx.doi.org/10.1371/journal.pone.0078046			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205084	gold, Green Published, Green Submitted			2022-12-27	WOS:000326032600064
J	Fish, EW; Krouse, MC; Stringfield, SJ; DiBerto, JF; Robinson, JE; Malanga, CJ				Fish, Eric W.; Krouse, Michael C.; Stringfield, Sierra J.; DiBerto, Jeffrey F.; Robinson, J. Elliott; Malanga, C. J.			Changes in Sensitivity of Reward and Motor Behavior to Dopaminergic, Glutamatergic, and Cholinergic Drugs in a Mouse Model of Fragile X Syndrome	PLOS ONE			English	Article							MENTAL-RETARDATION PROTEIN; LONG-TERM DEPRESSION; VENTRAL TEGMENTAL AREA; FMR1 KNOCKOUT MOUSE; SYNAPTIC-TRANSMISSION; STEREOLOGICAL METHODS; RECEPTOR BLOCKADE; DENDRITIC SPINES; BRAIN DOPAMINE; MICE	Fragile X syndrome (FXS) is a leading cause of intellectual disability. FXS is caused by loss of function of the FMR1 gene, and mice in which Fmr1 has been inactivated have been used extensively as a preclinical model for FXS. We investigated the behavioral pharmacology of drugs acting through dopaminergic, glutamatergic, and cholinergic systems in fragile X (Fmr1(-/Y)) mice with intracranial self-stimulation (ICSS) and locomotor activity measurements. We also measured brain expression of tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine biosynthesis. Fmr1(-/Y) mice were more sensitive than wild type mice to the rewarding effects of cocaine, but less sensitive to its locomotor stimulating effects. Anhedonic but not motor depressant effects of the atypical neuroleptic, aripiprazole, were reduced in Fmr1(-/Y) mice. The mGluR5-selective antagonist, 6-methyl-2-(phenylethynyl) pyridine (MPEP), was more rewarding and the preferential M1 antagonist, trihexyphenidyl, was less rewarding in Fmr1(-/Y) than wild type mice. Motor stimulation by MPEP was unchanged, but stimulation by trihexyphenidyl was markedly increased, in Fmr1(-/Y) mice. Numbers of midbrain TH+ neurons in the ventral tegmental area were unchanged, but were lower in the substantia nigra of Fmr1(-/Y) mice, although no changes in TH levels were found in their forebrain targets. The data are discussed in the context of known changes in the synaptic physiology and pharmacology of limbic motor systems in the Fmr1(-/Y) mouse model. Preclinical findings suggest that drugs acting through multiple neurotransmitter systems may be necessary to fully address abnormal behaviors in individuals with FXS.	[Fish, Eric W.; Krouse, Michael C.; DiBerto, Jeffrey F.; Robinson, J. Elliott; Malanga, C. J.] Univ N Carolina, Dept Neurol, Chapel Hill, NC 27515 USA; [Stringfield, Sierra J.; Robinson, J. Elliott; Malanga, C. J.] Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC USA; [Malanga, C. J.] Univ N Carolina, Carolina Inst Dev Disabil, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Malanga, CJ (corresponding author), Univ N Carolina, Dept Neurol, Chapel Hill, NC 27515 USA.	malangacj@neurology.unc.edu	Cabrera, Mariel/GMX-2706-2022	Robinson, J. Elliott/0000-0001-9417-3938; Malanga, C.J./0000-0003-4808-3995; Stringfield, Sierra/0000-0003-4840-0866	Basic and Clinical Research Award from Autism Speaks [2670]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F30AA021312] Funding Source: NIH RePORTER	Basic and Clinical Research Award from Autism Speaks; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by a Basic and Clinical Research Award (#2670) from Autism Speaks (www.autismspeaks.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baquet ZC, 2009, NEUROSCIENCE, V161, P1082, DOI 10.1016/j.neuroscience.2009.04.031; Bear MF, 2005, GENES BRAIN BEHAV, V4, P393, DOI 10.1111/j.1601-183X.2005.00135.x; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bellone C, 2005, EUR J NEUROSCI, V21, P1280, DOI 10.1111/j.1460-9568.2005.03979.x; Berry-Kravis E, 2011, J NEURODEV DISORD, V3, P193, DOI 10.1007/s11689-011-9074-7; Cheer JF, 2005, P NATL ACAD SCI USA, V102, P19150, DOI 10.1073/pnas.0509607102; Chen L, 2001, NEUROSCIENCE, V103, P1043, DOI 10.1016/S0306-4522(01)00036-7; Chen M, 2011, J NEUROSCI, V31, P9563, DOI 10.1523/JNEUROSCI.1701-11.2011; Cornish K, 2004, MENT RETARD DEV D R, V10, P11, DOI 10.1002/mrdd.20003; Cruz-Martin A, 2010, J NEUROSCI, V30, P7793, DOI 10.1523/JNEUROSCI.0577-10.2010; de Vrij FMS, 2008, NEUROBIOL DIS, V31, P127, DOI 10.1016/j.nbd.2008.04.002; Dobkin C, 2000, NEUROSCIENCE, V100, P423, DOI 10.1016/S0306-4522(00)00292-X; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Ebihara K, 2013, NEUROSCIENCE, V236, P332, DOI 10.1016/j.neuroscience.2013.01.012; Eliez S, 2001, BRAIN, V124, P1610, DOI 10.1093/brain/124.8.1610; English DF, 2012, NAT NEUROSCI, V15, P123, DOI 10.1038/nn.2984; Erickson CA, 2011, PSYCHOPHARMACOLOGY, V216, P85, DOI 10.1007/s00213-011-2194-7; FENG Y, 1995, SCIENCE, V268, P731, DOI 10.1126/science.7732383; Fisch GS, 1999, AM J MED GENET, V84, P277, DOI 10.1002/(SICI)1096-8628(19990528)84:3<277::AID-AJMG22>3.0.CO;2-W; Fish E, 2010, TCE-THE CHEM ENG, P2; Fulks JL, 2010, ACS CHEM NEUROSCI, V1, P679, DOI 10.1021/cn100032f; Gallagher A, 2012, J NEUROL, V259, P401, DOI 10.1007/s00415-011-6161-3; Garber K, 2006, CURR OPIN GENET DEV, V16, P270, DOI 10.1016/j.gde.2006.04.010; Gothelf D, 2008, ANN NEUROL, V63, P40, DOI 10.1002/ana.21243; Grillner P, 2000, NEUROSCIENCE, V96, P299, DOI 10.1016/S0306-4522(99)00579-5; Gruss M, 2004, NEUROCHEM INT, V45, P81, DOI 10.1016/j.neuint.2003.12.001; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hagerman RJ, 2009, PEDIATRICS, V123, P378, DOI 10.1542/peds.2008-0317; Hasbi A, 2009, P NATL ACAD SCI USA, V106, P21377, DOI 10.1073/pnas.0903676106; He CX, 2013, NEUROSCIENCE, V251, P120, DOI 10.1016/j.neuroscience.2012.03.049; Hoeft F, 2007, HUM BRAIN MAPP, V28, P543, DOI 10.1002/hbm.20406; Hoeft F, 2010, P NATL ACAD SCI USA, V107, P9335, DOI 10.1073/pnas.1002762107; Huang CC, 2011, J NEUROSCI, V31, P4194, DOI 10.1523/JNEUROSCI.5239-10.2011; Ivanco TL, 2002, HIPPOCAMPUS, V12, P47, DOI 10.1002/hipo.10004; Jung KM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2045; Kenny PJ, 2005, PSYCHOPHARMACOLOGY, V179, P247, DOI 10.1007/s00213-004-2069-2; Koos T, 2002, J NEUROSCI, V22, P529, DOI 10.1523/JNEUROSCI.22-02-00529.2002; Krueger DD, 2011, P NATL ACAD SCI USA, V108, P2587, DOI 10.1073/pnas.1013855108; LOVAAS OI, 1989, J BEHAV THER EXP PSY, V20, P17; Maccarrone M, 2010, NEUROPSYCHOPHARMACOL, V35, P1500, DOI 10.1038/npp.2010.19; MAES B, 1994, AM J MED GENET, V50, P190, DOI 10.1002/ajmg.1320500211; Mavrikaki M, 2010, INT J NEUROPSYCHOPH, V13, P541, DOI 10.1017/S1461145709991143; McNaughton CH, 2008, BEHAV NEUROSCI, V122, P293, DOI 10.1037/0735-7044.122.2.293; Menon V, 2004, P NATL ACAD SCI USA, V101, P3615, DOI 10.1073/pnas.0304544101; MILIARESSIS E, 1986, PHYSIOL BEHAV, V37, P85, DOI 10.1016/0031-9384(86)90388-4; Mineur YS, 2006, BEHAV BRAIN RES, V168, P172, DOI 10.1016/j.bbr.2005.11.004; Mineur YS, 2002, HIPPOCAMPUS, V12, P39, DOI 10.1002/hipo.10005; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; Moy SS, 2009, GENES BRAIN BEHAV, V8, P129, DOI 10.1111/j.1601-183X.2008.00452.x; Nakamoto M, 2007, P NATL ACAD SCI USA, V104, P15537, DOI 10.1073/pnas.0707484104; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Nimitvilai S, 2013, J PHARMACOL EXP THER, V344, P253, DOI 10.1124/jpet.112.199844; Paradee W, 1999, NEUROSCIENCE, V94, P185, DOI 10.1016/S0306-4522(99)00285-7; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pfeiffer BE, 2007, J NEUROSCI, V27, P3120, DOI 10.1523/JNEUROSCI.0054-07.2007; POP AS, 2012, PSYCHOPHARMACOLOGY B, P54376; REISS AL, 1992, AM J MED GENET, V43, P35, DOI 10.1002/ajmg.1320430106; Riday TT, 2012, J CLIN INVEST, V122, P4544, DOI 10.1172/JCI61888; Robinson JE, 2012, BEHAV BRAIN RES, V234, P76, DOI 10.1016/j.bbr.2012.06.012; Rogers SJ, 2001, J DEV BEHAV PEDIATR, V22, P409, DOI 10.1097/00004703-200112000-00008; Schotanus SM, 2008, NEUROPHARMACOLOGY, V54, P837, DOI 10.1016/j.neuropharm.2007.12.012; Sciamanna G, 2012, J NEUROSCI, V32, P11991, DOI 10.1523/JNEUROSCI.0041-12.2012; Smith WB, 2005, NEURON, V45, P765, DOI 10.1016/j.neuron.2005.01.015; Spencer CM, 2005, GENES BRAIN BEHAV, V4, P420, DOI 10.1111/j.1601-183X.2005.00123.x; Taha SA, 2006, J NEUROSCI, V26, P217, DOI 10.1523/JNEUROSCI.3227-05.2006; Tanda G, 2007, J PHARMACOL EXP THER, V321, P334, DOI 10.1124/jpet.106.118067; Thomas AM, 2012, PSYCHOPHARMACOLOGY, V219, P47, DOI 10.1007/s00213-011-2375-4; Threlfell S, 2010, J NEUROSCI, V30, P3398, DOI 10.1523/JNEUROSCI.5620-09.2010; Turner G, 1996, AM J MED GENET, V64, P196, DOI 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G; Van Dam D, 2000, BEHAV BRAIN RES, V117, P127, DOI 10.1016/S0166-4328(00)00296-5; Vanderklish PW, 2005, GENES BRAIN BEHAV, V4, P360, DOI 10.1111/j.1601-183X.2005.00134.x; Veeraragavan S, 2011, BEHAV NEUROSCI, V125, P783, DOI 10.1037/a0025202; Veeraragavan S, 2011, PSYCHOPHARMACOLOGY, V217, P143, DOI 10.1007/s00213-011-2276-6; Ventura R, 2004, BEHAV PHARMACOL, V15, P433, DOI 10.1097/00008877-200409000-00018; Volk LJ, 2007, J NEUROSCI, V27, P11624, DOI 10.1523/JNEUROSCI.2266-07.2007; Wan YH, 2011, J NEUROSCI, V31, P16685, DOI 10.1523/JNEUROSCI.2533-11.2011; Wang H, 2008, NEURON, V59, P634, DOI 10.1016/j.neuron.2008.06.027; Wang HS, 2010, J BIOL CHEM, V285, P21888, DOI 10.1074/jbc.M110.116293; Wassink TH, 2001, PSYCHIAT GENET, V11, P57, DOI 10.1097/00041444-200106000-00001; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; Yan QJ, 2005, NEUROPHARMACOLOGY, V49, P1053, DOI 10.1016/j.neuropharm.2005.06.004	82	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77896	10.1371/journal.pone.0077896	http://dx.doi.org/10.1371/journal.pone.0077896			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205018	Green Published, Green Submitted, gold			2022-12-27	WOS:000326029300124
J	Onyango, LA; Dunstan, RH; Roberts, TK; Macdonald, MM; Gottfries, J				Onyango, Laura A.; Dunstan, R. Hugh; Roberts, Timothy K.; Macdonald, Margaret M.; Gottfries, Johan			Phenotypic Variants of Staphylococci and Their Underlying Population Distributions Following Exposure to Stress	PLOS ONE			English	Article							SMALL-COLONY VARIANTS; VANCOMYCIN RESISTANCE; ANTIBIOTIC-RESISTANCE; CELL-SIZE; AUREUS; INFECTIONS; EPIDERMIDIS; BACTERIA; MODEL; WALL	This study investigated whether alterations in environmental conditions would induce the formation of small colony variant phenotypes (SCV) with associated changes in cell morphology and ultra-structure in S. aureus, s. epidermidis, and S. lugdunensis. Wild-type clinical isolates were exposed to low temperature (4 degrees C), antibiotic stress (penicillin G and vancomycin; 0-10,000 mu g mL(-1)), pH stress (pH 3-9) and osmotic challenge (NaCl concentrations of 0-20%). Changes in cell diameter, cell-wall thickness, and population distribution changes (n >= 300) were assessed via scanning and transmission electron microscopy (SEM and TEM), and compared to control populations. Our analyses found that prolonged exposure to all treatments resulted in the subsequent formation of SCV phenotypes. Observed SCVs manifested as minute colonies with reduced haemolysis and pigmentation (NaCl, pH and 4 degrees C treatments), or complete lack thereof (antibiotic treatments). SEM comparison analyses revealed significantly smaller cell sizes for SCV populations except in S. aureus and S. epidermidis 10% NaCl, and S. epidermidis 4 degrees C (p<0.05). Shifts in population distribution patterns were also observed with distinct sub-populations of smaller cells appearing for S. epidermidis, and S. lugdunensis. TEM analyses revealed significantly thicker cell-walls in all treatments and species except S. lugdunensis exposed to 4 degrees C. These findings suggest that staphylococci adapted to environmental stresses by altering their cell size and wall thickness which could represent the formation of altered phenotypes which facilitate survival under harsh conditions. The phenotypic response was governed by the type of prevailing environmental stress regime leading to appropriate alterations in ultra-structure and size, suggesting downstream changes in gene expression, the proteome, and metabolome.	[Onyango, Laura A.; Dunstan, R. Hugh; Roberts, Timothy K.; Macdonald, Margaret M.] Univ Newcastle, Environm & Pathogen Microbiol Lab, Sch Environm & Life Sci, Newcastle, NSW 2300, Australia; [Gottfries, Johan] Gothenburg Univ, Dept Chem, Gothenburg, Sweden	University of Newcastle; University of Gothenburg	Onyango, LA (corresponding author), Univ Newcastle, Environm & Pathogen Microbiol Lab, Sch Environm & Life Sci, Newcastle, NSW 2300, Australia.	lauraonyango@yahoo.ca	Onyango, Laura A./H-4675-2019; Gottfries, Johan/M-3445-2016; Roberts, Tim K/A-4286-2009	Gottfries, Johan/0000-0001-7135-4664; Onyango, Laura/0000-0002-5240-2023	University of Newcastle International Scholarship; Gideon Lang Scholarship; Harold Stannet Williams and Judith Mason Research Foundation	University of Newcastle International Scholarship; Gideon Lang Scholarship; Harold Stannet Williams and Judith Mason Research Foundation	This work was partially supported via a University of Newcastle International Scholarship and Gideon Lang Scholarship, and additional funding from the Harold Stannet Williams and Judith Mason Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almquist E, 1922, J INFECT DIS, V31, P483, DOI 10.1093/infdis/31.5.483; Baatout S, 2007, ACTA ASTRONAUT, V60, P451, DOI 10.1016/j.actaastro.2006.09.012; BADDOUR LM, 1987, REV INFECT DIS, V9, P1168; BADDOUR LM, 1988, J INFECT DIS, V157, P757, DOI 10.1093/infdis/157.4.757; Bergamini TM, 1996, J SURG RES, V60, P3, DOI 10.1006/jsre.1996.0002; Brown GK, 2001, AUST VET J, V79, P554, DOI 10.1111/j.1751-0813.2001.tb10747.x; Butt HL, 1998, J MED MICROBIOL, V47, P577, DOI 10.1099/00222615-47-7-577; Cui L, 2003, J CLIN MICROBIOL, V41, P5, DOI 10.1128/JCM.41.1.5-14.2003; Cui LZ, 2000, ANTIMICROB AGENTS CH, V44, P2276, DOI 10.1128/AAC.44.9.2276-2285.2000; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; Fabian FW, 1933, J BACTERIOL, V26, P543, DOI 10.1128/JB.26.6.543-558.1933; FAX CA, 2003, EXPERT REV ANTI-INFE, V4, P667; GOUDIE JG, 1955, J CLIN PATHOL, V8, P284, DOI 10.1136/jcp.8.4.284; HADLEY P, 1926, J INFECT DIS, V40, P4465; HALE JH, 1951, BRIT J EXP PATHOL, V32, P307; Hoffstadt RE, 1932, J INFECT DIS, V51, P216, DOI 10.1093/infdis/51.2.216; HOGT AH, 1983, FEMS MICROBIOL LETT, V18, P211; Kahl BC, 2003, J CLIN MICROBIOL, V41, P410, DOI 10.1128/JCM.41.1.410-413.2003; Kipp F, 2004, J CLIN MICROBIOL, V42, P1277, DOI 10.1128/JCM.42.3.1277-1279.2004; Leung MJ, 1998, J CLIN MICROBIOL, V36, P3096, DOI 10.1128/JCM.36.10.3096-3098.1998; Massey RC, 2001, CURR BIOL, V11, P1810, DOI 10.1016/S0960-9822(01)00507-3; Morita RY, 1997, BACTERIA OLIGOTROPHI, P193; Neut D, 2007, ACTA ORTHOP, V78, P299, DOI 10.1080/17453670710013843; Onyango LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029031; Onyango Laura A, 2010, BMC Res Notes, V3, P152, DOI 10.1186/1756-0500-3-152; Onyango Laura A., 2008, Journal of Nutritional & Environmental Medicine (Abingdon), V17, P56, DOI 10.1080/13590840801887272; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Prescott L. M., 2002, MICROBIOLOGY, P5; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Proctor RA, 1998, CLIN INFECT DIS, V27, P419, DOI 10.1086/514706; Schaaff F, 2003, INT J MED MICROBIOL, V293, P427, DOI 10.1078/1438-4221-00282; Seaman PF, 2007, J ANTIMICROB CHEMOTH, V59, P43, DOI 10.1093/jac/dkl450; Seifert H, 2005, EMERG INFECT DIS, V11, P1283, DOI 10.3201/eid1108.041177; Sifri CD, 2006, INFECT IMMUN, V74, P1091, DOI 10.1128/IAI.74.2.1091-1096.2006; Vesga O, 1996, J INFECT DIS, V173, P739, DOI 10.1093/infdis/173.3.739; VIJARANAKUL U, 1995, J BACTERIOL, V177, P5116, DOI 10.1128/jb.177.17.5116-5121.1995; von Eiff C, 2006, INJURY, V37, P26, DOI 10.1016/j.injury.2006.04.006; von Eiff Christof, 2003, P253; vonEiff C, 1997, CLIN INFECT DIS, V25, P1250, DOI 10.1086/516962; Weart RB, 2007, CELL, V130, P335, DOI 10.1016/j.cell.2007.05.043; WISE RI, 1956, ANN NY ACAD SCI, V65, P169, DOI 10.1111/j.1749-6632.1956.tb36636.x; WISE RI, 1954, J CLIN INVEST, V33, P1611, DOI 10.1172/JCI103041	42	45	45	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77614	10.1371/journal.pone.0077614	http://dx.doi.org/10.1371/journal.pone.0077614			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204894	gold, Green Published			2022-12-27	WOS:000326029300106
J	Ye, ZK; Tang, HL; Zhai, SD				Ye, Zhi-Kang; Tang, Hui-Lin; Zhai, Suo-Di			Benefits of Therapeutic Drug Monitoring of Vancomycin: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							RESISTANT STAPHYLOCOCCUS-AUREUS; INTENSIVE-CARE-UNIT; SERUM CONCENTRATIONS; PEDIATRIC-PATIENTS; COST-EFFECTIVENESS; PHARMACOKINETICS; INFECTIONS; EFFICACY; HEMODIALYSIS; BACTEREMIA	Background and Objective: The necessity of therapeutic drug monitoring (TDM) for vancomycin is controversial. The objective of the current review was to evaluate the available evidence for the necessity of TDM in patients given vancomycin to treat Gram-positive infections. Methods: Medline, Embase, Web of Sciences, the Cochrane Library and two Chinese literature databases (CNKI, CBM) were searched. Randomized controlled studies and observational studies that compared the clinical outcomes of TDM groups vs. non-TDM groups were included. Two reviewers independently extracted the data. The primary outcome was clinical efficacy of therapy. Secondary outcomes included vancomycin associated nephrotoxicity, duration of vancomycin therapy, length of hospital stay, and mortality. Meta-analysis was performed using the Mantel-Haenszel fixed effect method (FEM). Odds ratios (ORs) or weighted mean differences (WMD) with 95% confidence intervals (95%CIs) were calculated for categorical and continuous outcomes, respectively. Results: One randomized controlled trial (RCT) and five cohort studies were included in the meta-analysis. Compared with non-TDM groups, TDM groups had significantly higher rates of clinical efficacy (OR = 2.62, 95%CI 1.34-5.11 P = 0.005) and decreased rates of nephrotoxicity (OR = 0.25, 95%CI 0.13-0.48 P<0.0001). Subgroup analyses showed that TDM group had significantly higher rates of clinical efficacy in both cohort studies subgroup (OR = 3.04, 95%CI 1.34-6.90) and in Asian population subgroup (OR = 3.04, 95% CI 1.34-6.90). TDM group had significantly decreased rates of nephrotoxicity in all subgroup. There was no significant difference in duration of vancomycin therapy (WMD = -0.40, 95% CI -2.83-2.02 P = 0.74) or length of stay (WMD = -1.01, 95% CI -7.51-5.49 P = 0.76) between TDM and non-TDM groups. Subgroup analyses showed there were no differences in duration of vancomycin therapy. Only one study reported mortality rates. Conclusions: Studies to date show that TDM significantly increases the rate of clinical efficacy and decreases the rate of nephrotoxicity in patients treated with vancomycin.	[Ye, Zhi-Kang; Tang, Hui-Lin; Zhai, Suo-Di] Peking Univ, Hosp 3, Dept Pharm, Beijing 100871, Peoples R China; [Ye, Zhi-Kang] Peking Univ, Hlth Sci Ctr, Sch Pharmaceut Sci, Dept Pharm Adm & Clin Pharm, Beijing 100871, Peoples R China	Peking University; Peking University	Zhai, SD (corresponding author), Peking Univ, Hosp 3, Dept Pharm, Beijing 100871, Peoples R China.	zhaisuodi@163.com	Tang, Huilin/M-1668-2017	Tang, Huilin/0000-0002-5814-6657				Al-Kofide Hadeel, 2010, J Oncol Pharm Pract, V16, P245, DOI 10.1177/1078155209355847; [Anonymous], JPN J CHEMOTHER; Badran EF, 2011, INT J CLIN PHARM TH, V49, P252, DOI 10.5414/CP201456; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; CANTU TG, 1994, CLIN INFECT DIS, V18, P533; Cataldo MA, 2012, J ANTIMICROB CHEMOTH, V67, P17, DOI 10.1093/jac/dkr442; Commandeur D, 2011, MED MALADIES INFECT, V41, P410, DOI 10.1016/j.medmal.2011.01.012; Darko W, 2003, PHARMACOTHERAPY, V23, P643, DOI 10.1592/phco.23.5.643.32199; De Cock P, 2010, BASIC CLIN PHARM, V107, P250; deGatta MDF, 1996, CLIN PHARMACOL THER, V60, P332, DOI 10.1016/S0009-9236(96)90060-0; Dolton M, 2010, BURNS, V36, P469, DOI 10.1016/j.burns.2009.08.010; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eiland LS, 2011, ANN PHARMACOTHER, V45, P582, DOI 10.1345/aph.1P588; Golestaneh L, 2009, CLIN NEPHROL, V72, P286; Hidayat LK, 2006, ARCH INTERN MED, V166, P2138, DOI 10.1001/archinte.166.19.2138; Hochart C, 2011, MED MALADIES INFECT, V41, P652, DOI 10.1016/j.medmal.2011.09.014; Howden BP, 2004, CLIN INFECT DIS, V38, P521, DOI 10.1086/381202; Huang YZ, 2011, CHIN J INFEC CHEMOTH, V11, P295; Iwamoto T, 2003, BIOL PHARM BULL, V26, P876; Jeffres MN, 2006, CHEST, V130, P947, DOI 10.1378/chest.130.4.947; Karachalios GN, 1998, EPITHEORESE KLIN FAR, V16, P110; Khotaei Ghamar Taj, 2010, Acta Med Iran, V48, P91; LAU A H, 1988, Child Nephrology and Urology, V9, P232; Levine DP, 2006, CLIN INFECT DIS, V42, pS5, DOI 10.1086/491709; Li J, 2012, INT J ANTIMICROB AG, V39, P69, DOI 10.1016/j.ijantimicag.2011.08.017; Lodise TP, 2008, ANTIMICROB AGENTS CH, V52, P3315, DOI 10.1128/AAC.00113-08; Long C, 2011, EUR J PHARM SCI, V44, P195; Marengo LL, 2010, BRAZ J INFECT DIS, V14, P203, DOI 10.1590/S1413-86702010000200019; Mariani-Kurkdjian P, 2008, ARCH PEDIATRIE, V15, P1625, DOI 10.1016/j.arcped.2008.08.016; Matsumoto K, 2013, J INFECT CHEMOTHER; Miles MV, 1997, THER DRUG MONIT, V19, P265, DOI 10.1097/00007691-199706000-00004; MOCHIZUKI T, 2010, JPN J CHEMOTHER, V58, P233; Moellering RC, 2006, CLIN INFECT DIS, V42, pS3, DOI 10.1086/491708; MOELLERING RC, 1994, CLIN INFECT DIS, V18, P544, DOI 10.1093/clinids/18.4.544; Pea F, 2000, J ANTIMICROB CHEMOTH, V45, P329, DOI 10.1093/jac/45.3.329; Pea F, 2000, CLIN DRUG INVEST, V19, P213, DOI 10.2165/00044011-200019030-00006; PRYKA RD, 1994, ANN PHARMACOTHER, V28, P1397, DOI 10.1177/106002809402801212; Reis A G, 1996, J Pediatr (Rio J), V72, P225; Rybak Michael, 2009, Am J Health Syst Pharm, V66, P82, DOI 10.2146/ajhp080434; Rybak MJ, 2006, CLIN INFECT DIS, V42, pS35, DOI 10.1086/491712; Sakoulas G, 2004, J CLIN MICROBIOL, V42, P2398, DOI 10.1128/JCM.42.6.2398-2402.2004; van de Vijsel Lyndsay M, 2010, Can J Hosp Pharm, V63, P196; Vazquez M, 2008, INT J CLIN PHARM TH, V46, P140; Wells G., 2005, NEWCASTLE OTTAWA SCA; WELTY TE, 1994, ANN PHARMACOTHER, V28, P1335, DOI 10.1177/106002809402801201; [张弨 ZHANG Chao], 2009, [中国临床药理学杂志, The Chinese Journal of Clinical Pharmacology], V25, P329	46	103	115	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77169	10.1371/journal.pone.0077169	http://dx.doi.org/10.1371/journal.pone.0077169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204764	gold, Green Published, Green Submitted			2022-12-27	WOS:000326029300086
J	Saura, M; Fernandez, A; Rodriguez, MC; Toro, MA; Barragan, C; Fernandez, AI; Villanueva, B				Saura, Maria; Fernandez, Almudena; Carmen Rodriguez, M.; Toro, Miguel A.; Barragan, Carmen; Fernandez, Ana I.; Villanueva, Beatriz			Genome-Wide Estimates of Coancestry and Inbreeding in a Closed Herd of Ancient Iberian Pigs	PLOS ONE			English	Article							GENETIC DIVERSITY; INFORMATION; DEPRESSION; PEDIGREE; GROWTH	Maintaining genetic variation and controlling the increase in inbreeding are crucial requirements in animal conservation programs. The most widely accepted strategy for achieving these objectives is to maximize the effective population size by minimizing the global coancestry obtained from a particular pedigree. However, for most natural or captive populations genealogical information is absent. In this situation, microsatellites have been traditionally the markers of choice to characterize genetic variation, and several estimators of genealogical coefficients have been developed using marker data, with unsatisfactory results. The development of high-throughput genotyping techniques states the necessity of reviewing the paradigm that genealogical coancestry is the best parameter for measuring genetic diversity. In this study, the Illumina PorcineSNP60 BeadChip was used to obtain genome-wide estimates of rates of coancestry and inbreeding and effective population size for an ancient strain of Iberian pigs that is now in serious danger of extinction and for which very accurate genealogical information is available (the Guadyerbas strain). Genome-wide estimates were compared with those obtained from microsatellite and from pedigree data. Estimates of coancestry and inbreeding computed from the SNP chip were strongly correlated with genealogical estimates and these correlations were substantially higher than those between microsatellite and genealogical coefficients. Also, molecular coancestry computed from SNP information was a better predictor of genealogical coancestry than coancestry computed from microsatellites. Rates of change in coancestry and inbreeding and effective population size estimated from molecular data were very similar to those estimated from genealogical data. However, estimates of effective population size obtained from changes in coancestry or inbreeding differed. Our results indicate that genome-wide information represents a useful alternative to genealogical information for measuring and maintaining genetic diversity.	[Saura, Maria; Fernandez, Almudena; Carmen Rodriguez, M.; Barragan, Carmen; Fernandez, Ana I.; Villanueva, Beatriz] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Mejora Genet Anim, Madrid, Spain; [Toro, Miguel A.] Escuela Tecn Super Ingn Agron, Dept Anim Prod, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Saura, M (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Mejora Genet Anim, Madrid, Spain.	saura.maria@inia.es	Toro, Miguel Angel Angel/H-9370-2015; Saura, María/Q-1592-2018; Fernández, Ana Isabel/J-3265-2012; Toro, Miguel Angel/AAA-1309-2019; Alvarez, Saura/M-5098-2015; Muñoz, Almudena Fernández/AAB-4608-2019	Toro, Miguel Angel Angel/0000-0001-7460-2483; Fernández, Ana Isabel/0000-0002-1509-5191; Toro, Miguel Angel/0000-0001-7460-2483; Muñoz, Almudena Fernández/0000-0002-4495-9366; Saura, Maria/0000-0002-2744-2840	INIA [RZ2010-00009-00-00]; Juan de la Cierva fellowship from the Ministerio de Economia y Competitividad from Spain [JCI-2011-10896]	INIA(Instituto de Investigacion Agropecuaria (INIA)); Juan de la Cierva fellowship from the Ministerio de Economia y Competitividad from Spain	This work was supported by an INIA project (RZ2010-00009-00-00). MS was supported by a Juan de la Cierva fellowship (JCI-2011-10896) from the Ministerio de Economia y Competitividad from Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2010, NAT REV GENET, V11, P697, DOI 10.1038/nrg2844; CABALLERO A, 1994, HEREDITY, V73, P657, DOI 10.1038/hdy.1994.174; Caballero A, 2002, CONSERV GENET, V3, P289, DOI 10.1023/A:1019956205473; COCKERHAM CC, 1969, EVOLUTION, V23, P72, DOI 10.1111/j.1558-5646.1969.tb03496.x; de Cara MAR, 2011, J ANIM BREED GENET, V128, P456, DOI 10.1111/j.1439-0388.2011.00971.x; DOBAO MT, 1983, LIVEST PROD SCI, V10, P601, DOI 10.1016/0301-6226(83)90052-0; Engelsma KA, 2012, J ANIM BREED GENET, V129, P195, DOI 10.1111/j.1439-0388.2012.00987.x; Esteve-Codina A, 2011, HEREDITY, V107, P256, DOI 10.1038/hdy.2011.13; Fabuel E, 2004, HEREDITY, V93, P104, DOI 10.1038/sj.hdy.6800488; Fernandez A, 2002, J ANIM SCI, V80, P2267; Fernandez AI, 2012, 4 INT C QUANT GEN JU; Fernandez J, 2005, GENETICS, V170, P1313, DOI 10.1534/genetics.104.037325; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Hinrichs D, 2007, HEREDITY, V99, P81, DOI 10.1038/sj.hdy.6800968; Lenstra JA, 2012, ANIM GENET, V43, P483, DOI 10.1111/j.1365-2052.2011.02309.x; Li MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026256; Lopez-Bote CJ, 1998, MEAT SCI, V49, pS17, DOI 10.1016/S0309-1740(98)00072-2; Malecot G, 1948, MATH IHEREDITE; MEUWISSEN THE, 1992, GENET SEL EVOL, V24, P305, DOI 10.1051/gse:19920402; Ouborg NJ, 2010, TRENDS GENET, V26, P177, DOI 10.1016/j.tig.2010.01.001; Pemberton J, 2004, TRENDS ECOL EVOL, V19, P613, DOI 10.1016/j.tree.2004.09.010; Ramayo-Caldas Y, 2012, J ANIM SCI, V90, P2883, DOI 10.2527/jas.2011-4900; Rodriguez C, 2005, ANIM GENET, V36, P490, DOI 10.1111/j.1365-2052.2005.01358.x; Santure AW, 2010, MOL ECOL, V19, P1439, DOI 10.1111/j.1365-294X.2010.04554.x; Silio L, 2013, J ANIM BREED GENET, DOI [10.1111/jbg12031, DOI 10.1111/JBG12031]; Slate J, 2004, HEREDITY, V93, P255, DOI 10.1038/sj.hdy.6800485; Toro M, 2002, CONSERV GENET, V3, P309, DOI 10.1023/A:1019921131171; Toro MA, 2000, CONSERV BIOL, V14, P1843, DOI 10.1111/j.1523-1739.2000.99322.x; Toro MA, 2009, LIVEST SCI, V120, P174, DOI 10.1016/j.livsci.2008.07.003; Toro MA, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-27; Townsend S., 2004, BSAS OCCASIONAL PUBL, V30, P113; Varona L, 2002, GENET RES, V80, P145, DOI 10.1017/S0016672302005803	32	34	36	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e78314	10.1371/journal.pone.0078314	http://dx.doi.org/10.1371/journal.pone.0078314			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24205195	Green Published, gold, Green Submitted			2022-12-27	WOS:000326373800018
J	Arnold, LD; Braganza, M; Salih, R; Colditz, GA				Arnold, Lauren D.; Braganza, Melissa; Salih, Rondek; Colditz, Graham A.			Statistical Trends in the Journal of the American Medical Association and Implications for Training across the Continuum of Medical Education	PLOS ONE			English	Article							BIOSTATISTICS; RADIOLOGY	Background: Statistical training across the continuum of medical education may not have advanced at the pace of statistical reporting in the medical literature, yet a comprehensive understanding of statistical concepts most commonly presented in current research is critical to the effective practice of Evidence Based Medicine. The objective of this content analysis was to describe statistical techniques used in a leading medical journal, JAMA, across a 20-year period, with a focus on implications for medical education. Methods and Findings: Two issues of JAMA published each month in 1990, 2000, and 2010 were randomly selected; from these, 361 articles were reviewed. Primary focus, study design, and statistical components were abstracted and examined by year of publication. The number of published RCTs and cohort studies differed significantly across years of interest, with an increasing trend of publication. The most commonly reported statistics over the 20-year period of interest included measures of morbidity and mortality, descriptive statistics, and epidemiologic outcomes. However, between 1990 and 2010, there was an increase in reporting of more advanced methods, such as multivariable regression, multilevel modeling, survival analysis, and sensitivity analysis. While this study is limited by a focus on one specific journal, a strength is that the journal examined is widely read by a range of clinical specialties and is considered a leading journal in the medical field, setting standards for published research. Conclusions: The increases in frequency and complexity of statistical reporting in the literature over the past two decades may suggest that moving beyond basic statistical concepts to a more comprehensive understanding of statistical methods is an important component of clinicians' ability to effectively read and use the medical research. These findings provide information to consider as medical schools and graduate medical education training programs review and revise their statistical training components.	[Arnold, Lauren D.; Braganza, Melissa; Salih, Rondek; Colditz, Graham A.] Washington Univ, Sch Med, Dept Surg, Div Publ Hlth Sci, St Louis, MO 63110 USA; [Braganza, Melissa] Washington Univ, George Warren Brown Sch Social Work, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL)	Arnold, LD (corresponding author), St Louis Univ, Dept Epidemiol, Coll Publ Hlth & Social Justice, St Louis, MO 63103 USA.	larnold7@slu.edu	Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291	National Cancer Institute of the National Institutes of Health [P30CA091842-11S1]; American Cancer Society [CRP-03-194-07]; Barnes Jewish Hospital Foundation; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Barnes Jewish Hospital Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was not grant-funded. However, portions of the investigators' time for unfunded research projects were supported by several sources: the National Cancer Institute of the National Institutes of Health under award number P30CA091842-11S1 (GAC); CRP-03-194-07 American Cancer Society Cissy Hornung Clinical Research Professorship (GAC, LDA); and the Barnes Jewish Hospital Foundation (LDA, MB, RS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the American Cancer Society.	AAMC, 2010, MED SCH ADM REQ 2011; AAMC, 2011, MCAT2015 BETT TEST T; Agrawal S, 2009, MED USES STAT, P41; Bryn Mawr Health Professions Advising Office, 2012, MED SCH MATH REQ; CARDIEL MH, 1995, REV INVEST CLIN, V47, P197; COLDITZ GA, 1985, MED EDUC, V19, P248, DOI 10.1111/j.1365-2923.1985.tb01315.x; ELSTER AD, 1994, AM J ROENTGENOL, V163, P711, DOI 10.2214/ajr.163.3.8079874; EMERSON JD, 1983, NEW ENGL J MED, V309, P709, DOI 10.1056/NEJM198309223091206; Gebbie K, 2003, WHO WILL KEEP THE PUBLIC HEALTHY?, P27; Goldin J, 1996, CLIN RADIOL, V51, P47, DOI 10.1016/S0009-9260(96)80219-4; Hellems MA, 2007, PEDIATRICS, V119, P1083, DOI 10.1542/peds.2006-2330; Lambert DR, 2010, ACAD MED, V85, P356, DOI 10.1097/ACM.0b013e3181c87f73; Looney SW, 1998, ACAD MED, V73, P92, DOI 10.1097/00001888-199801000-00018; Rao G, 2010, ACAD MED, V85, P1794, DOI 10.1097/ACM.0b013e3181e7218c; REZNICK RK, 1987, SURGERY, V101, P611; Garcia BR, 2010, REV ESP ANEST REANIM, V57, P281, DOI 10.1016/S0034-9356(10)70228-0; Sabharwal R, 2002, ASS AM MED COLL ANAL, V2, P1; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Welch GE, 2002, AM J OBSTET GYNECOL, V186, P584, DOI 10.1067/mob.2002.122144; Windish DM, 2007, JAMA-J AM MED ASSOC, V298, P1010, DOI 10.1001/jama.298.9.1010	20	24	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77301	10.1371/journal.pone.0077301	http://dx.doi.org/10.1371/journal.pone.0077301			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204794	gold, Green Published, Green Submitted			2022-12-27	WOS:000326334500024
J	Fan, ZS; Jastrow, JD; Liang, C; Matamala, R; Miller, RM				Fan, Zhaosheng; Jastrow, Julie D.; Liang, Chao; Matamala, Roser; Miller, Raymond Michael			Priming Effects in Boreal Black Spruce Forest Soils: Quantitative Evaluation and Sensitivity Analysis	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; HYDRAULIC CONDUCTIVITY; INTERIOR ALASKA; DECOMPOSITION; MATTER; TURNOVER; RESPIRATION; MECHANISMS; TRANSPORT; FIRE	Laboratory studies show that introduction of fresh and easily decomposable organic carbon (OC) into soil-water systems can stimulate the decomposition of soil OC (SOC) via priming effects in temperate forests, shrublands, grasslands, and agro-ecosystems. However, priming effects are still not well understood in the field setting for temperate ecosystems and virtually nothing is known about priming effects (e. g., existence, frequency, and magnitude) in boreal ecosystems. In this study, a coupled dissolved OC (DOC) transport and microbial biomass dynamics model was developed to simultaneously simulate co-occurring hydrological, physical, and biological processes and their interactions in soil pore-water systems. The developed model was then used to examine the importance of priming effects in two black spruce forest soils, with and without underlying permafrost. Our simulations showed that priming effects were strongly controlled by the frequency and intensity of DOC input, with greater priming effects associated with greater DOC inputs. Sensitivity analyses indicated that priming effects were most sensitive to variations in the quality of SOC, followed by variations in microbial biomass dynamics (i.e., microbial death and maintenance respiration), highlighting the urgent need to better discern these key parameters in future experiments and to consider these dynamics in existing ecosystem models. Water movement carries DOC to deep soil layers that have high SOC stocks in boreal soils. Thus, greater priming effects were predicted for the site with favorable water movement than for the site with limited water flow, suggesting that priming effects might be accelerated for sites where permafrost degradation leads to the formation of dry thermokarst.	[Fan, Zhaosheng; Jastrow, Julie D.; Liang, Chao; Matamala, Roser; Miller, Raymond Michael] Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA	United States Department of Energy (DOE); Argonne National Laboratory	Fan, ZS (corresponding author), Argonne Natl Lab, Biosci Div, 9700 S Cass Ave, Argonne, IL 60439 USA.	zfan@anl.gov	Jastrow, Julie D./AAX-1631-2020	Jastrow, Julie D./0000-0001-7069-4560	U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, Climate and Environmental Science Division [DE-AC02-06CH11357]	U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, Climate and Environmental Science Division(United States Department of Energy (DOE))	This work was supported by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, Climate and Environmental Science Division under contract DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agafonov L, 2004, PALAEOGEOGR PALAEOCL, V209, P183, DOI 10.1016/j.palaeo.2004.02.024; Allison SD, 2010, NAT GEOSCI, V3, P336, DOI 10.1038/NGEO846; Barrett K, 2011, ECOL APPL, V21, P2380, DOI 10.1890/10-0896.1; Bengtson P, 2012, ECOL EVOL, V2, P1843, DOI 10.1002/ece3.311; Blagodatskaya E, 2011, SOIL BIOL BIOCHEM, V43, P778, DOI 10.1016/j.soilbio.2010.12.011; Blagodatsky SA, 1998, SOIL BIOL BIOCHEM, V30, P1757, DOI 10.1016/S0038-0717(98)00029-7; Blagodatsky S, 2010, SOIL BIOL BIOCHEM, V42, P1275, DOI 10.1016/j.soilbio.2010.04.005; Borken W, 2009, GLOBAL CHANGE BIOL, V15, P808, DOI 10.1111/j.1365-2486.2008.01681.x; Carrasco JJ, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000087; Cheng WX, 2014, NEW PHYTOL, V201, P31, DOI 10.1111/nph.12440; Cheng WX, 2009, SOIL BIOL BIOCHEM, V41, P1795, DOI 10.1016/j.soilbio.2008.04.018; Cheng WX, 1996, PLANT SOIL, V183, P263, DOI 10.1007/BF00011441; Euskirchen ES, 2009, ECOL APPL, V19, P1022, DOI 10.1890/08-0806.1; Fan ZS, 2011, SCI TOTAL ENVIRON, V409, P1836, DOI 10.1016/j.scitotenv.2011.02.009; Fan ZS, 2010, SOIL SCI, V175, P223, DOI 10.1097/SS.0b013e3181e0559a; Fan ZS, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000723; Fontaine S, 2004, ECOL LETT, V7, P314, DOI 10.1111/j.1461-0248.2004.00579.x; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; Freeman C, 2004, NATURE, V430, P195, DOI 10.1038/nature02707; Fu SL, 2002, PLANT SOIL, V238, P289, DOI 10.1023/A:1014488128054; Guenet B, 2010, EUR J SOIL SCI, V61, P384, DOI 10.1111/j.1365-2389.2010.01234.x; HAMBY DM, 1994, ENVIRON MONIT ASSESS, V32, P135, DOI 10.1007/BF00547132; Hamer U, 2005, GEODERMA, V128, P38, DOI 10.1016/j.geoderma.2004.12.014; Harden JW, 2006, GLOBAL CHANGE BIOL, V12, P2391, DOI 10.1111/j.1365-2486.2006.01255.x; Harden JW, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001826; Hartley IP, 2010, SOIL BIOL BIOCHEM, V42, P92, DOI 10.1016/j.soilbio.2009.10.004; Hobbie SE, 2000, GLOBAL CHANGE BIOL, V6, P196, DOI 10.1046/j.1365-2486.2000.06021.x; Jastrow JD, 2007, CLIMATIC CHANGE, V80, P5, DOI 10.1007/s10584-006-9178-3; Jorgenson MT, 2005, CAN J FOREST RES, V35, P2100, DOI 10.1139/X05-153; KIRCHMAN DL, 1991, NATURE, V352, P612, DOI 10.1038/352612a0; Kuzyakov Y, 2002, J PLANT NUTR SOIL SC, V165, P382, DOI 10.1002/1522-2624(200208)165:4<382::AID-JPLN382>3.0.CO;2-#; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Kuzyakov Y, 2010, SOIL BIOL BIOCHEM, V42, P1363, DOI 10.1016/j.soilbio.2010.04.003; Larionova AA, 2007, BIOGEOSCIENCES, V4, P1073, DOI 10.5194/bg-4-1073-2007; Letts MG, 2000, ATMOS OCEAN, V38, P141, DOI 10.1080/07055900.2000.9649643; Liang Chao, 2011, Nat Rev Microbiol, V9, P75, DOI 10.1038/nrmicro2386-c1; Liang C, 2011, BIOGEOCHEMISTRY, V106, P303, DOI 10.1007/s10533-010-9525-3; Liu HP, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005158; Loya WM, 2010, SOIL BIOL BIOCHEM, V36, P655; Mack MC, 2008, ECOSYSTEMS, V11, P209, DOI 10.1007/s10021-007-9117-9; Mackelprang R, 2011, NATURE, V480, P368, DOI 10.1038/nature10576; Manies K, 2004, SOIL DATA PICEA MARI; McCarthy JF, 2008, GEOCHIM COSMOCHIM AC, V72, P4725, DOI 10.1016/j.gca.2008.06.015; Miller AE, 2005, SOIL BIOL BIOCHEM, V37, P2195, DOI 10.1016/j.soilbio.2005.03.021; MUALEM Y, 1976, WATER RESOUR RES, V12, P513, DOI 10.1029/WR012i003p00513; Nottingham AT, 2009, APPL SOIL ECOL, V42, P183, DOI 10.1016/j.apsoil.2009.03.003; O'Donnell JA, 2012, ECOSYSTEMS, V15, P213, DOI 10.1007/s10021-011-9504-0; Panikova NS, 2006, SOIL BIOL BIOCHEM, V38, P785, DOI 10.1016/j.soilbio.2005.07.004; Pastor J, 2003, OIKOS, V100, P380, DOI 10.1034/j.1600-0706.2003.11774.x; Rasmussen C, 2007, SOIL SCI SOC AM J, V71, P1141, DOI 10.2136/sssaj2006.0375; Richardson JL, 2001, WETLANDS SOILS GENES; Schimel JP, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00348; Schuur EAG, 2006, GLOBAL CHANGE BIOL, V12, P165, DOI 10.1111/j.1365-2486.2005.01066.x; SELIM HM, 1977, SOIL SCI SOC AM J, V41, P3, DOI 10.2136/sssaj1977.03615995004100010007x; Simpson AJ, 2007, ENVIRON SCI TECHNOL, V41, P876, DOI 10.1021/es061576c; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Tian J, 2012, EUR J SOIL BIOL, V52, P67, DOI 10.1016/j.ejsobi.2012.07.002; VANGENUCHTEN MT, 1989, SOIL SCI SOC AM J, V53, P1303, DOI 10.2136/sssaj1989.03615995005300050001x; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; VANGENUCHTEN MT, 1984, SOIL SCI SOC AM J, V48, P703, DOI 10.2136/sssaj1984.03615995004800040002x; Weiss R, 2006, ECOL MODEL, V192, P441, DOI 10.1016/j.ecolmodel.2005.07.016; Wickland KP, 2008, BIOGEOCHEMISTRY, V87, P29, DOI 10.1007/s10533-007-9166-3; Wickland KP, 2010, CAN J FOREST RES, V40, P2123, DOI 10.1139/X10-163; Woolf D, 2012, BIOGEOCHEMISTRY, V111, P83, DOI 10.1007/s10533-012-9764-6	64	9	9	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77880	10.1371/journal.pone.0077880	http://dx.doi.org/10.1371/journal.pone.0077880			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205010	Green Published, gold, Green Submitted			2022-12-27	WOS:000326334500072
J	Ferrier, J; Bayet-Robert, M; Pereira, B; Daulhac, L; Eschalier, A; Pezet, D; Moulinoux, JP; Balayssac, D				Ferrier, Jeremy; Bayet-Robert, Mathilde; Pereira, Bruno; Daulhac, Laurence; Eschalier, Alain; Pezet, Denis; Moulinoux, Jacques-Philippe; Balayssac, David			A Polyamine-Deficient Diet Prevents Oxaliplatin-Induced Acute Cold and Mechanical Hypersensitivity in Rats	PLOS ONE			English	Article							NR2B-CONTAINING NMDA RECEPTORS; NR2B SUBUNIT; SPINAL-CORD; PAINFUL NEUROPATHY; DORSAL-HORN; GLUTAMATE; ANTINOCICEPTION; NEUROTOXICITY; CHEMOTHERAPY; INVOLVEMENT	Background: Oxaliplatin is an anticancer drug used for the treatment of advanced colorectal cancer, but it can also cause painful peripheral neuropathies. The pathophysiology of these neuropathies has not been yet fully elucidated, but may involve spinal N-methyl-D-aspartate (NMDA) receptors, particularly the NR2B subunit. As polyamines are positive modulators of NMDA-NR2B receptors and mainly originate from dietary intake, the modulation of polyamines intake could represent an interesting way to prevent/modulate neuropathic pain symptoms by opposing glutamate neurotransmission. Methods: The effect of a polyamine deficient diet was investigated in an animal model of oxaliplatin-induced acute pain hypersensitivity using behavioral tests (mechanical and cold hypersensitivity). The involvement of spinal glutamate neurotransmission was monitored by using a proton nuclear magnetic resonance spectroscopy based metabolomic approach and by assessing the expression and phosphorylation of the NR2B subunit of the NMDA receptor. Results: A 7-day polyamine deficient diet totally prevented oxaliplatin-induced acute cold hypersensitivity and mechanical allodynia. Oxaliplatin-induced pain hypersensitivity was not associated with an increase in NR2B subunit expression or phosphorylation, but with an increase of glutamate level in the spinal dorsal horn which was completely prevented by a polyamine deficient diet. As a validation that the oxaliplatin-induced hypersensitivity could be due to an increased activity of the spinal glutamate system, an intrathecal administration of the specific NR2B antagonist, ifenprodil, totally reversed oxaliplatin-induced mechanical and cold hypersensitivity. Conclusion: A polyamine deficient diet could represent a promising and valuable nutritional therapy to prevent oxaliplatin-induced acute pain hypersensitivity.	[Ferrier, Jeremy; Bayet-Robert, Mathilde; Daulhac, Laurence; Eschalier, Alain; Balayssac, David] Clermont Univ, Univ Auvergne, Clermont Ferrand, France; [Ferrier, Jeremy; Bayet-Robert, Mathilde; Daulhac, Laurence; Eschalier, Alain; Balayssac, David] INSERM, NEURODOL U1107, Clermont Ferrand, France; [Pereira, Bruno; Eschalier, Alain; Pezet, Denis; Balayssac, David] CHU Clermont Ferrand, Clermont Ferrand, France; [Moulinoux, Jacques-Philippe] Univ Rennes 1, EA 3891, Grp Rech Therapeut Anticanc, Rennes, France	Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Clermont Ferrand; Universite de Rennes	Balayssac, D (corresponding author), Clermont Univ, Univ Auvergne, Clermont Ferrand, France.	dbalayssac@chu-clermontferrand.fr	Pezet, Denis/I-4423-2017; ESCHALIER, Alain/L-9957-2015; Balayssac, David/AAZ-3007-2020; Balayssac, David/K-2265-2015	Pezet, Denis/0000-0001-9416-2876; Balayssac, David/0000-0002-6126-6588; Ferrier, Jeremy/0000-0001-9755-3565	University of Auvergne; INSERM; local branch of the Ligue contre le Cancer [French league against cancer]	University of Auvergne; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); local branch of the Ligue contre le Cancer [French league against cancer]	This work was supported by the University of Auvergne, INSERM and the local branch of the Ligue contre le Cancer [French league against cancer]. JF has received a PhD grant from the regional council of Auvergne and the European Community. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angenstein F, 2008, CEREB CORTEX, V18, P890, DOI 10.1093/cercor/bhm122; Attal N, 2009, PAIN, V144, P245, DOI 10.1016/j.pain.2009.03.024; Bachrach U, 2005, CURR PROTEIN PEPT SC, V6, P559, DOI 10.2174/138920305774933240; Balayssac D, 2011, EXPERT OPIN DRUG SAF, V10, P407, DOI 10.1517/14740338.2011.543417; Binder A, 2007, EUR J CANCER, V43, P2658, DOI 10.1016/j.ejca.2007.07.030; Boyce S, 1999, NEUROPHARMACOLOGY, V38, P611, DOI 10.1016/S0028-3908(98)00218-4; Carozzi VA, 2010, NEUROTOX RES, V17, P380, DOI 10.1007/s12640-009-9114-1; Daulhac L, 2006, MOL PHARMACOL, V70, P1246, DOI 10.1124/mol.106.025478; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; De Vry J, 2004, EUR J PHARMACOL, V491, P137, DOI 10.1016/j.ejphar.2004.03.051; Fisher K, 2000, J PAIN SYMPTOM MANAG, V20, P358, DOI 10.1016/S0885-3924(00)00213-X; FUHRMAN S, 1994, J NEUROCHEM, V62, P275; Gaboriau F, 2003, ANAL BIOCHEM, V318, P212, DOI 10.1016/S0003-2697(03)00214-8; Gamelin E, 2002, SEMIN ONCOL, V29, P21, DOI 10.1053/sonc.2002.35525; Gent P, 2001, Int J Palliat Nurs, V7, P354; Gu XP, 2010, EUR J PAIN, V14, P496, DOI 10.1016/j.ejpain.2009.09.001; Guo W, 2002, J NEUROSCI, V22, P6208; Hertz L, 1999, J NEUROSCI RES, V57, P417, DOI 10.1002/(SICI)1097-4547(19990815)57:4<417::AID-JNR1>3.3.CO;2-E; Kawamata M, 1996, PAIN, V68, P85, DOI 10.1016/S0304-3959(96)03222-8; Kergozien S, 1996, LIFE SCI, V58, P2209, DOI 10.1016/0024-3205(96)00215-9; Klein J, 2000, J NEURAL TRANSM, V107, P1027, DOI 10.1007/s007020070051; Ling B, 2007, TOXICOLOGY, V234, P176, DOI 10.1016/j.tox.2007.02.013; Ling B, 2007, PAIN, V128, P225, DOI 10.1016/j.pain.2006.09.016; Mihara Y, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-8; Millan MJ, 1999, PROG NEUROBIOL, V57, P1, DOI 10.1016/S0301-0082(98)00048-3; Milovic V, 2001, EUR J GASTROEN HEPAT, V13, P1021, DOI 10.1097/00042737-200109000-00004; Moinard C, 2005, CLIN NUTR, V24, P184, DOI 10.1016/j.clnu.2004.11.001; Narita M, 2007, LIFE SCI, V80, P852, DOI 10.1016/j.lfs.2006.11.015; Park SB, 2011, ONCOLOGIST, V16, P708, DOI 10.1634/theoncologist.2010-0248; Parsons CG, 2001, EUR J PHARMACOL, V429, P71, DOI 10.1016/S0014-2999(01)01307-3; Pasetto LM, 2006, CRIT REV ONCOL HEMAT, V59, P159, DOI 10.1016/j.critrevonc.2006.01.001; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Qu XX, 2009, EXP NEUROL, V215, P298, DOI 10.1016/j.expneurol.2008.10.018; Rivat C, 2008, PAIN, V137, P125, DOI 10.1016/j.pain.2007.08.021; Rzeski W, 2004, ANN NEUROL, V56, P351, DOI 10.1002/ana.20185; SEILER N, 1990, INT J BIOCHEM, V22, P211, DOI 10.1016/0020-711X(90)90332-W; Tofthagen C, 2012, SUPPORT CARE CANCER, V20, P583, DOI 10.1007/s00520-011-1127-7; Tofthagen C, 2010, J PALLIAT MED, V13, P1389, DOI 10.1089/jpm.2010.0124; TORGNER I, 1990, MOL CHEM NEUROPATHOL, V12, P11, DOI 10.1007/BF03160053; Verbeke G, 2009, SPRINGER SER STAT, P1; Williams K, 1997, BIOCHEM J, V325, P289, DOI 10.1042/bj3250289; Zhang W, 2009, ANESTH ANALG, V108, P1015, DOI 10.1213/ane.0b013e318193ffd2	42	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77828	10.1371/journal.pone.0077828	http://dx.doi.org/10.1371/journal.pone.0077828			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204988	gold, Green Published, Green Submitted			2022-12-27	WOS:000326334500066
J	Halu, A; Mondragon, RJ; Panzarasa, P; Bianconi, G				Halu, Arda; Mondragon, Raul J.; Panzarasa, Pietro; Bianconi, Ginestra			Multiplex PageRank	PLOS ONE			English	Article							SOCIAL NETWORKS; ORGANIZATIONS; COOPERATION; FRIENDSHIP	Many complex systems can be described as multiplex networks in which the same nodes can interact with one another in different layers, thus forming a set of interacting and co-evolving networks. Examples of such multiplex systems are social networks where people are involved in different types of relationships and interact through various forms of communication media. The ranking of nodes in multiplex networks is one of the most pressing and challenging tasks that research on complex networks is currently facing. When pairs of nodes can be connected through multiple links and in multiple layers, the ranking of nodes should necessarily reflect the importance of nodes in one layer as well as their importance in other interdependent layers. In this paper, we draw on the idea of biased random walks to define the Multiplex PageRank centrality measure in which the effects of the interplay between networks on the centrality of nodes are directly taken into account. In particular, depending on the intensity of the interaction between layers, we define the Additive, Multiplicative, Combined, and Neutral versions of Multiplex PageRank, and show how each version reflects the extent to which the importance of a node in one layer affects the importance the node can gain in another layer. We discuss these measures and apply them to an online multiplex social network. Findings indicate that taking the multiplex nature of the network into account helps uncover the emergence of rankings of nodes that differ from the rankings obtained from one single layer. Results provide support in favor of the salience of multiplex centrality measures, like Multiplex PageRank, for assessing the prominence of nodes embedded in multiple interacting networks, and for shedding a new light on structural properties that would otherwise remain undetected if each of the interacting networks were analyzed in isolation.	[Halu, Arda] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Mondragon, Raul J.] Queen Mary Univ London, Sch Elect Engn & Comp Sci, London, England; [Panzarasa, Pietro] Queen Mary Univ London, Sch Business & Management, London, England; [Bianconi, Ginestra] Queen Mary Univ London, Sch Math Sci, London, England	Northeastern University; University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London	Bianconi, G (corresponding author), Queen Mary Univ London, Sch Math Sci, London, England.	ginestra.bianconi@gmail.com	Bianconi, Ginestra/AAE-4114-2020; Bianconi, Ginestra/I-5742-2018	Bianconi, Ginestra/0000-0002-3380-887X; Bianconi, Ginestra/0000-0002-3380-887X; Halu, Arda/0000-0001-6217-790X	Queen Mary University of London; Northeastern University	Queen Mary University of London; Northeastern University	Queen Mary University of London and Northeastern University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Allesina S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000494; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Baym NK, 2004, NEW MEDIA SOC, V6, P299, DOI 10.1177/1461444804041438; Bianconi G, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062806; Blumm N, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.128701; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Brummitt CD, 2012, P NATL ACAD SCI USA, V109, pE680, DOI 10.1073/pnas.1110586109; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cardillo A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01344; DeDomenico M, 2013, ARXIV13060519; Donges JF, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/48007; Ferriani S, 2013, STRATEG ORGAN, V11, P7, DOI 10.1177/1476127012461576; Flament C., 1963, APPL GRAPH THEORY GR; Fortunato S, 2008, LECT NOTES COMPUT SC, V4936, P59, DOI 10.1007/978-3-540-78808-9_6; Fortunato S, 2007, INT J BIFURCAT CHAOS, V17, P2343, DOI 10.1142/S0218127407018439; Gibbons DE, 2004, ADMIN SCI QUART, V49, P238; Gimeno J, 1996, ADV STRATEG MANAGE, V13, P323; Gomez S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.028701; Gomez-Gardenes J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00620; Gomez-Gardenes J, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.065102; Halu A, 2013, EPL-EUROPHYS LETT, V102, DOI 10.1209/0295-5075/102/16002; Ingram P, 2008, RES ORGAN BEHAV, V28, P167, DOI 10.1016/j.riob.2008.04.006; Jeh G., 2003, P 12 INT C WORLD WID, P271, DOI DOI 10.1145/775152.775191; Kapferer B., 1969, SOCIAL NETWORKS URBA; Kim JY, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.058702; Kuwabara K, 2010, ADV GROUP PROCESS, V27, P239, DOI 10.1108/S0882-6145(2010)0000027012; Kuwabara K, 2011, AM SOCIOL REV, V76, P560, DOI 10.1177/0003122411414825; Lee S, 2011, J COMMUN, V61, P758, DOI 10.1111/j.1460-2466.2011.01566.x; LINCOLN JR, 1979, ADMIN SCI QUART, V24, P181, DOI 10.2307/2392493; Liu XM, 2005, INFORM PROCESS MANAG, V41, P1462, DOI 10.1016/j.ipm.2005.03.012; Lomi A, 2006, ORGAN SCI, V17, P313, DOI 10.1287/orsc.1060.0190; Maggioni MA, 2013, IND INNOV, V20, P185, DOI 10.1080/13662716.2013.791124; Markose S, 2013, COMMUNICATION; Mucha PJ, 2010, SCIENCE, V328, P876, DOI 10.1126/science.1184819; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nicosia V, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.058701; Panzarasa P, 2009, J AM SOC INF SCI TEC, V60, P911, DOI 10.1002/asi.21015; Rank ON, 2010, ORGAN SCI, V21, P745, DOI 10.1287/orsc.1090.0450; Saumell-Mendiola A, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.026106; Shipilov AV, 2012, ORGAN SCI, V23, P472, DOI 10.1287/orsc.1100.0568; Siudem G, 2013, ARXIV13032650; Sola L, 2013, ARXIV13057445; Szell M, 2010, P NATL ACAD SCI USA, V107, P13636, DOI 10.1073/pnas.1004008107; Uzzi B, 1996, AM SOCIOL REV, V61, P674, DOI 10.2307/2096399; VERBRUGGE LM, 1979, SOC FORCES, V57, P1286; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Wheeldon PD, 1969, SOC NETWORKS URBAN, P128; Yun Huang, 2009, 2009 International Conference on Computational Science and Engineering (CSE), P354, DOI 10.1109/CSE.2009.471; Zelizer Viviana A., 2005, PURCHASE INTIMACY; Zhao K, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/05/P05005	53	115	117	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78293	10.1371/journal.pone.0078293	http://dx.doi.org/10.1371/journal.pone.0078293			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243RL	24205186	Green Published, gold, Green Submitted			2022-12-27	WOS:000326334500110
J	Kichine, E; Di Falco, M; Hales, BF; Robaire, B; Chan, P				Kichine, Elsa; Di Falco, Marcos; Hales, Barbara F.; Robaire, Bernard; Chan, Peter			Analysis of the Sperm Head Protein Profiles in Fertile Men: Consistency across Time in the Levels of Expression of Heat Shock Proteins and Peroxiredoxins	PLOS ONE			English	Article							UBIQUITIN LIGASE COMPLEX; NUCLEAR-MATRIX; HUMAN SPERMATOZOA; STATISTICAL-MODEL; MASS-SPECTROMETRY; DNA-REPLICATION; SEMEN COAGULUM; PATERNAL DNA; BINDING; GENE	We investigated the identity and quantitative variations of proteins extracted from human sperm heads using a label-free Gel-MS approach. Sperm samples were obtained from three men with high sperm counts at three different time points. This design allowed us to analyse intra-individual and inter-individual variations of the human sperm head proteome. Each time point was analyzed in triplicate to minimize any background artifactual effects of the methodology on the variation analyses. Intra-individual analysis using the spectral counting method revealed that the expression levels of 90% of the common proteins identified in three samples collected at various time-points, separated by several months, had a coefficient of variation of less than 0.5 for each man. Across individuals, the expression level of more than 80% of the proteins had a CV under 0.7. Interestingly, 83 common proteins were found within the core proteome as defined by the intra-and inter-variation analyses set criteria (CV<0.7). Some of these uniformly expressed proteins were chaperones, peroxiredoxins, isomerases, and cytoskeletal proteins. Although there is a significant level of inter-individual variation in the protein profiles of human sperm heads even in a well-defined group of men with high sperm counts, the consistent expression levels of a wide range of proteins points to their essential role during spermatogenesis.	[Kichine, Elsa; Hales, Barbara F.; Robaire, Bernard] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Di Falco, Marcos] Concordia Univ, Struct & Funct Genom Ctr, Montreal, PQ, Canada; [Robaire, Bernard] McGill Univ, Dept Obstet & Gynecol, Montreal, PQ H3A 2T5, Canada; [Chan, Peter] McGill Univ, Ctr Hlth, Dept Urol, Montreal, PQ, Canada	McGill University; Concordia University - Canada; McGill University; McGill University	Chan, P (corresponding author), McGill Univ, Ctr Hlth, Dept Urol, Montreal, PQ, Canada.	MUHC35490@yahoo.ca			Canadian Institutes to Health Research [MOP86636]	Canadian Institutes to Health Research	The work is supported by an operating grant from the Canadian Institutes to Health Research awarded to Peter Chan (MOP86636). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN J, 1994, BIOESSAYS, V16, P259, DOI 10.1002/bies.950160409; Baker MA, 2007, PROTEOM CLIN APPL, V1, P524, DOI 10.1002/prca.200601013; Baker MA, 2011, ASIAN J ANDROL, V13, P6, DOI 10.1038/aja.2010.62; BOURDI M, 1995, ARCH BIOCHEM BIOPHYS, V323, P397, DOI 10.1006/abbi.1995.0060; Brewer L, 2002, J BIOL CHEM, V277, P38895, DOI 10.1074/jbc.M204755200; Brewer LR, 1999, SCIENCE, V286, P120, DOI 10.1126/science.286.5437.120; Campagno C, 2001, YEAST, V18, P663, DOI 10.1002/yea.715; Chelius D, 2002, J PROTEOME RES, V1, P317, DOI 10.1021/pr025517j; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; de Lamirande E, 2010, HUM REPROD, V25, P1619, DOI 10.1093/humrep/deq110; de Lamirande E, 2008, BBA-PROTEINS PROTEOM, V1784, P106, DOI 10.1016/j.bbapap.2007.08.024; de Lamirande E, 2007, SEMIN THROMB HEMOST, V33, P60, DOI 10.1055/s-2006-958463; Gong S, 2012, J ANDROL; Hawley SB, 2001, J BIOL CHEM, V276, P179, DOI 10.1074/jbc.M004919200; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kodama H, 1997, FERTIL STERIL, V68, P519, DOI 10.1016/S0015-0282(97)00236-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Martinez-Ruiz A, 2005, P NATL ACAD SCI USA, V102, P8525, DOI 10.1073/pnas.0407294102; Martins RP, 2004, J BIOL CHEM, V279, P51862, DOI 10.1074/jbc.M409415200; Naaby-Hansen S, 2010, J REPROD IMMUNOL, V84, P32, DOI 10.1016/j.jri.2009.09.006; Neilson KA, 2011, PROTEOMICS, V11, P535, DOI 10.1002/pmic.201000553; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; O'Flaherty C, 2011, BIOL REPROD, V84, P238, DOI 10.1095/biolreprod.110.085712; Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P663, DOI 10.1016/j.semcdb.2011.09.001; Ocampo J, 2005, TISSUE CELL, V37, P293, DOI 10.1016/j.tice.2005.03.003; Organization WH, 2010, WHO LAB MAN EX HUM S; OTTERSON GA, 1994, EMBO J, V13, P1216, DOI 10.1002/j.1460-2075.1994.tb06371.x; Ozawa K, 1999, J BIOL CHEM, V274, P6397, DOI 10.1074/jbc.274.10.6397; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; Poon S, 2000, BIOCHEMISTRY-US, V39, P15953, DOI 10.1021/bi002189x; PRICE ER, 1991, P NATL ACAD SCI USA, V88, P1903, DOI 10.1073/pnas.88.5.1903; Puglisi R, 2011, J CELL PHYSL; REBBE NF, 1989, J BIOL CHEM, V264, P15006; Redgrove KA, 2011, DEV BIOL, V356, P460, DOI 10.1016/j.ydbio.2011.05.674; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; ROBERT M, 1995, HUM REPROD, V10, P2192, DOI 10.1093/oxfordjournals.humrep.a136267; SCHNEIDER H, 1994, BIOCHEMISTRY-US, V33, P8218, DOI 10.1021/bi00193a007; Shaman JA, 2007, J CELL BIOCHEM, V102, P680, DOI 10.1002/jcb.21321; Shaman JA, 2006, BIOL REPROD, V75, P741, DOI 10.1095/biolreprod.106.055178; Shen HM, 1999, J ANDROL, V20, P718; Sotolongo B, 2003, BIOL REPROD, V69, P2029, DOI 10.1095/biolreprod.103.020594; Ward WS, 1999, BIOL REPROD, V60, P702, DOI 10.1095/biolreprod60.3.702; Wasiak S, 2002, J CELL BIOL, V158, P855, DOI 10.1083/jcb.200205078; Yahata T, 2000, J BIOL CHEM, V275, P8825, DOI 10.1074/jbc.275.12.8825; Yamauchi Y, 2007, BIOL REPROD, V77, P407, DOI 10.1095/biolreprod.107.061473; Yamauchi Y, 2007, BIOL REPROD, V76, P666, DOI 10.1095/biolreprod.106.057067	48	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77471	10.1371/journal.pone.0077471	http://dx.doi.org/10.1371/journal.pone.0077471			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204839	Green Published, Green Submitted, gold			2022-12-27	WOS:000326334500029
J	Liverani, M; Hawkins, B; Parkhurst, JO				Liverani, Marco; Hawkins, Benjamin; Parkhurst, Justin O.			Political and Institutional Influences on the Use of Evidence in Public Health Policy. A Systematic Review	PLOS ONE			English	Article							SCIENTIFIC EVIDENCE; DECISION-MAKERS; IMPLEMENTATION; CAPACITY; COUNTRIES; QUALITY; VACCINE; BREAST; RISK; DRUG	Background: There is increasing recognition that the development of evidence-informed health policy is not only a technical problem of knowledge exchange or translation, but also a political challenge. Yet, while political scientists have long considered the nature of political systems, the role of institutional structures, and the political contestation of policy issues as central to understanding policy decisions, these issues remain largely unexplored by scholars of evidence-informed policy making. Methods: We conducted a systematic review of empirical studies that examined the influence of key features of political systems and institutional mechanisms on evidence use, and contextual factors that may contribute to the politicisation of health evidence. Eligible studies were identified through searches of seven health and social sciences databases, websites of relevant organisations, the British Library database, and manual searches of academic journals. Relevant findings were extracted using a uniform data extraction tool and synthesised by narrative review. Findings: 56 studies were selected for inclusion. Relevant political and institutional aspects affecting the use of health evidence included the level of state centralisation and democratisation, the influence of external donors and organisations, the organisation and function of bureaucracies, and the framing of evidence in relation to social norms and values. However, our understanding of such influences remains piecemeal given the limited number of empirical analyses on this subject, the paucity of comparative works, and the limited consideration of political and institutional theory in these studies. Conclusions: This review highlights the need for a more explicit engagement with the political and institutional factors affecting the use of health evidence in decision-making. A more nuanced understanding of evidence use in health policy making requires both additional empirical studies of evidence use, and an engagement with theories and approaches beyond the current remit of public health or knowledge utilisation studies.	[Liverani, Marco; Hawkins, Benjamin; Parkhurst, Justin O.] Univ London London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Liverani, M (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Global Hlth & Dev, Keppel St, London WC1E 7HT, England.	marco.liverani@lshtm.ac.uk	Parkhurst, Justin/AAP-3615-2021		European Research Council [282118]	European Research Council(European Research Council (ERC)European Commission)	This study was supported by the European Research Council (grant no. 282118). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeysinghe S, 2012, POLICY STUDIES, V33, P37; AHPSR, 2004, STRENGTH HLTH SYST R; Allen P., 2007, EVID POLICY, V3, P119; [Anonymous], 2007, DESIGNS NATURE SCI D; [Anonymous], MONITORING FINANCIAL; Barnes A, 2014, HDB GLOBAL HLTH POLI; Beck M, 2005, PUBLIC ADMIN REV, V65, P396, DOI 10.1111/j.1540-6210.2005.00467.x; Behague D, 2009, SOC SCI MED, V69, P1539, DOI 10.1016/j.socscimed.2009.08.006; Bekker M, 2010, EVID POLICY, V6, P237, DOI 10.1332/174426410X502464; Berridge V, 1996, POLICY STUDIES, V17, P23, DOI DOI 10.1080/01442879608423691; Blume S, 2010, SOC SCI MED, V71, P1049, DOI 10.1016/j.socscimed.2010.06.023; Boaz Annette, 2011, BMC Res Notes, V4, P212, DOI 10.1186/1756-0500-4-212; Bowen, 2009, EVID POLICY, V5, P5, DOI [DOI 10.1332/174426409X395394, 10.1332/174426409X395394]; Brickman R., 1985, CONTROLLING CHEM POL; Broadbent E, 2012, EVIDENCE BASED POLIC; Burchett HED, 2012, HEALTH POLICY PLANN, V27, pII5, DOI 10.1093/heapol/czs035; Court J, 2005, BRIDGING RES POLICY; Daniels Karen, 2008, Health Res Policy Syst, V6, P12, DOI 10.1186/1478-4505-6-12; Davison C, 2013, CRITICAL EXAMINATION; de Goede J, 2012, SOC SCI MED, V74, P707, DOI 10.1016/j.socscimed.2011.11.014; De Vries R, 2006, SOC SCI MED, V62, P2694, DOI 10.1016/j.socscimed.2005.11.026; Dixon-Woods M., 2006, QUAL RES, V6, P27, DOI [10.1177/1468794106058867, DOI 10.1177/1468794106058867]; Dobbins Maureen, 2010, BMC Public Health, V10, P496, DOI 10.1186/1471-2458-10-496; Edstrom J, 2008, IDS BULL-I DEV STUD, V39, P71, DOI 10.1111/j.1759-5436.2008.tb00497.x; Ensor T, 2009, HEALTH POLICY, V90, P247, DOI 10.1016/j.healthpol.2008.06.009; Flitcroft K, 2011, SOC SCI MED, V72, P1039, DOI 10.1016/j.socscimed.2011.01.034; Flitcroft KL, 2011, EVID POLICY, V7, P307, DOI 10.1332/174426411X591735; Gamble VN, 2006, J HEALTH POLIT POLIC, V31, P93, DOI 10.1215/03616878-31-1-93; Gordon EJ, 2006, SOC SCI MED, V62, P2707, DOI 10.1016/j.socscimed.2005.11.024; Gordon J., 2005, EVID POLICY, V1, P391; Haas M, 2009, HEALTH POLICY, V92, P288, DOI 10.1016/j.healthpol.2009.05.002; Hamel N, 2011, SOC SCI MED, V72, P31, DOI 10.1016/j.socscimed.2010.09.051; Hammersley M, 2007, INT J RES METHOD EDU, V30, P287, DOI 10.1080/17437270701614782; Hanney SR, 2003, HLTH RES POLICY SYST, V12; Hanney Stephen R, 2009, Health Res Policy Syst, V7, P30, DOI 10.1186/1478-4505-7-30; Hanney SR, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-23; Haynes AS, 2011, MILBANK Q, V89, P564, DOI 10.1111/j.1468-0009.2011.00643.x; Hennink M, 2005, J HEALTH COMMUN, V10, P163, DOI 10.1080/10810730590915128; Hughes CE, 2007, DRUG ALCOHOL REV, V26, P363, DOI 10.1080/09595230701373859; Humphreys K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1316; Hunsmann M, 2012, SOC SCI MED, V74, P1477, DOI 10.1016/j.socscimed.2012.01.023; Hutchinson E, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-S1-S6; Iglesias CP, 2005, INT J TECHNOL ASSESS, V21, P1, DOI 10.1017/S0266462305050014; Innvaer Simon, 2002, J Health Serv Res Policy, V7, P239, DOI 10.1258/135581902320432778; Jasanoff S, 1986, RISK MANAGEMENT POLI; Jewell CJ, 2008, MILBANK Q, V86, P177, DOI 10.1111/j.1468-0009.2008.00519.x; KLEIN R, 1990, J HEALTH POLIT POLIC, V15, P501, DOI 10.1215/03616878-15-3-501; Kogan M, 1983, GOVT RES ROTSCHILD E; Kogan M, 2006, HIGH EDUC DYNAM, V11, P1; Landry R, 2003, PUBLIC ADMIN REV, V63, P192, DOI 10.1111/1540-6210.00279; Lasswell H., 1990, POLITICS WHO GETS WH; Lavis JN, 2002, MILBANK Q, V80, P125, DOI 10.1111/1468-0009.00005; Lavis John, 2005, J Health Serv Res Policy, V10 Suppl 1, P35, DOI 10.1258/1355819054308549; Lavis JN, 2009, HEALTH RES POLICY SY, V7, DOI 10.1186/1478-4505-7-S1-S4; Lavis JN, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000141; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Liu YL, 2006, J HEALTH POLIT POLIC, V31, P71, DOI 10.1215/03616878-31-1-71; Milewa T, 2005, SOC POLICY ADMIN, V39, P498, DOI 10.1111/j.1467-9515.2005.00452.x; Mitton C, 2007, MILBANK Q, V85, P729, DOI 10.1111/j.1468-0009.2007.00506.x; Monaghan M., 2011, EVIDENCE VERSUS POLI; Moodley J, 2000, COMBATING VITAMIN A; Mubyazi GM, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-51; Nattrass N, 2008, AFR AFFAIRS, V107, P157, DOI 10.1093/afraf/adm087; Orem Juliet Nabyonga, 2012, BMC Public Health, V12, P109, DOI 10.1186/1471-2458-12-109; Orton L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021704; Ottoson, 2009, N DIRECT EVAL, V2009, P7, DOI [DOI 10.1002/EV.310, https://doi.org/10.1002/ev.310]; Pappaioanou M, 2003, SOC SCI MED, V57, P1925, DOI 10.1016/S0277-9536(03)00058-3; Parkhurst JO, 2012, EVID POLICY, V8, P17, DOI 10.1332/174426412X620119; Peters B., 2017, REACTION RATE THEORY; Peters G, 2002, PUBLIC MANAGEMENT CR, P156; Peters G. B., 1995, POLITICS BUREAUCRACY; Pittman PM, 2006, J HEALTH POLIT POLIC, V31, P33, DOI 10.1215/03616878-31-1-33; Popay J, 2006, PRODUCT ESRC METHODS, pb92, DOI DOI 10.13140/2.1.1018.4643; Rennert G, 2003, RECENT RES CANCER, V163, P140; Reynolds J, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-43; Rockman B.A., 2008, OXFORD HDB POLITICAL; Saguy AC, 2005, J HEALTH POLIT POLIC, V30, P869, DOI 10.1215/03616878-30-5-869; Salvatella R, 2000, CHAGAR DIS FOOT MOUT; Schneider H, 2002, AFRICAN STUDIES, V61, P145, DOI DOI 10.1080/00020180220140118; Schwartz R, 2004, PUBLIC MONEY MANAGE, V24, P121, DOI 10.1111/j.1467-9302.2004.00404.x; Smith K, 2013, POLICY POLIT, V41, P81, DOI 10.1332/030557312X655413; Smith KE, 2007, SOC SCI MED, V64, P1438, DOI 10.1016/j.socscimed.2006.11.008; Starr M, 2009, INT J TECHNOL ASSESS, V25, P182, DOI 10.1017/S026646230909062X; Sumner A, 2008, EUR J DEV RES, V20, P712, DOI DOI 10.1080/09578810802493358; Theobald Sally, 2009, Health Res Policy Syst, V7, P26, DOI 10.1186/1478-4505-7-26; Thomson G, 2007, AUST NZ HLTH POLICY, P4; Tomson G, 2005, SOC SCI MED, V61, P1291, DOI 10.1016/j.socscimed.2005.01.014; Trostle J, 1999, HEALTH POLICY PLANN, V14, P103, DOI 10.1093/heapol/14.2.103; Tulloch O, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-S1-S10; Uneke CJ, 2011, EVID POLICY, V7, P251, DOI 10.1332/174426411X591744; van Kammen J, 2006, B WORLD HEALTH ORGAN, V84, P608, DOI 10.2471/BLT.05.028308; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400; Vogel D., 1986, NATL STYLES REGULATI; Waddell C, 2005, SOC SCI MED, V61, P1649, DOI 10.1016/j.socscimed.2005.03.032; WEISS CH, 1979, PUBLIC ADMIN REV, V39, P426, DOI 10.2307/3109916; Weiss CH., 1977, USING SOCIAL RES PUB; Wilson P, 2006, EVID POLICY, V2, P321; Wolf JB, 2007, J HEALTH POLIT POLIC, V32, P595, DOI 10.1215/03616878-2007-018; World Health Organization, 2004, WORLD REP KNOWL BETT	99	139	140	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77404	10.1371/journal.pone.0077404	http://dx.doi.org/10.1371/journal.pone.0077404			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243RL	24204823	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000326334500026
J	Wu, PY; Wu, HDI; Chou, TC; Sung, FC				Wu, Po-Yuan; Wu, Hong-Dar Isaac; Chou, Tzu-Chieh; Sung, Fung-Chang			Varicella Vaccination Alters the Chronological Trends of Herpes Zoster and Varicella	PLOS ONE			English	Article							EPIDEMIOLOGY; VIRUS; IMPACT; IMMUNIZATION; AUSTRALIA; EXPOSURE; CHILDREN; ADULTS; RISK; ERA	Background: Population studies on trends of varicella and herpes zoster (HZ) associated with varicella zoster vaccination and climate is limited. Methods: This study used insurance claims data to investigate the chronological changes in incident varicella and HZ associated with varicella zoster vaccination. Poisson regression was used to estimate the occurrence of varicella associated with the occurrence of HZ and vice versa by year, season, sex, temperature, and sunny hours. Results: The varicella incidence declined from 7.14 to 0.76 per 1,000 person-years in 2000-2009, whereas the HZ incidence increased from 4.04 to 6.24 per 1,000 person-years. Females tended to have a higher risk than men for HZ (p<0.0001) but not varicella. The monthly mean varicella incidence was the lowest in September (160 cases) and the highest in January (425 cases), while the mean HZ incidence was lower in February (370 cases) and higher in August (470 cases). HZ was negatively associated with the incidence of varicella before and after the varicella zoster vaccination (p<0.001), increased 1.6% within one week post-vaccination. The effect of temperature on HZ was attenuated by 18.5% (p<0.0001) in association with vaccination. The varicella risk was positively associated with sun exposure hours, but negatively associated with temperature only before vaccination. Conclusions: The varicella vaccination is effective in varicella prevention, but the incidence of HZ increases after vaccination. HZ has a stronger association with temperature and UV than with seasonality while varicella risk associated with temperature and UV is diminished.	[Wu, Po-Yuan; Chou, Tzu-Chieh; Sung, Fung-Chang] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Wu, Po-Yuan] China Med Univ Hosp, Dept Dermatol, Taichung, Taiwan; [Wu, Po-Yuan] China Med Univ, Sch Med, Taichung, Taiwan; [Wu, Hong-Dar Isaac] Natl Chung Hsing Univ, Dept Appl Math, Taichung 40227, Taiwan; [Sung, Fung-Chang] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; National Chung Hsing University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Sung, FC (corresponding author), China Med Univ, Dept Publ Hlth, Taichung, Taiwan.	fcsung.tw@gmail.com	Chou, Tzu-Chieh/D-2372-2014	Chou, Tzu-Chieh/0000-0002-9634-0637	National Sciences Council, Executive Yuan [NSC 100-2621-M-039-001]; China Medical University Hospital [1MS1]; Department of Health, Taiwan; Clinical Trial and Research Center for Excellence [DOH101-TD-B-111-004]; Cancer Research Center of Excellence [DOH101-TD-C-111-005]	National Sciences Council, Executive Yuan; China Medical University Hospital; Department of Health, Taiwan; Clinical Trial and Research Center for Excellence; Cancer Research Center of Excellence	The present study was supported in parts by the National Sciences Council, Executive Yuan (grant number NSC 100-2621-M-039-001), China Medical University Hospital (grant number 1MS1), Department of Health, Taiwan, Clinical Trial and Research Center for Excellence (grant number DOH101-TD-B-111-004), and Cancer Research Center of Excellence (DOH101-TD-C-111-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamiak B, 2010, VIROLOGY, V400, P197, DOI 10.1016/j.virol.2010.01.032; Brisson M, 2002, VACCINE, V20, P2500, DOI 10.1016/S0264-410X(02)00180-9; Brisson M, 2000, EPIDEMIOL INFECT, V125, P651, DOI 10.1017/S0950268800004714; Chao DY, 2011, EPIDEMIOL INFECT, P1; Donahue J. G., 2010, American Journal of Public Health, V100, P1116, DOI 10.2105/AJPH.2009.160002; Fleming DM, 2004, EPIDEMIOL INFECT, V132, P1, DOI 10.1017/S0950268803001523; Gaillat J, 2011, CLIN INFECT DIS, V53, P405, DOI 10.1093/cid/cir436; Gauthier A, 2009, EPIDEMIOL INFECT, V137, P38, DOI 10.1017/S0950268808000678; Gidding HF, 2005, AUST NZ J PUBL HEAL, V29, P544, DOI 10.1111/j.1467-842X.2005.tb00248.x; Hambleton S, 2008, FRONT BIOSCI-LANDMRK, V13, P2696, DOI 10.2741/2876; Heininger U, 2006, LANCET, V368, P1365, DOI 10.1016/S0140-6736(06)69561-5; Jardine A, 2011, EPIDEMIOL INFECT, V139, P658, DOI 10.1017/S0950268810001949; Jenke ACW, 2012, PEDIATR INFECT DIS J, V31, P1148, DOI 10.1097/INF.0b013e31826bac27; Karhunen M, 2010, EPIDEMIOL INFECT, V138, P469, DOI 10.1017/S0950268809990768; Leung J, 2011, CLIN INFECT DIS, V52, P332, DOI 10.1093/cid/ciq077; Lin F, 2000, J INFECT DIS, V181, P1897, DOI 10.1086/315492; Thomas SL, 2002, LANCET, V360, P678, DOI 10.1016/S0140-6736(02)09837-9; Thomas SL, 2004, LANCET INFECT DIS, V4, P26, DOI 10.1016/S1473-3099(03)00857-0; Toyama N, 2009, J MED VIROL, V81, P2053, DOI 10.1002/jmv.21599; Zak-Prelich M, 2002, EPIDEMIOL INFECT, V129, P593, DOI 10.1017/S0950268802007793	20	48	50	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77709	10.1371/journal.pone.0077709	http://dx.doi.org/10.1371/journal.pone.0077709			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204928	gold, Green Submitted, Green Published			2022-12-27	WOS:000326334500045
J	Marathe, NP; Regina, VR; Walujkar, SA; Charan, SS; Moore, ERB; Larsson, DGJ; Shouche, YS				Marathe, Nachiket P.; Regina, Viduthalai R.; Walujkar, Sandeep A.; Charan, Shakti Singh; Moore, Edward R. B.; Larsson, D. G. Joakim; Shouche, Yogesh S.			A Treatment Plant Receiving Waste Water from Multiple Bulk Drug Manufacturers Is a Reservoir for Highly Multi-Drug Resistant Integron-Bearing Bacteria	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; OCHROBACTRUM-INTERMEDIUM; GENE CASSETTE; EFFLUENT; IDENTIFICATION; CONTAMINATION; PREVALENCE; EXPOSURE; PATIENT; AGENTS	The arenas and detailed mechanisms for transfer of antibiotic resistance genes between environmental bacteria and pathogens are largely unclear. Selection pressures from antibiotics in situations where environmental bacteria and human pathogens meet are expected to increase the risks for such gene transfer events. We hypothesize that waste-water treatment plants (WWTPs) serving antibiotic manufacturing industries may provide such spawning grounds, given the high bacterial densities present there together with exceptionally strong and persistent selection pressures from the antibiotic-contaminated waste. Previous analyses of effluent from an Indian industrial WWTP that processes waste from bulk drug production revealed the presence of a range of drugs, including broad spectrum antibiotics at extremely high concentrations (mg/L range). In this study, we have characterized the antibiotic resistance profiles of 93 bacterial strains sampled at different stages of the treatment process from the WWTP against 39 antibiotics belonging to 12 different classes. A large majority (86%) of the strains were resistant to 20 or more antibiotics. Although there were no classically-recognized human pathogens among the 93 isolated strains, opportunistic pathogens such as Ochrobactrum intermedium, Providencia rettgeri, vancomycin resistant Enterococci (VRE), Aerococcus sp. and Citrobacter freundii were found to be highly resistant. One of the O. intermedium strains (ER1) was resistant to 36 antibiotics, while P. rettgeri (OSR3) was resistant to 35 antibiotics. Class 1 and 2 integrons were detected in 74/93 (80%) strains each, and 88/93 (95%) strains harbored at least one type of integron. The qPCR analysis of community DNA also showed an unprecedented high prevalence of integrons, suggesting that the bacteria living under such high selective pressure have an appreciable potential for genetic exchange of resistance genes via mobile gene cassettes. The present study provides insight into the mechanisms behind and the extent of multidrug resistance among bacteria living under an extreme antibiotic selection pressure.	[Marathe, Nachiket P.; Regina, Viduthalai R.; Walujkar, Sandeep A.; Charan, Shakti Singh; Shouche, Yogesh S.] Natl Ctr Cell Sci, Microbial Culture Collect MCC, Pune, Maharashtra, India; [Moore, Edward R. B.] Culture Collect Univ Gothenburg, Gothenburg, Sweden; [Moore, Edward R. B.; Larsson, D. G. Joakim] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); University of Gothenburg	Shouche, YS (corresponding author), Natl Ctr Cell Sci, Microbial Culture Collect MCC, Pune, Maharashtra, India.	yogesh@nccs.res.in	Larsson, D.G. Joakim/E-5243-2011; Marathe, Nachiket/AAJ-3565-2021	Larsson, D.G. Joakim/0000-0002-5496-0328; Marathe, Nachiket/0000-0003-2955-3402; Moore, Edward/0000-0001-7693-924X	Swedish International Development Agency (SIDA) [348-2008-6146]; Swedish Research Council (VR); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS); The Swedish Foundation for Strategic Environmental Research (MISTRA); Council of Scientific and Industrial Research (CSIR), New Delhi	Swedish International Development Agency (SIDA); Swedish Research Council (VR)(Swedish Research Council); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); The Swedish Foundation for Strategic Environmental Research (MISTRA); Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	The work was funded by the Swedish International Development Agency (SIDA) project nr. 348-2008-6146; this funding enabled the exchange of NPM between India and Sweden. The work was also funded by the Swedish Research Council (VR), the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) and The Swedish Foundation for Strategic Environmental Research (MISTRA). Nachiket Marathe held a fellowship from Council of Scientific and Industrial Research (CSIR), New Delhi, during the completion of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AM, 2005, J ANTIMICROB CHEMOTH, V55, P371, DOI 10.1093/jac/dkh534; Al-Jubouri MA, 2001, J CLIN PATHOL, V54, P412, DOI 10.1136/jcp.54.5.412-a; Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; [Anonymous], 2006, M2A9 CLSI; Apisarnthanarak A, 2005, DIAGN MICR INFEC DIS, V53, P153, DOI 10.1016/j.diagmicrobio.2005.05.014; Babic S, 2007, CHROMATOGRAPHIA, V65, P105, DOI 10.1365/s10337-006-0109-2; Barbosa TM, 2000, DRUG RESIST UPDATE, V3, P303, DOI 10.1054/drup.2000.0167; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Beijer K, 2013, CHEMOSPHERE, V90, P1149, DOI 10.1016/j.chemosphere.2012.09.023; Bhullar K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034953; Biskri L, 2003, ANTIMICROB AGENTS CH, V47, P3326, DOI 10.1128/AAC.47.10.3326-3331.2003; Carlsson G, 2009, ENVIRON TOXICOL CHEM, V28, P2656, DOI 10.1897/08-524.1; Chinedum IE, 2005, AFR J BIOTECHNOL, V4, P1606; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dharne MS, 2008, J MICROBIOL IMMUNOL, V41, P183; Drago L, 2001, J ANTIMICROB CHEMOTH, V48, P37, DOI 10.1093/jac/48.1.37; Fick J, 2009, ENVIRON TOXICOL CHEM, V28, P2522, DOI 10.1897/09-073.1; Finley RL, 2013, CLIN INFECT DIS, V57, P704, DOI 10.1093/cid/cit355; Forsberg KJ, 2012, SCIENCE, V337, P1107, DOI 10.1126/science.1220761; Gassama-Sow A, 2010, J INFECT DEV COUNTR, V4, P207, DOI 10.3855/jidc.583; Gaze W.H., 2013, EMERG INFECT DIS, V19, DOI [10.3201/eid1907.120871, DOI 10.3201/EID1907.120871]; Gaze WH, 2011, ISME J, V5, P1253, DOI 10.1038/ismej.2011.15; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Gunnarsson L, 2009, ENVIRON TOXICOL CHEM, V28, P2639, DOI 10.1897/09-120.1; Hansson K, 2002, J BACTERIOL, V184, P1712, DOI 10.1128/JB.184.6.1712-1721.2002; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Johnning A, 2013, APPL ENVIRON MICROB, V79, P7256, DOI 10.1128/AEM.02141-13; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Koreishi AF, 2006, OPHTHALMOLOGY, V113, P1463, DOI 10.1016/j.ophtha.2006.03.047; Kristiansson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017038; Larsson DGJ, 2007, J HAZARD MATER, V148, P751, DOI 10.1016/j.jhazmat.2007.07.008; Larsson DGJ, 2009, REGUL TOXICOL PHARM, V53, P161, DOI 10.1016/j.yrtph.2009.01.008; LEVESQUE C, 1995, ANTIMICROB AGENTS CH, V39, P185, DOI 10.1128/AAC.39.1.185; Li D, 2008, ENVIRON TOXICOL CHEM, V27, P80, DOI 10.1897/07-080.1; Li D, 2010, APPL ENVIRON MICROB, V76, P3444, DOI 10.1128/AEM.02964-09; Li D, 2009, ENVIRON MICROBIOL, V11, P1506, DOI 10.1111/j.1462-2920.2009.01878.x; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P44, DOI 10.1111/j.1574-6976.2008.00142.x; Marathe N, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-222; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Mazel D, 2000, ANTIMICROB AGENTS CH, V44, P1568, DOI 10.1128/AAC.44.6.1568-1574.2000; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; Moller LVM, 1999, J CLIN MICROBIOL, V37, P241; Moura A, 2007, J ANTIMICROB CHEMOTH, V60, P1243, DOI 10.1093/jac/dkm340; OBI CL, 1995, E AFR MED J, V72, P370; Praharaj I, 2012, Indian J Med Microbiol, V30, P242, DOI 10.4103/0255-0857.96713; Pruden A, 2013, ENVIRON HEALTH PERSP, V121, P878, DOI 10.1289/ehp.1206446; Ramirez MS, 2005, ANTIMICROB AGENTS CH, V49, P5179, DOI 10.1128/AAC.49.12.5179-5181.2005; Reid KC, 2001, CLIN INFECT DIS, V32, P1540, DOI 10.1086/320542; Rutgersson C, 2013, ENVIRON TOXICOL CHEM, V32, P577, DOI 10.1002/etc.2105; Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004; Sambhav K, 2011, J MED MICROBIOL, V60, P670, DOI 10.1099/jmm.0.016675-0; SAMBROOK J, 2000, MOL CLONING LAB MANU; Segura PA, 2009, ENVIRON HEALTH PERSP, V117, P675, DOI 10.1289/ehp.11776; Sim WJ, 2011, CHEMOSPHERE, V82, P179, DOI 10.1016/j.chemosphere.2010.10.026; Skurnik D, 2005, ANTIMICROB AGENTS CH, V49, P3062, DOI 10.1128/AAC.49.7.3062-3065.2005; Ramirez MS, 2010, ANTIMICROB AGENTS CH, V54, P699, DOI 10.1128/AAC.01392-08; Sommer MOA, 2010, VIRULENCE, V1, P299, DOI 10.4161/viru.1.4.12010; Thoma B, 2009, INT J MED MICROBIOL, V299, P209, DOI 10.1016/j.ijmm.2008.06.009; Wellington EMH, 2013, LANCET INFECT DIS, V13, P155, DOI 10.1016/S1473-3099(12)70317-1; White PA, 2001, ANTIMICROB AGENTS CH, V45, P2658, DOI 10.1128/AAC.45.9.2658-2661.2001; Wright MS, 2008, ISME J, V2, P417, DOI 10.1038/ismej.2008.8; Yoh M, 2005, J MED MICROBIOL, V54, P1077, DOI 10.1099/jmm.0.45846-0	64	72	76	3	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77310	10.1371/journal.pone.0077310	http://dx.doi.org/10.1371/journal.pone.0077310			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204801	gold, Green Published, Green Submitted			2022-12-27	WOS:000326270700025
J	Stessman, HAF; Mansoor, A; Zhan, FH; Linden, MA; Van Ness, B; Baughn, LB				Stessman, Holly A. F.; Mansoor, Aatif; Zhan, Fenghuang; Linden, Michael A.; Van Ness, Brian; Baughn, Linda B.			Bortezomib Resistance Can Be Reversed by Induced Expression of Plasma Cell Maturation Markers in a Mouse In Vitro Model of Multiple Myeloma	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; PROTEASOME INHIBITOR BORTEZOMIB; TRANSCRIPTION FACTOR XBP-1; B-CELL; DIFFERENTIATION; GENE; BLIMP-1; LIPOPOLYSACCHARIDE; LYMPHOCYTES; CANCER	Multiple myeloma (MM), the second most common hematopoietic malignancy, remains an incurable plasma cell (PC) neoplasm. While the proteasome inhibitor, bortezomib (Bz) has increased patient survival, resistance represents a major treatment obstacle as most patients ultimately relapse becoming refractory to additional Bz therapy. Current tests fail to detect emerging resistance; by the time patients acquire resistance, their prognosis is often poor. To establish immunophenotypic signatures that predict Bz sensitivity, we utilized Bz-sensitive and -resistant cell lines derived from tumors of the Bcl-X-L/Myc mouse model of PC malignancy. We identified significantly reduced expression of two markers (CD93, CD69) in "acquired" (Bz-selected) resistant cells. Using this phenotypic signature, we isolated a subpopulation of cells from a drug-naive, Bz-sensitive culture that displayed "innate" resistance to Bz. Although these genes were identified as biomarkers, they may indicate a mechanism for Bz-resistance through the loss of PC maturation which may be induced and/or selected by Bz. Significantly, induction of PC maturation in both "acquired" and "innate" resistant cells restored Bz sensitivity suggesting a novel therapeutic approach for reversing Bz resistance in refractory MM.	[Stessman, Holly A. F.; Mansoor, Aatif; Van Ness, Brian; Baughn, Linda B.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Zhan, Fenghuang] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Linden, Michael A.; Baughn, Linda B.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Iowa; University of Minnesota System; University of Minnesota Twin Cities	Van Ness, B (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA.	vanne001@umn.edu; lbaughn@umn.edu		Stessman, Holly/0000-0002-0764-3493; Linden, Michael/0000-0002-7433-1676	Millennium Pharmaceuticals, Inc.; University of Minnesota; Masonic Cancer Center [P30CA077598-09];  [P30CA77598]; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER	Millennium Pharmaceuticals, Inc.(Takeda Pharmaceutical Company Ltd); University of Minnesota(University of Minnesota System); Masonic Cancer Center; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	B.V.N. received research funding for this work from Millennium Pharmaceuticals, Inc. B.V.N. and L. B. B. received research funding for this work from the University of Minnesota Grant-In-Aid (http://www.research.umn.edu/advance/gia.html#.UYkNm6KNqsQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Array comparative genomic hybridization experiments were performed at the University of Minnesota Cytogenetics Core Laboratory with support from the Masonic Cancer Center Grant P30CA077598-09. Flow cytometry was performed at the Flow Cytometry Core Facility of the Masonic Cancer Center at the University of Minnesota supported by P30CA77598.	Adams J, 1999, CANCER RES, V59, P2615; Alsayed Y, 2007, BLOOD, V109, P2708, DOI 10.1182/blood-2006-07-035857; Angelin-Duclos C, 2000, J IMMUNOL, V165, P5462, DOI 10.4049/jimmunol.165.10.5462; Bao L, 2013, LEUK RES; Bhattacharya D, 2007, J IMMUNOL, V179, P6808, DOI 10.4049/jimmunol.179.10.6808; Boylan KLM, 2007, CANCER RES, V67, P4069, DOI 10.1158/0008-5472.CAN-06-3699; Chen-Kiang S, 2003, IMMUNOL REV, V194, P39, DOI 10.1034/j.1600-065X.2003.00065.x; Cheung WC, 2004, J CLIN INVEST, V113, P1763, DOI 10.1172/JCI200420369; Chevrier S, 2009, P NATL ACAD SCI USA, V106, P3895, DOI 10.1073/pnas.0809736106; Greenlee-Wacker MC, 2012, CURR DRUG TARGETS, V13, P411; Gu JL, 2012, BIOCHEM BIOPH RES CO, V420, P644, DOI 10.1016/j.bbrc.2012.03.056; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; KEARNEY JF, 1978, J IMMUNOL, V120, P158; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Lee EC, 2011, CLIN CANCER RES, V17, P7313, DOI 10.1158/1078-0432.CCR-11-0636; Ling SCW, 2012, HAEMATOL-HEMATOL J, V97, P64, DOI 10.3324/haematol.2011.043331; Lonial S, 2010, HEMATOL-AM SOC HEMAT, P303, DOI 10.1182/asheducation-2010.1.303; Mahindra A, 2012, NAT REV CLIN ONCOL, V9, P135, DOI 10.1038/nrclinonc.2012.15; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; Meister S, 2007, CANCER RES, V67, P1783, DOI 10.1158/0008-5472.CAN-06-2258; Moreau P, 2012, BLOOD, V120, P947, DOI 10.1182/blood-2012-04-403733; Mulligan G, 2007, BLOOD, V109, P3177, DOI 10.1182/blood-2006-09-044974; PLATICA M, 1985, J NATL CANCER I, V74, P197; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rajkumar SV, 2005, J CLIN ONCOL, V23, P630, DOI 10.1200/JCO.2005.11.030; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Richardson PG, 2007, BLOOD, V110, P3557, DOI 10.1182/blood-2006-08-036947; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Shaughnessy Jr JD, 2011, BLOOD; Stessman HA, 2013, LEUKEMIA; Stessman HA, 2013, MOL CANC THER; Tagoug I, 2013, EUR J PHARMACOL, V706, P11, DOI 10.1016/j.ejphar.2013.02.002	35	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77608	10.1371/journal.pone.0077608	http://dx.doi.org/10.1371/journal.pone.0077608			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204892	gold, Green Published, Green Submitted			2022-12-27	WOS:000326270700043
J	You, S; Piali, L; Kuhn, C; Steiner, B; Sauvaget, V; Valette, F; Clozel, M; Bach, JF; Chatenoud, L				You, Sylvaine; Piali, Luca; Kuhn, Chantal; Steiner, Beat; Sauvaget, Virginia; Valette, Fabrice; Clozel, Martine; Bach, Jean-Francois; Chatenoud, Lucienne			Therapeutic Use of a Selective S1P(1) Receptor Modulator Ponesimod in Autoimmune Diabetes	PLOS ONE			English	Article							REGULATORY T-CELLS; RELAPSING MULTIPLE-SCLEROSIS; GLUTAMIC-ACID DECARBOXYLASE; SPHINGOSINE 1-PHOSPHATE; NOD MICE; ORAL FINGOLIMOD; LYMPHOID ORGANS; B-CELLS; FTY720; TOLERANCE	In the present study, we investigated the therapeutic potential of a selective S1P(1) receptor modulator, ponesimod, to protect and reverse autoimmune diabetes in non-obese diabetic (NOD) mice. Ponesimod was administered orally to NOD mice starting at 6, 10, 13 and 16 weeks of age up to 35 weeks of age or to NOD mice showing recent onset diabetes. Peripheral blood and spleen B and T cell counts were significantly reduced after ponesimod administration. In pancreatic lymph nodes, B lymphocytes were increased and expressed a transitional 1-like phenotype. Chronic oral ponesimod treatment efficiently prevented autoimmune diabetes in 6, 10 and 16 week-old pre-diabetic NOD mice. Treatment withdrawal led to synchronized disease relapse. Ponesimod did not inhibit the differentiation of autoreactive T cells as assessed by adoptive transfer of lymphocytes from treated disease-free NOD mice. In addition, it did not affect the migration, proliferation and activation of transgenic BDC2.5 cells into the target tissue. However, ponesimod inhibited spreading of the T cell responses to islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP). Treatment of diabetic NOD mice with ponesimod induced disease remission. However, here again, upon treatment cessation, the disease rapidly recurred. This recurrence was effectively prevented by combination treatment with a CD3 antibody leading to the restoration of self-tolerance. In conclusion, treatment with a selective S1P(1) modulator in combination with CD3 antibody represents a promising therapeutic approach for the treatment of autoimmune diabetes.	[You, Sylvaine; Kuhn, Chantal; Sauvaget, Virginia; Valette, Fabrice; Bach, Jean-Francois; Chatenoud, Lucienne] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [You, Sylvaine; Kuhn, Chantal; Sauvaget, Virginia; Valette, Fabrice; Bach, Jean-Francois; Chatenoud, Lucienne] INSERM, U1013, Paris, France; [Piali, Luca; Steiner, Beat; Clozel, Martine] Actel Pharmaceut Ltd, Allschwil, Switzerland	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Actelion Pharmaceuticals Ltd	Chatenoud, L (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Paris, France.	lucienne.chatenoud@inserm.fr	You, Sylvaine/AAF-5600-2021	You, Sylvaine/0000-0002-1578-5205	INSERM; Fondation Day Solvay; Juvenile Diabetes Research Foundation (JDRF); Actelion Pharmaceuticals Ltd.	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation Day Solvay(Solvay SA); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Actelion Pharmaceuticals Ltd.	This work was supported by grants from INSERM, Fondation Day Solvay, the Juvenile Diabetes Research Foundation (JDRF) and funding from Actelion Pharmaceuticals Ltd. The authors' laboratory is a member of the Centaure network. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Battaglia M, 2006, DIABETES, V55, P1571, DOI 10.2337/db05-1576; Bolli MH, 2010, J MED CHEM, V53, P4198, DOI 10.1021/jm100181s; Brinkmann V, 2002, CURR OPIN IMMUNOL, V14, P569, DOI 10.1016/S0952-7915(02)00374-6; Brinkmann V, 2000, TRENDS PHARMACOL SCI, V21, P49, DOI 10.1016/S0165-6147(99)01419-4; Brossard P, 2013, BR J CLIN PHARM, DOI 10.1111/bcp.12129; Chatenoud L, 1997, J IMMUNOL, V158, P2947; CHATENOUD L, 1994, P NATL ACAD SCI USA, V91, P123, DOI 10.1073/pnas.91.1.123; Chatenoud L, 2007, NAT REV IMMUNOL, V7, P622, DOI 10.1038/nri2134; Chatenoud L, 2010, NAT REV ENDOCRINOL, V6, P149, DOI 10.1038/nrendo.2009.275; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Daniel C, 2007, MOL IMMUNOL, V44, P3305, DOI 10.1016/j.molimm.2007.02.026; Enee E, 2008, J IMMUNOL, V180, P5430, DOI 10.4049/jimmunol.180.8.5430; Kabashima K, 2006, J EXP MED, V203, P2683, DOI 10.1084/jem.20061289; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Keymeulen B, 2010, DIABETOLOGIA, V53, P614, DOI 10.1007/s00125-009-1644-9; Kovarik JM, 2004, J CLIN PHARMACOL, V44, P532, DOI 10.1177/0091270004264165; Krishnamurthy B, 2006, J CLIN INVEST, V116, P3258, DOI 10.1172/JCI29602; Lampropoulou V, 2010, IMMUNOL REV, V233, P146, DOI 10.1111/j.0105-2896.2009.00855.x; Ledgerwood LG, 2008, NAT IMMUNOL, V9, P42, DOI 10.1038/ni1534; LEHMANN PV, 1992, NATURE, V358, P155, DOI 10.1038/358155a0; Lepault F, 1998, LAB INVEST, V78, P551; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Maki T, 2005, TRANSPLANTATION, V79, P1051, DOI 10.1097/01.TP.0000161220.87548.EE; Maki T, 2002, TRANSPLANTATION, V74, P1684, DOI 10.1097/01.TP.0000038969.72218.0F; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matsuura M, 2000, INT J IMMUNOPHARMACO, V22, P323, DOI 10.1016/S0192-0561(99)00088-0; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; Miller SD, 1997, NAT MED, V3, P1133, DOI 10.1038/nm1097-1133; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Nikolova Z, 2001, TRANSPL IMMUNOL, V8, P267, DOI 10.1016/S0966-3274(01)00031-4; Okazaki H, 2002, J RHEUMATOL, V29, P707; Penaranda C, 2011, J IMMUNOL, V187, P2015, DOI 10.4049/jimmunol.1100713; Penaranda C, 2010, DIABETES, V59, P1461, DOI 10.2337/db09-1129; Piali L, 2011, J PHARMACOL EXP THER, V337, P547, DOI 10.1124/jpet.110.176487; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Salvadori M, 2006, AM J TRANSPLANT, V6, P2912, DOI 10.1111/j.1600-6143.2006.01552.x; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Sherry N., 2011, LANCET; Sobel K, 2013, J BIOL CHEM, V288, P14839, DOI 10.1074/jbc.M112.426726; Stadinski BD, 2010, NAT IMMUNOL, V11, P225, DOI 10.1038/ni.1844; TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0; Webb M, 2004, J NEUROIMMUNOL, V153, P108, DOI 10.1016/j.jneuroim.2004.04.015; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; You S, 2005, DIABETES, V54, P1415, DOI 10.2337/diabetes.54.5.1415; You S, 2012, AM J TRANSPLANT, V12, P2909, DOI 10.1111/j.1600-6143.2012.04213.x; You S, 2003, J IMMUNOL, V170, P4011, DOI 10.4049/jimmunol.170.8.4011; You S, 2007, P NATL ACAD SCI USA, V104, P6335, DOI 10.1073/pnas.0701171104; You S, 2006, IMMUNOL REV, V212, P185, DOI 10.1111/j.0105-2896.2006.00410.x	50	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77296	10.1371/journal.pone.0077296	http://dx.doi.org/10.1371/journal.pone.0077296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204793	gold, Green Submitted, Green Published			2022-12-27	WOS:000326152300018
J	Aronovich, EL; Hall, BC; Bell, JB; McIvor, RS; Hackett, PB				Aronovich, Elena L.; Hall, Bryan C.; Bell, Jason B.; McIvor, R. Scott; Hackett, Perry B.			Quantitative Analysis of alpha-L-Iduronidase Expression in Immunocompetent Mice Treated with the Sleeping Beauty Transposon System	PLOS ONE			English	Article							TRANSGENE EXPRESSION; GENE-TRANSFER; IN-VIVO; INTRAPERITONEAL INJECTION; FACTOR-IX; DNA; LIVER; VECTORS; INCREASES; THERAPY	The Sleeping Beauty transposon system, a non-viral, integrating vector that can deliver the alpha-L-iduronidase-encoding gene, is efficient in correcting mucopolysaccharidosis type I in NOD/SCID mice. However, in previous studies we failed to attain reliable long-term alpha-L-iduronidase expression in immunocompetent mice. Here, we focused on achieving sustained high-level expression in immunocompetent C57BL/6 mice. In our standard liver-directed treatment we hydrodynamically infuse mice with plasmids containing a SB transposon-encoding human alpha-L-iduronidase, along with a source of SB transposase. We sought to 1) minimize expression of the therapeutic enzyme in antigen-presenting cells, while avoiding promoter shutdown and gender bias, 2) increase transposition efficiency and 3) improve immunosuppression. By using a liver-specific promoter to drive IDUA expression, the SB100X hyperactive transposase and transient cyclophosphamide immunosuppression we achieved therapeutic-level (>= 100 wild-type) stabilized expression for 1 year in 50% of C57BL/6 mice. To gain insights into the causes of variability in transgene expression, we quantified the rates of alpha-L-iduronidase activity decay vis-a-vis transposition and transgene maintenance using the data obtained in this and previous studies. Our analyses showed that immune responses are the most important variable to control in order to prevent loss of transgene expression. Cumulatively, our results allow transition to pre-clinical studies of SB-mediated alpha-L-iduronidase expression and correction of mucopolysaccharidosis type I in animal models.	[Aronovich, Elena L.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; Univ Minnesota, Ctr Genome Engn, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Aronovich, EL (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	arono001@umn.edu	Wilson, Matthew H/K-3193-2013		National Institutes of Health [1R01DK082516, P01 HD32652]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD032652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082516] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by grants 1R01DK082516 and P01 HD32652 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammar Ismahen, 2012, Methods Mol Biol, V859, P229, DOI 10.1007/978-1-61779-603-6_13; Aronovich EL, 2007, J GENE MED, V9, P403, DOI 10.1002/jgm.1028; Aronovich EL, 2011, HUM MOL GENET, V20, pR14, DOI 10.1093/hmg/ddr140; Aronovich EL, 2009, MOL THER, V17, P1136, DOI 10.1038/mt.2009.87; Arruda VR, 2009, MOL THER, V17, P1492, DOI 10.1038/mt.2009.150; Bell JB, 2007, NAT PROTOC, V2, P3153, DOI 10.1038/nprot.2007.471; Bell JB, 2010, MOL THER, V18, P1796, DOI 10.1038/mt.2010.152; Chen ZY, 2008, MOL THER, V16, P548, DOI 10.1038/sj.mt.6300399; Chen ZY, 2003, MOL THER, V8, P495, DOI 10.1016/S1525-0016(03)00168-0; Cui ZB, 2002, J MOL BIOL, V318, P1221, DOI 10.1016/S0022-2836(02)00237-1; Das RG, 2007, LAB ANIM-UK, V41, P312, DOI 10.1258/002367707781282802; Garcia-Rivera MF, 2007, BRAIN RES BULL, V74, P429, DOI 10.1016/j.brainresbull.2007.07.018; Geurts AM, 2003, MOL THER, V8, P108, DOI 10.1016/S1525-0016(03)00099-6; Hackett PB, 2010, MOL THER, V18, P674, DOI 10.1038/mt.2010.2; Hackett PB, 2011, CURR GENE THER, V11, P341; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Izsvak Z, 2004, MOL CELL, V13, P279, DOI 10.1016/S1097-2765(03)00524-0; Izsvak Z, 2010, BIOESSAYS, V32, P756, DOI 10.1002/bies.201000027; Liu GY, 2004, J GENE MED, V6, P574, DOI 10.1002/jgm.486; Lu JM, 2013, MOL THER, V21, P954, DOI 10.1038/mt.2013.33; Maniar LEG, 2013, MOL THER, V21, P131, DOI 10.1038/mt.2012.244; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Miao CH, 2000, MOL THER, V1, P522, DOI 10.1006/mthe.2000.0075; MINER NA, 1969, APPL MICROBIOL, V17, P250, DOI 10.1128/AEM.17.2.250-251.1969; Neufeld EF, 2001, METABOLIC MOL BASES, VIII, P3427; Okuyama T, 1996, HUM GENE THER, V7, P637, DOI 10.1089/hum.1996.7.5-637; Osborn MJ, 2011, MOL THER, V19, P450, DOI 10.1038/mt.2010.249; Plasterk RHA, 1999, TRENDS GENET, V15, P326, DOI 10.1016/S0168-9525(99)01777-1; Podetz-Pedersen KM, 2010, HUM GENE THER, V21, P210, DOI 10.1089/hum.2009.128; Score PR, 2006, MOL THER, V13, P617, DOI 10.1016/j.ymthe.2005.10.015; Yant SR, 2004, MOL CELL BIOL, V24, P9239, DOI 10.1128/MCB.24.20.9239-9247.2004; Yant SR, 2000, NAT GENET, V25, P35, DOI 10.1038/75568; Zayed H, 2004, MOL THER, V9, P292, DOI 10.1016/j.ymthe.2003.11.024	34	14	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78161	10.1371/journal.pone.0078161	http://dx.doi.org/10.1371/journal.pone.0078161			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205141	Green Published, Green Submitted, gold			2022-12-27	WOS:000326032600076
J	Jamsai, D; Clark, BJ; Smith, SJ; Whittle, B; Goodnow, CC; Ormandy, CJ; O'Bryan, MK				Jamsai, Duangporn; Clark, Brett J.; Smith, Stephanie J.; Whittle, Belinda; Goodnow, Christopher C.; Ormandy, Christopher J.; O'Bryan, Moira K.			A Missense Mutation in the Transcription Factor ETV5 Leads to Sterility, Increased Embryonic and Perinatal Death, Postnatal Growth Restriction, Renal Asymmetry and Polydactyly in the Mouse	PLOS ONE			English	Article							SPERMATOGONIAL STEM-CELLS; SELF-RENEWAL; FAMILY; GENES; MICE; ERM; MAINTENANCE; INFERTILITY; DOWNSTREAM; FERTILITY	ETV5 (Ets variant gene 5) is a transcription factor that is required for fertility. In this study, we demonstrate that ETV5 plays additional roles in embryonic and postnatal developmental processes in the mouse. Through a genome-wide mouse mutagenesis approach, we generated a sterile mouse line that carried a nonsense mutation in exon 12 of the Etv5 gene. The mutation led to the conversion of lysine at position 412 into a premature termination codon (PTC) within the ETS DNA binding domain of the protein. We showed that the PTC-containing allele produced a highly unstable mRNA, which in turn resulted in an undetectable level of ETV5 protein. The Etv5 mutation resulted in male and female sterility as determined by breeding experiments. Mutant males were sterile due to a progressive loss of spermatogonia, which ultimately resulted in a Sertoli cell only phenotype by 8 week-of-age. Further, the ETV5 target genes Cxcr4 and Ccl9 were significantly down-regulated in mutant neonate testes. CXCR4 and CCL9 have been implicated in the maintenance and migration of spermatogonia, respectively. Moreover, the Etv5 mutation resulted in several developmental abnormalities including an increased incidence of embryonic and perinatal lethality, postnatal growth restriction, polydactyly and renal asymmetry. Thus, our data define a physiological role for ETV5 in many aspects of development including embryonic and perinatal survival, postnatal growth, limb patterning, kidney development and fertility.	[Jamsai, Duangporn; Clark, Brett J.; Smith, Stephanie J.; O'Bryan, Moira K.] Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic 3004, Australia; [Whittle, Belinda; Goodnow, Christopher C.] Australian Natl Univ, Australian Phen Facil, Canberra, ACT, Australia; [Ormandy, Christopher J.] Garvan Inst Med Res, Sydney, NSW, Australia	Monash University; Australian National University; Garvan Institute of Medical Research	Jamsai, D (corresponding author), Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic 3004, Australia.	duangporn.jamsai@monash.edu	Ormandy, Chris/G-4165-2014; Goodnow, Christopher C/V-8108-2018; O'Bryan, Moira K/F-8256-2012	Goodnow, Christopher C/0000-0001-5296-6155; O'Bryan, Moira K/0000-0001-7298-4940; Ormandy, Christopher/0000-0002-2504-7919	Australian Research Council (ARC); New South Wales Cancer Council; Cancer Institute New South Wales; Banque Nationale de Paris-Paribas Australia; RT Hall Trust; National Breast Cancer Foundation; National Health and Medical Research Council (NHMRC) of Australia [384297]; NHMRC [545805, 481310]; NHMRC Australia Fellowship	Australian Research Council (ARC)(Australian Research Council); New South Wales Cancer Council(Cancer Council New South Wales); Cancer Institute New South Wales; Banque Nationale de Paris-Paribas Australia; RT Hall Trust; National Breast Cancer Foundation; National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants the Australian Research Council (ARC) to MKO'B and CJO; the New South Wales Cancer Council, Cancer Institute New South Wales, Banque Nationale de Paris-Paribas Australia and New Zealand, RT Hall Trust, and the National Breast Cancer Foundation to CJO. DJ was a National Health and Medical Research Council (NHMRC) of Australia Peter Doherty Postdoctoral Fellow (#384297). MKO'B and CJO are NHMRC Senior Research Fellows (#545805, #481310). CCG is an NHMRC Australia Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borg CL, 2010, HUM REPROD UPDATE, V16, P205, DOI 10.1093/humupd/dmp032; Chen C, 2005, NATURE, V436, P1030, DOI 10.1038/nature03894; Eo J, 2008, J ENDOCRINOL, V198, P281, DOI 10.1677/JOE-08-0142; Eo J, 2011, MOL HUM REPROD, V17, P568, DOI 10.1093/molehr/gar021; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Jamsai D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056955; Jamsai D, 2010, SYST BIOL REPROD MED, V56, P246, DOI 10.3109/19396361003706424; Kanatsu-Shinohara M, 2012, CELL STEM CELL, V11, P567, DOI 10.1016/j.stem.2012.06.011; Latchman DS, 1996, NEW ENGL J MED, V334, P28, DOI 10.1056/NEJM199601043340108; Liu YR, 2003, DEV BIOL, V261, P10, DOI 10.1016/S0012-1606(03)00359-2; Lo JCY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002969; Lu BC, 2009, NAT GENET, V41, P1295, DOI 10.1038/ng.476; McLachlan RI, 2007, HUM REPROD, V22, P2, DOI 10.1093/humrep/del279; MONTE D, 1994, ONCOGENE, V9, P1397; O'Bryan MK, 2012, FERTIL STERIL, V98, P827, DOI 10.1016/j.fertnstert.2012.06.013; O'Donnell L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002698; Oatley JM, 2007, J BIOL CHEM, V282, P25842, DOI 10.1074/jbc.M703474200; Oatley JM, 2006, P NATL ACAD SCI USA, V103, P9524, DOI 10.1073/pnas.0603332103; Paratore C, 2002, DEV BIOL, V250, P168, DOI 10.1006/dbio.2002.0795; Schlesser HN, 2008, BIOL REPROD, V78, P483, DOI 10.1095/biolreprod.107.062935; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Simon L, 2010, STEM CELLS, V28, P1882, DOI 10.1002/stem.508; Tyagi G, 2009, BIOL REPROD, V81, P258, DOI 10.1095/biolreprod.108.075200; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Wu X, 2011, BIOL REPROD, V85, P1114, DOI 10.1095/biolreprod.111.091793; Yang QE, 2013, J CELL SCI, V126, P1009, DOI 10.1242/jcs.119826; Zhang Z, 2010, DEVELOPMENT, V137, P3417, DOI 10.1242/dev.051789; Zhang Z, 2009, DEV CELL, V16, P607, DOI 10.1016/j.devcel.2009.02.008	28	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77311	10.1371/journal.pone.0077311	http://dx.doi.org/10.1371/journal.pone.0077311			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204802	gold, Green Submitted, Green Published			2022-12-27	WOS:000326032600031
J	Kittan, NA; Allen, RM; Dhaliwal, A; Cavassani, KA; Schaller, M; Gallagher, KA; Carson, WF; Mukherjee, S; Grembecka, J; Cierpicki, T; Jarai, G; Westwick, J; Kunkel, SL; Hogaboam, CM				Kittan, Nicolai A.; Allen, Ronald M.; Dhaliwal, Abhay; Cavassani, Karen A.; Schaller, Matthew; Gallagher, Katherine A.; Carson, William F.; Mukherjee, Sumanta; Grembecka, Jolanta; Cierpicki, Tomasz; Jarai, Gabor; Westwick, John; Kunkel, Steven L.; Hogaboam, Cory M.			Cytokine Induced Phenotypic and Epigenetic Signatures Are Key to Establishing Specific Macrophage Phenotypes	PLOS ONE			English	Article							ALTERNATIVE ACTIVATION; TYPE-2 MACROPHAGES; MANNOSE RECEPTOR; GENE-EXPRESSION; DENDRITIC CELLS; IFN-GAMMA; POLARIZATION; MARKERS; CSF; INFLAMMATION	Macrophages (M Phi) play an essential role in innate immune responses and can either display a pro-inflammatory, classically activated phenotype (M1) or undergo an alternative activation program (M2) promoting immune regulation. M-CSF is used to differentiate monocytes into M Phi and IFN-gamma or IL-4+IL-13 to further polarize these cells towards M1 or M2, respectively. Recently, differentiation using only GM-CSF or M-CSF has been described to induce a M1- or M2-like phenotype, respectively. In this study, we combined both approaches by differentiating human M Phi in GMCSF or M-CSF followed by polarization with either IFN-gamma or IL-4+IL-13. We describe the phenotypic differences between CD14(hi) CD163(hi) CD206(int) FOLR2-expressing M-CSF M Phi and CD14(lo) CD163(lo) CD206(hi) GM-CSF M Phi but show that both macrophage populations reacted similarly to further polarization with IFN-gamma or IL-4+IL-13 with up-and down-regulation of common M1 and M2 marker genes. We also show that high expression of the mannose receptor (CD206), a marker of alternative activation, is a distinct feature of GM-CSF M Phi. Changes of the chromatin structure carried out by chromatin modification enzymes (CME) have been shown to regulate myeloid differentiation. We analyzed the expression patterns of CME during M Phi polarization and show that M1 up-regulate the histone methyltransferase MLL and demethylase KDM6B, while resting and M2 M Phi were characterized by DNA methyltransferases and histone deacetylases. We demonstrate that MLL regulates CXCL10 expression and that this effect could be abrogated using a MLL-Menin inhibitor. Taken together we describe the distinct phenotypic differences of GM-CSF or M-CSF M Phi and demonstrate that M Phi polarization is regulated by specific epigenetic mechanisms. In addition, we describe a novel role for MLL as marker for classical activation. Our findings provide new insights into M Phi polarization that could be helpful to distinguish M Phi activation states.	[Kittan, Nicolai A.; Allen, Ronald M.; Dhaliwal, Abhay; Cavassani, Karen A.; Schaller, Matthew; Carson, William F.; Mukherjee, Sumanta; Grembecka, Jolanta; Cierpicki, Tomasz; Kunkel, Steven L.; Hogaboam, Cory M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Gallagher, Katherine A.] Univ Michigan Hosp, Div Vasc Surg, Ann Arbor, MI 48109 USA; [Jarai, Gabor; Westwick, John] Novartis Inst Biomed Res, Resp Dis Area, Horsham, W Sussex, England	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Novartis	Hogaboam, CM (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	hogaboam@med.umich.edu	Schaller, Matthew/AAL-7640-2020; hogaboam, cory/M-3578-2014; Hogaboam, Cory M./AAI-1433-2021	Hogaboam, Cory M./0000-0003-3366-4850; Carson, William F/0000-0001-9459-3924	NIH [HL-31237]; Novartis Pharmaceuticals; NATIONAL CANCER INSTITUTE [R01CA160467] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031237, R01HL112897] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Pharmaceuticals(Novartis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by federal grants from the NIH (HL-31237) and in part by research funding from Novartis Pharmaceuticals (to Nicolai A. Kittan, Steven L. Kunkel and Cory M. Hogaboam). Gabor Jarai and John Westwick are employees of Novartis Institutes for Biomedical Research, UK (http://www.nibr.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambarus CA, 2012, J IMMUNOL METHODS, V375, P196, DOI 10.1016/j.jim.2011.10.013; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Eissenberg JC, 2010, DEV BIOL, V339, P240, DOI 10.1016/j.ydbio.2009.08.017; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Grembecka J, 2010, J BIOL CHEM, V285, P40690, DOI 10.1074/jbc.M110.172783; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Ivashkiv LB, 2013, TRENDS IMMUNOL, V34, P216, DOI 10.1016/j.it.2012.11.001; Joshi AD, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-52; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Lacey DC, 2012, J IMMUNOL, V188, P5752, DOI 10.4049/jimmunol.1103426; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Liu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052703; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Moreira AP, 2011, J INTERF CYTOK RES, V31, P485, DOI 10.1089/jir.2011.0027; Mullican SE, 2011, GENE DEV, V25, P2480, DOI 10.1101/gad.175950.111; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Pello OM, 2012, BLOOD, V119, P411, DOI 10.1182/blood-2011-02-339911; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Puig-Kroger A, 2009, CANCER RES, V69, P9395, DOI 10.1158/0008-5472.CAN-09-2050; Rice KL, 2007, ONCOGENE, V26, P6697, DOI 10.1038/sj.onc.1210755; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Segura E, 2012, J EXP MED, V209, P653, DOI 10.1084/jem.20111457; Shi AB, 2012, BLOOD, V120, P4461, DOI 10.1182/blood-2012-05-429274; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Staples KJ, 2012, J ALLERGY CLIN IMMUN, V130, P1404, DOI 10.1016/j.jaci.2012.07.023; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Stoger JL, 2012, ATHEROSCLEROSIS, V225, P461, DOI 10.1016/j.atherosclerosis.2012.09.013; Svensson J, 2011, J IMMUNOL, V187, P3671, DOI 10.4049/jimmunol.1100130; Takeuch O, 2011, EUR J IMMUNOL, V41, P2490, DOI 10.1002/eji.201141792; Pham TH, 2012, BLOOD, V119, pE161, DOI 10.1182/blood-2012-01-402453; Van den Bossche J, 2009, BLOOD, V114, P4664, DOI 10.1182/blood-2009-05-221598; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; Waldo SW, 2008, AM J PATHOL, V172, P1112, DOI 10.2353/ajpath.2008.070513; WANG X, 2012, J CELL SCI; Wen HT, 2008, BLOOD, V111, P1797, DOI 10.1182/blood-2007-08-106443; Yeh CH, 2010, INFLAMMATION, V33, P10, DOI 10.1007/s10753-009-9153-z; Yeruva S, 2008, INT J COLORECTAL DIS, V23, P305, DOI 10.1007/s00384-007-0396-6; Zeyda M, 2007, INT J OBESITY, V31, P1420, DOI 10.1038/sj.ijo.0803632	44	115	122	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78045	10.1371/journal.pone.0078045	http://dx.doi.org/10.1371/journal.pone.0078045			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205083	gold, Green Published, Green Submitted			2022-12-27	WOS:000326032600063
J	Xue, W; Huang, L; Dong, BC; Zhang, MX; Yu, FH				Xue, Wei; Huang, Lin; Dong, Bi-Cheng; Zhang, Ming-Xiang; Yu, Fei-Hai			Patchy Distributions of Competitors Affect the Growth of a Clonal Plant When the Competitor Density Is High	PLOS ONE			English	Article							MORPHOLOGICAL PLASTICITY; FORAGING BEHAVIOR; GRASSLAND PERENNIALS; SOLIDAGO-ALTISSIMA; SPATIAL-PATTERN; MODULAR CONCEPT; INTEGRATION; HETEROGENEITY; SPACE; OCCUPATION	Environments are patchy in not only abiotic factors but also biotic ones. Many studies have examined effects of spatial heterogeneity in abiotic factors such as light, water and nutrients on the growth of clonal plants, but few have tested those in biotic factors. We conducted a greenhouse experiment to examine how patchy distributions of competitors affect the growth of a rhizomatous wetland plant Bolboschoenus planiculmis and whether such effects depend on the density of the competitors. We grew one ramet of B. planiculmis in the center of each of the experimental boxes without competitors (Schoenoplectus triqueter), with a homogeneous distribution of the competitors of low or high density, and with a patchy distribution of the competitors of low or high density. The presence of competitors markedly decreased the growth (biomass, number of ramets, number of tubers and rhizome length) of the B. planiculmis clones. When the density of the competitors was low, the growth of B. planiculmis did not differ significantly between the competitor patches and competitor-free patches. However, when the density of the competitors was high, the growth of B. planiculmis was significantly higher in the competitor-free patches than in the competitor patches. Therefore, B. planiculmis can respond to patchy distributions of competitors by placing more ramets in competition-free patches when the density of competitors is high, but cannot do so when the density of competitors is low.	[Xue, Wei; Huang, Lin; Dong, Bi-Cheng; Zhang, Ming-Xiang; Yu, Fei-Hai] Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China	Beijing Forestry University	Zhang, MX (corresponding author), Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China.	zmx1972@126.com	Yu, Fei-Hai/O-9395-2016	Yu, Fei-Hai/0000-0001-5007-1745; Dong, Bi-Cheng/0000-0002-9658-9969	Forestry Commonwealth Project [201004078]; Fundamental Research Funds for the Central Universities [TD-JC-2013-1]; Program for New Century Excellent Talents in University [NECT-10-0234]	Forestry Commonwealth Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This research was supported by the Forestry Commonwealth Project (201004078), the Fundamental Research Funds for the Central Universities (TD-JC-2013-1) and the Program for New Century Excellent Talents in University (NECT-10-0234). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSON WG, 1991, AM J BOT, V78, P1508, DOI 10.2307/2444976; Cahill JF, 2003, J ECOL, V91, P532, DOI 10.1046/j.1365-2745.2003.00792.x; Day KJ, 2003, FUNCT ECOL, V17, P454, DOI 10.1046/j.1365-2435.2003.00758.x; de Kroon H, 2006, TRENDS ECOL EVOL, V21, P113, DOI 10.1016/j.tree.2005.11.021; de Kroon H, 2005, NEW PHYTOL, V166, P73, DOI 10.1111/j.1469-8137.2004.01310.x; De Kroon H, 2009, PLANT CELL ENVIRON, V32, P704, DOI 10.1111/j.1365-3040.2009.01936.x; Deegan B. M., 2004, Biology and Environment, V104B, P107, DOI 10.3318/BIOE.2004.104.2.107; DEKROON H, 1995, J ECOL, V83, P143, DOI 10.2307/2261158; Einsmann JC, 1999, J ECOL, V87, P609, DOI 10.1046/j.1365-2745.1999.00376.x; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; EVANS JP, 1995, ECOLOGY, V76, P1147, DOI 10.2307/1940922; He S, 1993, FLORA BEIJING; Huber-Sannwald E, 1998, ECOLOGY, V79, P2267, DOI 10.1890/0012-9658(1998)079[2267:EONPAR]2.0.CO;2; HUTCHINGS MJ, 1994, ADV ECOL RES, V25, P159, DOI 10.1016/S0065-2504(08)60215-9; Janecek S, 2004, FLORA, V199, P3, DOI 10.1078/0367-2530-00127; Janecek S, 2008, EVOL ECOL, V22, P325, DOI 10.1007/s10682-007-9203-7; Kleijn D, 1999, J ECOL, V87, P873, DOI 10.1046/j.1365-2745.1999.00406.x; Kume T, 2006, ANN BOT-LONDON, V98, P1271, DOI 10.1093/aob/mcl216; Li HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025629; Li HL, 2009, ECOL ENG, V35, P544, DOI 10.1016/j.ecoleng.2008.03.001; Louapre P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038288; Lucero DW, 2000, PLANT SOIL, V227, P1, DOI 10.1023/A:1026560128042; MACDONALD SE, 1993, J ECOL, V81, P769, DOI 10.2307/2261674; Macek P, 2003, PLANT ECOL, V168, P31, DOI 10.1023/A:1024460525317; MCCONNAUGHAY KDM, 1991, ECOLOGY, V72, P94, DOI 10.2307/1938905; MCCONNAUGHAY KDM, 1992, FUNCT ECOL, V6, P711, DOI 10.2307/2389968; Monzeglio U, 2005, OECOLOGIA, V145, P619, DOI 10.1007/s00442-005-0168-3; Monzeglio U, 2008, EVOL ECOL, V22, P723, DOI 10.1007/s10682-007-9197-1; Oborny B, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P155; Orrock JL, 2010, AM J BOT, V97, P694, DOI 10.3732/ajb.0900051; Price EAC, 1996, OIKOS, V75, P279, DOI 10.2307/3546251; Rebele F, 2000, PLANT ECOL, V147, P77, DOI 10.1023/A:1009808810378; Rich TCG, 2002, WATSONIA, V24, P56; ROSS MA, 1972, J ECOL, V60, P77, DOI 10.2307/2258041; SCHMID B, 1985, J ECOL, V73, P793, DOI 10.2307/2260147; SCHMID B, 1986, PROC R SOC SER B-BIO, V228, P173, DOI 10.1098/rspb.1986.0049; Semchenko M, 2008, NEW PHYTOL, V179, P1162, DOI 10.1111/j.1469-8137.2008.02543.x; SLADE AJ, 1987, J ECOL, V75, P95, DOI 10.2307/2260538; SLADE AJ, 1987, J ECOL, V75, P639, DOI 10.2307/2260196; SLADE AJ, 1987, J ECOL, V75, P1023, DOI 10.2307/2260311; Song YB, 2013, OECOLOGIA, V171, P317, DOI 10.1007/s00442-012-2430-9; Stark JM, 1994, EXPLOITATION ENV HET, P255; Stoll P, 2001, ECOLOGY, V82, P319, DOI 10.1890/0012-9658(2001)082[0319:IAACII]2.0.CO;2; Stoll P, 1998, J ECOL, V86, P341, DOI 10.1046/j.1365-2745.1998.00263.x; Stuefer Josef F., 1998, Perspectives in Plant Ecology Evolution and Systematics, V1, P47, DOI 10.1078/1433-8319-00051; Van Kleunen M, 2000, J EVOLUTION BIOL, V13, P237; van Kleunen M, 2000, EVOLUTION, V54, P1947, DOI 10.1111/j.0014-3820.2000.tb01239.x; vanderMaarel E, 1996, J VEG SCI, V7, P19, DOI 10.2307/3236412; von Felten S, 2008, J PLANT ECOL, V1, P33, DOI 10.1093/jpe/rtm006; Whitlock MC, 2007, J EVOLUTION BIOL, V20, P1772, DOI 10.1111/j.1420-9101.2007.01387.x; Wijesinghe DK, 2001, J ECOL, V89, P972, DOI 10.1111/j.1365-2745.2001.00618.x; Wu Z-Y, 2010, FLORA CHINA, V23; Yu FH, 2008, ANN BOT-LONDON, V102, P571, DOI 10.1093/aob/mcn119; Yu FH, 2001, EVOL ECOL, V15, P303, DOI 10.1023/A:1016032831038; Yuan H. G., 1991, Journal of Weed Science, V5, P17; Zhang XQ, 2006, FLORA, V201, P547, DOI 10.1016/j.flora.2005.12.002; Zheng Z-H, 2008, THESIS BEIJING FORES, P10	57	6	6	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78221	10.1371/journal.pone.0078221	http://dx.doi.org/10.1371/journal.pone.0078221			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205165	Green Published, gold			2022-12-27	WOS:000326032600083
J	Pascall, JC; Rotondo, S; Mukadam, AS; Oxley, D; Webster, J; Walker, SA; Piron, J; Carter, C; Ktistakis, NT; Butcher, GW				Pascall, John C.; Rotondo, Sergio; Mukadam, Aamir S.; Oxley, David; Webster, Judith; Walker, Simon A.; Piron, Jerry; Carter, Christine; Ktistakis, Nicholas T.; Butcher, Geoffrey W.			The Immune System GTPase GIMAP6 Interacts with the Atg8 Homologue GABARAPL2 and Is Recruited to Autophagosomes	PLOS ONE			English	Article							CELL-DEVELOPMENT; IAN FAMILY; GENE; SURVIVAL; RAT; EXPRESSION; LC3; IDENTIFICATION; POLYMORPHISM; DEGRADATION	The GIMAPs (GTPases of the immunity-associated proteins) are a family of small GTPases expressed prominently in the immune systems of mammals and other vertebrates. In mammals, studies of mutant or genetically-modified rodents have indicated important roles for the GIMAP GTPases in the development and survival of lymphocytes. No clear picture has yet emerged, however, of the molecular mechanisms by which they perform their function(s). Using biotin tag-affinity purification we identified a major, and highly specific, interaction between the human cytosolic family member GIMAP6 and GABARAPL2, one of the mammalian homologues of the yeast autophagy protein Atg8. Chemical cross-linking studies performed on Jurkat T cells, which express both GIMAP6 and GABARAPL2 endogenously, indicated that the two proteins in these cells readily associate with one another in the cytosol under normal conditions. The GIMAP6-GABARAPL2 interaction was disrupted by deletion of the last 10 amino acids of GIMAP6. The N-terminal region of GIMAP6, however, which includes a putative Atg8-family interacting motif, was not required. Over-expression of GIMAP6 resulted in increased levels of endogenous GABARAPL2 in cells. After culture of cells in starvation medium, GIMAP6 was found to localise in punctate structures with both GABARAPL2 and the autophagosomal marker MAP1LC3B, indicating that GIMAP6 re-locates to autophagosomes on starvation. Consistent with this finding, we have demonstrated that starvation of Jurkat T cells results in the degradation of GIMAP6. Whilst these findings raise the possibility that the GIMAPs play roles in the regulation of autophagy, we have been unable to demonstrate an effect of GIMAP6 over-expression on autophagic flux.	[Pascall, John C.; Rotondo, Sergio; Mukadam, Aamir S.; Carter, Christine; Butcher, Geoffrey W.] Babraham Inst, Cambridge, England; [Oxley, David; Webster, Judith] Babraham Inst, Mass Spectrometry Facil, Lab Lymphocyte Signalling & Dev, Cambridge, England; [Walker, Simon A.] Babraham Inst, Imaging Facil, Cambridge, England; [Piron, Jerry] Babraham Inst, Monoclonal Antibody Unit, Cambridge, England; [Ktistakis, Nicholas T.] Babraham Inst, Inositide Lab, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Butcher, GW (corresponding author), Babraham Inst, Cambridge, England.	geoff.butcher@babraham.ac.uk		Walker, Simon/0000-0001-9185-4922	Core Strategic Grant and Institute Strategic Grant [BBS/E/B/0000C0409]; UK BBSRC; BBSRC [BBS/E/B/0000l763]; Babraham Institute; Cambridge Commonwealth Trusts; BBSRC [BBS/E/B/000C0409, BBS/E/B/000C0413, BBS/E/B/000H0116, BBS/E/B/0000C241] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C241, BBS/E/B/000C0413, BBS/E/B/0000C042, BBS/E/B/000H0116, BBS/E/B/000C0409] Funding Source: researchfish	Core Strategic Grant and Institute Strategic Grant; UK BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Babraham Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cambridge Commonwealth Trusts; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Core Strategic Grant and Institute Strategic Grant (grant number BBS/E/B/0000C0409) funding by the UK BBSRC (http://www.bbsrc.ac.uk). SR was supported by PhD studentship funding (Grant number BBS/E/B/0000l763) from the BBSRC and The Babraham Institute; AM was supported by a PhD studentship from the Cambridge Commonwealth Trusts (http://www.admin.cam.ac.uk/students/studentregistry/fees/funding/trusts.html). The funders had no role in study design, data collection and anlysis, decision to publish, or preparation of the manuscript.	Aravind L, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00089; Barnes MJ, 2010, J IMMUNOL, V184, P3743, DOI 10.4049/jimmunol.0903164; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bhasin M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-342; Biller L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-63; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Carter C, 2007, J IMMUNOL, V179, P1784, DOI 10.4049/jimmunol.179.3.1784; Chadwick N, 2010, BLOOD CELL MOL DIS, V45, P201, DOI 10.1016/j.bcmd.2010.07.006; Chen YH, 2011, J EXP MED, V208, P923, DOI 10.1084/jem.20101192; Cousins L, 2006, GASTROENTEROLOGY, V131, P1475, DOI 10.1053/j.gastro.2006.09.023; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Dion C, 2005, INT IMMUNOL, V17, P1257, DOI 10.1093/intimm/dxh302; Drakas R, 2005, PROTEOMICS, V5, P132, DOI 10.1002/pmic.200400919; Drake KR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009806; ELDER ME, 1983, J IMMUNOL, V130, P1723; Groen H, 1996, J IMMUNOL, V156, P1269; Hellquist A, 2007, J MED GENET, V44, P314, DOI 10.1136/jmg.2006.046185; Hornum L, 2002, DIABETES, V51, P1972, DOI 10.2337/diabetes.51.6.1972; Itoh T, 2011, J CELL BIOL, V192, P839, DOI 10.1083/jcb.201008107; JACKSON R, 1981, DIABETES, V30, P887, DOI 10.2337/diabetes.30.10.887; Jokinen R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001161; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lang T, 1998, EMBO J, V17, P3597, DOI 10.1093/emboj/17.13.3597; Lee YJ, 2013, ANN RHEUM DIS, V72, P1510, DOI 10.1136/annrheumdis-2011-200288; Legesse-Miller A, 2000, J BIOL CHEM, V275, P32966, DOI 10.1074/jbc.M000917200; Legesse-Miller A, 1998, J BIOL CHEM, V273, P3105, DOI 10.1074/jbc.273.5.3105; Lim MK, 2009, LUPUS, V18, P1045, DOI 10.1177/0961203309106830; MacMurray AJ, 2002, GENOME RES, V12, P1029, DOI 10.1101/gr.412702; Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145; Nitta T, 2006, PLOS BIOL, V4, P593, DOI 10.1371/journal.pbio.0040103; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Pandarpurkar M, 2003, P NATL ACAD SCI USA, V100, P10382, DOI 10.1073/pnas.1832170100; Pellegrini M, 2004, J EXP MED, V200, P1189, DOI 10.1084/jem.20041328; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Reuber TL, 1996, PLANT CELL, V8, P241, DOI 10.1105/tpc.8.2.241; Sagiv Y, 2000, EMBO J, V19, P1494, DOI 10.1093/emboj/19.7.1494; Saunders A, 2010, BLOOD, V115, P3249, DOI 10.1182/blood-2009-08-237586; Saunders A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-53; Schnell S, 2006, BLOOD, V108, P591, DOI 10.1182/blood-2005-11-4616; Schulteis RD, 2008, BLOOD, V112, P4905, DOI 10.1182/blood-2008-03-146555; Schwefel D, 2010, P NATL ACAD SCI USA, V107, P20299, DOI 10.1073/pnas.1010322107; Shin JH, 2007, GENES IMMUN, V8, P503, DOI 10.1038/sj.gene.6364413; Shpilka T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-226; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Weidberg H, 2011, DEV CELL, V20, P444, DOI 10.1016/j.devcel.2011.02.006; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Wong Vivian Wy, 2010, Self Nonself, V1, P259, DOI 10.4161/self.1.3.12819; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	52	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77782	10.1371/journal.pone.0077782	http://dx.doi.org/10.1371/journal.pone.0077782			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24204963	Green Submitted, Green Published, gold			2022-12-27	WOS:000326022200076
J	Porphyre, T; Auty, HK; Tildesley, MJ; Gunn, GJ; Woolhouse, MEJ				Porphyre, Thibaud; Auty, Harriet K.; Tildesley, Michael J.; Gunn, George J.; Woolhouse, Mark E. J.			Vaccination against Foot-And-Mouth Disease: Do Initial Conditions Affect Its Benefit?	PLOS ONE			English	Article							NATURAL AEROSOLS; EPIDEMIC; VIRUS; FMD; TRANSMISSION; STRATEGIES; SPREAD; PIGS	When facing incursion of a major livestock infectious disease, the decision to implement a vaccination programme is made at the national level. To make this decision, governments must consider whether the benefits of vaccination are sufficient to outweigh potential additional costs, including further trade restrictions that may be imposed due to the implementation of vaccination. However, little consensus exists on the factors triggering its implementation on the field. This work explores the effect of several triggers in the implementation of a reactive vaccination-to-live policy when facing epidemics of foot-and-mouth disease. In particular, we tested whether changes in the location of the incursion and the delay of implementation would affect the epidemiological benefit of such a policy in the context of Scotland. To reach this goal, we used a spatial, premises-based model that has been extensively used to investigate the effectiveness of mitigation procedures in Great Britain. The results show that the decision to vaccinate, or not, is not straightforward and strongly depends on the underlying local structure of the population-at-risk. With regards to disease incursion preparedness, simply identifying areas of highest population density may not capture all complexities that may influence the spread of disease as well as the benefit of implementing vaccination. However, if a decision to vaccinate is made, we show that delaying its implementation in the field may markedly reduce its benefit. This work provides guidelines to support policy makers in their decision to implement, or not, a vaccination-to-live policy when facing epidemics of infectious livestock disease.	[Porphyre, Thibaud; Woolhouse, Mark E. J.] Univ Edinburgh, Ashworth Labs, Epidemiol Grp, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland; [Auty, Harriet K.; Gunn, George J.] Scotlands Rural Coll, Epidemiol Res Unit, Inverness, Scotland; [Tildesley, Michael J.] Univ Warwick, Ctr Complex Sci, Coventry CV4 7AL, W Midlands, England	University of Edinburgh; Scotland's Rural College; University of Warwick	Porphyre, T (corresponding author), Univ Edinburgh, Ashworth Labs, Epidemiol Grp, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland.	t.porphyre@ed.ac.uk	Porphyre, Thibaud/N-7581-2018	Porphyre, Thibaud/0000-0002-8552-9899; Auty, Harriet/0000-0002-6181-3780; Tildesley, Michael/0000-0002-6875-7232; Woolhouse, Mark/0000-0003-3765-8167	Centre of Expertise on Animal Disease Outbreaks (EPIC); Scottish Government [UEH/851/11]	Centre of Expertise on Animal Disease Outbreaks (EPIC); Scottish Government	This work was supported by the Centre of Expertise on Animal Disease Outbreaks (EPIC) funded by the Scottish Government (Programmes of Research 2011-2016 no. UEH/851/11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersen S, 2002, EPIDEMIOL INFECT, V128, P313, DOI 10.1017/S0950268801006501; Arnold ME, 2008, P ROY SOC B-BIOL SCI, V275, P107, DOI 10.1098/rspb.2007.1154; Backer JA, 2012, PREV VET MED, V107, P27, DOI 10.1016/j.prevetmed.2012.05.012; Barnett PV, 2002, VACCINE, V20, P1505, DOI 10.1016/S0264-410X(01)00503-5; Bates TW, 2003, AM J VET RES, V64, P805, DOI 10.2460/ajvr.2003.64.805; Bessell PR, 2010, EPIDEMICS-NETH, V2, P109, DOI 10.1016/j.epidem.2010.06.002; Bessell PR, 2010, INT J INFECT DIS, V14, pE210, DOI 10.1016/j.ijid.2009.05.003; Boender GJ, 2007, PLOS COMPUT BIOL, V3, P704, DOI 10.1371/journal.pcbi.0030071; Bouma A, 2003, PREV VET MED, V57, P155, DOI 10.1016/S0167-5877(02)00217-9; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Cottam EM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000050; DEFRA, 2005, D5100R3D5100R3 DEFRA; Donaldson AI, 2001, VET REC, V148, P602, DOI 10.1136/vr.148.19.602; Donaldson AI, 2001, VET REC, V148, P600, DOI 10.1136/vr.148.19.600; Galvani AP, 2007, P NATL ACAD SCI USA, V104, P5692, DOI 10.1073/pnas.0606774104; Gibbens JC, 2001, VET REC, V149, P729, DOI 10.1136/vr.149.24.729; Jewell CP, 2009, J R SOC INTERFACE, V6, P1145, DOI 10.1098/rsif.2008.0433; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Keeling MJ, 2003, NATURE, V421, P136, DOI 10.1038/nature01343; Kobayashi M, 2007, PREV VET MED, V79, P257, DOI 10.1016/j.prevetmed.2007.01.002; Morelli MJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002768; Orsel K, 2007, VACCINE, V25, P6381, DOI 10.1016/j.vaccine.2007.06.010; Parent KB, 2011, REV SCI TECH OIE, V30, P789; Quan M, 2009, J COMP PATHOL, V140, P225, DOI 10.1016/j.jcpa.2008.12.002; Savill Nicholas J, 2006, BMC Vet Res, V2, P3, DOI 10.1186/1746-6148-2-3; Schley D, 2009, EPIDEMIOL INFECT, V137, P1494, DOI 10.1017/S0950268809002349; Scottish Government, 2010, SCOTT GOV EX AN DIS; Tildesley MJ, 2008, P ROY SOC B-BIOL SCI, V275, P1459, DOI 10.1098/rspb.2008.0006; Tildesley MJ, 2012, PREV VET MED, V104, P224, DOI 10.1016/j.prevetmed.2011.11.007; Tildesley MJ, 2010, P NATL ACAD SCI USA, V107, P1041, DOI 10.1073/pnas.0909047107; Tildesley MJ, 2009, P ROY SOC B-BIOL SCI, V276, P3239, DOI 10.1098/rspb.2009.0427; Tildesley MJ, 2009, J THEOR BIOL, V258, P623, DOI 10.1016/j.jtbi.2009.02.019; Tildesley MJ, 2006, NATURE, V440, P83, DOI 10.1038/nature04324; Tomassen FHM, 2002, PREV VET MED, V54, P301, DOI 10.1016/S0167-5877(02)00053-3; Traulsen I, 2011, RES VET SCI, V91, P219, DOI 10.1016/j.rvsc.2010.12.016	35	27	27	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77616	10.1371/journal.pone.0077616	http://dx.doi.org/10.1371/journal.pone.0077616			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24204895	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000325489100176
J	Vercammen, A; Skilleter, AJ; Lenroot, R; Catts, SV; Weickert, CS; Weickert, TW				Vercammen, Ans; Skilleter, Ashley J.; Lenroot, Rhoshel; Catts, Stanley V.; Weickert, Cynthia Shannon; Weickert, Thomas W.			Testosterone Is Inversely Related to Brain Activity during Emotional Inhibition in Schizophrenia	PLOS ONE			English	Article							NEGATIVE SYMPTOMS; COGNITIVE-CONTROL; SELECTIVE ATTENTION; RESPONSE-INHIBITION; SERUM TESTOSTERONE; NEURAL MECHANISMS; HORMONES; SEVERITY; HEALTHY; TASK	Sex steroids affect cognitive function as well as emotion processing and regulation. They may also play a role in the pathophysiology of schizophrenia. However, the effects of sex steroids on cognition and emotion-related brain activation in schizophrenia are poorly understood. Our aim was to determine the extent to which circulating testosterone relates to brain activation in men with schizophrenia compared to healthy men during cognitive-emotional processing. We assessed brain activation in 18 men with schizophrenia and 22 age-matched healthy men during an emotional go/no-go task using fMRI and measured total serum testosterone levels on the same morning. We performed an ROI analysis to assess the relationship between serum testosterone and brain activation, focusing on cortical regions involved the emotional go/nogo task. Slower RT and reduced accuracy was observed when participants responded to neutral stimuli, while inhibiting responses to negative stimuli. Healthy men showed a robust increase in activation of the middle frontal gyrus when inhibiting responses to negative stimuli, but there was no significant association between activation and serum testosterone level in healthy men. Men with schizophrenia showed a less pronounced increase in activation when inhibiting responses to negative stimuli; however, they did show a strong inverse association between serum testosterone level and activation of the bilateral middle frontal gyrus and left insula. Additionally, increased accuracy during inhibition of response to negative words was associated with both higher serum testosterone levels and decreased activation of the middle frontal gyrus in men with schizophrenia only. We conclude that endogenous hormone levels, even within the normal range, may play an enhanced modulatory role in determining the neural and behavioural response during cognitive-emotional processing in schizophrenia.	[Vercammen, Ans; Skilleter, Ashley J.; Lenroot, Rhoshel; Catts, Stanley V.; Weickert, Cynthia Shannon; Weickert, Thomas W.] Neurosci Res Australia, Randwick, NSW, Australia; [Vercammen, Ans; Skilleter, Ashley J.; Lenroot, Rhoshel; Catts, Stanley V.; Weickert, Cynthia Shannon; Weickert, Thomas W.] Schizophrenia Res Inst, Darlinghurst, NSW, Australia; [Vercammen, Ans; Skilleter, Ashley J.; Lenroot, Rhoshel; Weickert, Cynthia Shannon; Weickert, Thomas W.] Univ New S Wales, Sch Psychiat, Randwick, NSW, Australia; [Catts, Stanley V.] Univ Queensland, Sch Med, Brisbane, Qld, Australia	Neuroscience Research Australia; University of New South Wales Sydney; University of Queensland	Weickert, TW (corresponding author), Neurosci Res Australia, Randwick, NSW, Australia.	t.weickert@neura.edu.au	Weickert, Thomas W/D-3827-2011; Weickert, Thomas/AAI-6324-2021; Catts, Stanley V/G-6917-2013; Weickert, Thomas/AFS-7669-2022	Weickert, Thomas W/0000-0002-6408-718X; Weickert, Thomas/0000-0002-6408-718X; Shannon Weickert, Cynthia/0000-0002-4560-0259; Vercammen, Ans/0000-0003-1229-9401	University of New South Wales School of Psychiatry; National Health and Medical Research Council [568807]; Neuroscience Research Australia; Australian Schizophrenia Research Bank; National Health and Medical Research Council of Australia; Pratt Foundation; Ramsay Health Care; Viertal Charitable Foundation; Schizophrenia Research Institute; New South Wales Ministry of Health; Macquarie Group; National Health and Medical Research Council (Australia) Senior Research Fellowship [1021970]	University of New South Wales School of Psychiatry; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Neuroscience Research Australia; Australian Schizophrenia Research Bank; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Pratt Foundation; Ramsay Health Care; Viertal Charitable Foundation; Schizophrenia Research Institute; New South Wales Ministry of Health; Macquarie Group; National Health and Medical Research Council (Australia) Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the University of New South Wales School of Psychiatry; National Health and Medical Research Council Project grant number 568807; Neuroscience Research Australia; and the Australian Schizophrenia Research Bank, which is supported by the National Health and Medical Research Council of Australia; the Pratt Foundation; Ramsay Health Care; and the Viertal Charitable Foundation. This work was also supported by the Schizophrenia Research Institute (utilising funding from the New South Wales Ministry of Health and the Macquarie Group). CSW is a recipient of a National Health and Medical Research Council (Australia) Senior Research Fellowship (1021970). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel KM, 2010, INT REV PSYCHIATR, V22, P417, DOI 10.3109/09540261.2010.515205; Aikey JL, 2002, HORM BEHAV, V42, P448, DOI 10.1006/hbeh.2002.1838; Akhondzadeh S, 2006, SCHIZOPHR RES, V84, P405, DOI 10.1016/j.schres.2006.02.008; Amin Z, 2006, NEUROIMAGE, V32, P457, DOI 10.1016/j.neuroimage.2006.03.013; Archer J, 2006, NEUROSCI BIOBEHAV R, V30, P319, DOI 10.1016/j.neubiorev.2004.12.007; Aydogan U, 2012, ENDOCR J, V59, P1099, DOI 10.1507/endocrj.EJ12-0134; BENTALL RP, 1989, BRIT J MED PSYCHOL, V62, P355, DOI 10.1111/j.2044-8341.1989.tb02845.x; Bradley MM, 1999, NORMS ENGLISH WORDS; Brett M., 2002, 8 INT C FUNCT MAPP H, V16, P497; CALEV A, 1993, PSYCHOPATHOLOGY, V26, P229, DOI 10.1159/000284827; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cherrier MM, 2007, PSYCHONEUROENDOCRINO, V32, P72, DOI 10.1016/j.psyneuen.2006.10.008; Chiu PH, 2008, NEUROIMAGE, V42, P988, DOI 10.1016/j.neuroimage.2008.04.248; Derntl B, 2009, PSYCHONEUROENDOCRINO, V34, P687, DOI 10.1016/j.psyneuen.2008.11.007; Eisenegger C, 2010, NATURE, V463, P356, DOI 10.1038/nature08711; Elliott R, 2000, NEUROREPORT, V11, P1739, DOI 10.1097/00001756-200006050-00028; Fernandez-Egea E, 2011, PSYCHOSOM MED, V73, P643, DOI 10.1097/PSY.0b013e318230343f; First M. B., 2007, STRUCTURED CLIN INTE; Goldstein M, 2007, NEUROIMAGE, V36, P1026, DOI 10.1016/j.neuroimage.2007.01.056; Gopin CB, 2011, BIPOLAR DISORD, V13, P164, DOI 10.1111/j.1399-5618.2011.00906.x; Goyal RO, 2004, ANN NY ACAD SCI, V1032, P291, DOI 10.1196/annals.1314.042; Gray JR, 2001, J EXP PSYCHOL GEN, V130, P436, DOI 10.1037//0096-3445.130.3.436; Grimm S, 2012, NEUROIMAGE, V61, P1188, DOI 10.1016/j.neuroimage.2012.04.004; Gyurak A, 2012, COGNITION EMOTION, V26, P103, DOI 10.1080/02699931.2011.557291; Hermans EJ, 2006, BIOL PSYCHIAT, V59, P872, DOI 10.1016/j.biopsych.2005.11.015; Howes OD, 2007, J CLIN PSYCHIAT, V68, P361, DOI 10.4088/JCP.v68n0302; Huber TJ, 2005, PSYCHONEUROENDOCRINO, V30, P111, DOI 10.1016/j.psyneuen.2004.05.010; Jasinska AJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00345; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Ko YH, 2008, J CLIN PSYCHOPHARM, V28, P375, DOI 10.1097/JCP.0b013e31817d5912; Ko YH, 2007, PSYCHONEUROENDOCRINO, V32, P385, DOI 10.1016/j.psyneuen.2007.02.002; Kohler Christian G, 2006, Cogn Neuropsychiatry, V11, P250, DOI 10.1080/13546800500188575; Kulkarni J, 2012, CURR OPIN PSYCHIATR, V25, P89, DOI 10.1097/YCO.0b013e328350360e; Leppanen JM, 2006, CURR OPIN PSYCHIATR, V19, P34, DOI 10.1097/01.yco.0000191500.46411.00; MATHEWS A, 1994, ANNU REV PSYCHOL, V45, P25, DOI 10.1146/annurev.psych.45.1.25; Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228; Mehta PH, 2010, J COGNITIVE NEUROSCI, V22, P2357, DOI 10.1162/jocn.2009.21389; Mendrek A, 2011, PSYCHONEUROENDOCRINO, V36, P1422, DOI 10.1016/j.psyneuen.2011.03.016; Montgomery J, 2004, J CLIN PSYCHIAT, V65, P1491, DOI 10.4088/JCP.v65n1108; Moore L, 2013, PSYCHONEUROENDOCRINO; Sankar JS, 2012, GENDER MED, V9, P232, DOI 10.1016/j.genm.2012.05.001; Shirayama Y, 2002, SCHIZOPHR RES, V58, P69, DOI 10.1016/S0920-9964(01)00367-X; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Honk J, 1999, HORM BEHAV, V36, P17, DOI 10.1006/hbeh.1999.1521; van Rijn S, 2011, PSYCHOL MED, V41, P1815, DOI 10.1017/S0033291710002576; van Wingen GA, 2009, NEUROPSYCHOPHARMACOL, V34, P539, DOI [10.1038/npp.2008.2, 10.1038/sj.npp.2008.2]; Vercammen A, 2012, J PSYCHIATR NEUROSCI, V37, P379, DOI 10.1503/jpn.110088; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Volman I, 2011, CEREB CORTEX, V21, P2282, DOI 10.1093/cercor/bhr001; Wechsler D., 1997, WECHSLER ADULT INTEL; Weickert TW, 2000, ARCH GEN PSYCHIAT, V57, P907, DOI 10.1001/archpsyc.57.9.907	52	12	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e77496	10.1371/journal.pone.0077496	http://dx.doi.org/10.1371/journal.pone.0077496			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	244FY	24204845	Green Published, gold, Green Submitted			2022-12-27	WOS:000326373800003
J	Echenique-Robba, P; Nelo-Bazan, MA; Carrodeguas, JA				Echenique-Robba, Pablo; Alejandra Nelo-Bazan, Maria; Carrodeguas, Jose A.			Reducing the Standard Deviation in Multiple-Assay Experiments Where the Variation Matters but the Absolute Value Does Not	PLOS ONE			English	Article							2 PROAPOPTOTIC DOMAINS; PROTEIN; APOPTOSIS; EXPOSURE; MODEL; PSAP	When the value of a quantity x for a number of systems (cells, molecules, people, chunks of metal, DNA vectors, so on) is measured and the aim is to replicate the whole set again for different trials or assays, despite the efforts for a near-equal design, scientists might often obtain quite different measurements. As a consequence, some systems' averages present standard deviations that are too large to render statistically significant results. This work presents a novel correction method of a very low mathematical and numerical complexity that can reduce the standard deviation of such results and increase their statistical significance. Two conditions are to be met: the inter-system variations of x matter while its absolute value does not, and a similar tendency in the values of x must be present in the different assays (or in other words, the results corresponding to different assays must present a high linear correlation). We demonstrate the improvements this method offers with a cell biology experiment, but it can definitely be applied to any problem that conforms to the described structure and requirements and in any quantitative scientific field that deals with data subject to uncertainty.	[Echenique-Robba, Pablo] CSIC, Inst Quim Fis Rocasolano, Madrid, Spain; [Echenique-Robba, Pablo; Alejandra Nelo-Bazan, Maria; Carrodeguas, Jose A.] Univ Zaragoza, Inst Biocomp & Fis Sistemas Complejos, Zaragoza, Spain; [Echenique-Robba, Pablo] Univ Zaragoza, Zaragoza Sci Ctr Adv Modeling, Zaragoza, Spain; [Echenique-Robba, Pablo] Univ Zaragoza, Dept Fs Teor, E-50009 Zaragoza, Spain; [Echenique-Robba, Pablo; Carrodeguas, Jose A.] Unidad Asociada IQFR BIFI, Madrid, Spain; [Alejandra Nelo-Bazan, Maria] Fdn Gran Mariscal de Ayacucho Fundayacucho, La Urbina, Venezuela; [Alejandra Nelo-Bazan, Maria; Carrodeguas, Jose A.] Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, Zaragoza, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Zaragoza; University of Zaragoza; University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Zaragoza	Echenique-Robba, P (corresponding author), CSIC, Inst Quim Fis Rocasolano, Madrid, Spain.	pablo.echenique.robba@gmail.com	Carrodeguas, Jose/L-7334-2014	Carrodeguas, Jose/0000-0003-0062-1029; Echenique-Robba, Pablo/0000-0001-8549-3139	Ministerio de Ciencia e Innovacion, Spain [FIS2009-13364-C02-01, BFU2009-11800]; Universidad de Zaragoza, Spain [UZ2012-CIE-06, UZ2010-BIO-03, UZ2011-BIO-02]; Grupo Consolidado "Biocomputacion y Fisica de Sistemas Complejos" (DGA, Spain)	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Universidad de Zaragoza, Spain; Grupo Consolidado "Biocomputacion y Fisica de Sistemas Complejos" (DGA, Spain)	This work has been supported by grants FIS2009-13364-C02-01 (Ministerio de Ciencia e Innovacion, Spain), UZ2012-CIE-06 (Universidad de Zaragoza, Spain), Grupo Consolidado "Biocomputacion y Fisica de Sistemas Complejos" (DGA, Spain), also by grants BFU2009-11800 (Ministerio de Ciencia e Innovacion, Spain), and UZ2010-BIO-03 and UZ2011-BIO-02 (Universidad de Zaragoza, Spain) to J.A.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JL, 2006, J COMPUT CHEM, V27, P238, DOI 10.1002/jcc.20337; Alvarez A, 2012, BIODIVERSITY ENRICHMENT IN A DIVERSE WORLD, P133, DOI 10.5772/48362; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Daniel W., 2009, BIOSTATISTICS FDN AN, V9; de Lendonck LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071029; DOERFFEL K, 1994, FRESEN J ANAL CHEM, V348, P183, DOI 10.1007/BF00325357; Galante RS, 2012, AN ACAD BRAS CIENC, V84, P469, DOI 10.1590/S0001-37652012000200016; Glenday AG, 2012, GROUND BASED AIRBORN, V8446; Gundersen S, 1998, J MOL STRUCT, V445, P35, DOI 10.1016/S0022-2860(97)00410-9; Johansson S, 2000, MON NOT R ASTRON SOC, V319, P163; Kirkup L., 2006, INTRO UNCERTAINTY ME; Konovalov IB, 2011, IZV ATMOS OCEAN PHY+, V47, P457, DOI 10.1134/S0001433811040062; Kutner M., 2005, APPL LINEAR STAT MOD; Lamarca V, 2008, EUR J CELL BIOL, V87, P325, DOI 10.1016/j.ejcb.2008.02.004; Lamarca V, 2007, AM J PHYSIOL-CELL PH, V293, pC1347, DOI 10.1152/ajpcell.00431.2006; Le CT, 2003, INTRO BIOSTATISTICS, DOI 10.1002/0471308889; Li T, 2013, BBA-MOL BASIS DIS, V1832, P453, DOI 10.1016/j.bbadis.2012.11.016; Mandel J, 1984, STAT ANAL EXPT DATA; Mao GZ, 2008, BBA-GEN SUBJECTS, V1780, P696, DOI 10.1016/j.bbagen.2008.01.013; Matsunoshita Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016234; Meloun M, 1993, CHEMOMETRICS ANAL CH, V1; Mickey R., 2004, APPL STAT ANAL VARIA; Niedostatkiewicz M, 2006, 18 IMEKO WORLD C; Pignatelli M, 2003, BIOCHEM J, V373, P739, DOI 10.1042/BJ20021918; Schagat T, 2007, CELL NOTES, V17, P9; Taylor J.R., 1997, INTRO ERROR ANAL STU, P181; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; Walpole RE., 2012, PROBABILITY STAT ENG, V9; Xu XM, 1999, J BIOL CHEM, V274, P32543, DOI 10.1074/jbc.274.46.32543; Xu XM, 2002, J BIOL CHEM, V277, P48913, DOI 10.1074/jbc.M209613200; Zhang W, 2012, BIOCHEM J, V445, P39, DOI 10.1042/BJ20120136	31	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78205	10.1371/journal.pone.0078205	http://dx.doi.org/10.1371/journal.pone.0078205			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205158	Green Published, Green Submitted, gold			2022-12-27	WOS:000326334500102
J	Henderson, KA; Anand, M; Bauch, CT				Henderson, Kirsten A.; Anand, Madhur; Bauch, Chris T.			Carrot or Stick? Modelling How Landowner Behavioural Responses Can Cause Incentive-Based Forest Governance to Backfire	PLOS ONE			English	Article							ENVIRONMENTAL SERVICES; SOCIAL NORMS; LAND-USE; DEFORESTATION; DYNAMICS; PAYMENTS; LESSONS; COMMONS; POOR	Mitigating the negative impacts of declining worldwide forest cover remains a significant socio-ecological challenge, due to the dominant role of human decision-making. Here we use a Markov chain model of land-use dynamics to examine the impact of governance on forest cover in a region. Each land parcel can be either forested or barren (deforested), and landowners decide whether to deforest their parcel according to perceived value (utility). We focus on three governance strategies: yearly incentive for conservation, one-time penalty for deforestation and one-time incentive for reforestation. The incentive and penalty are incorporated into the expected utility of forested land, which decreases the net gain of deforestation. By analyzing the equilibrium and stability of the landscape dynamics, we observe four possible outcomes: a stationary-forested landscape, a stationary-deforested landscape, an unstable landscape fluctuating near the equilibrium, and a cyclic-forested landscape induced by synchronized deforestation. We find that the two incentive-based strategies often result in highly fluctuating forest cover over decadal time scales or longer, and in a few cases, reforestation incentives actually decrease the average forest cover. In contrast, a penalty for deforestation results in the stable persistence of forest cover (generally >30%). The idea that larger conservation incentives will always yield higher and more stable forest cover is not supported in our findings. The decision to deforest is influenced by more than a simple, "rational" cost-benefit analysis: social learning and myopic, stochastic decision-making also have important effects. We conclude that design of incentive programs may need to account for potential counter-productive long-term effects due to behavioural feedbacks.	[Henderson, Kirsten A.; Bauch, Chris T.] Univ Guelph, Dept Math & Stat, Guelph, ON N1G 2W1, Canada; [Henderson, Kirsten A.; Anand, Madhur] Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada; [Bauch, Chris T.] Univ Waterloo, Dept Appl Math, Waterloo, ON N2L 3G1, Canada	University of Guelph; University of Guelph; University of Waterloo	Bauch, CT (corresponding author), Univ Guelph, Dept Math & Stat, Guelph, ON N1G 2W1, Canada.	cbauch@uwaterloo.ca			James S. McDonnell Foundation; Natural Sciences and Engineering Research Council of Canada	James S. McDonnell Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported by a James S. McDonnell Foundation Complex Systems Scholar Award to MA, and a Natural Sciences and Engineering Research Council of Canada Discovery Grant to CTB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2008, SCIENCE, V320, P1460, DOI 10.1126/science.1155369; Andersson KP, 2006, WORLD DEV, V34, P576, DOI 10.1016/j.worlddev.2005.08.009; Andersson K, 2007, J POLICY ANAL MANAG, V26, P99, DOI 10.1002/pam.20229; Angelsen A, 2008, VINNV PROGR REN MOV; Araujo C, 2009, ECOL ECON, V68, P2461, DOI 10.1016/j.ecolecon.2008.12.015; Banerjee O, 2009, FOREST POLICY ECON, V11, P244, DOI 10.1016/j.forpol.2009.04.004; Barbier E. B., 2004, American Journal of Agricultural Economics, V86, P1347, DOI 10.1111/j.0002-9092.2004.00688.x; BIKHCHANDANI S, 1992, J POLIT ECON, V100, P992, DOI 10.1086/261849; BINSWANGER HP, 1991, WORLD DEV, V19, P821, DOI 10.1016/0305-750X(91)90135-5; Bockstael NE, 1996, AM J AGR ECON, V78, P1168, DOI 10.2307/1243487; Bryant D, 1997, LAST FRONTIERS FORES; Caviglia-Harris J. L., 2005, Agricultural and Resource Economics Review, V34, P145; Chhatre A, 2008, P NATL ACAD SCI USA, V105, P13286, DOI 10.1073/pnas.0803399105; Daily GC, 1997, NATURES SERVICES SOC, DOI DOI 10.12987/9780300188479-039; Daniels AE, 2010, ECOL ECON, V69, P2116, DOI 10.1016/j.ecolecon.2010.06.011; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Fearnside PM, 2012, CLIM POLICY, V12, P70, DOI 10.1080/14693062.2011.581571; Grieg-Gran M, 2005, WORLD DEV, V33, P1511, DOI 10.1016/j.worlddev.2005.05.002; Griffiths Tom, 2007, SEEING RED AVOIDED D; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; Jarosz L., 1996, Liberation ecologies: environment, development, social movements., P148; Kaimowitz D.I.V, 1996, LIVESTOCK DEFORESTAT; Karsenty A, 2012, FOREST POLICY ECON, V18, P38, DOI [10.1016/j.forpol.2011.05.006, 10.1016/j.forpol.2012.03.001]; Kaufmann D, 2009, 4978 WORLD BANK; Klein J, 2002, GEOJOURNAL, V56, P1991; Liu WY, 2009, PROCEEDINGS OF THE SECOND INTERNATIONAL CONFERENCE ON ENVIRONMENTAL AND COMPUTER SCIENCE, P96, DOI 10.1109/ICECS.2009.68; McElwee PD, 2012, GEOFORUM, V43, P412, DOI 10.1016/j.geoforum.2011.04.010; Miles L, 2008, SCIENCE, V320, P1454, DOI 10.1126/science.1155358; Minang P.A., 2010, REDD COPENHAGEN WAY; Morse WC, 2009, ECOL SOC, V14; Ortiz-Malavasie E, 2003, IMPACTO PROGRAMA PAG; Ostrom E, 1999, SCIENCE, V284, P278, DOI 10.1126/science.284.5412.278; Ostrom E, 2000, J ECON PERSPECT, V14, P137, DOI 10.1257/jep.14.3.137; Ostrom E., 2015, GOVERNING COMMONS, DOI DOI 10.1017/CBO9781316423936; Pfaff A., 2008, WORKING PAPER SERIES; Phelps J, 2010, SCIENCE, V328, P312, DOI 10.1126/science.1187774; Sanchez-Azofeifa GA, 2007, CONSERV BIOL, V21, P1165, DOI 10.1111/j.1523-1739.2007.00751.x; Satake A, 2006, ECOL RES, V21, P370, DOI 10.1007/s11284-006-0167-9; Satake A, 2008, GLOBAL ENVIRON CHANG, V18, P768, DOI 10.1016/j.gloenvcha.2008.07.007; Satake A, 2007, ECOL ECON, V63, P452, DOI 10.1016/j.ecolecon.2006.11.018; Satake A, 2007, ECOL RES, V22, P21, DOI 10.1007/s11284-006-0077-x; Simsik M. J., 2002, GeoJournal, V58, P233, DOI 10.1023/B:GEJO.0000017954.58269.69; Smith J, 2006, FOREST POLICY ECON, V8, P458, DOI 10.1016/j.forpol.2005.08.001; Thompson MC, 2011, ENVIRON SCI POLICY, V14, P100, DOI 10.1016/j.envsci.2010.11.006; Umemiya C, 2010, ENVIRON SCI POLICY, V13, P695, DOI 10.1016/j.envsci.2010.07.002; Vincent JR, 2007, ECOL RES, V22, P3, DOI 10.1007/s11284-006-0070-4; Wilensky U, 1999, NETLOGO 5 0 2; Wunder S, 2008, ENVIRON DEV ECON, V13, P279, DOI 10.1017/S1355770X08004282; Zweibel E, 2010, CAN TAX J, V58, P25	49	19	19	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77735	10.1371/journal.pone.0077735	http://dx.doi.org/10.1371/journal.pone.0077735			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243RL	24204942	Green Published, Green Submitted, gold			2022-12-27	WOS:000326334500049
J	Yoshikawa, T; Wada, K; Lee, JJ; Mitsuda, T; Kidouchi, K; Kurosu, H; Morisawa, Y; Aminaka, M; Okubo, T; Kimura, S; Moriya, K				Yoshikawa, Toru; Wada, Koji; Lee, Jong Ja; Mitsuda, Toshihiro; Kidouchi, Kiyoshi; Kurosu, Hitomi; Morisawa, Yuji; Aminaka, Mayumi; Okubo, Takashi; Kimura, Satoshi; Moriya, Kyoji			Incidence Rate of Needlestick and Sharps Injuries in 67 Japanese Hospitals: A National Surveillance Study	PLOS ONE			English	Article							HEALTH-CARE WORKERS; PERCUTANEOUS INJURIES; BODY-FLUID; LONG-TERM; PREVENTION; BLOOD; SAFETY; EXPOSURES; SURGEONS; NURSES	Background: Determining incidence rates of needlestick and sharps injuries (NSIs) using data from multiple hospitals may help hospitals to compare their in-house data with national averages and thereby institute relevant measures to minimize NSIs. We aimed to determine the incidence rate of NSIs using the nationwide EPINet surveillance system. Methodology/Principal Findings: Data were analyzed from 5,463 cases collected between April 2009 and March 2011 from 67 Japanese HIV/AIDS referral hospitals that participated in EPINet-Japan. The NSI incidence rate was calculated as the annual number of cases with NSIs per 100 occupied beds, according to the demographic characteristics of the injured person, place, timing, device, and the patients' infectious status. The NSI incidence rates according to hospital size were analyzed by a non-parametric test of trend. The mean number of cases with NSIs per 100 occupied beds per year was 4.8 (95% confidence interval, 4.1-5.6) for 25 hospitals with 399 or fewer beds, 6.7 (5.9-7.4) for 24 hospitals with 400-799 beds, and 7.6 (6.7-8.5) for 18 hospitals with 800 or more beds (p-trend<0.01). NSIs frequently occurred in health care workers in their 20 s; the NSI incidence rate for this age group was 2.1 (1.6-2.5) for hospitals having 399 or fewer beds, 3.5 (3.0-4.1) for hospitals with 400-799 beds, and 4.5 (3.9-5.0) for hospitals with 800 or more beds (p-trend<0.01). Conclusions/Significance: The incidence rate of NSIs tended to be higher for larger hospitals and in workers aged less than 40 years; injury occurrence was more likely to occur in places such as patient rooms and operating rooms. Application of the NSI incidence rates by hospital size, as a benchmark, could allow individual hospitals to compare their NSI incidence rates with those of other institutions, which could facilitate the development of adequate control strategies.	[Yoshikawa, Toru] Inst Sci Labour, Dept Res, Kawasaki, Kanagawa, Japan; [Wada, Koji] Natl Ctr Global Hlth & Med, Bur Int Med Cooperat, Tokyo, Japan; [Lee, Jong Ja] Kobe Univ Hosp, Dept Infect Control & Prevent, Kobe, Hyogo, Japan; [Mitsuda, Toshihiro] Yokohama City Univ Med, Dept Infect Prevent & Control, Yokohama, Kanagawa, Japan; [Kidouchi, Kiyoshi] Tono Publ Hlth Ctr, Gifu, Japan; [Kurosu, Hitomi] Tokyo Metropolitan Hlth & Med Treatment Corp Ebar, Dept Nursing, Tokyo, Japan; [Morisawa, Yuji] Jichi Med Univ Hosp, Dept Infect Prevent & Control, Shimotsuke, Tochigi, Japan; [Aminaka, Mayumi] Natl Coll Nursing, Tokyo, Japan; [Okubo, Takashi] Tokyo Healthcare Univ Postgrad Sch, Dept Infect Prevent & Control, Tokyo, Japan; [Kimura, Satoshi] Tokyo Healthcare Univ, Tokyo, Japan; [Moriya, Kyoji] Univ Tokyo, Dept Infect Control & Prevent, Tokyo, Japan	National Center for Global Health & Medicine - Japan; Kobe University; Yokohama City University; Jichi Medical University; University of Tokyo	Wada, K (corresponding author), Natl Ctr Global Hlth & Med, Bur Int Med Cooperat, Tokyo, Japan.	kwada-sgy@umin.ac.jp	Yoshikawa, Toru/K-9984-2019	Yoshikawa, Toru/0000-0003-0383-1814	Ministry of Education, Science, Sports and Culture, Japan [22390108, H22]	Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Science, Sports and Culture, Japan (H22 Grant-in-Aid for Scientific Research (B) (No. 22390108, Representative Researcher: Toru Yoshikawa). The funders played no role in study design, data collection, analysis, the decision to publish, or preparation of this manuscript.	Alamgir H, 2008, AM J INFECT CONTROL, V36, P12, DOI 10.1016/j.ajic.2007.03.005; U.S. Public Health Service, 2001, MMWR Recomm Rep, V50, P1; Fitzsimons D, 2008, OCCUP ENVIRON MED, V65, P446, DOI 10.1136/oem.2006.032334; HAIDUVEN DJ, 1992, INFECT CONT HOSP EP, V13, P265, DOI 10.2307/30145501; Jagger J, 1997, J Intraven Nurs, V20, pS33; Jagger J, 1999, HDB MODERN HOSP SAFE, V5, P352; Jagger J DCG, 2003, OCCUPATIONAL EXPOSUR, P430; Jagger Janine, 2002, J Infus Nurs, V25, pS15, DOI 10.1097/00129804-200211001-00004; Jagger Janine, 2008, J Infect Public Health, V1, P62, DOI 10.1016/j.jiph.2008.10.002; Kidouchi K, 1997, Kansenshogaku Zasshi, V71, P108; Kidouchi Kiyoshi, 2002, Nihon Rinsho, V60, P2137; Lamontagne F, 2007, INFECT CONT HOSP EP, V28, P18, DOI 10.1086/510814; Lee J, 2007, AM J INFECT CONTROL, V35, pe162; Makary MA, 2007, NEW ENGL J MED, V356, P2693, DOI 10.1056/NEJMoa070378; Ministry of Health Labour and Welfare Japan, 2005, GUID INF CONTR HOSP; Ministry of Health Labour and Welfare Japan, 2010, HOSP REP; Nagao M, 2009, AM J INFECT CONTROL, V37, P541, DOI 10.1016/j.ajic.2009.01.009; Nagao Y, 2007, AM J INFECT CONTROL, V35, P407, DOI 10.1016/j.ajic.2006.03.015; National center of global health and medicine, HIV AIDS REF HOSP; Organisation for Economic Co-operation and Development, 2011, AV LENGTH STAY HOSP; Perry JC, 2012, AM J PSYCHIAT, V169, P916, DOI 10.1176/appi.ajp.2012.11091403; Perry J, 2012, AM J INFECT CONTROL, V40, P354, DOI 10.1016/j.ajic.2011.04.328; Phillips EK, 2012, NEW ENGL J MED, V366, P670, DOI 10.1056/NEJMc1110979; Shiao JSC, 2008, RES NURS HEALTH, V31, P172, DOI 10.1002/nur.20240; Shiao JSC, 2009, J OCCUP HEALTH, V51, P132, DOI 10.1539/joh.L8111; Smith DR, 2006, J HOSP INFECT, V64, P44, DOI 10.1016/j.jhin.2006.03.021; Smith DR, 2009, AM J INFECT CONTROL, V37, P545, DOI 10.1016/j.ajic.2008.11.004; Suzuki Rie, 2006, Kansenshogaku Zasshi, V80, P39; Thomas WJC, 2009, ANN ROY COLL SURG, V91, P12, DOI 10.1308/003588409X359213; Tuma S, 2006, CLIN INFECT DIS, V42, P1159, DOI 10.1086/501456; Wada K, 2007, INFECT CONT HOSP EP, V28, P507, DOI 10.1086/513448; Wicker S, 2008, INT ARCH OCC ENV HEA, V81, P347, DOI 10.1007/s00420-007-0219-7; Yang B, 2012, NURSE ED TO IN PRESS; Yoshikawa T, 2007, INFECT CONT HOSP EP, V28, P215, DOI 10.1086/510802; 윤용훈, 2011, Annals of Occupational and Environmental Medicine, V23, P371	35	25	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77524	10.1371/journal.pone.0077524	http://dx.doi.org/10.1371/journal.pone.0077524			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204856	Green Published, gold, Green Submitted			2022-12-27	WOS:000326334500032
J	Zhao, DP; Yu, KL; Zhang, XH; Zheng, LB				Zhao, Dapeng; Yu, Keli; Zhang, Xinghua; Zheng, Lianbin			Digit Ratio (2D:4D) and Handgrip Strength in Hani Ethnicity	PLOS ONE			English	Article							GRIP STRENGTH; PRENATAL TESTOSTERONE; SEX-DIFFERENCES; FINGER-LENGTH; 2D/4D; 2ND; PERFORMANCE; MEN; BEHAVIOR; HORMONE	Introduction: The ratio of the length of the second finger to the fourth finger (2D:4D) in humans is considered as a putative marker of prenatal exposure to testosterone, and has been progressively adopted as one useful tool to evaluate the effect of prenatal hormones in some traits such as physical ability. Handgrip strength is one authentic measure of physical ability and is generally used on the anthropological research within an evolutionary viewpoint. Methods: Here we present the first evidence on 2D: 4D and handgrip strength on adult participants of Hani ethnicity and explore the relationship between digit ratio (2D: 4D) and handgrip strength. We examined 2D: 4D and handgrip strength of 80 males and 60 females at Bubeng village, in the Yunnan province of China. Results: The mean 2D: 4D in females was higher than that in males for each hand. Females showed significantly higher 2D: 4D than males in the right hand rather than in the left hand. Males displayed significantly higher handgrip strength than females for both hands. Handgrip strength decreased with age for both sexes. A significant negative correlation between 2D: 4D and handgrip strength was found in the right hand of males. Conclusion: The relationship between 2D: 4D and handgrip strength may be attributed to evolutionary drive of sexual selection operating on fetal programming.	[Zhao, Dapeng; Yu, Keli; Zhang, Xinghua; Zheng, Lianbin] Tianjin Normal Univ, Coll Life Sci, Tianjin Key Lab Anim & Plant Resistance, Tianjin, Peoples R China; [Zhao, Dapeng] NW Univ Xian, Coll Life Sci, Xian 710069, Peoples R China	Tianjin Normal University; Northwest University Xi'an	Zhao, DP (corresponding author), Tianjin Normal Univ, Coll Life Sci, Tianjin Key Lab Anim & Plant Resistance, Tianjin, Peoples R China.	dpzhao329@gmail.com			National Natural Science Foundation of China [NSFC 31200293]; Talent Introduction Fund of Tianjin Normal University [5RL115]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Talent Introduction Fund of Tianjin Normal University	This study was supported by grants from National Natural Science Foundation of China (NSFC 31200293), and Talent Introduction Fund of Tianjin Normal University (5RL115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaway HC, 2009, AM J HUM BIOL, V21, P365, DOI 10.1002/ajhb.20892; BASSEY EJ, 1993, CLIN SCI, V84, P331, DOI 10.1042/cs0840331; Beaton AA, 2011, LATERALITY, V16, P136, DOI 10.1080/13576500903410369; Bennett M, 2010, J SPORT SCI, V28, P1415, DOI 10.1080/02640414.2010.510143; Berenbaum SA, 2011, FRONT NEUROENDOCRIN, V32, P183, DOI 10.1016/j.yfrne.2011.03.001; Coates JM, 2009, P NATL ACAD SCI USA, V106, P623, DOI 10.1073/pnas.0810907106; Cohen-Bendahan CCC, 2005, NEUROSCI BIOBEHAV R, V29, P353, DOI 10.1016/j.neubiorev.2004.11.004; COLLAER ML, 1995, PSYCHOL BULL, V118, P55, DOI 10.1037/0033-2909.118.1.55; Coyne SM, 2007, PERS INDIV DIFFER, V43, P865, DOI 10.1016/j.paid.2007.02.010; Fink B, 2006, AM J HUM BIOL, V18, P776, DOI 10.1002/ajhb.20549; Frederiksen H, 2006, ANN EPIDEMIOL, V16, P554, DOI 10.1016/j.annepidem.2005.10.006; Galis F, 2010, ARCH SEX BEHAV, V39, P57, DOI 10.1007/s10508-009-9485-7; Gallup AC, 2007, EVOL HUM BEHAV, V28, P423, DOI 10.1016/j.evolhumbehav.2007.07.001; GARN SM, 1975, AM J PHYS ANTHROPOL, V43, P327, DOI 10.1002/ajpa.1330430305; Hill R, 2012, J SPORT SCI, V30, P129, DOI 10.1080/02640414.2011.637947; Honekopp J, 2007, PSYCHONEUROENDOCRINO, V32, P313, DOI 10.1016/j.psyneuen.2007.01.007; Hone LSE, 2012, EVOL HUM BEHAV, V33, P780, DOI 10.1016/j.evolhumbehav.2012.07.003; Honekopp J, 2010, AM J HUM BIOL, V22, P619, DOI 10.1002/ajhb.21054; Honekopp J, 2010, PERS INDIV DIFFER, V48, P4, DOI 10.1016/j.paid.2009.08.009; KALLMAN DA, 1990, J GERONTOL, V45, pM82, DOI 10.1093/geronj/45.3.M82; Kamarul T, 2006, J Orthop Surg (Hong Kong), V14, P172; Kemper CJ, 2009, AM J HUM BIOL, V21, P188, DOI 10.1002/ajhb.20843; Kondo T, 1997, NATURE, V390, P29, DOI 10.1038/36234; Kuh D, 2006, J GERONTOL A-BIOL, V61, P702, DOI 10.1093/gerona/61.7.702; Longman D, 2011, AM J PHYS ANTHROPOL, V144, P337, DOI 10.1002/ajpa.21407; Lutchmaya S, 2004, EARLY HUM DEV, V77, P23, DOI 10.1016/j.earlhumdev.2003.12.002; Malas MA, 2006, EARLY HUM DEV, V82, P469, DOI 10.1016/j.earlhumdev.2005.12.002; Manning JT, 2013, ANDROLOGY-US, V1, P94, DOI 10.1111/j.2047-2927.2012.00013.x; Manning JT, 2009, AM J HUM BIOL, V21, P210, DOI 10.1002/ajhb.20855; Manning J.T., 2008, FINGER BOOK SEX BEHA; Manning JT, 2007, ARCH SEX BEHAV, V36, P223, DOI 10.1007/s10508-007-9171-6; Manning JT, 2007, AM J HUM BIOL, V19, P416, DOI 10.1002/ajhb.20603; Manning JT, 2011, P NATL ACAD SCI USA, V108, P16143, DOI 10.1073/pnas.1113312108; Manning JT, 2000, EVOL HUM BEHAV, V21, P163, DOI 10.1016/S1090-5138(00)00029-5; Manning JT, 2000, LATERALITY, V5, P121, DOI 10.1080/135765000396744; Manning JT, 2003, ANN HUM BIOL, V30, P579, DOI 10.1080/0301446032000112689; Manning JT, 2002, J SPORT MED PHYS FIT, V42, P446; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; Manning JT, 2001, EVOL HUM BEHAV, V22, P61, DOI 10.1016/S1090-5138(00)00063-5; Manning JT., 2002, DIGIT RATIO POINTER; MATHIOWETZ V, 1985, ARCH PHYS MED REHAB, V66, P69; McIntyre MH, 2006, AM J PHYS ANTHROPOL, V129, P143, DOI 10.1002/ajpa.20240; McIntyre MH, 2005, P ROY SOC B-BIOL SCI, V272, P1473, DOI 10.1098/rspb.2005.3100; MONTOYE HJ, 1977, RES QUART, V48, P109, DOI 10.1080/10671315.1977.10762158; Page ST, 2005, J CLIN ENDOCR METAB, V90, P1502, DOI 10.1210/jc.2004-1933; Peters M, 2002, AM J PHYS ANTHROPOL, V117, P209, DOI 10.1002/ajpa.10029; PETERSEN P, 1989, AM J OCCUP THER, V43, P444, DOI 10.5014/ajot.43.7.444; PHELPS VR, 1952, AM J HUM GENET, V4, P72; Rantanen T, 1998, J APPL PHYSIOL, V85, P2047, DOI 10.1152/jappl.1998.85.6.2047; Tamiya R, 2012, EVOL HUM BEHAV, V33, P130, DOI 10.1016/j.evolhumbehav.2011.07.003; Trivers R, 2006, HORM BEHAV, V49, P150, DOI 10.1016/j.yhbeh.2005.05.023; van Anders SM, 2007, AM J HUM BIOL, V19, P437, DOI 10.1002/ajhb.20634; Ventura T, 2013, EARLY HUM DEV, V89, P107, DOI 10.1016/j.earlhumdev.2012.08.009; Williams TJ, 2000, NATURE, V404, P455, DOI 10.1038/35006555; Zhao DP, 2012, AM J PHYS ANTHROPOL, V149, P266, DOI 10.1002/ajpa.22130; Zheng ZG, 2011, P NATL ACAD SCI USA, V108, P16289, DOI 10.1073/pnas.1108312108	56	11	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77958	10.1371/journal.pone.0077958	http://dx.doi.org/10.1371/journal.pone.0077958			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243RL	24205044	Green Published, gold, Green Submitted			2022-12-27	WOS:000326334500082
J	Li, XD; Guo, Q; Gao, JY; Yang, J; Zhang, W; Liang, YQ; Wu, DM; Liu, YF; Weng, JP; Li, QS; Zhang, Y				Li, Xiaodong; Guo, Qing; Gao, Jingying; Yang, Jing; Zhang, Wan; Liang, Yueqin; Wu, Dongmei; Liu, Yunfeng; Weng, Jianping; Li, Qingshan; Zhang, Yi			The Adenylyl Cyclase Inhibitor MDL-12,330A Potentiates Insulin Secretion via Blockade of Voltage-Dependent K+ Channels in Pancreatic Beta Cells	PLOS ONE			English	Article							NUCLEOTIDE-GATED CHANNELS; ELECTRICAL-ACTIVITY; CAMP; ISLETS; GLP-1; EPAC; CREB; GIP	Objective: Adenylyl cyclases (ACs) play important role in regulating pancreatic beta cell growth, survival and secretion through the synthesis of cyclic AMP (cAMP). MDL-12,330A and SQ 22536 are two AC inhibitors used widely to establish the role of ACs. The goal of this study was to examine the effects of MDL-12,330A and SQ 22536 on insulin secretion and underlying mechanisms. Methods: Patch-clamp recording, Ca2+ fluorescence imaging and radioimmunoassay were used to measure outward K+ currents, action potentials (APs), intracellular Ca2+ ([Ca2+](i)) and insulin secretion from rat pancreatic beta cells. Results: MDL-12,330A (10 mu mol/l) potentiated insulin secretion to 1.7 times of control in the presence of 8.3 mmol/l glucose, while SQ 22536 did not show significant effect on insulin secretion. MDL-12,330A prolonged AP durations (APDs) by inhibiting voltage-dependent K+ (K-V) channels, leading to an increase in [Ca2+](i) levels. It appeared that these effects induced by MDL-12,330A did not result from AC inhibition, since SQ 22536 did not show such effects. Furthermore, inhibition of the downstream effectors of AC/cAMP signaling by PKA inhibitor H89 and Epac inhibitor ESI-09, did not affect K-V channels and insulin secretion. Conclusion: The putative AC inhibitor MDL-12,330A enhances [Ca2+](i) and insulin secretion via inhibition of K-V channels rather than AC antagonism in beta cells, suggesting that the non-specific effects is needed to be considered for the right interpretation of the experimental results using this agent in the analyses of the role of AC in cell function.	[Li, Xiaodong; Guo, Qing; Gao, Jingying; Zhang, Wan; Liang, Yueqin; Wu, Dongmei; Zhang, Yi] Shanxi Med Univ, Dept Pharmacol, Taiyuan, Peoples R China; [Yang, Jing; Liu, Yunfeng] Shanxi Med Univ, Hosp 1, Dept Endocrinol, Taiyuan, Peoples R China; [Weng, Jianping] Sun Yat Sen Univ, Dept Endocrinol, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Li, Qingshan] Shanxi Med Univ, Sch Pharmaceut Sci, Taiyuan, Peoples R China	Shanxi Medical University; Shanxi Medical University; Sun Yat Sen University; Shanxi Medical University	Liu, YF (corresponding author), Shanxi Med Univ, Hosp 1, Dept Endocrinol, Taiyuan, Peoples R China.	nectarliu@163.com; nectarliu@163.com		Zhang, Yi/0000-0003-0305-3127; Liu, Yunfeng/0000-0003-2826-5804	National Natural Science Foundation of China [NSFC 81070662, 81273564, 81270882]; Natural Science Foundation of Shanxi Province [2012011039-8]; Shanxi Scholarship Council of China [2012-046]; Advanced Programs of Shanxi for the Returned Overseas Chinese Scholars [2011-762]; Department of Health of Shanxi Province [201201062]; Program for the Top Young Academic Leaders of Higher Learning Institutions of Shanxi [2011-24]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanxi Province(Natural Science Foundation of Shanxi Province); Shanxi Scholarship Council of China; Advanced Programs of Shanxi for the Returned Overseas Chinese Scholars; Department of Health of Shanxi Province; Program for the Top Young Academic Leaders of Higher Learning Institutions of Shanxi	This work was supported by grants to YZ (NSFC 81070662, 81273564) from National Natural Science Foundation of China, and by grants from Natural Science Foundation of Shanxi Province (2012011039-8), Shanxi Scholarship Council of China (2012-046) as well as Advanced Programs of Shanxi for the Returned Overseas Chinese Scholars (2011-762). This work was also supported by grants from Department of Health of Shanxi Province (201201062 to Y.L), Advanced Programs of Shanxi for the Returned Overseas Chinese Scholars (to YL) and National Natural Science Foundation of China (81270882 to JY). YZ was supported by Program for the Top Young Academic Leaders of Higher Learning Institutions of Shanxi (2011-24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almahariq M, 2013, MOL PHARMACOL, V83, P122, DOI 10.1124/mol.112.080689; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Cheng XD, 2008, ACTA BIOCH BIOPH SIN, V40, P651, DOI 10.1111/j.1745-7270.2008.00438.x; Collier JJ, 2004, BIOCHEM BIOPH RES CO, V324, P1018, DOI 10.1016/j.bbrc.2004.09.149; Gadea A, 1999, BRAIN RES, V838, P200, DOI 10.1016/S0006-8993(99)01683-2; Gopel S, 1999, J PHYSIOL-LONDON, V521, P717, DOI 10.1111/j.1469-7793.1999.00717.x; Insel PA, 2012, ACTA PHYSIOL, V204, P277, DOI 10.1111/j.1748-1716.2011.02273.x; Jacobson DA, 2007, CELL METAB, V6, P229, DOI 10.1016/j.cmet.2007.07.010; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Kim SJ, 2008, MOL CELL BIOL, V28, P1644, DOI 10.1128/MCB.00325-07; Liu DM, 2006, DIABETES, V55, P1043, DOI 10.2337/diabetes.55.04.06.db05-1089; MacDonald PE, 2003, DIABETOLOGIA, V46, P1046, DOI 10.1007/s00125-003-1159-8; MacDonald PE, 2002, J BIOL CHEM, V277, P44938, DOI 10.1074/jbc.M205532200; Nakazaki M, 2002, DIABETES, V51, P3440, DOI 10.2337/diabetes.51.12.3440; RAMPE D, 1987, J PHARMACOL EXP THER, V243, P402; Rich TC, 2002, ANN BIOMED ENG, V30, P1088, DOI 10.1114/1.1511242; RORSMAN P, 1994, DIABETES METAB, V20, P138; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Seifert R, 2012, TRENDS PHARMACOL SCI, V33, P64, DOI 10.1016/j.tips.2011.10.006; Yabe D, 2011, PROG BIOPHYS MOL BIO, V107, P248, DOI 10.1016/j.pbiomolbio.2011.07.010; Zhang Y, 2008, DIABETOLOGIA, V51, P2290, DOI 10.1007/s00125-008-1166-x; Zhang Y, 2009, J ENDOCRINOL, V203, P45, DOI 10.1677/JOE-09-0068	23	22	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77934	10.1371/journal.pone.0077934	http://dx.doi.org/10.1371/journal.pone.0077934			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205033	Green Published, gold, Green Submitted			2022-12-27	WOS:000326270700061
J	Zhuang, LL; Huang, BX; Feng, J; Zhu, LH; Jin, R; Qiu, LZ; Zhou, GP				Zhuang, Li-Li; Huang, Bo-Xian; Feng, Jie; Zhu, Liang-Hua; Jin, Rui; Qiu, Ling-Zhi; Zhou, Guo-Ping			All-Trans Retinoic Acid Modulates ORMDL3 Expression via Transcriptional Regulation	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; VITAMIN-A; RECEPTOR-ALPHA; T-CELLS; ASTHMA; RISK; GENE; DIFFERENTIATION; SUPPLEMENTATION; ASSOCIATION	All-trans retinoic acid (ATRA) is an active metabolite of Vitamin A, it shows protective effects on asthma, including maintains airway epithelial integrity, inhibits asthma effector cells differentiation, modulates immune response, et al. However, the promoting effect of ATRA on Th2 response has restricted the clinical application of ATRA in asthma treatment. ORMDL3 is a candidate gene of childhood onset asthma, and high-transcript of ORMDL3 is associated with the development of asthma. Here we show that ATRA increases ORMDL3 production in vitro via inducing PKA-dependent CREB phosphorylation which in turn binds to the CRE element in promoter region of ORMDL3 and initiates ORMDL3 transcription. This finding is in consistent with the previous reports that ATRA could regulate target genes without the presence of retinoic acid response element (RARE) in promoter region but through other signals such as PKA/CREB. Nevertheless, in the present study, the traditional signal pathway of ATRA, retinoic acid receptor (RAR) signal transduction pathway, indirectly modulated ORMDL3 expression. RAR-alpha agonist (Am-80) increased ORMDL3 production even though there was no RARE in ORMDL3 promoter, introns or 3'-downstream region. Besides, the signal of RAR might differ from that of ATRA since Am-80 failed to induce CREB activation. In conclusion, our data indicate that ATRA facilitates ORMDL3 production probable through PKA/CREB, and this may be a starting point for more detailed mechanism researches on ATRA and asthma.	[Zhuang, Li-Li; Feng, Jie; Zhu, Liang-Hua; Jin, Rui; Qiu, Ling-Zhi; Zhou, Guo-Ping] Nanjing Med Univ, Affiliated Hosp 1, Dept Pediat, Nanjing, Jiangsu, Peoples R China; [Huang, Bo-Xian] China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Huang, Bo-Xian] Nanjing Med Univ, Affiliated Hosp 1, Clin Ctr Reprod Med, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; China Pharmaceutical University; Nanjing Medical University	Zhou, GP (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Pediat, Nanjing, Jiangsu, Peoples R China.	gpzhou2003@gmail.com			National Natural Science Foundation of China [30872804, 81170661, 81300023]; Specialized Research Fund for the Doctoral Program of Higher Education [20113234110010]; Jiangsu Province Innovation Project for Graduate Student of China [CXZZ11_0714]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Jiangsu Province Innovation Project for Graduate Student of China; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National Natural Science Foundation of China (30872804 and 81170661 to GPZ, 81300023 to RJ), Specialized Research Fund for the Doctoral Program of Higher Education (20113234110010 to GPZ), the Jiangsu Province Innovation Project for Graduate Student of China (CXZZ11_0714 to LLZ) and the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2006, MOL BIOL CELL, V17, P566, DOI 10.1091/mbc.E05-06-0519; Allen S, 2009, THORAX, V64, P610, DOI 10.1136/thx.2008.101469; Barnes NC, 2004, AM J RESP CRIT CARE, V170, P830, DOI 10.1164/rccm.2408006; Bochkov YA, 2010, MUCOSAL IMMUNOL, V3, P69, DOI 10.1038/mi.2009.109; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Caliskan M, 2013, NEW ENGL J MED, V368, P1398, DOI 10.1056/NEJMoa1211592; Canon E, 2004, MOL BIOL CELL, V15, P5583, DOI 10.1091/mbc.E04-05-0439; Cantero-Recasens G, 2010, HUM MOL GENET, V19, P111, DOI 10.1093/hmg/ddp471; Checkley W, 2011, EUR RESPIR J, V38, P1310, DOI 10.1183/09031936.00006911; Checkley W, 2010, NEW ENGL J MED, V362, P1784, DOI 10.1056/NEJMoa0907441; Dawson HD, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-16; Day RM, 2006, AM J RESP CELL MOL, V34, P695, DOI 10.1165/rcmb.2005-0306OC; Denburg JA, 2001, INT ARCH ALLERGY IMM, V124, P246, DOI 10.1159/000053724; Devereux G, 2005, J ALLERGY CLIN IMMUN, V115, P1109, DOI 10.1016/j.jaci.2004.12.1139; Druilhe A, 2008, AM J RESP CELL MOL, V38, P276, DOI 10.1165/rcmb.2006-0453OC; Ferreira MAR, 2011, EUR J HUM GENET, V19, P458, DOI 10.1038/ejhg.2010.191; Gamble MV, 1999, J LIPID RES, V40, P2279; Grenningloh R, 2006, J IMMUNOL, V176, P5161, DOI 10.4049/jimmunol.176.9.5161; Hirota T, 2008, J ALLERGY CLIN IMMUN, V121, P769, DOI 10.1016/j.jaci.2007.09.038; Hjertson M, 2003, J INVEST DERMATOL, V120, P239, DOI 10.1046/j.1523-1747.2003.12030.x; Jin R, 2012, INT J BIOCH CELL BIO; Kim BS, 2010, P NATL ACAD SCI USA, V107, P8742, DOI 10.1073/pnas.0911756107; Kinoshita T, 2000, BLOOD, V95, P2821, DOI 10.1182/blood.V95.9.2821.009k11_2821_2828; Ko J, 2006, LIFE SCI, V79, P1293, DOI 10.1016/j.lfs.2006.03.046; Kull I, 2006, J ALLERGY CLIN IMMUN, V118, P1299, DOI 10.1016/j.jaci.2006.08.022; Litonjua AA, 2012, P NUTR SOC, V71, P67, DOI 10.1017/S002966511100334X; Lu TC, 2008, MOL CELL BIOL, V28, P5785, DOI 10.1128/MCB.00245-08; Mai XM, 2013, THORAX, V68, P25, DOI 10.1136/thoraxjnl-2012-202061; Makkonen KM, 2009, J BIOL CHEM, V284, P18270, DOI 10.1074/jbc.M109.012492; Maret M, 2007, J NUTR, V137, P2730, DOI 10.1093/jn/137.12.2730; McGowan SE, 2007, RESP PHYSIOL NEUROBI, V157, P281, DOI 10.1016/j.resp.2007.01.011; McGowan SE, 2004, AM J PHYSIOL-LUNG C, V286, pL437, DOI 10.1152/ajplung.00158.2003; Miller M, 2012, P NATL ACAD SCI USA, V109, P16648, DOI 10.1073/pnas.1204151109; Milner JD, 2004, PEDIATRICS, V114, P27, DOI 10.1542/peds.114.1.27; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nurmatov U, 2011, J ALLERGY CLIN IMMUN, V127, P724, DOI 10.1016/j.jaci.2010.11.001; Schuster GU, 2008, J IMMUNOL, V180, P1834, DOI 10.4049/jimmunol.180.3.1834; Sleiman PMA, 2008, J ALLERGY CLIN IMMUN, V122, P1225, DOI 10.1016/j.jaci.2008.06.041; Snyder R, 2013, J MOL ENDOCRINOL, V50, P361, DOI 10.1530/JME-12-0154; Spiegl N, 2008, BLOOD, V112, P3762, DOI 10.1182/blood-2008-01-135251; URBACH J, 1994, BIOCHEM J, V299, P459, DOI 10.1042/bj2990459; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Xu K, 2005, CANCER RES, V65, P7856, DOI 10.1158/0008-5472.CAN-05-1056; Zhao Q, 2004, LEUKEMIA, V18, P285, DOI 10.1038/sj.leu.2403226; Zhuang LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060630	47	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77304	10.1371/journal.pone.0077304	http://dx.doi.org/10.1371/journal.pone.0077304			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204796	Green Published, Green Submitted, gold			2022-12-27	WOS:000326270700024
J	Che, J; Mach, AJ; Go, DE; Talati, I; Ying, Y; Rao, JY; Kulkarni, RP; Di Carlo, D				Che, James; Mach, Albert J.; Go, Derek E.; Talati, Ish; Ying, Yong; Rao, Jianyu; Kulkarni, Rajan P.; Di Carlo, Dino			Microfluidic Purification and Concentration of Malignant Pleural Effusions for Improved Molecular and Cytomorphological Diagnostics	PLOS ONE			English	Article							DIFFERENTIAL-DIAGNOSIS; LUNG ADENOCARCINOMA; SAMPLE PREPARATION; SENSITIVE METHOD; CELLS; EGFR; MUTATIONS; CYTOLOGY	Evaluation of pleural fluids for metastatic cells is a key component of diagnostic cytopathology. However, a large background of smaller leukocytes and/or erythrocytes can make accurate diagnosis difficult and reduce specificity in identification of mutations of interest for targeted anti-cancer therapies. Here, we describe an automated microfluidic system (Centrifuge Chip) which employs microscale vortices for the size-based isolation and concentration of cancer cells and mesothelial cells from a background of blood cells. We are able to process non-diluted pleural fluids at 6 mL/min and enrich target cells significantly over the background; we achieved improved purity in all patient samples analyzed. The resulting isolated and viable cells are readily available for immunostaining, cytological analysis, and detection of gene mutations. To demonstrate the utility towards aiding companion diagnostics, we also show improved detection accuracy of KRAS gene mutations in lung cancer cells processed using the Centrifuge Chip, leading to an increase in the area under the curve (AUC) of the receiver operating characteristic from 0.90 to 0.99. The Centrifuge Chip allows for rapid concentration and processing of large volumes of bodily fluid samples for improved cytological diagnosis and purification of cells of interest for genetic testing, which will be helpful for enhancing diagnostic accuracy.	[Che, James; Mach, Albert J.; Go, Derek E.; Talati, Ish; Di Carlo, Dino] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA; [Ying, Yong; Rao, Jianyu] Univ Calif Los Angeles, Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90024 USA; [Kulkarni, Rajan P.] Univ Calif Los Angeles, Div Dermatol, Med Ctr, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Che, J (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.	che@seas.ucla.edu; jrao@mednet.ucla.edu; rkulkarn@ucla.edu; dicarlo@seas.ucla.edu			Office of Naval Research Young Investigator Program [20101030]; Coulter Foundation Translational Research Award [N00014-12-1-0847]	Office of Naval Research Young Investigator Program(Office of Naval Research); Coulter Foundation Translational Research Award	This work was partially supported by the Office of Naval Research Young Investigator Program (D.D. #20101030, http://www.onr.navy.mil/Science-Technology/Directorates/office-research-discovery-invention/Sponsored-Research/YIP.aspx) and a Coulter Foundation Translational Research Award (D.D. #N00014-12-1-0847, http://www.whcf.org/research-award/overview). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billah S, 2011, CANCER CYTOPATHOL, V119, P111, DOI 10.1002/cncy.20151; Boldrini L, 2007, J THORAC ONCOL, V2, P1086, DOI 10.1097/JTO.0b013e31815ba1fa; Chen J, 2012, LAB CHIP, V12, P1753, DOI 10.1039/c2lc21273k; Chowdhuri SR, 2012, MODERN PATHOL, V25, P548, DOI 10.1038/modpathol.2011.184; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; Doglioni C, 1996, AM J SURG PATHOL, V20, P1037, DOI 10.1097/00000478-199609000-00001; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Gossett DR, 2012, P NATL ACAD SCI USA, V109, P7630, DOI 10.1073/pnas.1200107109; Gossett DR, 2010, ANAL BIOANAL CHEM, V397, P3249, DOI 10.1007/s00216-010-3721-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hur SC, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3576780; KASHII T, 1994, J CANCER RES CLIN, V120, P143, DOI 10.1007/BF01202192; Kassis J, 2005, DIAGN CYTOPATHOL, V33, P316, DOI 10.1002/dc.20280; Kimura N, 2009, DIAGN CYTOPATHOL, V37, P885, DOI 10.1002/dc.21128; Mach AJ, 2013, LAB CHIP, V13, P1011, DOI 10.1039/c2lc41104k; Mach AJ, 2011, LAB CHIP, V11, P2827, DOI 10.1039/c1lc20330d; Malapelle U, 2012, J CLIN PATHOL, V65, P87, DOI 10.1136/jclinpath-2011-200296; Molina-Vila MA, 2008, J THORAC ONCOL, V3, P1224, DOI 10.1097/JTO.0b013e318189f579; Morlan J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004584; Papadopoulos N, 2006, NAT BIOTECHNOL, V24, P985, DOI 10.1038/nbt1234; SAHN SA, 1982, WESTERN J MED, V137, P99; Saliba AE, 2010, P NATL ACAD SCI USA, V107, P14524, DOI 10.1073/pnas.1001515107; Villena V, 2004, CHEST, V125, P156, DOI 10.1378/chest.125.1.156	24	29	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e78194	10.1371/journal.pone.0078194	http://dx.doi.org/10.1371/journal.pone.0078194			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24205153	Green Published, gold, Green Submitted			2022-12-27	WOS:000326241200055
J	Kim, A; Im, M; Yim, NH; Jung, YP; Ma, JY				Kim, Aeyung; Im, Minju; Yim, Nam-Hui; Jung, Young Pil; Ma, Jin Yeul			Aqueous Extract of Bambusae Caulis in Taeniam Inhibits PMA-Induced Tumor Cell Invasion and Pulmonary Metastasis: Suppression of NF-kappa B Activation through ROS Signaling	PLOS ONE			English	Article							TRITERPENOID-RICH EXTRACT; BAMBOO SHAVINGS; DOWN-REGULATION; IN-TAENIAM; CANCER; EXPRESSION; MMP-9; ANGIOGENESIS; MATRIX-METALLOPROTEINASE-9	Bamboo shavings (Bambusae Caulis in Taeniam, BCT) are widely used as a traditional Chinese medicine to control hypertension and cardiovascular disease, and to alleviate fever, vomiting, and diarrhea. It has been demonstrated that BCT reduces ovalbumin-induced airway inflammation by regulating pro-inflammatory cytokines, and decreases tumor growth in tumor-bearing mice. However, the effects of BCT on the metastatic potential of malignant cancer cells and the detailed mechanism of its anti-metastatic activity have not been examined previously. In this study, we investigated whether an aqueous extract of BCT (AE-BCT) reduces the metastatic potential of HT1080 cells, and elucidated the underlying anti-metastatic mechanism. In addition, we examined whether AE-BCT administration inhibits pulmonary metastasis of intravenously injected B16F10 cells in C57BL/6J mice. AE-BCT (50-250 mu g/ml) dose-dependently suppressed colony-forming activity under anchorage-dependent and -independent growth conditions. Pretreatment with AE-BCT efficiently inhibited cell migration, invasion, and adhesion. AE-BCT also dramatically suppressed PMA-induced MMP-9 activity and expression by blocking NF-kappa B activation and ERK phosphorylation. Production of intracellular ROS, a key regulator of NF-kappa B-induced MMP-9 activity, was almost completely blocked by pretreatment with AE-BCT. Furthermore, daily oral administration of AE-BCT at doses of 50 and 100 mg/kg efficiently inhibited lung metastasis of B16F10 cells injected into the tail veins of C57BL/6J mice with no systemic toxicity. These results demonstrate that AE-BCT significantly reduced the metastatic activity of highly malignant cancer cells by suppressing MMP-9 activity via inhibition of ROS-mediated NF-kappa B activation. These results indicate that AE-BCT may be a safe natural product for treatment of metastatic cancer.	[Kim, Aeyung; Im, Minju; Yim, Nam-Hui; Jung, Young Pil; Ma, Jin Yeul] Korea Inst Oriental Med KIOM, Korean Med KM Based Herbal Drug Dev Grp, Taejon, South Korea	Korea Institute of Oriental Medicine (KIOM)	Ma, JY (corresponding author), Korea Inst Oriental Med KIOM, Korean Med KM Based Herbal Drug Dev Grp, Taejon, South Korea.	jyma@kiom.re.kr			Ministry of Education, Science and Technology (MEST), Republic of Korea [K12050]	Ministry of Education, Science and Technology (MEST), Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work has been supported by the a Grant K12050 awarded to Korea Institute of Oriental Medicine (KIOM) from Ministry of Education, Science and Technology (MEST), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binker MG, 2011, BIOCHEM BIOPH RES CO, V405, P140, DOI 10.1016/j.bbrc.2011.01.023; Bussemakers MJG, 1996, WORLD J UROL, V14, P151; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Choi JH, 2010, FOOD CHEM TOXICOL, V48, P564, DOI 10.1016/j.fct.2009.11.033; Eom HW, 2012, INT J MOL MED, V30, P1512, DOI 10.3892/ijmm.2012.1128; Gondi CS, 2004, NEURON GLIA BIOL, V1, P165, DOI 10.1017/S1740925X04000237; Ham I, 2009, IMMUNOPHARM IMMUNOT, V31, P439, DOI 10.1080/08923970902769638; Hsieh HL, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-88; Jiang Zhong-Qing, 2003, Ai Zheng, V22, P178; Jiao JJ, 2007, PHYTOTHER RES, V21, P1135, DOI 10.1002/ptr.2223; Jin GH, 2012, ENVIRON TOXICOL PHAR, V34, P315, DOI 10.1016/j.etap.2012.05.001; Jinga DC, 2006, J CELL MOL MED, V10, P499, DOI 10.1111/j.1582-4934.2006.tb00415.x; Jung SH, 2007, BIOL PHARM BULL, V30, P1569, DOI 10.1248/bpb.30.1569; Kim A, 2009, CARCINOGENESIS, V30, P927, DOI 10.1093/carcin/bgp072; Kim BH, 2013, MOL CELLS, V35, P410, DOI 10.1007/s10059-013-0031-z; Kim SC, 2010, FOOD CHEM TOXICOL, V48, P1478, DOI 10.1016/j.fct.2010.03.014; Kim TS, 1999, J KOREAN MED SCI, V14, P263, DOI 10.3346/jkms.1999.14.3.263; Lee KJ, 2008, CANCER LETT, V268, P233, DOI 10.1016/j.canlet.2008.03.058; Lee KJ, 2006, FOOD CHEM TOXICOL, V44, P1890, DOI 10.1016/j.fct.2006.06.009; Lee SO, 2006, BIOCHEM BIOPH RES CO, V351, P118, DOI 10.1016/j.bbrc.2006.10.006; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; London CA, 2003, CANCER GENE THER, V10, P823, DOI 10.1038/sj.cgt.7700642; Lu BY, 2010, AFR J BIOTECHNOL, V9, P6430; McCawley LJ, 2000, MOL MED TODAY, V6, P149, DOI 10.1016/S1357-4310(00)01686-5; Morais C, 2010, APOPTOSIS, V15, P412, DOI 10.1007/s10495-009-0414-y; Patel LR, 2011, FUTURE ONCOL, V7, P1285, DOI [10.2217/fon.11.112, 10.2217/FON.11.112]; Ra J, 2010, J ETHNOPHARMACOL, V128, P241, DOI 10.1016/j.jep.2010.01.023; Seki T, 2010, EVID-BASED COMPL ALT, V7, P447, DOI 10.1093/ecam/nen026; Tobar N, 2010, MOL CELL BIOCHEM, V340, P195, DOI 10.1007/s11010-010-0418-5; Tsunoda S, 1998, ANTICANCER RES, V18, P153; Yang SF, 2010, FOOD CHEM TOXICOL, V48, P1052, DOI 10.1016/j.fct.2010.01.019; Yi L, 2012, BIOCHIMIE, V94, P2035, DOI 10.1016/j.biochi.2012.05.027	32	21	23	5	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e78061	10.1371/journal.pone.0078061	http://dx.doi.org/10.1371/journal.pone.0078061			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24205091	Green Published, gold, Green Submitted			2022-12-27	WOS:000326241200052
J	Korpetinou, A; Skandalis, SS; Moustakas, A; Happonen, KE; Tveit, H; Prydz, K; Labropoulou, VT; Giannopoulou, E; Kalofonos, HP; Blom, AM; Karamanos, NK; Theocharis, AD				Korpetinou, Angeliki; Skandalis, Spyros S.; Moustakas, Aristidis; Happonen, Kaisa E.; Tveit, Heidi; Prydz, Kristian; Labropoulou, Vassiliki T.; Giannopoulou, Efstathia; Kalofonos, Haralambos P.; Blom, Anna M.; Karamanos, Nikos K.; Theocharis, Achilleas D.			Serglycin Is Implicated in the Promotion of Aggressive Phenotype of Breast Cancer Cells	PLOS ONE			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; CANINE KIDNEY-CELLS; COMPLEMENT ACTIVATION; REGULATORY PROTEINS; CARCINOMA-CELLS; TUMOR-CELLS; IN-VITRO; EXPRESSION; IMMUNOTHERAPY; LOCALIZATION	Serglycin is a proteoglycan expressed by some malignant cells. It promotes metastasis and protects some tumor cells from complement system attack. In the present study, we show for the first time the in situ expression of serglycin by breast cancer cells by immunohistochemistry in patients' material. Moreover, we demonstrate high expression and constitutive secretion of serglycin in the aggressive MDA-MB-231 breast cancer cell line. Serglycin exhibited a strong cytoplasmic staining in these cells, observable at the cell periphery in a thread of filaments near the cell membrane, but also in filopodia-like structures. Serglycin was purified from conditioned medium of MDA-MB-231 cells, and represented the major proteoglycan secreted by these cells, having a molecular size of similar to 250 kDa and carrying chondroitin sulfate side chains, mainly composed of 4-sulfated (similar to 87%), 6-sulfated (similar to 10%) and non-sulfated (similar to 3%) disaccharides. Purified serglycin inhibited early steps of both the classical and the lectin pathways of complement by binding to C1q and mannose-binding lectin. Stable expression of serglycin in less aggressive MCF-7 breast cancer cells induced their proliferation, anchorage-independent growth, migration and invasion. Interestingly, over-expression of serglycin lacking the glycosaminoglycan attachment sites failed to promote these cellular functions, suggesting that glycanation of serglycin is a pre-requisite for its oncogenic properties. Our findings suggest that serglycin promotes a more aggressive cancer cell phenotype and may protect breast cancer cells from complement attack supporting their survival and expansion.	[Korpetinou, Angeliki; Skandalis, Spyros S.; Karamanos, Nikos K.; Theocharis, Achilleas D.] Univ Patras, Dept Chem, Biochem Lab, Patras, Greece; [Moustakas, Aristidis] Uppsala Univ, Ludwig Inst Canc Res, Sci Life Lab, Uppsala, Sweden; [Happonen, Kaisa E.; Blom, Anna M.] Lund Univ, Dept Lab Med, Div Med Prot Chem, Malmo, Sweden; [Tveit, Heidi; Prydz, Kristian] Univ Oslo, Dept Mol Biosci, Oslo, Norway; [Labropoulou, Vassiliki T.] Karamandane Childrens Hosp, Patras, Greece; [Giannopoulou, Efstathia; Kalofonos, Haralambos P.] Univ Hosp Patras, Clin Oncol Lab, Div Oncol, Patras Med Sch, Patras, Greece	University of Patras; Ludwig Institute for Cancer Research; Uppsala University; Lund University; University of Oslo; University of Patras	Theocharis, AD (corresponding author), Univ Patras, Dept Chem, Biochem Lab, Patras, Greece.	atheoch@upatras.gr	Blom, Anna/B-9607-2009; Karamanos, Nikos/A-3616-2008; theocharis, achilleas/F-6903-2010; Blom, Anna/AFS-7369-2022	Blom, Anna/0000-0002-1348-1734; Karamanos, Nikos/0000-0003-3618-0288; Theocharis, Achilleas/0000-0001-8611-2297; Happonen, Kaisa/0000-0002-8346-6302; Skandalis, Spyros/0000-0003-1156-2896	European Union (European Social Fund - ESF); Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF); European Social Fund; Mizutani Foundation for Glycosciences; Swedish Research Foundation [K2012-66X-14928-09-5]; Cancerfonden	European Union (European Social Fund - ESF)(European Social Fund (ESF)); Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF); European Social Fund(European Social Fund (ESF)); Mizutani Foundation for Glycosciences; Swedish Research Foundation; Cancerfonden(Swedish Cancer Society)	This research has been co-financed by the European Union (European Social Fund - ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund. This work was also supported in part by grants from Mizutani Foundation for Glycosciences (ADT), Swedish Research Foundation (K2012-66X-14928-09-5) and Cancerfonden (AMB, KEH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; BAATRUP G, 1994, EUR J SURG, V160, P503; Beauvais DM, 2003, EXP CELL RES, V286, P219, DOI 10.1016/S0014-4827(03)00126-5; Bjorge L, 2005, BRIT J CANCER, V92, P895, DOI 10.1038/sj.bjc.6602334; Blick T, 2010, J MAMMARY GLAND BIOL, V15, P235, DOI 10.1007/s10911-010-9175-z; Blom AM, 2003, MOL IMMUNOL, V39, P547, DOI 10.1016/S0161-5890(02)00213-4; BOURDON MA, 1985, P NATL ACAD SCI USA, V82, P1321, DOI 10.1073/pnas.82.5.1321; Cooney CA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2895; Donin N, 2003, CLIN EXP IMMUNOL, V131, P254, DOI 10.1046/j.1365-2249.2003.02066.x; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Fishelson Z, 2003, MOL IMMUNOL, V40, P109, DOI 10.1016/S0161-5890(03)00112-3; GROVER A, 1987, DIFFERENTIATION, V36, P138, DOI 10.1111/j.1432-0436.1987.tb00188.x; Guadamillas MC, 2011, J CELL SCI, V124, P3189, DOI 10.1242/jcs.072165; Iida J, 2007, BIOCHEM J, V403, P553, DOI 10.1042/BJ20061176; Jurianz K, 1999, MOL IMMUNOL, V36, P929, DOI 10.1016/S0161-5890(99)00115-7; KARAMANOS NK, 1995, J CHROMATOGR A, V696, P295, DOI 10.1016/0021-9673(94)01294-O; Kolset SO, 2008, CELL MOL LIFE SCI, V65, P1073, DOI 10.1007/s00018-007-7455-6; Kolset SO, 2004, BIOCHEM J, V379, P217, DOI 10.1042/BJ20031230; Kolset SO, 2011, J IMMUNOL, V187, P4927, DOI 10.4049/jimmunol.1100806; Kousidou OC, 2008, MOL ONCOL, V2, P223, DOI 10.1016/j.molonc.2008.06.002; Li XJ, 2011, CANCER RES, V71, P3162, DOI 10.1158/0008-5472.CAN-10-3557; Macor P, 2007, IMMUNOL LETT, V111, P6, DOI 10.1016/j.imlet.2007.04.014; MAILLET P, 1992, LEUKEMIA, V6, P1143; Malla N, 2013, FEBS J, V280, P2870, DOI 10.1111/febs.12291; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; Markiewski MM, 2009, CANCER RES, V69, P6367, DOI 10.1158/0008-5472.CAN-09-1918; Matsuda K, 2001, CANCER RES, V61, P5562; Meen AJ, 2011, J BIOL CHEM, V286, P2636, DOI 10.1074/jbc.M110.151944; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; NICULESCU F, 1992, AM J PATHOL, V140, P1039; Niemann CU, 2007, LEUKEMIA, V21, P2406, DOI 10.1038/sj.leu.2404975; Niemann CU, 2004, J LEUKOCYTE BIOL, V76, P406, DOI 10.1189/jlb.1003502; Okroj M, 2008, MOL IMMUNOL, V45, P169, DOI 10.1016/j.molimm.2007.04.025; OLDBERG A, 1981, J BIOL CHEM, V256, P847; Rutkowski MJ, 2010, MOL CANCER RES, V8, P1453, DOI 10.1158/1541-7786.MCR-10-0225; SCHICK BP, 1995, J CELL PHYSIOL, V165, P96, DOI 10.1002/jcp.1041650113; SCHICK BP, 1992, BIOCHEM J, V282, P651, DOI 10.1042/bj2820651; Schick BP, 2001, BLOOD, V97, P449, DOI 10.1182/blood.V97.2.449; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Skandalis SS, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-314; Skliris A., 2013, FEBS J; Skliris A, 2011, EUR J IMMUNOL, V41, P437, DOI 10.1002/eji.201040429; STELLRECHT CMM, 1993, J BIOL CHEM, V268, P4078; Theocharis AD, 2006, ADV PHARMACOL, V53, P281, DOI 10.1016/S1054-3589(05)53013-8; Theocharis AD, 2006, J BIOL CHEM, V281, P35116, DOI 10.1074/jbc.M601061200; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; Theocharis AD, 2000, BBA-MOL BASIS DIS, V1502, P201, DOI 10.1016/S0925-4439(00)00051-X; Theocharis AD, 2002, BBA-MOL BASIS DIS, V1588, P165, DOI 10.1016/S0925-4439(02)00161-8; Theocharis AD, 2003, INT J BIOCHEM CELL B, V35, P376, DOI 10.1016/S1357-2725(02)00264-9; TOYAMASORIMACHI N, 1995, J BIOL CHEM, V270, P7437, DOI 10.1074/jbc.270.13.7437; Tveit H, 2005, J BIOL CHEM, V280, P29596, DOI 10.1074/jbc.M503691200; Tveit H, 2009, TRAFFIC, V10, P1685, DOI 10.1111/j.1600-0854.2009.00984.x; Wang XH, 2010, JNCI-J NATL CANCER I, V102, P1496, DOI 10.1093/jnci/djq343; Ytting H, 2004, SCAND J GASTROENTERO, V39, P674, DOI 10.1080/00365520410005603; Zernichow L, 2006, FEBS J, V273, P536, DOI 10.1111/j.1742-4658.2005.05085.x; Zhang L, 2010, CONNECT TISSUE RES, V51, P230, DOI 10.3109/03008200903288902; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	57	54	58	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e78157	10.1371/journal.pone.0078157	http://dx.doi.org/10.1371/journal.pone.0078157			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24205138	Green Published, gold, Green Submitted			2022-12-27	WOS:000326373800014
J	Lin, C; Li, N; Wang, K; Zhao, X; Li, BQ; Sun, L; Lin, YX; Fan, JM; Zhang, M; Sun, HC				Lin, Chao; Li, Nan; Wang, Kang; Zhao, Xin; Li, Bai-Qiang; Sun, Lei; Lin, Yi-Xing; Fan, Jie-Mei; Zhang, Miao; Sun, Hai-Chen			Efficacy and Safety of Endovascular Treatment versus Intravenous Thrombolysis for Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; TISSUE-PLASMINOGEN ACTIVATOR; POOLED ANALYSIS; INTRAARTERIAL; THERAPY; TIME; FIBRINOLYSIS; INFARCTION	Background and Purpose: Although endovascular therapy (ET) is increasingly used in patients with moderate to severe acute ischemic stroke, its efficacy and safety remains controversial. We performed a meta-analysis aiming to compare the benefits and safety of endovascular treatment and intravenous thrombolysis in the treatment of acute ischemic stroke. Methods: We systematically searched PubMed, Embase, Science direct and Springer unitil July, 2013. The primary outcomes included good outcome (mRS <= 2) and excellent outcome (mRS <= 1) at 90 days or at trial end point. Secondary outcomes were occurrence of symptomatic hemorrhage and all-cause mortality. Results: Using a prespecified search strategy, 5 RCTs with 1106 patients comparing ET and intravenous thrombolysis (IVT) were included in the meta-analysis. ET and IVT were associated with similar good (43.06% vs 41.78%; OR=1.14; 95% CI, 0.77 to 1.69; P=0.52;) and excellent (30.43% vs 30.42%; OR=1.05; 95% CI, 0.80 to 1.38; P=0.72;) outcome. For additional end points, ET was not associated with increased occurrence of symptomatic hemorrhage (6.25% vs. 6.22%; OR=1.03; 95% CI, 0.62 to 1.69; P=0.91;), or all-cause mortality (18.45% vs. 17.35%; OR=1.00; 95% CI, 0.73 to 1.39; P=0.99;). Conclusions: Formal meta-analysis indicates that there are similar safety outcomes and functional independence with endovascular therapy and intravenous thrombolysis for acute ischemic stroke.	[Lin, Chao; Wang, Kang; Zhao, Xin; Li, Bai-Qiang; Sun, Lei; Lin, Yi-Xing; Fan, Jie-Mei; Sun, Hai-Chen] Nanjing Univ, Jinling Hosp, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China; [Li, Nan; Zhang, Miao] Nanjing Univ, Gulou Hosp, Dept Urol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Zhang, M (corresponding author), Nanjing Univ, Gulou Hosp, Dept Urol, Nanjing 210008, Jiangsu, Peoples R China.	316593580@qq.com; 124320158@qq.com	Demchuk, Andrew M/E-1103-2012	Demchuk, Andrew M/0000-0002-4930-7789	Jinling hospital [2013008]	Jinling hospital	This study was supporte d by the Jinling hospital (2013008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Berger C, 2001, STROKE, V32, P1330, DOI 10.1161/01.STR.32.6.1330; Boersma E, 2006, EUR HEART J, V27, P779, DOI 10.1093/eurheartj/ehi810; Broderick JP, 2013, NEW ENGL J MED, V368, P893, DOI 10.1056/NEJMoa1214300; Campbell BC, 2013, NEW ENGL J MED, V368, P2431, DOI [10.1056/NEJMc1304759, 10.1056/NEJMoa1213701]; Ciccone A, 2010, J NEUROINTERV SURG, V2, P74, DOI 10.1136/jnis.2009.001388; De Luca G, 2009, AM J EMERG MED, V27, P712, DOI 10.1016/j.ajem.2008.04.026; Ducrocq X, 2005, J NEURORADIOLOGY, V32, P26, DOI 10.1016/S0150-9861(05)83018-4; Furlan A, 1999, JAMA-J AM MED ASSOC, V282, P2003, DOI 10.1001/jama.282.21.2003; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hussein HM, 2010, AM J NEURORADIOL, V31, P454, DOI 10.3174/ajnr.A2006; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; Kidwell CS, 2003, STROKE, V34, P2729, DOI 10.1161/01.STR.0000097608.38779.CC; Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; Lansberg MG, 2012, CHEST, V141, pE601S, DOI 10.1378/chest.11-2302; Lee M, 2010, STROKE, V41, P932, DOI 10.1161/STROKEAHA.109.574335; Lees Kennedy R, 2010, Lancet, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lloyd-Jones D, 2010, CIRCULATION, V121, P215, DOI [10.1161/CIRCULATIONAHA.109.192667, DOI 10.1161/CIRCULATI0NAHA.109.192667.PUBMED:20019324]; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Molina CA, 2002, STROKE, V33, P1551, DOI 10.1161/01.STR.0000016323.13456.E5; Nam J, 2015, INT J STROKE, V10, P13, DOI 10.1111/j.1747-4949.2012.00914.x; National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, 1995, NEW ENGL J MED, V333, P1581, DOI [10.1056/NEJM199512143332401, DOI 10.1056/NEJM199512143332401]; Nogueira RG, 2012, LANCET, V380, P1231, DOI 10.1016/S0140-6736(12)61299-9; Rha JH, 2007, STROKE, V38, P967, DOI 10.1161/01.STR.0000258112.14918.24; Saver JL, 2012, LANCET, V380, P1241, DOI 10.1016/S0140-6736(12)61384-1; Sen S, 2009, NEUROCRIT CARE, V11, P76, DOI 10.1007/s12028-009-9204-1; Sugiura S, 2008, AM J NEURORADIOL, V29, P1061, DOI 10.3174/ajnr.A1012; Wardlaw JM, 2012, LANCET, V379, P2364, DOI 10.1016/S0140-6736(12)60738-7; Zhang B, 2010, CAN J NEUROL SCI, V37, P240, DOI 10.1017/S0317167100009999	31	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e77849	10.1371/journal.pone.0077849	http://dx.doi.org/10.1371/journal.pone.0077849			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24204995	Green Published, Green Submitted, gold			2022-12-27	WOS:000326373800009
J	Antony, AR; Alexopoulos, AV; Gonzalez-Martinez, JA; Mosher, JC; Jehi, L; Burgess, RC; So, NK; Galan, RF				Antony, Arun R.; Alexopoulos, Andreas V.; Gonzalez-Martinez, Jorge A.; Mosher, John C.; Jehi, Lara; Burgess, Richard C.; So, Norman K.; Galan, Roberto F.			Functional Connectivity Estimated from Intracranial EEG Predicts Surgical Outcome in Intractable Temporal Lobe Epilepsy	PLOS ONE			English	Article							NEURONAL COMPLEXITY LOSS; HUMAN CEREBRAL-CORTEX; NETWORKS; ONSET; MAGNETOENCEPHALOGRAPHY; SYNCHRONIZATION; LOBECTOMY; COHERENCE; SEIZURES; SYSTEM	This project aimed to determine if a correlation-based measure of functional connectivity can identify epileptogenic zones from intracranial EEG signals, as well as to investigate the prognostic significance of such a measure on seizure outcome following temporal lobe lobectomy. To this end, we retrospectively analyzed 23 adult patients with intractable temporal lobe epilepsy (TLE) who underwent an invasive stereo-EEG (SEEG) evaluation between January 2009 year and January 2012. A follow-up of at least one year was required. The primary outcome measure was complete seizure-freedom at last follow-up. Functional connectivity between two areas in the temporal lobe that were sampled by two SEEG electrode contacts was defined as Pearson's correlation coefficient of interictal activity between those areas. SEEG signals were filtered between 5 and 50 Hz prior to computing this correlation. The mean and standard deviation of the off diagonal elements in the connectivity matrix were also calculated. Analysis of the mean and standard deviation of the functional connections for each patient reveals that 90% of the patients who had weak and homogenous connections were seizure free one year after temporal lobectomy, whereas 85% of the patients who had stronger and more heterogeneous connections within the temporal lobe had recurrence of seizures. This suggests that temporal lobectomy is ineffective in preventing seizure recurrence for patients in whom the temporal lobe is characterized by weakly connected, homogenous networks. This pilot study shows promising potential of a simple measure of functional brain connectivity to identify epileptogenicity and predict the outcome of epilepsy surgery.	[Antony, Arun R.; Alexopoulos, Andreas V.; Gonzalez-Martinez, Jorge A.; Mosher, John C.; Jehi, Lara; Burgess, Richard C.; So, Norman K.] Cleveland Clin, Epilepsy Ctr, Cleveland, OH 44106 USA; [Galan, Roberto F.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University	Galan, RF (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA.	rfgalan@case.edu	Antony, Arun/ABD-2041-2020; Antony, Arun/W-2439-2018	Antony, Arun/0000-0002-0368-4570; Antony, Arun/0000-0002-0368-4570; Fernandez Galan, Roberto/0000-0003-1426-1917	Mt. Sinai Health Care Foundation	Mt. Sinai Health Care Foundation	RFG thanks the Mt. Sinai Health Care Foundation for financial support. This foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bettus G, 2008, EPILEPSY RES, V81, P58, DOI 10.1016/j.eplepsyres.2008.04.020; Bettus G, 2010, J NEUROL NEUROSUR PS, V81, P1147, DOI 10.1136/jnnp.2009.191460; Brazier M. A., 1972, EXPT NEUROLOGY, P263; BRAZIER MAB, 1968, ELECTROEN CLIN NEURO, V25, P309, DOI 10.1016/0013-4694(68)90171-5; BRAZIER MAB, 1952, ELECTROEN CLIN NEURO, V4, P201, DOI 10.1016/0013-4694(52)90010-2; Dauwels J, 2009, IEEE ENG MED BIO, P2180, DOI 10.1109/IEMBS.2009.5332447; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Elisevich K, 2011, EPILEPSIA, V52, P1110, DOI 10.1111/j.1528-1167.2011.02990.x; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; GOTMAN J, 1987, ELECTROEN CLIN NEURO, V67, P120, DOI 10.1016/0013-4694(87)90034-4; Guo ZL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044847, 10.1371/journal.pone.0028196]; Hari R, 2012, NEUROIMAGE, V61, P386, DOI 10.1016/j.neuroimage.2011.11.074; Jeha LE, 2006, NEUROLOGY, V66, P1938, DOI 10.1212/01.wnl.0000219810.71010.9b; Jehi LE, 2012, EPILEPSY CURR, V12, P238, DOI 10.5698/1535-7511-12.6.238; Ji GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063183; Kramer MA, 2012, NEUROSCIENTIST, V18, P360, DOI 10.1177/1073858411422754; Laufs H, 2012, CURR OPIN NEUROL, V25, P194, DOI 10.1097/WCO.0b013e3283515db9; Masterton RA, 2012, EPILEPSY RES, V99, P327, DOI 10.1016/j.eplepsyres.2011.12.014; McIntosh AM, 2004, BRAIN, V127, P2018, DOI 10.1093/brain/awh221; Moeller F, 2011, EPILEPSIA, V52, P515, DOI 10.1111/j.1528-1167.2010.02938.x; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Navarro V, 2005, EPILEPSIA, V46, P385, DOI 10.1111/j.0013-9580.2005.15504.x; Nunez PL, 2010, CLIN NEUROPHYSIOL, V121, P2177, DOI 10.1016/j.clinph.2010.04.029; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; Ortega GJ, 2008, EPILEPSIA, V49, P269, DOI 10.1111/j.1528-1167.2007.01266.x; Ortega GJ, 2008, NEUROSCI LETT, V447, P129, DOI 10.1016/j.neulet.2008.09.080; RAPPELSBERGER P, 1989, Brain Topography, V2, P63, DOI 10.1007/BF01128844; Richardson MP, 2012, J NEUROL NEUROSUR PS, V83, P1238, DOI 10.1136/jnnp-2011-301944; Rosenow F, 2001, BRAIN, V124, P1683, DOI 10.1093/brain/124.9.1683; Schevon CA, 2007, NEUROIMAGE, V35, P140, DOI 10.1016/j.neuroimage.2006.11.009; Spencer SS, 2005, NEUROLOGY, V65, P912, DOI 10.1212/01.wnl.0000176055.45774.71; Spencer SS, 2002, EPILEPSIA, V43, P219, DOI 10.1046/j.1528-1157.2002.26901.x; Steinke GK, 2011, PLOS ONE, V3, pe2148; Stufflebeam SM, 2011, J NEUROSURG, V114, P1693, DOI 10.3171/2011.1.JNS10482; Stufflebeam SM, 2009, HUM BRAIN MAPP, V30, P1813, DOI 10.1002/hbm.20792; Vapnik V., 1998, STAT LEARNING THEORY; Varotto G, 2012, EPILEPSIA, V53, P359, DOI 10.1111/j.1528-1167.2011.03352.x; Vollmar C, 2011, BRAIN, V134, P1710, DOI 10.1093/brain/awr098; Waites AB, 2006, ANN NEUROL, V59, P335, DOI 10.1002/ana.20733; Warren CP, 2010, J NEUROPHYSIOL, V104, P3530, DOI 10.1152/jn.00368.2010; Weber B, 1998, EPILEPSIA, V39, P922, DOI 10.1111/j.1528-1157.1998.tb01441.x; Widman G, 2000, EPILEPSIA, V41, P811, DOI 10.1111/j.1528-1157.2000.tb00247.x; Zaveri HR, 2009, NEUROREPORT, V20, P891, DOI 10.1097/WNR.0b013e32832c78e0	43	48	50	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77916	10.1371/journal.pone.0077916	http://dx.doi.org/10.1371/journal.pone.0077916			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205027	Green Published, Green Submitted, gold			2022-12-27	WOS:000326334500078
J	Antunes, LCM; Han, J; Pan, JX; Moreira, CJC; Azambuja, P; Borchers, CH; Carels, N				Antunes, Luis Caetano M.; Han, Jun; Pan, Jingxi; Moreira, Carlos J. C.; Azambuja, Patricia; Borchers, Christoph H.; Carels, Nicolas			Metabolic Signatures of Triatomine Vectors of Trypanosoma cruzi Unveiled by Metabolomics	PLOS ONE			English	Article							PROLIXUS STAL HEMIPTERA; RHODNIUS-PROLIXUS; CHAGAS-DISEASE; GUT MICROBIOTA; MIDGUT; DIFFERENTIATION; INOSITOL; PHOSPHOLIPIDS; EICOSANOIDS; CULTIVATION	Chagas disease is a trypanosomiasis whose causative agent is the protozoan parasite Trypanosoma cruzi, which is transmitted to humans by hematophagous insects known as triatomines and affects a large proportion of South America. The digestive tract of the insect vectors in which T. cruzi develops constitutes a dynamic environment that affects the development of the parasite. Thus, we set out to investigate the chemical composition of the triatomine intestinal tract through a metabolomics approach. We performed Direct Infusion Fourier Transform Ion Cyclotron Resonance Mass Spectrometry on fecal samples of three triatomine species (Rhodnius prolixus, Triatoma infestans, Panstrongylus megistus) fed with rabbit blood. We then identified groups of metabolites whose frequencies were either uniform in all species or enriched in each of them. By querying the Human Metabolome Database, we obtained putative identities of the metabolites of interest. We found that a core group of metabolites with uniform frequencies in all species represented approximately 80% of the molecules detected, whereas the other 20% varied among triatomine species. The uniform core was composed of metabolites of various categories, including fatty acids, steroids, glycerolipids, nucleotides, sugars, and others. Nevertheless, the metabolic fingerprint of triatomine feces differs depending on the species considered. The variable core was mainly composed of prenol lipids, amino acids, glycerolipids, steroids, phenols, fatty acids and derivatives, benzoic acid and derivatives, flavonoids, glycerophospholipids, benzopyrans, and quinolines. Triatomine feces constitute a rich and varied chemical medium whose constituents are likely to affect T. cruzi development and infectivity. The complexity of the fecal metabolome of triatomines suggests that it may affect triatomine vector competence for specific T. cruzi strains. Knowledge of the chemical environment of T. cruzi in its invertebrate host is likely to generate new ways to understand the factors influencing parasite proliferation as well as methods to control Chagas disease.	[Antunes, Luis Caetano M.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada; [Antunes, Luis Caetano M.; Carels, Nicolas] Fundacao Oswaldo Cruz, Ctr Desenvolvimento Tecnol Saude, Natl Inst Sci & Technol Innovat Neglected Dis INC, CNPq, Rio De Janeiro, Brazil; [Antunes, Luis Caetano M.] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Rio De Janeiro, Brazil; [Han, Jun; Pan, Jingxi; Borchers, Christoph H.] Univ Victoria, Genome BC Prote Ctr, Victoria, BC, Canada; [Moreira, Carlos J. C.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Doencas Parasitarias, Rio De Janeiro, Brazil; [Azambuja, Patricia; Carels, Nicolas] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Bioquim & Fisiol Insetos, Natl Inst Mol Entomol INCT ME,CNPq, Rio De Janeiro, Brazil; [Carels, Nicolas] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Genom Func & Bioinformat, Rio De Janeiro, Brazil	University of British Columbia; Center for Technological Development in Health (CDTS); Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; University of Victoria; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Carels, N (corresponding author), Fundacao Oswaldo Cruz, Ctr Desenvolvimento Tecnol Saude, Natl Inst Sci & Technol Innovat Neglected Dis INC, CNPq, Rio De Janeiro, Brazil.	nicolas.carels@cdts.fiocruz.br	de Azambuja Penna, Patricia/AAA-3763-2019; Carels, Nicolas/L-4687-2016; Antunes, Luis Caetano Martha/P-4988-2019; BORCHERS, Christoph/U-5964-2019	Carels, Nicolas/0000-0003-4547-7155; Martha Antunes, Luis Caetano/0000-0003-1686-0788; Azambuja, Patricia/0000-0002-1405-8743	Canadian Institutes of Health Research; Conselho de Desenvolvimento Cientifico e Tecnologico (CNPq) [374487/2012-0]; CNPq; Fundacao Oswaldo Cruz (FIOCRUZ) [40.3638/2008-9]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Centro de Desenvolvimento Tecnologico em Saude (CDTS); Genome Canada; Genome British Columbia	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Conselho de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Oswaldo Cruz (FIOCRUZ); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Centro de Desenvolvimento Tecnologico em Saude (CDTS); Genome Canada(Genome Canada); Genome British Columbia	This work was supported by a postdoctoral fellowship from the Canadian Institutes of Health Research and a Young Talent Fellowship (no. 374487/2012-0) from Conselho de Desenvolvimento Cientifico e Tecnologico (CNPq, http://www.cnpq.br/) to L. C. M. A.; by grants from CNPq to P. A. and N.C.; Fundacao Oswaldo Cruz (FIOCRUZ, http://www.fiocruz.br/)/PAPESV project to N.C. (no. 40.3638/2008-9); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, http://www.faperj.br/); Centro de Desenvolvimento Tecnologico em Saude (CDTS), Genome Canada and Genome British Columbia to L. C. M. A. P. A. is a Senior Scientist from CNPq; N.C. was a Visiting Scientist from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, http://www.capes.gov.br/) and FIOCRUZ/CDTS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Serrano A, 2001, MOL BIOCHEM PARASIT, V114, P143, DOI 10.1016/S0166-6851(01)00245-6; Aguilar HM, 2007, MEM I OSWALDO CRUZ, V102, P47, DOI 10.1590/S0074-02762007005000098; Alves-Ferreira M, 2009, MEM I OSWALDO CRUZ, V104, P1100, DOI 10.1590/S0074-02762009000800006; Antunes LCM, 2011, J BACTERIOL, V193, P4719, DOI 10.1128/JB.05132-11; Antunes LCM, 2011, INFECT IMMUN, V79, P1759, DOI 10.1128/IAI.01373-10; Antunes LCM, 2011, ANTIMICROB AGENTS CH, V55, P1494, DOI 10.1128/AAC.01664-10; Arena ET, 2011, INFECT IMMUN, V79, P4392, DOI 10.1128/IAI.05478-11; Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; AVILA JL, 1983, J GEN MICROBIOL, V129, P285; Azambuja P, 2005, AN ACAD BRAS CIENC, V77, P397, DOI 10.1590/S0001-37652005000300004; Azambuja P, 2004, EXP PARASITOL, V107, P89, DOI 10.1016/j.exppara.2004.04.007; Beard CB, 2001, INT J PARASITOL, V31, P621, DOI 10.1016/S0020-7519(01)00165-5; BILLINGSLEY PF, 1988, INT J INSECT MORPHOL, V17, P295, DOI 10.1016/0020-7322(88)90010-4; BILLINGSLEY PF, 1990, ANNU REV ENTOMOL, V35, P219, DOI 10.1146/annurev.en.35.010190.001251; Borges EC, 2006, EXP PARASITOL, V112, P130, DOI 10.1016/j.exppara.2005.09.008; Castro DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036591; Cavazzuti A, 2008, P NATL ACAD SCI USA, V105, P1448, DOI 10.1073/pnas.0704384105; Coura JR, 2010, ACTA TROP, V115, P5, DOI 10.1016/j.actatropica.2010.03.008; Croft SL, 2003, MOL BIOCHEM PARASIT, V126, P165, DOI 10.1016/S0166-6851(02)00283-9; D'Avila H, 2011, J INFECT DIS, V204, P951, DOI 10.1093/infdis/jir432; da Mota FF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001631; DOCAMPO R, 1991, BIOCHEM J, V275, P407, DOI 10.1042/bj2750407; Eichinger D, 2002, J BIOSCIENCES, V27, P589, DOI 10.1007/BF02704852; Einicker-Lamas M, 2007, EXP PARASITOL, V117, P171, DOI 10.1016/j.exppara.2007.04.011; FRAIDENRAICH D, 1993, P NATL ACAD SCI USA, V90, P10140, DOI 10.1073/pnas.90.21.10140; Garcia ES, 2010, MEM I OSWALDO CRUZ, V105, P605, DOI 10.1590/S0074-02762010000500001; Garcia ES, 2010, TRENDS PARASITOL, V26, P499, DOI 10.1016/j.pt.2010.07.003; GARCIA ES, 1991, PARASITOL TODAY, V7, P240, DOI 10.1016/0169-4758(91)90237-I; Garcia ES, 1999, MEM I OSWALDO CRUZ, V94, P213, DOI 10.1590/S0074-02761999000700033; Garcia ES, 1997, MOL BIOL INSECT DIS; Garcia ES, 1984, GENES ANTIGENS PARAS; Ginger ML, 2006, PHILOS T R SOC B, V361, P101, DOI 10.1098/rstb.2005.1756; Ginger ML, 2007, TRYPANOSOMES GENOME; Guerenstein PG, 2009, ACTA TROP, V110, P148, DOI 10.1016/j.actatropica.2008.09.019; Han J, 2008, METABOLOMICS, V4, P128, DOI 10.1007/s11306-008-0104-8; Han J, 2010, FUTURE MICROBIOL, V5, P153, DOI 10.2217/FMB.09.132; HILL P, 1976, PROC R SOC SER B-BIO, V194, P501, DOI 10.1098/rspb.1976.0091; HOUSEMAN JG, 1983, J INSECT PHYSIOL, V29, P141, DOI 10.1016/0022-1910(83)90137-3; Hyde JE, 2007, FEBS J, V274, P4688, DOI 10.1111/j.1742-4658.2007.05999.x; Kollien AH, 2004, INSECT MOL BIOL, V13, P569, DOI 10.1111/j.0962-1075.2004.00504.x; Kollien Astrid H., 1998, Tokai Journal of Experimental and Clinical Medicine, V23, P335; Kubata BK, 2002, J EXP MED, V196, P1241, DOI 10.1084/jem.20020885; LEHANE MJ, 1994, INT J PARASITOL, V24, P27, DOI 10.1016/0020-7519(94)90056-6; Lopez-Ordonez T, 2001, INSECT MOL BIOL, V10, P505, DOI 10.1046/j.0962-1075.2001.00290.x; Machado FS, 2011, ADV PARASIT, V76, P1, DOI 10.1016/B978-0-12-385895-5.00001-3; Martin FPJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00113; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; Michell RH, 2008, NAT REV MOL CELL BIO, V9, P151, DOI 10.1038/nrm2334; Moncayo A, 2006, ANN TROP MED PARASIT, V100, P663, DOI 10.1179/136485906X112248; Mukherjee S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016959; Noverr MC, 2003, CLIN MICROBIOL REV, V16, P517, DOI 10.1128/CMR.16.3.517-533.2003; PERLOWAGORASZUMLEWICZ A, 1994, MEM I OSWALDO CRUZ, V89, P603, DOI 10.1590/S0074-02761994000400018; Dias JCP, 2009, MEM I OSWALDO CRUZ, V104, P41, DOI 10.1590/S0074-02762009000900007; Prentki M, 2008, ENDOCR REV, V29, P647, DOI 10.1210/er.2008-0007; Rassi A, 1997, Rev Soc Bras Med Trop, V30, P93, DOI 10.1590/S0037-86821997000200002; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Reynolds TB, 2009, MICROBIOL-SGM, V155, P1386, DOI 10.1099/mic.0.025718-0; SCHAUB GA, 1987, PARASITOL RES, V73, P417, DOI 10.1007/BF00538198; Silva-Neto Mario A C, 2012, J Parasitol Res, V2012, P625838, DOI 10.1155/2012/625838; Snyder F, 2002, BIOCH LIPIDS LIPOPRO; Spiegel S, 1996, CURR OPIN CELL BIOL, V8, P159, DOI 10.1016/S0955-0674(96)80061-5; Stanley David, 2012, Insects, V3, P492, DOI 10.3390/insects3020492; Stanley DW, 2006, ENTOMOL EXP APPL, V119, P1, DOI 10.1111/j.1570-7458.2006.00406.x; Stanley DW, 1998, AM ZOOL, V38, P369; Torres C, 1999, BBA-GENE STRUCT EXPR, V1489, P428, DOI 10.1016/S0167-4781(99)00195-5; Vacchina P, 2008, J STEROID BIOCHEM, V111, P282, DOI 10.1016/j.jsbmb.2008.06.016; Vallejo GA, 2009, ACTA TROP, V110, P137, DOI 10.1016/j.actatropica.2008.10.001; Vial HJ, 2003, MOL BIOCHEM PARASIT, V126, P143, DOI 10.1016/S0166-6851(02)00281-5; Villalta F, 2009, PARASITOL RES, V104, P1251, DOI 10.1007/s00436-009-1383-3; Wainszelbaum MJ, 2003, BIOCHEM J, V375, P705, DOI 10.1042/BJ20021907	70	22	22	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77283	10.1371/journal.pone.0077283	http://dx.doi.org/10.1371/journal.pone.0077283			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204787	Green Published, gold, Green Submitted			2022-12-27	WOS:000326334500021
J	Cain, KE; Ketterson, ED				Cain, Kristal E.; Ketterson, Ellen D.			Costs and Benefits of Competitive Traits in Females: Aggression, Maternal Care and Reproductive Success	PLOS ONE			English	Article							DARK-EYED JUNCOS; HOME-RANGE SIZE; SEXUAL SELECTION; TESTOSTERONE PRODUCTION; OFFSPRING PHENOTYPE; TERRITORIAL DEFENSE; SOCIAL COMPETITION; YOLK ANDROGENS; NEST PREDATION; PARENTAL CARE	Recent research has shown that female expression of competitive traits can be advantageous, providing greater access to limited reproductive resources. In males increased competitive trait expression often comes at a cost, e. g. trading off with parental effort. However, it is currently unclear whether, and to what extent, females also face such tradeoffs, whether the costs associated with that tradeoff overwhelm the potential benefits of resource acquisition, and how environmental factors might alter those relationships. To address this gap, we examine the relationships between aggression, maternal effort, offspring quality and reproductive success in a common songbird, the dark-eyed junco (Junco hyemalis), over two breeding seasons. We found that compared to less aggressive females, more aggressive females spent less time brooding nestlings, but fed nestlings more frequently. In the year with better breeding conditions, more aggressive females produced smaller eggs and lighter hatchlings, but in the year with poorer breeding conditions they produced larger eggs and achieved greater nest success. There was no relationship between aggression and nestling mass after hatch day in either year. These findings suggest that though females appear to tradeoff competitive ability with some forms of maternal care, the costs may be less than previously thought. Further, the observed year effects suggest that costs and benefits vary according to environmental variables, which may help to account for variation in the level of trait expression.	[Cain, Kristal E.; Ketterson, Ellen D.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Cain, Kristal E.; Ketterson, Ellen D.] Ctr Integrat Study Anim Behav, Bloomington, IN USA; [Cain, Kristal E.] Australian Natl Univ, Res Sch Biol, Acton, Australia	Indiana University System; Indiana University Bloomington; Australian National University	Cain, KE (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN USA.	kristalcain@gmail.com		Cain, Kristal/0000-0002-6908-7015	National Science Foundation (NSF) [BSC 05-19211, IOS 08-20055, 09-10036]	National Science Foundation (NSF)(National Science Foundation (NSF))	Research was supported by National Science Foundation (NSF) grants to EK (BSC 05-19211 and IOS 08-20055) and an NSF Doctoral Dissertation Improvement Grant to KC (09-10036). KC was also supported by NSF Graduate Research Fellowship (www.nsfgrfp.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alvarez C, 2007, FUNCT ECOL, V21, P873, DOI 10.1111/j.1365-2435.2007.01300.x; Amundsen T, 2000, TRENDS ECOL EVOL, V15, P149, DOI 10.1016/S0169-5347(99)01800-5; Amundsen T, 1997, P ROY SOC B-BIOL SCI, V264, P1579, DOI 10.1098/rspb.1997.0220; Andersson Malte, 1994; [Anonymous], 1996, ADAPTATION NATURAL S; Ardia DR, 2010, P ROY SOC B-BIOL SCI, V277, P1881, DOI 10.1098/rspb.2009.2138; Arnott G, 2009, ANIM BEHAV, V78, P1221, DOI 10.1016/j.anbehav.2009.08.005; Badyaev AV, 2002, BEHAV ECOL, V13, P591, DOI 10.1093/beheco/13.5.591; BALPH MH, 1977, ANIM BEHAV, V25, P859, DOI 10.1016/0003-3472(77)90038-0; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; BOX GEP, 1962, BIOMETRIKA, V49, P93, DOI 10.2307/2333470; Briskie JV, 1999, P ROY SOC B-BIOL SCI, V266, P2153, DOI 10.1098/rspb.1999.0902; Cain KE, 2013, HORMONES BE IN PRESS; Cain KE, 2013, BEHAV ECOL, V24, P462, DOI 10.1093/beheco/ars186; Cain KE, 2012, BEHAV ECOL SOCIOBIOL, V66, P241, DOI 10.1007/s00265-011-1272-5; Cain KE, 2011, ETHOLOGY, V117, P786, DOI 10.1111/j.1439-0310.2011.01932.x; Chaine AS, 2008, SCIENCE, V319, P459, DOI 10.1126/science.1149167; Clotfelter ED, 2007, OECOLOGIA, V154, P493, DOI 10.1007/s00442-007-0859-z; Clotfelter ED, 2007, ETHOLOGY, V113, P18, DOI 10.1111/j.1439-0310.2006.01286.x; Clutton-Brock T, 2013, J ZOOL, V289, P151, DOI 10.1111/jzo.12023; Clutton-Brock T, 2009, ANIM BEHAV, V77, P3, DOI 10.1016/j.anbehav.2008.08.026; COONEY R, 1995, ANIM BEHAV, V49, P1635, DOI 10.1016/0003-3472(95)90086-1; Crowhurst CJ, 2012, ETHOLOGY, V118, P63, DOI 10.1111/j.1439-0310.2011.01986.x; Dingemanse NJ, 2004, P ROY SOC B-BIOL SCI, V271, P847, DOI 10.1098/rspb.2004.2680; Duckworth RA, 2003, BEHAV ECOL SOCIOBIOL, V55, P176, DOI 10.1007/s00265-003-0671-7; Duckworth RA, 2006, BEHAV ECOL, V17, P1011, DOI 10.1093/beheco/arl035; Elias DO, 2010, BEHAV ECOL, V21, P868, DOI 10.1093/beheco/arq073; Fedy BC, 2005, BEHAV ECOL SOCIOBIOL, V58, P414, DOI 10.1007/s00265-005-0928-4; Fisher MO, 2006, PLOS BIOL, V4, P1462, DOI 10.1371/journal.pbio.0040251; FITZPATRICK S, 1995, BIOL J LINN SOC, V55, P251, DOI 10.1111/j.1095-8312.1995.tb01063.x; Gil D, 2003, ARDEOLA, V50, P281; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; Griggio M, 2005, ANIM BEHAV, V69, P1243, DOI 10.1016/j.anbehav.2004.10.004; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Hall ML, 2008, ANIM BEHAV, V76, P65, DOI 10.1016/j.anbehav.2008.01.010; Heinsohn R, 1997, ANIM BEHAV, V53, P1143, DOI 10.1006/anbe.1996.0316; Heinsohn R, 2005, SCIENCE, V309, P617, DOI 10.1126/science.1112774; Hodge SJ, 2008, J ANIM ECOL, V77, P92, DOI 10.1111/j.1365-2656.2007.01318.x; Hofer H, 2003, EVOL ECOL, V17, P315, DOI 10.1023/A:1027352517231; Holberton RL, 2008, GEN COMP ENDOCR, V155, P641, DOI 10.1016/j.ygcen.2007.11.001; HOLBERTON RL, 1989, ANIM BEHAV, V37, P681, DOI 10.1016/0003-3472(89)90047-X; Janzen FJ, 2009, J EVOLUTION BIOL, V22, P2222, DOI 10.1111/j.1420-9101.2009.01838.x; Jawor JM, 2004, ANIM BEHAV, V67, P875, DOI 10.1016/j.anbehav.2003.05.015; Jawor JM, 2007, FUNCT ECOL, V21, P767, DOI 10.1111/j.1365-2435.2007.01280.x; Johnstone Rufus A., 1997, P155; Ketterson ED, 1999, AM NAT, V154, pS4, DOI 10.1086/303280; KETTERSON ED, 1992, AM NAT, V140, P980, DOI 10.1086/285451; Ketterson ED, 2002, DARK EYED JUNCO; KOPACHENA JG, 1993, WILSON BULL, V105, P48; Kraaijeveld K, 2007, ANIM BEHAV, V74, P657, DOI 10.1016/j.anbehav.2006.12.027; Krist M, 2011, BIOL REV, V86, P692, DOI 10.1111/j.1469-185X.2010.00166.x; Langmore NE, 2002, P ROY SOC B-BIOL SCI, V269, P2473, DOI 10.1098/rspb.2002.2167; Lebas NR, 2006, TRENDS ECOL EVOL, V21, P170, DOI 10.1016/j.tree.2006.01.007; Magrath MJL, 2003, TRENDS ECOL EVOL, V18, P424, DOI 10.1016/S0169-5347(03)00124-1; Marra PP, 2000, BEHAV ECOL, V11, P299, DOI 10.1093/beheco/11.3.299; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; Martin TE, 2008, PHILOS T R SOC B, V363, P1663, DOI 10.1098/rstb.2007.0009; McGlothlin JW, 2007, AM NAT, V170, P864, DOI 10.1086/522838; McGlothlin JW, 2010, AM NAT, V175, P687, DOI 10.1086/652469; Mila B, 2007, P R SOC B, V274, P2653, DOI 10.1098/rspb.2007.0852; Muller W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022675; Murphy TG, 2009, BEHAV ECOL, V20, P1348, DOI 10.1093/beheco/arp140; Navara KJ, 2005, PHYSIOL BIOCHEM ZOOL, V78, P570, DOI 10.1086/430689; Neudorf DL, 2002, ETHOLOGY, V108, P713, DOI 10.1046/j.1439-0310.2002.00806.x; O'Neal DM, 2008, HORM BEHAV, V54, P571, DOI 10.1016/j.yhbeh.2008.05.017; PACKER C, 1995, NATURE, V373, P60, DOI 10.1038/373060a0; Pryke SR, 2007, BEHAV ECOL, V18, P621, DOI 10.1093/beheco/arm020; Pryke SR, 2009, AM NAT, V174, P455, DOI 10.1086/605376; Reed WL, 2006, AM NAT, V167, P667, DOI 10.1086/503054; Reichard DG, 2012, WILSON J ORNITHOL, V124, P614, DOI 10.1676/11-189.1; Rosvall KA, 2008, ANIM BEHAV, V75, P1603, DOI 10.1016/j.anbehav.2007.09.038; Rosvall KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054120; Rosvall KA, 2011, BEHAV ECOL, V22, P1131, DOI 10.1093/beheco/arr106; Rosvall KA, 2011, ETHOLOGY, V117, P332, DOI 10.1111/j.1439-0310.2011.01881.x; Rubenstein DR, 2012, PHILOS T R SOC B, V367, P2248, DOI 10.1098/rstb.2011.0278; Rubenstein DR, 2009, NATURE, V462, P786, DOI 10.1038/nature08614; Sandell MI, 1998, P ROY SOC B-BIOL SCI, V265, P1307, DOI 10.1098/rspb.1998.0434; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Schwabl H, 2007, AM NAT, V170, P196, DOI 10.1086/519397; Shuster S. M., 2003, MONOGRAPHS BEHAV ECO; Simmons LW, 2008, J EVOLUTION BIOL, V21, P1227, DOI 10.1111/j.1420-9101.2008.01575.x; SLAGSVOLD T, 1993, ORNIS SCAND, V24, P155, DOI 10.2307/3676366; Sockman KW, 2000, P ROY SOC B-BIOL SCI, V267, P1451, DOI 10.1098/rspb.2000.1163; Starck J.M., 1998, AVIAN GROWTH DEV; Stiver KA, 2009, ETHOLOGY, V115, P1101, DOI 10.1111/j.1439-0310.2009.01707.x; Stockley P, 2011, BIOL REV, V86, P341, DOI 10.1111/j.1469-185X.2010.00149.x; Tobias JA, 2012, PHILOS T R SOC B, V367, P2274, DOI 10.1098/rstb.2011.0280; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Tuttle EM, 2003, BEHAV ECOL, V14, P425, DOI 10.1093/beheco/14.3.425; Valcu M, 2008, ANIM BEHAV, V75, P1949, DOI 10.1016/j.anbehav.2007.12.005; Vleck C.M., 1998, P WSPA 10 EUR POULTR, P163; Watson NL, 2010, P ROY SOC B-BIOL SCI, V277, P2035, DOI 10.1098/rspb.2009.2335; Weiss SL, 2009, BEHAV ECOL, V20, P1063, DOI 10.1093/beheco/arp098; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; Whittingham LA, 2002, ANIM BEHAV, V63, P63, DOI 10.1006/anbe.2001.1889; Whittingham LA, 2007, CONDOR, V109, P585, DOI 10.1650/8247.1; WOLF L, 1990, ANIM BEHAV, V39, P125, DOI 10.1016/S0003-3472(05)80732-8; YASUKAWA K, 1982, BEHAV ECOL SOCIOBIOL, V11, P13, DOI 10.1007/BF00297660	98	35	35	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77816	10.1371/journal.pone.0077816	http://dx.doi.org/10.1371/journal.pone.0077816			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204980	Green Published, gold			2022-12-27	WOS:000326334500064
J	Fuchs, A; Rempel, V; Muller, CE				Fuchs, Alexander; Rempel, Viktor; Mueller, Christa E.			The Natural Product Magnolol as a Lead Structure for the Development of Potent Cannabinoid Receptor Agonists	PLOS ONE			English	Article							CB2 RECEPTORS; ENDOCANNABINOID SYSTEM; GPR55; PHARMACOLOGY; LOCALIZATION; ACTIVATION; LIGANDS; INVERSE; TARGET; GPR18	Magnolol (4-allyl-2-(5-allyl-2-hydroxyphenyl)phenol), the main bioactive constituent of the medicinal plant Magnolia officinalis, and its main metabolite tetrahydromagnolol were recently found to activate cannabinoid (CB) receptors. We now investigated the structure-activity relationships of (tetrahydro) magnolol analogs with variations of the alkyl chains and the phenolic groups and could considerably improve potency. Among the most potent compounds were the dual CB1/CB2 full agonist 2-(2-methoxy-5-propyl-phenyl)-4-hexylphenol (61a, K-i CB1:0.00957 mu M; K-i CB2:0.0238 mu M), and the CB2-selective partial agonist 2-(2-hydroxy-5-propylphenyl)-4-pentylphenol (60, K-i CB1:0.362 mu M; K-i CB2:0.0371 mu M), which showed high selectivity versus GPR18 and GPR55. Compound 61b, an isomer of 61a, was the most potent GPR55 antagonist with an IC50 value of 3.25 mu M but was non-selective. The relatively simple structures, which possess no stereocenters, are easily accessible in a four-to five-step synthetic procedure from common starting materials. The central reaction step is the well-elaborated Suzuki-Miyaura cross-coupling reaction, which is suitable for a combinatorial chemistry approach. The scaffold is versatile and may be fine-tuned to obtain a broad range of receptor affinities, selectivities and efficacies.	[Fuchs, Alexander; Rempel, Viktor; Mueller, Christa E.] PharmaCtr Bonn, Inst Pharmaceut, Bonn, Germany		Muller, CE (corresponding author), PharmaCtr Bonn, Inst Pharmaceut, Bonn, Germany.	christa.mueller@uni-bonn.de	Müller, Christa Elisabeth/C-7748-2014	Müller, Christa Elisabeth/0000-0002-0013-6624	German Federal Ministery for Education and Research [BMBF 01EW0911]	German Federal Ministery for Education and Research	Funded by the German Federal Ministery for Education and Research (BMBF 01EW0911) in the frame of ERA-NET NEURON. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGHARAHIMI MR, 1995, J ORG CHEM, V60, P1856, DOI 10.1021/jo00111a052; Alexander SPH, 2012, BRIT J PHARMACOL, V165, P2411, DOI 10.1111/j.1476-5381.2011.01731.x; Anavi-Goffer S, 2012, J BIOL CHEM, V287, P91, DOI 10.1074/jbc.M111.296020; Bellocchio L, 2008, J NEUROENDOCRINOL, V20, P130, DOI 10.1111/j.1365-2826.2008.01682.x; Bisogno T, 2008, J NEUROENDOCRINOL, V20, P1, DOI 10.1111/j.1365-2826.2008.01676.x; Bradshaw HB, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-14; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; Felder CC, 1998, J PHARMACOL EXP THER, V284, P291; Gantz I, 1997, GENOMICS, V42, P462, DOI 10.1006/geno.1997.4752; Gertsch J, 2008, P NATL ACAD SCI USA, V105, P9099, DOI 10.1073/pnas.0803601105; Gertsch J, 2010, BRIT J PHARMACOL, V160, P523, DOI 10.1111/j.1476-5381.2010.00745.x; Hanus LO, 2010, CURR MED CHEM, V17, P1341, DOI 10.2174/092986710790980096; Henstridge CM, 2012, PHARMACOLOGY, V89, P179, DOI 10.1159/000336872; Henstridge CM, 2009, FASEB J, V23, P183, DOI 10.1096/fj.08-108670; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; Heynen-Genel S., 2010, PROBE REPORTS NIH MO, P1; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Kang JG, 2012, DIABETES METAB J, V36, P13, DOI 10.4093/dmj.2012.36.1.13; Kapur A, 2009, J BIOL CHEM, V284, P29817, DOI 10.1074/jbc.M109.050187; Kellenberger E, 2011, NAT PROD REP, V28, P1483, DOI 10.1039/c1np00026h; Kenakin T, 2001, FASEB J, V15, P598, DOI 10.1096/fj.00-0438rev; Kirilly E, 2012, ACTA PHYSIOL, V205, P41, DOI 10.1111/j.1748-1716.2012.02402.x; Koetter U, 2009, J ETHNOPHARMACOL, V124, P421, DOI 10.1016/j.jep.2009.05.040; Konakahara T, 2010, TETRAHEDRON LETT, V51, P2335, DOI 10.1016/j.tetlet.2010.02.125; Lee YJ, 2011, PHARMACOL THERAPEUT, V130, P157, DOI 10.1016/j.pharmthera.2011.01.010; Mancini I, 2009, BRIT J PHARMACOL, V158, P382, DOI 10.1111/j.1476-5381.2009.00154.x; McHugh D, 2012, BRIT J PHARMACOL, V165, P2414, DOI 10.1111/j.1476-5381.2011.01497.x; MCKILLOP A, 1974, TETRAHEDRON, V30, P1379, DOI 10.1016/S0040-4020(01)97250-3; Mechoulam R, 2013, ANNU REV PSYCHOL, V64, P21, DOI 10.1146/annurev-psych-113011-143739; MIYAURA N, 1979, TETRAHEDRON LETT, V20, P3437, DOI 10.1016/S0040-4039(01)95429-2; Morgan NH, 2009, NEUROPHARMACOLOGY, V57, P356, DOI 10.1016/j.neuropharm.2009.07.017; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; NORDSTEDT C, 1990, ANAL BIOCHEM, V189, P231, DOI 10.1016/0003-2697(90)90113-N; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pertwee RG, 2005, AAPS J, V7, pE625, DOI 10.1208/aapsj070364; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Pertwee RG, 2006, INT J OBESITY, V30, pS13, DOI 10.1038/sj.ijo.0803272; Rempel V, 2013, ACS MED CHEM LETT, V4, P41, DOI 10.1021/ml300235q; Rempel V, 2012, J MED CHEM, V55, P7967, DOI 10.1021/jm3008213; Ross RA, 1999, BRIT J PHARMACOL, V126, P665, DOI 10.1038/sj.bjp.0702351; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Schuehly W, 2011, CHEM BIOL, V18, P1053, DOI 10.1016/j.chembiol.2011.05.012; Sharir H, 2010, PHARMACOL THERAPEUT, V126, P301, DOI 10.1016/j.pharmthera.2010.02.004; Ulrich O., 1986, CHEM BER, V119, P3507; Yao BB, 2006, BRIT J PHARMACOL, V149, P145, DOI 10.1038/sj.bjp.0706838	45	24	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77739	10.1371/journal.pone.0077739	http://dx.doi.org/10.1371/journal.pone.0077739			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204944	Green Published, gold, Green Submitted			2022-12-27	WOS:000326334500050
J	Lan, WZ; Zhao, F; Lin, LX; Li, Z; Zeng, JW; Yang, ZK; Morgan, IG				Lan, Weizhong; Zhao, Feng; Lin, Lixia; Li, Zhen; Zeng, Junwen; Yang, Zhikuan; Morgan, Ian G.			Refractive Errors in 3-6 Year-Old Chinese Children: A Very Low Prevalence of Myopia?	PLOS ONE			English	Article							TABLE-MOUNTED AUTOREFRACTOR; HAND-HELD AUTOREFRACTOR; VISUAL IMPAIRMENT; PRESCHOOL-CHILDREN; SCHOOL-CHILDREN; SOUTHERN CHINA; RISK-FACTORS; POPULATION; INFANTS; RETINOSCOPY	Purpose: To examine the prevalence of refractive errors in children aged 3-6 years in China. Methods: Children were recruited for a trial of a home-based amblyopia screening kit in Guangzhou preschools, during which cycloplegic refractions were measured in both eyes of 2480 children. Cycloplegic refraction (from 3 to 4 drops of 1% cyclopentolate to ensure abolition of the light reflex) was measured by both autorefraction and retinoscopy. Refractive errors were defined as followed: myopia (at least -0.50 D in the worse eye), hyperopia (at least +2.00 D in the worse eye) and astigmatism (at least 1.50 D in the worse eye). Different definitions, as specified in the text, were also used to facilitate comparison with other studies. Results: The mean spherical equivalent refractive error was at least +1.22 D for all ages and both genders. The prevalence of myopia for any definition at any age was at most 2.5%, and lower in most cases. In contrast, the prevalence of hyperopia was generally over 20%, and declined slightly with age. The prevalence of astigmatism was between 6% and 11%. There was very little change in refractive error with age over this age range. Conclusions: Previous reports of less hyperopic mean spherical equivalent refractive error, and more myopia and less hyperopia in children of this age may be due to problems with achieving adequate cycloplegia in children with dark irises. Using up to 4 drops of 1% cyclopentolate may be necessary to accurately measure refractive error in paediatric studies of such children. Our results suggest that children from all ethnic groups may follow a similar pattern of early refractive development, with little myopia and a hyperopic mean spherical equivalent over +1.00 D up to the age of 5-6 yearsin most conditions.	[Lan, Weizhong; Zhao, Feng; Lin, Lixia; Zeng, Junwen; Yang, Zhikuan] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Li, Zhen] Shanxi Eye Hosp, Taiyuan, Shanxi, Peoples R China; [Yang, Zhikuan] Aier Eye Hosp Grp, Changsha, Hunan, Peoples R China; [Morgan, Ian G.] Australian Natl Univ, Res Sch Biol, ARC Ctr Excellence Vis Sci, Canberra, ACT, Australia; [Morgan, Ian G.] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Dept Prevent Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Shanxi Medical University; Australian National University; Sun Yat Sen University	Yang, ZK (corresponding author), Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China.	xo_yo2000@hotmail.com	Morgan, Ian G/D-1190-2009	Morgan, Ian G/0000-0002-4548-3574; Lan, Weizhong/0000-0002-3829-7415	National Natural Science Foundation of China, Beijing, China [81200714]; Foundation for Distinguished Young Talents in Higher Education of Guangdong, Guangdong Province, China [LYM 11009]; Science and Information Technology Bureau of Guangzhou, Guangdong Province, China [2011Y2-00018-3]	National Natural Science Foundation of China, Beijing, China(National Natural Science Foundation of China (NSFC)); Foundation for Distinguished Young Talents in Higher Education of Guangdong, Guangdong Province, China; Science and Information Technology Bureau of Guangzhou, Guangdong Province, China	Supported by the National Natural Science Foundation of China, Beijing, China (grant no.: 81200714;http://www.nsfc.gov.cn/); Foundation for Distinguished Young Talents in Higher Education of Guangdong, Guangdong Province, China (grant no.: LYM 11009;http://www.gdhed.edu.cn/) and the Science and Information Technology Bureau of Guangzhou, Guangdong Province, China (grant no.: 2011Y2-00018-3;http://www.gzsi.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHAN OYC, 1993, OPTOMETRY VISION SCI, V70, P501, DOI 10.1097/00006324-199306000-00009; Chen J, 2011, INVEST OPHTH VIS SCI, V52, P2456, DOI 10.1167/iovs.10-5441; COOK RC, 1951, AM J OPHTHALMOL, V34, P1407, DOI 10.1016/0002-9394(51)90481-3; Dandona R, 2002, INVEST OPHTH VIS SCI, V43, P615; Dirani M, 2010, INVEST OPHTH VIS SCI, V51, P1348, DOI 10.1167/iovs.09-3587; Farook M, 2005, OPTOMETRY VISION SCI, V82, P1066, DOI 10.1097/01.opx.0000192344.72997.7c; Giordano L, 2009, OPHTHALMOLOGY, V116, P739, DOI 10.1016/j.ophtha.2008.12.030; Goh PP, 2005, OPHTHALMOLOGY, V112, P678, DOI 10.1016/j.ophtha.2004.10.048; Gole GA, 2003, CLIN EXP OPHTHALMOL, V31, P341, DOI 10.1046/j.1442-9071.2003.00668.x; He MG, 2004, INVEST OPHTH VIS SCI, V45, P793, DOI 10.1167/iovs.03-1051; He MG, 2007, OPHTHALMOLOGY, V114, P374, DOI 10.1016/j.ophtha.2006.08.020; Jones LA, 2007, INVEST OPHTH VIS SCI, V48, P3524, DOI 10.1167/iovs.06-1118; Lan WZ, 2012, OPHTHALMOLOGY, V119, P1265, DOI 10.1016/j.ophtha.2011.12.027; Maul E, 2000, AM J OPHTHALMOL, V129, P445, DOI 10.1016/S0002-9394(99)00454-7; Mayer DL, 2001, ARCH OPHTHALMOL-CHIC, V119, P1625; Morgan I, 2005, PROG RETIN EYE RES, V24, P1, DOI 10.1016/j.preteyeres.2004.06.004; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Morgan IG, 2010, ACTA OPHTHALMOL, V88, P877, DOI 10.1111/j.1755-3768.2009.01800.x; Murthy GVS, 2002, INVEST OPHTH VIS SCI, V43, P623; Mutti DO, 2005, INVEST OPHTH VIS SCI, V46, P3074, DOI 10.1167/iovs.04-1040; Naidoo KS, 2003, INVEST OPHTH VIS SCI, V44, P3764, DOI 10.1167/iovs.03-0283; O'Donoghue L, 2010, BRIT J OPHTHALMOL, V94, P1155, DOI 10.1136/bjo.2009.176040; Ojaimi E, 2005, INVEST OPHTH VIS SCI, V46, P2748, DOI 10.1167/iovs.04-1324; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; Pennie FC, 2001, VISION RES, V41, P2799, DOI 10.1016/S0042-6989(01)00169-9; Pokharel GP, 2000, AM J OPHTHALMOL, V129, P436, DOI 10.1016/S0002-9394(99)00453-5; Prabakaran S, 2009, OPHTHAL PHYSL OPT, V29, P422, DOI 10.1111/j.1475-1313.2008.00616.x; Rose KA, 2008, ARCH OPHTHALMOL-CHIC, V126, P527, DOI 10.1001/archopht.126.4.527; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; SAUNDERS KJ, 1992, OPTOMETRY VISION SCI, V69, P615, DOI 10.1097/00006324-199208000-00004; SAUNDERS KJ, 1995, SURV OPHTHALMOL, V40, P207, DOI 10.1016/S0039-6257(95)80027-1; Saw SM, 2002, OPHTHALMOLOGY, V109, P2065, DOI 10.1016/S0161-6420(02)01220-4; SORSBY A, 1961, Memo Med Res Counc, V301(Special), P1; SORSBY A, 1960, BRIT MED J, V1, P1394, DOI 10.1136/bmj.1.5183.1394; Sorsby A, 1969, MED RES COUNC SPEC R, V309, P1; Varma R, 2010, OPHTHALMOLOGY, V117, P140, DOI 10.1016/j.ophtha.2009.06.009; Wen G, 2013, OPHTHALMOLOGY, V120, P2109, DOI 10.1016/j.ophtha.2013.06.039; Zhao F, 2010, CHINESE J OPTOM OPHT, V12, P138	38	48	48	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78003	10.1371/journal.pone.0078003	http://dx.doi.org/10.1371/journal.pone.0078003			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205064	gold, Green Published			2022-12-27	WOS:000326334500089
J	Mao, Y; Chen, H; Liang, H; Meric-Bernstam, F; Mills, GB; Chen, K				Mao, Yong; Chen, Han; Liang, Han; Meric-Bernstam, Funda; Mills, Gordon B.; Chen, Ken			CanDrA: Cancer-Specific Driver Missense Mutation Annotation with Optimized Features	PLOS ONE			English	Article							K-RAS MUTATIONS; SOMATIC MUTATIONS; ACTIVATION; MECHANISM; PATTERNS	Driver mutations are somatic mutations that provide growth advantage to tumor cells, while passenger mutations are those not functionally related to oncogenesis. Distinguishing drivers from passengers is challenging because drivers occur much less frequently than passengers, they tend to have low prevalence, their functions are multifactorial and not intuitively obvious. Missense mutations are excellent candidates as drivers, as they occur more frequently and are potentially easier to identify than other types of mutations. Although several methods have been developed for predicting the functional impact of missense mutations, only a few have been specifically designed for identifying driver mutations. As more mutations are being discovered, more accurate predictive models can be developed using machine learning approaches that systematically characterize the commonality and peculiarity of missense mutations under the background of specific cancer types. Here, we present a cancer driver annotation (CanDrA) tool that predicts missense driver mutations based on a set of 95 structural and evolutionary features computed by over 10 functional prediction algorithms such as CHASM, SIFT, and MutationAssessor. Through feature optimization and supervised training, CanDrA outperforms existing tools in analyzing the glioblastoma multiforme and ovarian carcinoma data sets in The Cancer Genome Atlas and the Cancer Cell Line Encyclopedia project.	[Mao, Yong; Chen, Han; Liang, Han; Chen, Ken] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Meric-Bernstam, Funda] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Chen, K (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA.	kchen3@mdanderson.org	Chen, Ken/AAU-1432-2021	Chen, Ken/0000-0003-4013-5279	National Institutes of Health [1R01CA172652, CA168394, CA083639, CA143883, UL1TR000371, 1U01CA180964]; MD Anderson Cancer Center Sheikh Khalifa Ben Zayed Al Nahyan Institute of Personalized Cancer Therapy; National Cancer Institute Cancer Center Support Grant [P30 CA016672]; NATIONAL CANCER INSTITUTE [U01CA168394, P50CA098258, R01CA172652, U24CA143883, P50CA083639, U01CA180964, P30CA016672] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson Cancer Center Sheikh Khalifa Ben Zayed Al Nahyan Institute of Personalized Cancer Therapy; National Cancer Institute Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by the National Institutes of Health (http://www.nih.gov/) [grant number 1R01CA172652, CA168394, CA083639, CA143883, UL1TR000371 and 1U01CA180964]; the MD Anderson Cancer Center Sheikh Khalifa Ben Zayed Al Nahyan Institute of Personalized Cancer Therapy (http://www.mdanderson.org/education-and-research/research-at-md-anderson/personalized-advanced-therapy/institute-for-personalized-cancer-therapy/index.html) and the National Cancer Institute Cancer Center Support Grant (http://cancercenters.cancer.gov/) [P30 CA016672]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Carter H, 2009, CANCER RES, V69, P6660, DOI 10.1158/0008-5472.CAN-09-1133; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Cristianini N, 2000, INTRO SUPPORT VECTOR; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; De S, 2011, NAT BIOTECHNOL, V29, P1103, DOI 10.1038/nbt.2030; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; HUGHES GF, 1968, IEEE T INFORM THEORY, V14, P55, DOI 10.1109/TIT.1968.1054102; Kaminker JS, 2007, NUCLEIC ACIDS RES, V35, pW595, DOI 10.1093/nar/gkm405; Karakas B, 2006, BRIT J CANCER, V94, P455, DOI 10.1038/sj.bjc.6602970; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kris MG, 2011, J CLIN ONCOL, V29, P7506; Lin CF, 2002, IEEE T NEURAL NETWOR, V13, P464, DOI 10.1109/72.991432; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Peter EH., 2000, PATTERN CLASSIFICATI; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Pratilas CA, 2011, CURR TOP MICROBIOL I; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Rivlin Noa, 2011, Genes Cancer, V2, P466, DOI 10.1177/1947601911408889; Rubin AF, 2009, P NATL ACAD SCI USA, V106, P21766, DOI 10.1073/pnas.0912499106; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Smith G, 2010, BRIT J CANCER, V102, P693, DOI 10.1038/sj.bjc.6605534; Statnikov A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-319; TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0; Tao Y, 2011, P NATL ACAD SCI USA, V108, P12042, DOI 10.1073/pnas.1108715108; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	49	67	67	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77945	10.1371/journal.pone.0077945	http://dx.doi.org/10.1371/journal.pone.0077945			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205039	gold, Green Submitted, Green Published			2022-12-27	WOS:000326334500080
J	Mons, U; Raum, E; Kramer, HU; Ruter, G; Rothenbacher, D; Rosemann, T; Szecsenyi, J; Brenner, H				Mons, Ute; Raum, Elke; Kraemer, Heike U.; Rueter, Gernot; Rothenbacher, Dietrich; Rosemann, Thomas; Szecsenyi, Joachim; Brenner, Hermann			Effectiveness of a Supportive Telephone Counseling Intervention in Type 2 Diabetes Patients: Randomized Controlled Study	PLOS ONE			English	Article							QUALITY IMPROVEMENT STRATEGIES; IMPROVING PRIMARY-CARE; GLYCEMIC CONTROL; CHRONIC ILLNESS; MELLITUS; RISK; MANAGEMENT; PREVALENCE; REGRESSION; DISEASE	Objectives: This randomized controlled trial investigated whether a patient-centered supportive counseling intervention comprising monthly telephone-based counseling sessions by practice nurses over 12 months improved diabetes-related medical and psycho-social outcomes above usual care in type 2 diabetes patients with poor glycemic control at baseline (HbA(1c) >7.5%) in a primary care setting. Research Design: Patients were individually randomized into intervention (n = 103) and usual care group (n = 101). The primary outcome was change in HbA(1c)-concentration after 12 and 18 months. Secondary outcomes were lipid levels, blood pressure, health-related quality of life and symptoms of depression. Follow-up-measurements were carried out after 6, 12 and 18 months to assess potential immediate and maintained effects of the intervention. For the multivariate analysis, hierarchical linear models were computed for each outcome to assess within-group changes in outcomes over time and between-group differences in patterns of change. Results: HbA(1c) (in %) decreased significantly from baseline to 12-month follow-up measurement both in the intervention (-0.44) and the usual care group (-0.51), but there was no significant between-group intervention effect. Significant improvements in the intervention group along with significant between-group differences were seen for health-related quality of life and, transiently, for systolic blood pressure and depression. Conclusions: Although we found no beneficial effect of the supportive telephone counseling in terms of a reduction of HbA1c above usual care, our findings suggest some beneficial effects on cardiovascular risk factors, quality of life and depression. Continuous efforts might be needed to sustain improvements in patient outcomes.	[Mons, Ute; Raum, Elke; Kraemer, Heike U.; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Rothenbacher, Dietrich] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Rosemann, Thomas] Univ Zurich Hosp, Dept Gen Practice & Hlth Serv Res, CH-8091 Zurich, Switzerland; [Szecsenyi, Joachim] Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ulm University; University of Zurich; University Zurich Hospital; Ruprecht Karls University Heidelberg	Mons, U (corresponding author), German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany.	u.mons@dkfz.de	Mons, Ute/AAO-4337-2021; Brenner, Hermann/B-4627-2017; Brenner, Hermann/ABE-6383-2020	Mons, Ute/0000-0003-1764-6783; Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572; Rothenbacher, Dietrich/0000-0002-3563-2791	German Federal Ministry of Education and Research [01GX0746]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This study was supported by a grant of the German Federal Ministry of Education and Research (01GX0746). The funding body had no role in the study design, the collection, analysis or interpretation of the data, the writing of the manuscript, or on the decision to submit the paper for publication.	BLOMQVIST N, 1987, J CLIN PERIODONTOL, V14, P34, DOI 10.1111/j.1600-051X.1987.tb01510.x; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; BRYK AS, 1987, PSYCHOL BULL, V101, P147, DOI 10.1037/0033-2909.101.1.147; Digenio AG, 2009, ANN INTERN MED, V150, P255, DOI 10.7326/0003-4819-150-4-200902170-00006; Glasgow RE, 2002, ANN BEHAV MED, V24, P80, DOI 10.1207/S15324796ABM2402_04; Godwin Marshall, 2003, BMC Med Res Methodol, V3, P28, DOI 10.1186/1471-2288-3-28; Gotz K, 2012, GMS PSYCHOSOC MED, V9; Heidemann C, 2013, BUNDESGESUNDHEITSBLA, V56, P668, DOI 10.1007/s00103-012-1662-5; KIRKMAN MS, 1994, DIABETES CARE, V17, P840, DOI 10.2337/diacare.17.8.840; Koster I, 2012, DEUT MED WOCHENSCHR, V137, P1013, DOI 10.1055/s-0032-1304891; Kramer HU, 2012, AM J MANAG CARE, V18, P362; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Piette JD, 2011, MED CARE, V49, P641, DOI 10.1097/MLR.0b013e318215d0c9; Pimouguet C, 2011, CAN MED ASSOC J, V183, pE115, DOI 10.1503/cmaj.091786; Renders CM, 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858, DOI 10.1002/14651858.CD001481]; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Seitz P, 2011, DIABETES OBES METAB, V13, P479, DOI 10.1111/j.1463-1326.2010.01347.x; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Shojania KG, 2006, JAMA-J AM MED ASSOC, V296, P427, DOI 10.1001/jama.296.4.427; Sox HC, 2010, MED CARE, V48, pS7, DOI 10.1097/MLR.0b013e3181da3709; Stead LF, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002850.pub2; Stock SAK, 2006, DIABETIC MED, V23, P299, DOI 10.1111/j.1464-5491.2005.01779.x; Stolar M, 2010, AM J MED, V123, pS3, DOI 10.1016/j.amjmed.2009.12.004; Tricco AC, 2012, LANCET, V379, P2252, DOI 10.1016/S0140-6736(12)60480-2; Vrijhoef HJM, 2002, INT J NURS STUD, V39, P441, DOI 10.1016/S0020-7489(01)00046-3; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Ware JE, 1995, SCORE SF 12 PHYS MEN; WEINBERER M, 1995, J GEN INTERN MED, V10, P59, DOI 10.1007/BF02600227; Woollard J, 2003, J CARDIOVASC RISK, V10, P31, DOI 10.1097/00043798-200302000-00007	32	20	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77954	10.1371/journal.pone.0077954	http://dx.doi.org/10.1371/journal.pone.0077954			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243RL	24205043	Green Submitted, Green Published, gold			2022-12-27	WOS:000326334500081
J	Zhu, JQ; Kang, LY; Ye, QF; Fan, GW; Liang, YB; Yan, C; Orgah, J				Zhu, Jinqiang; Kang, Liyuan; Ye, Qiaofeng; Fan, Guanwei; Liang, Yubin; Yan, Chen; Orgah, John			Effects of Shenfu Injection and Its Main Components on the Contraction of Isolated Rat Thoracic Aortic Rings	PLOS ONE			English	Article							GINSENOSIDES; RELAXATION; INJURY; FU	Background and Purpose: Shenfu injection (SFI), derived from the ancient traditional Chinese medicine (Red Radix Ginseng and Radix Aconitum Carmichaeli), has been widely used in the clinical for the treatment of cardiovascular diseases for more than 20 years. The present study aims to investigate the effects of SFI and its main components on the contraction of isolated rat thoracic aorta rings and the potential mechanisms of this action. Methodology/Principal Findings: The isolated rat thoracic aorta rings were initially treated with different concentrations of SFI, Hongshen injection (HSI, mainly containing ginsenoside) or Fupian injection (FPI, mainly containing aconite total alkaloids) separately. The control group was added an equal volume Krebs-Henseleit (K-H) solution. All three injections exhibited no obviously effects on the basal tension of the rings in the resting state. However, in the isolated thoracic aorta rings with intact endothelium, when the rings were first induced by 60 mM potassium chloride (KCl) or 1 mu M norepinephrine (NE) to the maximal contraction and then treated with above injections, SFI and HSI significantly inhibited the vasoconstriction induced by KCl or NE. In addition, FPI has a tendency to inhibit KCl-induced vasoconstriction and facilitate NE-induced vasoconstriction, but no significant difference. None of them showed obvious effect on the endothelium denuded vessels. Moreover, this procedure was repeated after pre-incubation of nitric oxide synthase (NOS) inhibitor N-G-nitro-L-arginine methyl ester (L-NAME), which suppressed the vasorelaxation effect of SFI and HSI. Conclusions and Implications: These results demonstrate that both SFI and HSI caused an apparent thoracic aorta relaxation by endothelium-dependent manner, which was associated with eNOS system, while FPI had no detectable vasodilator effect. This suggested that the ginsenoside from red Radix Ginseng may be the main active ingredient of SFI's vasodilator effect.	[Zhu, Jinqiang; Kang, Liyuan; Ye, Qiaofeng; Fan, Guanwei; Liang, Yubin; Yan, Chen] Tianjin Univ Tradit Chinese Med, Tianjin Key Lab Chinese Med Pharmacol, Inst Tradit Chinese Med, Tianjin, Peoples R China; [Orgah, John] Tianjin Int Joint Acad Biotechnol & Med, Res & Dev Ctr TCM, Tianjin, Peoples R China	Tianjin University of Traditional Chinese Medicine; Tianjin International Joint Academy of Biomedicine	Kang, LY (corresponding author), Tianjin Univ Tradit Chinese Med, Tianjin Key Lab Chinese Med Pharmacol, Inst Tradit Chinese Med, Tianjin, Peoples R China.	klyzm@163.com	FAN, GUANWEI/GWV-6480-2022; guanwei, fan/M-8193-2019; Orgah, John Owoicho/Q-7645-2019		National Key Basic Research and Development Program (973 Program) [2012CB518404]	National Key Basic Research and Development Program (973 Program)(National Basic Research Program of China)	This work was supported by the National Key Basic Research and Development Program (973 Program)-Component Compatibility regulation of the effective prescription for the treatment of cardiovascular disease (No.: 2012CB518404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo J, 2003, BRIT J PHARMACOL, V138, P63, DOI 10.1038/sj.bjp.0705027; [Anonymous], [No title captured]; [Anonymous], 2005, CHIN J NAT MED; [Anonymous], [No title captured]; Deng Q. Y., 2012, J NEW CHINESE MED, V44, P15; Ding YD, 2009, SHANDONG MED J, V49, P64; Gu W, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/464650; [侯雅竹 Hou Yazhu], 2011, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V11, P292; Hu HH, 2005, CHINESE J INTEGRATIV, V3, P67; Huang W, 2007, J LIAONING U TRADITI, V9, P5; Ji XF, 2013, CHINESE MED J-PEKING, V126, P697, DOI 10.3760/cma.j.issn.0366-6999.20121320; Ji XF, 2011, SHOCK, V35, P530, DOI 10.1097/SHK.0b013e31820e2058; KANG SY, 1995, LIFE SCI, V56, P1577, DOI 10.1016/0024-3205(95)00124-O; KIM ND, 1994, GEN PHARMACOL-VASC S, V25, P1071, DOI 10.1016/0306-3623(94)90121-X; Li QB, 1999, J GUANGDONG MED COLL, V17, P138; Li QB, 1999, J GUANGDONG MED COLL, V17, P138; Liu J. W., 2010, J LIAONING U TRADITI, V12, P242; Liu XH, 2010, CHINA PHARM, V19, P12; Liu YH, 2010, LIAONING J TRADITI S, VS1, P42; Liu Z, 2001, J NEW CHINESE MED, V33, P6; Nie Y.J., 2012, CHIN MED PHARM CHIN, V2, P64; Tu QY, 2009, LIAONING J TRADITION, V36, P1908; Wang YS, 1983, CHINESE MED PHARM AP, P16; Wang ZC, 2008, INT J TRADITIONAL CH, V30, P445; Xu SY, 1994, PHARM EXPT METHODOLO, P886; [闫福曼 Yan Fuman], 2009, [中药药理与临床, Pharmacology and Clinics of Chinese Materia Medica], V25, P8; Yang RJ, 2012, STUDY CHEM CONSTITUE; Zhang JZ, 2009, PRACTICAL J CARDIAC, V17, P470; [张晓膺 Zhang Xiaoying], 2005, [江苏医药, Jiangsu medical Journal], V31, P113; Zhao JR, 2009, PRACTICAL J CARDIAC, V17, P776; Zheng CD, 2008, CHIN J INTEGR MED, V14, P10, DOI 10.1007/s11655-008-0010-y; Zheng HK, 1997, TRADITIONAL CHINESE, P109; Zheng SY, 2004, AM J CHINESE MED, V32, P209, DOI 10.1142/S0192415X04001874; Zheng SY, 2004, J NANJING U NATURAL, V40, P193; Zhou LQ, 2007, J J LIAONING U TCM, V9, P209; [邹磊 ZOU Lei], 2009, [重庆医科大学学报, Acta Universitatis Scientiae Medicinae Chongqing], V34, P903	36	31	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78026	10.1371/journal.pone.0078026	http://dx.doi.org/10.1371/journal.pone.0078026			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205074	Green Submitted, gold, Green Published			2022-12-27	WOS:000326334500090
J	Ha, S; Baver, S; Huo, LH; Gata, A; Hairston, J; Huntoon, N; Li, WJ; Zhang, T; Benecchi, EJ; Ericsson, M; Hentges, ST; Bjorbaek, C				Ha, Sangdeuk; Baver, Scott; Huo, Lihong; Gata, Adriana; Hairston, Joyce; Huntoon, Nicholas; Li, Wenjing; Zhang, Thompson; Benecchi, Elizabeth J.; Ericsson, Maria; Hentges, Shane T.; Bjorbaek, Christian			Somato-Dendritic Localization and Signaling by Leptin Receptors in Hypothalamic POMC and AgRP Neurons	PLOS ONE			English	Article							AGOUTI-RELATED PROTEIN; PROOPIOMELANOCORTIN NEURONS; MESSENGER-RNA; INTERACTING PROTEIN; GENE-EXPRESSION; DYNAMIC CHANGES; NEUROPEPTIDE-Y; SOLITARY TRACT; NUCLEUS; RAT	Leptin acts via neuronal leptin receptors to control energy balance. Hypothalamic pro-opiomelanocortin (POMC) and agouti-related peptide (AgRP)/Neuropeptide Y (NPY)/GABA neurons produce anorexigenic and orexigenic neuropeptides and neurotransmitters, and express the long signaling form of the leptin receptor (LepRb). Despite progress in the understanding of LepRb signaling and function, the sub-cellular localization of LepRb in target neurons has not been determined, primarily due to lack of sensitive anti-LepRb antibodies. Here we applied light microscopy (LM), confocal-laser scanning microscopy (CLSM), and electron microscopy (EM) to investigate LepRb localization and signaling in mice expressing a HA-tagged LepRb selectively in POMC or AgRP/NPY/GABA neurons. We report that LepRb receptors exhibit a somato-dendritic expression pattern. We further show that LepRb activates STAT3 phosphorylation in neuronal fibers within several hypothalamic and hindbrain nuclei of wild-type mice and rats, and specifically in dendrites of arcuate POMC and AgRP/NPY/GABA neurons of Leprb(+/+) mice and in Leprb(db/db) mice expressing HA-LepRb in a neuron specific manner. We did not find evidence of LepRb localization or STAT3-signaling in axon-fibers or nerve-terminals of POMC and AgRP/NPY/GABA neurons. Three-dimensional serial EM-reconstruction of dendritic segments from POMC and AgRP/NPY/GABA neurons indicates a high density of shaft synapses. In addition, we found that the leptin activates STAT3 signaling in proximity to synapses on POMC and AgRP/NPY/GABA dendritic shafts. Taken together, these data suggest that the signaling-form of the leptin receptor exhibits a somato-dendritic expression pattern in POMC and AgRP/NPY/GABA neurons. Dendritic LepRb signaling may therefore play an important role in leptin's central effects on energy balance, possibly through modulation of synaptic activity via post-synaptic mechanisms.	[Ha, Sangdeuk; Baver, Scott; Huo, Lihong; Gata, Adriana; Hairston, Joyce; Huntoon, Nicholas; Li, Wenjing; Zhang, Thompson; Bjorbaek, Christian] Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol & Metab, Boston, MA 02215 USA; [Ha, Sangdeuk; Baver, Scott; Huo, Lihong; Gata, Adriana; Hairston, Joyce; Huntoon, Nicholas; Li, Wenjing; Zhang, Thompson; Bjorbaek, Christian] Harvard Univ, Sch Med, Boston, MA USA; [Benecchi, Elizabeth J.; Ericsson, Maria] Harvard Univ, Sch Med, Electron Microscopy Facil, Boston, MA USA; [Hentges, Shane T.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Colorado State University	Bjorbaek, C (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol & Metab, Boston, MA 02215 USA.	cbjorbae@bidmc.harvard.edu	Bjorbaek, Christian/S-4727-2019; Hentges, Shane T/B-9747-2012		American Diabetes Association [7-09-BS-17, 7-12-BS-010]; Boston Obesity Nutrition Research Center [DK46200]; National Institutes of Health [DK094040, DK060673]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094040, R01DK060673, R01DK078749, P30DK046200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM086262] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); Boston Obesity Nutrition Research Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by American Diabetes Association (grant numbers 7-09-BS-17 and 7-12-BS-010), Boston Obesity Nutrition Research Center (grant number DK46200), and National Institutes of Health (grant numbers DK094040 and DK060673). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2008, ENDOCRIN METAB CLIN, V37, P811, DOI 10.1016/j.ecl.2008.08.005; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; BJORBAEK C, 1995, DIABETES, V44, P90, DOI 10.2337/diabetes.44.1.90; Bjorbaek C, 1997, J BIOL CHEM, V272, P32686, DOI 10.1074/jbc.272.51.32686; Bjorbaek C, 2009, J INVEST MED, V57, P789, DOI 10.2310/JIM.0b013e3181bb0d49; Bouret SG, 2012, J NEUROSCI, V32, P1244, DOI 10.1523/JNEUROSCI.2277-11.2012; Coppari R, 2012, NAT REV DRUG DISCOV, V11, P692, DOI 10.1038/nrd3757; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; de Wall EV, 2008, ENDOCRINOLOGY, V149, P1773, DOI 10.1210/en.2007-1132; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Flynn Kevin C, 2013, Bioarchitecture, V3, P86; Francesconi A, 2002, J NEUROSCI, V22, P2196, DOI 10.1523/JNEUROSCI.22-06-02196.2002; Friedman JM, 2009, AM J CLIN NUTR, V89, p973S, DOI 10.3945/ajcn.2008.26788B; Gamber KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030485; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; GRAFSTEIN B, 1980, PHYSIOL REV, V60, P1167, DOI 10.1152/physrev.1980.60.4.1167; GRAY EG, 1959, NATURE, V183, P1592, DOI 10.1038/1831592a0; Haan C, 2006, BIOCHEM PHARMACOL, V72, P1538, DOI 10.1016/j.bcp.2006.04.013; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Hentges ST, 2007, J NEUROPHYSIOL, V97, P3298, DOI 10.1152/jn.00051.2007; Hill JW, 2010, CELL METAB, V11, P286, DOI 10.1016/j.cmet.2010.03.002; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; HORVATH TL, 1992, ENDOCRINOLOGY, V131, P2461, DOI 10.1210/en.131.5.2461; Huo LH, 2006, DIABETES, V55, P567, DOI 10.2337/diabetes.55.03.06.db05-1143; Huo LH, 2004, ENDOCRINOLOGY, V145, P2516, DOI 10.1210/en.2003-1242; Huo LH, 2007, ENDOCRINOLOGY, V148, P2189, DOI 10.1210/en.2006-1572; Huo L, 2009, CELL METAB, V9, P537, DOI 10.1016/j.cmet.2009.05.003; Irving AJ, 2006, NEUROSCIENCE, V138, P1137, DOI 10.1016/j.neuroscience.2005.11.042; JACOBOWITZ DM, 1978, P NATL ACAD SCI USA, V75, P6300, DOI 10.1073/pnas.75.12.6300; KISS JZ, 1984, BRAIN RES, V324, P91, DOI 10.1016/0006-8993(84)90625-5; Klemann CJHM, 2011, SYNAPSE, V65, P1222, DOI 10.1002/syn.20962; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Leinninger GM, 2008, ACTA PHYSIOL, V192, P49, DOI 10.1111/j.1748-1716.2007.01784.x; Liao GY, 2012, NAT MED, V18, P564, DOI 10.1038/nm.2687; Liu TM, 2012, NEURON, V73, P511, DOI 10.1016/j.neuron.2011.11.027; Lu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005655; MacLennan AJ, 2000, NEUROSCIENCE, V99, P761, DOI 10.1016/S0306-4522(00)90236-7; McKinney RA, 2010, J PHYSIOL-LONDON, V588, P107, DOI 10.1113/jphysiol.2009.178905; Mercer AJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00019; Mihaly E, 2000, J CLIN ENDOCR METAB, V85, P2596, DOI 10.1210/jc.85.7.2596; Moult PR, 2010, J NEUROSCI, V30, P4088, DOI 10.1523/JNEUROSCI.3614-09.2010; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Munzberg H, 2003, ENDOCRINOLOGY, V144, P2121, DOI 10.1210/en.2002-221037; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Ngwenya LB, 2005, J HISTOCHEM CYTOCHEM, V53, P821, DOI 10.1369/jhc.4A6605.2005; Nicolas CS, 2012, NEURON, V73, P374, DOI 10.1016/j.neuron.2011.11.024; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; O'Malley D, 2005, FASEB J, V19, P1917, DOI 10.1096/fj.05-4166fje; O'Malley D, 2007, MOL CELL NEUROSCI, V35, P559, DOI 10.1016/j.mcn.2007.05.001; Peters A., 1991, FINE STRUCTURE NERVO; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Piper ML, 2008, MOL ENDOCRINOL, V22, P751, DOI 10.1210/me.2007-0389; Qiu J, 2003, J NEUROSCI, V23, P9529; Reyes ARS, 2010, BRAIN RES, V1358, P71, DOI 10.1016/j.brainres.2010.08.080; Rivera JF, 2003, NAT NEUROSCI, V6, P243, DOI 10.1038/nn1020; Robertson SA, 2008, PHYSIOL BEHAV, V94, P637, DOI 10.1016/j.physbeh.2008.04.005; Scott MM, 2009, J COMP NEUROL, V514, P518, DOI 10.1002/cne.22025; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Shanley LJ, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0001.2001; Sickles DW, 2002, NEUROTOXICOLOGY, V23, P223, DOI 10.1016/S0161-813X(02)00025-6; Stowell JN, 1999, NEURON, V22, P525, DOI 10.1016/S0896-6273(00)80707-2; Stroh T, 2006, NEUROCHEM RES, V31, P247, DOI 10.1007/s11064-005-9013-7; Stuart G, 2008, DENDRITES; Taga T, 1996, J NEUROCHEM, V67, P1; Tahirovic S, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001644; Takahashi KA, 2005, ENDOCRINOLOGY, V146, P1043, DOI 10.1210/en.2004-1397; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Thompson JL, 2013, BIOL PSYCHIAT, V73, P860, DOI 10.1016/j.biopsych.2012.10.026; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Treweek JB, 2009, J COMP NEUROL, V512, P323, DOI 10.1002/cne.21884; van den Top M, 2004, NAT NEUROSCI, V7, P493, DOI 10.1038/nn1226; Verma NK, 2009, J BIOL CHEM, V284, P12349, DOI 10.1074/jbc.M807761200; Wang YJ, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/570413; White David W., 1996, Cytokine and Growth Factor Reviews, V7, P303, DOI 10.1016/S1359-6101(96)00040-8; White UA, 2011, CURR PHARM DESIGN, V17, P340; Wilson BD, 1999, ENDOCRINOLOGY, V140, P2387, DOI 10.1210/en.140.5.2387; Xu XH, 2006, J CELL SCI, V119, P452, DOI 10.1242/jcs.02750; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039	85	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77622	10.1371/journal.pone.0077622	http://dx.doi.org/10.1371/journal.pone.0077622			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204898	Green Submitted, Green Published, gold			2022-12-27	WOS:000326270700045
J	Liu, Y; Lu, XR; Xiang, FL; Lu, M; Feng, QP				Liu, Yin; Lu, Xiangru; Xiang, Fu-Li; Lu, Man; Feng, Qingping			Nitric Oxide Synthase-3 Promotes Embryonic Development of Atrioventricular Valves	PLOS ONE			English	Article							BICUSPID AORTIC-VALVE; MITRAL-VALVE; MESENCHYMAL TRANSITION; HEART DEVELOPMENT; CARDIAC VALVES; MICE; EXPRESSION; DISEASE; MOUSE; REGURGITATION	Nitric oxide synthase-3 (NOS3) has recently been shown to promote endothelial-to-mesenchymal transition (EndMT) in the developing atrioventricular (AV) canal. The present study was aimed to investigate the role of NOS3 in embryonic development of AV valves. We hypothesized that NOS3 promotes embryonic development of AV valves via EndMT. To test this hypothesis, morphological and functional analysis of AV valves were performed in wild-type (WT) and NOS3(-/-) mice at postnatal day 0. Our data show that the overall size and length of mitral and tricuspid valves were decreased in NOS3(-/-) compared with WT mice. Echocardiographic assessment showed significant regurgitation of mitral and tricuspid valves during systole in NOS3(-/-) mice. These phenotypes were all rescued by cardiac specific NOS3 overexpression. To assess EndMT, immunostaining of Snail1 was performed in the embryonic heart. Both total mesenchymal and Snail1(+) cells in the AV cushion were decreased in NOS3(-/-) compared with WT mice at E10.5 and E12.5, which was completely restored by cardiac specific NOS3 overexpression. In cultured embryonic hearts, NOS3 promoted transforming growth factor (TGF beta), bone morphogenetic protein (BMP2) and Snail1expression through cGMP. Furthermore, mesenchymal cell formation and migration from cultured AV cushion explants were decreased in the NOS3(-/-) compared with WT mice. We conclude that NOS3 promotes AV valve formation during embryonic heart development and deficiency in NOS3 results in AV valve insufficiency.	[Liu, Yin; Xiang, Fu-Li; Feng, Qingping] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Feng, Qingping] Univ Western Ontario, Dept Med, London, ON, Canada; [Lu, Xiangru; Feng, Qingping] Lawson Hlth Res Inst, London, ON, Canada; [Lu, Man] Sichuan Prov Peoples Hosp, Sichuan Acad Med Sci, Dept Ultrasound, Chengdu, Sichuan, Peoples R China	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Sichuan Provincial People's Hospital	Feng, QP (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada.	qfeng@uwo.ca		Feng, Qingping/0000-0001-9739-2765	Heart and Stroke Foundation of Ontario (HSFO) [NA-6774]; Canadian Institutes of Health Research	Heart and Stroke Foundation of Ontario (HSFO)(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by grants from Heart and Stroke Foundation of Ontario (HSFO, NA-6774) and the Canadian Institutes of Health Research (to Dr. Feng). Dr. Feng is a HSFO Career investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa E, 2006, CIRCULATION, V113, P1344, DOI 10.1161/CIRCULATIONAHA.105.591768; Akool ES, 2005, J BIOL CHEM, V280, P39403, DOI 10.1074/jbc.M504140200; Anyanwu AC, 2010, SEMIN THORAC CARDIOV, V22, P69, DOI 10.1053/j.semtcvs.2010.05.006; Bartram U, 2001, CIRCULATION, V103, P2745; Bloch W, 1999, CARDIOVASC RES, V43, P675, DOI 10.1016/S0008-6363(99)00160-1; Butcher JT, 2007, PHILOS T R SOC B, V362, P1489, DOI 10.1098/rstb.2007.2130; Camenisch TD, 2002, DEV BIOL, V248, P170, DOI 10.1006/dbio.2002.0731; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Chang ACY, 2011, DEV CELL, V21, P288, DOI 10.1016/j.devcel.2011.06.022; Chauvaud S, 1998, J THORAC CARDIOV SUR, V115, P84, DOI 10.1016/S0022-5223(98)99001-8; de Lange FJ, 2004, CIRC RES, V95, P645, DOI 10.1161/01.RES.0000141429.13560.cb; Feng QP, 2002, CIRCULATION, V106, P873, DOI 10.1161/01.CIR.0000024114.82981.EA; Foubert E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2585; Galley HF, 2001, BRIT J ANAESTH, V86, P388, DOI 10.1093/bja/86.3.388; GLICK BN, 1994, AM J CARDIOL, V73, P400, DOI 10.1016/0002-9149(94)90018-3; Gupta A, 2011, CARDIOL YOUNG, V21, P121, DOI 10.1017/S104795111000168X; Hammoud L, 2007, CARDIOVASC RES, V75, P359, DOI 10.1016/j.cardiores.2007.05.006; Hinton RB, 2011, ANNU REV PHYSIOL, V73, P29, DOI 10.1146/annurev-physiol-012110-142145; Hinton RB, 2008, AM J PHYSIOL-HEART C, V294, pH2480, DOI 10.1152/ajpheart.91431.2007; Hinton RB, 2006, CIRC RES, V98, P1431, DOI 10.1161/01.RES.0000224114.65109.4e; Horne BD, 2004, CIRCULATION, V110, P3143, DOI 10.1161/01.CIR.0000147189.85636.C3; Kokubo H, 2004, CIRC RES, V95, P540, DOI 10.1161/01.RES.0000141136.85194.f0; Kruithof BPT, 2007, DEV BIOL, V302, P208, DOI 10.1016/j.ydbio.2006.09.024; Lee TC, 2000, CIRCULATION, V101, P2345, DOI 10.1161/01.CIR.101.20.2345; Liu Y., 2012, EUR HEART J; Liu Y, 2012, DIFFERENTIATION, V84, DOI 10.1016/j.diff.2012.04.004; Malan D, 2004, FASEB J, V18, P1108, DOI 10.1096/fj.03-1158fje; Metukuri MR, 2009, WOUND REPAIR REGEN, V17, P578, DOI 10.1111/j.1524-475X.2009.00509.x; Mokadam NA, 2011, TEX HEART I J, V38, P9; MONCADA S, 1991, PHARMACOL REV, V43, P109; Murray SA, 2006, P NATL ACAD SCI USA, V103, P10300, DOI 10.1073/pnas.0602234103; Razavi HM, 2005, PHARMACOL THERAPEUT, V106, P147, DOI 10.1016/j.pharmthera.2004.11.006; RINDT H, 1993, J BIOL CHEM, V268, P5332; Rivera-Feliciano J, 2006, DEV BIOL, V295, P580, DOI 10.1016/j.ydbio.2006.03.043; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Schwappacher R, 2011, BMC PHARM, V11, P65; Seguela PE, 2011, ARCH CARDIOVASC DIS, V104, P465, DOI 10.1016/j.acvd.2011.06.004; Siu SC, 2010, J AM COLL CARDIOL, V55, P2789, DOI 10.1016/j.jacc.2009.12.068; Stout KK, 2009, CIRCULATION, V119, P3232, DOI 10.1161/CIRCULATIONAHA.108.782292; Sugi Y, 2004, DEV BIOL, V269, P505, DOI 10.1016/j.ydbio.2004.01.045; von Gise A, 2012, CIRC RES, V110, P1628, DOI 10.1161/CIRCRESAHA.111.259960; Xiang FL, 2009, CIRCULATION, V120, P1065, DOI 10.1161/CIRCULATIONAHA.108.839068; Yamagishi T, 2009, ANAT SCI INT, V84, P77, DOI 10.1007/s12565-009-0027-0	43	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77611	10.1371/journal.pone.0077611	http://dx.doi.org/10.1371/journal.pone.0077611			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204893	Green Submitted, Green Published, gold			2022-12-27	WOS:000326270700044
J	Rockey, DC; Weymouth, N; Shi, ZD				Rockey, Don C.; Weymouth, Nate; Shi, Zengdun			Smooth Muscle alpha Actin (Acta2) and Myofibroblast Function during Hepatic Wound Healing	PLOS ONE			English	Article							FOCAL ADHESION KINASE; AMINO-ACID SEQUENCE; FAT-STORING CELLS; SKELETAL-MUSCLE; STELLATE CELLS; EXTRACELLULAR-MATRIX; GRANULATION-TISSUE; LIVER-INJURY; GAMMA-ACTIN; IN-VIVO	Smooth muscle alpha actin (Acta2) expression is largely restricted to smooth muscle cells, pericytes and specialized fibroblasts, known as myofibroblasts. Liver injury, associated with cirrhosis, induces transformation of resident hepatic stellate cells into liver specific myofibroblasts, also known as activated cells. Here, we have used in vitro and in vivo wound healing models to explore the functional role of Acta2 in this transformation. Acta2 was abundant in activated cells isolated from injured livers but was undetectable in quiescent cells isolated from normal livers. Both cellular motility and contraction were dramatically increased in injured liver cells, paralleled by an increase in Acta2 expression, when compared with quiescent cells. Inhibition of Acta2 using several different techniques had no effect on cytoplasmic actin isoform expression, but led to reduced cellular motility and contraction. Additionally, Acta2 knockdown was associated with a significant reduction in Erk1/2 phosphorylation compared to control cells. The data indicate that Acta2 is important specifically in myofibroblast cell motility and contraction and raise the possibility that the Acta2 cytoskeleton, beyond its structural importance in the cell, could be important in regulating signaling processes during wound healing in vivo.	[Rockey, Don C.; Shi, Zengdun] Med Univ S Carolina, Dept Internal Med, Charleston, SC 29425 USA; [Weymouth, Nate] Univ Texas SW Med Ctr Dallas, Div Digest & Liver Dis, Dallas, TX 75390 USA	Medical University of South Carolina; University of Texas System; University of Texas Southwestern Medical Center Dallas	Rockey, DC (corresponding author), Med Univ S Carolina, Dept Internal Med, Charleston, SC 29425 USA.	rockey@musc.edu			National Institutes of Health [DK 02124, DK 50574, DK 57830]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002124, R01DK050574, R01DK057830] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (grants DK 02124, DK 50574, and DK 57830 to DCR). We thank Shmuel Tuvia for assistance with immunohistochemical studies and confocal imaging and John Chung for development of antisense oligonucleotides. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin E, 2013, BIOL CHEM IN PRESS; ARORA PD, 1994, J CELL PHYSIOL, V159, P161, DOI 10.1002/jcp.1041590120; Bartman T, 2004, PLOS BIOL, V2, P673, DOI 10.1371/journal.pbio.0020129; BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; BORDER WA, 1992, NATURE, V360, P361, DOI 10.1038/360361a0; Crawford K, 2002, MOL CELL BIOL, V22, P5887, DOI 10.1128/MCB.22.16.5887-5896.2002; DARBY I, 1990, LAB INVEST, V63, P21; Davis BH, 1996, CLIN LAB MED, V16, P361, DOI 10.1016/S0272-2712(18)30274-9; DELEEUW AM, 1984, HEPATOLOGY, V4, P392; DESMOULIERE A, 1995, EXP NEPHROL, V3, P134; FRIEDMAN SL, 1989, J CLIN INVEST, V84, P1780, DOI 10.1172/JCI114362; GABBIANI G, 1971, EXPERIENTIA, V27, P549, DOI 10.1007/BF02147594; Gabbiani G, 1981, Prog Clin Biol Res, V54, P183; GABBIANI G, 1972, J EXP MED, V135, P719, DOI 10.1084/jem.135.4.719; GAILIT J, 1994, CURR OPIN CELL BIOL, V6, P717, DOI 10.1016/0955-0674(94)90099-X; GARRELS JI, 1976, CELL, V9, P793, DOI 10.1016/0092-8674(76)90142-2; GATES RE, 1994, CELL GROWTH DIFFER, V5, P891; GRESSNER AM, 1995, J HEPATOL, V22, P28; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Herman IM, 1993, CURR OPIN CELL BIOL, V5, P48, DOI 10.1016/S0955-0674(05)80007-9; Hinz B, 2002, J CELL BIOL, V157, P657, DOI 10.1083/jcb.200201049; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; JOHNSON RJ, 1991, J CLIN INVEST, V87, P847, DOI 10.1172/JCI115089; Kapanci Y, 1997, MODERN PATHOL, V10, P1134; Karakozova M, 2006, SCIENCE, V313, P192, DOI 10.1126/science.1129344; KatoMinoura T, 1997, J CELL BIOL, V137, P649, DOI 10.1083/jcb.137.3.649; Khimji AK, 2008, AM J PATHOL, V173, P716, DOI 10.2353/ajpath.2008.071121; KISLAUSKIS EH, 1993, J CELL BIOL, V123, P165, DOI 10.1083/jcb.123.1.165; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; KOUNTOURAS J, 1984, BRIT J EXP PATHOL, V65, P305; KUHN C, 1991, AM J PATHOL, V138, P1257; Kumar A, 1997, P NATL ACAD SCI USA, V94, P4406, DOI 10.1073/pnas.94.9.4406; Liu ZA, 2010, BRIT J PHARMACOL, V159, P304, DOI 10.1111/j.1476-5381.2009.00477.x; MAHER JJ, 1990, J CLIN INVEST, V86, P1641, DOI 10.1172/JCI114886; Mayer DCG, 1997, J CELL BIOL, V139, P1477, DOI 10.1083/jcb.139.6.1477; McClain SA, 1996, AM J PATHOL, V149, P1257; MCHUGH KM, 1991, DEV BIOL, V148, P442, DOI 10.1016/0012-1606(91)90263-3; MITCHELL J, 1989, LAB INVEST, V60, P643; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; MIWA T, 1991, MOL CELL BIOL, V11, P3296, DOI 10.1128/MCB.11.6.3296; Nowak KJ, 2009, J CELL BIOL, V185, P903, DOI 10.1083/jcb.200812132; Okayama T, 2008, BBA-MOL BASIS DIS, V1782, P542, DOI 10.1016/j.bbadis.2008.06.006; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Paradis V, 2010, AM J PATHOL, V177, P1791, DOI 10.2353/ajpath.2010.100166; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; PROCTOR E, 1982, GASTROENTEROLOGY, V83, P1183; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; ROCHE WR, 1990, J PATHOL, V161, P281, DOI 10.1002/path.1711610402; ROCKEY DC, 1992, J SUBMICR CYTOL PATH, V24, P193; RonnovJessen L, 1996, J CELL BIOL, V134, P67, DOI 10.1083/jcb.134.1.67; RUBENSTEIN PA, 1990, BIOESSAYS, V12, P309, DOI 10.1002/bies.950120702; Santos MF, 1997, J CLIN INVEST, V100, P216, DOI 10.1172/JCI119515; Schildmeyer LA, 2000, FASEB J, V14, P2213, DOI 10.1096/fj.99-0927com; SCHMITTGRAFF A, 1994, VIRCHOWS ARCH, V425, P3, DOI 10.1007/BF00193944; Schurch W, 1998, AM J SURG PATHOL, V22, P141, DOI 10.1097/00000478-199802000-00001; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shafiei MS, 2012, LAB INVEST, V92, P305, DOI 10.1038/labinvest.2011.155; Sonnemann KJ, 2006, DEV CELL, V11, P387, DOI 10.1016/j.devcel.2006.07.001; Svegliati-Baroni G, 2003, J HEPATOL, V39, P528, DOI 10.1016/S0168-8278(03)00291-5; TANAKA Y, 1991, J PATHOL, V164, P273, DOI 10.1002/path.1711640314; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; VANDEKERCKHOVE J, 1978, J MOL BIOL, V126, P783, DOI 10.1016/0022-2836(78)90020-7; VANDEKERCKHOVE J, 1979, DIFFERENTIATION, V14, P123, DOI 10.1111/j.1432-0436.1979.tb01021.x; Weymouth N, 2012, DEV BIOL, V363, P1, DOI 10.1016/j.ydbio.2011.11.002; Yata Y, 2002, HEPATOLOGY, V35, P1022, DOI 10.1053/jhep.2002.32673	67	97	97	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77166	10.1371/journal.pone.0077166	http://dx.doi.org/10.1371/journal.pone.0077166			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204762	gold, Green Published, Green Submitted			2022-12-27	WOS:000326270700020
J	Molnar, F; Caragine, C; Caraco, T; Korniss, G				Molnar, Ferenc, Jr.; Caragine, Christina; Caraco, Thomas; Korniss, Gyorgy			Restoration Ecology: Two-Sex Dynamics and Cost Minimization	PLOS ONE			English	Article							HOST SPATIAL HETEROGENEITY; PHASE-TRANSITIONS; INVASION; DIFFUSION; EXTINCTION; MODELS; CONSEQUENCES; REPRODUCTION; COMPETITION; NUCLEATION	We model a spatially detailed, two-sex population dynamics, to study the cost of ecological restoration. We assume that cost is proportional to the number of individuals introduced into a large habitat. We treat dispersal as homogeneous diffusion in a one-dimensional reaction-diffusion system. The local population dynamics depends on sex ratio at birth, and allows mortality rates to differ between sexes. Furthermore, local density dependence induces a strong Allee effect, implying that the initial population must be sufficiently large to avert rapid extinction. We address three different initial spatial distributions for the introduced individuals; for each we minimize the associated cost, constrained by the requirement that the species must be restored throughout the habitat. First, we consider spatially inhomogeneous, unstable stationary solutions of the model's equations as plausible candidates for small restoration cost. Second, we use numerical simulations to find the smallest rectangular cluster, enclosing a spatially homogeneous population density, that minimizes the cost of assured restoration. Finally, by employing simulated annealing, we minimize restoration cost among all possible initial spatial distributions of females and males. For biased sex ratios, or for a significant between-sex difference in mortality, we find that sex-specific spatial distributions minimize the cost. But as long as the sex ratio maximizes the local equilibrium density for given mortality rates, a common homogeneous distribution for both sexes that spans a critical distance yields a similarly low cost.	[Molnar, Ferenc, Jr.; Caragine, Christina; Korniss, Gyorgy] Rensselaer Polytech Inst, Dept Phys Appl Phys & Astron, Troy, NY 12180 USA; [Caraco, Thomas] SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA	Rensselaer Polytechnic Institute; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Molnar, F (corresponding author), Rensselaer Polytech Inst, Dept Phys Appl Phys & Astron, Troy, NY 12180 USA.	molnaf@rpi.edu	Korniss, Gyorgy/A-7360-2011	Caraco, Thomas/0000-0002-8538-6007; Molnar, Ferenc/0000-0002-5614-3989; Caragine, Christina/0000-0002-5958-7200	National Science Foundation [DEB-0918413, DEB-0918392]; Direct For Biological Sciences [0918413] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The National Science Foundation supported this research under Grant Nos. DEB-0918413 and DEB-0918392. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allstadt A, 2007, EVOL ECOL RES, V9, P375; Allstadt A, 2009, J THEOR BIOL, V258, P537, DOI 10.1016/j.jtbi.2009.02.012; Aviles L, 2002, AM NAT, V159, P115, DOI 10.1086/324792; Berec L, 2001, AM NAT, V157, P217, DOI 10.1086/318626; Berec L, 2007, TRENDS ECOL EVOL, V22, P185, DOI 10.1016/j.tree.2006.12.002; Boukal DS, 2002, J THEOR BIOL, V218, P375, DOI 10.1006/jtbi.2002.3084; Buckley M, 2006, ENVIRON MANAGE, V38, P48, DOI 10.1007/s00267-005-0165-7; CARACO T, 1995, ECOLOGY, V76, P196, DOI 10.2307/1940641; Caraco T, 2001, THEOR POPUL BIOL, V59, P185, DOI 10.1006/tpbi.2000.1517; Caraco T, 1998, J THEOR BIOL, V192, P351, DOI 10.1006/jtbi.1998.0663; CASWELL H, 1986, AM NAT, V128, P707, DOI 10.1086/284598; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Dennis B., 1989, Natural Resource Modeling, V3, P481; DOI M, 1976, J PHYS A-MATH GEN, V9, P1479, DOI 10.1088/0305-4470/9/9/009; Ellner SP, 1998, J MATH BIOL, V36, P469, DOI 10.1007/s002850050109; Escudero C, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.021908; Fisher RA, 1930, GENETICAL THEORY NAT; Gandhi A, 1999, J THEOR BIOL, V200, P121, DOI 10.1006/jtbi.1999.0978; Gardiner C. W., 1985, HDB STOCHASTIC METHO, V3; Hall RJ, 2012, ENCY THEORETICAL ECO, P629; Hinrichsen H, 2000, ADV PHYS, V49, P815, DOI 10.1080/00018730050198152; Holl KD, 2000, RESTOR ECOL, V8, P260, DOI 10.1046/j.1526-100x.2000.80037.x; HOLMES EE, 1994, ECOLOGY, V75, P17, DOI 10.2307/1939378; Keitt TH, 2001, AM NAT, V157, P203, DOI 10.1086/318633; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Korniss G, 2005, J THEOR BIOL, V233, P137, DOI 10.1016/j.jtbi.2004.09.018; Korniss G, 1997, PHYS REV E, V56, P4072, DOI 10.1103/PhysRevE.56.4072; KORNISS G, 1995, EUROPHYS LETT, V32, P49, DOI 10.1209/0295-5075/32/1/009; Lande R, 1998, OIKOS, V83, P353, DOI 10.2307/3546849; Levine JM, 2004, ECOL LETT, V7, P975, DOI 10.1111/j.1461-0248.2004.00657.x; LEWIS MA, 1993, THEOR POPUL BIOL, V43, P141, DOI 10.1006/tpbi.1993.1007; Lindenmayer DB, 2002, CONSERV BIOL, V16, P338, DOI 10.1046/j.1523-1739.2002.00450.x; Machado E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.031603; McKane AJ, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.041902; Miller TEX, 2011, AM NAT, V177, P549, DOI 10.1086/659628; Molnar F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043364; Molnar F, 2011, CHEMOMETR INTELL LAB, V108, P76, DOI 10.1016/j.chemolab.2011.03.009; Moro E, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.025102; New York State Department of Environmental Conservation, 2012, CAN LYNX; NVIDIA, 2013, CUDA C PROGR GUID; O'Malley L, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.041116; O'Malley L, 2006, THEOR POPUL BIOL, V70, P464, DOI 10.1016/j.tpb.2006.06.006; O'Malley L, 2009, B MATH BIOL, V71, P1160, DOI 10.1007/s11538-009-9398-6; Pigolotti S, 2013, THEOR POPUL BIOL, V84, P72, DOI 10.1016/j.tpb.2012.12.002; Ramos RA, 1999, PHYS REV B, V59, P9053, DOI 10.1103/PhysRevB.59.9053; RIKVOLD PA, 1994, PHYS REV E, V49, P5080, DOI 10.1103/PhysRevE.49.5080; Robinson GR, 2000, ECOL APPL, V10, P174, DOI 10.1890/1051-0761(2000)010[0174:DSPORD]2.0.CO;2; Schiesser W. E., 1991, NUMERICAL METHOD LIN; Schmickl T, 2010, ECOL MODEL, V221, P1089, DOI 10.1016/j.ecolmodel.2009.12.028; Schmittmann B, 1995, STAT MECH DRIVEN DIF, V17; Shea K, 2000, J APPL ECOL, V37, P77, DOI 10.1046/j.1365-2664.2000.00467.x; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; Tauber UC, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/40/405002; Tainaka K, 2006, EUROPHYS LETT, V74, P554, DOI 10.1209/epl/i2005-10558-3; Tauber UC, 2005, J PHYS A-MATH GEN, V38, pR79, DOI 10.1088/0305-4470/38/17/R01; van Kampen N. G., 1981, STOCHASTIC PROCESSES	56	0	0	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77332	10.1371/journal.pone.0077332	http://dx.doi.org/10.1371/journal.pone.0077332			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204810	gold, Green Submitted, Green Published			2022-12-27	WOS:000326241200025
J	Neri, S; Bourin, P; Peyrafitte, JA; Cattini, L; Facchini, A; Mariani, E				Neri, Simona; Bourin, Philippe; Peyrafitte, Julie-Anne; Cattini, Luca; Facchini, Andrea; Mariani, Erminia			Human Adipose Stromal Cells (ASC) for the Regeneration of Injured Cartilage Display Genetic Stability after In Vitro Culture Expansion	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MICROSATELLITE INSTABILITY; BONE-MARROW; CHROMOSOMAL-ABERRATIONS; TELOMERASE ACTIVITY; TISSUE; TRANSFORMATION; ACQUISITION; EXPRESSION; CHONDROCYTES	Mesenchymal stromal cells are emerging as an extremely promising therapeutic agent for tissue regeneration due to their multi-potency, immune-modulation and secretome activities, but safety remains one of the main concerns, particularly when in vitro manipulation, such as cell expansion, is performed before clinical application. Indeed, it is well documented that in vitro expansion reduces replicative potential and some multi-potency and promotes cell senescence. Furthermore, during in vitro aging there is a decrease in DNA synthesis and repair efficiency thus leading to DNA damage accumulation and possibly inducing genomic instability. The European Research Project ADIPOA aims at validating an innovative cell-based therapy where autologous adipose stromal cells (ASCs) are injected in the diseased articulation to activate regeneration of the cartilage. The primary objective of this paper was to assess the safety of cultured ASCs. The maintenance of genetic integrity was evaluated during in vitro culture by karyotype and microsatellite instability analysis. In addition, RT-PCR array-based evaluation of the expression of genes related to DNA damage signaling pathways was performed. Finally, the senescence and replicative potential of cultured cells was evaluated by telomere length and telomerase activity assessment, whereas anchorage-independent clone development was tested in vitro by soft agar growth. We found that cultured ASCs do not show genetic alterations and replicative senescence during the period of observation, nor anchorage-independent growth, supporting an argument for the safety of ASCs for clinical use.	[Neri, Simona; Cattini, Luca; Facchini, Andrea; Mariani, Erminia] Rizzoli Orthoped Inst, Lab Immunorheumatol & Tissue Regenerat RAMSES, Bologna, Italy; [Bourin, Philippe; Peyrafitte, Julie-Anne] EFS PM, Toulouse, France; [Bourin, Philippe] CSA21, Toulouse, France; [Peyrafitte, Julie-Anne] Univ Toulouse 3, CNRS, INSERM, STROMALAB,UMR 5273,U1031, F-31062 Toulouse, France; [Facchini, Andrea; Mariani, Erminia] Univ Bologna, Med & Surg Sci Dept, Bologna, Italy	IRCCS Istituto Ortopedico Rizzoli; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Bologna	Neri, S (corresponding author), Rizzoli Orthoped Inst, Lab Immunorheumatol & Tissue Regenerat RAMSES, Bologna, Italy.	simona.neri@ior.it	Mariani, Erminia/AAE-8110-2021; Neri, Simona/C-6874-2019; Mariani, Erminia/C-6881-2019; Bourin, Philippe/J-2693-2019	Mariani, Erminia/0000-0002-4407-6707; Neri, Simona/0000-0003-3257-6293; Mariani, Erminia/0000-0002-4407-6707; Bourin, Philippe/0000-0002-9652-4380	ADIPOA EU FP7 project [241719]; RFO Bologna University; MIUR-FIRB [RBAP10KCNS]; Italian Health Ministry	ADIPOA EU FP7 project; RFO Bologna University; MIUR-FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Italian Health Ministry(Ministry of Health, Italy)	This work was supported by: ADIPOA EU FP7 project n. 241719; RFO Bologna University; MIUR-FIRB Project RBAP10KCNS, 5 per mille Funds, Italian Health Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annett K, 2005, EXP GERONTOL, V40, P976, DOI 10.1016/j.exger.2005.09.001; Ben-David U, 2012, CELL STEM CELL, V10, P10, DOI 10.1016/j.stem.2011.12.007; Ben-David U, 2011, CELL STEM CELL, V9, P97, DOI 10.1016/j.stem.2011.06.013; Bernardo ME, 2007, CANCER RES, V67, P9142, DOI 10.1158/0008-5472.CAN-06-4690; Bourin P, 2011, METHODS MOL BIOL, V702, P331, DOI 10.1007/978-1-61737-960-4_24; Bublik DR, 2010, J BIOL CHEM, V285, P5274, DOI 10.1074/jbc.M109.045948; Bukvic N, 2001, MUTAT RES-GEN TOX EN, V498, P159, DOI 10.1016/S1383-5718(01)00279-0; Buyanovskaya OA, 2009, B EXP BIOL MED+, V148, P109, DOI 10.1007/s10517-009-0647-3; Caestecker KW, 2013, EXP CELL RES, V319, P575, DOI 10.1016/j.yexcr.2012.11.013; Casteilla Louis, 2011, World J Stem Cells, V3, P25, DOI 10.4252/wjsc.v3.i4.25; Centeno CJ, 2010, CURR STEM CELL RES T, V5, P81, DOI 10.2174/157488810790442796; Chai JH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-512; Chang CL, 2002, AM J PHYSIOL-CELL PH, V283, pC148, DOI 10.1152/ajpcell.00422.2001; Choumerianou DM, 2008, CELL PROLIFERAT, V41, P909, DOI 10.1111/j.1365-2184.2008.00559.x; Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614; de la Fuente R, 2010, CANCER RES, V70, P6682, DOI 10.1158/0008-5472.CAN-10-2451; De Ugarte DA, 2003, IMMUNOL LETT, V89, P267, DOI 10.1016/S0165-2478(03)00108-1; Desando G, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4156; Duarte DM, 2012, REGEN MED, V7, P147, DOI [10.2217/rme.11.113, 10.2217/RME.11.113]; Garcia S, 2010, EXP CELL RES, V316, P1648, DOI 10.1016/j.yexcr.2010.02.016; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Gimble JM, 2011, STEM CELLS, V29, P749, DOI 10.1002/stem.629; Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026; Goedert M, 1997, EMBO J, V16, P3563, DOI 10.1093/emboj/16.12.3563; Goldring CEP, 2011, CELL STEM CELL, V8, P618, DOI 10.1016/j.stem.2011.05.012; Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138; Jackson AL, 1998, P NATL ACAD SCI USA, V95, P12468, DOI 10.1073/pnas.95.21.12468; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kagawa W, 2010, FEBS J, V277, P590, DOI 10.1111/j.1742-4658.2009.07503.x; Katz AJ, 2005, STEM CELLS, V23, P412, DOI 10.1634/stemcells.2004-0021; Kenyon J, 2012, BLOOD, V120, P3229, DOI 10.1182/blood-2011-12-401950; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Krichevsky S, 2004, EXP GERONTOL, V39, P507, DOI 10.1016/j.exger.2003.12.016; Lee SH, 2003, J IMMUNOL, V170, P2214, DOI 10.4049/jimmunol.170.4.2214; Lepperdinger G, 2008, EXP GERONTOL, V43, P1018, DOI 10.1016/j.exger.2008.07.004; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Liebermann Dan A., 2011, Critical Reviews in Oncogenesis, V16, P129; Lim IK, 2006, J CANCER RES CLIN, V132, P417, DOI 10.1007/s00432-006-0080-1; Lindroos B, 2011, STEM CELL REV REP, V7, P269, DOI 10.1007/s12015-010-9193-7; Lopez-Iglesias Pilar, 2011, World J Stem Cells, V3, P53, DOI 10.4252/wjsc.v3.i6.53; Manferdini C, 2013, ARTHRITIS RHEUM-US, V65, P1271, DOI 10.1002/art.37908; Mariani E, 2012, CURR PHARM DESIGN, V18, P1821, DOI 10.2174/138161212799859666; Mariani E, 2003, MECH AGEING DEV, V124, P403, DOI 10.1016/S0047-6374(03)00015-0; Maumus M, 2011, INT J OBESITY, V35, P1141, DOI 10.1038/ijo.2010.269; Maumus M, 2013, STEM CELL RES, V11, P834, DOI 10.1016/j.scr.2013.05.008; Meza-Zepeda LA, 2008, J CELL MOL MED, V12, P553, DOI 10.1111/j.1582-4934.2007.00146.x; Neri S, 2005, J GERONTOL A-BIOL, V60, P285, DOI 10.1093/gerona/60.3.285; Neri S, 2004, EXP GERONTOL, V39, P499, DOI 10.1016/j.exger.2003.11.017; Neri S, 2008, REJUV RES, V11, P565, DOI 10.1089/rej.2007.0639; Neri S, 2007, REJUV RES, V10, P145, DOI 10.1089/rej.2006.0510; Neri S, 2011, J CELL PHYSIOL, V226, P2579, DOI 10.1002/jcp.22603; Philippe B, 2010, STEM CELLS INT, V2010, DOI 10.4061/2010/503593; Poloni A, 2011, CELL TRANSPLANT, V20, P643, DOI 10.3727/096368910X536518; Rada T, 2009, TISSUE ENG PART B-RE, V15, P113, DOI 10.1089/ten.teb.2008.0423; Russell LM, 2007, CYTOGENET GENOME RES, V116, P181, DOI 10.1159/000098184; Sachs PC, 2012, CELL TISSUE RES, V349, P505, DOI 10.1007/s00441-012-1423-7; Sensebe L, 2010, VOX SANG, V98, P93, DOI 10.1111/j.1423-0410.2009.01227.x; Sensebe L, 2012, CELL STEM CELL, V10, P9, DOI 10.1016/j.stem.2011.12.005; Sensebe L, 2011, HUM GENE THER, V22, P19, DOI 10.1089/hum.2010.197; STONE JF, 1995, MUTAT RES-DNAGING G, V338, P107, DOI 10.1016/0921-8734(95)00016-Y; Tarte K, 2010, BLOOD, V115, P1549, DOI 10.1182/blood-2009-05-219907; Torsvik A, 2012, INT J BIOL SCI, V8, P1051, DOI 10.7150/ijbs.3665; Torsvik A, 2010, CANCER RES, V70, P6393, DOI 10.1158/0008-5472.CAN-10-1305; Toupet K, 2013, ARTHRITIS RHEUM-US, V65, P1786, DOI 10.1002/art.37960; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; Vaish M, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-26; Vilalta M, 2008, STEM CELLS DEV, V17, P993, DOI 10.1089/scd.2007.0201; von Bahr L, 2012, STEM CELLS, V30, P1575, DOI 10.1002/stem.1118; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wang Y, 2005, CYTOTHERAPY, V7, P509, DOI 10.1080/14653240500363216; Wiktor A, 2000, GENE CHROMOSOME CANC, V27, P11, DOI 10.1002/(SICI)1098-2264(200001)27:1<11::AID-GCC2>3.0.CO;2-I; Witkowska-Zimny M, 2011, CELL MOL BIOL LETT, V16, P236, DOI 10.2478/s11658-011-0005-0; Wojda A, 2006, J GERONTOL A-BIOL, V61, P763, DOI 10.1093/gerona/61.8.763; Wu JX, 2010, PROTEIN CELL, V1, P117, DOI 10.1007/s13238-010-0010-5; Zhang ZX, 2007, CELL BIOL INT, V31, P645, DOI 10.1016/j.cellbi.2006.11.025; Zhao YM, 2008, BIOCHEM BIOPH RES CO, V369, P1114, DOI 10.1016/j.bbrc.2008.03.011; Zheng L, 2011, NUCLEIC ACIDS RES, V39, P781, DOI 10.1093/nar/gkq884; Zhu YX, 2008, CELL BIOCHEM FUNCT, V26, P664, DOI 10.1002/cbf.1488; Zimmermann S, 2003, LEUKEMIA, V17, P1146, DOI 10.1038/sj.leu.2402962; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859; Zuk PA, 2010, MOL BIOL CELL, V21, P1783, DOI 10.1091/mbc.E09-07-0589	83	35	36	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77895	10.1371/journal.pone.0077895	http://dx.doi.org/10.1371/journal.pone.0077895			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24205017	Green Submitted, Green Published, gold			2022-12-27	WOS:000326241200048
J	Polverino, G; Phamduy, P; Porfiri, M				Polverino, Giovanni; Phamduy, Paul; Porfiri, Maurizio			Fish and Robots Swimming Together in a Water Tunnel: Robot Color and Tail-Beat Frequency Influence Fish Behavior	PLOS ONE			English	Article							GOLDEN SHINERS; VISUAL CUES; BODY-SIZE; ZEBRAFISH; RESPONSES; WILD; PREFERENCE; RISK; MOSQUITOFISH; PREDATION	The possibility of integrating bioinspired robots in groups of live social animals may constitute a valuable tool to study the basis of social behavior and uncover the fundamental determinants of animal functions and dysfunctions. In this study, we investigate the interactions between individual golden shiners (Notemigonus crysoleucas) and robotic fish swimming together in a water tunnel at constant flow velocity. The robotic fish is designed to mimic its live counterpart in the aspect ratio, body shape, dimension, and locomotory pattern. Fish positional preference with respect to the robot is experimentally analyzed as the robot's color pattern and tail-beat frequency are varied. Behavioral observations are corroborated by particle image velocimetry studies aimed at investigating the flow structure behind the robotic fish. Experimental results show that the time spent by golden shiners in the vicinity of the bioinspired robotic fish is the highest when the robot mimics their natural color pattern and beats its tail at the same frequency. In these conditions, fish tend to swim at the same depth of the robotic fish, where the wake from the robotic fish is stronger and hydrodynamic return is most likely to be effective.	[Polverino, Giovanni; Phamduy, Paul; Porfiri, Maurizio] NYU, Dept Mech & Aerosp Engn, Polytech Inst, Brooklyn, NY USA	New York University; New York University Tandon School of Engineering	Porfiri, M (corresponding author), NYU, Dept Mech & Aerosp Engn, Polytech Inst, Brooklyn, NY USA.	mporfiri@nyu.edu	Polverino, Giovanni/AAC-2556-2020	Polverino, Giovanni/0000-0001-9737-7995; Porfiri, Maurizio/0000-0002-1480-3539	National Science Foundation [CMMI-0745753, CMMI-0926791, DGE-0741714]; Honors Center of Italian Universities (H2CU); Div Of Civil, Mechanical, & Manufact Inn [0745753] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Honors Center of Italian Universities (H2CU); Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This research was supported by the National Science Foundation under Grant # CMMI-0745753. Additional support has been provided in part by the Honors Center of Italian Universities (H2CU) through a scholarship to G. Polverino and National Science Foundation under Grant # CMMI-0926791 and DGE-0741714. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaid N, 2013, BEHAV PROCESS, V100, P9, DOI 10.1016/j.beproc.2013.07.010; Abaid N, 2012, BEHAV BRAIN RES, V233, P545, DOI 10.1016/j.bbr.2012.05.047; Abaid N, 2012, BEHAV BRAIN RES, V232, P406, DOI 10.1016/j.bbr.2012.03.028; Altringham JD, 1999, J EXP BIOL, V202, P3397; BAKKER TCM, 1994, BEHAV ECOL, V5, P74, DOI 10.1093/beheco/5.1.74; Borazjani I, 2008, J EXP BIOL, V211, P1541, DOI 10.1242/jeb.015644; Cianca V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069661; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; de Margerie E, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/3/034001; Dijksterhuis A, 2001, ADV EXP SOC PSYCHOL, V33, P1, DOI 10.1016/S0065-2601(01)80003-4; Ellerby David J., 2013, P345; Engeszer RE, 2008, P NATL ACAD SCI USA, V105, P929, DOI 10.1073/pnas.0708778105; Engeszer RE, 2007, ZEBRAFISH, V4, P21, DOI 10.1089/zeb.2006.9997; Epps BP, 2009, EXP FLUIDS, V47, P927, DOI 10.1007/s00348-009-0684-8; Faria JJ, 2010, BEHAV ECOL SOCIOBIOL, V64, P1211, DOI 10.1007/s00265-010-0988-y; Fernandez-Juricic E, 2011, BEHAV ECOL, V22, P1304, DOI 10.1093/beheco/arr132; Fish Frank E., 2010, P90, DOI 10.1201/b10190-5; Frasca M, 2004, WORLD SCI SERIES NON; Gerlai R, 2010, MOLECULES, V15, P2609, DOI 10.3390/molecules15042609; Gerlai R, 2009, BEHAV BRAIN RES, V201, P318, DOI 10.1016/j.bbr.2009.03.003; Goth A, 2004, J EXP BIOL, V207, P2199, DOI 10.1242/jeb.01008; HALL DJ, 1979, J FISH RES BOARD CAN, V36, P1029, DOI 10.1139/f79-145; Halloy J, 2007, SCIENCE, V318, P1155, DOI 10.1126/science.1144259; Hanson KC, 2010, CAN J ZOOL, V88, P324, DOI 10.1139/Z10-006; Hemelrijk CK, 2012, INTERFACE FOCUS, V2, P726, DOI 10.1098/rsfs.2012.0025; Herskin J, 1998, J FISH BIOL, V53, P366, DOI 10.1006/jfbi.1998.0708; Hoare DJ, 2000, J FISH BIOL, V57, P1351, DOI 10.1006/jfbi.2000.1446; Killen SS, 2012, P ROY SOC B-BIOL SCI, V279, P357, DOI 10.1098/rspb.2011.1006; KOPMAN V, 2013, DESIGN MODELING CHAR, V18, P471, DOI DOI 10.1109/TMECH.2012.2222431; Kopman V, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0540; Krause J, 2002, LIVING GROUPS; Krause J, 2011, TRENDS ECOL EVOL, V26, P369, DOI 10.1016/j.tree.2011.03.015; Kubinyi E, 2004, BEHAV PROCESS, V65, P231, DOI 10.1016/j.beproc.2003.10.003; Kunzler R, 2001, BEHAV ECOL, V12, P681, DOI 10.1093/beheco/12.6.681; Liao JC, 2007, PHILOS T R SOC B, V362, P1973, DOI 10.1098/rstb.2007.2082; Liao JC, 2003, J EXP BIOL, V206, P1059, DOI 10.1242/jeb.00209; Lima SL, 1998, ADV STUD BEHAV, V27, P215; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Luca RM, 2012, BEHAV BRAIN RES, V226, P66, DOI 10.1016/j.bbr.2011.09.001; Marras S, 2012, J R SOC INTERFACE, V9, P1856, DOI 10.1098/rsif.2012.0084; Mazzi D, 2003, BEHAV ECOL SOCIOBIOL, V54, P156, DOI 10.1007/s00265-003-0609-0; MICHELSEN A, 1992, BEHAV ECOL SOCIOBIOL, V30, P143, DOI 10.1007/BF00166696; Partan SR, 2011, CURR ZOOL, V57, P140, DOI 10.1093/czoolo/57.2.140; Partan SR, 2009, ANIM BEHAV, V77, P1127, DOI 10.1016/j.anbehav.2008.12.029; Pather S, 2009, BEHAV BRAIN RES, V196, P323, DOI 10.1016/j.bbr.2008.09.013; Patricelli GL, 2002, NATURE, V415, P279, DOI 10.1038/415279a; PITCHER TJ, 1986, J FISH BIOL, V29, P83, DOI 10.1111/j.1095-8649.1986.tb05001.x; Pitcher TJ., 2001, ENCY OCEAN SCI, P975, DOI DOI 10.1006/RWOS.2001.0022; Pitcher TJ., 1993, Behaviour of teleost fishes, P363, DOI 10.1007/978-94-011-1578-0_12; Polverino G, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/3/036019; Polverino G, BIOINSPIR B IN PRESS; Polverino G, 2013, BEHAV BRAIN RES, V250, P133, DOI 10.1016/j.bbr.2013.05.008; Polverino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054315; Reebs SG, 2001, BEHAVIOUR, V138, P797, DOI 10.1163/156853901753172656; Rosenthal GG, 2005, ANIM BEHAV, V70, P1063, DOI 10.1016/j.anbehav.2005.02.005; Rosier RL, 2011, NAT ED KNOWL, V2, P8; Rossi C, 2012, SWIMMING PHYSL FISH; Rowland WJ, 1999, ENVIRON BIOL FISH, V56, P285, DOI 10.1023/A:1007517720723; Saverino C, 2008, BEHAV BRAIN RES, V191, P77, DOI 10.1016/j.bbr.2008.03.013; Seehausen O, 1999, J EVOLUTION BIOL, V12, P514, DOI 10.1046/j.1420-9101.1999.00055.x; Sfakiotakis M, 1999, IEEE J OCEANIC ENG, V24, P237, DOI 10.1109/48.757275; Snekser JL., 2010, INT J COMP PSYCHOL, V23, P70; Spinello C, 2013, ALCOHOL, V47, P391, DOI 10.1016/j.alcohol.2013.04.003; STAMHUIS EJ, 1995, J EXP BIOL, V198, P283; Su Z, 2012, INT J HUM RESOUR MAN, P1; Svendsen JC, 2003, J FISH BIOL, V62, P834, DOI 10.1046/j.1095-8649.2003.00068.x; Swain DT, 2012, P IEEE, V100, P150, DOI 10.1109/JPROC.2011.2165449; Takanishi A, 1998, INTERACTION CREATURE; Vaughan R, 2000, ROBOT AUTON SYST, V31, P109, DOI 10.1016/S0921-8890(99)00084-6; Videler JJ, 1993, FISH SWIMMING, P1, DOI [10.1007/978-94-011-1580-3, DOI 10.1007/978-94-011-1580-3]; Ward AJW, 2010, BEHAV ECOL, V21, P1315, DOI 10.1093/beheco/arq152; Wen L, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/3/036012; Wong K, 2010, BEHAV BRAIN RES, V208, P450, DOI 10.1016/j.bbr.2009.12.023	74	45	45	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77589	10.1371/journal.pone.0077589	http://dx.doi.org/10.1371/journal.pone.0077589			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204882	Green Published, gold, Green Submitted			2022-12-27	WOS:000326155400046
J	Zhou, TB; Qin, YH; Lei, FY; Huang, WF; Drummen, GPC				Zhou, Tian-Biao; Qin, Yuan-Han; Lei, Feng-Ying; Huang, Wei-Fang; Drummen, Gregor P. C.			Prohibitin Attenuates Oxidative Stress and Extracellular Matrix Accumulation in Renal Interstitial Fibrosis Disease	PLOS ONE			English	Article							UNILATERAL URETERAL OBSTRUCTION; RETINOIC ACID TREATMENT; MITOCHONDRIAL-FUNCTION; REPERFUSION INJURY; NEONATAL MICE; RAT-KIDNEY; EXPRESSION; PROTECTS; GENES; CELLS	Prohibitin is an evolutionary conserved and pleiotropic protein that has been implicated in various cellular functions, including proliferation, tumour suppression, apoptosis, transcription, and mitochondrial protein folding. Both prohibitin over- and under-expression have been implicated in various diseases and cell types. We recently demonstrated that prohibitin down-regulation results in increased renal interstitial fibrosis (RIF). Here we investigated the role of oxidative stress and prohibitin expression in RIF in unilateral ureteral obstructed rats. Lentivirus-based delivery vectors were used to knockdown or over- express prohibitin. Our results show that increased prohibitin expression was negatively correlated with the RIF index, reactive oxygen species, malon dialdehyde, transforming growth factor beta 1, collagen IV, fibronectin, and cell apoptosis index. In conclusion, we postulate that prohibitin acts as a positive regulator of mechanisms that counteract oxidative stress and extracellular matrix accumulation and therefore has an antioxidative effect.	[Zhou, Tian-Biao; Qin, Yuan-Han; Lei, Feng-Ying; Huang, Wei-Fang] GuangXi Med Univ, Dept Pediat Nephrol, Affiliated Hosp 1, Nanning, Peoples R China; [Zhou, Tian-Biao] Sun Yat Sen Univ, Dept Nephrol, Affiliated Hosp 6, Guangzhou 510275, Guangdong, Peoples R China; [Drummen, Gregor P. C.] Bio&Nano Solut, Cellular Stress & Ageing Program, Bionanosci & Bioimaging Program, Dusseldorf, Germany	Guangxi Medical University; Sun Yat Sen University	Qin, YH (corresponding author), GuangXi Med Univ, Dept Pediat Nephrol, Affiliated Hosp 1, Nanning, Peoples R China.	yuanhanqin@yahoo.cn		Li, Weijia/0000-0002-7546-6388; Drummen, Gregor/0000-0002-8746-7062	Nature Science Foundation of China [81060061, 81150017]; Natural Science Foundation of the Guangxi Zhuang Autonomous Region [0832121]; Health Department of Guangxi Zhuang Autonomous Region [200917]; Grant for External Collaborative Research AGE	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Guangxi Zhuang Autonomous Region(National Natural Science Foundation of Guangxi Province); Health Department of Guangxi Zhuang Autonomous Region; Grant for External Collaborative Research AGE	This study was supported by the Nature Science Foundation of China (no. 81060061 and no. 81150017), the Natural Science Foundation of the Guangxi Zhuang Autonomous Region (no. 0832121) and the Health Department of Guangxi Zhuang Autonomous Region (no. 200917), and a Grant for External Collaborative Research AGE-2009 (G.P.C.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTUS MS, 1995, GENE, V158, P291, DOI 10.1016/0378-1119(95)00164-2; An JZ, 2010, INT J MOL EPIDEMIOL, V1, P1; Barnes JL, 2011, CONTRIB NEPHROL, V169, P73, DOI 10.1159/000313946; Botto N, 2011, J PEDIATR UROL, V7, P310, DOI 10.1016/j.jpurol.2011.02.022; Cai GY, 2008, NEPHROL DIAL TRANSPL, V23, P1861, DOI 10.1093/ndt/gfm666; Chowdhury Indrajit, 2012, Front Biosci (Elite Ed), V4, P690; Correa-Costa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014298; de Lema GP, 2004, KIDNEY INT, V66, P1018, DOI 10.1111/j.1523-1755.2004.00850.x; Eis V, 2004, J AM SOC NEPHROL, V15, P337, DOI 10.1097/01.ASN.0000111246.87175.32; Funk AJ, 2012, NEUROPSYCHOPHARMACOL, V37, P896, DOI 10.1038/npp.2011.267; Guo W, 2007, MOL CELL BIOCHEM, V295, P167, DOI 10.1007/s11010-006-9286-4; Ha T, 2008, CARDIOVASC RES, V78, P546, DOI 10.1093/cvr/cvn037; He DY, 2011, BIOL PHARM BULL, V34, P1219, DOI 10.1248/bpb.34.1219; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Higgins DF, 2003, KIDNEY INT, V64, P2079, DOI 10.1046/j.1523-1755.2003.00306.x; Hu XR, 2010, EUR J PHARMACOL, V638, P84, DOI 10.1016/j.ejphar.2010.03.059; Hur W, 2011, CURR OPIN CHEM BIOL, V15, P162, DOI 10.1016/j.cbpa.2010.12.009; Isaka Y, 1996, NAT MED, V2, P418, DOI 10.1038/nm0496-418; Kim SY, 2007, BIOCHEM BIOPH RES CO, V360, P653, DOI 10.1016/j.bbrc.2007.06.118; Kobayashi H, 2012, J IMMUNOL, V188, P5106, DOI 10.4049/jimmunol.1103377; Li ZG, 2011, J BIOL CHEM, V286, P41323, DOI 10.1074/jbc.M111.259184; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsell DG, 2002, PEDIATR NEPHROL, V17, P470, DOI 10.1007/s00467-002-0910-6; Meng LQ, 2007, VASC PHARMACOL, V47, P174, DOI 10.1016/j.vph.2007.06.002; Meran S, 2011, INT J EXP PATHOL, V92, P158, DOI 10.1111/j.1365-2613.2011.00764.x; Morisada N, 2010, J PHARMACOL SCI, V114, P379, DOI 10.1254/jphs.10143FP; Nadimpalli R, 2000, J BIOL CHEM, V275, P29579, DOI 10.1074/jbc.M002339200; Neusser MA, 2010, AM J PATHOL, V176, P594, DOI 10.2353/ajpath.2010.090268; Nowak G, 2012, AM J PHYSIOL-RENAL, V303, pF515, DOI 10.1152/ajprenal.00072.2012; Qiao X, 2013, AM J PHYSIOL-RENAL, V304, pF112, DOI 10.1152/ajprenal.00054.2012; Qu X, 2012, J PATHOL; Radford MG, 1997, J AM SOC NEPHROL, V8, P199; Rastogi S, 2006, J BIOL CHEM, V281, P2951, DOI 10.1074/jbc.M508669200; Salhan D, 2012, AM J PHYSIOL-RENAL, V303, pF503, DOI 10.1152/ajprenal.00170.2012; Schleicher M, 2008, J CELL BIOL, V180, P101, DOI 10.1083/jcb.200706072; Sun DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033491; Suzuki Y, 2012, KIDNEY INT, V81, P865, DOI 10.1038/ki.2011.464; Takahashi S, 2011, BIOCHEM BIOPH RES CO, V405, P462, DOI 10.1016/j.bbrc.2011.01.054; Terashima H, 2010, AM J PHYSIOL-RENAL, V299, pF792, DOI 10.1152/ajprenal.00141.2009; Theiss AL, 2007, FASEB J, V21, P197, DOI 10.1096/fj.06-6801com; Thompson WE, 2001, ENDOCRINOLOGY, V142, P4076, DOI 10.1210/en.142.9.4076; Thornhill BA, 2007, KIDNEY INT, V72, P1103, DOI 10.1038/sj.ki.5002512; Wu HZ, 2011, ANAL BIOANAL CHEM, V399, P3431, DOI 10.1007/s00216-010-4463-4; Wu KJ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/163106; Xia Z, 2008, AM J NEPHROL, V28, P34, DOI 10.1159/000108759; Zhang DS, 2010, LAB INVEST, V90, P436, DOI 10.1038/labinvest.2009.149; Zhou TB, 2012, INT J MOL SCI, V13, P2769, DOI 10.3390/ijms13032769; Zhou TB, 2012, NEPHROLOGY, V17, P189, DOI 10.1111/j.1440-1797.2011.01522.x	48	24	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77187	10.1371/journal.pone.0077187	http://dx.doi.org/10.1371/journal.pone.0077187			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204768	Green Published, Green Submitted, gold			2022-12-27	WOS:000326155400029
J	Krawczyk-Balska, A; Lipiak, M				Krawczyk-Balska, Agata; Lipiak, Magdalena			Critical Role of a Ferritin-Like Protein in the Control of Listeria monocytogenes Cell Envelope Structure and Stability under beta-lactam Pressure	PLOS ONE			English	Article							WALL TEICHOIC-ACID; D-ALANINE; HYDROGEN-PEROXIDE; BACILLUS-SUBTILIS; SECA2-DEPENDENT SECRETION; LIPOTEICHOIC ACID; VEGETATIVE GROWTH; BINDING PROTEIN; IRON STORAGE; IDENTIFICATION	The human pathogen Listeria monocytogenes is susceptible to the beta-lactam antibiotics penicillin G and ampicillin, and these are the drugs of choice for the treatment of listerial infections. However, these antibiotics exert only a bacteriostatic effect on this bacterium and consequently, L. monocytogenes is regarded as beta-lactam tolerant. It is widely accepted that the phenomenon of bacterial tolerance to beta-lactams is due to the lack of adequate autolysin activity, but the mechanisms of L. monocytogenes tolerance to this class of antibiotics are poorly characterized. A ferritin-like protein (Fri) was recently identified as a mediator of beta-lactam tolerance in L. monocytogenes, but its function in this process remains unknown. The present study was undertaken to improve our understanding of L. monocytogenes tolerance to beta-lactams and to characterize the role of Fri in this phenomenon. A comparative physiological analysis of wild-type L. monocytogenes and a fri deletion mutant provided evidence of a multilevel mechanism controlling autolysin activity in cells grown under beta-lactam pressure, which leads to a reduction in the level and/or activity of cell wall-associated autolysins. This is accompanied by increases in the amount of teichoic acids, cell wall thickness and cell envelope integrity of L. monocytogenes grown in the presence of penicillin G, and provides the basis for the innate beta-lactam tolerance of this bacterium. Furthermore, this study revealed the inability of the L. monocytogenes Delta fri mutant to deplete autolysins from the cell wall, to adjust the content of teichoic acids and to maintain their D-alanylation at the correct level when treated with penicillin G, thus providing further evidence that Fri is involved in the control of L. monocytogenes cell envelope structure and stability under beta-lactam pressure.	[Krawczyk-Balska, Agata; Lipiak, Magdalena] Univ Warsaw, Fac Biol, Dept Appl Microbiol, Warsaw, Poland	University of Warsaw	Krawczyk-Balska, A (corresponding author), Univ Warsaw, Fac Biol, Dept Appl Microbiol, Warsaw, Poland.	akra@biol.uw.edu.pl	Krawczyk-Balska, Agata/AAX-3428-2021	Krawczyk-Balska, Agata/0000-0001-9809-8402	Polish Ministry of Science and Higher Education [N N302 229738]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was funded by the grant of Polish Ministry of Science and Higher Education N N302 229738. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abachin E, 2002, MOL MICROBIOL, V43, P1, DOI 10.1046/j.1365-2958.2002.02723.x; Andrews SC, 1998, ADV MICROB PHYSIOL, V40, P281, DOI 10.1016/S0065-2911(08)60134-4; Begley M, 2006, APPL ENVIRON MICROB, V72, P2231, DOI 10.1128/AEM.72.3.2231-2234.2006; Bera A, 2007, J BACTERIOL, V189, P280, DOI 10.1128/JB.01221-06; Bertsche U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067398; BIERBAUM G, 1987, J BACTERIOL, V169, P5452, DOI 10.1128/jb.169.12.5452-5458.1987; Bierne H, 2007, MICROBIOL MOL BIOL R, V71, P377, DOI 10.1128/MMBR.00039-06; Biswas R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041415; Blackman SA, 1998, MICROBIOL-UK, V144, P73, DOI 10.1099/00221287-144-1-73; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; BUBERT A, 1992, J BACTERIOL, V174, P8166, DOI 10.1128/JB.174.24.8166-8171.1992; Cabanes D, 2004, MOL MICROBIOL, V51, P1601, DOI 10.1111/j.1365-2958.2003.03945.x; Calhoun LN, 2011, INT J ANTIMICROB AG, V37, P261, DOI 10.1016/j.ijantimicag.2010.11.034; Carroll SA, 2003, J BACTERIOL, V185, P6801, DOI 10.1128/JB.185.23.6801-6808.2003; CHEN L, 1993, J BACTERIOL, V175, P5428, DOI 10.1128/JB.175.17.5428-5437.1993; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Desvaux M, 2010, J PROTEOME RES, V9, P5076, DOI 10.1021/pr1003642; Dubail I, 2006, J BACTERIOL, V188, P6580, DOI 10.1128/JB.00771-06; Dussurget O, 2005, FEMS MICROBIOL LETT, V250, P253, DOI 10.1016/j.femsle.2005.07.015; Fiorini F, 2008, GENE, V410, P113, DOI 10.1016/j.gene.2007.12.007; Forster BM, 2012, MOL MICROBIOL, V84, P405, DOI 10.1111/j.1365-2958.2012.08040.x; FOSTER SJ, 1992, J BACTERIOL, V174, P464, DOI 10.1128/jb.174.2.464-470.1992; GIUDICELLI S, 1984, J BACTERIOL, V158, P1188, DOI 10.1128/JB.158.3.1188-1190.1984; Glaser P, 2001, SCIENCE, V294, P849; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; Haikarainen T, 2010, CELL MOL LIFE SCI, V67, P341, DOI 10.1007/s00018-009-0168-2; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hebraud M, 2000, FEMS MICROBIOL LETT, V190, P29, DOI 10.1016/S0378-1097(00)00310-4; HEPTINSTALL S, 1970, NATURE, V225, P519, DOI 10.1038/225519a0; Hof H, 2003, FEMS IMMUNOL MED MIC, V35, P203, DOI 10.1016/S0928-8244(02)00466-2; Hof H, 1997, CLIN MICROBIOL REV, V10, P345, DOI 10.1128/CMR.10.2.345; Hyyrylainen HL, 2000, J BIOL CHEM, V275, P26696; Ishikawa T, 2003, J BACTERIOL, V185, P1010, DOI 10.1128/JB.185.3.1010-1017.2003; Kallipolitis BH, 2003, ANTIMICROB AGENTS CH, V47, P3421, DOI 10.1128/AAC.47.11.3421-3429.2003; Koch AL, 2001, ANTIMICROB AGENTS CH, V45, P2671, DOI 10.1128/AAC.45.10.2671-2675.2001; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Korsak D, 2005, FEMS MICROBIOL LETT, V251, P281, DOI 10.1016/j.femsle.2005.08.009; Krawczyk-Balska A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-278; Krawczyk-Balska A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-57; KUHN M, 1989, INFECT IMMUN, V57, P55, DOI 10.1128/IAI.57.1.55-61.1989; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lenz LL, 2003, P NATL ACAD SCI USA, V100, P12432, DOI 10.1073/pnas.2133653100; Lenz LL, 2002, MOL MICROBIOL, V45, P1043, DOI 10.1046/j.1365-2958.2002.03072.x; Liu XF, 2006, J BIOL CHEM, V281, P27827, DOI 10.1074/jbc.M601398200; Machata S, 2005, J BACTERIOL, V187, P8385, DOI 10.1128/JB.187.24.8385-8394.2005; McLauchlin J, 1997, REV MED MICROBIOL, V8, P1; McLaughlan AM, 1998, MICROBIOL-SGM, V144, P1359, DOI 10.1099/00221287-144-5-1359; Mohamed W, 2006, MOL GENET GENOMICS, V275, P344, DOI 10.1007/s00438-005-0090-8; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Newton SMC, 2005, MOL MICROBIOL, V55, P927, DOI 10.1111/j.1365-2958.2004.04436.x; Olsen KN, 2005, MICROBIOL-SGM, V151, P925, DOI 10.1099/mic.0.27552-0; Palumbo E, 2006, J BACTERIOL, V188, P3709, DOI 10.1128/JB.188.10.3709-3715.2006; Pandey R, 2012, INFECT IMMUN, V80, P3650, DOI 10.1128/IAI.00229-12; PARK SF, 1990, GENE, V94, P129, DOI 10.1016/0378-1119(90)90479-B; Pilgrim S, 2003, INFECT IMMUN, V71, P3473, DOI 10.1128/IAI.71.6.3473-3484.2003; Polidoro M, 2002, GENE, V296, P121, DOI 10.1016/S0378-1119(02)00839-9; Popowska M, 2012, ARCH MICROBIOL, V194, P255, DOI 10.1007/s00203-011-0752-3; Popowska Magdalena, 1999, Acta Microbiologica Polonica, V48, P141; Popowska M, 2009, J MICROBIOL BIOTECHN, V19, P932, DOI 10.4014/jmb.0810.557; Poyart C, 1997, FEMS MICROBIOL LETT, V156, P193, DOI 10.1016/S0378-1097(97)00423-0; Rea R, 2005, APPL ENVIRON MICROB, V71, P8314, DOI 10.1128/AEM.71.12.8314-8322.2005; Renier S, 2013, J PROTEOMICS, V80, P183, DOI 10.1016/j.jprot.2012.11.027; Renier S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042982; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Sambrook J., 2001, MOL CLONING LAB MANU; Schubert K, 2000, ARCH MICROBIOL, V173, P21, DOI 10.1007/s002030050003; SCHUCHAT A, 1991, CLIN MICROBIOL REV, V4, P169, DOI 10.1128/CMR.4.2.169-183.1991; Shockman GD., 1994, BACTERIAL CELL WALL, P131, DOI 10.1016/S0167-7306(08)60410-X; Steen A, 2005, J BACTERIOL, V187, P114, DOI 10.1128/JB.187.1.114-124.2005; Su MH, 2005, BIOCHEMISTRY-US, V44, P5572, DOI 10.1021/bi0472705; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; TOMASZ A, 1979, ANNU REV MICROBIOL, V33, P113, DOI 10.1146/annurev.mi.33.100179.000553; TOMASZ A, 1970, NATURE, V227, P138, DOI 10.1038/227138a0; Ueshima J, 2003, INFECT IMMUN, V71, P1170, DOI 10.1128/IAI.71.3.1170-1178.2003; Velayudhan J, 2007, MOL MICROBIOL, V63, P1495, DOI 10.1111/j.1365-2958.2007.05600.x; Wecke J, 1997, MICROBIOL-UK, V143, P2953, DOI 10.1099/00221287-143-9-2953; Wecke J, 1996, MICROB DRUG RESIST, V2, P123, DOI 10.1089/mdr.1996.2.123; Wehmhoner D, 2005, ELECTROPHORESIS, V26, P2450, DOI 10.1002/elps.200410348; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Wisniewski J, 2006, FEMS IMMUNOL MED MIC, V46, P330, DOI 10.1111/j.1574-695X.2006.00029.x; Zhao GH, 2002, J BIOL CHEM, V277, P27689, DOI 10.1074/jbc.M202094200	81	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77808	10.1371/journal.pone.0077808	http://dx.doi.org/10.1371/journal.pone.0077808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204978	Green Published, Green Submitted, gold			2022-12-27	WOS:000326152300031
J	Wong, FC; Woo, CC; Hsu, A; Tan, BKH				Wong, Fang Cheng; Woo, Chern Chiuh; Hsu, Annie; Tan, Benny Kwong Huat			The Anti-Cancer Activities of Vernonia amygdalina Extract in Human Breast Cancer Cell Lines Are Mediated through Caspase-Dependent and p53-Independent Pathways	PLOS ONE			English	Article							SESQUITERPENE LACTONES; INDEPENDENT APOPTOSIS; DNA-DAMAGE; P53; SUPPRESSION; TARGET; DEL	Breast cancer is currently the leading cause of cancer-related deaths among women globally. Notably, medicinal plant extracts may be a potential source for treatments of breast cancer. Vernonia amygdalina (VA) is a woody shrub reported to have not only diverse therapeutic effects but also anti-cancer properties. However, current research about the mechanisms of the anti-cancer potential of VA has been limited. This study aimed to investigate the mechanisms of action of VA that underlie its anti-cancer effects in human breast cancer cell lines (MCF-7 and MDA-MB-231 cells). Results from MTT assay revealed that VA inhibits the proliferation of MCF-7 and MDA-MB-231, in a time-and dose-dependent manner. The underlying mechanism of this growth inhibition involved the stimulation of cell-type specific G1/S phase cell cycle arrest in only MCF-7 cells, and not in MDA-MB-231 cells. While the growth arrest was associated with increased levels of p53 and p21, and a concomitant decrease in the levels of cyclin D1 and cyclin E, it was shown that VA causes cell cycle arrest through a p53-independent pathway as tested by the wild type p53 inhibitor, pifithrin-alpha. Furthermore, this study revealed that VA induces apoptosis in the two cell lines, as indicated by the increase in Annexin V-positive cells and sub-G1 population, and that this VA-induced apoptosis occurred through both extrinsic and intrinsic apoptotic pathways. The apoptosis in MCF-7 cells was also likely to be caspase-dependent and not p53 transcriptional-dependent. Given that approximately 70% of diagnosed breast cancers express ER-alpha, a crucial finding was that VA inhibits the expression of ER-alpha and its downstream player, Akt, highlighting the potential clinical significance of VA. Moreover, VA exhibits synergism when combined with doxorubicin, suggesting that it can complement current chemotherapy. Overall, this study demonstrates the potential applications of VA as an anti-cancer drug for breast cancer treatment.	[Wong, Fang Cheng; Woo, Chern Chiuh; Hsu, Annie; Tan, Benny Kwong Huat] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore	National University of Singapore	Tan, BKH (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore.	benny_tan@nuhs.edu.sg			Department of Pharmacology, National University of Singapore [C-184-000-610-031]	Department of Pharmacology, National University of Singapore	This study was supported by a grant (C-184-000-610-031) from the Department of Pharmacology, National University of Singapore (http://medicine.nus.edu.sg/medphc/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alawa CBI, 2003, VET PARASITOL, V113, P73, DOI 10.1016/S0304-4017(03)00040-2; Berger CE, 2012, J BIOL CHEM, V287, P30117, DOI 10.1074/jbc.M112.367326; Borner C, 1999, CELL DEATH DIFFER, V6, P497, DOI 10.1038/sj.cdd.4400525; Chen TF, 2009, INT J BIOCHEM CELL B, V41, P666, DOI 10.1016/j.biocel.2008.07.014; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Farombi EO, 2011, INT J ENV RES PUB HE, V8, P2533, DOI 10.3390/ijerph8062533; Ford CHJ, 2011, ANTICANCER RES, V31, P521; Fukutomi Takashi, 2002, Breast Cancer, V9, P95, DOI 10.1007/BF02967572; Han K, 2007, GYMNANTHEMUM AMYGDAL; Hao TQ, 2008, CHIN MED J, V121, P602; Ijeh II, 2011, J MED PLANTS RES, V5, P1051; Izevbigie EB, 2003, EXP BIOL MED, V228, P293, DOI 10.1177/153537020322800308; JISAKA M, 1993, BIOSCI BIOTECH BIOCH, V57, P833, DOI 10.1271/bbb.57.833; KUPCHAN SM, 1969, J ORG CHEM, V34, P3908, DOI 10.1021/jo01264a035; Ligresti G, 2008, MOL MED REP, V1, P451; Lumachi F, 2013, CURR MED CHEM, V20, P596, DOI 10.2174/092986713804999303; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Opata Michael M, 2006, Int J Environ Res Public Health, V3, P174, DOI 10.3390/ijerph2006030019; Rang H.P., 2007, RANG DALES PHARM; Rasoanaivo P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S4; Slee EA, 2004, ONCOGENE, V23, P2809, DOI 10.1038/sj.onc.1207516; Steelman LS, 2008, EXPERT OPIN THER TAR, V12, P1139, DOI [10.1517/14728222.12.9.1139, 10.1517/14728222.12.9.1139 ]; Suzuki K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/978312; Wang DD, 2012, J BIOL CHEM, V287, P12612, DOI 10.1074/jbc.M111.334151; Wang Z, 2010, TRANSL ONCOL, V3, P1, DOI 10.1593/tlo.09250; Watson MI, 2005, MOL CANCER THER, V4, P1369; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Yeap SK, 2010, J MED PLANTS RES, V4, P2787; Yedjou Clement, 2008, Int J Environ Res Public Health, V5, P337	30	54	55	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78021	10.1371/journal.pone.0078021	http://dx.doi.org/10.1371/journal.pone.0078021			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205071	Green Published, Green Submitted, gold			2022-12-27	WOS:000326152300040
J	Deeley, Q; Walsh, E; Oakley, DA; Bell, V; Koppel, C; Mehta, MA; Halligan, PW				Deeley, Quinton; Walsh, Eamonn; Oakley, David A.; Bell, Vaughan; Koppel, Cristina; Mehta, Mitul A.; Halligan, Peter W.			Using Hypnotic Suggestion to Model Loss of Control and Awareness of Movements: An Exploratory fMRI Study	PLOS ONE			English	Article							FUNCTIONAL-ANATOMY; MOTOR; CORTEX; SUPPLEMENTARY; SCHIZOPHRENIA; DELUSIONS; HYPNOSIS; AREA; SELF	The feeling of voluntary control and awareness of movement is fundamental to our notions of selfhood and responsibility for actions, yet can be lost in neuropsychiatric syndromes (e. g. delusions of control, non-epileptic seizures) and culturally influenced dissociative states (e. g. attributions of spirit possession). The brain processes involved remain poorly understood. We used suggestion and functional magnetic resonance imaging (fMRI) to investigate loss of control and awareness of right hand movements in 15 highly hypnotically suggestible subjects. Loss of perceived control of movements was associated with reduced connectivity between supplementary motor area (SMA) and motor regions. Reduced awareness of involuntary movements was associated with less activation in parietal cortices (BA 7, BA 40) and insula. Collectively these results suggest that the sense of voluntary control of movement may critically depend on the functional coupling of SMA with motor systems, and provide a potential neural basis for the narrowing of awareness reported in pathological and culturally influenced dissociative phenomena.	[Deeley, Quinton; Walsh, Eamonn] Kings Coll London, Inst Psychiat, Cultural & Social Neurosci Res Grp, London, England; [Oakley, David A.] UCL, Div Psychol & Language Sci, London WC1E 6BT, England; [Bell, Vaughan; Mehta, Mitul A.] Kings Coll London, Inst Psychiat, Cultural & Social Neurosci Res Grp, Ctr Neuroimaging Sci, London, England; [Koppel, Cristina] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Halligan, Peter W.] Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales	University of London; King's College London; University of London; University College London; University of London; King's College London; Imperial College London; Cardiff University	Deeley, Q (corresponding author), Kings Coll London, Inst Psychiat, Cultural & Social Neurosci Res Grp, London, England.	q.deeley@iop.kcl.ac.uk	Mehta, Mitul/F-3960-2010; Halligan, Peter W/A-1669-2010	Halligan, Peter W/0000-0003-2784-6690; Walsh, Eamonn/0000-0002-5614-6362; Deeley, Quinton/0000-0001-5306-0769	Psychiatry Research Trust; PAGTHZE; Panacea Society; PCFTXZA	Psychiatry Research Trust; PAGTHZE; Panacea Society; PCFTXZA	Funding came from The Psychiatry Research Trust, PAGTHZE, The Panacea Society, and PCFTXZA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APA, 2000, DIAGN STAT MAN MENT; Bell V, 2011, J NEUROL NEUROSUR PS, V82, P332, DOI 10.1136/jnnp.2009.199158; Berti A, 2005, SCIENCE, V309, P488, DOI 10.1126/science.1110625; Blakemore SJ, 2003, NEUROPSYCHOLOGIA, V41, P1058, DOI 10.1016/S0028-3932(02)00313-5; Brown RJ, 2011, EPILEPSY BEHAV, V22, P85, DOI 10.1016/j.yebeh.2011.02.016; Caceres A, 2009, NEUROIMAGE, V45, P758, DOI 10.1016/j.neuroimage.2008.12.035; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; de Haan S, 1999, PHENOMENOLOGY COGN S, V9, P373; Deeley P. Q., 2003, PHILOS PSYCHIATR PSY, V10, P161, DOI [10.1353/ppp.2003.0095, DOI 10.1353/PPP.2003.0095]; Deeley Q, 2012, ENCY RELIG SCI; Deeley Q, 2013, CORTEX, V49, P411, DOI 10.1016/j.cortex.2012.09.016; Deeley Q, 2012, INT J CLIN EXP HYP, V60, P206, DOI 10.1080/00207144.2012.648070; Desmurget M, 2009, SCIENCE, V324, P811, DOI 10.1126/science.1169896; Fornito A, 2012, NEUROIMAGE, V62, P2296, DOI 10.1016/j.neuroimage.2011.12.090; FRIED I, 1991, J NEUROSCI, V11, P3656; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Frith C, 2005, CONSCIOUS COGN, V14, P752, DOI 10.1016/j.concog.2005.04.002; Ganis G, 2004, COGNITIVE BRAIN RES, V20, P226, DOI 10.1016/j.cogbrainres.2004.02.012; GRAFTON ST, 1992, BRAIN, V115, P565, DOI 10.1093/brain/115.2.565; Haggard P, 1999, EXP BRAIN RES, V127, P102, DOI 10.1007/s002210050778; HYVARINEN J, 1974, BRAIN, V97, P673, DOI 10.1093/brain/97.1.673; Kasahara M, 2011, BRAIN INJURY, V25, P1170, DOI 10.3109/02699052.2011.608210; Kjaer TW, 2002, NEUROIMAGE, V17, P1080, DOI 10.1006/nimg.2002.1230; Kosslyn SM, 2003, PSYCHOL BULL, V129, P723, DOI 10.1037/0033-2909.129.5.723; Meindl T, 2008, EUR RADIOL, V18, P1102, DOI 10.1007/s00330-008-0869-1; MELLOR CS, 1970, BRIT J PSYCHIAT, V117, P15, DOI 10.1192/S0007125000192116; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Nieuwenhuys R, 2012, PROG BRAIN RES, V195, P123, DOI 10.1016/B978-0-444-53860-4.00007-6; Oakley D A, 1999, Cogn Neuropsychiatry, V4, P243, DOI 10.1080/135468099395954; Oakley DA, 2007, INT J CLIN EXP HYP, V55, P32, DOI 10.1080/00207140600995844; Oakley DA, 2011, CONSCIOUS COGN, V20, P328, DOI 10.1016/j.concog.2010.01.013; Oakley DA, 2009, TRENDS COGN SCI, V13, P264, DOI 10.1016/j.tics.2009.03.004; Oyebode F, 2008, SIMS SYMPTOMS MIND; Passingham RE, 2006, DOES CONSCIOUSNESS C; PENFIELD W, 1951, AMA ARCH NEUROL PSY, V66, P289, DOI 10.1001/archneurpsyc.1951.02320090038004; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Rocca MA, 2007, HUM BRAIN MAPP, V28, P218, DOI 10.1002/hbm.20271; Rosenberg HJ, 2000, EPILEPSIA, V41, P447, DOI 10.1111/j.1528-1157.2000.tb00187.x; ROUGET Gilbert, 1985, MUSIC TRANCE THEORY; Seligman R, 2008, CULT MED PSYCHIAT, V32, P31, DOI 10.1007/s11013-007-9077-8; Shor R. E., 1962, HARVARD GROUP SCALE; Spence SA, 2002, COGN NEUROPSYCHIATRY, P211, DOI 10.1080/13546800244000094; Waldvogel D, 1999, J CEREBR BLOOD F MET, V19, P1209, DOI 10.1097/00004647-199911000-00004	44	25	25	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78324	10.1371/journal.pone.0078324	http://dx.doi.org/10.1371/journal.pone.0078324			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205198	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000326032600094
J	Pridmore, RW				Pridmore, Ralph W.			Cone Photoreceptor Sensitivities and Unique Hue Chromatic Responses: Correlation and Causation Imply the Physiological Basis of Unique Hues	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; OPPONENT-COLORS THEORY; VISUAL PIGMENTS; SPECTRAL SENSITIVITIES; COMPLEMENTARY COLORS; QUANTITATIVE ASPECTS; RED-GREEN; MECHANISMS; REPRESENTATION; INFORMATION	This paper relates major functions at the start and end of the color vision process. The process starts with three cone photoreceptors transducing light into electrical responses. Cone sensitivities were once expected to be Red Green Blue color matching functions (to mix colors) but microspectrometry proved otherwise: they instead peak in yellowish, greenish, and blueish hues. These physiological functions are an enigma, unmatched with any set of psychophysical (behavioral) functions. The end-result of the visual process is color sensation, whose essential percepts are unique (or pure) hues red, yellow, green, blue. Unique hues cannot be described by other hues, but can describe all other hues, e. g., that hue is reddish-blue. They are carried by four opponent chromatic response curves but the literature does not specify whether each curve represents a range of hues or only one hue (a unique) over its wavelength range. Here the latter is demonstrated, confirming that opponent chromatic responses define, and may be termed, unique hue chromatic responses. These psychophysical functions also are an enigma, unmatched with any physiological functions or basis. Here both enigmas are solved by demonstrating the three cone sensitivity curves and the three spectral chromatic response curves are almost identical sets (Pearson correlation coefficients r from 0.95-1.0) in peak wavelengths, curve shapes, math functions, and curve crossover wavelengths, though previously unrecognized due to presentation of curves in different formats, e. g., log, linear. (Red chromatic response curve is largely nonspectral and thus derives from two cones.) Close correlation combined with deterministic causation implies cones are the physiological basis of unique hues. This match of three physiological and three psychophysical functions is unique in color vision.	Macquarie Univ, Dept Cognit Sci, Sydney, NSW 2109, Australia	Macquarie University	Pridmore, RW (corresponding author), Macquarie Univ, Dept Cognit Sci, Sydney, NSW 2109, Australia.	rpridmo@bigpond.net.au		pridmore, ralph/0000-0001-7166-7249				[Anonymous], 2004, CIE PUBL, V15, P2004; AYAMA M, 1982, SCIENCE, V215, P1538, DOI 10.1126/science.7063866; BENZSCHAWEL T, 1986, J OPT SOC AM A, V3, P1713, DOI 10.1364/JOSAA.3.001713; BOWMAKER JK, 1980, J PHYSIOL-LONDON, V298, P501, DOI 10.1113/jphysiol.1980.sp013097; BOYNTON RM, 1965, J OPT SOC AM, V55, P78, DOI 10.1364/JOSA.55.000078; Broackes J, 2011, REV PHILOS PSYCHOL, V2, P601, DOI 10.1007/s13164-011-0050-7; BUCHSBAUM G, 1983, PROC R SOC SER B-BIO, V220, P89, DOI 10.1098/rspb.1983.0090; Crick F, 1988, WHAT MAD PURSUIT PER; DARTNALL HJA, 1983, PROC R SOC SER B-BIO, V220, P115, DOI 10.1098/rspb.1983.0091; De Valois RL, 2000, P NATL ACAD SCI USA, V97, P4997, DOI 10.1073/pnas.97.9.4997; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P241, DOI 10.1113/jphysiol.1984.sp015499; DEVALOIS RL, 1993, VISION RES, V33, P1053, DOI 10.1016/0042-6989(93)90240-W; Dowling J. E., 1987, RETINA APPROACHABLE; Estevez O, 1979, THESIS U AMSTERDAM; Fairchild M. D., 2005, COLOR APPEARANCE MOD; FULD K, 1991, VISION RES, V31, P237, DOI 10.1016/0042-6989(91)90114-K; Gegenfurtner K. R., 1999, COLOR VISION GENES P; Geller E, 2003, MCGRAW HILL DICT MAT; GOURAS P, 1982, COLOR RES APPL, V7, P205, DOI 10.1002/col.5080070232; GUTH SL, 1980, J OPT SOC AM, V70, P197, DOI 10.1364/JOSA.70.000197; Guth SL, 2002, P AIC COL 01; Helmholtz H, 1856, H HDB PHYSL OPTIK; Hering H, 1878, LEHRE LICHTSINN; HURVICH LM, 1955, J OPT SOC AM, V45, P602, DOI 10.1364/JOSA.45.000602; Hurvich LM., 1981, COLOR VISION; Illari P., 2011, CAUSALITY SCI, DOI [DOI 10.1093/ACPROF:OSO/9780199574131.003.0002, 10.1093/acprof:oso/9780199574131.003.0002]; INGLING CR, 1978, SCIENCE, V201, P1221, DOI 10.1126/science.201.4362.1221; INGLING CR, 1977, VISION RES, V17, P1075, DOI 10.1016/0042-6989(77)90013-X; JAMESON D, 1955, J OPT SOC AM, V45, P546, DOI 10.1364/JOSA.45.000546; Jameson D., 1972, HDB SENSORY PHYSL, VVII; Jameson K., 1997, COLOR CATEGORIES THO; Johnson EN, 2001, NAT NEUROSCI, V4, P409, DOI 10.1038/86061; Judd D. B., 1975, COLOR BUSINESS SCI I; JUDD DB, 1949, J RES NAT BUR STAND, V42, P1, DOI 10.6028/jres.042.001; KULP TD, 1995, VISION RES, V35, P2967, DOI 10.1016/0042-6989(95)00049-6; Lankheet MJM, 1998, VISUAL NEUROSCI, V15, P37, DOI 10.1017/S0952523898151027; Lee TW, 2002, VISION RES, V42, P2095, DOI 10.1016/S0042-6989(02)00122-0; MARKS WB, 1964, SCIENCE, V143, P1181, DOI 10.1126/science.143.3611.1181; Mollon J., 1997, J DALTONS COLOUR VIS, V54, P391; Mollon JD, 2008, PERCEPTION, V37, P127; Mollon JD, 2009, CURR BIOL, V19, pR441, DOI 10.1016/j.cub.2009.05.008; Mollon J. D., 1995, COLOUR ART SCI; Mollon J.D., 1983, COLOUR VISION PHYSL; Morita T, 2004, NEUROIMAGE, V21, P1665, DOI 10.1016/j.neuroimage.2003.12.019; Nathans J, 1999, NEURON, V24, P299, DOI 10.1016/S0896-6273(00)80845-4; Pridmore RW, 2006, COLOR RES APPL, V31, P364, DOI 10.1002/col.20229; Pridmore RW, 2013, J OPT-INDIA, V42, P8, DOI 10.1007/s12596-012-0090-0; Pridmore RW, 2011, COLOR RES APPL, V36, P394, DOI 10.1002/col.20611; Pridmore RW, 2010, COLOR RES APPL, V35, P122, DOI 10.1002/col.20534; PRIDMORE RW, 1978, J OPT SOC AM, V68, P1490, DOI 10.1364/JOSA.68.001490; PRIDMORE RW, 1980, J OPT SOC AM, V70, P248, DOI 10.1364/JOSA.70.000248; Pridmore RW, 1999, VISION RES, V39, P3892, DOI 10.1016/S0042-6989(99)00086-3; Romeskie MI, 1976, THESIS BROWN U U MIC; SCHNAPF JL, 1987, NATURE, V325, P439, DOI 10.1038/325439a0; Schnapf JL, 1999, COLOR VISION GENES P; Sharpe LT., 1999, COLOR VISION GENES P, P89; Simpson John, 2000, OXFORD ENGLISH DICT; SMITH VC, 1975, VISION RES, V15, P161, DOI 10.1016/0042-6989(75)90203-5; Stiles WS, 1982, COLOR SCI CONCEPTS M, P591; STOCKMAN A, 1993, J OPT SOC AM A, V10, P2491, DOI 10.1364/JOSAA.10.002491; Stockman A, 2000, VISION RES, V40, P1711, DOI 10.1016/S0042-6989(00)00021-3; Stoughton CM, 2008, CURR BIOL, V18, pR698, DOI 10.1016/j.cub.2008.06.018; SVAETICHIN G, 1958, ANN NY ACAD SCI, V74, P385, DOI 10.1111/j.1749-6632.1958.tb39560.x; TAKAHASHI S, 1985, J OPT SOC AM A, V2, P705, DOI 10.1364/JOSAA.2.000705; Valberg A, 2001, VISION RES, V41, P1645, DOI 10.1016/S0042-6989(01)00041-4; VOS JJ, 1990, VISION RES, V30, P937, DOI 10.1016/0042-6989(90)90059-T; Wachtler T, 2003, NEURON, V37, P681, DOI 10.1016/S0896-6273(03)00035-7; Wandell BA, 1999, NEURON, V24, P901, DOI 10.1016/S0896-6273(00)81037-5; WERNER JS, 1979, J OPT SOC AM, V69, P422, DOI 10.1364/JOSA.69.000422; WERNER JS, 1979, PERCEPT PSYCHOPHYS, V25, P371, DOI 10.3758/BF03199845; Wuerger SM, 2005, VISION RES, V45, P3210, DOI 10.1016/j.visres.2005.06.016; Wyszecki G, 1982, COLOR SCI CONCEPTS M, P586; Wyszecki G, 1982, COLOR SCI, Vsecond; Young T., 1802, PHILOS T ROY SOC LON, V92, P12, DOI DOI 10.1098/RSTL.1802.0004	74	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77134	10.1371/journal.pone.0077134	http://dx.doi.org/10.1371/journal.pone.0077134			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204755	Green Published, gold, Green Submitted			2022-12-27	WOS:000326032600022
J	Rougeot, J; Renard, M; Randsholt, NB; Peronnet, F; Mouchel-Vielh, E				Rougeot, Julien; Renard, Myrtille; Randsholt, Neel B.; Peronnet, Frederique; Mouchel-Vielh, Emmanuele			The Elongin Complex Antagonizes the Chromatin Factor Corto for Vein versus Intervein Cell Identity in Drosophila Wings	PLOS ONE			English	Article							RNA-POLYMERASE-II; ELONGATION-FACTOR; REMODELING COMPLEX; UBIQUITIN LIGASE; GENE-EXPRESSION; BC COMPLEX; SCAFFOLD PROTEIN; POLYCOMB-GROUP; FACTOR-SIII; HOX GENE	Drosophila wings mainly consist of two cell types, vein and intervein cells. Acquisition of either fate depends on specific expression of genes that are controlled by several signaling pathways. The nuclear mechanisms that translate signaling into regulation of gene expression are not completely understood, but they involve chromatin factors from the Trithorax (TrxG) and Enhancers of Trithorax and Polycomb (ETP) families. One of these is the ETP Corto that participates in intervein fate through interaction with the Drosophila EGF Receptor - MAP kinase ERK pathway. Precise mechanisms and molecular targets of Corto in this process are not known. We show here that Corto interacts with the Elongin transcription elongation complex. This complex, that consists of three subunits (Elongin A, B, C), increases RNA polymerase II elongation rate in vitro by suppressing transient pausing. Analysis of phenotypes induced by EloA, B, or C deregulation as well as genetic interactions suggest that the Elongin complex might participate in vein vs intervein specification, and antagonizes corto as well as several TrxG genes in this process. Chromatin immunoprecipitation experiments indicate that Elongin C and Corto bind the vein-promoting gene rhomboid in wing imaginal discs. We propose that Corto and the Elongin complex participate together in vein vs intervein fate, possibly through tissue-specific transcriptional regulation of rhomboid.	[Rougeot, Julien; Renard, Myrtille; Randsholt, Neel B.; Peronnet, Frederique; Mouchel-Vielh, Emmanuele] Univ Paris 06, UMR7622, Paris, France; [Rougeot, Julien; Renard, Myrtille; Randsholt, Neel B.; Peronnet, Frederique; Mouchel-Vielh, Emmanuele] CNRS, Dev Biol Lab, UMR7622, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Mouchel-Vielh, E (corresponding author), Univ Paris 06, UMR7622, Paris, France.	emmanuele.mouchel@upmc.fr	Rougeot, Julien/GQI-4130-2022; Peronnet, Frederique/J-7101-2015; Rougeot, Julien/AAF-1269-2019	Peronnet, Frederique/0000-0003-1354-240X; Rougeot, Julien/0000-0001-6899-9306	UPMC; CNRS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947] Funding Source: NIH RePORTER	UPMC; CNRS(Centre National de la Recherche Scientifique (CNRS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Fundings from UPMC and CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Aso T, 1996, EMBO J, V15, P5557, DOI 10.1002/j.1460-2075.1996.tb00940.x; ASO T, 1995, SCIENCE, V269, P1439, DOI 10.1126/science.7660129; Aso T, 1997, BIOCHEM BIOPH RES CO, V241, P334, DOI 10.1006/bbrc.1997.7819; Aso T, 2000, J BIOL CHEM, V275, P6546, DOI 10.1074/jbc.275.9.6546; Beck S, 2010, ADV EXP MED BIOL, V689, P41; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Biehs B, 1998, DEVELOPMENT, V125, P4245; Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606; BRADSHER JN, 1993, J BIOL CHEM, V268, P25587; Brower CS, 2002, P NATL ACAD SCI USA, V99, P10353, DOI 10.1073/pnas.162424199; Chopra VS, 2009, GENE DEV, V23, P1505, DOI 10.1101/gad.1807309; Coisy M, 2004, MOL CELL, V15, P43, DOI 10.1016/j.molcel.2004.06.022; Coleno-Costes A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003006; Conaway JW, 1998, BBA-REV CANCER, V1377, pM49, DOI 10.1016/S0304-419X(97)00035-8; Crosby MA, 1999, MOL CELL BIOL, V19, P1159; Crozatier M, 2003, MECH DEVELOP, V120, P529, DOI 10.1016/S0925-4773(03)00041-8; Curtis BJ, 2011, DEV BIOL, V350, P534, DOI 10.1016/j.ydbio.2010.12.001; Daubresse G, 1999, DEVELOPMENT, V126, P1175; de Celis JF, 2003, BIOESSAYS, V25, P443, DOI 10.1002/bies.10258; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; FRISTROM D, 1994, DEVELOPMENT, V120, P2661; Gerber M, 2005, J BIOL CHEM, V280, P4017, DOI 10.1074/jbc.C400487200; Gerber M, 2004, MOL CELL BIOL, V24, P9911, DOI 10.1128/MCB.24.22.9911-9919.2004; GomezSkarmeta JL, 1996, CELL, V85, P95, DOI 10.1016/S0092-8674(00)81085-5; Grimaud C, 2006, CHROMOSOME RES, V14, P363, DOI 10.1007/s10577-006-1069-y; Guichard A, 1999, DEVELOPMENT, V126, P2663; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Kamura T, 2001, J BIOL CHEM, V276, P29748, DOI 10.1074/jbc.M103093200; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lopez A, 2001, MOL GENET GENOMICS, V266, P572, DOI 10.1007/s004380100572; Marenda DR, 2004, DEV BIOL, V267, P279, DOI 10.1016/j.ydbio.2003.10.040; Martin-Blanco E, 1999, DEVELOPMENT, V126, P5739; Mas G, 2009, EMBO J, V28, P326, DOI 10.1038/emboj.2008.299; Montagne J, 1996, DEVELOPMENT, V122, P2589; Mouchel-Vielh E, 2008, GENES CELLS, V13, P1099, DOI 10.1111/j.1365-2443.2008.01231.x; Mouchel-Vielh E, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-17; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; NG M, 1995, DEVELOPMENT, V121, P589; Ni JQ, 2008, NAT METHODS, V5, P49, DOI 10.1038/NMETH1146; Oh SW, 2003, GENETICS, V163, P195; Perez-Lluch S, 2011, NUCLEIC ACIDS RES, V39, P4628, DOI 10.1093/nar/gkq1322; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Rendina R, 2010, GENETICS, V186, P167, DOI 10.1534/genetics.110.118695; Roch F, 1998, DEVELOPMENT, V125, P1823; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Rozenblatt-Rosen O, 1998, P NATL ACAD SCI USA, V95, P4152, DOI 10.1073/pnas.95.8.4152; Salvaing J, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-9; Salvaing J, 2003, NUCLEIC ACIDS RES, V31, P2873, DOI 10.1093/nar/gkg381; Salvaing J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001658; Schuettengruber B, 2011, NAT REV MOL CELL BIO, V12, P799, DOI 10.1038/nrm3230; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; St Pierre SE, 2002, DEVELOPMENT, V129, P1273; STURTEVANT MA, 1993, GENE DEV, V7, P961, DOI 10.1101/gad.7.6.961; TAKAGI Y, 1995, J BIOL CHEM, V270, P24300, DOI 10.1074/jbc.270.41.24300; Takagi Y, 1996, J BIOL CHEM, V271, P25562, DOI 10.1074/jbc.271.41.25562; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Terriente-Felix A, 2011, DEV BIOL, V350, P382, DOI 10.1016/j.ydbio.2010.12.003; Terriente-Felix A, 2009, DEV BIOL, V329, P350, DOI 10.1016/j.ydbio.2009.03.010; Therrien M, 2000, GENETICS, V156, P1231; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Yamazaki K, 2002, J BIOL CHEM, V277, P26444, DOI 10.1074/jbc.M202859200; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zraly CB, 2003, DEV BIOL, V253, P291, DOI 10.1016/S0012-1606(02)00011-8	67	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77592	10.1371/journal.pone.0077592	http://dx.doi.org/10.1371/journal.pone.0077592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204884	Green Published, gold, Green Submitted			2022-12-27	WOS:000326032600037
J	Wu, XP; Adriany, G; Ugurbil, K; Van de Moortele, PF				Wu, Xiaoping; Adriany, Gregor; Ugurbil, Kamil; Van de Moortele, Pierre-Francois			Correcting for Strong Eddy Current Induced B0 Modulation Enables Two-Spoke RF Pulse Design with Parallel Transmission: Demonstration at 9.4T in the Human Brain	PLOS ONE			English	Article							RADIOFREQUENCY PULSES; 8 CHANNELS; EXCITATION; INHOMOGENEITY; TESLA; SENSE; COIL	Successful implementation of homogeneous slice-selective RF excitation in the human brain at 9.4T using 16-channel parallel transmission (pTX) is demonstrated. A novel three-step pulse design method incorporating fast real-time measurement of eddy current induced B0 variations as well as correction of resulting phase errors during excitation is described. To demonstrate the utility of the proposed method, phantom and in-vivo experiments targeting a uniform excitation in an axial slice were conducted using two-spoke pTX pulses. Even with the pre-emphasis activated, eddy current induced B0 variations with peak-to-peak values greater than 4 kHz were observed on our system during the rapid switches of slice selective gradients. This large B0 variation, when not corrected, resulted in drastically degraded excitation fidelity with the coefficient of variation (CV) of the flip angle calculated for the region of interest being large (similar to 12% in the phantom and similar to 35% in the brain). By comparison, excitation fidelity was effectively restored, and satisfactory flip angle uniformity was achieved when using the proposed method, with the CV value reduced to similar to 3% in the phantom and similar to 8% in the brain. Additionally, experimental results were in good agreement with the numerical predictions obtained from Bloch simulations. Slice-selective flip angle homogenization in the human brain at 9.4T using 16-channel 3D spoke pTX pulses is achievable despite of large eddy current induced excitation phase errors; correcting for the latter was critical in this success.	[Wu, Xiaoping; Adriany, Gregor; Ugurbil, Kamil; Van de Moortele, Pierre-Francois] Univ Minnesota, Sch Med, Ctr Magnet Resonance Res, Dept Radiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Wu, XP (corresponding author), Univ Minnesota, Sch Med, Ctr Magnet Resonance Res, Dept Radiol, Minneapolis, MN 55455 USA.	xiaoping.wu2010@gmail.com	Wu, Xiaoping/K-5569-2012; Van de Moortele, Pierre-François/H-5087-2011; Ugurbil, Kamil/AAD-6058-2022; Adriany, Gregor/AAK-1323-2020; Adriany, Gregor/R-6656-2016	Wu, Xiaoping/0000-0001-6021-9088; Van de Moortele, Pierre-François/0000-0002-6941-5947; Adriany, Gregor/0000-0002-6428-9005	W.M. Keck Foundation; NIH NIBIB [P41 EB015894]; NIH [R01 EB006835, R01 EB007327, S10 RR25437, R21 EB009133]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008079, S10RR025437] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY011374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB009133, R01EB006835, R01EB007327, P41EB015894] Funding Source: NIH RePORTER	W.M. Keck Foundation(W.M. Keck Foundation); NIH NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the W.M. Keck Foundation, NIH NIBIB P41 EB015894 (previously NIH NCRR P41 RR008079), and NIH R01 EB006835, R01 EB007327, S10 RR25437, R21 EB009133. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriany G, 2009, P INT SOC MAG RESON, V17, P3005; Cloos MA, 2012, MAGN RESON MED, V67, P72, DOI 10.1002/mrm.22978; Deelchand DK, 2010, J MAGN RESON, V206, P74, DOI 10.1016/j.jmr.2010.06.006; Grissom W, 2006, MAGN RESON MED, V56, P620, DOI 10.1002/mrm.20978; Katscher U, 2003, MAGNET RESON MED, V49, P144, DOI 10.1002/mrm.10353; Papadakis NG, 2000, MAGNET RESON MED, V44, P616, DOI 10.1002/1522-2594(200010)44:4<616::AID-MRM16>3.0.CO;2-T; Sbrizzi A, 2012, MAGN RESON MED, V67, P824, DOI 10.1002/mrm.23049; Schneider JT, 2011, MAGN RESON MED, V65, P409, DOI 10.1002/mrm.22635; Setsompop K, 2008, MAGN RESON MED, V59, P908, DOI 10.1002/mrm.21513; Setsompop K, 2006, MAGN RESON MED, V56, P1163, DOI 10.1002/mrm.21042; Setsompop K, 2008, MAGN RESON MED, V60, P1422, DOI 10.1002/mrm.21739; Ullmann P, 2005, MAGNET RESON MED, V54, P994, DOI 10.1002/mrm.20646; Van de Moortele P-F, 2007, P INT SOC MAG RESON, V15, P1676; Wu X, 2010, P INT SOC MAG RESON, V18, P107; Wu X, 2011, P INT SOC MAG RESON, V19, P4441; Wu XP, 2010, J MAGN RESON, V205, P161, DOI 10.1016/j.jmr.2010.04.018; Wu XP, 2010, MAGN RESON MED, V63, P524, DOI 10.1002/mrm.22247; WYSONG RE, 1993, MAGNET RESON MED, V29, P119, DOI 10.1002/mrm.1910290121; Yarnykh VL, 2007, MAGN RESON MED, V57, P192, DOI 10.1002/mrm.21120; Zhang ZH, 2007, MAGN RESON MED, V57, P842, DOI 10.1002/mrm.21221; Zhu YD, 2004, MAGNET RESON MED, V51, P775, DOI 10.1002/mrm.20011	21	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78078	10.1371/journal.pone.0078078	http://dx.doi.org/10.1371/journal.pone.0078078			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205098	Green Published, gold, Green Submitted			2022-12-27	WOS:000326032600069
J	Lai, LM; Wang, JJ; Tian, Y; Zhao, XC; Jiang, LH; Chen, X; Gao, Y; Wang, SM; Zheng, YR				Lai, Liming; Wang, Jianjian; Tian, Yuan; Zhao, Xuechun; Jiang, Lianhe; Chen, Xi; Gao, Yong; Wang, Shaoming; Zheng, Yuanrun			Organic Matter and Water Addition Enhance Soil Respiration in an Arid Region	PLOS ONE			English	Article							TEMPERATURE SENSITIVITY; CARBON-DIOXIDE; CLIMATE-CHANGE; DESERT SHRUBS; ELEVATED CO2; DEPENDENCE; INCREASES; RESPONSES; DECOMPOSITION; FEEDBACKS	Climate change is generally predicted to increase net primary production, which could lead to additional C input to soil. In arid central Asia, precipitation has increased and is predicted to increase further. To assess the combined effects of these changes on soil CO2 efflux in arid land, a two factorial manipulation experiment in the shrubland of an arid region in northwest China was conducted. The experiment used a nested design with fresh organic matter and water as the two controlled parameters. It was found that both fresh organic matter and water enhanced soil respiration, and there was a synergistic effect of these two treatments on soil respiration increase. Water addition not only enhanced soil C emission, but also regulated soil C sequestration by fresh organic matter addition. The results indicated that the soil CO2 flux of the shrubland is likely to increase with climate change, and precipitation played a dominant role in regulating soil C balance in the shrubland of an arid region.	[Lai, Liming; Wang, Jianjian; Zhao, Xuechun; Jiang, Lianhe; Zheng, Yuanrun] Chinese Acad Sci, Key Lab Resource Plants, Beijing Bot Garden, West China Subalpine Bot Garden,Inst Bot, Beijing, Peoples R China; [Wang, Jianjian] Univ Chinese Acad Sci, Beijing, Peoples R China; [Tian, Yuan; Chen, Xi] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Urumqi, Xinjiang, Peoples R China; [Gao, Yong] Inner Mongolia Agr Univ, Hohhot, Inner Mongolia, Peoples R China; [Wang, Shaoming] Key Lab Oasis Ecol Agr Xinjiang Bingtuan, Shihezi, Xinjiang, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Inner Mongolia Agricultural University	Zheng, YR (corresponding author), Chinese Acad Sci, Key Lab Resource Plants, Beijing Bot Garden, West China Subalpine Bot Garden,Inst Bot, Beijing, Peoples R China.	zhengyr@ibcas.ac.cn	liming, lai/HGB-0743-2022		China National Key Basic Research Program [2009CB825103, 2012CB956204]	China National Key Basic Research Program(National Basic Research Program of China)	This work was supported by China National Key Basic Research Program (2009CB825103, 2012CB956204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BINGEMAN C. W., 1953, Proceedings. Soil Science Society of America, V17, P34; Blagodatskaya E, 2008, BIOL FERT SOILS, V45, P115, DOI 10.1007/s00374-008-0334-y; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Borken W, 2009, GLOBAL CHANGE BIOL, V15, P808, DOI 10.1111/j.1365-2486.2008.01681.x; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2004, GLOBAL CHANGE BIOL, V10, P718, DOI 10.1111/j.1365-2486.2004.00762.x; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Fierer N, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002644; Fontaine S, 2004, ECOL LETT, V7, P314, DOI 10.1111/j.1461-0248.2004.00579.x; Fontaine S, 2003, SOIL BIOL BIOCHEM, V35, P837, DOI 10.1016/S0038-0717(03)00123-8; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; Gaumont-Guay D, 2006, AGR FOREST METEOROL, V140, P220, DOI 10.1016/j.agrformet.2006.08.003; GIFFORD RM, 1994, AUST J PLANT PHYSIOL, V21, P1, DOI 10.1071/PP9940001; Gill RA, 2002, NATURE, V417, P279, DOI 10.1038/417279a; Graf A, 2008, BIOGEOSCIENCES, V5, P1175, DOI 10.5194/bg-5-1175-2008; Hanson PJ, 2003, ECOL STU AN, V166, P163; Hashimoto S, 2005, J FOREST RES-JPN, V10, P409, DOI 10.1007/s10310-005-0164-9; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Ilstedt U, 2000, SOIL BIOL BIOCHEM, V32, P1591, DOI 10.1016/S0038-0717(00)00073-0; Jastrow JD, 2005, GLOBAL CHANGE BIOL, V11, P2057, DOI 10.1111/j.1365-2486.2005.01077.x; Jones CD, 2003, TELLUS B, V55, P642, DOI 10.1034/j.1600-0889.2003.01440.x; Lai LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070224; Lai LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048011; Lal R, 2009, LAND DEGRAD DEV, V20, P441, DOI 10.1002/ldr.934; Lavigne MB, 2004, TREE PHYSIOL, V24, P415, DOI 10.1093/treephys/24.4.415; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Luo Y, 2006, SOIL RESP ENV, DOI DOI 10.1016/B978-0-12-088782-8; Mahecha MD, 2010, SCIENCE, V329, P838, DOI 10.1126/science.1189587; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Pavelka M, 2007, PLANT SOIL, V292, P171, DOI 10.1007/s11104-007-9213-9; Qian WH, 2001, CLIMATIC CHANGE, V50, P419, DOI 10.1023/A:1010673212131; Raich JW, 2002, GLOBAL CHANGE BIOL, V8, P800, DOI 10.1046/j.1365-2486.2002.00511.x; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Reichstein M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027880; Rey A, 2002, GLOBAL CHANGE BIOL, V8, P851, DOI 10.1046/j.1365-2486.2002.00521.x; Sayer EJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001299; Schimel J, 2007, ECOLOGY, V88, P1386, DOI 10.1890/06-0219; Schindlbacher A, 2012, GLOBAL CHANGE BIOL, V18, P2270, DOI 10.1111/j.1365-2486.2012.02696.x; Smith SD, 2000, NATURE, V408, P79, DOI 10.1038/35040544; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P19; Sponseller RA, 2007, GLOBAL CHANGE BIOL, V13, P426, DOI 10.1111/j.1365-2486.2006.01307.x; SPSS, 2000, SPSS WIND VERS 13 0; Sulzman EW, 2005, BIOGEOCHEMISTRY, V73, P231, DOI 10.1007/s10533-004-7314-6; Trumbore S, 2006, GLOBAL CHANGE BIOL, V12, P141, DOI 10.1111/j.1365-2486.2006.01067.x; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wan S, 2007, GLOBAL CHANGE BIOL, V13, P2411, DOI 10.1111/j.1365-2486.2007.01433.x; Wilcox CS, 2004, J ARID ENVIRON, V56, P129, DOI 10.1016/S0140-1963(02)00324-5; Xiao CW, 2007, NEW PHYTOL, V174, P835, DOI 10.1111/j.1469-8137.2007.02054.x; [徐贵青 Xu Guiqing], 2004, [干旱区地理, Arid Land Geography], V27, P14; Xu H, 2006, PLANT SOIL, V285, P5, DOI 10.1007/s11104-005-5108-9; Yuste JC, 2007, GLOBAL CHANGE BIOL, V13, P2018, DOI 10.1111/j.1365-2486.2007.01415.x; Zheng Y, 2006, J ARID ENVIRON, V66, P113, DOI 10.1016/j.jaridenv.2005.09.005; Zheng YR, 2010, ENVIRON EXP BOT, V68, P31, DOI 10.1016/j.envexpbot.2009.11.005	55	18	18	4	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77659	10.1371/journal.pone.0077659	http://dx.doi.org/10.1371/journal.pone.0077659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204907	gold, Green Published, Green Submitted			2022-12-27	WOS:000326029300109
J	Page, K; Guttery, DS; Zahra, N; Primrose, L; Elshaw, SR; Pringle, JH; Blighe, K; Marchese, SD; Hills, A; Woodley, L; Stebbing, J; Coombes, RC; Shaw, JA				Page, Karen; Guttery, David S.; Zahra, Nathalie; Primrose, Lindsay; Elshaw, Shona R.; Pringle, J. Howard; Blighe, Kevin; Marchese, Stephanie D.; Hills, Allison; Woodley, Laura; Stebbing, Justin; Coombes, R. Charles; Shaw, Jacqueline A.			Influence of Plasma Processing on Recovery and Analysis of Circulating Nucleic Acids	PLOS ONE			English	Article							CANCER-PATIENTS; BREAST-CANCER; FREE DNA; MICRORNA; SERUM; EXPRESSION; QUANTIFICATION; FETAL	Circulating nucleic acids (CNAs) are under investigation as a liquid biopsy in cancer. However there is wide variation in blood processing and methods for isolation of circulating free DNA (cfDNA) and microRNAs (miRNAs). Here we compare the extraction efficiency and reproducibility of 4 commercially available kits for cfDNA and 3 for miRNA using spike-in of reference templates. We also compare the effects of increasing time between venepuncture and centrifugation and differential centrifugation force on recovery of CNAs. cfDNA was quantified by TaqMan qPCR and targeted deep sequencing. miRNA profiles were assessed with TaqMan low-density arrays and assays. The QIAamp (R) DNA Blood Mini and Circulating nucleic acid kits gave the highest recovery of cfDNA and efficient recovery (>90%) of a 564bp spike-in. Moreover, targeted sequencing revealed overlapping cfDNA profiles and variant depth, including detection of HER2 gene amplification, using the Ion AmpliSeq (TM) Cancer Hotspot Panel v2. Highest yields of miRNA and the synthetic Arabidopsis thaliana miR-159a spike-in were obtained using the miRNeasy Serum/Plasma kit, with saturation above 200 mu l of plasma. miRNA profiles showed significant variation with increasing time before centrifugation (p<0.001) and increasing centrifugation force, with depletion of platelet associated miRNAs, whereas cfDNA was unaffected. However, sample replicates showed excellent reproducibility on TaqMan low density arrays (rho = 0.96, p<0.0001). We also successfully generated miRNA profiles for plasma samples stored > 12 years, highlighting the potential for analysis of stored sample biobanks. In the era of the liquid biopsy, standardisation of methods is required to minimise variation, particularly for miRNA.	[Page, Karen; Guttery, David S.; Zahra, Nathalie; Primrose, Lindsay; Elshaw, Shona R.; Pringle, J. Howard; Blighe, Kevin; Shaw, Jacqueline A.] Univ Leicester, Leicester Royal Infirm, Dept Canc Studies & Mol Med, Leicester, Leics, England; [Marchese, Stephanie D.; Hills, Allison; Woodley, Laura; Stebbing, Justin; Coombes, R. Charles] ICTEM, Div Canc, London, England	University of Leicester	Shaw, JA (corresponding author), Univ Leicester, Leicester Royal Infirm, Dept Canc Studies & Mol Med, Leicester, Leics, England.	js39@le.ac.uk	Guttery, David/H-2011-2012	Guttery, David/0000-0003-0418-580X; Shaw, Jacqui/0000-0003-4227-503X; Blighe, Kevin/0000-0002-6322-6571; Page, Karen/0000-0003-0440-9244; Stebbing, Justin/0000-0002-1117-6947; Coombes, Raoul Charles/0000-0002-4811-1100	Cancer Research UK Clinical and Translational Research Committee Programme Award [C14315/A13462X]; Roy Castle Lung Cancer Foundation [2012 08]; Maria Tilton Fellowship from Hope Against Cancer; Cancer Research UK [14549, 13462] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-011-053] Funding Source: researchfish	Cancer Research UK Clinical and Translational Research Committee Programme Award; Roy Castle Lung Cancer Foundation; Maria Tilton Fellowship from Hope Against Cancer; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by a Cancer Research UK Clinical and Translational Research Committee Programme Award (Grant number C14315/A13462X to JAS and RCC) and a Roy Castle Lung Cancer Foundation Project Grant (Grant number 2012 08 Shaw to JAS and JHP). SRE was supported by the Maria Tilton Fellowship from Hope Against Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No company was involved in the design, data collection, interpretation, or funding of this project.	Cheng HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064795; Chiu RWK, 2001, CLIN CHEM, V47, P1607; Cuk K, 2013, INT J CANCER, V132, P1602, DOI 10.1002/ijc.27799; Duttagupta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020769; Eldh M, 2012, MOL IMMUNOL, V50, P278, DOI 10.1016/j.molimm.2012.02.001; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Jahr S, 2001, CANCER RES, V61, P1659; Jensen SG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-435; Jorde Rolf, 2012, BMC Res Notes, V5, P245, DOI 10.1186/1756-0500-5-245; Kim DJ, 2012, J MOL DIAGN, V14, P71, DOI 10.1016/j.jmoldx.2011.09.002; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kuhlmann JD, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-325; LEON SA, 1977, CANCER RES, V37, P646; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lodes MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006229; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Page K, 2011, BRIT J CANCER, V104, P1342, DOI 10.1038/bjc.2011.89; Page K, 2006, ANN NY ACAD SCI, V1075, P313, DOI 10.1196/annals.1368.042; Patel RS, 2011, ARCH ORAL BIOL, V56, P1506, DOI 10.1016/j.archoralbio.2011.05.015; Schwarzenbach H, 2012, CLIN CANCER RES, V18, P5719, DOI 10.1158/1078-0432.CCR-12-0142; Shaw JA, 2012, GENOME RES, V22, P220, DOI 10.1101/gr.123497.111; Shaw JA, 2011, BIOMARK MED, V5, P87, DOI 10.2217/BMM.10.118; Shen J, 2011, LAB INVEST, V91, P579, DOI 10.1038/labinvest.2010.194; Sozzi G, 2005, J NATL CANCER I, V97, P1848, DOI 10.1093/jnci/dji432; Su YH, 2008, ANN NY ACAD SCI, V1137, P197, DOI 10.1196/annals.1448.027; Umetani N, 2006, ANN NY ACAD SCI, V1075, P299, DOI 10.1196/annals.1368.040; van Schooneveld E, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3127; Willeit P, 2013, CIRC RES, V112, P595, DOI 10.1161/CIRCRESAHA.111.300539	31	128	134	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77963	10.1371/journal.pone.0077963	http://dx.doi.org/10.1371/journal.pone.0077963			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205045	Green Submitted, Green Published, gold			2022-12-27	WOS:000326029300127
J	Shearin, HK; Dvarishkis, AR; Kozeluh, CD; Stowers, RS				Shearin, Harold K.; Dvarishkis, Alisa R.; Kozeluh, Craig D.; Stowers, R. Steven			Expansion of the Gateway MultiSite Recombination Cloning Toolkit	PLOS ONE			English	Article							TARGETED GENE-EXPRESSION; DROSOPHILA-MELANOGASTER; SYNAPTIC-TRANSMISSION; TRANSGENE EXPRESSION; CHANNEL; NEURONS; HEARING; SYSTEMS	Precise manipulation of transgene expression in genetic model organisms has led to advances in understanding fundamental mechanisms of development, physiology, and genetic disease. Transgene construction is, however, a precondition of transgene expression, and often limits the rate of experimental progress. Here we report an expansion of the modular Gateway MultiSite recombination-cloning platform for high efficiency transgene assembly. The expansion includes two additional destination vectors and entry clones for the LexA binary transcription system, among others. These new tools enhance the expression levels possible with Gateway MultiSite generated transgenes and make possible the generation of LexA drivers and reporters with Gateway MultiSite cloning. In vivo data from transgenic Drosophila functionally validating each novel component are presented and include neuronal LexA drivers, LexAop2 red and green fluorescent synaptic vesicle reporters, TDC2 and TRH LexA, GAL4, and QF drivers, and LexAop2, UAS, and QUAS channelrhodopsin2 T159C reporters.	[Shearin, Harold K.; Dvarishkis, Alisa R.; Kozeluh, Craig D.; Stowers, R. Steven] Montana State Univ, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Stowers, RS (corresponding author), Montana State Univ, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA.	sstowers@montana.edu			Whitehall Foundation	Whitehall Foundation	This work received financial support from the Whitehall Foundation (http://www.whitehall.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; Baek M, 2013, DEVELOPMENT, V140, P2027, DOI 10.1242/dev.090902; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cole SH, 2005, J BIOL CHEM, V280, P14948, DOI 10.1074/jbc.M414197200; Deitcher DL, 1998, J NEUROSCI, V18, P2028; Gong ZF, 2004, J NEUROSCI, V24, P9059, DOI 10.1523/JNEUROSCI.1645-04.2004; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Kidokoro Y, 2003, NEUROSIGNALS, V12, P13, DOI 10.1159/000068912; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Lai SL, 2006, NAT NEUROSCI, V9, P703, DOI 10.1038/nn1681; NECKAMEYER WS, 1992, J BIOL CHEM, V267, P4199; Petersen LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024531; Pfeiffer BD, 2012, P NATL ACAD SCI USA, V109, P6626, DOI 10.1073/pnas.1204520109; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Potter CJ, 2010, CELL, V141, P536, DOI 10.1016/j.cell.2010.02.025; Sun YS, 2009, P NATL ACAD SCI USA, V106, P13606, DOI 10.1073/pnas.0906377106; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Vomel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001848; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Yan ZQ, 2013, NATURE, V493, P221, DOI 10.1038/nature11685	24	29	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77724	10.1371/journal.pone.0077724	http://dx.doi.org/10.1371/journal.pone.0077724			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204935	gold, Green Submitted, Green Published			2022-12-27	WOS:000326029300110
J	Taerum, SJ; Duong, TA; de Beer, ZW; Gillette, N; Sun, JH; Owen, DR; Wingfield, MJ				Taerum, Stephen J.; Duong, Tuan A.; de Beer, Z. Wilhelm; Gillette, Nancy; Sun, Jiang-Hua; Owen, Donald R.; Wingfield, Michael J.			Large Shift in Symbiont Assemblage in the Invasive Red Turpentine Beetle	PLOS ONE			English	Article							DENDROCTONUS BARK BEETLES; OPHIOSTOMATOID FUNGI; TOMICUS-PINIPERDA; PLANT INVASIONS; NORTH-AMERICA; VALENS COLEOPTERA; GENETIC-VARIATION; MYCANGIAL FUNGI; LODGEPOLE PINE; SP-NOV	Changes in symbiont assemblages can affect the success and impact of invasive species, and may provide knowledge regarding the invasion histories of their vectors. Bark beetle symbioses are ideal systems to study changes in symbiont assemblages resulting from invasions. The red turpentine beetle (Dendroctonus valens) is a bark beetle species that recently invaded China from its native range in North America. It is associated with ophiostomatalean fungi in both locations, although the fungi have previously been well-surveyed only in China. We surveyed the ophiostomatalean fungi associated with D. valens in eastern and western North America, and identified the fungal species using multi-gene phylogenies. From the 307 collected isolates (147 in eastern North America and 160 in western North America), we identified 20 species: 11 in eastern North America and 13 in western North America. Four species were shared between eastern North America and western North America, one species (Ophiostoma floccosum) was shared between western North America and China, and three species (Grosmannia koreana, Leptographium procerum, and Ophiostoma abietinum) were shared between eastern North America and China. Ophiostoma floccosum and O. abietinum have worldwide distributions, and were rarely isolated from D. valens. However, G. koreana and L. procerum are primarily limited to Asia and North America respectively. Leptographium procerum, which is thought to be native to North America, represented >45% of the symbionts of D. valens in eastern North America and China, suggesting D. valens may have been introduced to China from eastern North America. These results are surprising, as previous population genetics studies on D. valens based on the cytochrome oxidase I gene have suggested that the insect was introduced into China from western North America.	[Taerum, Stephen J.; Duong, Tuan A.; Wingfield, Michael J.] Univ Pretoria, Dept Genet, Forestry & Agr Biotechnol Inst, ZA-0002 Pretoria, South Africa; [de Beer, Z. Wilhelm; Wingfield, Michael J.] Univ Pretoria, Dept Microbiol & Plant Pathol, Forestry & Agr Biotechnol Inst, ZA-0002 Pretoria, South Africa; [Gillette, Nancy] US Forest Serv, Pacific Southwest Res Stn, USDA, Albany, CA USA; [Sun, Jiang-Hua] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Owen, Donald R.] Calif Dept Forestry & Fire Protect, Redding, CA USA	University of Pretoria; University of Pretoria; United States Department of Agriculture (USDA); United States Forest Service; Chinese Academy of Sciences; Institute of Zoology, CAS; California Department of Forestry and Fire Protection	de Beer, ZW (corresponding author), Univ Pretoria, Dept Microbiol & Plant Pathol, Forestry & Agr Biotechnol Inst, ZA-0002 Pretoria, South Africa.	Wilhelm.DeBeer@fabi.up.ac.za	de Beer, Z. Wilhelm/O-3194-2019; de Beer, Z. Wilhelm/B-6353-2008; de Beer, Wilhelm/AAK-9266-2020; Wingfield, Michael J/A-9473-2008; Duong, Tuan/I-9432-2012	de Beer, Z. Wilhelm/0000-0001-9758-8987; de Beer, Z. Wilhelm/0000-0001-9758-8987; Duong, Tuan/0000-0001-5110-1854; sun, jianghua/0000-0002-9465-3672	Tree Protection Cooperative Programme; USDA Forest Service, Western Wildland Environmental Threat Assessment Center, Prineville, Oregon, USA	Tree Protection Cooperative Programme; USDA Forest Service, Western Wildland Environmental Threat Assessment Center, Prineville, Oregon, USA	Funding came from Tree Protection Cooperative Programme http://www.fabinet.up.ac.za/research/tpcp, and the USDA Forest Service, Western Wildland Environmental Threat Assessment Center, Prineville, Oregon, USA http://www.fs.fed.us/wwetac/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AS, 2010, ENVIRON ENTOMOL, V39, P406, DOI 10.1603/EN09221; Alexander SA, 1988, LEPTOGRAPHIUM ROOT D, P97; Aschehoug ET, 2012, ECOLOGY, V93, P3, DOI 10.1890/11-1347.1; Aukema JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024587; Ayres MP, 2000, ECOLOGY, V81, P2198, DOI 10.1890/0012-9658(2000)081[2198:NBOPFB]2.0.CO;2; Butin H., 1990, SYDOWIA, V42, P193; Cai Y, 2011, J APPL ENTOMOL, V135, P302, DOI 10.1111/j.1439-0418.2010.01545.x; Cai YW, 2008, INSECT SCI, V15, P291, DOI 10.1111/j.1744-7917.2008.00213.x; Chen WM, 2005, NEW PHYTOL, V168, P661, DOI 10.1111/j.1469-8137.2005.01533.x; Cognato AI, 2005, AGR FOREST ENTOMOL, V7, P87, DOI 10.1111/j.1461-9555.2005.00243.x; de Beer ZW, 2013, OPHIOSTOMATOID FUNGI, P21; Dickie IA, 2010, NEW PHYTOL, V187, P475, DOI 10.1111/j.1469-8137.2010.03277.x; DiGuistini S, 2007, FEMS MICROBIOL LETT, V267, P151, DOI 10.1111/j.1574-6968.2006.00565.x; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Duong TA, 2012, MYCOLOGIA, V104, P715, DOI 10.3852/11-109; Erbilgin N, 2007, J CHEM ECOL, V33, P131, DOI 10.1007/s10886-006-9200-2; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hofstetter RW, 2006, OECOLOGIA, V147, P679, DOI 10.1007/s00442-005-0312-0; Hulcr J, 2011, P ROY SOC B-BIOL SCI, V278, P2866, DOI 10.1098/rspb.2011.1130; Humble LM, 2006, CAN J PLANT PATHOL, V28, pS256, DOI 10.1080/07060660609507383; Husseneder Claudia, 2010, Open Microbiol J, V4, P53, DOI 10.2174/1874285801004010053; Jacobs K, 2004, MYCOL RES, V108, P411, DOI 10.1017/S0953756204009748; Jacobs K, 2003, CAN J BOT, V81, P316, DOI [10.1139/B03-025, 10.1139/b03-025]; Jacobs K., 2001, LEPTOGRAPHIUM SPECIE; Jankowiak R, 2006, ANN FOREST SCI, V63, P801, DOI 10.1051/forest:2006063; Jankowiak R, 2012, DENDROBIOLOGY, V68, P43; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kenis M, 2009, BIOL INVASIONS, V11, P21, DOI 10.1007/s10530-008-9318-y; Kim JJ, 2005, MYCOTAXON, V91, P481; Kim JJ, 2005, MYCOL RES, V109, P275, DOI 10.1017/S0953756204002060; Kirisits T, 2004, BARK AND WOOD BORING INSECTS IN LIVING TREES IN EUROPE, A SYNTHESIS, P181, DOI 10.1007/978-1-4020-2241-8_10; Kirkendall LR, 2010, ZOOKEYS, P227, DOI 10.3897/zookeys.56.529; Klepzig KD, 2009, ENVIRON ENTOMOL, V38, P67, DOI 10.1603/022.038.0109; KLEPZIG KD, 1995, GREAT LAKES ENTOMOL, V28, P81; Knevel IC, 2004, OECOLOGIA, V141, P502, DOI 10.1007/s00442-004-1662-8; Lieutier F, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009066; Linnakoski R, 2012, ANTON LEEUW INT J G, V102, P375, DOI 10.1007/s10482-012-9747-6; Lombardero MJ, 2003, OIKOS, V102, P243, DOI 10.1034/j.1600-0706.2003.12599.x; Lu M, 2011, ECOLOGY, V92, P2013, DOI 10.1890/11-0687.1; Lu M, 2010, NEW PHYTOL, V187, P859, DOI 10.1111/j.1469-8137.2010.03316.x; Lu M, 2009, FUNGAL DIVERS, V38, P133; Lu Q, 2008, MYCOLOGIA, V100, P275, DOI 10.3852/mycologia.100.2.275; Lu Q, 2009, ANTON LEEUW INT J G, V96, P275, DOI 10.1007/s10482-009-9343-6; Masuya H, 2005, MYCOTAXON, V94, P159; Masuya Hayato, 2000, Mycoscience, V41, P425, DOI 10.1007/BF02461660; Masuya H, 2009, MYCOSCIENCE, V50, P212, DOI 10.1007/s10267-008-0474-9; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Nobre T, 2010, P ROY SOC B-BIOL SCI, V277, P359, DOI 10.1098/rspb.2009.1373; Nunez MA, 2009, ECOLOGY, V90, P2352, DOI 10.1890/08-2139.1; Owen D.R., 2010, RED TURPENTINE BEETL; Paine TD, 1997, ANNU REV ENTOMOL, V42, P179, DOI 10.1146/annurev.ento.42.1.179; PAJARES JA, 1990, ANN ENTOMOL SOC AM, V83, P171, DOI 10.1093/aesa/83.2.171; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prenter J, 2004, TRENDS ECOL EVOL, V19, P385, DOI 10.1016/j.tree.2004.05.002; Proctor HC, 2004, J PARASITOL, V90, P60, DOI 10.1645/GE-57R; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Rambaut A., 2007, TRACER 1 4; Reinhart KO, 2006, NEW PHYTOL, V170, P445, DOI 10.1111/j.1469-8137.2006.01715.x; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rudgers JA, 2005, OECOLOGIA, V144, P463, DOI 10.1007/s00442-005-0039-y; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Scott JJ, 2008, SCIENCE, V322, P63, DOI 10.1126/science.1160423; Seastedt TR, 2011, ANNU REV ECOL EVOL S, V42, P133, DOI 10.1146/annurev-ecolsys-102710-145057; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Six DL, 2011, ANTON LEEUW INT J G, V100, P231, DOI 10.1007/s10482-011-9582-1; Six DL, 2011, ANNU REV ENTOMOL, V56, P255, DOI 10.1146/annurev-ento-120709-144839; Six DL, 1998, ENVIRON ENTOMOL, V27, P1393, DOI 10.1093/ee/27.6.1393; Six DL, 2004, SYMBIOSIS, V37, P207; Six DL, 2003, CONT T ENT, P97; Six DL, 1999, ANN ENTOMOL SOC AM, V92, P159, DOI 10.1093/aesa/92.2.159; SPATAFORA JW, 1994, MYCOL RES, V98, P1, DOI 10.1016/S0953-7562(09)80327-4; Sun JH, 2004, ENVIRON ENTOMOL, V33, P206, DOI 10.1603/0046-225X-33.2.206; Uchitel A, 2011, OECOLOGIA, V165, P465, DOI 10.1007/s00442-010-1740-z; US Department of Agriculture Forest Service, 2001, FED REGISTER, V66, P48361; van der Putten WH, 2007, ISME J, V1, P28, DOI 10.1038/ismej.2007.9; Vasanthakumar A, 2008, ENVIRON ENTOMOL, V37, P1344, DOI 10.1603/0046-225X(2008)37[1344:GMOAIS]2.0.CO;2; Wang GY, 2009, ISME J, V3, P374, DOI 10.1038/ismej.2008.107; White EM, 2006, DIVERS DISTRIB, V12, P443, DOI 10.1111/j.1366-9516.2006.00265.x; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Whitney H.S., 1982, P183; WINGFIELD MJ, 1988, LEPTOGRAPHIUM ROOT D, P113; Wolfe BE, 2005, BIOSCIENCE, V55, P477, DOI 10.1641/0006-3568(2005)055[0477:BNGSCA]2.0.CO;2; Wood S. L., 1982, The bark and ambrosia beetles of North and Central America (Coleoptera : Scolytidae), a taxonomic monograph.; Yamaoka Yuichi, 2007, Mycoscience, V48, P100, DOI 10.1007/s10267-006-0337-1; Yan ZL, 2005, BIODIVERS CONSERV, V14, P1735, DOI 10.1007/s10531-004-0697-9; Zhou X.D., 2013, CBS KNAW FUNGAL BIOD, P91; Zhou XD, 2006, STUD MYCOL, P269, DOI 10.3114/sim.55.1.269; Zimmerman NB, 2012, P NATL ACAD SCI USA, V109, P13022, DOI 10.1073/pnas.1209872109; Zipfel RD, 2006, STUD MYCOL, P75, DOI 10.3114/sim.55.1.75	94	47	47	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78126	10.1371/journal.pone.0078126	http://dx.doi.org/10.1371/journal.pone.0078126			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205124	gold, Green Submitted, Green Published			2022-12-27	WOS:000326029300142
J	Takahashi, T; Kawakami, T; Mizuno, T; Minami, A; Uchida, Y; Saito, T; Matsui, S; Ogata, M; Usui, T; Sriwilaijaroen, N; Hiramatsu, H; Suzuki, Y; Suzuki, T				Takahashi, Tadanobu; Kawakami, Tatsuya; Mizuno, Takashi; Minami, Akira; Uchida, Yuko; Saito, Takehiko; Matsui, Shigeyuki; Ogata, Makoto; Usui, Taichi; Sriwilaijaroen, Nongluk; Hiramatsu, Hiroaki; Suzuki, Yasuo; Suzuki, Takashi			Sensitive and Direct Detection of Receptor Binding Specificity of Highly Pathogenic Avian Influenza A Virus in Clinical Samples	PLOS ONE			English	Article							CHEMOENZYMATIC SYNTHESIS; HEMAGGLUTININ; TRANSMISSION; GALACTOSE; ASSAY	Influenza A virus (IAV) recognizes two types of N-acetylneuraminic acid (Neu5Ac) by galactose (Gal) linkages, Neu5Ac alpha 2,3Gal and Neu5Ac alpha 2,6Gal. Avian IAV preferentially binds to Neu5Ac alpha 2,3Gal linkage, while human IAV preferentially binds to Neu5Ac alpha 2,6Gal linkage, as a virus receptor. Shift in receptor binding specificity of avian IAV from Neu5Ac alpha 2,3Gal linkage to Neu5Ac alpha 2,6Gal linkage is generally believed to be a critical factor for its transmission ability among humans. Surveillance of this shift of highly pathogenic H5N1 avian IAV (HPAI) is thought to be a very important for prediction and prevention of a catastrophic pandemic of HPAI among humans. In this study, we demonstrated that receptor binding specificity of IAV bound to sialo-glycoconjugates was sensitively detected by quantifying the HA gene with real-time reverse-transcription-PCR. The new assay enabled direct detection of receptor binding specificity of HPAIs in chicken clinical samples including trachea and cloaca swabs in only less than 4 h.	[Takahashi, Tadanobu; Kawakami, Tatsuya; Mizuno, Takashi; Minami, Akira; Suzuki, Takashi] Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka 4228526, Japan; [Uchida, Yuko; Saito, Takehiko] Natl Agr & Food Res Org NARO, Viral Dis & Epidemiol Res Div, Natl Inst Anim Hlth, Tsukuba, Ibaraki, Japan; [Uchida, Yuko; Saito, Takehiko] ZDCC, Bangkok, Thailand; [Matsui, Shigeyuki] Shizuoka Prefectural Livestock Inst, Swine & Poultry Res Ctr, Shizuoka, Japan; [Ogata, Makoto] Fukushima Natl Coll Technol, Dept Chem & Biochem, Iwaki, Fukushima, Japan; [Ogata, Makoto; Usui, Taichi] Shizuoka Univ, Grad Sch Sci & Technol, Dept Biosci, Shizuoka, Japan; [Usui, Taichi] Shizuoka Univ, Fac Agr, Dept Appl Biol Chem, Shizuoka 4228529, Japan; [Sriwilaijaroen, Nongluk; Hiramatsu, Hiroaki; Suzuki, Yasuo] Chubu Univ, Coll Life & Hlth Sci, Kasugai, Aichi 487, Japan; [Sriwilaijaroen, Nongluk] Thammasat Univ, Fac Med, Pathum Thani, Thailand	University of Shizuoka; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Shizuoka University; Shizuoka University; Chubu University; Thammasat University	Suzuki, T (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka 4228526, Japan.	Suzukit@u-shizuoka-ken.ac.jp	Saito, Takehiko/AFM-3038-2022	Ogata, Makoto/0000-0002-8319-1265; Sriwilaijaroen, Nongluk/0000-0001-7351-6102; Yasuo, Suzuki/0000-0003-3518-5642	MEXT/JSPS KAKENHI Grant [23590549]; Ministry of Agriculture, Forestry and Fisheries; Grants-in-Aid for Scientific Research [23590549, 24790080] Funding Source: KAKEN	MEXT/JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Agriculture, Forestry and Fisheries(Ministry of Agriculture Forestry & Fisheries - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in part, by a MEXT/JSPS KAKENHI Grant (Number C; 23590549) and by a grant of Research and development projects for application in promoting new policy of Agriculture, Forestry and Fisheries from the Ministry of Agriculture, Forestry and Fisheries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; CARROLL SM, 1981, J BIOL CHEM, V256, P8357; Costa T, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-28; GAMBARYAN AS, 1992, J VIROL METHODS, V39, P111, DOI 10.1016/0166-0934(92)90130-6; Gambaryan AS, 1998, VIROLOGY, V247, P170, DOI 10.1006/viro.1998.9224; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hidari KIPJ, 2008, GLYCOBIOLOGY, V18, P779, DOI 10.1093/glycob/cwn067; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Ito T, 1997, J VIROL, V71, P3357, DOI 10.1128/JVI.71.4.3357-3362.1997; Ito T, 2000, J VIROL, V74, P9300, DOI 10.1128/JVI.74.19.9300-9305.2000; Ogata M, 2007, BIOORGAN MED CHEM, V15, P1383, DOI 10.1016/j.bmc.2006.11.006; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Suzuki T, 1997, FEBS LETT, V404, P192, DOI 10.1016/S0014-5793(97)00127-0; Suzuki Y, 2005, BIOL PHARM BULL, V28, P399, DOI 10.1248/bpb.28.399; SUZUKI Y, 1992, VIROLOGY, V189, P121, DOI 10.1016/0042-6822(92)90687-K; Takahashi T, 2008, BIOCHEM BIOPH RES CO, V368, P550, DOI 10.1016/j.bbrc.2008.01.145; Takahashi T, 2012, FEBS OPEN BIO, V2, P261, DOI 10.1016/j.fob.2012.08.007; Takahashi T, 2009, FEBS LETT, V583, P3171, DOI 10.1016/j.febslet.2009.08.037; Takemae N, 2010, J GEN VIROL, V91, P938, DOI 10.1099/vir.0.016691-0; Uchida Y, 2012, VIRUS RES, V170, P109, DOI 10.1016/j.virusres.2012.09.004; Walther T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003223; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264	24	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78125	10.1371/journal.pone.0078125	http://dx.doi.org/10.1371/journal.pone.0078125			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205123	Green Published, Green Submitted, gold			2022-12-27	WOS:000326029300141
J	Chan, JK; Bhattacharyya, D; Lassen, KG; Ruelas, D; Greene, WC				Chan, Jonathan K.; Bhattacharyya, Darshana; Lassen, Kara G.; Ruelas, Debbie; Greene, Warner C.			Calcium/Calcineurin Synergizes with Prostratin to Promote NF-kappa B Dependent Activation of Latent HIV	PLOS ONE			English	Article							T-CELL-ACTIVATION; IMMUNODEFICIENCY-VIRUS TYPE-1; PROTEIN-KINASE-C; ANTIRETROVIRAL THERAPY; GENE-EXPRESSION; NUCLEAR-FACTOR; CALCINEURIN; INFECTION; REPLICATION; LYMPHOCYTES	Attempts to eradicate HIV have been thwarted by the persistence of a small pool of quiescent memory CD4 T cells that harbor a transcriptionally silent, integrated form of the virus that can produce infectious virions following an anamnestic immune response. Transcription factors downstream of T-cell receptor activation, such as NF-kappa B/Rel and nuclear factor of activated T cells (NFAT) transcription members, are considered important regulators of HIV transcription during acute HIV infection. We now report studies exploring their precise role as antagonists of HIV latency using cell and primary CD4 T cell models of HIV-1 latency. Surprisingly, RNA interference studies performed in J-Lat CD4 T cells suggested that none of the NFATs, including NFATc1, NFATc2, NFATc3, and NFAT5, played a key role in the reactivation of latent HIV. However, cyclosporin A markedly inhibited the reactivation response. These results were reconciled when calcium signaling through calcineurin was shown to potentiate prostratin induced activation of NF-kappa B that in turn stimulated the latent HIV long terminal repeat (LTR). Similar effects of calcineurin were confirmed in a primary CD4 T cell model of HIV latency. These findings highlight an important role for calcineurin in NF-kappa B-dependent induction of latent HIV transcription. Innovative approaches exploiting the synergistic actions of calcineurin and prostratin in the absence of generalized T-cell activation merit exploration as a means to attack the latent viral reservoir.	[Chan, Jonathan K.; Bhattacharyya, Darshana; Lassen, Kara G.; Ruelas, Debbie; Greene, Warner C.] Gladstone Inst Virol & Immunol, San Francisco, CA USA; [Greene, Warner C.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Greene, Warner C.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Greene, WC (corresponding author), Gladstone Inst Virol & Immunol, San Francisco, CA USA.	wgreene@gladstone.ucsf.edu			National Institutes of Health [P01 AI058708, P01 AI083050, P01 HD40543, R01 A065329, R01 MH064396, R21 AI080409]; University of California San Francisco-Gladstone Institute of Virology and Immunology Center for AIDS [P30 AI027763]; Arthritis Foundation [2PD-CHA-JO-A-8]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD040543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060537, P30AI027763, R21AI080409, P01AI083050, P01AI058708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Francisco-Gladstone Institute of Virology and Immunology Center for AIDS; Arthritis Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health grants P01 AI058708, P01 AI083050. P01 HD40543, R01 A065329, R01 MH064396, and R21 AI080409 and by University of California San Francisco-Gladstone Institute of Virology and Immunology Center for AIDS Research grant P30 AI027763. Jonathan Chan was supported by an Arthritis Foundation Postdoctoral Fellowship (2PD-CHA-JO-A-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosque A, 2009, BLOOD, V113, P58, DOI 10.1182/blood-2008-07-168393; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Burnett JC, 2010, J VIROL, V84, P5958, DOI 10.1128/JVI.00161-10; Burnett JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000260; Chan JKL, 2011, CURR OPIN HIV AIDS, V6, P12, DOI 10.1097/COH.0b013e32834124fd; Cron RQ, 2000, CLIN IMMUNOL, V94, P179, DOI 10.1006/clim.1999.4831; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; Fenard D, 2005, J IMMUNOL, V175, P6050, DOI 10.4049/jimmunol.175.9.6050; FRANTZ B, 1994, EMBO J, V13, P861, DOI 10.1002/j.1460-2075.1994.tb06329.x; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Kanno T, 1996, J IMMUNOL, V157, P5277; Kinoshita S, 1997, IMMUNITY, V6, P235, DOI 10.1016/S1074-7613(00)80326-X; Kinoshita S, 1998, CELL, V95, P595, DOI 10.1016/S0092-8674(00)81630-X; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Lassen KG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030176; Liszewski MK, 2009, METHODS, V47, P254, DOI 10.1016/j.ymeth.2009.01.002; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Oruganti SR, 2011, MOL IMMUNOL, V48, P1448, DOI 10.1016/j.molimm.2011.03.020; Palkowitsch L, 2011, J BIOL CHEM, V286, P7522, DOI 10.1074/jbc.M110.155895; PERKINS ND, 1994, MOL CELL BIOL, V14, P6570, DOI 10.1128/MCB.14.10.6570; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; Prins JM, 1999, AIDS, V13, P2405, DOI 10.1097/00002030-199912030-00012; Ranjbar S, 2006, PLOS PATHOG, V2, P1176, DOI 10.1371/journal.ppat.0020130; Reuse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006093; Sakane N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002184; Stellbrink HJ, 2002, AIDS, V16, P1479, DOI 10.1097/00002030-200207260-00004; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Swiggard WJ, 2005, J VIROL, V79, P14179, DOI 10.1128/JVI.79.22.14179-14188.2005; Trama J, 2000, J IMMUNOL, V165, P4884, DOI 10.4049/jimmunol.165.9.4884; Trushin SA, 2003, MOL CELL BIOL, V23, P7068, DOI 10.1128/MCB.23.19.7068-7081.2003; Trushin SA, 1999, J BIOL CHEM, V274, P22923, DOI 10.1074/jbc.274.33.22923; Tyagi M, 2010, J VIROL, V84, P6425, DOI 10.1128/JVI.01519-09; Wender PA, 2008, SCIENCE, V320, P649, DOI 10.1126/science.1154690; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; Williams SA, 2007, J VIROL, V81, P6043, DOI 10.1128/JVI.02074-06; Yang HC, 2009, J CLIN INVEST, V119, P3473, DOI 10.1172/JCI39199; Yang HC, 2009, P NATL ACAD SCI USA, V106, P6321, DOI 10.1073/pnas.0809536106; Zhang MC, 2012, J IMMUNOL, V189, P2746, DOI 10.4049/jimmunol.1103129; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	41	39	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77749	10.1371/journal.pone.0077749	http://dx.doi.org/10.1371/journal.pone.0077749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204950	Green Published, Green Submitted, gold			2022-12-27	WOS:000326334500054
J	Reinhard, F; van der Meer, JR				Reinhard, Friedrich; van der Meer, Jan Roelof			Improved Statistical Analysis of Low Abundance Phenomena in Bimodal Bacterial Populations	PLOS ONE			English	Article							GENE-EXPRESSION PATTERNS; SINGLE-CELL ANALYSIS; CLC GENOMIC ISLAND; BACILLUS-SUBTILIS; HETEROGENEITY; SPORULATION; ELEMENT; BISTABILITY; COLI; INDIVIDUALITY	Accurate detection of subpopulation size determinations in bimodal populations remains problematic yet it represents a powerful way by which cellular heterogeneity under different environmental conditions can be compared. So far, most studies have relied on qualitative descriptions of population distribution patterns, on population-independent descriptors, or on arbitrary placement of thresholds distinguishing biological ON from OFF states. We found that all these methods fall short of accurately describing small population sizes in bimodal populations. Here we propose a simple, statistics-based method for the analysis of small subpopulation sizes for use in the free software environment R and test this method on real as well as simulated data. Four so-called population splitting methods were designed with different algorithms that can estimate subpopulation sizes from bimodal populations. All four methods proved more precise than previously used methods when analyzing subpopulation sizes of transfer competent cells arising in populations of the bacterium Pseudomonas knackmussii B13. The methods' resolving powers were further explored by bootstrapping and simulations. Two of the methods were not severely limited by the proportions of subpopulations they could estimate correctly, but the two others only allowed accurate subpopulation quantification when this amounted to less than 25% of the total population. In contrast, only one method was still sufficiently accurate with subpopulations smaller than 1% of the total population. This study proposes a number of rational approximations to quantifying small subpopulations and offers an easy-to-use protocol for their implementation in the open source statistical software environment R.	[Reinhard, Friedrich; van der Meer, Jan Roelof] Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland	University of Lausanne	van der Meer, JR (corresponding author), Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland.	janroelof.vandermeer@unil.ch	van der Meer, Jan Roelof/G-6610-2012	van der Meer, Jan Roelof/0000-0003-1485-3082	Swiss National Science Foundation [3100A0-108199/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation under contract: 3100A0-108199/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anetzberger C, 2009, MOL MICROBIOL, V73, P267, DOI 10.1111/j.1365-2958.2009.06768.x; Avery SV, 2006, NAT REV MICROBIOL, V4, P577, DOI 10.1038/nrmicro1460; Balaban NQ, 2011, CURR OPIN GENET DEV, V21, P768, DOI 10.1016/j.gde.2011.10.001; Bates D, 2005, CELL, V121, P899, DOI 10.1016/j.cell.2005.04.013; Bates D, 2005, MOL MICROBIOL, V57, P380, DOI 10.1111/j.1365-2958.2005.04693.x; Bonifield HR, 2003, J BACTERIOL, V185, P3567, DOI 10.1128/JB.185.12.3567-3574.2003; Button DK, 2001, APPL ENVIRON MICROB, V67, P1636, DOI 10.1128/AEM.67.4.1636-1645.2001; Canty A, 2009, BOOT BOOTSTRAP R S P; Chai YR, 2008, MOL MICROBIOL, V67, P254, DOI 10.1111/j.1365-2958.2007.06040.x; Chastanet A, 2010, P NATL ACAD SCI USA, V107, P8486, DOI 10.1073/pnas.1002499107; Choonpradub C., 2005, SONGKLANAKARIN J SCI, V27, P649; Cleveland WS, 1994, ELEMENTS GRAPHING DA; Cozy LM, 2010, MOL MICROBIOL, V76, P273, DOI 10.1111/j.1365-2958.2010.07112.x; Davidson CJ, 2008, ANNU REV GENET, V42, P253, DOI 10.1146/annurev.genet.42.110807.091601; Davison AC, 1997, BOOTSTRAP METHODS TH; de Jong IG, 2012, ENVIRON MICROBIOL, V14, P3110, DOI 10.1111/j.1462-2920.2012.02892.x; de Jong IG, 2011, JOVE-J VIS EXP, DOI 10.3791/3145; de Jong IG, 2010, J BACTERIOL, V192, P2053, DOI 10.1128/JB.01484-09; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; FRIGGE M, 1989, AM STAT, V43, P50, DOI 10.2307/2685173; Gaillard M, 2006, J BACTERIOL, V188, P1999, DOI 10.1128/JB.188.5.1999-2013.2006; Gaillard M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-153; Gerhardt P, 1981, MANUAL METHODS GEN B; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; Kearns DB, 2005, GENE DEV, V19, P3083, DOI 10.1101/gad.1373905; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; Leveau JHJ, 2001, J BACTERIOL, V183, P6752, DOI 10.1128/JB.183.23.6752-6762.2001; Lidstrom ME, 2010, NAT CHEM BIOL, V6, P705, DOI [10.1038/nchembio.436, 10.1038/NCHEMBIO.436]; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; Lopez D, 2009, MOL MICROBIOL, V74, P609, DOI 10.1111/j.1365-2958.2009.06882.x; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; MacArthur BD, 2006, J R SOC INTERFACE, V3, P63, DOI 10.1098/rsif.2005.0080; Minoia M, 2008, P NATL ACAD SCI USA, V105, P20792, DOI 10.1073/pnas.0806164106; Miyazaki R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002818; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Ptashne M, 2006, CURR BIOL, V16, pR459, DOI 10.1016/j.cub.2006.05.037; R Development Core Team R, 2009, R LANG ENV STAT COMP; Ravatn R, 1998, J BACTERIOL, V180, P4360, DOI 10.1128/JB.180.17.4360-4369.1998; Ravatn R, 1998, J BACTERIOL, V180, P5505, DOI 10.1128/JB.180.21.5505-5514.1998; Reinhard F, 2013, CURR BIOL, V23, P255, DOI 10.1016/j.cub.2012.12.025; Remus-Emsermann MNP, 2010, ISME J, V4, P215, DOI 10.1038/ismej.2009.110; Sarkar D., 2009, LATTICE LATTICE GRAP; Sentchilo V, 2003, J BACTERIOL, V185, P4530, DOI 10.1128/JB.185.15.4530-4538.2003; Sentchilo V, 2003, MOL MICROBIOL, V49, P93, DOI 10.1046/j.1365-2958.2003.03548.x; Siegele DA, 1997, P NATL ACAD SCI USA, V94, P8168, DOI 10.1073/pnas.94.15.8168; Silander OK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002443; Smits WK, 2005, MOL MICROBIOL, V56, P604, DOI 10.1111/j.1365-2958.2005.04488.x; Strovas TJ, 2007, J BACTERIOL, V189, P7127, DOI 10.1128/JB.00746-07; Strovas TJ, 2009, MICROBIOL-SGM, V155, P2040, DOI 10.1099/mic.0.025890-0; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tecon R, 2006, ENVIRON MICROBIOL, V8, P697, DOI 10.1111/j.1462-2920.2005.00948.x; Tecon R, 2012, ENVIRON MICROBIOL, V14, P1325, DOI 10.1111/j.1462-2920.2012.02715.x; Tukey JW, 1977, EXPLORATORY DATA ANA; van der Woude MW, 2011, CURR OPIN MICROBIOL, V14, P205, DOI 10.1016/j.mib.2011.01.002; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; Veening JW, 2006, J APPL MICROBIOL, V101, P531, DOI 10.1111/j.1365-2672.2006.02911.x; Veening JW, 2008, P NATL ACAD SCI USA, V105, P4393, DOI 10.1073/pnas.0700463105; Veening JW, 2005, MOL MICROBIOL, V56, P1481, DOI 10.1111/j.1365-2958.2005.04659.x; Vlamakis H, 2008, GENE DEV, V22, P945, DOI 10.1101/gad.1645008; Wang P, 2010, CURR BIOL, V20, P1099, DOI 10.1016/j.cub.2010.04.045	61	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78288	10.1371/journal.pone.0078288	http://dx.doi.org/10.1371/journal.pone.0078288			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205184	gold, Green Published, Green Submitted			2022-12-27	WOS:000326334500109
J	Toychiev, AH; Yee, CW; Sagdullaev, BT				Toychiev, Abduqodir H.; Yee, Christopher W.; Sagdullaev, Botir T.			Correlated Spontaneous Activity Persists in Adult Retina and Is Suppressed by Inhibitory Inputs	PLOS ONE			English	Article							PATTERNED SPONTANEOUS ACTIVITY; DEVELOPING MAMMALIAN RETINA; EYE-SPECIFIC SEGREGATION; TIGER SALAMANDER RETINA; GANGLION-CELLS; BIPOLAR CELLS; AMACRINE CELLS; MOUSE RETINA; DEVELOPMENTAL-CHANGES; ACTION-POTENTIALS	Spontaneous rhythmic activity is a hallmark feature of the developing retina, where propagating retinal waves instruct axonal targeting and synapse formation. Retinal waves cease around the time of eye-opening; however, the fate of the underlying synaptic circuitry is unknown. Whether retinal waves are unique to the developing retina or if they can be induced in adulthood is not known. Combining patch-clamp techniques with calcium imaging, we demonstrate that propagative events persist in adult mouse retina when it is deprived of inhibitory input. This activity originates in bipolar cells, resembling glutamatergic stage III retinal waves. We find that, as it develops, the network interactions progressively curtail this activity. Together, this provides evidence that the correlated propagative neuronal activity can be induced in adult retina following the blockade of inhibitory interactions.	[Toychiev, Abduqodir H.; Yee, Christopher W.; Sagdullaev, Botir T.] Cornell Univ, Dept Neurol, Weill Med Coll, New York, NY 10021 USA; [Toychiev, Abduqodir H.; Yee, Christopher W.; Sagdullaev, Botir T.] Cornell Univ, Dept Ophthalmol, Weill Med Coll, New York, NY 10021 USA	Cornell University; Cornell University	Sagdullaev, BT (corresponding author), Cornell Univ, Dept Neurol, Weill Med Coll, New York, NY 10021 USA.	bos2005@med.cornell.edu			NIH [R01-EY020535]; NATIONAL EYE INSTITUTE [R01EY020535] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH grant R01-EY020535 (B. T. S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akrouh A, 2013, INTERSECTING CIRCUIT; Bansal A, 2000, J NEUROSCI, V20, P7672; Barkis WB, 2010, P NATL ACAD SCI USA, V107, P22302, DOI 10.1073/pnas.1008775108; Blankenship AG, 2011, J NEUROSCI, V31, P9998, DOI 10.1523/JNEUROSCI.5640-10.2011; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; Blankenship AG, 2009, NEURON, V62, P230, DOI 10.1016/j.neuron.2009.03.015; Bloomfield SA, 2009, NAT REV NEUROSCI, V10, P495, DOI 10.1038/nrn2636; BOOS R, 1993, J NEUROSCI, V13, P2874; Borowska J, 2011, J NEUROSCI, V31, P5000, DOI 10.1523/JNEUROSCI.5800-10.2011; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; Burrone J, 1997, J PHYSIOL-LONDON, V505, P571, DOI 10.1111/j.1469-7793.1997.571ba.x; Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; Chen S, 2002, J NEUROSCI, V22, P2165, DOI 10.1523/JNEUROSCI.22-06-02165.2002; Demas J, 2003, J NEUROSCI, V23, P2851; Demas J, 2006, NEURON, V50, P247, DOI 10.1016/j.neuron.2006.03.033; Demb JB, 1999, J NEUROSCI, V19, P9756; DeVries SH, 1999, J NEUROPHYSIOL, V81, P908, DOI 10.1152/jn.1999.81.2.908; Dong CJ, 1998, J NEUROPHYSIOL, V79, P2171, DOI 10.1152/jn.1998.79.4.2171; Eggers ED, 2006, J NEUROSCI, V26, P9413, DOI 10.1523/JNEUROSCI.2591-06.2006; Eggers ED, 2011, VISUAL NEUROSCI, V28, P95, DOI 10.1017/S0952523810000209; Eglen SJ, 2003, NEURON, V40, P1053, DOI 10.1016/S0896-6273(03)00808-0; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Fischer KF, 1998, J NEUROSCI, V18, P3767; GRUN G, 1982, PROG NEUROBIOL, V18, P257, DOI 10.1016/0301-0082(82)90012-0; Haverkamp S, 2004, J COMP NEUROL, V468, P251, DOI 10.1002/cne.10962; Hennig MH, 2011, J NEUROSCI, V31, P12159, DOI 10.1523/JNEUROSCI.3112-11.2011; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Ichinose T, 2007, J NEUROSCI, V27, P4756, DOI 10.1523/JNEUROSCI.0183-07.2007; Johnson J, 2004, J COMP NEUROL, V477, P386, DOI 10.1002/cne.20250; Kerschensteiner D, 2008, NEURON, V58, P851, DOI 10.1016/j.neuron.2008.04.025; LUKASIEWICZ PD, 1990, J NEUROSCI, V10, P210; Lukasiewicz PD, 1998, J NEUROPHYSIOL, V79, P3157, DOI 10.1152/jn.1998.79.6.3157; Ma YP, 2003, VISUAL NEUROSCI, V20, P131, DOI 10.1017/s0952523803202042; Margolis DJ, 2008, J NEUROSCI, V28, P6526, DOI 10.1523/JNEUROSCI.1533-08.2008; MASTRONARDE DN, 1989, TRENDS NEUROSCI, V12, P75, DOI 10.1016/0166-2236(89)90140-9; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Miller ED, 1999, VISUAL NEUROSCI, V16, P1133, DOI 10.1017/S0952523899166136; Murphy GJ, 2008, NAT NEUROSCI, V11, P318, DOI 10.1038/nn2045; Murphy GJ, 2006, NEURON, V52, P511, DOI 10.1016/j.neuron.2006.09.014; Myhr KL, 2001, J NEUROSCI, V21, P8664, DOI 10.1523/JNEUROSCI.21-21-08664.2001; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Pan F, 2007, VISUAL NEUROSCI, V24, P609, DOI 10.1017/S0952523807070472; Pan ZH, 2001, NEURON, V32, P89, DOI 10.1016/S0896-6273(01)00454-8; Petit-Jacques J, 2008, J NEUROPHYSIOL, V100, P993, DOI 10.1152/jn.01399.2007; Protti DA, 2000, NEURON, V25, P215, DOI 10.1016/S0896-6273(00)80884-3; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Sagdullaev BT, 2006, NEURON, V50, P923, DOI 10.1016/j.neuron.2006.05.015; Sagdullaev BT, 2011, J NEUROSCI, V31, P15102, DOI 10.1523/JNEUROSCI.1801-11.2011; Sampath AP, 2004, NEURON, V41, P431, DOI 10.1016/S0896-6273(04)00005-4; Sernagor E, 2003, J NEUROSCI, V23, P7621; Singer JH, 2001, J NEUROSCI, V21, P8514, DOI 10.1523/JNEUROSCI.21-21-08514.2001; Stacy RC, 2005, J NEUROSCI, V25, P9347, DOI 10.1523/JNEUROSCI.1800-05.2005; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Syed MM, 2004, J PHYSIOL-LONDON, V560, P533, DOI 10.1113/jphysiol.2004.066597; Torborg C, 2004, VISION RES, V44, P3347, DOI 10.1016/j.visres.2004.08.015; Torborg CL, 2005, NAT NEUROSCI, V8, P72, DOI 10.1038/nn1376; Toychiev AH, 2013, J NEUROSCI METH, V214, P105, DOI 10.1016/j.jneumeth.2013.01.016; Vardi N, 2000, J NEUROSCI, V20, P7657; Volgyi Zoltan, 2009, Orvosi Hetilap, V150, P2313, DOI 10.1556/OH.2009.28767; Wang CT, 2007, J NEUROSCI, V27, P9130, DOI 10.1523/JNEUROSCI.1293-07.2007; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Wong ROL, 1996, NEURON, V16, P1087, DOI 10.1016/S0896-6273(00)80135-X; Wong WT, 2000, J NEUROSCI, V20, P351, DOI 10.1523/JNEUROSCI.20-01-00351.2000; Xu HP, 2011, NEURON, V70, P1115, DOI 10.1016/j.neuron.2011.04.028; Yee CW, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00008; Zenisek D, 1998, VISUAL NEUROSCI, V15, P69, DOI 10.1017/S0952523898151064; Zhang LL, 2006, J COMP NEUROL, V499, P132, DOI 10.1002/cne.21100; Zhou ZJ, 2001, J NEUROSCI, V21, P5158, DOI 10.1523/JNEUROSCI.21-14-05158.2001; Zhou ZJ, 2000, J NEUROSCI, V20, P6570, DOI 10.1523/JNEUROSCI.20-17-06570.2000	72	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77658	10.1371/journal.pone.0077658	http://dx.doi.org/10.1371/journal.pone.0077658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204906	Green Submitted, Green Published, gold			2022-12-27	WOS:000326270700046
J	Greiner, AM; Chen, H; Spatz, JP; Kemkemer, R				Greiner, Alexandra M.; Chen, Hao; Spatz, Joachim P.; Kemkemer, Ralf			Cyclic Tensile Strain Controls Cell Shape and Directs Actin Stress Fiber Formation and Focal Adhesion Alignment in Spreading Cells	PLOS ONE			English	Article							DYNAMIC REORIENTATION; TENSIONAL HOMEOSTASIS; MATRIX-RIGIDITY; FORCE; POLARIZATION; FIBROBLASTS; GEOMETRY; COMPLEX; MICROTUBULES; ORIENTATION	The actin cytoskeleton plays a crucial role for the spreading of cells, but is also a key element for the structural integrity and internal tension in cells. In fact, adhesive cells and their actin stress fiber-adhesion system show a remarkable reorganization and adaptation when subjected to external mechanical forces. Less is known about how mechanical forces alter the spreading of cells and the development of the actin-cell-matrix adhesion apparatus. We investigated these processes in fibroblasts, exposed to uniaxial cyclic tensile strain (CTS) and demonstrate that initial cell spreading is stretch-independent while it is directed by the mechanical signals in a later phase. The total temporal spreading characteristic was not changed and cell protrusions are initially formed uniformly around the cells. Analyzing the actin network, we observed that during the first phase the cells developed a circumferential arc-like actin network, not affected by the CTS. In the following orientation phase the cells elongated perpendicular to the stretch direction. This occurred simultaneously with the de novo formation of perpendicular mainly ventral actin stress fibers and concurrent realignment of cell-matrix adhesions during their maturation. The stretch-induced perpendicular cell elongation is microtubule-independent but myosin II-dependent. In summary, a CTS-induced cell orientation of spreading cells correlates temporary with the development of the actomyosin system as well as contact to the underlying substrate by cell-matrix adhesions.	[Greiner, Alexandra M.; Chen, Hao] Karlsruhe Inst Technol, Dept Cell & Neurobiol, D-76021 Karlsruhe, Germany; [Spatz, Joachim P.; Kemkemer, Ralf] Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Stuttgart, Germany; [Spatz, Joachim P.] Heidelberg Univ, Dept Biophys Chem, Heidelberg, Germany; [Kemkemer, Ralf] Reutlingen Univ, Dept Appl Chem, Reutlingen, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Max Planck Society; Ruprecht Karls University Heidelberg	Kemkemer, R (corresponding author), Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Stuttgart, Germany.	ralf.kemkemer@is.mpg.de	Spatz, Joachim P/A-1107-2017; Greiner, Alexandra/G-1404-2013	Spatz, Joachim P/0000-0003-3419-9807; 	FHG-MPG (Fraunhofer-Gesellschaft and Max-Planck-Gesellschaft) project "Biomimetic matrices"; Baden-Wurttemberg-Stiftung, Kompetenznetz "Funktionelle Nanostrukturen"; Max Planck Society	FHG-MPG (Fraunhofer-Gesellschaft and Max-Planck-Gesellschaft) project "Biomimetic matrices"; Baden-Wurttemberg-Stiftung, Kompetenznetz "Funktionelle Nanostrukturen"; Max Planck Society(Max Planck Society)	Parts of the study were funded by the FHG-MPG (Fraunhofer-Gesellschaft and Max-Planck-Gesellschaft) project "Biomimetic matrices" and the Baden-Wurttemberg-Stiftung, Kompetenznetz "Funktionelle Nanostrukturen". The support of the Max Planck Society is highly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed WW, 2010, BIOMATERIALS, V31, P250, DOI 10.1016/j.biomaterials.2009.09.047; Alenghat Francis J, 2002, Sci STKE, V2002, ppe6, DOI 10.1126/stke.2002.119.pe6; Aratyn-Schaus Y, 2010, CURR BIOL, V20, P1145, DOI 10.1016/j.cub.2010.05.049; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Betapudi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008560; Brown RA, 1998, J CELL PHYSIOL, V175, P323, DOI 10.1002/(SICI)1097-4652(199806)175:3<323::AID-JCP10>3.0.CO;2-6; BUCK RC, 1980, EXP CELL RES, V127, P470, DOI 10.1016/0014-4827(80)90456-5; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; Cai YF, 2010, J CELL SCI, V123, P413, DOI 10.1242/jcs.058297; Cai YF, 2009, CURR OPIN CELL BIOL, V21, P47, DOI 10.1016/j.ceb.2009.01.020; Chen B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048346; Costa KD, 2002, CELL MOTIL CYTOSKEL, V52, P266, DOI 10.1002/cm.10056; Cuvelier D, 2007, CURR BIOL, V17, P694, DOI 10.1016/j.cub.2007.02.058; DARTSCH PC, 1986, ACTA ANAT, V125, P108; De R, 2008, BIOPHYS J, V94, pL29, DOI 10.1529/biophysj.107.126060; De R, 2007, NAT PHYS, V3, P655, DOI 10.1038/nphys680; Defilippi P, 1999, MICROSC RES TECHNIQ, V47, P67, DOI 10.1002/(SICI)1097-0029(19991001)47:1<67::AID-JEMT7>3.3.CO;2-G; Deibler M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022941; Dobereiner HG, 2005, J APPL PHYSIOL, V98, P1542, DOI 10.1152/japplphysiol.01181.2004; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Faust U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028963; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Goldyn AM, 2010, CYTOSKELETON, V67, P241, DOI 10.1002/cm.20439; Goldyn AM, 2009, J CELL SCI, V122, P3644, DOI 10.1242/jcs.054866; Hayakawa K, 2001, EXP CELL RES, V268, P104, DOI 10.1006/excr.2001.5270; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ingber DE, 2008, PROG BIOPHYS MOL BIO, V97, P163, DOI 10.1016/j.pbiomolbio.2008.02.005; Jungbauer S, 2008, BIOPHYS J, V95, P3470, DOI 10.1529/biophysj.107.128611; Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200; Kaunas R, 2005, P NATL ACAD SCI USA, V102, P15895, DOI 10.1073/pnas.0506041102; Kaunas R, 2011, CELL HEALTH CYTOSKEL, V3, P13, DOI 10.2147/CHC.S14984; Kaverina I, 2002, J CELL SCI, V115, P2283; Kurpinski K, 2006, P NATL ACAD SCI USA, V103, P16095, DOI 10.1073/pnas.0604182103; Lee CF, 2010, BIOCHEM BIOPH RES CO, V401, P344, DOI 10.1016/j.bbrc.2010.09.046; Lehnert D, 2004, J CELL SCI, V117, P41, DOI 10.1242/jcs.00836; McCaig CD, 1997, BIOESSAYS, V19, P819, DOI 10.1002/bies.950190912; Mizutani T, 2004, CELL MOTIL CYTOSKEL, V59, P242, DOI 10.1002/cm.20037; Neidlinger-Wilke C, 2001, J ORTHOP RES, V19, P286, DOI 10.1016/S0736-0266(00)00029-2; Oakes PW, 2012, J CELL BIOL, V196, P363, DOI 10.1083/jcb.201107042; Pierres A, 2008, BIOPHYS J, V94, P4114, DOI 10.1529/biophysj.107.125278; Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370; Puklin-Faucher E, 2009, J CELL SCI, V122, P179, DOI 10.1242/jcs.042127; Rehfeldt F, 2007, NAT PHYS, V3, P592, DOI 10.1038/nphys712; Schmoranzer J, 2003, J CELL SCI, V116, P4513, DOI 10.1242/jcs.00748; Suter DM, 1998, J CELL BIOL, V141, P227, DOI 10.1083/jcb.141.1.227; Thery M, 2006, CELL MOTIL CYTOSKEL, V63, P341, DOI 10.1002/cm.20126; Thery M, 2010, J CELL SCI, V123, P4201, DOI 10.1242/jcs.075150; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wehrle-Haller B, 2003, INT J BIOCHEM CELL B, V35, P39, DOI 10.1016/S1357-2725(02)00071-7; Wei ZS, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907745; Zemel A, 2010, NAT PHYS, V6, P468, DOI 10.1038/NPHYS1613; Zemel A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194110; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765; Zimerman B, 2004, CELL MOTIL CYTOSKEL, V58, P143, DOI 10.1002/cm.20005	56	67	67	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77328	10.1371/journal.pone.0077328	http://dx.doi.org/10.1371/journal.pone.0077328			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204809	Green Published, gold, Green Submitted			2022-12-27	WOS:000326241200024
J	Rinnerthaler, M; Lejskova, R; Grousl, T; Stradalova, V; Heeren, G; Richter, K; Breitenbach-Koller, L; Malinsky, J; Hasek, J; Breitenbach, M				Rinnerthaler, Mark; Lejskova, Renata; Grousl, Tomas; Stradalova, Vendula; Heeren, Gino; Richter, Klaus; Breitenbach-Koller, Lore; Malinsky, Jan; Hasek, Jiri; Breitenbach, Michael			Mmi1, the Yeast Homologue of Mammalian TCTP, Associates with Stress Granules in Heat-Shocked Cells and Modulates Proteasome Activity	PLOS ONE			English	Article							CONTROLLED TUMOR PROTEIN; SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; FORTILIN; IDENTIFICATION; MICROTUBULES; ORGANIZATION; EXPRESSION; MEMBRANE; REVEALS	As we have shown previously, yeast Mmi1 protein translocates from the cytoplasm to the outer surface of mitochondria when vegetatively growing yeast cells are exposed to oxidative stress. Here we analyzed the effect of heat stress on Mmi1 distribution. We performed domain analyses and found that binding of Mmi1 to mitochondria is mediated by its central alpha-helical domain (V-domain) under all conditions tested. In contrast, the isolated N-terminal flexible loop domain of the protein always displays nuclear localization. Using immunoelectron microscopy we confirmed re-location of Mmi1 to the nucleus and showed association of Mmi1 with intact and heat shock-altered mitochondria. We also show here that mmi1 Delta mutant strains are resistant to robust heat shock with respect to clonogenicity of the cells. To elucidate this phenotype we found that the cytosolic Mmi1 holoprotein re-localized to the nucleus even in cells heat-shocked at 40 degrees C. Upon robust heat shock at 46 degrees C, Mmi1 partly co-localized with the proteasome marker Rpn1 in the nuclear region as well as with the cytoplasmic stress granules defined by Rpg1 (eIF3a). We co-localized Mmi1 also with Bre5, Ubp3 and Cdc48 which are involved in the protein de-ubiquitination machinery, protecting protein substrates from proteasomal degradation. A comparison of proteolytic activities of wild type and mmi1 Delta cells revealed that Mmi1 appears to be an inhibitor of the proteasome. We conclude that one of the physiological functions of the multifunctional protein module, Mmi1, is likely in regulating degradation and/or protection of proteins thereby indirectly regulating the pathways leading to cell death in stressed cells.	[Rinnerthaler, Mark; Heeren, Gino; Richter, Klaus; Breitenbach-Koller, Lore; Breitenbach, Michael] Salzburg Univ, Dept Cell Biol, Div Genet, A-5020 Salzburg, Austria; [Lejskova, Renata; Grousl, Tomas; Hasek, Jiri] AS CR, Lab Cell Reprod, Inst Microbiol, Vvi, Prague, Czech Republic; [Stradalova, Vendula; Malinsky, Jan] AS CR, Microscopy Unit, Inst Expt Med, Vvi, Prague, Czech Republic	Salzburg University; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences	Hasek, J (corresponding author), AS CR, Lab Cell Reprod, Inst Microbiol, Vvi, Prague, Czech Republic.	hasek@biomed.cas.cz; michael.breitenbach@sbg.ac.at	Stradalova, Vendula/H-2458-2014; Groušl, Tomáš/I-1727-2014; Lejskova, Renata/I-1669-2014; Malinsky, Jan/H-2484-2014; Groušl, Tomáš/AAF-3655-2019; Hasek, Jiri/H-2427-2014; Rinnerthaler, Mark/AAE-3645-2020	Groušl, Tomáš/0000-0002-6996-1323; Lejskova, Renata/0000-0002-5664-7837; Malinsky, Jan/0000-0002-1433-0989; Groušl, Tomáš/0000-0002-6996-1323; Hasek, Jiri/0000-0001-6634-2386; Rinnerthaler, Mark/0000-0003-1190-0584; Breitenbach-Koller, Hannelore/0000-0002-8387-6408	Czech Science Foundation, CSF [P305/12/0480]; grant OeAD Aktion CZ [11/2012]; FWF Austria [S9302-B05]; EC, Brussels [512020 MIMAGE]; CSF [P302/11/0146];  [7AMB12ATOO2];  [RVO61388971]	Czech Science Foundation, CSF; grant OeAD Aktion CZ; FWF Austria(Austrian Science Fund (FWF)); EC, Brussels(European CommissionEuropean Commission Joint Research Centre); CSF; ; 	This work was supported by the grants P305/12/0480 (Czech Science Foundation, CSF), 7AMB12ATOO2 and RVO61388971 (to JH), by grant OeAD Aktion CZ 11/2012 (to MR), by grants S9302-B05 (FWF Austria) and 512020 MIMAGE (EC, Brussels) (to MB) and by grant P302/11/0146 (CSF) (to JM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Arcuri F, 2004, PROSTATE, V60, P130, DOI 10.1002/pros.20054; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bommer UA, 2012, OPEN ALLERGY J, V5, P19, DOI DOI 10.2174/1874838401205010019; Brachmann CB, 1998, YEAST, V14, P115; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Cans C, 2003, P NATL ACAD SCI USA, V100, P13892, DOI 10.1073/pnas.2335950100; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Diraison F, 2011, DIABETOLOGIA, V54, P368, DOI 10.1007/s00125-010-1958-7; Du L, 2007, BIOCHEMISTRY-MOSCOW+, V72, P843, DOI 10.1134/S0006297907080056; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; Gachet Y, 1999, J CELL SCI, V112, P1257; Gnanasekar M, 2002, MOL BIOCHEM PARASIT, V121, P107, DOI 10.1016/S0166-6851(02)00027-0; Graidist P, 2007, BIOCHEM J, V408, P181, DOI 10.1042/BJ20070679; Grousl T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057083; Grousl T, 2009, J CELL SCI, V122, P2078, DOI 10.1242/jcs.045104; Guerrero C, 2008, P NATL ACAD SCI USA, V105, P13333, DOI 10.1073/pnas.0801870105; HAGHIGHAT NG, 1992, MOL BIOCHEM PARASIT, V51, P99, DOI 10.1016/0166-6851(92)90205-X; Hanna J, 2007, FEBS LETT, V581, P2854, DOI 10.1016/j.febslet.2007.03.053; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kaake RM, 2010, J PROTEOME RES, V9, P2016, DOI 10.1021/pr1000175; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Klinger H, 2010, EXP GERONTOL, V45, P533, DOI 10.1016/j.exger.2010.03.016; Laun P, 2001, MOL MICROBIOL, V39, P1166, DOI 10.1046/j.1365-2958.2001.02317.x; Lettner T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011993; Li F, 2001, J BIOL CHEM, V276, P47542, DOI 10.1074/jbc.M108954200; Liu H, 2005, MOL CELL BIOL, V25, P3117, DOI 10.1128/MCB.25.8.3117-3126.2005; Ma YP, 2012, BIOCH RES INT, V2012, P1; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; Managbanag JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003802; Ossareh-Nazari B, 2010, EMBO REP, V11, P548, DOI 10.1038/embor.2010.74; Rid R, 2010, J STEROID BIOCHEM, V118, P29, DOI 10.1016/j.jsbmb.2009.09.015; Riezman H, 2004, CELL CYCLE, V3, P61; Rinnerthaler M, 2006, BBA-BIOENERGETICS, V1757, P631, DOI 10.1016/j.bbabio.2006.05.022; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Rossanese OW, 1999, J CELL BIOL, V145, P69, DOI 10.1083/jcb.145.1.69; Roth V, 2006, NEURAL COMPUT, V18, P942, DOI 10.1162/089976606775774679; Rupec RA, 1998, ONCOL RES, V10, P69; Schmidt I, 2007, FEBS J, V274, P5416, DOI 10.1111/j.1742-4658.2007.06069.x; Shenton D, 2003, BIOCHEM J, V374, P513, DOI 10.1042/BJ20030414; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Susini L, 2008, CELL DEATH DIFFER, V15, P1211, DOI 10.1038/cdd.2008.18; Takahara T, 2012, CELL CYCLE, V11, P3707, DOI 10.4161/cc.22044; Takahashi T, 2010, J TOXICOL SCI, V35, P945, DOI 10.2131/jts.35.945; Thaw P, 2001, NAT STRUCT BIOL, V8, P701, DOI 10.1038/90415; THOMAS G, 1981, P NATL ACAD SCI-BIOL, V78, P5712, DOI 10.1073/pnas.78.9.5712; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Yan Y, 2005, J PROTEOME RES, V4, P2007, DOI 10.1021/pr050175d; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; Zhang D, 2002, J BIOL CHEM, V277, P37430, DOI 10.1074/jbc.M207413200	54	19	19	1	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77791	10.1371/journal.pone.0077791	http://dx.doi.org/10.1371/journal.pone.0077791			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204967	Green Published, Green Submitted, gold			2022-12-27	WOS:000326241200040
J	Hartling, L; Scott, SD; Johnson, DW; Bishop, T; Klassen, TP				Hartling, Lisa; Scott, Shannon D.; Johnson, David W.; Bishop, Ted; Klassen, Terry P.			A Randomized Controlled Trial of Storytelling as a Communication Tool	PLOS ONE			English	Article							NARRATIVE COMMUNICATION; POSTOPERATIVE ANXIETY; STATISTICAL EVIDENCE; PEDIATRIC PRACTICE; CANCER PREVENTION; YOUNG-CHILDREN; PARENTS; INFORMATION; HEALTH; CROUP	Introduction: Stories may be an effective tool to communicate with patients because of their ability to engage the reader. Our objective was to evaluate the effectiveness of story booklets compared to standard information sheets for parents of children attending the emergency department (ED) with a child with croup. Methods: Parents were randomized to receive story booklets (n=208) or standard information sheets (n=205) during their ED visit. The primary outcome was change in anxiety between triage to ED discharge as measured by the State-Trait Anxiety Inventory. Follow-up telephone interviews were conducted at 1 and 3 days after discharge, then every other day until 9 days (or until resolution of symptoms), and at 1 year. Secondary outcomes included: expected future anxiety, event impact, parental knowledge, satisfaction, decision regret, healthcare utilization, time to symptom resolution. Results: There was no significant difference in the primary outcome of change in parental anxiety between recruitment and ED discharge (change of 5 points for the story group vs. 6 points for the comparison group, p=0.78). The story group showed significantly greater decision regret regarding their decision to go to the ED (p<0.001): 6.7% of the story group vs. 1.5% of the comparison group strongly disagreed with the statement "I would go for the same choice if I had to do it over again". The story group reported shorter time to resolution of symptoms (mean 3.7 days story group vs. 4.0 days comparison group, median 3 days both groups; log rank test, p=0.04). No other outcomes were different between study groups. Conclusions: Stories about parent experiences managing a child with croup did not reduce parental anxiety. The story group showed significantly greater decision regret and quicker time to resolution of symptoms. Further research is needed to better understand whether stories can be effective in improving patient-important outcomes.	[Hartling, Lisa] Univ Alberta, Dept Pediat, Alberta Res Ctr Hlth Evidence, Edmonton, AB, Canada; [Scott, Shannon D.] Univ Alberta, Fac Nursing, Edmonton, AB, Canada; [Johnson, David W.] Univ Calgary, Dept Pediat, Calgary, AB T2N 1N4, Canada; [Johnson, David W.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Bishop, Ted] Univ Alberta, Dept English & Film Studies, Edmonton, AB, Canada; [Klassen, Terry P.] Manitoba Inst Child Hlth, Winnipeg, MB, Canada	University of Alberta; University of Alberta; University of Calgary; University of Calgary; University of Alberta	Hartling, L (corresponding author), Univ Alberta, Dept Pediat, Alberta Res Ctr Hlth Evidence, Edmonton, AB, Canada.	hartling@ualberta.ca		Klassen, Terry/0000-0002-5309-7091; Scott, Shannon D./0000-0002-2251-3742	Canadian Institutes of Health Research Team in Pediatric Emergency Medicine; Canadian Institutes of Health Research	Canadian Institutes of Health Research Team in Pediatric Emergency Medicine; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded in part by the Canadian Institutes of Health Research Team in Pediatric Emergency Medicine. Dr. Lisa Hartling and Dr. Shannon Scott hold New Investigator Salary Awards from the Canadian Institutes of Health Research. The funding agencies had no role in the design, collection, analysis or interpretation of data; report writing; or decision to submit the article for publication. No additional external funding was received for this study.	Abrahamson CE, 1998, EDUCATION, V18, P400; BAESLER EJ, 1994, COMMUN RES, V21, P582, DOI 10.1177/009365094021005002; Bergman P, 1999, Clin Excell Nurse Pract, V3, P154; Bjornson C, 2010, EVID BASED CHILD HLT, V5, P1555, DOI [10.1002/ebch.613, DOI 10.1002/EBCH.613]; Bjornson CL, 2004, NEW ENGL J MED, V351, P1306, DOI 10.1056/NEJMoa033534; Brehaut JC, 2003, MED DECIS MAKING, V23, P281, DOI 10.1177/0272989X03256005; Butow P, 1998, PATIENT EDUC COUNS, V33, P129, DOI 10.1016/S0738-3991(97)00071-2; Caumo W, 2000, ACTA ANAESTH SCAND, V44, P782, DOI 10.1034/j.1399-6576.2000.440703.x; Charon R, 2004, NEW ENGL J MED, V350, P862, DOI 10.1056/NEJMp038249; Charon R, 2000, ACAD MED, V75, P23, DOI 10.1097/00001888-200001000-00008; Chelf JH, 2000, CANCER NURS, V23, P1, DOI 10.1097/00002820-200002000-00001; Chung AD, 2009, CURR ONCOL, V16, P174; D'Angelo AF, 2001, ANN M APR 28 MAY 1; DENNY FW, 1983, PEDIATRICS, V71, P871; Elliott D, 1993, Intensive Crit Care Nurs, V9, P195, DOI 10.1016/0964-3397(93)90027-U; Felder-Puiga R, 2003, INT J PEDIATR OTORHI, V67, P35, DOI 10.1016/S0165-5876(02)00359-2; Funakosi S, 2005, J PEDIATR SURG, V40, P1156, DOI 10.1016/j.jpedsurg.2005.03.059; Galloway S, 1997, J ADV NURS, V25, P1175, DOI 10.1046/j.1365-2648.1997.19970251175.x; Green MC, 2006, J COMMUN, V56, pS163, DOI 10.1111/j.1460-2466.2006.00288.x; Hahn Seokyung, 2005, BMC Med Res Methodol, V5, P10, DOI 10.1186/1471-2288-5-10; HANSEN BL, 1995, PATIENT EDUC COUNS, V25, P137, DOI 10.1016/0738-3991(95)00714-B; Hartling L, 2010, THESIS U ALBERTA CAN; Hartling L, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-64; HATCHER JW, 1989, J PEDIATR PSYCHOL, V14, P335, DOI 10.1093/jpepsy/14.3.335; HENRICKSON KJ, 1994, CLIN INFECT DIS, V18, P770, DOI 10.1093/clinids/18.5.770; Hinyard LJ, 2007, HEALTH EDUC BEHAV, V34, P777, DOI 10.1177/1090198106291963; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Humphris GM, 2006, BRIT DENT J, V201, P33, DOI 10.1038/sj.bdj.4813772; ISAACMAN DJ, 1992, PEDIATRICS, V89, P1204; Johnson DW, 2003, PEDIATR RES, V53, p185A; Karanci AN, 2003, J PSYCHOSOM RES, V55, P363, DOI 10.1016/S0022-3999(02)00631-1; Kirkpatrick M K, 1997, Nurse Educ, V22, P38, DOI 10.1097/00006223-199703000-00016; Kreuter MW, 2007, ANN BEHAV MED, V33, P221, DOI 10.1007/BF02879904; LAINE L, 1989, AM J DIS CHILD, V143, P374, DOI 10.1001/archpedi.1989.02150150136033; Larkey LK, 2007, PATIENT EDUC COUNS, V67, P272, DOI 10.1016/j.pec.2007.04.003; Leoutsakas D, 1996, AIDS EDUC PREV, V8, P375; Lindesmith K A, 1994, J Contin Educ Nurs, V25, P186; Mazor KM, 2007, PATIENT EDUC COUNS, V69, P145, DOI 10.1016/j.pec.2007.08.010; MCCONNOCHIE KM, 1988, AM J PUBLIC HEALTH, V78, P34, DOI 10.2105/AJPH.78.1.34; Melnyk BM, 2004, PEDIATRICS, V113, pE597, DOI 10.1542/peds.113.6.e597; Noell J, 1997, HEALTH EDUC BEHAV, V24, P87, DOI 10.1177/109019819702400109; Parkinson GW, 1999, CLIN PEDIATR, V38, P219, DOI 10.1177/000992289903800403; Pelusi J, 2005, J CANCER EDUC, V20, P12, DOI 10.1207/s15430154jce2001s_04; Petraglia J, 2007, J HEALTH COMMUN, V12, P493, DOI 10.1080/10810730701441371; Rossiter M., 2002, NARRATIVE STORIES AD; Scott S.D., 2012, ARTS HEALTH, V4, P162, DOI [10.1080/17533015.2012.65620, DOI 10.1080/17533015.2012.65620, DOI 10.1080/17533015.2012.656203]; Shapiro J, 2002, FAM MED, V34, P96; Slater MD, 2003, J NUTR EDUC BEHAV, V35, P255, DOI 10.1016/S1499-4046(06)60056-0; Smith D, 2003, DIAGNOSIS GOES LOW T; Smyth JM, 1999, JAMA-J AM MED ASSOC, V281, P1304, DOI 10.1001/jama.281.14.1304; Spielberger CD., 1984, STATE TRAIT ANXIETY; Werle Gretchen D, 2004, J Sch Nurs, V20, P81; WESTLEY CR, 1978, AM J DIS CHILD, V132, P484, DOI 10.1001/archpedi.1978.02120300044008; ZIMMERMAN LM, 1988, HEART LUNG, V17, P560	54	13	13	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77800	10.1371/journal.pone.0077800	http://dx.doi.org/10.1371/journal.pone.0077800			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	241GW	24204974	gold, Green Published, Green Submitted			2022-12-27	WOS:000326155400057
J	Ibragimova, I; Slifker, MJ; Maradeo, ME; Banumathy, G; Dulaimi, E; Uzzo, RG; Cairns, P				Ibragimova, Ilsiya; Slifker, Michael J.; Maradeo, Marie E.; Banumathy, Gowrishankar; Dulaimi, Essel; Uzzo, Robert G.; Cairns, Paul			Genome-Wide Promoter Methylome of Small Renal Masses	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; TUMOR-SUPPRESSOR GENES; DNA METHYLATION; KIDNEY CANCER; HYPERMETHYLATION PROFILE; PARTIAL NEPHRECTOMY; CELL SIGNATURE; X-INACTIVATION; CPG-ISLANDS; EPIGENETICS	The majority of renal cell carcinoma (RCC) is now incidentally detected and presents as small renal masses (SRMs) defined as <= 4 cm in size. SRMs are heterogeneous comprising several histological types of RCC each with different biology and behavior, and benign tumors mainly oncocytoma. The varied prognosis of the different types of renal tumor has implications for management options. A key epigenetic alteration involved in the initiation and progression of cancer is aberrant methylation in the promoter region of a gene. The hypermethylation is associated with transcriptional repression and is an important mechanism of inactivation of tumor suppressor genes in neoplastic cells. We have determined the genome-wide promoter methylation profiles of 47 pT1a and 2 pT1b clear cell, papillary or chromophobe RCC, 25 benign renal oncocytoma <= 4 cm and 4 normal renal parenchyma specimens by Infinium HumanMethylation27 beadchip technology. We identify gene promoter hypermethylation signatures that distinguish clear cell and papillary from each other, from chromophobe and oncocytoma, and from normal renal cells. Pairwise comparisons revealed genes aberrantly hypermethylated in a tumor type but unmethylated in normal, and often unmethylated in the other renal tumor types. About 0.4% to 1.7% of genes comprised the promoter methylome in SRMs. The Infinium methylation score for representative genes was verified by gold standard technologies. The genes identified as differentially methylated implicate pathways involved in metabolism, tissue response to injury, epithelial to mesenchymal transition (EMT), signal transduction and G-protein coupled receptors (GPCRs), cancer, and stem cell regulation in the biology of RCC. Our findings contribute towards an improved understanding of the development of RCC, the different biology and behavior of histological types, and discovery of molecular subtypes. The differential methylation signatures may have utility in early detection and particularly differential diagnosis for prognostic stratification as well as identify novel gene and pathway targets for therapeutic intervention.	[Ibragimova, Ilsiya; Maradeo, Marie E.; Banumathy, Gowrishankar; Cairns, Paul] Fox Chase Canc Ctr, Canc Epigenet Program, Philadelphia, PA 19111 USA; [Ibragimova, Ilsiya; Maradeo, Marie E.; Banumathy, Gowrishankar; Dulaimi, Essel; Uzzo, Robert G.; Cairns, Paul] Fox Chase Canc Ctr, Kidney Keystone Program, Philadelphia, PA 19111 USA; [Slifker, Michael J.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Dulaimi, Essel] Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA; [Uzzo, Robert G.] Fox Chase Canc Ctr, Dept Surg, Philadelphia, PA 19111 USA	Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center	Cairns, P (corresponding author), Fox Chase Canc Ctr, Canc Epigenet Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	Paul.Cairns@fccc.edu	Uzzo, Robert G./U-5238-2019		EDRN [3U01CA111242-05]; National Cancer Institute [P30 CA006927]; Action to Cure Kidney Cancer; NATIONAL CANCER INSTITUTE [P30CA006927, U01CA111242] Funding Source: NIH RePORTER	EDRN(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Action to Cure Kidney Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This publication was supported in part by the EDRN through grant number 3U01CA111242-05 and by P30 CA006927 from the National Cancer Institute, by Action to Cure Kidney Cancer, and by an individual's donation to study papillary RCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saleem T, 2004, CANCER GENET CYTOGEN, V152, P23, DOI 10.1016/j.cancergencyto.2003.10.001; [Anonymous], 2011, ILLUMINA BODY MAP DA; Arai E, 2012, CARCINOGENESIS, V33, P1487, DOI 10.1093/carcin/bgs177; Baldewijns MML, 2008, BBA-REV CANCER, V1785, P133, DOI 10.1016/j.bbcan.2007.12.002; Banumathy G, 2010, CANCER BIOL THER, V10, P658, DOI 10.4161/cbt.10.7.13247; Battagli C, 2003, CANCER RES, V63, P8695; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]; Cairns P, 2011, CANCER BIOMARK, V9, P461, DOI 10.3233/CBM-2011-0176; Corcoran AT, 2013, UROLOGY, V81, P707, DOI 10.1016/j.urology.2013.01.009; Costa VL, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-133; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dahl E, 2007, ONCOGENE, V26, P5680, DOI 10.1038/sj.onc.1210345; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; De Carvalho DD, 2012, CANCER CELL, V21, P655, DOI 10.1016/j.ccr.2012.03.045; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Delahunt B, 1997, MODERN PATHOL, V10, P537; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dulaimi E, 2004, CLIN CANCER RES, V10, P3972, DOI 10.1158/1078-0432.CCR-04-0175; Easwaran H, 2012, GENOME RES, V22, P837, DOI 10.1101/gr.131169.111; Edge SB, 2009, AJCC CANC STAGING MA, P479; Esteller M, 2001, CANCER RES, V61, P3225; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fang F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001875; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Feldmann G, 2010, CANCER RES, V70, P4460, DOI 10.1158/0008-5472.CAN-09-1107; Frank I, 2003, J UROLOGY, V170, P2217, DOI 10.1097/01.ju.0000095475.12515.5e; Gill IS, 2003, J UROLOGY, V170, P64, DOI 10.1097/01.ju.0000072272.02322.ff; Greenfield A, 1998, HUM MOL GENET, V7, P737, DOI 10.1093/hmg/7.4.737; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; He H, 2012, MOL CANCER RES, V10, P273, DOI 10.1158/1541-7786.MCR-11-0419; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hinoue T, 2012, GENOME RES, V22, P271, DOI 10.1101/gr.117523.110; Hoffman AM, 2011, EPIGENOMICS-UK, V3, P19, DOI 10.2217/EPI.10.64; Hoque MO, 2004, CANCER RES, V64, P5511, DOI 10.1158/0008-5472.CAN-04-0799; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ilhan A, 2011, HUM PATHOL, V42, P641, DOI 10.1016/j.humpath.2010.10.004; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kagara I, 2008, J UROLOGY, V180, P343, DOI 10.1016/j.juro.2008.02.044; Kalari S, 2010, ADV GENET, V70, P277, DOI [10.1016/B978-0-12-380866-0.60010-1, 10.1016/S0065-2660(10)70010-9]; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Linehan WM, 2010, NAT REV UROL, V7, P277, DOI 10.1038/nrurol.2010.47; McKiernan J, 2002, UROLOGY, V60, P1003, DOI 10.1016/S0090-4295(02)01967-2; McRonald FE, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-31; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Osanto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038298; Pavlovich CP, 2002, AM J SURG PATHOL, V26, P1542, DOI 10.1097/00000478-200212000-00002; Polascik TJ, 2002, UROLOGY, V60, P941, DOI 10.1016/S0090-4295(02)01825-3; Ricketts CJ, 2012, EPIGENETICS-US, V7, P278, DOI 10.4161/epi.7.3.19103; Riss J, 2006, CANCER RES, V66, P7216, DOI 10.1158/0008-5472.CAN-06-0040; Sambrook J., 2001, MOL CLONING LAB MANU; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Simard EP, 2012, CA-CANCER J CLIN, V62, P118, DOI 10.3322/caac.20141; Slater AA, 2013, EPIGENETICS, V8; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Smits KM, 2008, CLIN CANCER RES, V14, P782, DOI 10.1158/1078-0432.CCR-07-1753; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; ten Klooster JP, 2007, BIOL CELL, V99, P1, DOI 10.1042/BC20060071; The CCDS Database, 2013, CCDS DATABASE CURREN; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Tsuchiya KD, 2004, GENOME RES, V14, P1275, DOI 10.1101/gr.2575904; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Youssef YM, 2011, EUR UROL, V59, P721, DOI 10.1016/j.eururo.2011.01.004; Yusenko MV, 2010, INT J UROL, V17, P602, DOI 10.1111/j.1442-2042.2010.02574.x; Zeller C, 2013, AM J PATHOL, V182, P668, DOI 10.1016/j.ajpath.2012.11.040	75	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77309	10.1371/journal.pone.0077309	http://dx.doi.org/10.1371/journal.pone.0077309			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204800	gold, Green Published, Green Submitted			2022-12-27	WOS:000326152300019
J	Schmandke, A; Schmandke, A; Pietro, MA; Schwab, ME				Schmandke, Andre; Schmandke, Antonio; Pietro, Maurianne A.; Schwab, Martin E.			An Open Source Based High Content Screening Method for Cell Biology Laboratories Investigating Cell Spreading and Adhesion	PLOS ONE			English	Article							GLUCOCORTICOID RECEPTOR FUNCTION; NOGO-A; ANTIDEPRESSANT DRUGS; NERVOUS-SYSTEM; IN-VITRO; MIGRATION; GROWTH; ROLES; MOLECULE; CULTURE	Background: Adhesion dependent mechanisms are increasingly recognized to be important for a wide range of biological processes, diseases and therapeutics. This has led to a rising demand of pharmaceutical modulators. However, most currently available adhesion assays are time consuming and/or lack sensitivity and reproducibility or depend on specialized and expensive equipment often only available at screening facilities. Thus, rapid and economical high-content screening approaches are urgently needed. Results: We established a fully open source high-content screening method for identifying modulators of adhesion. We successfully used this method to detect small molecules that are able to influence cell adhesion and cell spreading of Swiss-3T3 fibroblasts in general and/or specifically counteract Nogo-A-Delta 20-induced inhibition of adhesion and cell spreading. The tricyclic anti-depressant clomipramine hydrochloride was shown to not only inhibit Nogo-A-Delta 20-induced cell spreading inhibition in 3T3 fibroblasts but also to promote growth and counteract neurite outgrowth inhibition in highly purified primary neurons isolated from rat cerebellum. Conclusions: We have developed and validated a high content screening approach that can be used in any ordinarily equipped cell biology laboratory employing exclusively freely available open-source software in order to find novel modulators of adhesion and cell spreading. The versatility and adjustability of the whole screening method will enable not only centers specialized in high-throughput screens but most importantly also labs not routinely employing screens in their daily work routine to investigate the effects of a wide range of different compounds or siRNAs on adhesion and adhesion-modulating molecules.	[Schmandke, Andre] Univ Zurich, Brain Res Inst, Zurich, Switzerland; Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Schmandke, A (corresponding author), Univ Zurich, Brain Res Inst, Zurich, Switzerland.	Andre.Schmandke@hifo.uzh.ch	Schwab, Martin E/B-6818-2016		European Union's Framework 7 program (Marie Curie Training Network: AXREGEN); Swiss National Science Foundation [310030B_138676/1]; European Research Council (ERC) [294115-NOGORISE]	European Union's Framework 7 program (Marie Curie Training Network: AXREGEN); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council (ERC)(European Research Council (ERC)European Commission)	This work was supported by research grants from the European Union's Framework 7 program (Marie Curie Training Network: AXREGEN; http://cordis.europa.eu/fp7/people/), the Swiss National Science Foundation (grant nr. 310030B_138676/1; www.snf.ch/) and the European Research Council (ERC advanced grant nr. 294115-NOGORISE; erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai RY, 2011, NEURO-ONCOLOGY, V13, P974, DOI 10.1093/neuonc/nor077; Budziszewska B, 2000, BRIT J PHARMACOL, V130, P1385, DOI 10.1038/sj.bjp.0703445; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chen J, 1995, J NEUROCHEM; Clegg Dennis O., 2000, Molecular Cell Biology Research Communications, V3, P1, DOI 10.1006/mcbr.1999.0175; EARNEST DL, 1992, J CELL BIOCHEM, P156; Espelt MV, 2011, HEPATOLOGY, V53, P2097, DOI 10.1002/hep.24294; Gillman PK, 2007, BRIT J PHARMACOL, V151, P737, DOI 10.1038/sj.bjp.0707253; GLOTZBACH RK, 1982, PSYCHOPHARMACOLOGY, V78, P25, DOI 10.1007/BF00470582; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Heemskerk Jill, 2005, Retina, V25, pS56, DOI 10.1097/00006982-200512001-00025; Huber AB, 2002, J NEUROSCI, V22, P3553; Joset A, 2010, J CELL BIOL, V188, P271, DOI 10.1083/jcb.200906089; Kempf A, 2013, PHYSIOLOGY, V28, P151, DOI 10.1152/physiol.00052.2012; Lah GJ, 2012, MOL CELL BIOL, V32, P968, DOI 10.1128/MCB.06128-11; Lai M, 2003, NEUROSCIENCE, V118, P975, DOI 10.1016/S0306-4522(03)00038-1; LOIKE JD, 1978, CANCER RES, V38, P2688; Maes M, 1999, NEGATIVE IMMUNOREGUL; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Mathis C, 2010, CEREB CORTEX, V20, P2380, DOI 10.1093/cercor/bhp307; Meur AML, 2007, CEREB CORTEX, V17, P2375, DOI 10.1093/cercor/bhl146; Miller AH, 2002, NEUROPSYCHOPHARMACOL, V27, P939, DOI 10.1016/S0893-133X(02)00381-0; Oertle T, 2003, J NEUROSCI, V23, P5393; Pariante C, 1997, MOLECULAR; Pariante CM, 2001, BRIT J PHARMACOL, V134, P1335, DOI 10.1038/sj.bjp.0704368; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; PRICE EA, 1995, CLIN EXP METASTAS, V13, P155, DOI 10.1007/BF00132203; Rolando C, 2012, J NEUROSCI, V32, P17788, DOI 10.1523/JNEUROSCI.3142-12.2012; Schmandke A, 2007, NEUROSCIENTIST, V13, P454, DOI 10.1177/1073858407303611; Shutova MS, 2010, CELL TISSUE BIOL, V4, P572; Sidera K, 2004, J BIOL CHEM, V279, P45379, DOI 10.1074/jbc.M405486200; Szabo D, 1999, CANCER LETT, V139, P115, DOI 10.1016/S0304-3835(99)00020-8; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tsujii M, 1995, CELL, P2; VASILIEV JM, 1970, J EMBRYOL EXP MORPH, V24, P625; Vedder H, 1999, J PSYCHIAT; Walchli T, 2013, P NATL ACAD SCI USA, V110, pE1943, DOI 10.1073/pnas.1216203110; Xia M, 2008, ENVIRON HEALTH PERSP, V116, P284, DOI 10.1289/ehp.10727; Xia ZL, 1999, J BIOCHEM MOL TOXIC, V13, P338, DOI 10.1002/(SICI)1099-0461(1999)13:6<338::AID-JBT8>3.3.CO;2-Z; Yang HJ, 2011, J CELL SCI, V124, P2552, DOI 10.1242/jcs.085340; Zhang XHD, 2011, J BIOMOL SCREEN, V16, P775, DOI 10.1177/1087057111405851; Zhu H, 2010, J PHARMACOL EXP THER, V334, P489, DOI 10.1124/jpet.110.165654	42	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78212	10.1371/journal.pone.0078212	http://dx.doi.org/10.1371/journal.pone.0078212			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205161	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000326032600082
J	Yamawaki, K; Ueda, S; Okada, T; Oshima, T; Kakitani, M; Kato, T; Tomizuka, K				Yamawaki, Kengo; Ueda, Shinobu; Okada, Tsutomu; Oshima, Takeshi; Kakitani, Makoto; Kato, Takashi; Tomizuka, Kazuma			Adult-Specific Systemic Over-Expression Reveals Novel In Vivo Effects of the Soluble Forms of ActRIIA, ActRIIB and BMPRII	PLOS ONE			English	Article							BETA SUPERFAMILY; II RECEPTOR; MUSCLE MASS; PROTEIN; IDENTIFICATION; GROWTH; MICE; MUTATIONS; ANEMIA; DIFFERENTIATION	Bone morphogenetic proteins (BMPs)/growth differentiation factors (GDFs), which belong to the TGF-beta superfamily, are pleiotropic factors that play a role in regulating the embryonic development and postnatal homeostasis of various organs and tissues by controlling cellular differentiation, proliferation and apoptosis. Conventional transgenic and knockout (KO) mouse approaches have provided only limited information regarding the in vivo functions of BMP signaling in adult animals due to the effects on prenatal development and the difficulty in manipulating multiligand signals simultaneously. We recently produced transgenic chimeric mice(Tg chimeras) in which the soluble IgG1-Fc fusion protein of three BMP type II receptors (ActRIIA, ActRIIB, BMPRII) was highly circulated (281-709 mu g/ml), specifically in adult mouse blood. Since each BMP receptor can bind to multiple BMP ligands, these Tg chimeras should be useful to investigate the effects of trapping multiple BMP ligands. Remarkably, some phenotypes were unexpected based on previous studies, such as KO mouse analyses, presumably representing the effects of the multiple ligand trapping. These phenotypes included increased red blood cells (RBCs) and decreased viability in adults. In a further study, we focused on the phenotype of increased RBCs and found that extramedullary hematopoiesis in the spleen, not in the bone marrow, was increased using histological and flow cytometric analyses. Although it remains to be elucidated whether the transgene products affect the tissues directly or indirectly, our data provide novel and important insight into the biological functions of the soluble IgG1-Fc fusion protein of three BMP type II receptors in adults, and our approach should have broad applications to research on other ligand receptor families and studies involving mouse models.	[Yamawaki, Kengo; Okada, Tsutomu; Oshima, Takeshi; Kakitani, Makoto] Kyowa Hakko Kirin Co Ltd, Biol Res Labs, Machida, Tokyo, Japan; [Ueda, Shinobu] Waseda Univ, Comprehens Res Org, Inst Innovat Design, Shinjuku Ku, Tokyo, Japan; [Kato, Takashi] Waseda Univ, Sch Educ, Dept Biol, Shinjuku Ku, Tokyo, Japan; [Tomizuka, Kazuma] Kyowa Hakko Kirin Calif Inc, San Diego, CA USA	Kyowa Kirin Ltd; Waseda University; Waseda University	Yamawaki, K (corresponding author), Kyowa Hakko Kirin Co Ltd, Biol Res Labs, Machida, Tokyo, Japan.	kengo.yamawaki@kyowa-kirin.co.jp; ktomizuka@kyowa-kirin-ca.com	Kato, Takashi/AFO-2557-2022	Kato, Takashi/0000-0003-0384-7971	Kyowa-Hakko Kirin Co. Ltd.; New Energy and Industrial Technology Development Organization (NEDO)	Kyowa-Hakko Kirin Co. Ltd.(Kyowa Kirin Ltd); New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO))	Financial support for this study was provided by Kyowa-Hakko Kirin Co. Ltd. This work was supported by the New Energy and Industrial Technology Development Organization (NEDO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auclair BA, 2007, GASTROENTEROLOGY, V133, P887, DOI 10.1053/j.gastro.2007.06.066; Bagarova J, 2013, MOL CELL BIOL, V33, P2413, DOI 10.1128/MCB.01595-12; Blake, 2007, SCI STKE, DOI DOI 10.1126/STKE.3992007CM1; Blank U, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-86; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Burton VJ, 2011, BLOOD, V117, P333, DOI 10.1182/blood-2010-05-285973; Cai J, 2012, FEBS LETT, V586, P1993, DOI 10.1016/j.febslet.2012.04.030; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Chantry AD, 2010, J BONE MINER RES, V25, P2357, DOI 10.1002/jbmr.142; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; DalCanto MC, 1997, ACTA NEUROPATHOL, V93, P537; Daluiski A, 2001, NAT GENET, V27, P84, DOI 10.1038/83810; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; de Caestecker M, 2004, CYTOKINE GROWTH F R, V15, P1, DOI 10.1016/j.cytogfr.2003.10.004; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fields SZ, 2013, EXPERT OPIN INV DRUG, V22, P87, DOI 10.1517/13543784.2013.738666; Gluhak-Heinrich J, 2010, BONE, V46, P1533, DOI 10.1016/j.bone.2010.02.024; Goldman DC, 2006, DEVELOPMENT, V133, P1933, DOI 10.1242/dev.02368; Gorman JR, 1996, IMMUNITY, V5, P241, DOI 10.1016/S1074-7613(00)80319-2; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Heinecke K, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-59; Javier AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042566; Jiao K, 2003, GENE DEV, V17, P2362, DOI 10.1101/gad.1124803; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Kakitani M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni083; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Koncarevic A, 2010, ENDOCRINOLOGY, V151, P4289, DOI 10.1210/en.2010-0134; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Lenox LE, 2009, EXP HEMATOL, V37, P549, DOI 10.1016/j.exphem.2009.01.004; Liu D, 2007, BLOOD, V110, P1502, DOI 10.1182/blood-2006-11-058594; Lowery JW, 2010, CYTOKINE GROWTH F R, V21, P287, DOI 10.1016/j.cytogfr.2010.06.001; Machado RD, 2006, HUM MUTAT, V27, P121, DOI 10.1002/humu.20285; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mazerbourg S, 2005, J BIOL CHEM, V280, P32122, DOI 10.1074/jbc.M504629200; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Millot S, 2010, BLOOD, V116, P6072, DOI 10.1182/blood-2010-04-281840; Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043; Murali D, 2005, DEVELOPMENT, V132, P913, DOI 10.1242/dev.01673; Raje N, 2010, CURR OPIN MOL THER, V12, P586; Rebbapragada A, 2003, MOL CELL BIOL, V23, P7230, DOI 10.1128/MCB.23.20.7230-7242.2003; Sako D, 2010, J BIOL CHEM, V285, P21037, DOI 10.1074/jbc.M110.114959; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Shimasaki S, 2004, ENDOCR REV, V25, P72, DOI 10.1210/er.2003-0007; Souza TA, 2008, MOL ENDOCRINOL, V22, P2689, DOI 10.1210/me.2008-0290; Tomizuka K, 2000, P NATL ACAD SCI USA, V97, P722, DOI 10.1073/pnas.97.2.722; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Yoon BS, 2005, P NATL ACAD SCI USA, V102, P5062, DOI 10.1073/pnas.0500031102; Zhang HB, 1996, DEVELOPMENT, V122, P2977; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhao GQ, 2003, GENESIS, V35, P43, DOI 10.1002/gene.10167; Zhao GQ, 2001, DEV BIOL, V240, P212, DOI 10.1006/dbio.2001.0448	54	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78076	10.1371/journal.pone.0078076	http://dx.doi.org/10.1371/journal.pone.0078076			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205096	Green Published, Green Submitted, gold			2022-12-27	WOS:000326032600067
J	Brown, CE; Warden, CD; Starr, R; Deng, XT; Badie, B; Yuan, YC; Forman, SJ; Barish, ME				Brown, Christine E.; Warden, Charles D.; Starr, Renate; Deng, Xutao; Badie, Behnam; Yuan, Yate-Ching; Forman, Stephen J.; Barish, Michael E.			Glioma IL13R alpha 2 Is Associated with Mesenchymal Signature Gene Expression and Poor Patient Prognosis	PLOS ONE			English	Article							INTERLEUKIN-13 RECEPTOR-ALPHA-2; GLIOBLASTOMA-MULTIFORME; MOLECULAR-BASIS; STEM-CELLS; CANCER; INFLAMMATION; IL-13; ANGIOGENESIS; RECOGNITION; FIBROSIS	A major challenge for successful immunotherapy against glioma is the identification and characterization of validated targets. We have taken a bioinformatics approach towards understanding the biological context of IL-13 receptor alpha 2 (IL13R alpha 2) expression in brain tumors, and its functional significance for patient survival. Querying multiple gene expression databases, we show that IL13R alpha 2 expression increases with glioma malignancy grade, and expression for high-grade tumors is bimodal, with approximately 58% of WHO grade IV gliomas over-expressing this receptor. By several measures, IL13R alpha 2 expression in patient samples and low-passage primary glioma lines most consistently correlates with the expression of signature genes defining mesenchymal subclass tumors and negatively correlates with proneural signature genes as defined by two studies. Positive associations were also noted with proliferative signature genes, whereas no consistent associations were found with either classical or neural signature genes. Probing the potential functional consequences of this mesenchymal association through IPA analysis suggests that IL13R alpha 2 expression is associated with activation of proinflammatory and immune pathways characteristic of mesenchymal subclass tumors. In addition, survival analyses indicate that IL13R alpha 2 over-expression is associated with poor patient prognosis, a single gene correlation ranking IL13R alpha 2 in the top similar to 1% of total gene expression probes with regard to survival association with WHO IV gliomas. This study better defines the functional consequences of IL13R alpha 2 expression by demonstrating association with mesenchymal signature gene expression and poor patient prognosis. It thus highlights the utility of IL13R alpha 2 as a therapeutic target, and helps define patient populations most likely to respond to immunotherapy in present and future clinical trials.	[Brown, Christine E.; Starr, Renate; Forman, Stephen J.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Immunotherapy & Tumor Immunol & Hematol, Duarte, CA 91010 USA; [Brown, Christine E.; Warden, Charles D.; Starr, Renate; Deng, Xutao; Badie, Behnam; Yuan, Yate-Ching; Forman, Stephen J.; Barish, Michael E.] City Hope Natl Med Ctr, Duarte, CA 91010 USA; [Warden, Charles D.; Deng, Xutao; Yuan, Yate-Ching] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA; [Badie, Behnam] City Hope Natl Med Ctr, Beckman Res Inst, Dept Neurosurg, Duarte, CA 91010 USA; [Barish, Michael E.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Neurosci, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Brown, CE (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Immunotherapy & Tumor Immunol & Hematol, Duarte, CA 91010 USA.	cbrown@coh.org		Brown, Christine/0000-0003-4915-8207; Warden, Charles/0000-0002-1827-4486	NCI [P30 CA33572-26]; General Clinical Research Center [M01 RR00043]; California Institute for Regenerative Medicine [CIRM TR3-05641]; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000043] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by NCI (P30 CA33572-26), General Clinical Research Center (M01 RR00043), California Institute for Regenerative Medicine (CIRM TR3-05641), and generous donations from the Chubb Charity Golf Tournament. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have no conflicting financial interests.	Beier CP, 2012, STEM CELLS DEV, V21, P2753, DOI 10.1089/scd.2011.0660; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown CE, 2012, CLIN CANCER RES, V18, P2199, DOI 10.1158/1078-0432.CCR-11-1669; Brown CE, 2009, CANCER RES, V69, P8886, DOI 10.1158/0008-5472.CAN-09-2687; Chiaramonte MG, 2003, J EXP MED, V197, P687, DOI 10.1084/jem.20020903; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Colman H, 2010, NEURO-ONCOLOGY, V12, P49, DOI 10.1093/neuonc/nop007; Debinski W, 1999, CLIN CANCER RES, V5, P985; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Fichtner-Feigl S, 2008, CANCER RES, V68, P3467, DOI 10.1158/0008-5472.CAN-07-5301; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Fujisawa T, 2011, INT J CANC; Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hodgson JG, 2009, NEURO-ONCOLOGY, V11, P477, DOI 10.1215/15228517-2008-113; Hsi LC, 2011, MOL CANCER THER, V10, P1149, DOI 10.1158/1535-7163.MCT-10-1064; Huse JT, 2011, GLIA, V59, P1190, DOI 10.1002/glia.21165; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jarboe JS, 2007, CANCER RES, V67, P7983, DOI 10.1158/0008-5472.CAN-07-1493; Joshi BH, 2008, NEURO-ONCOLOGY, V10, P265, DOI 10.1215/15228517-2007-066; Joshi BH, 2006, VITAM HORM, V74, P479, DOI 10.1016/S0083-6729(06)74019-5; Kahlon KS, 2004, CANCER RES, V64, P9160, DOI 10.1158/0008-5472.CAN-04-0454; Kawakami M, 2004, CANCER-AM CANCER SOC, V101, P1036, DOI 10.1002/cncr.20470; Kunwar S, 2010, NEURO-ONCOLOGY, V12, P871, DOI 10.1093/neuonc/nop054; Lee Y, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-52; Lottaz C, 2010, CANCER RES, V70, P2030, DOI 10.1158/0008-5472.CAN-09-1707; Lupardus PJ, 2010, STRUCTURE, V18, P332, DOI 10.1016/j.str.2010.01.003; MacDonald TT, 2006, NAT MED, V12, P13, DOI 10.1038/nm0106-13; McLendon RE, 2011, J ONCOL, V2011, DOI 10.1155/2011/397195; Lopez-Novoa JM, 2009, EMBO MOL MED, V1, P303, DOI 10.1002/emmm.200900043; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Murat A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005947; Natsume A, 2011, BRAIN TUMOR PATHOL, V28, P1, DOI 10.1007/s10014-010-0011-3; Petalidis LP, 2008, MOL CANCER THER, V7, P1013, DOI 10.1158/1535-7163.MCT-07-0177; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Saka M, 2010, J NEUROSURG, V113, P270, DOI 10.3171/2009.9.JNS09708; Stastny MJ, 2007, J PEDIAT HEMATOL ONC, V29, P669, DOI 10.1097/MPH.0b013e3181468c68; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Tabata Y, 2007, CURR ALLERGY ASTHM R, V7, P338, DOI 10.1007/s11882-007-0051-x; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wykosky J, 2008, CLIN CANCER RES, V14, P199, DOI 10.1158/1078-0432.CCR-07-1990; Yaghoubi SS, 2009, NAT CLIN PRACT ONCOL, V6, P53, DOI 10.1038/ncponc1278; [No title captured]; [No title captured]	49	86	93	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77769	10.1371/journal.pone.0077769	http://dx.doi.org/10.1371/journal.pone.0077769			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204956	Green Published, Green Submitted, gold			2022-12-27	WOS:000326029300114
J	Fischer, I; Steige, KA; Stephan, W; Mboup, M				Fischer, Iris; Steige, Kim A.; Stephan, Wolfgang; Mboup, Mamadou			Sequence Evolution and Expression Regulation of Stress-Responsive Genes in Natural Populations of Wild Tomato	PLOS ONE			English	Article							TIME QUANTITATIVE PCR; WATER-USE EFFICIENCY; LOCAL ADAPTATION; ASR GENE; NUCLEOTIDE POLYMORPHISM; MOLECULAR EVOLUTION; ADAPTIVE EVOLUTION; CANDIDATE GENES; DNA-BINDING; DROUGHT	The wild tomato species Solanum chilense and S. peruvianum are a valuable non-model system for studying plant adaptation since they grow in diverse environments facing many abiotic constraints. Here we investigate the sequence evolution of regulatory regions of drought and cold responsive genes and their expression regulation. The coding regions of these genes were previously shown to exhibit signatures of positive selection. Expression profiles and sequence evolution of regulatory regions of members of the Asr (ABA/water stress/ripening induced) gene family and the dehydrin gene pLC30-15 were analyzed in wild tomato populations from contrasting environments. For S. chilense, we found that Asr4 and pLC30-15 appear to respond much faster to drought conditions in accessions from very dry environments than accessions from more mesic locations. Sequence analysis suggests that the promoter of Asr2 and the downstream region of pLC30-15 are under positive selection in some local populations of S. chilense. By investigating gene expression differences at the population level we provide further support of our previous conclusions that Asr2, Asr4, and pLC30-15 are promising candidates for functional studies of adaptation. Our analysis also demonstrates the power of the candidate gene approach in evolutionary biology research and highlights the importance of wild Solanum species as a genetic resource for their cultivated relatives.	[Fischer, Iris; Steige, Kim A.; Stephan, Wolfgang; Mboup, Mamadou] Univ Munich, Sect Evolutionary Biol, Dept Biol 2, Planegg Martinsried, Germany	University of Munich	Fischer, I (corresponding author), INRA, AGAP 1334, UMR, F-34060 Montpellier, France.	irisfischer402@gmail.com	Stephan, Wolfgang/GOV-6503-2022		German Research Foundation [STE 325/13-1]; Graduiertenforderung nach dem Bayerischen Eliteforderungsgesetz	German Research Foundation(German Research Foundation (DFG)); Graduiertenforderung nach dem Bayerischen Eliteforderungsgesetz	This work was funded by grant STE 325/13-1 from the German Research Foundation to WS and a fellowship from the Graduiertenforderung nach dem Bayerischen Eliteforderungsgesetz to IF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JT, 2011, TRENDS GENET, V27, P258, DOI 10.1016/j.tig.2011.04.001; Arunyawat U, 2007, MOL BIOL EVOL, V24, P2310, DOI 10.1093/molbev/msm162; Baker RL, 2012, NEW PHYTOL, V196, P271, DOI 10.1111/j.1469-8137.2012.04245.x; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Baudry E, 2001, GENETICS, V158, P1725; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Bray EA, 1997, TRENDS PLANT SCI, V2, P48, DOI 10.1016/S1360-1385(97)82562-9; Carey LB, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001528; Carrari F, 2004, TRENDS PLANT SCI, V9, P57, DOI 10.1016/j.tplants.2003.12.004; Catalan A, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-654; CHEN RD, 1993, PLANT PHYSIOL, V103, P301, DOI 10.1104/pp.103.1.301; Chetelat RT, 2009, EUPHYTICA, V167, P77, DOI 10.1007/s10681-008-9863-6; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; Depaulis F, 1998, MOL BIOL EVOL, V15, P1788, DOI 10.1093/oxfordjournals.molbev.a025905; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Emerson JJ, 2010, PHILOS T R SOC B, V365, P2581, DOI 10.1098/rstb.2010.0005; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Fay JC, 2008, HEREDITY, V100, P191, DOI 10.1038/sj.hdy.6801000; Fay JC, 2000, GENETICS, V155, P1405; Ferea TL, 1999, P NATL ACAD SCI USA, V96, P9721, DOI 10.1073/pnas.96.17.9721; Fischer I, 2011, NEW PHYTOL, V190, P1032, DOI 10.1111/j.1469-8137.2011.03648.x; Fisher RA, 1930, GENETICAL THEORY NAT; Frankel N, 2003, MOL BIOL EVOL, V20, P1955, DOI 10.1093/molbev/msg214; Frankel N, 2007, PLANT MOL BIOL, V63, P719, DOI 10.1007/s11103-006-9120-0; Frankel N, 2006, GENE, V378, P74, DOI 10.1016/j.gene.2006.05.010; FU YX, 1993, GENETICS, V133, P693; Giombini MI, 2009, GENETICA, V136, P13, DOI 10.1007/s10709-008-9295-1; Grillo MA, 2009, EVOLUTION, V63, P870, DOI 10.1111/j.1558-5646.2008.00602.x; Guggisberg A, 2013, NEW PHYTOL, V199, P595, DOI 10.1111/nph.12258; Guo SG, 2013, NAT GENET, V45, P51, DOI 10.1038/ng.2470; Ha M, 2007, TRENDS GENET, V23, P162, DOI 10.1016/j.tig.2007.02.005; He F, 2012, MOL BIOL EVOL, V29, P3385, DOI 10.1093/molbev/mss146; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hodgins KA, 2013, MOL ECOL, V22, P2496, DOI 10.1111/mec.12179; Hutter S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r12; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; IUSEM ND, 1993, PLANT PHYSIOL, V102, P1353, DOI 10.1104/pp.102.4.1353; Jeanneau M, 2002, BIOCHIMIE, V84, P1127, DOI 10.1016/S0300-9084(02)00024-X; Kalifa Y, 2004, PLANT CELL ENVIRON, V27, P1459, DOI 10.1111/j.1365-3040.2004.01251.x; Kalifa Y, 2004, BIOCHEM J, V381, P373, DOI 10.1042/BJ20031800; Kane NC, 2008, MOL ECOL, V17, P384, DOI 10.1111/j.1365-294X.2007.03467.x; Kane NC, 2007, GENETICS, V175, P1823, DOI 10.1534/genetics.106.067728; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kirby DA, 1996, GENETICS, V144, P635, DOI 10.1093/genetics/144.2.635; Knight CA, 2006, MOL ECOL, V15, P1229, DOI 10.1111/j.1365-294X.2006.02818.x; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Konrad Z, 2008, PLANTA, V227, P1213, DOI 10.1007/s00425-008-0693-5; LANGE BW, 1990, GENETICS, V126, P921; Leinonen PH, 2011, EVOLUTION, V65, P90, DOI 10.1111/j.1558-5646.2010.01119.x; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li CM, 2012, GENE, V506, P93, DOI 10.1016/j.gene.2012.06.034; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; Maskin L, 2001, PLANT SCI, V161, P739, DOI 10.1016/S0168-9452(01)00464-2; Maskin L, 2008, MOL BIOL REP, V35, P501, DOI 10.1007/s11033-007-9114-2; Maskin L, 2007, BIOCHEM BIOPH RES CO, V352, P831, DOI 10.1016/j.bbrc.2006.11.115; Matzkin LM, 2012, MOL ECOL, V21, P2428, DOI 10.1111/j.1365-294X.2012.05549.x; Mboup M, 2012, MOL BIOL EVOL, V29, P3641, DOI 10.1093/molbev/mss176; Moyle LC, 2008, EVOLUTION, V62, P2995, DOI 10.1111/j.1558-5646.2008.00487.x; Muller L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-81; Nakazato T, 2010, AM J BOT, V97, P680, DOI 10.3732/ajb.0900216; Padmanabhan V, 1997, PLANT MOL BIOL, V35, P801, DOI 10.1023/A:1005897921567; Peralta I. E., 2008, Systematic Botany Monographs, V84; Philippe R, 2010, THEOR APPL GENET, V121, P769, DOI 10.1007/s00122-010-1348-z; Proost S, 2009, PLANT CELL, V21, P3718, DOI 10.1105/tpc.109.071506; R Development Core Team, 2012, R LANG ENV STAT COMP; Riihimaki M, 2005, GENETICA, V123, P63, DOI 10.1007/s10709-003-2711-7; Rorat T, 2006, PLANTA, V224, P205, DOI 10.1007/s00425-005-0200-1; Roselius K, 2005, GENETICS, V171, P753, DOI 10.1534/genetics.105.043877; ROSSI M, 1994, PLANT PHYSIOL, V104, P1073, DOI 10.1104/pp.104.3.1073; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Saumonneau A, 2008, FEBS LETT, V582, P3281, DOI 10.1016/j.febslet.2008.09.015; Schaefke B, 2013, MOL BIOL EVOL, V30, P2121, DOI 10.1093/molbev/mst114; Schneider A, 1997, PLANT PHYSIOL, V113, P335, DOI 10.1104/pp.113.2.335; Shen G, 2005, PLANT PHYSIOL BIOCH, V43, P836, DOI 10.1016/j.plaphy.2005.06.010; SILHAVY D, 1995, PLANT MOL BIOL, V27, P587, DOI 10.1007/BF00019324; Smith G, 2013, EVOLUTION, V67, P1950, DOI 10.1111/evo.12082; Song BH, 2011, J SYST EVOL, V49, P17, DOI 10.1111/j.1759-6831.2010.00111.x; Spooner DM, 2005, TAXON, V54, P43, DOI 10.2307/25065301; Stadler T, 2005, EVOLUTION, V59, P1268, DOI 10.1111/j.0014-3820.2005.tb01777.x; Stadler T, 2008, GENETICS, V178, P339, DOI 10.1534/genetics.107.081810; Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Tellier A, 2011, P NATL ACAD SCI USA, V108, P17052, DOI 10.1073/pnas.1111266108; Turner TL, 2010, NAT GENET, V42, P260, DOI 10.1038/ng.515; Wang CS, 1998, PLANT CELL PHYSIOL, V39, P1307, DOI 10.1093/oxfordjournals.pcp.a029335; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WILSON AC, 1974, P NATL ACAD SCI USA, V71, P2843, DOI 10.1073/pnas.71.7.2843; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Xia H, 2010, MOL ECOL, V19, P4144, DOI 10.1111/j.1365-294X.2010.04762.x; Yanez M, 2009, PLANT CELL REP, V28, P1497, DOI 10.1007/s00299-009-0749-4; Yang CY, 2005, PLANT PHYSIOL, V139, P836, DOI 10.1104/pp.105.065458	96	20	20	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78182	10.1371/journal.pone.0078182	http://dx.doi.org/10.1371/journal.pone.0078182			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205149	gold, Green Published, Green Submitted			2022-12-27	WOS:000326029300146
J	Koome, ME; Davidson, JO; Drury, PP; Mathai, S; Booth, LC; Gunn, AJ; Bennet, L				Koome, Miriam E.; Davidson, Joanne O.; Drury, Paul P.; Mathai, Sam; Booth, Lindsea C.; Gunn, Alistair Jan; Bennet, Laura			Antenatal Dexamethasone after Asphyxia Increases Neural Injury in Preterm Fetal Sheep	PLOS ONE			English	Article							BRAIN-INJURY; SYNTHETIC GLUCOCORTICOIDS; MATERNAL DEXAMETHASONE; SINGLE COURSE; NEUROPROTECTION; MATURATION; ISCHEMIA; CORTICOSTEROIDS; MYELINATION; HYPOTHERMIA	Background and Purpose: Maternal glucocorticoid treatment for threatened premature delivery dramatically improves neonatal survival and short-term morbidity; however, its effects on neurodevelopmental outcome are variable. We investigated the effect of maternal glucocorticoid exposure after acute asphyxia on injury in the preterm brain. Methods: Chronically instrumented singleton fetal sheep at 0.7 of gestation received asphyxia induced by complete umbilical cord occlusion for 25 minutes. 15 minutes after release of occlusion, ewes received a 3 ml i.m. injection of either dexamethasone (12 mg, n = 10) or saline (n = 10). Sheep were killed after 7 days recovery; survival of neurons in the hippocampus and basal ganglia, and oligodendrocytes in periventricular white matter were assessed using an unbiased stereological approach. Results: Maternal dexamethasone after asphyxia was associated with more severe loss of neurons in the hippocampus (CA3 regions, 290 +/- 76 vs 484 +/- 98 neurons/mm(2), mean +/- SEM, P<0.05) and basal ganglia (putamen, 538 +/- 112 vs 814 +/- 34 neurons/mm(2), P<0.05) compared to asphyxia-saline, and with greater loss of both total (913 +/- 77 vs 1201 +/- 75/mm(2), P<0.05) and immature/mature myelinating oligodendrocytes in periventricular white matter (66 +/- 8 vs 114 +/- 12/mm(2), P<0.05, vs sham controls 165 +/- 10/mm(2), P<0.001). This was associated with transient hyperglycemia (peak 3.5 +/- 0.2 vs. 1.4 +/- 0.2 mmol/L at 6 h, P<0.05) and reduced suppression of EEG power in the first 24 h after occlusion (maximum -1.5 +/- 1.2 dB vs. -5.0 +/- 1.4 dB in saline controls, P<0.01), but later onset and fewer overt seizures. Conclusions: In preterm fetal sheep, exposure to maternal dexamethasone during recovery from asphyxia exacerbated brain damage.	[Koome, Miriam E.; Davidson, Joanne O.; Drury, Paul P.; Mathai, Sam; Booth, Lindsea C.; Gunn, Alistair Jan; Bennet, Laura] Univ Auckland, Dept Physiol, Auckland, New Zealand	University of Auckland	Bennet, L (corresponding author), Univ Auckland, Dept Physiol, Auckland, New Zealand.	l.bennet@auckland.ac.nz	Davidson, Joanne/ABD-1694-2021	Booth, Lindsea/0000-0003-3093-5766; Gunn, Alistair/0000-0003-0656-7035; Davidson, Joanne/0000-0002-6781-4258; Bennet, Laura/0000-0002-4336-7596	Health Research Council of New Zealand; Auckland Medical Research Foundation; Lottery Health New Zealand	Health Research Council of New Zealand(Health Research Council of New Zealand); Auckland Medical Research Foundation; Lottery Health New Zealand	This study was supported by public good grants from the Health Research Council of New Zealand, the Auckland Medical Research Foundation, and Lottery Health New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham I, 1996, BRAIN RES, V733, P56; BARKS JDE, 1991, PEDIATR RES, V29, P558, DOI 10.1203/00006450-199106010-00008; Barrett RD, 2012, BRAIN RES, V1469, P35, DOI 10.1016/j.brainres.2012.06.018; Baud O, 1999, NEW ENGL J MED, V341, P1190, DOI 10.1056/NEJM199910143411604; Bennet L, 2010, SEMIN FETAL NEONAT M, V15, P253, DOI 10.1016/j.siny.2010.05.007; Bennet L, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/751694; Buser JR, 2012, ANN NEUROL, V71, P93, DOI 10.1002/ana.22627; Carlo WA, 2011, JAMA-J AM MED ASSOC, V306, P2348, DOI 10.1001/jama.2011.1752; Charles MS, 2012, NEUROBIOL DIS, V47, P29, DOI 10.1016/j.nbd.2012.03.021; Davidson JO, 2012, ANN NEUROL, V71, P121, DOI 10.1002/ana.22654; Davidson JO, 2011, J PHYSIOL-LONDON, V589, P3823, DOI 10.1113/jphysiol.2011.212043; Dean JM, 2006, NEUROSCIENCE, V142, P615, DOI 10.1016/j.neuroscience.2006.06.066; Dean JM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004669; Elitt CM, 2003, EARLY HUM DEV, V73, P1, DOI 10.1016/S0378-3782(03)00030-6; Filan P, 2005, BJOG-INT J OBSTET GY, V112, P504, DOI 10.1111/j.1471-0528.2004.00476.x; George SA, 2012, STROKE, V43, P3114, DOI 10.1161/STROKEAHA.112.671982; Glass HC, 2011, J PEDIATR-US, V159, P731, DOI 10.1016/j.jpeds.2011.07.015; Gunn A J, 2006, NeuroRx, V3, P154, DOI 10.1007/BF03207046; HAY WW, 1983, P SOC EXP BIOL MED, V173, P553, DOI 10.3181/00379727-173-41686; Hunter CJ, 2003, STROKE, V34, P2240, DOI 10.1161/01.STR.0000083623.77327.CE; Jakovcevski I, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.005.2009; Khan AA, 2011, PAEDIATR PERINAT EP, V25, P20, DOI 10.1111/j.1365-3016.2010.01147.x; KOIDE T, 1986, J CEREBR BLOOD F MET, V6, P395, DOI 10.1038/jcbfm.1986.72; LEBLANC MH, 1994, STROKE, V25, P1443, DOI 10.1161/01.STR.25.7.1443; MCINTOSH GH, 1979, NEUROPATH APPL NEURO, V5, P103, DOI 10.1111/j.1365-2990.1979.tb00664.x; Mehta S, 2003, J Postgrad Med, V49, P299; Ogilvy-Stuart AL, 2010, ARCH DIS CHILD-FETAL, V95, pF126, DOI 10.1136/adc.2008.154716; Quaedackers JS, 2005, BJOG-INT J OBSTET GY, V112, P182, DOI 10.1111/j.1471-0528.2004.00344.x; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Scheepens A, 2003, DEV BRAIN RES, V142, P67, DOI 10.1016/S0165-3806(03)00032-4; Scheepens A, 2003, J PHYSIOL-LONDON, V552, P163, DOI 10.1113/jphysiol.2003.043414; SCHER MS, 1993, PEDIATRICS, V91, P128; Segovia KN, 2008, ANN NEUROL, V63, P520, DOI 10.1002/ana.21359; Shinwell ES, 2009, SEMIN FETAL NEONAT M, V14, P164, DOI 10.1016/j.siny.2008.12.001; Singh RR, 2012, CLIN EXP PHARMACOL P, V39, P979, DOI 10.1111/1440-1681.12009; Tijsseling D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033369; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Whitelaw A, 2000, ARCH DIS CHILD-FETAL, V83, pF154, DOI 10.1136/fn.83.2.F154; WILLIAMS CE, 1992, ANN NEUROL, V31, P14, DOI 10.1002/ana.410310104	39	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77480	10.1371/journal.pone.0077480	http://dx.doi.org/10.1371/journal.pone.0077480			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204840	gold, Green Published, Green Submitted			2022-12-27	WOS:000326029300099
J	Wilson, MB; Spivak, M; Hegeman, AD; Rendahl, A; Cohen, JD				Wilson, Michael B.; Spivak, Marla; Hegeman, Adrian D.; Rendahl, Aaron; Cohen, Jerry D.			Metabolomics Reveals the Origins of Antimicrobial Plant Resins Collected by Honey Bees	PLOS ONE			English	Article							APIS-MELLIFERA; PROPOLIS; HYMENAEA; DISEASE; RESISTANCE; PHENOLICS; COLONIES	The deposition of antimicrobial plant resins in honey bee, Apis mellifera, nests has important physiological benefits. Resin foraging is difficult to approach experimentally because resin composition is highly variable among and between plant families, the environmental and plant-genotypic effects on resins are unknown, and resin foragers are relatively rare and often forage in unobservable tree canopies. Subsequently, little is known about the botanical origins of resins in many regions or the benefits of specific resins to bees. We used metabolomic methods as a type of environmental forensics to track individual resin forager behavior through comparisons of global resin metabolite patterns. The resin from the corbiculae of a single bee was sufficient to identify that resin's botanical source without prior knowledge of resin composition. Bees from our apiary discriminately foraged for resin from eastern cottonwood (Populus deltoides), and balsam poplar (P. balsamifera) among many available, even closely related, resinous plants. Cottonwood and balsam poplar resin composition did not show significant seasonal or regional changes in composition. Metabolomic analysis of resin from 6 North American Populus spp. and 5 hybrids revealed peaks characteristic to taxonomic nodes within Populus, while antimicrobial analysis revealed that resin from different species varied in inhibition of the bee bacterial pathogen, Paenibacillus larvae. We conclude that honey bees make discrete choices among many resinous plant species, even among closely related species. Bees also maintained fidelity to a single source during a foraging trip. Furthermore, the differential inhibition of P. larvae by Populus spp., thought to be preferential for resin collection in temperate regions, suggests that resins from closely related plant species many have different benefits to bees.	[Wilson, Michael B.; Hegeman, Adrian D.; Cohen, Jerry D.] Univ Minnesota, Dept Hort Sci, St Paul, MN 55108 USA; [Wilson, Michael B.; Hegeman, Adrian D.; Cohen, Jerry D.] Univ Minnesota, Microbial & Plant Genom Inst, St Paul, MN 55108 USA; [Spivak, Marla] Univ Minnesota, Dept Entomol, St Paul, MN USA; [Hegeman, Adrian D.] Univ Minnesota, Dept Plant Biol, St Paul, MN USA; [Rendahl, Aaron] Univ Minnesota, Sch Stat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Wilson, MB (corresponding author), Univ Minnesota, Dept Hort Sci, St Paul, MN 55108 USA.	wils0888@umn.edu	Cohen, Jerry/AAF-3737-2020; Spivak, Marla/AAI-5088-2020; Hegeman, Adrian/D-5984-2013	Cohen, Jerry/0000-0003-2816-8676; Rendahl, Aaron/0000-0001-5434-3592; Hegeman, Adrian/0000-0003-1008-6066	NSF Plant Genome Research Program [IOS-0923960, IOS-1238812]; NSF [IOS-0717530]; University of Minnesota College of Food, Agriculture, and Natural Resource Sciences; National Honey Board; Gordon and Margaret Bailey Endowment for Environmental Horticulture; University of Minnesota Graduate School; Direct For Biological Sciences [0923960, 1256992] Funding Source: National Science Foundation	NSF Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF(National Science Foundation (NSF)); University of Minnesota College of Food, Agriculture, and Natural Resource Sciences; National Honey Board; Gordon and Margaret Bailey Endowment for Environmental Horticulture; University of Minnesota Graduate School(University of Minnesota System); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this work was through the NSF Plant Genome Research Program grants IOS-0923960 and IOS-1238812 (http://www.nsf.gov/funding/pgm_summ.jsp?pims_id = 5338&org = BIO), NSF grant IOS-0717530, the University of Minnesota College of Food, Agriculture, and Natural Resource Sciences (www.cfans.umn.edu/), the National Honey Board (http://www.honey.com/honey-industry/honey-and-bee-research), the Gordon and Margaret Bailey Endowment for Environmental Horticulture, and the University of Minnesota Graduate School (http://www.grad.umn.edu/fellowships/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; ALFONSUS ERWIN C., 1933, GLEANINGS IN BEE CULT, V61, P92; ARRHENIUS SP, 1983, BIOCHEM SYST ECOL, V11, P361, DOI 10.1016/0305-1978(83)90037-6; Bankova V, 1998, APIDOLOGIE, V29, P361, DOI 10.1051/apido:19980406; Bankova V, 2006, NAT PROD COMMUN, V1, P1023; Bankova VS, 2000, APIDOLOGIE, V31, P3, DOI 10.1051/apido:2000102; Bastos EMAF, 2008, J INVERTEBR PATHOL, V97, P273, DOI 10.1016/j.jip.2007.10.007; Chapuisat M, 2007, P ROY SOC B-BIOL SCI, V274, P2013, DOI 10.1098/rspb.2007.0531; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Crane E, 1990, BEES BEEKEEPING SCI, P367; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; ENGLISH S, 1991, PHYTOCHEMISTRY, V30, P531, DOI 10.1016/0031-9422(91)83721-V; ENGLISH S, 1992, PHYTOCHEMISTRY, V31, P1255, DOI 10.1016/0031-9422(92)80272-G; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Evans JD, 2010, J INVERTEBR PATHOL, V103, pS62, DOI 10.1016/j.jip.2009.06.019; GHISALBERTI EL, 1979, BEE WORLD, V60, P59, DOI 10.1080/0005772X.1979.11097738; GILLIAM M, 1988, J INVERTEBR PATHOL, V52, P314, DOI 10.1016/0022-2011(88)90141-3; Greenway W, 1987, SILVAE GENET, V38, P28; Hamzeh M, 2004, AM J BOT, V91, P1398, DOI 10.3732/ajb.91.9.1398; Johnson R, 2010, HONEY BEE COLONY COL; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Kujumgiev A, 1999, J ETHNOPHARMACOL, V64, P235, DOI 10.1016/S0378-8741(98)00131-7; Langenheim J.H., 2003, PLANT RESINS CHEM EV; LANGENHEIM JH, 1983, BIOCHEM SYST ECOL, V11, P29, DOI 10.1016/0305-1978(83)90026-1; LANGENHEIM JH, 1981, BIOCHEM SYST ECOL, V9, P27, DOI 10.1016/0305-1978(81)90056-9; Leonhardt SD, 2010, CHEM SENSES, V35, P603, DOI 10.1093/chemse/bjq058; Leonhardt SD, 2009, BIOTROPICA, V41, P730, DOI 10.1111/j.1744-7429.2009.00535.x; LEVIN DA, 1976, ANNU REV ECOL SYST, V7, P121, DOI 10.1146/annurev.es.07.110176.001005; Mennerat A, 2009, ANIM BEHAV, V77, P569, DOI 10.1016/j.anbehav.2008.11.008; Schmid-Hempel P., 1998, Parasites in social insects.; SEELEY TD, 1976, INSECT SOC, V23, P495, DOI 10.1007/BF02223477; Simone M, 2009, EVOLUTION, V63, P3016, DOI 10.1111/j.1558-5646.2009.00772.x; Simone-Finstrom M, 2010, BEHAV ECOL SOCIOBIOL, V64, P1609, DOI 10.1007/s00265-010-0974-4; Simone-Finstrom MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034601; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Spivak M, 2001, APIDOLOGIE, V32, P555, DOI 10.1051/apido:2001103; Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504; Teixeira EW, 2005, EVID-BASED COMPL ALT, V2, P85, DOI 10.1093/ecam/neh055; USDA NRCS National Plant Data Team, 2013, USDA PLANTS DAT; van Dooremalen C, 2012, PLOS ONE, V7, DOI [DOI 10.1371/J0URNAL.P0NE.0036285, 10.1371/journal.pone.0036285]; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Wilson-Rich N, 2009, ANNU REV ENTOMOL, V54, P405, DOI 10.1146/annurev.ento.53.103106.093301; Witham TG, 1983, VARIABLE PLANTS HERB, P15	45	53	55	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77512	10.1371/journal.pone.0077512	http://dx.doi.org/10.1371/journal.pone.0077512			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204850	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300100
J	Gonzalo-Asensio, J; Ortega, AD; Rico-Perez, G; Pucciarelli, MG; Garcia-del Portillo, F				Gonzalo-Asensio, Jesus; Ortega, Alvaro D.; Rico-Perez, Gadea; Pucciarelli, M. Graciela; Portillo, Francisco Garcia-del			A Novel Antisense RNA from the Salmonella Virulence Plasmid pSLT Expressed by Non-Growing Bacteria inside Eukaryotic Cells	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; TRANSCRIPTIONAL LANDSCAPE; CHROMOSOMAL GENES; ENCODING GENES; MESSENGER-RNA; PERSISTENCE; SYSTEM; MACROPHAGES; ANTITOXIN	Bacterial small RNAs (sRNAs) are regulatory molecules playing relevant roles in response to environmental changes, stressful conditions and pathogenesis. The intracellular bacterial pathogen Salmonella enterica serovar Typhimurium (S. Typhimurium) is known to regulate expression of some sRNAs during colonization of fibroblasts. Here, we characterize a previously unknown sRNA encoded in the S. Typhimurium pSLT virulence plasmid that is specifically up-regulated by non-growing dormant bacteria persisting inside fibroblasts. This sRNA was inferred in microarray expression analyses, which unraveled enhanced transcriptional activity in the PSLT047-PSLT046 (mig5) intergenic region. The sRNA transcript was further identified as a 597-nucleotide molecule, which we named IesR-1, for 'Intracellular-expressed-sRNA-19. IesR-1 expression is low in bacteria growing in axenic cultures across a variety of experimental conditions but displays a marked increase (similar to 200-300 fold) following bacterial entry into fibroblasts. Remarkably, induction of IesR-1 expression is not prominent in bacteria proliferating within epithelial cells. IesR-1 deletion affects the control of bacterial growth in defined fibroblast cell lines and impairs virulence in a mouse infection model. Expression analyses performed in the PSLT047-iesR-1PSLT046 (mig5) region support a cis-acting regulatory mechanism of IesR-1 as antisense RNA over the PSLT047 transcript involving interaction at their respective 39 ends and modulation of PSLT047 protein levels. This model is sustained by the scarce production of PSLT047 protein observed in non-growing intracellular bacteria and the high amount of PSLT047 protein produced by bacteria carrying a truncated IesR-1 version with separated 59 and 39 regions. Taken together, these data reveal that S. Typhimurium sRNAs encoded in the pSLT virulence plasmid respond to a state of persistence inside the host cell. As exemplified by IesR-1, some of these sRNAs may contribute to diminish the relative levels of proteins, such as PSLT047, which are probably dispensable for the intracellular lifestyle.	[Gonzalo-Asensio, Jesus; Ortega, Alvaro D.; Rico-Perez, Gadea; Portillo, Francisco Garcia-del] CSIC, Ctr Nacl Biotecnol, Madrid, Spain; [Pucciarelli, M. Graciela] Univ Autonoma Madrid, Dept Mol Biol, Ctr Biol Mol Severo Ochoa CBMSO CSIC, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Garcia-del Portillo, F (corresponding author), CSIC, Ctr Nacl Biotecnol, Madrid, Spain.	fgportillo@cnb.csic.es	Ortega, Alvaro Dario/K-5394-2018; Gonzalo-Asensio, Jesús/E-4122-2013; García-del Portillo, Francisco/D-2576-2009	Ortega, Alvaro Dario/0000-0003-0691-7154; Gonzalo-Asensio, Jesús/0000-0001-8841-6593; Pucciarelli Morrone, Maria Graciela/0000-0002-4268-2316; Garcia-del Portillo, Francisco/0000-0002-4120-0530	Spanish Ministry of Economy and Competitiveness [BIO2010-18885, Consolider-CSD2008-00013-INTERMODS]; Agencia Estatal CSIC [PIE-201320E020]; Spanish Ministry of Economy and Competitiveness; Spanish Ministry of Education and Culture;  [CSD2008-00013-INTERMODS]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Agencia Estatal CSIC; Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Education and Culture(Spanish Government); 	This work was supported by grants BIO2010-18885 and Consolider-CSD2008-00013-INTERMODS from the Spanish Ministry of Economy and Competitiveness; and, PIE-201320E020 from the 'Agencia Estatal CSIC' (to F. G.-P.). J. G. A. held a 'Juan de la Cierva' contract from the Spanish Ministry of Economy and Competitiveness. G. R. P. holds a FPU (Formacion de Profesorado Universitario) fellowship from the Spanish Ministry of Education and Culture. A. D. O. is contracted under the CSD2008-00013-INTERMODS grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegado RA, 2008, CELL MICROBIOL, V10, P1259, DOI 10.1111/j.1462-5822.2008.01124.x; Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Arnvig KB, 2009, MOL MICROBIOL, V73, P397, DOI 10.1111/j.1365-2958.2009.06777.x; Blaser MJ, 2007, NATURE, V449, P843, DOI 10.1038/nature06198; Broz P, 2012, GUT MICROBES, V3, P62, DOI 10.4161/gmic.19141; Cano DA, 2001, INFECT IMMUN, V69, P6463, DOI 10.1128/IAI.69.10.6463-6474.2001; Chinni SV, 2010, NUCL ACIDS RES; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dominguez-Bernal G, 2008, VET MICROBIOL, V130, P298, DOI 10.1016/j.vetmic.2008.01.008; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Ferrara S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036553; FROST L, 1989, MOL GEN GENET, V218, P152, DOI 10.1007/BF00330578; Fu GK, 2004, GENOMICS, V84, P205, DOI 10.1016/j.ygeno.2004.01.011; Garcia-Calderon CB, 2007, J BACTERIOL, V189, P6635, DOI 10.1128/JB.00640-07; Gerdes K, 2007, CURR OPIN MICROBIOL, V10, P117, DOI 10.1016/j.mib.2007.03.003; Gerdes K, 2012, ANNU REV MICROBIOL, V66, P103, DOI 10.1146/annurev-micro-092611-150159; Gong H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002120; GOTTESMAN S, 2010, COLD SPRING HARB PER; Greenfield TJ, 2000, MOL MICROBIOL, V37, P652, DOI 10.1046/j.1365-2958.2000.02035.x; Greenfield TJ, 2001, MOL MICROBIOL, V42, P527, DOI 10.1046/j.1365-2958.2001.02663.x; HEADLEY VL, 1990, P NATL ACAD SCI USA, V87, P4179, DOI 10.1073/pnas.87.11.4179; Hebrard M, 2012, RNA BIOL, V9, P437, DOI 10.4161/rna.20480; Hershberg R, 2003, NUCLEIC ACIDS RES, V31, P1813, DOI 10.1093/nar/gkg297; Koo JT, 2011, P NATL ACAD SCI USA, V108, pE709, DOI 10.1073/pnas.1101655108; Koraimann G, 1996, MOL MICROBIOL, V21, P811, DOI 10.1046/j.1365-2958.1996.361401.x; Kroger C, 2012, P NATL ACAD SCI USA, V109, pE1277, DOI 10.1073/pnas.1201061109; Linehan SA, 2005, INFECT IMMUN, V73, P4354, DOI 10.1128/IAI.73.7.4354-4362.2005; Lober S, 2006, INT J MED MICROBIOL, V296, P435, DOI 10.1016/j.ijmm.2006.05.001; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mann B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002788; Mariscotti JF, 2009, J BACTERIOL, V191, P1855, DOI 10.1128/JB.01604-08; Masse E, 2003, CURR OPIN MICROBIOL, V6, P120, DOI 10.1016/S1369-5274(03)00027-4; Matsui H, 2001, J BACTERIOL, V183, P4652, DOI 10.1128/JB.183.15.4652-4658.2001; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; MCDOWALL KJ, 1994, J BIOL CHEM, V269, P10790; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Mraheil MA, 2011, NUCLEIC ACIDS RES, V39, P4235, DOI 10.1093/nar/gkr033; Nunez-Hernandez C, 2013, INFECT IMMUN, V81, P154, DOI 10.1128/IAI.01080-12; Opdyke JA, 2011, J MOL BIOL, V406, P29, DOI 10.1016/j.jmb.2010.12.009; Ortega AD, 2012, RNA BIOL, V9, P469, DOI 10.4161/rna.19317; Padalon-Brauch G, 2008, NUCLEIC ACIDS RES, V36, P1913, DOI 10.1093/nar/gkn050; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Portillo FGD, 2008, CURR OPIN MICROBIOL, V11, P46, DOI 10.1016/j.mib.2008.01.001; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; Sahr T, 2009, MOL MICROBIOL, V72, P741, DOI 10.1111/j.1365-2958.2009.06677.x; Santiviago CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000477; Silvaggi JM, 2005, J BACTERIOL, V187, P6641, DOI 10.1128/JB.187.19.6641-6650.2005; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Tedin K, 1996, J BIOL CHEM, V271, P17675, DOI 10.1074/jbc.271.30.17675; Thomason MK, 2010, ANNU REV GENET, V44, P167, DOI 10.1146/annurev-genet-102209-163523; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Valdivia RH, 1997, SCIENCE, V277, P2007, DOI 10.1126/science.277.5334.2007; Vogel J, 2003, NUCLEIC ACIDS RES, V31, P6435, DOI 10.1093/nar/gkg867; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043	57	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e77939	10.1371/journal.pone.0077939	http://dx.doi.org/10.1371/journal.pone.0077939			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24205037	gold, Green Submitted, Green Published			2022-12-27	WOS:000326373800010
J	Basannagari, B; Kala, CP				Basannagari, Basavaraj; Kala, Chandra Prakash			Climate Change and Apple Farming in Indian Himalayas: A Study of Local Perceptions and Responses	PLOS ONE			English	Article								Apple farming is an important activity and profession of farmer communities in the Himalayan states of India. At present, the traditional apple farming is under stress due to changes in climate. The present study was undertaken in an Indian Himalayan state, Himachal Pradesh, with the major aim of studying perceptions of farmers on the effects of climate change on apple farming along the altitudinal gradient. Through questionnaire survey, the perceptions of farmers were recorded at low hills (<2500 m), mid-hills (2500-3000 m), and upper hills (>3000 m). At all elevation range the majority of farmers reported that there was increase in atmospheric temperature, and hence at low hills 72% farmers believed that this increase in temperature was responsible for decline in fruit size and so that the quality. Thirty five percent farmers at high hills and 30% at mid hills perceived frost as a major cause for damaging apple farming whereas at low hills 24% farmers perceived hailstorm as the major deterrent for apple farming. The majority of farmers, along the altitude (92% at high hills, 79% at mid hills and 83% at low hills), reported decrease in snowfall. The majority of farmers at low altitude and mid altitude reported decline in apple farming whereas 71% farmers at high hill areas refused decline in apple farming. About 73-83% farmers admitted delay in apple's harvesting period. At mid hills apple scab and at low hills pest attack on apple crops are considered as the indicators of climate change. The change in land use practices was attributed to climate change and in many areas the land under apple farming was replaced for production of coarse grains, seasonal vegetables and other horticulture species. Scientific investigation claiming changes in Indian Himalayan climate corroborates perceptions of farmers, as examined during the present study.	[Basannagari, Basavaraj; Kala, Chandra Prakash] Indian Inst Forest Management, Bhopal, Madhya Pradesh, India	Indian Institute of Forest Management	Kala, CP (corresponding author), Indian Inst Forest Management, Bhopal, Madhya Pradesh, India.	cpkala@yahoo.co.uk	Kala, Chandra Prakash/E-9123-2017	Kala, Chandra Prakash/0000-0002-7792-8646				[Anonymous], 2012, EC SURVEY HIMACHAL P; [Anonymous], 2006, EC SURVEY HIMACHAL P; Asghar A, 2012, PAK J BOT, V44, P1913; Awasthi R P, 2001, PRODUCTIVITY TEMPERA, P1; Bawa KS, 2010, SCIENCE, V327, P1457, DOI 10.1126/science.1185164; Beattie BB, 1978, SCI HORTICULTURE, V7, P325; Byrne D.H, 1992, TEXAS HORTICULTURIST, V18, P8; Caprio JM, 1999, CAN J PLANT SCI, V79, P129, DOI 10.4141/P98-028; Dash SK, 2007, CURR SCI INDIA, V93, P782; Deodhar SY, 2007, INDIAN J EC BUSINESS, V6, P35; Forshey C G., 1990, P NEW YORK STATE HOR, V135, P71; Fujisawa M, 2013, REG ENVIRON CHANGE, V13, P1211, DOI 10.1007/s10113-013-0434-6; Ghosh SP, 1999, DECIDUOUS FRUIT PROD, P38; Jindal KK, 2000, PRODUCTIVITY TEMPERA, P12; JMAFF, 2008, COMPR COUNT GLOB WAR; Kala C. P., 2010, Journal of Forest Science (Prague), V56, P373, DOI 10.17221/113/2009-JFS; Kala CP, 2007, CURR SCI INDIA, V93, P1828; Knight T. A., 1801, PHILOS T R SOC LOND, V91, P333; KRONENBERG HG, 1979, NETH J AGR SCI, V27, P131; Lee H.-G., 2010, J EXP BIOMED SCI, V16, P213; Luedeling E, 2009, CLIMATIC CHANGE, V96, P219, DOI 10.1007/s10584-009-9581-7; Partap U, 2002, PRODUCTIVITY POLLINA, P104; Rana Ranbir Singh, 2008, ISPRS ARCHIES 38, P131; Renton A., 2009, 130 OXF INT; RICHARDSON E A, 1974, Hortscience, V9, P331; SAMISH RM, 1954, ANNU REV PLANT PHYS, V5, P183, DOI 10.1146/annurev.pp.05.060154.001151; Saure M. C., 1985, Horticultural Reviews, V7, P239, DOI 10.1002/9781118060735.ch6; Seo HH, 2003, EFFECTS CLIMATIC CHA; Sharma RP., 2006, TEMPERATE HORTICULTU, P7; Shrestha UB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036741; Silori, 2013, BIODIVERSITY COMMUNI, P259; Thamaraikannan M, 2010, FACTS YOU        SEP, P7; Vedwan N, 2001, CLIM RES, V19, P109, DOI 10.3354/cr019109; Xu JC, 2009, CONSERV BIOL, V23, P520, DOI 10.1111/j.1523-1739.2009.01237.x	34	40	41	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77976	10.1371/journal.pone.0077976	http://dx.doi.org/10.1371/journal.pone.0077976			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205051	Green Published, gold, Green Submitted			2022-12-27	WOS:000326334500084
J	Dilworth, MR; Andersson, I; Renshall, LJ; Cowley, E; Baker, P; Greenwood, S; Sibley, CP; Wareing, M				Dilworth, Mark Robert; Andersson, Irene; Renshall, Lewis James; Cowley, Elizabeth; Baker, Philip; Greenwood, Susan; Sibley, Colin Peter; Wareing, Mark			Sildenafil Citrate Increases Fetal Weight in a Mouse Model of Fetal Growth Restriction with a Normal Vascular Phenotype	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; KNOCKOUT MOUSE; PLACENTAL TRANSPORT; ADULT LIFE; RAT MODEL; INTRAUTERINE; PREECLAMPSIA; HYPERTENSION; PREGNANCIES; MORBIDITY	Fetal growth restriction (FGR) is defined as the inability of a fetus to achieve its genetic growth potential and is associated with a significantly increased risk of morbidity and mortality. Clinically, FGR is diagnosed as a fetus falling below the 5th centile of customised growth charts. Sildenafil citrate (SC, Viagra (TM)), a potent and selective phosphodiesterase-5 inhibitor, corrects ex vivo placental vascular dysfunction in FGR, demonstrating potential as a therapy for this condition. However, many FGR cases present without an abnormal vascular phenotype, as assessed by Doppler measures of uterine/umbilical artery blood flow velocity. Thus, we hypothesized that SC would not increase fetal growth in a mouse model of FGR, the placental-specific Igf2 knockout mouse, which has altered placental exchange capacity but normal placental blood flow. Fetal weights were increased (by 8%) in P0 mice following maternal SC treatment (0.4 mg/ml) via drinking water. There was also a trend towards increased placental weight in treated P0 mice (P = 0.056). Additionally, 75% of the P0 fetal weights were below the 5th centile, the criterion used to define human FGR, of the non-treated WT fetal weights; this was reduced to 51% when dams were treated with SC. Umbilical artery and vein blood flow velocity measures confirmed the lack of an abnormal vascular phenotype in the P0 mouse; and were unaffected by SC treatment. (14) C-methylaminoisobutyric acid transfer (measured to assess effects on placental nutrient transporter activity) per g placenta was unaffected by SC, versus untreated, though total transfer was increased, commensurate with the trend towards larger placentas in this group. These data suggest that SC may improve fetal growth even in the absence of an abnormal placental blood flow, potentially affording use in multiple sub-populations of individuals presenting with FGR.	[Dilworth, Mark Robert; Renshall, Lewis James; Cowley, Elizabeth; Greenwood, Susan; Sibley, Colin Peter; Wareing, Mark] Univ Manchester, Inst Human Dev, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England; [Dilworth, Mark Robert; Renshall, Lewis James; Cowley, Elizabeth; Greenwood, Susan; Sibley, Colin Peter; Wareing, Mark] Cent Manchester Univ Hosp NHS Fdn Trust, St Marys Hosp, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Andersson, Irene] Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada; [Baker, Philip] Univ Auckland, Liggins Inst, Auckland 1, New Zealand	University of Manchester; University of Manchester; University of Alberta; University of Auckland	Dilworth, MR (corresponding author), Univ Manchester, Inst Human Dev, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England.	m.r.dilworth@manchester.ac.uk	Dilworth, Mark/J-6395-2015; Wareing, Mark/J-6396-2015	Dilworth, Mark/0000-0002-7106-7451; Wareing, Mark/0000-0002-1333-0899; Greenwood, Susan/0000-0003-2867-4368	Medical Research Council Programme Grant [G0802770/92495]; Tommy's the Baby Charity, an Action Research Endowment Fund; Manchester Biomedical Research Centre; Greater Manchester Comprehensive Local Research Network; MRC [G0802770] Funding Source: UKRI; Medical Research Council [G0802770] Funding Source: researchfish	Medical Research Council Programme Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Tommy's the Baby Charity, an Action Research Endowment Fund; Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Greater Manchester Comprehensive Local Research Network; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by a Medical Research Council Programme Grant (G0802770/92495) awarded to CPS, MW, SLG and PNB. The Maternal and Fetal Health Research Centre is supported by funding from Tommy's the Baby Charity, an Action Research Endowment Fund, the Manchester Biomedical Research Centre and the Greater Manchester Comprehensive Local Research Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acolet D., 2008, CONFIDENTIAL ENQUIRY; BARKER DJP, 1988, BRIT MED J, V297, P134, DOI 10.1136/bmj.297.6641.134-b; BARKER DJP, 1990, BRIT MED J, V301, P259, DOI 10.1136/bmj.301.6746.259; Baschat AA, 2007, OBSTET NORMAL PROBLE, P771, DOI DOI 10.1016/B978-0-443-06930-7.50031-1; Bernstein IM, 2000, AM J OBSTET GYNECOL, V182, P198, DOI 10.1016/S0002-9378(00)70513-8; Bond H, 2008, J PHYSIOL-LONDON, V586, P2015, DOI 10.1113/jphysiol.2007.149104; Boolell M, 1996, Int J Impot Res, V8, P47; CHANG TC, 1994, BRIT J OBSTET GYNAEC, V101, P422, DOI 10.1111/j.1471-0528.1994.tb11916.x; Cnossen JS, 2008, CAN MED ASSOC J, V178, P701, DOI 10.1503/cmaj.070430; Constancia M, 2000, NAT GENET, V26, P203, DOI 10.1038/79930; Constancia M, 2005, P NATL ACAD SCI USA, V102, P19219, DOI 10.1073/pnas.0504468103; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Cox P, 2009, BEST PRACT RES CL OB, V23, P751, DOI 10.1016/j.bpobgyn.2009.06.006; Dilworth MR, 2011, PLACENTA, V32, P914, DOI 10.1016/j.placenta.2011.08.007; Dilworth MR, 2010, P NATL ACAD SCI USA, V107, P3894, DOI 10.1073/pnas.0911710107; Fisk NM, 2008, PLOS MED, V5, P22, DOI 10.1371/journal.pmed.0050022; Flexner LB, 1941, AM J PHYSIOL, V134, P0344, DOI 10.1152/ajplegacy.1941.134.2.344; Glazier JD, 1997, PEDIATR RES, V42, P514, DOI 10.1203/00006450-199710000-00016; Herraiz S, 2012, BJOG-INT J OBSTET GY, V119, P1394, DOI 10.1111/j.1471-0528.2012.03430.x; Jansson N, 2006, J PHYSIOL-LONDON, V576, P935, DOI 10.1113/jphysiol.2003.550004; Kusinski LC, 2011, PLACENTA, V32, P871, DOI 10.1016/j.placenta.2011.07.086; Kusinski LC, 2012, AM J PHYSIOL-REG I, V303, pR86, DOI 10.1152/ajpregu.00600.2011; Ladha F, 2005, AM J RESP CRIT CARE, V172, P750, DOI 10.1164/rccm.200503-510OC; Lee J, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100438; Lukowski R, 2008, ARTERIOSCL THROM VAS, V28, P1244, DOI 10.1161/ATVBAHA.108.166405; Marconi AM, 2009, REPROD SCI, V16, P373, DOI 10.1177/1933719108327591; Mayhew TM, 2007, PLACENTA, V28, P233, DOI 10.1016/j.placenta.2006.02.011; Mayhew TM, 2003, PLACENTA, V24, P219, DOI 10.1053/plac.2002.0900; Miller J, 2008, SEMIN PERINATOL, V32, P274, DOI 10.1053/j.semperi.2008.04.010; Miller SL, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.029; Nassar AH, 2012, AM J PERINAT, V29, P429, DOI 10.1055/s-0032-1304823; Niknafs P, 2001, AM J PERINAT, V18, P325, DOI 10.1055/s-2001-17856; Osmond C, 2007, STROKE, V38, P264, DOI 10.1161/01.STR.0000254471.72186.03; Pellicer B, 2011, BJOG-INT J OBSTET GY, V118, P615, DOI 10.1111/j.1471-0528.2010.02839.x; Pomorski M, 2012, ARCH GYNECOL OBSTET, V285, P331, DOI 10.1007/s00404-011-1968-9; Pyriochou A, 2007, J CELL PHYSIOL, V211, P197, DOI 10.1002/jcp.20929; Resnik R, 2002, OBSTET GYNECOL, V99, P490, DOI 10.1016/S0029-7844(01)01780-X; Satterfield MC, 2010, J NUTR, V140, P251, DOI 10.3945/jn.109.114678; Shibata E, 2008, PLACENTA, V29, P879, DOI 10.1016/j.placenta.2008.07.001; Sibley CP, 2004, P NATL ACAD SCI USA, V101, P8204, DOI 10.1073/pnas.0402508101; Stanley JL, 2012, HYPERTENSION, V59, P1021, DOI 10.1161/HYPERTENSIONAHA.111.186270; Van Bulck B, 2003, BJOG-INT J OBSTET GY, V110, P27; Villanueva-Garcia D, 2007, J OBSTET GYNAECOL, V27, P255, DOI 10.1080/01443610701194978; von Dadelszen P, 2011, BJOG-INT J OBSTET GY, V118, P624, DOI 10.1111/j.1471-0528.2010.02879.x; Walker DK, 1999, XENOBIOTICA, V29, P297, DOI 10.1080/004982599238687; Wareing M, 2005, J CLIN ENDOCR METAB, V90, P2550, DOI 10.1210/jc.2004-1831; Zhang L, 2006, BRAIN RES, V1118, P192, DOI 10.1016/j.brainres.2006.08.028	47	49	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77748	10.1371/journal.pone.0077748	http://dx.doi.org/10.1371/journal.pone.0077748			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204949	Green Submitted, Green Published, gold			2022-12-27	WOS:000326334500053
J	Fine, AB; Jaeger, TF; Farmer, TA; Qian, T				Fine, Alex B.; Jaeger, T. Florian; Farmer, Thomas A.; Qian, Ting			Rapid Expectation Adaptation during Syntactic Comprehension	PLOS ONE			English	Article							PHONOLOGICAL TYPICALITY; LANGUAGE-ACQUISITION; PROBABILISTIC MODELS; INSTANCE THEORY; INFORMATION; CONSTRAINTS; SPEECH; EXPERIENCE; PERCEPTION; PREDICTION	When we read or listen to language, we are faced with the challenge of inferring intended messages from noisy input. This challenge is exacerbated by considerable variability between and within speakers. Focusing on syntactic processing (parsing), we test the hypothesis that language comprehenders rapidly adapt to the syntactic statistics of novel linguistic environments (e. g., speakers or genres). Two self-paced reading experiments investigate changes in readers' syntactic expectations based on repeated exposure to sentences with temporary syntactic ambiguities (so-called "garden path sentences"). These sentences typically lead to a clear expectation violation signature when the temporary ambiguity is resolved to an a priori less expected structure (e. g., based on the statistics of the lexical context). We find that comprehenders rapidly adapt their syntactic expectations to converge towards the local statistics of novel environments. Specifically, repeated exposure to a priori unexpected structures can reduce, and even completely undo, their processing disadvantage (Experiment 1). The opposite is also observed: a priori expected structures become less expected (even eliciting garden paths) in environments where they are hardly ever observed (Experiment 2). Our findings suggest that, when changes in syntactic statistics are to be expected (e. g., when entering a novel environment), comprehenders can rapidly adapt their expectations, thereby overcoming the processing disadvantage that mistaken expectations would otherwise cause. Our findings take a step towards unifying insights from research in expectation-based models of language processing, syntactic priming, and statistical learning.	[Fine, Alex B.; Jaeger, T. Florian; Qian, Ting] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; [Jaeger, T. Florian] Univ Rochester, Dept Comp Sci, Rochester, NY 14627 USA; [Farmer, Thomas A.] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA	University of Rochester; University of Rochester; University of Iowa	Fine, AB (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA.	abfine@gmail.com	Jaeger, T. Florian/O-8224-2019	Jaeger, T. Florian/0000-0002-1158-7308	NSF; NIH [T32 DC000035]; NSF CAREER [IIS-1150028]; NIHCD [R01 HD075797]; Alfred P. Sloan Fellowship;  [NSF- BCS-0845059]; Div Of Information & Intelligent Systems [1150028] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD075797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000035] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NIHCD; Alfred P. Sloan Fellowship(Alfred P. Sloan Foundation); ; Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work presented here was partially funded by an NSF Graduate Research Fellowship to ABF, an NIH post-doctoral fellowship to TF (NIH training grant # T32 DC000035) and NSF- BCS-0845059, NSF CAREER IIS-1150028, NIHCD R01 HD075797, as well as an Alfred P. Sloan Fellowship to TFJ. The views expressed here are those of the authors and not necessarily those of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abla D, 2008, NEUROPSYCHOLOGIA, V46, P2787, DOI 10.1016/j.neuropsychologia.2008.05.012; Allen JS, 2003, J ACOUST SOC AM, V113, P544, DOI 10.1121/1.1528172; Arai M, 2007, COGNITIVE PSYCHOL, V54, P218, DOI 10.1016/j.cogpsych.2006.07.001; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; Bates E, 1987, MECH LANGUAGE ACQUIS; Battaglia PW, 2004, VISION RES, V44, P113, DOI 10.1016/j.visres.2003.09.010; BAUER L, 1985, J PHONETICS, V13, P61, DOI 10.1016/S0095-4470(19)30726-0; BELL A, 1984, LANG SOC, V13, P145, DOI 10.1017/S004740450001037X; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; Bock K, 2000, J EXP PSYCHOL GEN, V129, P177, DOI 10.1037//0096-3445.129.2.177; Bod R, 2006, LINGUIST REV, V23, P291, DOI 10.1515/TLR.2006.012; Boston MF, 2011, LANG COGNITIVE PROC, V26, P301, DOI 10.1080/01690965.2010.492228; Bradlow AR, 2008, COGNITION, V106, P707, DOI 10.1016/j.cognition.2007.04.005; BRAINE MDS, 1990, J MEM LANG, V29, P591, DOI 10.1016/0749-596X(90)90054-4; Branigan HP, 2005, J EXP PSYCHOL LEARN, V31, P468, DOI 10.1037/0278-7393.31.3.468; Branigan HP, 1999, PSYCHON B REV, V6, P635, DOI 10.3758/BF03212972; Chang F, 2006, PSYCHOL REV, V113, P234, DOI 10.1037/0033-295X.113.2.234; Chang F, 2000, J PSYCHOLINGUIST RES, V29, P217, DOI 10.1023/A:1005101313330; Chater N, 2006, TRENDS COGN SCI, V10, P287, DOI 10.1016/j.tics.2006.05.007; Clark A., 2012, BEHAV BRAIN SCI; Clark H.H., 1992, ARENAS LANGUAGE USE; Clarke CM, 2004, J ACOUST SOC AM, V116, P3647, DOI 10.1121/1.1815131; Clayards M, 2008, COGNITION, V108, P804, DOI 10.1016/j.cognition.2008.04.004; Courville AC, 2006, TRENDS COGN SCI, V10, P294, DOI 10.1016/j.tics.2006.05.004; Creel SC, 2008, COGNITION, V106, P633, DOI 10.1016/j.cognition.2007.03.013; Cuetos F., 1996, LANGUAGE PROCESSING, P145, DOI DOI 10.4324/9780203773970; Demberg V, 2008, COGNITION, V109, P193, DOI 10.1016/j.cognition.2008.07.008; Eckert Penelope, 2001, STYLE SOCIOLINGUISTI; Egner T, 2010, J NEUROSCI, V30, P16601, DOI 10.1523/JNEUROSCI.2770-10.2010; Eisner F, 2006, J ACOUST SOC AM, V119, P1950, DOI 10.1121/1.2178721; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; Farmer TA, 2013, BEHAV BRAIN SCI; Farmer TA, VERBAL WORKING UNPUB; Farmer TA, 2011, J EXP PSYCHOL LEARN, V37, P1318, DOI 10.1037/a0023063; Fedzechkina M, 2012, P NATL ACAD SCI USA, V109, P17897, DOI 10.1073/pnas.1215776109; Feldman NH, 2009, PSYCHOL REV, V116, P752, DOI 10.1037/a0017196; FERREIRA F, 1986, J MEM LANG, V25, P348, DOI 10.1016/0749-596X(86)90006-9; Fine A., 2010, P 2010 WORKSH COGN M, P18; Fine A. B., 2011, P 33 ANN M COGN SCI, P925; Fine AB, 2013, COGNITIVE SCI, V37, P578, DOI 10.1111/cogs.12022; Finegan Edward, 2001, STYLE SOCIOLINGUISTI, P235, DOI 10.1017/CBO9780511613258.015.; Frank SL, 2011, PSYCHOL SCI, V22, P829, DOI 10.1177/0956797611409589; FRAZIER L, 1978, COGNITION, V6, P291, DOI 10.1016/0010-0277(78)90002-1; Garnsey SM, 1997, J MEM LANG, V37, P58, DOI 10.1006/jmla.1997.2512; Giles Howard, 1991, CONTEXTS ACCOMMODATI; Glasser DM, 2011, P NATL ACAD SCI USA, V108, pE1080, DOI 10.1073/pnas.1101141108; Goldinger SD, 1996, J EXP PSYCHOL LEARN, V22, P1166, DOI 10.1037/0278-7393.22.5.1166; Gomez RL, 1999, COGNITION, V70, P109, DOI 10.1016/S0010-0277(99)00003-7; Gravano A, 2011, P 12 C INT SPEECH CO; Griffiths TL, 2010, TRENDS COGN SCI, V14, P357, DOI 10.1016/j.tics.2010.05.004; Grodner D.J., 2011, PROCESSING ACQUISITI, P239, DOI DOI 10.7551/MITPRESS/9780262015127.003.0010; Hale J, 2001, 2ND MEETING OF THE NORTH AMERICAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P159; Hare M, 2007, J MEM LANG, V56, P410, DOI 10.1016/j.jml.2006.08.007; Harrington Jonathan, 2000, J INT PHON ASSOC, V30, P63, DOI 10.1017/S0025100300006666; Hartsuiker RJ, 2008, J MEM LANG, V58, P214, DOI 10.1016/j.jml.2007.07.003; Jaeger TF, 2013, COGNITION, V127, P57, DOI 10.1016/j.cognition.2012.10.013; Jaeger TF, 2010, COGNITIVE PSYCHOL, V61, P23, DOI 10.1016/j.cogpsych.2010.02.002; Jaeger TF, 2013, BEHAV BRAIN SCI; Jurafsky D, 1996, COGNITIVE SCI, V20, P137, DOI 10.1207/s15516709cog2002_1; JUST MA, 1982, J EXP PSYCHOL GEN, V111, P228, DOI 10.1037/0096-3445.111.2.228; Kamide Y, 2003, J MEM LANG, V49, P133, DOI 10.1016/S0749-596X(03)00023-8; Kamide Y, 2012, COGNITION, V124, P66, DOI 10.1016/j.cognition.2012.03.001; Karuza EA, BRAIN LANGUAGE; Kaschak MP, 2008, J MEM LANG, V58, P862, DOI 10.1016/j.jml.2006.12.002; Kaschak MP, 2011, PSYCHON B REV, V18, P1133, DOI 10.3758/s13423-011-0157-y; Kaschak MP, 2011, MEM COGNITION, V39, P381, DOI 10.3758/s13421-010-0042-3; Kaschak MP, 2006, COGNITION, V99, pB73, DOI 10.1016/j.cognition.2005.07.002; Kaschak MP, 2004, J EXP PSYCHOL GEN, V133, P450, DOI 10.1037/0096-3445.133.3.450; Kemtes KA, 1997, PSYCHOL AGING, V12, P362, DOI 10.1037/0882-7974.12.2.362; Kim C, 2013, LANGUAGE SPEECH, V57; Kim Midam, 2011, Lab Phonol, V2, P125; KING J, 1991, J MEM LANG, V30, P580, DOI 10.1016/0749-596X(91)90027-H; Kleinschmidt D., 2011, P 2 WORKSH COGN MOD, P10; Kleinschmidt D, 2012, 25 M CUNY C HUM SENT; Kleinschmidt D. F., 2012, P 34 ANN M COGN SCI; Kleinschmidt DF, ROBUST SPEECH UNPUB; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; Kording KP, 2007, NAT NEUROSCI, V10, P779, DOI 10.1038/nn1901; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Kraljic T, 2006, PSYCHON B REV, V13, P262, DOI 10.3758/BF03193841; Krekelberg B, 2006, TRENDS NEUROSCI, V29, P250, DOI 10.1016/j.tins.2006.02.008; Kurumada C., 2012, P 35 ANN M COGN SCI; Ledoux K, 2007, PSYCHOL SCI, V18, P135, DOI 10.1111/j.1467-9280.2007.01863.x; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Levitan R, 2011, P 49 ANN M ASS COMP; Levy R, 2011, P 49 ANN M ASS COMP; Levy R, 2008, COGNITION, V106, P1126, DOI 10.1016/j.cognition.2007.05.006; Levy R, 2009, P NATL ACAD SCI USA, V106, P21086, DOI 10.1073/pnas.0907664106; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; Lipinski J, 2010, COGNITION, V115, P147, DOI 10.1016/j.cognition.2009.12.008; Logan GD, 2002, PSYCHOL REV, V109, P376, DOI 10.1037//0033-295X.109.2.376; LOGAN GD, 1988, PSYCHOL REV, V95, P492, DOI 10.1037/0033-295X.95.4.492; Luka BJ, 2012, J MEM LANG, V66, P345, DOI 10.1016/j.jml.2011.11.001; MACDONALD MC, 1994, PSYCHOL REV, V101, P676, DOI 10.1037/0033-295X.101.4.676; MACDONALD MC, 1992, COGNITIVE PSYCHOL, V24, P56, DOI 10.1016/0010-0285(92)90003-K; MacDonald MC, 2002, PSYCHOL REV, V109, P35, DOI 10.1037//0033-295X.109.1.35; McClelland J. L., 1998, RATIONAL MODELS COGN; McDonald SA, 2003, PSYCHOL SCI, V14, P648, DOI 10.1046/j.0956-7976.2003.psci_1480.x; McRae K, 1998, J MEM LANG, V38, P283, DOI 10.1006/jmla.1997.2543; Metzing C, 2003, J MEM LANG, V49, P201, DOI 10.1016/S0749-596X(03)00028-7; Misyak JB, 2012, LANG LEARN, V62, P302, DOI 10.1111/j.1467-9922.2010.00626.x; MITCHELL DC, 1995, J PSYCHOLINGUIST RES, V24, P469, DOI 10.1007/BF02143162; Myslin M, COMPREHENSION UNPUB; Narayanan S, 2002, ADV NEURAL INFORM PR, V14; Norris D, 2003, COGNITIVE PSYCHOL, V47, P204, DOI 10.1016/S0010-0285(03)00006-9; Norris D, 2008, PSYCHOL REV, V115, P357, DOI 10.1037/0033-295X.115.2.357; Pardo JS, 2006, J ACOUST SOC AM, V119, P2382, DOI 10.1121/1.2178720; Pickering MJ, 2008, PSYCHOL BULL, V134, P427, DOI 10.1037/0033-2909.134.3.427; Pickering MJ, 2004, BEHAV BRAIN SCI, V27, P169; Pickering MJ, 2000, J PSYCHOLINGUIST RES, V29, P205, DOI 10.1023/A:1005149129259; Qian T, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00228; Reali F, 2007, J MEM LANG, V57, P1, DOI 10.1016/j.jml.2006.08.014; Reitter D, 2011, COGNITIVE SCI, V35, P587, DOI 10.1111/j.1551-6709.2010.01165.x; Roland D, 2007, J MEM LANG, V57, P348, DOI 10.1016/j.jml.2007.03.002; Saffran JR, 1996, J MEM LANG, V35, P606, DOI 10.1006/jmla.1996.0032; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Sato Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019377; Sauermann A, INDUCING PRODU UNPUB; Seidenberg MS, 1999, COGNITIVE SCI, V23, P569, DOI 10.1207/s15516709cog2304_8; Smith NJ, 2013, COGNITION; Sonderegger M, 2010, COGNITION IN FLUX, P375; Staub A, 2006, J EXP PSYCHOL LEARN, V32, P425, DOI 10.1037/0278-7393.32.2.425; Staub A, 2009, J EXP PSYCHOL LEARN, V35, P806, DOI 10.1037/a0015123; Tabor W, 1997, LANG COGNITIVE PROC, V12, P211, DOI 10.1080/016909697386853; Tabossi P, 1994, ATTENTION PERFORMANC; Tagliamonte SA, 2005, ENGL LANG LINGUIST, V9, P1; TANENHAUS MK, 1995, SCIENCE, V268, P1632, DOI 10.1126/science.7777863; Tarr MJ, 2000, NAT NEUROSCI, V3, P764, DOI 10.1038/77666; Thothathiri M, 2008, COGNITION, V108, P51, DOI 10.1016/j.cognition.2007.12.012; Traxler MJ, 2008, PSYCHON B REV, V15, P149, DOI 10.3758/PBR.15.1.149; TRUESWELL JC, 1993, J EXP PSYCHOL LEARN, V19, P528, DOI 10.1037/0278-7393.19.3.528; TRUESWELL JC, 1994, J MEM LANG, V33, P285, DOI 10.1006/jmla.1994.1014; Turk-Browne NB, 2009, J COGNITIVE NEUROSCI, V21, P1934, DOI 10.1162/jocn.2009.21131; Vroomen J, 2004, SPEECH COMMUN, V44, P55, DOI 10.1016/j.specom.2004.03.009; Wallman J, 1998, J NEUROPHYSIOL, V80, P2405, DOI 10.1152/jn.1998.80.5.2405; WEINER EJ, 1983, J LINGUIST, V19, P29, DOI 10.1017/S0022226700007441; Wells JB, 2009, COGNITIVE PSYCHOL, V58, P250, DOI 10.1016/j.cogpsych.2008.08.002; Wonnacott E, 2008, COGNITIVE PSYCHOL, V56, P165, DOI 10.1016/j.cogpsych.2007.04.002; Yaeger-Dror Malcah., 1994, PHONOLOGICAL STRUCTU, P267, DOI DOI 10.1017/CBO9780511659461.016	139	210	211	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77661	10.1371/journal.pone.0077661	http://dx.doi.org/10.1371/journal.pone.0077661			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243RL	24204909	Green Submitted, gold, Green Published			2022-12-27	WOS:000326334500039
J	Martin, A; Moore, CL; Mallon, PWG; Hoy, JF; Emery, S; Belloso, WH; Phanuphak, P; Ferret, S; Cooper, DA; Boyd, MA				Martin, Allison; Moore, Cecilia L.; Mallon, Patrick W. G.; Hoy, Jennifer F.; Emery, Sean; Belloso, Waldo H.; Phanuphak, Praphan; Ferret, Samuel; Cooper, David A.; Boyd, Mark A.		Second-line Study Team	HIV Lipodystrophy in Participants Randomised to Lopinavir/Ritonavir (LPV/r)+2-3 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (N(t)RTI) or LPV/r plus Raltegravir as Second-Line Antiretroviral Therapy	PLOS ONE			English	Article							NUCLEOSIDE ANALOG THERAPY; BODY-COMPOSITION CHANGES; METABOLIC SYNDROME; PROTEASE INHIBITORS; HIV-1-INFECTED PATIENTS; CARDIOVASCULAR RISK; INFECTED PATIENTS; NAIVE SUBJECTS; MYOCARDIAL-INFARCTION; FAT DISTRIBUTION	Objective: To compare changes over 48 weeks in body fat, lipids, Metabolic Syndrome and cardiovascular disease risk between patients randomised 1:1 to lopinavir/ritonavir (r/LPV) plus raltegravir(RAL) compared to r/LPV plus 2-3 nucleoside/nucleotide reverse transcriptase inhibitors (N(t)RTIs) as second-line therapy. Methods: Participants were HIV-1 positive (>16 years) failing first-line treatment (2 consecutive HIV RNA >500 copies/mL) of NNRTI +2N(t)RTI. Whole body dual energy x-ray absorptiometry was performed at baseline and week 48. Data were obtained to calculate the Metabolic Syndrome and Framingham cardiovascular disease (CVD) risk score. Linear regression was used to compare mean differences between arms. Logistic regression compared incidence of metabolic syndrome. Associations between percent limb fat changes at 48 weeks with baseline variables were assessed by backward stepwise multivariate linear regression. Analyses were adjusted for gender, body mass index and smoking status. Results: 210 participants were randomised. The mean (95% CI) increase in limb fat over 48 weeks was 15.7% (5.3, 25.9) or 0.9 kg (0.2, 1.5) in the r/LPV+N(t)RTI arm and 21.1% (11.1, 31,1) or 1.3 kg (0.7, 1.9) in the r/LPV+RAL arm, with no significant difference between treatment arms (-5.4% [-0.4 kg], p>0.1). Increases in total body fat mass (kg) and trunk fat mass (kg) were also similar between groups. Total: HDL cholesterol ratio was significantly higher in the RAL arm (mean difference -0.4 (1.4); p = 0.03), there were no other differences in lipid parameters between treatment arms. There were no statistically significant differences in CVD risk or incidence of Metabolic Syndrome between the two treatment arms. The baseline predictors of increased limb fat were high viral load, high insulin and participant's not taking lipid lowering treatment. Conclusion: In patients switching to second line therapy, r/LPV combined with RAL demonstrated similar improvements in limb fat as an N(t) RTI + r/LPV regimen, but a worse total: HDL cholesterol ratio over 48 weeks.	[Martin, Allison; Moore, Cecilia L.; Emery, Sean; Cooper, David A.; Boyd, Mark A.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Mallon, Patrick W. G.] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland; [Hoy, Jennifer F.] Alfred Hosp, Melbourne, Vic, Australia; [Hoy, Jennifer F.] Monash Univ, Melbourne, Vic 3004, Australia; [Belloso, Waldo H.] Coordinac Invest Clin Acad Latinoamer, Buenos Aires, DF, Argentina; [Phanuphak, Praphan] Thai Red Cross AIDS Res Ctr, Bangkok, Thailand; [Ferret, Samuel] Hop St Louis, Paris, France	University of New South Wales Sydney; Kirby Institute; University College Dublin; Florey Institute of Neuroscience & Mental Health; Monash University; Thai Red Cross Society; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Martin, A (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW, Australia.	SECONDLINE@kirby.unsw.edu.au	Hoy, Jennifer/AAK-7968-2020; Emery, Sean/J-3825-2017; Emery, Sean/O-9122-2019	Emery, Sean/0000-0001-6072-8309; Emery, Sean/0000-0001-6072-8309; Espinosa, Nuria/0000-0003-2249-2352; Boyd, Mark/0000-0002-6848-3307; Moore, Cecilia/0000-0002-5438-6143; Hoy, Jennifer/0000-0002-6948-7086; Martin, Allison/0000-0001-6065-1188	Kirby Institute; Merck Co. Inc.; AbbVie Pty Ltd; NHMRC; amfAR	Kirby Institute; Merck Co. Inc.(Merck & Company); AbbVie Pty Ltd(AbbVie); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); amfAR	Funding for the Second-line study was provided by The Kirby Institute, Merck & Co. Inc., AbbVie Pty Ltd, NHMRC, and amfAR. The Kirby Institute was the sponsor and played a role in study design, data collection and analysis, decision to publish and preparation of the manuscript. Merck & Co and AbbVie had a representative on the Protocol Steering Committee but had no role in study design or data collection. They did review the analysis plan and manuscript, but did not draft these documents. NHMRC and amfAR had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboud M, 2010, INT J CLIN PRACT, V64, P1252, DOI 10.1111/j.1742-1241.2010.02424.x; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Ananworanich J, 2008, J ANTIMICROB CHEMOTH, V61, P1340, DOI 10.1093/jac/dkn097; [Anonymous], GUID US ANT AG HIV 1; Bacchetti P, 2005, JAIDS-J ACQ IMM DEF, V40, P121, DOI 10.1097/01.qai.0000182230.47819.aa; Bernasconi E, 2002, JAIDS-J ACQ IMM DEF, V31, P50, DOI 10.1097/00126334-200209010-00007; Bonfanti P, 2007, JAIDS-J ACQ IMM DEF, V45, P426, DOI 10.1097/QAI.0b013e318074ef83; Boyd MA, 2013, LANCET, V381, P2091, DOI 10.1016/S0140-6736(13)61164-2; Boyd MA, 2006, J INFECT DIS, V194, P642, DOI 10.1086/505709; Bruno R, 2002, JAIDS, V31, P363, DOI 10.1097/00126334-200211010-00015; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Carr A, 2000, AIDS, V14, pF25, DOI 10.1097/00002030-200002180-00001; Curran A, 2012, AIDS, V26, P475, DOI 10.1097/QAD.0b013e32834f3507; Dube MP, 2005, AIDS, V19, P1807, DOI 10.1097/01.aids.0000183629.20041.bb; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Gazzaruso C, 2002, DIABETES CARE, V25, P1253, DOI 10.2337/diacare.25.7.1253; Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Grunfeld C, 2009, AIDS, V23, P1841, DOI 10.1097/QAD.0b013e32832d3b85; Gupta V, 2011, INT J STD AIDS, V22, P46, DOI 10.1258/ijsa.2010.010193; Hadigan C, 2006, AM J PHYSIOL-ENDOC M, V290, pE289, DOI 10.1152/ajpendo.00273.2005; Iwamoto M, 2008, J CLIN PHARMACOL, V48, P726, DOI 10.1177/0091270008318007; Kotler DP, 2003, CLIN INFECT DIS, V37, pS47, DOI 10.1086/375891; Lennox JL, 2010, JAIDS-J ACQ IMM DEF, V55, P39, DOI 10.1097/QAI.0b013e3181da1287; Lichtenstein KA, 2001, AIDS, V15, P1389, DOI 10.1097/00002030-200107270-00008; Lichtenstein KA, 2003, JAIDS-J ACQ IMM DEF, V32, P48, DOI 10.1097/00126334-200301010-00007; Mallal SA, 2000, AIDS, V14, P1309, DOI 10.1097/00002030-200007070-00002; Mallon PWG, 2003, AIDS, V17, P971, DOI 10.1097/00002030-200305020-00005; Mamary EM, 2002, AIDS PATIENT CARE ST, V16, P39, DOI 10.1089/108729102753429389; Martin A, 2009, CLIN INFECT DIS, V49, P1591, DOI 10.1086/644769; Martinez E, 2001, LANCET, V357, P592, DOI 10.1016/S0140-6736(00)04056-3; Martinez E, 2010, AIDS, V24, P1697, DOI 10.1097/QAD.0b013e32833a608a; Miller KD, 1998, LANCET, V351, P871, DOI 10.1016/S0140-6736(97)11518-5; Minami R, 2011, J INFECT CHEMOTHER, V17, P183, DOI 10.1007/s10156-010-0101-5; Ofotokun I, 2012, AIDS RES HUM RETROV, V28, P1196, DOI 10.1089/aid.2011.0336; Palella FJ, 2004, CLIN INFECT DIS, V38, P903, DOI 10.1086/381684; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Ramkumar K, 2009, CORE EVID, V4, P131; Reynes J, 2013, AIDS RES HUM RETROV, V29, P256, DOI [10.1089/aid.2011.0275, 10.1089/AID.2011.0275]; Reynes J, 2011, HIV CLIN TRIALS, V12, P255, DOI 10.1310/hct1205-255; Saghayam S, 2007, CLIN INFECT DIS, V44, P295, DOI 10.1086/510491; Stein JH, 2008, LANCET, V371, P1391, DOI 10.1016/S0140-6736(08)60491-2; van der Valk M, 2001, AIDS, V15, P847, DOI 10.1097/00002030-200105040-00005; Wand H, 2005, ANTIVIR THER, V10, pL5; Wand H, 2007, AIDS, V21, P2445, DOI 10.1097/QAD.0b013e3282efad32; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Worm SW, 2010, AIDS, V24, P1537, DOI 10.1097/QAD.0b013e32833a0918	47	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77138	10.1371/journal.pone.0077138	http://dx.doi.org/10.1371/journal.pone.0077138			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204757	Green Published, Green Submitted, gold			2022-12-27	WOS:000326334500019
J	Sandt, CH; Fedorka-Cray, PJ; Tewari, D; Ostroff, S; Joyce, K; M'ikanatha, NM				Sandt, Carol H.; Fedorka-Cray, Paula J.; Tewari, Deepanker; Ostroff, Stephen; Joyce, Kevin; M'ikanatha, Nkuchia M.			A Comparison of Non-Typhoidal Salmonella from Humans and Food Animals Using Pulsed-Field Gel Electrophoresis and Antimicrobial Susceptibility Patterns	PLOS ONE			English	Article							SEROTYPE ENTERITIDIS INFECTIONS; UNITED-STATES; FOODBORNE ILLNESS; RISK-FACTORS; DIVERSITY; SITES	Salmonellosis is one of the most important foodborne diseases affecting humans. To characterize the relationship between Salmonella causing human infections and their food animal reservoirs, we compared pulsed-field gel electrophoresis (PFGE) and antimicrobial susceptibility patterns of non-typhoidal Salmonella isolated from ill humans in Pennsylvania and from food animals before retail. Human clinical isolates were received from 2005 through 2011 during routine public health operations in Pennsylvania. Isolates from cattle, chickens, swine and turkeys were recovered during the same period from federally inspected slaughter and processing facilities in the northeastern United States. We found that subtyping Salmonella isolates by PFGE revealed differences in antimicrobial susceptibility patterns and, for human Salmonella, differences in sources and invasiveness that were not evident from serotyping alone. Sixteen of the 20 most common human Salmonella PFGE patterns were identified in Salmonella recovered from food animals. The most common human Salmonella PFGE pattern, Enteritidis pattern JEGX01.0004 (JEGX01.0003ARS), was associated with more cases of invasive salmonellosis than all other patterns. In food animals, this pattern was almost exclusively (99%) found in Salmonella recovered from chickens and was present in poultry meat in every year of the study. Enteritidis pattern JEGX01.0004 (JEGX01.0003ARS) was associated with susceptibility to all antimicrobial agents tested in 94.7% of human and 97.2% of food animal Salmonella isolates. In contrast, multidrug resistance (resistance to three or more classes of antimicrobial agents) was observed in five PFGE patterns. Typhimurium patterns JPXX01.0003 (JPXX01.0003 ARS) and JPXX01.0018 (JPXX01.0002 ARS), considered together, were associated with resistance to five or more classes of antimicrobial agents: ampicillin, chloramphenicol, streptomycin, sulfonamides and tetracycline (ACSSuT), in 92% of human and 80% of food animal Salmonella isolates. The information from our study can assist in source attribution, outbreak investigations, and tailoring of interventions to maximize their impact on prevention.	[Sandt, Carol H.] Penn Dept Hlth, Bur Labs, Exton, PA USA; [Fedorka-Cray, Paula J.] ARS, USDA, Athens, GA USA; [Ostroff, Stephen; M'ikanatha, Nkuchia M.] Penn Dept Hlth, Div Infect Dis Epidemiol, Harrisburg, PA 17108 USA; [Tewari, Deepanker] Penn Dept Agr, Penn Vet Lab, Harrisburg, PA USA; [Joyce, Kevin] Ctr Dis Control & Prevent, Natl Antimicrobial Resistance Monitoring Syst, Atlanta, GA USA	United States Department of Agriculture (USDA); Centers for Disease Control & Prevention - USA	Sandt, CH (corresponding author), Penn Dept Hlth, Bur Labs, Exton, PA USA.	csandt@pa.gov		Cray, Paula/0000-0003-2951-4219; M'ikanatha, Nkuchia/0000-0002-5631-184X	Pennsylvania Department of Health through Centers for Disease Control and Prevention grant for National Antimicrobial Resistance Monitoring [ELC-04040]	Pennsylvania Department of Health through Centers for Disease Control and Prevention grant for National Antimicrobial Resistance Monitoring	This study was supported in part by the Pennsylvania Department of Health through Centers for Disease Control and Prevention grant (ELC-04040) for National Antimicrobial Resistance Monitoring. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaska JM, 2006, APPL ENVIRON MICROB, V72, P6632, DOI 10.1128/AEM.01038-06; Allard MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055254; Altekruse SF, 2006, EMERG INFECT DIS, V12, P1848; [Anonymous], 2012, ANN REPORT ZOONOSES; Brenner FW, 1998, IDENTIFICATION SEROT; Centers for Disease Control and Prevention, 2012, NAT ANT RES MON SYST; Centers for Disease Control and Prevention, 2010, INV UPD MULT OUTBR H; Centers for Disease Control and Prevention, 2013, MMWR-MORBID MORTAL W, V63, P41; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI; Currie A, 2005, EPIDEMIOL INFECT, V133, P809, DOI 10.1017/S0950268805004383; Dean AG, 2013, OPENEPI OPEN SOURCE; Dechet AM, 2006, CLIN INFECT DIS, V42, P747, DOI 10.1086/500320; Farmer J.J., 1995, MANUAL CLIN MICROBIO; Food and Drug Administration US, 2009, FED REGISTER, P33030; Gerner-Smidt P, 2006, FOODBORNE PATHOG DIS, V3, P9, DOI 10.1089/fpd.2006.3.9; Hoffmann M, 2013, GENOME ANNOUNCEMENTS, P1; Jackson CR, 2007, FOODBORNE PATHOG DIS, V4, P241, DOI 10.1089/fpd.2006.0067; Kimura AC, 2004, CLIN INFECT DIS, V38, pS244, DOI 10.1086/381576; Marcus R, 2007, EPIDEMIOL INFECT, V135, P84, DOI 10.1017/S0950268806006558; O'Brien SJ, 2012, CLIN INFECT DIS, DOI 101093/cid/cis967; Painter JA HR, 2013, EMERG INFECT DIS, P19; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Scharff RL, 2012, J FOOD PROTECT, V75, P123, DOI 10.4315/0362-028X.JFP-11-058; Soyer Y, 2010, FOODBORNE PATHOG DIS, V7, P707, DOI 10.1089/fpd.2009.0424; Swaminathan B, 2001, EMERG INFECT DIS, V7, P382; USDA, 2012, 2010 NARMS AN ARM AN; Vugia DJ, 2004, CLIN INFECT DIS, V38, pS149, DOI 10.1086/381581; Wegener HC, 2010, MEAT SCI, V84, P276, DOI 10.1016/j.meatsci.2009.06.025; Woo YK, 2006, J MICROBIOL, V44, P106; Zou M, 2012, FOODBORNE PATHOG DIS, V9, P232, DOI 10.1089/fpd.2011.1012	31	30	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77836	10.1371/journal.pone.0077836	http://dx.doi.org/10.1371/journal.pone.0077836			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204990	gold, Green Published			2022-12-27	WOS:000326334500067
J	Schanz, T; Lins, Y; Viefhaus, H; Barciaga, T; Labe, S; Preuschoft, H; Witzel, U; Sander, PM				Schanz, Tom; Lins, Yvonne; Viefhaus, Hanna; Barciaga, Thomas; Laebe, Sashima; Preuschoft, Holger; Witzel, Ulrich; Sander, P. Martin			Quantitative Interpretation of Tracks for Determination of Body Mass	PLOS ONE			English	Article							CONSTITUTIVE PARAMETERS; SAUROPOD; CONSISTENCY; CENTERS	To better understand the biology of extinct animals, experimentation with extant animals and innovative numerical approaches have grown in recent years. This research project uses principles of soil mechanics and a neoichnological field experiment with an African elephant to derive a novel concept for calculating the mass (i.e., the weight) of an animal from its footprints. We used the elephant's footprint geometry (i.e., vertical displacements, diameter) in combination with soil mechanical analyses (i.e., soil classification, soil parameter determination in the laboratory, Finite Element Analysis (FEA) and gait analysis) for the back analysis of the elephant's weight from a single footprint. In doing so we validated the first component of a methodology for calculating the weight of extinct dinosaurs. The field experiment was conducted under known boundary conditions at the Zoological Gardens Wuppertal with a female African elephant. The weight of the elephant was measured and the walking area was prepared with sediment in advance. Then the elephant was walked across the test area, leaving a trackway behind. Footprint geometry was obtained by laser scanning. To estimate the dynamic component involved in footprint formation, the velocity the foot reaches when touching the subsoil was determined by the Digital Image Correlation (DIC) technique. Soil parameters were identified by performing experiments on the soil in the laboratory. FEA was then used for the backcalculation of the elephant's weight. With this study, we demonstrate the adaptability of using footprint geometry in combination with theoretical considerations of loading of the subsoil during a walk and soil mechanical methods for prediction of trackmakers weight.	[Schanz, Tom; Lins, Yvonne; Viefhaus, Hanna; Barciaga, Thomas] Ruhr Univ Bochum, Lehrstuhl Grundbau Boden & Felsmech, Bochum, Germany; [Laebe, Sashima; Sander, P. Martin] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Bonn, Germany; [Preuschoft, Holger] Ruhr Univ Bochum, Inst Anat, Abt Funkt Morphol, Bochum, Germany; [Witzel, Ulrich] Ruhr Univ Bochum, Lehrstuhl Maschinenelemente & Konstrukt Lehre, Forsch Grp Biomech, Bochum, Germany	Ruhr University Bochum; University of Bonn; Ruhr University Bochum; Ruhr University Bochum	Schanz, T (corresponding author), Ruhr Univ Bochum, Lehrstuhl Grundbau Boden & Felsmech, Univ Str 150, Bochum, Germany.	tom.schanz@rub.de						Alexander RM, 2006, P ROY SOC B-BIOL SCI, V273, P1849, DOI 10.1098/rspb.2006.3532; ALEXANDER RM, 1976, NATURE, V261, P129, DOI 10.1038/261129a0; [Anonymous], 1979, 40191 DIN; Barnes Fran A., 1994, Gaia, V10, P37; Bates KT, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0009; Campione NE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-60; Christian Andreas, 1999, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V2, P81; COLBERT EDWIN H., 1962, AMER MUS NOVITATES, V2076, P1; Diedrich Cajus, 2011, Palaeobiodiversity Palaeoenvironments, V91, P129, DOI 10.1007/s12549-010-0044-y; Falkingham PL, 2011, J R SOC INTERFACE, V8, P1142, DOI 10.1098/rsif.2010.0634; Falkingham PL, 2011, BIOL LETTERS, V7, P142, DOI 10.1098/rsbl.2010.0403; Falkingham PL, 2010, PALAIOS, V25, P356, DOI 10.2110/palo.2009.p09-164r; Falkingham PL, 2009, PALAEOGEOGR PALAEOCL, V271, P69, DOI 10.1016/j.palaeo.2008.09.011; Farlow J.O., 1989, P371; Fischer R, 1998, MITTEILUNGEN I GEOLO, V37; Gatesy S, 2003, ICHNOS, V10; Genin JJ, 2010, J EXP BIOL, V213, P694, DOI 10.1242/jeb.035436; Gunga HC, 2008, FOSS REC, V11, P33, DOI 10.1002/mmng.200700011; Gunga HC, 2007, NATURWISSENSCHAFTEN, V94, P623, DOI 10.1007/s00114-007-0234-2; HAZEN A., 1892, MASSACHUSETTS STATE, V24, P539; Henderson DM, 1999, PALEOBIOLOGY, V25, P88; Henderson DM, 2006, J VERTEBR PALEONTOL, V26, P907, DOI 10.1671/0272-4634(2006)26[907:BGCOMS]2.0.CO;2; Henderson Donald M., 2003, Ichnos, V10, P99, DOI 10.1080/10420940390257914; Hutchinson JR, 2003, NATURE, V422, P493, DOI 10.1038/422493a; Ishigaki Shinobu, 2009, Memoir of the Fukui Prefectural Dinosaur Museum, V8, P1; Jackson SJ, 2010, ICHNOS, V17, P197, DOI 10.1080/10420940.2010.510026; Kaever M., 1974, B SOC GEOL FR, V16, P516, DOI DOI 10.2113/GSSGFBULL.S7-XVI.5.516; Klein N., 2011, BIOL SAUROPOD DINOSA; Knabe T, 2013, COMPUT GEOTECH, V49, P143, DOI 10.1016/j.compgeo.2012.10.002; Knabe T, 2012, CAN GEOTECH J, V49, P170, DOI [10.1139/t11-091, 10.1139/T11-091]; Lambe T.W., 1969, SOIL MECH; Lockley M. G., 2004, GERMANY ICHNOS, V11, P261; LOCKLEY MG, 1986, GEOL SOC AM BULL, V97, P1163, DOI 10.1130/0016-7606(1986)97<1163:NALDTS>2.0.CO;2; Lockley MG, 2001, GUIDEBOOK NEW MEXICO, V52; Manning PL, 2004, GEOL SOC SPEC PUBL, V228, P93, DOI 10.1144/GSL.SP.2004.228.01.06; Mannion PD, 2010, PALEOBIOLOGY, V36, P253, DOI 10.1666/08085.1; Milan J, 2006, PALAEONTOLOGY, V49, P405, DOI 10.1111/j.1475-4983.2006.00543.x; Ohde J, 1939, BAUINGENIEUR, V20, P93; Platt BF, 2012, PALAIOS, V27, P726, DOI 10.2110/palo.2012.p12-006r; Preuschoft Holger, 2011, P197; Prince N.K., 1989, P155; Rochter L., 2011, THESIS RUHR U BOCHUM; Sander PM, 2008, SCIENCE, V322, P200, DOI 10.1126/science.1160904; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Schanz T, 1996, GEOTECHNIQUE, V46, P145, DOI 10.1680/geot.1996.46.1.145; Schanz T., 1998, PREFAILURE DEFORMATI, V383-387; Schanz T., 1999, HARDENING SOIL MODEL; SHANZ T., 1998, MITT I GEOTECHNIK, V45; Thulborn T., 1990, DINOSAUR TRACKS; Wright JL, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P252	50	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77606	10.1371/journal.pone.0077606	http://dx.doi.org/10.1371/journal.pone.0077606			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204890	gold, Green Published, Green Submitted			2022-12-27	WOS:000326334500036
J	Vieira, DC; Fonseca, G				Vieira, Danilo Candido; Fonseca, Gustavo			The Importance of Vertical and Horizontal Dimensions of the Sediment Matrix in Structuring Nematodes Across Spatial Scales	PLOS ONE			English	Article							TURBULENT TIDAL CREEK; NORTH-SEA; COMMUNITY UNDERNEATH; SPECIES-DIVERSITY; MARINE NEMATODES; SULFIDE SYSTEM; FINE-SCALE; MEIOFAUNA; DISPERSAL; PATTERNS	Intensive surveys have been conducted to unravel spatial patterns of benthic infauna communities. Although it has been recognized that benthic organisms are spatially structured along the horizontal and vertical dimensions of the sediment, little is known on how these two dimensions interact with each other. In this study we investigated the interdependence between the vertical and horizontal dimensions in structuring marine nematodes assemblages. We tested whether the similarity in nematode species composition along the horizontal dimension was dependent on the vertical layer of the sediment. To test this hypothesis, three-cm interval sediment samples (15 cm depth) were taken independently from two bedforms in three estuaries. Results indicated that assemblages living in the top layers are more abundant, species rich and less variable, in terms of species presence/absence and relative abundances, than assemblages living in the deeper layers. Results showed that redox potential explained the greatest amount (12%) of variability in species composition, more than depth or particle size. The fauna inhabiting the more oxygenated layers were more homogeneous across the horizontal scales than those from the reduced layers. In contrast to previous studies, which suggested that reduced layers are characterized by a specific set of tolerant species, the present study showed that species assemblages in the deeper layers are more causal (characterized mainly by vagrant species). The proposed mechanism is that at the superficial oxygenated layers, species have higher chances of being resuspended and displaced over longer distances by passive transport, while at the deeper anoxic layers they are restricted to active dispersal from the above and nearby sediments. Such restriction in the dispersal potential together with the unfavorable environmental conditions leads to randomness in the presence of species resulting in the high variability between assemblages along the horizontal dimension.	[Vieira, Danilo Candido] Univ Fed Parana UFPR, CEM, Pontal Do Parana, Parana, Brazil; [Vieira, Danilo Candido; Fonseca, Gustavo] Univ Sao Paulo, Ctr Biol Marinha CEBIMar, Sao Paulo, Brazil	Universidade Federal do Parana; Universidade de Sao Paulo	Vieira, DC (corresponding author), Univ Fed Parana UFPR, CEM, Pontal Do Parana, Parana, Brazil.	vieiradc@yahoo.com.br	Vieira, Danilo/F-5176-2018; Fonseca, Gustavo/B-7673-2011; Fonseca, Gustavo/F-5138-2018	Vieira, Danilo/0000-0002-7989-6553; Fonseca, Gustavo/0000-0001-8625-4279; Fonseca, Gustavo/0000-0001-8625-4279	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/REUNI); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/14019-0]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/REUNI); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	DCV was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/REUNI) (http://www.capes.gov.br/); and GF was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) number 2009/14019-0 (http://www.fapesp.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2005, PERMUTATIONAL MULTIV; [Anonymous], 2004, PERMDISP FORTRAN COM; Boeckner MJ, 2009, HYDROBIOLOGIA, V624, P91, DOI 10.1007/s10750-008-9669-5; Bonsdorff E, 2003, BOREAL ENVIRON RES, V8, P135; Braeckman U, 2011, MAR ECOL PROG SER, V422, P179, DOI 10.3354/meps08910; CHANDLER GT, 1983, J EXP MAR BIOL ECOL, V69, P175, DOI 10.1016/0022-0981(83)90066-7; Chapman MG, 2010, MAR ECOL PROG SER, V398, P33, DOI 10.3354/meps08328; Commito JA, 2002, J EXP MAR BIOL ECOL, V268, P237, DOI 10.1016/S0022-0981(01)00386-0; Coull BC, 1999, AUST J ECOL, V24, P327, DOI 10.1046/j.1442-9993.1999.00979.x; Danovaro R, 2000, PROG OCEANOGR, V46, P367, DOI 10.1016/S0079-6611(00)00026-4; Danovaro R, 1995, PROG OCEANOGR, V36, P329, DOI 10.1016/0079-6611(96)00002-X; De Camargo M.G., 2006, REV BRAS GEOCI NC, V36, P371, DOI DOI 10.25249/0375-7536.2006362371378; Dias PC, 1996, TRENDS ECOL EVOL, V11, P326, DOI 10.1016/0169-5347(96)10037-9; ESKIN RA, 1985, BIOL BULL, V169, P615, DOI 10.2307/1541303; FENCHEL TM, 1970, MAR BIOL, V7, P255, DOI 10.1007/BF00367496; FENCHEL TM, 1978, ANNU REV ECOL SYST, V9, P99, DOI 10.1146/annurev.es.09.110178.000531; Fenchel T, 2008, BIOL REV, V83, P553, DOI 10.1111/j.1469-185X.2008.00054.x; FINDLAY SEG, 1981, ESTUAR COAST SHELF S, V12, P471, DOI 10.1016/S0302-3524(81)80006-0; Flach E, 2002, PROG OCEANOGR, V52, P433, DOI 10.1016/S0079-6611(02)00018-6; FLEEGER JW, 1987, STYGOLOGIA, V3, P35; FLEEGER JW, 1986, J EXP MAR BIOL ECOL, V95, P173, DOI 10.1016/0022-0981(86)90201-7; Fonseca G, 2011, AQUAT BIOL, V13, P27, DOI 10.3354/ab00347; Fonseca G, 2010, PROG OCEANOGR, V84, P174, DOI 10.1016/j.pocean.2009.11.001; Gallucci F, 2008, MAR ECOL PROG SER, V367, P173, DOI 10.3354/meps07537; Gallucci Fabiane, 2009, Marine Biodiversity, V39, P9; Gingold R, 2010, MAR BIOL, V157, P1741, DOI 10.1007/s00227-010-1447-z; Glud RN, 2008, MAR BIOL RES, V4, P243, DOI 10.1080/17451000801888726; GOODAY AJ, 1986, DEEP-SEA RES, V33, P1345, DOI 10.1016/0198-0149(86)90040-3; Gorley C.K., 2006, GETTING STARTED PRIM; HEIP C, 1985, OCEANOGR MAR BIOL, V23, P399; HODDA M, 1990, ESTUAR COAST SHELF S, V30, P325, DOI 10.1016/0272-7714(90)90001-8; Hodda M, 2007, ZOOTAXA, P265, DOI 10.11646/zootaxa.1668.1.14; Huettel M, 2003, HYDROBIOLOGIA, V494, P231, DOI 10.1023/A:1025426601773; JOINT IR, 1982, MAR BIOL, V72, P157, DOI 10.1007/BF00396916; Kotwicki L, 2005, HELGOLAND MAR RES, V59, P255, DOI 10.1007/s10152-005-0001-8; Levin LA, 2003, OCEANOGR MAR BIOL, V41, P1; Maria TF, 2012, ESTUAR COAST SHELF S, V97, P114, DOI 10.1016/j.ecss.2011.11.030; Modig H, 1998, J EXP MAR BIOL ECOL, V229, P133, DOI 10.1016/S0022-0981(98)00043-4; Moodley L, 2000, OPHELIA, V53, P203, DOI 10.1080/00785326.2000.10409450; OTT J, 1973, Netherlands Journal of Sea Research, V7, P233, DOI 10.1016/0077-7579(73)90047-1; PALMER MA, 1988, MAR ECOL PROG SER, V48, P81, DOI 10.3354/meps048081; PALMER MA, 1986, ESTUARIES, V9, P225, DOI 10.2307/1352134; PALMER MA, 1985, J MAR RES, V43, P179, DOI 10.1357/002224085788437280; Pinto TK, 2006, J MAR BIOL ASSOC UK, V86, P227, DOI 10.1017/S0025315406013075; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; REISE K, 1979, MAR BIOL, V54, P225, DOI 10.1007/BF00395785; Sandrini-Neto L., 2010, GAD GEN ANOVA DESIGN; Schratzberger M, 2007, MAR ENVIRON RES, V63, P368, DOI 10.1016/j.marenvres.2006.10.006; Schratzberger M, 2004, MAR BIOL, V145, P69, DOI 10.1007/s00227-004-1302-1; SOETAERT K, 1994, ESTUAR COAST SHELF S, V39, P367, DOI 10.1006/ecss.1994.1070; Soetaert K, 2002, MAR ECOL PROG SER, V242, P179, DOI 10.3354/meps242179; Spray SL, 2004, WETLANDS, P157; Steyaert M, 1999, J MAR BIOL ASSOC UK, V79, P253, DOI 10.1017/S0025315498000289; Steyaert M, 2007, J EXP MAR BIOL ECOL, V345, P175, DOI 10.1016/j.jembe.2007.03.001; Steyaert M, 2003, ESTUAR COAST SHELF S, V58, P353, DOI 10.1016/S0272-7714(03)00086-6; Suguio K., 1973, INTRO SEDIMENTOLOGIA; Teiwes M, 2007, J FRESHWATER ECOL, V22, P429, DOI 10.1080/02705060.2007.9664173; TIETJEN JH, 1969, OECOLOGIA, V2, P251, DOI 10.1007/BF00386114; Udalov AA, 2005, PROG OCEANOGR, V67, P1, DOI 10.1016/j.pocean.2005.02.020; Van Colen C, 2009, MAR ECOL PROG SER, V381, P189, DOI 10.3354/meps07914; Warwick R, 1998, SYNOPSES BRIT FAUNA, V53, P1; Wells JT, 1995, DEV SEDIMENTOL, V53, P179, DOI DOI 10.1016/S0070-4571(05)80026-3; Wetzel R.G., 2000, LIMNOLOGICAL ANAL, V3	63	13	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77704	10.1371/journal.pone.0077704	http://dx.doi.org/10.1371/journal.pone.0077704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204925	Green Published, gold, Green Submitted			2022-12-27	WOS:000326334500044
J	Li, DH; Chen, G; Yang, JC; Fan, XF; Gong, YS; Xu, GH; Cui, QH; Geng, B				Li, Danhua; Chen, Geng; Yang, Jichun; Fan, Xiaofang; Gong, Yongsheng; Xu, Guoheng; Cui, Qinghua; Geng, Bin			Transcriptome Analysis Reveals Distinct Patterns of Long Noncoding RNAs in Heart and Plasma of Mice with Heart Failure	PLOS ONE			English	Article							HUMAN-DISEASE; BIOMARKERS; NEURODEGENERATION; EXPRESSION	Objective: To assess the global changes in and characteristics of the transcriptome of long noncoding RNAs (LncRNAs) in heart tissue, whole blood and plasma during heart failure (HF) and association with expression of paired coding genes. Methods: Here we used microarray assay to examine the transcriptome of LncRNAs deregulated in the heart, whole blood, and plasma during HF in mice. We confirmed the changes in LncRNAs by quantitative PCR. Results: We revealed and confirmed a number of LncRNAs that were deregulated during HF, which suggests a potential role of LncRNAs in HF. Strikingly, the patterns of expression of LncRNA differed between plasma and other tissue during HF. LncRNA expression was associated with LncRNA length in all samples but not in plasma during HF, which suggests that the global association of LncRNA expression and LncRNA length in plasma could be biomarkers for HF. In total, 32 LncRNAs all expressed in the heart, whole blood and plasma showed changed expression with HF, so they may be biomarkers in HF. In addition, sense-overlapped LncRNAs tended to show consistent expression with their paired coding genes, whereas antisense-overlapped LncRNAs tended to show the opposite expression in plasma; so different types of LncRNAs may have different characteristics in HF. Interestingly, we revealed an inverse correlation between changes in expression of LncRNAs in plasma and in heart, so circulating levels of LncRNAs may not represent just passive leakage from the HF heart but also active regulation or release of circulatory cells or other cells during HF. Conclusions: We reveal stable expression of LncRNAs in plasma during HF, which suggests a newly described component in plasma. The distinct expression patterns of circulatory LncRNAs during HF indicate that LncRNAs may actively respond to stress and thus serve as biomarkers of HF diagnosis and treatment.	[Li, Danhua; Yang, Jichun; Xu, Guoheng; Cui, Qinghua; Geng, Bin] Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China; [Chen, Geng] Peking Univ, Sch Basic Med Sci, Dept Biomed Informat, Beijing 100871, Peoples R China; [Cui, Qinghua] Peking Univ, Inst Syst Biomed, Beijing 100871, Peoples R China; [Li, Danhua; Chen, Geng; Yang, Jichun; Xu, Guoheng; Cui, Qinghua; Geng, Bin] Peking Univ, MOE Key Lab Mol Cardiovasc Sci, Beijing 100871, Peoples R China; [Fan, Xiaofang; Gong, Yongsheng] Wenzhou Med Univ, Inst Hypoxia Med, Wenzhou, Zhejiang, Peoples R China	Peking University; Peking University; Peking University; Peking University; Wenzhou Medical University	Cui, QH (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China.	cuiqinghua@hsc.pku.edu.cn; bingeng@bjmu.edu.cn	Geng, Bin/ABB-6045-2020	Geng, Bin/0000-0001-7573-8710	Major State Basic Research Development Program of China [2012CB517806, 2012CB5106, 2009CB941603]; National Natural Science Foundation of China [81170235, 81070114]; Program for New Century Excellent Talents in University	Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This study was supported by the Major State Basic Research Development Program of China (Nos. 2012CB517806, 2012CB5106 and 2009CB941603), the National Natural Science Foundation of China (81170235 and 81070114), and the Program for New Century Excellent Talents in University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsheshet A, 2012, NAT REV CARDIOL, V9, P234, DOI 10.1038/nrcardio.2012.10; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Chen G, 2012, TRENDS MOL MED; Chen G, 2013, NUCLEIC ACIDS RES, V41, pD983, DOI 10.1093/nar/gks1099; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Creemers EE, 2011, NAT REV GENET, V12, P357, DOI 10.1038/nrg2983; Dharap A, 2012, STROKE, V43, P2800, DOI 10.1161/STROKEAHA.112.669465; Dorn GW, 2011, CIRC RES, V108, P1270, DOI 10.1161/CIRCRESAHA.110.229260; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Geng B, 2004, BIOCHEM BIOPH RES CO, V318, P756, DOI 10.1016/j.bbrc.2004.04.094; Johnson R, 2012, NEUROBIOL DIS, V46, P245, DOI 10.1016/j.nbd.2011.12.006; Kaya Z, 2012, CIRC RES, V110, P145, DOI 10.1161/CIRCRESAHA.111.243360; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Magistri M, 2012, TRENDS GENET, V28, P389, DOI 10.1016/j.tig.2012.03.013; Maisel AS, 2012, NAT REV CARDIOL, V9, P478, DOI 10.1038/nrcardio.2012.60; Mallardo M, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-19; Martin L, 2012, J CLIN INVEST, V122, P1589, DOI 10.1172/JCI60020; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; Nana-Sinkam SP, 2011, MOL ONCOL, V5, P483, DOI 10.1016/j.molonc.2011.10.003; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Qiu MT, 2013, TUMOUR BIOL; Renoux AJ, 2012, PROG NEUROBIOL, V97, P173, DOI 10.1016/j.pneurobio.2011.10.006; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Schonrock N, 2012, CIRC RES, V111, P1349, DOI 10.1161/CIRCRESAHA.112.268953; Sesto N, 2013, NAT REV MICROBIOL, V11, P75, DOI 10.1038/nrmicro2934; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Spizzo R, 2012, ONCOGENE; Sun L, 2013, P NATL ACAD SCI USA, V110, P3387, DOI 10.1073/pnas.1222643110; Tamargo J, 2011, NAT REV DRUG DISCOV, V10, P536, DOI 10.1038/nrd3431; Tsui NBY, 2002, CLIN CHEM, V48, P1647; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Yu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042377	36	59	72	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77938	10.1371/journal.pone.0077938	http://dx.doi.org/10.1371/journal.pone.0077938			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205036	Green Published, gold, Green Submitted			2022-12-27	WOS:000326270700062
J	Little, A; Medhanyie, A; Yebyo, H; Spigt, M; Dinant, GJ; Blanco, R				Little, Alex; Medhanyie, Araya; Yebyo, Henock; Spigt, Mark; Dinant, Geert-Jan; Blanco, Roman			Meeting Community Health Worker Needs for Maternal Health Care Service Delivery Using Appropriate Mobile Technologies in Ethiopia	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; EXTENSION WORKERS; PHONES; INTERVENTIONS; PERFORMANCE; RECORDS; TOOL	Background: Mobile health applications are complex interventions that essentially require changes to the behavior of health care professionals who will use them and changes to systems or processes in delivery of care. Our aim has been to meet the technical needs of Health Extension Workers (HEWs) and midwives for maternal health using appropriate mobile technologies tools. Methods: We have developed and evaluated a set of appropriate smartphone health applications using open source components, including a local language adapted data collection tool, health worker and manager user-friendly dashboard analytics and maternal-newborn protocols. This is an eighteen month follow-up of an ongoing observational research study in the northern of Ethiopia involving two districts, twenty HEWs, and twelve midwives. Results: Most health workers rapidly learned how to use and became comfortable with the touch screen devices so only limited technical support was needed. Unrestricted use of smartphones generated a strong sense of ownership and empowerment among the health workers. Ownership of the phones was a strong motivator for the health workers, who recognised the value and usefulness of the devices, so took care to look after them. A low level of smartphones breakage (8.3%, 3 from 36) and loss (2.7%) were reported. Each health worker made an average of 160 mins of voice calls and downloaded 27Mb of data per month, however, we found very low usage of short message service (less than 3 per month). Conclusions: Although it is too early to show a direct link between mobile technologies and health outcomes, mobile technologies allow health managers to more quickly and reliably have access to data which can help identify where there issues in the service delivery. Achieving a strong sense of ownership and empowerment among health workers is a prerequisite for a successful introduction of any mobile health program.	[Little, Alex; Medhanyie, Araya; Blanco, Roman] Univ Alcala De Henares, Coll Hlth Sci, Dept Surg, Madrid, Spain; [Medhanyie, Araya; Yebyo, Henock; Spigt, Mark] Mekelle Univ, Dept Publ Hlth, Mekelle, Ethiopia; [Medhanyie, Araya; Spigt, Mark; Dinant, Geert-Jan] Maastricht Univ, CAPHRI, Sch Publ Hlth & Primary Care, Maastricht, Netherlands	Universidad de Alcala; Mekelle University; Maastricht University; Maastricht University Medical Centre (MUMC)	Blanco, R (corresponding author), Digital Campus, Winchester, Hants, England.	roman.blanco@uah.es		Yebyo, Henock/0000-0001-5400-2448	Mekelle University (Ethiopia); Venture Strategies Innovations; Alcala University	Mekelle University (Ethiopia); Venture Strategies Innovations; Alcala University	This study was made possible through primary funding provided by Mekelle University (Ethiopia) (http://www.mu.edu.et). Venture Strategies Innovations (http://vsinnovations.org; AECID (http://www.aecid.es) and Alcala University (http://www.uah.es) also gave additional funding. Software development was supported by Digital Campus Ltd (http://www.digital-campus.org), a UK-based not for profit company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aboud FE, 2012, SOC SCI MED, V75, P589, DOI 10.1016/j.socscimed.2012.04.009; Aker JC, 2010, J ECON PERSPECT, V24, P207, DOI 10.1257/jep.24.3.207; Amoroso CL, 2010, STUD HEALTH TECHNOL, V160, P337, DOI 10.3233/978-1-60750-588-4-337; [Central Statistical Agency [Ethiopia] and ICF International], 2011, ETH DEM HLTH SURV; Collins F, 2012, SCI AM, V307, P16, DOI 10.1038/scientificamerican0712-16; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Earth Institute, 2010, BARR GAPS AFF MHEALT; Estrin D, 2010, SCIENCE, V330, P759, DOI 10.1126/science.1196187; Fishbein M, 2000, HDB HLTH PSYCHOL; Florez-Arango JF, 2011, J AM MED INFORM ASSN, V18, P131, DOI 10.1136/jamia.2010.010025; Free C, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001363, 10.1371/journal.pmed.1001362]; Gurman TA, 2012, J HEALTH COMMUN, V17, P82, DOI 10.1080/10810730.2011.649160; Lane Shannon J, 2006, BMC Med Inform Decis Mak, V6, P23, DOI 10.1186/1472-6947-6-23; Lemay NV, 2012, J HEALTH COMMUN, V17, P105, DOI 10.1080/10810730.2011.649106; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Lund S, 2012, BJOG-INT J OBSTET GY, V119, P1256, DOI 10.1111/j.1471-0528.2012.03413.x; Mechael P, 2009, MOTECHMHEALTH ETHNOG; Mechael P., 2010, BARRIERS GAPS AFFECT; Medhanyie A, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-44; Medhanyie A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-352; mHealth Alliance Vital Wave Consulting, 2013, SUST FIN MOB HLTH MH; Natons United, 2009, MILL DEV GOALS REP; Nilekani N, 2011, NATL MED J INDIA, V24, P133; Rotheram-Borus MJ, 2012, INT J TELEMED APPL, V2012, DOI 10.1155/2012/973237; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Swider SM, 2002, PUBLIC HEALTH NURS, V19, P11, DOI 10.1046/j.1525-1446.2002.19003.x; The PLOS Medicine, 2013, PLOS MED, DOI [10.1371/journal.pmed.1001395, DOI 10.1371/J0URNAL.PMED.1001395]; Tierney WM, 2010, STUD HEALTH TECHNOL, V160, P371, DOI 10.3233/978-1-60750-588-4-371; Tomlinson M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001382; Tomlinson M, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-51; van Heerden A, 2012, B WORLD HEALTH ORGAN, V90, P393, DOI 10.2471/BLT.11.099788; VitalWave Consulting, 2011, MHEALTH ETH STRAT NE; Walshe K, 2007, INT J QUAL HEALTH C, V19, P57, DOI 10.1093/intqhc/mzm004; Were MC, 2010, INT J MED INFORM, V79, P90, DOI 10.1016/j.ijmedinf.2009.11.006; World Health Organization, 2011, NEW HOR HLTH MOB TEC; Zurovac D, 2011, LANCET, V378, P795, DOI 10.1016/S0140-6736(11)60783-6	36	63	64	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77563	10.1371/journal.pone.0077563	http://dx.doi.org/10.1371/journal.pone.0077563			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	242VF	24204872	gold, Green Published, Green Submitted			2022-12-27	WOS:000326270700039
J	Malingriaux, EA; Rupprecht, A; Gille, L; Jovanovic, O; Jezek, P; Jaburek, M; Pohl, EE				Malingriaux, Elena A.; Rupprecht, Anne; Gille, Lars; Jovanovic, Olga; Jezek, Petr; Jaburek, Martin; Pohl, Elena E.			Fatty Acids are Key in 4-Hydroxy-2-Nonenal-Mediated Activation of Uncoupling Proteins 1 and 2	PLOS ONE			English	Article							OXIDATIVE STRESS; PROTON CONDUCTANCE; MEMBRANE-PROTEINS; MITOCHONDRIA; PRODUCT; RECONSTITUTION; CONFORMATION; ADDUCTION; TRANSPORT; MECHANISM	The production of reactive oxygen species (ROS) in mitochondria is very sensitive to the proton motive force and may be decreased by mild uncoupling, mediated e. g. by mitochondrial uncoupling proteins (UCPs). UCPs were conversely hypothesized to be activated by ROS. Conclusions from experiments studying the reactive product of lipid peroxidation 4-hydroxy-2-nonenal (HNE) in isolated mitochondria and UCP knock-out mice are highly controversial. Here we investigated the molecular mechanism of HNE action by evaluating the separate contributions of lipid and protein phases of the membrane and by comparing UCP1 and UCP2, which were reconstituted in planar lipid bilayers. We demonstrated that aldehyde does not directly activate either UCP1 or UCP2. However, HNE strongly potentiated the membrane conductance increase (G(m)) mediated by different long-chain fatty acids in UCP-containing and in UCP-free membranes and this suggest the involvement of both lipid-mediated and protein-mediated mechanisms with FA playing the central role. G(m) increase was concentration-dependent and exhibited a typical saturation kinetic with the binding constant 0.3 mM. By using Electron Paramagnetic Resonance, membrane fluidity change could be excluded as a cause for the HNE-mediated increase in the presence of FA. The impact of the HNE binding to definite positively charged UCP amino acid residues is discussed as a possible protein-mediated mechanism of the UCP activation.	[Malingriaux, Elena A.; Rupprecht, Anne; Jovanovic, Olga; Pohl, Elena E.] Univ Vet Med, Inst Physiol Pathophysiol & Biophys, Vienna, Austria; [Gille, Lars] Univ Vet Med, Inst Pharmacol & Toxicol, Vienna, Austria; [Jezek, Petr; Jaburek, Martin] Acad Sci Czech Republic, Inst Physiol, Prague, Czech Republic	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Pohl, EE (corresponding author), Univ Vet Med, Inst Physiol Pathophysiol & Biophys, Vienna, Austria.	elena.pohl@vedmeduni.ac.at	Pohl, Elena E./A-4025-2009; Jaburek, Martin/B-9652-2012; Jabůrek, Martin/H-1114-2019; Jezek, Petr/B-9264-2012	Pohl, Elena E./0000-0002-0604-5950; Jabůrek, Martin/0000-0002-4357-1116; Jezek, Petr/0000-0002-2720-9395	Deutsche Forschungsgemeinschaft [Po 524/3-1]; Austrian Research Funds [P 25123-820]; Czech Science Foundation [P302/10/0346]; Austrian Science Fund (FWF) [P 25123] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Research Funds(Austrian Science Fund (FWF)); Czech Science Foundation(Grant Agency of the Czech Republic); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Deutsche Forschungsgemeinschaft (Po 524/3-1 to EP, http://www.dfg.de/), Austrian Research Funds (P 25123-820 to EP, http://www.fwf.ac.at/) and Czech Science Foundation (P302/10/0346 to PJ, www.gacr.czc). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonenko YN, 1996, ARCH BIOCHEM BIOPHYS, V333, P225, DOI 10.1006/abbi.1996.0385; Azzu V, 2008, BIOCHEM J, V413, P323, DOI 10.1042/BJ20080321; Beck V, 2007, FASEB J, V21, P1137, DOI 10.1096/fj.06-7489com; Beck V, 2006, BBA-BIOENERGETICS, V1757, P474, DOI 10.1016/j.bbabio.2006.03.006; Berardi MJ, 2011, NATURE, V476, P109, DOI 10.1038/nature10257; Berliner Lj, 1976, SEELING SPIN LABELLI; Carbone DL, 2005, CHEM RES TOXICOL, V18, P1324, DOI 10.1021/tx050078z; Carini M, 2004, MASS SPECTROM REV, V23, P281, DOI 10.1002/mas.10076; Couplan E, 2002, J BIOL CHEM, V277, P26268, DOI 10.1074/jbc.M202535200; Dlaskova A, 2008, INT J BIOCHEM CELL B, V40, P2098, DOI 10.1016/j.biocel.2008.02.007; Doorn JA, 2006, CHEM RES TOXICOL, V19, P102, DOI 10.1021/tx0501839; Doorn JA, 2003, CHEM-BIOL INTERACT, V143, P93, DOI 10.1016/S0009-2797(02)00178-3; Echtay KS, 2005, BIOFACTORS, V24, P119, DOI 10.1002/biof.5520240114; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Esteves TC, 2006, BIOCHEM J, V395, P619, DOI 10.1042/BJ20052004; Esteves TC, 2005, BBA-BIOENERGETICS, V1709, P35, DOI 10.1016/j.bbabio.2005.06.002; Garlid KD, 1996, J BIOL CHEM, V271, P2615, DOI 10.1074/jbc.271.5.2615; Grimm S, 2011, FREE RADICAL RES, V45, P73, DOI 10.3109/10715762.2010.512040; Grimsrud PA, 2008, J BIOL CHEM, V283, P21837, DOI 10.1074/jbc.R700019200; Guichardant M, 1998, FREE RADICAL BIO MED, V25, P1049, DOI 10.1016/S0891-5849(98)00149-X; HEUKESHOVEN J, 1988, ELECTROPHORESIS, V9, P28, DOI 10.1002/elps.1150090106; Isom AL, 2004, J AM SOC MASS SPECTR, V15, P1136, DOI 10.1016/j.jasms.2004.03.013; Jaburek M, 1999, J BIOL CHEM, V274, P26003, DOI 10.1074/jbc.274.37.26003; Jezek J, 2010, PHYSIOL RES, V59, P737, DOI 10.33549/physiolres.931905; Korshunov S., 1997, FEBS LETT, V41, P15; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; LIN CS, 1982, BIOCHEMISTRY-US, V21, P2950, DOI 10.1021/bi00541a023; LIN CS, 1980, FEBS LETT, V113, P299, DOI 10.1016/0014-5793(80)80613-2; Lombardi A, 2008, BBA-BIOENERGETICS, V1777, P826, DOI 10.1016/j.bbabio.2008.04.019; Parker N, 2008, BIOSCIENCE REP, V28, P83, DOI 10.1042/BSR20080002; Petersen DR, 2004, FREE RADICAL BIO MED, V37, P937, DOI 10.1016/j.freeradbiomed.2004.06.012; Poli G, 2008, MED RES REV, V28, P569, DOI 10.1002/med.20117; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; Roede JR, 2008, CHEM RES TOXICOL, V21, P2289, DOI 10.1021/tx800244u; Rupprecht A, 2010, BIOPHYS J, V98, P1503, DOI 10.1016/j.bpj.2009.12.4301; Shabalina IG, 2006, J BIOL CHEM, V281, P13882, DOI 10.1074/jbc.M601387200; SHIN G, 1989, J MOL CELL CARDIOL, V21, P1029, DOI 10.1016/0022-2828(89)90801-8; SKULACHEV VP, 1991, FEBS LETT, V294, P158, DOI 10.1016/0014-5793(91)80658-P; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; Smith AMO, 2004, J BIOL CHEM, V279, P51944, DOI 10.1074/jbc.M408920200; Smorodchenko A, 2009, BBA-BIOMEMBRANES, V1788, P2309, DOI 10.1016/j.bbamem.2009.07.018; Stewart BJ, 2007, CHEM RES TOXICOL, V20, P1111, DOI 10.1021/tx700106v; Stuart LJ, 2006, ORG LETT, V8, P79, DOI 10.1021/ol052550d; Subramaniam R, 1997, J NEUROCHEM, V69, P1161; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Woyda-Ploszczyca AM, 2012, J BIOENERG BIOMEMBR, V44, P525, DOI 10.1007/s10863-012-9456-x; Zhang YX, 2011, ANTIOXID REDOX SIGN, V15, P2867, DOI 10.1089/ars.2010.3685	49	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77786	10.1371/journal.pone.0077786	http://dx.doi.org/10.1371/journal.pone.0077786			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204965	Green Published, Green Submitted, gold			2022-12-27	WOS:000326241200039
J	Derogis, PBMC; Freitas, FP; Marques, ASF; Cunha, D; Appolinario, PP; de Paula, F; Lourenco, TC; Murgu, M; Di Mascio, P; Medeiros, MHG; Miyamoto, S				Derogis, Priscilla B. M. C.; Freitas, Florencio P.; Marques, Anna S. F.; Cunha, Daniela; Appolinario, Patricia P.; de Paula, Fernando; Lourenco, Tiago C.; Murgu, Michael; Di Mascio, Paolo; Medeiros, Marisa H. G.; Miyamoto, Sayuri			The Development of a Specific and Sensitive LC-MS-Based Method for the Detection and Quantification of Hydroperoxy- and Hydroxydocosahexaenoic Acids as a Tool for Lipidomic Analysis	PLOS ONE			English	Article							SINGLET MOLECULAR-OXYGEN; PERFORMANCE LIQUID-CHROMATOGRAPHY; ELECTROSPRAY MASS-SPECTROMETRY; HYDROXY FATTY-ACIDS; DOCOSAHEXAENOIC ACID; NEURODEGENERATIVE DISEASES; HUMAN-PLATELETS; PEROXIDATION; MECHANISMS; BRAIN	Docosahexaenoic acid (DHA) is an n-3 polyunsaturated fatty acid that is highly enriched in the brain, and the oxidation products of DHA are present or increased during neurodegenerative disease progression. The characterization of the oxidation products of DHA is critical to understanding the roles that these products play in the development of such diseases. In this study, we developed a sensitive and specific analytical tool for the detection and quantification of twelve major DHA hydroperoxide (HpDoHE) and hydroxide (HDoHE) isomers (isomers at positions 4, 5, 7, 8, 10, 11, 13, 14, 16, 17, 19 and 20) in biological systems. In this study, HpDoHE were synthesized by photooxidation, and the corresponding hydroxides were obtained by reduction with NaBH4. The isolated isomers were characterized by LC-MS/MS, and unique and specific fragment ions were chosen to construct a selected reaction monitoring (SRM) method for the targeted quantitative analysis of each HpDoHE and HDoHE isomer. The detection limits for the LC-MS/MS-SRM assay were 1-670 pg for HpDoHE and 0.5-8.5 pg for HDoHE injected onto a column. Using this method, it was possible to detect the basal levels of HDoHE isomers in both rat plasma and brain samples. Therefore, the developed LC-MS/MS-SRM can be used as an important tool to identify and quantify the hydro(pero)xy derivatives of DHA in biological system and may be helpful for the oxidative lipidomic studies.	[Derogis, Priscilla B. M. C.; Freitas, Florencio P.; Cunha, Daniela; Appolinario, Patricia P.; Di Mascio, Paolo; Medeiros, Marisa H. G.; Miyamoto, Sayuri] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Marques, Anna S. F.; de Paula, Fernando; Lourenco, Tiago C.; Murgu, Michael] Waters Technol Brazil, Luiz Barssotti Applicat Lab, Sao Paulo, Brazil	Universidade de Sao Paulo	Miyamoto, S (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.	miyamoto@iq.usp.br	Miyamoto, Sayuri/A-2144-2008; Di Mascio, Paolo/D-1264-2014; Freitas, Florêncio P/K-4656-2014; Medeiros, Marisa H. G./A-5212-2008; de Medeiros, Marisa Helena Gennari/AAA-8015-2019	Miyamoto, Sayuri/0000-0002-5714-8984; Di Mascio, Paolo/0000-0003-4125-8350; Medeiros, Marisa H. G./0000-0002-5438-1174; de Medeiros, Marisa Helena Gennari/0000-0002-5438-1174; Bento Matos Cruz Derogis, Priscilla/0000-0003-2345-3996	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); CNPq (Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico); Instituto do Milenio: Redoxoma; INCT de Processos Redox em Biomedicina - Redoxoma; NAP-Redoxoma; CEPID-Redoxoma; Pro-Reitoria de Pesquisa-USP	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto do Milenio: Redoxoma; INCT de Processos Redox em Biomedicina - Redoxoma; NAP-Redoxoma; CEPID-Redoxoma; Pro-Reitoria de Pesquisa-USP	This work was supported by the Brazilian research funding institutions: FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo), CNPq (Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico), Instituto do Milenio: Redoxoma, INCT de Processos Redox em Biomedicina - Redoxoma, NAP-Redoxoma, CEPID-Redoxoma and Pro-Reitoria de Pesquisa-USP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appolinario PP, 2011, QUIM NOVA, V34, P1409, DOI 10.1590/S0100-40422011000800021; AVELDANO MI, 1983, J BIOL CHEM, V258, P9339; BAZAN NG, 1984, BIOCHEM BIOPH RES CO, V125, P741, DOI 10.1016/0006-291X(84)90601-6; Bazan NG, 2011, ANNU REV NUTR, V31, P321, DOI 10.1146/annurev.nutr.012809.104635; BENDANI MK, 1995, NEUROSCI LETT, V189, P159, DOI 10.1016/0304-3940(95)11482-C; Bernoud-Hubac N, 2001, J BIOL CHEM, V276, P30964, DOI 10.1074/jbc.M103768200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Buege J A, 1978, Methods Enzymol, V52, P302; Cheng ZY, 2007, CHEM REV, V107, P748, DOI 10.1021/cr040077w; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fer M, 2008, ARCH BIOCHEM BIOPHYS, V471, P116, DOI 10.1016/j.abb.2008.01.002; Gomolka B, 2011, PROSTAG OTH LIPID M, V94, P81, DOI 10.1016/j.prostaglandins.2010.12.006; HAMBRECHT GS, 1987, NEUROCHEM RES, V12, P1029, DOI 10.1007/BF00970932; Hong S, 2005, PROSTAG OTH LIPID M, V78, P107, DOI 10.1016/j.prostaglandins.2005.04.004; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Hong S, 2007, J AM SOC MASS SPECTR, V18, P128, DOI 10.1016/j.jasms.2006.09.002; Horrocks LA, 1999, PHARMACOL RES, V40, P211, DOI 10.1006/phrs.1999.0495; Iuliano L, 2011, CHEM PHYS LIPIDS, V164, P457, DOI 10.1016/j.chemphyslip.2011.06.006; Jira W, 1996, CHEM PHYS LIPIDS, V84, P165, DOI 10.1016/S0009-3084(96)02635-7; Kawai Y, 2007, CHEM RES TOXICOL, V20, P99, DOI 10.1021/tx060199e; Kerwin JL, 1996, ANAL BIOCHEM, V237, P56, DOI 10.1006/abio.1996.0200; KIM HY, 1990, PROSTAG OTH LIPID M, V40, P473, DOI 10.1016/0090-6980(90)90110-H; Lu Y, 2005, J LIPID RES, V46, P790, DOI 10.1194/jlr.D400020-JLR200; Lukiw WJ, 2008, J NUTR, V138, P2510, DOI 10.3945/jn.108.096016; Lyberg AM, 2006, LIPIDS, V41, P67, DOI 10.1007/s11745-006-5072-z; MacMillan DK, 1995, J AM SOC MASS SPECTR, V6, P1190, DOI 10.1016/1044-0305(95)00505-6; Miyamoto S, 2006, P NATL ACAD SCI USA, V103, P293, DOI 10.1073/pnas.0508170103; Miyamoto S, 2003, J AM CHEM SOC, V125, P6172, DOI 10.1021/ja029115o; Miyamoto S, 2003, J AM CHEM SOC, V125, P4510, DOI 10.1021/ja029262m; Miyamoto S, 2007, IUBMB LIFE, V59, P322, DOI 10.1080/15216540701242508; Murphy RC, 2001, CHEM REV, V101, P479, DOI 10.1021/cr9900883; Niki E, 2005, BIOCHEM BIOPH RES CO, V338, P668, DOI 10.1016/j.bbrc.2005.08.072; Niki E, 2009, FREE RADICAL BIO MED, V47, P469, DOI 10.1016/j.freeradbiomed.2009.05.032; Pratico D, 2004, AM J PATHOL, V164, P1655, DOI 10.1016/S0002-9440(10)63724-8; Roberts LJ, 1998, J BIOL CHEM, V273, P13605, DOI 10.1074/jbc.273.22.13605; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Sapieha P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001571; Schneider C, 2009, MOL NUTR FOOD RES, V53, P315, DOI 10.1002/mnfr.200800131; Seal JR, 2004, ANAL BIOANAL CHEM, V378, P1007, DOI 10.1007/s00216-003-2274-6; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Song WL, 2008, J BIOL CHEM, V283, P6, DOI 10.1074/jbc.M706124200; Sun YY, 2007, WAVE RANDOM COMPLEX, V17, P1, DOI 10.1080/17455030600791694; TERAO J, 1988, ANAL BIOCHEM, V169, P415, DOI 10.1016/0003-2697(88)90306-5; Uemi M, 2011, CHEM RES TOXICOL, V24, P887, DOI 10.1021/tx200079d; Westphal C, 2011, PROSTAG OTH LIPID M, V96, P99, DOI 10.1016/j.prostaglandins.2011.09.001; Yang J, 2009, ANAL CHEM, V81, P8085, DOI 10.1021/ac901282n; Yin HY, 2011, CHEM REV, V111, P5944, DOI 10.1021/cr200084z	49	31	32	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77561	10.1371/journal.pone.0077561	http://dx.doi.org/10.1371/journal.pone.0077561			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204871	Green Published, gold, Green Submitted			2022-12-27	WOS:000326152300025
J	Yang, J; Yang, YM; Ren, YN; Xie, RF; Zou, HJ; Fan, HH				Yang, Jie; Yang, Yiming; Ren, Yana; Xie, Rufeng; Zou, Hejian; Fan, Huahua			A Mouse Model of Adoptive Immunotherapeutic Targeting of Autoimmune Arthritis Using Allo-Tolerogenic Dendritic Cells	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; T-CELLS; C57BL/6 MICE; SUPPRESSOR-CELLS; RESPONSES	Objective: Tolerogenic dendritic cells (tDCs) are immunosuppressive cells with potent tolerogenic ability and are promising immunotherapeutic tools for treating rheumatoid arthritis (RA). However, it is currently unknown whether allogeneic tDCs (allo-tDCs) induce tolerance in RA, and whether the numbers of adoptively transferred allo-tDCs, or the requirement for pulsing with relevant auto-antigens are important. Methods: tDCs were derived from bone marrow precursors of C57BL/B6 mice, which were induced in vitro by GMCSF, IL-10 and TGF-beta 1. Collagen-induced arthritis (CIA) was modeled in D1 mice by immunization with type II collagen (CII) to test the therapeutic ability of allo-tDCs against CIA. Clinical and histopathologic scores, arthritic incidence, cytokine and anti-CII antibody secretion, and CD4(+)Th subsets were analyzed. Results: tDCs were characterized in vitro by a stable immature phonotype and a potent immunosuppressive ability. Following adoptive transfer of low doses (5x10(5)) of CII-loaded allo-tDCs, a remarkable anti-arthritic activity, improved clinical scores and histological end-points were found. Serological levels of inflammatory cytokines and anti-CII antibodies were also significantly lower in CIA mice treated with CII-pulsed allo-tDCs as compared with allo-tDCs. Moreover, treatment with allo-tDCs altered the proportion of Treg/Th17 cells. Conclusion: These findings suggested that allo-tDCs, especially following antigen loading, reduced the severity of CIA in a dose-dependent manner. The dampening of CIA was associated with modulated cytokine secretion, Treg/Th17 polarization and inhibition of anti-CII secretion. This study highlights the potential therapeutic utility of allo-tDCs in autoimmune arthritis and should facilitate the future design of allo-tDC immunotherapeutic strategies against RA.	[Yang, Jie; Yang, Yiming; Ren, Yana; Xie, Rufeng; Fan, Huahua] Shanghai Blood Ctr, Blood Engn Lab, Shanghai, Peoples R China; [Yang, Jie; Zou, Hejian] Fudan Univ, Huashan Hosp, Div Rheumatol, Shanghai 200433, Peoples R China	Fudan University	Fan, HH (corresponding author), Shanghai Blood Ctr, Blood Engn Lab, Shanghai, Peoples R China.	fanhuahua021@gmail.com			Science and Technology Commission of Shanghai Municipality [12GWZX0201, 11140902900]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was supported by a grant (12GWZX0201, 11140902900) from the Science and Technology Commission of Shanghai Municipality. The authors thank the Department of Animal Science in Shanghai Jiaotong University School of Medicine for the laboratory animal husbandry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio G, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00233; Backlund J, 2013, ANN RHEUM DIS, V72, P1225, DOI 10.1136/annrheumdis-2012-202055; Bevaart L, 2010, ARTHRITIS RHEUM-US, V62, P2192, DOI 10.1002/art.27503; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Criado G, 2009, ARTHRITIS RHEUM-US, V60, P1342, DOI 10.1002/art.24446; Cripps JG, 2011, INT IMMUNOPHARMACOL, V11, P789, DOI 10.1016/j.intimp.2011.01.026; Fujita S, 2006, BLOOD, V107, P3656, DOI 10.1182/blood-2005-10-4190; Gregori S, 2001, J IMMUNOL, V167, P1945, DOI 10.4049/jimmunol.167.4.1945; Haile LA, 2012, IMMUNOL INVEST, V41, P581, DOI 10.3109/08820139.2012.680635; Healy Louise J, 2008, Open Rheumatol J, V2, P71, DOI 10.2174/1874312900802010071; Heo YJ, 2010, IMMUNOL LETT, V127, P150, DOI 10.1016/j.imlet.2009.10.006; Inglis JJ, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2319; Inglis JJ, 2008, NAT PROTOC, V3, P612, DOI 10.1038/nprot.2008.19; Jaen O, 2009, IMMUNOLOGY, V126, P35, DOI 10.1111/j.1365-2567.2008.02875.x; Jiao Z, 2013, SCAND J RHEUMATOL, V42, P85, DOI 10.3109/03009742.2012.716450; Khan S, 2009, NAT REV RHEUMATOL, V5, P566, DOI 10.1038/nrrheum.2009.185; Ko HJ, 2010, J AUTOIMMUN, V34, P111, DOI 10.1016/j.jaut.2009.07.006; Kong N, 2012, ARTHRITIS RHEUM-US, V64, P2548, DOI 10.1002/art.34513; Kornete M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00165; Lan YY, 2006, J IMMUNOL, V177, P5868, DOI 10.4049/jimmunol.177.9.5868; Lim DS, 2009, EUR J IMMUNOL, V39, P1334, DOI 10.1002/eji.200838987; Lutzky V, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2200; Manicassamy S, 2011, IMMUNOL REV, V241, P206, DOI 10.1111/j.1600-065X.2011.01015.x; Martin E, 2007, ARTHRITIS RHEUM-US, V56, P2255, DOI 10.1002/art.22655; Park KS, 2009, MOD RHEUMATOL, V19, P581, DOI 10.1007/s10165-009-0210-0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Popov I, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2031; Rutella S, 2009, HUM IMMUNOL, V70, P360, DOI 10.1016/j.humimm.2009.01.023; Salazar L, 2007, EUR CYTOKINE NETW, V18, P78, DOI 10.1684/ecn.2007.0089; Stoop JN, 2010, ARTHRITIS RHEUM-US, V62, P3656, DOI 10.1002/art.27756; Torres-Aguilar H, 2010, J IMMUNOL, V184, P1765, DOI 10.4049/jimmunol.0902133; Zhao YP, 2012, RHEUMATOL INT, V32, P837, DOI 10.1007/s00296-011-2133-2	32	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77729	10.1371/journal.pone.0077729	http://dx.doi.org/10.1371/journal.pone.0077729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204938	Green Published, Green Submitted, gold			2022-12-27	WOS:000326152300030
J	Zhang, ZL; Wang, J; He, JX; Zheng, ZG; Zeng, XS; Zhang, CT; Ye, JM; Zhang, YJ; Zhong, NS; Lu, WJ				Zhang, Zili; Wang, Jian; He, Jianxing; Zheng, Zeguang; Zeng, Xiansheng; Zhang, Chenting; Ye, Jinmei; Zhang, Yajie; Zhong, Nanshan; Lu, Wenju			Genetic Variants in MUC4 Gene Are Associated with Lung Cancer Risk in a Chinese Population	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MUC4/SIALOMUCIN COMPLEX; MULTIPLE ASSOCIATIONS; PROGNOSTIC-FACTOR; EPITHELIAL-CELLS; DISEASE GENES; EXPRESSION; ACTIVATION; INFLAMMATION; CYTOKINES	Mucin MUC4, which is encoded by the MUC4 gene, plays an important role in epithelial cell proliferation and differentiation. Aberrant MUC4 overexpression is associated with invasive tumor proliferation and poor outcome in epithelial cancers. Collectively, the existing evidence suggests that MUC4 has tumor-promoter functions. In this study, we performed a case-control study of 1,048 incident lung cancer cases and 1,048 age-and sex frequency-matched cancer-free controls in a Chinese population to investigate the role of MUC4 gene polymorphism in lung cancer etiology. We identified nine SNPs that were significantly associated with increased lung cancer risk (P = 0.0425 for rs863582, 0.0333 for rs842226, 0.0294 for rs842225, 0.0010 for rs2550236, 0.0149 for rs2688515, 0.0191 for rs 2641773, 0.0058 for rs3096337, 0.0077 for rs859769, and 0.0059 for rs842461 in an additive model). Consistent with these single-locus analysis results, the haplotype analyses revealed an adverse effect of the haplotype "GGC" of rs3096337, rs859769, and rs842461 on lung cancer. Both the haplotype and diplotype "CTGAGC" of rs863582, rs842226, rs2550236, rs842225, and rs2688515 had an adverse effect on lung cancer, which is also consistent with the single-locus analysis. Moreover, we observed statistically significant interactions for rs863582 and rs842461 in heavy smokers. Our results suggest that MUC4 gene polymorphisms and their interaction with smoking may contribute to lung cancer etiology.	[Zhang, Zili; Wang, Jian; He, Jianxing; Zheng, Zeguang; Zhang, Chenting; Ye, Jinmei; Zhong, Nanshan; Lu, Wenju] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Zeng, Xiansheng] Xiangyang Cent Hosp, Dept Resp Med, Xiangyang, Hubei, Peoples R China; [Zhang, Yajie] Guangzhou Med Univ, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Lu, Wenju] Guangzhou Med Univ, Dept Lab Med, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Guangzhou Medical University; Guangzhou Medical University	Lu, WJ (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	wlu92@yahoo.com		He, Jianxing/0000-0003-1737-8192	National Natural Science Foundation of China [81070043, 81071917, 81173112, 81170052, 81220108001]; Chinese Central Government Key Research Projects of the 973 grants [2009CB522107]; Changjiang Scholars and Innovative Research Team in University grant [IRT0961]; Guangdong Natural Science Foundation [1035101200300000]; Guangdong Department of Science and Technology of China [2009B050700041, 2010B031600301]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme China; Guangdong Department of Education [cxzd1025]; Guangzhou Department of Education Yangcheng Scholarship [10A058S, 12A001S]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Central Government Key Research Projects of the 973 grants(National Basic Research Program of China); Changjiang Scholars and Innovative Research Team in University grant(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangdong Department of Science and Technology of China; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme China; Guangdong Department of Education; Guangzhou Department of Education Yangcheng Scholarship	This work was supported by the National Natural Science Foundation of China (81070043, 81071917, 81173112, 81170052, 81220108001), the Chinese Central Government Key Research Projects of the 973 grants (2009CB522107), a Changjiang Scholars and Innovative Research Team in University grant (IRT0961), a Guangdong Natural Science Foundation team grant (1035101200300000), the Guangdong Department of Science and Technology of China (2009B050700041, 2010B031600301), the Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2008) China, a Guangdong Department of Education research grant (cxzd1025), and a Guangzhou Department of Education Yangcheng Scholarship (10A058S, 12A001S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER KB, 1994, ANN NY ACAD SCI, V725, P128, DOI 10.1111/j.1749-6632.1994.tb00275.x; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; AMES BN, 1995, P NATL ACAD SCI USA, V92, P5258, DOI 10.1073/pnas.92.12.5258; Andrianifahanana M, 2005, ONCOGENE, V24, P6143, DOI 10.1038/sj.onc.1208756; BALAGUE C, 1994, GASTROENTEROLOGY, V106, P1054, DOI 10.1016/0016-5085(94)90767-6; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Buisine MP, 1999, AM J RESP CELL MOL, V20, P209, DOI 10.1165/ajrcmb.20.2.3259; Choudhury A, 2004, BRIT J CANCER, V90, P657, DOI 10.1038/sj.bjc.6601604; CHURCHILL GA, 1994, GENETICS, V138, P963; COHEN BH, 1977, LANCET, V2, P523; Dabbagh K, 1999, J IMMUNOL, V162, P6233; Davies DE, 1999, ALLERGY, V54, P771; Dudbridge F, 2006, AM J HUM GENET, V78, P1094, DOI 10.1086/504527; Dudbridge F, 2004, AM J HUM GENET, V75, P424, DOI 10.1086/423738; Dudbridge Frank, 2006, Human Genomics, V2, P310; Fischer BM, 1999, AM J RESP CELL MOL, V20, P413, DOI 10.1165/ajrcmb.20.3.3393; Fitzpatrick FA, 2001, INT IMMUNOPHARMACOL, V1, P1651, DOI 10.1016/S1567-5769(01)00102-3; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Godschalk R, 2002, CARCINOGENESIS, V23, P2081, DOI 10.1093/carcin/23.12.2081; GROSS MS, 1992, ANN GENET-PARIS, V35, P21; Jankovic M, 2004, PEDIATR BLOOD CANCER, V42, P106, DOI 10.1002/pbc.10418; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jepson S, 2002, ONCOGENE, V21, P7524, DOI 10.1038/sj.onc.1205970; JONES DG, 1973, J ANAT, V116, P470; Komatsu M, 2001, ONCOGENE, V20, P461, DOI 10.1038/sj.onc.1204106; Lamblin G, 2001, GLYCOCONJUGATE J, V18, P661, DOI 10.1023/A:1020867221861; Leikauf GD, 2002, CHEST, V121, p166S, DOI 10.1378/chest.121.5_suppl.166S; LEWONTIN RC, 1988, GENETICS, V120, P849; Li JD, 1997, P NATL ACAD SCI USA, V94, P967, DOI 10.1073/pnas.94.3.967; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Llinares K, 2004, MODERN PATHOL, V17, P150, DOI 10.1038/modpathol.3800027; Longphre M, 1999, J CLIN INVEST, V104, P1375, DOI 10.1172/JCI6097; Mariette C, 2004, BIOCHEM J, V377, P701, DOI 10.1042/BJ20031132; MARIN MG, 1994, PHARMACOL REV, V46, P35; Nadel JA, 2001, RESP RES, V2, P85, DOI 10.1186/rr43; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; OGATA S, 1992, CANCER RES, V52, P5971; Ohashi J, 2001, J HUM GENET, V46, P478, DOI 10.1007/s100380170048; Perrais M, 2001, J BIOL CHEM, V276, P30923, DOI 10.1074/jbc.M104204200; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Saitou M, 2005, J CLIN PATHOL, V58, P845, DOI 10.1136/jcp.2004.023572; Sasco AJ, 2002, CANCER CAUSE CONTROL, V13, P609, DOI 10.1023/A:1019504210176; Singh AP, 2007, CANCER RES, V67, P433, DOI 10.1158/0008-5472.CAN-06-3114; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stram DO, 2003, HUM HERED, V55, P27, DOI 10.1159/000071807; Takeyama K, 2001, AM J PHYSIOL-LUNG C, V280, pL165, DOI 10.1152/ajplung.2001.280.1.L165; Tamada S, 2006, CLIN CANCER RES, V12, P4257, DOI 10.1158/1078-0432.CCR-05-2814; Tsou JA, 2002, ONCOGENE, V21, P5450, DOI 10.1038/sj.onc.1205605; Vainio H, 2001, ANN NY ACAD SCI, V952, P177, DOI 10.1111/j.1749-6632.2001.tb02740.x; Weber B, 2006, CELL SIGNAL, V18, P1748, DOI 10.1016/j.cellsig.2006.01.017; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972; Zhang H, 2003, RESPIROLOGY, V8, P17, DOI 10.1046/j.1440-1843.2003.00433.x; Zhang Jie, 2009, Zhonghua Zhongliu Zazhi, V31, P66, DOI 10.3760/cma.j.issn.0253-3766.2009.01.017	53	7	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77723	10.1371/journal.pone.0077723	http://dx.doi.org/10.1371/journal.pone.0077723			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204934	Green Published, gold, Green Submitted			2022-12-27	WOS:000326032600045
J	Tiwari, RP; Rajkonwar, C; Patel, SJ				Tiwari, Raghavendra Prasad; Rajkonwar, Chinmoy; Patel, Satish Jaychandbhai			Funalichnus bhubani isp nov from Bhuban Formation, Surma Group (Lower -Middle Miocene) of Aizawl, Mizoram, India	PLOS ONE			English	Article							ICHNOGENUS; BASIN	A new ichnospecies of the ichnogenus Funalichnus Pokorny is described from the Middle Bhuban Unit, Bhuban Formation, Surma Group (Lower - Middle Miocene) of Aizawl, Mizoram, India. Funalichnus bhubani isp. Nov. Is a large burrow displaying cylindrical segments that are oriented nearly perpendicular to the bedding plane. The new ichnospecies can be identified on the basis of general form, size, unlined passive filling and twisted rod-like structure. The association of Funalichnus bhubani isp. Nov. With Arenicolites, Diplocraterion, Ophiomorpha Psilonichnus Skolithos and Thalassinoides points to its bathymetric restriction. The deep extension of the burrow in clastic sediments provides a favourable condition for preservation in the shoreface environment and occurrence in fine-to medium-grained clastic sediments may be a preservational preference.	[Tiwari, Raghavendra Prasad; Rajkonwar, Chinmoy] Mizoram Univ, Dept Geol, Aizawl, Mizoram, India; [Patel, Satish Jaychandbhai] Maharaja Sayajirao Univ, Fac Sci, Dept Geol, Baroda, Gujarat, India	Mizoram University; Maharaja Sayajirao University Baroda	Tiwari, RP (corresponding author), Mizoram Univ, Dept Geol, Aizawl, Mizoram, India.	rptmzu@rediffmail.com	Tiwari, R P/AAS-8101-2020	Tiwari, Raghavendra/0000-0001-6083-4654	Department of Science & Technology, Govt. of India, New Delhi [ESS/16/254(3)/2005]	Department of Science & Technology, Govt. of India, New Delhi(Department of Science & Technology (India))	Department of Science & Technology, Govt. of India, New Delhi, grant received vide no. ESS/16/254(3)/2005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOWN TM, 1983, PALAEOGEOGR PALAEOCL, V43, P95, DOI 10.1016/0031-0182(83)90050-0; d'Orbigny A, 1850, OURS ELEMENTAIRE PAL, V1, P1; Dasgupta S., 1982, Records of the Geological Survey of India, V112, P31; FREY RW, 1984, J PALEONTOL, V58, P333; Fritsch A, 1883, STUDIEN GEBIETE BOHM, VV, P139; Fritsch A, 1872, COMISSION BEI FRANTI, P51; Ganju J. L., 1975, B GEOLOGY MINERALOGI, V48, P28; GEINITZ H.B, 1842, CHARAKTERISTIK SCHIC, P63; Geinitz HB, 1850, CHARAKTERISTIK SCHIC, P63; Kachhara R. P., 2003, J PALEONTOL SOC INDI, V48, P59; Karunakaran, 1974, MISCELLANEOUS PUBLIC, V30, P93; MacEachern J.A., 1992, APPL ICHNOLOGY PETRO, V17, P57; MacEachern James A., 2007, P52, DOI 10.1016/B978-044452949-7/50130-3; Mehrotra R.C., 2001, Ichnos, V8, P63; Mehrotra R. C., 2002, Biological Memoirs, V28, P45; Pokorny R, 2008, ICHNOS, V15, P51, DOI 10.1080/10420940701192922; Rajkonwar C, 2013, HIMAL GEOL, V34, P18; Seilacher A., 1967, Marine Geology, V5, P413, DOI 10.1016/0025-3227(67)90051-5; Singh MC, 2010, J GEOL SOC INDIA, V76, P573, DOI 10.1007/s12594-010-0118-5; Tiwari R.P., 2001, Journal of the Palaeontological Society of India, V46, P147; Tiwari R. P., 2006, Journal of the Palaeontological Society of India, V51, P33; Tiwari RP, 2011, J EARTH SYST SCI, V120, P1127, DOI 10.1007/s12040-011-0131-0; Tiwari Raghavendra Prasad, 2000, Tertiary Research, V20, P79; Walker R.G., 1992, FACIES MODELS RESPON, P407	24	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77839	10.1371/journal.pone.0077839	http://dx.doi.org/10.1371/journal.pone.0077839			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204992	gold, Green Submitted, Green Published			2022-12-27	WOS:000326029300118
J	Chen, DB; Gao, H; Lu, LY; Zhou, T				Chen, Duan-Bing; Gao, Hui; Lu, Linyuan; Zhou, Tao			Identifying Influential Nodes in Large-Scale Directed Networks: The Role of Clustering	PLOS ONE			English	Article							COMPLEX NETWORKS; LINK PREDICTION; CENTRALITY; DYNAMICS	Identifying influential nodes in very large-scale directed networks is a big challenge relevant to disparate applications, such as accelerating information propagation, controlling rumors and diseases, designing search engines, and understanding hierarchical organization of social and biological networks. Known methods range from node centralities, such as degree, closeness and betweenness, to diffusion-based processes, like PageRank and LeaderRank. Some of these methods already take into account the influences of a node's neighbors but do not directly make use of the interactions among it's neighbors. Local clustering is known to have negative impacts on the information spreading. We further show empirically that it also plays a negative role in generating local connections. Inspired by these facts, we propose a local ranking algorithm named ClusterRank, which takes into account not only the number of neighbors and the neighbors' influences, but also the clustering coefficient. Subject to the susceptible-infected-recovered (SIR) spreading model with constant infectivity, experimental results on two directed networks, a social network extracted from delicious.com and a large-scale short-message communication network, demonstrate that the ClusterRank outperforms some benchmark algorithms such as PageRank and LeaderRank. Furthermore, ClusterRank can also be applied to undirected networks where the superiority of ClusterRank is significant compared with degree centrality and k-core decomposition. In addition, ClusterRank, only making use of local information, is much more efficient than global methods: It takes only 191 seconds for a network with about 107 nodes, more than 15 times faster than PageRank.	[Chen, Duan-Bing; Gao, Hui; Zhou, Tao] Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Web Sci Ctr, Chengdu 610054, Peoples R China; [Lu, Linyuan] Hangzhou Normal Univ, Alibaba Business Coll, Inst Informat Econ, Hangzhou, Zhejiang, Peoples R China; [Chen, Duan-Bing] Univ Fribourg, Dept Phys, CH-1700 Fribourg, Switzerland	University of Electronic Science & Technology of China; Hangzhou Normal University; University of Fribourg	Lu, LY (corresponding author), Hangzhou Normal Univ, Alibaba Business Coll, Inst Informat Econ, Hangzhou, Zhejiang, Peoples R China.	linyuan.lue@unifr.ch	zhou, tao/GQA-3572-2022	Zhou, Tao/0000-0003-0561-2316	National Natural Science Foundation of China [11222543, 90924011, 60903073, 11205042]; International Scientific Cooperation and Communication Project of Sichuan Province in China [2010HH0002]; Huawei university-enterprise cooperation [YBCB2011057]; Hangzhou Normal University [2011QDL29, 2011QDL31]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Scientific Cooperation and Communication Project of Sichuan Province in China; Huawei university-enterprise cooperation(Huawei Technologies); Hangzhou Normal University	This work was partially supported by the National Natural Science Foundation of China under Grant Nos. 11222543, 90924011, 60903073 and 11205042, and the International Scientific Cooperation and Communication Project of Sichuan Province in China under Grant No. 2010HH0002. D. B. C. acknowledges the Huawei university-enterprise cooperation project YBCB2011057. L. L. acknowledges the research start-up fund of Hangzhou Normal University under Grant Nos. 2011QDL29 and 2011QDL31. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Aral S, 2012, SCIENCE, V337, P337, DOI 10.1126/science.1215842; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Bonacich P, 2007, SOC NETWORKS, V29, P555, DOI 10.1016/j.socnet.2007.04.002; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Chen DB, 2013, ARXIV13057480; Chen DB, 2012, PHYSICA A, V391, P1777, DOI 10.1016/j.physa.2011.09.017; Ding LJ, 2011, KYBERNETES, V40, P814, DOI 10.1108/03684921111142359; Eguiluz VM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.108701; Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107; Feng X, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2011-20207-x; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Galan JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020474; Jiang LL, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/40001; Kim H, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.026107; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Li Q, 2013, ARXIV13065042; Liu Z, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/48007; Lu LY, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/12/123005; Lu LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021202; Lu LY, 2011, PHYSICA A, V390, P1150, DOI 10.1016/j.physa.2010.11.027; Masuda N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025190; Mislove A, 2007, IMC'07: PROCEEDINGS OF THE 2007 ACM SIGCOMM INTERNET MEASUREMENT CONFERENCE, P29; Narayanam R, 2011, IEEE T AUTOM SCI ENG, V8, P130, DOI 10.1109/TASE.2010.2052042; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Perc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033027; Petermann T, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066116; SABIDUSSI G, 1966, PSYCHOMETRIKA, V31, P581, DOI 10.1007/BF02289527; Saito K, 2012, KNOWL INF SYST, V30, P613, DOI 10.1007/s10115-011-0396-2; Soffer SN, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.057101; Trpevski D, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.056102; Ugander J, 2012, P NATL ACAD SCI USA, V109, P5962, DOI 10.1073/pnas.1116502109; Vespignani A, 2012, NAT PHYS, V8, P32, DOI 10.1038/nphys2160; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wei DJ, 2013, PHYSICA A, V392, P2564, DOI 10.1016/j.physa.2013.01.054; Weng J., 2010, P 3 ACM INT C WEB SE, P261, DOI [10.1145/1718487.1718520, DOI 10.1145/1718487.1718520]; Wu XA, 2006, CHINESE PHYS LETT, V23, P1046, DOI 10.1088/0256-307X/23/4/079; Wu XJ, 2011, PHYS LETT A, V375, P1559, DOI 10.1016/j.physleta.2011.02.052; Yang HX, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.045101; Yang R, 2007, PHYS LETT A, V364, P189, DOI 10.1016/j.physleta.2006.12.021; Zhang XH, 2013, KNOWL-BASED SYST, V42, P74, DOI 10.1016/j.knosys.2013.01.017; Zhang YL, 2011, IEEE INT CONF TRUST, P1512, DOI [10.1109/TrastCom.2011.209, 10.1109/TrustCom.2011.209]; Zhou T, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.046141; Zhou T, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.056109; Zhou T, 2006, PROG NAT SCI-MATER, V16, P452; Zhou YB, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/3/033033	50	227	250	18	172	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e77455	10.1371/journal.pone.0077455	http://dx.doi.org/10.1371/journal.pone.0077455			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24204833	gold, Green Published			2022-12-27	WOS:000326373800001
J	Hoshino, S; Sakamoto, K; Vassilopoulos, S; Camus, SM; Griffin, CA; Esk, C; Torres, JA; Ohkoshi, N; Ishii, A; Tamaoka, A; Funke, BH; Kucherlapati, R; Margeta, M; Rando, TA; Brodsky, FM				Hoshino, Sachiko; Sakamoto, Kazuho; Vassilopoulos, Stephane; Camus, Stephane M.; Griffin, Christine A.; Esk, Christopher; Torres, Jorge A.; Ohkoshi, Norio; Ishii, Akiko; Tamaoka, Akira; Funke, Birgit H.; Kucherlapati, Raju; Margeta, Marta; Rando, Thomas A.; Brodsky, Frances M.			The CHC22 Clathrin-GLUT4 Transport Pathway Contributes to Skeletal Muscle Regeneration	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; IDIOPATHIC INFLAMMATORY MYOPATHIES; HEAVY-CHAIN ISOFORM; GLUCOSE-TRANSPORTER; PLASMA-MEMBRANE; SATELLITE CELLS; INSULIN ACTION; IN-VITRO; GLUT4; EXPRESSION	Mobilization of the GLUT4 glucose transporter from intracellular storage vesicles provides a mechanism for insulin-responsive glucose import into skeletal muscle. In humans, clathrin isoform CHC22 participates in formation of the GLUT4 storage compartment in skeletal muscle and fat. CHC22 function is limited to retrograde endosomal sorting and is restricted in its tissue expression and species distribution compared to the conserved CHC17 isoform that mediates endocytosis and several other membrane traffic pathways. Previously, we noted that CHC22 was expressed at elevated levels in regenerating rat muscle. Here we investigate whether the GLUT4 pathway in which CHC22 participates could play a role in muscle regeneration in humans and we test this possibility using CHC22-transgenic mice, which do not normally express CHC22. We observed that GLUT4 expression is elevated in parallel with that of CHC22 in regenerating skeletal muscle fibers from patients with inflammatory and other myopathies. Regenerating human myofibers displayed concurrent increases in expression of VAMP2, another regulator of GLUT4 transport. Regenerating fibers from wild-type mouse skeletal muscle injected with cardiotoxin also showed increased levels of GLUT4 and VAMP2. We previously demonstrated that transgenic mice expressing CHC22 in their muscle over-sequester GLUT4 and VAMP2 and have defective GLUT4 trafficking leading to diabetic symptoms. In this study, we find that muscle regeneration rates in CHC22 mice were delayed compared to wildtype mice, and myoblasts isolated from these mice did not proliferate in response to glucose. Additionally, CHC22-expressing mouse muscle displayed a fiber type switch from oxidative to glycolytic, similar to that observed in type 2 diabetic patients. These observations implicate the pathway for GLUT4 transport in regeneration of both human and mouse skeletal muscle, and demonstrate a role for this pathway in maintenance of muscle fiber type. Extrapolating these findings, CHC22 and GLUT4 can be considered markers of muscle regeneration in humans.	[Hoshino, Sachiko; Sakamoto, Kazuho; Vassilopoulos, Stephane; Camus, Stephane M.; Griffin, Christine A.; Esk, Christopher; Torres, Jorge A.; Brodsky, Frances M.] Univ Calif San Francisco, GW Hooper Fdn, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Hoshino, Sachiko; Sakamoto, Kazuho; Vassilopoulos, Stephane; Camus, Stephane M.; Griffin, Christine A.; Esk, Christopher; Torres, Jorge A.; Brodsky, Frances M.] Univ Calif San Francisco, Dept Pharmaceut Chem, GW Hooper Fdn, San Francisco, CA USA; [Hoshino, Sachiko; Sakamoto, Kazuho; Vassilopoulos, Stephane; Camus, Stephane M.; Griffin, Christine A.; Esk, Christopher; Torres, Jorge A.; Brodsky, Frances M.] Univ Calif San Francisco, Dept Microbiol & Immunol, GW Hooper Fdn, San Francisco, CA 94143 USA; [Hoshino, Sachiko; Ishii, Akiko; Tamaoka, Akira] Univ Tsukuba, Fac Med, Dept Neurol, Tsukuba, Ibaraki, Japan; [Sakamoto, Kazuho] Fukushima Med Univ, Sch Med, Dept Pharmacol, Fukushima, Japan; [Ohkoshi, Norio] Natl Univ Corp Tsukuba Univ Technol, Fac Hlth Sci, Dept Hlth, Tsukuba, Ibaraki, Japan; [Funke, Birgit H.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Funke, Birgit H.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Margeta, Marta] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Kucherlapati, Raju; Rando, Thomas A.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Tsukuba; Fukushima Medical University; Tsukuba University of Technology; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; Stanford University	Brodsky, FM (corresponding author), Univ Calif San Francisco, GW Hooper Fdn, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.	Frances.Brodsky@ucsf.edu	vassilopoulos, stéphane/F-6041-2014; vassilopoulos, stephane/AAF-3865-2021; Kucherlapati, Raju/ABC-8807-2021	vassilopoulos, stephane/0000-0003-0172-330X; Sakamoto, Kazuho/0000-0002-1665-2236; Rando, Thomas/0000-0001-5843-8564; Brodsky, Frances/0000-0002-1334-9258; Camus, Stephane/0000-0002-4326-1724; Margeta, Marta/0000-0001-6889-2488; Esk, Christopher/0000-0003-1833-0801	NIH [R01-GM038093, R56-DK083589, P30-DK063720, R01-DK095663, R01-HD47863, P01 AG036695, R37 AG023806, R01 AR056849, R01 AR062185]; Muscular Dystrophy Association; Fondation Recherche Medicale; American Heart Association; JSPS KAKENHI [25460338]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056849, R01AR062185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095663, P30DK063720, R56DK083589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG023806, R01AG023806, P01AG036695] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Fondation Recherche Medicale; American Heart Association(American Heart Association); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants R01-GM038093, R56-DK083589, P30-DK063720 (a Pilot and Feasibility Study from the UCSF DERC) and R01-DK095663 to FMB, R01-HD47863 to RK, a CDA from the Muscular Dystrophy Association to SH, a grant from the Fondation Recherche Medicale to SV, a grant from the American Heart Association to SMC, grants from the NIH (P01 AG036695, R37 AG023806, R01 AR056849, R01 AR062185) and the Muscular Dystrophy Association to TAR, and JSPS KAKENHI Grant Number 25460338 to KS.	ACTON SL, 1990, J CELL BIOL, V111, P1419, DOI 10.1083/jcb.111.4.1419; Bakirtzi K, 2009, J NEUROSCI, V29, P5193, DOI 10.1523/JNEUROSCI.0858-09.2009; BAO S, 1990, IMMUNOL CELL BIOL, V68, P235, DOI 10.1038/icb.1990.33; Bogan JS, 2012, ANNU REV BIOCHEM, V81, P507, DOI 10.1146/annurev-biochem-060109-094246; BOOTH FW, 1991, PHYSIOL REV, V71, P541, DOI 10.1152/physrev.1991.71.2.541; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; BRODSKY FM, 1985, J CELL BIOL, V101, P2047, DOI 10.1083/jcb.101.6.2047; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; CARLSON BM, 1983, MED SCI SPORT EXER, V15, P187; De Bleecker JL, 1999, NEUROMUSCULAR DISORD, V9, P239, DOI 10.1016/S0960-8966(98)00126-6; Esk C, 2010, J CELL BIOL, V188, P131, DOI 10.1083/jcb.200908057; Fazakerley DJ, 2009, J CELL SCI, V122, P727, DOI 10.1242/jcs.041178; Ganley IG, 2008, J CELL BIOL, V180, P159, DOI 10.1083/jcb.200707136; Gaster M, 2000, AM J PHYSIOL-ENDOC M, V278, pE910, DOI 10.1152/ajpendo.2000.278.5.E910; Grundtman C, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2139; HICKEY MS, 1995, AM J PHYSIOL-ENDOC M, V268, pE453, DOI 10.1152/ajpendo.1995.268.3.E453; Horsley V, 2001, J CELL BIOL, V153, P329, DOI 10.1083/jcb.153.2.329; Hoshino S, 2001, J MUSCLE RES CELL M, V22, P185, DOI 10.1023/A:1010553104341; Hou JCQ, 2007, CURR OPIN CELL BIOL, V19, P466, DOI 10.1016/j.ceb.2007.04.018; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Jansen KM, 2006, J CELL BIOL, V174, P403, DOI 10.1083/jcb.200601102; Keller SR, 2004, BIOL PHARM BULL, V27, P761, DOI 10.1248/bpb.27.761; KERN M, 1990, BIOCHEM J, V270, P397, DOI 10.1042/bj2700397; Klip A, 2009, APPL PHYSIOL NUTR ME, V34, P481, DOI 10.1139/H09-047; Kuru S, 2003, ACTA NEUROPATHOL, V105, P217, DOI 10.1007/s00401-002-0632-4; Lanner JT, 2009, FASEB J, V23, P1728, DOI 10.1096/fj.08-116814; Liu SH, 2001, EMBO J, V20, P272, DOI 10.1093/emboj/20.1.272; Moreno H, 2003, J BIOL CHEM, V278, P40557, DOI 10.1074/jbc.M306609200; Nakanishi K, 2007, FASEB J, V21, P2994, DOI 10.1096/fj.06-6408com; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Randhawa VK, 2000, MOL BIOL CELL, V11, P2403, DOI 10.1091/mbc.11.7.2403; Randhawa VK, 2004, MOL BIOL CELL, V15, P5565, DOI 10.1091/mbc.E04-03-0266; Roher N, 2008, ENDOCRINOLOGY, V149, P1880, DOI 10.1210/en.2007-1045; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Sheehan D.C., 1987, THEORY PRACTICE HIST; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; SUNADA Y, 1995, CURR OPIN NEUROL, V8, P379, DOI 10.1097/00019052-199510000-00010; Tajika Y, 2007, CELL TISSUE RES, V328, P573, DOI 10.1007/s00441-006-0376-0; Tews DS, 1996, J NEUROPATH EXP NEUR, V55, P342, DOI 10.1097/00005072-199603000-00009; Towler MC, 2004, TRAFFIC, V5, P129, DOI 10.1111/j.1600-0854.2003.00164.x; Towler MC, 2004, MOL BIOL CELL, V15, P3181, DOI 10.1091/mbc.E04-03-0249; Vassilopoulos S, 2009, SCIENCE, V324, P1192, DOI 10.1126/science.1171529; Wakeham DE, 2005, P NATL ACAD SCI USA, V102, P7209, DOI 10.1073/pnas.0502058102; White T P, 1993, Exerc Sport Sci Rev, V21, P263; Woo JS, 2010, EXP MOL MED, V42, P614, DOI 10.3858/emm.2010.42.9.061; Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x	46	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77787	10.1371/journal.pone.0077787	http://dx.doi.org/10.1371/journal.pone.0077787			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204966	Green Published, gold			2022-12-27	WOS:000326334500060
J	Xu, PJ; Lu, B; Xiao, HJ; Fu, XW; Murphy, RW; Wu, KM				Xu, Pengjun; Lu, Bin; Xiao, Haijun; Fu, Xiaowei; Murphy, Robert W.; Wu, Kongming			The Evolution and Expression of the Moth Visual Opsin Family	PLOS ONE			English	Article							HELICOVERPA-ARMIGERA LEPIDOPTERA; BAYESIAN POSTERIOR PROBABILITIES; COLOR-VISION; GENE-EXPRESSION; ADAPTIVE EVOLUTION; BLUE OPSIN; EYES; DUPLICATION; PIGMENTS; BUTTERFLIES	Because visual genes likely evolved in response to their ambient photic environment, the dichotomy between closely related nocturnal moths and diurnal butterflies forms an ideal basis for investigating their evolution. To investigate whether the visual genes of moths are associated with nocturnal dim-light environments or not, we cloned long-wavelength (R), blue (B) and ultraviolet (UV) opsin genes from 12 species of wild-captured moths and examined their evolutionary functions. Strong purifying selection appeared to constrain the functions of the genes. Dark-treatment altered the levels of mRNA expression in Helicoverpa armigera such that R and UV opsins were up-regulated after dark-treatment, the latter faster than the former. In contrast, B opsins were not significantly up-regulated. Diel changes of opsin mRNA levels in both wild-captured and lab-reared individuals showed no significant fluctuation within the same group. However, the former group had significantly elevated levels of expression compared with the latter. Consequently, environmental conditions appeared to affect the patterns of expression. These findings and the proportional expression of opsins suggested that moths potentially possessed color vision and the visual system played a more important role in the ecology of moths than previously appreciated. This aspect did not differ much from that of diurnal butterflies.	[Xu, Pengjun; Xiao, Haijun; Fu, Xiaowei; Wu, Kongming] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Lu, Bin] Chinese Acad Sci, Chengdu Inst Biol, Dept Herpetol, Chengdu, Sichuan, Peoples R China; [Murphy, Robert W.] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology	Wu, KM (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	kmwu@ippcaas.cn	XIAO, Haijun/AAJ-5321-2021; Xiao, Haijun/HGE-3088-2022	XIAO, Haijun/0000-0002-0832-0493; Xiao, Haijun/0000-0002-0832-0493	National Basic Research Program of China [2012CB114104]; Science Fund for Creative Research Groups of the National Science Foundation of China [31321004]	National Basic Research Program of China(National Basic Research Program of China); Science Fund for Creative Research Groups of the National Science Foundation of China	This work was supported by National Basic Research Program of China (No. 2012CB114104) and Science Fund for Creative Research Groups of the National Science Foundation of China (No. 31321004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awata H, 2009, J COMP PHYSIOL A, V195, P401, DOI 10.1007/s00359-009-0418-7; Baird E, 2011, BIOL LETTERS, V7, P499, DOI 10.1098/rsbl.2010.1205; BERNARD GD, 1979, J COMP PHYSIOL, V134, P95, DOI 10.1007/BF00610467; Briscoe AD, 2000, J MOL EVOL, V51, P110, DOI 10.1007/s002390010071; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Briscoe AD, 2010, P NATL ACAD SCI USA, V107, P3628, DOI 10.1073/pnas.0910085107; Carleton K, 2009, INTEGR ZOOL, V4, P75, DOI 10.1111/j.1749-4877.2008.00137.x; Chittka L, 1996, NATURWISSENSCHAFTEN, V83, P136, DOI 10.1007/BF01142181; CUTLER DE, 1995, J EXP BIOL, V198, P1909; DANTHANARAYANA W, 1976, AUST J ZOOL, V24, P65, DOI 10.1071/ZO9760065; Douglas RH, 1998, PROG RETIN EYE RES, V17, P597, DOI 10.1016/S1350-9462(98)00002-0; Drummond AJ, 2007, TRACER V1 4, V1.4; Endler JA, 1998, TRENDS ECOL EVOL, V13, P415, DOI 10.1016/S0169-5347(98)01471-2; Erixon P, 2003, SYST BIOL, V52, P665, DOI 10.1080/10635150390235485; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feng HQ, 2005, B ENTOMOL RES, V95, P361, DOI 10.1079/BER2005367; Feng HQ, 2009, J ECON ENTOMOL, V102, P95, DOI 10.1603/029.102.0114; Feng HQ, 2004, J ECON ENTOMOL, V97, P1874, DOI 10.1603/0022-0493-97.6.1874; FRANK K D, 1988, Journal of the Lepidopterists' Society, V42, P63; Frentiu FD, 2007, MOL BIOL EVOL, V24, P2016, DOI 10.1093/molbev/msm132; Frentiu FD, 2007, P NATL ACAD SCI USA, V104, P8634, DOI 10.1073/pnas.0701447104; Fuller RC, 2004, J COMP PHYSIOL A, V190, P147, DOI 10.1007/s00359-003-0478-z; Fuller RC, 2011, MOL ECOL, V20, P3321, DOI 10.1111/j.1365-294X.2011.05180.x; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hofmann CM, 2010, MOL ECOL, V19, P2064, DOI 10.1111/j.1365-294X.2010.04621.x; Hofmann CM, 2009, INTEGR COMP BIOL, V49, P630, DOI 10.1093/icb/icp079; Hope AJ, 1997, P ROY SOC B-BIOL SCI, V264, P155, DOI 10.1098/rspb.1997.0023; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Hunt DM, 2001, J EXP BIOL, V204, P3333; Jackowska M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-24; Jiggins CD, 2001, NATURE, V411, P302, DOI 10.1038/35077075; Kashiyama K, 2009, MOL BIOL EVOL, V26, P299, DOI 10.1093/molbev/msn251; Kelber A, 2003, INTEGR COMP BIOL, V43, P571, DOI 10.1093/icb/43.4.571; Kelber A, 1999, J EXP BIOL, V202, P2619; Koyanagi M, 2008, J MOL EVOL, V66, P130, DOI 10.1007/s00239-008-9065-9; Larmuseau MHD, 2010, MOL ECOL, V19, P2256, DOI 10.1111/j.1365-294X.2010.04643.x; Lewis T, 1984, ELEMENTS FRONTIERS I; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-242; Nielsen R, 1998, GENETICS, V148, P929; O'Quin KE, 2010, MOL BIOL EVOL, V27, P2839, DOI 10.1093/molbev/msq171; Oba Y, 2009, GENE, V436, P66, DOI 10.1016/j.gene.2009.02.001; Parry JWL, 2005, CURR BIOL, V15, P1734, DOI 10.1016/j.cub.2005.08.010; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salcedo E, 1999, J NEUROSCI, V19, P10716, DOI 10.1523/JNEUROSCI.19-24-10716.1999; Sasagawa H, 2003, EUR J NEUROSCI, V17, P963, DOI 10.1046/j.1460-9568.2003.02528.x; Sauman I, 2005, NEURON, V46, P457, DOI 10.1016/j.neuron.2005.03.014; Schmitz L, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-338; Sison-Mangus MP, 2008, J EXP BIOL, V211, P361, DOI 10.1242/jeb.012617; Sison-Mangus MP, 2006, J EXP BIOL, V209, P3079, DOI 10.1242/jeb.02360; Smith AR, 2011, MOL ECOL, V20, P299, DOI 10.1111/j.1365-294X.2010.04935.x; Spaethe J, 2004, MOL BIOL EVOL, V21, P1583, DOI 10.1093/molbev/msh162; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stavenga DG, 2006, ARTHROPOD STRUCT DEV, V35, P307, DOI 10.1016/j.asd.2006.08.011; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tobler M, 2010, BIOL LETTERS, V6, P98, DOI 10.1098/rsbl.2009.0549; Wagner HJ, 1998, PROG RETIN EYE RES, V17, P637, DOI 10.1016/S1350-9462(98)00003-2; Warrant E, 2011, ANNU REV ENTOMOL, V56, P239, DOI 10.1146/annurev-ento-120709-144852; Wei Guo-Shu, 2002, Acta Entomologica Sinica, V45, P323; Weiss MR, 2001, VISION LEARNING SOME; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yack JE, 2007, ARTHROPOD STRUCT DEV, V36, P11, DOI 10.1016/j.asd.2006.07.001; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yokoyama S, 1999, P NATL ACAD SCI USA, V96, P6279, DOI 10.1073/pnas.96.11.6279; Yokoyama S, 2000, FEBS LETT, V486, P167, DOI 10.1016/S0014-5793(00)02269-9	67	15	18	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78140	10.1371/journal.pone.0078140	http://dx.doi.org/10.1371/journal.pone.0078140			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24205129	Green Published, gold			2022-12-27	WOS:000326334500099
J	Fischer, J; Bohm, S; Muller, T; Witt, H; Sarrazin, C; Susser, S; Migaud, P; Schott, E; Stewart, G; Brodzinski, A; Fulop, B; van Bommel, F; George, J; Berg, T				Fischer, Janett; Boehm, Stephan; Mueller, Tobias; Witt, Heiko; Sarrazin, Christoph; Susser, Simone; Migaud, Pascal; Schott, Eckart; Stewart, Graeme; Brodzinski, Annika; Fueloep, Balazs; van Boemmel, Florian; George, Jacob; Berg, Thomas			Association of IFNL3 rs12979860 and rs8099917 with Biochemical Predictors of Interferon Responsiveness in Chronic Hepatitis C Virus Infection	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; TREATMENT-NAIVE PATIENTS; GENETIC-VARIATION; INTERLEUKIN 28B; IL28B GENOTYPE; SPONTANEOUS CLEARANCE; SERUM-CHOLESTEROL; TREATMENT FAILURE; EXPRESSION; RIBAVIRIN	Background & Aims: Genetic variations near the interferon lambda 3 gene (IFNL3, IL28B) are the most powerful predictors for sustained virologic response (SVR) in patients with chronic hepatitis C virus (HCV) infection, compared to other biochemical or histological baseline parameters. We evaluated whether the interplay of both IFNL3 polymorphisms rs12979860 and rs8099917 together with non-genetic clinical factors contributes to the predictive role of these genetic variants. Methods: The cohort comprised 1,402 patients of European descent with chronic HCV type 1 infection. 1,298 patients received interferon-based antiviral therapy, and 719 (55%) achieved SVR. The IFNL3 polymorphisms were genotyped by polymerase chain reaction and melting curve analysis. Results: A significant correlation was found between the IFNL3 polymorphisms and biochemical as well as virologic predictors of treatment outcome such as ALT, GGT, cholesterol, and HCV RNA levels. In multivariate regression analysis, IFLN3 SNPs, HCV RNA levels, and the GGT/ALT ratio were independent predictors of SVR. Dependent on the GGT/ALT ratio and on the HCV RNA concentration, significant variations in the likelihood for achieving SVR were observed in both, carriers of the responder as well as non-responder alleles. Conclusions: Our data support a clear association between IFNL3 genotypes and baseline parameters known to impact interferon responsiveness. Improved treatment outcome prediction was achieved when these predictors were considered in combination with the IFNL3 genotype.	[Fischer, Janett; Boehm, Stephan; Mueller, Tobias; Brodzinski, Annika; Fueloep, Balazs; van Boemmel, Florian; Berg, Thomas] Univ Klinikum Leipzig, Sekt Hepatol, Klin & Poliklin Gastroenterol & Rheumatol, Leipzig, Germany; [Witt, Heiko] Tech Univ Munich, Kinderklin Schwabing, D-80290 Munich, Germany; [Witt, Heiko] Tech Univ Munich, Else Kroner Fresenius Zentrum EKFZ Munich, D-80290 Munich, Germany; [Sarrazin, Christoph; Susser, Simone] JW Goethe Univ Hosp, Med Klin 1, Frankfurt, Germany; [Migaud, Pascal; Schott, Eckart] Univ Hosp Charite, Campus Virchow Klinikum, Dept Gastroenterol & Hepatol, Berlin, Germany; [Stewart, Graeme] Westmead Hosp, Inst Immunol & Allergy Res, Westmead, NSW, Australia; [Stewart, Graeme; George, Jacob] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia; [George, Jacob] Westmead Hosp, Storr Liver Unit, Westmead, NSW, Australia	Leipzig University; Technical University of Munich; Technical University of Munich; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Sydney	Fischer, J (corresponding author), Univ Klinikum Leipzig, Sekt Hepatol, Klin & Poliklin Gastroenterol & Rheumatol, Leipzig, Germany.	janett.fischer@medizin.uni-leipzig.de	George, jacob/P-1496-2014	Berg, Thomas/0000-0003-0003-6241; Mueller, Tobias/0000-0003-3426-5421; Migaud, Pascal/0000-0002-5659-9345	German Competence Network for Viral Hepatitis (Hep-Net); German Ministry of Education and Research (BMBF) [01 KI 0437, 10.1.3, 10.1, 01KI0787]; EU-Vigilance network of excellence combating viral resistance (VIRGIL) [LSHM-CT-2004-503359]; Australian Research Council Linkage Project Grant [LPO0990067]; National Health and Medical Research Council Grant [1006759]; Robert W. Storr Bequest to the Sydney Medical Foundation, University of Sydney	German Competence Network for Viral Hepatitis (Hep-Net); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); EU-Vigilance network of excellence combating viral resistance (VIRGIL); Australian Research Council Linkage Project Grant(Australian Research Council); National Health and Medical Research Council Grant(National Health and Medical Research Council (NHMRC) of Australia); Robert W. Storr Bequest to the Sydney Medical Foundation, University of Sydney	This work was supported by the German Competence Network for Viral Hepatitis (Hep-Net), funded by the German Ministry of Education and Research (BMBF, grant number 01 KI 0437, project number 10.1.3 and Core Project number 10.1, grant number 01KI0787), by the EU-Vigilance network of excellence combating viral resistance (VIRGIL, project number LSHM-CT-2004-503359). Parts of the work were supported by an Australian Research Council Linkage Project Grant (LPO0990067), a National Health and Medical Research Council Grant (1006759) and the Robert W. Storr Bequest to the Sydney Medical Foundation, University of Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2011, J MED VIROL, V83, P1597, DOI 10.1002/jmv.22158; Akuta N, 2012, INTERVIROLOGY, V55, P417, DOI 10.1159/000323526; Amanzada A, 2012, DIGESTION, V86, P218, DOI 10.1159/000339879; Asahina Y, 2012, HEPATOLOGY, V55, P20, DOI 10.1002/hep.24623; Asselah T, 2012, J HEPATOL, V56, P527, DOI 10.1016/j.jhep.2011.09.008; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Berg T, 2003, HEPATOLOGY, V37, P600, DOI 10.1053/jhep.2003.50106; Berg T, 2011, HEPATOLOGY, V54, p375A; Berg T, 2009, HEPATOLOGY, V50, P369, DOI 10.1002/hep.22991; Bibert S, 2013, J EXP MED, V210, P1109, DOI 10.1084/jem.20130012; Booth D, 2013, NAT GENET, V45, P119, DOI 10.1038/ng.2537; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Cho O, 2010, CYTOKINE, V51, P93, DOI 10.1016/j.cyto.2010.03.004; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Everhart JE, 2013, HEPATOLOGY, V57, P1725, DOI 10.1002/hep.26203; Fabris C, 2012, J MED VIROL, V84, P747, DOI 10.1002/jmv.23259; Feld JJ, 2007, HEPATOLOGY, V46, P1548, DOI 10.1002/hep.21853; Fischer J, 2012, HEPATOLOGY, V55, P1700, DOI 10.1002/hep.25582; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Harrison SA, 2010, HEPATOLOGY, V52, P864, DOI 10.1002/hep.23787; Heim MH, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13586; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Jacobson IM, 2012, J VIRAL HEPATITIS, V19, P1, DOI 10.1111/j.1365-2893.2012.01590.x; Ladero JM, 2012, J GASTROEN HEPATOL, V27, P279, DOI 10.1111/j.1440-1746.2011.06834.x; LARNER AC, 1986, J BIOL CHEM, V261, P453; Lupberger J, 2013, HEPATOLOGY, V58, P1225, DOI [10.1002/hep.26443, 10.1002/hep.26404]; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Mirza S, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-71; Naggie S, 2012, HEPATOLOGY, V56, P444, DOI 10.1002/hep.25647; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Petta S, 2012, ANTIVIR THER, V17, P823, DOI 10.3851/IMP2100; Petta S, 2012, J HEPATOL, V56, P1356, DOI 10.1016/j.jhep.2012.01.007; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rauch A, 2009, PHARMACOGENOMICS, V10, P1819, DOI 10.2217/PGS.09.121; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sarasin-Filipowicz M, 2009, MOL CELL BIOL, V29, P4841, DOI 10.1128/MCB.00224-09; Sarrazin C, 2011, GASTROENTEROLOGY, V141, P1656, DOI 10.1053/j.gastro.2011.07.019; SCHECTMAN G, 1992, ARTERIOSCLER THROMB, V12, P1053, DOI 10.1161/01.ATV.12.9.1053; Sheridan DA, 2013, CLIN RES HEPATOL GAS, V37, P10, DOI 10.1016/j.clinre.2012.07.002; Shiffman ML, 2012, LIVER INT, V32, P54, DOI 10.1111/j.1478-3231.2011.02718.x; Siagris D, 2006, J VIRAL HEPATITIS, V13, P56, DOI 10.1111/j.1365-2893.2005.00655.x; Stattermayer AF, 2011, CLIN GASTROENTEROL H, V9, P344, DOI 10.1016/j.cgh.2010.07.019; Sulkowski MS, 2011, HEPATOLOGY, V54, p473A; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thompson AJ, 2012, HEPATOLOGY, V56, P373, DOI 10.1002/hep.25792; Tillmann HL, 2010, GASTROENTEROLOGY, V139, P1586, DOI 10.1053/j.gastro.2010.07.005; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Weich V, 2011, J GASTROENTEROL, V46, P1427, DOI 10.1007/s00535-011-0458-y; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	52	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77530	10.1371/journal.pone.0077530	http://dx.doi.org/10.1371/journal.pone.0077530			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204859	Green Published, Green Submitted, gold			2022-12-27	WOS:000326270700035
J	Esposito, A; Popleteeva, M; Venkitaraman, AR				Esposito, Alessandro; Popleteeva, Marina; Venkitaraman, Ashok R.			Maximizing the Biochemical Resolving Power of Fluorescence Microscopy	PLOS ONE			English	Article							PHOTON ECONOMY; SEPARATION; SPEED	Most recent advances in fluorescence microscopy have focused on achieving spatial resolutions below the diffraction limit. However, the inherent capability of fluorescence microscopy to non-invasively resolve different biochemical or physical environments in biological samples has not yet been formally described, because an adequate and general theoretical framework is lacking. Here, we develop a mathematical characterization of the biochemical resolution in fluorescence detection with Fisher information analysis. To improve the precision and the resolution of quantitative imaging methods, we demonstrate strategies for the optimization of fluorescence lifetime, fluorescence anisotropy and hyperspectral detection, as well as different multi-dimensional techniques. We describe optimized imaging protocols, provide optimization algorithms and describe precision and resolving power in biochemical imaging thanks to the analysis of the general properties of Fisher information in fluorescence detection. These strategies enable the optimal use of the information content available within the limited photon-budget typically available in fluorescence microscopy. This theoretical foundation leads to a generalized strategy for the optimization of multi-dimensional optical detection, and demonstrates how the parallel detection of all properties of fluorescence can maximize the biochemical resolving power of fluorescence microscopy, an approach we term Hyper Dimensional Imaging Microscopy (HDIM). Our work provides a theoretical framework for the description of the biochemical resolution in fluorescence microscopy, irrespective of spatial resolution, and for the development of a new class of microscopes that exploit multi-parametric detection systems.	[Esposito, Alessandro; Popleteeva, Marina; Venkitaraman, Ashok R.] Univ Cambridge, MRC, Canc Unit, Cambridge, England	University of Cambridge	Esposito, A (corresponding author), Univ Cambridge, MRC, Canc Unit, Cambridge, England.	ae275@hutchison-mrc.cam.ac.uk	Esposito, Alessandro/A-8536-2008	Esposito, Alessandro/0000-0002-5051-091X	United Kingdom Medical Research Council; MRC [G1001522, MC_UU_12022/8, MC_UU_12022/1, MC_U105359877, G1001521] Funding Source: UKRI; Medical Research Council [MC_UU_12022/8, MC_U105359877, MC_UU_12022/1, G1001521, G1001522] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded in ARV's laboratory by the United Kingdom Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader AN, 2007, OPT EXPRESS, V15, P6934, DOI 10.1364/OE.15.006934; BALLEW RM, 1991, ANAL CHIM ACTA, V245, P121, DOI 10.1016/S0003-2670(00)80210-X; Barber PR, 2005, PROC SPIE, V5700, P171, DOI 10.1117/12.590510; Becker W, 2003, PROC SPIE, V4963, P175, DOI 10.1117/12.472866; Becker W, 2004, MICROSC RES TECHNIQ, V63, P58, DOI 10.1002/jemt.10421; Becker W., 2004, P SOC PHOTO-OPT INS, V5223, P1; Chan SP, 2001, ANAL CHEM, V73, P4486, DOI 10.1021/ac0102361; Clayton AHA, 2004, J MICROSC-OXFORD, V213, P1, DOI 10.1111/j.1365-2818.2004.01265.x; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Draaijer A., 1995, P491; Esposito A, 2005, OPT EXPRESS, V13; Esposito A., 2007, STANDARDIZATION FLUO; Esposito A., 2004, CURRENT PROTOCOLS CE; Esposito A, 2007, J OPT SOC AM A, V24, P3261, DOI 10.1364/JOSAA.24.003261; Esposito A, 2011, OPT EXPRESS, V19, P2546, DOI 10.1364/OE.19.002546; Fereidouni F, 2012, OPT EXPRESS, V20, P12729, DOI 10.1364/OE.20.012729; Gerritsen H. C., 2009, FRET FLIM IMAGING TE; Gerritsen HC, 2002, J MICROSC-OXFORD, V206, P218, DOI 10.1046/j.1365-2818.2002.01031.x; GOOD HP, 1984, J PHYS CHEM-US, V88, P5435, DOI 10.1021/j150666a066; Gratton E, 2003, J BIOMEDICAL OPTICS, V8; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; KOLLNER M, 1992, CHEM PHYS LETT, V200, P199, DOI 10.1016/0009-2614(92)87068-Z; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Li DDU, 2012, SENSORS-BASEL, V12, P5650, DOI 10.3390/s120505650; Lidke KA, 2005, IEEE T IMAGE PROCESS, V14, P1237, DOI 10.1109/TIP.2005.852458; Mukamel EA, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.168102; Neher R, 2004, J MICROSC-OXFORD, V213, P46, DOI 10.1111/j.1365-2818.2004.01262.x; Neher RA, 2009, BIOPHYS J, V96, P3791, DOI 10.1016/j.bpj.2008.10.068; O'Connor D. V., 1984, TIME CORRELATED SING; Palero JA, 2006, OPT EXPRESS, V14, P4395, DOI 10.1364/OE.14.004395; Pancheri L, 2009, PROC EUR SOLID-STATE, P429; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Watkins LP, 2004, BIOPHYS J, V86, P4015, DOI 10.1529/biophysj.103.037739	33	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77392	10.1371/journal.pone.0077392	http://dx.doi.org/10.1371/journal.pone.0077392			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204821	Green Submitted, Green Published, gold			2022-12-27	WOS:000326241200027
J	Alvarez, ML; Khosroheidari, M; Eddy, E; Kiefer, J				Alvarez, M. Lucrecia; Khosroheidari, Mahdieh; Eddy, Elena; Kiefer, Jeff			Role of MicroRNA 1207-5P and Its Host Gene, the Long Non-Coding RNA Pvt1, as Mediators of Extracellular Matrix Accumulation in the Kidney: Implications for Diabetic Nephropathy	PLOS ONE			English	Article							STAGE RENAL-DISEASE; SMAD PROTEINS; PHYSICAL INTERACTION; INTRONIC MICRORNAS; MESSENGER-RNAS; HUMAN-CELLS; HB-EGF; BETA; KINASE; EXPRESSION	Diabetic nephropathy is the most common cause of chronic kidney failure and end-stage renal disease in the Western World. One of the major characteristics of this disease is the excessive accumulation of extracellular matrix (ECM) in the kidney glomeruli. While both environmental and genetic determinants are recognized for their role in the development of diabetic nephropathy, epigenetic factors, such as DNA methylation, long non-coding RNAs, and microRNAs, have also recently been found to underlie some of the biological mechanisms, including ECM accumulation, leading to the disease. We previously found that a long non-coding RNA, the plasmacytoma variant translocation 1 (PVT1), increases plasminogen activator inhibitor 1 (PAI-1) and transforming growth factor beta 1 (TGF-beta 1) in mesangial cells, the two main contributors to ECM accumulation in the glomeruli under hyperglycemic conditions, as well as fibronectin 1 (FN1), a major ECM component. Here, we report that miR-1207-5p, a PVT1-derived microRNA, is abundantly expressed in kidney cells, and is upregulated by glucose and TGF-beta 1. We also found that like PVT1, miR-1207-5p increases expression of TGF-beta 1, PAI-1, and FN1 but in a manner that is independent of its host gene. In addition, regulation of miR-1207-5p expression by glucose and TGF beta 1 is independent of PVT1. These results provide evidence supporting important roles for miR-1207-5p and its host gene in the complex pathogenesis of diabetic nephropathy.	[Alvarez, M. Lucrecia; Khosroheidari, Mahdieh; Eddy, Elena; Kiefer, Jeff] Translat Genom Res Inst, Diabet Cardiovasc & Metab Dis Ctr, Phoenix, AZ USA	Translational Genomics Research Institute	Alvarez, ML (corresponding author), Translat Genom Res Inst, Diabet Cardiovasc & Metab Dis Ctr, Phoenix, AZ USA.	lucrecia.alvarez@asu.edu	Jeff/ABB-2636-2021	Jeff/0000-0002-1238-3120	American Diabetes Association	American Diabetes Association(American Diabetes Association)	This work was funded by the American Diabetes Association (http://www.diabetes.org). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez ML, 2013, DIABETOLOGIA, V56, P444, DOI 10.1007/s00125-012-2768-x; Alvarez ML, 2013, DIABETES RES CLIN PR, V99, P1, DOI 10.1016/j.diabres.2012.10.010; Alvarez ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018671; Barsotti AM, 2012, J BIOL CHEM, V287, P2509, DOI 10.1074/jbc.M111.322875; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Berezhna SY, 2006, P NATL ACAD SCI USA, V103, P7682, DOI 10.1073/pnas.0600148103; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Davis BN, 2010, MOL CELL, V39, P373, DOI 10.1016/j.molcel.2010.07.011; Deshpande SD, 2013, DIABETES; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gao X, 2012, IUBMB LIFE, V64, P835, DOI 10.1002/iub.1079; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; Ha H, 2003, J AM SOC NEPHROL, V14, pS246, DOI 10.1097/01.ASN.0000077411.98742.54; Hanson RL, 2007, DIABETES, V56, P975, DOI 10.2337/db06-1072; Hou CC, 2005, AM J PATHOL, V166, P761, DOI 10.1016/S0002-9440(10)62297-3; Huang CM, 2002, DIABETES, V51, P3577, DOI 10.2337/diabetes.51.12.3577; Huppi K, 2008, MOL CANCER RES, V6, P212, DOI 10.1158/1541-7786.MCR-07-0105; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kanwar YS, 2008, EXP BIOL MED, V233, P4, DOI 10.3181/0705-MR-134; Kato M, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003389; Kato M, 2012, EXP CELL RES, V318, P993, DOI 10.1016/j.yexcr.2012.02.034; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Langlois MA, 2005, J BIOL CHEM, V280, P16949, DOI 10.1074/jbc.M501591200; Lee HB, 2005, NEPHROLOGY, V10, pS11, DOI 10.1111/j.1440-1797.2005.00449.x; Lee HB, 2003, J AM SOC NEPHROL, V14, pS241, DOI 10.1097/01.ASN.0000077410.66390.0F; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; Millis MP, 2007, DIABETES, V56, P3027, DOI 10.2337/db07-0675; Monteys AM, 2010, RNA, V16, P495, DOI 10.1261/rna.1731910; Moran VA, 2012, NUCLEIC ACIDS RES, V40, P6391, DOI 10.1093/nar/gks296; NELSON RG, 1995, DIABETES CARE, V18, P182, DOI 10.2337/diacare.18.2.182; Ng DPK, 2005, CURR MOL MED, V5, P509, DOI 10.2174/1566524054553504; Ng YY, 2005, KIDNEY INT, V67, pS83, DOI 10.1111/j.1523-1755.2005.09421.x; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; Papagregoriou G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031021; Ravid M, 1998, ARCH INTERN MED, V158, P998, DOI 10.1001/archinte.158.9.998; Reddy MA, 2011, J AM SOC NEPHROL, V22, P2182, DOI 10.1681/ASN.2011060629; Reeves WB, 2000, P NATL ACAD SCI USA, V97, P7667, DOI 10.1073/pnas.97.14.7667; Robb GB, 2005, NAT STRUCT MOL BIOL, V12, P133, DOI 10.1038/nsmb886; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Samarakoon R, 2012, CELL TISSUE RES, V347, P117, DOI 10.1007/s00441-011-1181-y; Seong HA, 2005, J BIOL CHEM, V280, P42897, DOI 10.1074/jbc.M507539200; Seong HA, 2007, J BIOL CHEM, V282, P12272, DOI 10.1074/jbc.M609279200; Smith JP, 2009, AM J PHYSIOL-RENAL, V296, pF957, DOI 10.1152/ajprenal.90490.2008; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Thomas MC, 2012, CURR OPIN NEPHROL HY, V21, P195, DOI 10.1097/MNH.0b013e328350313e; Treiber T, 2010, MOL CELL, V39, P315, DOI 10.1016/j.molcel.2010.07.020; Uchiyama-Tanaka Y, 2002, KIDNEY INT, V62, P799, DOI 10.1046/j.1523-1755.2002.00537.x; Watanabe Y, 2010, MOL CELL, V37, P123, DOI 10.1016/j.molcel.2009.10.028; Yan B, 2012, DNA CELL BIOL, V31, pS34, DOI 10.1089/dna.2011.1544; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Zhou L, 2010, J AM SOC NEPHROL, V21, P31, DOI 10.1681/ASN.2008111133	57	118	138	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77468	10.1371/journal.pone.0077468	http://dx.doi.org/10.1371/journal.pone.0077468			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204837	Green Published, Green Submitted, gold			2022-12-27	WOS:000326155400038
J	Sardar, P; Chatterjee, S; Wu, WC; Lichstein, E; Ghosh, J; Aikat, S; Mukherjee, D				Sardar, Partha; Chatterjee, Saurav; Wu, Wen-Chih; Lichstein, Edgar; Ghosh, Joydeep; Aikat, Shamik; Mukherjee, Debabrata			New Oral Anticoagulants Are Not Superior to Warfarin in Secondary Prevention of Stroke or Transient Ischemic Attacks, but Lower the Risk of Intracranial Bleeding: Insights from a Meta-Analysis and Indirect Treatment Comparisons	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; STRATIFICATION SCHEMES; SUBGROUP ANALYSIS; VENOUS THROMBOEMBOLISM; TASK-FORCE; DABIGATRAN; APIXABAN; EFFICACY; SAFETY; RIVAROXABAN	Purpose: Patients with Atrial Fibrillation (AF) and prior stroke are classified as high risk in all risk stratification schemes. A systematic review and meta-analysis was performed to compare the efficacy and safety of New Oral Anticoagulants (NOACs) to warfarin in patients with AF and previous stroke or transient ischemic attack (TIA). Methods: Three randomized controlled trials (RCTs), including total 14527 patients, comparing NOACs (apixaban, dabigatran and rivaroxaban) with warfarin were included in the analysis. Primary efficacy endpoint was ischemic stroke, and primary safety endpoint was intracranial bleeding. Random-effects models were used to pool efficacy and safety data across RCTs. RevMan and Stata software were used for direct and indirect comparisons, respectively. Results: In patients with AF and previous stroke or TIA, effects of NOACs were not statistically different from that of warfarin, in reduction of stroke (Odds Ratio [OR] 0.86, 95% confidence interval [CI] 0.73- 1.01), disabling and fatal stroke (OR 0.85, 95% CI 0.71-1.04), and all-cause mortality (OR 0.90, 95% CI 0.79-1.02). Randomization to NOACs was associated with a significantly lower risk of intracranial bleeding (OR 0.42, 95% CI 0.25-0.70). There were no major differences in efficacy between apixaban, dabigatran (110 mg BID and 150 mg BID) and rivaroxaban. Major bleeding was significantly lower with apixaban and dabigatran (110 mg BID) compared with dabigatran (150 mg BID) and rivaroxaban. Conclusion: NOACs may not be more effective than warfarin in the secondary prevention of ischemic stroke in patients with a prior history of cerebrovascular ischemia, but have a lower risk of intracranial bleeding.	[Sardar, Partha] New York Med Coll, Metropolitan Hosp Ctr, Dept Med, New York, NY 10029 USA; [Chatterjee, Saurav; Wu, Wen-Chih] Brown Univ, Providence, RI 02912 USA; [Chatterjee, Saurav; Wu, Wen-Chih] Providence VAMC, Providence, RI USA; [Lichstein, Edgar; Ghosh, Joydeep] Maimonides Hosp, Brooklyn, NY 11219 USA; [Aikat, Shamik] Univ Kentucky, Div Cardiol, Gill Heart Inst, Lexington, KY USA; [Mukherjee, Debabrata] Texas Tech Univ, Hlth Sci Ctr, El Paso, TX USA	Metropolitan Hospital Center; New York Medical College; Brown University; Maimonides Medical Center; University of Kentucky; Texas Tech University System; Texas Tech University	Sardar, P (corresponding author), New York Med Coll, Metropolitan Hosp Ctr, Dept Med, New York, NY 10029 USA.	parthasardarmd@gmail.com	Mukherjee, Debabrata/AAG-1486-2019	Mukherjee, Debabrata/0000-0002-5131-3694				Adam SS, 2012, ANN INTERN MED, V157, P796, DOI 10.7326/0003-4819-157-10-201211200-00532; Baker WL, 2012, CIRC-CARDIOVASC QUAL, V5, P711, DOI 10.1161/CIRCOUTCOMES.112.966572; Biondi-Zoccai G, 2013, HEART LUNG VESSEL, V5, P40; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Chatterjee S, 2013, JAMA NEUROL IN PRESS; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; De Caterina R, 2012, J AM COLL CARDIOL, V59, P1413, DOI 10.1016/j.jacc.2012.02.008; Dentali F, 2012, CIRCULATION, V126, P2381, DOI 10.1161/CIRCULATIONAHA.112.115410; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diener HC, 2010, LANCET NEUROL, V9, P1157, DOI 10.1016/S1474-4422(10)70274-X; Dogliotti A, 2013, CLIN CARDIOL, V36, P61, DOI 10.1002/clc.22081; Easton JD, 2012, LANCET NEUROL, V11, P503, DOI 10.1016/S1474-4422(12)70092-3; Ezekowitz MD, 2010, STROKE, V41, pS17, DOI 10.1161/STROKEAHA.110.598201; Fang MC, 2008, J AM COLL CARDIOL, V51, P810, DOI 10.1016/j.jacc.2007.09.065; Friberg L, 2012, EUR HEART J, V33, P1500, DOI 10.1093/eurheartj/ehr488; Gage BF, 2004, CIRCULATION, V110, P2287, DOI 10.1161/01.CIR.0000145172.55640.93; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hankey GJ, 2012, LANCET NEUROL, V11, P315, DOI 10.1016/S1474-4422(12)70042-X; Harenberg J, 2012, INT ANGIOL, V31, P330; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jansen JP, 2011, VALUE HEALTH, V14, P417, DOI 10.1016/j.jval.2011.04.002; Kwong JSW, 2013, CARDIOVASC DRUG THER, V27, P23, DOI 10.1007/s10557-012-6426-9; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lip GYH, 2012, J AM COLL CARDIOL, V60, P738, DOI 10.1016/j.jacc.2012.03.019; Lopes RD, 2012, LANCET, V380, P1749, DOI 10.1016/S0140-6736(12)60986-6; Lopes RD, 2011, STROKE, V42, P3477, DOI 10.1161/STROKEAHA.111.625392; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mantha S, 2012, THROMB HAEMOSTASIS, V108, P476, DOI 10.1160/TH12-02-0093; Miller CS, 2012, AM J CARDIOL, V110, P453, DOI 10.1016/j.amjcard.2012.03.049; Oldgren J, 2011, ANN INTERN MED, V155, P660, DOI 10.7326/0003-4819-155-10-201111150-00004; Olesen Jonas Bjerring, 2011, BMJ, V342, pd124, DOI 10.1136/bmj.d124; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Rasmussen LH, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7097; Sardar P, 2013, DRUGS, V73, P1171, DOI 10.1007/s40265-013-0082-7; Saxena R., 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000187.PUB2; Uchino K, 2012, ARCH INTERN MED, V172, P397, DOI 10.1001/archinternmed.2011.1666; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003	38	53	58	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77694	10.1371/journal.pone.0077694	http://dx.doi.org/10.1371/journal.pone.0077694			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204920	Green Published, gold, Green Submitted			2022-12-27	WOS:000326155400050
J	Afolabi, MO; Ndure, J; Drammeh, A; Darboe, F; Mehedi, SR; Rowland-Jones, SL; Borthwick, N; Black, A; Ambler, G; John-Stewart, GC; Reilly, M; Hanke, T; Flanagan, KL				Afolabi, Muhammed O.; Ndure, Jorjoh; Drammeh, Abdoulie; Darboe, Fatoumatta; Mehedi, Shams-Rony; Rowland-Jones, Sarah L.; Borthwick, Nicola; Black, Antony; Ambler, Gwen; John-Stewart, Grace C.; Reilly, Marie; Hanke, Tomas; Flanagan, Katie L.			A Phase I Randomized Clinical Trial of Candidate Human Immunodeficiency Virus type 1 Vaccine MVA.HIVA Administered to Gambian Infants	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; EXPRESSING HIV-1 GAG; PRIME-BOOST REGIMEN; ANKARA MVA; RECOMBINANT BCG; DNA; SAFETY; IMMUNOGENICITY; CELLS; IMMUNIZATION	Background: A vaccine to decrease transmission of human immunodeficiency virus type 1 (HIV-1) during breast-feeding would complement efforts to eliminate infant HIV-1 infection by antiretroviral therapy. Relative to adults, infants have distinct immune development, potentially high-risk of transmission when exposed to HIV-1 and rapid progression to AIDS when infected. To date, there have been only three published HIV-1 vaccine trials in infants. Trial Design: We conducted a randomized phase I clinical trial PedVacc 001 assessing the feasibility, safety and immunogenicity of a single dose of candidate vaccine MVA.HIVA administered intramuscularly to 20-week-old infants born to HIV-1-negative mothers in The Gambia. Methods: Infants were followed to 9 months of age with assessment of safety, immunogenicity and interference with Expanded Program on Immunization (EPI) vaccines. The trial is the first stage of developing more complex prime-boost vaccination strategies against breast milk transmission of HIV-1. Results: From March to October 2010, 48 infants (24 vaccine and 24 no-treatment) were enrolled with 100% retention. The MVA.HIVA vaccine was safe with no difference in adverse events between vaccinees and untreated infants. Two vaccine recipients (9%) and no controls had positive ex vivo interferon-gamma ELISPOT assay responses. Antibody levels elicited to the EPI vaccines, which included diphtheria, tetanus, whole-cell pertussis, hepatitis B virus, Haemophilus influenzae type b and oral poliovirus, reached protective levels for the vast majority and were similar between the two arms. Conclusions: A single low-dose of MVA.HIVA administered to 20-week-old infants in The Gambia was found to be safe and without interference with the induction of protective antibody levels by EPI vaccines, but did not alone induce sufficient HIV-1-specific responses. These data support the use of MVA carrying other transgenes as a boosting vector within more complex prime-boost vaccine strategies against transmission of HIV-1 and/or other infections in this age group. Trial Registration: ClinicalTrials.gov NCT00982579 The Pan African Clinical Trials Registry PACTR2008120000904116	[Afolabi, Muhammed O.; Ndure, Jorjoh; Drammeh, Abdoulie; Darboe, Fatoumatta; Flanagan, Katie L.] MRC Unit, Fajara, Gambia; [Mehedi, Shams-Rony] MRC Unit, Stat & Data Management Dept, Fajara, Gambia; [Rowland-Jones, Sarah L.] Univ Oxford, Jenner Inst, Oxford, England; [Borthwick, Nicola; Black, Antony; Ambler, Gwen; John-Stewart, Grace C.; Hanke, Tomas] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Borthwick, Nicola; Black, Antony; Ambler, Gwen; John-Stewart, Grace C.; Hanke, Tomas] Univ Washington, Dept Med, Seattle, WA USA; [Borthwick, Nicola; Black, Antony; Ambler, Gwen; John-Stewart, Grace C.; Hanke, Tomas] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Reilly, Marie] Dept Med Epidemiol & Biostat, Stockholm, Sweden	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; Jenner Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hanke, T (corresponding author), Univ Washington, Dept Biostat, Seattle, WA 98195 USA.	tomas.hanke@ndm.ox.ac.uk	John-Stewart, Grace/U-3351-2019; John-Stewart, Grace/L-3650-2019	Afolabi, Muhammed/0000-0002-9967-6419; John-Stewart, Grace/0000-0002-4301-1573; Flanagan, Katie/0000-0002-1575-1953; Darboe, Fatoumatta/0000-0001-5945-3715	European and Developing Countries Clinical Trials Partnership (EDCTP) [CT.2006.33111.002]; MRC UK; SIDA (Swedish International Development Cooperation Agency); MRC [MC_U137884179] Funding Source: UKRI; Medical Research Council [MC_U137884179, G1000800f] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD054314] Funding Source: NIH RePORTER	European and Developing Countries Clinical Trials Partnership (EDCTP); MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); SIDA (Swedish International Development Cooperation Agency); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the European and Developing Countries Clinical Trials Partnership (EDCTP; CT.2006.33111.002) with co-funding from MRC UK and SIDA (Swedish International Development Cooperation Agency). The MRC Unit in The Gambia provided the infrastructure to perform the study, which was sponsored by MRC UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetifa IMO, 2009, INT J LAB HEMATOL, V31, P615, DOI 10.1111/j.1751-553X.2008.01087.x; [Anonymous], 2012, GLOB REP UNAIDS REP; Bejon P, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010029; Borkowsky W, 2000, J INFECT DIS, V181, P890, DOI 10.1086/315298; Borthwick N, 2012, IMMUNOGENICITY UNIVE; Buchanan AM, 2010, TROP MED INT HEALTH, V15, P1011, DOI 10.1111/j.1365-3156.2010.02585.x; Cebere I, 2006, VACCINE, V24, P417, DOI 10.1016/j.vaccine.2005.08.041; Chapman R, 2010, CURR HIV RES, V8, P282, DOI 10.2174/157016210791208686; Coutsoudis A, 2004, J INFECT DIS, V189, P2154, DOI 10.1086/420834; Cunningham CK, 2001, CLIN INFECT DIS, V32, P801, DOI 10.1086/319215; Dorrell L, 2005, AIDS, V19, P1321, DOI 10.1097/01.aids.0000180104.65640.16; Dorrell L, 2007, VACCINE, V25, P3277, DOI 10.1016/j.vaccine.2007.01.005; Dorrell L, 2006, J VIROL, V80, P4705, DOI 10.1128/JVI.80.10.4705-4716.2006; Eggers M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-347; Goonetilleke N, 2006, J VIROL, V80, P4717, DOI 10.1128/JVI.80.10.4717-4728.2006; Hanke T, 2000, NAT MED, V6, P951, DOI 10.1038/79626; Hanke T, 2003, J GEN VIROL, V84, P361, DOI 10.1099/vir.0.18738-0; Hanke T, 2007, J GEN VIROL, V88, P1, DOI 10.1099/vir.0.82493-0; Hanke T, 2011, EUR J IMMUNOL, V41, P3390, DOI 10.1002/eji.201190072; Hicar MD, 2013, CURR HIV RES, V11, P137, DOI 10.2174/1570162X11311020006; Hopkins R, 2011, EUR J IMMUNOL, V41, P3542, DOI 10.1002/eji.201141962; Hopkins R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020067; Im EJ, 2007, J VIROL, V81, P9408, DOI 10.1128/JVI.00707-07; Im Eung-Jun, 2004, Expert Rev Vaccines, V3, pS89, DOI 10.1586/14760584.3.4.S89; JACOBS WR, 1987, NATURE, V327, P532, DOI 10.1038/327532a0; Jaoko W, 2008, VACCINE, V26, P2788, DOI 10.1016/j.vaccine.2008.02.071; Johnson DC, 2005, J INFECT DIS, V192, P2129, DOI 10.1086/498163; Joseph J, 2006, EXPERT REV VACCINES, V5, P827, DOI 10.1586/14760584.5.6.827; Kintu K, 2013, JAIDS-J ACQ IMM DEF, V63, P1, DOI 10.1097/QAI.0b013e31827f1c2d; Kourtis AP, 2007, AM J OBSTET GYNECOL, V197, pS113, DOI 10.1016/j.ajog.2007.03.003; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; Luzuriaga Katherine, 2002, AIDS Reviews, V4, P21; MAYR A, 1978, ZBL BAKT MIK HYG B, V167, P375; Mbori-Ngacha D, 2001, JAMA-J AM MED ASSOC, V286, P2413, DOI 10.1001/jama.286.19.2413; McFarland EJ, 2001, J INFECT DIS, V184, P1331, DOI 10.1086/323994; McFarland EJ, 2006, AIDS, V20, P1481, DOI 10.1097/01.aids.0000237363.33994.45; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Miles DJC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002905; Mo HM, 1998, AIDS RES HUM RETROV, V14, P607, DOI 10.1089/aid.1998.14.607; Mwau M, 2004, J GEN VIROL, V85, P911, DOI 10.1099/vir.0.19701-0; Ondondo BO, 2006, EUR J IMMUNOL, V36, P2585, DOI 10.1002/eji.200636508; ONWUKEME KE, 1991, TROP GEOGR MED, V43, P171; Ota MOC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002461; Peters BS, 2007, VACCINE, V25, P2120, DOI 10.1016/j.vaccine.2006.11.016; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Quinto L, 2006, TROP MED INT HEALTH, V11, P1741, DOI 10.1111/j.1365-3156.2006.01764.x; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richardson BA, 2003, J VIROL, V77, P7120, DOI 10.1128/JVI.77.12.7120-7123.2003; Rosario M, 2010, J VIROL, V84, P7815, DOI 10.1128/JVI.00726-10; Rosario M, 2010, J VIROL, V84, P5898, DOI 10.1128/JVI.02607-09; Rousseau CM, 2003, J INFECT DIS, V187, P741, DOI 10.1086/374273; Saubi N, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/516219; UNAIDS, 2012, REP GLOB AIDS EP 201; van Gageldonk PGM, 2008, J IMMUNOL METHODS, V335, P79, DOI 10.1016/j.jim.2008.02.018; Winstone N, 2009, EUR J IMMUNOL, V39, P975, DOI 10.1002/eji.200839167; Yang HB, 2007, J IMMUNOL, V179, P597, DOI 10.4049/jimmunol.179.1.597; Young SL, 2011, ADV NUTR, V2, P225, DOI 10.3945/an.110.000224	58	15	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78289	10.1371/journal.pone.0078289	http://dx.doi.org/10.1371/journal.pone.0078289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205185	Green Published, gold, Green Submitted			2022-12-27	WOS:000326152300047
J	Dhooghe, B; Noel, S; Bouzin, C; Behets-Wydemans, G; Leal, T				Dhooghe, Barbara; Noel, Sabrina; Bouzin, Caroline; Behets-Wydemans, Gaetane; Leal, Teresinha			Correction of Chloride Transport and Mislocalization of CFTR Protein by Vardenafil in the Gastrointestinal Tract of Cystic Fibrosis Mice	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; RECEPTOR-MEDIATED ENDOCYTOSIS; NASAL POTENTIAL DIFFERENCE; PHOSPHODIESTERASE-5 INHIBITORS; LUNG INFLAMMATION; WILD-TYPE; MOUSE; DELTA-F508-CFTR; GENE; F508DEL-CFTR	Although lung disease is the major cause of mortality in cystic fibrosis (CF), gastrointestinal (GI) manifestations are the first hallmarks in 15-20% of affected newborns presenting with meconium ileus, and remain major causes of morbidity throughout life. We have previously shown that cGMP-dependent phosphodiesterase type 5 (PDE5) inhibitors rescue defective CF Transmembrane conductance Regulator (CFTR)-dependent chloride transport across the mouse CF nasal mucosa. Using F508del-CF mice, we examined the transrectal potential difference 1 hour after intraperitoneal injection of the PDE5 inhibitor vardenafil or saline to assess the amiloride-sensitive sodium transport and the chloride gradient and forskolin-dependent chloride transport across the GI tract. In the same conditions, we performed immunohistostaining studies in distal colon to investigate CFTR expression and localization. F508del-CF mice displayed increased sodium transport and reduced chloride transport compared to their wild-type littermates. Vardenafil, applied at a human therapeutic dose (0.14 mg/kg) used to treat erectile dysfunction, increased chloride transport in F508del-CF mice. No effect on sodium transport was detected. In crypt colonocytes of wild-type mice, the immunofluorescence CFTR signal was mostly detected in the apical cell compartment. In F508del-CF mice, a 25% reduced signal was observed, located mostly in the subapical region. Vardenafil increased the peak of intensity of the fluorescence CFTR signal in F508del-CF mice and displaced it towards the apical cell compartment. Our findings point out the intestinal mucosa as a valuable tissue to study CFTR transport function and localization and to evaluate efficacy of therapeutic strategies in CF. From our data we conclude that vardenafil mediates potentiation of the CFTR chloride channel and corrects mislocalization of the mutant protein. The study provides compelling support for targeting the cGMP signaling pathway in CF pharmacotherapy.	[Dhooghe, Barbara; Noel, Sabrina; Leal, Teresinha] Catholic Univ Louvain, Louvain Ctr Toxicol & Appl Pharmacol LTAP, Inst Expt & Clin Res IREC, B-1200 Brussels, Belgium; [Bouzin, Caroline; Behets-Wydemans, Gaetane] Catholic Univ Louvain, IREC Imaging Platform Pole Pharmacol & Therapeut, Inst Expt & Clin Res IREC, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain	Leal, T (corresponding author), Catholic Univ Louvain, Louvain Ctr Toxicol & Appl Pharmacol LTAP, Inst Expt & Clin Res IREC, B-1200 Brussels, Belgium.	teresinha.leal@uclouvain.be	Noel, Sabrina/H-5567-2011	Noel, Sabrina/0000-0003-1803-6434	European Economic Community European Coordination Action for Research in Cystic Fibrosis EU [FP6 LHHM-CT-2005-018932]	European Economic Community European Coordination Action for Research in Cystic Fibrosis EU	Breeding pairs of Cftrtm1EUR (F508del (FVB/129)) mice obtained from the MC Rotterdam, Rotterdam, The Netherlands, with the support of European Economic Community European Coordination Action for Research in Cystic Fibrosis EU FP6 LHHM-CT-2005-018932. The authors thank Vaincre la Mucoviscidose for providing Cftr knockout mice. Vardenafil was a gift from Bayer Pharma (Berlin, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Al-Nakkash L, 1999, PFLUG ARCH EUR J PHY, V437, P553, DOI 10.1007/s004240050817; Amaral MD, 2013, CURR PHARM DESIGN, V19, P3497; Ameen N, 2000, HISTOCHEM CELL BIOL, V114, P69; ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; Birault V, 2013, CURR OPIN CHEM BIOL, V17, P353, DOI 10.1016/j.cbpa.2013.04.020; Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; Carvalho-Oliveira I, 2004, J HISTOCHEM CYTOCHEM, V52, P193, DOI 10.1177/002215540405200207; CHAO AC, 1994, EMBO J, V13, P1065, DOI 10.1002/j.1460-2075.1994.tb06355.x; Chen EYJ, 2000, BIOCHEMISTRY-US, V39, P3797, DOI 10.1021/bi992620m; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Cobb BR, 2003, AM J RESP CELL MOL, V29, P410, DOI 10.1165/rcmb.2002-0247OC; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; Dormer RL, 2005, THORAX, V60, P55, DOI 10.1136/thx.2003.019778; Gadsby David C., 1999, Physiological Reviews, V79, pS77; Golin-Bisello F, 2005, AM J PHYSIOL-CELL PH, V289, pC708, DOI 10.1152/ajpcell.00544.2004; Grubb BR, 1997, AM J PHYSIOL-GASTR L, V273, pG258, DOI 10.1152/ajpgi.1997.273.2.G258; Heda GD, 2001, AM J PHYSIOL-CELL PH, V280, pC166, DOI 10.1152/ajpcell.2001.280.1.C166; Huaux F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064341; Hug MJ, 2011, METHODS MOL BIOL, V741, P87, DOI 10.1007/978-1-61779-117-8_7; Ismailov II, 1996, J BIOL CHEM, V271, P4725; Jouret F, 2007, J AM SOC NEPHROL, V18, P707, DOI 10.1681/ASN.2006030269; Kelley TJ, 1998, AM J PHYSIOL-LUNG C, V274, pL990, DOI 10.1152/ajplung.1998.274.6.L990; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KNOWLES MR, 1995, HUM GENE THER, V6, P445, DOI 10.1089/hum.1995.6.4-445; Legssyer R, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-134; Leier G, 2012, CELL PHYSIOL BIOCHEM, V29, P775, DOI 10.1159/000265129; Leonard A., 2012, OJRD, V02, P43, DOI [10.4236/ojrd.2012.22007, DOI 10.4236/OJRD.2012.22007]; Leonard A, 2012, J CYST FIBROS, V11, P231, DOI 10.1016/j.jcf.2011.12.004; Lubamba B, 2011, EUR RESPIR J, V37, P72, DOI 10.1183/09031936.00013510; Lubamba B, 2008, AM J RESP CRIT CARE, V177, P506, DOI 10.1164/rccm.200703-344OC; Lubamba B, 2012, J CYST FIBROS, V11, P266, DOI 10.1016/j.jcf.2012.03.003; Lubamba B, 2009, AM J RESP CRIT CARE, V179, P1022, DOI 10.1164/rccm.200901-0049OC; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Mendes Filipa, 2004, J Cyst Fibros, V3 Suppl 2, P37, DOI 10.1016/j.jcf.2004.05.008; Mendes Filipa, 2004, J Cyst Fibros, V3 Suppl 2, P69, DOI 10.1016/j.jcf.2004.05.016; Merk D, 2013, EXPERT OPIN DRUG DIS, V8, P691, DOI 10.1517/17460441.2013.788495; MIDDLETON PG, 1994, EUR RESPIR J, V7, P2050; Moniz S, 2013, ACS CHEM BIOL, V8, P432, DOI 10.1021/cb300484r; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Pier GB, 2012, J EXP MED, V209, P1235, DOI 10.1084/jem.20121248; Poschet JF, 2007, AM J PHYSIOL-LUNG C, V293, pL712, DOI 10.1152/ajplung.00314.2006; Raggi C, 2011, PFLUG ARCH EUR J PHY, V462, P851, DOI 10.1007/s00424-011-1026-2; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rotella DP, 2002, NAT REV DRUG DISCOV, V1, P674, DOI 10.1038/nrd893; Rowe SM, 2013, COLD SPRING HARB PER, V3; Rowe SM, 2012, THORAX, V67, P882, DOI 10.1136/thoraxjnl-2012-202550; Sermet-Gaudelus I, 2010, AM J RESP CRIT CARE, V182, P1262, DOI 10.1164/rccm.201001-0137OC; Stutts MJ, 1997, J BIOL CHEM, V272, P14037, DOI 10.1074/jbc.272.22.14037; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; VANDOORNINCK JH, 1995, EMBO J, V14, P4403, DOI 10.1002/j.1460-2075.1995.tb00119.x; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Weiner SA, 2008, PEDIATR RES, V63, P73, DOI 10.1203/PDR.0b013e31815b4bc6; WELSH MJ, 1982, SCIENCE, V218, P1219, DOI 10.1126/science.6293054; Wilschanski M, 2007, GUT, V56, P1153, DOI 10.1136/gut.2004.062786	55	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77314	10.1371/journal.pone.0077314	http://dx.doi.org/10.1371/journal.pone.0077314			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204804	Green Published, gold, Green Submitted			2022-12-27	WOS:000326152300020
J	Hoey, SE; Buonocore, F; Cox, CJ; Hammond, VJ; Perkinton, MS; Williams, RJ				Hoey, Sarah E.; Buonocore, Federica; Cox, Carla J.; Hammond, Victoria J.; Perkinton, Michael S.; Williams, Robert J.			AMPA Receptor Activation Promotes Non-Amyloidogenic Amyloid Precursor Protein Processing and Suppresses Neuronal Amyloid-beta Production	PLOS ONE			English	Article							SYNAPSE-ASSOCIATED PROTEIN-97; ALPHA-SECRETASE CLEAVAGE; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; PHOSPHORYLATION; DISINTEGRIN; OLIGOMERS; TRANSMISSION; STIMULATION; TRAFFICKING	Soluble oligomeric amyloid beta peptide (A beta) generated from processing of the amyloid precursor protein (APP) plays a central role in the pathogenesis of Alzheimer's Disease (AD) and through actions at glutamatergic synapses affects excitability and plasticity. The physiological control of APP processing is not fully understood but stimulation of synaptic NMDA receptors (NMDAR) can suppress A beta levels through an ERK-dependent increase in alpha-secretase activity. AMPA-type glutamate receptors (AMPAR) couple to ERK phosphorylation independently of NMDAR activation raising the possibility that stimulation of AMPAR might similarly promote non-amyloidogenic APP processing. We have tested this hypothesis by investigating whether AMPAR directly regulate APP processing in cultured mouse cortical neurons, by analyzing APP C-terminal fragments (CTFs), soluble APP (sAPP), A beta levels, and cleavage of an APP-GAL4 reporter protein. We report that direct stimulation of AMPAR increases non-amyloidogenic alpha-secretase-mediated APP processing and inhibits A beta production. Processing was blocked by the matrix metalloproteinase inhibitor TAPI-1 but was only partially dependent on Ca2+ influx and ERK activity. AMPAR can therefore, be added to the repertoire of receptors that couple to non-amyloidogenic APP processing at glutamatergic synapses and thus pharmacological targeting of AMPAR could potentially influence the development and progression of A beta pathology in AD.	[Hoey, Sarah E.; Buonocore, Federica; Perkinton, Michael S.; Williams, Robert J.] Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England; [Cox, Carla J.; Hammond, Victoria J.; Williams, Robert J.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of London; King's College London; University of Bath	Williams, RJ (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England.	r.j.williams@bath.ac.uk	Buonocore, Federica/AAT-7804-2020; Williams, Robert/A-9180-2008	Williams, Robert/0000-0002-2369-1989	Alzheimer's Society [126]; Research in Ageing [278]; MRC; BBSRC; Alzheimer&quot;s Society [126] Funding Source: researchfish	Alzheimer's Society; Research in Ageing; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Alzheimer&quot;s Society	This work was supported by grants from the Alzheimer's Society to MSP and RJW (http://www.alzheimers.org.uk) SEH was supported by a studentship from Research in Ageing (Ref 278). CJC is supported by an MRC-doctoral training grant joint with the Alzheimer's Society (Ref 126) and VJH by a BBSRC doctoral training grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JJ, 2008, NEUROBIOL AGING, V29, P992, DOI 10.1016/j.neurobiolaging.2007.01.003; Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Back S, 2007, J NEUROSCI RES, V85, P2580, DOI 10.1002/jnr.21239; Bordji K, 2010, J NEUROSCI, V30, P15927, DOI 10.1523/JNEUROSCI.3021-10.2010; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Buxbaum JD, 1998, J NEUROSCI, V18, P9629; Chang PKY, 2012, EUR J NEUROSCI, V35, P1908, DOI 10.1111/j.1460-9568.2012.08165.x; Chappell AS, 2007, NEUROLOGY, V68, P1008, DOI 10.1212/01.wnl.0000260240.46070.7c; Choudhry F, 2012, NEUROBIOL AGING, V33, P960, DOI 10.1016/j.neurobiolaging.2010.07.008; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Desdouits-Magnen J, 1998, J NEUROCHEM, V70, P524; FAZELI MS, 1994, NEUROSCI LETT, V169, P77, DOI 10.1016/0304-3940(94)90360-3; Gianni D, 2003, J BIOL CHEM, V278, P9290, DOI 10.1074/jbc.M211899200; Goodger ZV, 2009, J CELL SCI, V122, P3703, DOI 10.1242/jcs.048090; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hayashi T, 1999, NATURE, V397, P72, DOI 10.1038/16269; Hoe HS, 2009, J BIOL CHEM, V284, P8495, DOI 10.1074/jbc.M900141200; Hoey SE, 2009, J NEUROSCI, V29, P4442, DOI 10.1523/JNEUROSCI.6017-08.2009; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Ishida A, 1997, NEUROREPORT, V8, P2133, DOI 10.1097/00001756-199707070-00009; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kim SH, 2010, J NEUROSCI, V30, P3870, DOI 10.1523/JNEUROSCI.4717-09.2010; Klein WL, 2013, J ALZHEIMERS DIS, V33, pS49, DOI 10.3233/JAD-2012-129039; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lee RKK, 1996, ANN NY ACAD SCI, V777, P338, DOI 10.1111/j.1749-6632.1996.tb34443.x; Lesne S, 2005, J NEUROSCI, V25, P9367, DOI 10.1523/JNEUROSCI.0849-05.2005; Lichtenthaler SF, 2011, J NEUROCHEM, V116, P10, DOI 10.1111/j.1471-4159.2010.07081.x; Marcello E, 2007, J NEUROSCI, V27, P1682, DOI 10.1523/JNEUROSCI.3439-06.2007; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Mauceri D, 2004, J BIOL CHEM, V279, P23813, DOI 10.1074/jbc.M402796200; Meziane H, 1998, P NATL ACAD SCI USA, V95, P12683, DOI 10.1073/pnas.95.21.12683; Mills J, 1997, J NEUROSCI, V17, P9415; Minano-Molina AJ, 2011, J BIOL CHEM, V286, P27311, DOI 10.1074/jbc.M111.227504; Molina-Holgado F, 2008, J NEUROCHEM, V105, P2466, DOI 10.1111/j.1471-4159.2008.05332.x; Obregon D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1781; Perkinton MS, 2004, J BIOL CHEM, V279, P22084, DOI 10.1074/jbc.M311479200; Perkinton MS, 1999, J NEUROSCI, V19, P5861, DOI 10.1523/JNEUROSCI.19-14-05861.1999; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Rainey-Smith SR, 2010, J NEUROCHEM, V113, P692, DOI 10.1111/j.1471-4159.2010.06634.x; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Schroeter H, 2007, J NEUROCHEM, V101, P1596, DOI 10.1111/j.1471-4159.2006.04434.x; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; SHIGEMATSU K, 1992, BRAIN RES, V592, P353, DOI 10.1016/0006-8993(92)91697-D; Small DH, 2012, NEURODEGENER DIS, V10, P76, DOI 10.1159/000333126; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Ting JT, 2007, P NATL ACAD SCI USA, V104, P353, DOI 10.1073/pnas.0608807104; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Venkitaramani DV, 2007, J NEUROSCI, V27, P11832, DOI 10.1523/JNEUROSCI.3478-07.2007; Verges DK, 2011, J NEUROSCI, V31, P11328, DOI 10.1523/JNEUROSCI.0607-11.2011; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wan XZ, 2012, J NEUROSCI, V32, P3910, DOI 10.1523/JNEUROSCI.3916-11.2012; Wang YZ, 1997, NATURE, V389, P502, DOI 10.1038/39062; Williams RJ, 2012, FREE RADICAL BIO MED, V52, P35, DOI 10.1016/j.freeradbiomed.2011.09.010	58	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78155	10.1371/journal.pone.0078155	http://dx.doi.org/10.1371/journal.pone.0078155			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205136	gold, Green Published, Green Submitted			2022-12-27	WOS:000326152300043
J	Kang, C; Kim, SC; Lee, SH; Jeong, JH; Kim, DS; Kim, DH				Kang, Changwoo; Kim, Seong Chun; Lee, Soo Hoon; Jeong, Jin Hee; Kim, Dong Seob; Kim, Dong Hoon			Absolute Lymphocyte Count as a Predictor of Mortality in Emergency Department Patients with Paraquat Poisoning	PLOS ONE			English	Article							B-CELL-LYMPHOMA; FOLLICULAR LYMPHOMAS; CLINICAL-FEATURES; PROGNOSTIC-FACTOR; HEART-FAILURE; SURVIVAL; TOXICITY; DEATH; MECHANISMS	Background: Paraquat (PQ) is a potent, highly toxic and widely used herbicide. The major medical problems associated with PQ are accidental or suicidal ingestion. There are several prognostic markers of PQ poisoning, with the serum PQ concentration considered to be the best indicator of outcome. However, the measurement of such markers is limited in many hospitals. Objective: The present study was conducted to investigate the association of absolute lymphocyte count (ALC) and the 30-day mortality rate in patients with PQ poisoning. Methods: We performed a retrospective analysis of patients admitted to the emergency department after paraquat poisoning between January 2010 and April 2013. Independent risk factors including ALC for 30-day mortality were determined. The ALC was categorized in quartiles as <= 1700, 1700 to 3200, 3200 to 5000, and >5000. Univariate and multivariate Cox proportional hazard analysis were performed to determine the independent risk factors for mortality. Results: A total of 136 patients were included in the study, and the 30-day mortality was 73.5%. ALC was significantly higher in nonsurvivors than in survivors. The highest ALC quartile (ALC>5000; hazard ratio, 2.58; 95% CI, 1.08-6.21) was associated with increased mortality in multivariate analysis. In addition, old age, lower arterial PaCO2, increased peripheral neutrophil count, and high serum levels of creatinine were associated with mortality. Conclusion: The absolute lymphocyte count is associated with the 30-day mortality rate in patients with paraquat poisoning.	[Kang, Changwoo; Kim, Seong Chun; Lee, Soo Hoon; Jeong, Jin Hee; Kim, Dong Seob; Kim, Dong Hoon] Gyeongsang Natl Univ Hosp, Dept Emergency Med, Jinju, South Korea	Gyeongsang National University; Gyeongsang National University Hospital	Kim, SC (corresponding author), Gyeongsang Natl Univ Hosp, Dept Emergency Med, Jinju, South Korea.	gsimem@naver.com		Lee, Soo Hoon/0000-0002-2512-5905; Jeong, Jin Hee/0000-0002-1042-9359				Acanfora D, 2001, AM HEART J, V142, P167, DOI 10.1067/mhj.2001.115792; Behl D, 2007, BRIT J HAEMATOL, V137, P409, DOI 10.1111/j.1365-2141.2007.06596.x; Castelino DJ, 1997, AUST NZ J MED, V27, P170, DOI 10.1111/j.1445-5994.1997.tb00934.x; Corsini E, 2013, TOXICOLOGY, V307, P123, DOI 10.1016/j.tox.2012.10.009; Cox MC, 2008, BRIT J HAEMATOL, V141, P265, DOI 10.1111/j.1365-2141.2008.07028.x; Cox MC, 2008, LEUKEMIA LYMPHOMA, V49, P1745, DOI 10.1080/10428190802226425; Dinis-Oliveira RJ, 2008, CRIT REV TOXICOL, V38, P13, DOI 10.1080/10408440701669959; Gil HW, 2008, CLIN TOXICOL, V46, P515, DOI 10.1080/15563650701549403; Jones GM, 2000, J TOXICOL-CLIN TOXIC, V38, P123, DOI 10.1081/CLT-100100926; Kim DH, 2007, LEUKEMIA, V21, P2227, DOI 10.1038/sj.leu.2404780; Lee EY, 2002, TOXICOL IND HEALTH, V18, P201, DOI 10.1191/0748233702th141oa; Lee Y, 2012, CLIN TOXICOL, V50, P52, DOI 10.3109/15563650.2011.639716; Liu X., 2013, ABSTR APPL ANAL, P1, DOI [10.1002/humu.22376, DOI 10.1002/HUMU.22376]; LUSTER MI, 1993, ENVIRON HEALTH PERSP, V100, P219, DOI 10.2307/3431528; Min YG, 2011, CLIN TOXICOL, V49, P840, DOI 10.3109/15563650.2011.619137; Ommen SR, 1997, AM J CARDIOL, V79, P812, DOI 10.1016/S0002-9149(96)00878-8; Ommen SR, 2002, PACE, V25, P1424, DOI 10.1046/j.1460-9592.2002.01424.x; Ommen SR, 1998, CIRCULATION, V97, P19, DOI 10.1161/01.CIR.97.1.19; Paolillo N, 2011, INT J IMMUNOPATH PH, V24, P861, DOI 10.1177/039463201102400405; Porrata LF, 2009, AM J HEMATOL, V84, P93, DOI 10.1002/ajh.21337; Senarathna L, 2009, QJM-INT J MED, V102, P251, DOI 10.1093/qjmed/hcp006; Siddiqui M, 2006, BRIT J HAEMATOL, V134, P596, DOI 10.1111/j.1365-2141.2006.06232.x; Suntres ZE, 2002, TOXICOLOGY, V180, P65, DOI 10.1016/S0300-483X(02)00382-7; Weng CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051743; Zouridakis EG, 2000, AM J CARDIOL, V86, P449, DOI 10.1016/S0002-9149(00)00963-2	25	16	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78160	10.1371/journal.pone.0078160	http://dx.doi.org/10.1371/journal.pone.0078160			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205140	Green Published, gold, Green Submitted			2022-12-27	WOS:000326152300044
J	Rodrigues, FS; Souza, MA; Magni, DV; Ferreira, APO; Mota, BC; Cardoso, AM; Paim, M; Xavier, LL; Ferreira, J; Schetinger, MRC; Da Costa, JC; Royes, LFF; Fighera, MR				Rodrigues, Fernanda S.; Souza, Mauren A.; Magni, Danieli V.; Ferreira, Ana Paula O.; Mota, Bibiana C.; Cardoso, Andreia M.; Paim, Mariana; Xavier, Leder L.; Ferreira, Juliano; Schetinger, Maria Rosa C.; Da Costa, Jaderson C.; Royes, Luiz Fernando F.; Fighera, Michele R.			N-Acetylcysteine Prevents Spatial Memory Impairment Induced by Chronic Early Postnatal Glutaric Acid and Lipopolysaccharide in Rat Pups	PLOS ONE			English	Article							COA DEHYDROGENASE-DEFICIENCY; NITRIC-OXIDE SYNTHASES; NA+-K+-ATPASE; NA+,K+-ATPASE ACTIVITY; OXIDATIVE STRESS; ALZHEIMER-DISEASE; REDOX STATE; COGNITIVE DEFICITS; DORSAL-HIPPOCAMPUS; HYDROGEN-PEROXIDE	Background and Aims: Glutaric aciduria type I (GA-I) is characterized by accumulation of glutaric acid (GA) and neurological symptoms, such as cognitive impairment. Although this disease is related to oxidative stress and inflammation, it is not known whether these processes facilitate the memory impairment. Our objective was to investigate the performance of rat pups chronically injected with GA and lipopolysaccharide (LPS) in spatial memory test, antioxidant defenses, cytokines levels, Na+, K+-ATPase activity, and hippocampal volume. We also evaluated the effect of N-acetylcysteine (NAC) on theses markers. Methods: Rat pups were injected with GA (5umol g of body weight-1, subcutaneously; twice per day; from 5th to 28th day of life), and were supplemented with NAC (150mg/kg/day; intragastric gavage; for the same period). LPS (2mg/kg; E. coli 055 B5) or vehicle (saline 0.9%) was injected intraperitoneally, once per day, from 25th to 28th day of life. Oxidative stress and inflammatory biomarkers as well as hippocampal volume were assessed. Results: GA caused spatial learning deficit in the Barnes maze and LPS potentiated this effect. GA and LPS increased TNF-alpha and IL-1 beta levels. The co-administration of these compounds potentiated the increase of IL-1 beta levels but not TNF-alpha levels in the hippocampus. GA and LPS increased TBARS (thiobarbituric acid-reactive substance) content, reduced antioxidant defenses and inhibited Na+, K+-ATPase activity. GA and LPS co-administration did not have additive effect on oxidative stress markers and Na+, K+ pump. The hippocampal volume did not change after GA or LPS administration. NAC protected against impairment of spatial learning and increase of cytokines levels. NAC Also protected against inhibition of Na+, K+-ATPase activity and oxidative markers. Conclusions: These results suggest that inflammatory and oxidative markers may underlie at least in part of the neuropathology of GA-I in this model. Thus, NAC could represent a possible adjuvant therapy in treatment of children with GA-I.	[Rodrigues, Fernanda S.; Souza, Mauren A.; Ferreira, Ana Paula O.; Mota, Bibiana C.; Fighera, Michele R.] Univ Fed Santa Maria, Dept Neuropsiquiatria, Ctr Ciencias Saude, BR-97119900 Santa Maria, RS, Brazil; [Rodrigues, Fernanda S.; Souza, Mauren A.; Ferreira, Ana Paula O.; Mota, Bibiana C.; Cardoso, Andreia M.; Ferreira, Juliano; Schetinger, Maria Rosa C.; Royes, Luiz Fernando F.; Fighera, Michele R.] Univ Fed Santa Maria, Ctr Ciencias Nat & Exatas, Programa Posgrad Ciencias Biol Bioquim Toxicol, BR-97119900 Santa Maria, RS, Brazil; [Da Costa, Jaderson C.] Pontificia Univ Catolica Rio Grande do Sul, Inst Pesquisas Biomed, Lab Neurociencias, Porto Alegre, RS, Brazil; [Da Costa, Jaderson C.] Pontificia Univ Catolica Rio Grande do Sul, Inst Cerebro, Porto Alegre, RS, Brazil; [Paim, Mariana; Xavier, Leder L.] Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Dept Ciencias Fisiol, Porto Alegre, RS, Brazil; [Rodrigues, Fernanda S.; Souza, Mauren A.; Ferreira, Ana Paula O.; Mota, Bibiana C.; Royes, Luiz Fernando F.; Fighera, Michele R.] Univ Fed Santa Maria, Lab Bioquim Exercicio BIOEX, Dept Metodos & Tecn Desportivas, Ctr Educ Fis & Desportos, BR-97119900 Santa Maria, RS, Brazil; [Royes, Luiz Fernando F.; Fighera, Michele R.] Univ Fed Santa Maria, Dept Fisiol & Farmacol, Programa Posgrad Farmacol, Ctr Ciencias Saude, BR-97119900 Santa Maria, RS, Brazil; [Magni, Danieli V.] Univ Reg Integrada Alto Uruguai & Missoes, Santiago, RS, Brazil	Universidade Federal de Santa Maria (UFSM); Universidade Federal de Santa Maria (UFSM); Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Federal de Santa Maria (UFSM); Universidade Federal de Santa Maria (UFSM); Universidade Regional Integrada do Alto Uruguai e das Missoes (URI)	Fighera, MR (corresponding author), Univ Fed Santa Maria, Dept Neuropsiquiatria, Ctr Ciencias Saude, BR-97119900 Santa Maria, RS, Brazil.	mrfighera@yahoo.com.br	Fighera, Michele R/J-9576-2014; DaCosta, Jaderson/C-4968-2015; royes, luiz/T-3581-2019; Cardoso, Andréia M/ABH-9732-2020; Xavier, Leder Leal/G-4540-2014; de Abreu, Daniela dsa Souza/C-4103-2015; Ferreira, Juliano/A-9803-2013; Schetinger, Maria Rosa Chitolina/I-7658-2019; Souza, Mauren/A-7990-2015	DaCosta, Jaderson/0000-0001-6776-1515; Cardoso, Andréia M/0000-0003-4243-8855; Xavier, Leder Leal/0000-0002-7213-4935; de Abreu, Daniela dsa Souza/0000-0003-1142-7926; Ferreira, Juliano/0000-0002-9562-0602; royes, luiz/0000-0003-4045-4827; Fighera, Michele/0000-0002-3111-7530; Chitolina Schetinger, Maria Rosa/0000-0002-5240-8935	FAPERGS / CNPQ [Pronem: 11/2082-4]	FAPERGS / CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS))	The present work was supported by FAPERGS / CNPQ (grants: Pronem: 11/2082-4). The funders had the role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Barrientos RM, 2002, BEHAV BRAIN RES, V134, P291, DOI 10.1016/S0166-4328(02)00043-8; BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; Beauchamp MH, 2009, J INHERIT METAB DIS, V32, pS207, DOI 10.1007/s10545-009-1167-z; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Bilbo SD, 2005, BEHAV NEUROSCI, V119, P293, DOI 10.1037/0735-7044.119.1.293; Block ML, 2007, BIOCHEM SOC T, V35, P1127, DOI 10.1042/BST0351127; Boneh A, 2008, MOL GENET METAB, V94, P287, DOI 10.1016/j.ymgme.2008.03.005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burton BK, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.6.e69; Casadesus G, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-2; Crack PJ, 2006, J NEURAL TRANSM, V113, P645, DOI 10.1007/s00702-005-0352-y; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; de Haan JB, 1998, J BIOL CHEM, V273, P22528, DOI 10.1074/jbc.273.35.22528; de Paula S, 2009, PEDIATR RES, V65, P631, DOI 10.1203/PDR.0b013e31819ed5c8; dos Reis EA, 2002, BRAIN RES, V951, P151, DOI 10.1016/S0006-8993(02)03077-9; Dringen R, 1999, J NEUROCHEM, V72, P2523, DOI 10.1046/j.1471-4159.1999.0722523.x; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Eriksson C, 2000, CYTOKINE, V12, P423, DOI 10.1006/cyto.1999.0582; Fan Y, 2008, NEUROIMAGE, V41, P277, DOI 10.1016/j.neuroimage.2008.02.043; Farooqui T., 2011, PARKINSONS DIS, P247; Ferreira GD, 2005, NEUROCHEM RES, V30, P1123, DOI 10.1007/s11064-005-7711-9; Ferreira GD, 2008, BEHAV BRAIN RES, V187, P411, DOI 10.1016/j.bbr.2007.10.003; Fighera MR, 2006, NEUROBIOL DIS, V22, P611, DOI 10.1016/j.nbd.2006.01.002; File SE, 1996, PHARMACOL BIOCHEM BE, V54, P123, DOI 10.1016/0091-3057(95)02108-6; Fiske CH, 1927, SCIENCE, V65, P401, DOI 10.1126/science.65.1686.401; Forshammar J, 2011, J BIOL CHEM, V286, P31586, DOI 10.1074/jbc.M111.247767; Frantseva MV, 2000, EUR J NEUROSCI, V12, P1431, DOI 10.1046/j.1460-9568.2000.00016.x; Funk CBR, 2005, BRAIN, V128, P711, DOI 10.1093/brain/awh401; Goncalves JF, 2012, FOOD CHEM TOXICOL, V50, P3709, DOI 10.1016/j.fct.2012.07.016; Goncalves JF, 2010, CHEM-BIOL INTERACT, V186, P53, DOI 10.1016/j.cbi.2010.04.011; GOODMAN SI, 1987, ENZYME, V38, P76, DOI 10.1159/000469193; Goodman SI, 2001, PRENATAL DIAG, V21, P1167, DOI 10.1002/pd.201; GOODMAN SI, 1977, J PEDIATR-US, V90, P746, DOI 10.1016/S0022-3476(77)81240-7; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; GUNDERSEN RW, 1987, DEV BIOL, V121, P423, DOI 10.1016/0012-1606(87)90179-5; Hao LY, 2010, NEUROSCIENCE, V166, P763, DOI 10.1016/j.neuroscience.2010.01.006; Harting I, 2009, BRAIN, V132, P1764, DOI 10.1093/brain/awp112; Hein AM, 2007, NEUROSCIENCE, V150, P754, DOI 10.1016/j.neuroscience.2007.10.003; Hellstrom IC, 2005, HIPPOCAMPUS, V15, P656, DOI 10.1002/hipo.20086; Hemmens B, 1998, METH MOL B, V100, P1; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Ikeda T, 2005, AM J OBSTET GYNECOL, V192, P719, DOI 10.1016/j.ajog.2004.12.048; Ikegaya Y, 2003, SYNAPSE, V47, P54, DOI 10.1002/syn.10154; Alles YCJ, 2010, BRAIN RES, V1356, P130, DOI 10.1016/j.brainres.2010.07.106; Kierdorf K, 2010, RESULTS PROBL CELL D, V51, P173, DOI 10.1007/400_2008_15; Kolker S, 2006, BRAIN, V129, pE54, DOI 10.1093/brain/awl137; Koeller DM, 2002, HUM MOL GENET, V11, P347, DOI 10.1093/hmg/11.4.347; Kolker S, 1999, J INHERIT METAB DIS, V22, P259; Kolker S, 2002, J NEUROSCI RES, V68, P424, DOI 10.1002/jnr.10187; Kreydiyyeh SI, 2004, PFLUG ARCH EUR J PHY, V448, P231, DOI 10.1007/s00424-004-1242-0; Kreydiyyeh SI, 2004, CYTOKINE, V26, P1, DOI 10.1016/j.cyto.2003.11.014; Kulkens S, 2005, NEUROLOGY, V64, P2142, DOI 10.1212/01.WNL.0000167428.12417.B2; LEES GJ, 1993, NEUROSCIENCE, V54, P287, DOI 10.1016/0306-4522(93)90254-D; Lima FD, 2008, BEHAV BRAIN RES, V193, P306, DOI 10.1016/j.bbr.2008.05.013; Lima TTF, 1998, BRAIN RES, V802, P55, DOI 10.1016/S0006-8993(98)00563-0; Liu SH, 1997, NEUROSCI LETT, V234, P166, DOI 10.1016/S0304-3940(97)00686-1; Lundborg C, 2011, J NEUROCHEM, V119, P686, DOI 10.1111/j.1471-4159.2011.07465.x; Maeda Shigeru, 2008, Neuropsychiatr Dis Treat, V4, P663; Magni DV, 2007, BRAIN RES, V1185, P336, DOI 10.1016/j.brainres.2007.09.023; Magni DV, 2011, EPILEPSY RES, V93, P138, DOI 10.1016/j.eplepsyres.2010.11.007; Magni DV, 2009, INT J DEV NEUROSCI, V27, P65, DOI 10.1016/j.ijdevneu.2008.09.004; Martinovich GG, 2005, EUR BIOPHYS J BIOPHY, V34, P937, DOI 10.1007/s00249-005-0470-3; Matsumoto Y, 2001, EUR J PHARMACOL, V430, P283, DOI 10.1016/S0014-2999(01)01374-7; MISRA HP, 1972, J BIOL CHEM, V247, P6960; Mukhopadhyay C, 2008, J POSTGRAD MED, V54, P35, DOI 10.4103/0022-3859.39189; Muriel P, 2000, NITRIC OXIDE-BIOL CH, V4, P333, DOI 10.1006/niox.2000.0285; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Nguyen KT, 1998, J NEUROSCI, V18, P2239; Nishi A, 1999, J NEUROCHEM, V73, P1492, DOI 10.1046/j.1471-4159.1999.0731492.x; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Olcese JM, 2009, J PINEAL RES, V47, P82, DOI 10.1111/j.1600-079X.2009.00692.x; Oliveira MS, 2009, J NEUROCHEM, V109, P416, DOI 10.1111/j.1471-4159.2009.05961.x; Olivera-Bravo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020831; Patil Neela, 2004, Indian J Pediatr, V71, P948; PERRELLA O, 1992, J NEUROL, V239, P387; Pugh CR, 1998, BRAIN BEHAV IMMUN, V12, P212, DOI 10.1006/brbi.1998.0524; PUTTFARCKEN PS, 1993, BRAIN RES, V624, P223, DOI 10.1016/0006-8993(93)90081-W; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Rosales-Corral S, 2004, J NEUROIMMUNOL, V150, P20, DOI 10.1016/j.jneuroim.2004.01.005; Rosales-Corral S, 2010, ANTIOXID REDOX SIGN, V13, P193, DOI 10.1089/ars.2009.2629; Sauer SW, 2006, J NEUROCHEM, V97, P899, DOI 10.1111/j.1471-4159.2006.03813.x; Scaini G, 2012, BEHAV BRAIN RES, V231, P92, DOI 10.1016/j.bbr.2012.03.004; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schmidt C, 2007, J AM SOC NEPHROL, V18, P1072, DOI 10.1681/ASN.2006050454; Seminotti B, 2012, MOL GENET METAB, V106, P31, DOI 10.1016/j.ymgme.2012.03.002; Sparkman NL, 2005, PHYSIOL BEHAV, V85, P278, DOI 10.1016/j.physbeh.2005.04.015; Strauss KA, 2003, AM J MED GENET C, V121C, P38, DOI 10.1002/ajmg.c.20007; Strauss KA, 2003, AM J MED GENET C, V121C, P53, DOI 10.1002/ajmg.c.20008; Strauss KA, 2007, BRAIN, V130, P1905, DOI 10.1093/brain/awm058; Ullrich K, 1999, J INHERIT METAB DIS, V22, P392, DOI 10.1023/A:1005595921323; Victor VM, 2003, FREE RADICAL RES, V37, P919, DOI 10.1080/1071576031000148727; Viviani B, 2003, J NEUROSCI, V23, P8692; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Wyse ATS, 2000, NEUROREPORT, V11, P2331, DOI 10.1097/00001756-200007140-00052; Yang MJ, 2003, ACTA CRYSTALLOGR D, V59, P146, DOI 10.1107/S0907444902018024; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Zhan H, 2004, NEUROL RES, V26, P35, DOI 10.1179/016164104773026507; Zhang XY, 2007, JPN J OPHTHALMOL, V51, P14, DOI 10.1007/s10384-006-0382-5; Zinnanti WJ, 2007, J CLIN INVEST, V117, P3258, DOI 10.1172/JCI31617	101	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78332	10.1371/journal.pone.0078332	http://dx.doi.org/10.1371/journal.pone.0078332			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205200	Green Published, gold, Green Submitted			2022-12-27	WOS:000326152300049
J	Xu, YL; Zhu, JY; Gao, L; Liu, Y; Shen, J; Shen, C; Matfin, G; Wu, XH				Xu, Yili; Zhu, Jiayu; Gao, Li; Liu, Yun; Shen, Jie; Shen, Chong; Matfin, Glenn; Wu, Xiaohong			Hyperuricemia as an Independent Predictor of Vascular Complications and Mortality in Type 2 Diabetes Patients: A Meta-Analysis	PLOS ONE			English	Article							SERUM URIC-ACID; PERIPHERAL ARTERIAL-DISEASE; ENDOTHELIAL DYSFUNCTION; INSULIN-RESISTANCE; RENAL-DISEASE; CARDIOVASCULAR MORTALITY; KIDNEY-DISEASE; RISK-FACTORS; MELLITUS; ASSOCIATION	Background: Recent data have suggested that serum uric acid (SUA) level is positively associated with the development of type 2 diabetes (T2DM). Whether SUA is also independently associated with the development of vascular complications and mortality in T2DM is controversial. Methods: A computerized literature search of MEDLINE, Embase and PubMed database was conducted and the odds ratio (OR) or hazard ratio (HR) for per 0.1mmol/l increase in SUA in each study was calculated. Cochrane's Q and I-2 statistics were used to evaluate heterogeneity among studies and pooling OR and HR with 95% confidence intervals (CIs) were calculated using random-effects models and fixed-effects models. The pooled analysis was performed using Stata 10.0. Results: Our search yielded 9 eligible articles (16 ORs and HRs) including 20,891 T2DM patients. Pooled estimates for the relationship suggested that each 0.1 mmol/l increase in SUA resulted in a 28% increase in the risk of diabetic vascular complications and a 9% increase in the risk of diabetic mortality. In stratification-analysis, the positive relationship between SUA and vascular complications remained significant irrespective of mean age, adjustment for metabolic variables and medications. However, it was inconsistent in different populations (significantly positive in the Asian but not in Australian and Italian population) and sample sizes (significantly positive in the relatively large sample size [>= 1000] but non-significant in the small sample size [<1000]). Conclusions: Results of this meta-analysis supported elevated SUA as an independent predictor of vascular complications and mortality in T2DM patients. SUA-lowering therapies might be helpful for prevention and treatment of vascular complications in this population.	[Xu, Yili; Zhu, Jiayu; Gao, Li; Shen, Jie; Wu, Xiaohong] Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China; [Liu, Yun] Nanjing Med Univ, Affiliated Hosp 1, Dept Geriatr, Nanjing, Jiangsu, Peoples R China; [Shen, Chong] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Matfin, Glenn] Int Diabet Ctr, Minneapolis, MN USA	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; International Diabetes Center	Wu, XH (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China.	drxhwu@njmu.edu.cn		Wu, Xiaohong/0000-0001-5984-3342	National Natural Science Foundation of China [81070621, 81261120566]; International Science and technology cooperation plan-the key national and regional research and development cooperation projects [BZ2011042]; Jiangsu Province key medical personnel project [RC2011068]; Projects in the Jiangsu Science & Technology Pillar Program [BE 2011802]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science and technology cooperation plan-the key national and regional research and development cooperation projects; Jiangsu Province key medical personnel project; Projects in the Jiangsu Science & Technology Pillar Program	XW is supported by National Natural Science Foundation of China (81070621 and 81261120566), International Science and technology cooperation plan-the key national and regional research and development cooperation projects (BZ2011042), Jiangsu Province key medical personnel project (RC2011068) and the Projects in the Jiangsu Science & Technology Pillar Program (BE 2011802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benz K, 2011, CONTRIB NEPHROL, V172, P139, DOI 10.1159/000328695; BERLIN JA, 1993, EPIDEMIOLOGY, V4, P218, DOI 10.1097/00001648-199305000-00005; Bonakdaran S., 2011, Eastern Mediterranean Health Journal, V17, P640; Cai XL, 2006, CHINESE MED J-PEKING, V119, P822, DOI 10.1097/00029330-200605020-00005; CAPPUCCIO FP, 1993, JAMA-J AM MED ASSOC, V270, P354, DOI 10.1001/jama.270.3.354; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Doria A, 2011, NAT REV NEPHROL, V7, P495, DOI 10.1038/nrneph.2011.107; Feldman T., 1995, Harefuah, V128, P681; FOX IH, 1981, METABOLISM, V30, P616, DOI 10.1016/0026-0495(81)90142-6; Fukui M, 2008, METABOLISM, V57, P625, DOI 10.1016/j.metabol.2007.12.005; GALVAN AQ, 1995, AM J PHYSIOL-ENDOC M, V268, pE1, DOI 10.1152/ajpendo.1995.268.1.E1; HANNA AK, 1985, CLIN INVEST MED, V8, P109; Hong Q, 2012, CELL CALCIUM, V51, P402, DOI 10.1016/j.ceca.2012.01.003; Ito H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027817; Jiang Y, 2011, EUR J EPIDEMIOL, V26, P863, DOI 10.1007/s10654-011-9617-y; Kamiyama M, 2012, J PHARMACOL SCI, V119, P314, DOI 10.1254/jphs.12076FP; Kim ES, 2011, J DIABETES COMPLICAT, V25, P309, DOI 10.1016/j.jdiacomp.2010.09.004; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Kosugi T, 2009, AM J PHYSIOL-RENAL, V297, pF481, DOI 10.1152/ajprenal.00092.2009; Kuo CF, 2013, RHEUMATOLOGY, V52, P127, DOI 10.1093/rheumatology/kes223; Lehto S, 1998, STROKE, V29, P635, DOI 10.1161/01.STR.29.3.635; Li Yu-lin, 2011, Zhonghua Nei Ke Za Zhi, V50, P555; Lv Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056864; Mazza A, 2007, ACTA DIABETOL, V44, P99, DOI 10.1007/s00592-007-0249-3; Murea M, 2012, ADV CHRONIC KIDNEY D, V19, P419, DOI 10.1053/j.ackd.2012.07.008; Muscelli E, 1996, AM J HYPERTENS, V9, P746, DOI 10.1016/0895-7061(96)00098-2; Ong G, 2010, DIABETOLOGIA, V53, P1288, DOI 10.1007/s00125-010-1735-7; Panee J, 2012, CYTOKINE, V60, P1, DOI 10.1016/j.cyto.2012.06.018; Panero F, 2012, ATHEROSCLEROSIS, V221, P183, DOI 10.1016/j.atherosclerosis.2011.11.042; Panero F, 2011, HIGH BLOOD PRESS CAR, V18, P70; Papanas N, 2011, ANGIOLOGY, V62, P291, DOI 10.1177/0003319710394164; Pontiroli AE, 1998, ACTA DIABETOL, V35, P52, DOI 10.1007/s005920050101; Puddu P, 2012, J CARDIOL, V59, P235, DOI 10.1016/j.jjcc.2012.01.013; Shankar A, 2008, ATHEROSCLEROSIS, V196, P749, DOI 10.1016/j.atherosclerosis.2006.12.029; Shelmadine B, 2009, ANATOL J CARDIOL, V9, P385; Shrban AO, 2008, DIABETES CARE, V31, pS215, DOI 10.2337/dc08-s257; Suryadevara S, 2012, THROMB HAEMOSTASIS, V108, P930, DOI 10.1160/TH12-06-0397; Tapp RJ, 2003, DIABETIC MED, V20, P105, DOI 10.1046/j.1464-5491.2003.00881.x; Tassone EJ, 2011, EUR J CLIN INVEST, V41, P81; Tseng CH, 2004, DIABETIC MED, V21, P724, DOI 10.1111/j.1464-5491.2004.01239.x; Viswanathan Vijay, 2010, J Assoc Physicians India, V58, P612; Wang MY, 2012, AGING CELL, V11, P500, DOI 10.1111/j.1474-9726.2012.00813.x; Wen CP, 2010, AM J KIDNEY DIS, V56, P273, DOI 10.1053/j.ajkd.2010.01.024; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; YANKO L, 1983, BRIT J OPHTHALMOL, V67, P759, DOI 10.1136/bjo.67.11.759; Zoppini G, 2012, DIABETES CARE, V35, P99, DOI 10.2337/dc11-1346; Zoppini G, 2009, DIABETES CARE, V32, P1716, DOI 10.2337/dc09-0625	47	50	54	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78206	10.1371/journal.pone.0078206	http://dx.doi.org/10.1371/journal.pone.0078206			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24205159	gold, Green Published, Green Submitted			2022-12-27	WOS:000326152300045
J	Buric, M; Kouba, A; Kozak, P				Buric, Milos; Kouba, Antonin; Kozak, Pavel			Reproductive Plasticity in Freshwater Invader: From Long-Term Sperm Storage to Parthenogenesis	PLOS ONE			English	Article							CRAYFISH ORCONECTES-LIMOSUS; MARMORKREBS MARBLED CRAYFISH; LIFE-HISTORY PARAMETERS; INVASIVE CRAYFISH; GENETIC DIVERSITY; MATE CHOICE; EGG; TEMPERATURE; PREVALENCE; FECUNDITY	Orconectes limosus, a North American crayfish species, is one of the most important aquatic invaders in European inland waters. Despite more than 120 years occurrence in Europe and intense research, there are still gaps in knowledge of its life history and ecology. Investigation into O. limosus invasive success requires identifying the mechanisms that enabled them to establish dense and widespread populations from small initial numbers without observable limitation by an introduction bottleneck. In part, O. limosus success may lie in its ability to reproduce by facultative parthenogenesis. Moreover, there are possible other mating scenarios, because of two mating seasons (autumn and spring) in O. limosus. This work investigated the effect of four reproductive scenarios (autumn mating only, spring mating only, autumn and spring mating, and without mating) on the reproductive success of O. limosus. Females successfully reproduced in all tested mating regimes using parthenogenesis as well as log term sperm storage. This reproductive plasticity likely facilitates the overwhelming success of O. limosus spread and establishment in new localities. It can explain the spread of O. limosus from the initial introduction of 90 specimens to most of continental Europe and Great Britain. These conclusions imply a serious threat, not only for autochthonous European astacofauna, but for other aquatic organisms as well as entire ecosystems.	[Buric, Milos] Univ South Bohemia, Fac Fisheries & Protect Waters, South Bohemian Res Ctr Aquaculture & Biodivers Hy, Ceske Budejovice, Vodnany, Czech Republic; Univ South Bohemia, Res Inst Fish Culture & Hydrobiol, Ceske Budejovice, Vodnany, Czech Republic	University of South Bohemia Ceske Budejovice; University of South Bohemia Ceske Budejovice	Buric, M (corresponding author), Univ South Bohemia, Fac Fisheries & Protect Waters, South Bohemian Res Ctr Aquaculture & Biodivers Hy, Ceske Budejovice, Vodnany, Czech Republic.	buric@frov.jcu.cz	Kozák, Pavel/G-5025-2015; Kouba, Antonín/C-9338-2015; Buric, Milos/F-8114-2015	Kozák, Pavel/0000-0002-6985-1538; Kouba, Antonín/0000-0001-8118-8612; Buric, Milos/0000-0003-2220-5579	project CENAKVA [cZ.1.05/2.1.00/01.0024]; Czech Science Foundation [P505/12/0545]	project CENAKVA; Czech Science Foundation(Grant Agency of the Czech Republic)	The study was supported by the by the project CENAKVA No. cZ.1.05/2.1.00/01.0024, and by Czech Science Foundation project No. P505/12/0545. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBAUGH D W, 1973, Southwestern Naturalist, V18, P97, DOI 10.2307/3669916; Andrews EA, 1910, J EXP ZOOL, V9, P235, DOI 10.1002/jez.1400090202; Andrews EA, 1907, THE YOUNG OF THE CRA, VXXXV; Aquiloni L, 2009, FRESHWATER BIOL, V54, P1510, DOI 10.1111/j.1365-2427.2009.02169.x; Belanger RM, 2006, BEHAVIOUR, V143, P713, DOI 10.1163/156853906777791342; BERRILL M, 1984, ANIM BEHAV, V32, P333, DOI 10.1016/S0003-3472(84)80265-1; Berry FC, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-25; Buric M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020281; Buric M, 2010, ZOOLOGY, V113, P301, DOI 10.1016/j.zool.2010.06.001; Buric M, 2010, ZOOL STUD, V49, P28; Buric M, 2009, AQUAT SCI, V71, P473, DOI 10.1007/s00027-009-0102-6; BUTLER MJ, 1985, OECOLOGIA, V66, P168, DOI 10.1007/BF00379851; CLUTTONBROCK TH, 1992, Q REV BIOL, V67, P437, DOI 10.1086/417793; Dieguez-Uribeondo J, 2006, B FR PECHE PISCIC, P1303, DOI 10.1051/kmae:2006036; DUBE P, 1992, AQUACULTURE, V102, P161, DOI 10.1016/0044-8486(92)90298-Y; Filipova L, 2011, J N AM BENTHOL SOC, V30, P871, DOI 10.1899/10-130.1; Galeotti P, 2006, P ROY SOC B-BIOL SCI, V273, P1105, DOI 10.1098/rspb.2005.3345; Galeotti P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043771; Gherardi F, 2001, BIOLOGY OF FRESHWATER CRAYFISH, P258; Gherardi F, 2010, REV SCI TECH OIE, V29, P241, DOI 10.20506/rst.29.2.1973; Gherardi F, 2011, NEW FRONTIERS IN CRU, P20; Gherardi F, 2006, ARCH HYDROBIOL, V165, P557, DOI 10.1127/0003-9136/2006/0165-0557; Gherardi F, 2011, AQUAT SCI, V73, P185, DOI 10.1007/s00027-011-0181-z; Hamr P, 2001, BIOLOGY OF FRESHWATER CRAYFISH, P585; Holdich DM, 2009, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2009025; Holdich David, 2007, Aquatic Invasions, V2, P1, DOI 10.3391/ai.2007.2.1.1; Holdich DM, 1999, CRUSTACEAN ISS, V11, P281; Hulak M, 2010, J APPL GENET, V51, P73, DOI 10.1007/BF03195713; Klocker CA, 2004, NORTHEAST NAT, V11, P167, DOI 10.1656/1092-6194(2004)011[0167:IAAICO]2.0.CO;2; Kossakowski J, 1966, RAKI WARSZAWA PANSTW; Kozak P, 2006, B FR PECHE PISCIC, P1171, DOI 10.1051/kmae:2006019; Kozubikova E, 2009, CONSERV BIOL, V23, P1204, DOI 10.1111/j.1523-1739.2009.01240.x; Lindqvist OV, 1999, CRUSTACEAN ISS, V11, P23; Lozan Jose Luis, 2000, Limnologica, V30, P156, DOI 10.1016/S0075-9511(00)80010-9; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Martin P, 2007, NATURWISSENSCHAFTEN, V94, P843, DOI 10.1007/s00114-007-0260-0; Martin P, 2010, CONTRIB ZOOL, V79, P107, DOI 10.1163/18759866-07903003; McDonald M, 1893, REPORT OF THE UNITED; Momot Walter T., 1995, Reviews in Fisheries Science, V3, P33; Musil M., 2010, Freshwater Crayfish, V17, P189; Nystrom P, 1996, FRESHWATER BIOL, V36, P631, DOI 10.1046/j.1365-2427.1996.d01-528.x; Perdikaris C, 2012, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2011077; Pieplow U, 1938, Z FISCHEREI, V36, P349; Puky M, 2006, B FR PECHE PISCIC, P919, DOI 10.1051/kmae:2006031; Pysek P, 2010, P NATL ACAD SCI USA, V107, P12157, DOI 10.1073/pnas.1002314107; REYNOLDS JD, 1992, INVERTEBR REPROD DEV, V22, P253, DOI 10.1080/07924259.1992.9672278; Reynolds JD, 2001, BIOLOGY OF FRESHWATER CRAYFISH, P152; Rubolini D, 2007, FRESHWATER BIOL, V52, P1898, DOI 10.1111/j.1365-2427.2007.01814.x; Schulz H.K., 2006, Freshwater Crayfish, V15, P212; SMITH DG, 1981, OHIO J SCI, V81, P169; Souty-Grosset C, 2006, ATLAS OF CRAYFISH IN, V64; Stebbing PD, 2003, J CHEM ECOL, V29, P465, DOI 10.1023/A:1022646414938; Strayer DL, 2010, FRESHWATER BIOL, V55, P152, DOI 10.1111/j.1365-2427.2009.02380.x; Stucki Thomas P., 2002, Freshwater Crayfish, V13, P463; TAUGBOL T, 1990, Aquaculture and Fisheries Management, V21, P17, DOI 10.1111/j.1365-2109.1990.tb00378.x; VANDENBRINK FWB, 1988, ARCH HYDROBIOL, V114, P275; Villanelli F, 1998, FRESHWATER BIOL, V40, P305, DOI 10.1046/j.1365-2427.1998.00355.x; Vitousek PM, 1996, AM SCI, V84, P468; Vogt G, 1999, CRUSTACEAN ISS, V11, P87; Walker D, 2002, MOL ECOL, V11, P2115, DOI 10.1046/j.1365-294X.2002.01609.x; Wickins JF, 2002, CRUSTACEAN FARMING R; Yue GH, 2008, INT J BIOL SCI, V4, P279; Yue GH, 2010, BIOL INVASIONS, V12, P2697, DOI 10.1007/s10530-009-9675-1; Yue GH, 2010, INT J BIOL SCI, V6, P107; [No title captured]	65	30	31	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77597	10.1371/journal.pone.0077597	http://dx.doi.org/10.1371/journal.pone.0077597			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204886	Green Published, Green Submitted, gold			2022-12-27	WOS:000326032600038
J	Lemonakis, N; Gikas, E; Halabalaki, M; Skaltsounis, AL				Lemonakis, Nikolaos; Gikas, Evagelos; Halabalaki, Maria; Skaltsounis, Alexios-Leandros			Development and Validation of a Combined Methodology for Assessing the Total Quality Control of Herbal Medicinal Products - Application to Oleuropein Preparations	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHY; PHENOLIC-COMPOUNDS; OLIVE OIL; LEAF EXTRACT; RAT PLASMA; HYDROXYTYROSOL; ANTIOXIDANT; METABOLITES; LEAVES; HPLC	Oleuropein (OE) is a secoiridoid glycoside, which occurs mostly in the Oleaceae family presenting several pharmacological properties, including antioxidant, cardio-protective, anti-atherogenic effects etc. Based on these findings OE is commercially available, as Herbal Medicinal Product (HMP), claimed for its antioxidant effects. As there are general provisions of the medicine regulating bodies e. g. European Medicines Agency, the quality of the HMP's must always be demonstrated. Therefore, a novel LC-MS methodology was developed and validated for the simultaneous quantification of OE and its main degradation product, hydroxytyrosol (HT), for the relevant OE claimed HMP's. The internal standard (IS) methodology was employed and separation of OE, HT and IS was achieved on a C18 Fused Core column with 3.1 min overall run time employing the SIM method for the analytical signal acquisition. The method was validated according to the International Conference on Harmonisation requirements and the results show adequate linearity (r(2) > 0.99) over a wide concentration range [0.1-15 mu g/mL (n=12)] and a LLOQ value of 0.1 mu g/mL, for both OE and HT. Furthermore, as it would be beneficial to control the quality taking into account all the substances of the OE claimed HMP's; a metabolomics-like approach has been developed and applied for the total quality control of the different preparations employing UHPLC-HRMS-multivariate analysis (MVA). Four OE-claimed commercial HMP's have been randomly selected and MVA similarity-based measurements were performed. The results showed that the examined samples could also be differentiated as evidenced according to their scores plot. Batch to batch reproducibility between the samples of the same brand has also been determined and found to be acceptable. Overall, the developed combined methodology has been found to be an efficient tool for the monitoring of the HMP's total quality. Only one OE HMP has been found to be consistent to its label claim.	[Lemonakis, Nikolaos; Halabalaki, Maria; Skaltsounis, Alexios-Leandros] Natl & Kapodistrian Univ Athens, Dept Pharmacognosy & Nat Prod Chem, Fac Pharm, Athens 11528, Greece; [Gikas, Evagelos] Natl & Kapodistrian Univ Athens, Dept Pharmaceut Chem, Fac Pharm, Athens 11528, Greece	National & Kapodistrian University of Athens; National & Kapodistrian University of Athens	Skaltsounis, AL (corresponding author), Natl & Kapodistrian Univ Athens, Dept Pharmacognosy & Nat Prod Chem, Fac Pharm, Athens 11528, Greece.	skaltsounis@pharm.uoa.gr	Gikas, Evagelos/H-6226-2019; skaltsounis, alexios leandros/AAE-9617-2019; Halabalaki, Maria/AAD-2127-2020	Gikas, Evagelos/0000-0002-0107-9991; Halabalaki, Maria/0000-0001-5620-0165	SYNERGASIA PROGRAMME; European Regional Development Fund; National Resources [OSTEOPRO-1076]; Commission of the European Community through the INsPiRE project [284460]	SYNERGASIA PROGRAMME; European Regional Development Fund(European Commission); National Resources; Commission of the European Community through the INsPiRE project	The present work was funded by SYNERGASIA 2009 PROGRAMME, which is co-funded by the European Regional Development Fund and National Resources (Project code: OSTEOPRO-1076) as well as by the Commission of the European Community through the INsPiRE project (EU-FP7-REGPOT-2011-1, proposal 284460). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Acquaviva R, 2012, INT J ONCOL, V41, P31, DOI 10.3892/ijo.2012.1428; Agalias A, 2005, J LIQ CHROMATOGR R T, V28, P1557, DOI 10.1081/JLC-200058355; Agalias A, 2007, J AGR FOOD CHEM, V55, P2671, DOI 10.1021/jf063091d; Andreadou I, 2006, J NUTR, V136, P2213, DOI 10.1093/jn/136.8.2213; [Anonymous], 2010, ICH HARM TRIP GUID V; Aouidi F, 2012, IND CROP PROD, V37, P292, DOI 10.1016/j.indcrop.2011.12.024; Aturki Z, 2008, ELECTROPHORESIS, V29, P1643, DOI 10.1002/elps.200700547; Bazoti FN, 2010, BIOMED CHROMATOGR, V24, P506, DOI 10.1002/bmc.1319; Briante R, 2002, J AGR FOOD CHEM, V50, P4934, DOI 10.1021/jf025540p; Dierkes G, 2012, J AGR FOOD CHEM, V60, P7597, DOI 10.1021/jf3020574; Galli C, 1999, LIPIDS, V34, pS23, DOI [10.1007/BF02562224, 10.1007/s11745-999-333-4]; Granados-Principal S, 2010, NUTR REV, V68, P191, DOI 10.1111/j.1753-4887.2010.00278.x; Hadad GM, 2012, J CHROMATOGR SCI, V50, P509, DOI 10.1093/chromsci/bms041; Japon-Lujan R, 2006, J CHROMATOGR A, V1136, P185, DOI 10.1016/j.chroma.2006.09.081; Jemai H, 2009, J AGR FOOD CHEM, V57, P8798, DOI 10.1021/jf901280r; Keys A, 1997, Nutrition, V13, P250; Kontogianni VG, 2012, NAT PROD RES, V26, P186, DOI 10.1080/14786419.2011.582842; Lan K, 2010, J CHROMATOGR A, V1217, P1414, DOI 10.1016/j.chroma.2009.12.031; Lozano-Sanchez J, 2011, J AGR FOOD CHEM, V59, P11491, DOI 10.1021/jf202596q; Manchon N, 2010, TALANTA, V82, P1986, DOI 10.1016/j.talanta.2010.08.050; Omar Syed Haris, 2010, Saudi Pharm J, V18, P111, DOI 10.1016/j.jsps.2010.05.005; Orozco-Solano MI, 2012, J CHROMATOGR A, V1258, P108, DOI 10.1016/j.chroma.2012.08.057; Ortega-Garcia F, 2010, J SCI FOOD AGR, V90, P2295, DOI 10.1002/jsfa.4085; Pereira AP, 2007, MOLECULES, V12, P1153, DOI 10.3390/12051153; Poudyal H, 2010, J NUTR, V140, P946, DOI 10.3945/jn.109.117812; RENAUD S, 1995, AM J CLIN NUTR, V61, p1360S, DOI 10.1093/ajcn/61.6.1360S; Romani A, 1999, J AGR FOOD CHEM, V47, P964, DOI 10.1021/jf980264t; Scoditti E, 2012, ARCH BIOCHEM BIOPHYS, V527, P81, DOI 10.1016/j.abb.2012.05.003; Stagos D, 2012, FOOD CHEM TOXICOL, V50, P4115, DOI 10.1016/j.fct.2012.08.033; Tan HW, 2003, J CHROMATOGR B, V785, P187, DOI 10.1016/S1570-0232(02)00855-3; Visioli F, 2001, Curr Atheroscler Rep, V3, P64, DOI 10.1007/s11883-001-0012-0; Williamson EM, 2001, PHYTOMEDICINE, V8, P401, DOI 10.1078/0944-7113-00060; Yang PL, 2009, J SEP SCI, V32, P1816, DOI 10.1002/jssc.200900005; Zhang HM, 2012, J PHARMACEUT BIOMED, V62, P258, DOI 10.1016/j.jpba.2012.01.010; Zhou T, 2011, BIOMED CHROMATOGR, V25, P1360, DOI 10.1002/bmc.1609; Zoidou E, 2010, J AGR FOOD CHEM, V58, P46, DOI 10.1021/jf903405e	36	8	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78277	10.1371/journal.pone.0078277	http://dx.doi.org/10.1371/journal.pone.0078277			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205178	Green Submitted, gold, Green Published			2022-12-27	WOS:000326032600089
J	Beurskens, CJ; Aslami, H; de Beer, FM; Vroom, MB; Preckel, B; Horn, J; Juffermans, NP				Beurskens, Charlotte J.; Aslami, Hamid; de Beer, Friso M.; Vroom, Margreeth B.; Preckel, Benedikt; Horn, Janneke; Juffermans, Nicole P.			Heliox Allows for Lower Minute Volume Ventilation in an Animal Model of Ventilator-Induced Lung Injury	PLOS ONE			English	Article							LOW TIDAL VOLUME; OXYGEN MIXTURES; GAS-EXCHANGE; PROTECTION	Background: Helium is a noble gas with a low density, allowing for lower driving pressures and increased carbon dioxide (CO2) diffusion. Since application of protective ventilation can be limited by the development of hypoxemia or acidosis, we hypothesized that therefore heliox facilitates ventilation in an animal model of ventilator-induced lung injury. Methods: Sprague-Dawley rats (N=8 per group) were mechanically ventilated with heliox (50% oxygen; 50% helium). Controls received a standard gas mixture (50% oxygen; 50% air). VILI was induced by application of tidal volumes of 15 mL kg(-1); lung protective ventilated animals were ventilated with 6 mL kg-1. Respiratory parameters were monitored with a pneumotach system. Respiratory rate was adjusted to maintain arterial pCO(2) within 4.5-5.5 kPa, according to hourly drawn arterial blood gases. After 4 hours, bronchoalveolar lavage fluid (BALF) was obtained. Data are mean (SD). Results: VILI resulted in an increase in BALF protein compared to low tidal ventilation (629 (324) vs. 290 (181) mu g mL(-1); p<0.05) and IL-6 levels (640 (8.7) vs. 206 (8.7) pg mL(-1); p<0.05), whereas cell counts did not differ between groups after this short course of mechanical ventilation. Ventilation with heliox resulted in a decrease in mean respiratory minute volume ventilation compared to control (123 +/- 0.6 vs. 146 +/- 8.9 mL min(-1), P<0.001), due to a decrease in respiratory rate (22 (0.4) vs. 25 (2.1) breaths per minute; p<0.05), while pCO(2) levels and tidal volumes remained unchanged, according to protocol. There was no effect of heliox on inspiratory pressure, while compliance was reduced. In this mild lung injury model, heliox did not exert anti-inflammatory effects. Conclusions: Heliox allowed for a reduction in respiratory rate and respiratory minute volume during VILI, while maintaining normal acid-base balance. Use of heliox may be a useful approach when protective tidal volume ventilation is limited by the development of severe acidosis.	[Beurskens, Charlotte J.; Aslami, Hamid; de Beer, Friso M.; Preckel, Benedikt; Juffermans, Nicole P.] Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anaesthesiol, NL-1105 AZ Amsterdam, Netherlands; [Preckel, Benedikt] Univ Amsterdam, Acad Med Ctr, Dept Anaesthesiol, NL-1105 AZ Amsterdam, Netherlands; [Beurskens, Charlotte J.; de Beer, Friso M.; Vroom, Margreeth B.; Horn, Janneke; Juffermans, Nicole P.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Beurskens, CJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anaesthesiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.j.beurskens@amc.nl	Horn, Janneke/ACB-3607-2022	Preckel, Benedikt/0000-0003-4412-9183	NWO ZonMW Clinical Fellowship [90700269]	NWO ZonMW Clinical Fellowship	This work was supported by a NWO ZonMW Clinical Fellowship to Dr. N.P. Juffermans (project number: 90700269). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Allah Shamel A, 2003, Pediatr Crit Care Med, V4, P353, DOI 10.1097/01.PCC.0000074267.11280.78; Aslami H, 2013, CYTOKINE, V61, P614, DOI 10.1016/j.cyto.2012.11.018; Aslami H, 2012, TRANSL RES, V159, P110, DOI 10.1016/j.trsl.2011.10.005; Bein T, 2009, ANAESTHESIA, V64, P195, DOI 10.1111/j.1365-2044.2008.05735.x; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Chevrolet JC, 2001, CRIT CARE, V5, P179; Determann RM, 2010, CRIT CARE, V14, DOI 10.1186/cc8230; Frazier MD, 2010, PAEDIATR RESPIR REV, V11, P46, DOI 10.1016/j.prrv.2009.10.008; Gentile MA, 2011, RESP CARE, V56, P1341, DOI 10.4187/respcare.01442; George R, 2001, J Perinatol, V21, P395, DOI 10.1038/sj.jp.7210530; GLUCK EH, 1990, CHEST, V98, P693, DOI 10.1378/chest.98.3.693; Hegeman MA, 2013, CRIT CARE RES PRACT, V2013, DOI 10.1155/2013/435236; Hess DR, 2006, RESPIR CARE, V51, P608; Katz A, 2001, AM J RESP CRIT CARE, V164, P260, DOI 10.1164/ajrccm.164.2.2006105; Katz AL, 2003, CRIT CARE MED, V31, P2006, DOI 10.1097/01.CCM.0000070584.00490.7B; Kneyber MCJ, 2009, CRIT CARE, V13, DOI 10.1186/cc7880; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Lucchinetti E, 2009, ANESTH ANALG, V109, P101, DOI 10.1213/ane.0b013e3181a27e4b; Nawab US, 2005, PEDIATR PULM, V40, P524, DOI 10.1002/ppul.20304; Oei GTML, 2010, ANESTHESIOLOGY, V112, P1503, DOI 10.1097/ALN.0b013e3181d9cb5e; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Schultz MJ, 2007, ANESTHESIOLOGY, V106, P1226, DOI 10.1097/01.anes.0000267607.25011.e8; Siddappa Rajashekhar, 2005, Pediatr Crit Care Med, V6, P70, DOI 10.1097/01.PCC.0000149138.65083.EF; Terragni PP, 2007, AM J RESP CRIT CARE, V175, P160, DOI 10.1164/rccm.200607-915OC; Terragni PP, 2009, ANESTHESIOLOGY, V111, P826, DOI 10.1097/ALN.0b013e3181b764d2; Venkataraman ST, 2006, RESPIR CARE, V51, P632; Yilmaz S, 2013, ANN THORAC MED, V8, P46, DOI 10.4103/1817-1737.105719	27	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78159	10.1371/journal.pone.0078159	http://dx.doi.org/10.1371/journal.pone.0078159			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205139	Green Submitted, gold, Green Published			2022-12-27	WOS:000326029300145
J	Munoz-Pareja, M; Guallar-Castillon, P; Mesas, AE; Lopez-Garcia, E; Rodriguez-Artalejo, F				Munoz-Pareja, Maritza; Guallar-Castillon, Pilar; Mesas, Arthur E.; Lopez-Garcia, Esther; Rodriguez-Artalejo, Fernando			Obesity-Related Eating Behaviors Are Associated with Higher Food Energy Density and Higher Consumption of Sugary and Alcoholic Beverages: A Cross-Sectional Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; ADULT-POPULATION; BODY-WEIGHT; ABDOMINAL OBESITY; DIET QUALITY; US ADULTS; PATTERNS; SPAIN; YOUNG; RISK	Objectives: Obesity-related eating behaviors (OREB) are associated with higher energy intake. Total energy intake can be decomposed into the following constituents: food portion size, food energy density, the number of eating occasions, and the energy intake from energy-rich beverages. To our knowledge this is the first study to examine the association between the OREB and these energy components. Methods: Data were taken from a cross-sectional study conducted in 2008-2010 among 11,546 individuals representative of the Spanish population aged >= 18 years. Information was obtained on the following 8 self-reported OREB: not planning how much to eat before sitting down, eating precooked/canned food or snacks bought at vending machines or at fast-food restaurants, not choosing low-energy foods, not removing visible fat from meat or skin from chicken, and eating while watching TV. Usual diet was assessed with a validated diet history. Analyses were performed with linear regression with adjustment for main confounders. Results: Compared to individuals with <= 1 OREB, those with >= 5 OREB had a higher food energy density (beta 0.10; 95% CI 0.08, 0.12 kcal/g/day; p-trend <0.001) and a higher consumption of sugary drinks (beta 7; 95% CI -7, 20 ml/day; p-trend <0.05) and of alcoholic beverages (beta 24; 95% CI 10, 38 ml/day; p-trend <0.001). Specifically, a higher number of OREB was associated with higher intake of dairy products and red meat, and with lower consumption of fresh fruit, oily fish and white meat. No association was found between the number of OREB and food portion size or the number of eating occasions. Conclusions: OREB were associated with higher food energy density and higher consumption of sugary and alcoholic beverages. Avoiding OREB may prove difficult because they are firmly socially rooted, but these results may nevertheless serve to palliate the undesirable effects of OREB by reducing the associated energy intake.	[Munoz-Pareja, Maritza; Guallar-Castillon, Pilar; Lopez-Garcia, Esther; Rodriguez-Artalejo, Fernando] Univ Autonoma Madrid IdiPaz, Dept Prevent Med & Publ Hlth, CIBERESP, Madrid, Spain; [Mesas, Arthur E.] Univ Estadual Londrina, Dept Saude Colet, Londrina, Brazil	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universidade Estadual de Londrina	Rodriguez-Artalejo, F (corresponding author), Univ Autonoma Madrid IdiPaz, Dept Prevent Med & Publ Hlth, CIBERESP, Madrid, Spain.	fernando.artalejo@uam.es	Lopez-Garcia, Esther/A-8894-2019; Guallar-Castillon, Pilar/F-1533-2016; Mesas, Arthur/AAK-3361-2021; Mesas, Arthur Eumann/AAG-9545-2020; Mesas, Arthur Eumann/P-5879-2018	Guallar-Castillon, Pilar/0000-0003-4759-6713; Mesas, Arthur/0000-0002-0088-8607; Mesas, Arthur Eumann/0000-0002-0088-8607; Mesas, Arthur Eumann/0000-0002-0088-8607	Sanofi-Aventis; FIS [PI09/1626, PI12/1166]; Catedra UAM de Epidemiologia y Control del Riesgo Cardiovascular; Plan Nacional sobre Drogas (Ministry of Health of Spain) [06/2010]	Sanofi-Aventis(Sanofi-Aventis); FIS(Instituto de Salud Carlos III); Catedra UAM de Epidemiologia y Control del Riesgo Cardiovascular; Plan Nacional sobre Drogas (Ministry of Health of Spain)	The ENRICA study was funded by Sanofi-Aventis. Additional funding for data collection was obtained from FIS grant PI09/1626 and from the 'Catedra UAM de Epidemiologia y Control del Riesgo Cardiovascular'. Specific funding for this analysis was obtained from FIS grant PI12/1166 and from grant 06/2010 from the Plan Nacional sobre Drogas (Ministry of Health of Spain). The ENRICA study is being run by an independent academic steering committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, Int J Epidemiol, V26 Suppl 1, pS91; [Anonymous], 1997, Int J Epidemiol, V26 Suppl 1, pS100; [Anonymous], 2009, STAT SURV DAT REF MA; Bell EA, 1998, AM J CLIN NUTR, V67, P412; Bell EA, 2001, AM J CLIN NUTR, V73, P1010; Bellisle F, 1997, BRIT J NUTR, V77, pS57, DOI 10.1079/BJN19970104; Bes-Rastrollo M, 2008, AM J CLIN NUTR, V88, P769, DOI 10.1093/ajcn/88.3.769; Bleich SN, 2009, AM J CLIN NUTR, V89, P372, DOI 10.3945/ajcn.2008.26883; Breslow RA, 2010, J AM DIET ASSOC, V110, P551, DOI 10.1016/j.jada.2009.12.026; Brown CM, 2008, INT J OBESITY, V32, pS28, DOI 10.1038/ijo.2008.204; Cleland VJ, 2008, AM J CLIN NUTR, V87, P1148, DOI 10.1093/ajcn/87.5.1148; Dapcich V, 2004, SENC; Duffey KJ, 2007, OBESITY, V15, P2739, DOI 10.1038/oby.2007.326; Duffey KJ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001050; Mesas AE, 2012, J NUTR, V142, P1321, DOI 10.3945/jn.112.158154; Feldman S, 2007, J NUTR EDUC BEHAV, V39, P257, DOI 10.1016/j.jneb.2007.04.181; Gidding SS, 2009, CIRCULATION, V119, P1161, DOI 10.1161/CIRCULATIONAHA.109.191856; Gutierrez-Fisac JL, 2012, OBES REV, V13, P388, DOI 10.1111/j.1467-789X.2011.00964.x; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Katzen M, 2006, EAT DRINK WEIGHT LES; Leon-Munoz LM, 2012, J NUTR; Mesas AE, 2012, OBES REV, V13, P858, DOI 10.1111/j.1467-789X.2012.01005.x; Mesas AE, 2012, OBES REV, V13, P106, DOI 10.1111/j.1467-789X.2011.00936.x; Ministerio de Sanidad y Consumo, 2007, AL SAL GUIA FAM; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Ng SW, 2012, BRIT J NUTR, V108, P536, DOI 10.1017/S0007114511006465; Rey-Lopez JP, 2011, PUBLIC HEALTH NUTR, V14, P1563, DOI 10.1017/S1368980011000383; Paeratakul S, 2003, J AM DIET ASSOC, V103, P1332, DOI 10.1016/S0002-8223(03)01086-1; Pan A, 2011, CURR OPIN CLIN NUTR, V14, P385, DOI 10.1097/MCO.0b013e328346df36; Pols MA, 1997, INT J EPIDEMIOL, V26, pS181, DOI 10.1093/ije/26.suppl_1.S181; Popkin BM, 2010, AM J CLIN NUTR, V91, P1342, DOI 10.3945/ajcn.2009.28962; Popkin BM, 2006, AM J CLIN NUTR, V83, P529, DOI 10.1093/ajcn.83.3.529; Rodriguez-Artalejo F, 2011, REV ESP CARDIOL, V64, P876, DOI 10.1016/j.recesp.2011.05.019; Rolls BJ, 2010, P NUTR SOC, V69, P70, DOI 10.1017/S0029665109991674; Rolls BJ, 2006, J AM DIET ASSOC, V106, P543, DOI 10.1016/j.jada.2006.01.014; Sayon-Orea C, 2011, NUTR REV, V69, P419, DOI 10.1111/j.1753-4887.2011.00403.x; Schroder H, 2007, BRIT J NUTR, V98, P1274, DOI 10.1017/S0007114507781436; Thomson M, 2008, AM J HEALTH PROMOT, V22, P329, DOI 10.4278/ajhp.22.5.329; Valencia-Martin JL, 2011, ALCOHOL CLIN EXP RES, V35, P2075, DOI 10.1111/j.1530-0277.2011.01559.x; Wiecha JL, 2006, J AM DIET ASSOC, V106, P1624, DOI 10.1016/j.jada.2006.07.007; Yeomans MR, 2010, PHYSIOL BEHAV, V100, P82, DOI 10.1016/j.physbeh.2010.01.012	41	19	20	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77137	10.1371/journal.pone.0077137	http://dx.doi.org/10.1371/journal.pone.0077137			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204756	Green Published, Green Submitted, gold			2022-12-27	WOS:000326029300084
J	Rensch, U; Klein, G; Kehrenberg, C				Rensch, Ulrike; Klein, Guenter; Kehrenberg, Corinna			Analysis of Triclosan-Selected Salmonella enterica Mutants of Eight Serovars Revealed Increased Aminoglycoside Susceptibility and Reduced Growth Rates	PLOS ONE			English	Article							MULTIDRUG EFFLUX PUMPS; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; FLUOROQUINOLONE RESISTANCE; PREVENTION CONCENTRATIONS; BENZALKONIUM CHLORIDE; ANTIBIOTIC-RESISTANCE; ADAPTIVE RESISTANCE; TYPHIMURIUM; EXPRESSION	The biocide triclosan (TRC) is used in a wide range of household, personal care, veterinary, industrial and medical products to control microbial growth. This extended use raises concerns about a possible association between the application of triclosan and the development of antibiotic resistance. In the present study we determined triclosan mutant prevention concentrations (MPC) for Salmonella enterica isolates of eight serovars and investigated selected mutants for their mechanisms mediating decreased susceptibility to triclosan. MPCTRC values were 8 - 64-fold higher than MIC values and ranged between 1 - 16 mu g/ml. The frequencies at which mutants were selected varied between 1.3 x 10(-10) - 9.9 x 10(-11). Even if MIC values of mutants decreased by 3-7 dilution steps in the presence of the efflux pump inhibitor Phe-Arg-beta-naphtylamide, only minor changes were observed in the expression of genes encoding efflux components or regulators, indicating that neither the major multidrug efflux pump AcrAB-TolC nor AcrEF are up-regulated in triclosan-selected mutants. Nucleotide sequence comparisons confirmed the absence of alterations in the regulatory regions acrRA, soxRS, marORAB, acrSE and ramRA of selected mutants. Single bp and deduced Gly(93)-> Val amino acid exchanges were present in fabI, the target gene of triclosan, starting from a concentration of 1 mu g/ml TRC used for MPC determinations. The fabI genes were up to 12.4-fold up-regulated. Complementation experiments confirmed the contribution of Gly(93)-> Val exchanges and fabI overexpression to decreased triclosan susceptibility. MIC values of mutants compared to parent strains were even equal or resulted in a more susceptible phenotype (1-2 dilution steps) for the aminoglycoside antibiotics kanamycin and gentamicin as well as for the biocide chlorhexidine. Growth rates of selected mutants were significantly lower and hence, might partly explain the rare occurrence of Salmonella field isolates exhibiting decreased susceptibility to triclosan.	[Rensch, Ulrike; Klein, Guenter; Kehrenberg, Corinna] Univ Vet Med Hannover, Inst Food Qual & Food Safety, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation	Kehrenberg, C (corresponding author), Univ Vet Med Hannover, Inst Food Qual & Food Safety, Hannover, Germany.	corinna.kehrenberg@tiho-hannover.de	Kehrenberg, Corinna/GSI-9835-2022; Klein, Günter/G-5321-2013	Klein, Günter/0000-0003-1931-2701	Federal Institute for Risk Assessment [FK3 1329-450]	Federal Institute for Risk Assessment	The study was in parts financially supported by the Federal Institute for Risk Assessment (grant FK3 1329-450). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzeed YM, 2008, ANTIMICROB AGENTS CH, V52, P2428, DOI 10.1128/AAC.00084-08; Baucheron S, 2002, MICROB DRUG RESIST, V8, P281, DOI 10.1089/10766290260469543; Braoudaki M, 2004, J CLIN MICROBIOL, V42, P73, DOI 10.1128/JCM.42.1.73-78.2004; Cerf O, 2010, INT J FOOD MICROBIOL, V136, P247, DOI 10.1016/j.ijfoodmicro.2009.10.002; Clinical and Laboratory Standards Institute, 2018, VET08 CLSI, V4th; Condell O, 2012, J PROTEOMICS, V75, P4505, DOI 10.1016/j.jprot.2012.04.044; Condell O, 2012, APPL ENVIRON MICROB, V78, P3087, DOI 10.1128/AEM.07534-11; Copitch JL, 2010, INT J ANTIMICROB AG, V36, P247, DOI 10.1016/j.ijantimicag.2010.04.012; Cottell A, 2009, J HOSP INFECT, V72, P71, DOI 10.1016/j.jhin.2009.01.014; Dann AB, 2011, J APPL TOXICOL, V31, P285, DOI 10.1002/jat.1660; Drlica K, 2003, J ANTIMICROB CHEMOTH, V52, P11, DOI 10.1093/jac/dkg269; Ghosh S, 2011, MOL MICROBIOL, V79, P1547, DOI 10.1111/j.1365-2958.2011.07544.x; Heath RJ, 1999, J BIOL CHEM, V274, P11110, DOI 10.1074/jbc.274.16.11110; Hernandez A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002103; Jones RD, 2000, AM J INFECT CONTROL, V28, P184, DOI 10.1016/S0196-6553(00)90027-0; Joynson JA, 2002, J APPL MICROBIOL, V93, P96, DOI 10.1046/j.1365-2672.2002.01667.x; Karatzas KAG, 2008, APPL ENVIRON MICROB, V74, P1508, DOI 10.1128/AEM.01931-07; Karatzas KAG, 2007, J ANTIMICROB CHEMOTH, V60, P947, DOI 10.1093/jac/dkm314; Kehrenberg C, 2007, J ANTIMICROB CHEMOTH, V59, P886, DOI 10.1093/jac/dkm072; Kehrenberg C, 2009, J ANTIMICROB CHEMOTH, V64, P1175, DOI 10.1093/jac/dkp347; Lambert RJW, 2004, J APPL MICROBIOL, V97, P699, DOI 10.1111/j.1365-2672.2004.02345.x; Loughlin MF, 2002, J ANTIMICROB CHEMOTH, V49, P631, DOI 10.1093/jac/49.4.631; Lubarsky HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031183; McMurry LM, 1998, NATURE, V394, P531, DOI 10.1038/28970; McMurry LM, 1998, FEMS MICROBIOL LETT, V166, P305, DOI 10.1016/S0378-1097(98)00347-4; Michael GB, 2008, INT J ANTIMICROB AG, V32, P120, DOI 10.1016/j.ijantimicag.2008.02.024; Middleton JH, 2013, ECOTOX ENVIRON SAFE, V88, P79, DOI 10.1016/j.ecoenv.2012.10.025; Nishino K, 2009, BBA-PROTEINS PROTEOM, V1794, P834, DOI 10.1016/j.bbapap.2009.02.002; Olliver A, 2005, ANTIMICROB AGENTS CH, V49, P289, DOI 10.1128/AAC.49.1.289-301.2005; Olliver A, 2004, FEMS MICROBIOL LETT, V238, P267, DOI 10.1016/j.femsle.2004.07.046; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Preisler A, 2006, J ANTIMICROB CHEMOTH, V57, P430, DOI 10.1093/jac/dki475; Randall LP, 2004, J ANTIMICROB CHEMOTH, V54, P688, DOI 10.1093/jac/dkh360; Randall LP, 2004, J ANTIMICROB CHEMOTH, V54, P621, DOI 10.1093/jac/dkh376; Rensch U, 2013, J FOOD PROTECT, V76, P653, DOI 10.4315/0362-028X.JFP-12-420; Russell AD, 2004, J ANTIMICROB CHEMOTH, V53, P693, DOI 10.1093/jac/dkh171; Schweizer HP, 2001, FEMS MICROBIOL LETT, V202, P1, DOI 10.1111/j.1574-6968.2001.tb10772.x; Stickler DJ, 2008, ANTIMICROB AGENTS CH, V52, P991, DOI 10.1128/AAC.01094-07; Tabak M, 2007, FEMS MICROBIOL LETT, V267, P200, DOI 10.1111/j.1574-6968.2006.00547.x; Webber MA, 2008, J ANTIMICROB CHEMOTH, V62, P83, DOI 10.1093/jac/dkn137; Whitehead RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022833; Yamasaki S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3078; Zheng J, 2009, J ANTIMICROB CHEMOTH, V63, P95, DOI 10.1093/jac/dkn448	43	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e78310	10.1371/journal.pone.0078310	http://dx.doi.org/10.1371/journal.pone.0078310			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24205194	Green Published, Green Submitted, gold			2022-12-27	WOS:000326029300153
J	Sousounis, K; Ogura, A; Tsonis, PA				Sousounis, Konstantinos; Ogura, Atsushi; Tsonis, Panagiotis A.			Transcriptome Analysis of Nautilus and Pygmy Squid Developing Eye Provides Insights in Lens and Eye Evolution	PLOS ONE			English	Article							DROSOPHILA EYE; ALIGNMENT; PROTEINS; GENES; PAX-6; TOOL; GAP; NF1	Coleoid cephalopods like squids have a camera-type eye similar to vertebrates. On the other hand, Nautilus (Nautiloids) has a pinhole eye that lacks lens and cornea. Since pygmy squid and Nautilus are closely related species they are excellent model organisms to study eye evolution. Having being able to collect Nautilus embryos, we employed next-generation RNA sequencing using Nautilus and pygmy squid developing eyes. Their transcriptomes were compared and analyzed. Enrichment analysis of Gene Ontology revealed that contigs related to nucleic acid binding were largely up-regulated in squid, while the ones related to metabolic processes and extracellular matrix-related genes were up-regulated in Nautilus. These differences are most likely correlated with the complexity of tissue organization in these species. Moreover, when the analysis focused on the eye-related contigs several interesting patterns emerged. First, contigs from both species related to eye tissue differentiation and morphogenesis as well as to cilia showed best hits with their Human counterparts, while contigs related to rabdomeric photoreceptors showed the best hit with their Drosophila counterparts. This bolsters the idea that eye morphogenesis genes have been generally conserved in evolution, and compliments other studies showing that genes involved in photoreceptor differentiation clearly follow the diversification of invertebrate (rabdomeric) and vertebrate (ciliated) photoreceptors. Interestingly some contigs showed as good a hit with Drosophila and Human homologues in Nautilus and squid samples. One of them, capt/CAP1, is known to be preferentially expressed in Drosophila developing eye and in vertebrate lens. Importantly our analysis also provided evidence of gene duplication and diversification of their function in both species. One of these genes is the Neurofibromatosis 1 (NF1/Nf1), which in mice has been implicated in lens formation, suggesting a hitherto unsuspected role in the evolution of the lens in molluscs.	[Sousounis, Konstantinos; Tsonis, Panagiotis A.] Univ Dayton, Dept Biol, Dayton, OH 45469 USA; [Sousounis, Konstantinos; Tsonis, Panagiotis A.] Univ Dayton, Ctr Tissue Regenerat & Engn, Dayton, OH 45469 USA; [Ogura, Atsushi] Ochanomizu Univ, Ochadai Acad Prod, Tokyo 112, Japan	University of Dayton; University of Dayton; Ochanomizu University	Ogura, A (corresponding author), Ochanomizu Univ, Ochadai Acad Prod, Tokyo 112, Japan.	aogu@whelix.info; ptsonis1@udayton.edu		Sousounis, Konstantinos/0000-0002-5577-6207	NIH [EY10540]; University of Dayton Office for Academic Affairs through the Graduate Student Summer Fellowship Program; NATIONAL EYE INSTITUTE [R01EY010540] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24770002] Funding Source: KAKEN	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Dayton Office for Academic Affairs through the Graduate Student Summer Fellowship Program; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study is supported by NIH grant EY10540 to PAT, and Grant-in-Aid for Young Scientists (B) to AO. KS is supported in part by the University of Dayton Office for Academic Affairs through the Graduate Student Summer Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; Carbe C, 2011, HUM MOL GENET, V20, P1315, DOI 10.1093/hmg/ddr014; Carthew RW, 2007, CURR OPIN GENET DEV, V17, P309, DOI 10.1016/j.gde.2007.05.001; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Czerny T, 1999, MOL CELL, V3, P297, DOI 10.1016/S1097-2765(00)80457-8; Fain GL, 2010, CURR BIOL, V20, pR114, DOI 10.1016/j.cub.2009.12.006; Gehring WJ, 2012, EVOL DEV, V14, P34, DOI 10.1111/j.1525-142X.2011.00528.x; KhosrowShahian F, 2002, MECH DEVELOP, V113, P211, DOI 10.1016/S0925-4773(02)00033-3; Land MF, 2002, ANIMAL EYES; Laycock-van Spyk Sebastian, 2011, Human Genomics, V5, P623; Lin CM, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-46; Myhre S, 2006, BIOINFORMATICS, V22, P2020, DOI 10.1093/bioinformatics/btl334; Nilsson DE, 2013, VISUAL NEUROSCI, V30, P5, DOI 10.1017/S0952523813000035; Ogura A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01432; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Shigeno S, 2008, J MORPHOL, V269, P1, DOI 10.1002/jmor.10564; Sun HM, 1997, P NATL ACAD SCI USA, V94, P5156, DOI 10.1073/pnas.94.10.5156; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wagner GP, 2007, NAT REV GENET, V8, P473, DOI 10.1038/nrg2099; Yoshida M, 2011, GENE, V483, P63, DOI 10.1016/j.gene.2011.05.027	22	6	6	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e78054	10.1371/journal.pone.0078054	http://dx.doi.org/10.1371/journal.pone.0078054			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24205087	gold, Green Submitted, Green Published			2022-12-27	WOS:000326019400148
J	Tarnutzer, AA; Bertolini, G; Bockisch, CJ; Straumann, D; Marti, S				Tarnutzer, Alexander A.; Bertolini, Giovanni; Bockisch, Christopher J.; Straumann, Dominik; Marti, Sarah			Modulation of Internal Estimates of Gravity during and after Prolonged Roll-Tilts	PLOS ONE			English	Article							INNERVATING OTOLITH ORGANS; PERCEIVED DIRECTION; VESTIBULAR NEURONS; VISUAL ORIENTATION; DYNAMIC PROPERTIES; STATIC TILTS; BODY-TILT; HEAD; ADAPTATION; PERCEPTION	Perceived direction of gravity, as assessed by the subjective visual vertical (SVV), shows roll-angle dependent errors that drift over time and a bias upon return to upright. According to Bayesian observer theory, the estimated direction of gravity is derived from the posterior probability distribution by combining sensory input and prior knowledge about earth-vertical in a statistically optimal fashion. Here we aimed to further characterize the stability of SVV during and after prolonged roll-tilts. Specifically we asked whether the post-tilt bias is related to the drift pattern while roll-tilted. Twenty-nine healthy human subjects (23-56yo) repetitively adjusted a luminous arrow to the SVV over periods of 5min while upright, roll-tilted (+/- 45 degrees, +/- 90 degrees), and immediately after returning to upright. Significant (p<0.05) drifts (median absolute drift-amplitude: 10 degrees/5min) were found in 71% (+/- 45 degrees) and 78% (+/- 90 degrees) of runs. At +/- 90 degrees roll-tilt significant increases in absolute adjustment errors were more likely (76%), whereas significant increases (56%) and decreases (44%) were about equally frequent at +/- 45 degrees. When returning to upright, an initial bias towards the previous roll-position followed by significant exponential decay (median time-constant: 71sec) was noted in 47% of all runs (all subjects pooled). No significant correlations were found between the drift pattern during and immediately after prolonged roll-tilt. We conclude that the SVV is not stable during and after prolonged roll-tilt and that the direction and magnitude of drift are individually distinct and roll-angle-dependent. Likely sensory and central adaptation and random-walk processes contribute to drift while roll-tilted. Lack of correlation between the drift and the post-tilt bias suggests that it is not the inaccuracy of the SVV estimate while tilted that determines post-tilt bias, but rather the previous head-roll orientation relative to gravity. We therefore favor central adaptation, most likely a shift in prior knowledge towards the previous roll orientation, to explain the post-tilt bias.	[Tarnutzer, Alexander A.; Bertolini, Giovanni; Bockisch, Christopher J.; Straumann, Dominik; Marti, Sarah] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Bockisch, Christopher J.] Univ Zurich Hosp, Dept Otorhinolaryngol, CH-8091 Zurich, Switzerland; [Bockisch, Christopher J.] Univ Zurich Hosp, Dept Ophthalmol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Tarnutzer, AA (corresponding author), Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland.	alexander.tarnutzer@access.uzh.ch	Bertolini, Giovanni/H-3510-2016; Tarnutzer, Alexander/H-3236-2019; Bertolini, Giovanni/W-4117-2019	Bertolini, Giovanni/0000-0003-2428-9454; Tarnutzer, Alexander/0000-0002-6984-6958; Bertolini, Giovanni/0000-0003-2428-9454; Bockisch, Christopher/0000-0003-1054-2578	Swiss National Science Foundation, Berne, Switzerland [32003B_130163/1]; Betty and David Koetser Foundation for Brain Research, Zurich, Switzerland; Center of Integrative Human Physiology, University of Zurich, Switzerland; Bonizzi-Theler-Foundation, Zurich, Switzerland	Swiss National Science Foundation, Berne, Switzerland(Swiss National Science Foundation (SNSF)); Betty and David Koetser Foundation for Brain Research, Zurich, Switzerland; Center of Integrative Human Physiology, University of Zurich, Switzerland; Bonizzi-Theler-Foundation, Zurich, Switzerland	Swiss National Science Foundation (grant number: 32003B_130163/1), Berne, Switzerland; the Betty and David Koetser Foundation for Brain Research, Zurich, Switzerland; the Center of Integrative Human Physiology, University of Zurich, Switzerland; Bonizzi-Theler-Foundation, Zurich, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbonizio G, 2002, SPATIAL VISION, V16, P45, DOI 10.1163/15685680260433904; Adrian ED, 1943, J PHYSIOL-LONDON, V101, P389, DOI 10.1113/jphysiol.1943.sp003995; AGRESTI A, 1992, STAT SCI, V7, P131, DOI DOI 10.1214/SS/1177011454; Angelaki DE, 2009, CURR OPIN NEUROBIOL, V19, P452, DOI 10.1016/j.conb.2009.06.008; Aubert H., 1861, ARCH PATHOL ANAT, V20, P381, DOI DOI 10.1007/BF02355256; Bensmaia SJ, 2005, J NEUROPHYSIOL, V94, P3023, DOI 10.1152/jn.00002.2005; Berniker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012686; Bockisch CJ, 2001, VISION RES, V41, P2127, DOI 10.1016/S0042-6989(01)00094-3; BRANDT T, 1994, ANN NEUROL, V35, P403, DOI 10.1002/ana.410350406; Clemens IAH, 2011, J NEUROSCI, V31, P5365, DOI 10.1523/JNEUROSCI.6472-10.2011; Clifford CWG, 2002, TRENDS COGN SCI, V6, P136, DOI 10.1016/S1364-6613(00)01856-8; COLLEWIJN H, 1985, EXP BRAIN RES, V59, P185, DOI 10.1007/BF00237678; DAY RH, 1969, PSYCHOL BULL, V71, P33, DOI 10.1037/h0026872; DAY RH, 1966, SCIENCE, V154, P1201, DOI 10.1126/science.154.3753.1201; DAY RH, 1968, Q J EXP PSYCHOL, V20, P290, DOI 10.1080/14640746808400163; De Vrijer M, 2008, J NEUROPHYSIOL, V99, P915, DOI 10.1152/jn.00921.2007; DIAMOND SG, 1982, ANN OTO RHINOL LARYN, V91, P225, DOI 10.1177/000348948209100222; DIAMOND SG, 1983, NEUROLOGY, V33, P1460, DOI 10.1212/WNL.33.11.1460; FERNANDEZ C, 1972, J NEUROPHYSIOL, V35, P978, DOI 10.1152/jn.1972.35.6.978; FERNANDEZ C, 1976, J NEUROPHYSIOL, V39, P970, DOI 10.1152/jn.1976.39.5.970; FURMAN JMR, 1989, BIOL CYBERN, V61, P255, DOI 10.1007/BF00203172; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; Hahn JF, 1968, SKIN SENSES, P322; HAMMETT ST, 1994, VISION RES, V34, P31, DOI 10.1016/0042-6989(94)90254-2; Jaggi-Schwarz K, 2003, EXP BRAIN RES, V149, P340, DOI 10.1007/s00221-002-1343-y; Kaptein RG, 2004, J NEUROPHYSIOL, V91, P2205, DOI 10.1152/jn.00804.2003; Klier EM, 2005, J NEUROPHYSIOL, V94, P468, DOI 10.1152/jn.00700.2004; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Laurens J, 2007, BIOL CYBERN, V96, P389, DOI 10.1007/s00422-006-0133-1; LECHNERSTEINLEITNER S, 1978, PSYCHOL RES-PSYCH FO, V40, P65, DOI 10.1007/BF00308464; LEIGH RJ, 1981, ANN NY ACAD SCI, V374, P619, DOI 10.1111/j.1749-6632.1981.tb30906.x; Leigh RJ, 2006, NEUROLOGY EYE MOVEME, P254; LEVINSON E, 1976, VISION RES, V16, P779, DOI 10.1016/0042-6989(76)90189-9; Lewis RF, 2011, J VESTIBUL RES-EQUIL, V21, P323, DOI 10.3233/VES-2011-0422; LOWENSTEIN O, 1949, J PHYSIOL-LONDON, V110, P392, DOI 10.1113/jphysiol.1949.sp004448; MACADAR O, 1984, EXP NEUROL, V86, P147, DOI 10.1016/0014-4886(84)90075-X; MacNeilage PR, 2007, EXP BRAIN RES, V179, P263, DOI 10.1007/s00221-006-0792-0; Merfeld DM, 2001, J NEUROPHYSIOL, V85, P1648, DOI 10.1152/jn.2001.85.4.1648; MILLER E F 2nd, 1962, Acta Otolaryngol, V54, P479, DOI 10.3109/00016486209126967; MITTELSTAEDT H, 1983, NATURWISSENSCHAFTEN, V70, P272, DOI 10.1007/BF00404833; Mueller GE, 1916, Z PSYCHOL PHYSL SINN, V49, P109; NAPIER JR, 1956, J BONE JOINT SURG BR, V38, P902, DOI 10.1302/0301-620X.38B4.902; Pansell T, 2005, ANN NY ACAD SCI, V1039, P554, DOI 10.1196/annals.1325.066; Pansell T, 2005, STRABISMUS, V13, P115, DOI 10.1080/09273970500216408; Pavlou M, 2003, J NEUROPHYSIOL, V90, P622, DOI 10.1152/jn.00960.2002; Perennou DA, 2008, BRAIN, V131, P2401, DOI 10.1093/brain/awn170; SCHONE H, 1968, Z VERGL PHYSIOL, V60, P440, DOI 10.1007/BF00297938; SCHOR RH, 1984, J NEUROPHYSIOL, V51, P136, DOI 10.1152/jn.1984.51.1.136; SCHOR RH, 1974, EXP BRAIN RES, V20, P347; Schuler JR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-83; Series P, 2009, NEURAL COMPUT, V21, P3271, DOI 10.1162/neco.2009.09-08-869; Seydell A, 2010, J VISION, V10, DOI 10.1167/10.4.1; SHIMAZU H, 1965, J NEUROPHYSIOL, V28, P991, DOI 10.1152/jn.1965.28.6.991; Straube A, 1997, J NEUROPHYSIOL, V77, P874, DOI 10.1152/jn.1997.77.2.874; Tarnutzer AA, 2012, EXP BRAIN RES, V222, P427, DOI 10.1007/s00221-012-3230-5; Tarnutzer AA, 2012, J VESTIBUL RES-EQUIL, V22, P41, DOI 10.3233/VES-2011-0436; Tarnutzer AA, 2009, J NEUROPHYSIOL, V102, P1657, DOI 10.1152/jn.00007.2008; Tarnutzer AA, 2009, EXP BRAIN RES, V195, P621, DOI 10.1007/s00221-009-1823-4; Torre K, 2009, HUM MOVEMENT SCI, V28, P297, DOI 10.1016/j.humov.2009.01.001; Tribukait A, 2003, NEUROBIOL LEARN MEM, V80, P1, DOI 10.1016/S1074-7427(03)00041-8; UDODEHAE.HA, 1970, PERCEPT PSYCHOPHYS, V8, P137, DOI 10.3758/BF03210192; van Beuzekom AD, 2000, J NEUROPHYSIOL, V84, P11, DOI 10.1152/jn.2000.84.1.11; Van Huffel S, 1991, TOTAL LEAST SQUARES; VIDAL J, 1971, KYBERNETIK, V9, P205, DOI 10.1007/BF00289582; WADE NJ, 1968, PERCEPT PSYCHOPHYS, V3, P215, DOI 10.3758/BF03212730; WADE NJ, 1970, Q J EXP PSYCHOL, V22, P423, DOI 10.1080/14640747008401916; WADE NJ, 1968, PERCEPT PSYCHOPHYS, V3, P324, DOI 10.3758/BF03212477; Wade SW, 1997, VISION RES, V37, P1071, DOI 10.1016/S0042-6989(96)00252-0	69	25	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e78079	10.1371/journal.pone.0078079	http://dx.doi.org/10.1371/journal.pone.0078079			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24205099	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000325814200096
J	Wen, H; Miao, HX; Bennett, EE; Adamo, NM; Chen, L				Wen, Han; Miao, Houxun; Bennett, Eric E.; Adamo, Nick M.; Chen, Lei			Flexible Retrospective Phase Stepping in X-Ray Scatter Correction and Phase Contrast Imaging Using Structured Illumination	PLOS ONE			English	Article							FRINGE-PATTERN ANALYSIS; PRIMARY MODULATION; EXPOSURE	The development of phase contrast methods for diagnostic x-ray imaging is inspired by the potential of seeing the internal structures of the human body without the need to deposit any harmful radiation. An efficient class of x-ray phase contrast imaging and scatter correction methods share the idea of using structured illumination in the form of a periodic fringe pattern created with gratings or grids. They measure the scatter and distortion of the x-ray wavefront through the attenuation and deformation of the fringe pattern via a phase stepping process. Phase stepping describes image acquisition at regular phase intervals by shifting a grating in uniform steps. However, in practical conditions the actual phase intervals can vary from step to step and also spatially. Particularly with the advent of electromagnetic phase stepping without physical movement of a grating, the phase intervals are dependent upon the focal plane of interest. We describe a demodulation algorithm for phase stepping at arbitrary and position-dependent (APD) phase intervals without assuming a priori knowledge of the phase steps. The algorithm retrospectively determines the spatial distribution of the phase intervals by a Fourier transform method. With this ability, grating-based x-ray imaging becomes more adaptable and robust for broader applications.	[Wen, Han; Miao, Houxun; Bennett, Eric E.; Adamo, Nick M.] NHLBI, Imaging Phys Lab, Biochem & Biophys Ctr, NIH, Bethesda, MD 20892 USA; [Chen, Lei] NIST, Ctr Nanoscale Sci & Technol, Gaithersburg, MD 20899 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institute of Standards & Technology (NIST) - USA	Wen, H (corresponding author), NHLBI, Imaging Phys Lab, Biochem & Biophys Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	wenh@nhlbi.nih.gov	Bennett, Eric E/F-1070-2018; Bennett, Eric/A-2551-2013; Bennett, Eric/Q-6451-2019; Wen, Han/G-3081-2010; Miao, Houxun/N-8233-2013	Bennett, Eric E/0000-0001-6577-9869; Bennett, Eric/0000-0001-6577-9869; Bennett, Eric/0000-0001-6577-9869; Wen, Han/0000-0001-6844-2997; Miao, Houxun/0000-0001-7910-3413	Division of Intramural Research of the National Heart, Lung and Blood Institute, National Institutes of Health (NIH) (part of the U.S. Federal Government); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004606] Funding Source: NIH RePORTER	Division of Intramural Research of the National Heart, Lung and Blood Institute, National Institutes of Health (NIH) (part of the U.S. Federal Government); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work is funded by the Division of Intramural Research of the National Heart, Lung and Blood Institute, National Institutes of Health (NIH) (part of the U.S. Federal Government), with which all but one of the authors are affiliated. The research is performed as official duty in fulfilling the general Mission of NIH.	BONE DJ, 1986, APPL OPTICS, V25, P1653, DOI 10.1364/AO.25.001653; BRUNING JH, 1974, APPL OPTICS, V13, P2693, DOI 10.1364/AO.13.002693; Goldberg KA, 2001, APPL OPTICS, V40, P2886, DOI 10.1364/AO.40.002886; Miao H, 2013, MOTIONLESS PHASE STE; Momose A, 2003, JPN J APPL PHYS 2, V42, pL866, DOI 10.1143/JJAP.42.L866; MOMOSE A, 1995, MED PHYS, V22, P375, DOI 10.1118/1.597472; MOMOSE A, 1995, NUCL INSTRUM METH A, V352, P622, DOI 10.1016/0168-9002(95)90017-9; Morgan KS, 2011, OPT EXPRESS, V19, P19781, DOI 10.1364/OE.19.019781; Pfeiffer F, 2008, NAT MATER, V7, P134, DOI 10.1038/nmat2096; Pfeiffer F, 2006, NAT PHYS, V2, P258, DOI 10.1038/nphys265; Roessl E, 2012, PROC SPIE, V8313, DOI 10.1117/12.911255; Schorner K, 2012, IEEE T NUCL SCI, V59, P3278, DOI 10.1109/TNS.2012.2218127; Smith-Bindman R, 2012, JAMA-J AM MED ASSOC, V307, P2400, DOI 10.1001/jama.2012.5960; TAKEDA M, 1982, J OPT SOC AM, V72, P156, DOI 10.1364/JOSA.72.000156; Tapfer A, 2011, MED PHYS, V38, P5910, DOI 10.1118/1.3644844; Thuring T, 2013, SKELETAL RADIOL, V42, P827, DOI 10.1007/s00256-013-1606-7; Weitkamp T, 2005, OPT EXPRESS, V13, P6296, DOI 10.1364/OPEX.13.006296; Wen H, 2008, IEEE T MED IMAGING, V27, P997, DOI 10.1109/TMI.2007.912393; Zanette I, 2012, P NATL ACAD SCI USA, V109, P10199, DOI 10.1073/pnas.1117861109; Zhu L, 2006, IEEE T MED IMAGING, V25, P1573, DOI 10.1109/TMI.2006.884636	20	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e78276	10.1371/journal.pone.0078276	http://dx.doi.org/10.1371/journal.pone.0078276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24205177	Green Published, Green Submitted, gold			2022-12-27	WOS:000326373800017
J	Casado, C; Pernas, M; Sandonis, V; Alvaro-Cifuentes, T; Olivares, I; Fuentes, R; Martinez-Prats, L; Grau, E; Ruiz, L; Delgado, R; Rodriguez, C; del Romero, J; Lopez-Galindez, C				Casado, Concepcion; Pernas, Maria; Sandonis, Virginia; Alvaro-Cifuentes, Tamara; Olivares, Isabel; Fuentes, Rosa; Martinez-Prats, Lorena; Grau, Eulalia; Ruiz, Lidia; Delgado, Rafael; Rodriguez, Carmen; del Romero, Jorge; Lopez-Galindez, Cecilio			Identification of a Cluster of HIV-1 Controllers Infected with Low Replicating Viruses	PLOS ONE			English	Article							ENVELOPE GLYCOPROTEIN; ELITE SUPPRESSORS; VIRAL REPLICATION; CYTOPLASMIC TAIL; V3 LOOP; TYPE-1; SEQUENCE; GAG; DETERMINANTS; ASSOCIATION	Long term non-progressor patients (LTNPs) are characterized by the natural control of HIV-1 infection. This control is related to host genetic, immunological and virological factors. In this work, phylogenetic analysis of the proviral nucleotide sequences in env gene from a Spanish HIV-1 LTNPs cohort identified a cluster of 6 HIV-1 controllers infected with closely-related viruses. The patients of the cluster showed common clinical and epidemiological features: drug user practices, infection in the same city (Madrid, Spain) and at the same time (late 70's-early 80's). All cluster patients displayed distinct host alleles associated with HIV control. Analysis of the virus envelope nucleotide sequences showed ancestral characteristic, lack of evolution and presence of rare amino-acids. Biological characterization of recombinant viruses with the envelope proteins from the cluster viruses showed very low replicative capacity in TZMbl and U87-CD4/CCR5 cells. The lack of clinical progression in the viral cluster patients with distinct combinations of protective host genotypes, but infected by low replicating viruses, indicate the important role of the virus in the non-progressor phenotype in these patients.	[Casado, Concepcion; Pernas, Maria; Sandonis, Virginia; Alvaro-Cifuentes, Tamara; Olivares, Isabel; Fuentes, Rosa; Lopez-Galindez, Cecilio] Inst Salud Carlos III, CNM, Madrid, Spain; [Martinez-Prats, Lorena; Delgado, Rafael] Inst Invest Hosp 12 Octubre I 12, Lab Microbiol Mol, Madrid, Spain; [Grau, Eulalia; Ruiz, Lidia] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, IrsiCaixa Fdn, E-08193 Barcelona, Spain; [Rodriguez, Carmen; del Romero, Jorge] Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, CSS, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Microelectronica (CNM); Instituto de Salud Carlos III; Hospital Universitario 12 de Octubre; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa	Lopez-Galindez, C (corresponding author), Inst Salud Carlos III, CNM, Madrid, Spain.	clopez@isciii.es	Lopez-Galindez, Cecilio/A-3603-2008; Pernas, Maria/E-3998-2018; Olivares, Isabel/F-3083-2016; Ruiz, Lidia/ABF-9720-2021; Sandonís, Virginia/K-2884-2014; DELGADO, RAFAEL/A-2938-2012; Casado, Concepcion/F-3060-2016; Delgado, Rafael/C-4910-2016	Lopez-Galindez, Cecilio/0000-0002-2324-9584; Pernas, Maria/0000-0003-2966-0160; Olivares, Isabel/0000-0002-2347-5717; Sandonís, Virginia/0000-0001-5762-7531; Casado, Concepcion/0000-0003-3412-2877; Delgado, Rafael/0000-0002-6912-4736; Grau, Eulalia/0000-0002-2442-9165	MICINN Spain [SAF 2007-61036, 2010-17226]; Fundacion para la investigacion y prevencion del SIDA en Espana (FIPSE) Spain [36558/06, 36641/07, 36779/08, 360766/09]; RETIC de Investigacion en SIDA of the Fondo de Investigaciones Sanitarias (FISss) [RD06/006/0036]; FIPSE [36749]; ISCIII-FIS [PI080806, PI1101580]; Instituto de Salud Carlos III; Spanish Health Department [RD06/006/0035]	MICINN Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion para la investigacion y prevencion del SIDA en Espana (FIPSE) Spain; RETIC de Investigacion en SIDA of the Fondo de Investigaciones Sanitarias (FISss); FIPSE; ISCIII-FIS(Instituto de Salud Carlos III); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Health Department	Work in CNM is supported by grants [SAF 2007-61036 and 2010-17226] from MICINN Spain, by grants [36558/06, 36641/07, 36779/08, 360766/09] from Fundacion para la investigacion y prevencion del SIDA en Espana (FIPSE) Spain, and in part by the RETIC de Investigacion en SIDA [RD06/006/0036] of the Fondo de Investigaciones Sanitarias (FISss). Work in H12 de Octubre was financed by FIPSE [36749], and ISCIII-FIS [PI080806 and PI1101580] to RD. The HIV BioBank, integrated in the Spanish AIDS Research Network, is supported by the Instituto de Salud Carlos III, Spanish Health Department (Grant no RD06/006/0035) and FIPSE. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALBERT J, 1994, J VIROL, V68, P5918, DOI 10.1128/JVI.68.9.5918-5924.1994; Alexander L, 2000, J VIROL, V74, P4361, DOI 10.1128/JVI.74.9.4361-4376.2000; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; [Anonymous], 2014, TRACER V1 6; Antoni S, 2007, AIDS RES HUM RETROV, V23, P1377, DOI 10.1089/aid.2007.0113; Appay V, 2011, CURR OPIN HIV AIDS, V6, P157, DOI 10.1097/COH.0b013e3283453dfd; Apps R, 2013, SCIENCE, V340, P87, DOI 10.1126/science.1232685; Bello G, 2004, J GEN VIROL, V85, P399, DOI 10.1099/vir.0.19365-0; Berger CT, 2011, CURR OPIN HIV AIDS, V6, P208, DOI 10.1097/COH.0b013e3283457798; Blaak H, 1998, J INFECT DIS, V177, P600, DOI 10.1086/514219; Blankson JN, 2007, J VIROL, V81, P2508, DOI 10.1128/JVI.02165-06; Bobkov A, 2001, AIDS RES HUM RETROV, V17, P257, DOI 10.1089/088922201750063188; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brumme ZL, 2011, JAIDS-J ACQ IMM DEF, V56, P100, DOI 10.1097/QAI.0b013e3181fe9450; Bunnik EM, 2010, NAT MED, V16, P995, DOI 10.1038/nm.2203; Campbell TB, 2003, J VIROL, V77, P12105, DOI 10.1128/JVI.77.22.12105-12112.2003; Casado C, 2001, J GEN VIROL, V82, P2495, DOI 10.1099/0022-1317-82-10-2495; Casado C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011079; Cormier EG, 2002, J VIROL, V76, P8953, DOI 10.1128/JVI.76.17.8953-8957.2002; Curlin ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001228; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Gilbert MTP, 2007, P NATL ACAD SCI USA, V104, P18566, DOI 10.1073/pnas.0705329104; Gnanakaran S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002209; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hersperger AR, 2011, CURR OPIN HIV AIDS, V6, P169, DOI 10.1097/COH.0b013e3283454c39; Huthoff H, 2004, J VIROL, V78, P4907, DOI 10.1128/JVI.78.9.4907-4913.2004; Jiang JY, 2007, J VIROL, V81, P9999, DOI 10.1128/JVI.00592-07; Julg B, CLIN INFECT DIS, V51, P233; Lai RPJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002442; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Lamine A, 2007, AIDS, V21, P1043, DOI 10.1097/QAD.0b013e3280d5a7ac; Land A, 2003, FASEB J, V17, P1058, DOI 10.1096/fj.02-0811com; Lassen KG, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000377; Li Y, 1996, P NATL ACAD SCI USA, V93, P9606, DOI 10.1073/pnas.93.18.9606; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Mascola Jr, 1999, METH MOLEC MED, V17, P317, DOI 10.1385/0-89603-369-4:317; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Miura T, 2008, J VIROL, V82, P8422, DOI 10.1128/JVI.00535-08; Miura T, 2010, J VIROL, V84, P7581, DOI 10.1128/JVI.00286-10; Miura T, 2009, J VIROL, V83, P2743, DOI 10.1128/JVI.02265-08; Miura T, 2009, J VIROL, V83, P140, DOI 10.1128/JVI.01471-08; Murakami T, 2000, P NATL ACAD SCI USA, V97, P343, DOI 10.1073/pnas.97.1.343; O'Connell KA, 2010, J VIROL, V84, P7018, DOI 10.1128/JVI.00548-10; Olivares I, 1998, AIDS RES HUM RETROV, V14, P1649, DOI 10.1089/aid.1998.14.1649; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; PERUCHO M, 1980, CELL, V22, P309, DOI 10.1016/0092-8674(80)90178-6; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Russell ES, 2011, J VIROL, V85, P8253, DOI 10.1128/JVI.00197-11; Salgado M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-94; Sandonis V, 2009, VIROLOGY, V391, P73, DOI 10.1016/j.virol.2009.05.022; Smith SM, 2003, J BIOL CHEM, V278, P44816, DOI 10.1074/jbc.M307546200; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Volz EM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002552; Wang B, 2003, VIROLOGY, V312, P135, DOI 10.1016/S0042-6822(03)00159-4; Yang PL, 2010, J VIROL, V84, P59, DOI 10.1128/JVI.00899-09; [No title captured]	63	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77663	10.1371/journal.pone.0077663	http://dx.doi.org/10.1371/journal.pone.0077663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204910	Green Published, gold, Green Submitted			2022-12-27	WOS:000326334500040
J	Daine, K; Hawton, K; Singaravelu, V; Stewart, A; Simkin, S; Montgomery, P				Daine, Kate; Hawton, Keith; Singaravelu, Vinod; Stewart, Anne; Simkin, Sue; Montgomery, Paul			The Power of the Web: A Systematic Review of Studies of the Influence of the Internet on Self-Harm and Suicide in Young People	PLOS ONE			English	Article							ONLINE; ADOLESCENTS; BEHAVIOR; YOUTH; ASSOCIATION; ADDICTION; CLUSTERS; WEBSITES; IDEATION; ENGAGE	Background: There is concern that the internet is playing an increasing role in self-harm and suicide. In this study we systematically review and analyse research literature to determine whether there is evidence that the internet influences the risk of self-harm or suicide in young people. Methods: An electronic literature search was conducted using the PsycINFO, MEDLINE, EMBASE, Scopus, and CINAHL databases. Articles of interest were those that included empirical data on the internet, self-harm or suicide, and young people. The articles were initially screened based on titles and abstracts, then by review of the full publications, after which those included in the review were subjected to data extraction, thematic analysis and quality rating. Results: Youth who self-harm or are suicidal often make use of the internet. It is most commonly used for constructive reasons such as seeking support and coping strategies, but may exert a negative influence, normalising self-harm and potentially discouraging disclosure or professional help-seeking. The internet has created channels of communication that can be misused to 'cyber-bully' peers; both cyber-bullying and general internet use have been found to correlate with increased risk of self-harm, suicidal ideation, and depression. Correlations have also been found between internet exposure and violent methods of self-harm. Conclusions: Internet use may exert both positive and negative effects on young people at risk of self-harm or suicide. Careful high quality research is needed to better understand how internet media may exert negative influences and should also focus on how the internet might be utilised to intervene with vulnerable young people.	[Daine, Kate; Montgomery, Paul] Univ Oxford, Ctr Evidence Based Intervent, Oxford, England; [Hawton, Keith; Simkin, Sue] Univ Oxford, Warneford Hosp, Dept Psychiat, Ctr Suicide Res, Oxford, England; [Singaravelu, Vinod; Stewart, Anne] Oxford Hlth NHS Fdn Trust, Warneford Hosp, Oxford, England	University of Oxford; University of Oxford	Hawton, K (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Ctr Suicide Res, Oxford, England.	keith.hawton@psych.ox.ac.uk		Montgomery, Paul/0000-0001-8008-1370	National Institute for Health Research [NF-SI-0508-10053] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Alao AO, 2006, CYBERPSYCHOL BEHAV, V9, P489, DOI 10.1089/cpb.2006.9.489; Baker D, 2008, CRISIS, V29, P118, DOI 10.1027/0227-5910.29.3.118; Barak A, 2006, COUNS PSYCHOTHER RES, V6, P186, DOI 10.1080/14733140600848203; Becker K, 2004, NORD J PSYCHIAT, V58, P111, DOI 10.1080/08039480410005602; BOLLEN KA, 1982, AM SOCIOL REV, V47, P802, DOI 10.2307/2095217; Collings S. C., 2011, MEDIA INFLUENCES SUI; Critical Appraisal Skills Programme, 2012, CRIT APPR SKILLS PRO; Duggan JM, 2012, SCH MENT HEALTH, V4, P56, DOI 10.1007/s12310-011-9065-6; Dunlop SM, 2011, J CHILD PSYCHOL PSYC, V52, P1073, DOI 10.1111/j.1469-7610.2011.02416.x; Durkee T, 2011, INT J ENV RES PUB HE, V8, P3938, DOI 10.3390/ijerph8103938; Eichenberg C, 2008, CYBERPSYCHOL BEHAV, V11, P107, DOI 10.1089/cpb.2007.9924; GOULD MS, 1990, AM J PUBLIC HEALTH, V80, P211, DOI 10.2105/AJPH.80.2.211; Haw C, 2013, SUICIDE LIFE-THREAT, V43, P97, DOI 10.1111/j.1943-278X.2012.00130.x; Hawton K, 2002, BMJ-BRIT MED J, V325, P1207, DOI 10.1136/bmj.325.7374.1207; Hawton K, 2003, J CHILD PSYCHOL PSYC, V44, P1191, DOI 10.1111/1469-7610.00200; Hawton K, 2002, BRIT MED J, V325, P1374, DOI 10.1136/bmj.325.7377.1374; Hawton K, 2012, LANCET, V379, P2373, DOI 10.1016/S0140-6736(12)60322-5; Hay C, 2010, J YOUTH ADOLESCENCE, V39, P446, DOI 10.1007/s10964-009-9502-0; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hinduja S, 2010, ARCH SUICIDE RES, V14, P206, DOI 10.1080/13811118.2010.494133; Jones R, 2011, PSYCHIATR BULL, V35, P364, DOI 10.1192/pb.bp.110.033449; Katsumata Y, 2008, PSYCHIAT CLIN NEUROS, V62, P744, DOI 10.1111/j.1440-1819.2008.01880.x; Kim K, 2006, INT J NURS STUD, V43, P185, DOI 10.1016/j.ijnurstu.2005.02.005; Lam LT, 2009, INJURY PREV, V15, P403, DOI 10.1136/ip.2009.021949; Madge N, 2011, EUR CHILD ADOLES PSY, V20, P499, DOI 10.1007/s00787-011-0210-4; Messias E, 2011, SUICIDE LIFE-THREAT, V41, P307, DOI 10.1111/j.1943-278X.2011.00030.x; Mitchell KJ, 2007, PREV MED, V45, P392, DOI 10.1016/j.ypmed.2007.05.008; Muehlenkamp JJ, 2012, CHILD ADOLESC PSYCHI, V6; O'Connor RC, 2012, BRIT J PSYCHIAT, V200, P330, DOI 10.1192/bjp.bp.111.097808; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Phillips DP., 1992, ASSESSEMENT PREDICTI, P499; Rodham K., 2009, UNDERSTANDING NONSUI, P37; Schmidtke A, 1989, SUICIDE ITS PREVENTI, P313; Smithson J, 2011, QUAL HEALTH RES, V21, P1567, DOI 10.1177/1049732311413784; Smithson J, 2011, DISCOURSE STUD, V13, P487, DOI 10.1177/1461445611403356; Szumilas M, 2009, CAN J PSYCHIAT, V54, P596, DOI 10.1177/070674370905400904; Whitlock JL, 2006, DEV PSYCHOL, V42, P407, DOI 10.1037/0012-1649.42.3.407	37	194	197	5	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77555	10.1371/journal.pone.0077555	http://dx.doi.org/10.1371/journal.pone.0077555			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243RL	24204868	Green Published, gold, Green Submitted			2022-12-27	WOS:000326334500034
J	Donohue, SL; DeSantis, LRG; Schubert, BW; Ungar, PS				Donohue, Shelly L.; DeSantis, Larisa R. G.; Schubert, Blaine W.; Ungar, Peter S.			Was the Giant Short-Faced Bear a Hyper-Scavenger? A New Approach to the Dietary Study of Ursids Using Dental Microwear Textures	PLOS ONE			English	Article							URSUS-SPELAEUS; FEEDING-BEHAVIOR; LARGE CARNIVORES; GENOMES REVEAL; ARCTODUS-SIMUS; POLAR BEARS; BROWN BEARS; FOOD-HABITS; SUN BEARS; LA-BREA	Dramatic environmental changes associated with global cooling since the late Miocene, and the onset of glacial-interglacial cycles in the Pleistocene served as a backdrop to the evolutionary radiation of modern bears (family Ursidae). These environmental changes likely prompted changes in food availability, and triggered dietary adaptations that served as motive forces in ursid evolution. Here, we assess correspondence of dental microwear textures of first and second lower molars with diet in extant ursids. We use the resulting baseline data to evaluate the hypothesis that the Pleistocene giant short-faced bear, Arctodus simus, was a bone consumer and hyper-scavenger at Rancho La Brea, California, USA. Significant variation along the tooth row is consistent with functional differentiation, with the second molar serving as a better dietary recorder than the first. Results evince significant variation among species: carnivorous and omnivorous ursids (Ursus maritimus, U. americanus) have significantly higher and more variable complexity (Asfc) than more herbivorous ones (Ailuropoda melanoleuca, Tremarctos ornatus, U. malayanus), and A. melanoleuca is differentiated from U. maritimus and U. americanus by significantly higher and more variable anisotropy (epLsar) values. Arctodus simus from Rancho La Brea exhibits wear attributes most comparable to its closest living relative (T. ornatus), which is inconsistent with hard-object (e. g., bone) consumption, and the hypothesis that short-faced bears were bone consuming hyper-scavengers across their range.	[Donohue, Shelly L.; DeSantis, Larisa R. G.] Vanderbilt Univ, Dept Earth & Environm Sci, Nashville, TN 37235 USA; [Schubert, Blaine W.] Dept Geosci, Johnson City, TN USA; [Schubert, Blaine W.] Don Sundquist Ctr Excellence Paleontol, Johnson City, TN USA; [Ungar, Peter S.] Univ Arkansas, Dept Anthropol, Fayetteville, AR 72701 USA	Vanderbilt University; University of Arkansas System; University of Arkansas Fayetteville	DeSantis, LRG (corresponding author), Vanderbilt Univ, Dept Earth & Environm Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	larisa.desantis@vanderbilt.edu		DeSantis, Larisa/0000-0003-1159-9154	Geologic Society of America; American Society of Mammalogists; Vanderbilt University; University of Arkansas; National Science Foundation [EAR1053839]	Geologic Society of America; American Society of Mammalogists; Vanderbilt University; University of Arkansas; National Science Foundation(National Science Foundation (NSF))	This research was funded by the Geologic Society of America, the American Society of Mammalogists, Vanderbilt University, the University of Arkansas, and the National Science Foundation (EAR1053839). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes I, 2002, SCIENCE, V295, P2267, DOI 10.1126/science.1067814; Bentzen TW, 2007, CAN J ZOOL, V85, P596, DOI 10.1139/Z07-036; BOCHERENS H, 1995, CR ACAD SCI II, V320, P779; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Christiansen P, 1999, ANN ZOOL FENN, V36, P93; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; DAEGLING DJ, 1994, S AFR J SCI, V90, P527; DEROCHER AE, 1993, ARCTIC, V46, P251; DeSantis LRG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052453; DIERENFELD ES, 1982, J NUTR, V112, P636, DOI 10.1093/jn/112.4.636; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Dyck MG, 2009, J MAMMAL, V90, P585, DOI 10.1644/08-MAMM-A-103R2.1; EMSLIE SD, 1985, CONTRIBUTIONS SCI NA, V0371, P00001; Evans AR, 2007, NATURE, V445, P78, DOI 10.1038/nature05433; Figueirido B, 2009, J ZOOL, V277, P70, DOI 10.1111/j.1469-7998.2008.00511.x; Figueirido B, 2010, J VERTEBR PALEONTOL, V30, P262, DOI 10.1080/02724630903416027; Fox-Dobbs K, 2008, PALAEOGEOGR PALAEOCL, V261, P30, DOI 10.1016/j.palaeo.2007.12.011; Fredriksson GM, 2006, BIOL J LINN SOC, V89, P489, DOI 10.1111/j.1095-8312.2006.00688.x; Goillot C, 2009, PALAEOGEOGR PALAEOCL, V271, P13, DOI 10.1016/j.palaeo.2008.09.004; Hansen RL, 2010, ZOO BIOL, V29, P470, DOI 10.1002/zoo.20280; Haupt RJ, 2013, J MAMMAL, V94, P856, DOI 10.1644/12-MAMM-A-204.1; Krause J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-220; Kurten B., 1980, PLEISTOCENE MAMMALS; Kurten B., 1967, ACTA ZOOL FENN, V117, P1; Long Y, 2004, GIANT PANDAS BIOL CO, P103; Matheus, 2003, LOCOMOTOR ADAPTATION; Matheus PE, 1995, QUATERNARY RES, V44, P447, DOI 10.1006/qres.1995.1090; Meloro C, 2011, J VERTEBR PALEONTOL, V31, P428, DOI 10.1080/02724634.2011.550357; Merceron G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009542; Miller W, 2012, P NATL ACAD SCI USA, V109, pE2382, DOI 10.1073/pnas.1210506109; O'Keefe F. Robin, 2009, Contributions in Science (Los Angeles), P1; Peigne S, 2009, P NATL ACAD SCI USA, V106, P15390, DOI 10.1073/pnas.0907373106; PEYTON B, 1980, J MAMMAL, V61, P639, DOI 10.2307/1380309; Pinto-Llona AC, 2013, PALAEOGEOGR PALAEOCL, V370, P41, DOI 10.1016/j.palaeo.2012.11.017; Plavcan JM, 2001, EVOL ANTHROPOL, V10, P204, DOI 10.1002/evan.20001; Prideaux GJ, 2009, P NATL ACAD SCI USA, V106, P11646, DOI 10.1073/pnas.0900956106; RAINE RM, 1990, INT C BEAR, V8, P297; Roof Jayde C., 1997, Florida Field Naturalist, V25, P92; Sacco T, 2004, J ZOOL, V263, P41, DOI 10.1017/S0952836904004856; Schaller G.B., 1985, GIANT PANDAS WOLONG; Schmitt E, 2011, THESIS E TENNESSEE S; Schubert BW, 2010, J ZOOL, V280, P257, DOI 10.1111/j.1469-7998.2009.00656.x; Schubert BW, 2009, BOREAS, V38, P482, DOI 10.1111/j.1502-3885.2009.00090.x; Schulz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056167; Scott JR, 2012, MAMMALIA, V76, P157, DOI 10.1515/mammalia-2011-0083; Scott RS, 2006, J HUM EVOL, V51, P339, DOI 10.1016/j.jhevol.2006.04.006; Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822; Sorkin B, 2006, HIST BIOL, V18, P375, DOI 10.1080/08912960600618073; Stratman Marty R., 1999, Florida Field Naturalist, V27, P95; TEAFORD MF, 1989, AM J PHYS ANTHROPOL, V80, P447, DOI 10.1002/ajpa.1330800405; Thiemann GW, 2008, ECOL MONOGR, V78, P591, DOI 10.1890/07-1050.1; Ungar PS, 2003, SCANNING, V25, P185, DOI 10.1002/sca.4950250405; VANVALKENBURGH B, 1993, SCIENCE, V261, P456, DOI 10.1126/science.261.5120.456; Wong ST, 2002, URSUS, V13, P127; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	55	45	48	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77531	10.1371/journal.pone.0077531	http://dx.doi.org/10.1371/journal.pone.0077531			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204860	Green Submitted, Green Published, gold			2022-12-27	WOS:000326334500033
J	Gharbi, M; Flegg, JA; Pradines, B; Berenger, A; Ndiaye, M; Djimde, AA; Roper, C; Hubert, V; Kendjo, E; Venkatesan, M; Brasseur, P; Gaye, O; Offianan, AT; Penali, L; Le Bras, J; Guerin, PJ				Gharbi, Myriam; Flegg, Jennifer A.; Pradines, Bruno; Berenger, Ako; Ndiaye, Magatte; Djimde, Abdoulaye A.; Roper, Cally; Hubert, Veronique; Kendjo, Eric; Venkatesan, Meera; Brasseur, Philippe; Gaye, Oumar; Offianan, Andre T.; Penali, Louis; Le Bras, Jacques; Guerin, Philippe J.		French Natl Reference Ctr Imported	Surveillance of Travellers: An Additional Tool for Tracking Antimalarial Drug Resistance in Endemic Countries	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; IN-VITRO RESISTANCE; SULFADOXINE-PYRIMETHAMINE; DIHYDROFOLATE-REDUCTASE; CHLOROQUINE RESISTANCE; MOLECULAR MARKERS; DIHYDROPTEROATE SYNTHASE; COMBINATION THERAPY; GENETIC DIVERSITY; SELECTIVE SWEEPS	Introduction: There are growing concerns about the emergence of resistance to artemisinin-based combination therapies (ACTs). Since the widespread adoption of ACTs, there has been a decrease in the systematic surveillance of antimalarial drug resistance in many malaria-endemic countries. The aim of this work was to test whether data on travellers returning from Africa with malaria could serve as an additional surveillance system of local information sources for the emergence of drug resistance in endemic-countries. Methodology: Data were collected from travellers with symptomatic Plasmodium falciparum malaria returning from Senegal (n = 1,993), Mali (n = 2,372), Cote d'Ivoire (n = 4,778) or Cameroon (n = 3,272) and recorded in the French Malaria Reference Centre during the period 1996-2011. Temporal trends of the proportion of parasite isolates that carried the mutant genotype, pfcrt 76T, a marker of resistance to chloroquine (CQ) and pfdhfr 108N, a marker of resistance to pyrimethamine, were compared for travellers and within-country surveys that were identified through a literature review in PubMed. The in vitro response to CQ was also compared between these two groups for parasites from Senegal. Results: The trends in the proportion of parasites that carried pfcrt 76T, and pfdhfr 108N, were compared for parasites from travellers and patients within-country using the slopes of the curves over time; no significant differences in the trends were found for any of the 4 countries. These results were supported by in vitro analysis of parasites from the field in Senegal and travellers returning to France, where the trends were also not significantly different. Conclusion: The results have not shown different trends in resistance between parasites derived from travellers or from parasites within-country. This work highlights the value of an international database of drug responses in travellers as an additional tool to assess the emergence of drug resistance in endemic areas where information is limited.	[Gharbi, Myriam; Le Bras, Jacques] Inst Rech & Dev, UMR 216, Paris, France; [Gharbi, Myriam; Le Bras, Jacques] Fac Pharm, PRES Sorbonne Paris Cite, Paris, France; [Gharbi, Myriam; Flegg, Jennifer A.; Venkatesan, Meera; Penali, Louis; Le Bras, Jacques; Guerin, Philippe J.] WorldWide Antimalarial Resistance Network, Oxford, England; [Gharbi, Myriam; Guerin, Philippe J.] Sorbonne Paris Cite, Ecole Hautes Etud Sante Publ, Rennes, France; [Flegg, Jennifer A.; Guerin, Philippe J.] Univ Oxford, Ctr Trop Med, Oxford, England; [Flegg, Jennifer A.; Guerin, Philippe J.] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Pradines, Bruno] Inst Rech Biomed Armees, Dept Infectiol Terrain, Marseille, France; [Pradines, Bruno] Aix Marseille Univ, Unite Rech Malad Infect & Trop Emergentes, Marseille, France; [Pradines, Bruno] Ctr Natl Reference Paludisme, Marseille, France; [Berenger, Ako; Offianan, Andre T.] Inst Pasteur Cote Ivoire, Malariol Dept, Abidjan, Cote Ivoire; [Ndiaye, Magatte; Gaye, Oumar] Univ Cheikh Anta Diop, Fac Med & Pharm, Serv Parasitol, Dakar, Senegal; [Djimde, Abdoulaye A.] Univ Sci Tech & Technol Bamako, Fac Pharm, Malaria Res & Training Ctr, Bamako, Mali; [Djimde, Abdoulaye A.] Univ Sci Tech & Technol Bamako, Fac Pharm, Dept Epidemiol Parasit Dis, Bamako, Mali; [Roper, Cally] London Sch Hyg & Trop Med, Pathogen Mol Biol Dept Infect Trop Dis, London WC1, England; [Hubert, Veronique; Le Bras, Jacques] CHU Bichat Claude Bernard, AP HP, Ctr Natl Reference Paludisme, Paris, France; [Hubert, Veronique; Le Bras, Jacques] CHU Bichat Claude Bernard, AP HP, Serv Parasitol Mycol, Paris, France; [Kendjo, Eric] CHU Pitie Salpetriere, AP HP, Ctr Natl Reference Paludisme, Paris, France; [Kendjo, Eric] CHU Pitie Salpetriere, AP HP, Serv Parasitol Mycol, Paris, France; [Venkatesan, Meera] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Brasseur, Philippe] Inst Rech Dev, UMR 198, Dakar, Senegal; [Guerin, Philippe J.] INSERM, UMR Epidemiol Informat Syst Modeling S 707, Paris, France; [Guerin, Philippe J.] Univ Paris 06, Paris, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; Worldwide Antimalarial Resistance Network (WWARN); University of Oxford; University of Oxford; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); University Cheikh Anta Diop Dakar; University of Science & Technology of Bamako; University of Science & Technology of Bamako; University of London; London School of Hygiene & Tropical Medicine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University System of Maryland; University of Maryland Baltimore; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Gharbi, M (corresponding author), Inst Rech & Dev, UMR 216, Paris, France.	m.gharbi@yahoo.fr	Benoit-Vical, Francoise/E-3938-2016; Roper, Cally/K-2989-2013; KENDJO, Eric/AAI-7830-2021; Guerin, Philippe/AAH-8873-2021	Benoit-Vical, Francoise/0000-0002-9468-4823; Roper, Cally/0000-0002-6545-309X; KENDJO, Eric/0000-0002-2632-0964; Flegg, Jennifer/0000-0002-8809-726X; Pradines, Bruno/0000-0002-2360-3803; Guerin, Philippe/0000-0002-6008-2963; /0000-0001-7338-8745; Gharbi, Myriam/0000-0002-8994-2816	Doctoral Network of the Ecole des Hautes Etudes en Sante Publique, Rennes, France; Institut National de Veille Sanitaire, St Maurice, France	Doctoral Network of the Ecole des Hautes Etudes en Sante Publique, Rennes, France; Institut National de Veille Sanitaire, St Maurice, France	This study was supported in part by a grant for doctoral studies to MG from the Doctoral Network of the Ecole des Hautes Etudes en Sante Publique, Rennes, France and a grant for CNRpaludisme from Institut National de Veille Sanitaire, St Maurice, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ako Berenger Aristide, 2012, Infect Drug Resist, V5, P113, DOI 10.2147/IDR.S31409; [Anonymous], 2011, GLOB PLAN ART RES CO; Armitage P., 1980, STAT METHODS MED RES; Basco LK, 2002, AM J TROP MED HYG, V67, P388, DOI 10.4269/ajtmh.2002.67.388; Basco LK, 2002, AM J TROP MED HYG, V67, P378, DOI 10.4269/ajtmh.2002.67.378; Basco LK, 2002, AM J TROP MED HYG, V67, P392, DOI 10.4269/ajtmh.2002.67.392; Basco LK., 2007, FIELD APPL IN VITRO; Bertin G, 2005, J ANTIMICROB CHEMOTH, V55, P788, DOI 10.1093/jac/dki097; Bob NS, 2010, PLOS ONE, V5, pe9817, DOI DOI 10.1371/journal.pone.0009817; Brasseur P, 1999, T ROY SOC TROP MED H, V93, P645, DOI 10.1016/S0035-9203(99)90083-4; CHABASSE D, 1988, T ROY SOC TROP MED H, V82, P547, DOI 10.1016/0035-9203(88)90499-3; CHARMOT G, 1988, T ROY SOC TROP MED H, V82, P392, DOI 10.1016/0035-9203(88)90131-9; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Dicko A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-9; Djaman JA, 2007, ANN TROP MED PARASIT, V101, P103, DOI 10.1179/136485907X154584; Djaman JA, 2010, EUR J SCI RES, V40, P10; Djimde A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403; Djimde AA, 2004, J INFECT DIS, V190, P853, DOI 10.1086/422758; Djimde AA, 2008, AM J TROP MED HYG, V78, P455, DOI 10.4269/ajtmh.2008.78.455; Djimde AA, 2010, FEMS IMMUNOL MED MIC, V58, P113, DOI 10.1111/j.1574-695X.2009.00641.x; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Doumbo OK, 2000, J INFECT DIS, V182, P993, DOI 10.1086/315787; Durand R, 2001, MOL BIOCHEM PARASIT, V114, P95, DOI 10.1016/S0166-6851(01)00247-X; Fall B, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-310; Faye B, 2011, PARASITOL RES, V109, P133, DOI 10.1007/s00436-010-2236-9; FOGH S, 1979, T ROY SOC TROP MED H, V73, P228, DOI 10.1016/0035-9203(79)90220-7; Gautret P., 2012, EURO SURVEILL B EUR, P17; Guerin PJ, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-8; HELLGREN U, 1987, T ROY SOC TROP MED H, V81, P728, DOI 10.1016/0035-9203(87)90008-3; Henry M, 2006, AM J TROP MED HYG, V75, P146, DOI 10.4269/ajtmh.2006.75.146; Jafari S, 2004, J INFECT DIS, V189, P195, DOI 10.1086/380910; Kaddouri H, 2006, ANTIMICROB AGENTS CH, V50, P3343, DOI 10.1128/AAC.00367-06; KEAN BH, 1979, JAMA-J AM MED ASSOC, V241, P395, DOI 10.1001/jama.241.4.395; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Le Nagard H, 2011, COMPUT METH PROG BIO, V104, P10, DOI 10.1016/j.cmpb.2010.08.003; LEBRAS J, 1984, T ROY SOC TROP MED H, V78, P410, DOI 10.1016/0035-9203(84)90137-8; LEBRAS J, 1985, LANCET, V2, P1071; LEBRAS J, 1986, LANCET, V2, P1043; MacPherson DW, 2009, EMERG INFECT DIS, V15, P1727, DOI 10.3201/eid1511.090419; Mbacham WF, 2009, AFRICAN J BIOTECHNOL, V8, P6; Mbacham WF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-34; McCollum AM, 2008, ANTIMICROB AGENTS CH, V52, P4089, DOI 10.1128/AAC.00623-08; Menard S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-113; MORAN JS, 1983, LANCET, V2, P171; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Ndiaye D, 2005, TROP MED INT HEALTH, V10, P1176, DOI 10.1111/j.1365-3156.2005.01506.x; Ndiaye D, 2010, AM J TROP MED HYG, V82, P228, DOI 10.4269/ajtmh.2010.09-0470; Ndiaye M, 2012, AM J TROP MED HYG, V87, P640, DOI 10.4269/ajtmh.2012.11-0709; Neequaye J, 1986, LANCET, V1, P2; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Noranate N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000139; OLSEN VV, 1984, LANCET, V1, P1462; Ouattara L, 2010, TROPICAL J PHARM RES, V9, P8; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Plowe CV, 1997, J INFECT DIS, V176, P1590, DOI 10.1086/514159; Poumerol G, 2010, INT TRAV HLTH; Pradines B, 2006, J ANTIMICROB CHEMOTH, V57, P1093, DOI 10.1093/jac/dkl117; Pradines B, 2002, TROP MED INT HEALTH, V7, P265, DOI 10.1046/j.1365-3156.2002.00848.x; Pradines B, 1998, J ANTIMICROB CHEMOTH, V42, P333, DOI 10.1093/jac/42.3.333; Pradines B, 2006, J CLIN MICROBIOL, V44, P2404, DOI 10.1128/JCM.00623-06; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Sabatinelli G, 2001, Euro Surveill, V6, P61; SANSONETTI PJ, 1985, LANCET, V1, P1154; Sarr O, 2005, PARASITOL RES, V97, P136, DOI 10.1007/s00436-005-1406-7; Sarr O, 2008, PARASITOL RES, V103, P765, DOI 10.1007/s00436-008-1038-9; Sibley CH, 2008, TRENDS PARASITOL, V24, P43, DOI 10.1016/j.pt.2007.09.008; Tahar R, 2006, AM J TROP MED HYG, V75, P396, DOI 10.4269/ajtmh.2006.75.396; Tekete M, 2009, MALARIA J, V8, DOI [10.1186/1475-2875-8-S1-S4, 10.1186/1475-2875-8-34]; Thera MA, 2005, J INFECT DIS, V192, P1823, DOI 10.1086/498249; Thomas SM, 2002, AM J TROP MED HYG, V66, P474, DOI 10.4269/ajtmh.2002.66.474; Vestergaard LS, 2007, AM J TROP MED HYG, V77, P153, DOI 10.4269/ajtmh.2007.77.153; Wele M, 2011, ACTA TROP, V119, P11, DOI 10.1016/j.actatropica.2011.01.002; WHO, 2020, REP ANT DRUG EFF RES; Wilson ME, 2003, J APPL MICROBIOL, V94, p1S; Woodrow CJ, 2013, ANTIMICROB AGENTS CH, V57, P3121, DOI 10.1128/AAC.02350-12; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; World Health Organization, 2013, MAN SEV MAL PRACT HD; Wurtz N, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-197	78	8	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77775	10.1371/journal.pone.0077775	http://dx.doi.org/10.1371/journal.pone.0077775			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204960	Green Published, Green Accepted, gold			2022-12-27	WOS:000326334500058
J	Huang, R; Zhao, M; Yang, XF; Huang, JM; Yang, Y; Chen, BF; Tan, JB; Huang, JK; Li, Z; Lv, YJ; Ji, GY				Huang, Rui; Zhao, Min; Yang, Xingfen; Huang, Junming; Yang, Ying; Chen, Bifeng; Tan, Jianbin; Huang, Jiankang; Li, Zhi; Lv, Yingjian; Ji, Guiyuan			Effects of Prunella vulgaris on the Mice Immune Function	PLOS ONE			English	Article							EXTRACT; ACID	The present study was designed to evaluate the effects of Prunella Vulgaris (P. vulgaris) on the immune function in mice. The mice were randomly divided into one control group and three treatment groups of 10 mice each. The control group received pure water and the treatment groups received P. vulgaris extract at concentrations of 0.15, 0.30 and 0.90 g/kg BW orally for 30 days, respectively. Changes in cell immune function, non-specific immunity and humoral immunity function were evaluated. Active lymphocytes and T lymphocyte subsets were determined by fluorescence-activated cell sorting (FACS). Certain Serum concentrations of cytokines were measured by enzyme-linked immunosorbent assay (ELISA). The results showed that, for cell immune function, compared with the control group, foot pad thickness in high dose group increased significantly (p<0.01), whereas no significant difference in the proliferative ability of splenic lymphocytes was observed among all groups (p>0.05). For non-specific immunity, NK cell activity increased significantly in a dose-dependent manner in P. vulgaris treated mice (p<0.01), mononuclear-macrophage function in medium and high dose P. vulgaris treated mice were significantly higher than that of the control group (p<0.05). For humoral immunity, no significant differences were observed in terms of the half value of hemolysis (HC50), number of hemolytic plaques and serum IgG level (p>0.05). The percentage of active T and Th lymphocytes of mice peripheral blood in high dose group were significantly higher than that of the control group (p<0.01). There was no significant difference in serum levels of IL-1 beta, IL-4, IL-10 and IFN-gamma among all of the four groups (p>0.05). The data indicated that 0.90 g/kg BW P. vulgaris extract (equivalent to 7.5 g/kg BW crude drug) had some effect on cellular immune function and non-specific immune function in mice.	[Huang, Rui; Zhao, Min; Yang, Xingfen; Huang, Junming; Yang, Ying; Chen, Bifeng; Tan, Jianbin; Huang, Jiankang; Li, Zhi; Lv, Yingjian; Ji, Guiyuan] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Huang, Rui; Ji, Guiyuan] Guangdong Prov Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Huang, Rui] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China	Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; Sun Yat Sen University	Yang, XF (corresponding author), Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China.	xingfenyang@hotmail.com			National High Technology Research and Development Program 863 [2010AA023001]; Guangdong Natural Science Foundation [S2013010013289]; Guangdong science and technology plan project [201300000161]; Guangdong provincial bureau of Chinese medicine project [20132108]	National High Technology Research and Development Program 863(National High Technology Research and Development Program of China); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangdong science and technology plan project; Guangdong provincial bureau of Chinese medicine project	The authors thank the National High Technology Research and Development Program 863 (2010AA023001), Guangdong Natural Science Foundation project (S2013010013289), Guangdong science and technology plan project (201300000161), and the Guangdong provincial bureau of Chinese medicine project (20132108) for their financial contributions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen C.Y., 2009, CHIN GER J CLIN ONCO, V8, P426, DOI [10.1007/s10330-009-0067-x, DOI 10.1007/S10330-009-0067-X]; Fan YL, 2001, PHARM CLIN CHINESE M, V17, P10; Fuentes-Arderiu X, 2009, CYTOM PART B-CLIN CY, V76B, P291, DOI 10.1002/cyto.b.20479; Han EH, 2009, FOOD CHEM TOXICOL, V47, P62, DOI 10.1016/j.fct.2008.10.010; Harput US, 2006, PHYTOTHER RES, V20, P157, DOI 10.1002/ptr.1805; He R., 2009, WORLD SCI TECH, V11, P834; Huang N, 2009, J AGR FOOD CHEM, V57, P10579, DOI 10.1021/jf9023728; Ikeda Y, 2007, J IMMUNOL, V178, P4854, DOI 10.4049/jimmunol.178.8.4854; Jiang LH, 2007, LISHIZHEN MED MAT ME, V18, P2622; Liu GM, 2009, J CHIN MED MAT, V3, P1920; Ministry of Health of the people's Republic of China, 2003, INT SIST U ESP ESP E, P22; Pharmacopoeia Commission of People's Republic of China, 2010, PHARM PEOPL REP CH 1; Psotova J, 2005, FITOTERAPIA, V76, P556, DOI 10.1016/j.fitote.2005.04.019; Ryu SY, 2000, PLANTA MED, V66, P358, DOI 10.1055/s-2000-8531; Wang GX, 2009, CH J PUBLIC HLTH, V25, P1468; Warnatz K, 2008, CYTOM PART B-CLIN CY, V74B, P261, DOI 10.1002/cyto.b.20432; Yang Kun, 2007, Zhongguo Zhong Xi Yi Jie He Za Zhi, V27, P37; Zdarilova A, 2009, TOXICOL IN VITRO, V23, P386, DOI 10.1016/j.tiv.2008.12.021; Zheng Y., 2004, CHINESE J INTEGRATED, V12, P10; 陆军, 2012, [临床检验杂志, Chinese Journal of Clinical Laboratory Science], V30, P49; 王文佳, 2010, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V21, P107	21	15	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77355	10.1371/journal.pone.0077355	http://dx.doi.org/10.1371/journal.pone.0077355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204816	Green Published, Green Submitted, gold			2022-12-27	WOS:000326334500025
J	Idema, T; Dubuis, JO; Kang, L; Manning, ML; Nelson, PC; Lubensky, TC; Liu, AJ				Idema, Timon; Dubuis, Julien O.; Kang, Louis; Manning, M. Lisa; Nelson, Philip C.; Lubensky, Tom C.; Liu, Andrea J.			The Syncytial Drosophila Embryo as a Mechanically Excitable Medium	PLOS ONE			English	Article							F-ACTIN; CELL-DIVISION; LIVING CELLS; CALCIUM; MICRORHEOLOGY; CYTOSKELETON; DYNAMICS; CLEAVAGE; GASTRULATION; MICRODOMAINS	Mitosis in the early syncytial Drosophila embryo is highly correlated in space and time, as manifested in mitotic wavefronts that propagate across the embryo. In this paper we investigate the idea that the embryo can be considered a mechanically-excitable medium, and that mitotic wavefronts can be understood as nonlinear wavefronts that propagate through this medium. We study the wavefronts via both image analysis of confocal microscopy videos and theoretical models. We find that the mitotic waves travel across the embryo at a well-defined speed that decreases with replication cycle. We find two markers of the wavefront in each cycle, corresponding to the onsets of metaphase and anaphase. Each of these onsets is followed by displacements of the nuclei that obey the same wavefront pattern. To understand the mitotic wavefronts theoretically we analyze wavefront propagation in excitable media. We study two classes of models, one with biochemical signaling and one with mechanical signaling. We find that the dependence of wavefront speed on cycle number is most naturally explained by mechanical signaling, and that the entire process suggests a scenario in which biochemical and mechanical signaling are coupled.	[Idema, Timon; Kang, Louis; Nelson, Philip C.; Lubensky, Tom C.; Liu, Andrea J.] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; [Dubuis, Julien O.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Manning, M. Lisa] Syracuse Univ, Dept Phys, Syracuse, NY USA	University of Pennsylvania; Princeton University; Syracuse University	Liu, AJ (corresponding author), Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA.	ajliu@sas.upenn.edu	Nelson, Philip C/I-6251-2015; Idema, Timon/I-6547-2012; Liu, Andrea/GYD-4759-2022; Manning, Lisa/B-1746-2012; Liu, Andrea J/K-3968-2017	Nelson, Philip C/0000-0002-1782-3076; Idema, Timon/0000-0002-8901-5342; Liu, Andrea/0000-0002-2295-2729; Manning, Lisa/0000-0001-7682-2324; Liu, Andrea J/0000-0002-2295-2729	Netherlands Organization for Scientific Research (NWO); National Science Foundation (NSF) [NSF-DMR-1104637]; NSF [NSF-DMR-1104707]; Division Of Materials Research [1104707] Funding Source: National Science Foundation	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The study was supported by a Rubicon grant from the Netherlands Organization for Scientific Research (NWO) to T. I., http://www.nwo.nl/rubicon; Grant NSF-DMR-1104637 from the National Science Foundation (NSF) to A.J.L., and grant NSF-DMR-1104707 from the NSF to L. K. and T. C. L., http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGLADZE KI, 1982, NATURE, V296, P424, DOI 10.1038/296424a0; Alberts B, 2008, MOL BIOL CELL; ALLBRITTON NL, 1993, CELL CALCIUM, V14, P691, DOI 10.1016/0143-4160(93)90095-N; [Anonymous], 2007, PRINCIPLES CONDENSED; Bischofs IB, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.021911; Cao J, 2010, CURR BIOL, V20, P770, DOI 10.1016/j.cub.2010.02.060; DEVREOTES P, 1989, SCIENCE, V245, P1054, DOI 10.1126/science.2672337; Doi M., 1986, THEORY POLYM DYNAMIC; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Farge E, 2003, CURR BIOL, V13, P1365, DOI 10.1016/S0960-9822(03)00576-1; FOE VE, 1983, J CELL SCI, V61, P31; FOE VE, 1989, DEVELOPMENT, V107, P1; Foe Victoria E., 1993, P149; Gardel ML, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.188102; Gardel ML, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.158302; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Guigas G, 2007, BIOPHYS J, V93, P316, DOI 10.1529/biophysj.106.099267; Idema T, 2013, ARXIV13043657; Idema T, 2013, EUR BIOPHYS J BIOPHY, V42, P647, DOI 10.1007/s00249-013-0912-2; Jaffe LF, 2008, PHILOS T R SOC B, V363, P1311, DOI 10.1098/rstb.2007.2249; JANMEY PA, 1994, J BIOL CHEM, V269, P32503; KAGEYAMA T, 1986, ZOOL SCI, V3, P1046; KANE DA, 1992, NATURE, V360, P735, DOI 10.1038/360735a0; KANE DA, 1993, DEVELOPMENT, V119, P447; Kanesaki T, 2011, INTEGR BIOL-UK, V3, P1112, DOI 10.1039/c1ib00059d; KARR TL, 1986, J CELL BIOL, V102, P1494, DOI 10.1083/jcb.102.4.1494; KEATING TJ, 1994, J CELL SCI, V107, P2229; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; LANG I, 1986, J CELL BIOL, V102, P1183, DOI 10.1083/jcb.102.4.1183; Lee KJ, 1996, PHYS REV LETT, V76, P1174, DOI 10.1103/PhysRevLett.76.1174; LEVINE H, 1991, PHYS REV LETT, V66, P2400, DOI 10.1103/PhysRevLett.66.2400; MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425; MULLER O, 1991, MACROMOLECULES, V24, P3111; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Palmer A, 1999, BIOPHYS J, V76, P1063, DOI 10.1016/S0006-3495(99)77271-1; Parry H, 2006, BIOCHEM SOC T, V34, P385, DOI 10.1042/BST0340385; Parry H, 2005, J CELL BIOL, V171, P47, DOI 10.1083/jcb.200503139; Ranft J, 2010, P NATL ACAD SCI USA, V107, P20863, DOI 10.1073/pnas.1011086107; Saka Y, 2001, DEV BIOL, V229, P307, DOI 10.1006/dbio.2000.0101; SATOH N, 1977, DEV GROWTH DIFFER, V19, P111; SCHEJTER ED, 1993, ANNU REV CELL BIOL, V9, P67, DOI 10.1146/annurev.cellbio.9.1.67; SCHMIDT CF, 1989, MACROMOLECULES, V22, P3638, DOI 10.1021/ma00199a023; Schotz EM, 2004, THESIS U KONSTANZ KO; SILVER RB, 1989, DEV BIOL, V131, P11; SILVER RB, 1990, ANN NY ACAD SCI, V582, P207; Stevenson VA, 2001, NAT CELL BIOL, V3, P68, DOI 10.1038/35050579; SULLIVAN W, 1995, CURR OPIN CELL BIOL, V7, P18, DOI 10.1016/0955-0674(95)80040-9; Thomas AP, 1996, FASEB J, V10, P1505, DOI 10.1096/fasebj.10.13.8940296; TRINKAUS JP, 1992, DEVELOPMENT, P75; Tyson JJ, 2011, CURR BIOL, V21, pR185, DOI 10.1016/j.cub.2011.01.042; WARN RM, 1984, J CELL BIOL, V98, P156, DOI 10.1083/jcb.98.1.156; Whitaker M, 2008, PHILOS T R SOC B, V363, P1401, DOI 10.1098/rstb.2008.2259; Wilhelm C, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.028101; WINFREE AT, 1972, SCIENCE, V175, P634, DOI 10.1126/science.175.4022.634; Wirtz D, 2009, ANNU REV BIOPHYS, V38, P301, DOI 10.1146/annurev.biophys.050708.133724; Yamada S, 2000, BIOPHYS J, V78, P1736, DOI 10.1016/S0006-3495(00)76725-7	56	27	28	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77216	10.1371/journal.pone.0077216	http://dx.doi.org/10.1371/journal.pone.0077216			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204774	Green Submitted, Green Published, gold			2022-12-27	WOS:000326334500020
J	Zhang, SQ; Mu, YG; Zhang, JZH; Xu, WX				Zhang, Saiqun; Mu, Yuguang; Zhang, John Z. H.; Xu, Weixin			Effect of Self-Assembly of Fullerene Nano-Particles on Lipid Membrane	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATION; STABLE COLLOIDAL DISPERSIONS; C-60 FULLERENES; COMPUTER-SIMULATION; WATER; TRANSLOCATION; CLUSTERS; NANOMATERIALS; CYTOTOXICITY; ANTIOXIDANTS	Carbon nanoparticles can penetrate the cell membrane and cause cytotoxicity. The diffusion feature and translocation free energy of fullerene through lipid membranes is well reported. However, the knowledge on self-assembly of fullerenes and resulting effects on lipid membrane is poorly addressed. In this work, the self-assembly of fullerene nanoparticles and the resulting influence on the dioleoylphosphtidylcholine (DOPC) model membrane were studied by using all-atom molecular dynamics simulations with explicit solvents. Our simulation results confirm that gathered small fullerene cluster can invade lipid membrane. Simulations show two pathways: 1) assembly process is completely finished before penetration; 2) assembly process coincides with penetration. Simulation results also demonstrate that in the membrane interior, fullerene clusters tend to stay at the position which is 1.0 nm away from the membrane center. In addition, the diverse microscopic stacking mode (i.e., equilateral triangle, tetrahedral pentahedral, trigonal bipyramid and octahedron) of these small fullerene clusters are well characterized. Thus our simulations provide a detailed high-resolution characterization of the microscopic structures of the small fullerene clusters. Further, we found the gathered small fullerene clusters have significant adverse disturbances to the local structure of the membrane, but no great influence on the global integrity of the lipid membrane, which suggests the prerequisite of high-content fullerene for cytotoxicity.	[Zhang, Saiqun; Xu, Weixin] E China Normal Univ, Inst Adv Interdisciplinary Res, Shanghai 200062, Peoples R China; [Mu, Yuguang] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Zhang, John Z. H.; Xu, Weixin] E China Normal Univ, State Key Lab Precis Spect, Shanghai 200062, Peoples R China; [Zhang, John Z. H.] NYU, Dept Chem, New York, NY 10003 USA	East China Normal University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; East China Normal University; New York University	Xu, WX (corresponding author), E China Normal Univ, Inst Adv Interdisciplinary Res, Shanghai 200062, Peoples R China.	wxxu@sat.ecnu.edu.cn			National Natural Science Foundation of China [21003048, 10974054, 20933002, 11204083]; Research Fund for the Doctoral Program of Higher Education of China [20120076120033]; Shanghai PuJiang program [12PJ1403000]; State Key Laboratory of Precision spectroscopy, East China Normal University; IDA Cloud Computing Call, NTU Tier 1 [RG 23/11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Shanghai PuJiang program(Shanghai Pujiang Program); State Key Laboratory of Precision spectroscopy, East China Normal University; IDA Cloud Computing Call, NTU Tier 1	The authors thank the National Natural Science Foundation of China (Grants No. 21003048, 10974054, 20933002 and 11204083). WXX is grateful to Research Fund for the Doctoral Program of Higher Education of China(20120076120033), Shanghai PuJiang program (12PJ1403000) and Open Research Fund of the State Key Laboratory of Precision spectroscopy, East China Normal University, for financial support. YGM gratefully thanks the support of the IDA Cloud Computing Call, NTU Tier 1 grant RG 23/11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alargova RG, 2001, J AM CHEM SOC, V123, P10460, DOI 10.1021/ja010202a; Alivisatos AP, 2005, ANNU REV BIOMED ENG, V7, P55, DOI 10.1146/annurev.bioeng.7.060804.100432; Allen WJ, 2009, J COMPUT CHEM, V30, P1952, DOI 10.1002/jcc.21172; Andrievsky G, 2005, FULLER NANOTUB CAR N, V13, P363, DOI 10.1080/15363830500237267; ANDRIEVSKY GV, 1995, J CHEM SOC CHEM COMM, P1281, DOI 10.1039/c39950001281; Andrievsky GV, 1999, CHEM PHYS LETT, V300, P392, DOI 10.1016/S0009-2614(98)01393-1; Baker GL, 2008, TOXICOL SCI, V101, P122, DOI 10.1093/toxsci/kfm243; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bortolus M, 2011, LANGMUIR, V27, P12560, DOI 10.1021/la202524r; Branz W, 2000, CHEM PHYS LETT, V328, P245, DOI 10.1016/S0009-2614(00)00929-5; Bulavin L, 2000, PHYS CHEM CHEM PHYS, V2, P1627, DOI 10.1039/a907786c; Calvaresi M, 2009, SMALL, V5, P2191, DOI 10.1002/smll.200900528; Chang R, 2010, B KOREAN CHEM SOC, V31, P3195, DOI 10.5012/bkcs.2010.31.11.3195; Chen CY, 2005, NANO LETT, V5, P2050, DOI 10.1021/nl051624b; Choudhury N, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2217442; Cirifalco LA, 1991, J PHYS CHEM-US, V95, P5370; Cruts B, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-4; Deguchi S, 2001, LANGMUIR, V17, P6013, DOI 10.1021/la010651o; Dhawan A, 2006, ENVIRON SCI TECHNOL, V40, P7394, DOI 10.1021/es0609708; Ding HM, 2012, ACS NANO, V6, P1230, DOI 10.1021/nn2038862; Doye JPK, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.235409; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dugan LL, 2001, PARKINSONISM RELAT D, V7, P243, DOI 10.1016/S1353-8020(00)00064-X; Dugan LL, 1997, P NATL ACAD SCI USA, V94, P9434, DOI 10.1073/pnas.94.17.9434; Fiedler SL, 2010, BIOPHYS J, V99, P144, DOI 10.1016/j.bpj.2010.03.039; Fortner JD, 2005, ENVIRON SCI TECHNOL, V39, P4307, DOI 10.1021/es048099n; Hansen K, 1997, Z PHYS D ATOM MOL CL, V40, P361, DOI 10.1007/s004600050228; Hansen K, 1996, J CHEM PHYS, V105, P6088, DOI 10.1063/1.472448; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hofinger S, 2011, BIOMATERIALS, V32, P7079, DOI 10.1016/j.biomaterials.2011.06.011; Hou WC, 2011, LANGMUIR, V27, P11899, DOI 10.1021/la2017837; HWANG KC, 1993, NATURE, V361, P138, DOI 10.1038/361138a0; Ikeda A, 2012, CHEM-ASIAN J, V7, P605, DOI 10.1002/asia.201100792; Innocenzi P, 2001, CHEM MATER, V13, P3126, DOI 10.1021/cm0110223; Isobe H, 2006, CHEM-ASIAN J, V1, P167, DOI 10.1002/asia.200600051; Kim H, 2008, J CHEM THEORY COMPUT, V4, P335, DOI 10.1021/ct700211y; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; Lai K, 2013, PHYS CHEM CHEM PHYS, V15, P270, DOI 10.1039/c2cp42027a; Li LW, 2007, J PHYS CHEM B, V111, P4067, DOI 10.1021/jp064982r; Li LW, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2121647; Li LW, 2006, J PHYS CHEM B, V110, P10509, DOI 10.1021/jp060718m; Li WF, 2012, P NATL ACAD SCI USA, V109, P17789, DOI 10.1073/pnas.1201807109; Oberdorster E, 2004, ENVIRON HEALTH PERSP, V112, P1058, DOI 10.1289/ehp.7021; Oberdrster E, 2004, 227 ACS NAT M AN CA; Osawa E., 2002, PERSPECTIVES FULLERE; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Pogodin S, 2012, ACS NANO, V6, P10555, DOI 10.1021/nn3028858; Qiao R, 2007, NANO LETT, V7, P614, DOI 10.1021/nl062515f; Revell P. A., 2006, Nanotechnology Perceptions, V2, P283; Roslyakov A, 1999, ZH AKAD MED NAUK UKR, V5, P338; Rossi G, 2013, PHYS SCRIPTA, V87, DOI 10.1088/0031-8949/87/05/058503; RUOFF RS, 1991, NATURE, V350, P663, DOI 10.1038/350663b0; Sayes CM, 2005, BIOMATERIALS, V26, P7587, DOI 10.1016/j.biomaterials.2005.05.027; Sayes CM, 2004, NANO LETT, V4, P1881, DOI 10.1021/nl0489586; SIJBESMA R, 1993, J AM CHEM SOC, V115, P6510, DOI 10.1021/ja00068a006; Tieleman DP, 1997, BBA-REV BIOMEMBRANES, V1331, P235, DOI 10.1016/S0304-4157(97)00008-7; Tremblay JF, 2002, CHEM ENG NEWS, V80, P16; Ungurenasu C, 2000, J MED CHEM, V43, P3186, DOI 10.1021/jm991175q; Utsunomiya S, 2002, ENVIRON SCI TECHNOL, V36, P4943, DOI 10.1021/es025872a; Wang IC, 1999, J MED CHEM, V42, P4614, DOI 10.1021/jm990144s; Wang W, 2009, P NATL ACAD SCI USA, V106, P5517, DOI 10.1073/pnas.0809649106; Wang ZN, 2009, CHEMPHYSCHEM, V10, P2284, DOI 10.1002/cphc.200900328; Wong-Ekkabut J, 2008, NAT NANOTECHNOL, V3, P363, DOI 10.1038/nnano.2008.130; Xu WX, 2008, BIOPHYS CHEM, V137, P116, DOI 10.1016/j.bpc.2008.08.002; Xu WX, 2009, J PHYS CHEM B, V113, P7308, DOI 10.1021/jp8106827; Zhang WH, 2000, PHYS REV B, V62, P8276, DOI 10.1103/PhysRevB.62.8276; Zhang YJ, 2011, J AM CHEM SOC, V133, P6882, DOI 10.1021/ja1109425	67	18	19	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77436	10.1371/journal.pone.0077436	http://dx.doi.org/10.1371/journal.pone.0077436			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204827	Green Published, Green Submitted, gold			2022-12-27	WOS:000326270700029
J	Xia, XF; Wang, XY; Li, QR; Li, N; Li, JS				Xia, Xianfeng; Wang, Xinying; Li, Qiurong; Li, Ning; Li, Jieshou			Essential Amino Acid Enriched High-Protein Enteral Nutrition Modulates Insulin-Like Growth Factor-1 System Function in a Rat Model of Trauma-Hemorrhagic Shock	PLOS ONE			English	Article							IGF-BINDING PROTEIN-1; SKELETAL-MUSCLE; MOLECULAR-MECHANISMS; MAMMALIAN TARGET; LEUCINE; SUPPLEMENTATION; RESISTANCE; PLASMA; STIMULATION; RESTRICTION	Background: Nutrition support for critically ill patients supplemented with additional modular protein may promote skeletal muscle protein anabolism in addition to counteracting acute nitrogen loss. The present study was designed to investigate whether the essential amino acid (EAA) enriched high-protein enteral nutrition (EN) modulates the insulin-like growth factor-1 (IGF-1) system and activates the mammalian target of rapamycin (mTOR) anabolic signaling pathway in a trauma-hemorrhagic shock (T-HS) rat model. Methodology/Principal Findings: Male Sprague-Dawley rats (n = 90, 278.18 +/- 0.94 g) were randomly assigned to 5 groups: (1) normal control, (2) pair-fed, (3) T-HS, (4) T-HS and standard EN, and (5) T-HS and EAA enriched high-protein EN. Six animals from each group were harvested on days 2, 4, and 6 for serum, gastrocnemius, soleus, and extensor digitorum longus sample collection. T-HS significantly reduced muscle mass. Nutrition support maintained muscle mass, especially the EAA enriched high-protein EN. Meanwhile, a pronounced derangement in IGF-1-IGFBPs axis as well as impaired mTOR transduction was observed in the T-HS group. Compared with animals receiving standard EN, those receiving EAA enriched high-protein EN presented 18% higher serum free IGF-1 levels following 3 days of nutrition support and 22% higher after 5 days. These changes were consistent with the concomitant elevation in serum insulin and reduction in corticosterone levels. In addition, phosphorylations of downstream anabolic signaling effectors - including protein kinase B, mTOR, and ribosomal protein S6 kinase1 - increased significantly in rats receiving EAA enriched high-protein EN. Conclusion/Significance: Our findings firstly demonstrate the beneficial effect of EAA enriched high-protein EN on the metabolic modulation of skeletal muscle protein anabolism by regulating the IGF-1 system and downstream anabolic signaling transduction.	[Xia, Xianfeng; Wang, Xinying; Li, Qiurong; Li, Ning; Li, Jieshou] Nanjing Univ, Sch Med, Jinling Hosp, Res Inst Gen Surg, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Wang, XY (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Res Inst Gen Surg, Nanjing 210008, Jiangsu, Peoples R China.	wxinying@263.net	Xia, Xianfeng/Y-6601-2018; Li, jie/GXG-4583-2022	Xia, Xianfeng/0000-0003-4718-8189; 	National Natural Science Foundation in China [81070282]; Natural Science Foundation in Jiangsu Province [BK2010460]	National Natural Science Foundation in China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation in Jiangsu Province(Natural Science Foundation of Jiangsu Province)	The authors' research project is sponsored by the National Natural Science Foundation in China (81070282) and the Natural Science Foundation in Jiangsu Province (BK2010460). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral AG, 2010, PANCREAS, V39, P847, DOI 10.1097/MPA.0b013e3181d37210; Belizon A, 2007, SURG ENDOSC, V21, P653, DOI 10.1007/s00464-006-9103-x; Biolo G, 1997, NUTRITION, V13, pS52, DOI 10.1016/S0899-9007(97)00206-2; Bohe J, 2003, J PHYSIOL-LONDON, V552, P315, DOI 10.1113/jphysiol.2003.050674; CAREY LC, 1970, ANN SURG, V172, P342, DOI 10.1097/00000658-197009000-00004; CHAUDRY IH, 1976, CAN J PHYSIOL PHARM, V54, P736, DOI 10.1139/y76-102; Chen Y, 2011, AM J PHYSIOL-ENDOC M, V301, pE873, DOI 10.1152/ajpendo.00068.2011; Chevalley T, 2010, CLIN NUTR, V29, P78, DOI 10.1016/j.clnu.2009.07.003; Clemmons DR, 2009, TRENDS ENDOCRIN MET, V20, P349, DOI 10.1016/j.tem.2009.04.002; Dickinson JM, 2011, J NUTR, V141, P856, DOI 10.3945/jn.111.139485; Elijah IE, 2011, BEST PRACT RES CL EN, V25, P759, DOI 10.1016/j.beem.2011.06.002; Foster EB, 2012, AMINO ACIDS, V42, P1405, DOI 10.1007/s00726-011-0837-y; Frost RA, 1999, ENDOCRINOLOGY, V140, P3962, DOI 10.1210/en.140.9.3962; Fujita S, 2007, J PHYSIOL-LONDON, V582, P813, DOI 10.1113/jphysiol.2007.134593; Gomes MR, 2003, NUTR RES, V23, P1239, DOI 10.1016/S0271-5317(03)00114-3; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Howell JJ, 2011, TRENDS ENDOCRIN MET, V22, P94, DOI 10.1016/j.tem.2010.12.003; Janssen JAMJL, 2003, J ENDOCRINOL INVEST, V26, P588, DOI 10.1007/BF03345225; Katsanos CS, 2006, AM J PHYSIOL-ENDOC M, V291, pE381, DOI 10.1152/ajpendo.00488.2005; Kelley KM, 1996, INT J BIOCHEM CELL B, V28, P619, DOI 10.1016/1357-2725(96)00005-2; Klaude M, 2012, CLIN SCI, V122, P133, DOI 10.1042/CS20110233; Lang CH, 2002, AM J PHYSIOL-REG I, V282, pR207, DOI 10.1152/ajpregu.00319.2001; Lang CH, 2004, SHOCK, V22, P326, DOI 10.1097/01.shk.0000136096.03931.ed; Lang CH, 2003, ENDOCRINOLOGY, V144, P3922, DOI 10.1210/en.2002-0192; Li L, 2009, ENDOCRINOLOGY, V150, P24, DOI 10.1210/en.2008-0742; [罗楠 Luo Nan], 2004, [肠外与肠内营养, Parenteral & Enteral Nutrition], V11, P367; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Ma YC, 2003, AM J PHYSIOL-GASTR L, V284, pG107, DOI 10.1152/ajpgi.00217.2002; Macotela Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021187; McClave SA, 2009, JPEN-PARENTER ENTER, V33, P277, DOI 10.1177/0148607109335234; Minard G, 1998, WORLD J SURG, V22, P213, DOI 10.1007/s002689900372; Nystrom G, 2009, METABOLISM, V58, P787, DOI 10.1016/j.metabol.2009.01.015; Okamoto I, 2010, JPN J CLIN ONCOL, V40, P222, DOI 10.1093/jjco/hyp155; Pasiakos SM, 2011, AM J CLIN NUTR, V94, P809, DOI 10.3945/ajcn.111.017061; Pedrosa RG, 2010, APPL PHYSIOL NUTR ME, V35, P180, DOI 10.1139/H09-132; Sanchez-Gomez M, 1999, BRIT J NUTR, V81, P145, DOI 10.1017/S0007114599000288; Skipworth RJE, 2006, SURG-J R COLL SURG E, V4, P273, DOI 10.1016/S1479-666X(06)80004-1; Svanberg E, 2000, AM J PHYSIOL-ENDOC M, V279, pE1145, DOI 10.1152/ajpendo.2000.279.5.E1145; Takenaka A, 2000, J NUTR, V130, P2910, DOI 10.1093/jn/130.12.2910; Thompson LH, 2008, MOL MED, V14, P715, DOI 10.2119/2008-00081.Thompson; Thorell A, 1999, Curr Opin Clin Nutr Metab Care, V2, P69, DOI 10.1097/00075197-199901000-00012; Thorell A, 1992, CLIN NUTR, V11, P48; Wallin MKEB, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-2; Wang XM, 2007, METHOD ENZYMOL, V431, P113, DOI 10.1016/S0076-6879(07)31007-0; WILMORE DW, 1976, ANN SURG, V183, P314, DOI 10.1097/00000658-197603000-00018; Wojnar MM, 1999, AM J PHYSIOL-ENDOC M, V276, pE455, DOI 10.1152/ajpendo.1999.276.3.E455; Yang J, 2012, J BIOL CHEM, V287, P24795, DOI 10.1074/jbc.M112.344259; Yang SY, 2010, LAB INVEST, V90, P391, DOI 10.1038/labinvest.2009.139; Zhai LD, 2009, J ENDOCRINOL, V203, P365, DOI 10.1677/JOE-09-0269	49	6	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77823	10.1371/journal.pone.0077823	http://dx.doi.org/10.1371/journal.pone.0077823			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204984	Green Submitted, gold, Green Published			2022-12-27	WOS:000326241200044
J	Di Russo, F; Berchicci, M; Perri, RL; Ripani, FR; Ripani, M				Di Russo, Francesco; Berchicci, Marika; Perri, Rinaldo Livio; Ripani, Francesca Romana; Ripani, Maurizio			A Passive Exoskeleton Can Push Your Life Up: Application on Multiple Sclerosis Patients	PLOS ONE			English	Article							LOCALIZATION; LATENCY; MEG	In the present study, we report the benefits of a passive and fully articulated exoskeleton on multiple sclerosis patients by means of behavioral and electrophysiological measures, paying particular attention to the prefrontal cortex activity. Multiple sclerosis is a neurological condition characterized by lesions of the myelin sheaths that encapsulate the neurons of the brain, spine and optic nerve, and it causes transient or progressive symptoms and impairments in gait and posture. Up to 50% of multiple sclerosis patients require walking aids and 10% are wheelchair-bound 15 years following the initial diagnosis. We tested the ability of a new orthosis, the "Human Body Posturizer", designed to improve the structural and functional symmetry of the body through proprioception, in multiple sclerosis patients. We observed that a single Human Body Posturizer application improved mobility, ambulation and response accuracy, in all of the tested patients. Most importantly, we associated these clinical observations and behavioral effects to changes in brain activity, particularly in the prefrontal cortex.	[Di Russo, Francesco; Berchicci, Marika; Perri, Rinaldo Livio; Ripani, Maurizio] Univ Rome Foro Italico, Dept Human Movement Social & Hlth Sci, Rome, Italy; [Di Russo, Francesco] IRCCS Santa Lucia Fdn, Neuropsychol Unit, Rome, Italy; [Ripani, Francesca Romana] Univ Roma La Sapienza, Dept Anat Histol Forens Med & Locomotor Sci, I-00185 Rome, Italy	Foro Italico University of Rome; IRCCS Santa Lucia; Sapienza University Rome	Di Russo, F (corresponding author), Univ Rome Foro Italico, Dept Human Movement Social & Hlth Sci, Rome, Italy.	francesco.dirusso@uniroma4.it	Di Russo, Francesco/N-6686-2015; Perri, Rinaldo/U-2480-2017	Di Russo, Francesco/0000-0002-3127-9433; Perri, Rinaldo/0000-0002-7343-9669; , Marika/0000-0001-8470-191X; RIPANI, Maurizio/0000-0003-4450-8511	University of Rome "Foro Italico" [RIC-109/2012]	University of Rome "Foro Italico"	The work was funded by the University of Rome "Foro Italico" (www.uniroma4.it), research grant number RIC-109/2012. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Omaishi J, 1999, J LEUKOCYTE BIOL, V65, P444, DOI 10.1002/jlb.65.4.444; Albert J, 2013, NEUROIMAGE, V76, P272, DOI 10.1016/j.neuroimage.2013.03.011; Albrecht H, 2001, MULT SCLER J, V7, P105, DOI 10.1191/135245801678227621; Aminoff JC, 2001, J CLIN NEUROPHYSIOL, V18, P372, DOI 10.1097/00004691-200107000-00009; Berchicci M, 2013, J GERONTOL A-BIOL, V68, P1337, DOI 10.1093/gerona/glt094; Berchicci M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00135; Berchicci M, 2012, NEUROIMAGE, V62, P1750, DOI 10.1016/j.neuroimage.2012.06.031; Berger TW, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046017; Bozzacchi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047783; Bozzacchi C, 2012, BIOL PSYCHOL, V89, P503, DOI 10.1016/j.biopsycho.2011.12.020; Ciccarelli A., 2012, ITAL J ANAT EMBRYOL, V117, P41; Colaiacomo B., 2011, ITAL J ANAT EMBRYOL, V116, P46; Dollar AM, 2008, IEEE T ROBOT, V24, P144, DOI 10.1109/TRO.2008.915453; Ferris Daniel P, 2005, Top Spinal Cord Inj Rehabil, V11, P34; Fuster J.M., 2013, PRINCIPLES FRONTAL L, P11; Goldman MD, 2008, MULT SCLER J, V14, P383, DOI 10.1177/1352458507082607; Grasso R, 2004, BRAIN, V127, P1019, DOI 10.1093/brain/awh115; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Ilmoniemi R J, 1993, Brain Topogr, V5, P331, DOI 10.1007/BF01128686; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Larson EB, 2002, CORTEX, V38, P201, DOI 10.1016/S0010-9452(08)70650-6; Lin FH, 2006, NEUROIMAGE, V31, P160, DOI 10.1016/j.neuroimage.2005.11.054; Lucci G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056566; Oldfield R.C., 1971, NEUROPSYCHOLOGIA, V104, P199; Rahman T, 2007, IEEE T NEUR SYS REH, V15, P244, DOI 10.1109/TNSRE.2007.897026; Tsermentseli S, 2012, CORTEX, V48, P166, DOI 10.1016/j.cortex.2011.02.004; Whelan R, 2010, CLIN NEUROPHYSIOL, V121, P1420, DOI 10.1016/j.clinph.2010.03.019; Zimmermann P., 1995, TEST ATTENTIONAL PER	29	28	29	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77348	10.1371/journal.pone.0077348	http://dx.doi.org/10.1371/journal.pone.0077348			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204814	Green Published, gold, Green Submitted			2022-12-27	WOS:000326155400036
J	Klaus, VH; Holzel, N; Prati, D; Schmitt, B; Schoning, I; Schrumpf, M; Fischer, M; Kleinebecker, T				Klaus, Valentin H.; Hoelzel, Norbert; Prati, Daniel; Schmitt, Barbara; Schoening, Ingo; Schrumpf, Marion; Fischer, Markus; Kleinebecker, Till			Organic vs. Conventional Grassland Management: Do N-15 and C-13 Isotopic Signatures of Hay and Soil Samples Differ?	PLOS ONE			English	Article							STABLE-ISOTOPE; PLANT-COMMUNITIES; DELTA-N-15 VALUES; RATIO ANALYSIS; CARBON; DELTA-C-13; FOLIAR; TOOL; FERTILIZATION; BIODIVERSITY	Distinguishing organic and conventional products is a major issue of food security and authenticity. Previous studies successfully used stable isotopes to separate organic and conventional products, but up to now, this approach was not tested for organic grassland hay and soil. Moreover, isotopic abundances could be a powerful tool to elucidate differences in ecosystem functioning and driving mechanisms of element cycling in organic and conventional management systems. Here, we studied the delta N-15 and delta C-13 isotopic composition of soil and hay samples of 21 organic and 34 conventional grasslands in two German regions. We also used Delta delta N-15 (delta N-15 plant - delta N-15 soil) to characterize nitrogen dynamics. In order to detect temporal trends, isotopic abundances in organic grasslands were related to the time since certification. Furthermore, discriminant analysis was used to test whether the respective management type can be deduced from observed isotopic abundances. Isotopic analyses revealed no significant differences in delta C-13 in hay and delta C-13 in both soil and hay between management types, but showed that delta C-13 abundances were significantly lower in soil of organic compared to conventional grasslands. delta C-15 values implied that management types did not substantially differ in nitrogen cycling. Only delta C-13 in soil and hay showed significant negative relationships with the time since certification. Thus, our result suggest that organic grasslands suffered less from drought stress compared to conventional grasslands most likely due to a benefit of higher plant species richness, as previously shown by manipulative biodiversity experiments. Finally, it was possible to correctly classify about two third of the samples according to their management using isotopic abundances in soil and hay. However, as more than half of the organic samples were incorrectly classified, we infer that more research is needed to improve this approach before it can be efficiently used in practice.	[Klaus, Valentin H.; Hoelzel, Norbert; Kleinebecker, Till] Univ Munster, Inst Landscape Ecol, D-48149 Munster, Germany; [Prati, Daniel; Schmitt, Barbara; Fischer, Markus] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Schoening, Ingo; Schrumpf, Marion] Max Planck Inst Biogeochem, D-07745 Jena, Germany	University of Munster; University of Bern; Max Planck Society	Klaus, VH (corresponding author), Univ Munster, Inst Landscape Ecol, D-48149 Munster, Germany.	v.klaus@uni-muenster.de	Schrumpf, Marion/C-1671-2013; Schöning, Ingo/D-3341-2009; Fischer, Markus/C-6411-2008; Hölzel, Norbert/H-8753-2013	Schöning, Ingo/0000-0002-9830-5026; Fischer, Markus/0000-0002-5589-5900; Hölzel, Norbert/0000-0002-6367-3400; Kleinebecker, Till/0000-0003-1121-2861; Schrumpf, Marion/0000-0003-4219-4125; Klaus, Valentin H./0000-0002-7469-6800	DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" [FI 1246/6-1, FI1246/9-1, HO 3830/2-2, SCHR 1181/2-1]	DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories"	The work has been funded by the DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" (FI 1246/6-1, FI1246/9-1, HO 3830/2-2, SCHR 1181/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 2001, PLANT BIOLOGY, V3, P299, DOI 10.1055/s-2001-16454; Baisden WT, 2002, GLOBAL BIOGEOCHEM CY, V16, P64, DOI DOI 10.1029/2001GB001822; Batary P, 2010, ECOSYSTEMS ENV, V136, P35; Bateman AS, 2007, ISOT ENVIRON HEALT S, V43, P237, DOI 10.1080/10256010701550732; Bateman AS, 2007, J AGR FOOD CHEM, V55, P2664, DOI 10.1021/jf0627726; Bateman AS, 2005, J AGR FOOD CHEM, V53, P5760, DOI 10.1021/jf050374h; Bluthgen N, 2012, BASIC APPL ECOL, V13, P207, DOI 10.1016/j.baae.2012.04.001; Bol R, 2004, ISOT ENVIRON HEALT S, V40, P81, DOI 10.1080/10256010310001605955; Boner M, 2004, ANAL BIOANAL CHEM, V378, P301, DOI 10.1007/s00216-003-2347-6; Caldeira MC, 2001, ECOL LETT, V4, P439, DOI 10.1046/j.1461-0248.2001.00238.x; Camin F, 2011, FOOD CHEM, V125, P1072, DOI 10.1016/j.foodchem.2010.09.081; Camin F, 2007, J SCI FOOD AGR, V87, P1330, DOI 10.1002/jsfa.2853; de Bello F, 2009, AGR ECOSYST ENVIRON, V131, P303, DOI 10.1016/j.agee.2009.02.002; del Amor FM, 2008, J ENVIRON QUAL, V37, P182, DOI 10.2134/jeq2007.0329; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Franke BM, 2005, EUR FOOD RES TECHNOL, V221, P493, DOI 10.1007/s00217-005-1158-8; Georgi M, 2005, PLANT SOIL, V275, P93, DOI 10.1007/s11104-005-0258-3; Gubsch M, 2011, PLANT CELL ENVIRON, V34, P895, DOI 10.1111/j.1365-3040.2011.02287.x; Haas G, 2001, AGR ECOSYST ENVIRON, V83, P43, DOI 10.1016/S0167-8809(00)00160-2; Hobbie EA, 2012, NEW PHYTOL, V196, P367, DOI 10.1111/j.1469-8137.2012.04300.x; HOGBERG P, 1993, PLANT SOIL, V152, P207, DOI 10.1007/BF00029090; Hole DG, 2005, BIOL CONSERV, V122, P113, DOI 10.1016/j.biocon.2004.07.018; Jumpponen A, 2005, J ECOL, V93, P1136, DOI 10.1111/j.1365-2745.2005.01045.x; Kahmen A, 2008, OECOLOGIA, V156, P861, DOI 10.1007/s00442-008-1028-8; Klaus VH, 2013, AGR ECOSYST ENVIRON, V177, P1, DOI 10.1016/j.agee.2013.05.019; Kleinebecker T, 15N NATURAL AB UNPUB; Molkentin J, 2009, J AGR FOOD CHEM, V57, P785, DOI 10.1021/jf8022029; Nakano A, 2003, PLANT SOIL, V255, P343, DOI 10.1023/A:1026180700963; Neilson R, 1998, SOIL BIOL BIOCHEM, V30, P1773, DOI 10.1016/S0038-0717(98)00038-8; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rapisarda P, 2005, J AGR FOOD CHEM, V53, P2664, DOI 10.1021/jf048733g; Santruckova H, 2000, FUNCT ECOL, V14, P108, DOI 10.1046/j.1365-2435.2000.00402.x; Schaack D., 2010, AMI MARKTBILANZ OKO; Schmidt O, 2005, FOOD CHEM, V91, P545, DOI 10.1016/j.foodchem.2004.08.036; Schwertl M, 2005, AGR ECOSYST ENVIRON, V109, P153, DOI 10.1016/j.agee.2005.01.015; Shangguan ZP, 2000, ENVIRON EXP BOT, V44, P141, DOI 10.1016/S0098-8472(00)00064-2; Socher SA, 2012, J ECOL, V100, P1391, DOI 10.1111/j.1365-2745.2012.02020.x; Venables WN., 2002, MODERN APPL STAT S 4; Watzka M, 2006, SOIL BIOL BIOCHEM, V38, P1564, DOI 10.1016/j.soilbio.2005.11.007; Werner RA, 2001, RAPID COMMUN MASS SP, V15, P501, DOI 10.1002/rcm.258; Wrage N, 2011, NUTR CYCL AGROECOSYS, V90, P189, DOI 10.1007/s10705-011-9421-9	41	10	11	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78134	10.1371/journal.pone.0078134	http://dx.doi.org/10.1371/journal.pone.0078134			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24205126	Green Published, Green Submitted, gold			2022-12-27	WOS:000326155400072
J	Guan, NY; Wei, L; Luo, ZG; Tao, DC				Guan, Naiyang; Wei, Lei; Luo, Zhigang; Tao, Dacheng			Limited-Memory Fast Gradient Descent Method for Graph Regularized Nonnegative Matrix Factorization	PLOS ONE			English	Article							INFORMATION	Graph regularized nonnegative matrix factorization (GNMF) decomposes a nonnegative data matrix X is an element of R-mxn to the product of two lower-rank nonnegative factor matrices, i.e., W is an element of R-mxr and H is an element of R-rxn (r<min{m,n}) and aims to preserve the local geometric structure of the dataset by minimizing squared Euclidean distance or Kullback-Leibler (KL) divergence between X and WH. The multiplicative update rule (MUR) is usually applied to optimize GNMF, but it suffers from the drawback of slow-convergence because it intrinsically advances one step along the rescaled negative gradient direction with a non-optimal step size. Recently, a multiple step-sizes fast gradient descent (MFGD) method has been proposed for optimizing NMF which accelerates MUR by searching the optimal step-size along the rescaled negative gradient direction with Newton's method. However, the computational cost of MFGD is high because 1) the high-dimensional Hessian matrix is dense and costs too much memory; and 2) the Hessian inverse operator and its multiplication with gradient cost too much time. To overcome these deficiencies of MFGD, we propose an efficient limited-memory FGD (L-FGD) method for optimizing GNMF. In particular, we apply the limited-memory BFGS (L-BFGS) method to directly approximate the multiplication of the inverse Hessian and the gradient for searching the optimal step size in MFGD. The preliminary results on real-world datasets show that L-FGD is more efficient than both MFGD and MUR. To evaluate the effectiveness of L-FGD, we validate its clustering performance for optimizing KL-divergence based GNMF on two popular face image datasets including ORL and PIE and two text corpora including Reuters and TDT2. The experimental results confirm the effectiveness of L-FGD by comparing it with the representative GNMF solvers.	[Guan, Naiyang; Wei, Lei; Luo, Zhigang] Natl Univ Def Technol, Sch Comp Sci, Natl Key Lab Parallel & Distributed Proc, Changsha, Hunan, Peoples R China; [Tao, Dacheng] Univ Technol Sydney, Ctr Quantum Computat & Intelligent Syst, Sydney, NSW 2007, Australia; [Tao, Dacheng] Univ Technol Sydney, Fac Engn & Informat Technol, Sydney, NSW 2007, Australia	National University of Defense Technology - China; University of Technology Sydney; University of Technology Sydney	Luo, ZG (corresponding author), Natl Univ Def Technol, Sch Comp Sci, Natl Key Lab Parallel & Distributed Proc, Changsha, Hunan, Peoples R China.	zgluo@nudt.edu.cn; Dacheng.Tao@uts.edu.au			Scientific Research Plan Project of National University of Defense Technology [JC13-06-01]; Australian Research Council [120103730]	Scientific Research Plan Project of National University of Defense Technology; Australian Research Council(Australian Research Council)	This work was partially supported by Scientific Research Plan Project of National University of Defense Technology (No. JC13-06-01) and Australian Research Council Discovery Project (120103730). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belkin M, 2006, J MACH LEARN RES, V7, P2399; Cai D, 2011, IEEE T PATTERN ANAL, V33, P1548, DOI 10.1109/TPAMI.2010.231; Cieri Chris, 1999, P DARPA BROADC NEWS, P57; Tao DC, 2007, KNOWL INF SYST, V13, P1, DOI 10.1007/s10115-006-0050-6; Devarajan K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000029; Graham D., 1998, FACE RECOGNITION, V163, P446, DOI DOI 10.1007/978-3-642-72201-1_25; Guan N., 2012, ARXIV12073438V1; Guan NY, 2012, IEEE T NEUR NET LEAR, V23, P1087, DOI 10.1109/TNNLS.2012.2197827; Guan NY, 2012, IEEE T SIGNAL PROCES, V60, P2882, DOI 10.1109/TSP.2012.2190406; Guan NY, 2011, IEEE T NEURAL NETWOR, V22, P1218, DOI 10.1109/TNN.2011.2157359; Guan NY, 2011, IEEE T IMAGE PROCESS, V20, P2030, DOI 10.1109/TIP.2011.2105496; Hoyer PO, 2004, J MACH LEARN RES, V5, P1457; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; LIU DC, 1989, MATH PROGRAM, V45, P503, DOI 10.1007/BF01589116; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; Samaria F. S., 1994, Proceedings of the Second IEEE Workshop on Applications of Computer Vision (Cat. No.94TH06742), P138, DOI 10.1109/ACV.1994.341300; Sandler R, 2011, IEEE T PATTERN ANAL, V33, P1590, DOI 10.1109/TPAMI.2011.18; Tao DC, 2007, IEEE T PATTERN ANAL, V29, P1700, DOI 10.1109/TPAMI.2007.1096; Tao DC, 2009, IEEE T PATTERN ANAL, V31, P260, DOI 10.1109/TPAMI.2008.70; Tao DP, 2012, NEUROCOMPUTING, V91, P11, DOI 10.1016/j.neucom.2012.02.024; Vavasis SA, 2009, SIAM J OPTIMIZ, V20, P1364, DOI 10.1137/070709967; Zafeiriou S, 2006, IEEE T NEURAL NETWOR, V17, P683, DOI 10.1109/TNN.2006.873291	24	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77162	10.1371/journal.pone.0077162	http://dx.doi.org/10.1371/journal.pone.0077162			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204761	gold, Green Published, Green Submitted			2022-12-27	WOS:000326032600023
J	Poon, E; Yan, B; Zhang, SH; Rushing, S; Keung, W; Ren, LH; Lieu, DK; Geng, L; Kong, CW; Wang, JX; Wong, HS; Boheler, KR; Li, RA				Poon, Ellen; Yan, Bin; Zhang, Shaohong; Rushing, Stephanie; Keung, Wendy; Ren, Lihuan; Lieu, Deborah K.; Geng, Lin; Kong, Chi-Wing; Wang, Jiaxian; Wong, Hau San; Boheler, Kenneth R.; Li, Ronald A.			Transcriptome-Guided Functional Analyses Reveal Novel Biological Properties and Regulatory Hierarchy of Human Embryonic Stem Cell-Derived Ventricular Cardiomyocytes Crucial for Maturation	PLOS ONE			English	Article							FACILITATED MATURATION; SARCOPLASMIC-RETICULUM; CARDIAC MYOCYTES; GENE-EXPRESSION; HUMAN HEART; DIFFERENTIATION; CONDUCTION; PHOSPHORYLATION; MORPHOGENESIS; ENRICHMENT	Human (h) embryonic stem cells (ESC) represent an unlimited source of cardiomyocytes (CMs); however, these differentiated cells are immature. Thus far, gene profiling studies have been performed with non-purified or non-chamber specific CMs. Here we took a combinatorial approach of using systems biology to guide functional discoveries of novel biological properties of purified hESC-derived ventricular (V) CMs. We profiled the transcriptomes of hESCs, hESC-, fetal (hF) and adult (hA) VCMs, and showed that hESC-VCMs displayed a unique transcriptomic signature. Not only did a detailed comparison between hESC-VCMs and hF-VCMs confirm known expression changes in metabolic and contractile genes, it further revealed novel differences in genes associated with reactive oxygen species (ROS) metabolism, migration and cell cycle, as well as potassium and calcium ion transport. Following these guides, we functionally confirmed that hESC-VCMs expressed I-KATP with immature properties, and were accordingly vulnerable to hypoxia/reoxygenation-induced apoptosis. For mechanistic insights, our coexpression and promoter analyses uncovered a novel transcriptional hierarchy involving select transcription factors (GATA4, HAND1, NKX2.5, PPARGC1A and TCF8), and genes involved in contraction, calcium homeostasis and metabolism. These data highlight novel expression and functional differences between hESC-VCMs and their fetal counterparts, and offer insights into the underlying cell developmental state. These findings may lead to mechanism-based methods for in vitro driven maturation.	[Poon, Ellen; Keung, Wendy; Ren, Lihuan; Geng, Lin; Kong, Chi-Wing; Wang, Jiaxian; Boheler, Kenneth R.; Li, Ronald A.] Univ Hong Kong, LKS Fac Med, Stem Cell & Regenerat Med Consortium, Hong Kong, Hong Kong, Peoples R China; [Keung, Wendy; Ren, Lihuan; Geng, Lin; Kong, Chi-Wing; Wang, Jiaxian; Li, Ronald A.] Univ Hong Kong, LKS Fac Med, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; [Yan, Bin] Hong Kong Baptist Univ, Dept Biol, Hong Kong, Hong Kong, Peoples R China; [Zhang, Shaohong; Wong, Hau San] City Univ Hong Kong, Dept Comp Sci, Hong Kong, Hong Kong, Peoples R China; [Zhang, Shaohong] Guangzhou Univ, Dept Comp Sci, Guangzhou, Guangdong, Peoples R China; [Rushing, Stephanie; Lieu, Deborah K.; Wang, Jiaxian; Li, Ronald A.] Mt Sinai Sch Med, Cardiovasc Res Ctr, New York, NY USA; [Lieu, Deborah K.] Univ Calif Davis, Dept Internal Med, Div Cardiovasc Med, Davis, CA 95616 USA; [Boheler, Kenneth R.] Johns Hopkins Univ, Div Cardiol, Baltimore, MD USA	University of Hong Kong; University of Hong Kong; Hong Kong Baptist University; City University of Hong Kong; Guangzhou University; Icahn School of Medicine at Mount Sinai; University of California System; University of California Davis; Johns Hopkins University	Li, RA (corresponding author), Univ Hong Kong, LKS Fac Med, Stem Cell & Regenerat Med Consortium, Hong Kong, Hong Kong, Peoples R China.	ronaldli@hku.hk	Poon, Ellen/ABD-6962-2020	Poon, Ellen/0000-0002-9280-3681; Lieu, Deborah/0000-0002-3765-3203; WONG, Hau-San/0000-0002-1530-7529; Keung, Wendy/0000-0002-6827-6754	Research Grant Council of HKSAR (TBRS) [T13-706/11]; SCRMC of the University of Hong Kong; Faculty Cores of the University of Hong Kong; Science Faculty of Hong Kong Baptist University [FRG2/12-13/066]	Research Grant Council of HKSAR (TBRS); SCRMC of the University of Hong Kong; Faculty Cores of the University of Hong Kong; Science Faculty of Hong Kong Baptist University	"This work was supported by the Research Grant Council of HKSAR (TBRS, T13-706/11), SCRMC and Faculty Cores of the University of Hong Kong, and the Science Faculty of Hong Kong Baptist University (FRG2/12-13/066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Beqqali A, 2006, STEM CELLS, V24, P1956, DOI 10.1634/stemcells.2006-0054; Binah O, 2007, J ELECTROCARDIOL, V40, pS192, DOI 10.1016/j.jelectrocard.2007.05.035; Braam SR, 2010, STEM CELL RES, V4, P107, DOI 10.1016/j.scr.2009.11.004; Briggs LE, 2008, CIRC RES, V103, P580, DOI 10.1161/CIRCRESAHA.108.171835; Cai CL, 2005, DEVELOPMENT, V132, P2475, DOI 10.1242/dev.01832; Cao F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003474; Caspi O, 2009, STEM CELLS DEV, V18, P161, DOI 10.1089/scd.2007.0280; Charron F, 1999, MOL CELL BIOL, V19, P4355; Christoffels VM, 2004, DEV DYNAM, V229, P763, DOI 10.1002/dvdy.10487; Christoffels VM, 2000, DEV BIOL, V223, P266, DOI 10.1006/dbio.2000.9753; Coles JG, 2005, J THORAC CARDIOV SUR, V129, P1128, DOI 10.1016/j.jtcvs.2004.11.055; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; DEBAKKER JMT, 1993, CIRCULATION, V88, P915, DOI 10.1161/01.CIR.88.3.915; Despa S, 2005, CIRC RES, V97, P252, DOI 10.1161/01.RES.0000176532.97731.e5; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; FERRARI R, 1993, EUR HEART J, V14, P25; Fu JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027417; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; Hoogaars WMH, 2007, GENE DEV, V21, P1098, DOI 10.1101/gad.416007; IWASA T, 1985, J BIOCHEM-TOKYO, V98, P577, DOI 10.1093/oxfordjournals.jbchem.a135313; Kehat I, 2002, CIRC RES, V91, P659, DOI 10.1161/01.RES.0000039084.30342.9B; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kocic I, 2001, CARDIOVASC RES, V51, P59, DOI 10.1016/S0008-6363(01)00279-6; Kushnir A, 2010, P NATL ACAD SCI USA, V107, P10274, DOI 10.1073/pnas.1005843107; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Li RA, 2000, CIRC RES, V87, P837, DOI 10.1161/01.RES.87.10.837; Lieu DK, 2013, CIRC-ARRHYTHMIA ELEC, V6, P191, DOI 10.1161/CIRCEP.111.973420; Lieu DK, 2009, STEM CELLS DEV, V18, P1493, DOI 10.1089/scd.2009.0052; Lieu DK, 2013, DRUG DISCOV TODAY DI; Liu J, 2007, STEM CELLS, V25, P3038, DOI 10.1634/stemcells.2007-0549; Liu J, 2009, AM J PHYSIOL-CELL PH, V297, pC152, DOI 10.1152/ajpcell.00060.2009; Liu YQ, 2008, INVEST OPHTH VIS SCI, V49, P1843, DOI 10.1167/iovs.07-0789; Mio Y, 2008, ANESTHESIOLOGY, V108, P612, DOI 10.1097/ALN.0b013e318167af2d; Mummery C, 2002, J ANAT, V200, P233, DOI 10.1046/j.1469-7580.2002.00031.x; Pillekamp F, 2012, STEM CELLS DEV, V21, P2111, DOI 10.1089/scd.2011.0312; Poon E, 2011, MOL PHARMACEUT, V8, P1495, DOI 10.1021/mp2002363; Rust W, 2009, REGEN MED, V4, P225, DOI 10.2217/17460751.4.2.225; Sartiani L, 2007, STEM CELLS, V25, P1136, DOI 10.1634/stemcells.2006-0466; Satin J, 2004, J PHYSIOL-LONDON, V559, P479, DOI 10.1113/jphysiol.2004.068213; Satin J, 2008, STEM CELLS, V26, P1961, DOI 10.1634/stemcells.2007-0591; Severs NJ, 2008, CARDIOVASC RES, V80, P9, DOI 10.1093/cvr/cvn133; Singh MK, 2005, DEVELOPMENT, V132, P2697, DOI 10.1242/dev.01854; Sizarov A, 2011, CIRCULATION, V123, P1125, DOI 10.1161/CIRCULATIONAHA.110.980607; Snir M, 2003, AM J PHYSIOL-HEART C, V285, pH2355, DOI 10.1152/ajpheart.00020.2003; Synnergren J, 2011, PHYSL GENOMICS; Synnergren J, 2008, J BIOTECHNOL, V134, P162, DOI 10.1016/j.jbiotec.2007.11.011; Synnergren J, 2011, PHYSIOL GENOMICS, V43, P581, DOI 10.1152/physiolgenomics.00074.2010; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wang JX, 2013, BIOMATERIALS, V34, P8878, DOI 10.1016/j.biomaterials.2013.07.039; Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91; Xu XQ, 2009, STEM CELLS, V27, P2163, DOI 10.1002/stem.166; Xue T, 2005, CIRCULATION, V111, P11, DOI 10.1161/01.CIR.0000151313.18547.A2; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yoshida M, 2005, J BIOL CHEM, V280, P3500, DOI 10.1074/jbc.M406618200	55	32	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77784	10.1371/journal.pone.0077784	http://dx.doi.org/10.1371/journal.pone.0077784			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204964	Green Published, Green Submitted, gold			2022-12-27	WOS:000326032600048
J	Song, WJ; Morice, AH; Kim, MH; Lee, SE; Jo, EJ; Lee, SM; Han, JW; Kim, TH; Kim, SH; Jang, HC; Kim, KW; Cho, SH; Min, KU; Chang, YS				Song, Woo-Jung; Morice, Alyn H.; Kim, Min-Hye; Lee, Seung-Eun; Jo, Eun-Jung; Lee, Sang-Min; Han, Ji-Won; Kim, Tae Hui; Kim, Sae-Hoon; Jang, Hak-Chul; Kim, Ki Woong; Cho, Sang-Heon; Min, Kyung-Up; Chang, Yoon-Seok			Cough in the Elderly Population: Relationships with Multiple Comorbidity	PLOS ONE			English	Article							QUALITY-OF-LIFE; RESPIRATORY SYMPTOMS; PREVALENCE; CONSTIPATION; COMMUNITY; DIAGNOSIS; ASTHMA; MANAGEMENT; NEUROPATHY; THRESHOLD	Background: The epidemiology of cough in the elderly population has not been studied comprehensively. The present study aimed to investigate the epidemiology of cough in a community elderly population, particularly in relation with their comorbidity. Methods: A cross-sectional analysis was performed using a baseline dataset from the Korean Longitudinal Study on Health and Aging, a community-based elderly population cohort study. Three types of cough (frequent cough, chronic persistent cough, and nocturnal cough) were defined using questionnaires. Comorbidity was examined using a structured questionnaire. Health-related quality of life was assessed using the Short Form 36 questionnaire. Results: The prevalence was 9.3% for frequent cough, 4.6% for chronic persistent cough, and 7.3% for nocturnal cough. In multivariate logistic regression analyses, smoking, asthma and allergic rhinitis were found to be risk factors for cough in the elderly. Interestingly, among comorbidities, constipation and uncontrolled diabetes mellitus (HbA1c >= 8%) were also found to have positive associations with elderly cough. In the Short Form 36 scores, chronic persistent cough was independently related to impairment of quality of life, predominantly in the mental component. Conclusions: Cough has a high prevalence and is detrimental to quality of life in the elderly. Associations with smoking, asthma and rhinitis confirmed previous findings in younger populations. Previously unrecognised relationships with constipation and uncontrolled diabetes mellitus suggested the multi-faceted nature of cough in the elderly.	[Song, Woo-Jung; Kim, Min-Hye; Lee, Seung-Eun; Jo, Eun-Jung; Kim, Sae-Hoon; Cho, Sang-Heon; Min, Kyung-Up; Chang, Yoon-Seok] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Song, Woo-Jung; Kim, Min-Hye; Lee, Seung-Eun; Jo, Eun-Jung; Kim, Sae-Hoon; Cho, Sang-Heon; Min, Kyung-Up; Chang, Yoon-Seok] Seoul Natl Univ, Med Res Ctr, Inst Allergy & Clin Immunol, Seoul, South Korea; [Morice, Alyn H.] Univ Hull, Castle Hill Hosp, Hull York Med Sch, Cottingham, East Yorkshire, England; [Lee, Seung-Eun; Jo, Eun-Jung; Kim, Sae-Hoon; Jang, Hak-Chul; Chang, Yoon-Seok] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, Gyeonggi Do, South Korea; [Lee, Sang-Min] Gachon Univ, Gil Med Ctr, Dept Internal Med, Inchon, South Korea; [Han, Ji-Won; Kim, Tae Hui; Kim, Ki Woong] Seoul Natl Univ, Bundang Hosp, Dept Neuropsychiat, Songnam, Gyeonggi Do, South Korea; [Kim, Ki Woong] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); University of Hull; University of York - UK; Seoul National University (SNU); Gachon University; Seoul National University (SNU); Seoul National University (SNU)	Chang, YS (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.	addchang@snu.ac.kr	Jang, Hak Chul/D-9637-2012; Lee, Seung Eun/ABG-1607-2021; Kim, Ki Woong/D-5801-2012; Kim, Tae Hui/AAR-9213-2020; Chang, Yoon-Seok/J-5628-2012	Jang, Hak Chul/0000-0002-4188-6536; Lee, Seung Eun/0000-0002-4266-7722; Kim, Ki Woong/0000-0002-1103-3858; Chang, Yoon-Seok/0000-0003-3157-0447; Lee, Sang Min/0000-0002-9568-2096; Song, Woo-Jung/0000-0002-4630-9922; Kim, Tae Hui/0000-0003-0133-5227	Seongnam City Government in Republic of Korea [800-20050211]; Korean Health Technology R&D Project, Ministry for Health, Welfare, & Family Affairs, Republic of Korea [A092077]	Seongnam City Government in Republic of Korea; Korean Health Technology R&D Project, Ministry for Health, Welfare, & Family Affairs, Republic of Korea	This study was supported by the grant for Developing Seongnam Health Promotion Program for the Elderly from Seongnam City Government in Republic of Korea (Grant No. 800-20050211), and by the grant from the Korean Health Technology R&D Project, Ministry for Health, Welfare, & Family Affairs, Republic of Korea (grant no. A092077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Bair MJ, 2010, DIABETIC MED, V27, P578, DOI 10.1111/j.1464-5491.2010.02971.x; Bende M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00251; Birring SS, 2003, THORAX, V58, P339, DOI 10.1136/thorax.58.4.339; Birring SS, 2011, AM J RESP CRIT CARE, V183, P708, DOI 10.1164/rccm.201007-1017CI; Brutsche MH, 2006, THORAX, V61, P671, DOI 10.1136/thx.2005.052241; Canning BJ, 2006, RESP PHYSIOL NEUROBI, V152, P223, DOI 10.1016/j.resp.2006.03.001; Chung KF, 2011, PULM PHARMACOL THER, V24, P267, DOI 10.1016/j.pupt.2011.01.012; Chung KF, 2008, LANCET, V371, P1364, DOI 10.1016/S0140-6736(08)60595-4; Dicpinigaitis PV, 2012, LUNG, V190, P593, DOI 10.1007/s00408-012-9420-x; Faruqi S, 2011, RESPIROLOGY, V16, P1150, DOI 10.1111/j.1440-1843.2011.02014.x; Ford AC, 2006, THORAX, V61, P975, DOI 10.1136/thx.2006.060087; French CT, 2002, CHEST, V121, P1123, DOI 10.1378/chest.121.4.1123; Gallegos-Orozco JF, 2012, AM J GASTROENTEROL, V107, P18, DOI 10.1038/ajg.2011.349; Grassi M, 2011, NUTR HOSP, V26, P659, DOI [10.1590/S0212-16112011000400001, 10.3305/nh.2011.26.4.5109]; Hamdan AL, 2013, J VOICE, V27, P495, DOI 10.1016/j.jvoice.2012.07.010; Herbert M, 2013, DIABET MED IN PRESS; Irwin RS, 2006, CHEST, V129, p1S, DOI 10.1378/chest.129.1_suppl.1S; IRWIN RS, 1981, AM REV RESPIR DIS, V123, P413; Janson C, 2001, EUR RESPIR J, V18, P647, DOI 10.1183/09031936.01.00098701; Kagamimori S, 1996, CLIN EXP ALLERGY, V26, P262; Karur PS, 2012, EUR RESPIR REV, V21, P257, DOI 10.1183/09059180.00000212; Kinekawa F, 2001, AM J GASTROENTEROL, V96, P2026, DOI 10.1016/S0002-9270(01)02425-X; Kinekawa Fumihiko, 2004, Nihon Rinsho, V62, P1546; Kinsella K, 2009, INT POPULATION REPOR; LEE JH, 1992, PAIN, V50, P231, DOI 10.1016/0304-3959(92)90167-A; Liard R., 2000, EUR RESP MON, V5, P154; Lodefalk M, 2010, PEDIATR DIABETES, V11, P265, DOI 10.1111/j.1399-5448.2010.00664.x; Ludviksdottir D, 1996, CHEST, V109, P1262, DOI 10.1378/chest.109.5.1262; MANNING AP, 1978, BRIT MED J, V2, P653, DOI 10.1136/bmj.2.6138.653; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; Mirabelli MC, 2012, J OCCUP ENVIRON MED, V54, P157, DOI 10.1097/JOM.0b013e31823e3a52; Morice AH, 2011, LUNG, V189, P73, DOI 10.1007/s00408-010-9272-1; Morice AH, 2004, EUR RESPIR J, V24, P481, DOI 10.1183/09031936.04.00027804; Morice AH, 2004, PULM PHARMACOL THER, V17, P343, DOI 10.1016/j.pupt.2004.09.005; Morice AH, 2002, PULM PHARMACOL THER, V15, P253, DOI 10.1006/pupt.2002.0352; MORRIS JF, 1976, WESTERN J MED, V125, P110; Nam BH, 2003, J HLTH INFO STAT, V28, P3; Nellesen D, 2013, POSTGRAD MED, V125, DOI 10.3810/pgm.2013.03.2640; Park J. H., 2007, PSYCHIAT INVEST, V4, P84; Pratter MR, 2006, CHEST, V129, p59S, DOI 10.1378/chest.129.1_suppl.59S; Smit LAM, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-26; 성예나, 2009, [Korean Journal of Clinical Pharmacy, 한국임상약학회지], V19, P167; Varechova S, 2007, J PHYSIOL PHARMACOL, V58, P705; VIANNA LG, 1988, THORAX, V43, P569, DOI 10.1136/thx.43.7.569; Voll-Aanerud M, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-107; Wang XB, 2008, WORLD J GASTROENTERO, V14, P709, DOI 10.3748/wjg.14.709; Winge K, 2003, J NEUROL NEUROSUR PS, V74, P13, DOI 10.1136/jnnp.74.1.13; Yamanda Shinsuke, 2008, Cough, V4, P11, DOI 10.1186/1745-9974-4-11	49	41	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78081	10.1371/journal.pone.0078081	http://dx.doi.org/10.1371/journal.pone.0078081			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24205100	Green Published, gold, Green Submitted			2022-12-27	WOS:000326032600070
J	Bernardi, G; Ricciardi, E; Sani, L; Gaglianese, A; Papasogli, A; Ceccarelli, R; Franzoni, F; Galetta, F; Santoro, G; Goebel, R; Pietrini, P				Bernardi, Giulio; Ricciardi, Emiliano; Sani, Lorenzo; Gaglianese, Anna; Papasogli, Alessandra; Ceccarelli, Riccardo; Franzoni, Ferdinando; Galetta, Fabio; Santoro, Gino; Goebel, Rainer; Pietrini, Pietro			How Skill Expertise Shapes the Brain Functional Architecture: An fMRI Study of Visuo-Spatial and Motor Processing in Professional Racing-Car and Naive Drivers	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; HIGH-RESOLUTION EEG; AGE-RELATED-CHANGES; EFFECTIVE CONNECTIVITY; CORTICAL ACTIVITY; METHODOLOGICAL ISSUES; ALZHEIMERS-DISEASE; SIGNAL VARIABILITY; NEURAL EFFICIENCY; DEFAULT NETWORK	The present study was designed to investigate the brain functional architecture that subserves visuo-spatial and motor processing in highly skilled individuals. By using functional magnetic resonance imaging (fMRI), we measured brain activity while eleven Formula racing-car drivers and eleven naive' volunteers performed a motor reaction and a visuo-spatial task. Tasks were set at a relatively low level of difficulty such to ensure a similar performance in the two groups and thus avoid any potential confounding effects on brain activity due to discrepancies in task execution. The brain functional organization was analyzed in terms of regional brain response, inter-regional interactions and blood oxygen level dependent (BOLD) signal variability. While performance levels were equal in the two groups, as compared to nave drivers, professional drivers showed a smaller volume recruitment of task-related regions, stronger connections among task-related areas, and an increased information integration as reflected by a higher signal temporal variability. In conclusion, our results demonstrate that, as compared to nave subjects, the brain functional architecture sustaining visuo-motor processing in professional racing-car drivers, trained to perform at the highest levels under extremely demanding conditions, undergoes both 'quantitative' and 'qualitative' modifications that are evident even when the brain is engaged in relatively simple, non-demanding tasks. These results provide novel evidence in favor of an increased 'neural efficiency' in the brain of highly skilled individuals.	[Bernardi, Giulio; Ricciardi, Emiliano; Sani, Lorenzo; Gaglianese, Anna; Pietrini, Pietro] Univ Pisa, Lab Clin Biochem & Mol Biol, Pisa, Italy; [Bernardi, Giulio; Pietrini, Pietro] Univ Pisa, Clin Psychol Branch, AOUP Santa Chiara, Pisa, Italy; [Ricciardi, Emiliano] Fdn Reg Toscana CNR G Monasterio, MRI Lab, Pisa, Italy; [Papasogli, Alessandra; Ceccarelli, Riccardo] Formula Med, Viareggio, Italy; [Franzoni, Ferdinando; Galetta, Fabio; Santoro, Gino] Univ Pisa, Dept Clin & Sperimental Med, Sport Med Unit, AOUP Santa Chiara, Pisa, Italy; [Goebel, Rainer] Univ Maastricht, Maastricht Brain Imaging Ctr, Maastricht, Netherlands	University of Pisa; University of Pisa; University of Pisa; Maastricht University	Pietrini, P (corresponding author), Univ Pisa, Lab Clin Biochem & Mol Biol, Pisa, Italy.	pietro.pietrini@med.unipi.it	Bernardi, Giulio/B-1452-2012; Pietrini, Pietro/Z-4202-2019; Franzoni, Ferdinando/AAC-2220-2019; Ricciardi, Emiliano/E-6929-2011; Gaglianese, Anna/AAS-2372-2020	Bernardi, Giulio/0000-0003-4045-7075; Franzoni, Ferdinando/0000-0003-2132-8788; Ricciardi, Emiliano/0000-0002-7178-9534; Gaglianese, Anna/0000-0002-3660-8654; Goebel, Rainer/0000-0003-1780-2467	Fondazione Cassa di Risparmio di Lucca (Lucca, Italy)	Fondazione Cassa di Risparmio di Lucca (Lucca, Italy)	This study was supported in part by a grant from the Fondazione Cassa di Risparmio di Lucca (Lucca, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abreu AM, 2012, EUR J NEUROSCI, V35, P1646, DOI 10.1111/j.1460-9568.2012.08104.x; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Baumeister J, 2008, EUR J APPL PHYSIOL, V104, P625, DOI 10.1007/s00421-008-0811-x; Bischof HJ, 2007, NEUROREPORT, V18, P461, DOI 10.1097/WNR.0b013e328014204e; Boehler CN, 2010, NEUROIMAGE, V52, P1621, DOI 10.1016/j.neuroimage.2010.04.276; Brancucci A, 2012, J NEUROSCI RES, V90, P1299, DOI 10.1002/jnr.23045; Buchel C, 1999, SCIENCE, V283, P1538, DOI 10.1126/science.283.5407.1538; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Calhoun VD, 2002, HUM BRAIN MAPP, V16, P158, DOI 10.1002/hbm.10032; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Chang Y, 2011, NMR BIOMED, V24, P366, DOI 10.1002/nbm.1600; Chein JM, 2005, COGNITIVE BRAIN RES, V25, P607, DOI 10.1016/j.cogbrainres.2005.08.013; Chen G, 2012, NEUROIMAGE, V60, P747, DOI 10.1016/j.neuroimage.2011.12.060; Chen G, 2011, COMPUT BIOL MED, V41, P1142, DOI 10.1016/j.compbiomed.2011.09.004; Chikazoe J, 2010, CURR OPIN PSYCHIATR, V23, P267, DOI 10.1097/YCO.0b013e3283387a9f; Chuah YML, 2006, J NEUROSCI, V26, P7156, DOI 10.1523/JNEUROSCI.0906-06.2006; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Del Percio C, 2011, NEUROSCIENCE, V175, P198, DOI 10.1016/j.neuroscience.2010.11.031; Del Percio C, 2008, NEUROIMAGE, V42, P1544, DOI 10.1016/j.neuroimage.2008.05.061; Del Percio C, 2010, CLIN NEUROPHYSIOL, V121, P482, DOI 10.1016/j.clinph.2009.12.004; Del Percio C, 2009, HUM BRAIN MAPP, V30, P3527, DOI 10.1002/hbm.20776; Deshpande G, 2009, HUM BRAIN MAPP, V30, P1361, DOI 10.1002/hbm.20606; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Freo U, 2005, AM J PSYCHIAT, V162, P2061, DOI 10.1176/appi.ajp.162.11.2061; Friston K, 2012, NEUROIMAGE, V61, P1300, DOI 10.1016/j.neuroimage.2012.04.018; Garrett DD, 2013, NEUROSCI BIOBEHAV R, V37, P610, DOI 10.1016/j.neubiorev.2013.02.015; Garrett DD, 2011, J NEUROSCI, V31, P4496, DOI 10.1523/JNEUROSCI.5641-10.2011; Garrett DD, 2010, J NEUROSCI, V30, P4914, DOI 10.1523/JNEUROSCI.5166-09.2010; Ghosh A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000196; Gobel EW, 2011, NEUROIMAGE, V58, P1150, DOI 10.1016/j.neuroimage.2011.06.090; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; Goh JOS, 2011, AGING DIS, V2, P30; Grady CL, 2008, ANN NY ACAD SCI, V1124, P127, DOI 10.1196/annals.1440.009; Grady CL, 2010, CEREB CORTEX, V20, P1432, DOI 10.1093/cercor/bhp207; GRADY CL, 1994, J NEUROSCI, V14, P1450, DOI 10.1523/JNEUROSCI.14-03-01450.1994; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; HAIER RJ, 1988, INTELLIGENCE, V12, P199, DOI 10.1016/0160-2896(88)90016-5; HAIER RJ, 1992, BRAIN RES, V570, P134, DOI 10.1016/0006-8993(92)90573-R; Hamilton JP, 2011, MOL PSYCHIATR, V16, P763, DOI 10.1038/mp.2010.46; Han SD, 2009, DEMENT GERIATR COGN, V27, P1, DOI 10.1159/000182420; Haslinger B, 2004, HUM BRAIN MAPP, V22, P206, DOI 10.1002/hbm.20028; Heitger MH, 2012, NEUROIMAGE, V61, P633, DOI 10.1016/j.neuroimage.2012.03.067; Jancke L, 2000, COGNITIVE BRAIN RES, V10, P177, DOI 10.1016/S0926-6410(00)00028-8; Jeong M, 2006, ANN NUCL MED, V20, P623, DOI 10.1007/BF02984660; Kelly AMC, 2005, CEREB CORTEX, V15, P1089, DOI 10.1093/cercor/bhi005; Kim YT, 2011, BEHAV BRAIN RES, V223, P342, DOI 10.1016/j.bbr.2011.04.053; Koeneke S, 2004, NEUROREPORT, V15, P1279, DOI 10.1097/01.wnr.0000127463.10147.e7; Krings T, 2000, NEUROSCI LETT, V278, P189, DOI 10.1016/S0304-3940(99)00930-1; Leo A, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/720278; Lipp I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051316; Luo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036568; Lustig C, 2009, NEUROPSYCHOL REV, V19, P504, DOI 10.1007/s11065-009-9119-9; Ma LS, 2010, BRAIN RES, V1318, P64, DOI 10.1016/j.brainres.2009.12.073; Mattay VS, 2002, NEUROLOGY, V58, P630, DOI 10.1212/WNL.58.4.630; McIntosh AR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000106; Meister I, 2005, HUM BRAIN MAPP, V25, P345, DOI 10.1002/hbm.20112; Milton J, 2008, METHODS, V45, P336, DOI 10.1016/j.ymeth.2008.05.002; Milton J, 2007, NEUROIMAGE, V35, P804, DOI 10.1016/j.neuroimage.2007.01.003; Mohr PNC, 2010, J NEUROSCI, V30, P7755, DOI 10.1523/JNEUROSCI.1560-10.2010; Nakata H, 2010, BRAIN RES REV, V62, P197, DOI 10.1016/j.brainresrev.2009.11.006; Neubauer AC, 2009, NEUROSCI BIOBEHAV R, V33, P1004, DOI 10.1016/j.neubiorev.2009.04.001; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Papadelis C, 2007, CLIN NEUROPHYSIOL, V118, P1906, DOI 10.1016/j.clinph.2007.04.031; Patel R, 2013, NEUROREHAB NEURAL RE, V27, P187, DOI 10.1177/1545968312461718; Pietrini P, 2000, INT J PSYCHOPHYSIOL, V37, P87, DOI 10.1016/S0167-8760(00)00097-0; Poldrack RA, 2000, NEUROIMAGE, V12, P1, DOI 10.1006/nimg.2000.0596; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reithler J, 2010, NEUROIMAGE, V52, P263, DOI 10.1016/j.neuroimage.2010.03.073; Ricciardi E, 2013, NEUROPHARMACOLOGY, V64, P305, DOI 10.1016/j.neuropharm.2012.07.003; Ross JS, 2003, AM J NEURORADIOL, V24, P1036; Rypma B, 2006, NEUROIMAGE, V33, P969, DOI 10.1016/j.neuroimage.2006.05.065; Rypma B, 2009, INTELLIGENCE, V37, P207, DOI 10.1016/j.intell.2008.12.004; Seo J, 2012, BEHAV BRAIN RES, V229, P185, DOI 10.1016/j.bbr.2012.01.019; Spiers HJ, 2007, NEUROIMAGE, V36, P245, DOI 10.1016/j.neuroimage.2007.02.032; Sun FT, 2007, CEREB CORTEX, V17, P1227, DOI 10.1093/cercor/bhl033; Talairach J., 1988, COPLANAR STEREOTAXIC; Taubert M, 2011, NEUROIMAGE, V57, P1492, DOI 10.1016/j.neuroimage.2011.05.078; Toni I, 2002, CEREB CORTEX, V12, P1040, DOI 10.1093/cercor/12.10.1040; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Uchiyama Y, 2003, NEUROSCI LETT, V352, P199, DOI 10.1016/j.neulet.2003.08.072; Valdes-Sosa PA, 2011, NEUROIMAGE, V58, P339, DOI 10.1016/j.neuroimage.2011.03.058; von Neumann J, 1941, ANN MATH STAT, V12, P153, DOI 10.1214/aoms/1177731746; Wei GX, 2010, BRAIN RES, V1341, P52, DOI 10.1016/j.brainres.2009.08.014; Wu T, 2008, J PHYSIOL-LONDON, V586, P4295, DOI 10.1113/jphysiol.2008.153445; Yarrow K, 2009, NAT REV NEUROSCI, V10, P585, DOI 10.1038/nrn2672	87	46	46	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77764	10.1371/journal.pone.0077764	http://dx.doi.org/10.1371/journal.pone.0077764			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204955	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000326029300113
J	Foucreau, N; Piscart, C; Puijalon, S; Hervant, F				Foucreau, Natacha; Piscart, Christophe; Puijalon, Sara; Hervant, Frederic			Effect of Climate-Related Change in Vegetation on Leaf Litter Consumption and Energy Storage by Gammarus pulex from Continental or Mediterranean Populations	PLOS ONE			English	Article							EUCALYPTUS-GLOBULUS; STREAM ECOSYSTEMS; TROPICAL STREAMS; SUMMER DROUGHT; CHANGE IMPACTS; GAS-EXCHANGE; DECOMPOSITION; GROWTH; RIVER; PHYSIOLOGY	As a consequence of global warming, it is important to characterise the potential changes occurring for some functional processes through the intra-specific study of key species. Changes in species distribution, particularly when key or engineer species are affected, should contribute to global changes in ecosystem functioning. In this study, we examined the potential consequences induced by global warming on ecosystem functioning in term of organic matter recycling. We compared consumption of leaf litter by some shredder populations (Gammarus pulex) between five tree species inhabiting continental (i.e., the northern region of the Rhone River Valley) and/or Mediterranean (i.e., the southern region of the Rhone River Valley) conditions. To consider any potential adaptation of the gammarid population to vegetation in the same climate conditions, three populations of the key shredder Gammarus pulex from the northern region and three from the southern region of the Rhone River Valley were used. We experimentally compared the effects of the geographical origin of both the gammarid populations and the leaf litter species on the shredding activity and the physiological state of animals (through body triglyceride content). This study demonstrated that leaf toughness is more important than geographical origin for determining shredder leaf litter consumption. The overall consumption rate of the gammarid populations from the southern region of Rhone Valley was much higher than that of the populations from the northern region, but no clear differences between the origins of the leaf litter (i.e., continental vs. Mediterranean) were observed. The northwards shift of G. pulex populations adapted to warmer conditions might significantly modify organic matter recycling in continental streams. As gammarid populations can demonstrate local adaptations to certain leaf species as a trophic resource, changes in riparian vegetation associated with climate change might locally affect the leaf litter degradation process by this shredder.	[Foucreau, Natacha; Piscart, Christophe; Puijalon, Sara; Hervant, Frederic] Univ Lyon 1, CNRS, ENTPE, UMR Ecol Hydrosyst Nat & Anthropises 5023, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Foucreau, N (corresponding author), Univ Lyon 1, CNRS, ENTPE, UMR Ecol Hydrosyst Nat & Anthropises 5023, F-69622 Villeurbanne, France.	natacha.foucreau@univ-lyon1.fr	Piscart, christophe/AAD-8973-2019; Puijalon, Sara/ABA-6520-2020	Piscart, christophe/0000-0002-4054-4542; Puijalon, Sara/0000-0002-1942-7958	National Research Agency - Agence Nationale de la Recherche - ANR [ANR-09-CEP-006-01]	National Research Agency - Agence Nationale de la Recherche - ANR(French National Research Agency (ANR))	The national research agency for funds (program Wetchange ANR-09-CEP-006-01 of the National Research Agency - Agence Nationale de la Recherche - ANR) http://www.agence-nationale-recherche.fr/en/project-based-funding-to-advance-french-research/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelho M, 2008, INT REV HYDROBIOL, V93, P358, DOI 10.1002/iroh.200711019; BARLOCHE.F, 1973, OIKOS, V24, P295, DOI 10.2307/3543888; Becker J, 2013, FRESHWATER BIOL, V58, P372, DOI 10.1111/fwb.12065; Boyero L, 2011, ECOL LETT, V14, P289, DOI 10.1111/j.1461-0248.2010.01578.x; Canhoto C, 1996, HYDROBIOLOGIA, V333, P79, DOI 10.1007/BF00017570; Canhoto C, 1999, MICROBIAL ECOL, V37, P163, DOI 10.1007/s002489900140; Cheaib A, 2012, ECOL LETT, V15, P533, DOI 10.1111/j.1461-0248.2012.01764.x; Clarke A, 2004, FUNCT ECOL, V18, P252, DOI 10.1111/j.0269-8463.2004.00842.x; CLARKE A, 1985, MAR BIOL, V88, P247, DOI 10.1007/BF00392587; Clemens HP, 1950, SAY CONTR STONE LAB, V12; Costa FO, 1999, ACTA OECOL, V20, P305, DOI 10.1016/S1146-609X(99)00136-8; Costa GC, 2008, J BIOGEOGR, V35, P637, DOI 10.1111/j.1365-2699.2007.01809.x; Cottin D, 2012, NATURWISSENSCHAFTEN, V99, P259, DOI 10.1007/s00114-012-0894-4; CUMMINS KW, 1974, BIOSCIENCE, V24, P631, DOI 10.2307/1296676; Daufresne M, 2004, GLOBAL CHANGE BIOL, V10, P124, DOI 10.1046/j.1529-8817.2003.00720.x; De Micco V, 2008, TREES-STRUCT FUNCT, V22, P643, DOI 10.1007/s00468-008-0222-y; Dehedin A, 2013, GLOBAL CHANGE BIOL, V19, P763, DOI 10.1111/gcb.12084; DELONG MD, 1993, CAN J FISH AQUAT SCI, V50, P1891, DOI 10.1139/f93-211; di Lascio A, 2011, FUND APPL LIMNOL, V179, P193, DOI 10.1127/1863-9135/2011/0179-0193; GALLARDO A, 1993, ECOLOGY, V74, P152, DOI 10.2307/1939510; GESSNER MO, 1994, ECOLOGY, V75, P1807, DOI 10.2307/1939639; Graca MAS, 2001, FRESHWATER BIOL, V46, P947, DOI 10.1046/j.1365-2427.2001.00729.x; Gulis V, 2006, FRESHWATER BIOL, V51, P1655, DOI 10.1111/j.1365-2427.2006.01615.x; Hervant F, 2002, J EXP BIOL, V205, P2079; Hervant F, 1999, J EXP BIOL, V202, P3587; IPCC, 2007, CONTRIBUTION WORKING; Koop JHE, 2008, LIMNOLOGICA, V38, P378, DOI 10.1016/j.limno.2008.05.004; Kramer K, 2008, FOREST ECOL MANAG, V255, P3893, DOI 10.1016/j.foreco.2008.03.044; Lecerf A, 2005, OECOLOGIA, V146, P432, DOI 10.1007/s00442-005-0212-3; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Logan CA, 2012, MAR ECOL PROG SER, V450, P93, DOI 10.3354/meps09491; Maazouzi C, 2009, FUND APPL LIMNOL, V175, P327, DOI 10.1127/1863-9135/2009/0175-0327; Menendez M, 2012, HYDROBIOLOGIA, V691, P135, DOI 10.1007/s10750-012-1064-6; Moretti M, 2007, LIMNOLOGICA, V37, P250, DOI 10.1016/j.limno.2007.01.003; Moser B, 2011, J ECOL, V99, P1229, DOI 10.1111/j.1365-2745.2011.01841.x; Onoda Y, 2011, ECOL LETT, V14, P301, DOI 10.1111/j.1461-0248.2010.01582.x; Ostrofsky ML, 1997, J N AM BENTHOL SOC, V16, P750, DOI 10.2307/1468168; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pinkster S., 1972, BIJDR DIERK, V42, P165; Pinna M, 2004, INT REV HYDROBIOL, V89, P484, DOI 10.1002/iroh.200410765; Piscart C, 2011, BIOL INVASIONS, V13, P2861, DOI 10.1007/s10530-011-9969-y; Piscart C, 2011, FRESHWATER BIOL, V56, P325, DOI 10.1111/j.1365-2427.2010.02500.x; Piscart C, 2009, ENVIRON POLLUT, V157, P1011, DOI 10.1016/j.envpol.2008.10.010; Portner HO, 2005, SCI MAR, V69, P271; Rigling A, 2013, GLOBAL CHANGE BIOL, V19, P229, DOI 10.1111/gcb.12038; Rosset V, 2011, BIOL CONSERV, V144, P2311, DOI 10.1016/j.biocon.2011.06.009; Roth-Nebelsick A, 2013, PLANT CELL ENVIRON, V36, P579, DOI 10.1111/j.1365-3040.2012.02597.x; Seibel BA, 2007, PHILOS T R SOC B, V362, P2061, DOI 10.1098/rstb.2007.2101; Seibel BA, 2007, J EXP BIOL, V210, P1, DOI 10.1242/jeb.02588; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Somero GN, 2012, ANNU REV MAR SCI, V4, P39, DOI 10.1146/annurev-marine-120710-100935; Stillman JH, 2000, PHYSIOL BIOCHEM ZOOL, V73, P200, DOI 10.1086/316738; Sutcliffe D.W., 1993, Freshwater Forum, V3, P26; Torres-Ruiz M, 2010, HYDROBIOLOGIA, V651, P265, DOI 10.1007/s10750-010-0305-9; Traill LW, 2010, J ANIM ECOL, V79, P937, DOI 10.1111/j.1365-2656.2010.01695.x; Van der Putten WH, 2012, ANNU REV ECOL EVOL S, V43, P365, DOI 10.1146/annurev-ecolsys-110411-160423; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Warren CR, 2007, OECOLOGIA, V154, P1, DOI 10.1007/s00442-007-0803-2; Wesolowski T, 2006, FOREST ECOL MANAG, V237, P387, DOI 10.1016/j.foreco.2006.09.061; Whiteley NM, 2011, J EXP MAR BIOL ECOL, V400, P70, DOI 10.1016/j.jembe.2011.02.027; WILLOUGHBY LG, 1976, FRESHWATER BIOL, V6, P577, DOI 10.1111/j.1365-2427.1976.tb01647.x; Winder M, 2004, ECOLOGY, V85, P2100, DOI 10.1890/04-0151	63	14	14	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77242	10.1371/journal.pone.0077242	http://dx.doi.org/10.1371/journal.pone.0077242			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204778	Green Published, gold, Green Submitted			2022-12-27	WOS:000326029300092
J	Kus, R; Duszyk, A; Milanowski, P; Labecki, M; Bierzynska, M; Radzikowska, Z; Michalska, M; Zygierewicz, J; Suffczynski, P; Durka, PJ				Kus, Rafal; Duszyk, Anna; Milanowski, Piotr; Labecki, Maciej; Bierzynska, Maria; Radzikowska, Zofia; Michalska, Magdalena; Zygierewicz, Jaroslaw; Suffczynski, Piotr; Durka, Piotr Jerzy			On the Quantification of SSVEP Frequency Responses in Human EEG in Realistic BCI Conditions	PLOS ONE			English	Article								This article concerns one of the most important problems of brain-computer interfaces (BCI) based on Steady State Visual Evoked Potentials (SSVEP), that is the selection of the a-priori most suitable frequencies for stimulation. Previous works related to this problem were done either with measuring systems that have little in common with actual BCI systems (e. g., single flashing LED) or were presented on a small number of subjects, or the tested frequency range did not cover a broad spectrum. Their results indicate a strong SSVEP response around 10 Hz, in the range 13-25 Hz, and at high frequencies in the band of 40-60 Hz. In the case of BCI interfaces, stimulation with frequencies from various ranges are used. The frequencies are often adapted for each user separately. The selection of these frequencies, however, was not yet justified in quantitative group-level study with proper statistical account for inter-subject variability. The aim of this study is to determine the SSVEP response curve, that is, the magnitude of the evoked signal as a function of frequency. The SSVEP response was induced in conditions as close as possible to the actual BCI system, using a wide range of frequencies (5-30 Hz, in step of 1 Hz). The data were obtained for 10 subjects. SSVEP curves for individual subjects and the population curve was determined. Statistical analysis were conducted both on the level of individual subjects and for the group. The main result of the study is the identification of the optimal range of frequencies, which is 12-18 Hz, for the registration of SSVEP phenomena. The applied criterion of optimality was: to find the largest contiguous range of frequencies yielding the strong and constant-level SSVEP response.	[Kus, Rafal; Milanowski, Piotr; Labecki, Maciej; Michalska, Magdalena; Zygierewicz, Jaroslaw; Suffczynski, Piotr; Durka, Piotr Jerzy] Univ Warsaw, Fac Phys, Warsaw, Poland; [Duszyk, Anna; Radzikowska, Zofia] Univ Social Sci & Humanities, Dept Psychol, Warsaw, Poland; [Bierzynska, Maria] M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, PL-02093 Warsaw, Poland	University of Warsaw; SWPS University of Social Sciences & Humanities; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Kus, R (corresponding author), Univ Warsaw, Fac Phys, Warsaw, Poland.	rkus@fuw.edu.pl	Suffczynski, Piotr/ABG-5183-2020	Duszyk, Anna/0000-0002-5984-2339; Zygierewicz, Jaroslaw/0000-0002-7536-0735; Durka, Piotr/0000-0001-5816-8082; Suffczynski, Piotr/0000-0002-2300-1415	Ventures Programme of Foundation for Polish Science operated within the Innovative Economy Operational Programme (IE OP) within European Regional Development Fund; Polish funds for science	Ventures Programme of Foundation for Polish Science operated within the Innovative Economy Operational Programme (IE OP) within European Regional Development Fund; Polish funds for science	The work was partially supported by the Ventures Programme of Foundation for Polish Science operated within the Innovative Economy Operational Programme (IE OP) 2007-2013 within European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The additional part of the funding was from Polish funds for science.	Bakardjian H, 2010, NEUROSCI LETT, V469, P34, DOI 10.1016/j.neulet.2009.11.039; Benjamini Y, 2001, ANN STAT, V29, P1165; Brunner C, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025010; Cecotti H, 2010, IEEE T NEUR SYS REH, V18, P127, DOI 10.1109/TNSRE.2009.2039594; Durka PJ, 2012, B POL ACAD SCI-TECH, V60, P427, DOI 10.2478/v10175-012-0054-1; Fuchs S, 2008, NEUROIMAGE, V41, P1086, DOI 10.1016/j.neuroimage.2008.02.040; Fukunaga K., 2013, INTRO STAT PATTERN R; Herrmann CS, 2001, EXP BRAIN RES, V137, P346, DOI 10.1007/s002210100682; Hwang HJ, 2012, J NEUROSCI METH, V208, P59, DOI 10.1016/j.jneumeth.2012.04.011; Kaashoek I, 2008, TECHNICAL REPORT; KOLES Z J, 1990, Brain Topography, V2, P275, DOI 10.1007/BF01129656; KOLES ZJ, 1991, ELECTROEN CLIN NEURO, V79, P440, DOI 10.1016/0013-4694(91)90163-X; KOLES ZJ, 1994, ELECTROEN CLIN NEURO, V91, P319, DOI 10.1016/0013-4694(94)90119-8; KOLES ZJ, 1995, ELECTROEN CLIN NEURO, V95, P219, DOI 10.1016/0013-4694(95)00083-B; Lin ZL, 2007, IEEE T BIO-MED ENG, V54, P1172, DOI 10.1109/TBME.2006.889197; Lopez-Gordo MA, 2011, CLIN NEUROPHYSIOL, V122, P128, DOI 10.1016/j.clinph.2010.05.021; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Molina GM, 2010, 18 EUR SIGN P C EUSI; Muller-Putz GR, 2005, J NEURAL ENG, V2, P123, DOI 10.1088/1741-2560/2/4/008; Ng K, 2011, ENG MED BIOL SOC EMB; Ng KB, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036008; Niedermeyer E., 2011, NIEDERMEYERS ELECTRO, V6; Pastor MA, 2003, J NEUROSCI, V23, P11621; REGAN D, 1968, ELECTROEN CLIN NEURO, V25, P231, DOI 10.1016/0013-4694(68)90020-5; REGAN D, 1975, NATURE, V253, P401, DOI 10.1038/253401a0; Volosyak I, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036020; Wang Y, 2005, 1 INT C NEUR INT CON; Wang Y, 2006, IEEE T NEUR SYS REH, V14, P234, DOI 10.1109/TNSRE.2006.875576	28	68	68	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77536	10.1371/journal.pone.0077536	http://dx.doi.org/10.1371/journal.pone.0077536			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204862	Green Published, Green Submitted, gold			2022-12-27	WOS:000326029300102
J	Wei, SQ; Moon, HG; Zheng, YJ; Liang, XL; An, CH; Jin, Y				Wei, Shuquan; Moon, Hyung-Geun; Zheng, Yijie; Liang, Xiaoliang; An, Chang Hyeok; Jin, Yang			Flotillin-2 Modulates Fas Signaling Mediated Apoptosis after Hyperoxia in Lung Epithelial Cells	PLOS ONE			English	Article							DEATH DOMAIN; LIPID RAFTS; CAVEOLIN-1; PROTEIN; ACTIVATION; EXPRESSION; INTERACTS; RECEPTOR; PATHWAY; STRESS	Lipid rafts are subdomains of the cell membrane with distinct protein composition and high concentrations of cholesterol and glycosphingolipids. Raft proteins are thought to mediate diverse cellular processes including signal transduction. However, its cellular mechanisms remain unclear. Caveolin-1 (cav-1, marker protein of caveolae) has been thought as a switchboard between extracellular matrix (ECM) stimuli and intracellular signals. Flotillin-2/reggie-1(Flot-2) is another ubiquitously expressed raft protein which defines non-caveolar raft microdomains (planar raft). Its cellular function is largely uncharacterized. Our novel studies demonstrated that Flot-2, in conjunction with cav-1, played important functions on controlling cell death via regulating Fas pathways. Using Beas2B epithelial cells, we found that in contrast to cav-1, Flot-2 conferred cytoprotection via preventing Fas mediated death-inducing signaling complex (DISC) formation, subsequently suppressed caspase-8 mediated extrinsic apoptosis. Moreover, Flot-2 reduced the mitochondria mediated intrinsic apoptosis by regulating the Bcl-2 family and suppressing cytochrome C release from mitochondria to cytosol. Flot-2 further modulated the common apoptosis pathway and inhibited caspase-3 activation via up-regulating the members in the inhibitor of apoptosis (IAP) family. Last, Flot-2 interacted with cav-1 and limited its expression. Taken together, we found that Flot-2 protected cells from Fas induced apoptosis and counterbalanced the pro-apoptotic effects of cav-1. Thus, Flot-2 played crucial functions in cellular homeostasis and cell survival, suggesting a differential role of individual raft proteins.	[Wei, Shuquan; Moon, Hyung-Geun; Zheng, Yijie; Liang, Xiaoliang; An, Chang Hyeok; Jin, Yang] Harvard Univ, Brigham & Womens Hosp, Div Pulm & Crit Care, Dept Med,Med Sch, Boston, MA 02115 USA; [Wei, Shuquan] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Guangzhou, Guangdong, Peoples R China	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Guangzhou Medical University	Jin, Y (corresponding author), Harvard Univ, Brigham & Womens Hosp, Div Pulm & Crit Care, Dept Med,Med Sch, Boston, MA 02115 USA.	yjin@rics.bwh.harvard.edu		An, Chang Hyeok/0000-0001-9145-1322	National Institutes of Health (NIH) [R01 HL102076]; Flight Attendant Medical Research Institute (FAMRI) CIA grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102076] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute (FAMRI) CIA grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (NIH) R01 HL102076 (Y.J.) and Flight Attendant Medical Research Institute (FAMRI) CIA grant (http://www.famri.org/researchers/current_and_upcoming_awards.html) (Y.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algeciras-Schimnich A, 2003, P NATL ACAD SCI USA, V100, P11445, DOI 10.1073/pnas.2034995100; Aoki T, 1999, EXP CELL RES, V253, P629, DOI 10.1006/excr.1999.4652; Barnhart BC, 2003, SEMIN IMMUNOL, V15, P185, DOI 10.1016/S1044-5323(03)00031-9; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Budinger GRS, 2011, AM J RESP CRIT CARE, V183, P1043, DOI 10.1164/rccm.201002-0181OC; Camhi S L, 1995, New Horiz, V3, P170; Cande C, 2002, BIOCHIMIE, V84, P215, DOI 10.1016/S0300-9084(02)01374-3; Chen ZH, 2010, P NATL ACAD SCI USA, V107, P18880, DOI 10.1073/pnas.1005574107; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Denecker G, 2001, CELL MOL LIFE SCI, V58, P356, DOI 10.1007/PL00000863; Ding Y, 2005, PROTEIN EXPRES PURIF, V42, P137, DOI 10.1016/j.pep.2005.03.001; Eguchi Y, 1997, CANCER RES, V57, P1835; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Eramo A, 2004, EUR J IMMUNOL, V34, P1930, DOI 10.1002/eji.200324786; Fernow I, 2007, EUR J CELL BIOL, V86, P345, DOI 10.1016/j.ejcb.2007.03.004; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Gajate C, 2001, BLOOD, V98, P3860, DOI 10.1182/blood.V98.13.3860; Gajate C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005044; Guo YH, 2009, BLOOD, V113, P4431, DOI 10.1182/blood-2008-07-169433; Langhorst MF, 2008, EUR J CELL BIOL, V87, P211, DOI 10.1016/j.ejcb.2007.12.001; Lee PJ, 2003, FREE RADICAL BIO MED, V35, P341, DOI 10.1016/S0891-5849(03)00279-X; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Lemaire C, 1998, FEBS LETT, V425, P266, DOI 10.1016/S0014-5793(98)00252-X; Li WP, 2001, J CELL SCI, V114, P1397; Li-Weber M, 2003, SEMIN IMMUNOL, V15, P145, DOI 10.1016/S1044-5323(03)00030-7; Matsumura H, 2000, J CELL BIOL, V151, P1247, DOI 10.1083/jcb.151.6.1247; Mollinedo F, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.41; Morrow IC, 2002, J BIOL CHEM, V277, P48834, DOI 10.1074/jbc.M209082200; Newman GR, 1999, CELL TISSUE RES, V295, P111, DOI 10.1007/s004410051217; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Park EK, 2009, J PATHOL, V218, P337, DOI 10.1002/path.2531; Pavlides S, 2010, CELL CYCLE, V9, P2201, DOI 10.4161/cc.9.11.11848; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Rajalingam K, 2007, APOPTOSIS, V12, P1503, DOI 10.1007/s10495-007-0067-7; Rajendran L, 2007, BIOL CHEM, V388, P307, DOI 10.1515/BC.2007.034; Saelens X, 2004, ONCOGENE, V23, P2861, DOI 10.1038/sj.onc.1207523; Siegel RM, 2000, NAT IMMUNOL, V1, P469, DOI 10.1038/82712; Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919; Volonte D, 2008, AM J PHYSIOL-HEART C, V294, pH392, DOI 10.1152/ajpheart.01039.2007; Wang X, 2003, J BIOL CHEM, V278, P29184, DOI 10.1074/jbc.M301624200; Wang XQ, 2006, J INVEST DERMATOL, V126, P951, DOI 10.1038/sj.jid.5700282; WYLLIE AH, 1986, HISTOPATHOLOGY, V10, P995; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Yang YL, 2000, CELL RES, V10, P169, DOI 10.1038/sj.cr.7290046; Yerbes R, 2011, BBA-MOL CELL RES, V1813, P168, DOI 10.1016/j.bbamcr.2010.10.003; Zhang M, 2011, FREE RADICAL BIO MED, V50, P1252, DOI 10.1016/j.freeradbiomed.2011.02.031; Zhang M, 2009, AM J PHYSIOL-LUNG C, V297, pL945, DOI 10.1152/ajplung.00081.2009; Zhao F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-479; Zhao XX, 2009, BIOCHEM BIOPH RES CO, V378, P21, DOI 10.1016/j.bbrc.2008.10.123; Zhu XD, 2011, J BIOL CHEM, V286, P8231, DOI 10.1074/jbc.M110.145888	50	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77519	10.1371/journal.pone.0077519	http://dx.doi.org/10.1371/journal.pone.0077519			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204853	Green Published, Green Submitted, gold			2022-12-27	WOS:000326029300101
J	Zhao, HY; Casillas, E; Shroff, H; Patterson, GH; Schuck, P				Zhao, Huaying; Casillas, Ernesto, Jr.; Shroff, Hari; Patterson, George H.; Schuck, Peter			Tools for the Quantitative Analysis of Sedimentation Boundaries Detected by Fluorescence Optical Analytical Ultracentrifugation	PLOS ONE			English	Article							PROTEIN	Fluorescence optical detection in sedimentation velocity analytical ultracentrifugation allows the study of macromolecules at nanomolar concentrations and below. This has significant promise, for example, for the study of systems of high-affinity protein interactions. Here we describe adaptations of the direct boundary modeling analysis approach implemented in the software SEDFIT that were developed to accommodate unique characteristics of the confocal fluorescence detection system. These include spatial gradients of signal intensity due to scanner movements out of the plane of rotation, temporal intensity drifts due to instability of the laser and fluorophores, and masking of the finite excitation and detection cone by the sample holder. In an extensive series of experiments with enhanced green fluorescent protein ranging from low nanomolar to low micromolar concentrations, we show that the experimental data provide sufficient information to determine the parameters required for first-order approximation of the impact of these effects on the recorded data. Systematic deviations of fluorescence optical sedimentation velocity data analyzed using conventional sedimentation models developed for absorbance and interference optics are largely removed after these adaptations, resulting in excellent fits that highlight the high precision of fluorescence sedimentation velocity data, thus allowing a more detailed quantitative interpretation of the signal boundaries that is otherwise not possible for this system.	[Zhao, Huaying; Schuck, Peter] Natl Inst Biomed Imaging & Bioengn, Dynam Macromol Assembly Sect, Lab Cellular Imaging & Macromol Biophys, NIH, Bethesda, MD USA; [Casillas, Ernesto, Jr.; Patterson, George H.] Natl Inst Biomed Imaging & Bioengn, Sect Biophoton, NIH, Bethesda, MD USA; [Shroff, Hari] Natl Inst Biomed Imaging & Bioengn, Sect High Resolut Opt Imaging, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Schuck, P (corresponding author), Natl Inst Biomed Imaging & Bioengn, Dynam Macromol Assembly Sect, Lab Cellular Imaging & Macromol Biophys, NIH, Bethesda, MD USA.	schuckp@mail.nih.gov	Patterson, George/ABI-4751-2020; Schuck, Peter/AAA-6888-2020; Shroff, Hari/E-7247-2016	Schuck, Peter/0000-0002-8859-6966; Shroff, Hari/0000-0003-3613-8215; Casillas, Ernesto/0000-0002-9202-0206	National Institute of Biomedical Imaging and Bioengineering; National Institute of Child Health and Human Development, National Institutes of Health; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000051, ZIAEB000074, ZIAEB000071] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the Intramural Research Programs of the National Institute of Biomedical Imaging and Bioengineering and the National Institute of Child Health and Human Development, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, AN ULTR FLUOR DET SY, DOI Lakewood, NJ; Bailey MF, 2009, ANAL BIOCHEM, V390, P218, DOI 10.1016/j.ab.2009.03.045; Brown PH, 2008, COMPUT PHYS COMMUN, V178, P105, DOI 10.1016/j.cpc.2007.08.012; Brown PH, 2009, EUR BIOPHYS J BIOPHY, V38, P1079, DOI 10.1007/s00249-009-0514-1; Ghirlando R, 2013, ANAL BIOCHEM, V440, P81, DOI 10.1016/j.ab.2013.05.011; Harding SE, 2010, BIOCHEM SOC T, V38, P901, DOI 10.1042/BST0380901; Howlett GJ, 2006, CURR OPIN CHEM BIOL, V10, P430, DOI 10.1016/j.cbpa.2006.08.017; Kingsbury JS, 2011, METHOD ENZYMOL, V492, P283, DOI 10.1016/B978-0-12-381268-1.00021-5; Kroe RR, 2009, ANAL BIOCHEM, V390, P1, DOI 10.1016/j.ab.2008.11.033; Lyons DF, 2013, ANAL BIOCHEM, V437, P133, DOI 10.1016/j.ab.2013.02.019; MacGregor IK, 2004, BIOPHYS CHEM, V108, P165, DOI 10.1016/j.bpc.2003.10.018; Mok YF, 2011, METHODS, V54, P67, DOI 10.1016/j.ymeth.2010.10.004; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Schuck P, 1999, BIOPHYS J, V76, P2288, DOI 10.1016/S0006-3495(99)77384-4; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P, 2001, J BIOL CHEM, V276, P9679, DOI 10.1074/jbc.M009398200; Schuck Peter, 2013, Biophys Rev, V5, P159, DOI 10.1007/s12551-013-0106-2; Schuck P, 2011, METHODS, V54, P1, DOI 10.1016/j.ymeth.2011.04.003; Schuck P, 2010, ANAL BIOCHEM, V401, P280, DOI 10.1016/j.ab.2010.02.037; Svedberg T, 1940, THE ULTRACENTRIFUGE; Zhao HY, 2012, J GEN PHYSIOL, V139, P371, DOI 10.1085/jgp.201210770	21	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77245	10.1371/journal.pone.0077245	http://dx.doi.org/10.1371/journal.pone.0077245			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204779	gold, Green Published, Green Submitted			2022-12-27	WOS:000326029300093
J	Jin, X; Yi, L; Chen, ML; Chen, CY; Chang, H; Zhang, T; Wang, L; Zhu, JD; Zhang, QY; Mi, MT				Jin, Xin; Yi, Long; Chen, Ming-liang; Chen, Chun-ye; Chang, Hui; Zhang, Ting; Wang, Li; Zhu, Jun-dong; Zhang, Qian-yong; Mi, Man-tian			Delphinidin-3-Glucoside Protects against Oxidized Low-Density Lipoprotein-Induced Mitochondrial Dysfunction in Vascular Endothelial Cells via the Sodium-Dependent Glucose Transporter SGLT1	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; LIPID-PEROXIDATION; OXIDATIVE STRESS; ANTHOCYANINS; RESVERATROL; APOPTOSIS; ANTIOXIDANTS; CONSUMPTION; METABOLISM; INHIBITION	Delphinidin-3-glucoside (Dp) is a member of a family of bioactive compounds known as anthocyanins that occur naturally in pigmented plants and are known to ameliorate oxidative stress. Previous studies have showed that Dp decreased oxidative stress in vascular endothelial cells, however, the underlying mechanisms remain largely unknown. In the present study, we showed that pretreatment with Dp significantly suppressed oxidized low-density lipoprotein (oxLDL)-induced cell proliferation inhibition and apoptosis in primary human umbilical vein endothelial cells (HUVECs). Also, Dp pretreatment attenuated oxLDL-induced mitochondrial dysfunction via decreased reactive oxygen species (ROS) and superoxide anion generation, thereby repressing mitochondrial membrane potential and closing mitochondrial permeability transition pore. Furthermore, in vitro and in vivo data showed that Dp was transported into endothelial cells in a temperature, concentration, and time-dependent manner via the sodium-dependent glucose transporter (SGLT1). Suppression of SGLT1 by its substrate glucose, its inhibitor phlorizin or SGLT1 siRNA blocked Dp transportation. Repression of SGLT1 significantly inhibited Dp function of ameliorating mitochondrial dysfunction induced by pro-apoptotic factors (Apoptosis-inducing factor, Cytochrome c, Caspase-3 and Bax/Bcl-2 ratio). Taken together, our data indicate that Dp protects VECs via the SGLT1-ROS-mitochodria pathway. This new insight may help to elucidate the molecular mechanisms underlying the vascular protection afforded by Dp, and anthocyanins in general, in the context of prevention of endothelial dysfunction and atherosclerosis.	[Jin, Xin; Yi, Long; Chen, Ming-liang; Chen, Chun-ye; Chang, Hui; Zhang, Ting; Wang, Li; Zhu, Jun-dong; Zhang, Qian-yong; Mi, Man-tian] Third Mil Med Univ, Chongqing Med Nutr Res Ctr, Inst Mil Prevent Med, Res Ctr Nutr & Food Safety,Chongqing Key Lab Nutr, Chongqing, Peoples R China	Army Medical University	Mi, MT (corresponding author), Third Mil Med Univ, Chongqing Med Nutr Res Ctr, Inst Mil Prevent Med, Res Ctr Nutr & Food Safety,Chongqing Key Lab Nutr, Chongqing, Peoples R China.	mi_mt2009@hotmail.com	Chen, Mingliang/AGH-3195-2022	Chang, Hui/0000-0001-6693-2570	National Natural Science Foundation of China [81000133, 81202202]; Youth Innovation Foundation of the Third Military Medical University [2012XJQ06]; Key Scientific and Technological Project of Chongqing [CSTC, 2011AB5040]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Foundation of the Third Military Medical University; Key Scientific and Technological Project of Chongqing	This work was supported by the General Program of National Natural Science Foundation of China [grant numbers: 81000133 and 81202202], the Youth Innovation Foundation of the Third Military Medical University (2012XJQ06) and the Key Scientific and Technological Project of Chongqing [grant number CSTC, 2011AB5040]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albano E, 2008, MOL ASPECTS MED, V29, P9, DOI 10.1016/j.mam.2007.09.004; Antonsson B, 2000, EXP CELL RES, V256, P50, DOI 10.1006/excr.2000.4839; Ballinger SW, 2005, FREE RADICAL BIO MED, V38, P1278, DOI 10.1016/j.freeradbiomed.2005.02.014; Bertelli A, 1998, DRUG EXP CLIN RES, V24, P133; Biasutto L, 2010, MOLECULES, V15, P6570, DOI 10.3390/molecules15096570; Cao GH, 2001, AM J CLIN NUTR, V73, P920; Chang HC, 2011, J CEREBR BLOOD F MET, V31, P842, DOI 10.1038/jcbfm.2010.180; Chen CY, 2011, CELL BIOCHEM BIOPHYS, V61, P337, DOI 10.1007/s12013-011-9216-2; Chen CY, 2010, CHEM-BIOL INTERACT, V183, P105, DOI 10.1016/j.cbi.2009.09.024; Chen PN, 2006, CANCER LETT, V235, P248, DOI 10.1016/j.canlet.2005.04.033; Cooke D, 2005, EUR J CANCER, V41, P1931, DOI 10.1016/j.ejca.2005.06.009; Danz EDB, 2009, FREE RADICAL BIO MED, V46, P1589, DOI 10.1016/j.freeradbiomed.2009.03.011; Dauchet L, 2009, NAT REV CARDIOL, V6, P599, DOI 10.1038/nrcardio.2009.131; Deng TL, 2008, CELL BIOL INT, V32, P1425, DOI 10.1016/j.cellbi.2008.08.013; Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820; German JB, 2000, ANNU REV NUTR, V20, P561, DOI 10.1146/annurev.nutr.20.1.561; Gronbaek M, 1996, BRIT MED J, V313, P365, DOI 10.1136/bmj.313.7053.365; Henry-Vitrac C, 2006, EUR J NUTR, V45, P376, DOI 10.1007/s00394-006-0609-8; Hoye AT, 2008, ACCOUNTS CHEM RES, V41, P87, DOI 10.1021/ar700135m; Juan ME, 1999, ANAL CHEM, V71, P747, DOI 10.1021/ac9808831; Kahkonen MP, 2003, J AGR FOOD CHEM, V51, P628, DOI 10.1021/jf025551i; Kim J, 2009, TOXICOL LETT, V188, P45, DOI 10.1016/j.toxlet.2009.03.006; Kuhnau J, 1976, World Rev Nutr Diet, V24, P117; Latchoumycandane C, 2002, TOXICOLOGY, V171, P127, DOI 10.1016/S0300-483X(01)00563-7; Lazze MC, 2004, CARCINOGENESIS, V25, P1427, DOI 10.1093/carcin/bgh138; Liu S, 2010, AM J PHYSIOL-ENDOC M, V299, pE351, DOI 10.1152/ajpendo.00005.2010; Mauray A, 2010, GENES NUTR, V5, P343, DOI 10.1007/s12263-010-0171-0; Mazza Giuseppe Joe, 2007, Ann Ist Super Sanita, V43, P369; McGhie TK, 2003, J AGR FOOD CHEM, V51, P4539, DOI 10.1021/jf026206w; Murphy MP, 2008, BBA-BIOENERGETICS, V1777, P1028, DOI 10.1016/j.bbabio.2008.03.029; Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110; Murphy MP, 2003, J BIOL CHEM, V278, P48534, DOI 10.1074/jbc.M308529200; Pendurthi UR, 1999, ARTERIOSCL THROM VAS, V19, P419, DOI 10.1161/01.ATV.19.2.419; Prior RL, 2006, FREE RADICAL RES, V40, P1014, DOI 10.1080/10715760600758522; Qu MY, 2011, NEUROCHEM INT, V59, P1095, DOI 10.1016/j.neuint.2011.10.005; Robertson JD, 2000, CRIT REV TOXICOL, V30, P609, DOI 10.1080/10408440008951122; Salvayre R, 2002, BBA-MOL CELL BIOL L, V1585, P213, DOI 10.1016/S1388-1981(02)00343-8; Schramm DD, 1999, J NUTR BIOCHEM, V10, P193, DOI 10.1016/S0955-2863(98)00104-1; Seeram NP, 2002, J AGR FOOD CHEM, V50, P5308, DOI 10.1021/jf025671q; Smith RAJ, 2004, METHOD ENZYMOL, V382, P45; Smith RAJ, 2003, P NATL ACAD SCI USA, V100, P5407, DOI 10.1073/pnas.0931245100; Teng ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029647; Thomas SR, 2008, ANTIOXID REDOX SIGN, V10, P1713, DOI 10.1089/ars.2008.2027; Tsuda T, 2003, J NUTR, V133, P2125, DOI 10.1093/jn/133.7.2125; Tsuda T, 2000, FEBS LETT, V484, P207, DOI 10.1016/S0014-5793(00)02150-5; Wang Y, 2012, J NUTR, V142, P1033, DOI 10.3945/jn.112.157701; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; Wu DF, 2003, ALCOHOL RES HEALTH, V27, P277; Wu XL, 2006, J AGR FOOD CHEM, V54, P4069, DOI 10.1021/jf060300l; Xie XP, 2012, J AGR FOOD CHEM, V60, P1850, DOI 10.1021/jf204461z; Xu JW, 2004, FEBS LETT, V574, P176, DOI 10.1016/j.febslet.2004.08.027; Yao Y, 2007, NEUROTOXICOLOGY, V28, P93, DOI 10.1016/j.neuro.2006.07.015; Yi L, 2010, FEBS LETT, V584, P583, DOI 10.1016/j.febslet.2009.12.006; Youdim KA, 2000, FREE RADICAL BIO MED, V29, P51, DOI 10.1016/S0891-5849(00)00329-4; Youdim KA, 2003, J NEUROCHEM, V85, P180, DOI 10.1046/j.1471-4159.2003.01652.x; Yung Lai Ming, 2006, Cardiovascular & Hematological Disorders - Drug Targets, V6, P1; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	59	58	61	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68617	10.1371/journal.pone.0068617	http://dx.doi.org/10.1371/journal.pone.0068617			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	24205095	Green Submitted, Green Published, gold			2022-12-27	WOS:000324146200023
J	Ahmed, I; Greenwood, R; Costello, BD; Ratcliffe, NM; Probert, CS				Ahmed, Iftikhar; Greenwood, Rosemary; Costello, Ben de lacy; Ratcliffe, Norman M.; Probert, Chris S.			An Investigation of Fecal Volatile Organic Metabolites in Irritable Bowel Syndrome	PLOS ONE			English	Article							ULCERATIVE-COLITIS; METHANE PRODUCTION; CALPROTECTIN; MARKERS; DISEASE; EPIDEMIOLOGY; INFLAMMATION; PERFORMANCE; BIOMARKERS; DIAGNOSIS	Diagnosing irritable bowel syndrome (IBS) can be a challenge; many clinicians resort to invasive investigations in order to rule out other diseases and reassure their patients. Volatile organic metabolites (VOMs) are emitted from feces; understanding changes in the patterns of these VOMs could aid our understanding of the etiology of the disease and the development of biomarkers, which can assist in the diagnosis of IBS. We report the first comprehensive study of the fecal VOMs patterns in patients with diarrhea-predominant IBS (IBS-D), active Crohn's disease (CD), ulcerative colitis (UC) and healthy controls. 30 patients with IBS-D, 62 with CD, 48 with UC and 109 healthy controls were studied. Diagnosis of IBS-D was made using the Manning criteria and all patients with CD and UC met endoscopic, histologic and/or radiologic criteria. Fecal VOMs were extracted by solid phase microextraction (SPME) and analyzed by gas chromatography-mass spectrometry (GC-MS). 240 VOMs were identified. Univariate analysis showed that esters of short chain fatty acids, cyclohexanecarboxylic acid and its ester derivatives were associated with IBS-D (p<0.05), while aldehydes were more abundant in IBD (p<0.05). A predictive model, developed by multivariate analysis, separated IBS-D from active CD, UC and healthy controls with a sensitivity of 94%, 96% and 90%; and a specificity of 82%, 80% and 80% respectively (p<0.05). The understanding of the derivation of these VOMs may cast light on the etiology of IBS-D and IBD. These data show that fecal VOMs analyses could contribute to the diagnosis of IBS-D, for which there is no laboratory test, as well as IBD.	[Ahmed, Iftikhar] Univ Bristol, Bristol Royal Infirm, Dept Gastroenterol, Bristol, Avon, England; [Greenwood, Rosemary] Bristol Royal Infirm & Gen Hosp, Dept Res & Dev, Bristol, Avon, England; [Costello, Ben de lacy; Ratcliffe, Norman M.] Univ W England, Dept Appl Sci, Bristol BS16 1QY, Avon, England; [Probert, Chris S.] Univ Liverpool, Dept Gastroenterol, Inst Translat Med, Liverpool L69 3BX, Merseyside, England	Bristol Royal Infirmary; University of Bristol; Bristol Royal Infirmary; University of West England; University of Liverpool	Ratcliffe, NM (corresponding author), Univ W England, Dept Appl Sci, Bristol BS16 1QY, Avon, England.	norman.ratcliffe@uwe.ac.uk	De Lacy Costello, Ben/I-8259-2019; de Lacy Costello, Ben/ABG-2043-2021	de Lacy Costello, Ben/0000-0003-2999-6801; Probert, Christopher/0000-0003-4550-0239; Wu, Feibo/0000-0001-8797-3398	University of Bristol	University of Bristol	Iftikhar Ahmed received research fellowship from University of Bristol. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham BP, 2012, GASTROENTEROL CLIN N, V41, P483, DOI 10.1016/j.gtc.2012.01.007; Ahmed I, 2011, THESIS U BRISTOL; Ali F, 2007, GUT, V56, P1, DOI 10.1136/gut.2006.117598; Azpiroz F, 2007, NEUROGASTROENT MOTIL, V19, P62, DOI 10.1111/j.1365-2982.2006.00875.x; Chang L, 2004, ALIMENT PHARM THER, V20, P31, DOI 10.1111/j.1365-2036.2004.02183.x; Codling C, 2010, DIGEST DIS SCI, V55, P392, DOI 10.1007/s10620-009-0934-x; Costa F, 2005, GUT, V54, P364, DOI 10.1136/gut.2004.043406; Costello BDL, 2008, J BREATH RES, V2, DOI 10.1088/1752-7155/2/3/037023; D'Inca R, 2008, AM J GASTROENTEROL, V103, P2007, DOI 10.1111/j.1572-0241.2008.01870.x; De Preter V, 2011, MOL NUTR FOOD RES, V55, P714, DOI 10.1002/mnfr.201000442; Sanchez MDG, 2006, MED CLIN-BARCELONA, V127, P41; Dixon E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018471; Drossman DA, 2005, GASTROENTEROLOGY, V128, P580, DOI 10.1053/j.gastro.2004.12.006; Drossman Douglas A, 2006, Chin J Dig Dis, V7, P181, DOI 10.1111/j.1443-9573.2006.00265.x; Durant JA, 1997, ANAEROBE, V3, P391, DOI 10.1006/anae.1997.0129; Elia M, 2008, ALIMENT PHARM THER, V27, P120, DOI 10.1111/j.1365-2036.2007.03544.x; Furnari M, 2012, J GASTROINTEST LIVER, V21, P157; Garcia-Sanchez V, 2010, J CROHNS COLITIS, V4, P144, DOI 10.1016/j.crohns.2009.09.008; Garner CE, 2009, T ROY SOC TROP MED H, V103, P1171, DOI 10.1016/j.trstmh.2009.02.004; Garner CE, 2007, FASEB J, V21, P1675, DOI 10.1096/fj.06-6927com; Garner CE, 2009, J PEDIATR GASTR NUTR, V49, P559, DOI 10.1097/MPG.0b013e3181a3bfbc; Gisbert JP, 2009, DIGEST LIVER DIS, V41, P56, DOI 10.1016/j.dld.2008.05.008; Gonlachanvit S, 2004, GUT, V53, P1577, DOI 10.1136/gut.2004.041632; Grundy D, 2006, GASTROENTEROLOGY, V130, P1391, DOI 10.1053/j.gastro.2005.11.060; HARVEY RF, 1980, LANCET, V1, P514; HEGAZI F Z, 1980, Zentralblatt fuer Bakteriologie Parasitenkunde Infektionskrankheiten und Hygiene Zweite Naturwissenschaftliche Abteilung Mikrobiologie der Landwirtschaft der Technologie und des Umweltschutzes, V135, P212; Jones J, 2000, GUT, V47, pII1, DOI 10.1136/gut.47.suppl_2.ii1; Kajander K, 2009, WORLD J GASTROENTERO, V15, P6068, DOI 10.3748/wjg.15.6068; Konikoff MR, 2006, INFLAMM BOWEL DIS, V12, P524, DOI 10.1097/00054725-200606000-00013; MANNING AP, 1978, BRIT MED J, V2, P653, DOI 10.1136/bmj.2.6138.653; Maxion-Bergemann S, 2006, PHARMACOECONOMICS, V24, P21, DOI 10.2165/00019053-200624010-00002; Mulak A, 2004, MED SCI MONITOR, V10, pRA55; Ong DK, J GASTROENTEROL HEPA, V25, P1366; Oresic M, 2006, EXPERT REV MOL DIAGN, V6, P575, DOI 10.1586/14737159.6.4.575; Otten CMT, 2008, CLIN CHEM LAB MED, V46, P1275, DOI 10.1515/CCLM.2008.246; Pelli MA, 1999, DIS COLON RECTUM, V42, P71, DOI 10.1007/BF02235186; Phillips M, 2003, CHEST, V123, P2115, DOI 10.1378/chest.123.6.2115; Phillips Michael, 2003, Breast J, V9, P184, DOI 10.1046/j.1524-4741.2003.09309.x; Pimentel M, 2003, DIGEST DIS SCI, V48, P86, DOI 10.1023/A:1021738515885; Probert CSJ, 2009, J GASTROINTEST LIVER, V18, P337; Probert CSJ, 2004, GUT, V53, P58, DOI 10.1136/gut.53.1.58; Quigley EMM, 2006, DIGEST LIVER DIS, V38, P717, DOI 10.1016/j.dld.2006.05.009; Quigley Eamonn M M, 2005, Chin J Dig Dis, V6, P122, DOI 10.1111/j.1443-9573.2005.00202.x; Reddymasu SC, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-23; SANDLER RS, 1990, GASTROENTEROLOGY, V99, P409, DOI 10.1016/0016-5085(90)91023-Y; Schlotterbeck G, 2006, PHARMACOGENOMICS, V7, P1055, DOI 10.2217/14622416.7.7.1055; Schoepfer AM, 2008, INFLAMM BOWEL DIS, V14, P32, DOI 10.1002/ibd.20275; SEO M, 1995, AM J GASTROENTEROL, V90, P1759; Shen Q, 2011, EUROPEAN J NUTR, P1; Silberer H, 2005, CLIN LAB, V51, P117; Staudacher HM, 2011, J HUM NUTR DIET, V24, P487, DOI 10.1111/j.1365-277X.2011.01162.x; STONE M, 1977, J R STAT SOC B, V39, P44, DOI 10.1111/j.2517-6161.1977.tb01603.x; Tana C, 2010, NEUROGASTROENT MOTIL, V22, P512, DOI 10.1111/j.1365-2982.2009.01427.x; Tibble JA, 2002, GASTROENTEROLOGY, V123, P450, DOI 10.1053/gast.2002.34755; Whitehead WE, 2010, AM J GASTROENTEROL, V105, P814, DOI 10.1038/ajg.2010.56; Xue RY, 2008, RAPID COMMUN MASS SP, V22, P1181, DOI 10.1002/rcm.3466; Zumarraga L, 1997, ALIMENT PHARM THERAP, V11, P1067, DOI 10.1046/j.1365-2036.1997.00250.x	57	188	193	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58204	10.1371/journal.pone.0058204	http://dx.doi.org/10.1371/journal.pone.0058204			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	24205003	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849200042
J	Liu, Y; He, XF; Lu, YT; Long, H; Song, Y; Qi, ST				Liu Yi; He Xiao-feng; Lu Yun-tao; Long Hao; Song Ye; Qi Song-tao			Association between the XRCC1 Arg399Gln Polymorphism and Risk of Cancer: Evidence from 297 Case-Control Studies	PLOS ONE			English	Article							BASE EXCISION-REPAIR; DNA-POLYMERASE BETA; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; GENE POLYMORPHISM; LIGASE III; METAANALYSIS; SUSCEPTIBILITY; ARG194TRP	Background: The Arg399Gln polymorphism in the X-ray cross-complementing group 1 (XRCC1) had been implicated in cancer susceptibility. The previous published data on the association between XRCC1 Arg399Gln polymorphism and cancer risk remained controversial. Methodology/Principal Findings: To derive a more precise estimation of the association between the XRCC1 Arg399Gln polymorphism and overall cancer risk, we performed a meta-analysis of 297 case-control studies, in which a total of 93,941 cases and 121,480 controls were included. Overall, significantly increased cancer risk was observed in any genetic model (dominant model: odds ration [OR] = 1.04, 95% confidence interval [CI] = 1.01-1.07; recessive model: OR = 1.08, 95% CI = 1.03-1.13; additive model: OR = 1.09, 95% CI = 1.04-1.14) when all eligible studies were pooled into the meta-analysis. In further stratified and sensitivity analyses, significantly elevated hepatocellular and breast cancers risk were observed in Asians (dominant model: OR = 1.39, 95% CI = 1.06-1.84) and in Indians (dominant model: OR = 1.64, 95% CI = 1.31-2.04; recessive model: OR = 1.94, 95% CI = 1.09-3.47; additive model: OR = 2.06, 95% CI = 1.50-2.84), respectively. Conclusions/Significance: This meta-analysis suggests the participation of XRCC1 Arg399Gln is a genetic susceptibility for hepatocellular cancer in Asians and breast cancer in Indians. Moreover, our work also points out the importance of new studies for Arg399Gln association in some cancer types, such as glioma, gastric cancer, and oral cancer, where at least some of the covariates responsible for heterogeneity could be controlled, to obtain a more conclusive understanding about the function of the XRCC1 Arg399Gln polymorphism in cancer development.	[Liu Yi; Lu Yun-tao; Long Hao; Song Ye; Qi Song-tao] Southern Med Univ, Nanfang Hosp, Neurosurg Dept, Guangzhou, Guangdong, Peoples R China; [He Xiao-feng] Peace Hosp, Changzhi Med Coll, Dept Res, Changzhi, Peoples R China	Southern Medical University - China; Changzhi Medical College	Qi, ST (corresponding author), Southern Med Univ, Nanfang Hosp, Neurosurg Dept, Guangzhou, Guangdong, Peoples R China.	liuyi86818@126.com	Chen, Mingliang/AGH-3195-2022	Chang, Hui/0000-0001-6693-2570				BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; Cappelli E, 1997, J BIOL CHEM, V272, P23970, DOI 10.1074/jbc.272.38.23970; Chen D, 2008, J BIOL CHEM, V283, P15381, DOI 10.1074/jbc.M710296200; Dai LP, 2012, MOL BIOL REP, V39, P9535, DOI 10.1007/s11033-012-1818-2; Davey SG, 1997, LANCET, V350, P1182, DOI DOI 10.1016/S0140-6736(05)63833-0; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duan WH, 2012, ASIAN PAC J CANCER P, V13, P3601, DOI 10.7314/APJCP.2012.13.8.3601; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang YS, 2009, MUTAGENESIS, V24, P331, DOI 10.1093/mutage/gep013; Kiyohara C, 2006, LUNG CANCER, V54, P267, DOI 10.1016/j.lungcan.2006.08.009; Klug SJ, 2009, LANCET ONCOL, V10, P772, DOI 10.1016/S1470-2045(09)70187-1; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Li HH, 2009, BREAST, V18, P183, DOI 10.1016/j.breast.2009.03.008; Li J, 2013, TUMOR BIOL, V34, P261, DOI 10.1007/s13277-012-0546-5; Li Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030186, 10.1371/journal.pone.0029003, 10.1371/journal.pone.0042558, 10.1371/journal.pone.0030835, 10.1371/journal.pone.0044441, 10.1371/journal.pone.0035543, 10.1371/journal.pone.0035122]; Liu BM, 2012, GENET MOL RES, V11, P3852, DOI 10.4238/2012.November.12.2; Liu F, 2011, LIVER INT, V31, P804, DOI 10.1111/j.1478-3231.2011.02508.x; Liu L, 2013, MOL BIOL REP, V40, P3943, DOI 10.1007/s11033-012-2471-5; Lu AL, 2001, CELL BIOCHEM BIOPHYS, V35, P141, DOI 10.1385/CBB:35:2:141; MANTEL N, 1959, J NATL CANCER I, V22, P719; Moore DJ, 2000, P NATL ACAD SCI USA, V97, P13649, DOI 10.1073/pnas.250477597; Saadat M, 2009, BREAST CANCER RES TR, V115, P137, DOI 10.1007/s10549-008-0051-0; Shen MR, 1998, CANCER RES, V58, P604; Tebbs RS, 1999, DEV BIOL, V208, P513, DOI 10.1006/dbio.1999.9232; Thacker J, 2003, DNA REPAIR, V2, P655, DOI 10.1016/S1568-7864(03)00062-4; Vidal AE, 2001, EMBO J, V20, P6530, DOI 10.1093/emboj/20.22.6530; Wang YD, 2009, CANCER LETT, V285, P134, DOI 10.1016/j.canlet.2009.05.005; Wei B, 2011, PROSTATE CANCER P D, V14, P225, DOI 10.1038/pcan.2011.26; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Wu KS, 2011, ASIAN PAC J CANCER P, V12, P2237; Xie T, 2012, WORLD J GASTROENTERO, V18, P4207, DOI 10.3748/wjg.v18.i31.4207; Yu Z, 1999, ENVIRON MOL MUTAGEN, V33, P3, DOI 10.1002/(SICI)1098-2280(1999)33:1<3::AID-EM2>3.0.CO;2-L; Zhang Huina, 2010, Wei Sheng Yan Jiu, V39, P664	35	58	61	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78071	10.1371/journal.pone.0078071	http://dx.doi.org/10.1371/journal.pone.0078071			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24205095	Green Published, Green Submitted, gold			2022-12-27	WOS:000326270700071
J	Kong, LQ; Zhu, XD; Xu, HX; Zhang, JB; Lu, L; Wang, WQ; Zhang, QB; Wu, WZ; Wang, L; Fan, J; Tang, ZY; Sun, HC				Kong, Ling-Qun; Zhu, Xiao-Dong; Xu, Hua-Xiang; Zhang, Ju-Bo; Lu, Lu; Wang, Wen-Quan; Zhang, Qiang-Bo; Wu, Wei-Zhong; Wang, Lu; Fan, Jia; Tang, Zhao-You; Sun, Hui-Chuan			The Clinical Significance of the CD163+and CD68+Macrophages in Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; HEMOGLOBIN SCAVENGER RECEPTOR; SOLUBLE CD163; CURATIVE RESECTION; HUMAN MONOCYTES; BREAST-CANCER; EXPRESSION; INFILTRATION; SURVIVAL; ANTIGEN	Our previous study has found that the abundance of peritumoral CD68(+) macrophages was associated with poor prognosis in hepatocellular carcinoma (HCC) after resection. However, CD68 staining could not discriminate the protumoral or tumoricidal subpopulations from pan-macrophages. CD163 is a marker of alternatively activated macrophages. In this study, the clinical significance of CD163(+) cells in tumors and peritumoral liver tissues was evaluated in a cohort of 295 patients with HCC after curative resection. We found that the density of CD163(+) cells was well correlated with that of CD68(+) cells in both tumors and peritumoral liver tissues but was much more. Immunostaining on consecutive sections and flow cytometry assay on surgical resected specimens further supported the findings that the CD163+ cells was more abundant than CD68(+) cells. The density of peritumoral CD68(+) cells was associated with poor recurrence-free survival (RFS) and poor overall survival (OS) (P = 0.004 and P = 0.001, respectively), whereas the CD163(+) cells have no prognostic values either in tumors or in peritumoral liver tissues. In another cohort of 107 HCC patients, preoperative plasma concentration of soluble form of CD163 (sCD163) was associated with active hepatitis-related factors but not associated with the markers of tumor invasion. In conclusion, both the CD163(+) cells local infiltration and plasma sCD163 were of limited significance in HCC, and they were more likely markers related to active hepatitis rather than tumor progression.	[Kong, Ling-Qun; Zhu, Xiao-Dong; Xu, Hua-Xiang; Zhang, Ju-Bo; Lu, Lu; Wang, Wen-Quan; Zhang, Qiang-Bo; Wu, Wei-Zhong; Wang, Lu; Fan, Jia; Tang, Zhao-You; Sun, Hui-Chuan] Fudan Univ, Liver Canc Inst, Minist Educ China, Key Lab Carcinogenesis & Canc Invas, Shanghai 200433, Peoples R China; [Kong, Ling-Qun; Zhu, Xiao-Dong; Xu, Hua-Xiang; Zhang, Ju-Bo; Lu, Lu; Wang, Wen-Quan; Zhang, Qiang-Bo; Wu, Wei-Zhong; Wang, Lu; Fan, Jia; Tang, Zhao-You; Sun, Hui-Chuan] Fudan Univ, Zhongshan Hosp, Minist Educ China, Key Lab Carcinogenesis & Canc Invas, Shanghai 200433, Peoples R China; [Xu, Hua-Xiang] Fudan Univ, Shanghai Canc Ctr, Dept Pancreat & Hepatobiliary Surg, Shanghai 200433, Peoples R China	Fudan University; Ministry of Education, China; Fudan University; Ministry of Education, China; Fudan University	Sun, HC (corresponding author), Fudan Univ, Liver Canc Inst, Minist Educ China, Key Lab Carcinogenesis & Canc Invas, Shanghai 200433, Peoples R China.	sun.huichuan@zs-hospital.sh.cn	Zhu, Xiao-Dong/A-8197-2010; Fan, Jia/C-6689-2017	Zhu, Xiao-Dong/0000-0001-9864-6763; Sun, Hui-Chuan/0000-0003-3761-7058	National Natural Science Foundation of China [30872504, 81020108025]; China National "211'' Project for Higher Education	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National "211'' Project for Higher Education	This study was jointly supported by National Natural Science Foundation of China (30872504, 81020108025), and China National "211'' Project for Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; FALINI B, 1993, AM J PATHOL, V142, P1359; Farinha P, 2005, BLOOD, V106, P2169, DOI 10.1182/blood-2005-04-1565; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Hamada I, 2002, ANTICANCER RES, V22, P4281; Hanada T, 2000, INT J UROL, V7, P263, DOI 10.1046/j.1442-2042.2000.00190.x; Hiraoka A, 2005, J GASTROENTEROL, V40, P52, DOI 10.1007/s00535-004-1493-8; Hogger P, 1998, J IMMUNOL, V161, P1883; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jensen TO, 2009, J CLIN ONCOL, V27, P3330, DOI 10.1200/JCO.2008.19.9919; Koide N, 2004, AM J GASTROENTEROL, V99, P1667, DOI 10.1111/j.1572-0241.2004.30733.x; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Komohara Y, 2006, J HISTOCHEM CYTOCHEM, V54, P763, DOI 10.1369/jhc.5A6871.2006; Komohara Y, 2011, CANCER SCI, V102, P1424, DOI 10.1111/j.1349-7006.2011.01945.x; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Kuang DM, 2009, J EXP MED, V206, P1327, DOI 10.1084/jem.20082173; Lau SK, 2004, AM J CLIN PATHOL, V122, P794, DOI 10.1309/QHD6YFN81KQXUUH6; LAW SKA, 1993, EUR J IMMUNOL, V23, P2320, DOI 10.1002/eji.1830230940; Lee CH, 2008, CLIN CANCER RES, V14, P1423, DOI 10.1158/1078-0432.CCR-07-1712; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Lissbrant IF, 2000, INT J ONCOL, V17, P445; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Matsushita N, 2002, CLIN EXP IMMUNOL, V130, P156, DOI 10.1046/j.1365-2249.2002.01963.x; Moestrup SK, 2004, ANN MED, V36, P347, DOI 10.1080/07853890410033171; Moller HJ, 2007, J HEPATOL, V47, P671, DOI 10.1016/j.jhep.2007.05.014; Nguyen TDT, 2005, AM J SURG PATHOL, V29, P617, DOI 10.1097/01.pas.0000157940.80538.ec; Ohno S, 2004, ANTICANCER RES, V24, P3335; Qian YB, 2006, CANCER, V107, P1562, DOI 10.1002/cncr.22206; Ritter M, 1999, PATHOBIOLOGY, V67, P257, DOI 10.1159/000028105; Roayaie S, 2009, GASTROENTEROLOGY, V137, P850, DOI 10.1053/j.gastro.2009.06.003; Sanchez C, 1999, J IMMUNOL, V162, P5230; Shabo I, 2008, INT J CANCER, V123, P780, DOI 10.1002/ijc.23527; Shabo I, 2009, INT J CANCER, V125, P1826, DOI 10.1002/ijc.24506; Sobin LHGM., 2009, TNM CLASSIFICATION M, V7th; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Sulahian TH, 2001, J IMMUNOL METHODS, V252, P25, DOI 10.1016/S0022-1759(01)00328-3; Sun HC, 2007, J HEPATOL, V47, P684, DOI 10.1016/j.jhep.2007.06.019; Sun HC, 2007, J SURG ONCOL, V96, P37, DOI 10.1002/jso.20772; Tsutsui S, 2005, ONCOL REP, V14, P425; Zhu XD, 2008, J CLIN ONCOL, V26, P2707, DOI 10.1200/JCO.2007.15.6521	42	85	88	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59771	10.1371/journal.pone.0059771	http://dx.doi.org/10.1371/journal.pone.0059771			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	24205176	Green Submitted, Green Published, gold			2022-12-27	WOS:000317263900027
J	An, YY; Zhang, MX; Liu, GB; Han, RL; Liang, ZS				An, Yuyan; Zhang, Meixiang; Liu, Guobin; Han, Ruilian; Liang, Zongsuo			Proline Accumulation in Leaves of Periploca sepium via Both Biosynthesis Up-Regulation and Transport during Recovery from Severe Drought	PLOS ONE			English	Article							SALT-STRESS; SECONDARY METABOLISM; ANTIOXIDANT ENZYMES; EXOGENOUS PROLINE; OXIDATIVE STRESS; PLANT; TOLERANCE; GROWTH; GENE; SENESCENCE	Drought resistance and recovery ability are two important requisites for plant adaptation to drought environments. Proline (Pro) metabolism has been a major concern in plant drought tolerance. However, roles of Pro metabolism in plant recovery ability from severe drought stress are largely unexplored. Periploca sepium Bunge has gained increasing attention for its adaptation to dry environments. Here, we investigated Pro metabolism in different tissues of P. sepium seedlings in the course of drought stress and recovery. We found that leaf Pro metabolism response during post-drought recovery was dependant on drought severity. Pro biosynthesis was down-regulated during recovery from -0.4 MPa but increased continually and notably during recovery from -1.0 MPa. Significant correlation between Pro concentration and Delta 1-pyrroline-5-carboxylate synthetase activity indicates that Glutamate pathway is the predominant synthesis route during both drought and re-watering periods. Ornithine delta-aminotransferase activity was up-regulated significantly only during recovery from -1.0 MPa, suggesting positive contribution of ornithine pathway to improving plant recovery capacity from severe drought. In addition to up-regulation of biosynthesis, Pro transport from stems and roots also contributed to high Pro accumulation in leaves and new buds during recovery from -1.0 MPa, as indicated by the combined analysis of Pro concentration and its biosynthesis in stems, roots and new buds. Except its known roles as energy, carbon and nitrogen sources for plant rapid recovery, significant positive correlation between Pro concentration and total antioxidant activity indicates that Pro accumulation can also promote plant damage repair ability by up-regulating antioxidant activity during recovery from severe drought stress.	[An, Yuyan; Zhang, Meixiang; Liang, Zongsuo] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Liu, Guobin; Han, Ruilian; Liang, Zongsuo] Chinese Acad Sci, Res Ctr Soil & Water Conservat & Ecol Environm, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS	Liang, ZS (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.	liangzs@ms.iswc.ac.cn			knowledge Innovation Project of Chinese Academy of Science [KZCX2-YW-443]	knowledge Innovation Project of Chinese Academy of Science(Knowledge Innovation Program of the Chinese Academy of Sciences)	This research was supported by knowledge Innovation Project of Chinese Academy of Science (KZCX2-YW-443). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Q, 2013, INT J MOL SCI, V14, P818, DOI 10.3390/ijms14010818; Alia, 2001, AMINO ACIDS, V21, P195; An YY, 2011, S AFR J BOT, V77, P446, DOI 10.1016/j.sajb.2010.11.003; An YY, 2013, ACTA PHYSIOL PLANT, V35, P959, DOI 10.1007/s11738-012-1139-z; Bamba T, 2007, Z NATURFORSCH C, V62, P579; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; BLUM A, 1976, CROP SCI, V16, P428, DOI 10.2135/cropsci1976.0011183X001600030030x; Boyer JS, 2010, J EXP BOT, V61, P3493, DOI 10.1093/jxb/erq231; [陈玲 CHEN Ling], 2007, [西北林学院学报, Journal of Northwest Forestry College], V22, P142; Fernandes AJD, 2012, SCI WORLD J, DOI 10.1100/2012/923462; de Carvalho K, 2013, MOL BIOL REP, V40, P3269, DOI 10.1007/s11033-012-2402-5; de Carvalho MHC, 2008, PLANT SIGNAL BEHAV, V3, P156, DOI 10.4161/psb.3.3.5536; Diaz P, 2005, PLANT GROWTH REGUL, V46, P223, DOI 10.1007/s10725-005-0860-7; Girousse C, 1996, PLANT PHYSIOL, V111, P109, DOI 10.1104/pp.111.1.109; Hayat S, 2012, PLANT SIGNAL BEHAV, V7, P1456, DOI 10.4161/psb.21949; HOOD DW, 1992, GENE, V115, P5, DOI 10.1016/0378-1119(92)90533-U; Hoque MA, 2007, J PLANT PHYSIOL, V164, P553, DOI 10.1016/j.jplph.2006.03.010; Kaul S, 2008, AMINO ACIDS, V34, P315, DOI 10.1007/s00726-006-0407-x; Kim GB, 2013, J PLANT PHYSIOL, V170, P291, DOI 10.1016/j.jplph.2012.10.004; Kishor PBK, 2005, CURR SCI INDIA, V88, P424; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Lehmann S, 2010, AMINO ACIDS, V39, P949, DOI 10.1007/s00726-010-0525-3; Lin CC, 2002, PLANT GROWTH REGUL, V36, P275, DOI 10.1023/A:1016518013449; Luo YY, 2011, ACTA PHYSIOL PLANT, V33, P79, DOI 10.1007/s11738-010-0519-5; Lutts S, 1999, PHYSIOL PLANTARUM, V105, P450, DOI 10.1034/j.1399-3054.1999.105309.x; Mattioli R, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-236; Mattioli R, 2009, PLANT SIGNAL BEHAV, V4, P1016, DOI 10.4161/psb.4.11.9797; MCMICHAEL BL, 1977, CROP SCI, V17, P905, DOI 10.2135/cropsci1977.0011183X001700060022x; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; MORGAN JM, 1984, ANNU REV PLANT PHYS, V35, P299, DOI 10.1146/annurev.pp.35.060184.001503; Munne-Bosch S, 2004, FUNCT PLANT BIOL, V31, P203, DOI 10.1071/FP03236; Nounjan N, 2012, J PLANT PHYSIOL, V169, P596, DOI 10.1016/j.jplph.2012.01.004; Oh MM, 2009, J PLANT PHYSIOL, V166, P180, DOI 10.1016/j.jplph.2008.04.015; Pinheiro C, 2004, J PLANT PHYSIOL, V161, P1203, DOI 10.1016/j.jplph.2004.01.016; Ramakrishna A, 2011, PLANT SIGNAL BEHAV, V6, P1720, DOI 10.4161/psb.6.11.17613; Raymond MJ, 2002, ANN BOT-LONDON, V89, P813, DOI 10.1093/aob/mcf082; Richards J. H., 1993, P 17 INT GRASSL C PA, P85; Sharma S, 2011, PLANT PHYSIOL, V157, P292, DOI 10.1104/pp.111.183210; Signorelli S, 2013, PLANT PHYSIOL BIOCH, V64, P80, DOI 10.1016/j.plaphy.2012.12.017; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; SMIRNOFF N, 1989, PHYTOCHEMISTRY, V28, P1057, DOI 10.1016/0031-9422(89)80182-7; SMITH IK, 1988, ANAL BIOCHEM, V175, P408, DOI 10.1016/0003-2697(88)90564-7; Sun JK, 2011, PLANT SOIL ENVIRON, V57, P139, DOI 10.17221/227/2010-PSE; Sunkar R, 2010, METHODS MOL BIOL, V639, P1, DOI 10.1007/978-1-60761-702-0; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Vankova R, 2012, PLANT SIGNAL BEHAV, V7, P19, DOI 10.4161/psb.7.1.18375; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Verslues Paul E, 2010, Arabidopsis Book, V8, pe0140, DOI 10.1199/tab.0140; VOETBERG GS, 1991, PLANT PHYSIOL, V96, P1125, DOI 10.1104/pp.96.4.1125; Yang YL, 2011, ECOTOX ENVIRON SAFE, V74, P733, DOI 10.1016/j.ecoenv.2010.10.035; You J, 2012, PLANT SCI, V197, P59, DOI 10.1016/j.plantsci.2012.09.002; Zhu ZB, 2009, ENVIRON EXP BOT, V66, P326, DOI 10.1016/j.envexpbot.2009.03.017	53	45	50	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e69942	10.1371/journal.pone.0069942	http://dx.doi.org/10.1371/journal.pone.0069942			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185WH	23875011	Green Published, gold, Green Submitted			2022-12-27	WOS:000322000600061
J	An, Y; Yi, SY; Fitzpatrick, A; Gupta, V; Prak, PR; Oum, S; LoGerfo, JP				An, Yom; Yi, Siyan; Fitzpatrick, Annette; Gupta, Vinay; Prak, Piseth Raingsey; Oum, Sophal; LoGerfo, James P.			Appropriate Body Mass Index and Waist Circumference Cutoff for Overweight and Central Obesity among Adults in Cambodia	PLOS ONE			English	Article							METABOLIC SYNDROME; RISK-FACTORS; HYPERTENSION; PREVALENCE; POINTS; ASSOCIATION; CONSUMPTION; PREVENTION; DISORDERS; VALUES	Background: Body mass index (BMI) and waist circumference (WC) are used in risk assessment for the development of non-communicable diseases (NCDs) worldwide. Within a Cambodian population, this study aimed to identify an appropriate BMI and WC cutoff to capture those individuals that are overweight and have an elevated risk of vascular disease. Methodology/Principal Findings: We used nationally representative cross-sectional data from the STEP survey conducted by the Department of Preventive Medicine, Ministry of Health, Cambodia in 2010. In total, 5,015 subjects between age 25 and 64 years were included in the analyses. Chi-square, Fisher's Exact test and Student t-test, and multiple logistic regression were performed. Of total, 35.6% (n=1,786) were men, and 64.4% (n=3,229) were women. Mean age was 43.0 years (SD=11.2 years) and 43.6 years (SD=10.9 years) for men and women, respectively. Significant association of subjects with hypertension and hypercholesterolemia was found in those with BMI >= 23.0 kg/m(2) and with WC >80.0 cm in both sexes. The Area Under the Curve (AUC) from Receiver Operating Characteristic curves was significantly greater in both sexes (all p-values <0.001) when BMI of 23.0 kg/m(2) was used as the cutoff point for overweight compared to that using WHO BMI classification for overweight (BMI >= 25.0 kg/m(2)) for detecting the three cardiovascular risk factors. Similarly, AUC was also significantly higher in men (p-value <0.001) when using WC of 80.0 cm as the cutoff point for central obesity compared to that recommended by WHO (WC >= 94.0 cm in men). Conclusion: Lower cutoffs for BMI and WC should be used to identify of risks of hypertension, diabetes, and hypercholesterolemia for Cambodian aged between 25 and 64 years.	[An, Yom] Natl Inst Publ Hlth, Sch Publ Hlth, Phnom Penh, Cambodia; [An, Yom] Royal Acad Cambodia, Inst Biol Med & Agr, Phnom Penh, Cambodia; [Yi, Siyan] Stanford Univ, Freeman Spogli Inst Int Studies, Walter H Shorenstein Asia Pacific Res Ctr, Asia Hlth Policy Program, Stanford, CA 94305 USA; [Fitzpatrick, Annette; Gupta, Vinay; LoGerfo, James P.] Univ Washington, Med Ctr, Dept Internal Med, Seattle, WA 98195 USA; [Fitzpatrick, Annette; Gupta, Vinay; LoGerfo, James P.] Univ Washington, Med Ctr, Dept Global Hlth, Seattle, WA 98195 USA; [Prak, Piseth Raingsey] Minist Hlth, Dept Prevent Med, Phnom Penh, Cambodia; [Oum, Sophal] Univ Hlth Sci, Phnom Penh, Cambodia	Stanford University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	An, Y (corresponding author), Natl Inst Publ Hlth, Sch Publ Hlth, Phnom Penh, Cambodia.	anyomniph@gmail.com						Aye M, 2012, SINGAP MED J, V53, P545; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bei-Fan Z, 2002, ASIA PAC J CLIN NUTR, V11, pS685, DOI 10.1046/j.1440-6047.11.s8.9.x; Billington CJ, 2000, ARCH INTERN MED, V160, P898, DOI 10.1001/archinte.160.7.898; Chiu M, 2011, DIABETES CARE, V34, P1741, DOI 10.2337/dc10-2300; Inoue S, 2000, ASIA PACIFIC PERSPEC; Jitnarin N, 2011, EAT WEIGHT DISORD-ST, V16, pE242, DOI 10.1007/BF03327467; Jo I, 2001, J HYPERTENS, V19, P1523, DOI 10.1097/00004872-200109000-00002; Klein S, 2007, OBESITY, V15, P1061, DOI 10.1038/oby.2007.632; Ko GTC, 1999, INT J OBESITY, V23, P1136, DOI 10.1038/sj.ijo.0801043; Li G, 2002, Obes Rev, V3, P167, DOI 10.1046/j.1467-789X.2002.00067.x; Oanh THT, 2009, ASIA PAC J CLIN NUTR, V18, P226; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Pan WH, 2004, AM J CLIN NUTR, V79, P31; Prasad D S, 2012, J Cardiovasc Dis Res, V3, P204, DOI 10.4103/0975-3583.98895; Sesso HD, 2008, HYPERTENSION, V51, P1080, DOI 10.1161/HYPERTENSIONAHA.107.104968; Snehalatha C, 2003, DIABETES CARE, V26, P1380, DOI 10.2337/diacare.26.5.1380; Sophal Oum PRP, 2010, PREVALENCE NONCOMMUN; Tuan NT, 2008, J NUTR, V138, P1377, DOI 10.1093/jn/138.7.1377; Tuan NT, 2009, AM J CLIN NUTR, V89, P1905, DOI 10.3945/ajcn.2008.26809; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Villegas R, 2003, DIABETES CARE, V26, P3198, DOI 10.2337/diacare.26.11.3198-a; Weng X, 2006, EUR J CLIN NUTR, V60, P931, DOI 10.1038/sj.ejcn.1602396; Wildman RP, 2004, AM J CLIN NUTR, V80, P1129, DOI 10.1093/ajcn/80.5.1129; Worachartcheewan A, 2012, DIABETES RES CLIN PR, V98, pE16, DOI 10.1016/j.diabres.2012.09.018; World Health Organization, 2001, SUMM SURV RISK FACT; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; ZWEIG MH, 1993, CLIN CHEM, V39, P561	28	45	50	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77897	10.1371/journal.pone.0077897	http://dx.doi.org/10.1371/journal.pone.0077897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	23875011	Green Published, gold, Green Submitted			2022-12-27	WOS:000326032600052
J	Xu, XJ; Shou, XJ; Li, J; Jia, MX; Zhang, JS; Guo, Y; Wei, QY; Zhang, XT; Han, SP; Zhang, R; Han, JS				Xu, Xin-Jie; Shou, Xiao-Jing; Li, Jin; Jia, Mei-Xiang; Zhang, Ji-Shui; Guo, Yan; Wei, Qing-Yun; Zhang, Xiu-Ting; Han, Song-Ping; Zhang, Rong; Han, Ji-Sheng			Mothers of Autistic Children: Lower Plasma Levels of Oxytocin and Arg-Vasopressin and a Higher Level of Testosterone	PLOS ONE			English	Article							ARGININE-VASOPRESSIN; SOCIAL-BEHAVIOR; SPECTRUM; GENES; BRAIN; DISORDERS; PHENOTYPE; PARENTS; BROADER; WOMEN	Background: Autism is a pervasive neurodevelopmental disorder, thought to be caused by a combination of genetic heritability and environmental risk factors. Some autistic-like traits have been reported in mothers of autistic children. We hypothesized that dysregulation of oxytocin (OXT), Arg-vasopressin (AVP) and sex hormones, found in autistic children, may also exist in their mothers. Methods: We determined plasma levels of OXT (40 in autism vs. 26 in control group), AVP (40 vs. 17) and sex hormones (61 vs. 47) in mothers of autistic and normal children by enzyme immunoassay and radioimmunoassay, respectively and investigated their relationships with the children's autistic behavior scores (Childhood Autism Rating Scale (CARS) and Autism Behavior Checklist (ABC)). Results: Significantly lower plasma concentrations of OXT (p<0.001) and AVP (p<0.001), as well as a higher level of plasma testosterone (p<0.05), were found in mothers of autistic children vs. those of control. The children's autistic behavior scores were negatively associated with maternal plasma levels of OXT and AVP. Conclusions: These results suggest that dysregulation of OXT, AVP and/or testosterone systems exist in mothers of autistic children, which may impact children's susceptibility to autism.	[Xu, Xin-Jie; Shou, Xiao-Jing; Li, Jin; Zhang, Rong; Han, Ji-Sheng] Peking Univ, Neurosci Res Inst, Sch Basic Med Sci, Beijing 100871, Peoples R China; [Xu, Xin-Jie; Shou, Xiao-Jing; Li, Jin; Zhang, Rong; Han, Ji-Sheng] Peking Univ, Dept Neurobiol, Sch Basic Med Sci, Beijing 100871, Peoples R China; [Xu, Xin-Jie; Shou, Xiao-Jing; Li, Jin; Zhang, Rong; Han, Ji-Sheng] Peking Univ, Minist Educ, Key Lab Neurosci, Natl Hlth & Family Planning Commiss, Beijing 100871, Peoples R China; [Jia, Mei-Xiang] Peking Univ, Mental Hlth Inst, Beijing 100871, Peoples R China; [Zhang, Ji-Shui] Capital Univ Med Sci, Beijing Childrens Hosp, Dept Neurol, Beijing, Peoples R China; [Zhang, Ji-Shui] Capital Univ Med Sci, Beijing Childrens Hosp, Ctr Rehabil, Beijing, Peoples R China; [Guo, Yan] Beijing Univ Chinese Med, Dept Ophthalmol, Affiliated Hosp 3, Beijing, Peoples R China; [Wei, Qing-Yun] Beijing Yangguang Youyi Rehabil Ctr, Beijing, Peoples R China; [Zhang, Xiu-Ting] Beijing Tongkang Rehabil Ctr, Beijing, Peoples R China; [Han, Song-Ping] HANS Int Inc, Belle Mead, NJ USA	Peking University; Peking University; Peking University; Peking University; Capital Medical University; Capital Medical University; Beijing University of Chinese Medicine	Zhang, R (corresponding author), Peking Univ, Neurosci Res Inst, Sch Basic Med Sci, Beijing 100871, Peoples R China.	zhangrong@bjmu.edu.cn; hanjisheng@bjmu.edu.cn	XU, XINJIE/GQH-5210-2022; Jia, Mei/GXZ-9967-2022; Zhang, Rong/O-5078-2017; Wang, Minggui/AAR-8281-2020	Zhang, Rong/0000-0002-6889-5571; Wang, Minggui/0000-0001-7682-5859	National Natural Science Foundation of China [81271507]; Peking University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking University(Peking University)	This project was supported by grants from the National Natural Science Foundation of China (81271507, http://www.nsfc.gov.cn/) to JSH. The study was also supported by Peking University Special Project for promoting joint research between basic and clinical sciences (http://www.pku.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ayadhi Laila Y, 2005, Neurosciences (Riyadh), V10, P47; Andari E, 2010, P NATL ACAD SCI USA, V107, P4389, DOI 10.1073/pnas.0910249107; Auyeung B, 2009, BRIT J PSYCHOL, V100, P1, DOI 10.1348/000712608X311731; BANKS WA, 1992, PROG BRAIN RES, V91, P139; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Carter MT, 2013, CLIN GENET, V83, P399, DOI 10.1111/cge.12101; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Ebstein RP, 2012, HORM BEHAV, V61, P359, DOI 10.1016/j.yhbeh.2011.12.014; Green JJ, 2010, NEUROTHERAPEUTICS, V7, P250, DOI 10.1016/j.nurt.2010.05.006; Green LA, 2001, BIOL PSYCHIAT, V50, P609, DOI 10.1016/S0006-3223(01)01139-8; Gregory SG, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-62; Guastella AJ, 2008, BIOL PSYCHIAT, V63, P3, DOI 10.1016/j.biopsych.2007.06.026; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Harony H, 2010, NEUROSIGNALS, V18, P82, DOI 10.1159/000321035; Hollander E, 2003, NEUROPSYCHOPHARMACOL, V28, P193, DOI 10.1038/sj.npp.1300021; Ingudomnuku E, 2007, HORM BEHAV, V51, P597, DOI 10.1016/j.yhbeh.2007.02.001; Keefe DL, 2002, ARCH SEX BEHAV, V31, P401, DOI 10.1023/A:1019883923346; Kose S, 2013, PSYCHIAT CLIN NEUROS, V67, P20, DOI 10.1111/pcn.12005; Kuehn BM, 2011, JAMA-J AM MED ASSOC, V305, P659, DOI 10.1001/jama.2011.117; Lukas M, 2012, BEHAV BRAIN RES; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Mikolajczak M, 2010, BIOL PSYCHOL, V85, P182, DOI 10.1016/j.biopsycho.2010.05.010; Modahl C, 1998, BIOL PSYCHIAT, V43, P270, DOI 10.1016/S0006-3223(97)00439-3; Mohammadi Mohammad Reza, 2012, Iran J Psychiatry, V7, P157; Murakami G, 2011, EUR J NEUROSCI, V34, P469, DOI 10.1111/j.1460-9568.2011.07761.x; Palomba S, 2012, CLIN ENDOCRINOL, V77, P898, DOI 10.1111/j.1365-2265.2012.04443.x; Rellini E, 2004, J AUTISM DEV DISORD, V34, P703, DOI 10.1007/s10803-004-5290-2; Rice Catherine, 2009, Morbidity and Mortality Weekly Report, V58, P1; Ronald A, 2011, AM J MED GENET B, V156B, P255, DOI 10.1002/ajmg.b.31159; Ruta L, 2011, PSYCHONEUROENDOCRINO, V36, P1154, DOI 10.1016/j.psyneuen.2011.02.007; Santangelo SL, 2005, AM J PHARMACOGENOMIC, V5, P71, DOI 10.2165/00129785-200505020-00001; Sarachana T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017116; Schmidtova E, 2010, ENDOCRINOLOGIST, V20, P245, DOI 10.1097/TEN.0b013e3181f661d2; Ufer F, 2013, CLIN ENDOCRINOL, V78, P431, DOI 10.1111/cen.12006; Wheelwright S, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-10; Xu XJ, 2012, NEUROCHEM RES, V37, P2270; Zhang R, 2012, RES DEV DISABIL, V33, P1136, DOI 10.1016/j.ridd.2012.02.001	37	50	53	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74849	10.1371/journal.pone.0074849	http://dx.doi.org/10.1371/journal.pone.0074849			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086383	Green Submitted, Green Published, gold			2022-12-27	WOS:000325218700043
J	Shen, LJ; Chen, FY; Zhang, Y; Cao, LF; Kuang, Y; Zhong, M; Wang, T; Zhong, H				Shen, Li-Jing; Chen, Fang-Yuan; Zhang, Yong; Cao, Lan-Fang; Kuang, Ying; Zhong, Min; Wang, Ting; Zhong, Hua			MYCN Transgenic Zebrafish Model with the Characterization of Acute Myeloid Leukemia and Altered Hematopoiesis	PLOS ONE			English	Article							GENE-EXPRESSION; DNA-DAMAGE; STEM-CELLS; TGF-BETA; C-MYC; DIFFERENTIATION; SCL; PROLIFERATION; ARREST; GROWTH	Background: Amplification of MYCN (N-Myc) oncogene has been reported as a frequent event and a poor prognostic marker in human acute myeloid leukemia (AML). The molecular mechanisms and transcriptional networks by which MYCN exerts its influence in AML are largely unknown. Methodology/Principal Findings: We introduced murine MYCN gene into embryonic zebrafish through a heat-shock promoter and established the stable germline Tg(MYCN: HSE:EGFP) zebrafish. N-Myc downstream regulated gene 1 (NDRG1), negatively controlled by MYCN in human and functionally involved in neutrophil maturation, was significantly under-expressed in this model. Using peripheral blood smear detection, histological section and flow cytometric analysis of single cell suspension from kidney and spleen, we found that MYCN overexpression promoted cell proliferation, enhanced the repopulating activity of myeloid cells and the accumulation of immature hematopoietic blast cells. MYCN enhanced primitive hematopoiesis by upregulating sc1 and Imo2 expression and promoted myelopoiesis by inhibiting gata1 expression and inducing pu.1, mpo expression. Microarray analysis identified that cell cycle, glycolysis/gluconeogenesis, MAPK/Ras, and p53-mediated apoptosis pathways were upregulated. In addition, mismatch repair, transforming and growth factor beta(TGF beta) were downregulated in MYCN-overexpressing blood cells (p<0.01). All of these signaling pathways are critical in the proliferation and malignant transformation of blood cells. Conclusion/Significance: The above results induced by overexpression of MYCN closely resemble the main aspects of human AML, suggesting that MYCN plays a role in the etiology of AML. MYCN reprograms hematopoietic cell fate by regulating NDRG1 and several lineage-specific hematopoietic transcription factors. Therefore, this MYCN transgenic zebrafish model facilitates dissection of MYCN-mediated signaling in vivo, and enables high-throughput scale screens to identify the potential therapeutic targets.	[Shen, Li-Jing; Chen, Fang-Yuan; Zhang, Yong; Zhong, Min; Wang, Ting; Zhong, Hua] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Hematol, Shanghai 200030, Peoples R China; [Cao, Lan-Fang] Shanghai Jiao Tong Univ, Sch Med, Dept Pediat, Renji Hosp, Shanghai 200030, Peoples R China; [Kuang, Ying] Shanghai Res Ctr Biomodel Organisms, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Chen, FY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Hematol, Shanghai 200030, Peoples R China.	chenfangyuan62@163.com	; Rehman, Jalees/J-8258-2012	Marsboom, Glenn/0000-0001-6309-7557; Rehman, Jalees/0000-0002-2787-9292; Zhou, Yongqiang/0000-0003-1402-345X; Toth, Peter/0000-0003-2168-0124; Osburn, Christopher/0000-0002-9334-4202	National Natural Science Foundation of China [30900636]; Science and Technology Commission of Shanghai Municipality Grant [08JCI414900]; Science and Technology Fund Project of Shanghai Jiaotong University School of Medicine [09XJ21066]; Science and Technology Commission of Shanghai Fund Project of TCM guide project [12401906700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality Grant(Science & Technology Commission of Shanghai Municipality (STCSM)); Science and Technology Fund Project of Shanghai Jiaotong University School of Medicine; Science and Technology Commission of Shanghai Fund Project of TCM guide project	This work was supported in part by National Natural Science Foundation of China Grant (30900636), Science and Technology Commission of Shanghai Municipality Grant (08JCI414900), Science and Technology Fund Project of Shanghai Jiaotong University School of Medicine (09XJ21066), Science and Technology Commission of Shanghai Fund Project of TCM guide project (12401906700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JC, 2008, MOL CELL BIOL, V28, P7286, DOI 10.1128/MCB.00752-08; Akers LJ, 2011, LEUKEMIA RES, V35, P814, DOI 10.1016/j.leukres.2010.12.028; Bajoghli B, 2004, DEV BIOL, V271, P416, DOI 10.1016/j.ydbio.2004.04.006; BECKMANN RP, 1992, J CELL BIOL, V117, P1137, DOI 10.1083/jcb.117.6.1137; Bell E, 2007, CELL CYCLE, V6, P1249, DOI 10.4161/cc.6.10.4222; Bell E, 2006, CELL CYCLE, V5, P2639, DOI 10.4161/cc.5.22.3443; Chen J, 2007, LEUKEMIA, V21, P462, DOI 10.1038/sj.leu.2404546; Chen Q, 2008, BLOOD, V111, P4690, DOI 10.1182/blood-2007-09-112904; CUNNIFF NFA, 1993, J BIOL CHEM, V268, P8317; de Boer J, 2011, LEUKEMIA, V25, P321, DOI 10.1038/leu.2010.253; Delgado M Dolores, 2010, Genes Cancer, V1, P605, DOI 10.1177/1947601910377495; Dooley KA, 2005, DEV BIOL, V277, P522, DOI 10.1016/j.ydbio.2004.09.004; El Omari K, 2011, BLOOD, V117, P2146, DOI 10.1182/blood-2010-07-293357; Fujimori H, 2008, J HEPATOL, V48, P962, DOI 10.1016/j.jhep.2008.01.031; Gupta Tripti, 2010, J Vis Exp, DOI 10.3791/1717; Halloran MC, 2000, DEVELOPMENT, V127, P1953; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jagadeeswaran P, 1999, BRIT J HAEMATOL, V107, P731, DOI 10.1046/j.1365-2141.1999.01763.x; Kawagoe H, 2007, CANCER RES, V67, P10677, DOI 10.1158/0008-5472.CAN-07-1118; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Langenau DM, 2005, P NATL ACAD SCI USA, V102, P6068, DOI 10.1073/pnas.0408708102; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Le HY, 2008, J BIOL CHEM, V283, P17652, DOI 10.1074/jbc.M710517200; Levantini E, 2011, EMBO J, V30, P4059, DOI 10.1038/emboj.2011.285; Liao EC, 1998, GENE DEV, V12, P621, DOI 10.1101/gad.12.5.621; Lin YW, 2010, BLOOD, V115, P824, DOI 10.1182/blood-2009-07-233445; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meyer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007768; Milella M, 2001, J CLIN INVEST, V108, P851, DOI 10.1172/JCI200112807; Ng KP, 2011, LEUKEMIA, V25, P1739, DOI 10.1038/leu.2011.159; Paik EJ, 2010, INT J DEV BIOL, V54, P1127, DOI 10.1387/ijdb.093042ep; Patterson LJ, 2007, BLOOD, V109, P2389, DOI 10.1182/blood-2006-02-003087; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Rinaldi A, 2011, BRIT J HAEMATOL, V154, P590, DOI 10.1111/j.1365-2141.2011.08789.x; Rowley AF, 1997, THROMB HAEMOSTASIS, V77, P227; Scandurra M, 2010, HEMATOL ONCOL, V28, P62, DOI 10.1002/hon.932; Shafizadeh E, 2004, CURR OPIN HEMATOL, V11, P255, DOI 10.1097/01.moh.0000138686.15806.71; Sheppard RD, 1998, ONCOGENE, V17, P2073, DOI 10.1038/sj.onc.1202125; Sugihara E, 2006, CANCER RES, V66, P4020, DOI 10.1158/0008-5472.CAN-05-3250; Sun W, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-22; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Tschan MP, 2010, LEUKEMIA RES, V34, P393, DOI 10.1016/j.leukres.2009.08.037; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE, P11; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wu H, 2012, ONCOL LETT, V3, P1119, DOI 10.3892/ol.2012.614; Yeh JRJ, 2008, DEVELOPMENT, V135, P401, DOI 10.1242/dev.008904	47	209	220	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59070	10.1371/journal.pone.0059070	http://dx.doi.org/10.1371/journal.pone.0059070			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	24204740	Green Published, gold, Green Submitted			2022-12-27	WOS:000316409800054
J	Wang, FQ; Wang, L; Xu, ZY; Liang, GL				Wang, Fuqiang; Wang, Ling; Xu, Zhiyang; Liang, Gaolin			Identification and Analysis of Multi-Protein Complexes in Placenta	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; NATIVE GEL-ELECTROPHORESIS; PLASMA-MEMBRANE; PROTEOMIC ANALYSIS; PROTEASOME; UBIQUITINATION; DEGRADATION; PREECLAMPSIA; HOMEOSTASIS; EXPRESSION	Placental malfunction induces pregnancy disorders which contribute to life-threatening complications for both the mother and the fetus. Identification and characterization of placental multi-protein complexes is an important step to integratedly understand the protein-protein interaction networks in placenta which determine placental function. In this study, blue native/sodium dodecyl sulfate polyacrylamide gel electrophoresis (BN/SDS-PAGE) and Liquid chromatography-tandem mass spectrometry (LC-MS/MS) were used to screen the multi-protein complexes in placenta. 733 unique proteins and 34 known and novel heterooligomeric multi-protein complexes including mitochondrial respiratory chain complexes, integrin complexes, proteasome complexes, histone complex, and heat shock protein complexes were identified. A novel protein complex, which involves clathrin and small conductance calcium-activated potassium (SK) channel protein 2, was identified and validated by antibody based gel shift assay, co-immunoprecipitation and immunouorescence staining. These results suggest that BN/SDS-PAGE, when integrated with LC-MS/MS, is a very powerful and versatile tool for the investigation of placental protein complexes. This work paves the way for deeper functional characterization of the placental protein complexes associated with pregnancy disorders.	[Wang, Fuqiang; Liang, Gaolin] Univ Sci & Technol China, Dept Chem, CAS Key Lab Soft Matter Chem, Hefei 230026, Anhui, Peoples R China; [Wang, Fuqiang; Wang, Ling; Xu, Zhiyang] Nanjing Med Univ, Anal Ctr, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Nanjing Medical University	Liang, GL (corresponding author), Univ Sci & Technol China, Dept Chem, CAS Key Lab Soft Matter Chem, Hefei 230026, Anhui, Peoples R China.	gliang@ustc.edu.cn	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	National Natural Science Foundation of China [21175122, 91127036]; Nanjing Medical University [2011NJMU269, 2011NJMU270]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing Medical University	This work was supported by the National Natural Science Foundation of China (Grants 21175122 and 91127036) and Technology Development Key Project Fund of Nanjing Medical University (Grants 2011NJMU269 and 2011NJMU270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell AN, 2011, CELL STEM CELL, V8, P525, DOI 10.1016/j.stem.2011.03.008; Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; CARVER W, 1995, J CELL PHYSIOL, V165, P425, DOI 10.1002/jcp.1041650224; Chenette EJ, 2012, NAT CELL BIOL, V14, P566; Cox B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012526; CRAIG EA, 1993, MICROBIOL REV, V57, P402, DOI 10.1128/MMBR.57.2.402-414.1993; DAMSKY CH, 1994, DEVELOPMENT, V120, P3657; Ekambaram P, 2011, INDIAN J BIOCHEM BIO, V48, P243; Eubel H, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-11; Feikova S, 2000, NEOPLASMA, V47, P212; Garnica AD, 1996, J AM COLL NUTR, V15, P206; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Hayes MJ, 2004, TRAFFIC, V5, P571, DOI 10.1111/j.1600-0854.2004.00210.x; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Johnstone ED, 2011, PROTEOMICS, V11, P4077, DOI 10.1002/pmic.201000505; Katz A, 2007, MOL CELL PROTEOMICS, V6, P1459, DOI 10.1074/mcp.M700002-MCP200; Lafond J, 2006, INT REV CYTOL, V250, P109, DOI 10.1016/S0074-7696(06)50004-X; Lemarie A, 2011, ONCOGENE, V30, P3985, DOI 10.1038/onc.2011.167; LEWIS PN, 1976, CAN J BIOCHEM CELL B, V54, P641, DOI 10.1139/o76-093; Li XW, 2009, J PROTEOME RES, V8, P3475, DOI 10.1021/pr900101d; Lipkowitz S, 2003, BREAST CANCER RES, V5, P8, DOI 10.1186/bcr541; Liu K, 2009, MOL CELL PROTEOMICS, V8, P495, DOI 10.1074/mcp.M800250-MCP200; Mari G, 2007, CLIN OBSTET GYNECOL, V50, P497, DOI 10.1097/GRF.0b013e31804c96a9; Marin R, 2008, PLACENTA, V29, P671, DOI 10.1016/j.placenta.2008.06.003; Pedarzani P, 2008, CELL MOL LIFE SCI, V65, P3196, DOI 10.1007/s00018-008-8216-x; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Reisinger Veronika, 2007, Proteomics, V7 Suppl 1, P6, DOI 10.1002/pmic.200700205; Robinson JM, 2008, PLACENTA, V29, P135, DOI 10.1016/j.placenta.2007.12.005; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schmitt HP, 2006, MED HYPOTHESES, V67, P311, DOI 10.1016/j.mehy.2006.02.023; Smart EJ, 2004, P NATL ACAD SCI USA, V101, P3450, DOI 10.1073/pnas.0400441101; Soltys BJ, 1996, EXP CELL RES, V222, P16, DOI 10.1006/excr.1996.0003; Streicher WW, 2009, BIOCHEMISTRY-US, V48, P2788, DOI 10.1021/bi8019959; Thorn SR, 2011, SEMIN REPROD MED, V29, P225, DOI 10.1055/s-0031-1275516; Ueki H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00827; Van Blerkom J, 2009, SEMIN CELL DEV BIOL, V20, P354, DOI 10.1016/j.semcdb.2008.12.005; Wang HX, 2006, J CELL PHYSIOL, V206, P616, DOI 10.1002/jcp.20508; Williamson R, 2002, J NEUROSCI, V22, P10, DOI 10.1523/JNEUROSCI.22-01-00010.2002; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Zhang HJ, 2012, DEVELOPMENT, V139, P2071, DOI 10.1242/dev.077347; Zhang Q, 2010, PROTEOM CLIN APPL, V4, P538, DOI 10.1002/prca.200900048; Zhang Y, 2008, PROTEOMICS, V8, P4344, DOI 10.1002/pmic.200800294	46	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62988	10.1371/journal.pone.0062988	http://dx.doi.org/10.1371/journal.pone.0062988			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23638173	Green Published, gold, Green Submitted			2022-12-27	WOS:000321662800072
J	Wang, F; Song, XX; Li, XJ; Xin, J; Wang, SX; Yang, WD; Wang, J; Wu, KC; Chen, XY; Liang, JM; Tian, J; Cao, F				Wang, Fu; Song, Xinxing; Li, Xiujuan; Xin, Jing; Wang, Shenxu; Yang, Weidong; Wang, Jing; Wu, Kaichun; Chen, Xiaoyuan; Liang, Jimin; Tian, Jie; Cao, Feng			Noninvasive Visualization of MicroRNA-16 in the Chemoresistance of Gastric Cancer Using a Dual Reporter Gene Imaging System	PLOS ONE			English	Article							DRUG-RESISTANCE; MAPK PATHWAYS; CELLS; CHEMOTHERAPY; ACTIVATION	MicroRNAs (miRNAs) have been implicated to play a central role in the development of drug resistance in a variety of malignancies. However, many studies were conducted at the in vitro level and could not provide the in vivo information on the functions of miRNAs in the anticancer drug resistance. Here, we introduced a dual reporter gene imaging system for noninvasively monitoring the kinetic expression of miRNA-16 during chemoresistance in gastric cancer both in vitro and in vivo. Human sodium iodide symporter (hNIS) and firefly luciferase (Fluc) genes were linked to form hNIS/Fluc double fusion reporter gene and then generate human gastric cancer cell line NF-3xmir16 and its multidrug resistance cell line NF-3xmir16/VCR. Radioiodide uptake and Fluc luminescence signals in vitro correlated well with viable cell numbers. The luciferase activities and radioiodide uptake in NF-3xmir16 cells were remarkably repressed by exogenous or endogenous miRNA-16. The NF-3xmir16/VCR cells showed a significant increase of I-131 uptake and luminescence intensity compared to NF-3xmir16 cells. The radioactivity from in vivo Tc-99m-pertechnetate imaging and the intensity from bioluminescence imaging were also increased in NF-3xmir16/VCR compared with that in NF-3xmir16 tumor xenografts. Furthermore, using this reporter gene system, we found that etoposide (VP-16) and 5-fluorouracil (5-FU) activated miRNA-16 expression in vitro and in vivo, and the upregulation of miRNA-16 is p38MAPK dependent but NF-kappa B independent. This dual imaging reporter gene may be served as a novel tool for in vivo imaging of microRNAs in the chemoresistance of cancers, as well as for early detection and diagnosis in clinic.	[Wang, Fu; Xin, Jing; Liang, Jimin] Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China; [Wang, Fu; Song, Xinxing; Li, Xiujuan; Wang, Shenxu; Cao, Feng] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Shaanxi, Peoples R China; [Wang, Fu; Song, Xinxing; Li, Xiujuan; Wang, Shenxu; Cao, Feng] Fourth Mil Med Univ, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Yang, Weidong; Wang, Jing] Fourth Mil Med Univ, Xijing Hosp, Dept Nucl Med, Xian 710032, Shaanxi, Peoples R China; [Wu, Kaichun] Fourth Mil Med Univ, Xijing Hosp, Dept Digest Dis, Xian 710032, Shaanxi, Peoples R China; [Chen, Xiaoyuan] Natl Inst Biomed Imaging & Bioengn, Lab Mol Imaging & Nanomed, NIH, Bethesda, MD USA; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China	Xidian University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); Chinese Academy of Sciences; Institute of Automation, CAS	Liang, JM (corresponding author), Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China.	jimleung@mail.xidian.edu.cn; tian@ieee.org; wind8828@gmail.com	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	Program of the National Basic Research and Development Program of China (973) [2012CB518101, 2011CB707702]; National Natural Science Foundation of China [81090272, 81090274, 81227901]; China Department of Education [2010CXTD01]; 863 Program of China [2012AA02A603]; National Key Technology Support Program [2012BAI23B06]	Program of the National Basic Research and Development Program of China (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Department of Education; 863 Program of China(National High Technology Research and Development Program of China); National Key Technology Support Program(National Key Technology R&D Program)	This work was supported by the Program of the National Basic Research and Development Program of China (973) under Grant No. 2012CB518101, 2011CB707702, the National Natural Science Foundation of China under Grant Nos. 81090272, 81090274, 81227901, Innovation Team Development Grant by China Department of Education (2010CXTD01), 863 Program of China (2012AA02A603) and the National Key Technology Support Program under Grant No. 2012BAI23B06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KE, 2010, MOL CANCER THER, V9, P3126, DOI 10.1158/1535-7163.MCT-10-0397; Baguley BC, 2010, MOL BIOTECHNOL, V46, P308, DOI 10.1007/s12033-010-9321-2; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blasberg RG, 2002, J CELL BIOCHEM, P172, DOI 10.1002/jcb.10433; Boldt S, 2002, CARCINOGENESIS, V23, P1831, DOI 10.1093/carcin/23.11.1831; Broxterman HJ, 2009, DRUG RESIST UPDATE, V12, P114, DOI 10.1016/j.drup.2009.07.001; Chung JK, 2002, J NUCL MED, V43, P1188; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Jo MH, 2012, BIOMATERIALS, V33, P6456, DOI 10.1016/j.biomaterials.2012.05.057; Kang JH, 2008, J NUCL MED, V49, p164S, DOI 10.2967/jnumed.107.045955; Kang WJ, 2012, BIOMATERIALS, V33, P6430, DOI 10.1016/j.biomaterials.2012.05.056; Kim JK, 2012, BIOMATERIALS, V33, P207, DOI 10.1016/j.biomaterials.2011.09.023; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Ma J, 2010, CANCER GENE THER, V17, P523, DOI 10.1038/cgt.2010.18; Mansouri A, 2003, J BIOL CHEM, V278, P19245, DOI 10.1074/jbc.M208134200; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Rivera F, 2007, CANCER TREAT REV, V33, P315, DOI 10.1016/j.ctrv.2007.01.004; Sarkar FH, 2010, DRUG RESIST UPDATE, V13, P57, DOI 10.1016/j.drup.2010.02.001; TROPPMAIR J, 1994, J BIOL CHEM, V269, P7030; Wang F, 2011, EUR J NUCL MED MOL I, V38, P1572, DOI 10.1007/s00259-011-1786-0; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Yang SY, 2011, INT J ONCOL, V38, P1695, DOI 10.3892/ijo.2011.982; Zheng TS, 2010, INT J CANCER, V126, P2, DOI 10.1002/ijc.24782	25	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61792	10.1371/journal.pone.0061792	http://dx.doi.org/10.1371/journal.pone.0061792			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23638173	gold, Green Submitted, Green Published			2022-12-27	WOS:000317907200086
J	Wang, F; Hu, CM; Hua, XT; Song, L; Xia, QY				Wang, Fei; Hu, Cuimei; Hua, Xiaoting; Song, Liang; Xia, Qingyou			Translationally Controlled Tumor Protein, a Dual Functional Protein Involved in the Immune Response of the Silkworm, Bombyx mori	PLOS ONE			English	Article							HISTAMINE-RELEASING FACTOR; DROSOPHILA-MELANOGASTER; PATHOGEN RECOGNITION; CELL-PROLIFERATION; SCAVENGER RECEPTOR; INNATE IMMUNITY; PHAGE DISPLAY; TCTP; IDENTIFICATION; INFECTION	Insect gut immunity is the first line of defense against oral infection. Although a few immune-related molecules in insect intestine has been identified by genomics or proteomics approach with comparison to well-studied tissues, such as hemolymph or fat body, our knowledge about the molecular mechanism underlying the gut immunity which would involve a variety of unidentified molecules is still limited. To uncover additional molecules that might take part in pathogen recognition, signal transduction or immune regulation in insect intestine, a T7 phage display cDNA library of the silkworm midgut is constructed. By use of different ligands for biopanning, Translationally Controlled Tumor Protein (TCTP) has been selected. BmTCTP is produced in intestinal epithelial cells and released into the gut lumen. The protein level of BmTCTP increases at the early time points during oral microbial infection and declines afterwards. In vitro binding assay confirms its activity as a multi-ligand binding molecule and it can further function as an opsonin that promotes the phagocytosis of microorganisms. Moreover, it can induce the production of anti-microbial peptide via a signaling pathway in which ERK is required and a dynamic tyrosine phosphorylation of certain cytoplasmic membrane protein. Taken together, our results characterize BmTCTP as a dual-functional protein involved in both the cellular and the humoral immune response of the silkworm, Bombyx mori.	[Wang, Fei; Hu, Cuimei; Hua, Xiaoting; Song, Liang; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China	Southwest University - China	Xia, QY (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	xiaqy@swu.edu.cn	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	National Basic Research Program of China [2012CB114600]; Natural Science Foundation of China [31201854]; Fundamental Research Funds for the Central Universities [XDJK2009B033]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the grant of "National Basic Research Program of China'' (http://www.973.gov.cn/Default_3.aspx) (2012CB114600), "Natural Science Foundation of China'' (http://www.nsfc.gov.cn/Portal0/default152.htm) (31201854) and "Fundamental Research Funds for the Central Universities'' (XDJK2009B033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amson R, 2012, NAT MED, V18, P91, DOI 10.1038/nm.2546; Amzallag N, 2004, J BIOL CHEM, V279, P46104, DOI 10.1074/jbc.M404850200; Aoun RB, 2011, J INNATE IMMUN, V3, P52, DOI 10.1159/000321554; Chen SH, 2007, MOL BIOL CELL, V18, P2525, DOI 10.1091/mbc.E07-02-0188; Chen TS, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-16; Chung YSA, 2011, J BIOL CHEM, V286, P26524, DOI 10.1074/jbc.M110.214007; Cronin SJF, 2009, SCIENCE, V325, P340, DOI 10.1126/science.1173164; Davis MM, 2012, J INNATE IMMUN, V4, P273, DOI 10.1159/000332947; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; Govind S, 2008, INSECT SCI, V15, P29, DOI 10.1111/j.1744-7917.2008.00185.x; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; He NH, 2005, ANTIVIR RES, V66, P39, DOI 10.1016/j.antiviral.2004.12.010; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Hu XL, 2012, MOL BIOL REP, V39, P3427, DOI 10.1007/s11033-011-1114-6; Huang JX, 2012, ANTIMICROB AGENTS CH, V56, P4569, DOI 10.1128/AAC.00567-12; Huang LL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008098; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jung J, 2004, J BIOL CHEM, V279, P49868, DOI 10.1074/jbc.M400895200; Kashiwakura JI, 2012, J CLIN INVEST, V122, P218, DOI 10.1172/JCI59072; Kim CH, 2010, J BIOL CHEM, V285, P25243, DOI 10.1074/jbc.M110.134940; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Lee JM, 2004, COMP BIOCHEM PHYS B, V139, P35, DOI 10.1016/j.cbpc.2004.06.004; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; Meyvis Y, 2009, INT J PARASITOL, V39, P1205, DOI 10.1016/j.ijpara.2009.02.017; Nayak S, 2010, FISH SHELLFISH IMMUN, V29, P544, DOI 10.1016/j.fsi.2010.05.010; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; Nie ZM, 2010, MOL BIOL REP, V37, P2621, DOI 10.1007/s11033-009-9787-9; Niikura M, 2004, POULTRY SCI, V83, P1117, DOI 10.1093/ps/83.7.1117; Nupan B, 2011, DEV COMP IMMUNOL, V35, P469, DOI 10.1016/j.dci.2010.11.016; Ochiai M, 2000, J BIOL CHEM, V275, P4995, DOI 10.1074/jbc.275.7.4995; Oliveira GD, 2012, SCIENCE, V335, P856, DOI 10.1126/science.1209678; Pan MH, 2010, TISSUE CELL, V42, P42, DOI 10.1016/j.tice.2009.07.002; Panrat T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033291; Pauchet Y, 2009, J BIOL CHEM, V284, P2214, DOI 10.1074/jbc.M806204200; Pauchet Y, 2008, J PROTEOME RES, V7, P1629, DOI 10.1021/pr7006208; PEARSON A, 1995, P NATL ACAD SCI USA, V92, P4056, DOI 10.1073/pnas.92.9.4056; Ponnuvel KM, 2003, J VIROL, V77, P10725, DOI 10.1128/JVI.77.19.10725-10729.2003; Popova-Butler A, 2009, J INSECT PHYSIOL, V55, P264, DOI 10.1016/j.jinsphys.2008.12.008; Povelones M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002023; Rinnerthaler M, 2006, BBA-BIOENERGETICS, V1757, P631, DOI 10.1016/j.bbabio.2006.05.022; Shitomi Y, 2006, J BIOCHEM, V139, P223, DOI 10.1093/jb/mvj024; Song KH, 2008, J INSECT PHYSIOL, V54, P1271, DOI 10.1016/j.jinsphys.2008.06.010; Sunagar SG, 2011, J INSECT PHYSIOL, V57, P1707, DOI 10.1016/j.jinsphys.2011.09.009; Thaw P, 2001, NAT STRUCT BIOL, V8, P701, DOI 10.1038/90415; Tonganunt M, 2008, FISH SHELLFISH IMMUN, V25, P633, DOI 10.1016/j.fsi.2008.08.006; Venugopal T, 2005, COMP BIOCHEM PHYS B, V142, P8, DOI 10.1016/j.cbpc.2005.04.011; Vonakis BM, 2008, BLOOD, V111, P1789, DOI 10.1182/blood-2007-07-104364; Wang F, 2009, EUR J IMMUNOL, V39, P254, DOI 10.1002/eji.200838472; Wang LH, 2006, IMMUNOBIOLOGY, V211, P251, DOI 10.1016/j.imbio.2006.01.001; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Wu S, 2010, DEV COMP IMMUNOL, V34, P1191, DOI 10.1016/j.dci.2010.06.013; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; Zhang J, 2012, P NATL ACAD SCI USA, V109, pE926, DOI 10.1073/pnas.1106300109; Zhang S, 2011, COMP FUNCT GENOM, DOI 10.1155/2011/876064	55	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69284	10.1371/journal.pone.0069284	http://dx.doi.org/10.1371/journal.pone.0069284			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23638173	Green Submitted, Green Published, gold			2022-12-27	WOS:000322132100052
J	Wang, FQ; Wang, L; Shi, ZH; Liang, GL				Wang, Fuqiang; Wang, Ling; Shi, Zhonghua; Liang, Gaolin			Comparative N-Glycoproteomic and Phosphoproteomic Profiling of Human Placental Plasma Membrane between Normal and Preeclampsia Pregnancies with High-Resolution Mass Spectrometry	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; LATE-ONSET PREECLAMPSIA; UTERINE ARTERY DOPPLER; METASTASIS SUPPRESSOR; SIGNALING NETWORKS; QUANTITATIVE PROTEOMICS; TROPHOBLAST INVASION; IN-VITRO; EXPRESSION; KISS-1	Preeclampsia is a serious complication of pregnancy, which affects 2-8% of all pregnancies and is one of the leading causes of maternal and perinatal mortality and morbidity worldwide. To better understand the molecular mechanisms involved in pathological development of placenta in preeclampsia, we used high-resolution LC-MS/MS technologies to construct a comparative N-glycoproteomic and phosphoproteomic profiling of human placental plasma membrane in normal and preeclamptic pregnancies. A total of 1027 N-glyco-and 2094 phospho-sites were detected in human placental plasma membrane, and 5 N-glyco-and 38 phospho-proteins, respectively, with differentially expression were definitively identified between control and preeclamptic placental plasma membrane. Further bioinformatics analysis indicated that these differentially expressed proteins correlate with several specific cellular processes occurring during pathological changes of preeclamptic placental plasma membrane.	[Wang, Fuqiang; Liang, Gaolin] Univ Sci & Technol China, Dept Chem, CAS Key Lab Soft Matter Chem, Hefei, Anhui, Peoples R China; [Wang, Fuqiang; Wang, Ling; Shi, Zhonghua] Nanjing Med Univ, State Key Lab Reprod Med, Anal Ctr, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Nanjing Medical University	Liang, GL (corresponding author), Univ Sci & Technol China, Dept Chem, CAS Key Lab Soft Matter Chem, Hefei, Anhui, Peoples R China.	gliang@ustc.edu.cn	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	National Natural Science Foundation of China [21175122, 91127036]; Technology Development Key Project Fund of Nanjing Medical University [2011NJMU269, 2011NJMU270]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Technology Development Key Project Fund of Nanjing Medical University	This work was supported by the National Natural Science Foundation of China (Grants 21175122 and 91127036) and Technology Development Key Project Fund of Nanjing Medical University (Grants 2011NJMU269 and 2011NJMU270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck BH, 2010, EUR J CANCER, V46, P1283, DOI 10.1016/j.ejca.2010.02.023; Bilban M, 2004, J CELL SCI, V117, P1319, DOI 10.1242/jcs.00971; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Cartwright JE, 2012, J ENDOCRINOL, V214, P79, DOI 10.1530/JOE-12-0091; Crispi F, 2008, ULTRASOUND OBST GYN, V31, P303, DOI 10.1002/uog.5184; Danussi C, 2012, CANCER PREV RES, V5, P1131, DOI 10.1158/1940-6207.CAPR-12-0076-T; Danussi C, 2011, J CELL BIOL, V195, P131, DOI 10.1083/jcb.201008013; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Eastabrook G, 2011, BEST PRACT RES CL OB, V25, P435, DOI 10.1016/j.bpobgyn.2011.01.005; Fleischer S, 1974, Methods Enzymol, V31, P6; Hiden U, 2007, REV ENDOCR METAB DIS, V8, P31, DOI 10.1007/s11154-007-9030-8; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Ilic D, 2001, AM J PATHOL, V159, P93, DOI 10.1016/S0002-9440(10)61677-X; Janneau JL, 2002, J CLIN ENDOCR METAB, V87, P5336, DOI 10.1210/jc.2002-021093; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Li CF, 2012, PLACENTA, V33, P47, DOI 10.1016/j.placenta.2011.10.008; Mead EJ, 2007, BRIT J PHARMACOL, V151, P1143, DOI 10.1038/sj.bjp.0707295; MEEKINS JW, 1994, BRIT J OBSTET GYNAEC, V101, P669, DOI 10.1111/j.1471-0528.1994.tb13182.x; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Oudejans CBM, 2007, HUM GENET, V120, P607, DOI 10.1007/s00439-006-0259-1; Park DW, 2012, AM J REPROD IMMUNOL, V67, P132, DOI 10.1111/j.1600-0897.2011.01073.x; Ping C, 2007, SCI CHINA SER C, V50, P731, DOI 10.1007/s11427-007-0103-4; Plasencia W, 2008, ULTRASOUND OBST GYN, V32, P138, DOI 10.1002/uog.5402; Qiao Chong, 2005, Zhonghua Fu Chan Ke Za Zhi, V40, P585; [乔宠 Qiao Chong], 2003, [中国实用妇科与产科杂志, Chineses Journal of Practical Gynecology and Obstetrics], V19, P289; Qin HQ, 2013, CHEM COMMUN, V49, P5162, DOI 10.1039/c3cc41479e; Raymond D, 2011, OBSTET GYNECOL SURV, V66, P497, DOI 10.1097/OGX.0b013e3182331028; Roseweir AK, 2012, PLACENTA, V33, P408, DOI 10.1016/j.placenta.2012.02.001; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Staun-Ram Elsebeth, 2004, Reprod Biol Endocrinol, V2, P59, DOI 10.1186/1477-7827-2-59; Takino T, 2003, ONCOGENE, V22, P4617, DOI 10.1038/sj.onc.1206542; Tena-Sempere M, 2008, NAT MED, V14, P1196, DOI 10.1038/nm1108-1196; Thelemann A, 2005, MOL CELL PROTEOMICS, V4, P356, DOI 10.1074/mcp.M400118-MCP200; Vazquez-Alaniz F, 2011, EUR J OBSTET GYN R B, V159, P67, DOI 10.1016/j.ejogrb.2011.07.019; von Dadelszen P, 2003, HYPERTENS PREGNANCY, V22, P143, DOI 10.1081/PRG-120021060; Walker JJ, 2000, LANCET, V356, P1260, DOI 10.1016/S0140-6736(00)02800-2; Wolf-Yadlin A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100094; Xu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016046; Xu P, 2001, BIOL REPROD, V65, P240, DOI 10.1095/biolreprod65.1.240; Yan CH, 2001, J BIOL CHEM, V276, P1164, DOI 10.1074/jbc.M008681200; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200	43	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80480	10.1371/journal.pone.0080480	http://dx.doi.org/10.1371/journal.pone.0080480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	23638173	Green Published, Green Submitted, gold			2022-12-27	WOS:000327258600065
J	Wang, FP; Li, L; Li, J; Wang, JY; Wang, LY; Jiang, W				Wang, Fu-ping; Li, Lei; Li, Jing; Wang, Ji-yao; Wang, Ling-yan; Jiang, Wei			RETRACTED: High Mobility Group Box-1 Promotes the Proliferation and Migration of Hepatic Stellate Cells via TLR4-Dependent Signal Pathways of PI3K/Akt and JNK (Retracted article. See vol. 14, 2019)	PLOS ONE			English	Article; Retracted Publication							GLYCATION END-PRODUCTS; RECEPTOR 4; LIVER FIBROSIS; KAPPA-B; HMGB1; PROTEIN; RAT; EXPRESSION; APOPTOSIS; INFLAMMATION	Background: The migration of hepatic stellate cells (HSCs) is essential to the hepatic fibrotic response, and recently High-mobility group box 1 (HMGB1) has been shown up-regulated during liver fibrosis. Nevertheless, whether HMGB1 can modulate the proliferation and migration of HSCs is poorly understood, as well as the involved intracellular signaling. In this study, we examined the effect of HMGB1 on proliferation, migration, pro-fibrotic function of HSCs and investigated whether toll-like family of receptor 4 (TLR4) dependent signal pathway is involved in the intracellular signaling regulation. Methodology/Principal Findings: Modified transwell chamber system to mimic the space of Disse was used to evaluate the migration of human primary HSCs, and the protein expressions of related signal factors were evaluated by western blot. Cell proliferation was analyzed by MTT assay, the pro-fibrotic functions of HSCs by qRT-PCR and ELISA respectively. Recombinant human HMGB1 could significantly promote migration of HSCs under both haptotactic and chemotactic stimulation, especially the latter. Human TLR4 neutralizing antibody could markedly inhibit HMGB1-induced migration of HSCs. HMGB1 could enhance the phosphorylation of JNK and PI3K/Akt, and TLR4 neutralizing antibody inhibited HMGB1-enhanced phosphorylation of JNK and PI3K/Akt and activation of NF-kappa B. JNK inhibitor (SP600125) and PI3K inhibitor (LY 294002) significantly inhibited HMGB1-induced proliferation and migration of HSCs, and also reduced HMGB1-enhanced related collagen expressions and pro-fibrotic cytokines production. Conclusions/Significance: HMGB1 could significantly enhance migration of HSCs in vitro, and TLR4-dependent JNK and PI3K/Akt signal pathways are involved in the HMGB1-induced proliferation, migration and pro-fibrotic effects of HSCs, which indicates HMGB1 might be an effective target to treat liver fibrosis.	[Wang, Fu-ping; Li, Lei; Wang, Ji-yao; Jiang, Wei] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China; [Li, Jing] Tongji Univ, Tongji Hosp, Dept Gastroenterol, Shanghai 200092, Peoples R China; [Wang, Ling-yan] Fudan Univ, Zhongshan Hosp, Biomed Res Ctr, Shanghai 200433, Peoples R China	Fudan University; Tongji University; Fudan University	Jiang, W (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China.	jiang.wei@zs-hospital.sh.cn	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	National Nature Science Foundation of China [30300151, 81070341]; Shanghai Nature Science Foundation [09ZR1406000]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Nature Science Foundation	This study is supported by grants from the National Nature Science Foundation of China (No. 30300151 &81070341, http://www.nsfc.gov.cn) and Shanghai Nature Science Foundation (No. 09ZR1406000, http://www.stcsm.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Bai D, 2009, INT J CANCER, V125, P2863, DOI 10.1002/ijc.24748; Beaulieu JM, 2007, TRENDS PHARMACOL SCI, V28, P166, DOI 10.1016/j.tips.2007.02.006; Brenner DA, 2000, J HEPATOL, V32, P32, DOI 10.1016/S0168-8278(00)80413-4; Chen GQ, 2004, J INTERF CYTOK RES, V24, P329, DOI 10.1089/107999004323142187; Chen XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050668; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Fehrenbach H, 2001, HEPATOLOGY, V34, P943, DOI 10.1053/jhep.2001.28788; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Hamada N, 2008, AM J RESP CELL MOL, V39, P440, DOI 10.1165/rcmb.2007-0330OC; He ZY, 2009, J RECEPT SIG TRANSD, V29, P119, DOI 10.1080/10799890902845690; Ilmakunnas M, 2008, LIVER TRANSPLANT, V14, P1517, DOI 10.1002/lt.21573; Inoue R, 2005, BRIT J PHARMACOL, V146, P633, DOI 10.1038/sj.bjp.0706373; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Ito I, 2007, J BIOL CHEM, V282, P16336, DOI 10.1074/jbc.M608467200; Kao YH, 2008, TRANSPL P, V40, P2704, DOI 10.1016/j.transproceed.2008.07.055; Kim CH, 2010, INT J ONCOL, V36, P117, DOI 10.3892/ijo_00000482; Kim DE, 2012, BIOCHEM BIOPH RES CO, V421, P436, DOI 10.1016/j.bbrc.2012.03.131; Kim SY, 2012, BIOCHEM BIOPH RES CO, V419, P466, DOI 10.1016/j.bbrc.2012.02.015; Lang A, 2000, J HEPATOL, V33, P49, DOI 10.1016/S0168-8278(00)80159-2; Lange SS, 2008, P NATL ACAD SCI USA, V105, P10320, DOI 10.1073/pnas.0803181105; Li L, 2012, LIVER INT, V32, P1093, DOI 10.1111/j.1478-3231.2012.02809.x; Lin YL, 2009, J GASTROEN HEPATOL, V24, P453, DOI 10.1111/j.1440-1746.2008.05573.x; Lohwasser C, 2009, WORLD J GASTROENTERO, V15, P5789, DOI 10.3748/wjg.15.5789; Ma JJ, 2009, LIVER INT, V29, P567, DOI 10.1111/j.1478-3231.2009.01981.x; Mitola S, 2006, J IMMUNOL, V176, P12, DOI 10.4049/jimmunol.176.1.12; Nogueira-Machado JA, 2011, EXPERT OPIN THER TAR, V15, P1023, DOI 10.1517/14728222.2011.575360; Novo E, 2012, J PATHOL, V226, P588, DOI 10.1002/path.3005; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Pradere JP, 2010, SEMIN LIVER DIS, V30, P232, DOI 10.1055/s-0030-1255353; Rauvala H, 2010, BBA-GENE REGUL MECH, V1799, P164, DOI 10.1016/j.bbagrm.2009.11.012; Reif S, 2003, J BIOL CHEM, V278, P8083, DOI 10.1074/jbc.M212927200; Reyes-Gordillo K, 2011, AM J PATHOL, V178, P2100, DOI 10.1016/j.ajpath.2011.01.025; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schnabl B, 2008, BIOCHEM BIOPH RES CO, V375, P210, DOI 10.1016/j.bbrc.2008.07.150; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Son G, 2009, HEPATOLOGY, V50, P1512, DOI 10.1002/hep.23186; Tang XM, 2009, BIOL PHARM BULL, V32, P963, DOI 10.1248/bpb.32.963; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Uyama N, 2012, LAB INVEST, V92, P57, DOI 10.1038/labinvest.2011.150; Vinas O, 2003, HEPATOLOGY, V38, P919, DOI 10.1053/jhep.2003.50392; Wang X, 2011, J HEPATOL, V55, P379, DOI 10.1016/j.jhep.2010.10.040; Xia JR, 2008, INT J MOL SCI, V9, P638, DOI 10.3390/ijms9040638; Yamada S, 2007, CLIN CHIM ACTA, V375, P36, DOI 10.1016/j.cca.2006.07.019; Yang CQ, 2003, GASTROENTEROLOGY, V124, P147, DOI 10.1053/gast.2003.50012; Yang J, 2012, MOL BIOL REP, V39, P3361, DOI 10.1007/s11033-011-1106-6; Yang LC, 2012, LEUKEMIA LYMPHOMA, V53, P315, DOI 10.3109/10428194.2011.616962	48	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64373	10.1371/journal.pone.0064373	http://dx.doi.org/10.1371/journal.pone.0064373			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23638173	Green Published, gold			2022-12-27	WOS:000319081900089
J	Li, YY; Xie, J; Wu, SY; Xia, J; Zhang, PF; Liu, C; Zhang, P; Huang, X				Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi			Protein Kinase Regulated by dsRNA Downregulates the Interferon Production in Dengue Virus- and dsRNA-Stimulated Human Lung Epithelial Cells	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; PKR-DEPENDENT ACTIVATION; CELLULAR ACTIVATOR; RIG-I; BINDING PROTEIN; ADAPTER IPS-1; INDUCTION; INFECTION; TRANSLATION	Background: Dengue virus (DENV) is found in the tropical and subtropical regions and affects millions of people annually. Currently, no specific vaccine or antiviral treatment against dengue virus is available. Innate immunity has been shown to be important for host resistance to DENV infection. Although protein kinase regulated by double-stranded RNA (PKR) has been found to promote the innate signaling in response to infection by several viruses, its role in the innate response to DENV infection is still unclear. Our study aimed to investigate the role of PKR in DENV-induced innate immune responses. Methodology/Principal Findings: By RNAi, silencing of PKR significantly enhanced the expression of interferon (IFN)-beta in DENV infected human lung epithelial A549 cells. Western blot and immunofluorescence microscopy data showed that PKR knockdown upregulated the activation of innate signaling cascades including p38 and JNK mitogen-activated protein kinases (MAPKs), interferon regulatory factor-3 and NF-kappa B, following DENV2 infection. Likewise, a negative regulatory effect of PKR on the IFN production was also observed in poly(IC) challenged cells. Moreover, the PKR knockdown-mediated IFN induction was attenuated by RIG-I or IPS-1 silencing. Finally, overexpression of a catalytically inactive PKR mutant (K296R), but not of a mutant lacking dsRNA binding activity (K64E) or the double mutant (K64EK296R), reversed the IFN induction mediated by PKR knockdown, suggesting that the dsRNA binding activity is required for PKR to downregulate IFN production. Conclusions/Significance: PKR acts as a negative regulator of IFN induction triggered by DENVs and poly(IC), and this regulation relies on its dsRNA binding activity. These findings reveal a novel regulatory role for PKR in innate immunity, suggesting that PKR might be a promising target for anti-DENV treatments.	[Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi] Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Immunol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhang, P (corresponding author), Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Immunol, Guangzhou 510275, Guangdong, Peoples R China.	zhangp36@mail.sysu.edu.cn; huangxi6@mail.sysu.edu.cn	Liu, Hongliang/P-3444-2014; Scott, Colin/A-4682-2009; Oakeshott, John/B-5365-2009; Teese, Mark George/B-4307-2008; Chen, Huaping/O-3096-2014	Liu, Hongliang/0000-0001-7639-0904; Scott, Colin/0000-0001-6110-6982; Oakeshott, John/0000-0001-8324-7874; Tollefsbol, Trygve/0000-0002-0284-1511; Li, Yong/0000-0002-3595-6673; Li, Yongwen/0000-0001-6102-2949; Teese, Mark George/0000-0002-8003-4918; HUANG, XI/0000-0002-4829-8390; Song, Yajun/0000-0002-6628-2747; Chen, Huaping/0000-0002-9835-5138; Yang, Xianwei/0000-0003-4388-9674	National Natural Science Foundation of China [30972763, 81261160323, 81171576, 30901345, U0832006]; Guangdong innovative research team program [2009010058]; Guangdong Province Universities and Colleges Pearl River School Funded Scheme [2009]; Guangdong Natural Science Foundation [10251008901000013]; National Basic Research Program of China [2010CB530004]; Doctoral Fund of Ministry of Education of China [20100171110047]; Fundamental Research Funds for the Central Universities of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong innovative research team program; Guangdong Province Universities and Colleges Pearl River School Funded Scheme; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); National Basic Research Program of China(National Basic Research Program of China); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (30972763, 81261160323, 81171576, 30901345, U0832006), Guangdong innovative research team program (NO. 2009010058), Guangdong Province Universities and Colleges Pearl River School Funded Scheme (NO. 2009), Guangdong Natural Science Foundation (10251008901000013), National Basic Research Program of China (2010CB530004), Doctoral Fund of Ministry of Education of China (20100171110047), Fundamental Research Funds for the Central Universities of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Arnaud N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002289; Arnaud N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010575; Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888; Barry G, 2009, J GEN VIROL, V90, P1382, DOI 10.1099/vir.0.007336-0; Bonnet MC, 2006, CELL SIGNAL, V18, P1865, DOI 10.1016/j.cellsig.2006.02.010; Bonnet MC, 2000, MOL CELL BIOL, V20, P4532, DOI 10.1128/MCB.20.13.4532-4542.2000; Boonyaratanakornkit J, 2011, J VIROL, V85, P1495, DOI 10.1128/JVI.01297-10; Brown MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034055; Cheung BKW, 2005, J IMMUNOL, V175, P7218, DOI 10.4049/jimmunol.175.11.7218; COLTHURST DR, 1987, EUR J BIOCHEM, V166, P357, DOI 10.1111/j.1432-1033.1987.tb13523.x; Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000; Diamond MS, 2001, VIROLOGY, V289, P297, DOI 10.1006/viro.2001.1114; Garaigorta U, 2009, CELL HOST MICROBE, V6, P513, DOI 10.1016/j.chom.2009.11.004; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gil J, 2000, APOPTOSIS, V5, P107, DOI 10.1023/A:1009664109241; Gil J, 2004, MOL CELL BIOL, V24, P4502, DOI 10.1128/MCB.24.10.4502-4512.2004; Gilfoy FD, 2007, J VIROL, V81, P11148, DOI 10.1128/JVI.00446-07; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Ito T, 1999, J BIOL CHEM, V274, P15427, DOI 10.1074/jbc.274.22.15427; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999; Katze Michael G., 1995, Trends in Microbiology, V3, P75, DOI 10.1016/S0966-842X(00)88880-0; Kok KH, 2011, CELL HOST MICROBE, V9, P299, DOI 10.1016/j.chom.2011.03.007; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; Langland JO, 1999, BIOCHEMISTRY-US, V38, P6361, DOI 10.1021/bi982410u; Lee YR, 2007, VIRUS RES, V126, P216, DOI 10.1016/j.virusres.2007.03.003; McAllister CS, 2012, J BIOL CHEM, V287, P36384, DOI 10.1074/jbc.M112.390039; McAllister CS, 2010, J VIROL, V84, P380, DOI 10.1128/JVI.02630-08; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Nakayama Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000966; Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926; Patel CV, 2000, J BIOL CHEM, V275, P37993, DOI 10.1074/jbc.M004762200; Pereira RMS, 2010, FASEB J, V24, P617, DOI 10.1096/fj.09-140053; Pfaller CK, 2011, CURR OPIN IMMUNOL, V23, P573, DOI 10.1016/j.coi.2011.08.009; Pindel A, 2011, J INTERF CYTOK RES, V31, P59, DOI 10.1089/jir.2010.0099; Porterfield J S, 1980, Med Trop (Mars), V40, P493; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; RUSSELL PK, 1967, J IMMUNOL, V99, P291; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Sadler AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000311; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; SAMUEL CE, 1993, J BIOL CHEM, V268, P7603; Schulz O, 2010, CELL HOST MICROBE, V7, P354, DOI 10.1016/j.chom.2010.04.007; Sen A, 2011, J VIROL, V85, P3717, DOI 10.1128/JVI.02634-10; Silva AM, 2004, J BIOL CHEM, V279, P37670, DOI 10.1074/jbc.M406554200; Srivastava SP, 1998, J BIOL CHEM, V273, P2416, DOI 10.1074/jbc.273.4.2416; Thomas Stephen J, 2003, Adv Virus Res, V61, P235, DOI 10.1016/S0065-3527(03)61006-7; Tissari J, 2005, J IMMUNOL, V174, P4289, DOI 10.4049/jimmunol.174.7.4289; Umareddy I, 2008, J GEN VIROL, V89, P3052, DOI 10.1099/vir.0.2008/001594-0; Weber F, 2006, J INTERF CYTOK RES, V26, P1, DOI 10.1089/jir.2006.26.1; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Xu Z, 2000, MOL CELL BIOL, V20, P5285, DOI 10.1128/MCB.20.14.5285-5299.2000; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07; Zhang P, 2009, J VIROL, V83, P5718, DOI 10.1128/JVI.00224-09; Zhang P, 2008, J BIOL CHEM, V283, P34580, DOI 10.1074/jbc.M807029200	63	321	342	10	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55108	10.1371/journal.pone.0055108	http://dx.doi.org/10.1371/journal.pone.0055108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23342141	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400065
